#term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
PMID:28761062	(2017) T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.	29	156	1.33	9.10e-22	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000288266,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000331831,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000366395,9606.ENSP00000371067,9606.ENSP00000375844,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000384262,9606.ENSP00000390651,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478319	CETP,IFNG,FABP4,NOX4,APPL1,CXCL10,EDNRA,GAS6,SIRT6,CAV1,KCNJ11,SREBF1,SGK1,CYP2J2,PTEN,ANGPTL2,TXN,MTHFR,SYVN1,JAK2,CAPN10,NFE2L2,GGT1,HPSE,IRAK4,BDNF,CCL5,NR1H3,GREM1
PMID:26798653	(2016) A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications.	23	150	1.25	1.18e-14	9606.ENSP00000225275,9606.ENSP00000261037,9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000330382,9606.ENSP00000339916,9606.ENSP00000346508,9606.ENSP00000352264,9606.ENSP00000354995,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000427424,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MPO,COL8A1,AMBP,VDAC1,TIMP3,CCR5,CXCL10,APOL1,PDGFB,LIMK2,PDGFA,CD2AP,ABCG1,RBP4,ANGPTL2,BMP2,EDN1,JAK2,AGTR1,TNFAIP8,CCL5,GREM1,VEGFA
PMID:28506744	(2017) Hepatic stellate cells as key target in liver fibrosis.	25	205	1.15	2.19e-14	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,ENPP2,THBS1,NOX4,IGF1R,KLF10,CXCL10,CXCL11,HNF4A,GAS6,SREBF1,ELN,MAP3K5,CXCL9,PTEN,NOX1,CNR2,EDN1,JAK2,BCL2,RHOA,MYD88,AGTR1,CCL5,VEGFA
PMID:32089709	(2020) Dental Stem Cell-Derived SecretomeConditioned Medium: The Future for Regenerative Therapeutic Applications.	22	174	1.16	1.85e-12	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000284031,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD38,SOX9,DDAH1,CXCL11,CD34,ANGPT2,PDGFB,ANG,CAV1,CNTF,BMP2,EDN1,BCL2,NPY,FGFR1,NTF3,RHOA,BDNF,MME,CCL5,VEGFA
PMID:29997513	(2018) Near to Ones Heart: The Intimate Relationship Between the Placenta and Fetal Heart.	18	96	1.33	4.33e-12	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000444198,9606.ENSP00000475344,9606.ENSP00000478570	MAPK1,TGFB1,EPOR,LPL,ANGPT2,EDNRA,COMT,PTGS2,EDN1,JAK2,BCL2,NPY,RHOA,BDNF,AGTR1,CITED2,APLNR,VEGFA
PMID:32365893	(2020) The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.	17	88	1.35	2.01e-11	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000317674,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000398048,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,CCR5,CXCL10,CXCL11,ANGPT2,APOL1,CCL20,CXCL9,BAMBI,JAK2,BCL2,ALPK1,RHOA,MYD88,CCL5,VEGFA
PMID:29467963	(2018) New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.	20	158	1.16	4.03e-11	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,IGF1R,CCR5,CXCL10,CXCL11,CD34,MAPK7,CCL20,PTGS2,ENTPD1,PTEN,JAK2,BCL2,RHOA,BDNF,TRPC1,PROM1,CCL5,VEGFA
PMID:27609747	(2016) Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.	18	120	1.24	9.14e-11	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,SOX9,HSPB1,CDH1,IGF1R,ALDH1A1,MMP14,STAT5A,CD47,VIP,PTGS2,PTEN,NOX1,JAK2,BCL2,RHOA,PROM1,VEGFA
PMID:30220913	(2018) Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering.	16	90	1.31	3.80e-10	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CCR5,CXCL10,CXCL11,CD34,PDGFB,STAT5A,PDGFA,ELN,CXCL9,PTGS2,BMP2,JAK2,PDGFD,CCL5,VEGFA
PMID:30673862	(2019) Review of Biomarkers in Ocular Matrices: Challenges and Opportunities.	17	114	1.23	5.69e-10	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,ENPP2,CCR5,AQP5,CXCL10,CXCL11,ANGPT2,ELN,CXCL9,CNTF,VIP,EDN1,NTF3,BDNF,CCL5,VEGFA
PMID:31804513	(2019) Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research.	20	193	1.08	8.68e-10	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000321853,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000375844,9606.ENSP00000383232,9606.ENSP00000384364,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000419422,9606.ENSP00000477707,9606.ENSP00000478570	TGFB1,FABP4,IGF1R,ATM,PLIN1,SERPINF2,KCNJ11,SREBF1,COMT,EDN1,SHBG,CAPN10,GGT1,NPY,SAA1,BDNF,FTO,AGTR1,NR1H3,VEGFA
PMID:34297416	(2022) Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimers disease.	20	194	1.07	8.71e-10	9606.ENSP00000200676,9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000345708,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000366395,9606.ENSP00000368683,9606.ENSP00000375844,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	CETP,MAPK1,MPO,HSPB1,CHI3L1,APC,IGF1R,CXCL10,KCNJ11,PTGS2,PTEN,TXN,SYVN1,EDN1,CAPN10,GAP43,NFE2L2,BCL2,FGFR1,MME
PMID:33815113	(2021) Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update.	16	99	1.27	9.42e-10	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000311005,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,MPO,CDH1,PLIN1,MAPK7,EDNRA,PTGS2,PTEN,BMP2,EDN1,NFE2L2,BCL2,RHOA,BDNF,AGTR1,VEGFA
PMID:31037148	(2019) Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.	17	120	1.21	9.42e-10	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000477707,9606.ENSP00000478570	NOX4,IGF1R,LPL,HNF4A,EDNRA,SREBF1,ELN,MAP3K5,PTEN,EDN1,JAK2,NFE2L2,BCL2,NPY,MYD88,NR1H3,VEGFA
PMID:30008326	(2018) CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized Arteries.	13	47	1.5	9.42e-10	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000347041,9606.ENSP00000351671,9606.ENSP00000376865,9606.ENSP00000380365,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	MPO,LPL,CD34,ANGPT2,PDGFB,ANG,FMOD,CCL20,PDGFD,RGN,SAA1,CCL5,VEGFA
PMID:32754592	(2020) Niches for Skeletal Stem Cells of Mesenchymal Origin.	16	102	1.26	1.24e-09	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,CCR5,CD34,EBF1,PDGFB,ANG,ELN,PTGS2,PTEN,ALPL,JAK2,PDGFD,FGFR1,CCL5,GREM1,VEGFA
PMID:34917515	(2021) The Role of Decorin and Biglycan Signaling in Tumorigenesis.	14	65	1.39	1.31e-09	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,NOX4,TIMP3,IGF1R,CXCL10,ANGPT2,CCL20,ELN,CXCL9,NOX1,RHOA,MYD88,CCL5,VEGFA
PMID:33745018	(2021) Angiodiversity and organotypic functions of sinusoidal endothelial cells.	17	126	1.19	1.41e-09	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000475344,9606.ENSP00000477707,9606.ENSP00000478570	IFNG,FABP4,THBS1,NOX4,CD34,ANGPT2,PDGFB,CAV1,CXCL9,BMP2,EDN1,PDGFD,FGFR1,MYD88,APLNR,NR1H3,VEGFA
PMID:27092172	(2016) Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.	15	84	1.31	1.41e-09	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,SOX9,APC,CDH1,KLF10,ONECUT1,HNF4A,ANGPT2,EBF1,STAT5A,PTGS2,PTEN,EDN1,JAK2,VEGFA
PMID:35211124	(2022) Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.	18	156	1.12	2.30e-09	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CD38,CD69,CDH1,CCR5,CXCL10,CXCL11,CD34,STAT5A,ELN,CD247,CXCL9,CD47,ENTPD1,BCL2,HPSE,MYD88,PROM1,CCL5
PMID:33036204	(2020) Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies.	14	69	1.37	2.30e-09	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,NOX4,MMP14,CD34,ANGPT2,PDGFB,PTGS2,PTEN,EDN1,FGFR1,BDNF,PROM1,VEGFA
PMID:35356091	(2022) Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies.	17	134	1.16	2.81e-09	9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000331831,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	P2RY1,CD34,MAPK7,GAS6,ABCG1,CD47,ENTPD1,HSPG2,BMP2,JAK2,BCL2,IRAK4,RHOA,AGTR1,PROM1,CCL5,VEGFA
PMID:35069986	(2021) Strategies to improve regenerative potential of mesenchymal stem cells.	13	54	1.44	2.81e-09	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,SOX9,HSPB1,CXCL10,CXCL11,LPL,CD34,SIRT6,CCL20,BMP2,BCL2,CCL5,VEGFA
PMID:33121005	(2020) Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds.	15	92	1.27	3.65e-09	9606.ENSP00000216181,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000298352,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000384957,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,MPO,NOX4,NGB,P2RY1,PTGS2,CYP2J2,NOX1,EDN1,JAK2,NFE2L2,F11,RHOA,CCL5,VEGFA
PMID:33607159	(2021) COVID-19, cytokines, inflammation, and spices: How are they related?	15	95	1.26	5.34e-09	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000477707	MPO,CDH1,NOX4,ATM,CXCL10,CXCL11,CXCL9,EDN1,JAK2,NFE2L2,BCL2,MME,AGTR1,CCL5,NR1H3
PMID:31921628	(2019) Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.	22	292	0.94	6.17e-09	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,THBS1,CDH1,IGF1R,CCR5,CXCL10,CXCL11,MMP14,HNF4A,GAS6,ANG,CAV1,STAT5A,PRKAA1,CD47,ENTPD1,PTEN,BCL2,NTF3,RHOA,PROM1,VEGFA
PMID:34655056	(2022) Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.	16	119	1.19	6.39e-09	9606.ENSP00000225275,9606.ENSP00000285407,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000419313,9606.ENSP00000478570	MPO,KLF10,LPL,PDGFB,SIRT6,CNTF,PTGS2,PTEN,NFE2L2,BCL2,NPY,NTF3,BDNF,MME,TRPC1,VEGFA
PMID:34572138	(2021) Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled.	16	119	1.19	6.39e-09	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CHI3L1,THBS1,CXCL10,CXCL11,CD34,CCL20,ELN,CXCL9,S100A12,PTEN,BMP2,MYD88,RARRES2,CCL5,VEGFA
PMID:30112360	(2018) Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimers Disease.	17	144	1.13	6.46e-09	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,CD34,MAPK7,CNTF,VIP,KL,JAK2,GAP43,BCL2,NTF3,MYD88,BDNF,MME,PROM1,CCL5,VEGFA
PMID:30116482	(2018) Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance.	16	121	1.18	7.28e-09	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000284031,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	HSPB1,NOX4,ATM,DDAH1,PRKAA1,MAP3K5,PTEN,TXN,EDN1,KL,NFE2L2,BCL2,NPY,IRAK4,RHOA,MYD88
PMID:34439380	(2021) Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications.	17	146	1.13	7.41e-09	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,MMP14,CD34,PDGFB,CXCL9,PTGS2,ENTPD1,PTEN,JAK2,BCL2,IRAK4,MYD88,BDNF,PROM1,CCL5,VEGFA
PMID:34679751	(2021) Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses.	15	99	1.24	7.41e-09	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,IFNG,NOX4,ATM,CXCL10,CD34,STAT5A,PTEN,NOX1,TXN,JAK2,G6PD,NFE2L2,BCL2,VEGFA
PMID:29333215	(2017) Markers and Biomarkers of Endothelium: When Something Is Rotten in the State.	15	99	1.24	7.41e-09	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000321334,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000360997,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,NOX4,LPL,CD34,ANGPT2,LPA,SIRT6,CAV1,CD47,ADAMTS13,NOX1,EDN1,RHOA,PROM1,VEGFA
PMID:29085333	(2017) Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.	15	100	1.24	7.71e-09	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000477707,9606.ENSP00000478570	THBS1,NOX4,VDAC1,IGF1R,MMP14,SIRT6,COMT,PTGS2,SGK1,PTEN,EDN1,NFE2L2,AGTR1,NR1H3,VEGFA
PMID:33613514	(2020) Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases.	16	123	1.18	7.85e-09	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000376865,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CDH1,LPL,CD34,ANGPT2,CCL20,PTGS2,ENTPD1,PDGFD,NTF3,BDNF,MME,PROM1,CCL5,VEGFA
PMID:33976959	(2021) Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.	13	62	1.38	8.08e-09	9606.ENSP00000226760,9606.ENSP00000229135,9606.ENSP00000345708,9606.ENSP00000349860,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000418823,9606.ENSP00000419422,9606.ENSP00000478570	WFS1,IFNG,KCNJ11,GFPT1,MAP3K5,PTGS2,EDN1,JAK2,NFE2L2,NPY,FTO,AGTR1,VEGFA
PMID:34440074	(2021) NF-kappaB in Gastric Cancer Development and Therapy.	15	101	1.23	8.08e-09	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000398048,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,CXCL10,CXCL11,HNF4A,CCL20,PTGS2,CNR1,PTEN,NOX1,BCL2,ALPK1,MYD88,CCL5,VEGFA
PMID:34869682	(2021) Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger.	16	124	1.17	8.08e-09	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000376865,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	HSPB1,THBS1,IGF1R,ATM,CD34,ANGPT2,SERPINF2,CAV1,ABCG1,PTEN,ALPL,BMP2,PDGFD,MYD88,AGTR1,VEGFA
PMID:19725916	(2009) The aortic ring model of angiogenesis: a quarter century of search and discovery.	15	101	1.23	8.08e-09	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,THBS1,CDH1,TIMP3,CXCL10,MMP14,CD34,PDGFB,UNC5B,PTEN,KL,JAK2,NPY,FGFR1,VEGFA
PMID:30479916	(2018) Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents.	13	63	1.38	8.51e-09	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CD34,CCL20,CNTF,PTGS2,BAMBI,JAK2,NFE2L2,BCL2,BDNF,CCL5,VEGFA
PMID:21344348	(2011) Epithelial-mesenchymal interactions in biliary diseases.	15	102	1.23	8.51e-09	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,THBS1,CDH1,CD34,MAPK7,HNF4A,ANGPT2,PDGFB,PDGFA,ELN,HSPG2,EDN1,PDGFD,VEGFA,HNF1B
PMID:32759750	(2020) Extracellular Vesicles and MicroRNA: Putative Role in Diagnosis and Treatment of Diabetic Retinopathy.	13	64	1.37	9.91e-09	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CCR5,CXCL10,MMP14,ANGPT2,PDGFB,SIRT6,PTGS2,PTEN,BCL2,AGTR1,CCL5,VEGFA
PMID:33329391	(2020) Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.	16	127	1.16	1.00e-08	9606.ENSP00000215832,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000375844,9606.ENSP00000414303	MAPK1,CHI3L1,FABP4,CDH1,IGF1R,PLIN1,SREBF1,PTGS2,PTEN,AR,MTHFR,EDN1,SHBG,JAK2,CAPN10,BDNF
PMID:35055157	(2022) Molecular Mechanisms Leading from Periodontal Disease to Cancer.	16	130	1.15	1.33e-08	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,HSPB1,CDH1,CXCL10,CXCL11,MMP14,HNF4A,GAS6,CCL20,PTEN,BCL2,NTF3,MYD88,PROM1,CCL5,VEGFA
PMID:31213009	(2019) The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance.	14	85	1.28	1.33e-08	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,MAPK1,THBS1,CDH1,IGF1R,ATM,HNF4A,SIRT6,ELN,PTEN,EDN1,BCL2,PROM1,VEGFA
PMID:31772665	(2019) Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.	14	85	1.28	1.33e-08	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000284031,9606.ENSP00000297785,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	THBS1,CDH1,DDAH1,ALDH1A1,CXCL11,MMP14,CD34,PTEN,JAK2,BCL2,RHOA,PROM1,VEGFA,UHRF1
PMID:34386318	(2021) Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects.	14	86	1.27	1.44e-08	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,IGF1R,CXCL10,CD34,CD247,CXCL9,CD47,BCL2,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:33339407	(2020) Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder.	13	68	1.34	1.72e-08	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	CD34,HNF4A,SREBF1,ELN,MAP3K5,ABCG1,PTGS2,ADAMTS13,EDN1,JAK2,BCL2,AGTR1,VEGFA
PMID:31920664	(2019) The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair.	15	110	1.2	1.88e-08	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IGF1R,CXCL10,CD34,SERPINF2,GAS6,PTGS2,PTEN,BMP2,EDN1,BCL2,IRAK4,RHOA,CCL5,VEGFA
PMID:23567332	(2013) Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposis sarcoma-associated herpes virus associated malignancies.	15	110	1.2	1.88e-08	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD38,CDH1,TIMP3,ATM,CXCL10,ANGPT2,ANG,CCL20,PTGS2,RHOA,BDNF,MME,CCL5,VEGFA
PMID:33815112	(2021) A New Therapeutic Candidate for Cardiovascular Diseases: Berberine.	12	52	1.42	1.99e-08	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,HNF4A,PTGS2,PTEN,TXN,EDN1,JAK2,NFE2L2,BCL2,MYD88,CCL5
PMID:35159370	(2022) Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas.	15	111	1.19	2.00e-08	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310520,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,SOX9,COL8A1,CDH1,IGF1R,ATM,ALDH1A1,ERCC4,TXN,NFE2L2,BCL2,FGFR1,PROM1,CCL5,VEGFA
PMID:33537958	(2021) Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection.	16	136	1.13	2.13e-08	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000321334,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,CD38,CHI3L1,CDH1,CXCL10,ANGPT2,LPA,PDGFB,STAT5A,SREBF1,JAK2,BCL2,FGFR1,MYD88,AGTR1,VEGFA
PMID:32014047	(2020) Angiocrine endothelium: from physiology to cancer.	15	112	1.19	2.16e-08	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,IGF1R,CXCL10,MMP14,ANGPT2,PDGFB,CXCL9,BMP2,EDN1,BCL2,FGFR1,NTF3,BDNF,CCL5,VEGFA
PMID:34108441	(2021) Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.	19	223	0.99	2.33e-08	9606.ENSP00000215832,9606.ENSP00000232219,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000403495,9606.ENSP00000478319,9606.ENSP00000478570	MAPK1,RBP1,CDH1,NOX4,VDAC1,CXCL11,HNF4A,GAS6,CAV1,CCL20,ELN,PTGS2,PTEN,JAK2,BCL2,PLA2G2A,LTA,GREM1,VEGFA
PMID:35055124	(2022) The Role of Tumor Microenvironment in the Pathogenesis of Sezary Syndrome.	15	113	1.18	2.34e-08	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CHI3L1,CXCL10,CXCL11,CD34,ANGPT2,ANG,STAT5A,CCL20,ELN,CXCL9,CD47,ENTPD1,BCL2,CCL5
PMID:33904115	(2022) Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos.	17	165	1.07	2.51e-08	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000384262,9606.ENSP00000385834,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000475344	MAPK1,TGFB1,IFNG,THBS1,TIMP3,CXCL10,MMP14,ANGPT2,PDGFA,CXCL9,EDN1,SHBG,HPSE,TF,FGFR1,RHOA,APLNR
PMID:33260826	(2020) Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.	10	26	1.65	2.51e-08	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CXCL10,MAP3K5,CXCL9,ENTPD1,PTEN,TXN,NFE2L2,BCL2,CCL5
PMID:33113859	(2020) Involvement of Essential Signaling Cascades and Analysis of Gene Networks in Diabesity.	14	92	1.24	2.63e-08	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000321853,9606.ENSP00000345708,9606.ENSP00000360522,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000419422,9606.ENSP00000474412	TGFB1,THBS1,IGF1R,CCR5,CXCL10,HNF4A,SERPINF2,KCNJ11,RBP4,NPY,BDNF,FTO,AGTR1,CCL5
PMID:32796696	(2020) The Importance of Breast Adipose Tissue in Breast Cancer.	15	115	1.18	2.76e-08	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,ENPP2,CCR5,PLIN1,CXCL10,EBF1,STAT5A,SREBF1,ABCG1,PTGS2,PTEN,JAK2,RARRES2,CCL5,VEGFA
PMID:33805996	(2021) Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin.	13	73	1.31	2.97e-08	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000354511,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MPO,CDH1,ATM,CAV1,COMT,SGK1,PTEN,TXN,G6PD,NFE2L2,BCL2,RHOA,VEGFA
PMID:32962281	(2020) The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.	17	168	1.07	2.97e-08	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000360247,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,CDH1,NOX4,IGF1R,ATM,SREBF1,ABCG1,CYP2J2,RBP4,PTEN,MAFB,EDN1,G6PD,NFE2L2,BCL2,MYD88,VEGFA
PMID:33167585	(2020) The Potential Mechanisms of the Neuroprotective Actions of Oil Palm Phenolics: Implications for Neurodegenerative Diseases.	12	55	1.4	2.97e-08	9606.ENSP00000229135,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000379256,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,PRDX2,CXCL10,PTGS2,TXN,NCALD,NFE2L2,BCL2,NTF3,LTA,BDNF,CCL5
PMID:22973518	(2012) Cell signals influencing hepatic fibrosis.	15	116	1.17	2.97e-08	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CXCL10,CD34,ELN,PTEN,EDN1,JAK2,BCL2,SAA1,IRAK4,RHOA,MYD88,CCL5,GREM1,VEGFA
PMID:34588998	(2021) The wHole Story About Fenestrations in LSEC.	11	40	1.5	3.07e-08	9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,EDNRA,PDGFB,SIRT6,CAV1,CD47,VIP,EDN1,NPY,RHOA,VEGFA
PMID:34899348	(2021) Roles of Macrophages in Atherogenesis.	17	169	1.06	3.07e-08	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CXCL11,EDNRA,ELN,CXCL9,ABCG1,CD47,EDN1,BCL2,PLA2G2A,SAA1,MYD88,AGTR1,CCL5,VEGFA
PMID:27965466	(2017) Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.	14	94	1.23	3.07e-08	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	IFNG,FABP4,NOX4,VDAC1,ATM,CXCL10,LPL,SREBF1,PTGS2,PTEN,NOX1,TXN,G6PD,NFE2L2
PMID:32346605	(2020) Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?	13	74	1.31	3.16e-08	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,MPO,CCR5,CXCL10,GAS6,CXCL9,CD47,PTEN,BCL2,RHOA,LTA,CCL5,VEGFA
PMID:21265830	(2011) Novel therapeutic approaches for pulmonary fibrosis.	12	56	1.39	3.17e-08	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,NOX4,CXCL10,CXCL11,CD34,HNF4A,PDGFA,ELN,EDN1,RHOA,VEGFA
PMID:33809061	(2021) Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge.	13	76	1.29	4.16e-08	9606.ENSP00000259486,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000351908,9606.ENSP00000354995,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000418525,9606.ENSP00000418823	ENPP2,NOX4,LPL,LPA,MAP3K5,ABCG1,SGK1,EDN1,MYD88,BDNF,RARRES2,MME,FTO
PMID:33123472	(2020) Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer.	14	97	1.22	4.18e-08	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000361883,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,CDH1,IGF1R,APPL1,ALDH1A1,CXCL10,MAPK7,CAP1,ANGPTL2,EDN1,JAK2,RHOA,RARRES2,VEGFA
PMID:35071359	(2021) The Complex Interplay of Inflammation, Metabolism, Epigenetics, and Sex in Calcific Disease of the Aortic Valve.	11	42	1.48	4.37e-08	9606.ENSP00000245479,9606.ENSP00000306884,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL11,SIRT6,PTGS2,AR,BMP2,KL,BCL2,MYD88,CCL5,VEGFA
PMID:33810295	(2021) Phenotypic Modulation of Macrophages and Vascular Smooth Muscle Cells in Atherosclerosis-Nitro-Redox Interconnections.	13	77	1.29	4.61e-08	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478319	NOX4,PDGFB,PDGFA,ELN,PTEN,TXN,BMP2,PDGFD,BCL2,FGFR1,RHOA,AGTR1,GREM1
PMID:34576149	(2021) Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy.	14	98	1.22	4.61e-08	9606.ENSP00000292303,9606.ENSP00000306124,9606.ENSP00000315011,9606.ENSP00000337332,9606.ENSP00000352264,9606.ENSP00000364683,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000419313,9606.ENSP00000478570	CCR5,PRKCE,EDNRA,SIRT6,CD2AP,BAMBI,MTHFR,EDN1,BCL2,HPSE,IRAK4,MYD88,TRPC1,VEGFA
PMID:34199293	(2021) MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.	17	176	1.05	4.99e-08	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,CDH1,TIMP3,IGF1R,ATM,DDAH1,CXCL10,MMP14,MAPK7,CAV1,STAT5A,PRKAA1,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:30934773	(2019) The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis.	12	59	1.37	4.99e-08	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000426809	CD38,CDH1,ATM,ALDH1A1,CD34,CAV1,CD47,PTEN,AR,BCL2,HPSE,PROM1
PMID:27913120	(2017) Gene delivery nanoparticles to modulate angiogenesis.	12	59	1.37	4.99e-08	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,TIMP3,LPL,ANGPT2,PDGFB,ELN,PTGS2,HSPG2,BMP2,FGFR1,AGTR1,VEGFA
PMID:34147844	(2021) The redox-senescence axis and its therapeutic targeting.	13	78	1.28	5.02e-08	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,ATM,CXCL11,LPL,CD34,MAPK7,PTEN,NOX1,NFE2L2,BCL2,RARRES2,CCL5,VEGFA
PMID:33430277	(2021) Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy.	14	100	1.21	5.47e-08	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,CDH1,TIMP3,MMP14,EDNRA,CAV1,ELN,PTGS2,RBP4,PTEN,EDN1,JAK2,BCL2,VEGFA
PMID:34068679	(2021) Melanoma Progression under Obesity: Focus on Adipokines.	14	100	1.21	5.47e-08	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	CDH1,CCR5,MMP14,CAV1,STAT5A,SREBF1,PTGS2,CAP1,JAK2,LTA,RARRES2,CCL5,APLNR,VEGFA
PMID:34833928	(2021) Therapeutic Screening of Herbal Remedies for the Management of Diabetes.	12	60	1.36	5.52e-08	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,LPL,HNF4A,CAV1,SREBF1,PTGS2,RBP4,JAK2,G6PD,NFE2L2,RHOA,VEGFA
PMID:33224886	(2020) The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.	16	150	1.09	5.52e-08	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,CCR5,CXCL11,MAPK7,ANG,CCL20,CD47,PTGS2,PTEN,ANGPTL2,JAK2,MYD88,PROM1,CCL5,VEGFA
PMID:32987705	(2020) IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.	13	80	1.27	6.29e-08	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478319,9606.ENSP00000478570	MPO,CD69,CDH1,CXCL10,STAT5A,CCL20,PTGS2,SGK1,JAK2,RHOA,MYD88,GREM1,VEGFA
PMID:23819063	(2013) The role of chronic inflammation in obesity-associated cancers.	13	80	1.27	6.29e-08	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	MAPK1,FABP4,IGF1R,PLIN1,LPL,SIRT6,PTGS2,PTEN,SHBG,JAK2,BCL2,NPY,VEGFA
PMID:31046833	(2019) Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.	14	102	1.2	6.48e-08	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,CDH1,FADS2,CXCL10,CXCL11,CD34,ANG,CXCL9,PTGS2,ENTPD1,PTEN,BCL2,BDNF,VEGFA
PMID:28835854	(2017) Retinal and choroidal angiogenesis: a review of new targets.	13	81	1.27	6.99e-08	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,TIMP3,CXCL10,CXCL11,ANGPT2,SERPINF2,PDGFB,ANG,PDGFA,CXCL9,ANGPTL2,EDN1,VEGFA
PMID:24978432	(2014) Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).	14	103	1.19	7.14e-08	9606.ENSP00000225275,9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000478570	MPO,ENPP2,CXCL10,MMP14,CD34,MAPK7,ELN,MAP3K5,PTEN,HSPG2,EDN1,MYD88,RARRES2,VEGFA
PMID:32494846	(2020) Molecular mechanisms governing offspring metabolic programming in rodent models of in utero stress.	16	155	1.07	8.07e-08	9606.ENSP00000215832,9606.ENSP00000222572,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000383232,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000475344,9606.ENSP00000484631	MAPK1,PON2,CD69,FABP4,IGF1R,LPL,HNF4A,KCNJ11,SREBF1,PTEN,JAK2,GGT1,NPY,FGFR1,APLNR,PMP22
PMID:29218009	(2017) Drugs and Targets in Fibrosis.	12	63	1.34	8.36e-08	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000284031,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,TIMP3,DDAH1,CCR5,EDNRA,VIP,NOX1,EDN1,AGTR1,CCL5,VEGFA
PMID:33796536	(2021) The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy.	13	83	1.26	8.73e-08	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CD34,STAT5A,PDGFA,CCL20,ENTPD1,BCL2,MYD88,MME,CCL5,VEGFA
PMID:34095111	(2021) The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.	17	185	1.02	8.73e-08	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,THBS1,CDH1,IGF1R,MMP14,CD34,STAT5A,CCL20,CD47,PTGS2,ENTPD1,PTEN,JAK2,BCL2,FGFR1,CCL5,VEGFA
PMID:32028565	(2020) Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy.	13	83	1.26	8.73e-08	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,SOX9,IGF1R,CXCL10,CD34,GAS6,CCL20,CXCL9,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:27818690	(2016) Stem Cells of Dental Origin: Current Research Trends and Key Milestones towards Clinical Application.	13	83	1.26	8.73e-08	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,SOX9,THBS1,ALDH1A1,CD34,ANG,CNTF,BMP2,FGFR1,NTF3,BDNF,MME,VEGFA
PMID:26445145	(2015) RNA-Seq Analysis of Abdominal Fat in Genetically Fat and Lean Chickens Highlights a Divergence in Expression of Genes Controlling Adiposity, Hemostasis, and Lipid Metabolism.	19	249	0.94	8.73e-08	9606.ENSP00000216862,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000321853,9606.ENSP00000322898,9606.ENSP00000358513,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000477707,9606.ENSP00000478319,9606.ENSP00000478570	CYP24A1,FABP4,THBS1,IGF1R,FADS2,PLIN1,LPL,SERPINF2,EBF1,CNR1,TXN,AR,EDN1,JAK2,NPY,AGTR1,NR1H3,GREM1,VEGFA
PMID:32326073	(2020) Contribution of Macrophages and T Cells in Skeletal Metastasis.	15	130	1.12	8.77e-08	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	CD38,SOX9,CHI3L1,CAV1,PDGFA,SREBF1,CCL20,CD247,CD47,ENTPD1,EDN1,MYD88,CCL5,VEGFA,HNF1B
PMID:31208019	(2019) Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs.	13	84	1.25	9.48e-08	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000478319	FABP4,NOX4,ATM,LPL,PTGS2,CNR1,RBP4,BMP2,EDN1,JAK2,NPY,RARRES2,GREM1
PMID:33841508	(2021) Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development.	14	107	1.18	1.02e-07	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,ANGPT2,PDGFB,CAV1,PTGS2,PTEN,AR,BCL2,FGFR1,PROM1,CCL5,VEGFA
PMID:34360849	(2021) Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta.	14	107	1.18	1.02e-07	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	MPO,FABP4,NOX4,IGF1R,CXCL10,STAT5A,PRKAA1,CXCL9,JAK2,NFE2L2,BCL2,RARRES2,CCL5,VEGFA
PMID:33926146	(2021) The Roles of Nitric Oxide SynthaseNitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches.	9	21	1.69	1.03e-07	9606.ENSP00000284031,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	DDAH1,CAV1,PTGS2,EDN1,BCL2,RHOA,LTA,BDNF,VEGFA
PMID:32532126	(2020) Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-beta1 Inhibition.	15	132	1.12	1.03e-07	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CDH1,NOX4,IGF1R,CCR5,ANG,CAV1,STAT5A,EDN1,BCL2,RHOA,MYD88,AGTR1,CCL5,VEGFA
PMID:34151902	(2020) Recent Developments in Diabetic Retinal Neurodegeneration: A Literature Review.	10	33	1.54	1.03e-07	9606.ENSP00000315011,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	EDNRA,SIRT6,CNTF,ENTPD1,TXN,EDN1,BDNF,AGTR1,PROM1,VEGFA
PMID:30450940	(2019) Contribution of Oxidative Stress and Impaired Biogenesis of Pancreatic beta-Cells to Type 2 Diabetes.	15	132	1.12	1.03e-07	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000246553,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356213,9606.ENSP00000360522,9606.ENSP00000362057,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000401399	MPO,SOX9,FFAR1,NOX4,CCR5,LPL,KCNJ11,SREBF1,MAP3K5,VIP,RBP4,NOX1,MAFB,BCL2,MYD88
PMID:29556499	(2018) In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction.	13	85	1.25	1.03e-07	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000376865	TGFB1,HSPB1,TIMP3,CXCL10,CXCL11,MMP14,ANG,CAV1,CXCL9,VIP,TXN,BMP2,PDGFD
PMID:26994427	(2016) Vascular endothelium - Gatekeeper of vessel health.	12	65	1.33	1.03e-07	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,EDNRA,CAV1,ELN,PTGS2,EDN1,FGFR1,RHOA,AGTR1,PROM1,VEGFA
PMID:33776451	(2021) Role and Therapeutic Potential of Melatonin in Various Type of Cancers.	14	108	1.17	1.05e-07	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000336762,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CDH1,IGF1R,ALDH1A1,ANG,SGK1,PTEN,AR,EDN1,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:26682001	(2016) Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.	11	48	1.42	1.05e-07	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000426809	CD38,NOX4,ATM,ALDH1A1,CD34,PTEN,NOX1,TXN,G6PD,NFE2L2,PROM1
PMID:23433458	(2013) Eicosanoids in metabolic syndrome.	18	221	0.97	1.05e-07	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000360522,9606.ENSP00000383364,9606.ENSP00000401399,9606.ENSP00000445772,9606.ENSP00000478570	MAPK1,IFNG,FFAR1,FABP4,FADS2,PLIN1,LPL,CD34,HNF4A,CAV1,SREBF1,PTGS2,CYP2J2,RBP4,PLA2G2A,MYD88,LTB4R2,VEGFA
PMID:27130805	(2016) Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases.	13	86	1.24	1.10e-07	9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,PRDX2,HNF4A,MAP3K5,PTGS2,PTEN,TXN,AR,JAK2,NFE2L2,MYD88,CCL5,VEGFA
PMID:25962679	(2015) New therapeutic targets for cancer bone metastasis.	13	86	1.24	1.10e-07	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,THBS1,CDH1,IGF1R,CXCL10,HNF4A,GAS6,BMP2,EDN1,PDGFD,FGFR1,CCL5,VEGFA
PMID:26078762	(2015) Glioblastoma Circulating Cells: Reality, Trap or Illusion?	12	66	1.32	1.10e-07	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,THBS1,CDH1,ATM,ALDH1A1,CXCL10,GAS6,CXCL9,PTEN,HSPG2,PROM1,VEGFA
PMID:30911653	(2018) Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis.	15	134	1.11	1.12e-07	9606.ENSP00000222139,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	EPOR,CD69,CDH1,NOX4,CD34,PTEN,AR,BAMBI,BMP2,JAK2,BCL2,RHOA,MYD88,VEGFA,HNF1B
PMID:34677429	(2021) Anti-Inflammatory and Anticancer Effects of Microalgal Carotenoids.	13	87	1.24	1.20e-07	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,MPO,IFNG,SIRT6,CAV1,CD47,EDN1,JAK2,NFE2L2,BCL2,MYD88,CCL5,VEGFA
PMID:31935797	(2020) Curcumin as a Therapeutic Option in Retinal Diseases.	11	49	1.41	1.20e-07	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,TGFB1,ATM,ERCC4,PTGS2,TXN,EDN1,JAK2,BCL2,RHOA,VEGFA
PMID:24710538	(2012) Redox mechanisms in regulation of adipocyte differentiation: beyond a general stress response.	11	49	1.41	1.20e-07	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000371067	FABP4,NOX4,IGF1R,PLIN1,LPL,SIRT6,STAT5A,SREBF1,NOX1,BMP2,JAK2
PMID:33390169	(2021) Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.	14	110	1.17	1.21e-07	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,CCR5,ALDH1A1,CXCL10,CXCL11,MMP14,CCL20,CXCL9,JAK2,RARRES2,PROM1,CCL5,VEGFA
PMID:34017260	(2021) Coordinated Contribution of NADPH Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Metabolic Syndrome and Its Implication in Renal Dysfunction.	12	67	1.31	1.22e-07	9606.ENSP00000221930,9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,PON2,NOX4,MAP3K5,PTGS2,NOX1,TXN,EDN1,G6PD,BCL2,AGTR1,VEGFA
PMID:31861818	(2019) Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis.	12	67	1.31	1.22e-07	9606.ENSP00000225275,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000363596,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	MPO,ENPP2,THBS1,NOX4,PLIN1,LPL,SREBF1,NOX1,CNR2,TXN,EDN1,VEGFA
PMID:35269636	(2022) Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.	16	164	1.05	1.31e-07	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,FABP4,CDH1,IGF1R,CCR5,ALDH1A1,CXCL10,CD34,EDNRA,CD47,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:32385745	(2020) Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review.	13	88	1.23	1.31e-07	9606.ENSP00000229135,9606.ENSP00000259407,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,BAAT,CDH1,MMP14,VIP,PTGS2,SGK1,PTEN,EDN1,BCL2,NPY,VEGFA,HNF1B
PMID:33144864	(2020) Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells.	13	88	1.23	1.31e-07	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CD69,IFNG,IGF1R,CXCL10,CD34,PDGFA,CD47,BMP2,BDNF,MME,PROM1,VEGFA
PMID:24713112	(2014) Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers.	13	88	1.23	1.31e-07	9606.ENSP00000215832,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CHI3L1,THBS1,CDH1,AMBP,CXCL10,MMP14,CAV1,CCL20,PTEN,HSPG2,CCL5,VEGFA
PMID:30542344	(2018) Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.	15	137	1.1	1.36e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CDH1,ATM,HNF4A,EBF1,STAT5A,CXCL9,CD47,PTGS2,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:28983598	(2017) PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review).	10	35	1.52	1.39e-07	9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	PDGFB,STAT5A,PDGFA,PTGS2,JAK2,PDGFD,NFE2L2,BCL2,FGFR1,RHOA
PMID:18177509	(2007) Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.	13	89	1.23	1.42e-07	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000427424,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,MMP14,ANGPT2,CCL20,VIP,PTEN,BMP2,BCL2,TNFAIP8,CCL5,VEGFA
PMID:32993787	(2020) The role of microenvironment in tumor angiogenesis.	14	113	1.15	1.55e-07	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IFNG,CDH1,MMP14,PDGFA,PTEN,BMP2,KL,PDGFD,BCL2,RHOA,MYD88,PROM1,VEGFA
PMID:33747489	(2021) Therapeutic perspective of thymoquinone: A mechanistic treatise.	13	90	1.22	1.59e-07	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	MPO,CXCL10,MAP3K5,PTGS2,PTEN,TXN,JAK2,NFE2L2,BCL2,BDNF,PROM1,VEGFA,UHRF1
PMID:35334544	(2022) The Interplay between Tumour Microenvironment Components in Malignant Melanoma.	16	168	1.04	1.70e-07	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CHI3L1,FABP4,CCR5,ALDH1A1,CD34,CAV1,PTGS2,RBP4,PTEN,BCL2,LTA,MME,PROM1,CCL5,VEGFA
PMID:34489714	(2021) An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update.	14	114	1.15	1.70e-07	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	CD38,NOX4,IGF1R,CCR5,CD34,SIRT6,SGK1,NOX1,KL,JAK2,RHOA,MYD88,AGTR1,VEGFA
PMID:26649044	(2016) Extracellular Vesicles: Evolving Factors in Stem Cell Biology.	10	36	1.5	1.70e-07	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000293599,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,AQP5,CD34,HNF4A,BCL2,RHOA,MME,PROM1,VEGFA
PMID:33991137	(2021) An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract.	11	52	1.39	1.82e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IFNG,CDH1,CCR5,CXCL10,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:34439995	(2021) Candidate Glaucoma Biomarkers: From Proteins to Metabolites, and the Pitfalls to Clinical Applications.	15	141	1.09	1.82e-07	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000259486,9606.ENSP00000298352,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000375844,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,MPO,HSPB1,ENPP2,NGB,CXCL10,MMP14,ANG,CNTF,TXN,EDN1,KL,CAPN10,BDNF,VEGFA
PMID:34685739	(2021) Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression.	14	115	1.15	1.82e-07	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,HNF4A,PDGFA,ELN,MAP3K5,CXCL9,PTGS2,PTEN,EDN1,BCL2,RHOA,CCL5,VEGFA
PMID:28400729	(2017) Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling.	11	52	1.39	1.82e-07	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000426809	CD38,CDH1,CD34,HNF4A,GAS6,STAT5A,PTEN,AR,JAK2,PDGFD,PROM1
PMID:22331622	(2012) Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes.	11	52	1.39	1.82e-07	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000426809	MPO,NOX4,PRDX2,CD34,PDGFB,STAT5A,ELN,PTEN,NOX1,JAK2,PROM1
PMID:34122412	(2021) Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.	16	170	1.03	1.90e-07	9606.ENSP00000013807,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,CHI3L1,FABP4,CDH1,CXCL10,HNF4A,STAT5A,CCL20,ELN,PTEN,EDN1,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:31159366	(2019) ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.	13	92	1.21	1.90e-07	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000285407,9606.ENSP00000292303,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,SOX9,NOX4,KLF10,CCR5,MAPK7,PDGFB,CCL20,MAP3K5,NOX1,EDN1,RHOA,VEGFA
PMID:22873223	(2012) Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.	13	92	1.21	1.90e-07	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TIMP3,CCR5,PDGFB,CAV1,SREBF1,CXCL9,PTGS2,PTEN,EDN1,BCL2,CCL5,VEGFA
PMID:32837665	(2020) 10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020.	14	116	1.14	1.93e-07	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000358513,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CHI3L1,PRDX2,CAV1,ELN,CNR1,TXN,AR,EDN1,BCL2,RHOA,MYD88,CCL5,VEGFA
PMID:19152120	(2008) Fifth International Workshop on the CCN Family of Genes: Abstracts and Posters October 18-22, 2008.	15	142	1.08	1.93e-07	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,SOX9,THBS1,CDH1,TIMP3,IGF1R,MMP14,CD34,HNF4A,STAT5A,ELN,BMP2,EDN1,RHOA,VEGFA
PMID:32867470	(2020) Biomaterials for Bioprinting Microvasculature.	11	53	1.38	2.02e-07	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,PDGFA,ELN,BMP2,EDN1,PDGFD,FGFR1,PROM1,VEGFA
PMID:23149823	(2013) Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitus.	13	93	1.21	2.06e-07	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412	TGFB1,THBS1,CDH1,NOX4,CCL20,MAP3K5,PTEN,EDN1,NFE2L2,IRAK4,MYD88,AGTR1,CCL5
PMID:23733640	(2011) Pathophysiology of the diabetic kidney.	15	143	1.08	2.06e-07	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000349860,9606.ENSP00000351671,9606.ENSP00000352264,9606.ENSP00000356832,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000402152,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CDH1,NOX4,HNF4A,GFPT1,CCL20,CD2AP,SGK1,NOX1,TXN,EDN1,RHOA,SLC12A3,CCL5,VEGFA
PMID:34940759	(2021) The Role of microRNAs in the Mammary Gland Development, Health, and Function of Cattle, Goats, and Sheep.	14	117	1.14	2.08e-07	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000477707,9606.ENSP00000478570	FABP4,CDH1,IGF1R,FADS2,STAT5A,PRKAA1,SREBF1,PTGS2,S100A12,PTEN,BCL2,MYD88,NR1H3,VEGFA
PMID:34588926	(2021) The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis.	16	172	1.03	2.12e-07	9606.ENSP00000248553,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,ENPP2,CDH1,ATM,HNF4A,CAV1,SREBF1,PTGS2,RBP4,PTEN,JAK2,BCL2,NPY,RARRES2,PROM1,VEGFA
PMID:29734668	(2018) Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.	13	94	1.2	2.26e-07	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,CXCL10,ANGPT2,CCL20,CXCL9,EDN1,JAK2,BCL2,AGTR1,PROM1,CCL5,VEGFA
PMID:33912050	(2021) Active Components and Pharmacological Effects of Cornus officinalis: Literature Review.	11	54	1.37	2.32e-07	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362463,9606.ENSP00000363973,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185	FABP4,NOX4,CXCL10,EDNRA,SREBF1,PTGS2,GLO1,ALPL,EDN1,NFE2L2,BCL2
PMID:32116650	(2020) Adipose-Derived Molecules-Untouched Horizons in Alzheimers Disease Biology.	11	54	1.37	2.32e-07	9606.ENSP00000200676,9606.ENSP00000232219,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CETP,RBP1,LPL,ANGPT2,RBP4,ANGPTL2,SAA1,BDNF,RARRES2,CCL5,VEGFA
PMID:28275367	(2017) PPAR-gamma Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.	11	54	1.37	2.32e-07	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,SOX9,CDH1,IGF1R,CXCL10,CCL20,PTGS2,PTEN,SHBG,BCL2,VEGFA
PMID:35328822	(2022) Renal Cell Cancer and Obesity.	12	73	1.28	2.34e-07	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418823,9606.ENSP00000478570	FABP4,CDH1,TIMP3,IGF1R,MAPK7,PTGS2,PTEN,SHBG,BCL2,NPY,FTO,VEGFA
PMID:32974152	(2020) Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles.	12	73	1.28	2.34e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	CD38,CD69,THBS1,ATM,CCR5,CXCL10,LPL,CD34,JAK2,BCL2,LTA,VEGFA
PMID:26587547	(2015) Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.	12	73	1.28	2.34e-07	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000375844,9606.ENSP00000418823,9606.ENSP00000419422,9606.ENSP00000478570,9606.ENSP00000480291	CETP,PON2,IFNG,CCR5,HNF4A,KCNJ11,MTHFR,CAPN10,FTO,AGTR1,VEGFA,HNF1B
PMID:21396984	(2011) Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stemprogenitor cells.	12	73	1.28	2.34e-07	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,SOX9,APC,CDH1,IGF1R,STAT5A,PTGS2,PTEN,AR,BCL2,PROM1,VEGFA
PMID:35401519	(2022) Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review.	13	95	1.2	2.42e-07	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000380252,9606.ENSP00000384262,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CD69,CXCL10,ANGPT2,CXCL9,ENTPD1,ADAMTS13,NFE2L2,HPSE,AGTR1,CCL5,VEGFA
PMID:20169190	(2010) Kaposis sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.	13	95	1.2	2.42e-07	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,MMP14,CD34,ANGPT2,ANG,CCL20,CXCL9,PTGS2,RHOA,LTA,BDNF,CCL5,VEGFA
PMID:34025641	(2021) Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.	15	146	1.07	2.48e-07	9606.ENSP00000228434,9606.ENSP00000281382,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD69,PIGF,CCR5,CXCL10,MMP14,CD34,ANGPT2,STAT5A,CD247,CXCL9,PTGS2,ENTPD1,JAK2,CCL5,VEGFA
PMID:33182828	(2020) Curcumin against Prostate Cancer: Current Evidence.	15	146	1.07	2.48e-07	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000308208,9606.ENSP00000351908,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,IGF1R,PRKCE,MMP14,MAP3K5,VIP,PTGS2,PTEN,AR,BMP2,NFE2L2,BCL2,PROM1,VEGFA,HNF1B
PMID:35096619	(2021) Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma.	12	74	1.27	2.56e-07	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,THBS1,CXCL10,CXCL11,CD34,ANGPT2,CXCL9,PTGS2,EDN1,FGFR1,PROM1,VEGFA
PMID:24757526	(2014) Adult Stem Cells and Diseases of Aging.	12	74	1.27	2.56e-07	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000478570	TIMP3,IGF1R,ATM,HNF4A,SIRT6,CAV1,SREBF1,PTGS2,SGK1,PTEN,KL,VEGFA
PMID:30581539	(2019) Fates of CD8+ T cells in Tumor Microenvironment.	13	96	1.19	2.63e-07	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,PTGS2,ENTPD1,PTEN,EDN1,CCL5,VEGFA
PMID:29731353	(2018) Advances in Meningeal Immunity.	10	39	1.47	2.68e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CXCL10,CXCL11,CXCL9,NPY,MYD88,BDNF,CCL5,VEGFA
PMID:35406450	(2022) Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue.	14	121	1.12	2.80e-07	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000426809,9606.ENSP00000475344,9606.ENSP00000478570	MAPK1,FABP4,CCR5,MMP14,HNF4A,RBP4,PTEN,AR,JAK2,BCL2,RARRES2,PROM1,APLNR,VEGFA
PMID:32878635	(2020) The potential roles of exosomes in pancreatic cancer initiation and metastasis.	14	121	1.12	2.80e-07	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,THBS1,CXCL10,PDGFB,SIRT6,CAV1,CCL20,RBP4,PTEN,KL,BCL2,SAA1,RHOA,VEGFA
PMID:33113766	(2020) Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.	12	75	1.27	2.84e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000293599,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	IFNG,CDH1,IGF1R,AQP5,MMP14,EDNRA,COMT,PTGS2,PTEN,EDN1,NFE2L2,VEGFA
PMID:34373466	(2021) The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.	13	97	1.19	2.87e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CD69,AMBP,CCR5,CXCL10,CXCL11,CXCL9,ENTPD1,BCL2,LTA,BDNF,MME,CCL5
PMID:32962079	(2020) Preventive Triple Gene Therapy Reduces the Negative Consequences of Ischemia-Induced Brain Injury after Modelling Stroke in a Rat.	11	56	1.35	2.90e-07	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,HSPB1,CXCL10,CD34,CCL20,CNTF,BCL2,LTA,BDNF,CCL5,VEGFA
PMID:30366466	(2018) Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance.	11	56	1.35	2.90e-07	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000362524,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CCR5,ANGPTL2,SHBG,JAK2,MYD88,AGTR1,PROM1,CCL5,VEGFA
PMID:29156643	(2017) Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.	16	178	1.01	2.95e-07	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000475344,9606.ENSP00000478570	MAPK1,SOX9,APC,ATM,ALDH1A1,EDNRA,MAP3K5,CD247,CD47,PTEN,EDN1,JAK2,BCL2,PROM1,APLNR,VEGFA
PMID:34305919	(2021) Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis.	15	149	1.06	2.99e-07	9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000390651,9606.ENSP00000418823,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,IGF1R,ATM,CCR5,CXCL10,SIRT6,CCL20,MAP3K5,CXCL9,PTGS2,CNR2,IRAK4,FTO,CCL5,VEGFA
PMID:27039901	(2016) Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues.	12	76	1.26	3.14e-07	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000300055,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000475344,9606.ENSP00000478570	FABP4,THBS1,PLIN1,MMP14,LPL,CD34,EBF1,SREBF1,PTEN,BMP2,APLNR,VEGFA
PMID:17663771	(2007) Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options.	10	40	1.46	3.14e-07	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CDH1,CD34,PDGFB,BAMBI,EDN1,PDGFD,PROM1,GREM1,VEGFA
PMID:34209679	(2021) New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis.	15	150	1.06	3.21e-07	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,CHI3L1,THBS1,CXCL10,CXCL11,CD34,ANGPT2,GAS6,ANG,CXCL9,PTGS2,S100A12,PTEN,FGFR1,VEGFA
PMID:30967773	(2019) Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells.	11	57	1.35	3.29e-07	9606.ENSP00000226279,9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ENPP2,ATM,ALDH1A1,CD34,SREBF1,PTGS2,PTEN,NFE2L2,BCL2,PROM1
PMID:31534972	(2019) The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease.	11	57	1.35	3.29e-07	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000352264,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,NOX4,PDGFB,SREBF1,CD2AP,TXN,EDN1,NFE2L2,RHOA,VEGFA
PMID:23085514	(2013) Redox regulation of stemprogenitor cells and bone marrow niche.	11	57	1.35	3.29e-07	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ATM,PRKCE,MMP14,CD34,MAP3K5,PTEN,NOX1,TXN,BCL2,VEGFA
PMID:35203305	(2022) C-C Chemokine Receptor 7 in Cancer.	13	99	1.18	3.39e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,ATM,CCR5,CD34,EDNRA,PTGS2,EDN1,JAK2,BCL2,RHOA,PROM1,VEGFA
PMID:35273164	(2022) Signaling pathways and targeted therapy for myocardial infarction.	15	151	1.06	3.40e-07	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	MPO,SOX9,THBS1,CD34,MAPK7,PTGS2,PTEN,JAK2,PDGFD,NFE2L2,IRAK4,RHOA,MYD88,MME,VEGFA
PMID:35413089	(2022) KLF11 deficiency enhances chemokine generation and fibrosis in murine unilateral ureteral obstruction.	15	151	1.06	3.40e-07	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000285407,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478319	THBS1,TIMP3,KLF10,CXCL11,PDGFB,CAV1,PDGFA,CCL20,EDN1,JAK2,BCL2,MYD88,LTA,CCL5,GREM1
PMID:35204118	(2022) The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors.	12	77	1.25	3.42e-07	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000419422	TGFB1,NOX4,SIRT6,PRKAA1,SREBF1,ELN,PTGS2,NOX1,EDN1,NFE2L2,GGT1,AGTR1
PMID:34684080	(2021) Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy.	12	77	1.25	3.42e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000325548,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,ATM,CXCL10,CXCL11,CNDP2,CXCL9,PTGS2,MTHFR,BCL2,CCL5,VEGFA
PMID:35095910	(2021) Anti-Inflammatory Effects of Acupuncture at ST36 Point: A Literature Review in Animal Studies.	14	124	1.11	3.42e-07	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,CDH1,P2RY1,CXCL10,SREBF1,CCL20,VIP,PTGS2,NPY,BDNF,MME,CCL5,VEGFA
PMID:33670202	(2021) Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes.	10	41	1.45	3.62e-07	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CD38,CXCL10,ELN,CXCL9,CD47,ENTPD1,PTEN,CCL5,GREM1,VEGFA
PMID:27282780	(2016) Organizing pneumonia in mice and men.	10	41	1.45	3.62e-07	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	TGFB1,MPO,IFNG,CHI3L1,THBS1,CXCL10,PDGFB,CXCL9,LTA,VEGFA
PMID:32422305	(2020) Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.	11	58	1.34	3.64e-07	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,CD38,CXCL10,CAV1,PTGS2,EDN1,NFE2L2,BCL2,CCL5,VEGFA
PMID:33321819	(2020) Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.	13	100	1.17	3.64e-07	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,CXCL10,CXCL11,MMP14,PDGFA,CD47,PTEN,BCL2,RHOA,VEGFA
PMID:31321561	(2019) Adaptive Immunity in Hypertension.	11	58	1.34	3.64e-07	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412	CD69,TIMP3,CCR5,CXCL10,CXCL11,CXCL9,SGK1,EDN1,RHOA,AGTR1,CCL5
PMID:22253564	(2012) TGFbeta signaling and cardiovascular diseases.	11	58	1.34	3.64e-07	9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478319,9606.ENSP00000478570	MMP14,EDNRA,PDGFB,PTGS2,BAMBI,BMP2,EDN1,RHOA,AGTR1,GREM1,VEGFA
PMID:19222802	(2009) The good and the bad of chemokineschemokine receptors in melanoma.	11	58	1.34	3.64e-07	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,MMP14,CD34,ANGPT2,CXCL9,PTEN,CCL5,VEGFA
PMID:34938271	(2021) Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.	12	78	1.25	3.71e-07	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000475344	IFNG,CCR5,EDNRA,CXCL9,PTGS2,CNR1,CNR2,JAK2,NPY,RHOA,CCL5,APLNR
PMID:32512891	(2020) Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.	12	78	1.25	3.71e-07	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,FABP4,CDH1,ALDH1A1,MMP14,CD34,PTEN,JAK2,MYD88,PROM1,CCL5,VEGFA
PMID:25634975	(2015) Regulation of signal transduction by reactive oxygen species in the cardiovascular system.	12	78	1.25	3.71e-07	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,NOX4,ATM,MAP3K5,CD47,PTEN,NOX1,TXN,NFE2L2,BCL2,RHOA,VEGFA
PMID:33801681	(2021) Redox Homeostasis in Pancreatic beta-Cells: From Development to Failure.	13	101	1.17	3.88e-07	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000246553,9606.ENSP00000263317,9606.ENSP00000302630,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000362410,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000419313,9606.ENSP00000480291	MAPK1,SOX9,FFAR1,NOX4,ONECUT1,MAPK7,MAP3K5,MAFB,TXN,NFE2L2,MYD88,TRPC1,HNF1B
PMID:34178125	(2021) Molecular mechanisms and associated cell signalling pathways underlying the anticancer properties of phytochemical compounds from Aloe species (Review).	14	126	1.11	3.88e-07	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	MPO,CDH1,TIMP3,ATM,CD34,HNF4A,ANG,PTGS2,PTEN,JAK2,BCL2,MYD88,VEGFA,HNF1B
PMID:34439842	(2021) Role of Phytonutrients in Nutrigenetics and Nutrigenomics Perspective in Curing Breast Cancer.	14	126	1.11	3.88e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,ATM,ALDH1A1,MMP14,SREBF1,PTGS2,PTEN,SHBG,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:32471207	(2020) Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.	14	126	1.11	3.88e-07	9606.ENSP00000255409,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CHI3L1,NOX4,CCR5,CXCL10,CXCL11,SREBF1,MAP3K5,CXCL9,PTGS2,PTEN,JAK2,CCL5,GREM1,VEGFA
PMID:27822228	(2016) Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response.	11	59	1.33	4.04e-07	9606.ENSP00000222139,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CD69,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,BCL2,BDNF,CCL5,VEGFA
PMID:25814684	(2015) Endothelial cell metabolism in normal and diseased vasculature.	11	59	1.33	4.04e-07	9606.ENSP00000256104,9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000349860,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000365777,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,DDAH1,LPL,PDGFB,CAV1,GFPT1,ELN,ABCG1,MTHFR,RHOA,VEGFA
PMID:24514166	(2014) HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.	12	79	1.24	4.05e-07	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	IFNG,HSPB1,CDH1,CAV1,MAP3K5,PTGS2,PTEN,G6PD,BCL2,RHOA,MME,VEGFA
PMID:28134254	(2017) Schwann cell interactions with axons and microvessels in diabetic neuropathy.	10	42	1.44	4.07e-07	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,CDH1,CXCL10,CXCL11,CAV1,CXCL9,CNTF,BCL2,BDNF,VEGFA
PMID:27814727	(2016) Myofibroblasts and lung fibrosis induced by carbon nanotube exposure.	10	42	1.44	4.07e-07	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	THBS1,CDH1,NOX4,MMP14,PDGFB,CAV1,PDGFA,PTEN,NFE2L2,VEGFA
PMID:34253242	(2021) A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.	13	102	1.17	4.17e-07	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,IGF1R,CXCL11,MMP14,CD34,ANGPT2,ANG,PTGS2,PTEN,PDGFD,BCL2,VEGFA
PMID:19413999	(2009) Inflammatory cytokines in vascular dysfunction and vascular disease.	13	102	1.17	4.17e-07	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CCR5,CD34,EDNRA,CAV1,ELN,PTGS2,EDN1,RHOA,LTA,TRPC1,CCL5,VEGFA
PMID:30602942	(2018) Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis.	9	28	1.57	4.27e-07	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	THBS1,CD34,CAV1,PTGS2,TXN,BCL2,PROM1,VEGFA,HNF1B
PMID:24740187	(2014) Recent highlights of ATVB: diabetes mellitus.	9	28	1.57	4.27e-07	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	MPO,FABP4,NOX4,LPL,PTGS2,RBP4,EDN1,RHOA,VEGFA
PMID:34393784	(2021) Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.	14	128	1.1	4.41e-07	9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,PLIN1,CXCL10,ANGPT2,STAT5A,CNR1,PTEN,EDN1,JAK2,BCL2,RHOA,MYD88,CCL5,VEGFA
PMID:32708786	(2020) Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity.	14	128	1.1	4.41e-07	9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000401720,9606.ENSP00000477707	IGF1R,SIRT6,KCNJ11,SREBF1,PTGS2,SGK1,PTEN,KL,NFE2L2,BCL2,NPY,RHOA,GK,NR1H3
PMID:33854965	(2021) Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming.	13	103	1.16	4.49e-07	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,NOX4,IGF1R,ALDH1A1,CAV1,STAT5A,SGK1,PTEN,HSPG2,BCL2,RHOA,BDNF,VEGFA
PMID:34571842	(2021) Therapeutic Potential of Complementary and Alternative Medicines in Peripheral Nerve Regeneration: A Systematic Review.	11	60	1.32	4.49e-07	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000484631	NOX4,IGF1R,CNTF,GAP43,BCL2,NTF3,BDNF,TRPC1,PROM1,VEGFA,PMP22
PMID:32939324	(2020) Immune responses during COVID-19 infection.	13	103	1.16	4.49e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	CD38,CD69,FABP4,CCR5,CXCL10,CXCL11,ANGPT2,STAT5A,CXCL9,MYD88,AGTR1,APLNR,VEGFA
PMID:33105647	(2020) Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update.	11	60	1.32	4.49e-07	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL10,CXCL11,CD34,EDNRA,ELN,CXCL9,ADAMTS13,EDN1,CCL5,VEGFA
PMID:31853950	(2019) Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.	11	60	1.32	4.49e-07	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000478319,9606.ENSP00000478570	CD34,CAV1,STAT5A,COMT,VIP,PTGS2,AR,EDN1,SHBG,GREM1,VEGFA
PMID:32259163	(2019) Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.	11	60	1.32	4.49e-07	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,CD34,PDGFB,ANG,PDGFA,PTGS2,PDGFD,BCL2,FGFR1,VEGFA
PMID:17315600	(2005) Pathophysiology of tumor neovascularization.	11	60	1.32	4.49e-07	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,PDGFB,CXCL9,EDN1,BCL2,FGFR1,PROM1,VEGFA
PMID:34938177	(2021) Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer.	10	43	1.43	4.63e-07	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,MMP14,ANGPT2,PDGFB,PDGFA,PTEN,AR,BCL2,RHOA,VEGFA
PMID:33059037	(2020) The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential.	10	43	1.43	4.63e-07	9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	MAP3K5,PTGS2,NOX1,EDN1,GAP43,BCL2,BDNF,MME,AGTR1,VEGFA
PMID:34187567	(2021) MicroRNAs: emerging driver of cancer perineural invasion.	13	104	1.16	4.83e-07	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,IGF1R,CCR5,MMP14,PTEN,BCL2,FGFR1,NTF3,RHOA,MYD88,BDNF,CCL5,VEGFA
PMID:34405016	(2021) Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy.	12	81	1.23	4.83e-07	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000354782,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,ATM,STAT5A,SREBF1,MAP3K5,CD247,NOX1,JAK2,NFE2L2,BCL2,VEGFA
PMID:34552965	(2021) Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms.	12	81	1.23	4.83e-07	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000403495,9606.ENSP00000477707,9606.ENSP00000478570	NOX4,LPL,CAV1,SREBF1,ABCG1,PTGS2,EDN1,JAK2,G6PD,LTA,NR1H3,VEGFA
PMID:33066029	(2020) Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms.	12	81	1.23	4.83e-07	9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	VDAC1,ATM,CXCL10,CD47,PTEN,BCL2,NTF3,RHOA,MYD88,BDNF,CCL5,VEGFA
PMID:33456670	(2020) Oxidative Stress in Ischemic Heart Disease.	13	104	1.16	4.83e-07	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000474412	IFNG,HSPB1,NOX4,EDNRA,SIRT6,NOX1,TXN,EDN1,NFE2L2,BCL2,RHOA,MME,CCL5
PMID:20458021	(2010) Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.	12	81	1.23	4.83e-07	9606.ENSP00000284031,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	DDAH1,CD34,EDNRA,PDGFA,ELN,BMP2,EDN1,BCL2,MME,PROM1,CCL5,VEGFA
PMID:32197620	(2020) Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.	11	61	1.32	4.91e-07	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000427424,9606.ENSP00000474412	TGFB1,IFNG,CCR5,CXCL10,MMP14,PDGFB,PDGFA,EDN1,LTA,TNFAIP8,CCL5
PMID:33028808	(2020) Emerging role of tumor cell plasticity in modifying therapeutic response.	14	130	1.09	4.91e-07	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000480291,9606.ENSP00000484631	THBS1,CDH1,ATM,ALDH1A1,MMP14,GAS6,CD47,PTEN,AR,FGFR1,PROM1,CCL5,HNF1B,PMP22
PMID:28807717	(2017) Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.	11	61	1.32	4.91e-07	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	MAPK1,THBS1,CDH1,NOX4,CD34,PDGFB,ELN,HSPG2,RHOA,GREM1,VEGFA
PMID:25270087	(2015) The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.	11	61	1.32	4.91e-07	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ATM,CCR5,ALDH1A1,HNF4A,JAK2,PDGFD,RHOA,PROM1,VEGFA
PMID:33800564	(2021) Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?	9	29	1.55	4.98e-07	9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CXCL10,MMP14,CXCL9,PTGS2,EDN1,RHOA,CCL5,VEGFA
PMID:35406582	(2022) Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7.	12	82	1.23	5.23e-07	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ALDH1A1,CXCL10,CXCL11,MMP14,CD34,AR,JAK2,PROM1,CCL5,VEGFA
PMID:34201952	(2021) Flavonoids in Skin Senescence Prevention and Treatment.	10	44	1.42	5.29e-07	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252	IFNG,THBS1,IGF1R,CXCL10,CXCL11,ELN,CXCL9,PTGS2,JAK2,NFE2L2
PMID:30388215	(2019) Biomarkers in abnormal uterine bleeding+.	10	44	1.42	5.29e-07	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,EDNRA,CAV1,BMP2,EDN1,SHBG,BCL2,SAA1,CCL5,VEGFA
PMID:24391835	(2013) Humoral activity of cord blood-derived stemprogenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders.	10	44	1.42	5.29e-07	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CD34,PDGFA,BAMBI,BCL2,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:22629298	(2012) High-throughput sequence analysis of turbot (Scophthalmus maximus) transcriptome using 454-pyrosequencing for the discovery of antiviral immune genes.	16	190	0.99	5.32e-07	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000385834,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,HSPB1,ATM,PRDX2,CXCL10,CXCL11,CD247,CXCL9,PTEN,BCL2,TF,IRAK4,MYD88,LTA,CCL5,VEGFA
PMID:34360625	(2021) Critical Roles of Lysophospholipid Receptors in Activation of Neuroglia and Their Neuroinflammatory Responses.	11	62	1.31	5.49e-07	9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412	ENPP2,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,NFE2L2,BCL2,RHOA,BDNF,CCL5
PMID:32157802	(2020) The role of ultrasound in enhancing mesenchymal stromal cell-based therapies.	11	62	1.31	5.49e-07	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,FABP4,P2RY1,CXCL10,PTGS2,NOX1,BCL2,BDNF,TRPC1,CCL5,VEGFA
PMID:27217783	(2016) Stem cell technology in breast cancer: current status and potential applications.	11	62	1.31	5.49e-07	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,ATM,ALDH1A1,CD34,CD47,BCL2,HPSE,PROM1,CCL5,VEGFA
PMID:34830374	(2021) The Modulatory Influence of Plant-Derived Compounds on Human Keratinocyte Function.	14	132	1.09	5.61e-07	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356213,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000445772,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,CDH1,ATM,CXCL10,CXCL11,VIP,NFE2L2,BCL2,FGFR1,RHOA,MME,LTB4R2,VEGFA,HNF1B
PMID:22834835	(2013) Functions of S100 proteins.	14	132	1.09	5.61e-07	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CDH1,CXCL10,CAV1,PTGS2,S100A12,NOX1,EDN1,BCL2,FGFR1,MYD88,CCL5,VEGFA
PMID:35163650	(2022) FAK in Cancer: From Mechanisms to Therapeutic Strategies.	12	83	1.22	5.69e-07	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,MMP14,ANGPT2,PDGFB,GAS6,CAV1,JAK2,BCL2,RHOA,CCL5,VEGFA
PMID:34298665	(2021) Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation.	12	83	1.22	5.69e-07	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000477707	MAPK1,HSPB1,IGF1R,ATM,MAPK7,STAT5A,PTGS2,PTEN,AR,PLA2G2A,RHOA,NR1H3
PMID:34589395	(2021) Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.	12	83	1.22	5.69e-07	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,NOX4,IGF1R,EDNRA,CD2AP,PTEN,EDN1,JAK2,NFE2L2,BCL2,MYD88,VEGFA
PMID:34944826	(2021) The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis.	12	83	1.22	5.69e-07	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,THBS1,CDH1,IGF1R,CCR5,PDGFA,PTEN,JAK2,BCL2,LTA,CCL5,VEGFA
PMID:27837398	(2016) Role of MicroRNA in Endothelial Dysfunction and Hypertension.	12	83	1.22	5.69e-07	9606.ENSP00000221930,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MAPK7,STAT5A,ELN,CXCL9,PTGS2,EDN1,G6PD,BCL2,AGTR1,CCL5,VEGFA
PMID:35154561	(2022) Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.	9	30	1.54	5.98e-07	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,NOX4,CXCL10,CD34,CNTF,BCL2,RHOA,CCL5,VEGFA
PMID:33842335	(2021) Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis.	10	45	1.41	5.98e-07	9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000419422,9606.ENSP00000478570	IGF1R,APPL1,PTEN,AR,SHBG,JAK2,BCL2,TRPC1,AGTR1,VEGFA
PMID:33912600	(2021) Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.	11	63	1.3	5.98e-07	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	NOX4,TIMP3,EDNRA,ELN,PTEN,EDN1,NFE2L2,BCL2,RHOA,MME,VEGFA
PMID:34183697	(2021) Accelerated burn wound healing with photobiomodulation therapy involves activation of endogenous latent TGF-beta1.	10	45	1.41	5.98e-07	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CCL20,CXCL9,PTGS2,BCL2,MYD88,LTA,CCL5,VEGFA
PMID:32340207	(2020) Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.	12	84	1.22	5.98e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL11,PDGFB,CCL20,CXCL9,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:30787933	(2019) Molecular Players in Hematologic Tumor Cell Trafficking.	12	84	1.22	5.98e-07	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD38,CDH1,CCR5,CXCL10,CXCL11,MMP14,CD34,CXCL9,PTEN,BCL2,RHOA,VEGFA
PMID:30842735	(2019) Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer.	10	45	1.41	5.98e-07	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,NOX4,CXCL10,PTGS2,PTEN,EDN1,BCL2,RHOA,CCL5,VEGFA
PMID:28194256	(2017) Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).	9	30	1.54	5.98e-07	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,NOX4,SIRT6,NOX1,G6PD,NFE2L2,BCL2,BDNF,VEGFA
PMID:27294114	(2016) Retinal Macroglial Responses in Health and Disease.	9	30	1.54	5.98e-07	9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,EDNRA,CCL20,ELN,CNTF,EDN1,BDNF,CCL5,VEGFA
PMID:28115924	(2016) Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.	11	63	1.3	5.98e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CDH1,FADS2,LPL,CAV1,CCL20,PTEN,ANGPTL2,BCL2,BDNF,VEGFA
PMID:23897679	(2013) Reactive oxygen species in pulmonary vascular remodeling.	11	63	1.3	5.98e-07	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,NOX4,DDAH1,CD34,EDNRA,ELN,NOX1,EDN1,RHOA,CCL5,VEGFA
PMID:21236334	(2011) Redox signaling in cardiac myocytes.	11	63	1.3	5.98e-07	9606.ENSP00000263317,9606.ENSP00000263774,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,NDUFS3,MAP3K5,PTGS2,PTEN,NOX1,TXN,JAK2,G6PD,BCL2,VEGFA
PMID:21547012	(2011) Is peroxisome proliferator-activated receptor gamma (PPARgamma) a therapeutic target for the treatment of pulmonary hypertension?	11	63	1.3	5.98e-07	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,EDNRA,ELN,PTGS2,PTEN,NOX1,BMP2,EDN1,BCL2,CCL5,VEGFA
PMID:20691848	(2010) Lung organogenesis.	14	133	1.08	5.98e-07	9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000293599,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478319,9606.ENSP00000478570	EPOR,SOX9,CDH1,TIMP3,IGF1R,AQP5,MMP14,PDGFB,PDGFA,FMOD,ELN,HSPG2,GREM1,VEGFA
PMID:20840865	(2010) Oxidative stress, inflammation, and cancer: how are they linked?	11	63	1.3	5.98e-07	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,THBS1,NOX4,PTGS2,PTEN,TXN,NFE2L2,BCL2,PROM1,CCL5,VEGFA
PMID:19302038	(2009) Immune and inflammatory mechanisms of atherosclerosis (*).	14	133	1.08	5.98e-07	9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	PON2,MPO,FABP4,CCR5,CXCL10,CXCL11,CXCL9,ABCG1,PTGS2,EDN1,MYD88,CCL5,NR1H3,VEGFA
PMID:33599076	(2021) Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.	13	108	1.14	6.24e-07	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	ERCC1,SOX9,CHI3L1,TIMP3,ATM,CAV1,PTEN,AR,BMP2,BCL2,RHOA,BDNF,VEGFA
PMID:33808241	(2021) Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine.	12	85	1.21	6.66e-07	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CXCL11,CD34,SIRT6,PDGFA,ELN,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:32664664	(2020) The Impact of Dietary Supplementation of Whole Foods and Polyphenols on Atherosclerosis.	11	64	1.3	6.66e-07	9606.ENSP00000215832,9606.ENSP00000222572,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,PON2,THBS1,CCR5,SREBF1,ELN,ABCG1,NOX1,TXN,MYD88,CCL5
PMID:32198236	(2020) Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.	15	164	1.02	6.80e-07	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	ATM,PRDX2,LPL,CD34,MAPK7,STAT5A,SREBF1,PTGS2,ENTPD1,MTHFR,JAK2,NFE2L2,BCL2,NPY,VEGFA
PMID:34884444	(2021) Skin Aging, Cellular Senescence and Natural Polyphenols.	13	109	1.14	6.82e-07	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401720,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,HSPB1,IGF1R,ATM,CXCL10,PTGS2,PTEN,EDN1,BCL2,GK,LTA,CCL5,VEGFA
PMID:32351946	(2020) Bioengineering of Pulmonary Epithelium With Preservation of the Vascular Niche.	9	31	1.52	7.08e-07	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000293599,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,NOX4,AQP5,MMP14,CD34,HSPG2,EDN1,FGFR1,VEGFA
PMID:25974903	(2015) Antifibrotic therapies in the liver.	9	31	1.52	7.08e-07	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CCR5,PDGFB,ELN,CNR1,NOX1,EDN1,CCL5,VEGFA
PMID:23418602	(2013) Induction of CCL8MCP-2 by mycobacteria through the activation of TLR2PI3KAkt signaling pathway.	9	31	1.52	7.08e-07	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,PDGFB,PDGFA,CXCL9,PDGFD,MYD88,CCL5
PMID:33436584	(2021) Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.	15	165	1.02	7.22e-07	9606.ENSP00000216181,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,IFNG,ATM,CXCL11,STAT5A,SREBF1,GFPT1,CCL20,PTEN,NOX1,NFE2L2,BCL2,FGFR1,CCL5,VEGFA
PMID:34205032	(2021) Pleiotropic and Potentially Beneficial Effects of Reactive Oxygen Species on the Intracellular Signaling Pathways in Endothelial Cells.	12	86	1.21	7.33e-07	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,NOX4,ATM,MAPK7,ANGPT2,MAP3K5,PTEN,NOX1,EDN1,NFE2L2,RHOA,VEGFA
PMID:34830452	(2021) Cervical Carcinoma: Oncobiology and Biomarkers.	12	86	1.21	7.33e-07	9606.ENSP00000013807,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,THBS1,CDH1,TIMP3,ALDH1A1,MMP14,CD34,ANG,PTEN,BCL2,PROM1,VEGFA
PMID:33806538	(2021) Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing.	13	110	1.13	7.38e-07	9606.ENSP00000013807,9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,EPOR,SOX9,HSPB1,VDAC1,IGF1R,ATM,ALDH1A1,CD47,PTGS2,BCL2,PROM1,VEGFA
PMID:33922139	(2021) Oxidative Stress in Cancer Cell Metabolism.	13	110	1.13	7.38e-07	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ATM,PRDX2,SIRT6,CAV1,MAP3K5,PTGS2,PTEN,NOX1,TXN,NFE2L2,BCL2,VEGFA
PMID:33665161	(2020) Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.	11	65	1.29	7.39e-07	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	SOX9,APC,CDH1,ATM,ALDH1A1,HNF4A,PTGS2,BAMBI,JAK2,BCL2,PROM1
PMID:31130595	(2019) Adult Stem Cell Functioning in the Tumor Micro-Environment.	11	65	1.29	7.39e-07	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CD34,CXCL9,EDN1,JAK2,RHOA,MME,CCL5,VEGFA
PMID:33266387	(2020) Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism.	14	137	1.07	7.62e-07	9606.ENSP00000228434,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	CD69,NOX4,VDAC1,IGF1R,ATM,CD34,SIRT6,STAT5A,ENTPD1,PTEN,TXN,NFE2L2,RHOA,VEGFA
PMID:34434114	(2021) Oxidative Stress, Kinase Activation, and Inflammatory Pathways Involved in Effects on Smooth Muscle Cells During Pulmonary Artery Hypertension Under Hypobaric Hypoxia Exposure.	10	47	1.39	7.77e-07	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	NOX4,CAV1,MAP3K5,PTGS2,PTEN,TXN,EDN1,JAK2,BCL2,CCL5
PMID:33116817	(2020) Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility.	10	47	1.39	7.77e-07	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,CAV1,PTGS2,PTEN,JAK2,FGFR1,PROM1,VEGFA
PMID:26273424	(2015) Redox Regulation in Cancer Stem Cells.	10	47	1.39	7.77e-07	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,MAP3K5,PTGS2,PTEN,G6PD,BCL2,PROM1,VEGFA
PMID:29700084	(2018) Reactive Oxygen Species in Metabolic and Inflammatory Signaling.	13	111	1.13	7.94e-07	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	PON2,NOX4,VDAC1,ATM,MAP3K5,PTEN,NOX1,TXN,G6PD,NFE2L2,BCL2,MYD88,VEGFA
PMID:25566502	(2014) The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.	12	87	1.2	7.95e-07	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	FABP4,CDH1,IGF1R,HNF4A,PDGFB,PTEN,BMP2,EDN1,PDGFD,BCL2,FGFR1,VEGFA
PMID:25829250	(2015) Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.	14	138	1.07	8.15e-07	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,VDAC1,TIMP3,IGF1R,HNF4A,ELN,HSPG2,BCL2,FGFR1,RHOA,PROM1,CCL5,VEGFA
PMID:35163413	(2022) Neutrophil Death in Myeloproliferative Neoplasms: Shedding More Light on Neutrophils as a Pathogenic Link to Chronic Inflammation.	11	66	1.28	8.28e-07	9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,ATM,CXCL10,CXCL11,CD34,STAT5A,CCL20,CXCL9,JAK2,BCL2,VEGFA
PMID:34204425	(2021) NADPH Oxidases: Redox Regulators of Stem Cell Fate and Function.	11	66	1.28	8.28e-07	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,NOX4,ATM,CD34,NOX1,TXN,BMP2,EDN1,NFE2L2,BCL2,VEGFA
PMID:28638788	(2017) Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.	11	66	1.28	8.28e-07	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	IGF1R,ALDH1A1,HNF4A,SIRT6,PTGS2,PTEN,JAK2,AGTR1,PROM1,VEGFA,HNF1B
PMID:26883165	(2016) Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.	11	66	1.28	8.28e-07	9606.ENSP00000265333,9606.ENSP00000301522,9606.ENSP00000337332,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	VDAC1,PRDX2,SIRT6,VIP,PTGS2,PTEN,TXN,NFE2L2,BCL2,NTF3,BDNF
PMID:33255561	(2020) Maternal Docosahexaenoic Acid Status during Pregnancy and Its Impact on Infant Neurodevelopment.	9	32	1.51	8.33e-07	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	FFAR1,FABP4,CDH1,FADS2,CAV1,PTGS2,NPY,BDNF,VEGFA
PMID:20345850	(2010) Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature.	9	32	1.51	8.33e-07	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000402152,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,EDNRA,ELN,NOX1,AR,SLC12A3,AGTR1,CCL5,VEGFA
PMID:32375405	(2020) PPAR BetaDelta and the Hallmarks of Cancer.	13	112	1.13	8.52e-07	9606.ENSP00000229135,9606.ENSP00000232219,9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000363641,9606.ENSP00000478570	IFNG,RBP1,APC,THBS1,CDH1,PDGFB,SIRT6,CAV1,PTGS2,PTEN,ANGPTL2,TXN,VEGFA
PMID:32260126	(2020) Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives.	12	88	1.2	8.69e-07	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000474412	NOX4,CCR5,CXCL10,CXCL11,PDGFB,PDGFA,ELN,MAP3K5,CXCL9,NOX1,BCL2,CCL5
PMID:32689931	(2020) Redox control in the pathophysiology of influenza virus infection.	12	88	1.2	8.69e-07	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	HSPB1,NOX4,VDAC1,PRDX2,CXCL10,CXCL9,NOX1,TXN,BCL2,IRAK4,MYD88,CCL5
PMID:30518128	(2018) Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies.	12	88	1.2	8.69e-07	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,THBS1,CDH1,CXCL10,CD34,HNF4A,PDGFB,STAT5A,ELN,PDGFD,PROM1,VEGFA
PMID:33673730	(2021) An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage.	10	48	1.38	8.80e-07	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000478570	CD38,CD69,CD34,STAT5A,ELN,JAK2,BCL2,NPY,RARRES2,VEGFA
PMID:29580581	(2018) Acute Kidney Injury and Progression of Diabetic Kidney Disease.	10	48	1.38	8.80e-07	9606.ENSP00000216075,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000334329,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	MIOX,NOX4,EDNRA,UNC5B,PTEN,EDN1,JAK2,RHOA,GREM1,VEGFA
PMID:29065504	(2017) A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis.	10	48	1.38	8.80e-07	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000445772,9606.ENSP00000478570	IFNG,NOX4,ATM,PTEN,NOX1,BCL2,RHOA,AGTR1,LTB4R2,VEGFA
PMID:33248932	(2020) Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.	11	67	1.28	9.14e-07	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000349860,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,SIRT6,GFPT1,ELN,PTGS2,NOX1,TXN,EDN1,NFE2L2,AGTR1,VEGFA
PMID:20932114	(2010) Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.	11	67	1.28	9.14e-07	9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000419422,9606.ENSP00000478570	CXCL11,LPL,CXCL9,ABCG1,PTEN,ANGPTL2,HSPG2,EDN1,PLA2G2A,AGTR1,VEGFA
PMID:33811715	(2021) The roles and regulation of the KLF5 transcription factor in cancers.	14	140	1.06	9.19e-07	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,CCR5,MAPK7,HNF4A,PDGFA,SREBF1,MAP3K5,PTGS2,PTEN,AR,BCL2,CCL5,VEGFA,HNF1B
PMID:34164391	(2021) MicroRNAs as Important Regulators Mediate the Multiple Differentiation of Mesenchymal Stromal Cells.	12	89	1.19	9.49e-07	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000285407,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,FABP4,KLF10,LPL,HNF4A,SIRT6,PTEN,BMP2,MYD88,PROM1,GREM1,VEGFA
PMID:35052518	(2021) Molecular Mechanistic Pathways Targeted by Natural Antioxidants in the Prevention and Treatment of Chronic Kidney Disease.	12	89	1.19	9.49e-07	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	CD38,CDH1,NOX4,SIRT6,PTEN,NFE2L2,BCL2,IRAK4,RHOA,MYD88,AGTR1,VEGFA
PMID:32456359	(2020) The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.	12	89	1.19	9.49e-07	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,MMP14,CD34,CCL20,CXCL9,PTEN,BCL2,RARRES2,CCL5,VEGFA
PMID:31629410	(2019) Tumor-associated macrophages: an accomplice in solid tumor progression.	12	89	1.19	9.49e-07	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CHI3L1,CDH1,ANGPT2,PDGFB,CCL20,CD247,CD47,PTGS2,BCL2,CCL5,VEGFA
PMID:28272347	(2017) Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.	12	89	1.19	9.49e-07	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,ATM,CXCL10,CXCL11,CXCL9,PTGS2,MTHFR,BCL2,PROM1,CCL5,VEGFA
PMID:35269741	(2022) Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.	14	141	1.06	9.83e-07	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000356213,9606.ENSP00000357726,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,HSPB1,P2RY1,CXCL10,VIP,S100A12,HSPG2,EDN1,BCL2,NPY,MYD88,BDNF,CCL5,VEGFA
PMID:29451216	(2018) Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury?	9	33	1.5	9.87e-07	9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CNTF,PTGS2,GAP43,BCL2,RHOA,MYD88,BDNF,CCL5,VEGFA
PMID:22583402	(2012) Cancer prevention with promising natural products: mechanisms of action and molecular targets.	13	114	1.12	9.87e-07	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	MPO,HSPB1,THBS1,CDH1,ANG,PTGS2,PTEN,JAK2,G6PD,NFE2L2,BCL2,VEGFA,HNF1B
PMID:34052208	(2021) Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance.	10	49	1.37	1.00e-06	9606.ENSP00000222305,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	USF2,ALDH1A1,PRDX2,CD34,TXN,G6PD,NFE2L2,BCL2,PROM1,VEGFA
PMID:33167521	(2020) Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.	10	49	1.37	1.00e-06	9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000478570	CHI3L1,FABP4,PTGS2,RBP4,JAK2,NFE2L2,RHOA,MYD88,RARRES2,VEGFA
PMID:34803696	(2021) Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis.	11	68	1.27	1.01e-06	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,FABP4,IGF1R,CXCL10,CXCL11,EDNRA,CXCL9,JAK2,RHOA,AGTR1,VEGFA
PMID:32194418	(2020) Interactions Among Non-Coding RNAs in Diabetic Nephropathy.	11	68	1.27	1.01e-06	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000419422	TGFB1,CDH1,NOX4,TIMP3,EDNRA,MAP3K5,CD2AP,PTEN,MAFB,BCL2,AGTR1
PMID:32626540	(2020) Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers.	11	68	1.27	1.01e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000360997,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CCR5,CD34,ADAMTS13,ANGPTL2,EDN1,BCL2,RARRES2,MME,PROM1,VEGFA
PMID:32998408	(2020) Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.	11	68	1.27	1.01e-06	9606.ENSP00000228434,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CD69,NOX4,CXCL10,MMP14,CXCL9,EDN1,IRAK4,RHOA,AGTR1,CCL5,VEGFA
PMID:31766246	(2019) Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements.	11	68	1.27	1.01e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IFNG,CDH1,NOX4,SIRT6,PTGS2,PTEN,NOX1,TXN,BCL2,VEGFA
PMID:29271951	(2017) Neural Stem Cells and Its Derivatives as a New Material for Melanin Inhibition.	11	68	1.27	1.01e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809	MAPK1,TGFB1,IFNG,CD34,HNF4A,GAS6,CD47,CNTF,BDNF,MME,PROM1
PMID:29357128	(2017) Contribution of Adipose Tissue to Development of Cancer.	12	90	1.19	1.01e-06	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,ATM,CXCL10,HNF4A,ANGPT2,ELN,CXCL9,PTGS2,RHOA,CCL5,VEGFA
PMID:22856431	(2012) Prostate cancer and parasitism of the bone hematopoietic stem cell niche.	11	68	1.27	1.01e-06	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CD38,SOX9,CDH1,ALDH1A1,CD34,GAS6,PTEN,AR,JAK2,BCL2,PROM1
PMID:33817704	(2020) Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology.	14	143	1.05	1.12e-06	9606.ENSP00000232219,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	RBP1,THBS1,CCR5,MMP14,PDGFA,PTGS2,PTEN,EDN1,FGFR1,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:35345441	(2022) The roles of catechins in regulation of systemic inflammation.	11	69	1.26	1.13e-06	9606.ENSP00000225275,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303	MPO,PLIN1,CXCL10,SREBF1,PTGS2,JAK2,NFE2L2,BCL2,IRAK4,MYD88,BDNF
PMID:27959632	(2017) The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.	12	91	1.18	1.13e-06	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000376865,9606.ENSP00000478570	MAPK1,THBS1,MMP14,ANGPT2,PDGFB,PDGFA,FMOD,ELN,PTEN,HSPG2,PDGFD,VEGFA
PMID:34489872	(2021) Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging.	10	50	1.36	1.15e-06	9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD34,SERPINF2,PTEN,EDN1,KL,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:32494148	(2020) Vascular Calcification: An Important Understanding in Nephrology.	10	50	1.36	1.15e-06	9606.ENSP00000245479,9606.ENSP00000265333,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000426809	SOX9,VDAC1,CD34,GAS6,ELN,SGK1,BMP2,KL,BCL2,PROM1
PMID:29740396	(2018) Redox-Dependent Inflammation in Islet Transplantation Rejection.	10	50	1.36	1.15e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,STAT5A,CXCL9,TXN,JAK2,BCL2,MYD88,CCL5,VEGFA
PMID:28164134	(2017) Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury.	13	116	1.11	1.15e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000351908,9606.ENSP00000352264,9606.ENSP00000356438,9606.ENSP00000356515,9606.ENSP00000362057,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,CCR5,MAP3K5,CD2AP,PTGS2,UTRN,NOX1,HSPG2,EDN1,AGTR1,CCL5,VEGFA
PMID:24212789	(2011) Colorectal cancer stem cells and cell death.	10	50	1.36	1.15e-06	9606.ENSP00000257430,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	APC,ALDH1A1,CD34,KCNJ11,PTEN,BMP2,BCL2,PROM1,GREM1,VEGFA
PMID:32653522	(2020) The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions.	9	34	1.48	1.17e-06	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,PTGS2,G6PD,NFE2L2,BCL2,MME,AGTR1,CCL5,VEGFA
PMID:21864249	(2012) Vascular effects of estrogenic menopausal hormone therapy.	9	34	1.48	1.17e-06	9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,CAV1,ELN,AR,EDN1,SHBG,NFE2L2,RHOA,VEGFA
PMID:35046380	(2022) Impact of Arterial Hypertension on the Eye: A Review of the Pathogenesis, Diagnostic Methods, and Treatment of Hypertensive Retinopathy.	8	21	1.64	1.18e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IFNG,NOX4,EDNRA,NOX1,EDN1,AGTR1,VEGFA
PMID:34211387	(2021) Role of Neuron and Glia in Alzheimers Disease and Associated Vascular Dysfunction.	12	92	1.18	1.23e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	MPO,IFNG,IGF1R,CCR5,ANGPT2,PDGFB,SIRT6,SREBF1,ABCG1,MYD88,MME,VEGFA
PMID:32933217	(2020) Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action.	12	92	1.18	1.23e-06	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,MPO,IFNG,LPA,SREBF1,PTGS2,PTEN,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:28203259	(2017) Insights into the Action Mechanisms of Traditional Chinese Medicine in Osteoarthritis.	11	70	1.26	1.23e-06	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000444198,9606.ENSP00000478570	IFNG,SOX9,TIMP3,CXCL10,CCL20,MAP3K5,PTGS2,BCL2,MYD88,CITED2,VEGFA
PMID:27076594	(2016) Microarray analysis in pulmonary hypertension.	13	117	1.11	1.23e-06	9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000261037,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478319,9606.ENSP00000478570	IFNG,ENPP2,COL8A1,P2RY1,CXCL10,PTGS2,BMP2,EDN1,JAK2,RHOA,BDNF,GREM1,VEGFA
PMID:26501341	(2015) The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation.	12	92	1.18	1.23e-06	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,ANG,STAT5A,CCL20,CXCL9,PTGS2,JAK2,BCL2,CCL5,VEGFA
PMID:24281174	(2010) The emerging role of the phosphatidylinositol 3-kinase aktmammalian target of rapamycin signaling network in cancer stem cell biology.	12	92	1.18	1.23e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CD38,CDH1,IGF1R,ATM,CD34,SREBF1,MAP3K5,SGK1,PTEN,BCL2,RHOA,PROM1
PMID:18947376	(2008) Vascular involvement in rheumatic diseases: vascular rheumatology.	12	92	1.18	1.23e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,MTHFR,EDN1,CCL5,VEGFA
PMID:34639215	(2021) Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved.	10	51	1.35	1.30e-06	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,VDAC1,MMP14,ANGPT2,CAV1,PTGS2,EDN1,BCL2,RHOA,VEGFA
PMID:32850151	(2020) Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies.	10	51	1.35	1.30e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CD34,PDGFB,PDGFA,CXCL9,PDGFD,MYD88,VEGFA
PMID:34071306	(2021) MacrophagesMicroglia in the Glioblastoma Tumor Microenvironment.	13	118	1.1	1.32e-06	9606.ENSP00000259486,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,IGF1R,CCR5,CXCL10,MMP14,ANGPT2,CD47,PTGS2,ENTPD1,PTEN,PROM1,CCL5,VEGFA
PMID:32114741	(2020) Manipulated Mesenchymal Stem Cells Applications in Neurodegenerative Diseases.	12	93	1.17	1.33e-06	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,CXCL11,CD34,ANG,CXCL9,BCL2,NTF3,BDNF,MME,CCL5,VEGFA
PMID:32499786	(2020) The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses.	14	146	1.04	1.35e-06	9606.ENSP00000216181,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,CCR5,CXCL10,CXCL11,STAT5A,CCL20,CD247,CXCL9,CD47,ENTPD1,BCL2,MME,CCL5,VEGFA
PMID:29350049	(2018) Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanisms and RiskBenefit Analysis.	14	146	1.04	1.35e-06	9606.ENSP00000013807,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,NOX4,VDAC1,ATM,MAPK7,CAV1,CCL20,PTGS2,PTEN,NOX1,TXN,JAK2,BCL2,VEGFA
PMID:35269553	(2022) Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling.	11	71	1.25	1.38e-06	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	NOX4,PDGFB,CAV1,TXN,EDN1,JAK2,G6PD,TRPC1,CCL5,APLNR,VEGFA
PMID:35391712	(2022) Biomedical features and therapeutic potential of rosmarinic acid.	11	71	1.25	1.38e-06	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,HSPB1,NOX4,SREBF1,PTGS2,EDN1,JAK2,BCL2,RHOA,BDNF,VEGFA
PMID:33801659	(2021) PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.	11	71	1.25	1.38e-06	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000285407,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	IGF1R,ATM,KLF10,STAT5A,SGK1,PTEN,JAK2,BCL2,FGFR1,MYD88,VEGFA
PMID:34943903	(2021) Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.	11	71	1.25	1.38e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,ATM,ANGPT2,PTGS2,CNR1,EDN1,BCL2,RHOA,CCL5,VEGFA
PMID:32900697	(2020) Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR obob mouse model of type 2 diabetes.	9	35	1.47	1.38e-06	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000474412	NOX4,PLIN1,CXCL10,ABCG1,NOX1,JAK2,NFE2L2,PROM1,CCL5
PMID:32992449	(2020) MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages.	11	71	1.25	1.38e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,CCR5,CXCL10,ANGPT2,PDGFB,CCL20,PTEN,LTA,CCL5,GREM1,VEGFA
PMID:30468628	(2019) New therapeutics based on emerging concepts in pulmonary fibrosis.	11	71	1.25	1.38e-06	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	ENPP2,CDH1,CAV1,PDGFA,ELN,PTEN,EDN1,BCL2,RHOA,GREM1,VEGFA
PMID:31331089	(2019) Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection.	11	71	1.25	1.38e-06	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,HSPB1,CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:24765137	(2014) Molecular mechanisms of chemoresistance in osteosarcoma (Review).	9	35	1.47	1.38e-06	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000310520,9606.ENSP00000351908,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CD38,IGF1R,CD34,ERCC4,MAP3K5,BMP2,BCL2,VEGFA
PMID:17760836	(2007) Mast cells in vulnerable atherosclerotic plaques--a view to a kill.	11	71	1.25	1.38e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CCL20,ELN,CXCL9,VIP,EDN1,CCL5,VEGFA
PMID:33505469	(2020) Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells.	13	119	1.1	1.40e-06	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000354901,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CD34,FMOD,CXCL9,KL,BCL2,NTF3,MME,PROM1,CCL5,VEGFA
PMID:32103869	(2020) Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer.	14	147	1.04	1.41e-06	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000479617	MAPK1,APC,THBS1,CDH1,CXCL10,MAPK7,CCL20,MAP3K5,PTEN,JAK2,BCL2,CCL5,VEGFA,UHRF1
PMID:27242736	(2016) Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus.	12	94	1.17	1.43e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,ANG,CCL20,CXCL9,PTGS2,NTF3,LTA,CCL5,VEGFA
PMID:33532143	(2021) Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective.	10	52	1.35	1.45e-06	9606.ENSP00000221930,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000380365,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,MAP3K5,NOX1,JAK2,NFE2L2,RGN,BCL2,MYD88,BDNF,VEGFA
PMID:34440886	(2021) Mesenchymal Stem Cells in Adipose Tissue and Extracellular Vesicles in Ovarian Cancer Patients: A Bridge toward Metastatic Diffusion or a New Therapeutic Opportunity?	10	52	1.35	1.45e-06	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CCR5,CXCL10,CD34,PTEN,JAK2,BCL2,RHOA,CCL5,VEGFA
PMID:32340136	(2020) Progenitor Cells Activated by Platelet Lysate in Human Articular Cartilage as a Tool for Future Cartilage Engineering and Reparative Strategies.	10	52	1.35	1.45e-06	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,SOX9,CHI3L1,THBS1,CD34,ANG,CCL20,RBP4,CCL5,VEGFA
PMID:32671136	(2020) Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects.	8	22	1.62	1.45e-06	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	IGF1R,PTGS2,PTEN,JAK2,FGFR1,MYD88,AGTR1,VEGFA
PMID:33276797	(2020) The critical role of endothelial function in fine particulate matter-induced atherosclerosis.	10	52	1.35	1.45e-06	9606.ENSP00000266085,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000477707,9606.ENSP00000478570	TIMP3,EDNRA,ELN,ABCG1,PTGS2,EDN1,MYD88,AGTR1,NR1H3,VEGFA
PMID:33343348	(2020) Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage.	10	52	1.35	1.45e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MPO,NOX4,CAV1,TXN,EDN1,JAK2,BCL2,RHOA,MYD88,VEGFA
PMID:31277312	(2019) Regulation of Gene Expression under Hypoxic Conditions.	10	52	1.35	1.45e-06	9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478319,9606.ENSP00000478570	ATM,ANG,STAT5A,PDGFA,CCL20,NOX1,EDN1,NFE2L2,GREM1,VEGFA
PMID:31817084	(2019) Anti-Inflammatory and Anticancer Properties of Bioactive Compounds from Sesamum indicum L.-A Review.	10	52	1.35	1.45e-06	9606.ENSP00000225275,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000477707,9606.ENSP00000478570	MPO,SREBF1,COMT,PTGS2,EDN1,BCL2,NTF3,BDNF,NR1H3,VEGFA
PMID:29302067	(2018) Biased signalling: from simple switches to allosteric microprocessors.	10	52	1.35	1.45e-06	9606.ENSP00000246553,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000358513,9606.ENSP00000419422,9606.ENSP00000475344	FFAR1,IGF1R,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,CNR1,AGTR1,APLNR
PMID:34690699	(2021) Old Stars and New Players in the Brain Tumor Microenvironment.	11	72	1.25	1.49e-06	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,MMP14,PDGFB,PDGFA,CD47,PTEN,JAK2,BDNF,PROM1,CCL5,VEGFA
PMID:34956172	(2021) Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.	13	120	1.1	1.49e-06	9606.ENSP00000216181,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	MYH9,THBS1,CDH1,ATM,CXCL10,CXCL11,CD34,CCL20,CXCL9,PTEN,BCL2,FGFR1,VEGFA
PMID:31867277	(2019) The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy.	11	72	1.25	1.49e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,MMP14,PDGFA,CD247,CD47,BCL2,FGFR1,CCL5,VEGFA
PMID:32676138	(2019) The Importance of Natural Antioxidants in the Treatment of Spinal Cord Injury in Animal Models: An Overview.	11	72	1.25	1.49e-06	9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	SIRT6,STAT5A,PTEN,TXN,JAK2,GAP43,BCL2,RHOA,BDNF,CCL5,VEGFA
PMID:29868332	(2018) Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress.	11	72	1.25	1.49e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CAV1,KCNJ11,CCL20,MAP3K5,ENTPD1,EDN1,NFE2L2,MYD88,CCL5
PMID:27867386	(2016) Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity.	11	72	1.25	1.49e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,PDGFB,CCL20,CXCL9,CD47,PTGS2,CCL5,VEGFA
PMID:23111102	(2013) Pancreatic cancer chemoprevention by phytochemicals.	11	72	1.25	1.49e-06	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,IGF1R,ATM,HNF4A,MAP3K5,PTEN,TXN,JAK2,BCL2,RHOA,VEGFA
PMID:22084619	(2011) Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.	13	120	1.1	1.49e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,THBS1,CDH1,ANGPT2,PDGFB,PDGFA,SGK1,PTEN,PDGFD,BCL2,PROM1,VEGFA
PMID:35432718	(2022) Targeting Oxidative Stress and Endothelial Dysfunction Using Tanshinone IIA for the Treatment of Tissue Inflammation and Fibrosis.	12	95	1.16	1.52e-06	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,NOX4,EDNRA,CAV1,PTEN,EDN1,JAK2,BCL2,RHOA,BDNF,MME,VEGFA
PMID:34966386	(2021) Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis.	12	95	1.16	1.52e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CXCL10,CD34,CCL20,CXCL9,PTGS2,S100A12,JAK2,BCL2,MYD88,MME,VEGFA
PMID:31979082	(2020) Preclinical Pharmacological Activities of Epigallocatechin-3-gallate in Signaling Pathways: An Update on Cancer.	12	95	1.16	1.52e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,STAT5A,COMT,PTGS2,PTEN,AR,JAK2,BCL2,MYD88,CCL5,VEGFA
PMID:19374334	(2009) Molecular regulation of tumor angiogenesis and perfusion via redox signaling.	12	95	1.16	1.52e-06	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000362524,9606.ENSP00000363641,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,NOX4,MMP14,CAV1,CD47,PTEN,NOX1,ANGPTL2,TXN,HSPG2,FGFR1,VEGFA
PMID:34072966	(2021) Transferring Plasmon Effect on a Biological System: Expression of Biological Polymers in Chronic Rejection and Inflammatory Rat Model.	9	36	1.46	1.56e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,ELN,NFE2L2,PROM1,CCL5,VEGFA
PMID:34249228	(2021) Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.	13	121	1.09	1.56e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,THBS1,CDH1,CCR5,AQP5,CXCL10,MMP14,CD34,PTGS2,NFE2L2,BCL2,RHOA,VEGFA
PMID:32443915	(2020) Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis.	13	121	1.09	1.56e-06	9606.ENSP00000260356,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	THBS1,ALDH1A1,HNF4A,EDNRA,GAS6,PTEN,AR,BMP2,EDN1,PROM1,CCL5,VEGFA,HNF1B
PMID:29282247	(2018) Highlighting Diabetes Mellitus: The Epidemic Continues.	9	36	1.46	1.56e-06	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000346508,9606.ENSP00000360522,9606.ENSP00000360997,9606.ENSP00000478570	IFNG,FABP4,NOX4,LPL,LPA,PDGFA,RBP4,ADAMTS13,VEGFA
PMID:27903845	(2017) Protein biomarkers of mood disorders.	9	36	1.46	1.56e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CXCL10,COMT,PTGS2,RBP4,EDN1,PLA2G2A,BDNF,VEGFA
PMID:28743464	(2017) Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.	13	121	1.09	1.56e-06	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,MPO,THBS1,NOX4,CD34,ANGPT2,PTGS2,BCL2,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:26379552	(2015) Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.	9	36	1.46	1.56e-06	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CCR5,EDNRA,PTGS2,S100A12,EDN1,LTA,AGTR1,VEGFA
PMID:33967750	(2021) Neuroprotective Effect for Cerebral Ischemia by Natural Products: A Review.	11	73	1.24	1.59e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	MPO,NOX4,ANGPT2,CAV1,EDN1,JAK2,NFE2L2,BCL2,BDNF,AGTR1,VEGFA
PMID:31362427	(2019) Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadnes Thread.	10	53	1.34	1.59e-06	9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	PON2,MPO,NOX4,NOX1,TXN,EDN1,KL,BCL2,MME,VEGFA
PMID:32038243	(2019) Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases.	10	53	1.34	1.59e-06	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	HSPB1,NOX4,PTGS2,PTEN,BMP2,NFE2L2,BCL2,MYD88,AGTR1,VEGFA
PMID:28612009	(2017) Cardiac Cell Senescence and Redox Signaling.	10	53	1.34	1.59e-06	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175	MAPK1,NOX4,ATM,CAV1,MAP3K5,PTEN,NOX1,TXN,EDN1,RHOA
PMID:27375834	(2016) Molecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic Implications.	10	53	1.34	1.59e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399	IFNG,CDH1,ATM,CXCL10,CAV1,TXN,G6PD,BCL2,RHOA,MYD88
PMID:26690121	(2015) Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.	11	73	1.24	1.59e-06	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000380252	IGF1R,ATM,PRKCE,SREBF1,PTGS2,PTEN,TXN,AR,EDN1,G6PD,NFE2L2
PMID:22888373	(2012) High Density Lipoprotein and its Dysfunction.	10	53	1.34	1.59e-06	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000321853,9606.ENSP00000354995,9606.ENSP00000383364,9606.ENSP00000384906	CETP,MPO,AMBP,LPL,APOL1,LPA,SERPINF2,ABCG1,PLA2G2A,SAA1
PMID:22220184	(2011) The pivotal role of airway smooth muscle in asthma pathophysiology.	11	73	1.24	1.59e-06	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412	CD38,HSPB1,CCR5,CXCL10,CD34,ELN,VIP,HSPG2,EDN1,RHOA,CCL5
PMID:32102441	(2020) Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role.	12	96	1.16	1.61e-06	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000347041,9606.ENSP00000354901,9606.ENSP00000365256,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,ATM,CXCL10,CXCL11,GAS6,STAT5A,FMOD,CXCL9,CLCN5,JAK2,BCL2,VEGFA
PMID:27845732	(2016) The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.	12	96	1.16	1.61e-06	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412	THBS1,IGF1R,CXCL10,CD34,SREBF1,CXCL9,PTEN,BMP2,JAK2,MME,PROM1,CCL5
PMID:35276844	(2022) Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5.	11	74	1.23	1.78e-06	9606.ENSP00000200676,9606.ENSP00000226279,9606.ENSP00000259486,9606.ENSP00000300055,9606.ENSP00000321334,9606.ENSP00000337332,9606.ENSP00000354995,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000477707	CETP,CD38,ENPP2,PLIN1,LPA,SIRT6,ABCG1,TXN,JAK2,G6PD,NR1H3
PMID:35329914	(2022) Advances in the Treatment of Giant Cell Arteritis.	9	37	1.45	1.78e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,EDNRA,CXCL9,EDN1,JAK2,VEGFA
PMID:33805795	(2021) The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials.	10	54	1.33	1.78e-06	9606.ENSP00000229135,9606.ENSP00000300055,9606.ENSP00000314897,9606.ENSP00000321334,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,PLIN1,ANGPT2,LPA,PTEN,G6PD,NFE2L2,BCL2,VEGFA,HNF1B
PMID:33918290	(2021) The Hallmarks of Flavonoids in Cancer.	13	123	1.09	1.78e-06	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,STAT5A,SREBF1,PTGS2,PTEN,TXN,JAK2,NFE2L2,BCL2,MYD88,CCL5,VEGFA
PMID:34067108	(2021) The Role of JAKSTAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.	9	37	1.45	1.78e-06	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PDGFB,PDGFA,NOX1,EDN1,JAK2,BCL2,AGTR1,VEGFA
PMID:34503065	(2021) Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy.	11	74	1.23	1.78e-06	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,MMP14,CD34,ANGPT2,PDGFB,CD47,ENTPD1,PTEN,JAK2,CCL5,VEGFA
PMID:34834200	(2021) Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview.	11	74	1.23	1.78e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354511,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000414303	IFNG,NOX4,EDNRA,PDGFB,CCL20,COMT,NOX1,EDN1,RHOA,LTA,BDNF
PMID:32195233	(2020) Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing.	11	74	1.23	1.78e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CD34,PDGFA,CCL20,ELN,PTGS2,PTEN,PROM1,CCL5,VEGFA
PMID:32793401	(2020) Molecular mechanisms and clinical management of cancer bone metastasis.	12	97	1.15	1.78e-06	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CDH1,IGF1R,CCR5,EDNRA,STAT5A,ELN,PTGS2,AR,EDN1,CCL5,VEGFA
PMID:32879300	(2020) FGFFGFR signaling in health and disease.	13	123	1.09	1.78e-06	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000358513,9606.ENSP00000363827,9606.ENSP00000369442,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000478570	EPOR,IFNG,SOX9,THBS1,CXCL11,ELN,MAP3K5,CNR1,HSPG2,KL,NPY,FGFR1,VEGFA
PMID:32978374	(2020) Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?	10	54	1.33	1.78e-06	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	THBS1,CXCL10,CAV1,STAT5A,CCL20,TXN,NFE2L2,BCL2,MYD88,CCL5
PMID:33339409	(2020) Extracellular Vesicles from Adipose Tissue Stem Cells in Diabetes and Associated Cardiovascular Disease; Pathobiological Impact and Therapeutic Potential.	12	97	1.15	1.78e-06	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	SOX9,FABP4,CD34,STAT5A,SREBF1,RBP4,ALPL,BMP2,EDN1,BCL2,MME,VEGFA
PMID:31565001	(2019) Let my liver rather heat with wine - a review of hepatic fibrosis pathophysiology and emerging therapeutics.	13	123	1.09	1.78e-06	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000285407,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SOX9,KLF10,HNF4A,PDGFB,GAS6,ELN,MAP3K5,PTEN,BCL2,MYD88,CCL5,VEGFA
PMID:31875871	(2019) Mechanoresponse of stem cells for vascular repair.	8	23	1.6	1.78e-06	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809	TGFB1,CD34,PDGFB,PDGFA,EDN1,RHOA,AGTR1,PROM1
PMID:30123112	(2018) MicrogliaAstrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors.	12	97	1.15	1.78e-06	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354995,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,CXCL10,MMP14,ANGPT2,CCL20,ABCG1,LTA,BDNF,PROM1,CCL5,VEGFA
PMID:30283000	(2018) Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS.	12	97	1.15	1.78e-06	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,IGF1R,ATM,HNF4A,MAP3K5,CNTF,PTEN,JAK2,FGFR1,RHOA,BDNF,VEGFA
PMID:28210075	(2017) Pancreatic stellate cell: Pandoras box for pancreatic disease biology.	11	74	1.23	1.78e-06	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,MMP14,PTGS2,EDN1,JAK2,FGFR1,BDNF,MME,CCL5,VEGFA
PMID:28932124	(2017) Marketed drugs used for the management of hypercholesterolemia as anticancer armament.	11	74	1.23	1.78e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,IGF1R,ATM,CD34,PTGS2,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:26074879	(2015) Identifying Common Genetic Risk Factors of Diabetic Neuropathies.	10	54	1.33	1.78e-06	9606.ENSP00000216181,9606.ENSP00000292303,9606.ENSP00000339916,9606.ENSP00000348069,9606.ENSP00000365777,9606.ENSP00000379256,9606.ENSP00000402152,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,CCR5,LIMK2,SREBF1,MTHFR,NCALD,SLC12A3,AGTR1,CCL5,VEGFA
PMID:26347199	(2015) A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3KAkt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat ...	11	74	1.23	1.78e-06	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000390651,9606.ENSP00000393312,9606.ENSP00000477707	MAPK1,CD38,FABP4,NOX4,NOX1,JAK2,BCL2,PLA2G2A,IRAK4,FGFR1,NR1H3
PMID:22811423	(2012) Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.	12	97	1.15	1.78e-06	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000360250,9606.ENSP00000378046,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000444198,9606.ENSP00000478570	EPOR,CD34,ANGPT2,EDNRA,PDGFB,ENTPD1,FKBP2,BCL2,RHOA,TRPC1,CITED2,VEGFA
PMID:20100589	(2010) Novel aspects of corneal angiogenic and lymphangiogenic privilege.	12	97	1.15	1.78e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,CDH1,MMP14,PDGFB,PDGFA,FMOD,ELN,PTGS2,HSPG2,EDN1,FGFR1,VEGFA
PMID:18805939	(2009) Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis.	10	54	1.33	1.78e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CDH1,CCR5,COMT,PTEN,AR,LTA,CCL5,VEGFA
PMID:33673710	(2021) Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell.	15	183	0.97	1.80e-06	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000427424,9606.ENSP00000478319	CD69,SOX9,CDH1,IGF1R,CD34,HNF4A,ANGPT2,PDGFA,ELN,PTGS2,BMP2,MYD88,PROM1,TNFAIP8,GREM1
PMID:31653058	(2019) Immunobiology of Atherosclerosis: A Complex Net of Interactions.	14	152	1.03	1.80e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,ELN,CXCL9,ABCG1,PTGS2,ENTPD1,JAK2,NFE2L2,RHOA,MYD88,CCL5,VEGFA
PMID:33777750	(2021) The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy.	13	124	1.08	1.87e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,PDGFB,ANG,CCL20,CXCL9,CD47,PTGS2,ENTPD1,CCL5,VEGFA
PMID:33995677	(2021) The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.	12	98	1.15	1.87e-06	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000284031,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,IGF1R,DDAH1,SIRT6,PTEN,MAFB,BMP2,BCL2,FGFR1,RHOA,CCL5,VEGFA
PMID:34069740	(2021) HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development.	12	98	1.15	1.87e-06	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,SOX9,CDH1,IGF1R,PRKCE,LPL,STAT5A,SREBF1,PTEN,JAK2,BCL2,VEGFA
PMID:34248142	(2021) Inflammation and tumor progression: signaling pathways and targeted intervention.	16	217	0.93	1.87e-06	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CD34,ANGPT2,ELN,CD247,CD47,PTGS2,ENTPD1,JAK2,BCL2,IRAK4,MYD88,CCL5,VEGFA
PMID:31885581	(2019) The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective.	12	98	1.15	1.87e-06	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CD34,CAV1,CD47,PTEN,EDN1,JAK2,BCL2,RHOA,PROM1,CCL5,VEGFA
PMID:28018358	(2016) Endothelial Response to Glucocorticoids in Inflammatory Diseases.	12	98	1.15	1.87e-06	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,FABP4,NOX4,TIMP3,CXCL10,CXCL11,CAV1,CCL20,CXCL9,MYD88,CCL5,VEGFA
PMID:35158804	(2022) Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment.	11	75	1.23	1.89e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,PDGFB,STAT5A,CD47,ENTPD1,PTEN,JAK2,NFE2L2,BCL2,VEGFA
PMID:33754031	(2021) The double-edged roles of ROS in cancer prevention and therapy.	11	75	1.23	1.89e-06	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	NOX4,ATM,MAPK7,MAP3K5,PTEN,NOX1,TXN,G6PD,BCL2,RHOA,PROM1
PMID:34745106	(2021) The Role of Innate Immune System in the Human Amniotic Membrane and Human Amniotic Fluid in Protection Against Intra-Amniotic Infections and Inflammation.	11	75	1.23	1.89e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	MPO,IFNG,CXCL10,ANGPT2,CXCL9,PTGS2,BCL2,NTF3,MYD88,BDNF,CCL5
PMID:33634164	(2020) Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies.	11	75	1.23	1.89e-06	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,EPOR,SOX9,CD34,ANGPT2,STAT5A,PTGS2,PTEN,AGTR1,PROM1,VEGFA
PMID:30687812	(2018) Oral Ibuprofen Interferes with Cellular Healing Responses in a Murine Model of Achilles Tendinopathy.	11	75	1.23	1.89e-06	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	CDH1,AMBP,CCR5,CXCL10,CXCL11,CXCL9,PTGS2,RHOA,MYD88,LTA,CCL5
PMID:28840539	(2017) Recent advances in pharmacological research on Ecklonia species: a review.	11	75	1.23	1.89e-06	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000321853,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,FABP4,PLIN1,LPL,SERPINF2,SIRT6,SREBF1,PTGS2,NFE2L2,BCL2,VEGFA
PMID:23720270	(2012) Exercise training and peripheral arterial disease.	14	153	1.02	1.89e-06	9606.ENSP00000222139,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000478570	EPOR,THBS1,TIMP3,MMP14,ANGPT2,PDGFB,UNC5B,CD47,ENTPD1,PTEN,EDN1,JAK2,NPY,VEGFA
PMID:28611316	(2017) Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.	16	218	0.93	1.93e-06	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,SOX9,CDH1,ATM,ALDH1A1,MMP14,HNF4A,SIRT6,STAT5A,PTGS2,PTEN,KL,JAK2,BCL2,PROM1,VEGFA
PMID:35163444	(2022) Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis.	13	125	1.08	1.94e-06	9606.ENSP00000215832,9606.ENSP00000222305,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,USF2,MMP14,LPL,CD34,MAPK7,PDGFB,PDGFA,CCL20,PDGFD,BCL2,CCL5,VEGFA
PMID:35203258	(2022) Dissecting miRNA-Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine.	10	55	1.32	1.94e-06	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000364683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,FABP4,IGF1R,PTGS2,S100A12,BAMBI,RHOA,AGTR1,CCL5,VEGFA
PMID:32272502	(2020) The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.	10	55	1.32	1.94e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	CCR5,CXCL10,CD247,CXCL9,PTGS2,ENTPD1,PTEN,CCL5,NR1H3,VEGFA
PMID:33072245	(2020) Markers of Endothelial Cells in Normal and Pathological Conditions.	10	55	1.32	1.94e-06	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,NOX4,ANGPT2,SIRT6,CAV1,CD47,ADAMTS13,EDN1,RHOA,VEGFA
PMID:31024258	(2019) Beyond Trophic Factors: Exploiting the Intrinsic Regenerative Properties of Adult Neurons.	10	55	1.32	1.94e-06	9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000334329,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303	APC,HNF4A,UNC5B,CNTF,PTEN,BMP2,GAP43,FGFR1,NTF3,BDNF
PMID:31718027	(2019) The Novel Perspectives of Adipokines on Brain Health.	10	55	1.32	1.94e-06	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000288266,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,ENPP2,APPL1,JAK2,BCL2,NPY,RHOA,BDNF,RARRES2,VEGFA
PMID:30255805	(2018) Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining.	13	125	1.08	1.94e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000346148,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000375844,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000419422	TGFB1,IFNG,HNF4A,PDGFB,PRKAA1,COMT,PTGS2,MTHFR,CAPN10,NPY,BDNF,FTO,AGTR1
PMID:24551591	(2014) Syndecans as modulators and potential pharmacological targets in cancer progression.	10	55	1.32	1.94e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,IGF1R,MMP14,CAV1,ELN,HSPG2,FGFR1,RHOA,VEGFA
PMID:25535075	(2014) The role of reactive oxygen species in microvascular remodeling.	10	55	1.32	1.94e-06	9606.ENSP00000232219,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	RBP1,NOX4,MMP14,ELN,PTEN,NOX1,EDN1,RHOA,AGTR1,VEGFA
PMID:23958185	(2013) Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits.	10	55	1.32	1.94e-06	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000474412	MPO,CD38,CD69,CXCL10,CAV1,PTGS2,PTEN,EDN1,JAK2,CCL5
PMID:24058777	(2012) STAT3 signaling in pulmonary arterial hypertension.	10	55	1.32	1.94e-06	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CD34,CAV1,STAT5A,PTEN,EDN1,JAK2,BCL2,RHOA,VEGFA
PMID:20163989	(2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation.	10	55	1.32	1.94e-06	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,CXCL11,CD34,ANG,CCL20,CXCL9,CCL5,VEGFA
PMID:35096805	(2021) Therapeutic Mesenchymal StemStromal Cells: Value, Challenges and Optimization.	12	99	1.14	1.96e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CXCL10,CXCL11,CD34,ANG,CXCL9,PTGS2,ENTPD1,BCL2,CCL5,VEGFA
PMID:35153741	(2021) An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases.	12	99	1.14	1.96e-06	9606.ENSP00000200676,9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000317674,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412	CETP,MAPK1,MPO,CCR5,CXCL10,CD34,APOL1,PDGFB,CXCL9,PTGS2,BCL2,CCL5
PMID:31979368	(2020) The Endocannabinoid System: A Target for Cancer Treatment.	12	99	1.14	1.96e-06	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,HNF4A,ANGPT2,PTGS2,CNR1,AR,EDN1,BCL2,RHOA,PROM1,VEGFA
PMID:27935822	(2016) Adipose tissue in control of metabolism.	12	99	1.14	1.96e-06	9606.ENSP00000285407,9606.ENSP00000288266,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000478570	KLF10,APPL1,PLIN1,LPL,EBF1,STAT5A,SREBF1,JAK2,NPY,BDNF,RARRES2,VEGFA
PMID:25132266	(2015) MicroRNA regulons in tumor microenvironment.	12	99	1.14	1.96e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000349860,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,IGF1R,MMP14,GAS6,GFPT1,CCL20,PTEN,BCL2,FGFR1,CCL5,VEGFA
PMID:35082332	(2022) Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula.	9	38	1.44	1.98e-06	9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,AMBP,ANGPT2,ANG,CCL20,CXCL9,BDNF,CCL5,VEGFA
PMID:32276503	(2020) Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells.	9	38	1.44	1.98e-06	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD38,CD69,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:32318236	(2020) The Effects of Natural Iridoids and Anthocyanins on Selected Parameters of Liver and Cardiovascular System Functions.	9	38	1.44	1.98e-06	9606.ENSP00000200676,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000477707	CETP,NOX4,LPL,SREBF1,ELN,PTGS2,NFE2L2,BCL2,NR1H3
PMID:32925069	(2020) Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimers Disease.	9	38	1.44	1.98e-06	9606.ENSP00000221930,9606.ENSP00000309757,9606.ENSP00000351908,9606.ENSP00000354511,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000477707	TGFB1,LPL,MAP3K5,COMT,ABCG1,BCL2,BDNF,FTO,NR1H3
PMID:33569380	(2020) Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies.	9	38	1.44	1.98e-06	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,NOX4,ANGPT2,ELN,TXN,NFE2L2,BCL2,BDNF,VEGFA
PMID:24146830	(2013) Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells.	9	38	1.44	1.98e-06	9606.ENSP00000256104,9606.ENSP00000261037,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,COL8A1,CXCL10,ELN,CXCL9,PTGS2,ALPL,BDNF,VEGFA
PMID:34646376	(2021) Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function.	11	76	1.22	2.00e-06	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000321853,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	FABP4,LPL,SERPINF2,PTEN,TXN,EDN1,NPY,RHOA,BDNF,AGTR1,VEGFA
PMID:32943996	(2020) The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis.	11	76	1.22	2.00e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,CDH1,TIMP3,MMP14,HNF4A,CCL20,ELN,AR,JAK2,RHOA,VEGFA
PMID:33066172	(2020) Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways.	11	76	1.22	2.00e-06	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CD38,ALDH1A1,CXCL11,CD34,CCL20,PTGS2,PTEN,MME,PROM1,VEGFA
PMID:31281380	(2019) Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies.	11	76	1.22	2.00e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CDH1,IGF1R,CXCL10,CD34,ANG,BCL2,MYD88,CCL5,VEGFA
PMID:29387042	(2018) Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.	11	76	1.22	2.00e-06	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000400175,9606.ENSP00000418823,9606.ENSP00000478570	CD38,VDAC1,IGF1R,HNF4A,SREBF1,ELN,PTGS2,RBP4,RHOA,FTO,VEGFA
PMID:23781214	(2013) Adipokines mediate inflammation and insulin resistance.	11	76	1.22	2.00e-06	9606.ENSP00000292303,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	CCR5,PLIN1,SREBF1,RBP4,PTEN,ANGPTL2,JAK2,RARRES2,CCL5,APLNR,VEGFA
PMID:16983403	(2006) Improving the outcome of patients with castration-resistant prostate cancer through rational drug development.	8	24	1.58	2.01e-06	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,EDNRA,PTEN,AR,EDN1,BCL2,PROM1,VEGFA
PMID:33330580	(2020) Bisphenols and Risk of Breast Cancer: A Narrative Review of the Impact of Diet and Bioactive Food Components.	12	100	1.14	2.09e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,TIMP3,IGF1R,ALDH1A1,CAV1,CCL20,PTGS2,PTEN,BCL2,HPSE,VEGFA,HNF1B
PMID:31561501	(2019) Interplay between BMPs and Reactive Oxygen Species in Cell Signaling and Pathology.	12	100	1.14	2.09e-06	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478319	NOX4,ATM,MAP3K5,PTGS2,PTEN,NOX1,TXN,ALPL,BMP2,NFE2L2,BCL2,GREM1
PMID:28824650	(2017) Developmental and Functional Control of Natural Killer Cells by Cytokines.	12	100	1.14	2.09e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CD69,CD34,ANGPT2,STAT5A,CD247,JAK2,BCL2,IRAK4,MYD88,MME,CCL5
PMID:33604548	(2019) Cytokines frequently implicated in myeloproliferative neoplasms.	10	56	1.31	2.11e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,PDGFB,PDGFA,ELN,JAK2,PDGFD,CCL5,VEGFA
PMID:29392844	(2018) Preconditioning influences mesenchymal stem cell properties in vitro and in vivo.	10	56	1.31	2.11e-06	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANG,CCL20,JAK2,MYD88,BDNF,PROM1,CCL5,VEGFA
PMID:27136535	(2016) The Role of Chemokines in Promoting Colorectal Cancer InvasionMetastasis.	10	56	1.31	2.11e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,STAT5A,CCL20,CXCL9,PTGS2,PTEN,JAK2,CCL5,VEGFA
PMID:21331154	(2011) The endotoxin-induced neuroinflammation model of Parkinsons disease.	10	56	1.31	2.11e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	MPO,IFNG,CD47,PTGS2,NOX1,NFE2L2,BCL2,MYD88,BDNF,CCL5
PMID:19182515	(2009) Paths of FGFR-driven tumorigenesis.	10	56	1.31	2.11e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ANGPT2,PTEN,AR,BCL2,FGFR1,PROM1,VEGFA
PMID:19884985	(2009) Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.	15	187	0.97	2.11e-06	9606.ENSP00000228434,9606.ENSP00000261037,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000357726,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CD69,COL8A1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,SGK1,S100A12,TXN,BCL2,FGFR1,CCL5,VEGFA
PMID:34355542	(2021) Harness the functions of gut microbiome in tumorigenesis for cancer treatment.	11	77	1.22	2.18e-06	9606.ENSP00000225275,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000356729,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000401399	MPO,APC,CDH1,CXCL10,SIRT6,CXCL9,PTGS2,FMO3,PTEN,RHOA,MYD88
PMID:32711004	(2020) Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.	13	127	1.07	2.18e-06	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000478570	IFNG,FABP4,ENPP2,IGF1R,FADS2,LPL,SREBF1,PTEN,AR,G6PD,BCL2,PLA2G2A,VEGFA
PMID:33312396	(2020) Role of platelets and breast cancer stem cells in metastasis.	11	77	1.22	2.18e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,ALDH1A1,CD34,ANG,MAP3K5,PTGS2,RHOA,BDNF,CCL5,VEGFA
PMID:31737038	(2019) Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis.	13	127	1.07	2.18e-06	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000356832,9606.ENSP00000358513,9606.ENSP00000362410,9606.ENSP00000363596,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000400175	MAPK1,IGF1R,CXCL11,SGK1,CNR1,MAFB,CNR2,AR,ALPL,BMP2,JAK2,PDGFD,RHOA
PMID:33809973	(2021) Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer.	12	101	1.14	2.26e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000321853,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000384262,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,MMP14,SERPINF2,STAT5A,ELN,PTEN,HSPG2,JAK2,HPSE,VEGFA
PMID:24728412	(2014) Paracrine effects of stem cells in wound healing and cancer progression (Review).	9	39	1.42	2.28e-06	9606.ENSP00000260356,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ALDH1A1,CD34,PDGFD,BCL2,BDNF,PROM1,CCL5,VEGFA
PMID:23641349	(2013) Cell therapy for diabetic neuropathy using adult stem or progenitor cells.	9	39	1.42	2.28e-06	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,CD34,ANG,PDGFA,CNTF,NTF3,BDNF,PROM1,VEGFA
PMID:17254334	(2007) Primary sclerosing cholangitis--the arteriosclerosis of the bile duct?	9	39	1.42	2.28e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,THBS1,PDGFB,ENTPD1,EDN1,BDNF,CCL5,VEGFA
PMID:33294307	(2021) Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study.	10	57	1.31	2.39e-06	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CCR5,STAT5A,ELN,NOX1,JAK2,BCL2,AGTR1,CCL5,VEGFA
PMID:34408415	(2021) Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy.	10	57	1.31	2.39e-06	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	MAPK1,CD69,STAT5A,CCL20,CD47,ENTPD1,PTEN,MYD88,LTA,CCL5
PMID:31920721	(2019) Where Metabolism Meets Senescence: Focus on Endothelial Cells.	10	57	1.31	2.39e-06	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000478570	CD38,FABP4,ATM,LPL,CD34,PTGS2,EDN1,G6PD,NFE2L2,VEGFA
PMID:28730141	(2017) Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma.	10	57	1.31	2.39e-06	9606.ENSP00000013807,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CHI3L1,THBS1,ANG,CAV1,ENTPD1,PTEN,BDNF,PROM1,VEGFA
PMID:27748151	(2016) Ageing in the musculoskeletal system.	10	57	1.31	2.39e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000478570	TGFB1,IFNG,FABP4,PDGFB,SIRT6,PDGFA,ELN,KL,JAK2,VEGFA
PMID:23076807	(2012) Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.	10	57	1.31	2.39e-06	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CCR5,CXCL10,EDNRA,CAV1,MAP3K5,CXCL9,EDN1,MYD88,CCL5
PMID:34208589	(2021) Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?	11	78	1.21	2.41e-06	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000369816,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CDH1,IGF1R,PTGS2,PTEN,BMP2,SHBG,G6PD,NFE2L2,BCL2,VEGFA
PMID:32899442	(2020) Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals.	14	158	1.01	2.45e-06	9606.ENSP00000222305,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	USF2,APC,CDH1,ATM,CAV1,PTGS2,S100A12,PTEN,NOX1,TXN,JAK2,BCL2,RHOA,VEGFA
PMID:33260925	(2020) The Tumor Microenvironment-A Metabolic Obstacle to NK Cells Activity.	12	102	1.13	2.45e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CCR5,CXCL10,CXCL11,CD34,STAT5A,CXCL9,ENTPD1,RHOA,CCL5,VEGFA
PMID:30648107	(2018) A New Insight into the Roles of MiRNAs in Metabolic Syndrome.	12	102	1.13	2.45e-06	9606.ENSP00000255409,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	CHI3L1,HNF4A,CAV1,SREBF1,ABCG1,SGK1,PTEN,EDN1,NFE2L2,BCL2,NPY,VEGFA
PMID:26913068	(2016) Tumour progression and metastasis.	12	102	1.13	2.45e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,HNF4A,ANGPT2,PDGFB,ANG,CAV1,ELN,CXCL9,CCL5,VEGFA
PMID:25888494	(2015) Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy.	12	102	1.13	2.45e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CCR5,CD34,ANGPT2,PTGS2,EDN1,BCL2,BDNF,PROM1,CCL5,VEGFA
PMID:24672479	(2014) Transcriptomics of post-stroke angiogenesis in the aged brain.	12	102	1.13	2.45e-06	9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000261037,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000418823,9606.ENSP00000478570	TGFB1,LAMC1,COL8A1,CXCL10,MMP14,HNF4A,ANGPT2,PDGFB,ELN,ANGPTL2,FTO,VEGFA
PMID:22154653	(2012) Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.	12	102	1.13	2.45e-06	9606.ENSP00000225275,9606.ENSP00000284031,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000475344,9606.ENSP00000478570	MPO,DDAH1,MMP14,CAV1,ENTPD1,NOX1,TXN,IRAK4,RHOA,TRPC1,APLNR,VEGFA
PMID:32973495	(2020) A Potent Antioxidant Endogenous Neurohormone Melatonin, Rescued MCAO by Attenuating Oxidative Stress-Associated Neuroinflammation.	8	25	1.57	2.46e-06	9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	SIRT6,MAP3K5,PTGS2,TXN,EDN1,NFE2L2,BCL2,BDNF
PMID:21280155	(2011) Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?	8	25	1.57	2.46e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ANG,BCL2,NTF3,MME,CCL5,VEGFA
PMID:35250573	(2022) Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.	10	58	1.3	2.66e-06	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,ALDH1A1,MMP14,CD34,PTEN,BCL2,MYD88,PROM1,VEGFA
PMID:33503905	(2021) Summary of Natural Products Ameliorate Concanavalin A-Induced Liver Injury: Structures, Sources, Pharmacological Effects, and Mechanisms of Action.	11	79	1.2	2.66e-06	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	MPO,CD69,CCR5,CXCL10,CXCL11,CXCL9,JAK2,G6PD,NFE2L2,BCL2,CCL5
PMID:33664576	(2021) Research Trends and Regulation of CCL5 in Prostate Cancer.	9	40	1.41	2.66e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ANG,STAT5A,PTEN,AR,JAK2,CCL5,VEGFA
PMID:33804633	(2021) Cell-Matrix Interactions in the Eye: From Cornea to Choroid.	9	40	1.41	2.66e-06	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000478570	MAPK1,THBS1,NOX4,TIMP3,MMP14,ELN,HSPG2,EDN1,VEGFA
PMID:34566422	(2021) Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimers Disease: Inhibition of Neuroinflammation.	10	58	1.3	2.66e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ANGPT2,PDGFB,NFE2L2,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:34642632	(2021) Corneal Allografts: Factors for and against Acceptance.	10	58	1.3	2.66e-06	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000360250,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,STAT5A,CXCL9,VIP,ENTPD1,NPY,CCL5,VEGFA
PMID:34791817	(2021) Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.	13	130	1.06	2.66e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CDH1,IGF1R,ALDH1A1,PTGS2,CNR1,PTEN,BMP2,JAK2,BCL2,PROM1,VEGFA,HNF1B
PMID:34917616	(2021) Steroid-Induced Osteonecrosis of the Femoral Head: Novel Insight Into the Roles of Bone Endothelial Cells in Pathogenesis and Treatment.	9	40	1.41	2.66e-06	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFB,PTEN,BMP2,EDN1,NFE2L2,BCL2,PROM1,VEGFA
PMID:32348616	(2020) Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.	9	40	1.41	2.66e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ALDH1A1,AR,BMP2,JAK2,PROM1,VEGFA
PMID:32823917	(2020) Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease.	12	103	1.13	2.66e-06	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252	EPOR,MPO,NOX4,DDAH1,LPL,LPA,PTGS2,NOX1,TXN,EDN1,KL,NFE2L2
PMID:32887518	(2020) Ceramic Scaffolds in a Vacuum Suction Handle for Intraoperative Stromal Cell Enrichment.	9	40	1.41	2.66e-06	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000369816,9606.ENSP00000474412	CHI3L1,THBS1,AMBP,CD34,ANG,RBP4,BMP2,SHBG,CCL5
PMID:33072751	(2020) The Roles of TGF-beta Signaling in Cerebrovascular Diseases.	11	79	1.2	2.66e-06	9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	TIMP3,MAPK7,ANGPT2,PDGFB,PTEN,BAMBI,BMP2,EDN1,RHOA,GREM1,VEGFA
PMID:31075951	(2019) American Ginseng (Panax quinquefolium L.) as a Source of Bioactive Phytochemicals with Pro-Health Properties.	9	40	1.41	2.66e-06	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000301522,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,PLIN1,PRDX2,SREBF1,EDN1,BCL2,MME,CCL5,VEGFA
PMID:31363385	(2019) Recent advances and perspectives in next generation sequencing application to the genetic research of type 2 diabetes.	10	58	1.3	2.66e-06	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000360997,9606.ENSP00000375844,9606.ENSP00000401399,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,KCNJ11,SREBF1,ABCG1,ADAMTS13,CAPN10,MYD88,FTO,HNF1B
PMID:31552878	(2019) Effect of intermittent hyperoxia on stem cell mobilization and cytokine expression.	7	14	1.76	2.66e-06	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ATM,CD34,ANG,PROM1,CCL5,VEGFA
PMID:31814880	(2019) Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies.	9	40	1.41	2.66e-06	9606.ENSP00000263317,9606.ENSP00000349860,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000362463,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,GFPT1,PTGS2,NOX1,GLO1,G6PD,NFE2L2,BCL2,VEGFA
PMID:29355711	(2018) Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.	11	79	1.2	2.66e-06	9606.ENSP00000215832,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CCL20,CNTF,PTGS2,TXN,NFE2L2,BCL2,BDNF,MME,CCL5,VEGFA
PMID:29459345	(2018) Melanoma exosomes promote mixed M1 and M2 macrophage polarization.	9	40	1.41	2.66e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,MYD88,CCL5,VEGFA
PMID:29956461	(2018) The regulatory role of microRNAs in angiogenesis-related diseases.	13	130	1.06	2.66e-06	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,SOX9,THBS1,CDH1,TIMP3,HNF4A,ANGPT2,STAT5A,PTEN,BCL2,FGFR1,PROM1,VEGFA
PMID:28744148	(2017) Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.	11	79	1.2	2.66e-06	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,CD34,MAPK7,HNF4A,PTEN,PDGFD,RHOA,PROM1,VEGFA
PMID:28841158	(2017) Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.	10	58	1.3	2.66e-06	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CCL20,CNTF,BMP2,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:29348771	(2017) A Review on the Medicinal Plant Dalbergia odorifera Species: Phytochemistry and Biological Activity.	9	40	1.41	2.66e-06	9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,ELN,PTGS2,PTEN,BMP2,EDN1,JAK2,BCL2,VEGFA
PMID:25700367	(2015) PDGFRalpha in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer.	9	40	1.41	2.66e-06	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000478570	MAPK1,CDH1,CXCL11,HNF4A,PDGFB,PDGFA,PTEN,PDGFD,VEGFA
PMID:26257740	(2015) MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities.	9	40	1.41	2.66e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MPO,IFNG,CCR5,CXCL10,ELN,ABCG1,CCL5,GREM1,VEGFA
PMID:26395334	(2015) Eyeing the Cyr61CTGFNOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities.	10	58	1.3	2.66e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	MAPK1,TGFB1,ENPP2,THBS1,CDH1,PDGFA,ALPL,BMP2,GREM1,VEGFA
PMID:24740729	(2014) Lipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?	9	40	1.41	2.66e-06	9606.ENSP00000200676,9606.ENSP00000246553,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000401399,9606.ENSP00000418525	CETP,FFAR1,LPL,SIRT6,SREBF1,ABCG1,NOX1,MYD88,MME
PMID:24998240	(2014) Protein kinases and associated pathways in pluripotent state and lineage differentiation.	14	160	1.0	2.66e-06	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478319	MAPK1,CDH1,IGF1R,CD34,ANGPT2,STAT5A,PTEN,BMP2,JAK2,BCL2,FGFR1,RHOA,PROM1,GREM1
PMID:25436148	(2014) Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system.	9	40	1.41	2.66e-06	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000402152,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	PON2,NOX4,CXCL11,PTGS2,SGK1,SLC12A3,MME,CCL5,VEGFA
PMID:21497738	(2011) Mechanisms of hepatic fibrogenesis.	10	58	1.3	2.66e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000358513,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,SREBF1,CXCL9,CNR1,BAMBI,EDN1,CCL5,VEGFA
PMID:22025123	(2011) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.	11	79	1.2	2.66e-06	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,NOX4,CXCL10,EDNRA,ELN,PTGS2,PTEN,BAMBI,EDN1,AGTR1,VEGFA
PMID:24212934	(2011) Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer.	10	58	1.3	2.66e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,MYD88,CCL5,VEGFA
PMID:20041838	(2010) Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.	9	40	1.41	2.66e-06	9606.ENSP00000315011,9606.ENSP00000321853,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	EDNRA,SERPINF2,ELN,COMT,MTHFR,EDN1,RHOA,AGTR1,VEGFA
PMID:18404423	(2007) Shaping immune responses through the activation of dendritic cells P2 receptors.	10	58	1.3	2.66e-06	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000474412	THBS1,CCR5,P2RY1,CXCL10,CXCL11,CD34,CXCL9,CD47,ENTPD1,CCL5
PMID:35163897	(2022) Beneficial Health Effects of Glucosinolates-Derived Isothiocyanates on Cardiovascular and Neurodegenerative Diseases.	13	131	1.06	2.77e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,LPL,SREBF1,PTGS2,PTEN,GAP43,NFE2L2,RHOA,BDNF,MME,CCL5,VEGFA
PMID:34067242	(2021) Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential.	11	80	1.2	2.81e-06	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IGF1R,CCR5,CXCL10,STAT5A,PTGS2,SGK1,EDN1,JAK2,BCL2,VEGFA
PMID:34141616	(2021) Radiation Resistance: A Matter of Transcription Factors.	11	80	1.2	2.81e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,ATM,ALDH1A1,PTGS2,TXN,AR,JAK2,BCL2,PROM1,VEGFA
PMID:32708049	(2020) Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors.	11	80	1.2	2.81e-06	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412	SOX9,IGF1R,ATM,ALDH1A1,CXCL9,PTEN,AR,JAK2,BCL2,RHOA,CCL5
PMID:30413826	(2019) Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.	11	80	1.2	2.81e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,CCR5,PTGS2,ENTPD1,NOX1,JAK2,MYD88,LTA,CCL5,VEGFA
PMID:30669338	(2019) The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry.	11	80	1.2	2.81e-06	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	THBS1,MMP14,ANGPT2,ANG,ELN,CD47,PTEN,BMP2,BCL2,FGFR1,MME
PMID:30965656	(2019) Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments.	11	80	1.2	2.81e-06	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	MPO,CDH1,NOX4,ATM,CD34,NOX1,EDN1,KL,BCL2,AGTR1,VEGFA
PMID:32382711	(2019) The effects of growth hormone on therapy resistance in cancer.	11	80	1.2	2.81e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,ALDH1A1,CD34,STAT5A,ABCG1,PTEN,JAK2,BCL2,VEGFA
PMID:30429887	(2018) The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.	11	80	1.2	2.81e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CCL20,PTGS2,JAK2,SAA1,IRAK4,RHOA,MME,CCL5,VEGFA
PMID:19390566	(2009) Immunoregulatory functions of mTOR inhibition.	11	80	1.2	2.81e-06	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,CXCL11,CD34,STAT5A,CXCL9,PTEN,MYD88,CCL5,VEGFA
PMID:35006395	(2021) Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia.	10	59	1.29	2.87e-06	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ATM,CCR5,ALDH1A1,CD34,STAT5A,CD47,BCL2,PROM1,VEGFA
PMID:30314283	(2018) CEACAM1 in Liver Injury, Metabolic and Immune Regulation.	10	59	1.29	2.87e-06	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354782,9606.ENSP00000368683,9606.ENSP00000381185	CD69,IFNG,CDH1,IGF1R,HNF4A,STAT5A,SREBF1,CD247,EDN1,BCL2
PMID:24815358	(2015) Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.	10	59	1.29	2.87e-06	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000375844,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000419422,9606.ENSP00000478570	TIMP3,MMP14,LPL,ELN,ABCG1,CAPN10,BCL2,PLA2G2A,AGTR1,VEGFA
PMID:33806390	(2021) HIV-Exposed Seronegative Sex Workers Express Low T-Cell Activation and an Intact Ectocervical Tissue Microenvironment.	8	26	1.55	2.91e-06	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185	CD69,CDH1,CCR5,CXCL10,CCL20,CXCL9,ENTPD1,BCL2
PMID:23475077	(2014) Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.	8	26	1.55	2.91e-06	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,THBS1,CD34,ANGPT2,PDGFB,FGFR1,PROM1,VEGFA
PMID:22749173	(2012) HIV persistence: chemokines and their signalling pathways.	8	26	1.55	2.91e-06	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000400175	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,RHOA
PMID:33391518	(2021) Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.	12	105	1.12	2.93e-06	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000418009,9606.ENSP00000418525,9606.ENSP00000445772,9606.ENSP00000478570	CD69,FABP4,CAV1,SREBF1,CXCL9,ABCG1,CD47,ENTPD1,RARRES2,MME,LTB4R2,VEGFA
PMID:33925575	(2021) Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.	13	132	1.05	2.93e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CCR5,CXCL10,CXCL11,CD34,CCL20,ELN,CXCL9,PTEN,BCL2,CCL5,VEGFA
PMID:34712322	(2021) Molecular Mechanisms and Functions of lncRNAs in the Inflammatory Reaction of Diabetes Mellitus.	9	41	1.4	2.93e-06	9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	TIMP3,PTEN,NOX1,JAK2,BCL2,RHOA,MYD88,MME,VEGFA
PMID:34943862	(2021) Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases.	12	105	1.12	2.93e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000246553,9606.ENSP00000300055,9606.ENSP00000354995,9606.ENSP00000360250,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,FFAR1,PLIN1,ABCG1,ENTPD1,RBP4,EDN1,AGTR1,LTB4R2,CCL5,VEGFA
PMID:31897542	(2020) Epigenetics in age-related macular degeneration: new discoveries and future perspectives.	9	41	1.4	2.93e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,THBS1,ANGPT2,PDGFB,SIRT6,TXN,BCL2,MYD88,VEGFA
PMID:30895179	(2019) Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure.	12	105	1.12	2.93e-06	9606.ENSP00000260356,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,KLF10,CD34,ANGPT2,PDGFB,SIRT6,CAV1,PDGFA,EDN1,PDGFD,RHOA,VEGFA
PMID:30048707	(2018) 20-HETE in the regulation of vascular and cardiac function.	9	41	1.4	2.93e-06	9606.ENSP00000246553,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	FFAR1,HNF4A,ELN,AR,EDN1,G6PD,AGTR1,CCL5,VEGFA
PMID:30197479	(2018) Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives.	9	41	1.4	2.93e-06	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CD34,EDNRA,PTGS2,EDN1,BCL2,RHOA,MYD88,VEGFA
PMID:22240445	(2012) Novel tyrosine kinase signaling pathways:  implications in vascular remodeling.	9	41	1.4	2.93e-06	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,PDGFB,GAS6,CAV1,PDGFA,JAK2,PDGFD,FGFR1,VEGFA
PMID:21194007	(2011) A systems view of epithelial-mesenchymal transition signaling states.	14	162	1.0	2.93e-06	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000426809	MAPK1,THBS1,CDH1,IGF1R,PRDX2,MMP14,GAS6,PTGS2,TXN,BMP2,JAK2,NFE2L2,FGFR1,PROM1
PMID:21223965	(2011) Chemokines in health and disease.	12	105	1.12	2.93e-06	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CXCL11,MMP14,CCL20,CXCL9,PTEN,MYD88,CCL5,NR1H3,VEGFA
PMID:33418929	(2021) IL-12 Family Cytokines in Cancer and Immunotherapy.	11	81	1.19	3.02e-06	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,ENTPD1,JAK2,BCL2,CCL5,VEGFA
PMID:33670492	(2021) Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines.	11	81	1.19	3.02e-06	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000361021,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	FABP4,CDH1,IGF1R,APPL1,PTEN,CAP1,JAK2,RARRES2,AGTR1,APLNR,VEGFA
PMID:33673405	(2021) Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.	11	81	1.19	3.02e-06	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,GAS6,CXCL9,HSPG2,JAK2,BCL2,FGFR1,MME,CCL5,VEGFA
PMID:34956899	(2021) Osteosarcoma and Metastasis.	11	81	1.19	3.02e-06	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,THBS1,CDH1,IGF1R,MMP14,PTEN,ANGPTL2,BCL2,FGFR1,CCL5,VEGFA
PMID:35127700	(2021) Inflammation and Myeloid Cells in Cancer Progression and Metastasis.	11	81	1.19	3.02e-06	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,GAS6,CXCL9,CD47,PTGS2,ENTPD1,CCL5,VEGFA
PMID:29499103	(2018) Precision medicine in diabetes prevention, classification and management.	11	81	1.19	3.02e-06	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000226760,9606.ENSP00000288266,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000356438,9606.ENSP00000375844,9606.ENSP00000403495,9606.ENSP00000480291	CETP,PON2,WFS1,APPL1,LPL,HNF4A,KCNJ11,PTGS2,CAPN10,LTA,HNF1B
PMID:32900001	(2020) The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.	16	230	0.9	3.09e-06	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000227868,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000478570	ERCC1,MAPK1,PDHX,FABP4,NOX4,ATM,CCR5,CXCL10,CD34,CCL20,NOX1,TXN,JAK2,RHOA,LTA,VEGFA
PMID:31805752	(2019) Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.	13	133	1.05	3.09e-06	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000284031,9606.ENSP00000308208,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,FABP4,THBS1,CDH1,DDAH1,MMP14,SREBF1,PTEN,BCL2,NPY,MYD88,CCL5,VEGFA
PMID:33613850	(2021) Cancer stem cells and macrophages: molecular connections and future perspectives against cancer.	10	60	1.28	3.17e-06	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,ALDH1A1,CD34,CCL20,CD47,PTGS2,BCL2,PROM1,CCL5,VEGFA
PMID:34440278	(2021) Pharmacological Properties of Polyphenols: Bioavailability, Mechanisms of Action, and Biological Effects in In Vitro Studies, Animal Models, and Humans.	10	60	1.28	3.17e-06	9606.ENSP00000013807,9606.ENSP00000256104,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	ERCC1,FABP4,SIRT6,SREBF1,PTEN,EDN1,JAK2,BCL2,BDNF,VEGFA
PMID:34764771	(2021) Assessing the effect of human dental pulp mesenchymal stem cell secretome on human oral, breast, and melanoma cancer cell lines.	10	60	1.28	3.17e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,CDH1,ATM,CXCL10,CD34,ANGPT2,BMP2,BCL2,VEGFA
PMID:33101419	(2020) Herb-Derived Products: Natural Tools to Delay and Counteract Stem Cell Senescence.	10	60	1.28	3.17e-06	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	ERCC1,ATM,CD34,SIRT6,BMP2,BCL2,BDNF,PROM1,VEGFA,HNF1B
PMID:31398937	(2019) The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update.	10	60	1.28	3.17e-06	9606.ENSP00000245479,9606.ENSP00000246553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,FFAR1,CDH1,IGF1R,CCR5,CXCL10,PTGS2,BCL2,CCL5,VEGFA
PMID:31505789	(2019) Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models.	10	60	1.28	3.17e-06	9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000361883,9606.ENSP00000369816,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	IGF1R,SIRT6,PTGS2,PTEN,CAP1,SHBG,RHOA,RARRES2,APLNR,VEGFA
PMID:26740741	(2015) Interplay Between Metabolism and Oncogenic Process: Role of microRNAs.	12	106	1.11	3.17e-06	9606.ENSP00000227868,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	PDHX,THBS1,CDH1,IGF1R,SIRT6,PTEN,EDN1,G6PD,NFE2L2,BCL2,RHOA,VEGFA
PMID:22359288	(2012) DNA methylation in promoter region as biomarkers in prostate cancer.	10	60	1.28	3.17e-06	9606.ENSP00000232219,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000418525	RBP1,APC,CDH1,TIMP3,IGF1R,LPL,CAV1,PTGS2,BCL2,MME
PMID:32028963	(2020) Crosstalk between autophagy and metabolic regulation of cancer stem cells.	11	82	1.19	3.31e-06	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000349860,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000426809	CD38,ALDH1A1,CD34,SIRT6,GFPT1,TXN,G6PD,NFE2L2,RHOA,MYD88,PROM1
PMID:32503307	(2020) Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.	11	82	1.19	3.31e-06	9606.ENSP00000013807,9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,MYH9,CDH1,IGF1R,ATM,CCL20,PTGS2,PTEN,NFE2L2,FGFR1,VEGFA
PMID:30532012	(2019) The lung microenvironment: an important regulator of tumour growth and metastasis.	11	82	1.19	3.31e-06	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,IGF1R,MMP14,ANGPT2,GAS6,PTGS2,JAK2,FGFR1,LTB4R2,CCL5,VEGFA
PMID:20637061	(2010) Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1+c-Kit+ population from the fetal to adult stages of development.	11	82	1.19	3.31e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000445772,9606.ENSP00000475344	CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,ENTPD1,MYD88,BDNF,LTB4R2,APLNR
PMID:29263924	(....) redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy.	11	82	1.19	3.31e-06	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000445772	CDH1,NOX4,MMP14,HNF4A,MAP3K5,PTEN,NOX1,TXN,RHOA,PROM1,LTB4R2
PMID:35281302	(2022) Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future.	9	42	1.39	3.33e-06	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000358513,9606.ENSP00000362463,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000419422	CD34,EDNRA,CNR1,GLO1,EDN1,KL,JAK2,NFE2L2,AGTR1
PMID:32620049	(2020) Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors.	9	42	1.39	3.33e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000384262,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,ANGPT2,CD247,CXCL9,HPSE,CCL5,VEGFA
PMID:32858940	(2020) Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?	9	42	1.39	3.33e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,CDH1,CXCL10,PTEN,PDGFD,BCL2,BDNF,AGTR1,VEGFA
PMID:28955710	(2017) Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology.	9	42	1.39	3.33e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,STAT5A,MAP3K5,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:27230798	(2016) The next generation of therapeutics for chronic kidney disease.	9	42	1.39	3.33e-06	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000317674,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000478570	NOX4,CCR5,APOL1,ELN,MAP3K5,PTEN,NOX1,JAK2,VEGFA
PMID:23316132	(2012) Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection.	9	42	1.39	3.33e-06	9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,EDNRA,ELN,MAP3K5,CNTF,EDN1,GAP43,BDNF,VEGFA
PMID:21903148	(2011) The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.	9	42	1.39	3.33e-06	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,CNTF,BMP2,GAP43,NTF3,BDNF,PROM1,VEGFA
PMID:21975295	(2011) Hydrogen peroxide: a Jekyll and Hyde signalling molecule.	9	42	1.39	3.33e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000445772	TGFB1,IFNG,NOX4,STAT5A,MAP3K5,PTEN,NOX1,TXN,LTB4R2
PMID:20865011	(2010) Kaposis sarcoma and its associated herpesvirus.	9	42	1.39	3.33e-06	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,ATM,CD34,ANGPT2,ANG,PTGS2,BCL2,RHOA,VEGFA
PMID:30060511	(2018) Revisiting the Advances in Isolation, Characterization and Secretome of Adipose-Derived StromalStem Cells.	12	107	1.11	3.36e-06	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000322898,9606.ENSP00000337332,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CCR5,CD34,HNF4A,ANGPT2,EBF1,SIRT6,FMOD,BMP2,BDNF,CCL5,VEGFA
PMID:35204706	(2022) Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives.	8	27	1.53	3.45e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000304767,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000376865,9606.ENSP00000474412	MPO,THBS1,P2RY1,PDGFB,PDGFA,ELN,PDGFD,CCL5
PMID:29167395	(2017) Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.	8	27	1.53	3.45e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000383232	IFNG,CDH1,CXCL10,CXCL11,MMP14,ELN,CXCL9,GGT1
PMID:24027672	(2013) Current evidence linking polyunsaturated Fatty acids with cancer risk and progression.	8	27	1.53	3.45e-06	9606.ENSP00000278840,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000445772,9606.ENSP00000478570	FADS2,CD34,ANGPT2,PTGS2,AR,BCL2,LTB4R2,VEGFA
PMID:19956432	(2009) Integrin signaling aberrations in prostate cancer.	8	27	1.53	3.45e-06	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	IGF1R,PTEN,AR,EDN1,BCL2,RHOA,MME,VEGFA
PMID:35256842	(2022) Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review.	13	135	1.04	3.49e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	MPO,IFNG,MMP14,MAPK7,PTEN,JAK2,NFE2L2,RHOA,MYD88,BDNF,PROM1,VEGFA,HNF1B
PMID:35371975	(2022) IL-6JAKSTAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment.	10	61	1.28	3.49e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ALDH1A1,CNTF,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:33818447	(2021) A review on the neuroprotective effects of hyperbaric oxygen therapy.	10	61	1.28	3.49e-06	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CAV1,PTGS2,BMP2,GAP43,NFE2L2,BCL2,NTF3,BDNF,VEGFA
PMID:33066211	(2020) Antioxidant and Biological Properties of Mesenchymal Cells Used for Therapy in Retinitis Pigmentosa.	10	61	1.28	3.49e-06	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,IFNG,PRDX2,CD34,ANG,CNTF,GAP43,BCL2,BDNF,VEGFA
PMID:30076548	(2019) The therapeutic potential of targeting the endothelial-to-mesenchymal transition.	10	61	1.28	3.49e-06	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422	HSPB1,NOX4,MAPK7,CAV1,BMP2,EDN1,FGFR1,RHOA,MME,AGTR1
PMID:29064461	(2017) Endocrine Disruptors Leading to Obesity and Related Diseases.	10	61	1.28	3.49e-06	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,CDH1,LPL,PTGS2,RBP4,ANGPTL2,AR,BMP2,RARRES2,VEGFA
PMID:26106142	(2015) Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.	10	61	1.28	3.49e-06	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	CD69,CDH1,IGF1R,ATM,CXCL9,PTGS2,AR,G6PD,BCL2,VEGFA
PMID:24473167	(2014) Marine low molecular weight natural products as potential cancer preventive compounds.	10	61	1.28	3.49e-06	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,HSPB1,IGF1R,ATM,STAT5A,PTGS2,JAK2,BCL2,MYD88,VEGFA
PMID:21092315	(2010) Long descending cervical propriospinal neurons differ from thoracic propriospinal neurons in response to low thoracic spinal injury.	10	61	1.28	3.49e-06	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,HSPB1,CNTF,TXN,GAP43,BCL2,NPY,FGFR1,NTF3,BDNF
PMID:34830815	(2021) Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives.	11	83	1.18	3.54e-06	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,ATM,ANGPT2,PDGFB,CAV1,PTEN,BCL2,FGFR1,RARRES2,CCL5,VEGFA
PMID:30758706	(2019) Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?	11	83	1.18	3.54e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,TGFB1,CD69,IFNG,SIRT6,STAT5A,PTGS2,TXN,IRAK4,MYD88,CCL5
PMID:31505803	(2019) Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.	11	83	1.18	3.54e-06	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,ATM,ALDH1A1,GAS6,PTGS2,PTEN,AR,JAK2,PROM1,VEGFA
PMID:31750245	(2019) Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells.	11	83	1.18	3.54e-06	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,CCR5,CXCL10,CXCL11,CD34,CD247,CXCL9,ENTPD1,CCL5,VEGFA
PMID:34207884	(2021) Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead.	12	108	1.11	3.60e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,CXCL10,CD247,CXCL9,BCL2,HPSE,FGFR1,PROM1,CCL5,VEGFA
PMID:24439368	(2014) What we talk about when we talk about fat.	12	108	1.11	3.60e-06	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000418009,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,PLIN1,CD34,EBF1,CAV1,SREBF1,RBP4,BMP2,RARRES2,MME,CCL5,VEGFA
PMID:19061437	(2009) PPARs and the cardiovascular system.	12	108	1.11	3.60e-06	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000419422,9606.ENSP00000478570	CXCL10,LPL,MAPK7,CAV1,CXCL9,ABCG1,PTEN,TXN,EDN1,PLA2G2A,AGTR1,VEGFA
PMID:20090210	(2009) Mediators of ocular angiogenesis.	12	108	1.11	3.60e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,TIMP3,CCR5,MMP14,ANGPT2,CXCL9,PTGS2,FGFR1,AGTR1,CCL5,VEGFA
PMID:34769446	(2021) Dental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential.	13	136	1.04	3.69e-06	9606.ENSP00000215832,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354511,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL11,CD34,ANGPT2,COMT,CNTF,BMP2,BCL2,RHOA,BDNF,MME,CCL5,VEGFA
PMID:31270397	(2019) The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Session.	13	136	1.04	3.69e-06	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD69,CCR5,CD34,ANGPT2,ELN,CD247,CXCL9,PTEN,JAK2,BCL2,MME
PMID:31681564	(2019) Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance.	13	136	1.04	3.69e-06	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809	SOX9,APC,IGF1R,ALDH1A1,PTGS2,PTEN,TXN,AR,JAK2,NFE2L2,BCL2,BDNF,PROM1
PMID:31212986	(2019) Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?	9	43	1.38	3.77e-06	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CCR5,MMP14,PDGFB,ANG,EDN1,BCL2,PROM1,VEGFA
PMID:31861156	(2019) Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.	9	43	1.38	3.77e-06	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	TGFB1,THBS1,NOX4,TIMP3,SREBF1,PTEN,TXN,NFE2L2,BCL2
PMID:30081463	(2018) Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.	9	43	1.38	3.77e-06	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,MPO,CCR5,CD34,CAV1,JAK2,PROM1,CCL5,VEGFA
PMID:34218797	(2021) Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.	14	167	0.98	3.83e-06	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000347041,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000384262,9606.ENSP00000384906,9606.ENSP00000419422,9606.ENSP00000478319	CD38,CHI3L1,THBS1,CXCL10,CXCL11,FMOD,CD247,CXCL9,EDN1,PLA2G2A,HPSE,SAA1,AGTR1,GREM1
PMID:32456226	(2020) Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications.	14	167	0.98	3.83e-06	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,IGF1R,MAPK7,CAV1,PTGS2,NOX1,JAK2,NFE2L2,BCL2,FGFR1,RHOA,PROM1,VEGFA
PMID:32754274	(2020) Stem cell programs in cancer initiation, progression, and therapy resistance.	14	167	0.98	3.83e-06	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CDH1,ALDH1A1,CD34,HNF4A,PTEN,JAK2,BCL2,MYD88,MME,FTO,PROM1,VEGFA
PMID:34480570	(2022) The Impact of Long-term Physical Inactivity on Adipose Tissue Immunometabolism.	10	62	1.27	3.86e-06	9606.ENSP00000229135,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,AMBP,CXCL10,CD34,PRKAA1,SREBF1,CCL20,SAA1,CCL5,VEGFA
PMID:33589595	(2021) Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.	12	109	1.1	3.86e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CDH1,ATM,CD34,HNF4A,CAV1,PTEN,AR,JAK2,RHOA,MME,PROM1
PMID:33677234	(2021) In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review.	10	62	1.27	3.86e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CCL20,CXCL9,PTGS2,BCL2,LTA,CCL5,VEGFA
PMID:33758607	(2021) Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma.	12	109	1.1	3.86e-06	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000383232,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000478570,9606.ENSP00000480291	ERCC1,CDH1,ATM,ALDH1A1,PTEN,TXN,BCL2,GGT1,FGFR1,MME,VEGFA,HNF1B
PMID:33922556	(2021) Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?	10	62	1.27	3.86e-06	9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000478570	CD69,IGF1R,CXCL10,CXCL11,GAS6,CCL20,CXCL9,ENTPD1,PTEN,VEGFA
PMID:34698884	(2021) MicroRNA-34a: the bad guy in age-related vascular diseases.	10	62	1.27	3.86e-06	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000477707	SOX9,ATM,HNF4A,ELN,ABCG1,BMP2,KL,NFE2L2,BCL2,NR1H3
PMID:35010954	(2021) Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.	10	62	1.27	3.86e-06	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,IGF1R,ELN,CNTF,PTEN,JAK2,NFE2L2,BCL2,CCL5,VEGFA
PMID:32091396	(2020) Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta.	13	137	1.04	3.86e-06	9606.ENSP00000013807,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000365256,9606.ENSP00000478570	ERCC1,IFNG,FABP4,ENPP2,THBS1,CD34,HNF4A,EBF1,ELN,PTGS2,ALPL,CLCN5,VEGFA
PMID:32230747	(2020) Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial.	10	62	1.27	3.86e-06	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000419313,9606.ENSP00000478570	MAPK1,NOX4,IGF1R,CD34,STAT5A,ELN,KL,JAK2,TRPC1,VEGFA
PMID:32457653	(2020) Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells.	10	62	1.27	3.86e-06	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CXCL11,CD34,MAP3K5,HSPG2,EDN1,BCL2,RHOA,AGTR1,CCL5,VEGFA
PMID:32982722	(2020) The Role of Eicosanoids in Gynecological Malignancies.	11	84	1.18	3.86e-06	9606.ENSP00000246553,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000445772,9606.ENSP00000478570	FFAR1,CD34,HNF4A,EDNRA,SIRT6,PTEN,EDN1,BCL2,FGFR1,LTB4R2,VEGFA
PMID:33101283	(2020) Neutrophil: A New Player in Metastatic Cancers.	10	62	1.27	3.86e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,CCR5,CXCL10,MMP14,CD247,CD47,PTGS2,BCL2,VEGFA
PMID:33198257	(2020) Biological Activity of Berberine-A Summary Update.	11	84	1.18	3.86e-06	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	APC,CDH1,ATM,SREBF1,PTGS2,PTEN,MAFB,JAK2,BCL2,BDNF,VEGFA
PMID:31363792	(2019) The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms.	11	84	1.18	3.86e-06	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	FFAR1,FABP4,CCR5,CXCL10,SIRT6,ABCG1,PTGS2,TXN,RHOA,MYD88,CCL5
PMID:29772777	(2018) Oxidative Stress in Preeclampsia and Placental Diseases.	11	84	1.18	3.86e-06	9606.ENSP00000263317,9606.ENSP00000265132,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,AMBP,CAV1,PTGS2,NOX1,TXN,EDN1,NFE2L2,BCL2,AGTR1,VEGFA
PMID:27787930	(2017) Stromal contributions to the carcinogenic process.	11	84	1.18	3.86e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CXCL10,MMP14,PDGFB,CXCL9,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:29244857	(2017) Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.	10	62	1.27	3.86e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,TIMP3,CXCL10,CXCL11,ANGPT2,ANG,LTA,CCL5,VEGFA
PMID:26116759	(2016) Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.	10	62	1.27	3.86e-06	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303	IFNG,IGF1R,PDGFA,CNTF,EDN1,BCL2,NPY,FGFR1,NTF3,BDNF
PMID:27586516	(2016) Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction.	10	62	1.27	3.86e-06	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,IGF1R,CD34,ANG,PTEN,JAK2,BCL2,BDNF,CCL5,VEGFA
PMID:21448265	(2011) Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages.	10	62	1.27	3.86e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000403495,9606.ENSP00000474412	CD38,IFNG,FABP4,PLIN1,CXCL10,CD34,CXCL9,CD47,LTA,CCL5
PMID:29094041	(2017) MicroRNA as a Therapeutic Target in Cardiac Remodeling.	14	168	0.98	3.97e-06	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000306124,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,THBS1,CDH1,VDAC1,TIMP3,PRKCE,CXCL11,ELN,PTEN,EDN1,BCL2,FGFR1,RHOA,AGTR1
PMID:34970551	(2021) Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.	8	28	1.52	4.05e-06	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	IGF1R,CCR5,CXCL10,CXCL9,PTEN,JAK2,BCL2,CCL5
PMID:30922331	(2019) High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways.	8	28	1.52	4.05e-06	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,THBS1,TIMP3,HNF4A,PDGFB,PDGFA,EDN1,VEGFA
PMID:31205939	(2019) Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities.	8	28	1.52	4.05e-06	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CD34,HNF4A,CD47,PTEN,PROM1,CCL5,VEGFA
PMID:31849644	(2019) Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction.	8	28	1.52	4.05e-06	9606.ENSP00000200676,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CETP,CD34,ANGPT2,ELN,BMP2,EDN1,PROM1,VEGFA
PMID:28075449	(2017) Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.	8	28	1.52	4.05e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,TGFB1,IFNG,IGF1R,PTEN,BCL2,CCL5,VEGFA
PMID:34138315	(2021) Recent Advancements in Nanomedicine for Cold Tumor Immunotherapy.	12	110	1.1	4.09e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CCL20,ELN,CXCL9,CD47,PTGS2,ENTPD1,PTEN,CCL5,VEGFA
PMID:35346266	(2022) Non-coding RNAs in the regulation of blood-brain barrier functions in central nervous system disorders.	13	138	1.04	4.10e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000379256,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,THBS1,SIRT6,CAV1,PTEN,NCALD,PLA2G2A,RHOA,MYD88,BDNF,CCL5,VEGFA
PMID:21318045	(2011) Recent Advances in the Pathobiology of Hodgkins Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.	13	138	1.04	4.10e-06	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000419422	THBS1,ATM,ALDH1A1,CD34,EDNRA,STAT5A,CD47,PTGS2,PTEN,JAK2,BCL2,MME,AGTR1
PMID:31878316	(2019) Multiple Biological Effects of an Iridoid Glucoside, Catalpol and Its Underlying Molecular Mechanisms.	11	85	1.17	4.14e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000475344,9606.ENSP00000478570	MPO,IFNG,NOX4,IGF1R,GAP43,NFE2L2,BCL2,RHOA,BDNF,APLNR,VEGFA
PMID:29752993	(2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy.	11	85	1.17	4.14e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CXCL10,CD34,CD47,PTEN,AR,PROM1,CCL5,VEGFA
PMID:25448041	(2015) Epigenetic targets for novel therapies of lung diseases.	11	85	1.17	4.14e-06	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD38,CXCL10,CAV1,STAT5A,ELN,PTGS2,PTEN,NFE2L2,BCL2,RHOA,VEGFA
PMID:25952672	(2015) Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts.	14	169	0.98	4.19e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000384262,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000477707	MAPK1,TGFB1,CD38,THBS1,COL8A1,CXCL10,CXCL11,GAS6,CXCL9,HPSE,MYD88,LTA,CCL5,NR1H3
PMID:35237381	(2022) Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.	10	63	1.26	4.21e-06	9606.ENSP00000226760,9606.ENSP00000354511,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525	WFS1,COMT,CNTF,NFE2L2,BCL2,NTF3,RHOA,MYD88,BDNF,MME
PMID:33059744	(2020) Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.	10	63	1.26	4.21e-06	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,IGF1R,CCR5,ALDH1A1,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:23840250	(2013) Cardiovascular effects of salvianolic Acid B.	10	63	1.26	4.21e-06	9606.ENSP00000228434,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CD69,PRDX2,CXCL10,CXCL11,CXCL9,EDN1,JAK2,NFE2L2,BCL2,VEGFA
PMID:34035882	(2021) Perivascular cell-derived extracellular vesicles stimulate colorectal cancer revascularization after withdrawal of antiangiogenic drugs.	9	44	1.37	4.22e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CD34,ANGPT2,GAS6,PROM1,CCL5,VEGFA
PMID:34680897	(2021) Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review.	7	16	1.7	4.22e-06	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CD38,ATM,ALDH1A1,CD34,PROM1,VEGFA
PMID:31723086	(2020) Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease.	9	44	1.37	4.22e-06	9606.ENSP00000222305,9606.ENSP00000309757,9606.ENSP00000322898,9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000376865,9606.ENSP00000377192	USF2,LPL,EBF1,PTEN,GLO1,AR,MTHFR,PDGFD,G6PD
PMID:32117120	(2020) Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children.	9	44	1.37	4.22e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185	THBS1,CDH1,TIMP3,CXCL10,CXCL11,CXCL9,PTGS2,JAK2,BCL2
PMID:32273900	(2020) The Mtb-HIV syndemic interaction: why treating M. tuberculosis infection may be crucial for HIV-1 eradication.	9	44	1.37	4.22e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CD38,IFNG,CCR5,CXCL10,CD34,CXCL9,MYD88,PROM1,CCL5
PMID:33411679	(2020) Transplanting Rac1-silenced bone marrow mesenchymal stem cells promote neurological function recovery in TBI mice.	9	44	1.37	4.22e-06	9606.ENSP00000222139,9606.ENSP00000260356,9606.ENSP00000331831,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,THBS1,GAS6,NOX1,EDN1,BCL2,NTF3,BDNF,VEGFA
PMID:30828330	(2019) Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.	9	44	1.37	4.22e-06	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000377192,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,IGF1R,CXCL10,CXCL11,CXCL9,ENTPD1,G6PD,CCL5,VEGFA
PMID:31057415	(2019) Repeated Changes to the Gravitational Field Negatively Affect the Serum Concentration of Select Growth Factors and Cytokines.	9	44	1.37	4.22e-06	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,PDGFB,PDGFA,CCL20,CXCL9,CCL5,VEGFA
PMID:29599653	(2018) Corneal Innervation and Sensation: The Eye and Beyond.	7	16	1.7	4.22e-06	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,VIP,GAP43,NPY,NTF3,BDNF,VEGFA
PMID:28220995	(2017) Development of hydrogels for regenerative engineering.	7	16	1.7	4.22e-06	9606.ENSP00000229135,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000478570	IFNG,PDGFA,ELN,CNTF,BMP2,NTF3,VEGFA
PMID:25886184	(2015) Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?	9	44	1.37	4.22e-06	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,CD38,CDH1,IGF1R,CD34,CD47,BCL2,PROM1,VEGFA
PMID:26448394	(2015) The balance of powers: Redox regulation of fibrogenic pathways in kidney injury.	9	44	1.37	4.22e-06	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,SIRT6,PTEN,NOX1,TXN,EDN1,BCL2,RHOA,AGTR1
PMID:21727900	(2011) Bone marrow stem cell mobilization in stroke: a bonehead may be good after all!	9	44	1.37	4.22e-06	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,CNTF,BMP2,GAP43,NTF3,BDNF,PROM1,VEGFA
PMID:19830133	(2009) Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature.	7	16	1.7	4.22e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,VEGFA
PMID:28084334	(2017) Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.	13	139	1.03	4.30e-06	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	MAPK1,IGF1R,ATM,GAS6,PTEN,AR,JAK2,NFE2L2,BCL2,FGFR1,RHOA,MYD88,MME
PMID:32891711	(2021) Carcinogenesis: Failure of resolution of inflammation?	12	111	1.09	4.33e-06	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000478570	CDH1,CXCL10,CD47,PTGS2,CYP2J2,NOX1,JAK2,NFE2L2,BCL2,MYD88,RARRES2,VEGFA
PMID:35052703	(2021) Cancer Studies under Space Conditions: Finding Answers Abroad.	12	111	1.09	4.33e-06	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,ATM,MMP14,CAV1,PRKAA1,PDGFA,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:31819192	(2020) Reprogramming of fatty acid metabolism in cancer.	12	111	1.09	4.33e-06	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000278840,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,ENPP2,FADS2,SREBF1,PTGS2,SGK1,PTEN,AR,G6PD,NFE2L2,CCL5,VEGFA
PMID:27888618	(2017) Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.	12	111	1.09	4.33e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,ONECUT1,HNF4A,PTEN,BCL2,RHOA,MYD88,LTA,PROM1,VEGFA
PMID:35311140	(2022) Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance.	11	86	1.17	4.45e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,BDNF,PROM1,CCL5,VEGFA,HNF1B
PMID:34829987	(2021) Alveologenesis: What Governs Secondary Septa Formation.	11	86	1.17	4.45e-06	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000232219,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000478570	EPOR,IFNG,RBP1,SOX9,TIMP3,IGF1R,CD34,PDGFA,ELN,FGFR1,VEGFA
PMID:34955553	(2021) Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects.	11	86	1.17	4.45e-06	9606.ENSP00000222572,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	PON2,THBS1,NOX4,CD34,CAV1,ELN,PTGS2,HSPG2,EDN1,AGTR1,VEGFA
PMID:35370628	(2021) Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.	11	86	1.17	4.45e-06	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,FABP4,THBS1,LPL,PTGS2,TXN,EDN1,JAK2,BCL2,MYD88,VEGFA
PMID:31100966	(2019) Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.	11	86	1.17	4.45e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,THBS1,IGF1R,CCR5,CAV1,STAT5A,PTEN,BCL2,RHOA,BDNF,VEGFA
PMID:34071497	(2021) The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.	13	140	1.03	4.60e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000264717,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000475344,9606.ENSP00000478570	IFNG,NOX4,GCKR,HNF4A,SIRT6,SREBF1,NOX1,JAK2,GAP43,NFE2L2,PROM1,APLNR,VEGFA
PMID:32426267	(2020) Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.	13	140	1.03	4.60e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ATM,ALDH1A1,MMP14,CAV1,PDGFA,CD47,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:33159500	(2020) Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast-like synoviocytes.	10	64	1.25	4.62e-06	9606.ENSP00000260356,9606.ENSP00000306124,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,PRKCE,CXCL11,CCL20,CXCL9,PTEN,SHBG,BDNF,CCL5,VEGFA
PMID:28060743	(2017) 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.	10	64	1.25	4.62e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTEN,KL,JAK2,NFE2L2,AGTR1,GREM1,VEGFA
PMID:26779291	(2016) Epigenetic associations in relation to cardiovascular prevention and therapeutics.	10	64	1.25	4.62e-06	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	NOX4,LPL,STAT5A,PRKAA1,SREBF1,ABCG1,MTHFR,EDN1,BCL2,AGTR1
PMID:27688777	(2016) The Neurovascular Properties of Dental Stem Cells and Their Importance in Dental Tissue Engineering.	10	64	1.25	4.62e-06	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,CD34,ANGPT2,ANG,BMP2,EDN1,BCL2,NTF3,BDNF,VEGFA
PMID:26431273	(2015) Caveolin-1, a stress-related oncotarget, in drug resistance.	10	64	1.25	4.62e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,HNF4A,CAV1,PTEN,BCL2,RHOA,VEGFA
PMID:24880953	(2014) Graft microvascular disease in solid organ transplantation.	10	64	1.25	4.62e-06	9606.ENSP00000225275,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,PDGFB,CCL20,MAP3K5,TXN,HSPG2,EDN1,BCL2,CCL5,VEGFA
PMID:34887773	(2021) Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential.	12	112	1.09	4.64e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,CAV1,PTGS2,BMP2,BCL2,PLA2G2A,RHOA,MYD88,CCL5,VEGFA
PMID:32429087	(2020) The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management.	12	112	1.09	4.64e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,IGF1R,EDNRA,PTGS2,EDN1,JAK2,NPY,NTF3,RHOA,BDNF,AGTR1,VEGFA
PMID:35073973	(2022) Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.	9	45	1.36	4.76e-06	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000358513,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,THBS1,CDH1,STAT5A,MAP3K5,CNR1,EDN1,BCL2,VEGFA
PMID:35138248	(2022) Fibroblast mechanotransduction network predicts targets for mechano-adaptive infarct therapies.	8	29	1.5	4.76e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000351908,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000418525	IFNG,NOX4,TIMP3,MAP3K5,BAMBI,EDN1,MYD88,MME
PMID:35270001	(2022) Isolation of Platelet-Derived Exosomes from Human Platelet-Rich Plasma: Biochemical and Morphological Characterization.	9	45	1.36	4.76e-06	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000265333,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,THBS1,VDAC1,ANG,CAV1,SHBG,BDNF,CCL5,VEGFA
PMID:35409139	(2022) Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.	11	87	1.16	4.76e-06	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CCR5,CXCL11,GAS6,CD47,JAK2,BCL2,FGFR1,PROM1,CCL5,VEGFA
PMID:33239677	(2021) The fibrotic and immune microenvironments as targetable drivers of metastasis.	8	29	1.5	4.76e-06	9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,ENPP2,CDH1,CCR5,CXCL10,ELN,CXCL9,VEGFA
PMID:33445725	(2021) Ocular Delivery of Polyphenols: Meeting the Unmet Needs.	8	29	1.5	4.76e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,NOX4,CXCL10,PTGS2,NOX1,NFE2L2,BCL2,VEGFA
PMID:33806465	(2021) The Roadmap of Colorectal Cancer Screening.	11	87	1.16	4.76e-06	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD69,IFNG,APC,CXCL10,CXCL11,CXCL9,PTGS2,S100A12,PTEN,PROM1,VEGFA
PMID:33995644	(2021) Phytochemicals in Chemoprevention: A Cost-Effective Complementary Approach.	9	45	1.36	4.76e-06	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,TIMP3,COMT,PTEN,EDN1,JAK2,BCL2,VEGFA
PMID:34199460	(2021) Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme.	11	87	1.16	4.76e-06	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	HSPB1,IGF1R,PDGFB,PDGFA,SGK1,PTEN,TXN,JAK2,BCL2,LTA,VEGFA
PMID:34233721	(2021) Schwann cells promote prevascularization and osteogenesis of tissue-engineered bone via bone marrow mesenchymal stem cell-derived endothelial cells.	8	29	1.5	4.76e-06	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000356213,9606.ENSP00000369816,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	MMP14,CD34,VIP,SHBG,GAP43,NPY,BDNF,VEGFA
PMID:34746830	(2021) Signalling mechanisms in the cardiovascular protective effects of estrogen: With a focus on rapidmembrane signalling.	9	45	1.36	4.76e-06	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,NOX4,CAV1,PTGS2,PTEN,NOX1,EDN1,RHOA,AGTR1
PMID:34944905	(2021) Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer.	9	45	1.36	4.76e-06	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,FABP4,CDH1,NOX4,ATM,CAP1,JAK2,CCL5,VEGFA
PMID:34950032	(2021) Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases.	11	87	1.16	4.76e-06	9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	MAPK7,CAV1,PTGS2,EDN1,JAK2,NFE2L2,BCL2,BDNF,AGTR1,APLNR,VEGFA
PMID:35069206	(2021) A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4-Tetrahydroxystilbene-2-O-beta-D-Glucoside.	11	87	1.16	4.76e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	MPO,NOX4,CXCL11,CD34,PTGS2,KL,GAP43,NFE2L2,BCL2,RHOA,BDNF
PMID:32120856	(2020) Adipocytes in Breast Cancer, the Thick and the Thin.	9	45	1.36	4.76e-06	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000361883,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,ENPP2,CDH1,IGF1R,PLIN1,LPL,CAP1,CCL5,VEGFA
PMID:32392722	(2020) Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress-Related Neurodegeneration.	9	45	1.36	4.76e-06	9606.ENSP00000221930,9606.ENSP00000298352,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,NGB,CNTF,PTGS2,NFE2L2,BCL2,NTF3,BDNF,VEGFA
PMID:32708322	(2020) Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?	9	45	1.36	4.76e-06	9606.ENSP00000225275,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	MPO,AQP5,CXCL10,CXCL11,PTGS2,JAK2,NFE2L2,BDNF,VEGFA
PMID:33072861	(2020) 3D Immunocompetent Organ-on-a-Chip Models.	11	87	1.16	4.76e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,CCR5,CXCL10,CD34,ELN,CXCL9,BMP2,EDN1,CCL5,VEGFA
PMID:33114087	(2020) Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR-ABL-Negative Myeloproliferative Neoplasm.	11	87	1.16	4.76e-06	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,ATM,PRDX2,CXCL10,CD34,PDGFB,S100A12,JAK2,BCL2,CCL5,VEGFA
PMID:31085370	(2019) Emerging class of omega-3 fatty acid endocannabinoids & their derivatives.	9	45	1.36	4.76e-06	9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000360247,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	CCL20,PTGS2,CNR1,CYP2J2,CNR2,BCL2,RHOA,MYD88,VEGFA
PMID:29389978	(2018) Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.	8	29	1.5	4.76e-06	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000474412	MPO,CCR5,CXCL10,CXCL11,ELN,CXCL9,S100A12,CCL5
PMID:30524222	(2018) The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration.	11	87	1.16	4.76e-06	9606.ENSP00000222139,9606.ENSP00000248553,9606.ENSP00000298352,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,HSPB1,NGB,CNTF,GAP43,NFE2L2,BCL2,NTF3,RHOA,BDNF,VEGFA
PMID:28664158	(2017) Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases.	11	87	1.16	4.76e-06	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CDH1,PTEN,CNR2,AR,JAK2,BCL2,NPY,MYD88,CCL5,VEGFA
PMID:29055013	(2017) A Synthetic CD8alpha:MyD88 Coreceptor Enhances CD8(+) T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens.	9	45	1.36	4.76e-06	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,CD38,CD69,CXCL10,CXCL9,ENTPD1,IRAK4,MYD88,CCL5
PMID:24834430	(2014) Oncolytic viral therapy: targeting cancer stem cells.	8	29	1.5	4.76e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,ATM,CXCL10,CD34,PTGS2,PROM1,VEGFA
PMID:25063693	(2014) Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease.	9	45	1.36	4.76e-06	9606.ENSP00000284031,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000354995,9606.ENSP00000362463,9606.ENSP00000365777,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000478570	DDAH1,SREBF1,GFPT1,ABCG1,GLO1,MTHFR,G6PD,RHOA,VEGFA
PMID:23935251	(2013) Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinsons disease.	9	45	1.36	4.76e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	MPO,CXCL10,CD47,CNTF,PTGS2,BCL2,NTF3,BDNF,CCL5
PMID:24047403	(2013) Redox signaling in pathophysiology of hypertension.	8	29	1.5	4.76e-06	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,EDNRA,TXN,EDN1,JAK2,RHOA,AGTR1,VEGFA
PMID:22489273	(2012) Varicose veins: role of mechanotransduction of venous hypertension.	8	29	1.5	4.76e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,ELN,EDN1,AGTR1,CCL5,VEGFA
PMID:20195780	(2010) Abstracts of the 16th Annual Society on NeuroImmune Pharmacology (SNIP) Conference. April 13-17, 2010. Manhattan Beach, California, USA.	14	172	0.97	4.76e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000356213,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412	CD38,CD69,ALDH1A1,CXCL10,CXCL11,CD34,PDGFB,VIP,CNR2,BCL2,MYD88,BDNF,PROM1,CCL5
PMID:24387160	(2014) Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes.	12	113	1.09	4.87e-06	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000383364,9606.ENSP00000418009,9606.ENSP00000426809,9606.ENSP00000427424,9606.ENSP00000478570	IGF1R,CXCL10,CD34,HNF4A,MAP3K5,PTGS2,BMP2,PLA2G2A,RARRES2,PROM1,TNFAIP8,VEGFA
PMID:34714516	(2022) A modular map of Bradykinin-mediated inflammatory signaling network.	10	65	1.25	5.01e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,TGFB1,HSPB1,CDH1,PRKCE,CD34,PTGS2,RHOA,PROM1,VEGFA
PMID:33407555	(2021) Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans.	10	65	1.25	5.01e-06	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000385834,9606.ENSP00000419422	CETP,TGFB1,LAMC1,DDAH1,LPL,HSPG2,EDN1,SAA1,TF,AGTR1
PMID:33582450	(2021) Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.	10	65	1.25	5.01e-06	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	MAPK1,CD69,CXCL10,ANGPT2,PTGS2,EDN1,MYD88,AGTR1,APLNR,VEGFA
PMID:31328152	(2019) Endothelial Cell Mechanotransduction in the Dynamic Vascular Environment.	10	65	1.25	5.01e-06	9606.ENSP00000285407,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	KLF10,MMP14,CD34,CAV1,ELN,BMP2,FGFR1,RHOA,MME,VEGFA
PMID:27144894	(2016) Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.	10	65	1.25	5.01e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,HNF4A,PTGS2,PTEN,AR,MTHFR,BCL2,VEGFA
PMID:34112221	(2021) Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis.	11	88	1.16	5.16e-06	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IFNG,SOX9,CDH1,CXCL11,HNF4A,PTEN,RHOA,CCL5,VEGFA
PMID:33050237	(2020) Emergence of Cancer-Associated Fibroblasts as an Indispensable Cellular Player in Bone Metastasis Process.	11	88	1.16	5.16e-06	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000334329,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,CDH1,CCR5,CD34,UNC5B,ELN,PTEN,HSPG2,CCL5,VEGFA
PMID:29200988	(2017) Molecular signaling mechanisms behind polyphenol-induced bone anabolism.	11	88	1.16	5.16e-06	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,HNF4A,PTGS2,NOX1,ALPL,BMP2,EDN1,BCL2,CCL5,VEGFA
PMID:35328492	(2022) The Fight against Cancer by Microgravity: The Multicellular Spheroid as a Metastasis Model.	12	114	1.08	5.28e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ATM,MMP14,CD34,CAV1,PRKAA1,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:34685692	(2021) Vascular Endothelial Cells: Heterogeneity and Targeting Approaches.	12	114	1.08	5.28e-06	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000322898,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000475344	FABP4,CXCL10,CXCL11,MMP14,CD34,ANGPT2,EBF1,PDGFB,CXCL9,EDN1,MME,APLNR
PMID:32961800	(2020) Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.	12	114	1.08	5.28e-06	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310520,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,MAPK1,IGF1R,ALDH1A1,ERCC4,CD47,PTGS2,BCL2,FGFR1,RHOA,PROM1,VEGFA
PMID:33925529	(2021) Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wntbeta-Catenin and JAKSTAT Pathway in Human Outer Root Sheath Cells and Hair Follicles.	9	46	1.35	5.31e-06	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478570	SOX9,CXCL10,CXCL11,CD34,STAT5A,CXCL9,BMP2,JAK2,VEGFA
PMID:34203660	(2021) Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma.	9	46	1.35	5.31e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CXCL9,PTGS2,PTEN,CCL5,VEGFA
PMID:35054241	(2021) Urinary Biomarkers in Interstitial CystitisBladder Pain Syndrome and Its Impact on Therapeutic Outcome.	9	46	1.35	5.31e-06	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363827,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,PTGS2,NOX1,HSPG2,BDNF,VEGFA
PMID:32182751	(2020) Polymer- and Hybrid-Based Biomaterials for Interstitial, Connective, Vascular, Nerve, Visceral and Musculoskeletal Tissue Engineering.	7	17	1.68	5.31e-06	9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,ELN,CNTF,BMP2,NTF3,BDNF,VEGFA
PMID:32468022	(2020) Targeting cancer stem cells in cholangiocarcinoma (Review).	9	46	1.35	5.31e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,HNF4A,PTGS2,JAK2,BCL2,PROM1,VEGFA
PMID:31052319	(2019) Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression.	9	46	1.35	5.31e-06	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000477707	FABP4,IGF1R,CXCL10,CAV1,SREBF1,PTEN,AR,CCL5,NR1H3
PMID:28902366	(2017) Heat shock protein 27 (HSPB1) suppresses the PDGF-BB-induced migration of osteoblasts.	7	17	1.68	5.31e-06	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000400175	MAPK1,HSPB1,PDGFB,PDGFA,EDN1,PDGFD,RHOA
PMID:26697502	(2016) Islet Stellate Cells Isolated from Fibrotic Islet of Goto-Kakizaki Rats Affect Biological Behavior of Beta-Cell.	9	46	1.35	5.31e-06	9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	MMP14,MAPK7,PDGFB,PDGFA,CD47,EDN1,FGFR1,CCL5,VEGFA
PMID:27019552	(2016) Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers.	7	17	1.68	5.31e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:27092490	(2016) Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids.	9	46	1.35	5.31e-06	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,PLIN1,LPL,SREBF1,RBP4,G6PD,BCL2,BDNF,VEGFA
PMID:27047255	(2015) MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.	9	46	1.35	5.31e-06	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	CD69,IFNG,CD34,PRKAA1,PTEN,BMP2,JAK2,BCL2,MME
PMID:24591761	(2014) Molecular markers for breast cancer: prediction on tumor behavior.	9	46	1.35	5.31e-06	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,ATM,CCR5,MMP14,CAV1,PTEN,BCL2,CCL5,VEGFA
PMID:24391823	(2013) The effect of gestational age on angiogenic gene expression in the rat placenta.	9	46	1.35	5.31e-06	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000444198,9606.ENSP00000478570	THBS1,MMP14,ANGPT2,CAV1,PTGS2,PLA2G2A,RHOA,CITED2,VEGFA
PMID:23798302	(2012) Pathophysiology of acute kidney injury.	14	174	0.97	5.31e-06	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MPO,HSPB1,CDH1,CD34,EDNRA,EDN1,KL,BCL2,FGFR1,RHOA,MYD88,PROM1,CCL5,VEGFA
PMID:34769277	(2021) Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress.	13	143	1.02	5.32e-06	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,VDAC1,SIRT6,MAP3K5,COMT,PTGS2,PTEN,NOX1,TXN,NFE2L2,BCL2,BDNF,VEGFA
PMID:32831123	(2018) 38th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 20-23 March 2018.	13	143	1.02	5.32e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000384957,9606.ENSP00000414303,9606.ENSP00000474412	MPO,IFNG,HSPB1,CHI3L1,CXCL10,ANGPT2,CXCL9,S100A12,ADAMTS13,EDN1,F11,BDNF,CCL5
PMID:35327376	(2022) Oxidative Stress in IschemiaReperfusion Injuries following Acute Ischemic Stroke.	10	66	1.24	5.51e-06	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	NOX4,VDAC1,SIRT6,MAP3K5,PTGS2,TXN,JAK2,NFE2L2,BCL2,BDNF
PMID:35401176	(2022) A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin.	10	66	1.24	5.51e-06	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,APC,TIMP3,IGF1R,PRKCE,HNF4A,MAP3K5,PTGS2,BCL2,VEGFA
PMID:32959892	(2021) Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.	11	89	1.15	5.51e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000474412	MAPK1,TGFB1,IFNG,CXCL10,CAV1,PRKAA1,PTGS2,JAK2,BCL2,SAA1,CCL5
PMID:33559479	(2021) Stem Cell Therapy for Spinal Cord Injury.	8	30	1.49	5.51e-06	9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,PDGFA,CNTF,PTEN,GAP43,NTF3,BDNF,VEGFA
PMID:33707963	(2021) Chinese Herbs and Repurposing Old Drugs as Therapeutic Agents in the Regulation of Oxidative Stress and Inflammation in Pulmonary Diseases.	11	89	1.15	5.51e-06	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,PTGS2,SGK1,TXN,EDN1,NFE2L2,BCL2,RHOA,MYD88,CCL5,VEGFA
PMID:33854480	(2021) Thrombospondin 1 in Metabolic Diseases.	8	30	1.49	5.51e-06	9606.ENSP00000222305,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000478570	USF2,IFNG,THBS1,IGF1R,SREBF1,CD47,JAK2,VEGFA
PMID:34221857	(2021) Role of CD8(+) T lymphocyte cells: Interplay with stromal cells in tumor microenvironment.	11	89	1.15	5.51e-06	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,CXCL10,CXCL11,CD247,CXCL9,PTGS2,ENTPD1,PTEN,CCL5,VEGFA
PMID:34638659	(2021) Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties.	11	89	1.15	5.51e-06	9606.ENSP00000222572,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	PON2,THBS1,NOX4,CD34,CAV1,ELN,PTGS2,HSPG2,EDN1,AGTR1,VEGFA
PMID:34948944	(2021) Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.	12	115	1.08	5.51e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,NOX4,CXCL10,SREBF1,CXCL9,RBP4,ANGPTL2,BDNF,RARRES2,CCL5,VEGFA
PMID:35008275	(2021) Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma.	10	66	1.24	5.51e-06	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,MPO,CDH1,ANGPT2,ANG,PTGS2,PTEN,EDN1,PROM1,VEGFA
PMID:31727783	(2020) Targeting the interleukin-17 immune axis for cancer immunotherapy.	10	66	1.24	5.51e-06	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,MAPK7,CCL20,CXCL9,ENTPD1,BCL2,VEGFA
PMID:32316192	(2020) Mitochondrial Protection by PARP Inhibition.	10	66	1.24	5.51e-06	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	CD38,VDAC1,ATM,MAPK7,SIRT6,MAP3K5,PTEN,TXN,NFE2L2,BCL2
PMID:32546764	(2020) Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis.	10	66	1.24	5.51e-06	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	FABP4,CDH1,CXCL10,CD34,PDGFB,CXCL9,LTA,CCL5,GREM1,VEGFA
PMID:32569616	(2020) Three dimensional engineered models to study hypoxia biology in breast cancer.	12	115	1.08	5.51e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CCR5,MMP14,ANGPT2,CAV1,PTGS2,G6PD,NFE2L2,FGFR1,RHOA,PROM1,VEGFA
PMID:33007927	(2020) Neuroinflammation in Primary Open-Angle Glaucoma.	11	89	1.15	5.51e-06	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,THBS1,ELN,CXCL9,PTGS2,TXN,EDN1,NFE2L2,MYD88,BDNF,VEGFA
PMID:33033558	(2020) Senescent mesenchymal stemstromal cells and restoring their cellular functions.	10	66	1.24	5.51e-06	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	CD38,CD34,SIRT6,FMOD,BMP2,NFE2L2,BCL2,FGFR1,BDNF,VEGFA
PMID:33114328	(2020) Cancer-Associated Fibroblasts: Understanding Their Heterogeneity.	11	89	1.15	5.51e-06	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	SOX9,CDH1,NOX4,CXCL10,CAV1,PDGFA,CD47,AR,BCL2,MME,VEGFA
PMID:31547627	(2019) Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.	13	144	1.02	5.51e-06	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CCR5,CXCL10,CD34,CAV1,STAT5A,ELN,CXCL9,CD47,ENTPD1,MME,CCL5,VEGFA
PMID:31607955	(2019) Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension.	8	30	1.49	5.51e-06	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,CAV1,MAP3K5,NOX1,EDN1,BCL2,AGTR1,VEGFA
PMID:29075990	(2018) Biology of portal hypertension.	8	30	1.49	5.51e-06	9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	EDNRA,PDGFB,CAV1,ENTPD1,EDN1,NPY,RHOA,VEGFA
PMID:29563103	(2018) Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates.	8	30	1.49	5.51e-06	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000349860,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,GFPT1,CD247,CXCL9,CCL5,VEGFA
PMID:31069313	(2018) Perspective: Biophysical regulation of cancerous and normal blood cell lineages in hematopoietic malignancies.	8	30	1.49	5.51e-06	9606.ENSP00000226279,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000478570	CD38,MMP14,CD34,ELN,CD47,PTGS2,RHOA,VEGFA
PMID:27878431	(2017) Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.	8	30	1.49	5.51e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,ANG,CXCL9,LTA,CCL5,VEGFA
PMID:28490838	(2017) Adipokine Contribution to the Pathogenesis of Osteoarthritis.	11	89	1.15	5.51e-06	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000478570	CD69,SOX9,IGF1R,CD34,SIRT6,PTGS2,CAP1,JAK2,MYD88,RARRES2,VEGFA
PMID:26791722	(2016) Angiocrine functions of organ-specific endothelial cells.	11	89	1.15	5.51e-06	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,MMP14,CD34,ANGPT2,BMP2,EDN1,FGFR1,NTF3,BDNF,PROM1,VEGFA
PMID:25814653	(2015) MicroRNAs in cardiovascular disease: an introduction for clinicians.	11	89	1.15	5.51e-06	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000419422	THBS1,NOX4,TIMP3,IGF1R,LPL,STAT5A,PRKAA1,SREBF1,ABCG1,PTEN,AGTR1
PMID:25853091	(2015) Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer.	11	89	1.15	5.51e-06	9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351671,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,CXCL11,CD34,CAV1,PDGFA,FMOD,CCL20,HSPG2,RHOA,PROM1,VEGFA
PMID:24473089	(2014) Gelatinase BMMP-9 in Tumour Pathogenesis and Progression.	11	89	1.15	5.51e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,CDH1,TIMP3,CD34,ELN,PTGS2,TXN,AR,BCL2,VEGFA
PMID:26816738	(2013) Cancer stem cells in prostate cancer.	8	30	1.49	5.51e-06	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,PTEN,AR,BCL2,PROM1,VEGFA
PMID:22153719	(2012) Targeting Src family kinases in anti-cancer therapies: turning promise into triumph.	8	30	1.49	5.51e-06	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	EPOR,IGF1R,PTEN,AR,JAK2,BCL2,RHOA,VEGFA
PMID:22389737	(2012) Regulation of global gene expression in human Loa loa infection is a function of chronicity.	10	66	1.24	5.51e-06	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	TGFB1,CD69,IGF1R,CCR5,CCL20,CD247,PTEN,JAK2,BCL2,CCL5
PMID:22530130	(2012) Castration-resistant prostate cancer: mechanisms, targets, and treatment.	8	30	1.49	5.51e-06	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,EDNRA,PTEN,AR,EDN1,BCL2,PROM1,VEGFA
PMID:21906325	(2011) Erythropoietin (EPO) in acute kidney injury.	8	30	1.49	5.51e-06	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000402152,9606.ENSP00000478570	EPOR,MPO,STAT5A,SGK1,JAK2,BCL2,SLC12A3,VEGFA
PMID:18779056	(2008) Trophic factors in the carotid body.	8	30	1.49	5.51e-06	9606.ENSP00000315011,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	EDNRA,CNTF,VIP,EDN1,NPY,FGFR1,BDNF,VEGFA
PMID:31382445	(2019) Short Term Results of Fibrin Gel Obtained from Cord Blood Units: A Preliminary in Vitro Study.	6	8	1.94	5.54e-06	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000478570	TGFB1,CD34,PDGFA,MAP3K5,PTEN,VEGFA
PMID:34638282	(2021) Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential.	14	176	0.96	5.70e-06	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,HSPB1,CDH1,ALDH1A1,MAPK7,CAV1,SREBF1,CXCL9,PTGS2,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:35317658	(2022) The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.	10	67	1.23	5.88e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000384957,9606.ENSP00000393312,9606.ENSP00000478570	MPO,THBS1,ANGPT2,CD47,PTGS2,ADAMTS13,EDN1,F11,FGFR1,VEGFA
PMID:35406721	(2022) Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.	12	116	1.08	5.88e-06	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000331831,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,NOX4,EDNRA,GAS6,SREBF1,PTEN,NOX1,TXN,EDN1,BCL2,FGFR1,VEGFA
PMID:33499083	(2021) TGF-beta in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment.	11	90	1.15	5.88e-06	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD69,THBS1,NOX4,CCR5,MMP14,CAV1,STAT5A,ENTPD1,RHOA,CCL5,VEGFA
PMID:33596985	(2021) Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages.	9	47	1.34	5.88e-06	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,CXCL9,CD47,PTEN,AR,JAK2,FGFR1,LTA,VEGFA
PMID:33776206	(2021) Taming of Covid-19: potential and emerging application of mesenchymal stem cells.	12	116	1.08	5.88e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	MPO,IFNG,CCR5,CXCL10,CD34,ELN,CXCL9,ENTPD1,NTF3,LTA,AGTR1,VEGFA
PMID:33935770	(2021) Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease.	9	47	1.34	5.88e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,LPL,CD34,ANGPT2,MAP3K5,EDN1,CCL5,VEGFA
PMID:34007284	(2021) Microgravity, Stem Cells, and Cancer: A New Hope for Cancer Treatment.	9	47	1.34	5.88e-06	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809	CDH1,ATM,CD34,CAV1,CNTF,PTEN,BCL2,BDNF,PROM1
PMID:34063828	(2021) Inflammation-Induced Tumorigenesis and Metastasis.	12	116	1.08	5.88e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000474412	IFNG,CDH1,IGF1R,ATM,ALDH1A1,PTGS2,PTEN,AR,JAK2,BCL2,IRAK4,CCL5
PMID:34065757	(2021) Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance.	10	67	1.23	5.88e-06	9606.ENSP00000200676,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CETP,STAT5A,SREBF1,ABCG1,PTGS2,PTEN,TXN,BCL2,RHOA,VEGFA
PMID:34685585	(2021) Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.	9	47	1.34	5.88e-06	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	HSPB1,NOX4,ELN,NOX1,TXN,EDN1,NFE2L2,AGTR1,VEGFA
PMID:34686755	(2021) Keratoconus patients exhibit a distinct ocular surface immune cell and inflammatory profile.	9	47	1.34	5.88e-06	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IFNG,CXCL10,CXCL11,ANG,CXCL9,CCL5,VEGFA
PMID:34708034	(2021) The Potential Use of Cannabis in Tissue Fibrosis.	10	67	1.23	5.88e-06	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,CXCL10,CD34,EDNRA,PDGFB,MAP3K5,EDN1,FGFR1,AGTR1,VEGFA
PMID:34768869	(2021) From Primary MSC Culture of Adipose Tissue to Immortalized Cell Line Producing Cytokines for Potential Use in Regenerative Medicine Therapy or Immunotherapy.	10	67	1.23	5.88e-06	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,ANG,CXCL9,CNTF,LTA,CCL5,VEGFA
PMID:32993038	(2020) The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.	12	116	1.08	5.88e-06	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,SOX9,CDH1,IGF1R,ATM,HNF4A,PTEN,JAK2,BCL2,RHOA,PROM1,VEGFA
PMID:33194742	(2020) Estrogen Receptor Beta (ERbeta): A Ligand Activated Tumor Suppressor.	11	90	1.15	5.88e-06	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000259486,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000366395,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,HSPB1,ENPP2,KLF10,CXCL10,CAV1,CXCL9,PTEN,SYVN1,BCL2,VEGFA
PMID:31510091	(2019) Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments.	10	67	1.23	5.88e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185	MPO,NOX4,CXCL10,CD34,SIRT6,MAP3K5,PTGS2,NOX1,NFE2L2,BCL2
PMID:31889913	(2019) Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers.	11	90	1.15	5.88e-06	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000352264,9606.ENSP00000360522,9606.ENSP00000361883,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000385834,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,AMBP,CD2AP,RBP4,CAP1,HSPG2,JAK2,TF,MME,PROM1,VEGFA
PMID:30405637	(2018) A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the Skin.	10	67	1.23	5.88e-06	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,EDN1,CCL5,VEGFA
PMID:30572925	(2018) A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke.	10	67	1.23	5.88e-06	9606.ENSP00000229135,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,HNF4A,ANGPT2,CAV1,PTGS2,IRAK4,MYD88,LTA,BDNF,VEGFA
PMID:30647531	(2018) Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology.	11	90	1.15	5.88e-06	9606.ENSP00000278616,9606.ENSP00000283928,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000365777,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000474412	ATM,JAZF1,CXCL10,HNF4A,EBF1,CCL20,NOX1,MTHFR,KL,BCL2,CCL5
PMID:28384236	(2017) An integrated method for the identification of novel genes related to oral cancer.	9	47	1.34	5.88e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000360247,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CCR5,CCL20,CYP2J2,JAK2,MYD88,CCL5,VEGFA
PMID:28660188	(2017) microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.	10	67	1.23	5.88e-06	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412	THBS1,NOX4,CD34,CAV1,ELN,CXCL9,PTEN,EDN1,AGTR1,CCL5
PMID:28938696	(2017) The molecular mechanisms of chemoresistance in cancers.	12	116	1.08	5.88e-06	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,ATM,ALDH1A1,MMP14,CAV1,PTEN,JAK2,PDGFD,BCL2,PROM1,VEGFA
PMID:25613284	(2015) Genome-wide immunity studies in the rabbit: transcriptome variations in peripheral blood mononuclear cells after in vitro stimulation by LPS or PMA-Ionomycin.	11	90	1.15	5.88e-06	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000384906,9606.ENSP00000401399	CD69,IFNG,CHI3L1,THBS1,CXCL10,CXCL11,STAT5A,CCL20,S100A12,SAA1,MYD88
PMID:24373791	(2014) Soy isoflavones and prostate cancer: a review of molecular mechanisms.	11	90	1.15	5.88e-06	9606.ENSP00000248553,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,APC,CDH1,IGF1R,CXCL10,HNF4A,PTEN,AR,BCL2,PROM1,VEGFA
PMID:24443420	(2014) Role of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineering.	9	47	1.34	5.88e-06	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CD34,HNF4A,CAV1,ELN,PTGS2,HSPG2,RHOA,PROM1,VEGFA
PMID:21640163	(2012) S-nitrosylation in the regulation of gene transcription.	10	67	1.23	5.88e-06	9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	HNF4A,MAP3K5,PTGS2,PTEN,TXN,BCL2,RHOA,MYD88,BDNF,VEGFA
PMID:20061852	(2010) Molecular mediators of angiogenesis.	9	47	1.34	5.88e-06	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,TIMP3,MMP14,PDGFB,CAV1,EDN1,BCL2,FGFR1,VEGFA
PMID:18508657	(2008) The different functions of Stat5 and chromatin alteration through Stat5 proteins.	10	67	1.23	5.88e-06	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000302630,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000444198	EPOR,IFNG,ONECUT1,EBF1,STAT5A,JAK2,BCL2,FGFR1,LTA,CITED2
PMID:17020621	(2006) Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion.	11	90	1.15	5.88e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CXCL11,ANGPT2,CCL20,CXCL9,CNTF,NTF3,BDNF,CCL5,VEGFA
PMID:33825941	(2021) Manifold role of ubiquitin in Helicobacter pylori infection and gastric cancer.	13	146	1.01	6.16e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000398048,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,TIMP3,ATM,CXCL10,HNF4A,CCL20,MAP3K5,PTGS2,BCL2,IRAK4,ALPK1,MYD88,VEGFA
PMID:32560163	(2020) Adipogenesis: A Complex Interplay of Multiple Molecular Determinants and Pathways.	13	146	1.01	6.16e-06	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000257430,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000418009	SOX9,FABP4,APC,KLF10,CD34,MAPK7,HNF4A,EBF1,SIRT6,STAT5A,SREBF1,BMP2,RARRES2
PMID:29872722	(2018) Organotropism: new insights into molecular mechanisms of breast cancer metastasis.	12	117	1.07	6.18e-06	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384262,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	ENPP2,CDH1,ANGPT2,CCL20,CD47,PTGS2,PTEN,JAK2,HPSE,FGFR1,PROM1,VEGFA
PMID:24405801	(2013) Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stemprogenitor cell and mesenchymal stromal cell populations.	12	117	1.07	6.18e-06	9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000475344	TGFB1,EPOR,CXCL10,CXCL11,CD34,GAS6,CXCL9,JAK2,FGFR1,PROM1,CCL5,APLNR
PMID:33785864	(2021) Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.	8	31	1.47	6.29e-06	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CD38,IGF1R,CD34,STAT5A,CD47,JAK2,BCL2,PROM1
PMID:32128842	(2020) Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis.	8	31	1.47	6.29e-06	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SOX9,CXCL10,CCL20,EDN1,BCL2,CCL5,VEGFA
PMID:32490016	(2020) A Review of Last Decade Developments on Epiretinal Membrane Pathogenesis.	11	91	1.14	6.29e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,TIMP3,CXCL10,CXCL11,ANGPT2,EDNRA,PDGFA,EDN1,CCL5,VEGFA
PMID:27529277	(2016) Spices for Prevention and Treatment of Cancers.	11	91	1.14	6.29e-06	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,HSPB1,CDH1,MMP14,PTGS2,PTEN,AR,JAK2,BCL2,RHOA,VEGFA
PMID:24551432	(2014) Downregulation of MMP2 and Bcl-2 in Adipose Derived Stem Cells (ASCs) following Transfection with IP-10 Gene.	8	31	1.47	6.29e-06	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CXCL10,CXCL11,CD34,HNF4A,CXCL9,BCL2,VEGFA
PMID:24265713	(2013) Heterogeneity of functional properties of Clone 66 murine breast cancer cells expressing various stem cell phenotypes.	8	31	1.47	6.29e-06	9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	CCR5,ALDH1A1,CXCL10,CXCL11,CD34,CXCL9,PROM1,CCL5
PMID:23728975	(2012) Motility, survival, and proliferation.	11	91	1.14	6.29e-06	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175	HSPB1,NOX4,CD34,EDNRA,CAV1,ELN,PTGS2,EDN1,JAK2,BCL2,RHOA
PMID:35054949	(2022) Melatonin Promotes Antler Growth by Accelerating MT1-Mediated Mesenchymal Cell Differentiation and Inhibiting VEGF-Induced Degeneration of Chondrocytes.	7	18	1.65	6.48e-06	9606.ENSP00000245479,9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000478570	SOX9,PRDX2,CAV1,STAT5A,JAK2,NPY,VEGFA
PMID:32069832	(2020) Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications.	10	68	1.23	6.48e-06	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000360522,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,ELN,ENTPD1,RBP4,ADAMTS13,EDN1,RARRES2,CCL5,VEGFA
PMID:33178051	(2020) Flow-Induced Transcriptomic Remodeling of Endothelial Cells Derived From Human Induced Pluripotent Stem Cells.	10	68	1.23	6.48e-06	9606.ENSP00000260356,9606.ENSP00000284031,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000444198,9606.ENSP00000475344,9606.ENSP00000478570	THBS1,DDAH1,CD34,ANGPT2,PDGFB,CAV1,EDN1,CITED2,APLNR,VEGFA
PMID:33223667	(2020) Plasma Biomarkers as Potential Predictors of Functional Dependence in Daily Life Activities after Ischemic Stroke: A Single Center Study.	7	18	1.65	6.48e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	MPO,IFNG,CCR5,PDGFB,BCL2,BDNF,CCL5
PMID:33585254	(2020) Withaferin A Acts as a Novel Regulator of Liver X Receptor-alpha in HCC.	7	18	1.65	6.48e-06	9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ANG,PDGFA,ABCG1,EDN1,NFE2L2,BCL2,VEGFA
PMID:30319358	(2018) Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimers Disease.	10	68	1.23	6.48e-06	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,SOX9,THBS1,PTEN,GAP43,BCL2,NTF3,BDNF,MME,VEGFA
PMID:24965580	(2014) Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection.	7	18	1.65	6.48e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399	MPO,IFNG,CXCL10,CXCL11,CCL20,CXCL9,MYD88
PMID:21845431	(2012) Endothelium--role in regulation of coagulation and inflammation.	10	68	1.23	6.48e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,MMP14,ANGPT2,PTGS2,ENTPD1,ADAMTS13,EDN1,CCL5,VEGFA
PMID:35159340	(2022) Three Months of Strength Training Changes the Gene Expression of Inflammation-Related Genes in PBMC of Older Women: A Randomized Controlled Trial.	13	147	1.01	6.51e-06	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000419422,9606.ENSP00000445772	TGFB1,CD69,IFNG,CXCL10,CXCL11,SIRT6,STAT5A,PTGS2,NFE2L2,BCL2,PLA2G2A,AGTR1,LTB4R2
PMID:35240982	(2022) Molecular hydrogen is a potential protective agent in the management of acute lung injury.	9	48	1.33	6.52e-06	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000293599,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399	TGFB1,MPO,AQP5,PDGFB,EDN1,NFE2L2,BCL2,RHOA,MYD88
PMID:33921049	(2021) Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies.	9	48	1.33	6.52e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,NOX4,VDAC1,ANGPT2,PTGS2,EDN1,BCL2,RHOA,VEGFA
PMID:34184731	(2021) Mapping the transcriptomic changes of endothelial compartment in human hippocampus across aging and mild cognitive impairment.	14	179	0.95	6.52e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000301522,9606.ENSP00000314897,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,TGFB1,EPOR,PRDX2,ANGPT2,PRKAA1,SREBF1,PTEN,EDN1,PDGFD,NFE2L2,BCL2,FGFR1,RHOA
PMID:34804998	(2021) Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy.	9	48	1.33	6.52e-06	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399	MPO,CAV1,CCL20,PTGS2,NOX1,NFE2L2,BCL2,RHOA,MYD88
PMID:35011666	(2021) AGEs-Induced and Endoplasmic Reticulum StressInflammation-Mediated Regulation of GLUT4 Expression and Atherogenesis in Diabetes Mellitus.	9	48	1.33	6.52e-06	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000358513,9606.ENSP00000362463,9606.ENSP00000401399	CETP,PON2,NOX4,LPL,SREBF1,ABCG1,CNR1,GLO1,MYD88
PMID:30843659	(2019) Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial.	9	48	1.33	6.52e-06	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CD34,JAK2,BCL2,LTA,MME,CCL5,VEGFA
PMID:30947260	(2019) Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.	9	48	1.33	6.52e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CCR5,CXCL10,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:31652839	(2019) The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.	9	48	1.33	6.52e-06	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683	FABP4,LPL,HNF4A,SREBF1,ELN,PTEN,NOX1,TXN,EDN1
PMID:28536380	(2016) Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?	9	48	1.33	6.52e-06	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:25960621	(2015) Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis.	9	48	1.33	6.52e-06	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000357726,9606.ENSP00000383364,9606.ENSP00000478570	CETP,MPO,CD69,FABP4,THBS1,CDH1,S100A12,PLA2G2A,VEGFA
PMID:23527185	(2013) Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia.	9	48	1.33	6.52e-06	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354511,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANG,COMT,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:35345849	(2022) Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies.	12	118	1.07	6.53e-06	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000479617	NOX4,CCR5,CXCL10,CXCL11,CXCL9,CD47,PTGS2,ENTPD1,JAK2,CCL5,VEGFA,UHRF1
PMID:35268581	(2022) Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis.	11	92	1.14	6.79e-06	9606.ENSP00000225275,9606.ENSP00000246553,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MPO,FFAR1,ENPP2,CDH1,NOX4,PTGS2,PTEN,NOX1,BCL2,RHOA,VEGFA
PMID:35366956	(2022) Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.	11	92	1.14	6.79e-06	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000362524,9606.ENSP00000369816,9606.ENSP00000375844,9606.ENSP00000418009,9606.ENSP00000419422	CETP,TGFB1,FADS2,PLIN1,LPL,KCNJ11,ANGPTL2,SHBG,CAPN10,RARRES2,AGTR1
PMID:32610077	(2020) Transcriptional and Functional Analysis of CD1c(+) Human Dendritic Cells Identifies a CD163(+) Subset Priming CD8(+)CD103(+) T Cells.	11	92	1.14	6.79e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CD69,CDH1,AMBP,CXCL10,CXCL11,CD34,CXCL9,S100A12,MME,CCL5
PMID:33262763	(2020) A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy.	11	92	1.14	6.79e-06	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CXCL10,CXCL11,CD34,ANGPT2,CXCL9,PTEN,EDN1,CCL5,VEGFA
PMID:31900911	(2019) Prostate Cancer Energetics and Biosynthesis.	11	92	1.14	6.79e-06	9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000427424,9606.ENSP00000478570	IGF1R,SREBF1,GFPT1,PTGS2,PTEN,AR,G6PD,NFE2L2,FGFR1,TNFAIP8,VEGFA
PMID:30618558	(2018) Mechanisms Involved in the Neuroprotection of Electroacupuncture Therapy for Ischemic Stroke.	11	92	1.14	6.79e-06	9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000475344,9606.ENSP00000478570	CAV1,STAT5A,PTGS2,CNR1,GAP43,BCL2,RHOA,MYD88,BDNF,APLNR,VEGFA
PMID:28286618	(2017) Molecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine.	11	92	1.14	6.79e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IFNG,SOX9,CXCL10,CD34,PTGS2,BMP2,BDNF,CCL5,VEGFA
PMID:23583330	(2013) Redox signaling in cardiovascular health and disease.	11	92	1.14	6.79e-06	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PON2,NOX4,MAP3K5,PTGS2,PTEN,NOX1,TXN,JAK2,RHOA,BDNF,VEGFA
PMID:32545828	(2020) Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System.	13	148	1.0	6.85e-06	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	MAPK1,CXCL10,PDGFA,CNTF,PTGS2,GAP43,NFE2L2,BCL2,NTF3,RHOA,MYD88,BDNF,CCL5
PMID:31286981	(2019) Genetic and molecular biology of breast cancer among Iranian patients.	13	148	1.0	6.85e-06	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	ERCC1,MAPK1,CYP24A1,HSPB1,ATM,ALDH1A1,HNF4A,CAV1,PTEN,MTHFR,BCL2,MME,VEGFA
PMID:24692138	(2014) Energy metabolism in the liver.	13	148	1.0	6.85e-06	9606.ENSP00000222305,9606.ENSP00000256104,9606.ENSP00000264717,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000401720	USF2,FABP4,GCKR,PLIN1,LPL,HNF4A,SIRT6,STAT5A,SREBF1,ABCG1,JAK2,G6PD,GK
PMID:34977871	(2021) NF-kappaB signaling in inflammation and cancer.	12	119	1.06	7.03e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,SOX9,CCR5,CXCL10,CD34,BCL2,IRAK4,MYD88,PROM1,CCL5,VEGFA
PMID:35057010	(2022) Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of Glioblastoma.	10	69	1.22	7.08e-06	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,ANGPT2,PTGS2,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:34906138	(2021) IRAK1-regulated IFN-gamma signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.	10	69	1.22	7.08e-06	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CD34,CCL20,CXCL9,PTEN,JAK2,BCL2,IRAK4,MYD88,CCL5
PMID:34976728	(2021) Inflammatory mechanisms linking obesity and tendinopathy.	10	69	1.22	7.08e-06	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000418009,9606.ENSP00000478570	MPO,HSPB1,FABP4,CXCL10,LPL,CCL20,NOX1,BMP2,RARRES2,VEGFA
PMID:32577796	(2020) Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.	10	69	1.22	7.08e-06	9606.ENSP00000259486,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412	ENPP2,NOX4,CCR5,CXCL10,PDGFB,CAV1,BCL2,RHOA,BDNF,CCL5
PMID:31671788	(2019) Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine.	10	69	1.22	7.08e-06	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,MMP14,CD34,PTEN,ALPL,EDN1,BCL2,RHOA,BDNF,VEGFA
PMID:31709180	(2019) Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment.	10	69	1.22	7.08e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ATM,ALDH1A1,CD34,CD47,BCL2,MME,PROM1,VEGFA
PMID:26900402	(2016) Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cells.	10	69	1.22	7.08e-06	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	MAPK1,TIMP3,IGF1R,CCR5,CXCL11,STAT5A,JAK2,MYD88,BDNF,CCL5
PMID:25115920	(2014) Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media.	10	69	1.22	7.08e-06	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,CD34,ANG,ELN,CXCL9,HSPG2,BMP2,CCL5,VEGFA
PMID:24077237	(2013) Polyphenols: benefits to the cardiovascular system in health and in aging.	10	69	1.22	7.08e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	MPO,IFNG,IGF1R,CAV1,ELN,TXN,EDN1,BCL2,AGTR1,VEGFA
PMID:22267953	(2011) Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix.	10	69	1.22	7.08e-06	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	HSPB1,THBS1,MMP14,CD34,CD47,PTEN,HSPG2,BCL2,FGFR1,VEGFA
PMID:35326123	(2022) Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension.	9	49	1.33	7.35e-06	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,NOX4,CAV1,EDN1,NFE2L2,RHOA,CCL5,VEGFA
PMID:35406562	(2022) Vitamin D and Hypoxia: Points of Interplay in Cancer.	11	93	1.13	7.35e-06	9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,IFNG,APC,VDAC1,IGF1R,ATM,ANGPT2,PTEN,NFE2L2,BCL2,VEGFA
PMID:33462336	(2021) Protein co-expression networks identified from HOT lesions of ER+HER2-Ki-67high luminal breast carcinomas.	9	49	1.33	7.35e-06	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,IGF1R,PRDX2,CAV1,MAP3K5,PTEN,TXN,NFE2L2,VEGFA
PMID:33796300	(2021) Metformin: The next angiogenesis panacea?	8	32	1.46	7.35e-06	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000380252,9606.ENSP00000478570	THBS1,CXCL10,CD34,PDGFB,ANG,CAV1,NFE2L2,VEGFA
PMID:33807553	(2021) Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?	9	49	1.33	7.35e-06	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD247,CXCL9,ENTPD1,PTEN,MYD88,CCL5,VEGFA
PMID:33883040	(2021) Mitochondrial metabolism as a target for acute myeloid leukemia treatment.	9	49	1.33	7.35e-06	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185	CD38,NOX4,VDAC1,CD34,MAP3K5,PTEN,NOX1,NFE2L2,BCL2
PMID:33917287	(2021) The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking.	11	93	1.13	7.35e-06	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,CAV1,CXCL9,CD47,EDN1,LTA,CCL5,VEGFA
PMID:34322664	(2021) Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer.	11	93	1.13	7.35e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000354995,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,IGF1R,ATM,ALDH1A1,ABCG1,ENTPD1,PTEN,AR,NFE2L2,BCL2,PROM1
PMID:34360613	(2021) Cytokine-Laden Extracellular Vesicles Predict Patient Prognosis after Cerebrovascular Accident.	9	49	1.33	7.35e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ANG,CCL20,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:34681692	(2021) Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy.	9	49	1.33	7.35e-06	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD34,PDGFA,CCL20,PTEN,JAK2,BCL2,RHOA,CCL5,VEGFA
PMID:35095911	(2021) CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors.	8	32	1.46	7.35e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD247,CXCL9,ENTPD1,CCL5,VEGFA
PMID:32151085	(2020) Secretome of Senescent Adipose-Derived Mesenchymal Stem Cells Negatively Regulates Angiogenesis.	11	93	1.13	7.35e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,TIMP3,CXCL10,CD34,ANGPT2,ADAMTS13,EDN1,LTA,CCL5,VEGFA
PMID:32517019	(2020) Computational Analysis of Transcriptomic and Proteomic Data for Deciphering Molecular Heterogeneity and Drug Responsiveness in Model Human Hepatocellular Carcinoma Cell Lines.	9	49	1.33	7.35e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000393312,9606.ENSP00000477707	MAPK1,TGFB1,CDH1,IGF1R,HNF4A,GAS6,CAV1,FGFR1,NR1H3
PMID:32607320	(2020) Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer.	9	49	1.33	7.35e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,PTEN,TXN,NFE2L2,BCL2,LTA,VEGFA
PMID:32885153	(2020) New insights into the pathogenesis of Peyronies disease: A narrative review.	12	120	1.06	7.35e-06	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000400175,9606.ENSP00000401399	IFNG,HSPB1,THBS1,NOX4,MMP14,FMOD,PTEN,HSPG2,BCL2,HPSE,RHOA,MYD88
PMID:33379400	(2020) Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.	11	93	1.13	7.35e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	CDH1,TIMP3,MMP14,EDNRA,CAV1,FMOD,ELN,NOX1,ANGPTL2,HSPG2,VEGFA
PMID:31450710	(2019) Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.	11	93	1.13	7.35e-06	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,CCR5,CXCL10,PDGFB,PTGS2,PDGFD,BCL2,PROM1,CCL5,VEGFA
PMID:30323574	(2018) Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.	8	32	1.46	7.35e-06	9606.ENSP00000288266,9606.ENSP00000322898,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000369442,9606.ENSP00000369816,9606.ENSP00000380252,9606.ENSP00000418009	APPL1,EBF1,SREBF1,RBP4,KL,SHBG,NFE2L2,RARRES2
PMID:30619286	(2018) Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.	11	93	1.13	7.35e-06	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,IGF1R,CCR5,CD247,PTGS2,PTEN,IRAK4,MYD88,PROM1,CCL5,VEGFA
PMID:28645930	(2017) Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications.	8	32	1.46	7.35e-06	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363973,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,NOX4,MAPK7,CAV1,NOX1,ALPL,RHOA,VEGFA
PMID:28767189	(2017) Administration of signalling molecules dictates stem cell homing for in situ regeneration.	9	49	1.33	7.35e-06	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CCL20,CXCL9,PTGS2,BMP2,CCL5,VEGFA
PMID:28070238	(2016) Hematological disorders and pulmonary hypertension.	8	32	1.46	7.35e-06	9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	DDAH1,CXCL10,CD34,CAV1,EDN1,JAK2,PROM1,VEGFA
PMID:25542976	(2015) Natural history of beta-cell adaptation and failure in type 2 diabetes.	11	93	1.13	7.35e-06	9606.ENSP00000226760,9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000345708,9606.ENSP00000349860,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000480291	WFS1,SOX9,ONECUT1,HNF4A,STAT5A,KCNJ11,GFPT1,TXN,JAK2,BCL2,HNF1B
PMID:25895867	(2015) Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.	8	32	1.46	7.35e-06	9606.ENSP00000200676,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000477707,9606.ENSP00000478570	CETP,APOL1,LPA,ABCG1,PTEN,BCL2,NR1H3,VEGFA
PMID:26132605	(2015) Potential clinical application of interleukin-27 as an antitumor agent.	8	32	1.46	7.35e-06	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000478570	CD69,TIMP3,CXCL10,STAT5A,PTGS2,ENTPD1,JAK2,VEGFA
PMID:26249165	(2015) Transplant biopsy beyond light microscopy.	8	32	1.46	7.35e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CD34,CAV1,CXCL9,CCL5
PMID:26481314	(2015) Endothelial cell control of thrombosis.	8	32	1.46	7.35e-06	9606.ENSP00000261037,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000384957,9606.ENSP00000474412,9606.ENSP00000478570	COL8A1,ANGPT2,ENTPD1,ADAMTS13,EDN1,F11,CCL5,VEGFA
PMID:24834056	(2014) Mitochondria, endothelial cell function, and vascular diseases.	9	49	1.33	7.35e-06	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175	PON2,NOX4,DDAH1,EDNRA,MAP3K5,NOX1,TXN,BCL2,RHOA
PMID:25364579	(2014) Hepatitis B virus X protein accelerates the development of hepatoma.	9	49	1.33	7.35e-06	9606.ENSP00000229135,9606.ENSP00000232219,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000478570	IFNG,RBP1,APC,CDH1,ALDH1A1,STAT5A,RBP4,AR,VEGFA
PMID:23947354	(2013) Tissue-resident memory T cells.	9	49	1.33	7.35e-06	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,IFNG,CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:22402315	(2012) Prostate cancer stem cell biology.	9	49	1.33	7.35e-06	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CD38,SOX9,CDH1,ALDH1A1,CD34,PTEN,AR,BCL2,PROM1
PMID:33413649	(2021) Infrapatellar fat pad-derived mesenchymal stem cell-based spheroids enhance their therapeutic efficacy to reverse synovitis and fat pad fibrosis.	10	70	1.22	7.66e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412	TGFB1,IFNG,FABP4,CXCL10,CXCL9,ALPL,BMP2,MME,PROM1,CCL5
PMID:34363351	(2021) Sustained expression of inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent plasma donors.	10	70	1.22	7.66e-06	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000384906,9606.ENSP00000478570	TGFB1,CD38,IFNG,PRDX2,CXCL10,CXCL11,STAT5A,CCL20,SAA1,VEGFA
PMID:34746270	(2021) Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer.	10	70	1.22	7.66e-06	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CXCL11,CD34,MAPK7,ANG,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:27418745	(2016) Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury.	10	70	1.22	7.66e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000358513,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CXCL10,ELN,CNR1,HSPG2,BCL2,NPY,NTF3,BDNF,VEGFA
PMID:24333264	(2014) Antioxidant gene therapy against neuronal cell death.	10	70	1.22	7.66e-06	9606.ENSP00000263317,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	NOX4,ANG,CNTF,NOX1,TXN,G6PD,BCL2,BDNF,MME,VEGFA
PMID:23639002	(2013) Redox regulation of protein kinases.	10	70	1.22	7.66e-06	9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	ATM,PDGFB,CAV1,MAP3K5,PTEN,NOX1,TXN,PDGFD,FGFR1,VEGFA
PMID:23251903	(2012) Radiation-induced effects and the immune system in cancer.	10	70	1.22	7.66e-06	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,CXCL11,CXCL9,CD47,ENTPD1,BCL2,MYD88,CCL5,VEGFA
PMID:34200849	(2021) Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs.	11	94	1.13	7.80e-06	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000284031,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX4,ATM,DDAH1,SIRT6,CAV1,PTEN,TXN,NFE2L2,PROM1,VEGFA
PMID:31240205	(2019) Insights on the Multifunctional Activities of Magnolol.	11	94	1.13	7.80e-06	9606.ENSP00000225275,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362463,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,PLIN1,LPL,SREBF1,PTGS2,GLO1,NFE2L2,BCL2,RHOA,BDNF,VEGFA
PMID:28881698	(2017) Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.	11	94	1.13	7.80e-06	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000362410,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ATM,MAPK7,STAT5A,MAP3K5,PTEN,NOX1,MAFB,TXN,BCL2,VEGFA
PMID:34063583	(2021) Challenges of Diagnosing Antibody-Mediated Rejection: The Role of Invasive and Non-Invasive Biomarkers.	6	9	1.88	7.88e-06	9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000419422	CXCL10,EDNRA,CXCL9,HSPG2,EDN1,AGTR1
PMID:34992414	(2021) The Anti-Inflammatory Actions and Mechanisms of Acupuncture from Acupoint to Target Organs via Neuro-Immune Regulation.	12	121	1.06	7.88e-06	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IGF1R,CXCL10,VIP,PTGS2,CNR1,JAK2,NPY,RHOA,MYD88,BDNF,VEGFA
PMID:33334030	(2020) New Actors Driving the Epithelial-Mesenchymal Transition in Cancer: The Role of Leptin.	12	121	1.06	7.88e-06	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,SOX9,CDH1,HNF4A,STAT5A,PTGS2,PTEN,BAMBI,JAK2,NPY,RHOA,VEGFA
PMID:21152127	(2011) Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology.	6	9	1.88	7.88e-06	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,CD34,AR,BCL2,MME,VEGFA
PMID:22046502	(2011) Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.	12	121	1.06	7.88e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CD34,ANGPT2,CCL20,PTGS2,ENTPD1,BCL2,MYD88,LTA,CCL5,VEGFA
PMID:19084927	(2008) Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.	6	9	1.88	7.88e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:17912012	(2007) Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis.	6	9	1.88	7.88e-06	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34831037	(2021) Channeling the Force: Piezo1 Mechanotransduction in Cancer Metastasis.	7	19	1.63	7.94e-06	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD69,CDH1,MMP14,CAV1,EDN1,BCL2,VEGFA
PMID:20617365	(2011) Identification of diagnostic serum protein profiles of glioblastoma patients.	7	19	1.63	7.94e-06	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000403495	IFNG,CHI3L1,THBS1,CXCL10,RBP4,BMP2,LTA
PMID:34841720	(2021) The multicellular signalling network of ovarian cancer metastases.	13	151	1.0	7.99e-06	9606.ENSP00000266085,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	TIMP3,KLF10,CXCL10,CXCL11,CXCL9,BMP2,EDN1,SAA1,IRAK4,BDNF,CCL5,GREM1,VEGFA
PMID:34842275	(2021) Vitamin A cycle byproducts explain retinal damage and molecular changes thought to initiate retinal degeneration.	13	151	1.0	7.99e-06	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412	TGFB1,CCR5,CXCL10,CXCL11,PRKAA1,PDGFA,FMOD,CXCL9,CNTF,PTEN,BCL2,LTA,CCL5
PMID:33198314	(2020) Tyrosine Kinase Receptors in Oncology.	13	151	1.0	7.99e-06	9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MAPK7,PDGFB,SREBF1,PTGS2,SGK1,PTEN,NFE2L2,BCL2,FGFR1,NTF3,RHOA,BDNF,VEGFA
PMID:33928077	(2021) TRP Channels in Brain Tumors.	9	50	1.32	8.12e-06	9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,VDAC1,ALDH1A1,AR,JAK2,BCL2,TRPC1,PROM1,VEGFA
PMID:33995026	(2021) Pharmacological Benefits of Triphala: A Perspective for Allergic Rhinitis.	9	50	1.32	8.12e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,VIP,PTGS2,TXN,G6PD,MYD88,CCL5,VEGFA
PMID:34503252	(2021) The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options.	9	50	1.32	8.12e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,MMP14,CD34,ELN,HSPG2,BCL2,RHOA,VEGFA
PMID:34650558	(2021) Human Whartons Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-alpha and Interferon-gamma Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.	9	50	1.32	8.12e-06	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250	TGFB1,CD69,IFNG,CCR5,CXCL10,CXCL11,CD34,CXCL9,ENTPD1
PMID:33081797	(2020) Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches.	9	50	1.32	8.12e-06	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,MAPK7,PTEN,NOX1,EDN1,NFE2L2,BCL2,VEGFA
PMID:33178674	(2020) Gene Expression Signatures of Synovial Fluid Multipotent Stromal Cells in Advanced Knee Osteoarthritis and Following Knee Joint Distraction.	9	50	1.32	8.12e-06	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478319	TGFB1,SOX9,FABP4,TIMP3,CD34,CCL20,PTGS2,CCL5,GREM1
PMID:33584698	(2020) Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation.	9	50	1.32	8.12e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,BCL2,LTA,CCL5
PMID:19043612	(2008) The Role of PPARs in the Endothelium: Implications for Cancer Therapy.	9	50	1.32	8.12e-06	9606.ENSP00000232219,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	RBP1,THBS1,CXCL10,CXCL11,ANGPT2,CXCL9,PTGS2,EDN1,VEGFA
PMID:35303907	(2022) The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALSFTD.	12	122	1.05	8.40e-06	9606.ENSP00000228434,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CHI3L1,CXCL10,ANG,PTGS2,EDN1,NFE2L2,IRAK4,MYD88,BDNF,CCL5,VEGFA
PMID:33678805	(2021) The key roles of cancer stem cell-derived extracellular vesicles.	11	95	1.12	8.40e-06	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CDH1,ALDH1A1,CD34,CD47,PTGS2,PTEN,RHOA,PROM1,VEGFA
PMID:33800703	(2021) Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications.	10	71	1.21	8.40e-06	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,TIMP3,ALDH1A1,MMP14,PTEN,BMP2,BCL2,GREM1,VEGFA,HNF1B
PMID:33941245	(2021) ROS and TGFbeta: from pancreatic tumour growth to metastasis.	10	71	1.21	8.40e-06	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,THBS1,CDH1,NOX4,TIMP3,PTEN,TXN,RHOA,PROM1,VEGFA
PMID:35062245	(2021) miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19.	11	95	1.12	8.40e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000317674,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,CDH1,IGF1R,CXCL10,CD34,APOL1,ELN,PTEN,BCL2,MYD88,VEGFA
PMID:31572524	(2019) Recent progress regarding kaempferol for the treatment of various diseases.	11	95	1.12	8.40e-06	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,SOX9,THBS1,ATM,SREBF1,MAP3K5,PTGS2,ANGPTL2,BCL2,MYD88,VEGFA
PMID:28574454	(2017) Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate.	11	95	1.12	8.40e-06	9606.ENSP00000229135,9606.ENSP00000264717,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418823	IFNG,GCKR,PLIN1,LPL,HNF4A,SREBF1,GFPT1,ABCG1,BCL2,BDNF,FTO
PMID:29062170	(2017) Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.	12	122	1.05	8.40e-06	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000322898,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,CDH1,CCR5,EBF1,CAV1,ELN,PTEN,SHBG,JAK2,BCL2,FGFR1,VEGFA
PMID:25405854	(2015) The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.	8	33	1.45	8.40e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,ENTPD1,CCL5,VEGFA
PMID:25916268	(2015) Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.	10	71	1.21	8.40e-06	9606.ENSP00000216862,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CYP24A1,FABP4,CDH1,ANGPT2,COMT,EDN1,BCL2,RHOA,AGTR1,VEGFA
PMID:25549350	(2014) HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.	8	33	1.45	8.40e-06	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANGPT2,ANG,PDGFA,EDN1,PROM1,CCL5,VEGFA
PMID:24369540	(2013) Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction.	10	71	1.21	8.40e-06	9606.ENSP00000226760,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000480291	WFS1,CD34,STAT5A,PRKAA1,SREBF1,PTEN,EDN1,BCL2,PROM1,HNF1B
PMID:22572241	(2012) Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease.	8	33	1.45	8.40e-06	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CHI3L1,CCR5,CXCL10,CXCL11,ELN,CXCL9,MYD88,CCL5
PMID:23691481	(2012) Role of adiponectin and its receptors in cancer.	8	33	1.45	8.40e-06	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000288266,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CD38,APPL1,SREBF1,PTGS2,PTEN,BCL2,VEGFA
PMID:27340590	(2012) The Dual Role of TGFbeta in Human Cancer: From Tumor Suppression to Cancer Metastasis.	11	95	1.12	8.40e-06	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000285407,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,IFNG,CDH1,TIMP3,KLF10,STAT5A,PTGS2,JAK2,BCL2,RHOA,VEGFA
PMID:21572958	(2011) Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1beta and lactoferrin.	8	33	1.45	8.40e-06	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,ANG,CXCL9,LTA,CCL5,VEGFA
PMID:21677296	(2011) The adventitia: a dynamic interface containing resident progenitor cells.	8	33	1.45	8.40e-06	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ELN,CXCL9,EDN1,MYD88,CCL5,VEGFA
PMID:20370585	(2010) Molecular pathways involved in loss of graft function in kidney transplant recipients.	8	33	1.45	8.40e-06	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000444198,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,ATM,ANGPT2,EDN1,AGTR1,CITED2,GREM1,VEGFA
PMID:34453639	(2021) The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance.	12	123	1.05	9.00e-06	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,IGF1R,ATM,ALDH1A1,MMP14,HNF4A,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:34943117	(2021) Flavonoids Present in Propolis in the Battle against Photoaging and Psoriasis.	11	96	1.12	9.13e-06	9606.ENSP00000225275,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CCL20,MAP3K5,PTGS2,TXN,JAK2,NFE2L2,BCL2,IRAK4,MYD88,VEGFA
PMID:32690952	(2020) The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.	11	96	1.12	9.13e-06	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,THBS1,CCR5,CXCL10,CD247,CXCL9,CD47,PTGS2,PROM1,CCL5,VEGFA
PMID:32765518	(2020) Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis.	11	96	1.12	9.13e-06	9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD69,ATM,CCR5,CXCL10,CXCL11,SREBF1,CXCL9,PTEN,BCL2,CCL5,VEGFA
PMID:33316884	(2020) Extracellular Vesicles in Hematological Malignancies: From Biomarkers to Therapeutic Tools.	11	96	1.12	9.13e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IGF1R,CXCL10,CD34,ENTPD1,PTEN,BCL2,MYD88,CCL5,VEGFA
PMID:30901834	(2019) Impact of ERK5 on the Hallmarks of Cancer.	11	96	1.12	9.13e-06	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CDH1,ATM,CXCL10,MAPK7,SGK1,PTEN,BCL2,NTF3,CCL5,VEGFA
PMID:35055140	(2022) The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders?	10	72	1.2	9.16e-06	9606.ENSP00000216862,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000360247,9606.ENSP00000363641,9606.ENSP00000474412	CYP24A1,FABP4,NOX4,CXCL10,CXCL11,LPL,SREBF1,CYP2J2,TXN,CCL5
PMID:35204122	(2022) Bioactive Compounds of Citrus Fruits: A Review of Composition and Health Benefits of Carotenoids, Flavonoids, Limonoids, and Terpenes.	9	51	1.31	9.16e-06	9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000477707	PLIN1,SREBF1,ABCG1,PTGS2,PTEN,NFE2L2,BCL2,BDNF,NR1H3
PMID:35214113	(2022) Mesenchymal StemStromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential.	10	72	1.2	9.16e-06	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD69,IFNG,CD34,CXCL9,PTGS2,LTA,BDNF,CCL5,VEGFA
PMID:34277408	(2021) Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.	10	72	1.2	9.16e-06	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,IGF1R,ALDH1A1,STAT5A,PTEN,BCL2,MYD88,MME,PROM1,VEGFA
PMID:34451925	(2021) Extracellular Vesicles: A Double-Edged Sword in Sepsis.	10	72	1.2	9.16e-06	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,BCL2,MYD88,CCL5,VEGFA
PMID:34679742	(2021) The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications.	9	51	1.31	9.16e-06	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000384957	TGFB1,NOX4,PRDX2,CXCL10,CXCL9,CD47,TXN,EDN1,F11
PMID:34873408	(2021) Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review.	10	72	1.2	9.16e-06	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000383364,9606.ENSP00000401399,9606.ENSP00000477707	CETP,MPO,CD34,SREBF1,ABCG1,EDN1,NFE2L2,PLA2G2A,MYD88,NR1H3
PMID:34876129	(2021) Virus infection induced pulmonary fibrosis.	9	51	1.31	9.16e-06	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412	CDH1,NOX4,CXCL10,CXCL11,CXCL9,EDN1,BCL2,RHOA,CCL5
PMID:32220831	(2020) Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.	10	72	1.2	9.16e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,ALDH1A1,GFPT1,PTEN,EDN1,BCL2,PROM1,VEGFA
PMID:32973492	(2020) Traditional Uses, Chemical Constituents, Biological Properties, Clinical Settings, and Toxicities of Abelmoschus manihot L.: A Comprehensive Review.	9	51	1.31	9.16e-06	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,NOX4,CXCL10,LPL,CXCL9,NOX1,BCL2,BDNF,VEGFA
PMID:33123356	(2020) The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies.	9	51	1.31	9.16e-06	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000317674,9606.ENSP00000362463,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000402152,9606.ENSP00000418823,9606.ENSP00000419422	TGFB1,CCR5,APOL1,GLO1,MTHFR,EDN1,SLC12A3,FTO,AGTR1
PMID:33208173	(2020) Differences and similarities between cancer and somatic stem cells: therapeutic implications.	10	72	1.2	9.16e-06	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,STAT5A,CD47,AR,MYD88,PROM1,VEGFA
PMID:29488209	(2019) Decorin-mediated oncosuppression - a potential future adjuvant therapy for human epithelial cancers.	9	51	1.31	9.16e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478570	IFNG,THBS1,CDH1,TIMP3,IGF1R,CAV1,ELN,HSPG2,VEGFA
PMID:31052565	(2019) Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications.	9	51	1.31	9.16e-06	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,ALDH1A1,PTEN,BCL2,RHOA,MME,PROM1,VEGFA
PMID:31127148	(2019) Chronic myeloid leukemia stem cells.	10	72	1.2	9.16e-06	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185	CD38,IFNG,ATM,CD34,STAT5A,CD47,PTEN,BMP2,JAK2,BCL2
PMID:31684144	(2019) Balancing STAT Activity as a Therapeutic Strategy.	10	72	1.2	9.16e-06	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,CXCL10,CXCL11,STAT5A,CXCL9,CNTF,JAK2,BCL2,VEGFA
PMID:31864423	(2019) Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases.	9	51	1.31	9.16e-06	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,ELN,PTEN,BCL2,NTF3,BDNF,PROM1,VEGFA
PMID:29196458	(2018) Integrin alpha4beta7 Blockade Preferentially Impacts CCR6(+) Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques.	9	51	1.31	9.16e-06	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,CCR5,CXCL10,CXCL11,CXCL9,MME,CCL5,VEGFA
PMID:29298879	(2018) Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.	10	72	1.2	9.16e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTEN,AR,JAK2,BCL2,FGFR1,CCL5,VEGFA
PMID:29311384	(2018) Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.	9	51	1.31	9.16e-06	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000401399,9606.ENSP00000478570	MPO,THBS1,CD47,PTGS2,JAK2,NFE2L2,GGT1,MYD88,VEGFA
PMID:30310531	(2018) Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitorstem cells.	9	51	1.31	9.16e-06	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	SOX9,ALDH1A1,CD34,PTEN,BCL2,NTF3,RHOA,TRPC1,VEGFA
PMID:30534079	(2018) Mechanisms and Modulation of OxidativeNitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia.	9	51	1.31	9.16e-06	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	MPO,HSPB1,NOX4,PTGS2,EDN1,NFE2L2,MME,AGTR1,VEGFA
PMID:26196442	(2016) The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration.	9	51	1.31	9.16e-06	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000478570	FABP4,CD34,STAT5A,PDGFA,MAP3K5,PTGS2,AR,BMP2,VEGFA
PMID:25665066	(2015) The multifaceted role of curcumin in cancer prevention and treatment.	10	72	1.2	9.16e-06	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,CAV1,STAT5A,CNTF,PTGS2,AR,EDN1,JAK2,BCL2,VEGFA
PMID:24809778	(2014) Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.	9	51	1.31	9.16e-06	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	TGFB1,IFNG,CCR5,CXCL10,CXCL11,CD34,CXCL9,JAK2,CCL5
PMID:24076568	(2013) Novel strategies targeting cancer stem cells through phytochemicals and their analogs.	10	72	1.2	9.16e-06	9606.ENSP00000226279,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CD38,APC,CDH1,ALDH1A1,CD34,PTEN,AR,BCL2,RHOA,PROM1
PMID:21722728	(2011) Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling.	9	51	1.31	9.16e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000298352,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000377192	IFNG,NOX4,NGB,MAP3K5,PTGS2,NOX1,TXN,EDN1,G6PD
PMID:19673606	(2009) Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection.	9	51	1.31	9.16e-06	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	HSPB1,THBS1,COL8A1,CAV1,HSPG2,RHOA,BDNF,AGTR1,VEGFA
PMID:33535613	(2021) Targeting Oncoimmune Drivers of Cancer Metastasis.	12	124	1.05	9.45e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CCR5,CXCL10,HNF4A,CD247,BCL2,RHOA,MYD88,PROM1,CCL5,VEGFA
PMID:23372425	(2012) Bladder cancer: a simple model becomes complex.	12	124	1.05	9.45e-06	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000364683,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,SOX9,THBS1,CDH1,TIMP3,MAPK7,PTEN,AR,BAMBI,MTHFR,BCL2,VEGFA
PMID:19014652	(2008) Redox mechanisms in hepatic chronic wound healing and fibrogenesis.	12	124	1.05	9.45e-06	9606.ENSP00000265333,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	VDAC1,SREBF1,ELN,MAP3K5,PTGS2,NOX1,TXN,EDN1,JAK2,BCL2,MYD88,CCL5
PMID:34123834	(2021) Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review).	11	97	1.12	9.72e-06	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,SIRT6,SREBF1,SGK1,PTEN,NOX1,NFE2L2,BCL2,VEGFA
PMID:34199901	(2021) CRISPRCas9: Principle, Applications, and Delivery through Extracellular Vesicles.	11	97	1.12	9.72e-06	9606.ENSP00000226760,9606.ENSP00000257430,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303	WFS1,APC,CCR5,CD34,HNF4A,CAV1,NPY,NTF3,RHOA,MYD88,BDNF
PMID:34830902	(2021) Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer.	11	97	1.12	9.72e-06	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,MAPK1,THBS1,IGF1R,ATM,SIRT6,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:32192494	(2020) Noncoding RNAs in gastric cancer: implications for drug resistance.	11	97	1.12	9.72e-06	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,SOX9,CDH1,TIMP3,IGF1R,CAV1,ABCG1,PTEN,BCL2,FGFR1,RHOA
PMID:29351514	(2018) The ACE2Angiotensin-(1-7)MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).	11	97	1.12	9.72e-06	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,CD34,MAPK7,SIRT6,PTGS2,PTEN,EDN1,RHOA,MME,AGTR1,VEGFA
PMID:20159032	(2010) STAT1 and pathogens, not a friendly relationship.	11	97	1.12	9.72e-06	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD38,ATM,CCR5,CXCL10,STAT5A,CXCL9,ENTPD1,JAK2,BCL2,MYD88,VEGFA
PMID:35371005	(2022) Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza.	8	34	1.43	9.73e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33300684	(2021) Leonurine, a potential drug for the treatment of cardiovascular system and central nervous system diseases.	7	20	1.61	9.73e-06	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000356832,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,NOX4,SGK1,NFE2L2,BCL2,BDNF,VEGFA
PMID:33879215	(2021) The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior.	8	34	1.43	9.73e-06	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,ALDH1A1,CD34,PTEN,JAK2,BCL2,FGFR1,VEGFA
PMID:33919266	(2021) Photodynamic Therapy as an Oxidative Anti-Tumor Modality: Negative Effects of Nitric Oxide on Treatment Efficacy.	7	20	1.61	9.73e-06	9606.ENSP00000225275,9606.ENSP00000306884,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185	MPO,CXCL11,MAP3K5,PTGS2,PTEN,TXN,BCL2
PMID:31949487	(2020) STAT3 signaling in ovarian cancer: a potential therapeutic target.	8	34	1.43	9.73e-06	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ALDH1A1,STAT5A,JAK2,BCL2,LTB4R2,CCL5,VEGFA
PMID:32210089	(2020) Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.	8	34	1.43	9.73e-06	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	NOX4,PTGS2,NOX1,EDN1,NFE2L2,RHOA,MME,VEGFA
PMID:32967334	(2020) Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.	8	34	1.43	9.73e-06	9606.ENSP00000200676,9606.ENSP00000265132,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000360522,9606.ENSP00000384906	CETP,AMBP,LPL,APOL1,LPA,ABCG1,RBP4,SAA1
PMID:33287438	(2020) Effect of Type of Pregnancy on Transcriptional and Plasma Metabolic Response in Sheep and Its Further Effect on Progeny Lambs.	7	20	1.61	9.73e-06	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IGF1R,LPL,ANGPT2,SREBF1,BCL2,VEGFA
PMID:29483947	(2018) Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.	7	20	1.61	9.73e-06	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,SHBG,BCL2,CCL5,VEGFA
PMID:30406106	(2018) Recent Advances in Endothelial Colony Forming Cells Toward Their Use in Clinical Translation.	8	34	1.43	9.73e-06	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,THBS1,ATM,STAT5A,PTEN,EDN1,JAK2,VEGFA
PMID:30534107	(2018) Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.	8	34	1.43	9.73e-06	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000478570	CD38,AMBP,CCR5,CXCL10,CD34,SAA1,LTA,VEGFA
PMID:28396983	(2017) The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes.	7	20	1.61	9.73e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CDH1,EDNRA,PTGS2,EDN1,AGTR1,VEGFA
PMID:28881794	(2017) Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN.	7	20	1.61	9.73e-06	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,TIMP3,STAT5A,PTEN,BCL2,RHOA,PROM1
PMID:25595590	(2015) Chemokine-mediated inflammation in the degenerating retina is coordinated by Muller cells, activated microglia, and retinal pigment epithelium.	8	34	1.43	9.73e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,MYD88,LTA,CCL5
PMID:26000250	(2015) Hypoxia-independent drivers of melanoma angiogenesis.	8	34	1.43	9.73e-06	9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	ATM,MMP14,ANGPT2,ANG,PTEN,TXN,EDN1,VEGFA
PMID:24550656	(2014) Microarray analysis for genes associated with angiogenesis in diabetic OLETF keratocytes.	8	34	1.43	9.73e-06	9606.ENSP00000266085,9606.ENSP00000284031,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000444198,9606.ENSP00000478570	TIMP3,DDAH1,ANGPT2,EDN1,NPY,AGTR1,CITED2,VEGFA
PMID:25140155	(2014) Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol.	7	20	1.61	9.73e-06	9606.ENSP00000284031,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	DDAH1,SIRT6,NOX1,TXN,EDN1,RHOA,AGTR1
PMID:23983717	(2013) Intracoronary Infusion of Autologous CD133(+) Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing.	8	34	1.43	9.73e-06	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANG,CNTF,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:24304724	(2013) Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.	7	20	1.61	9.73e-06	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	CDH1,MMP14,CAV1,STAT5A,PTEN,JAK2,BCL2
PMID:22115830	(2012) Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of beta-catenin.	7	20	1.61	9.73e-06	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000478319	APC,CDH1,HNF4A,PTEN,BAMBI,BMP2,GREM1
PMID:22401856	(2012) Reactive oxygen and nitrogen species in pulmonary hypertension.	8	34	1.43	9.73e-06	9606.ENSP00000263317,9606.ENSP00000298352,9606.ENSP00000306124,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683	NOX4,NGB,PRKCE,EDNRA,PTGS2,NOX1,TXN,EDN1
PMID:22554253	(2012) Preventive immunization of aged and juvenile non-human primates to beta-amyloid.	8	34	1.43	9.73e-06	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,CXCL10,CXCL11,CXCL9,PTGS2,CCL5,VEGFA
PMID:22727560	(2012) Role of TWEAK in lupus nephritis: a bench-to-bedside review.	8	34	1.43	9.73e-06	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ANGPT2,CXCL9,JAK2,SAA1,CCL5,VEGFA
PMID:23251142	(2012) Modulation of PPAR-gamma by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases.	8	34	1.43	9.73e-06	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351671	IFNG,FABP4,PLIN1,CXCL10,PRKCE,LPL,SREBF1,CCL20
PMID:35328389	(2022) Bisphenol A (BPA) Leading to Obesity and Cardiovascular Complications: A Compilation of Current In Vivo Study.	10	73	1.2	9.81e-06	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000478570	FABP4,LPL,CAV1,SREBF1,NPY,NTF3,MYD88,BDNF,FTO,VEGFA
PMID:33478130	(2021) Autocrine TGF-beta in Cancer: Review of the Literature and Caveats in Experimental Analysis.	10	73	1.2	9.81e-06	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000384262,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,MMP14,HNF4A,ANGPT2,PTEN,ANGPTL2,HPSE,RHOA,VEGFA
PMID:34445477	(2021) The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets.	10	73	1.2	9.81e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	MAPK1,TGFB1,SREBF1,ELN,ABCG1,CNTF,PTGS2,EDN1,NFE2L2,VEGFA
PMID:34768801	(2021) NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond.	10	73	1.2	9.81e-06	9606.ENSP00000228434,9606.ENSP00000263317,9606.ENSP00000321334,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD69,NOX4,LPA,CCL20,NOX1,EDN1,GAP43,BCL2,RHOA,VEGFA
PMID:31336602	(2019) The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.	10	73	1.2	9.81e-06	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478253,9606.ENSP00000478570	CD38,SOX9,CDH1,IGF1R,ALDH1A1,CD34,BCL2,PROM1,MTHFD1L,VEGFA
PMID:30409213	(2018) Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells.	10	73	1.2	9.81e-06	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000478570	THBS1,ATM,CD34,ANG,CAV1,PTEN,BCL2,RHOA,RARRES2,VEGFA
PMID:24712303	(2014) Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma.	10	73	1.2	9.81e-06	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,HSPB1,IGF1R,ATM,ERCC4,HNF4A,CAV1,SREBF1,BCL2,VEGFA
PMID:34950252	(2021) Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.	12	125	1.04	9.87e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,IGF1R,CD34,PTGS2,PTEN,JAK2,NFE2L2,BCL2,SAA1,CCL5,VEGFA,HNF1B
PMID:30912746	(2019) Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury.	12	125	1.04	9.87e-06	9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	THBS1,COL8A1,TIMP3,CXCL10,CD34,PDGFB,PDGFA,FMOD,ELN,CCL5,APLNR,VEGFA
PMID:35327485	(2022) Potential Anti-Inflammatory Effects of a New Lyophilized Formulation of the Conditioned Medium Derived from Periodontal Ligament Stem Cells.	9	52	1.3	9.93e-06	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,PDGFA,PTGS2,PDGFD,MYD88,LTA,CCL5,VEGFA
PMID:33498875	(2021) Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer.	9	52	1.3	9.93e-06	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,ATM,CAV1,PTEN,NOX1,TXN,LTB4R2,CCL5,VEGFA
PMID:33742062	(2021) Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19.	9	52	1.3	9.93e-06	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,IFNG,THBS1,TIMP3,CXCL10,CXCL11,CXCL9,CCL5
PMID:30046616	(2018) Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications.	9	52	1.3	9.93e-06	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000345708,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CD34,KCNJ11,BMP2,JAK2,BCL2,BDNF,PROM1,VEGFA
PMID:30169853	(2018) Cytokines and radiation-induced pulmonary injuries.	9	52	1.3	9.93e-06	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,CXCL11,CCL20,ELN,CXCL9,BCL2,CCL5,VEGFA
PMID:27094811	(2016) Hypoxia-inducible factors as molecular targets for liver diseases.	9	52	1.3	9.93e-06	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CCR5,ANGPT2,PDGFB,PDGFA,SREBF1,ENTPD1,BCL2,VEGFA
PMID:25866469	(2015) Protein Expression by Human Pulmonary Artery Smooth Muscle Cells Containing a BMPR2 Mutation and the Action of ET-1 as Determined by Proteomic Mass Spectrometry.	9	52	1.3	9.93e-06	9606.ENSP00000248553,9606.ENSP00000315011,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,EDNRA,ALPL,BMP2,EDN1,G6PD,BCL2,RHOA,VEGFA
PMID:23798836	(2013) Hidden keys in stroma: Unlocking the tumor progression.	9	52	1.3	9.93e-06	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,CXCL10,CD34,PDGFB,CXCL9,PTGS2,PROM1,VEGFA
PMID:34484567	(2021) Cross-Talk between Oxidative Stress and m(6)A RNA Methylation in Cancer.	11	98	1.11	1.02e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418823	CDH1,NOX4,MAPK7,MAP3K5,PTEN,NOX1,TXN,NFE2L2,BCL2,RHOA,FTO
PMID:32326376	(2020) Phenolic Compounds Exerting Lipid-Regulatory, Anti-Inflammatory and Epigenetic Effects as Complementary Treatments in Cardiovascular Diseases.	11	98	1.11	1.02e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000477707,9606.ENSP00000478570	CETP,MPO,NOX4,LPL,SREBF1,ABCG1,TXN,JAK2,G6PD,NR1H3,VEGFA
PMID:31064104	(2019) Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential.	11	98	1.11	1.02e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,SOX9,CDH1,MMP14,MAP3K5,PTGS2,CNR1,PTEN,JAK2,BCL2,VEGFA
PMID:30178305	(2018) Radiation, inflammation and the immune response in cancer.	11	98	1.11	1.02e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,CCL20,MAP3K5,PTGS2,ENTPD1,TXN,NFE2L2,BCL2,CCL5,VEGFA
PMID:21521171	(2011) Ras family small GTPase-mediated neuroprotective signaling in stroke.	12	126	1.04	1.06e-05	9606.ENSP00000222139,9606.ENSP00000248553,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000475344,9606.ENSP00000478570	EPOR,HSPB1,MAPK7,MAP3K5,PTGS2,SGK1,PTEN,TXN,BCL2,BDNF,APLNR,VEGFA
PMID:35211104	(2022) Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review.	10	74	1.19	1.08e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000301522,9606.ENSP00000312987,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000398048,9606.ENSP00000401399,9606.ENSP00000403495	CDH1,TIMP3,PRDX2,HNF4A,NOX1,JAK2,BCL2,ALPK1,MYD88,LTA
PMID:35269469	(2022) Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women.	10	74	1.19	1.08e-05	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000349860,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067	CD69,SOX9,FABP4,FADS2,CCR5,CD34,GFPT1,PTGS2,AR,JAK2
PMID:35379361	(2022) Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects.	10	74	1.19	1.08e-05	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,ATM,ANG,PTGS2,PTEN,BMP2,BCL2,NTF3,MYD88,VEGFA
PMID:33916703	(2021) Lipofilling in Breast Oncological Surgery: A Safe Opportunity or Risk for Cancer Recurrence?	10	74	1.19	1.08e-05	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CDH1,ATM,CD34,RBP4,ANGPTL2,JAK2,PDGFD,CCL5,VEGFA
PMID:33105588	(2020) Perivascular Inflammation in Pulmonary Arterial Hypertension.	10	74	1.19	1.08e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	MPO,NOX4,CCR5,CD34,EDNRA,PTEN,EDN1,MYD88,PROM1,VEGFA
PMID:30703416	(2019) Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.	10	74	1.19	1.08e-05	9606.ENSP00000232219,9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	RBP1,FABP4,ALDH1A1,LPL,STAT5A,SREBF1,RBP4,JAK2,MYD88,VEGFA
PMID:30585246	(2018) Extracellular Vesicles as Conduits of Non-Coding RNA Emission and Intercellular Transfer in Brain Tumors.	10	74	1.19	1.08e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,TIMP3,ANG,CD47,PTEN,GAP43,RHOA,BDNF,CCL5,VEGFA
PMID:28770020	(2017) Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.	10	74	1.19	1.08e-05	9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	VDAC1,ATM,ALDH1A1,HNF4A,MAP3K5,PTGS2,PTEN,TXN,BCL2,VEGFA
PMID:24495159	(2014) The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment.	10	74	1.19	1.08e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CD38,ALDH1A1,CD34,CD47,PTEN,TXN,JAK2,BCL2,VEGFA
PMID:17658951	(2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.	10	74	1.19	1.08e-05	9606.ENSP00000246553,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000349860,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418823	FFAR1,PLIN1,LPL,KCNJ11,GFPT1,COMT,MTHFR,NPY,BDNF,FTO
PMID:33436555	(2021) Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.	13	157	0.98	1.09e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CCL20,ELN,PTGS2,ENTPD1,PTEN,NOX1,EDN1,BCL2,FGFR1,CCL5,VEGFA
PMID:34202136	(2021) Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics.	13	157	0.98	1.09e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,IGF1R,ATM,CXCL10,CXCL11,HNF4A,PDGFB,CD2AP,PTEN,NFE2L2,BCL2,MME,VEGFA
PMID:24798458	(2014) The immunosuppressant Protosappanin A diminished recipient T cell migration into allograft via inhibition of IP-10 in rat heart transplant.	6	10	1.84	1.09e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:23456865	(2013) Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.	6	10	1.84	1.09e-05	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,IFNG,STAT5A,JAK2,BDNF,VEGFA
PMID:23702167	(2013) Impact of antiretroviral therapy on lung immunology and inflammation.	6	10	1.84	1.09e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL9,LTA,CCL5
PMID:23734310	(2013) Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands.	6	10	1.84	1.09e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CD69,IFNG,CXCL10,CXCL9,PTGS2,CCL5
PMID:24084215	(2013) Inhibition of phosphatidylinositol 3-kinaseAkt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells.	6	10	1.84	1.09e-05	9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,ELN,PTEN,EDN1,RHOA,VEGFA
PMID:18187931	(2008) Microarray analysis of glomerular gene expression in murine lupus nephritis.	6	10	1.84	1.09e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34497524	(2021) Comprehensive Analysis of Key Genes, Signaling Pathways and miRNAs in Human Knee Osteoarthritis: Based on Bioinformatics.	11	99	1.11	1.10e-05	9606.ENSP00000256104,9606.ENSP00000261037,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000334329,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000478570	FABP4,COL8A1,LPL,CD34,ANGPT2,UNC5B,MAP3K5,PTGS2,GAP43,NFE2L2,VEGFA
PMID:32133298	(2020) The Engagement Between MDSCs and Metastases: Partners in Crime.	11	99	1.11	1.10e-05	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD38,THBS1,CCR5,ALDH1A1,MMP14,CD34,CD247,PTGS2,ENTPD1,CCL5,VEGFA
PMID:32998300	(2020) Therapeutic Potential of beta-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.	11	99	1.11	1.10e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,MPO,ATM,SREBF1,ELN,PTGS2,CNR1,G6PD,BCL2,BDNF,VEGFA
PMID:33192583	(2020) Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.	11	99	1.11	1.10e-05	9606.ENSP00000260356,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	THBS1,SIRT6,PTGS2,RBP4,BMP2,EDN1,JAK2,NPY,RARRES2,APLNR,VEGFA
PMID:21184860	(2011) The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer.	11	99	1.11	1.10e-05	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ATM,CXCL10,PTGS2,TXN,AR,EDN1,NFE2L2,BCL2,CCL5,VEGFA
PMID:35015703	(2022) Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism.	9	53	1.29	1.11e-05	9606.ENSP00000200676,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000321334,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000363641	CETP,PLIN1,LPL,HNF4A,LPA,ANG,CAV1,SREBF1,TXN
PMID:35333871	(2022) Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography.	15	227	0.88	1.11e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,ATM,CD34,ANG,SIRT6,CAV1,PDGFA,PTEN,BMP2,EDN1,KL,JAK2,BCL2,VEGFA
PMID:35409299	(2022) Role of Obesity, Physical Exercise, Adipose Tissue-Skeletal Muscle Crosstalk and Molecular Advances in Barretts Esophagus and Esophageal Adenocarcinoma.	9	53	1.29	1.11e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,CNTF,PTGS2,BCL2,BDNF,RARRES2,PROM1,VEGFA
PMID:33986872	(2021) Triple-negative breast cancer: A run-through of features, classification and current therapies.	9	53	1.29	1.11e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000480291	ATM,CXCL10,CXCL11,PTEN,AR,BCL2,PROM1,CCL5,HNF1B
PMID:34111453	(2021) Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.	8	35	1.42	1.11e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,JAK2,LTA,CCL5,VEGFA
PMID:34295897	(2021) Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.	8	35	1.42	1.11e-05	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANG,CNTF,GAP43,RHOA,BDNF,PROM1,VEGFA
PMID:31963368	(2020) Immune Dysregulation in HFpEF: A Target for Mesenchymal StemStromal Cell Therapy.	9	53	1.29	1.11e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CD34,CXCL9,JAK2,MME,CCL5,VEGFA
PMID:32042068	(2020) Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?	9	53	1.29	1.11e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ATM,HNF4A,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:32119719	(2020) African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity.	8	35	1.42	1.11e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CD38,CD69,CCR5,CXCL10,CXCL11,MYD88,CCL5
PMID:32226378	(2020) Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension.	9	53	1.29	1.11e-05	9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CXCL11,EDNRA,NOX1,EDN1,BCL2,RHOA,CCL5,VEGFA
PMID:33194755	(2020) COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?	8	35	1.42	1.11e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	MPO,THBS1,CCR5,CXCL10,IRAK4,MYD88,AGTR1,VEGFA
PMID:33333951	(2020) Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems.	9	53	1.29	1.11e-05	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,PTGS2,JAK2,NFE2L2,BCL2,NTF3,RHOA,BDNF,VEGFA
PMID:33708382	(2020) Cardiovascular protection effect of chlorogenic acid: focus on the molecular mechanism.	9	53	1.29	1.11e-05	9606.ENSP00000304767,9606.ENSP00000315011,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	P2RY1,EDNRA,ABCG1,PTGS2,EDN1,TRPC1,CCL5,NR1H3,VEGFA
PMID:30832981	(2019) Emerging roles of and therapeutic strategies targeting BRD4 in cancer.	9	53	1.29	1.11e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CXCL9,CD47,BMP2,MYD88,LTA,CCL5,VEGFA
PMID:30845657	(2019) The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.	8	35	1.42	1.11e-05	9606.ENSP00000232219,9606.ENSP00000260356,9606.ENSP00000283928,9606.ENSP00000354511,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	RBP1,THBS1,JAZF1,COMT,AR,BCL2,MME,VEGFA
PMID:30849489	(2019) Reactive species-induced microvascular dysfunction in ischemiareperfusion.	9	53	1.29	1.11e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683	MPO,CD38,THBS1,NOX4,VDAC1,CD47,NOX1,TXN,EDN1
PMID:30935064	(2019) STIM-Orai Channels and Reactive Oxygen Species in the Tumor Microenvironment.	8	35	1.42	1.11e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000478570	CDH1,NOX4,PTEN,NOX1,TXN,BCL2,TRPC1,VEGFA
PMID:31169021	(2019) Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development.	9	53	1.29	1.11e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,NOX4,CAV1,NOX1,TXN,EDN1,CCL5,GREM1,VEGFA
PMID:31404983	(2019) The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review.	9	53	1.29	1.11e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363596,9606.ENSP00000419422,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CD34,CXCL9,CNR2,AGTR1,CCL5
PMID:31877991	(2019) TRPC Channels in Proteinuric Kidney Diseases.	8	35	1.42	1.11e-05	9606.ENSP00000263317,9606.ENSP00000352264,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000419422	NOX4,CD2AP,EDN1,KL,BCL2,RHOA,TRPC1,AGTR1
PMID:29904388	(2018) Niches for the Long-Term Maintenance of Tissue-Resident Memory T Cells.	9	53	1.29	1.11e-05	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CD69,FABP4,CDH1,CCR5,CXCL10,STAT5A,CXCL9,MYD88,CCL5
PMID:27022202	(2016) Advancing biomaterials of human origin for tissue engineering.	9	53	1.29	1.11e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CD34,ELN,CNTF,PTGS2,HSPG2,BMP2,CCL5,VEGFA
PMID:27200351	(2016) p38 MAPK Signaling in Osteoblast Differentiation.	12	127	1.04	1.11e-05	9606.ENSP00000245479,9606.ENSP00000246553,9606.ENSP00000248553,9606.ENSP00000311005,9606.ENSP00000347041,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,FFAR1,HSPB1,MAPK7,FMOD,MAP3K5,PTGS2,ANGPTL2,EDN1,NPY,RHOA,VEGFA
PMID:27610139	(2016) The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma.	9	53	1.29	1.11e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	SOX9,CDH1,IGF1R,CD34,HNF4A,CD47,PTEN,BCL2,PROM1
PMID:26056345	(2015) Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.	8	35	1.42	1.11e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419422	TGFB1,THBS1,NOX4,EDNRA,BMP2,EDN1,JAK2,AGTR1
PMID:26100668	(2015) Aquaporin-3-mediated hydrogen peroxide transport is required for NF-kappaB signalling in keratinocytes and development of psoriasis.	8	35	1.42	1.11e-05	9606.ENSP00000229135,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067	IFNG,PRDX2,CXCL10,CCL20,CXCL9,PTEN,NOX1,JAK2
PMID:25346720	(2014) Could cord blood cell therapy reduce preterm brain injury?	8	35	1.42	1.11e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,CD34,ANG,NTF3,BDNF,PROM1,VEGFA
PMID:24265156	(2013) What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway.	9	53	1.29	1.11e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	APC,CDH1,IGF1R,STAT5A,SGK1,PTEN,AR,JAK2,BCL2
PMID:21745318	(2012) Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.	8	35	1.42	1.11e-05	9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	KLF10,CD34,ANGPT2,EDNRA,CAV1,EDN1,MYD88,VEGFA
PMID:22070687	(2012) Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.	9	53	1.29	1.11e-05	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,MMP14,LPL,CAV1,ELN,EDN1,BCL2,RHOA,VEGFA
PMID:23201837	(2012) Lipophilic micronutrients and adipose tissue biology.	9	53	1.29	1.11e-05	9606.ENSP00000216862,9606.ENSP00000232219,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000371067	CYP24A1,RBP1,SOX9,ALDH1A1,LPL,STAT5A,SREBF1,RBP4,JAK2
PMID:21933389	(2011) The Alzheimers disease signature: potential perspectives for novel biomarkers.	9	53	1.29	1.11e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000352264,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,IFNG,CHI3L1,THBS1,CD2AP,EDN1,GAP43,BDNF,VEGFA
PMID:20026286	(2010) The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue.	9	53	1.29	1.11e-05	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,FABP4,ATM,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:20530063	(2010) PPARgamma as a potential therapeutic target in pulmonary hypertension.	8	35	1.42	1.11e-05	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000474412	NOX4,EDNRA,ELN,PTGS2,PTEN,NOX1,EDN1,CCL5
PMID:26435732	(2010) Biomarkers of primary open-angle glaucoma.	8	35	1.42	1.11e-05	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,THBS1,CAV1,ELN,HSPG2,EDN1,RHOA,VEGFA
PMID:16318412	(2006) Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach.	9	53	1.29	1.11e-05	9606.ENSP00000229135,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,KLF10,CXCL10,PDGFA,ELN,EDN1,BCL2,AGTR1,VEGFA
PMID:15256003	(2004) Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: potential relevance in ocular inflammation and respiratory infection.	8	35	1.42	1.11e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412	MPO,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CNTF,CCL5
PMID:34360616	(2021) Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.	10	75	1.19	1.15e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANG,SIRT6,ELN,CXCL9,BCL2,CCL5,VEGFA
PMID:32806528	(2020) Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage-Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities.	10	75	1.19	1.15e-05	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377192	MAPK1,CD38,PRDX2,CD34,EBF1,STAT5A,ELN,PTEN,JAK2,G6PD
PMID:32850012	(2020) Important players in carcinogenesis as potential targets in cancer therapy: an update.	10	75	1.19	1.15e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000293599,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,CDH1,IGF1R,AQP5,STAT5A,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:29560266	(2018) The role of tumor microenvironment in resistance to anti-angiogenic therapy.	10	75	1.19	1.15e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CD34,PDGFB,STAT5A,PTGS2,FGFR1,CCL5,VEGFA
PMID:25727152	(2015) Glycosylation alterations in lung and brain cancer.	10	75	1.19	1.15e-05	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000384262,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CDH1,IGF1R,PDGFB,PTEN,HSPG2,HPSE,FGFR1,PROM1,VEGFA
PMID:22665999	(2012) The molecular biology of soft-tissue sarcomas and current trends in therapy.	10	75	1.19	1.15e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,IGF1R,MAPK7,ANGPT2,PDGFB,PTEN,BCL2,PROM1,VEGFA
PMID:35392236	(2022) Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.	12	128	1.03	1.16e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,CCR5,ALDH1A1,CD34,CD47,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:33270507	(2021) Precision Redox: The Key for Antioxidant Pharmacology.	7	21	1.58	1.16e-05	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,PRDX2,MAP3K5,PTEN,NOX1,TXN,NFE2L2
PMID:33465292	(2021) Pleiotropic activity of nerve growth factor in regulating cardiac functions and counteracting pathogenesis.	7	21	1.58	1.16e-05	9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,VIP,EDN1,NPY,NTF3,BDNF,VEGFA
PMID:34639160	(2021) Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists.	11	100	1.1	1.16e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	MPO,CDH1,NOX4,CXCL10,SIRT6,PTGS2,NOX1,JAK2,BCL2,MME,CCL5
PMID:34977044	(2021) Ferroptosis Signaling and Regulators in Atherosclerosis.	11	100	1.1	1.16e-05	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000278840,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,NOX4,FADS2,HNF4A,SREBF1,ABCG1,PTGS2,NOX1,TXN,CCL5,VEGFA
PMID:32246586	(2020) Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review.	7	21	1.58	1.16e-05	9606.ENSP00000013807,9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,EPOR,IGF1R,ATM,PTGS2,BCL2,VEGFA
PMID:32467737	(2020) Role of extra cellular proteins in gastric cancer progression and metastasis: an update.	11	100	1.1	1.16e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000478570	TGFB1,THBS1,CDH1,TIMP3,MMP14,STAT5A,ELN,PTGS2,PTEN,HPSE,VEGFA
PMID:32528879	(2020) Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment.	11	100	1.1	1.16e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000263774,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,NOX4,NDUFS3,CAV1,PTGS2,PTEN,NOX1,JAK2,BCL2,FGFR1,VEGFA
PMID:32587457	(2020) A systems genetics approach to revealing the Pdgfb molecular network of the retina.	7	21	1.58	1.16e-05	9606.ENSP00000221930,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,HNF4A,PDGFB,PDGFA,PTEN,FGFR1,VEGFA
PMID:32872540	(2020) Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases.	12	128	1.03	1.16e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364	MAPK1,FABP4,PLIN1,MAPK7,CAV1,SREBF1,MAP3K5,PTGS2,SGK1,JAK2,BCL2,NPY
PMID:29562781	(2018) Placenta-Derived Cells for Acute Brain Injury.	7	21	1.58	1.16e-05	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANGPT2,CNTF,PTGS2,NTF3,BDNF,VEGFA
PMID:29675018	(2018) Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.	11	100	1.1	1.16e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,ANGPT2,ANG,STAT5A,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:28512445	(2017) The Therapeutic Value of Bone Marrow-Derived Endothelial Progenitor Cell Transplantation after Intracerebral Hemorrhage in Rats.	7	21	1.58	1.16e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IFNG,CD34,BCL2,BDNF,PROM1,VEGFA
PMID:26739969	(2016) Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia.	7	21	1.58	1.16e-05	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000360247,9606.ENSP00000365777,9606.ENSP00000414303,9606.ENSP00000418823	WFS1,JAZF1,HNF4A,CYP2J2,MTHFR,BDNF,FTO
PMID:27050277	(2016) Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.	7	21	1.58	1.16e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	TGFB1,CDH1,PDGFB,PDGFA,CXCL9,PTGS2,VEGFA
PMID:23994756	(2014) Altered gene products involved in the malignant reprogramming of cancer stemprogenitor cells and multitargeted therapies.	11	100	1.1	1.16e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,CDH1,ALDH1A1,SREBF1,PTGS2,PTEN,AR,BCL2,RHOA,PROM1,VEGFA
PMID:24672247	(2014) Clusterin: a key player in cancer chemoresistance and its inhibition.	7	21	1.58	1.16e-05	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,THBS1,CDH1,IGF1R,ATM,BCL2,VEGFA
PMID:25421534	(2014) Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis.	11	100	1.1	1.16e-05	9606.ENSP00000229135,9606.ENSP00000264717,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000360522,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418823	IFNG,GCKR,PLIN1,HNF4A,SIRT6,RBP4,TXN,NFE2L2,BCL2,NPY,FTO
PMID:21439064	(2011) Expression of Ets-1, Ang-2 and maspin in ovarian cancer and their role in tumor angiogenesis.	7	21	1.58	1.16e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,CD34,ANGPT2,AR,BCL2,VEGFA
PMID:33028824	(2020) NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential.	13	159	0.97	1.17e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000227868,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000393312,9606.ENSP00000414303	MPO,CD38,PDHX,NOX4,ATM,LPL,SIRT6,SREBF1,NOX1,TXN,G6PD,FGFR1,BDNF
PMID:32561858	(2020) A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.	14	193	0.92	1.21e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000362410,9606.ENSP00000363827,9606.ENSP00000368683	MPO,CD38,IFNG,CHI3L1,FABP4,TIMP3,P2RY1,CXCL10,ANGPT2,PDGFA,CXCL9,MAFB,HSPG2,EDN1
PMID:34073849	(2021) Isolation and Establishment of a Highly Proliferative, Cancer Stem Cell-Like, and Naturally Immortalized Triple-Negative Breast Cancer Cell Line, KAIMRC2.	9	54	1.28	1.22e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000426809	THBS1,CDH1,IGF1R,ALDH1A1,CD34,STAT5A,CD47,JAK2,PROM1
PMID:34364389	(2021) Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.	9	54	1.28	1.22e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000362463,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,NOX4,SREBF1,GLO1,EDN1,NFE2L2,RHOA,MYD88,VEGFA
PMID:34442627	(2021) The Role of the Oral Microbiota in the Etiopathogenesis of Oral Squamous Cell Carcinoma.	9	54	1.28	1.22e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	TGFB1,IFNG,HSPB1,CDH1,CXCL10,CXCL11,CXCL9,PTEN,VEGFA
PMID:34513071	(2021) Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review).	9	54	1.28	1.22e-05	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	CETP,IFNG,CDH1,VDAC1,CCL20,PTEN,BCL2,NPY,VEGFA
PMID:34632314	(2021) Friends and foes: Extracellular vesicles in aging and rejuvenation.	9	54	1.28	1.22e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,IGF1R,PRDX2,CXCL10,CAV1,CD47,PTGS2,BDNF,VEGFA
PMID:26142202	(2015) Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function.	9	54	1.28	1.22e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CAV1,CXCL9,ENTPD1,BCL2,NPY,CCL5
PMID:24156323	(2013) Role of hypoxia-inducible factors in breast cancer metastasis.	9	54	1.28	1.22e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,MMP14,ANGPT2,PDGFB,PTEN,CCL5,VEGFA
PMID:19571573	(2009) Micromanaging vascular biology: tiny microRNAs play big band.	9	54	1.28	1.22e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CDH1,TIMP3,CD34,PTEN,MAFB,BCL2,AGTR1,VEGFA
PMID:34534695	(2022) Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals.	8	36	1.41	1.24e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CAV1,CXCL9,NFE2L2,BCL2,CCL5,VEGFA
PMID:35055432	(2022) Adipose-Derived Stem Cells for Facial Rejuvenation.	8	36	1.41	1.24e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,CD34,ELN,NOX1,NFE2L2,BCL2,VEGFA
PMID:35269467	(2022) Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States-Current View of Knowledge.	10	76	1.18	1.24e-05	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000401399	FFAR1,FABP4,NOX4,PLIN1,LPL,SREBF1,PTGS2,CNR1,BCL2,MYD88
PMID:33587826	(2021) Vascular reconstitution in the tumor for more effective tumor immunotherapy.	8	36	1.41	1.24e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000475344,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,PDGFB,CXCL9,APLNR,VEGFA
PMID:33766119	(2021) Macrophages and microglia: the cerberus of glioblastoma.	11	101	1.1	1.24e-05	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,MMP14,CD34,PDGFB,CD47,ENTPD1,PTEN,PROM1,CCL5,VEGFA
PMID:33809369	(2021) Investigating T Cell Immunity in Cancer: Achievements and Prospects.	8	36	1.41	1.24e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CXCL9,EDN1,CCL5,VEGFA
PMID:33868176	(2021) Mechanisms That Underly T Cell Immunity in Graves Orbitopathy.	10	76	1.18	1.24e-05	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412	IGF1R,CXCL10,CXCL11,CD34,CCL20,CXCL9,PTGS2,JAK2,LTA,CCL5
PMID:34298701	(2021) Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma.	10	76	1.18	1.24e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,CDH1,IGF1R,CXCL10,PTGS2,PTEN,BCL2,SAA1,CCL5,VEGFA
PMID:34425388	(2021) Mechanisms underlying unidirectional laminar shear stress-mediated Nrf2 activation in endothelial cells: Amplification of low shear stress signaling by primary cilia.	10	76	1.18	1.24e-05	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,IGF1R,CAV1,MAP3K5,PTGS2,NOX1,FGFR1,RHOA,BDNF,VEGFA
PMID:34552922	(2021) Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment.	11	101	1.1	1.24e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,CDH1,TIMP3,MMP14,CD34,ANG,ELN,PTEN,BCL2,FGFR1,VEGFA
PMID:35083233	(2021) Human Amniotic Epithelial Cells Secretome: Components, Bioactivity, and Challenges.	11	101	1.1	1.24e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CD34,PDGFB,ANG,CNTF,BCL2,FGFR1,BDNF,CCL5,VEGFA
PMID:32616235	(2020) Dietary genistein supplementation protects against lipopolysaccharide-induced intestinal injury through altering transcriptomic profile.	12	129	1.03	1.24e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000355370,9606.ENSP00000362057,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000477707	CDH1,NOX4,IGF1R,ALDH1A1,PLIN1,HNF4A,CNTF,NOX1,MTHFR,BCL2,MYD88,NR1H3
PMID:32872659	(2020) STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy.	10	76	1.18	1.24e-05	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ATM,ALDH1A1,CXCL10,CD34,STAT5A,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:32938662	(2020) 3D curvature-instructed endothelial flow response and tissue vascularization.	12	129	1.03	1.24e-05	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000317674,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,NOX4,ANGPT2,APOL1,PDGFB,GAS6,CAV1,PDGFA,BAMBI,BMP2,EDN1,VEGFA
PMID:32967342	(2020) Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.	10	76	1.18	1.24e-05	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,PRKCE,CXCL11,CD34,PDGFA,CXCL9,JAK2,CCL5,VEGFA
PMID:33299638	(2020) Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects.	10	76	1.18	1.24e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CD34,CCL20,CXCL9,RARRES2,MME,PROM1,CCL5,VEGFA
PMID:31100969	(2019) Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension.	8	36	1.41	1.24e-05	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478319	HSPB1,NOX4,CAV1,NOX1,AR,BMP2,EDN1,GREM1
PMID:31174611	(2019) DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.	8	36	1.41	1.24e-05	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	ERCC1,TGFB1,ATM,CXCL10,CXCL11,CXCL9,PTEN,CCL5
PMID:29898663	(2018) Cell type-specific analysis of transcriptome changes in the porcine endometrium on Day 12 of pregnancy.	12	129	1.03	1.24e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000383364,9606.ENSP00000384364,9606.ENSP00000390651,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CD34,ANGPT2,STAT5A,PTGS2,BMP2,PLA2G2A,NPY,IRAK4,CCL5,VEGFA
PMID:30010035	(2018) A Systems Biology Approach for Studying Heterotopic Ossification: Proteomic Analysis of Clinical Serum and Tissue Samples.	8	36	1.41	1.24e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000368104,9606.ENSP00000384906,9606.ENSP00000393312,9606.ENSP00000478319	MPO,IFNG,THBS1,CXCL10,BMP2,SAA1,FGFR1,GREM1
PMID:28120845	(2017) Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.	8	36	1.41	1.24e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,CCL20,CXCL9,ENTPD1,CCL5
PMID:28544785	(2017) Inhibition of CXCL12CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.	8	36	1.41	1.24e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,JAK2,BCL2,RHOA,VEGFA
PMID:29089667	(2017) Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.	11	101	1.1	1.24e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000418009,9606.ENSP00000478570	CXCL10,CXCL11,ANG,STAT5A,CXCL9,PTGS2,JAK2,BCL2,IRAK4,RARRES2,VEGFA
PMID:27761230	(2016) Therapeutic potential of the renin angiotensin system in ischaemic stroke.	8	36	1.41	1.24e-05	9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	MMP14,PTGS2,EDN1,GAP43,BDNF,MME,AGTR1,VEGFA
PMID:25708542	(2015) The crossroads between cancer stem cells and aging.	8	36	1.41	1.24e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,PTEN,BCL2,PROM1,VEGFA
PMID:25889213	(2015) Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.	8	36	1.41	1.24e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CD34,ANG,CXCL9,PROM1,CCL5,VEGFA
PMID:26309780	(2015) Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells.	8	36	1.41	1.24e-05	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,ATM,CD34,ANG,BMP2,BCL2,PROM1,VEGFA
PMID:26697140	(2015) Critical Roles of Reactive Oxygen Species in Age-Related Impairment in Ischemia-Induced Neovascularization by Regulating Stem and Progenitor Cell Function.	8	36	1.41	1.24e-05	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000426809,9606.ENSP00000478570	CD38,NOX4,ATM,CD34,SIRT6,NOX1,PROM1,VEGFA
PMID:25367033	(2014) Pericellular proteolysis in cancer.	11	101	1.1	1.24e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,MMP14,CAV1,CXCL9,HSPG2,PDGFD,CCL5,VEGFA
PMID:23207723	(2013) New targets for treatment of diabetic nephropathy:  what we have learned from animal models.	8	36	1.41	1.24e-05	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252	SOX9,NOX4,STAT5A,COMT,PTGS2,NOX1,JAK2,NFE2L2
PMID:23455471	(2013) Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.	12	129	1.03	1.24e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000259486,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000383364,9606.ENSP00000400175	TGFB1,IFNG,SOX9,HSPB1,ENPP2,PTGS2,ALPL,BMP2,EDN1,KL,PLA2G2A,RHOA
PMID:24203995	(2013) Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development.	8	36	1.41	1.24e-05	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	FABP4,ENPP2,ANG,SIRT6,SREBF1,PTEN,AR,VEGFA
PMID:22558514	(2012) Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.	8	36	1.41	1.24e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CXCL9,EDN1,MYD88,MME,CCL5,VEGFA
PMID:22846863	(2012) Clinical implications of cancer stem cell biology in hepatocellular carcinoma.	8	36	1.41	1.24e-05	9606.ENSP00000226279,9606.ENSP00000257430,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,APC,CD34,HNF4A,PTEN,BCL2,PROM1,VEGFA
PMID:20835995	(2009) Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products.	8	36	1.41	1.24e-05	9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000478570	MMP14,PDGFB,CAV1,PDGFA,CD47,PTEN,HSPG2,VEGFA
PMID:20066135	(2008) Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress.	8	36	1.41	1.24e-05	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	NOX4,CD34,CAV1,MAP3K5,NOX1,BCL2,PROM1,VEGFA
PMID:25010388	(2014) HMGB1 in health and disease.	15	231	0.87	1.29e-05	9606.ENSP00000216181,9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000360997,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000478570	MYH9,MPO,HSPB1,TIMP3,SIRT6,CCL20,VIP,ADAMTS13,TXN,JAK2,BCL2,PLA2G2A,NPY,MYD88,VEGFA
PMID:33637672	(2021) Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.	12	130	1.03	1.30e-05	9606.ENSP00000246553,9606.ENSP00000297785,9606.ENSP00000302630,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	FFAR1,ALDH1A1,ONECUT1,MMP14,HNF4A,PTGS2,CYP2J2,BCL2,AGTR1,LTB4R2,CCL5,VEGFA
PMID:33917233	(2021) Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives.	12	130	1.03	1.30e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ATM,AQP5,MMP14,HNF4A,PTEN,BCL2,NTF3,RHOA,VEGFA
PMID:34824200	(2021) Signaling pathways and intervention therapies in sepsis.	12	130	1.03	1.30e-05	9606.ENSP00000261037,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000357726,9606.ENSP00000360997,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	COL8A1,NOX4,ANGPT2,CAV1,S100A12,ADAMTS13,TXN,EDN1,BCL2,RHOA,MYD88,VEGFA
PMID:28929459	(2018) Revisiting ovarian cancer microenvironment: a friend or a foe?	12	130	1.03	1.30e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000383232,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,FABP4,ENPP2,CCR5,CXCL10,CD34,CXCL9,GGT1,MME,PROM1,CCL5,VEGFA
PMID:35204131	(2022) Involvement of Inflammasome Components in Kidney Disease.	11	102	1.09	1.32e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000474412	MPO,CD69,CDH1,NOX4,EDNRA,SREBF1,PTEN,NOX1,EDN1,NFE2L2,CCL5
PMID:34600587	(2021) A single-cell interactome of human tooth germ from growing third molar elucidates signaling networks regulating dental development.	11	102	1.09	1.32e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000356832,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478319	CD69,IFNG,SOX9,CCR5,EDNRA,SGK1,ALPL,BMP2,FGFR1,CCL5,GREM1
PMID:31690961	(2020) Tumor angiogenesis: causes, consequences, challenges and opportunities.	11	102	1.09	1.32e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,PDGFB,CXCL9,FGFR1,PROM1,CCL5,APLNR,VEGFA
PMID:32218149	(2020) The Blood Circulating Rare Cell Population. What is it and What is it Good For?	11	102	1.09	1.32e-05	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000334329,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,THBS1,CDH1,CD34,UNC5B,STAT5A,PDGFA,CD47,MME,PROM1,VEGFA
PMID:28577571	(2017) Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.	11	102	1.09	1.32e-05	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000264717,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000362524,9606.ENSP00000477707	CETP,PON2,GCKR,FADS2,LPL,HNF4A,LPA,SREBF1,ABCG1,ANGPTL2,NR1H3
PMID:35187885	(2022) Molecular hydrogen is a promising therapeutic agent for pulmonary disease.	9	55	1.27	1.34e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418009	MPO,CDH1,AQP5,MAP3K5,PTEN,NFE2L2,BCL2,RHOA,RARRES2
PMID:34134617	(2021) Downregulated luteolytic pathways in the transcriptome of early pregnancy bovine corpus luteum are mimicked by interferon-tau in vitro.	9	55	1.27	1.34e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,THBS1,TIMP3,PDGFB,PTGS2,EDN1,BCL2,VEGFA
PMID:34249016	(2021) Metabolic Control of Smoldering Neuroinflammation.	10	77	1.17	1.34e-05	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412	CD38,FABP4,CXCL10,LPL,SREBF1,PTGS2,MAFB,NFE2L2,BDNF,CCL5
PMID:34439332	(2021) Ovarian Cancer and Cancer Stem Cells-Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology.	10	77	1.17	1.34e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,CD34,HNF4A,PTEN,BCL2,MYD88,PROM1,VEGFA
PMID:34539580	(2021) The Effect of Local Renin Angiotensin System in the Common Types of Cancer.	9	55	1.27	1.34e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,PTGS2,BCL2,RHOA,MME,AGTR1,PROM1,VEGFA
PMID:32695828	(2020) Mechanisms of Herbal Nephroprotection in diabetes mellitus.	9	55	1.27	1.34e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000352264,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,NOX4,CAV1,CD2AP,PTGS2,EDN1,BCL2,VEGFA
PMID:33202734	(2020) Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines.	9	55	1.27	1.34e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,SAA1,LTA,CCL5,VEGFA
PMID:30394682	(2019) The role of tumour microenvironment: a new vision for cholangiocarcinoma.	10	77	1.17	1.34e-05	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CDH1,CCR5,CXCL10,HNF4A,CXCL9,PDGFD,FGFR1,CCL5,VEGFA
PMID:30573183	(2019) Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses.	9	55	1.27	1.34e-05	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478253,9606.ENSP00000478570	ATM,CD34,PTEN,TXN,G6PD,NFE2L2,PROM1,MTHFD1L,VEGFA
PMID:30606242	(2019) The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine.	9	55	1.27	1.34e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,ELN,PTGS2,PTEN,NTF3,BDNF,PROM1,VEGFA
PMID:31394796	(2019) CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs.	9	55	1.27	1.34e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,SOX9,CDH1,CD34,CD47,JAK2,NFE2L2,RHOA,VEGFA
PMID:31886303	(2019) Vascular Macrophages in Atherosclerosis.	10	77	1.17	1.34e-05	9606.ENSP00000200676,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	CETP,CCR5,CXCL10,CXCL11,GAS6,CXCL9,CD47,PTGS2,MYD88,CCL5
PMID:29695257	(2018) Comparative omics and feeding manipulations in chicken indicate a shift of the endocrine role of visceral fat towards reproduction.	9	55	1.27	1.34e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,TGFB1,IFNG,IGF1R,PLIN1,RBP4,PTEN,BCL2,VEGFA
PMID:27239344	(2016) Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity.	10	77	1.17	1.34e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CD34,STAT5A,CXCL9,PTGS2,CCL5,VEGFA
PMID:27612948	(2016) Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies.	10	77	1.17	1.34e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,CD34,PDGFB,ANG,CNTF,EDN1,BDNF,CCL5,VEGFA
PMID:24333397	(2014) Cell based therapies for ischemic stroke: from basic science to bedside.	9	55	1.27	1.34e-05	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,IFNG,THBS1,CD34,CNTF,BCL2,NTF3,BDNF,VEGFA
PMID:25152735	(2014) Platelets and their chemokines in atherosclerosis-clinical applications.	10	77	1.17	1.34e-05	9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,P2RY1,CXCL11,LPL,CD34,MAPK7,PTEN,RHOA,CCL5,VEGFA
PMID:25275309	(2014) Synergy between sphingosine 1-phosphate and lipopolysaccharide signaling promotes an inflammatory, angiogenic and osteogenic response in human aortic valve interstitial cells.	10	77	1.17	1.34e-05	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,CCL20,CXCL9,PTGS2,BMP2,LTA,BDNF,CCL5,VEGFA
PMID:25427253	(2014) Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.	9	55	1.27	1.34e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CCR5,PTGS2,KL,JAK2,NPY,FGFR1,MYD88,CCL5
PMID:23261166	(2013) Emerging roles of PDGF-D in EMT progression during tumorigenesis.	10	77	1.17	1.34e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,MMP14,PDGFA,PTGS2,SGK1,PTEN,PDGFD,BCL2,VEGFA
PMID:24061039	(2013) Gastric cancer-molecular and clinical dimensions.	10	77	1.17	1.34e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000346148,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,PRKAA1,PTGS2,PTEN,MTHFR,FGFR1,PROM1,VEGFA
PMID:21197104	(2011) Gene Expression Profiling for In Silico Microdissection of Hodgkins Lymphoma Microenvironment and Identification of Prognostic Features.	9	55	1.27	1.34e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,THBS1,CCR5,ALDH1A1,CXCL10,CXCL11,EDNRA,CCL20,CXCL9
PMID:21599948	(2011) Understanding Streptococcus suis serotype 2 infection in pigs through a transcriptional approach.	10	77	1.17	1.34e-05	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,CCR5,CXCL10,CXCL11,CD34,STAT5A,CXCL9,JAK2,MYD88,VEGFA
PMID:34782557	(2022) Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury.	7	22	1.56	1.40e-05	9606.ENSP00000330382,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	PDGFB,CNTF,BMP2,FGFR1,NTF3,BDNF,VEGFA
PMID:34104389	(2021) Three dimensional porous scaffolds derived from collagen, elastin and fibrin proteins orchestrate adipose tissue regeneration.	7	22	1.56	1.40e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000478570	SOX9,FABP4,MMP14,CD34,CAV1,ELN,VEGFA
PMID:33717049	(2020) Differential Elevation of Inflammation and CD4(+) T Cell Activation in Kenyan Female Sex Workers and Non-Sex Workers Using Depot-Medroxyprogesterone Acetate.	7	22	1.56	1.40e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:23356456	(2013) Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.	7	22	1.56	1.40e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	MPO,IFNG,CXCL10,ELN,CXCL9,EDN1,CCL5
PMID:22116822	(2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors.	7	22	1.56	1.40e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CD34,CXCL9,ENTPD1,VEGFA
PMID:21360237	(2011) Targeting microvasculature for neuroprotection after SCI.	7	22	1.56	1.40e-05	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,MMP14,CD34,ANGPT2,BDNF,PROM1,VEGFA
PMID:20425481	(2010) Antifibrotic therapies: will we ever get there?	7	22	1.56	1.40e-05	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,CXCL11,CNR1,CNR2,EDN1,AGTR1,VEGFA
PMID:35069912	(2022) Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma.	11	103	1.09	1.41e-05	9606.ENSP00000216862,9606.ENSP00000263317,9606.ENSP00000304767,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000377192,9606.ENSP00000381185	CYP24A1,NOX4,P2RY1,HNF4A,CAV1,SREBF1,PTEN,AR,BMP2,G6PD,BCL2
PMID:34199498	(2021) An Insight into the microRNAs Associated with Arteriovenous and Cavernous Malformations of the Brain.	11	103	1.09	1.41e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,THBS1,CDH1,TIMP3,MAPK7,CAV1,STAT5A,PTEN,BCL2,BDNF,VEGFA
PMID:32063886	(2019) Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis.	11	103	1.09	1.41e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000383364,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,CCL20,MAP3K5,PTGS2,SGK1,PLA2G2A,LTA,BDNF,CCL5,VEGFA
PMID:33391459	(2021) Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions.	8	37	1.4	1.42e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,SOX9,ELN,PTGS2,BMP2,NFE2L2,BCL2,VEGFA
PMID:33732236	(2021) A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries.	8	37	1.4	1.42e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360997,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL9,ADAMTS13,SAA1,CCL5,VEGFA
PMID:33748139	(2021) Hyperphosphatemia and Cardiovascular Disease.	8	37	1.4	1.42e-05	9606.ENSP00000245479,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000393312	SOX9,GAS6,ELN,SGK1,PTEN,EDN1,KL,FGFR1
PMID:34001267	(2021) The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives.	8	37	1.4	1.42e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000390651,9606.ENSP00000478570	THBS1,TIMP3,IGF1R,ANGPT2,ELN,EDN1,IRAK4,VEGFA
PMID:34916607	(2021) Senescent tumor cells: an overlooked adversary in the battle against cancer.	8	37	1.4	1.42e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ATM,CD34,PTEN,ANGPTL2,JAK2,BCL2,PROM1
PMID:32119829	(2020) Swimming Against the Current: MAIT Cell Function Is Preserved in the Peritoneum of Advanced Liver Disease Patients.	6	11	1.8	1.42e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412	CD69,IFNG,CCR5,CXCL10,CCL20,CCL5
PMID:32121532	(2020) Isatis tinctoria L. (Woad): A Review of its Botany, Ethnobotanical Uses, Phytochemistry, Biological Activities, and Biotechnological Studies.	8	37	1.4	1.42e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,CXCL10,PDGFB,CXCL9,JAK2,GAP43,BCL2,CCL5
PMID:32724454	(2020) Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.	13	163	0.96	1.42e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000478570	HSPB1,CDH1,NOX4,PDGFB,CAV1,MAP3K5,PTGS2,ANGPTL2,KL,JAK2,BCL2,IRAK4,VEGFA
PMID:32834001	(2020) Cell signaling model for arterial mechanobiology.	6	11	1.8	1.42e-05	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	THBS1,MMP14,EDNRA,EDN1,RHOA,AGTR1
PMID:33138181	(2020) Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.	8	37	1.4	1.42e-05	9606.ENSP00000229135,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	IFNG,P2RY1,CXCL10,EDNRA,ENTPD1,EDN1,RHOA,AGTR1
PMID:30760809	(2019) Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa.	8	37	1.4	1.42e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CD38,IFNG,CXCL10,CXCL11,CCL20,CXCL9,ENTPD1,CCL5
PMID:31547508	(2019) Molecular Mechanisms of Cardiac Remodeling and Regeneration in Physical Exercise.	8	37	1.4	1.42e-05	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,HSPB1,TIMP3,ANGPT2,PTEN,BCL2,BDNF,VEGFA
PMID:31637257	(2019) The Biochemical Markers Associated with the Occurrence of Coronary Spasm.	6	11	1.8	1.42e-05	9606.ENSP00000225275,9606.ENSP00000315011,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175	MPO,EDNRA,TXN,EDN1,NPY,RHOA
PMID:28420961	(2017) The Role of Astrocytes in Neuroprotection after Brain Stroke: Potential in Cell Therapy.	8	37	1.4	1.42e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,THBS1,CNTF,BMP2,NFE2L2,RHOA,BDNF,VEGFA
PMID:29095436	(2017) RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers.	8	37	1.4	1.42e-05	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000426809,9606.ENSP00000474412	SOX9,CXCL10,CXCL11,HNF4A,PDGFB,CCL20,PROM1,CCL5
PMID:26545124	(2016) Blocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues.	6	11	1.8	1.42e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD38,IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:25158234	(2014) Pomegranate and its components as alternative treatment for prostate cancer.	8	37	1.4	1.42e-05	9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,PRKCE,PTEN,AR,BCL2,RHOA,CCL5,VEGFA
PMID:26785066	(2014) Oxidative Stress and the Use of Antioxidants in Stroke.	8	37	1.4	1.42e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000298352,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	CDH1,NOX4,NGB,MAP3K5,PTGS2,NOX1,TXN,BCL2
PMID:23384232	(2013) Depression pathogenesis and treatment: what can we learn from blood mRNA expression?	8	37	1.4	1.42e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,CDH1,PTGS2,PLA2G2A,NTF3,BDNF,VEGFA
PMID:22910888	(2012) Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.	8	37	1.4	1.42e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,IGF1R,LPL,CAV1,JAK2,NPY,CCL5,VEGFA
PMID:23326670	(2012) Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology.	8	37	1.4	1.42e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000321853,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000383364	MPO,CDH1,SERPINF2,MAP3K5,PTGS2,AR,BCL2,PLA2G2A
PMID:21256906	(2011) Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.	6	11	1.8	1.42e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19414358	(2009) Genetic and molecular abnormalities in cholangiocarcinogenesis.	8	37	1.4	1.42e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,TGFB1,IFNG,CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:33738282	(2021) Could Extracellular Vesicles Contribute to Generation or Awakening of Sleepy Metastatic Niches?	10	78	1.17	1.44e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000478570	THBS1,CDH1,TIMP3,CXCL10,PDGFB,GAS6,CXCL9,PTGS2,ENTPD1,VEGFA
PMID:34535145	(2021) Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs.	10	78	1.17	1.44e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000369816,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IGF1R,PTGS2,SGK1,PTEN,TXN,SHBG,NFE2L2,BCL2,VEGFA
PMID:33343560	(2020) Tumor-Associated Neutrophils and Macrophages-Heterogenous but Not Chaotic.	10	78	1.17	1.44e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	MPO,IFNG,THBS1,CDH1,ANGPT2,CD47,PTEN,JAK2,RHOA,VEGFA
PMID:33353117	(2020) Hydrogen Sulfide and Carnosine: Modulation of Oxidative Stress and Inflammation in Kidney and Brain Axis.	10	78	1.17	1.44e-05	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000325548,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422	HSPB1,NOX4,CNDP2,MAP3K5,PTGS2,PTEN,TXN,NFE2L2,BCL2,AGTR1
PMID:31137753	(2019) Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health.	10	78	1.17	1.44e-05	9606.ENSP00000225275,9606.ENSP00000278840,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000356729,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	MPO,FADS2,SIRT6,SREBF1,COMT,PTGS2,FMO3,BCL2,MME,VEGFA
PMID:30250825	(2018) Transforming Growth Factor-beta-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.	10	78	1.17	1.44e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX4,CAV1,ELN,PTEN,NOX1,BCL2,RHOA,PROM1,VEGFA
PMID:25544772	(2014) A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.	10	78	1.17	1.44e-05	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000288266,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525	MAPK1,ATM,APPL1,SIRT6,STAT5A,PTGS2,PTEN,BCL2,RHOA,MME
PMID:18221535	(2008) Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells.	10	78	1.17	1.44e-05	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000321853,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,HNF4A,SERPINF2,PDGFB,SREBF1,BMP2,JAK2,BCL2,MME,VEGFA
PMID:35236381	(2022) The long and short non-coding RNAs modulating EZH2 signaling in cancer.	9	56	1.27	1.46e-05	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000427424,9606.ENSP00000474412	CDH1,MMP14,PTEN,AR,BCL2,RHOA,BDNF,TNFAIP8,CCL5
PMID:35419162	(2022) Targeting Nrf2-Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals.	9	56	1.27	1.46e-05	9606.ENSP00000225275,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	MPO,MAP3K5,PTGS2,EDN1,GAP43,NFE2L2,BCL2,MYD88,BDNF
PMID:34285540	(2021) Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury - A Narrative Review.	9	56	1.27	1.46e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399	MPO,CDH1,NOX4,EDNRA,MAP3K5,PTEN,EDN1,BCL2,MYD88
PMID:32559663	(2020) Adipocytokines: Are they the Theory of Everything?	9	56	1.27	1.46e-05	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000360522,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000478570	IFNG,FABP4,RBP4,CAP1,JAK2,BCL2,NPY,RARRES2,VEGFA
PMID:33344645	(2020) Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.	9	56	1.27	1.46e-05	9606.ENSP00000263317,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PRKCE,PTEN,TXN,AR,EDN1,JAK2,BCL2,VEGFA
PMID:33363037	(2020) Sexual Dimorphism in Colon Cancer.	9	56	1.27	1.46e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,ATM,STAT5A,SREBF1,PTGS2,PTEN,SHBG,JAK2,VEGFA
PMID:30959975	(2019) The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.	9	56	1.27	1.46e-05	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,ANGPT2,ELN,PTEN,NOX1,BCL2,CCL5,VEGFA
PMID:31561620	(2019) NF-kappaB Dependent Chemokine Signaling in Pancreatic Cancer.	9	56	1.27	1.46e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,PROM1,CCL5,VEGFA
PMID:29507357	(2018) TNFalpha and IL-1beta modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons.	9	56	1.27	1.46e-05	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	SOX9,IGF1R,PDGFB,SREBF1,PTEN,BCL2,NTF3,RHOA,BDNF
PMID:28834402	(2017) Concise Review: Fetal Membranes in Regenerative Medicine: New Tricks from an Old Dog?	9	56	1.27	1.46e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000363827,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,CD34,STAT5A,CNTF,HSPG2,GAP43,NTF3,BDNF,VEGFA
PMID:26543505	(2015) Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.	9	56	1.27	1.46e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,THBS1,CXCL10,CCL20,CNTF,VIP,MYD88,BDNF,CCL5
PMID:24502410	(2014) The roles of mesenchymal stem cells in tumor inflammatory microenvironment.	9	56	1.27	1.46e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,BMP2,EDN1,PROM1,CCL5,VEGFA
PMID:23280476	(2013) An integrated understanding of the physiological response to elevated extracellular phosphate.	9	56	1.27	1.46e-05	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000478319,9606.ENSP00000478570	IGF1R,CD34,FMOD,PTGS2,SGK1,KL,NFE2L2,GREM1,VEGFA
PMID:22705152	(2012) Effect of anticoagulants on multiplexed measurement of cytokinechemokines in healthy subjects.	9	56	1.27	1.46e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,PDGFB,CXCL9,SAA1,LTA,CCL5,VEGFA
PMID:25328909	(2014) The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.	13	164	0.96	1.48e-05	9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	IGF1R,ANGPT2,CAV1,KCNJ11,ELN,PTEN,BCL2,FGFR1,RHOA,MYD88,AGTR1,APLNR,VEGFA
PMID:35055089	(2022) Cellular and Molecular Targets for Non-Invasive, Non-Pharmacological TherapeuticRehabilitative Interventions in Acute Ischemic Stroke.	11	104	1.09	1.49e-05	9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000478570	STAT5A,MAP3K5,PTGS2,JAK2,GAP43,NFE2L2,BCL2,RHOA,BDNF,RARRES2,VEGFA
PMID:35002629	(2021) Reactive Astrocytes in Central Nervous System Injury: Subgroup and Potential Therapy.	11	104	1.09	1.49e-05	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,CCR5,EDNRA,CAV1,PTGS2,PTEN,EDN1,FGFR1,MYD88,BDNF,VEGFA
PMID:31178721	(2019) Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment.	11	104	1.09	1.49e-05	9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809	DDAH1,CXCL10,CD34,CAV1,PTEN,EDN1,NFE2L2,BCL2,MYD88,BDNF,PROM1
PMID:29271260	(2018) Protein biomarkers for subtyping breast cancer and implications for future research.	11	104	1.09	1.49e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000375844,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	MAPK1,THBS1,CDH1,IGF1R,CAV1,PTEN,AR,CAPN10,BCL2,FGFR1,MME
PMID:30233358	(2018) Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.	12	133	1.02	1.53e-05	9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,VDAC1,ATM,SREBF1,PTGS2,PTEN,EDN1,G6PD,BCL2,BDNF,AGTR1,VEGFA
PMID:26539195	(2015) Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity.	14	199	0.91	1.55e-05	9606.ENSP00000248553,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000401399,9606.ENSP00000474412	HSPB1,FABP4,THBS1,CDH1,CCR5,CXCL10,CXCL11,CD34,CXCL9,CD47,ENTPD1,TXN,MYD88,CCL5
PMID:33515210	(2021) Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis.	10	79	1.16	1.57e-05	9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,EDNRA,STAT5A,CCL20,PTEN,JAK2,BCL2,RHOA,CCL5,VEGFA
PMID:33676416	(2021) PD-1 immunobiology in glomerulonephritis and renal cell carcinoma.	10	79	1.16	1.57e-05	9606.ENSP00000216862,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000317674,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000478570	CYP24A1,MPO,IFNG,CXCL10,CXCL11,APOL1,SIRT6,CXCL9,NFE2L2,VEGFA
PMID:33919732	(2021) New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.	10	79	1.16	1.57e-05	9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,STAT5A,CCL20,PTGS2,ENTPD1,PTEN,JAK2,MYD88,CCL5,VEGFA
PMID:33923722	(2021) Mycosis Fungoides and Sezary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy.	10	79	1.16	1.57e-05	9606.ENSP00000229135,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,HNF4A,STAT5A,CD247,PTEN,JAK2,BCL2,FGFR1,RHOA,VEGFA
PMID:34708037	(2021) The Roles of Non-coding RNA in the Development and Regeneration of Hair Follicles: Current Status and Further Perspectives.	10	79	1.16	1.57e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	SOX9,CDH1,TIMP3,EDNRA,PTEN,BMP2,JAK2,BCL2,NTF3,BDNF
PMID:34858342	(2021) miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.	10	79	1.16	1.57e-05	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,TIMP3,PDGFB,SIRT6,S100A12,PTEN,EDN1,BCL2,BDNF,VEGFA
PMID:32344908	(2020) Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms.	10	79	1.16	1.57e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380365,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,HNF4A,MAP3K5,VIP,PTEN,AR,RGN,BCL2,VEGFA
PMID:33050580	(2020) Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance.	10	79	1.16	1.57e-05	9606.ENSP00000259486,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000478570	ENPP2,IGF1R,ATM,CXCL10,MMP14,ELN,CXCL9,PTGS2,ENTPD1,VEGFA
PMID:31261914	(2019) Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application.	10	79	1.16	1.57e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412	CD38,ATM,CCL20,CD247,CD47,JAK2,BCL2,MYD88,MME,CCL5
PMID:31496619	(2019) Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance.	10	79	1.16	1.57e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000377192,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CCR5,CXCL10,PDGFB,CXCL9,G6PD,SAA1,CCL5,VEGFA
PMID:31614478	(2019) IschemiaReperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies.	10	79	1.16	1.57e-05	9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,EPOR,IFNG,SIRT6,PTGS2,BMP2,BCL2,LTA,AGTR1,VEGFA
PMID:29515996	(2018) Exosome-Based Cell-Cell Communication in the Tumor Microenvironment.	11	105	1.08	1.61e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CD34,STAT5A,CD247,ENTPD1,PTEN,BCL2,MYD88,CCL5,VEGFA
PMID:28098760	(2017) Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.	11	105	1.08	1.61e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,CXCL10,PDGFB,PDGFA,CXCL9,CD47,PDGFD,BCL2,PROM1,VEGFA
PMID:26437435	(2015) 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.	11	105	1.08	1.61e-05	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	TGFB1,FABP4,ALDH1A1,CXCL10,PRKCE,PTGS2,TXN,NFE2L2,BCL2,MME,CCL5
PMID:15369600	(2004) Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs.	11	105	1.08	1.61e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000479617	CD38,CXCL10,CD34,HNF4A,CCL20,ELN,MAFB,BCL2,MME,CCL5,UHRF1
PMID:35130977	(2022) Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19.	8	38	1.38	1.62e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,BCL2,LTA,BDNF,CCL5,VEGFA
PMID:35150338	(2022) Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactions.	8	38	1.38	1.62e-05	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368104,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CCR5,CD34,ANGPT2,BMP2,RARRES2,CCL5,VEGFA
PMID:33115334	(2021) Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients.	8	38	1.38	1.62e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000483018	CXCL10,CXCL11,CXCL9,NPY,BDNF,CCL5,VEGFA,ABO
PMID:33537555	(2021) Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease.	8	38	1.38	1.62e-05	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422	IGF1R,CD34,MAPK7,EDNRA,ELN,EDN1,NFE2L2,AGTR1
PMID:33707934	(2021) Research advances of secretory proteins in malignant tumors.	14	200	0.91	1.62e-05	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CHI3L1,ENPP2,CDH1,IGF1R,CCR5,PTEN,AR,JAK2,BCL2,AGTR1,PROM1,CCL5,VEGFA
PMID:33804548	(2021) Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.	9	57	1.26	1.62e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,STAT5A,PTGS2,PTEN,AR,JAK2,BCL2,VEGFA
PMID:34127731	(2021) Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro.	9	57	1.26	1.62e-05	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD69,IFNG,CXCL10,CD34,PDGFB,PTGS2,CCL5,VEGFA
PMID:34135841	(2021) Genetic Determinants Highlight the Existence of Shared Etiopathogenetic Mechanisms Characterizing Age-Related Macular Degeneration and Neurodegenerative Disorders.	8	38	1.38	1.62e-05	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000478570	MAPK1,CYP24A1,TGFB1,IFNG,COL8A1,TIMP3,SIRT6,VEGFA
PMID:34202812	(2021) Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.	8	38	1.38	1.62e-05	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CCR5,ANGPT2,PTGS2,CNR1,RHOA,CCL5,VEGFA
PMID:34466001	(2021) Simultaneous Follicular Lymphoma and Myelofibrosis: Report of a Case with Review of the Literature.	8	38	1.38	1.62e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CD38,CDH1,CD34,JAK2,BCL2,MME,VEGFA
PMID:34658913	(2021) Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches - Pulmonary DiseaseAsthma.	9	57	1.26	1.62e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,CDH1,NOX4,CXCL10,ELN,PTGS2,NFE2L2,BCL2,CCL5
PMID:34790202	(2021) Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators.	9	57	1.26	1.62e-05	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CD38,FABP4,CXCL10,STAT5A,CCL20,CXCL9,JAK2,BCL2,CCL5
PMID:34840969	(2021) The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19.	9	57	1.26	1.62e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CD34,CXCL9,PTGS2,ENTPD1,BMP2,CCL5,VEGFA
PMID:32326308	(2020) Integrin alphavbeta3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation.	8	38	1.38	1.62e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,THBS1,CAV1,ELN,PTGS2,PTEN,BCL2,VEGFA
PMID:32495527	(2020) Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves Orbitopathy.	8	38	1.38	1.62e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,IGF1R,CCR5,CXCL10,CXCL11,CXCL9,PTGS2,CCL5
PMID:33113992	(2020) Anti-Angiogenic Properties of Ginsenoside Rg3.	8	38	1.38	1.62e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,MAPK7,ANG,PTGS2,PTEN,BCL2,VEGFA
PMID:33145014	(2020) Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases.	8	38	1.38	1.62e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,CCL20,ELN,CXCL9,JAK2,VEGFA
PMID:33194645	(2020) Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.	12	134	1.01	1.62e-05	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CDH1,CXCL10,CXCL11,PDGFB,CCL20,CD47,PTGS2,MAFB,JAK2,CCL5,VEGFA
PMID:33320912	(2020) 4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography.	13	166	0.95	1.62e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CDH1,ATM,CD34,ANG,CAV1,PDGFA,PTEN,BMP2,EDN1,JAK2,BCL2,VEGFA
PMID:33365025	(2020) Tumor-Associated Macrophages in Tumor Immunity.	9	57	1.26	1.62e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,SREBF1,CCL20,CXCL9,CD47,PTGS2,CCL5,VEGFA
PMID:31151297	(2019) Identification of Proteins Differentially Expressed by Adipose-derived Mesenchymal Stem Cells Isolated from Immunodeficient Mice.	13	166	0.95	1.62e-05	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000301522,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,MYH9,HSPB1,VDAC1,PRDX2,MMP14,CD34,CAV1,STAT5A,GLO1,TXN,RHOA,VEGFA
PMID:31727671	(2019) Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.	9	57	1.26	1.62e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,IGF1R,ATM,PTEN,JAK2,FGFR1,RHOA,VEGFA
PMID:31744106	(2019) Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis.	9	57	1.26	1.62e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418823	MAPK1,FABP4,LPL,PTEN,AR,BMP2,BCL2,RHOA,FTO
PMID:29449867	(2018) Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.	8	38	1.38	1.62e-05	9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000259407,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000380252	CYP24A1,IFNG,BAAT,CDH1,HNF4A,PTEN,KL,NFE2L2
PMID:30283796	(2018) Research progress on signaling pathways in cirrhotic portal hypertension.	8	38	1.38	1.62e-05	9606.ENSP00000229135,9606.ENSP00000284031,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,DDAH1,PTGS2,EDN1,JAK2,RHOA,AGTR1,VEGFA
PMID:30467547	(2018) S100RAGE-Mediated Inflammation and Modified Cholesterol Lipoproteins as Mediators of Osteoblastic Differentiation of Vascular Smooth Muscle Cells.	8	38	1.38	1.62e-05	9606.ENSP00000225275,9606.ENSP00000357726,9606.ENSP00000360250,9606.ENSP00000362057,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000383364	MPO,S100A12,ENTPD1,NOX1,ALPL,BMP2,KL,PLA2G2A
PMID:30498499	(2018) Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors.	9	57	1.26	1.62e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000474412	CD69,CDH1,CXCL10,CCL20,ELN,CXCL9,ENTPD1,EDN1,CCL5
PMID:28000852	(2017) Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).	9	57	1.26	1.62e-05	9606.ENSP00000215832,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000427424,9606.ENSP00000478570	MAPK1,LAMC1,CDH1,MMP14,HNF4A,PTEN,AR,TNFAIP8,VEGFA
PMID:28433660	(2017) Redox regulation of gasotransmission in the vascular system: A focus on angiogenesis.	9	57	1.26	1.62e-05	9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000304767,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000478570	NOX4,DDAH1,P2RY1,PDGFB,CAV1,PTEN,NOX1,TXN,VEGFA
PMID:26395640	(2016) Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome.	8	38	1.38	1.62e-05	9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000478570	CDH1,PRDX2,CD34,ELN,PTGS2,AR,SHBG,VEGFA
PMID:26881021	(2016) The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults.	9	57	1.26	1.62e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,NOX4,SIRT6,PTGS2,NOX1,NFE2L2,BCL2,BDNF,VEGFA
PMID:27698613	(2016) The Influence of the Gut Microbiota on Host Physiology: In Pursuit of Mechanisms.	8	38	1.38	1.62e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,PTEN,NOX1,NFE2L2,NPY,CCL5
PMID:25914264	(2015) Myeloid cells in hepatocellular carcinoma.	9	57	1.26	1.62e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,CXCL10,ANGPT2,CD247,PTGS2,MYD88,CCL5,VEGFA
PMID:26503998	(2015) Natural Products That Target Cancer Stem Cells.	9	57	1.26	1.62e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,COMT,PTEN,BMP2,BCL2,PROM1,VEGFA
PMID:29765833	(2015) How the Body Talks to the Brain; Peripheral Mediators of Physical Activity-Induced Proliferation in the Adult Hippocampus.	8	38	1.38	1.62e-05	9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000356832,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,CNTF,VIP,SGK1,NPY,NTF3,BDNF,VEGFA
PMID:24713998	(2014) Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9NGAL in Leukaemias.	8	38	1.38	1.62e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CDH1,TIMP3,CXCL11,CD34,CXCL9,BCL2,VEGFA
PMID:23685952	(2013) Understanding and targeting cancer stem cells: therapeutic implications and challenges.	8	38	1.38	1.62e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,CD47,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:22783202	(2012) Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.	8	38	1.38	1.62e-05	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,EDNRA,NOX1,TXN,EDN1,NFE2L2,AGTR1,VEGFA
PMID:22889225	(2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity.	9	57	1.26	1.62e-05	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000360522,9606.ENSP00000362057,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	FFAR1,FABP4,NOX4,LPL,RBP4,NOX1,RARRES2,CCL5,VEGFA
PMID:20932435	(2010) Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects.	8	38	1.38	1.62e-05	9606.ENSP00000229135,9606.ENSP00000301522,9606.ENSP00000321853,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,PRDX2,SERPINF2,ANG,ELN,PTGS2,LTA,CCL5
PMID:19477432	(2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.	8	38	1.38	1.62e-05	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ENPP2,CDH1,IGF1R,STAT5A,CCL20,PTEN,BCL2,VEGFA
PMID:33818490	(2021) Corneal neuromediator profiles following laser refractive surgery.	7	23	1.54	1.65e-05	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	IFNG,CNTF,VIP,BCL2,NPY,NTF3,BDNF
PMID:31552884	(2020) Peripheral nerve injury induced changes in the spinal cord and strategies to counteractenhance the changes to promote nerve regeneration.	7	23	1.54	1.65e-05	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	CNTF,VIP,GAP43,BCL2,NPY,NTF3,BDNF
PMID:32397357	(2020) A Role of Inflammation and Immunity in Essential Hypertension-Modeled and Analyzed Using Petri Nets.	7	23	1.54	1.65e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL11,EDN1,AGTR1,CCL5,VEGFA
PMID:31431809	(2019) Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells.	7	23	1.54	1.65e-05	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000380252,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CD34,NFE2L2,NTF3,BDNF,CCL5,VEGFA
PMID:29423045	(2018) Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3KAKTmTOR pathway.	7	23	1.54	1.65e-05	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CD38,HSPB1,CD34,STAT5A,JAK2,BCL2,PROM1
PMID:30158437	(2018) The Virology of Taterapox Virus In Vitro.	7	23	1.54	1.65e-05	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,RHOA,MYD88,LTA,CCL5,VEGFA
PMID:28053515	(2017) Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.	7	23	1.54	1.65e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:28468787	(2017) Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST-Segment Elevation Myocardial Infarction.	7	23	1.54	1.65e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	MPO,THBS1,CXCL11,CCL20,CXCL9,BDNF,CCL5
PMID:26871947	(2016) Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-lo castration-resistant cells.	7	23	1.54	1.65e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312	SOX9,CDH1,IGF1R,PTEN,AR,BCL2,FGFR1
PMID:27909409	(2016) 3,5,3-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice.	7	23	1.54	1.65e-05	9606.ENSP00000232219,9606.ENSP00000312987,9606.ENSP00000354511,9606.ENSP00000362463,9606.ENSP00000380365,9606.ENSP00000401720,9606.ENSP00000477707	RBP1,HNF4A,COMT,GLO1,RGN,GK,NR1H3
PMID:26085929	(2015) Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.	7	23	1.54	1.65e-05	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:22757958	(2012) O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?	7	23	1.54	1.65e-05	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000349860,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175	NOX4,EDNRA,GFPT1,MAP3K5,TXN,EDN1,RHOA
PMID:21814055	(2011) Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.	7	23	1.54	1.65e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	ERCC1,CDH1,EDNRA,PTGS2,PTEN,EDN1,VEGFA
PMID:20579746	(2010) TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis.	7	23	1.54	1.65e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,BCL2,BDNF,VEGFA
PMID:33549103	(2021) Signaling pathways of EBV-induced oncogenesis.	10	80	1.16	1.66e-05	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,MYH9,MAPK7,HNF4A,STAT5A,MAP3K5,PTEN,JAK2,CCL5,VEGFA
PMID:34185186	(2021) Proceedings of Reanimation 2021, the French Intensive Care Society International Congress.	10	80	1.16	1.66e-05	9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000317674,9606.ENSP00000360997,9606.ENSP00000474412,9606.ENSP00000478570	MPO,AMBP,CXCL10,CD34,ANGPT2,EDNRA,APOL1,ADAMTS13,CCL5,VEGFA
PMID:34205975	(2021) Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.	10	80	1.16	1.66e-05	9606.ENSP00000200676,9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	CETP,CXCL10,APOL1,LPA,ABCG1,PTGS2,ADAMTS13,PLA2G2A,CCL5,VEGFA
PMID:32085497	(2020) Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.	10	80	1.16	1.66e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,ALDH1A1,SREBF1,AR,BCL2,PROM1,VEGFA
PMID:30885246	(2019) Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.	10	80	1.16	1.66e-05	9606.ENSP00000255409,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,ENPP2,THBS1,NOX4,ATM,CD34,ANG,BDNF,CCL5,VEGFA
PMID:31379957	(2019) Signal Transduction Pathways of Acupuncture for Treating Some Nervous System Diseases.	10	80	1.16	1.66e-05	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CAV1,MAP3K5,COMT,PTGS2,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:30149506	(2018) Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension.	10	80	1.16	1.66e-05	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	MAPK1,CD34,CAV1,ELN,BAMBI,BMP2,EDN1,RHOA,GREM1,VEGFA
PMID:35022030	(2022) The role of m6A RNA methylation in cancer metabolism.	12	135	1.01	1.68e-05	9606.ENSP00000013807,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000418823,9606.ENSP00000478570	ERCC1,CXCL10,MAPK7,HNF4A,CAV1,CXCL9,SGK1,PTEN,G6PD,RHOA,FTO,VEGFA
PMID:33886609	(2021) Generation of cryopreserved macrophages from normal and genetically engineered human pluripotent stem cells for disease modelling.	11	106	1.08	1.68e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412	CD38,IFNG,CHI3L1,AMBP,CXCL10,CXCL11,CD34,CCL20,CXCL9,CD47,CCL5
PMID:34482267	(2021) Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAKSTAT signaling pathways.	11	106	1.08	1.68e-05	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495	FABP4,IGF1R,CCR5,CXCL10,STAT5A,PTEN,JAK2,BCL2,IRAK4,MYD88,LTA
PMID:29044509	(2018) Comprehensive transcriptome analysis of fluid shear stress altered gene expression in renal epithelial cells.	12	135	1.01	1.68e-05	9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185	TGFB1,LAMC1,THBS1,CXCL10,MAPK7,PDGFB,STAT5A,PDGFA,PTGS2,EDN1,JAK2,BCL2
PMID:30134622	(2018) Inside the Endometrial Cell Signaling Subway: Mind the Gap(s).	11	106	1.08	1.68e-05	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	APC,IGF1R,ANGPT2,ANG,STAT5A,PTGS2,AR,BMP2,RHOA,CCL5,VEGFA
PMID:28664935	(2017) Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.	12	135	1.01	1.68e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,CDH1,IGF1R,ATM,CD34,GAS6,PTEN,JAK2,NFE2L2,FGFR1,RHOA,MYD88
PMID:31637020	(....) the interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports.	11	106	1.08	1.68e-05	9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	STAT5A,ELN,PTGS2,PTEN,NOX1,BCL2,RHOA,BDNF,PROM1,CCL5,VEGFA
PMID:35309368	(2022) Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.	9	58	1.25	1.78e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CAV1,CD247,CXCL9,VIP,NPY,CCL5
PMID:33558827	(2021) Chemokines and chemokine receptors during COVID-19 infection.	9	58	1.25	1.78e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	MPO,CD38,CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:34819924	(2021) Comprehensive Mapping of the Cell Response to Borrelia bavariensis in the Brain Microvascular Endothelial Cells in vitro Using RNA-Seq.	12	136	1.01	1.78e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	THBS1,CXCL10,CXCL11,ANGPT2,CCL20,ELN,CD47,PTGS2,SAA1,IRAK4,MYD88,CCL5
PMID:34948088	(2021) Regenerative Potential of Mesenchymal Stem Cells (MSCs) Secretome for Liver Fibrosis Therapies.	9	58	1.25	1.78e-05	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000478570	IGF1R,CXCL10,CCL20,ELN,CXCL9,CNTF,BCL2,NTF3,VEGFA
PMID:32184830	(2020) Oral Mesenchymal StemProgenitor Cells: The Immunomodulatory Masters.	9	58	1.25	1.78e-05	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	NOX4,CD34,PTGS2,ENTPD1,BMP2,BCL2,BDNF,MME,CCL5
PMID:32957737	(2020) Ultrasound Therapy: Experiences and Perspectives for Regenerative Medicine.	9	58	1.25	1.78e-05	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MYH9,SOX9,CD34,CAV1,BMP2,BCL2,RHOA,BDNF,VEGFA
PMID:33261212	(2020) The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.	9	58	1.25	1.78e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000352264,9606.ENSP00000362463,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MPO,NOX4,CD2AP,GLO1,JAK2,NFE2L2,RHOA,MYD88,VEGFA
PMID:33263009	(2020) Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics.	9	58	1.25	1.78e-05	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,MMP14,CD34,HNF4A,ANGPT2,PTEN,BCL2,VEGFA,HNF1B
PMID:33374806	(2020) Beta-Arrestins and Receptor Signaling in the Vascular Endothelium.	9	58	1.25	1.78e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000475344	CXCL10,CXCL11,EDNRA,CAV1,CXCL9,BMP2,EDN1,AGTR1,APLNR
PMID:30800123	(2019) Support of Tumor Endothelial Cells by Chemokine Receptors.	9	58	1.25	1.78e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,STAT5A,CXCL9,JAK2,CCL5,VEGFA
PMID:31443516	(2019) Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.	9	58	1.25	1.78e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,STAT5A,PTEN,AR,JAK2,BCL2,VEGFA
PMID:31515941	(2019) The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma.	9	58	1.25	1.78e-05	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,AMBP,CD34,CNTF,PTEN,JAK2,BCL2,MYD88,MME
PMID:30157906	(2018) Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma.	9	58	1.25	1.78e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,CXCL10,MMP14,HNF4A,SREBF1,PTGS2,JAK2,RHOA,VEGFA
PMID:28913358	(2017) Central Modulation of Neuroinflammation by Neuropeptides and Energy-Sensing Hormones during Obesity.	9	58	1.25	1.78e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000414303	IFNG,CXCL10,CXCL11,CXCL9,VIP,NPY,MYD88,LTA,BDNF
PMID:29026447	(2017) Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy.	12	136	1.01	1.78e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683	MAPK1,FABP4,THBS1,NOX4,TIMP3,MMP14,ANGPT2,SIRT6,PTEN,ALPL,BMP2,EDN1
PMID:32288791	(2017) Kaempferol - A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements.	9	58	1.25	1.78e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000478570	MPO,CDH1,SREBF1,COMT,PTGS2,BMP2,BCL2,IRAK4,VEGFA
PMID:26941801	(2016) Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis.	9	58	1.25	1.78e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,NOX4,CAV1,PTGS2,EDN1,RHOA,MYD88,GREM1,VEGFA
PMID:27557501	(2016) Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.	9	58	1.25	1.78e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360997,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL11,CXCL9,ADAMTS13,LTA,BDNF,VEGFA
PMID:26147292	(2015) The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects Endothelial Gene Expression.	9	58	1.25	1.78e-05	9606.ENSP00000285407,9606.ENSP00000301522,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	KLF10,PRDX2,ANGPT2,PTGS2,EDN1,BCL2,CCL5,NR1H3,VEGFA
PMID:26238487	(2015) The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.	9	58	1.25	1.78e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CD34,STAT5A,CXCL9,JAK2,MYD88,CCL5,VEGFA
PMID:24516514	(2014) Gene expression profiling and secretome analysis differentiate adult-derived human liver stemprogenitor cells and human hepatic stellate cells.	9	58	1.25	1.78e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000397297,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,MMP14,ELN,NTF3,PROM1,CCL5,VEGFA
PMID:23365490	(2013) Vitreous mediators in retinal hypoxic diseases.	9	58	1.25	1.78e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	IFNG,IGF1R,CXCL10,CD34,CXCL9,BCL2,AGTR1,APLNR,VEGFA
PMID:35163586	(2022) Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC.	11	107	1.07	1.80e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,STAT5A,PTGS2,PTEN,AR,JAK2,BCL2,RHOA,VEGFA
PMID:33369720	(2021) Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer.	8	39	1.37	1.80e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CD38,ATM,CD247,ENTPD1,PTEN,AR,BCL2,VEGFA
PMID:33569633	(2021) Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides.	8	39	1.37	1.80e-05	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CXCL10,CD34,ANGPT2,S100A12,EDN1,PROM1,VEGFA
PMID:33924428	(2021) Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?	11	107	1.07	1.80e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,ENTPD1,PTEN,RHOA,CCL5,VEGFA
PMID:34631530	(2021) Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors.	11	107	1.07	1.80e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,HNF4A,CAV1,SREBF1,PTEN,JAK2,G6PD,NFE2L2,CCL5,VEGFA
PMID:34852849	(2021) Cancer associated-fibroblast-derived exosomes in cancer progression.	10	81	1.15	1.80e-05	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANGPT2,CAV1,CD47,PTGS2,PTEN,BCL2,RHOA,CCL5,VEGFA
PMID:34945151	(2021) Effects of Thyroid Hormone on Tissue Hypoxia: Relevance to Sepsis Therapy.	8	39	1.37	1.80e-05	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,NOX4,ANGPT2,EDNRA,BCL2,FGFR1,BDNF,VEGFA
PMID:31963445	(2020) The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.	8	39	1.37	1.80e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000384906	CETP,MPO,AMBP,LPL,APOL1,LPA,ABCG1,SAA1
PMID:32000802	(2020) Predictive biomarkers and mechanisms underlying resistance to PD1PD-L1 blockade cancer immunotherapy.	10	81	1.15	1.80e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CD38,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,CD47,PTEN,JAK2,VEGFA
PMID:32005273	(2020) Myeloid-derived suppressor cells-new and exciting players in lung cancer.	10	81	1.15	1.80e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,ATM,CCR5,CXCL10,STAT5A,CD247,ENTPD1,CCL5,GREM1,VEGFA
PMID:32012897	(2020) Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinsons Disease.	8	39	1.37	1.80e-05	9606.ENSP00000248553,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CXCL11,CD34,MAP3K5,TXN,BCL2,BDNF,VEGFA
PMID:32296047	(2020) Molecular principles of metastasis: a hallmark of cancer revisited.	10	81	1.15	1.80e-05	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000384906,9606.ENSP00000478570	SOX9,HSPB1,THBS1,CDH1,MMP14,GAS6,ELN,PTEN,SAA1,VEGFA
PMID:32405226	(2020) Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.	10	81	1.15	1.80e-05	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CHI3L1,CDH1,NOX4,CXCL10,HNF4A,PTGS2,NOX1,NFE2L2,BCL2,VEGFA
PMID:32610601	(2020) Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers.	10	81	1.15	1.80e-05	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD38,CCR5,CXCL10,CD34,CD247,CXCL9,PTEN,CCL5,VEGFA
PMID:32640349	(2020) The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix.	10	81	1.15	1.80e-05	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	TIMP3,CD34,PDGFB,ELN,MAP3K5,CXCL9,PDGFD,FGFR1,MYD88,VEGFA
PMID:32984031	(2020) A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression.	11	107	1.07	1.80e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,MMP14,CAV1,FMOD,ELN,HSPG2,BCL2,VEGFA
PMID:33225962	(2020) Application of adipose-derived stem cells in photoaging: basic science and literature review.	8	39	1.37	1.80e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,CD34,ELN,NOX1,NFE2L2,BCL2,VEGFA
PMID:33238558	(2020) Pigment Epithelium-Derived Factor and Sex Hormone-Responsive Cancers.	8	39	1.37	1.80e-05	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,MMP14,CAV1,CD47,AR,NFE2L2,RHOA,VEGFA
PMID:30723314	(2019) Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.	8	39	1.37	1.80e-05	9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000419422	PON2,MPO,NOX4,EDNRA,PTGS2,NOX1,EDN1,AGTR1
PMID:31771212	(2019) TGFbeta Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer.	11	107	1.07	1.80e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478319	MAPK1,IFNG,SOX9,CDH1,HNF4A,PTEN,BAMBI,KL,BCL2,RHOA,GREM1
PMID:29968076	(2018) Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms.	8	39	1.37	1.80e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000475344	CD38,CD69,CCR5,CXCL10,CXCL9,PTEN,JAK2,APLNR
PMID:30356354	(2018) Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.	10	81	1.15	1.80e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CDH1,ALDH1A1,MAPK7,JAK2,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:29259582	(2017) Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.	8	39	1.37	1.80e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:25772134	(2016) Engineering Stem Cells for Biomedical Applications.	10	81	1.15	1.80e-05	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,ANG,CNTF,BCL2,NTF3,BDNF,MME,PROM1,VEGFA
PMID:26901191	(2016) The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders.	8	39	1.37	1.80e-05	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000285407,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,MPO,KLF10,SREBF1,ELN,BCL2,CCL5,VEGFA
PMID:26981570	(2016) Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research.	8	39	1.37	1.80e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	MPO,CD38,IFNG,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:27338365	(2016) ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies.	8	39	1.37	1.80e-05	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,PDGFB,PDGFA,PTGS2,PTEN,NOX1,NFE2L2,VEGFA
PMID:26221589	(2015) Human miR-221222 in Physiological and Atherosclerotic Vascular Remodeling.	11	107	1.07	1.80e-05	9606.ENSP00000229135,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,KLF10,CD34,CAV1,STAT5A,CD47,PTEN,HSPG2,JAK2,AGTR1,VEGFA
PMID:26555194	(2015) MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones.	8	39	1.37	1.80e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000376865	MAPK1,IGF1R,SGK1,PTEN,ALPL,BMP2,JAK2,PDGFD
PMID:24414193	(2014) The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.	11	107	1.07	1.80e-05	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000426809	SOX9,HSPB1,CDH1,MMP14,GAS6,CAV1,PTEN,AR,PDGFD,FGFR1,PROM1
PMID:24451143	(2014) Signaling involved in hair follicle morphogenesis and development.	10	81	1.15	1.80e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478319	SOX9,CDH1,TIMP3,HNF4A,PDGFA,PTEN,BAMBI,FGFR1,BDNF,GREM1
PMID:21946060	(2012) Fetal hypoxia and programming of matrix metalloproteinases.	8	39	1.37	1.80e-05	9606.ENSP00000266085,9606.ENSP00000306124,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	TIMP3,PRKCE,MMP14,MAPK7,EDN1,NPY,BDNF,VEGFA
PMID:22203898	(2012) Molecular Crosstalk between Integrins and Cadherins: Do Reactive Oxygen Species Set the Talk?	8	39	1.37	1.80e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,CAV1,PTGS2,PTEN,NOX1,RHOA,VEGFA
PMID:19954947	(2010) Antiobesity mechanisms of action of conjugated linoleic acid.	8	39	1.37	1.80e-05	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384364	FABP4,FADS2,PLIN1,LPL,SREBF1,PTGS2,BCL2,NPY
PMID:20401335	(2009) Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.	10	81	1.15	1.80e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000351908,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000377192,9606.ENSP00000383364,9606.ENSP00000478570	CETP,MPO,IGF1R,MAP3K5,MTHFR,EDN1,KL,G6PD,PLA2G2A,VEGFA
PMID:35216673	(2022) A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.	13	169	0.95	1.85e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000474412	MPO,CD38,CD69,IFNG,CXCL10,CD34,STAT5A,CCL20,ENTPD1,SAA1,LTA,MME,CCL5
PMID:34219130	(2021) The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.	13	169	0.95	1.85e-05	9606.ENSP00000222572,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	PON2,ENPP2,THBS1,CDH1,ATM,SIRT6,CAV1,PTGS2,JAK2,SAA1,RHOA,CCL5,VEGFA
PMID:28211916	(2017) Role of endothelial nitric oxide synthase and endothelin-1 polymorphism genes with the pathogenesis of intraventricular hemorrhage in preterm infants.	6	12	1.76	1.85e-05	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000478570	EDNRA,CAV1,VIP,EDN1,NPY,VEGFA
PMID:26315837	(2015) Isoliquiritigenin Inhibits Interferon-gamma-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1STAT1, IRF3MyD88, ERKMAPK, JNKMAPK and PI3KAkt Signaling Pathways.	6	12	1.76	1.85e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399	IFNG,CXCL10,CXCL11,CXCL9,JAK2,MYD88
PMID:12960247	(2003) The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.	6	12	1.76	1.85e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34909665	(2021) Prostate cancer: Therapeutic prospect with herbal medicine.	12	137	1.0	1.86e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,ATM,HNF4A,CAV1,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:34356110	(2021) The Importance of Being PI3K in the RAS Signaling Network.	11	108	1.07	1.91e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,IGF1R,CXCL10,GAS6,ELN,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:34502510	(2021) High-Throughput Gene and Protein Analysis Revealed the Response of Disc Cells to Vitamin D, Depending on the VDR FokI Variants.	11	108	1.07	1.91e-05	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000427424,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,TIMP3,IGF1R,CCR5,ANG,CCL20,CXCL9,LTA,TNFAIP8,CCL5,VEGFA
PMID:34943820	(2021) Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.	11	108	1.07	1.91e-05	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,ATM,CD34,CD47,PTGS2,SGK1,PTEN,JAK2,BCL2,MYD88,VEGFA
PMID:30455693	(2018) The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.	11	108	1.07	1.91e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CXCL10,CXCL11,CCL20,ELN,CXCL9,HSPG2,MYD88,CCL5,VEGFA
PMID:24940801	(2014) Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo.	11	108	1.07	1.91e-05	9606.ENSP00000216181,9606.ENSP00000260356,9606.ENSP00000298352,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000362410,9606.ENSP00000362524,9606.ENSP00000397297	MYH9,THBS1,NGB,CXCL10,HNF4A,ANGPT2,ANG,STAT5A,MAFB,ANGPTL2,NTF3
PMID:33287630	(2021) Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications.	9	59	1.24	1.94e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CXCL11,CD34,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:33436044	(2021) Targeting hypoxic tumor microenvironment in pancreatic cancer.	13	170	0.94	1.94e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377280,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,IGF1R,ANGPT2,PDGFB,SIRT6,CAV1,PTGS2,PTEN,FBXO8,RHOA,PROM1,VEGFA,UHRF1
PMID:33581501	(2021) Advances in immunotherapy for COVID-19: A comprehensive review.	9	59	1.24	1.94e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CD38,CXCL10,CCL20,CXCL9,ENTPD1,JAK2,MYD88,BDNF,VEGFA
PMID:34067095	(2021) Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.	10	82	1.15	1.94e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000426809	THBS1,CDH1,PRDX2,STAT5A,PTEN,AR,JAK2,G6PD,BCL2,PROM1
PMID:34071790	(2021) Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells.	10	82	1.15	1.94e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,MPO,CDH1,AQP5,PTGS2,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:34093852	(2021) Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control.	10	82	1.15	1.94e-05	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,VDAC1,CXCL10,PDGFB,PTGS2,PTEN,NOX1,ANGPTL2,EDN1,VEGFA
PMID:34575451	(2021) From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment.	9	59	1.24	1.94e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	MPO,NOX4,CXCL10,MAP3K5,PTGS2,NOX1,NFE2L2,BDNF,VEGFA
PMID:34790246	(2021) Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle.	9	59	1.24	1.94e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303	MPO,NOX4,PTGS2,EDN1,JAK2,NFE2L2,BCL2,LTA,BDNF
PMID:35010703	(2021) Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy.	9	59	1.24	1.94e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,CXCL10,ANGPT2,PDGFB,HSPG2,NFE2L2,MYD88,BDNF,VEGFA
PMID:33019660	(2020) Growth Factors in the Carotid Body-An Update.	9	59	1.24	1.94e-05	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,EDNRA,CNTF,BMP2,FGFR1,NTF3,MYD88,BDNF,VEGFA
PMID:33282730	(2020) Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology.	10	82	1.15	1.94e-05	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,AMBP,IGF1R,CAV1,STAT5A,CD47,PTEN,AR,BCL2,VEGFA
PMID:30854108	(2019) The Role of Polymorphisms in Genes of PI3KAkt Signaling Pathway on Prostate.	10	82	1.15	1.94e-05	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000258341,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,EPOR,LAMC1,IGF1R,ANGPT2,PDGFB,PDGFA,JAK2,FGFR1,VEGFA
PMID:30881110	(2019) Targeting stem cells in the realm of drug-resistant breast cancer.	10	82	1.15	1.94e-05	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,IGF1R,ALDH1A1,CAV1,PTEN,AR,BCL2,MME,PROM1,VEGFA
PMID:31687078	(2019) ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis.	9	59	1.24	1.94e-05	9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	NOX4,SREBF1,MAP3K5,PTGS2,NOX1,TXN,BCL2,IRAK4,MYD88
PMID:29545811	(2018) Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts.	10	82	1.15	1.94e-05	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CDH1,CXCL10,CD34,CCL20,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:29601503	(2018) The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.	9	59	1.24	1.94e-05	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANGPT2,CCL20,PTGS2,BCL2,MYD88,PROM1,CCL5,VEGFA
PMID:29868481	(2018) Phosphoinositide 3-KinaseAkt Signaling and Redox Metabolism in Cancer.	9	59	1.24	1.94e-05	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000380365,9606.ENSP00000478570	NOX4,VDAC1,IGF1R,SGK1,PTEN,NOX1,G6PD,RGN,VEGFA
PMID:28464819	(2017) Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.	10	82	1.15	1.94e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362463,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	SOX9,CDH1,LPL,SREBF1,PTGS2,GLO1,EDN1,BCL2,BDNF,CCL5
PMID:27313539	(2016) Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?	9	59	1.24	1.94e-05	9606.ENSP00000248553,9606.ENSP00000321853,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,SERPINF2,PTGS2,S100A12,EDN1,BDNF,RARRES2,CCL5,VEGFA
PMID:17979879	(2007) Recent advances in cancer stemprogenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.	10	82	1.15	1.94e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,CD34,PTGS2,PTEN,AR,BMP2,BCL2,PROM1,VEGFA
PMID:33828985	(2021) Exosomes and Their Role in Cancer Progression.	7	24	1.53	1.95e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000478570	CDH1,CD34,CD47,PTGS2,PTEN,BAMBI,VEGFA
PMID:34064048	(2021) Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).	7	24	1.53	1.95e-05	9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384957,9606.ENSP00000474412	PTGS2,CNR1,ADAMTS13,EDN1,JAK2,F11,CCL5
PMID:34439556	(2021) Hyperphosphatemia-Induced OxidantAntioxidant Imbalance Impairs Vascular Relaxation and Induces Inflammation and Fibrosis in Old Mice.	7	24	1.53	1.95e-05	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252	NOX4,EDNRA,ELN,NOX1,EDN1,KL,NFE2L2
PMID:34572356	(2021) Oxidative Stress-Related Susceptibility to Aneurysm in Marfans Syndrome.	7	24	1.53	1.95e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000419422	MPO,NOX4,CXCL11,ELN,NOX1,BCL2,AGTR1
PMID:32162665	(2020) Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage.	7	24	1.53	1.95e-05	9606.ENSP00000278616,9606.ENSP00000356832,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000418009	ATM,SGK1,TXN,BMP2,KL,NFE2L2,RARRES2
PMID:32937950	(2020) Oxidative Stress in Cardiovascular Diseases.	7	24	1.53	1.95e-05	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252	NOX4,PRDX2,MAP3K5,NOX1,TXN,EDN1,NFE2L2
PMID:32377288	(2019) Medicinal Plants in the Prevention and Treatment of Colon Cancer.	7	24	1.53	1.95e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IFNG,PTGS2,PTEN,NFE2L2,BCL2,VEGFA
PMID:28324005	(2017) Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein FK in Diabetic Mice.	7	24	1.53	1.95e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252	MAPK1,IFNG,NOX4,EDNRA,NOX1,EDN1,NFE2L2
PMID:28360858	(2017) Saponins from Sanguisorba officinalis Improve Hematopoiesis by Promoting Survival through FAK and Erk12 Activation and Modulating Cytokine Production in Bone Marrow.	7	24	1.53	1.95e-05	9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD34,SERPINF2,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:25688743	(2015) mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma.	7	24	1.53	1.95e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,ANGPT2,PDGFB,FGFR1,RHOA,VEGFA
PMID:21847128	(2011) Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.	7	24	1.53	1.95e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:33407613	(2021) Hypoxia and the phenomenon of immune exclusion.	11	109	1.07	2.03e-05	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANGPT2,PDGFB,GAS6,CXCL9,CD47,ENTPD1,PTEN,EDN1,CCL5,VEGFA
PMID:33917605	(2021) Cannabidiol and the Canonical WNTbeta-Catenin Pathway in Glaucoma.	8	40	1.36	2.03e-05	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000363596,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTGS2,CNR1,NOX1,CNR2,NFE2L2,BCL2,VEGFA
PMID:34177952	(2021) Exosomes and Melatonin: Where Their Destinies Intersect.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,SOX9,PTEN,NOX1,BMP2,BCL2,CCL5,VEGFA
PMID:34203180	(2021) CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354782,9606.ENSP00000381185	MPO,CD38,CD69,ATM,CD34,ELN,CD247,BCL2
PMID:34439289	(2021) Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers.	8	40	1.36	2.03e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,CDH1,ATM,PTGS2,PTEN,HPSE,RHOA,VEGFA
PMID:34621768	(2021) The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review.	8	40	1.36	2.03e-05	9606.ENSP00000352264,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	CD2AP,PTGS2,PTEN,EDN1,JAK2,RHOA,GREM1,VEGFA
PMID:34680186	(2021) Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities.	8	40	1.36	2.03e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,MAP3K5,PTGS2,PTEN,NOX1,BCL2,VEGFA
PMID:35058937	(2021) Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection.	8	40	1.36	2.03e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000403495,9606.ENSP00000474412	CD38,CDH1,CCR5,CXCL10,ELN,ENTPD1,LTA,CCL5
PMID:32346535	(2020) Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.	11	109	1.07	2.03e-05	9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ENPP2,CXCL10,CXCL11,CD34,HNF4A,ANGPT2,CXCL9,NFE2L2,BCL2,PROM1,VEGFA
PMID:32408480	(2020) Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase-Implications for Diabetes Progression.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	MPO,NOX4,DDAH1,PTGS2,NOX1,EDN1,NFE2L2,VEGFA
PMID:33304782	(2020) Natural products remodel cancer-associated fibroblasts in desmoplastic tumors.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000363596,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	MPO,IFNG,CDH1,CAV1,CNR2,JAK2,RHOA,VEGFA
PMID:33519523	(2020) The Role of Glycocalyx and Caveolae in Vascular Homeostasis and Diseases.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000419422	MPO,NOX4,CAV1,NOX1,TXN,HSPG2,RHOA,AGTR1
PMID:31357412	(2019) Adipogenesis: A Necessary but Harmful Strategy.	11	109	1.07	2.03e-05	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000285407,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,NOX4,KLF10,PLIN1,LPL,CD34,SREBF1,RBP4,BMP2,RARRES2,VEGFA
PMID:31396153	(2019) The Endothelium in Acromegaly.	8	40	1.36	2.03e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000381185	CETP,MPO,CHI3L1,CD34,ANGPT2,ELN,EDN1,BCL2
PMID:28257480	(2017) Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.	11	109	1.07	2.03e-05	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000390651,9606.ENSP00000478570	MAPK1,SOX9,CDH1,TIMP3,ATM,ALDH1A1,ANGPT2,PTEN,BMP2,IRAK4,VEGFA
PMID:28538665	(2017) Molecular Basis of Alcohol-Related Gastric and Colon Cancer.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000474412	MPO,IFNG,CDH1,CXCL10,CXCL9,PTGS2,MTHFR,CCL5
PMID:28842514	(2017) Impaired innate immune gene profiling in airway smooth muscle cells from chronic cough patients.	8	40	1.36	2.03e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000384364,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	MPO,IFNG,CXCL10,CXCL11,NPY,LTA,BDNF,CCL5
PMID:25521298	(2014) HSV-2-driven increase in the expression of alpha4beta7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection.	8	40	1.36	2.03e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:24212663	(2011) Cancer stem cells in breast cancer.	8	40	1.36	2.03e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,MYD88,MME,PROM1,VEGFA
PMID:20609215	(2010) Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion.	8	40	1.36	2.03e-05	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000346148,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CXCL11,CD34,EDNRA,PRKAA1,EDN1,BCL2,PROM1,VEGFA
PMID:19118492	(2009) PPARgamma and its ligands: therapeutic implications in cardiovascular disease.	8	40	1.36	2.03e-05	9606.ENSP00000256104,9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	FABP4,DDAH1,LPL,PTGS2,SGK1,EDN1,AGTR1,VEGFA
PMID:35054987	(2022) The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.	12	139	1.0	2.08e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000362524,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,CCR5,ALDH1A1,HNF4A,SIRT6,CAV1,SREBF1,ANGPTL2,PROM1,CCL5,VEGFA
PMID:34068970	(2021) Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.	10	83	1.14	2.08e-05	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CXCL10,CAV1,CXCL9,JAK2,NFE2L2,BCL2,NPY,MYD88,CCL5
PMID:31746396	(2020) Hypoxia-inducible factors in hepatocellular carcinoma (Review).	10	83	1.14	2.08e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX4,VDAC1,ANGPT2,ANG,CCL20,ENTPD1,PTEN,PROM1,VEGFA
PMID:32708142	(2020) Tumor-Associated Macrophage Status in Cancer Treatment.	10	83	1.14	2.08e-05	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,GAS6,CCL20,CD47,BCL2,LTA,CCL5,VEGFA
PMID:33046797	(2020) Molecular tracing of prostate cancer lethality.	10	83	1.14	2.08e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000445772,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,PTEN,AR,BMP2,BCL2,PROM1,LTB4R2,VEGFA
PMID:33073244	(2020) Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?	10	83	1.14	2.08e-05	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	CD38,FABP4,CCR5,CXCL10,STAT5A,CCL20,CXCL9,JAK2,MYD88,VEGFA
PMID:30976737	(2019) Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship.	10	83	1.14	2.08e-05	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,MMP14,MAP3K5,PTGS2,BAMBI,EDN1,MYD88,PROM1,CCL5,VEGFA
PMID:29322778	(2018) Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.	12	139	1.0	2.08e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,ATM,CD34,CAV1,MAP3K5,TXN,AR,JAK2,G6PD,BCL2,VEGFA
PMID:26514730	(2016) WNT-5A: signaling and functions in health and disease.	10	83	1.14	2.08e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL11,PTGS2,KL,BCL2,RHOA,MYD88,VEGFA
PMID:25590298	(2015) Mechanisms and applications of interleukins in cancer immunotherapy.	10	83	1.14	2.08e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CCL20,CXCL9,PTGS2,BCL2,PROM1,CCL5,VEGFA
PMID:20078222	(2010) Mitochondrial energetics and therapeutics.	10	83	1.14	2.08e-05	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ATM,SIRT6,CAV1,MAP3K5,NOX1,TXN,G6PD,BCL2,VEGFA
PMID:35335986	(2022) Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics.	9	60	1.24	2.11e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,MPO,CD34,CCL20,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:35399657	(2022) Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis.	9	60	1.24	2.11e-05	9606.ENSP00000225275,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000477707	MPO,MAPK7,PDGFB,ABCG1,EDN1,JAK2,BCL2,CCL5,NR1H3
PMID:34239993	(2021) The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.	9	60	1.24	2.11e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,MPO,CD69,LPL,CD34,PTGS2,RBP4,MME,VEGFA
PMID:34721299	(2021) Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects.	9	60	1.24	2.11e-05	9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000363827,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	ANGPT2,STAT5A,HSPG2,KL,BCL2,NPY,FGFR1,LTA,VEGFA
PMID:34992601	(2021) Macrophage Polarization and Alveolar Bone Healing Outcome: Despite a Significant M2 Polarizing Effect, VIP and PACAP Treatments Present a Minor Impact in Alveolar Bone Healing in Homeostatic Conditions.	9	60	1.24	2.11e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CCL20,VIP,ALPL,BMP2,CCL5,VEGFA
PMID:33316953	(2020) Deciphering Adipose Tissue Extracellular Vesicles Protein Cargo and Its Role in Obesity.	9	60	1.24	2.11e-05	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000360522,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,THBS1,PLIN1,LPL,SIRT6,CAV1,RBP4,RARRES2,VEGFA
PMID:31060335	(2019) Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.	9	60	1.24	2.11e-05	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	APC,IGF1R,SREBF1,COMT,PTGS2,SHBG,BCL2,RHOA,VEGFA
PMID:32082158	(2019) Roles for Exosome in Various Kidney Diseases and Disorders.	9	60	1.24	2.11e-05	9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000293599,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412	MPO,AMBP,VDAC1,AQP5,ANG,CAV1,MME,PROM1,CCL5
PMID:28946660	(2017) Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds.	9	60	1.24	2.11e-05	9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185	MPO,ATM,CXCL10,PRKCE,PTGS2,PTEN,AR,NFE2L2,BCL2
PMID:29116422	(2017) Progranulin and its biological effects in cancer.	9	60	1.24	2.11e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,IGF1R,ATM,MMP14,EDN1,BCL2,PROM1,VEGFA
PMID:26899500	(2016) Cancer stem cells and chemoresistance: The smartest survives the raid.	9	60	1.24	2.11e-05	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CD38,CDH1,IGF1R,ATM,CD34,BCL2,PROM1,VEGFA
PMID:26283915	(2015) Elusive roles for reactive astrocytes in neurodegenerative diseases.	9	60	1.24	2.11e-05	9606.ENSP00000229135,9606.ENSP00000304767,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	IFNG,P2RY1,CNTF,PTGS2,JAK2,NFE2L2,BDNF,MME,CCL5
PMID:24618337	(2014) Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.	9	60	1.24	2.11e-05	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000426809	SOX9,HSPB1,CDH1,ALDH1A1,PTEN,AR,PDGFD,FGFR1,PROM1
PMID:23528888	(2013) The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin.	9	60	1.24	2.11e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,CCR5,ALDH1A1,EDNRA,CAV1,PTEN,MYD88,PROM1,CCL5
PMID:24132110	(2013) The roles of TGFbeta in the tumour microenvironment.	9	60	1.24	2.11e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,KLF10,PDGFB,PTEN,BAMBI,RHOA,CCL5,VEGFA
PMID:20083193	(2010) Linking oxidative stress to inflammation: Toll-like receptors.	9	60	1.24	2.11e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MPO,IFNG,HSPB1,NOX4,CXCL10,TXN,BCL2,IRAK4,MYD88
PMID:32486098	(2020) Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages.	13	172	0.94	2.12e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,NOX4,CXCL10,CD34,ANGPT2,CXCL9,S100A12,MAFB,JAK2,MYD88,CCL5,VEGFA
PMID:20680494	(2011) Proper laboratory notebook practices: protecting your intellectual property.	13	172	0.94	2.12e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000385834,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CD34,PDGFB,CAV1,CXCL9,VIP,BCL2,TF,RHOA,BDNF,CCL5,VEGFA
PMID:34373568	(2021) Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities.	11	110	1.06	2.14e-05	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000474412	CHI3L1,CDH1,IGF1R,ATM,GAS6,CD47,CNTF,PTEN,JAK2,BDNF,CCL5
PMID:34689842	(2021) Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.	11	110	1.06	2.14e-05	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,CXCL11,STAT5A,PTGS2,ENTPD1,PTEN,BCL2,MYD88,CCL5,VEGFA
PMID:35087852	(2021) Liver Fibrosis-From Mechanisms of Injury to Modulation of Disease.	11	110	1.06	2.14e-05	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	CD69,THBS1,CCR5,PDGFB,CCL20,ELN,JAK2,RHOA,MYD88,AGTR1,VEGFA
PMID:33738136	(2021) Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy.	12	140	0.99	2.20e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000478570	ERCC1,CDH1,TIMP3,IGF1R,CD34,PDGFB,STAT5A,PDGFA,PTEN,BCL2,FTO,VEGFA
PMID:28638822	(2017) Extracellular Vesicles in Renal Pathophysiology.	12	140	0.99	2.20e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000402152,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	MPO,THBS1,CDH1,ANG,STAT5A,CD2AP,PTEN,BCL2,SLC12A3,MME,PROM1,VEGFA
PMID:34692550	(2021) The Emerging Roles of Long Noncoding RNAs as Hallmarks of Lung Cancer.	10	84	1.14	2.27e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,ALDH1A1,CXCL10,CD34,PDGFB,BCL2,RHOA,PROM1,VEGFA,HNF1B
PMID:32517735	(2020) Triple-negative breast cancer molecular subtyping and treatment progress.	10	84	1.14	2.27e-05	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412	IGF1R,CXCL10,CXCL11,CXCL9,PTEN,AR,BMP2,BCL2,FGFR1,CCL5
PMID:28270795	(2017) The Leptin Receptor Complex: Heavier Than Expected?	10	84	1.14	2.27e-05	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000478570	EPOR,CDH1,IGF1R,STAT5A,PTGS2,PTEN,JAK2,NPY,MYD88,VEGFA
PMID:33217763	(2021) Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?	8	41	1.35	2.32e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,MMP14,CXCL9,AR,EDN1,CCL5,VEGFA
PMID:33732247	(2021) The Dynamic Immune Response of Yellow Catfish (Pelteobagrus fulvidraco) Infected With Edwardsiella ictaluri Presenting the Inflammation Process.	11	111	1.06	2.32e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495	MAPK1,IFNG,CCR5,CXCL11,CCL20,MAP3K5,CXCL9,JAK2,IRAK4,MYD88,LTA
PMID:33761782	(2021) Human NK cells: From development to effector functions.	11	111	1.06	2.32e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CDH1,CCR5,CXCL10,CD34,CD247,MME,PROM1,CCL5,VEGFA
PMID:34205870	(2021) The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities.	8	41	1.35	2.32e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000311005,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000418525	TGFB1,MPO,MAPK7,ELN,TXN,EDN1,NFE2L2,MME
PMID:34680494	(2021) New Insights into the Activities of D-Chiro-Inositol: A Narrative Review.	8	41	1.35	2.32e-05	9606.ENSP00000216075,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MIOX,IFNG,NOX4,PTGS2,NFE2L2,BCL2,BDNF,VEGFA
PMID:34829671	(2021) Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies.	8	41	1.35	2.32e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	THBS1,NOX4,SIRT6,MAP3K5,NOX1,TXN,G6PD,NFE2L2
PMID:33298926	(2020) TGFbeta-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts.	8	41	1.35	2.32e-05	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000478570	CD69,THBS1,CXCL10,CXCL11,CD34,CXCL9,MME,VEGFA
PMID:33316872	(2020) Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems.	8	41	1.35	2.32e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809	CDH1,ALDH1A1,CD47,PTEN,JAK2,BCL2,FGFR1,PROM1
PMID:31531178	(2019) Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis.	8	41	1.35	2.32e-05	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000474412	NOX4,MAP3K5,NOX1,TXN,JAK2,G6PD,NFE2L2,CCL5
PMID:31547882	(2019) Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.	8	41	1.35	2.32e-05	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,TIMP3,IGF1R,PTGS2,PTEN,PDGFD,RHOA,VEGFA
PMID:31801883	(2019) Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.	8	41	1.35	2.32e-05	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,ANG,PTEN,AR,BCL2,PROM1,VEGFA
PMID:29863786	(2018) Rat astrocytes during anoxia: Secretome profile of cytokines and chemokines.	8	41	1.35	2.32e-05	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,JAK2,BDNF,CCL5,VEGFA
PMID:30246033	(2018) Caveolin-1-Knockout Mouse as a Model of Inflammatory Diseases.	8	41	1.35	2.32e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CAV1,CXCL9,JAK2,NFE2L2,CCL5,VEGFA
PMID:28624477	(2017) Nanoformulations for combination or cascade anticancer therapy.	8	41	1.35	2.32e-05	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CD38,ATM,CD34,ELN,PTEN,BCL2,VEGFA
PMID:28725636	(2017) Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.	11	111	1.06	2.32e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000426809	CDH1,ALDH1A1,CCL20,PTEN,BMP2,EDN1,JAK2,RHOA,BDNF,FTO,PROM1
PMID:28804501	(2017) Regulatory Role of Redox Balance in Determination of Neural Precursor Cell Fate.	8	41	1.35	2.32e-05	9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,MAP3K5,PTEN,NOX1,TXN,NFE2L2,BCL2,VEGFA
PMID:29054417	(2017) The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium.	8	41	1.35	2.32e-05	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000444198,9606.ENSP00000478570	ATM,CD34,STAT5A,PTGS2,NOX1,BCL2,CITED2,VEGFA
PMID:27881869	(2016) Netrin-1-Induced Stem Cell Bioactivity Contributes to the Regeneration of Injured Tissues via the Lipid Raft-Dependent Integrin alpha6beta4 Signaling Pathway.	8	41	1.35	2.32e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000334329,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,CD34,UNC5B,CAV1,BCL2,RHOA,VEGFA
PMID:24563824	(2013) MicroRNAs and Cardiovascular Disease.	8	41	1.35	2.32e-05	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,IGF1R,SREBF1,ELN,ABCG1,PTEN,BCL2,VEGFA
PMID:24213119	(2011) Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells.	8	41	1.35	2.32e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,PTEN,PDGFD,BCL2,PROM1
PMID:19672262	(2009) Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer.	8	41	1.35	2.32e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000478570	THBS1,CXCL10,CXCL11,PDGFB,PDGFA,CXCL9,PDGFD,VEGFA
PMID:17979880	(2007) Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors.	8	41	1.35	2.32e-05	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,PDGFB,PDGFA,PDGFD,RHOA,PROM1,VEGFA
PMID:35032287	(2022) An integrated in silico analysis highlighted angiogenesis regulating miRNA-mRNA network in PCOS pathophysiology.	7	25	1.51	2.33e-05	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000363827,9606.ENSP00000369816,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,PDGFB,PDGFA,HSPG2,SHBG,FGFR1,VEGFA
PMID:35053602	(2022) Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?	9	61	1.23	2.33e-05	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD69,THBS1,CCL20,CD47,PTEN,AR,RHOA,CCL5,VEGFA
PMID:33777002	(2021) In Vitro Culture Expansion Shifts the Immune Phenotype of Human Adipose-Derived Mesenchymal Stem Cells.	9	61	1.23	2.33e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000474412	CD38,IFNG,FABP4,CXCL10,SIRT6,PDGFA,PTEN,BMP2,CCL5
PMID:33967696	(2021) Inflammation-Mediated Angiogenesis in Ischemic Stroke.	9	61	1.23	2.33e-05	9606.ENSP00000222139,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	EPOR,ANGPT2,PDGFB,PDGFA,JAK2,PDGFD,BCL2,FGFR1,VEGFA
PMID:34503062	(2021) Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors.	9	61	1.23	2.33e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,ALDH1A1,STAT5A,PTEN,JAK2,BCL2,PROM1,VEGFA,HNF1B
PMID:34572548	(2021) Mediterranean Diet Food Components as Possible Adjuvant Therapies to Counteract Breast and Prostate Cancer Progression to Bone Metastasis.	9	61	1.23	2.33e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000480291	SOX9,CDH1,HNF4A,EDNRA,AR,EDN1,BCL2,RHOA,HNF1B
PMID:34771453	(2021) CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells.	9	61	1.23	2.33e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANG,CCL20,ELN,CXCL9,CD47,CCL5,VEGFA
PMID:34790203	(2021) Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal StemStromal Cells for Osteoarticular Disease Treatment.	9	61	1.23	2.33e-05	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,MMP14,CD34,CXCL9,HSPG2,BMP2,JAK2,FGFR1,VEGFA
PMID:34831936	(2021) Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study.	7	25	1.51	2.33e-05	9606.ENSP00000285407,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000363973,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000478570	KLF10,MAPK7,HNF4A,ALPL,MTHFR,SHBG,VEGFA
PMID:35111060	(2021) Culinary Spices in Food and Medicine: An Overview of Syzygium aromaticum (L.) Merr. and L. M. Perry [Myrtaceae].	7	25	1.51	2.33e-05	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185	CETP,IFNG,ALDH1A1,CXCL10,CXCL11,CXCL9,BCL2
PMID:31979129	(2020) Advances in HDL: Much More than Lipid Transporters.	7	25	1.51	2.33e-05	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000222572,9606.ENSP00000260356,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000360522	CETP,TGFB1,PON2,THBS1,APOL1,LPA,RBP4
PMID:32326163	(2020) MAP Kinases Pathways in Gastric Cancer.	9	61	1.23	2.33e-05	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,MAPK7,MAP3K5,PTGS2,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:32527042	(2020) Genomic Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.	7	25	1.51	2.33e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,BCL2,CCL5,VEGFA
PMID:32708801	(2020) Glia and Neural Stem and Progenitor Cells of the Healthy and Ischemic Brain: The Workplace for the Wnt Signaling Pathway.	9	61	1.23	2.33e-05	9606.ENSP00000225275,9606.ENSP00000298352,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000480291	MPO,NGB,HNF4A,BMP2,BCL2,RHOA,BDNF,VEGFA,HNF1B
PMID:33321931	(2020) MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.	9	61	1.23	2.33e-05	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	TIMP3,CXCL10,PTEN,EDN1,JAK2,BCL2,CCL5,NR1H3,VEGFA
PMID:33364199	(2020) The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives.	9	61	1.23	2.33e-05	9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	FADS2,LPL,CAV1,SREBF1,ABCG1,PTEN,AR,BCL2,PROM1
PMID:30393084	(2019) Chemoprotective Effects of Dietary Grape Powder on UVB Radiation-Mediated Skin Carcinogenesis in SKH-1 Hairless Mice.	7	25	1.51	2.33e-05	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	HSPB1,NOX4,PRDX2,PTGS2,NFE2L2,BCL2,CCL5
PMID:31333587	(2019) Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction.	7	25	1.51	2.33e-05	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000337332,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,ANGPT2,EDNRA,SIRT6,AR,EDN1,VEGFA
PMID:29338773	(2018) Chemokine ligand-receptor interactions critically regulate cutaneous wound healing.	9	61	1.23	2.33e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,MMP14,ANG,CCL20,CXCL9,CCL5,VEGFA
PMID:29648680	(2018) Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?	7	25	1.51	2.33e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,CXCL9,EDN1,CCL5,VEGFA
PMID:29853908	(2018) Potential Roles of Dental Pulp Stem Cells in Neural Regeneration and Repair.	9	61	1.23	2.33e-05	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANG,EDN1,NTF3,RHOA,LTA,BDNF,CCL5,VEGFA
PMID:30322133	(2018) Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair.	9	61	1.23	2.33e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,TIMP3,MMP14,CAV1,ELN,CD47,RHOA,MME,VEGFA
PMID:30483123	(2018) Updates in Anthracycline-Mediated Cardiotoxicity.	9	61	1.23	2.33e-05	9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,VDAC1,IGF1R,ATM,PTEN,EDN1,NFE2L2,BCL2,VEGFA
PMID:27683128	(2017) Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.	7	25	1.51	2.33e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000384262,9606.ENSP00000478570	THBS1,CDH1,ALDH1A1,CD47,AR,HPSE,VEGFA
PMID:28534034	(2017) Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men.	7	25	1.51	2.33e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:26694039	(2016) Pathophysiology of bronchoconstriction: role of oxidatively damaged DNA repair.	7	25	1.51	2.33e-05	9606.ENSP00000263317,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683	NOX4,CCL20,VIP,PTGS2,NOX1,TXN,EDN1
PMID:27341633	(2016) Omics-based approaches to understand mechanosensitive endothelial biology and atherosclerosis.	9	61	1.23	2.33e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	THBS1,TIMP3,MAPK7,ANGPT2,PDGFA,SREBF1,EDN1,RHOA,AGTR1
PMID:26294111	(2015) Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.	9	61	1.23	2.33e-05	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000321853,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,EDNRA,SERPINF2,COMT,PTGS2,EDN1,RHOA,AGTR1,VEGFA
PMID:24508120	(2014) Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.	9	61	1.23	2.33e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000347041,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,TIMP3,IGF1R,HNF4A,FMOD,RHOA,MYD88,CCL5,VEGFA
PMID:24733068	(2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.	9	61	1.23	2.33e-05	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000474412	CETP,TGFB1,CCR5,CXCL10,LPL,SREBF1,RBP4,ANGPTL2,CCL5
PMID:25501026	(2014) Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.	7	25	1.51	2.33e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000418525	CD38,CD34,STAT5A,CXCL9,JAK2,FGFR1,MME
PMID:23068073	(2013) Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.	7	25	1.51	2.33e-05	9606.ENSP00000260356,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000360522,9606.ENSP00000401720,9606.ENSP00000474412	THBS1,PLIN1,CXCL10,LPL,RBP4,GK,CCL5
PMID:23405235	(2013) Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.	9	61	1.23	2.33e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ATM,CXCL10,CAV1,CXCL9,PTGS2,PTEN,BCL2,RHOA,VEGFA
PMID:24058799	(2013) The regulation of inflammation by interferons and their STATs.	9	61	1.23	2.33e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CD34,STAT5A,CXCL9,JAK2,MYD88,CCL5
PMID:24081879	(2013) Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.	7	25	1.51	2.33e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000478570	IFNG,THBS1,CXCL10,MMP14,ANGPT2,CD47,VEGFA
PMID:22135047	(2012) Nuclear receptors as modulators of the tumor microenvironment.	7	25	1.51	2.33e-05	9606.ENSP00000216862,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	CYP24A1,THBS1,CCR5,PTGS2,NOX1,CCL5,VEGFA
PMID:22110171	(2011) Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.	9	61	1.23	2.33e-05	9606.ENSP00000226760,9606.ENSP00000228434,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000321334,9606.ENSP00000345708,9606.ENSP00000369816,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,CD69,JAZF1,HNF4A,LPA,KCNJ11,SHBG,FTO,HNF1B
PMID:20371345	(2010) Matrix metalloproteinases: regulators of the tumor microenvironment.	9	61	1.23	2.33e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000351807,9606.ENSP00000360997,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CXCL11,ANGPT2,SERPINF2,ELN,ADAMTS13,CCL5,VEGFA
PMID:18803816	(2008) Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells.	7	25	1.51	2.33e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD34,CXCL9,BDNF,PROM1,CCL5,VEGFA
PMID:31892850	(2020) Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery.	6	13	1.73	2.40e-05	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,GAP43,BCL2,NPY,BDNF,VEGFA
PMID:26208095	(2015) PPARgamma Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.	6	13	1.73	2.40e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185	THBS1,NOX4,PTEN,BMP2,EDN1,BCL2
PMID:20218920	(2010) Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.	6	13	1.73	2.40e-05	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CNTF,NTF3,BDNF,PROM1,VEGFA
PMID:34067929	(2021) Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.	10	85	1.13	2.41e-05	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CD69,THBS1,CDH1,MMP14,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:34429666	(2021) Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension.	10	85	1.13	2.41e-05	9606.ENSP00000285407,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000356213,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	KLF10,EDNRA,ELN,MAP3K5,VIP,NOX1,EDN1,RHOA,CCL5,VEGFA
PMID:34572009	(2021) The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.	10	85	1.13	2.41e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	CD38,ALDH1A1,CD34,ELN,CD47,PTEN,PROM1,CCL5,VEGFA,HNF1B
PMID:34778378	(2021) MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets.	10	85	1.13	2.41e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,ANGPT2,ANG,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:31830503	(2020) Mammalian phospholipase D: Function, and therapeutics.	10	85	1.13	2.41e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	MAPK1,TGFB1,MPO,CDH1,ANG,PTGS2,PTEN,TXN,EDN1,VEGFA
PMID:32054102	(2020) Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma.	11	112	1.05	2.41e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,STAT5A,CCL20,CXCL9,VIP,MYD88,RARRES2,VEGFA
PMID:32489346	(2020) Pathogenesis of psoriasis in the omic era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.	10	85	1.13	2.41e-05	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD69,CCR5,CXCL10,CXCL11,CD34,CCL20,S100A12,CCL5,VEGFA
PMID:33194695	(2020) Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment.	10	85	1.13	2.41e-05	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000321334,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000477707,9606.ENSP00000478570	FABP4,FADS2,PLIN1,LPA,CAV1,SREBF1,ABCG1,PTGS2,NR1H3,VEGFA
PMID:33321955	(2020) Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation.	10	85	1.13	2.41e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000478570	MPO,CDH1,PTGS2,TXN,EDN1,NFE2L2,IRAK4,RARRES2,AGTR1,VEGFA
PMID:31555593	(2019) New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment.	10	85	1.13	2.41e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,TIMP3,CCR5,CXCL10,PTEN,BMP2,PROM1,CCL5,VEGFA
PMID:28826224	(2018) Differential Impact of Flavonoids on Redox Modulation, Bioenergetics, and Cell Signaling in Normal and Tumor Cells: A Comprehensive Review.	11	112	1.05	2.41e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	CD38,IFNG,TIMP3,CXCL10,HNF4A,ELN,COMT,PTEN,NOX1,BCL2,VEGFA
PMID:30577495	(2018) Molecular Repolarisation of Tumour-Associated Macrophages.	10	85	1.13	2.41e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000346148,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,ANGPT2,PRKAA1,CXCL9,PTGS2,JAK2,MYD88,CCL5,VEGFA
PMID:28212521	(2017) Angiogenesis in the atherosclerotic plaque.	10	85	1.13	2.41e-05	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000362524,9606.ENSP00000393312,9606.ENSP00000478570	MPO,MMP14,ANGPT2,PDGFB,CAV1,ELN,ABCG1,ANGPTL2,FGFR1,VEGFA
PMID:26985248	(2016) Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications.	10	85	1.13	2.41e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,THBS1,CDH1,MAPK7,HNF4A,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:19783480	(2009) Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability.	10	85	1.13	2.41e-05	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	MPO,ANGPT2,CAV1,CCL20,CD47,ENTPD1,PTEN,RHOA,TRPC1,VEGFA
PMID:34922630	(2021) Chronic myeloid leukemia stem cells: targeting therapeutic implications.	13	175	0.93	2.43e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000445772	CD38,ATM,MMP14,CD34,HNF4A,STAT5A,CD47,PTGS2,PTEN,BMP2,JAK2,BCL2,LTB4R2
PMID:35111368	(2022) Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases.	9	62	1.22	2.55e-05	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,ATM,SIRT6,CAV1,PTEN,TXN,BCL2,BDNF,VEGFA
PMID:35241159	(2022) The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimers disease: crosstalk between autophagy and apoptosis.	9	62	1.22	2.55e-05	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,IGF1R,CXCL10,ANGPT2,PTEN,BCL2,BDNF,CCL5,VEGFA
PMID:35280688	(2022) Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.	9	62	1.22	2.55e-05	9606.ENSP00000229135,9606.ENSP00000322898,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	IFNG,EBF1,SGK1,PTEN,TXN,BCL2,RHOA,MYD88,MME
PMID:35402261	(2022) Long Noncoding RNA: Shining Stars in the Immune Microenvironment of Gastric Cancer.	9	62	1.22	2.55e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,CDH1,CXCL10,MMP14,ELN,CXCL9,SGK1,PTEN,VEGFA
PMID:33850422	(2021) Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review.	9	62	1.22	2.55e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CD69,IFNG,CXCL10,STAT5A,CCL20,JAK2,MYD88,CCL5
PMID:33854888	(2021) Crosstalk between Bone and Nerves within Bone.	9	62	1.22	2.55e-05	9606.ENSP00000331831,9606.ENSP00000334329,9606.ENSP00000354511,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	GAS6,UNC5B,COMT,VIP,BMP2,NPY,NTF3,BDNF,VEGFA
PMID:34502453	(2021) TNF-alpha and IFN-gamma Participate in Improving the Immunoregulatory Capacity of Mesenchymal StemStromal Cells: Importance of Cell-Cell Contact and Extracellular Vesicles.	9	62	1.22	2.55e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CD34,CCL20,CXCL9,PTGS2,CCL5,VEGFA
PMID:34578651	(2021) Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.	9	62	1.22	2.55e-05	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,SOX9,CD34,PDGFB,ELN,BMP2,BCL2,BDNF,VEGFA
PMID:32503591	(2020) Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment.	9	62	1.22	2.55e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,IGF1R,PDGFB,CAV1,STAT5A,CD47,PTEN,EDN1,VEGFA
PMID:32872372	(2020) Involvement of STAT5 in Oncogenesis.	9	62	1.22	2.55e-05	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,IFNG,CDH1,NOX4,SREBF1,PTGS2,JAK2,BCL2,VEGFA
PMID:30389614	(2019) Elucidating the contributory role of microRNA to cardiovascular diseases (a review).	9	62	1.22	2.55e-05	9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	CHI3L1,TIMP3,IGF1R,LPL,ELN,ABCG1,PTEN,BCL2,FGFR1
PMID:30643357	(2019) Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma.	9	62	1.22	2.55e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	APC,CDH1,NOX4,PTGS2,NOX1,AR,BCL2,RHOA,VEGFA
PMID:30834270	(2019) Stem Cells from the Apical Papilla: A Promising Source for Stem Cell-Based Therapy.	9	62	1.22	2.55e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000478570	TGFB1,SOX9,FABP4,LPL,CD34,ANG,BMP2,NTF3,VEGFA
PMID:31831021	(2019) Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects.	9	62	1.22	2.55e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,IGF1R,HNF4A,SREBF1,PTEN,BCL2,PROM1,VEGFA
PMID:28286898	(2018) The molecular biology of pelvi-ureteric junction obstruction.	9	62	1.22	2.55e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,VIP,PTGS2,EDN1,NPY,AGTR1,CCL5,VEGFA
PMID:30013512	(2018) Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis.	9	62	1.22	2.55e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	FABP4,CDH1,PLIN1,CD34,CAV1,PTEN,AR,JAK2,BCL2
PMID:30271341	(2018) Emerging Therapies in the Management of Advanced-Stage Gastric Cancer.	9	62	1.22	2.55e-05	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CD38,CDH1,ATM,CD247,PTEN,JAK2,PROM1,VEGFA
PMID:29197379	(2017) Factors involved in cancer metastasis: a better understanding to seed and soil hypothesis.	9	62	1.22	2.55e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CAV1,CCL20,PTGS2,PTEN,AR,CCL5,VEGFA
PMID:26487502	(2016) Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.	9	62	1.22	2.55e-05	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000337332,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	IFNG,CXCL11,SIRT6,GAP43,BCL2,NPY,BDNF,MME,VEGFA
PMID:27482235	(2016) Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies.	9	62	1.22	2.55e-05	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANG,CNTF,BMP2,JAK2,BCL2,NTF3,BDNF,VEGFA
PMID:28932823	(2016) ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy.	9	62	1.22	2.55e-05	9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000358513,9606.ENSP00000369442,9606.ENSP00000419422,9606.ENSP00000477707,9606.ENSP00000480291	HNF4A,STAT5A,SREBF1,CCL20,CNR1,KL,AGTR1,NR1H3,HNF1B
PMID:26391551	(2015) Role of microRNAs in Vascular Remodeling.	9	62	1.22	2.55e-05	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	IGF1R,CD34,STAT5A,ELN,PTEN,EDN1,BCL2,RHOA,AGTR1
PMID:23284893	(2012) Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis.	12	143	0.98	2.55e-05	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,HSPB1,CXCL10,CXCL11,ANGPT2,CCL20,BCL2,RHOA,MYD88,BDNF,CCL5,VEGFA
PMID:20951732	(2011) The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies.	9	62	1.22	2.55e-05	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CD34,STAT5A,MAP3K5,TXN,JAK2,NFE2L2,BCL2,VEGFA
PMID:21622291	(2011) Chemokines: key players in cancer progression and metastasis.	9	62	1.22	2.55e-05	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,CXCL10,CXCL11,MMP14,CXCL9,AR,CCL5,VEGFA
PMID:20045011	(2010) RSK in tumorigenesis: connections to steroid signaling.	9	62	1.22	2.55e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,ATM,MAPK7,AR,BCL2,FGFR1,RHOA,BDNF,VEGFA
PMID:33620071	(2022) The vasculature: a therapeutic target in heart failure?	8	42	1.34	2.56e-05	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000475344,9606.ENSP00000478570	MPO,FABP4,LPL,ANGPT2,EDNRA,EDN1,APLNR,VEGFA
PMID:34662529	(2022) Full-coverage regulations of autophagy by ROS: from induction to maturation.	8	42	1.34	2.56e-05	9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	ATM,CAV1,PRKAA1,MAP3K5,PTEN,TXN,NFE2L2,BCL2
PMID:34820571	(2022) A single-cell transcriptome of mesenchymal stromal cells to fabricate bioactive hydroxyapatite materials for bone regeneration.	11	113	1.05	2.56e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000322898,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000364683,9606.ENSP00000376865,9606.ENSP00000478570	TGFB1,SOX9,COL8A1,TIMP3,EBF1,PTGS2,PTEN,ALPL,BAMBI,PDGFD,VEGFA
PMID:33562156	(2021) Potential of Caffeine in Alzheimers Disease-A Review of Experimental Studies.	8	42	1.34	2.56e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,IFNG,PTGS2,NFE2L2,BCL2,BDNF,CCL5,VEGFA
PMID:33692219	(2021) N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells.	8	42	1.34	2.56e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000474412	CD69,CDH1,CXCL10,CXCL11,CD34,AR,JAK2,CCL5
PMID:33921099	(2021) Alternative Vascularization Mechanisms in Tumor Resistance to Therapy.	8	42	1.34	2.56e-05	9606.ENSP00000260356,9606.ENSP00000284031,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000426809	THBS1,DDAH1,CXCL11,MMP14,CD34,ANGPT2,CD47,PROM1
PMID:33995341	(2021) Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.	8	42	1.34	2.56e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,MAPK7,MYD88,LTA,AGTR1,CCL5,VEGFA
PMID:34113444	(2021) Detection of cytokine storm in patients with achalasia using ELISA.	8	42	1.34	2.56e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,CCL5,VEGFA
PMID:32164244	(2020) Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases.	8	42	1.34	2.56e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000321334,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422	CETP,MPO,LPA,CAV1,ABCG1,JAK2,BCL2,AGTR1
PMID:32973750	(2020) MAIT Cells at the Fetal-Maternal Interface During Pregnancy.	8	42	1.34	2.56e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CD38,CD69,THBS1,CCR5,CXCL10,CXCL11,CCL20,CXCL9
PMID:29628794	(2018) Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance.	8	42	1.34	2.56e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,CCR5,ALDH1A1,CD34,EDNRA,BCL2,PROM1,CCL5
PMID:28148265	(2017) Cancer stem cell niche models and contribution by mesenchymal stromastem cells.	8	42	1.34	2.56e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	THBS1,CDH1,CCR5,MMP14,ELN,BCL2,PROM1,CCL5
PMID:28686225	(2017) Retrospective Proteomic Screening of 100 Breast Cancer Tissues.	11	113	1.05	2.56e-05	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000301522,9606.ENSP00000361021,9606.ENSP00000361883,9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,HSPB1,VDAC1,PRDX2,PTEN,CAP1,GLO1,TXN,JAK2,RHOA,VEGFA
PMID:29167448	(2017) Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy.	8	42	1.34	2.56e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CCL20,ELN,CXCL9,RARRES2,CCL5
PMID:27177292	(2016) Low expression of leptin and its association with breast cancer: A transcriptomic study.	8	42	1.34	2.56e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000478570	TGFB1,IFNG,ATM,CXCL10,CXCL9,JAK2,NPY,VEGFA
PMID:26047816	(2015) Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.	8	42	1.34	2.56e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IFNG,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:22982179	(2013) Role of the retinal vascular endothelial cell in ocular disease.	11	113	1.05	2.56e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,IGF1R,CCR5,CXCL10,CXCL11,CCL20,EDN1,BCL2,CCL5,VEGFA
PMID:21189141	(2010) Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.	8	42	1.34	2.56e-05	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,HSPB1,CAV1,COMT,EDN1,SHBG,RHOA,VEGFA
PMID:35268340	(2022) The Role of Extracellular Matrix Proteins in Breast Cancer.	10	86	1.13	2.57e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478570	TGFB1,THBS1,CDH1,IGF1R,MMP14,CAV1,STAT5A,ELN,HSPG2,VEGFA
PMID:34209224	(2021) Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans.	10	86	1.13	2.57e-05	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418009	MPO,FABP4,SREBF1,MAP3K5,PTGS2,KL,G6PD,BCL2,BDNF,RARRES2
PMID:34503058	(2021) The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer.	10	86	1.13	2.57e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,VIP,NPY,CCL5,VEGFA
PMID:30591657	(2018) Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.	10	86	1.13	2.57e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,PROM1,CCL5,VEGFA
PMID:28614624	(2017) New insights into the role of EMT in tumor immune escape.	10	86	1.13	2.57e-05	9606.ENSP00000013807,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,THBS1,CDH1,ATM,CXCL10,CCL20,PTGS2,PTEN,BCL2,VEGFA
PMID:27231010	(2016) Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.	10	86	1.13	2.57e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,TIMP3,ATM,ANGPT2,PTEN,BCL2,FGFR1,CCL5,VEGFA
PMID:35006466	(2021) Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer.	12	144	0.98	2.70e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000477707,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,SREBF1,CCL20,PTGS2,PTEN,JAK2,BCL2,RHOA,NR1H3,VEGFA
PMID:23188744	(2013) Systems analysis of biological networks in skeletal muscle function.	12	144	0.98	2.70e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000258341,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000356515,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000478570	MAPK1,TGFB1,IFNG,LAMC1,IGF1R,MMP14,LPL,PTGS2,UTRN,HSPG2,NFE2L2,VEGFA
PMID:15663962	(2005) Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis.	5	5	2.06	2.70e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:35015819	(2022) Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CD47,CCL5
PMID:33544313	(2021) Regression of portal hypertension: underlying mechanisms and therapeutic strategies.	7	26	1.49	2.73e-05	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CD34,EDNRA,ELN,MAP3K5,EDN1,RHOA,VEGFA
PMID:33849537	(2021) Mesenchymal stemstromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications.	11	114	1.05	2.73e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,CCR5,CD47,PTEN,EDN1,JAK2,BCL2,PROM1,CCL5,GREM1,VEGFA
PMID:34038217	(2021) Acute myeloid leukemia with T lymphoblastic lymphoma: a case report and literature review.	7	26	1.49	2.73e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,PDGFA,JAK2,BCL2,MME
PMID:35052735	(2021) Off-Target Effects of Antidepressants on Vascular Function and Structure.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,LPA,PTGS2,EDN1,CCL5,VEGFA
PMID:32095823	(2020) Profiles of immune cell infiltration in head and neck squamous carcinoma.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:31844561	(2019) The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,SAA1,CCL5
PMID:28389623	(2017) Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments.	7	26	1.49	2.73e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5
PMID:28868093	(2017) On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,FMOD,ELN,PTGS2,EDN1,BCL2,VEGFA
PMID:28931951	(2017) Screening of miRNA profiles and construction of regulation networks in early and late lactation of dairy goat mammary glands.	7	26	1.49	2.73e-05	9606.ENSP00000222305,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000381185	USF2,IGF1R,CAV1,STAT5A,AR,MTHFR,BCL2
PMID:26845775	(2016) Di (2-ethylhexyl) Phthalate Exposure Impairs Growth of Antral Follicle in Mice.	7	26	1.49	2.73e-05	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000362463,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478319	ATM,CCR5,GLO1,EDN1,BCL2,RHOA,GREM1
PMID:27102866	(2016) Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses.	7	26	1.49	2.73e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000477707	MPO,IFNG,CAV1,ABCG1,PTGS2,MYD88,NR1H3
PMID:27793180	(2016) Specific disruption of Lnk in murine endothelial progenitor cells promotes dermal wound healing via enhanced vasculogenesis, activation of myofibroblasts, and suppression of inflammatory cell recruitment.	7	26	1.49	2.73e-05	9606.ENSP00000222139,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CCR5,CD34,STAT5A,JAK2,CCL5,VEGFA
PMID:24170072	(2014) Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.	7	26	1.49	2.73e-05	9606.ENSP00000221930,9606.ENSP00000321853,9606.ENSP00000356515,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,SERPINF2,UTRN,BMP2,NTF3,BDNF,VEGFA
PMID:24577966	(2014) Translating Kochs postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000361021	IFNG,THBS1,TIMP3,MMP14,EDNRA,ELN,PTEN
PMID:25071932	(2014) In vitro pre-vascularisation of tissue-engineered constructs A co-culture perspective.	7	26	1.49	2.73e-05	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ELN,PTGS2,HSPG2,EDN1,PROM1,VEGFA
PMID:21803027	(2011) Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.	7	26	1.49	2.73e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:19756239	(2009) The Role of Inflammation in the Pathogenesis of Colorectal Cancer.	7	26	1.49	2.73e-05	9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,APC,PTGS2,EDN1,BCL2,MYD88,VEGFA
PMID:34529222	(2022) Modulation of endothelium function by fatty acids.	10	87	1.12	2.77e-05	9606.ENSP00000200676,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000348069,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	CETP,FABP4,LPL,ANGPT2,SREBF1,ENTPD1,PTEN,EDN1,MYD88,VEGFA
PMID:35053329	(2022) Atypical Roles of the Chemokine Receptor ACKR3CXCR7 in Platelet Pathophysiology.	9	63	1.22	2.77e-05	9606.ENSP00000248553,9606.ENSP00000304767,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,P2RY1,CXCL11,CD34,ENTPD1,FGFR1,PROM1,CCL5,VEGFA
PMID:35326602	(2022) Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity.	9	63	1.22	2.77e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,MMP14,CD47,ENTPD1,BCL2,MYD88,CCL5,VEGFA
PMID:35418990	(2022) Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury.	9	63	1.22	2.77e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	MPO,CD69,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,ENTPD1,CCL5
PMID:34103085	(2021) Epigenetic mechanisms underlying prostate cancer radioresistance.	10	87	1.12	2.77e-05	9606.ENSP00000257430,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	APC,TIMP3,ATM,ALDH1A1,STAT5A,PTGS2,PTEN,AR,PROM1,VEGFA
PMID:34307543	(2021) Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update.	13	178	0.92	2.77e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000475344,9606.ENSP00000478570	APC,CDH1,MMP14,HNF4A,ANGPT2,PTGS2,PTEN,AR,BCL2,RHOA,PROM1,APLNR,VEGFA
PMID:34884923	(2021) Designing Cardiovascular Implants Taking in View the Endothelial Basement Membrane.	9	63	1.22	2.77e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,ANGPT2,CAV1,HSPG2,RHOA,BDNF,PROM1,VEGFA
PMID:34917895	(2021) Understanding menstrual blood-derived stromalstem cells: Definition and properties. Are we rushing into their therapeutic applications?	9	63	1.22	2.77e-05	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFB,PDGFA,ELN,PTEN,BCL2,BDNF,PROM1,VEGFA
PMID:35056905	(2021) Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.	10	87	1.12	2.77e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,SGK1,PTEN,KL,BCL2,AGTR1,CCL5,VEGFA
PMID:31989830	(2020) Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.	10	87	1.12	2.77e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,ATM,CAV1,PTGS2,TXN,G6PD,NFE2L2,PROM1,VEGFA,UHRF1
PMID:32560387	(2020) Human Mesenchymal Stem Cells Overexpressing Interleukin 2 Can Suppress Proliferation of Neuroblastoma Cells in Co-Culture and Activate Mononuclear Cells In Vitro.	9	63	1.22	2.77e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CD34,CCL20,CXCL9,BCL2,BDNF,VEGFA
PMID:32599856	(2020) Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.	9	63	1.22	2.77e-05	9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	CXCL10,APOL1,CXCL9,NPY,RHOA,AGTR1,CCL5,APLNR,VEGFA
PMID:32630452	(2020) Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets.	9	63	1.22	2.77e-05	9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000360997,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,MMP14,LPL,ADAMTS13,NOX1,TXN,EDN1,RHOA,VEGFA
PMID:32704173	(2020) Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.	9	63	1.22	2.77e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CXCL10,PDGFB,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:33228048	(2020) Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells.	10	87	1.12	2.77e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CXCL11,CXCL9,BCL2,MYD88,BDNF,CCL5,VEGFA
PMID:33344447	(2020) A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance.	10	87	1.12	2.77e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000418823,9606.ENSP00000478570	CD38,ATM,ANGPT2,CXCL9,CD47,ENTPD1,PTEN,JAK2,FTO,VEGFA
PMID:30862794	(2019) Comparative Transcriptome and Methylome Analysis in Human Skeletal Muscle Anabolism, Hypertrophy and Epigenetic Memory.	10	87	1.12	2.77e-05	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000419422	MYH9,TGFB1,THBS1,TIMP3,ATM,HNF4A,AR,HSPG2,RHOA,AGTR1
PMID:31376432	(2019) Environmental exposures, stem cells, and cancer.	10	87	1.12	2.77e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,IGF1R,ALDH1A1,MMP14,CD34,ANG,MME,PROM1,VEGFA
PMID:31803621	(2019) Multiple Targets of the Canonical WNTbeta-Catenin Signaling in Cancers.	9	63	1.22	2.77e-05	9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	CXCL11,HNF4A,CAV1,ELN,CXCL9,CD47,PTGS2,PTEN,VEGFA
PMID:31849690	(2019) PM2.5, Fine Particulate Matter: A Novel Player in the Epithelial-Mesenchymal Transition?	9	63	1.22	2.77e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,HNF4A,PDGFA,PTEN,NOX1,JAK2,RHOA,VEGFA
PMID:31906255	(2019) Melatonin Promotes Uterine and Placental Health: Potential Molecular Mechanisms.	9	63	1.22	2.77e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,TIMP3,PTGS2,TXN,BMP2,NFE2L2,BCL2,BDNF,VEGFA
PMID:28174094	(2017) Recent advances in hepatocellular carcinoma therapy.	10	87	1.12	2.77e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,SREBF1,PTEN,NFE2L2,BCL2,FTO,PROM1,VEGFA
PMID:26457242	(2015) Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol3,3-Diindolylmethane: Anti-Oxidative StressInflammation, Nrf2, EpigeneticsEpigenomics and In Vivo Cancer Chemopreventive Efficacy.	9	63	1.22	2.77e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	IFNG,CDH1,PTGS2,PTEN,TXN,AR,NFE2L2,BCL2,MYD88
PMID:26538820	(2015) Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation.	9	63	1.22	2.77e-05	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2,CCL5,VEGFA
PMID:20737283	(2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.	10	87	1.12	2.77e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,IGF1R,ATM,ANGPT2,PTGS2,AR,JAK2,BCL2,VEGFA
PMID:19150398	(2009) Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.	10	87	1.12	2.77e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000300055,9606.ENSP00000354511,9606.ENSP00000363596,9606.ENSP00000365777,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000369816,9606.ENSP00000384364	TGFB1,CD38,PLIN1,COMT,CNR2,MTHFR,BMP2,KL,SHBG,NPY
PMID:35279217	(2022) Improvement of the anticancer efficacy of PD-1PD-L1 blockade via combination therapy and PD-L1 regulation.	11	115	1.04	2.89e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000378046,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,CD34,CD247,CD47,PTGS2,PTEN,JAK2,FKBP2,CCL5,VEGFA
PMID:35328609	(2022) Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.	8	43	1.33	2.89e-05	9606.ENSP00000216862,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000401399,9606.ENSP00000427424,9606.ENSP00000478570,9606.ENSP00000480291	CYP24A1,HNF4A,PTEN,HSPG2,MYD88,TNFAIP8,VEGFA,HNF1B
PMID:33530455	(2021) The CXCL12 Crossroads in Cancer Stem Cells and Their Niche.	11	115	1.04	2.89e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,KLF10,ALDH1A1,CD34,AR,FGFR1,RHOA,MME,PROM1,VEGFA
PMID:34417511	(2021) The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems.	8	43	1.33	2.89e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CD34,CCL20,CNTF,PTEN,G6PD,PROM1,VEGFA
PMID:34803715	(2021) New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease.	8	43	1.33	2.89e-05	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,NOX4,CXCL10,PTEN,JAK2,RHOA,CCL5,VEGFA
PMID:34884962	(2021) The Important Role of Endothelium and Extracellular Vesicles in the Cellular Mechanism of Aortic Aneurysm Formation.	8	43	1.33	2.89e-05	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CHI3L1,THBS1,TIMP3,FMOD,ELN,PTEN,RHOA,VEGFA
PMID:31924195	(2020) Construction of asthma related competing endogenous RNA network revealed novel long non-coding RNAs and potential new drugs.	8	43	1.33	2.89e-05	9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419313	IGF1R,PRKCE,STAT5A,PTEN,JAK2,BCL2,BDNF,TRPC1
PMID:32796770	(2020) Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System.	8	43	1.33	2.89e-05	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,PDGFB,PDGFA,ELN,PTEN,EDN1,FGFR1,VEGFA
PMID:33050199	(2020) Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-beta Cascade in Alzheimers Disease.	8	43	1.33	2.89e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	MAPK1,IFNG,PRKCE,PTGS2,BCL2,BDNF,MME,VEGFA
PMID:33117148	(2020) Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases.	8	43	1.33	2.89e-05	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MYH9,TGFB1,PTGS2,JAK2,NFE2L2,BCL2,BDNF,VEGFA
PMID:33275451	(2020) Pathological Cardiopulmonary Evaluation of Rats Chronically Exposed to Traffic-Related Air Pollution.	8	43	1.33	2.89e-05	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000474412	ERCC1,TGFB1,IFNG,IGF1R,G6PD,NFE2L2,RHOA,CCL5
PMID:30761081	(2019) A Perception on Genome-Wide Genetic Analysis of Metabolic Traits in Arab Populations.	8	43	1.33	2.89e-05	9606.ENSP00000200676,9606.ENSP00000226760,9606.ENSP00000261037,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000418823	CETP,WFS1,COL8A1,JAZF1,HNF4A,KCNJ11,SREBF1,FTO
PMID:31571869	(2019) Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications.	8	43	1.33	2.89e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,THBS1,CDH1,CD34,BCL2,RHOA,PROM1,VEGFA
PMID:31807240	(2019) Molecular targets of pomegranate (Punica granatum) in preventing cancer metastasis.	8	43	1.33	2.89e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,PTGS2,PTEN,BCL2,RHOA,CCL5,VEGFA
PMID:29495398	(2018) Melatonin and Cancer Hallmarks.	8	43	1.33	2.89e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTGS2,PTEN,EDN1,BCL2,VEGFA
PMID:28446248	(2017) The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids.	8	43	1.33	2.89e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,CD34,ANGPT2,ANG,PTGS2,BCL2,RHOA,VEGFA
PMID:28569176	(2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis.	8	43	1.33	2.89e-05	9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	ENPP2,ATM,SIRT6,CCL20,G6PD,BCL2,MYD88,VEGFA
PMID:27323403	(2016) FH535, a beta-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.	8	43	1.33	2.89e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,HNF4A,ANGPT2,ANG,PDGFA,PROM1,VEGFA
PMID:25577280	(2015) Molecular mechanisms of CD8(+) T cell trafficking and localization.	8	43	1.33	2.89e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000403495	CD69,CDH1,CCR5,CXCL10,CXCL11,CD34,CXCL9,LTA
PMID:25649306	(2015) Role of angiogenesis in endodontics: contributions of stem cells and proangiogenic and antiangiogenic factors to dental pulp regeneration.	8	43	1.33	2.89e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000478570	IFNG,THBS1,CD34,ANGPT2,PDGFB,PTGS2,NPY,VEGFA
PMID:26537449	(2015) Novel genes associated with lymph node metastasis in triple negative breast cancer.	8	43	1.33	2.89e-05	9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000363822	TGFB1,LAMC1,CXCL10,CXCL11,CD34,CXCL9,CNTF,AR
PMID:26617531	(2015) Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts.	8	43	1.33	2.89e-05	9606.ENSP00000232219,9606.ENSP00000298352,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478319,9606.ENSP00000478570	RBP1,NGB,ELN,PTEN,EDN1,BDNF,GREM1,VEGFA
PMID:25606051	(2014) Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis.	8	43	1.33	2.89e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000358513,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IFNG,ELN,CNR1,EDN1,RHOA,AGTR1,VEGFA
PMID:22187483	(2012) Regulation of immune responses by prostaglandin E2.	8	43	1.33	2.89e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,PTGS2,PTEN,CCL5,VEGFA
PMID:23737167	(2011) Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.	8	43	1.33	2.89e-05	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,EDNRA,CAV1,ELN,VIP,EDN1,CCL5,VEGFA
PMID:22293025	(2010) Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb.	8	43	1.33	2.89e-05	9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	NOX4,DDAH1,EDNRA,CAV1,NOX1,EDN1,FGFR1,VEGFA
PMID:20012172	(2009) Urothelial carcinoma: stem cells on the edge.	8	43	1.33	2.89e-05	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412	CD38,FABP4,ALDH1A1,CD34,CD47,PTEN,PROM1,CCL5
PMID:12953097	(2003) The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)CXCL12.	8	43	1.33	2.89e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5
PMID:25949827	(2015) Emerging risk biomarkers in cardiovascular diseases and disorders.	12	146	0.98	2.98e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000256104,9606.ENSP00000283928,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000384906,9606.ENSP00000474412	CETP,MPO,IFNG,HSPB1,FABP4,JAZF1,CCR5,CXCL10,SREBF1,PTEN,SAA1,CCL5
PMID:33671547	(2021) Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.	10	88	1.12	2.99e-05	9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CCR5,CXCL10,STAT5A,SREBF1,RBP4,ANGPTL2,JAK2,CCL5,VEGFA
PMID:34140953	(2021) Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms.	10	88	1.12	2.99e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	ATM,CXCL10,CD34,STAT5A,CXCL9,JAK2,BCL2,IRAK4,MYD88,VEGFA
PMID:34262910	(2021) Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases.	10	88	1.12	2.99e-05	9606.ENSP00000221930,9606.ENSP00000322898,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422	TGFB1,EBF1,COMT,PTGS2,PTEN,EDN1,KL,NFE2L2,BCL2,AGTR1
PMID:34764668	(2021) Neuroinflammation and Modulation Role of Natural Products After Spinal Cord Injury.	10	88	1.12	2.99e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CCR5,CXCL10,CAV1,CCL20,CXCL9,PTGS2,GAP43,MYD88,CCL5
PMID:35008878	(2021) Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration.	10	88	1.12	2.99e-05	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD34,PDGFA,CNTF,GAP43,BCL2,MYD88,BDNF,MME,CCL5,VEGFA
PMID:32848613	(2020) Glia Crosstalk in Neuroinflammatory Diseases.	10	88	1.12	2.99e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CD47,CNTF,PTGS2,NTF3,MYD88,BDNF,CCL5
PMID:31504268	(2019) Non-coding RNA in endothelial-to-mesenchymal transition.	10	88	1.12	2.99e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,IFNG,CDH1,CXCL11,MAPK7,PTGS2,BMP2,FGFR1,RHOA,VEGFA
PMID:28824543	(2017) Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?	10	88	1.12	2.99e-05	9606.ENSP00000229135,9606.ENSP00000278840,9606.ENSP00000341208,9606.ENSP00000356213,9606.ENSP00000363641,9606.ENSP00000383364,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418823	IFNG,FADS2,STAT5A,VIP,TXN,PLA2G2A,NPY,MYD88,BDNF,FTO
PMID:23415095	(2013) GPCRs in stem cell function.	10	88	1.12	2.99e-05	9606.ENSP00000226279,9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000475344	CD38,P2RY1,CD34,CNTF,PTEN,EDN1,NPY,RHOA,PROM1,APLNR
PMID:21129153	(2011) Bone regeneration and stem cells.	10	88	1.12	2.99e-05	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	MPO,SOX9,IGF1R,CD34,PDGFB,PDGFA,BAMBI,EDN1,FGFR1,VEGFA
PMID:35106954	(2022) The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.	9	64	1.21	3.02e-05	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,CCR5,CXCL10,CD34,ANGPT2,PTGS2,MME,AGTR1,VEGFA
PMID:35163030	(2022) Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.	9	64	1.21	3.02e-05	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,HSPB1,CDH1,TIMP3,PDGFB,MAP3K5,PTGS2,BCL2,VEGFA
PMID:35203301	(2022) Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements.	9	64	1.21	3.02e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000385834,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,RBP4,PTEN,JAK2,BCL2,TF,VEGFA
PMID:32919977	(2021) Immunopathology of Hyperinflammation in COVID-19.	9	64	1.21	3.02e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,MPO,FABP4,CXCL10,CXCL11,CXCL9,IRAK4,MYD88,VEGFA
PMID:32974851	(2021) Differentiation of Cells Isolated from Afterbirth Tissues into Hepatocyte-Like Cells and Their Potential Clinical Application in Liver Regeneration.	9	64	1.21	3.02e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,SOX9,CDH1,ONECUT1,CD34,HNF4A,CD47,PROM1,VEGFA
PMID:33925129	(2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.	9	64	1.21	3.02e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,PTGS2,PTEN,BCL2,FGFR1,PROM1,VEGFA
PMID:34208113	(2021) Classification of Non-Small Cell Lung Cancers Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade.	9	64	1.21	3.02e-05	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	TGFB1,ATM,CXCL10,CXCL11,STAT5A,CXCL9,PTEN,NFE2L2,VEGFA
PMID:34691061	(2021) Neuroinflammatory Triangle Presenting Novel Pharmacological Targets for Ischemic Brain Injury.	9	64	1.21	3.02e-05	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,PDGFB,CXCL9,EDN1,JAK2,BCL2,MYD88,BDNF,VEGFA
PMID:30816576	(2020) Endothelial cell-cardiomyocyte crosstalk in heart development and disease.	9	64	1.21	3.02e-05	9606.ENSP00000309757,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000362524,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000475344,9606.ENSP00000478570	LPL,EDNRA,PDGFB,ANGPTL2,TXN,BMP2,EDN1,APLNR,VEGFA
PMID:32015330	(2020) Erythropoietin and its derivatives: from tissue protection to immune regulation.	9	64	1.21	3.02e-05	9606.ENSP00000222139,9606.ENSP00000228434,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	EPOR,CD69,GAS6,STAT5A,SGK1,PTEN,JAK2,MYD88,VEGFA
PMID:32061923	(2020) Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.	9	64	1.21	3.02e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000384364,9606.ENSP00000426809,9606.ENSP00000474412	CXCL10,CXCL11,CD34,CAV1,CXCL9,ENTPD1,NPY,PROM1,CCL5
PMID:32253815	(2020) Chemokines and chemokine receptors: A new strategy for breast cancer therapy.	9	64	1.21	3.02e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL9,PTGS2,ENTPD1,BCL2,CCL5,VEGFA
PMID:33256844	(2020) Epigenetic regulation of inflammation in periodontitis: cellular mechanisms and therapeutic potential.	9	64	1.21	3.02e-05	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000479617	CXCL10,MMP14,STAT5A,CCL20,PTGS2,BMP2,MYD88,CCL5,UHRF1
PMID:33488736	(2020) Adipose-Derived Stem Cells: Current Applications and Future Directions in the Regeneration of Multiple Tissues.	9	64	1.21	3.02e-05	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	MPO,SOX9,CD34,BMP2,BCL2,BDNF,PROM1,VEGFA,HNF1B
PMID:31374938	(2019) Neuroprotective Peptides in Retinal Disease.	9	64	1.21	3.02e-05	9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	IGF1R,SIRT6,VIP,NPY,NTF3,BDNF,AGTR1,APLNR,VEGFA
PMID:31717786	(2019) The Yin-Yang Regulation of Reactive Oxygen Species and MicroRNAs in Cancer.	9	64	1.21	3.02e-05	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	HSPB1,NOX4,ATM,PRDX2,STAT5A,PTEN,TXN,NFE2L2,VEGFA
PMID:29205942	(2018) Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.	9	64	1.21	3.02e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ELN,AR,BCL2,FGFR1,RHOA,PROM1,VEGFA
PMID:29736174	(2018) Diabetic Ephrin-B2-Stimulated Peripheral Blood Mononuclear Cells Enhance Poststroke Recovery in Mice.	9	64	1.21	3.02e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CD34,PDGFB,CCL20,CXCL9,PTGS2,FGFR1,BDNF,VEGFA
PMID:30119678	(2018) Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.	9	64	1.21	3.02e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,CDH1,ANGPT2,GAS6,PTGS2,AR,BCL2,RHOA,VEGFA
PMID:28927416	(2017) Tumor-related interleukins: old validated targets for new anti-cancer drug development.	9	64	1.21	3.02e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CDH1,STAT5A,AR,JAK2,BCL2,MYD88,PROM1,VEGFA
PMID:23064233	(2013) Tumor stroma as targets for cancer therapy.	9	64	1.21	3.02e-05	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CD34,PDGFB,ELN,PTGS2,PTEN,PDGFD,BCL2,VEGFA
PMID:22897573	(2012) Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?	9	64	1.21	3.02e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303	CXCL10,CD34,CCL20,CXCL9,BCL2,IRAK4,RHOA,MYD88,BDNF
PMID:23029541	(2012) Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.	9	64	1.21	3.02e-05	9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000474412	IGF1R,CXCL11,CD34,PDGFB,CXCL9,BCL2,LTA,MME,CCL5
PMID:20644627	(2010) Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes.	13	180	0.92	3.03e-05	9606.ENSP00000226760,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000363641,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,SOX9,IGF1R,JAZF1,HNF4A,KCNJ11,PTEN,MAFB,TXN,BAMBI,BCL2,FTO,HNF1B
PMID:33670551	(2021) Pathogenetic Features and Current Management of Glioblastoma.	11	116	1.04	3.06e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,CD34,ANGPT2,PDGFA,CD47,ENTPD1,PTEN,FGFR1,PROM1,VEGFA
PMID:34220337	(2021) Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer.	11	116	1.04	3.06e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ANG,CCL20,PTGS2,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:34631691	(2021) FOXO4 Inhibits the Migration and Metastasis of Colorectal Cancer by Regulating the APC2beta-Catenin Axis.	6	14	1.69	3.06e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000426809	APC,CDH1,ALDH1A1,ABCG1,BCL2,PROM1
PMID:34869574	(2021) miRNAs Related to Different Processes of Fracture Healing: An Integrative Overview.	11	116	1.04	3.06e-05	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418823,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,MMP14,SIRT6,STAT5A,PTEN,BMP2,BCL2,RHOA,FTO,VEGFA,HNF1B
PMID:32466488	(2020) Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.	11	116	1.04	3.06e-05	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CDH1,ALDH1A1,CD34,HNF4A,CD47,PTEN,BCL2,PROM1,VEGFA
PMID:28435293	(2017) Expression and significance of GRHL2 in esophageal cancer.	6	14	1.69	3.06e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,PTGS2,PTEN,PROM1,VEGFA
PMID:25626988	(2015) Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.	6	14	1.69	3.06e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000368683	IFNG,NOX4,ELN,CNR1,NOX1,EDN1
PMID:25870196	(2015) 6beta-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.	6	14	1.69	3.06e-05	9606.ENSP00000354511,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422	COMT,AR,EDN1,JAK2,RHOA,AGTR1
PMID:26083468	(2015) T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN.	6	14	1.69	3.06e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000474412	CD38,CD69,IFNG,CCR5,CXCL10,CCL5
PMID:26197361	(2015) Progress in corneal wound healing.	11	116	1.04	3.06e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,STAT5A,ELN,CNTF,HSPG2,BMP2,RHOA,BDNF,PROM1,VEGFA
PMID:26586955	(2015) From bench to bedside: use of human adipose-derived stem cells.	6	14	1.69	3.06e-05	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,CD34,BMP2,NTF3,BDNF,VEGFA
PMID:26634157	(2015) The Morphofunctional Effect of the Transplantation of Bone Marrow Stromal Cells and Predegenerated Peripheral Nerve in Chronic Paraplegic Rat Model via Spinal Cord Transection.	6	14	1.69	3.06e-05	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,GAP43,NTF3,BDNF,VEGFA
PMID:22787113	(2012) Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.	6	14	1.69	3.06e-05	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,EDNRA,CAV1,NOX1,EDN1,VEGFA
PMID:22195251	(2011) Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV.	6	14	1.69	3.06e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:16454813	(2006) Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus.	6	14	1.69	3.06e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:34629100	(2021) Advances in the study of emodin: an update on pharmacological properties and mechanistic basis.	12	147	0.97	3.11e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IFNG,PLIN1,CXCL10,SREBF1,PTEN,AR,BMP2,MYD88,CCL5,VEGFA
PMID:33623012	(2021) Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation.	10	89	1.11	3.17e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	CD69,CXCL10,CD34,ANG,CCL20,CXCL9,JAK2,LTA,BDNF,CCL5
PMID:33628367	(2021) Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance.	7	27	1.47	3.17e-05	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,PTGS2,PTEN,TXN,G6PD,NFE2L2,BCL2
PMID:33666848	(2021) A comprehensive review on the carcinogenic potential of bisphenol A: clues and evidence.	10	89	1.11	3.17e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000363822,9606.ENSP00000475344,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,PTGS2,SGK1,PTEN,ANGPTL2,AR,APLNR,VEGFA
PMID:34341666	(2021) Elucidating the Pivotal Neuroimmunomodulation of Stem Cells in Spinal Cord Injury Repair.	7	27	1.47	3.17e-05	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CNTF,GAP43,BCL2,BDNF,PROM1,VEGFA
PMID:34359722	(2021) A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer.	7	27	1.47	3.17e-05	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,ALDH1A1,CD34,PTEN,MYD88,PROM1,VEGFA
PMID:34513695	(2021) Translational Potential of RNA Derived From Extracellular Vesicles in Multiple Myeloma.	7	27	1.47	3.17e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,CXCL10,ALPL,BCL2,CCL5,VEGFA,HNF1B
PMID:34824210	(2021) The JAKSTAT signaling pathway: from bench to clinic.	13	181	0.92	3.17e-05	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495	EPOR,IFNG,CXCL10,SIRT6,STAT5A,CNTF,PTGS2,RBP4,ANGPTL2,BMP2,JAK2,BCL2,LTA
PMID:34977025	(2021) Cross-Tissue Characterization of Heterogeneities of Mesenchymal Stem Cells and Their Differentiation Potentials.	10	89	1.11	3.17e-05	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000261037,9606.ENSP00000300055,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000363641,9606.ENSP00000363973,9606.ENSP00000384906	TGFB1,FABP4,COL8A1,PLIN1,MMP14,STAT5A,CCL20,TXN,ALPL,SAA1
PMID:31732494	(2020) Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.	7	27	1.47	3.17e-05	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000478570	CD38,THBS1,CXCL10,CD34,PTGS2,ENTPD1,VEGFA
PMID:32106613	(2020) Potential Applications of NRF2 Modulators in Cancer Therapy.	10	89	1.11	3.17e-05	9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000336762,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478253,9606.ENSP00000478570	CDH1,FADS2,ANG,TXN,G6PD,NFE2L2,BCL2,RHOA,MTHFD1L,VEGFA
PMID:32848611	(2020) Overview of General and Discriminating Markers of Differential Microglia Phenotypes.	10	89	1.11	3.17e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000362410,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	CCR5,CXCL10,GAS6,CCL20,CXCL9,CD47,MAFB,BDNF,MME,CCL5
PMID:33177789	(2020) Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.	7	27	1.47	3.17e-05	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422	EDNRA,CAV1,EDN1,NPY,RHOA,MME,AGTR1
PMID:31284593	(2019) Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative StemProgenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction.	7	27	1.47	3.17e-05	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFA,EDN1,BCL2,BDNF,PROM1,VEGFA
PMID:31406951	(2019) Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.	7	27	1.47	3.17e-05	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478319,9606.ENSP00000478570	NOX4,CAV1,NOX1,TXN,NFE2L2,GREM1,VEGFA
PMID:31728204	(2019) From expression footprints to causal pathways: contextualizing large signaling networks with CARNIVAL.	7	27	1.47	3.17e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,IFNG,ATM,PDGFB,NTF3,RHOA,BDNF
PMID:29097590	(2018) Molecular and cellular underpinnings of normal and abnormal human placental blood flows.	7	27	1.47	3.17e-05	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,ANGPT2,CAV1,PTGS2,EDN1,FGFR1,VEGFA
PMID:30572591	(2018) Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis.	7	27	1.47	3.17e-05	9606.ENSP00000248553,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000384906,9606.ENSP00000478570	HSPB1,ELN,TXN,MTHFR,NFE2L2,SAA1,VEGFA
PMID:28538706	(2017) The Importance of Pericytes in Healing: Wounds and other Pathologies.	7	27	1.47	3.17e-05	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,CD34,ELN,RHOA,VEGFA
PMID:27014073	(2016) Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?	7	27	1.47	3.17e-05	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,CAV1,ELN,NOX1,EDN1,RHOA,AGTR1
PMID:27117494	(2016) Chronic cerebrovascular dysfunction after traumatic brain injury.	7	27	1.47	3.17e-05	9606.ENSP00000232219,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000478570	RBP1,CAV1,ELN,VIP,HSPG2,EDN1,VEGFA
PMID:24349118	(2013) Systems biology analysis of Brucella infected Peyers patch reveals rapid invasion with modest transient perturbations of the host transcriptome.	10	89	1.11	3.17e-05	9606.ENSP00000216181,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	MYH9,CXCL10,CXCL11,CXCL9,CD47,PTEN,BCL2,RHOA,MYD88,CCL5
PMID:21736953	(2012) Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.	7	27	1.47	3.17e-05	9606.ENSP00000200676,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000400175	CETP,IGF1R,LPL,LPA,ABCG1,JAK2,RHOA
PMID:21992606	(2011) Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.	7	27	1.47	3.17e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CCR5,CXCL10,STAT5A,CCL20,CXCL9,BCL2
PMID:22044691	(2011) Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.	7	27	1.47	3.17e-05	9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	CDH1,ANG,CAV1,PTEN,BCL2,FGFR1,MME
PMID:33358567	(2021) Biological functions of MAIT cells in tissues.	8	44	1.32	3.19e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000403495	TGFB1,CD38,CD69,CCR5,CXCL10,PDGFB,CCL20,LTA
PMID:33430254	(2021) Estrogen Receptors: Therapeutic Perspectives for the Treatment of Cardiac Dysfunction after Myocardial Infarction.	8	44	1.32	3.19e-05	9606.ENSP00000225275,9606.ENSP00000321334,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	MPO,LPA,GAS6,PTGS2,BCL2,RHOA,TRPC1,VEGFA
PMID:33923136	(2021) Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases.	8	44	1.32	3.19e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,IFNG,MAP3K5,PTGS2,NFE2L2,MYD88,CCL5,VEGFA
PMID:33925013	(2021) Molecular Targets of Manganese-Induced Neurotoxicity: A Five-Year Update.	11	117	1.03	3.19e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	IGF1R,ATM,CXCL10,MAPK7,SIRT6,MAP3K5,SGK1,JAK2,BCL2,BDNF,CCL5
PMID:34054797	(2021) Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.	8	44	1.32	3.19e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,LPL,CCL20,CXCL9,CCL5
PMID:34691077	(2021) Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis.	8	44	1.32	3.19e-05	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000363641,9606.ENSP00000401399,9606.ENSP00000474412	SOX9,IGF1R,CCR5,CXCL10,CD47,TXN,MYD88,CCL5
PMID:34703224	(2021) Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature.	8	44	1.32	3.19e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CDH1,CXCL10,PTGS2,NFE2L2,BDNF,CCL5,VEGFA
PMID:34977870	(2021) Tumor metastasis: Mechanistic insights and therapeutic interventions.	11	117	1.03	3.19e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,CCR5,CXCL10,CXCL11,CCL20,ELN,CXCL9,RHOA,CCL5,VEGFA
PMID:31492897	(2020) Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.	8	44	1.32	3.19e-05	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	CD38,SOX9,FABP4,CDH1,LPL,CD34,BCL2,MME
PMID:32104005	(2020) Dental Pulp Stem Cells: Advances to Applications.	8	44	1.32	3.19e-05	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	CD34,PDGFB,PDGFA,PDGFD,NFE2L2,FGFR1,BDNF,VEGFA
PMID:32382012	(2020) The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors.	8	44	1.32	3.19e-05	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,HNF4A,ANGPT2,PDGFB,NFE2L2,PROM1,VEGFA
PMID:32575899	(2020) Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.	8	44	1.32	3.19e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD47,ENTPD1,PTEN,JAK2,CCL5,VEGFA
PMID:32659999	(2020) The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective.	8	44	1.32	3.19e-05	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,PTEN,CAP1,JAK2,IRAK4,MYD88,CCL5,VEGFA
PMID:33193091	(2020) Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms.	8	44	1.32	3.19e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,STAT5A,CCL20,CXCL9,CCL5,VEGFA
PMID:33274002	(2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention.	8	44	1.32	3.19e-05	9606.ENSP00000222572,9606.ENSP00000226279,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	PON2,CD38,ANG,SIRT6,NOX1,TXN,G6PD,NFE2L2
PMID:33282862	(2020) Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.	11	117	1.03	3.19e-05	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	TGFB1,NOX4,TIMP3,LPL,SIRT6,ABCG1,NOX1,EDN1,BCL2,LTA,VEGFA
PMID:33371368	(2020) Adipocyte-Derived Leptin Promotes PAI-1 -Mediated Breast Cancer Metastasis in a STAT3miR-34a Dependent Manner.	8	44	1.32	3.19e-05	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000478570	ENPP2,CDH1,IGF1R,STAT5A,PDGFA,SREBF1,JAK2,VEGFA
PMID:35117940	(2020) MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers.	11	117	1.03	3.19e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,MAPK7,ANGPT2,CCL20,PTEN,BCL2,RHOA,BDNF,VEGFA
PMID:30509603	(2019) Redox regulation of cell state and fate.	8	44	1.32	3.19e-05	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	NOX4,ATM,SIRT6,PTEN,TXN,BCL2,PROM1,VEGFA
PMID:30520375	(2019) Neuroprotective Role of Hypothermia in Hypoxic-ischemic Brain Injury: Combined Therapies using Estrogen.	8	44	1.32	3.19e-05	9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000298352,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,VDAC1,IGF1R,NGB,GAP43,BCL2,BDNF,VEGFA
PMID:30937279	(2019) Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management.	8	44	1.32	3.19e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000331831,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,CCR5,CXCL10,EDNRA,GAS6,AR,EDN1,VEGFA
PMID:31223285	(2019) Recent Advances in Studies of Molecular Hydrogen against Sepsis.	8	44	1.32	3.19e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	MPO,CDH1,MAP3K5,EDN1,KL,NFE2L2,BCL2,RHOA
PMID:31753020	(2019) Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer.	8	44	1.32	3.19e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	MAPK1,THBS1,CDH1,MMP14,GAS6,AR,EDN1,VEGFA
PMID:31888042	(2019) Kinetics of Tear Fluid Proteins after Endothelial Keratoplasty and Predictive Factors for Recovery from Corneal Haze.	8	44	1.32	3.19e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:29962348	(2018) Reactive Oxygen Species as Intracellular Signaling Molecules in the Cardiovascular System.	8	44	1.32	3.19e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000478570	MPO,NOX4,STAT5A,PTEN,NOX1,TXN,JAK2,VEGFA
PMID:30283435	(2018) A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis.	8	44	1.32	3.19e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,EDNRA,CAV1,NOX1,EDN1,RHOA,VEGFA
PMID:26880765	(2016) T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function.	8	44	1.32	3.19e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CXCL9,ENTPD1,BCL2,CCL5
PMID:26941482	(2016) Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer.	8	44	1.32	3.19e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CD47,EDN1,NFE2L2,RHOA,VEGFA
PMID:25621126	(2015) Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes.	8	44	1.32	3.19e-05	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000352264,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ANGPT2,PDGFB,CD2AP,HSPG2,EDN1,RHOA,VEGFA
PMID:26664429	(2015) Resveratrol and liver: A systematic review.	8	44	1.32	3.19e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000377192,9606.ENSP00000380252	TGFB1,IFNG,PLIN1,SIRT6,SREBF1,RBP4,G6PD,NFE2L2
PMID:25197663	(2014) New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients.	8	44	1.32	3.19e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,ATM,MMP14,CD34,ANGPT2,PROM1,VEGFA
PMID:25287686	(2014) The intricate role of CXCR4 in cancer.	8	44	1.32	3.19e-05	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,MMP14,CD34,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:22232476	(2012) Dry eye disease: an immune-mediated ocular surface disorder.	8	44	1.32	3.19e-05	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CCR5,CXCL10,CXCL11,CXCL9,PTGS2,CCL5,VEGFA
PMID:21215757	(2011) Regulation of myocardial growth and death by NADPH oxidase.	8	44	1.32	3.19e-05	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,SIRT6,MAP3K5,NOX1,EDN1,G6PD,BDNF,VEGFA
PMID:21682898	(2011) Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes.	8	44	1.32	3.19e-05	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,CCL20,CXCL9,PTGS2,BDNF,CCL5,VEGFA
PMID:21861939	(2011) Myofibroblast differentiation and survival in fibrotic disease.	11	117	1.03	3.19e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175	TGFB1,THBS1,NOX4,CXCL10,CD34,PDGFB,CAV1,PTEN,EDN1,BCL2,RHOA
PMID:20037743	(2010) Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.	8	44	1.32	3.19e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,IGF1R,EDNRA,PTGS2,PTEN,EDN1,JAK2,VEGFA
PMID:35027818	(2022) Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.	9	65	1.2	3.22e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IFNG,THBS1,ELN,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:34251989	(2021) The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.	9	65	1.2	3.22e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IFNG,CDH1,CXCL10,CCL20,LTA,CCL5,VEGFA
PMID:34676046	(2021) Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumab.	9	65	1.2	3.22e-05	9606.ENSP00000255409,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,AMBP,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5,VEGFA
PMID:34867402	(2021) Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.	12	148	0.97	3.22e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,MAP3K5,PTGS2,PTEN,JAK2,NFE2L2,BCL2,RHOA,MYD88,VEGFA
PMID:34917512	(2021) Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review.	9	65	1.2	3.22e-05	9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CCR5,BAMBI,BCL2,RHOA,BDNF,PROM1,CCL5,VEGFA
PMID:31999538	(2020) The Role of the Epicardium During Heart Development and Repair.	9	65	1.2	3.22e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,SOX9,CDH1,IGF1R,ALDH1A1,PDGFA,BMP2,FGFR1,VEGFA
PMID:32205839	(2020) Plasminogen is a master regulator and a potential drug candidate for the healing of radiation wounds.	9	65	1.2	3.22e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,IFNG,THBS1,MMP14,PDGFA,CXCL9,PTGS2,RHOA,VEGFA
PMID:32207341	(2020) Mesenchymal Stem Cell-Derived Extracellular Vesicles in Tissue Regeneration.	9	65	1.2	3.22e-05	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000478570	SOX9,CXCL10,CD34,ANG,CAV1,ELN,PTEN,PDGFD,VEGFA
PMID:32521759	(2020) Flavonoids in Cancer Metastasis.	9	65	1.2	3.22e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000445772	CDH1,TIMP3,IGF1R,MMP14,PTEN,JAK2,RHOA,PROM1,LTB4R2
PMID:30931303	(2019) Low Density Receptor-Related Protein 1 Interactions With the Extracellular Matrix: More Than Meets the Eye.	9	65	1.2	3.22e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000356515,9606.ENSP00000384262,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,TIMP3,MMP14,PDGFB,UTRN,HPSE,RHOA,BDNF,VEGFA
PMID:31101122	(2019) Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications.	9	65	1.2	3.22e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,PTEN,AR,MME,CCL5,VEGFA
PMID:32038644	(2019) Extracellular Vesicles in Glioblastoma Tumor Microenvironment.	9	65	1.2	3.22e-05	9606.ENSP00000260356,9606.ENSP00000265333,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,VDAC1,MMP14,ANG,CAV1,PTEN,BCL2,BDNF,VEGFA
PMID:30200262	(2018) Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance.	9	65	1.2	3.22e-05	9606.ENSP00000226279,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809	CD38,APC,CDH1,ATM,ALDH1A1,CD34,HNF4A,PTEN,PROM1
PMID:30298008	(2018) Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases.	9	65	1.2	3.22e-05	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,TIMP3,IGF1R,SGK1,EDN1,JAK2,BCL2,RHOA,VEGFA
PMID:28553634	(2017) Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System.	9	65	1.2	3.22e-05	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000363827,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,ANGPT2,SIRT6,CNTF,HSPG2,NTF3,BDNF,PROM1,VEGFA
PMID:27042264	(2016) Genetics of cardiovascular and renal complications in diabetes.	9	65	1.2	3.22e-05	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000317674,9606.ENSP00000325548,9606.ENSP00000339916,9606.ENSP00000368683,9606.ENSP00000402152,9606.ENSP00000478319,9606.ENSP00000478570	PON2,NOX4,APOL1,CNDP2,LIMK2,EDN1,SLC12A3,GREM1,VEGFA
PMID:25529933	(2015) Regulation of tissue morphogenesis by endothelial cell-derived signals.	9	65	1.2	3.22e-05	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,MMP14,HNF4A,ANGPT2,PDGFB,BMP2,FGFR1,BDNF,VEGFA
PMID:25867824	(2015) HeparinHeparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.	9	65	1.2	3.22e-05	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000478319,9606.ENSP00000478570	CHI3L1,CXCL10,LPL,PDGFB,ANG,HSPG2,FGFR1,GREM1,VEGFA
PMID:26634153	(2015) Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics.	9	65	1.2	3.22e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000354995,9606.ENSP00000357726,9606.ENSP00000383364,9606.ENSP00000384906	CETP,MPO,HSPB1,LPL,APOL1,ABCG1,S100A12,PLA2G2A,SAA1
PMID:24744610	(2014) Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application.	9	65	1.2	3.22e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL11,CD34,CXCL9,PTGS2,CCL5,VEGFA
PMID:22931291	(2012) Roles of microRNAs in atherosclerosis and restenosis.	9	65	1.2	3.22e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000478570	MPO,THBS1,CD34,ELN,PTEN,EDN1,BCL2,PLA2G2A,VEGFA
PMID:20017699	(2010) Stem cell paracrine actions and tissue regeneration.	9	65	1.2	3.22e-05	9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	ANG,PTGS2,HSPG2,BMP2,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:35406619	(2022) MMP9: A Tough Target for Targeted Therapy for Cancer.	10	90	1.11	3.38e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,IGF1R,CXCL10,CXCL11,STAT5A,ELN,CXCL9,BCL2,MYD88,VEGFA
PMID:34667157	(2021) Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy.	10	90	1.11	3.38e-05	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD69,CCR5,CXCL10,CXCL11,ANGPT2,CXCL9,JAK2,CCL5,VEGFA
PMID:31979420	(2020) Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways.	10	90	1.11	3.38e-05	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,PRDX2,CAV1,PDGFA,EDN1,NFE2L2,BCL2,RHOA,CCL5,VEGFA
PMID:29418079	(2018) Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.	10	90	1.11	3.38e-05	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CD38,CD34,HNF4A,STAT5A,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:30338879	(2018) Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia.	10	90	1.11	3.38e-05	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000321853,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,MMP14,EDNRA,SERPINF2,COMT,PTGS2,NOX1,RHOA,AGTR1,VEGFA
PMID:29270905	(2017) The Oxygen Paradox, the French Paradox, and age-related diseases.	10	90	1.11	3.38e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MPO,NOX4,ATM,ELN,PTEN,HSPG2,NFE2L2,MYD88,BDNF,VEGFA
PMID:22076326	(2011) Rosacea: The cytokine and chemokine network.	10	90	1.11	3.38e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CNTF,MYD88,LTA,CCL5,VEGFA
PMID:19647099	(2009) Systems-based candidate genes for human response to influenza infection.	10	90	1.11	3.38e-05	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,CD69,IFNG,VDAC1,CCR5,CXCL10,BCL2,SAA1,MYD88,CCL5
PMID:34073059	(2021) Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin.	12	149	0.97	3.40e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,CDH1,ATM,CXCL11,HNF4A,SREBF1,PTGS2,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:35087844	(2021) An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease.	11	118	1.03	3.40e-05	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000419422,9606.ENSP00000477707	TGFB1,IGF1R,CXCL10,PRKCE,HNF4A,SIRT6,CAV1,PDGFA,SREBF1,AGTR1,NR1H3
PMID:31354915	(2019) Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation.	11	118	1.03	3.40e-05	9606.ENSP00000222572,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000285407,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	PON2,IFNG,NOX4,KLF10,ABCG1,NOX1,TXN,EDN1,RHOA,CCL5,VEGFA
PMID:35163998	(2022) Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia.	9	66	1.2	3.57e-05	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CXCL10,CD34,ANGPT2,PTGS2,BMP2,MYD88,VEGFA,HNF1B
PMID:35177953	(2022) Exploring the Relationship of Perivascular Adipose Tissue Inflammation and the Development of Vascular Pathologies.	9	66	1.2	3.57e-05	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000474412	NOX4,CCR5,PLIN1,PTGS2,NOX1,EDN1,RARRES2,AGTR1,CCL5
PMID:35217532	(2022) Specialized interferon action in COVID-19.	9	66	1.2	3.57e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000384906,9606.ENSP00000474412	THBS1,CXCL10,CXCL11,PDGFA,CCL20,JAK2,PDGFD,SAA1,CCL5
PMID:35387194	(2022) Personalized Dietary Recommendations Based on Lipid-Related Genetic Variants: A Systematic Review.	8	45	1.31	3.57e-05	9606.ENSP00000200676,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000418823	CETP,FADS2,LPL,LPA,SREBF1,MTHFR,SHBG,FTO
PMID:33529945	(2021) Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review.	8	45	1.31	3.57e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000361883,9606.ENSP00000474412	CXCL10,CXCL11,PDGFB,STAT5A,PDGFA,CXCL9,CAP1,CCL5
PMID:33921222	(2021) The Influence of Anti-Diabetic Drugs on Prostate Cancer.	8	45	1.31	3.57e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,IGF1R,CXCL10,PTEN,AR,BCL2,VEGFA,HNF1B
PMID:34206632	(2021) Nutrigenomics of Dietary Lipids.	8	45	1.31	3.57e-05	9606.ENSP00000229135,9606.ENSP00000246553,9606.ENSP00000278840,9606.ENSP00000339191,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000477707,9606.ENSP00000478570	IFNG,FFAR1,FADS2,CAV1,NFE2L2,MYD88,NR1H3,VEGFA
PMID:34345204	(2021) The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives.	9	66	1.2	3.57e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000444198	MAPK1,CDH1,MMP14,SGK1,PTEN,JAK2,BCL2,RHOA,CITED2
PMID:34359956	(2021) TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells.	8	45	1.31	3.57e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000418009,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CNTF,RARRES2,CCL5
PMID:34360965	(2021) High-Density Lipoproteins in Kidney Disease.	8	45	1.31	3.57e-05	9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000314897,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000360522,9606.ENSP00000384906	MPO,AMBP,ANGPT2,APOL1,LPA,ABCG1,RBP4,SAA1
PMID:34582846	(2021) Resolvin D1, therapeutic target in acute respiratory distress syndrome.	9	66	1.2	3.57e-05	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,AQP5,ELN,PTGS2,SGK1,NFE2L2,BCL2,MYD88,VEGFA
PMID:35008609	(2021) Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake.	9	66	1.2	3.57e-05	9606.ENSP00000225275,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000477707,9606.ENSP00000478570	MPO,SIRT6,ELN,ABCG1,PTGS2,EDN1,JAK2,NR1H3,VEGFA
PMID:35069988	(2021) Regulating the fate of stem cells for regenerating the intervertebral disc degeneration.	8	45	1.31	3.57e-05	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CCR5,CD34,BMP2,BDNF,PROM1,CCL5,VEGFA
PMID:31969707	(2020) Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo.	9	66	1.2	3.57e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,AMBP,CCR5,CXCL10,CD34,LTA,CCL5,VEGFA
PMID:32317975	(2020) Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety.	9	66	1.2	3.57e-05	9606.ENSP00000215832,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,LPL,SREBF1,PTGS2,PTEN,EDN1,NFE2L2,BCL2,VEGFA
PMID:32422889	(2020) Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions.	9	66	1.2	3.57e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,CXCL10,CXCL11,CXCL9,PTGS2,AR,CCL5,VEGFA
PMID:32668733	(2020) Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response.	9	66	1.2	3.57e-05	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000419422	NOX4,VDAC1,SREBF1,MAP3K5,ABCG1,JAK2,BCL2,TRPC1,AGTR1
PMID:32670064	(2020) Treating Different Diseases With the Same Method-A Traditional Chinese Medicine Concept Analyzed for Its Biological Basis.	8	45	1.31	3.57e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000354511,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303	IFNG,IGF1R,COMT,CNTF,PTEN,BMP2,BCL2,BDNF
PMID:32707850	(2020) Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.	9	66	1.2	3.57e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,MAPK7,CCL20,CXCL9,MYD88,CCL5,VEGFA
PMID:32717779	(2020) Dietary Polyphenols in Cancer Chemoprevention: Implications in Pancreatic Cancer.	9	66	1.2	3.57e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ALDH1A1,SREBF1,TXN,NFE2L2,BCL2,PROM1,VEGFA
PMID:32823989	(2020) Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.	9	66	1.2	3.57e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CD34,ANGPT2,PDGFB,ANG,FGFR1,CCL5,VEGFA
PMID:33408628	(2020) Regulatory Roles of Bone in Neurodegenerative Diseases.	9	66	1.2	3.57e-05	9606.ENSP00000292303,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,KL,BCL2,FGFR1,NTF3,RHOA,BDNF,CCL5,VEGFA
PMID:29478325	(2019) Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.	12	150	0.96	3.57e-05	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,ATM,CD34,HNF4A,STAT5A,PTGS2,PTEN,NOX1,JAK2,BCL2,RHOA,VEGFA
PMID:31357397	(2019) Hepatitis C Virus as a Unique Human Model Disease to Define Differences in the Transcriptional Landscape of T Cells in Acute versus Chronic Infection.	8	45	1.31	3.57e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000285407,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,CD38,IFNG,KLF10,CCR5,STAT5A,MYD88,CCL5
PMID:31379812	(2019) Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1.	9	66	1.2	3.57e-05	9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CCR5,CXCL10,CXCL11,HNF4A,TXN,BCL2,CCL5,VEGFA
PMID:31618926	(2019) Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?	9	66	1.2	3.57e-05	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	SOX9,CCR5,MMP14,CD34,SIRT6,CCL20,JAK2,BCL2,CCL5
PMID:29662554	(2018) Effect of beta-hydroxy-beta-methylbutyrate on miRNA expression in differentiating equine satellite cells exposed to hydrogen peroxide.	9	66	1.2	3.57e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL11,CAV1,CD47,PTEN,JAK2,SAA1,BDNF,CCL5
PMID:29914215	(2018) Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.	8	45	1.31	3.57e-05	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000402152,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000474412	MPO,CAV1,PTEN,RHOA,SLC12A3,BDNF,AGTR1,CCL5
PMID:26527320	(2016) Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.	8	45	1.31	3.57e-05	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	CD38,HSPB1,CDH1,CD34,PTEN,NFE2L2,PROM1,VEGFA
PMID:27872612	(2016) Systems Biomedicine of Rabies Delineates the Affected Signaling Pathways.	9	66	1.2	3.57e-05	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,CXCL10,PDGFA,PTEN,JAK2,BCL2,RHOA,MYD88,CCL5
PMID:25242643	(2015) The neuroimmunology of degeneration and regeneration in the peripheral nervous system.	9	66	1.2	3.57e-05	9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	CD47,CNTF,VIP,PTEN,GAP43,BCL2,NPY,BDNF,VEGFA
PMID:25603797	(2015) MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.	8	45	1.31	3.57e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,ANG,CCL20,PTEN,VEGFA
PMID:26343581	(2015) Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.	8	45	1.31	3.57e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570,9606.ENSP00000484631	CDH1,CXCL10,CXCL9,PTGS2,CCL5,APLNR,VEGFA,PMP22
PMID:24398859	(2014) RANK-mediated signaling network and cancer metastasis.	9	66	1.2	3.57e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,TIMP3,GAS6,CAV1,SREBF1,AR,BCL2,VEGFA
PMID:24402695	(2014) Vitamin D and cancer: the promise not yet fulfilled.	8	45	1.31	3.57e-05	9606.ENSP00000216862,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,APC,CDH1,HNF4A,PTEN,G6PD,BCL2,VEGFA
PMID:25013383	(2014) Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.	9	66	1.2	3.57e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,ANGPT2,PDGFB,SIRT6,TXN,JAK2,BCL2,VEGFA
PMID:25206311	(2014) Developments in renal pharmacogenomics and applications in chronic kidney disease.	8	45	1.31	3.57e-05	9606.ENSP00000216181,9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000317674,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000419422	MYH9,CYP24A1,TGFB1,CCR5,APOL1,MTHFR,NFE2L2,AGTR1
PMID:20015202	(2011) Growth factors in ischemic stroke.	9	66	1.2	3.57e-05	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,CD34,STAT5A,PTGS2,JAK2,BCL2,LTA,BDNF,VEGFA
PMID:21165486	(2011) Gene transcriptional networks integrate microenvironmental signals in human breast cancer.	8	45	1.31	3.57e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000474412	THBS1,CCR5,PDGFB,STAT5A,CXCL9,ANGPTL2,JAK2,CCL5
PMID:21199333	(2011) Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction.	8	45	1.31	3.57e-05	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,TIMP3,CD34,ELN,BMP2,GAP43,BCL2,VEGFA
PMID:21615592	(2011) Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.	9	66	1.2	3.57e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,PDGFB,SREBF1,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:20924352	(2010) Dynamic interaction networks in a hierarchically organized tissue.	8	45	1.31	3.57e-05	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,THBS1,CXCL10,CD34,PDGFB,PROM1,CCL5,VEGFA
PMID:19628035	(2009) Nox proteins in signal transduction.	9	66	1.2	3.57e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,NOX4,STAT5A,MAP3K5,NOX1,TXN,EDN1,JAK2,VEGFA
PMID:20616900	(2009) Targeted therapy in the treatment of malignant gliomas.	8	45	1.31	3.57e-05	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	ANGPT2,PDGFB,PDGFA,CNR1,PTEN,EDN1,PROM1,VEGFA
PMID:35311066	(2022) Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.	11	119	1.03	3.59e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CCL20,CXCL9,PTGS2,BAMBI,BCL2,PROM1,CCL5,VEGFA
PMID:33858433	(2021) Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin.	11	119	1.03	3.59e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000418823,9606.ENSP00000478570	MAPK1,CDH1,VDAC1,ATM,MAPK7,PTGS2,BCL2,MYD88,LTA,FTO,VEGFA
PMID:33925648	(2021) In Silico Exploration of the Potential Role of Acetaminophen and Pesticides in the Etiology of Autism Spectrum Disorder.	11	119	1.03	3.59e-05	9606.ENSP00000216075,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000321853,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000397297,9606.ENSP00000414303	MIOX,IFNG,SOX9,FABP4,IGF1R,SERPINF2,SIRT6,PTEN,MTHFR,NTF3,BDNF
PMID:34451909	(2021) Extracellular Vesicles in Skin Wound Healing.	11	119	1.03	3.59e-05	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	MYH9,SOX9,CD34,CCL20,ELN,PTGS2,PTEN,NOX1,BMP2,BCL2,VEGFA
PMID:32585893	(2020) Molecular Bases of Drug Resistance in Hepatocellular Carcinoma.	11	119	1.03	3.59e-05	9606.ENSP00000013807,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,ENPP2,CDH1,IGF1R,ALDH1A1,ANGPT2,PTEN,BCL2,FGFR1,PROM1,VEGFA
PMID:28135002	(2016) IschemiaReperfusion.	11	119	1.03	3.59e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000306124,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,NOX4,PRKCE,CD47,PTEN,TXN,EDN1,BCL2,CCL5,VEGFA
PMID:18286481	(2008) The 20th Aspen Cancer Conference: Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and Cancer Therapy 2005.	11	119	1.03	3.59e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,CDH1,TIMP3,ATM,HNF4A,PTGS2,PTEN,EDN1,BCL2,VEGFA
PMID:34028626	(2021) Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing.	10	91	1.1	3.60e-05	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	FABP4,CXCL10,MMP14,CD34,GAS6,CAV1,ELN,EDN1,FGFR1,VEGFA
PMID:34568077	(2021) The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment.	10	91	1.1	3.60e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,ALDH1A1,CXCL10,CCL20,CXCL9,RHOA,PROM1,CCL5,VEGFA
PMID:33364239	(2020) Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and InsulinInsulin-Like Growth Factor Signaling.	10	91	1.1	3.60e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,ANGPT2,CAV1,PDGFA,JAK2,BCL2,FGFR1,RHOA,VEGFA
PMID:31492960	(2019) Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.	10	91	1.1	3.60e-05	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000401720,9606.ENSP00000474412	NOX4,CCR5,PRDX2,LPL,SREBF1,ABCG1,PTGS2,G6PD,GK,CCL5
PMID:29361725	(2018) Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.	10	91	1.1	3.60e-05	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,IGF1R,CCR5,CD34,PTGS2,EDN1,FGFR1,MME,CCL5,VEGFA
PMID:29681949	(2018) Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment.	10	91	1.1	3.60e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,IGF1R,ATM,ALDH1A1,CD34,GAS6,PTEN,PROM1,VEGFA
PMID:27413414	(2016) Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.	10	91	1.1	3.60e-05	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,HSPB1,CHI3L1,CXCL10,CXCL11,CXCL9,NPY,BDNF,CCL5,VEGFA
PMID:25892662	(2015) Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.	10	91	1.1	3.60e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,ATM,HNF4A,SREBF1,PTGS2,PTEN,JAK2,BCL2,VEGFA,HNF1B
PMID:24743777	(2014) STAT3 Target Genes Relevant to Human Cancers.	10	91	1.1	3.60e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,STAT5A,PTGS2,PTEN,JAK2,BCL2,SAA1,CCL5,VEGFA
PMID:19519926	(2009) Cartilage homeostasis in health and rheumatic diseases.	10	91	1.1	3.60e-05	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,CHI3L1,THBS1,TIMP3,MMP14,FMOD,PTGS2,HSPG2,BMP2,VEGFA
PMID:16623957	(2006) How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome.	10	91	1.1	3.60e-05	9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000222305,9606.ENSP00000248553,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000400175	CYP24A1,TGFB1,USF2,HSPB1,ALDH1A1,PRDX2,HNF4A,SREBF1,BMP2,RHOA
PMID:35073997	(2022) The role and therapeutic potential of stem cells in skeletal muscle in sarcopenia.	7	28	1.46	3.62e-05	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	FABP4,CD34,CAV1,BCL2,FGFR1,PROM1,VEGFA
PMID:33439746	(2021) LncRNA CCDC26 Interacts with CELF2 Protein to Enhance Myeloid Leukemia Cell Proliferation and Invasion via the circRNA_ANKIB1miR-195-5pPRR11 Axis.	7	28	1.46	3.62e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,TGFB1,CDH1,TIMP3,IGF1R,PTEN,BCL2
PMID:34611417	(2021) Impact of High Serum Levels of MMP-7, MMP-9, TGF-beta and PDGF Macrophage Activation Markers on Severity of COVID-19 in Obese-Diabetic Patients.	7	28	1.46	3.62e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901	CD38,CD69,IFNG,CXCL10,CXCL11,ELN,CXCL9
PMID:32029136	(2020) Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review.	7	28	1.46	3.62e-05	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000363641,9606.ENSP00000368683	CETP,IFNG,CXCL10,CXCL11,LPL,TXN,EDN1
PMID:32204409	(2020) Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses.	7	28	1.46	3.62e-05	9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,ATM,ALDH1A1,PTGS2,PTEN,BCL2,VEGFA
PMID:33244194	(2020) Efficacy and safety of anti-hepatic fibrosis drugs.	7	28	1.46	3.62e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000351908,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000474412	TGFB1,IFNG,CCR5,MAP3K5,JAK2,AGTR1,CCL5
PMID:33291410	(2020) Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.	7	28	1.46	3.62e-05	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	TIMP3,CD34,GAP43,BCL2,LTA,AGTR1,VEGFA
PMID:31198626	(2019) Identification and characterization of mRNAs and lncRNAs in the uterus of polytocous and monotocous Small Tail Han sheep (Ovis aries).	7	28	1.46	3.62e-05	9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000400175	CYP24A1,TGFB1,PTGS2,ALPL,BAMBI,EDN1,RHOA
PMID:31443313	(2019) Hypoxia Rapidly Induces the Expression of Cardiomyogenic Factors in Human Adipose-Derived Adherent Stromal Cells.	7	28	1.46	3.62e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000363973,9606.ENSP00000478570	SOX9,FABP4,CD34,ANG,CAV1,ALPL,VEGFA
PMID:29599981	(2018) Oxidative stress response induced by chemotherapy in leukemia treatment.	7	28	1.46	3.62e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000478570	MAPK1,IFNG,CD34,MAPK7,PTEN,NOX1,VEGFA
PMID:29862995	(2018) An update-tissue engineered nerve grafts for the repair of peripheral nerve injuries.	7	28	1.46	3.62e-05	9606.ENSP00000229135,9606.ENSP00000285407,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,KLF10,CNTF,GAP43,NTF3,BDNF,VEGFA
PMID:27059917	(2016) Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.	7	28	1.46	3.62e-05	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:27379099	(2016) Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis.	7	28	1.46	3.62e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000384906,9606.ENSP00000474412	CCR5,CXCL10,MMP14,CXCL9,ENTPD1,SAA1,CCL5
PMID:26273420	(2015) Increased Oxidative Stress as a Selective Anticancer Therapy.	7	28	1.46	3.62e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,TXN,BCL2,PROM1,VEGFA
PMID:24633084	(2014) Recent advances in the molecular characterization of circulating tumor cells.	7	28	1.46	3.62e-05	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000384262,9606.ENSP00000426809	IGF1R,ALDH1A1,CD47,PTEN,AR,HPSE,PROM1
PMID:25380521	(2014) MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.	7	28	1.46	3.62e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,NOX4,SIRT6,PTEN,NOX1,BCL2,PROM1
PMID:22989616	(2013) Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.	7	28	1.46	3.62e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,VIP,BCL2,VEGFA
PMID:23268184	(2013) p42p44-MAPK and PI3K are sufficient for IL-6 family cytokinesgp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAKSTAT activation.	7	28	1.46	3.62e-05	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000371067	MAPK1,EPOR,MAPK7,STAT5A,CNTF,EDN1,JAK2
PMID:24099797	(2013) Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.	7	28	1.46	3.62e-05	9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,ELN,COMT,EDN1,SHBG,RHOA,VEGFA
PMID:16207316	(2005) Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.	7	28	1.46	3.62e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:32376430	(2021) Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.	6	15	1.66	3.82e-05	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726	MPO,CXCL10,CXCL11,CCL20,CXCL9,S100A12
PMID:33572395	(2021) Epigenetic Alterations in Triple-Negative Breast Cancer-The Critical Role of Extracellular Matrix.	11	120	1.02	3.82e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000384262,9606.ENSP00000478570	SOX9,CDH1,TIMP3,ALDH1A1,MMP14,STAT5A,PTEN,AR,JAK2,HPSE,VEGFA
PMID:33776470	(2021) Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.	11	120	1.02	3.82e-05	9606.ENSP00000225275,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000474412,9606.ENSP00000478570	MPO,KLF10,CD34,ANGPT2,PDGFB,CAV1,ELN,PTGS2,MTHFR,CCL5,VEGFA
PMID:34070901	(2021) Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.	9	67	1.19	3.82e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,THBS1,CDH1,PTEN,HSPG2,BCL2,FGFR1,PROM1,VEGFA
PMID:34566995	(2021) Immune Landscape of CMV Infection in Cancer Patients: From Canonical Diseases Toward Virus-Elicited Oncomodulation.	9	67	1.19	3.82e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	THBS1,CD34,CD47,PTGS2,BCL2,PROM1,CCL5,VEGFA,HNF1B
PMID:34707996	(2021) Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review.	6	15	1.66	3.82e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000393312	MPO,CD38,CD34,STAT5A,JAK2,FGFR1
PMID:34737734	(2021) Neutrophil-Dependent Immunity During Pulmonary Infections and Inflammations.	11	120	1.02	3.82e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000360997,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CDH1,CCR5,CD34,CCL20,S100A12,ADAMTS13,MYD88,CCL5,VEGFA
PMID:34766135	(2021) Lipid metabolism in cancer progression and therapeutic strategies.	11	120	1.02	3.82e-05	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	FABP4,ENPP2,PLIN1,HNF4A,CAV1,STAT5A,SREBF1,ABCG1,PTEN,AR,VEGFA
PMID:34899290	(2021) Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension.	9	67	1.19	3.82e-05	9606.ENSP00000222139,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	EPOR,NOX4,EDNRA,PTGS2,EDN1,BCL2,RHOA,TRPC1,VEGFA
PMID:31884019	(2020) Angiotensin II and aldosterone activate retinal microglia.	6	15	1.66	3.82e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,NOX4,CXCL10,NOX1,CCL5,VEGFA
PMID:32169432	(2020) Gene Polymorphisms Affecting Erectile Dysfunction.	6	15	1.66	3.82e-05	9606.ENSP00000221930,9606.ENSP00000284031,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000478570	TGFB1,DDAH1,HNF4A,AR,MTHFR,VEGFA
PMID:32358509	(2020) PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.	9	67	1.19	3.82e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,PDGFB,PDGFA,CXCL9,PTEN,JAK2,CCL5,VEGFA
PMID:32599818	(2020) Tissue-Engineered Models for Glaucoma Research.	9	67	1.19	3.82e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297	THBS1,TIMP3,MAPK7,CAV1,ELN,MAP3K5,CNTF,BCL2,NTF3
PMID:32842471	(2020) In Vitro Maturation of Retinal Pigment Epithelium Is Essential for Maintaining High Expression of Key Functional Genes.	6	15	1.66	3.82e-05	9606.ENSP00000266085,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	TIMP3,GAS6,PDGFA,CNTF,BDNF,VEGFA
PMID:33262757	(2020) Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment.	11	120	1.02	3.82e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,FMOD,ELN,CD47,HSPG2,BMP2,MYD88,LTA,CCL5,VEGFA
PMID:33364941	(2020) Roles of Hydrogen Sulfide Donors in Common Kidney Diseases.	9	67	1.19	3.82e-05	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,MMP14,CAV1,PTGS2,TXN,NFE2L2,BCL2,MYD88,VEGFA
PMID:33585565	(2020) Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress.	9	67	1.19	3.82e-05	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	NOX4,PRDX2,MAP3K5,PTGS2,TXN,NFE2L2,BCL2,PROM1,VEGFA
PMID:31572390	(2019) Chemokines in Physiological and Pathological Bone Remodeling.	9	67	1.19	3.82e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,BMP2,CCL5,VEGFA
PMID:30526687	(2018) Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.	9	67	1.19	3.82e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CD34,HNF4A,ANG,BCL2,MME,CCL5,VEGFA
PMID:28228756	(2017) Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.	6	15	1.66	3.82e-05	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,EDNRA,NOX1,EDN1,AGTR1,VEGFA
PMID:25266611	(2014) Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.	6	15	1.66	3.82e-05	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000480291	EPOR,STAT5A,JAK2,BDNF,VEGFA,HNF1B
PMID:23326293	(2012) Herbal Compound Songyou Yin Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness.	6	15	1.66	3.82e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,BCL2,PROM1
PMID:21299457	(2011) Chronic myeloid leukemia cells refractoryresistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state.	6	15	1.66	3.82e-05	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000393312	CD38,NOX4,CD34,STAT5A,JAK2,FGFR1
PMID:21884937	(2011) Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling.	6	15	1.66	3.82e-05	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000346508,9606.ENSP00000368104	FABP4,PLIN1,CD34,EBF1,PDGFA,BMP2
PMID:18481258	(2008) iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells.	6	15	1.66	3.82e-05	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067	NOX4,MAP3K5,PTGS2,NOX1,TXN,JAK2
PMID:17015796	(2006) The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.	6	15	1.66	3.82e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:33623917	(2021) The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials.	10	92	1.1	3.84e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,SOX9,CXCL10,ELN,CD47,PTGS2,NFE2L2,BDNF,VEGFA
PMID:34299300	(2021) The Role of PI3KAKT and MAPK Signaling Pathways in Erythropoietin Signalization.	10	92	1.1	3.84e-05	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	EPOR,CDH1,CD34,MAPK7,STAT5A,PTEN,JAK2,BCL2,RHOA,BDNF
PMID:34503196	(2021) Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma.	10	92	1.1	3.84e-05	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,SOX9,ATM,CXCL10,ANGPT2,CCL20,CXCL9,NFE2L2,FGFR1,VEGFA
PMID:34572488	(2021) Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics.	10	92	1.1	3.84e-05	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000478570	CD38,HSPB1,CDH1,CD34,MAP3K5,PTGS2,JAK2,BCL2,HPSE,VEGFA
PMID:33059757	(2020) Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.	10	92	1.1	3.84e-05	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,CXCL10,CD34,CXCL9,PTGS2,PTEN,BCL2,RHOA,BDNF,VEGFA
PMID:30241339	(2018) Pleiotropic Effects of Metformin on Cancer.	10	92	1.1	3.84e-05	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,TGFB1,CDH1,IGF1R,SREBF1,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:24327604	(2013) Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.	10	92	1.1	3.84e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CD38,HSPB1,CDH1,IGF1R,ALDH1A1,PTEN,MAFB,BCL2,VEGFA
PMID:22457663	(2012) Genetics of recurrent miscarriage: challenges, current knowledge, future directions.	10	92	1.1	3.84e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IFNG,CCR5,ANGPT2,AR,MTHFR,JAK2,LTA,AGTR1,VEGFA
PMID:33803178	(2021) Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook.	8	46	1.3	3.93e-05	9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000401399,9606.ENSP00000475344,9606.ENSP00000477707,9606.ENSP00000478570	SREBF1,MAP3K5,PTEN,TXN,MYD88,APLNR,NR1H3,VEGFA
PMID:34073079	(2021) Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.	8	46	1.3	3.93e-05	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PTGS2,PTEN,NOX1,G6PD,BCL2,AGTR1,VEGFA
PMID:34178725	(2021) miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection.	8	46	1.3	3.93e-05	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD69,CXCL10,CXCL11,CXCL9,IRAK4,CCL5,VEGFA
PMID:34330963	(2021) Experimental long-term diabetes mellitus alters the transcriptome and biomechanical properties of the rat urinary bladder.	8	46	1.3	3.93e-05	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000384262,9606.ENSP00000414303,9606.ENSP00000478319,9606.ENSP00000478570	TIMP3,MMP14,ELN,CNTF,HPSE,BDNF,GREM1,VEGFA
PMID:34659640	(2021) Insights into the Role of Oxidative Stress in Ovarian Cancer.	8	46	1.3	3.93e-05	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,STAT5A,PTEN,NOX1,TXN,G6PD,BCL2,VEGFA
PMID:32197363	(2020) Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.	8	46	1.3	3.93e-05	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,CD34,SERPINF2,GAS6,ELN,PTEN,EDN1,VEGFA
PMID:32488850	(2020) Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.	12	152	0.96	3.93e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000360250,9606.ENSP00000363596,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,CDH1,CXCL10,STAT5A,CXCL9,CNTF,ENTPD1,CNR2,JAK2,CCL5,VEGFA
PMID:32939265	(2020) Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia.	8	46	1.3	3.93e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399	CD38,CD69,ATM,LPL,CD47,ENTPD1,BCL2,MYD88
PMID:33153019	(2020) PDIA3 Expression in Glioblastoma Modulates MacrophageMicroglia Pro-Tumor Activation.	8	46	1.3	3.93e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000363641	THBS1,CXCL10,CXCL11,ANGPT2,ANG,CCL20,PTGS2,TXN
PMID:33192323	(2020) Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation.	8	46	1.3	3.93e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	CCR5,CXCL10,PTGS2,JAK2,NFE2L2,BCL2,BDNF,CCL5
PMID:31167470	(2019) Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.	8	46	1.3	3.93e-05	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000330382,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CDH1,ATM,ALDH1A1,PDGFB,JAK2,PROM1,VEGFA
PMID:31694240	(2019) Therapeutic Properties of Mesenchymal Stem Cell on Organ Ischemia-Reperfusion Injury.	8	46	1.3	3.93e-05	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,MPO,IGF1R,NOX1,BMP2,BCL2,PROM1,VEGFA
PMID:31798528	(2019) Global Transcriptomic Analysis of the Canine corpus luteum (CL) During the First Half of Diestrus and Changes Induced by in vivo Inhibition of Prostaglandin Synthase 2 (PTGS2COX2).	8	46	1.3	3.93e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175	TGFB1,IFNG,SOX9,THBS1,PDGFB,PTGS2,EDN1,RHOA
PMID:31934266	(2019) Spotlight on ROS and beta3-Adrenoreceptors Fighting in Cancer Cells.	8	46	1.3	3.93e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,CAV1,PTGS2,TXN,NFE2L2,BCL2,VEGFA
PMID:30210548	(2018) Comparative Analysis of Human Adipose-Derived Mesenchymal Stem Cells from Orbital and Abdominal Fat.	8	46	1.3	3.93e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SOX9,FABP4,CXCL10,CD34,BMP2,CCL5,VEGFA
PMID:31214666	(2018) Positive and negative conditioning in the neonatal brain.	8	46	1.3	3.93e-05	9606.ENSP00000248553,9606.ENSP00000306124,9606.ENSP00000314897,9606.ENSP00000345708,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,PRKCE,ANGPT2,KCNJ11,BCL2,MYD88,BDNF,VEGFA
PMID:26950115	(2016) Endoplasmic Reticulum Stress and Associated ROS.	8	46	1.3	3.93e-05	9606.ENSP00000222572,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000366395,9606.ENSP00000380252,9606.ENSP00000400175	PON2,IFNG,NOX4,MAP3K5,NOX1,SYVN1,NFE2L2,RHOA
PMID:27061197	(2016) Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.	8	46	1.3	3.93e-05	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000347041,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363827	NOX4,TIMP3,CCR5,PDGFB,FMOD,MAP3K5,NOX1,HSPG2
PMID:25981295	(2015) Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases.	8	46	1.3	3.93e-05	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	IGF1R,CAV1,PTEN,EDN1,JAK2,RHOA,AGTR1,VEGFA
PMID:26491232	(2015) Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes.	8	46	1.3	3.93e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,NOX4,PTEN,NOX1,JAK2,NFE2L2,MYD88,VEGFA
PMID:28930206	(2015) Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm.	8	46	1.3	3.93e-05	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,HSPB1,STAT5A,TXN,G6PD,NFE2L2,BCL2,VEGFA
PMID:25268390	(2014) The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing.	8	46	1.3	3.93e-05	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,THBS1,PTGS2,PTEN,RHOA,BDNF,CCL5,VEGFA
PMID:22713929	(2013) Acute myelogenous leukemia stem cells: from Bench to Bedside.	8	46	1.3	3.93e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ATM,ALDH1A1,CD34,CD47,BCL2,PROM1,VEGFA
PMID:23306188	(2013) Nutrigenetics and metabolic disease: current status and implications for personalised nutrition.	8	46	1.3	3.93e-05	9606.ENSP00000264717,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000375844,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000480291	GCKR,PLIN1,HNF4A,CAPN10,LTA,BDNF,FTO,HNF1B
PMID:22724021	(2012) Tamarindus indica extract alters release of alpha enolase, apolipoprotein A-I, transthyretin and Rab GDP dissociation inhibitor beta from HepG2 cells.	8	46	1.3	3.93e-05	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000360522,9606.ENSP00000384906	CETP,LPL,APOL1,LPA,SREBF1,ABCG1,RBP4,SAA1
PMID:23077035	(2012) Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors.	8	46	1.3	3.93e-05	9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412	P2RY1,CXCL10,EDNRA,CXCL9,PTGS2,EDN1,MYD88,CCL5
PMID:24281711	(2012) The influence of estrogens on the biological and therapeutic actions of growth hormone in the liver.	8	46	1.3	3.93e-05	9606.ENSP00000232219,9606.ENSP00000302630,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000384364	RBP1,ONECUT1,LPL,HNF4A,STAT5A,SREBF1,JAK2,NPY
PMID:19059306	(2009) NADPH oxidases and angiotensin II receptor signaling.	8	46	1.3	3.93e-05	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,IGF1R,MAP3K5,PTEN,NOX1,TXN,RHOA,AGTR1
PMID:35158779	(2022) Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective.	11	121	1.02	4.00e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CD247,CXCL9,CD47,PTGS2,ENTPD1,JAK2,CCL5,VEGFA
PMID:21912565	(2012) New insight into immunity and immunopathology of Rickettsial diseases.	11	121	1.02	4.00e-05	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CAV1,CXCL9,CAP1,JAK2,G6PD,BCL2,RHOA,MYD88,LTA,CCL5
PMID:23354550	(2013) Global NeuroAIDS roundtable.	14	224	0.86	4.02e-05	9606.ENSP00000221930,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	TGFB1,VDAC1,IGF1R,CCR5,PRDX2,CXCL10,CXCL11,CD34,CCL20,CXCL9,TXN,BCL2,BDNF,CCL5
PMID:23760224	(2013) Effects of a novel herbal formulation JSK on acute spinal cord injury in rats.	5	6	1.98	4.02e-05	9606.ENSP00000298352,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000478570	NGB,PTGS2,GAP43,RHOA,VEGFA
PMID:12829909	(2003) Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts.	5	6	1.98	4.02e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:10079101	(1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.	5	6	1.98	4.02e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:31979395	(2020) Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases.	10	93	1.09	4.14e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,NOX4,ATM,PTGS2,CNR1,PTEN,KL,NFE2L2,CCL5,VEGFA
PMID:32863858	(2020) Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases.	10	93	1.09	4.14e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	MAPK1,FABP4,FADS2,SREBF1,ABCG1,PTGS2,PTEN,G6PD,NFE2L2,BCL2
PMID:24457057	(2014) A four-marker signature of TNF-RII, TGF-alpha, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.	10	93	1.09	4.14e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000369816,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,TIMP3,CXCL10,CXCL11,CCL20,CXCL9,SHBG,SAA1,BDNF,VEGFA
PMID:22654878	(2012) Mast cell chemotaxis - chemoattractants and signaling pathways.	10	93	1.09	4.14e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000445772,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CD34,CCL20,PTEN,NOX1,RHOA,LTB4R2,CCL5
PMID:19351767	(2009) Role of eotaxin-1 signaling in ovarian cancer.	10	93	1.09	4.14e-05	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,HSPB1,CCR5,CXCL10,STAT5A,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:35058726	(2022) Recent progress (2015-2020) in the investigation of the pharmacological effects and mechanisms of ginsenoside Rb1, a main active ingredient in Panax ginseng Meyer.	9	68	1.18	4.17e-05	9606.ENSP00000300055,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PLIN1,PTEN,JAK2,NFE2L2,BCL2,NPY,RHOA,BDNF,VEGFA
PMID:35126704	(2022) Update on the etiopathogenesis of psoriasis (Review).	9	68	1.18	4.17e-05	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000381185	CD69,FABP4,CDH1,CCR5,LPL,CCL20,S100A12,JAK2,BCL2
PMID:33586025	(2021) Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model.	9	68	1.18	4.17e-05	9606.ENSP00000221930,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000369816	TGFB1,PLIN1,LPL,EDNRA,SREBF1,PTGS2,AR,EDN1,SHBG
PMID:33791228	(2021) The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma.	9	68	1.18	4.17e-05	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000401399,9606.ENSP00000478319	MAPK1,TIMP3,SIRT6,STAT5A,ELN,PTEN,BAMBI,MYD88,GREM1
PMID:33833983	(2021) PPAR-alpha Modulators as Current and Potential Cancer Treatments.	9	68	1.18	4.17e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,NOX4,LPL,SREBF1,PTGS2,NOX1,BCL2,MYD88,VEGFA
PMID:34539578	(2021) Bombesin Receptor Family Activation and CNSNeural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.	9	68	1.18	4.17e-05	9606.ENSP00000267484,9606.ENSP00000292303,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	RTN1,CCR5,VIP,PTEN,EDN1,BCL2,NPY,CCL5,VEGFA
PMID:34725562	(2021) ROS as Regulators of Cellular Processes in Melanoma.	9	68	1.18	4.17e-05	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PRDX2,MAP3K5,PTEN,NOX1,TXN,NFE2L2,BCL2,VEGFA
PMID:31989839	(2020) Involvement of Myeloid Cells and Noncoding RNA in Abdominal Aortic Aneurysm Disease.	9	68	1.18	4.17e-05	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CHI3L1,CCR5,STAT5A,ELN,S100A12,PTEN,CCL5,VEGFA
PMID:32021257	(2020) Resistance Mechanism of PD-1PD-L1 Blockade in the Cancer-Immunity Cycle.	9	68	1.18	4.17e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,ENTPD1,PTEN,JAK2,CCL5,VEGFA
PMID:32153503	(2020) Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin.	9	68	1.18	4.17e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,IGF1R,CXCL10,CCL20,RBP4,PTEN,CCL5,VEGFA
PMID:30844720	(2019) Mechanisms of obesity-induced metabolic and vascular dysfunctions.	9	68	1.18	4.17e-05	9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000478319	DDAH1,LPL,CAV1,RBP4,PTEN,ANGPTL2,JAK2,NPY,GREM1
PMID:30850822	(2019) Cholangiocyte pathobiology.	9	68	1.18	4.17e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000357726,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,CXCL10,PDGFB,CCL20,VIP,S100A12,HNF1B
PMID:31070059	(2019) The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.	9	68	1.18	4.17e-05	9606.ENSP00000222305,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000478570	USF2,NOX4,ATM,PTEN,NOX1,EDN1,BCL2,FTO,VEGFA
PMID:31680947	(2019) Oxidized Lipids in Persistent Pain States.	9	68	1.18	4.17e-05	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000278840,9606.ENSP00000360247,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000445772,9606.ENSP00000478570	FFAR1,FABP4,ENPP2,FADS2,CYP2J2,RHOA,BDNF,LTB4R2,VEGFA
PMID:31921870	(2019) Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.	9	68	1.18	4.17e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,CCR5,PDGFB,PTEN,PDGFD,BCL2,PROM1,VEGFA
PMID:29565290	(2018) Role of Inflammation in Diabetic Retinopathy.	9	68	1.18	4.17e-05	9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,ANGPT2,CCL20,CNTF,PTGS2,BDNF,AGTR1,CCL5,VEGFA
PMID:29657326	(2018) Exploring vitamin D metabolism and function in cancer.	9	68	1.18	4.17e-05	9606.ENSP00000216862,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	CYP24A1,ATM,PTGS2,PTEN,TXN,KL,G6PD,NFE2L2,BCL2
PMID:26569225	(2015) Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy.	9	68	1.18	4.17e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,ATM,PRDX2,PTGS2,SGK1,PTEN,JAK2,BCL2,VEGFA
PMID:25110692	(2014) The role of chemoattractant receptors in shaping the tumor microenvironment.	9	68	1.18	4.17e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,PROM1,LTB4R2,CCL5,VEGFA
PMID:24023546	(2013) Cellular kinetics of perivascular MSC precursors.	9	68	1.18	4.17e-05	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,ANGPT2,PDGFB,PTGS2,FGFR1,MME,CCL5,VEGFA
PMID:24575418	(2013) MicroRNA in diabetic nephropathy: renin angiotensin, aGERAGE, and oxidative stress pathway.	9	68	1.18	4.17e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000265132,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,NOX4,AMBP,TIMP3,PTGS2,PTEN,NOX1,AGTR1,VEGFA
PMID:20221895	(2010) Diet, microRNAs and prostate cancer.	9	68	1.18	4.17e-05	9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PRKCE,MAPK7,SIRT6,CAV1,AR,PDGFD,BCL2,VEGFA
PMID:35005554	(2022) The evolution of knowledge on genes associated with human diseases.	7	29	1.44	4.20e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	MAPK1,IFNG,PTGS2,NFE2L2,BCL2,NPY,BDNF
PMID:33120051	(2021) Placental macrophages: Origin, heterogeneity, function and role in pregnancy-associated infections.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CXCL9,MME,VEGFA
PMID:33317250	(2021) Anti-fibrotic treatments for chronic liver diseases: The present and the future.	7	29	1.44	4.20e-05	9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000364683,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,ELN,MAP3K5,NOX1,BAMBI,MYD88,CCL5
PMID:33628274	(2021) Research Progress on Stem Cell Therapies for Articular Cartilage Regeneration.	7	29	1.44	4.20e-05	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,THBS1,CD34,CCL20,ELN,BMP2,VEGFA
PMID:33858491	(2021) N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions.	7	29	1.44	4.20e-05	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	MPO,FABP4,CDH1,PLIN1,PDGFB,PDGFA,VEGFA
PMID:34452081	(2021) Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,ELN,CD47,PTEN,PROM1
PMID:34831368	(2021) Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000317674,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	CDH1,NOX4,APOL1,CAV1,EDN1,RHOA,AGTR1
PMID:35052739	(2021) The Cardiovascular System in Space: Focus on In Vivo and In Vitro Studies.	7	29	1.44	4.20e-05	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ELN,BMP2,EDN1,RHOA,CCL5,VEGFA
PMID:31914018	(2020) Curcumin: From a controversial panacea to effective antineoplastic products.	7	29	1.44	4.20e-05	9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CAV1,SREBF1,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:32109373	(2020) The Fetal-Maternal Immune Interface in Uterus Transplantation.	7	29	1.44	4.20e-05	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD69,IFNG,CXCL10,CXCL9,CCL5,VEGFA
PMID:32599797	(2020) The Antioxidant, Anti-Inflammatory, and Neuroprotective Properties of the Synthetic Chalcone Derivative AN07.	7	29	1.44	4.20e-05	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	IGF1R,PTGS2,PTEN,NFE2L2,BCL2,RHOA,BDNF
PMID:32723565	(2020) Ca(2+) as a therapeutic target in cancer.	11	122	1.02	4.20e-05	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	CDH1,VDAC1,CD34,CAV1,STAT5A,PTEN,AR,BCL2,RHOA,TRPC1,VEGFA
PMID:32984022	(2020) Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.	7	29	1.44	4.20e-05	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000354782,9606.ENSP00000418525	EPOR,CD38,IFNG,CD34,EBF1,CD247,MME
PMID:33292641	(2020) The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications.	7	29	1.44	4.20e-05	9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185	PRDX2,CD34,MAP3K5,PTGS2,TXN,JAK2,BCL2
PMID:30961670	(2019) Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAKSTAT3PD-L1 pathway.	7	29	1.44	4.20e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,ATM,SREBF1,JAK2,BCL2,VEGFA
PMID:31717576	(2019) The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives.	7	29	1.44	4.20e-05	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CCR5,CXCL10,SREBF1,MAP3K5,CCL5,VEGFA
PMID:29541275	(2018) Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000427424,9606.ENSP00000478570	CDH1,HNF4A,CD247,BCL2,MYD88,TNFAIP8,VEGFA
PMID:29872621	(2018) Biomacromolecules as carriers in drug delivery and tissue engineering.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CAV1,ELN,TXN,BMP2,BCL2,VEGFA
PMID:30050001	(2018) High-Throughput Approaches onto Uncover (Epi)Genomic Architecture of Type 2 Diabetes.	11	122	1.02	4.20e-05	9606.ENSP00000226760,9606.ENSP00000278616,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418823	WFS1,ATM,JAZF1,HNF4A,CAV1,KCNJ11,SREBF1,ABCG1,NPY,BDNF,FTO
PMID:28194184	(2017) Signal Factors Secreted by 2D and Spheroid Mesenchymal Stem Cells and by Cocultures of Mesenchymal Stem Cells Derived Microvesicles and Retinal Photoreceptor Neurons.	7	29	1.44	4.20e-05	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:26919105	(2016) Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.	7	29	1.44	4.20e-05	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CD38,ANGPT2,STAT5A,EDN1,JAK2,VEGFA
PMID:25617825	(2015) Adipose-derived stromal vascular fraction cells isolated from old animals exhibit reduced capacity to support the formation of microvascular networks.	7	29	1.44	4.20e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,ANGPT2,PDGFB,CD47,PROM1,VEGFA
PMID:26447335	(2015) Synergy of endothelial and neural progenitor cells from adipose-derived stem cells to preserve neurovascular structures in rat hypoxic-ischemic brain injury.	7	29	1.44	4.20e-05	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,BCL2,FGFR1,BDNF,PROM1,VEGFA
PMID:25988147	(2014) Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators.	13	188	0.9	4.20e-05	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000226760,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000414303	MAPK1,MYH9,WFS1,APC,ATM,SIRT6,KCNJ11,PTEN,AR,HSPG2,JAK2,FGFR1,BDNF
PMID:23263794	(2013) Influences of spasmolytic powder on pgp expression of Coriaria Lactone-kindling drug-resistant epileptic rat model.	13	188	0.9	4.20e-05	9606.ENSP00000221930,9606.ENSP00000265132,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000354511,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,AMBP,ATM,GAS6,COMT,CNR1,PTEN,GAP43,BCL2,NPY,BDNF,AGTR1,VEGFA
PMID:24052946	(2013) Functional vascular endothelium derived from human induced pluripotent stem cells.	7	29	1.44	4.20e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANGPT2,CXCL9,EDN1,CCL5,VEGFA
PMID:21251982	(2011) Endothelins and their receptors in cancer: identification of therapeutic targets.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,HNF4A,EDNRA,EDN1,BCL2,MME,VEGFA
PMID:21858799	(2011) Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.	7	29	1.44	4.20e-05	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,PDGFB,PDGFA,PTGS2,PDGFD,FGFR1,VEGFA
PMID:20051913	(2010) Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.	7	29	1.44	4.20e-05	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,EDNRA,CAV1,NOX1,EDN1,CCL5,VEGFA
PMID:19028258	(2008) Dendritic cells and chemokine-directed migration in transplantation: where are we headed?	7	29	1.44	4.20e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,CCR5,CXCL11,CD34,CXCL9,PTGS2,CCL5
PMID:35178363	(2022) Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma.	8	47	1.29	4.37e-05	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CD34,HNF4A,PTEN,AR,JAK2,BCL2,VEGFA
PMID:35216255	(2022) Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer.	8	47	1.29	4.37e-05	9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	ALDH1A1,STAT5A,PTEN,JAK2,BCL2,RHOA,BDNF,VEGFA
PMID:33451077	(2021) Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis.	8	47	1.29	4.37e-05	9606.ENSP00000216181,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,CD38,CDH1,IGF1R,CD34,BCL2,PROM1,VEGFA
PMID:33472580	(2021) Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines.	10	94	1.09	4.37e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,PTEN,BMP2,EDN1,BCL2,BDNF,CCL5,VEGFA
PMID:33800213	(2021) Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs.	8	47	1.29	4.37e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,CCL5
PMID:34066328	(2021) Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells.	8	47	1.29	4.37e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,APPL1,PTEN,AR,JAK2,BCL2,VEGFA
PMID:34147113	(2021) Zoology, chemical composition, pharmacology, quality control and future perspective of Musk (Moschus): a review.	8	47	1.29	4.37e-05	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,MAP3K5,JAK2,BCL2,MYD88,BDNF,CCL5,VEGFA
PMID:34193864	(2021) Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19.	8	47	1.29	4.37e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,MMP14,CCL20,LTA,CCL5,VEGFA
PMID:34367926	(2021) Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells.	8	47	1.29	4.37e-05	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,PTGS2,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:34522587	(2021) Influencing factors and strategies of enhancing nanoparticles into tumors in vivo.	8	47	1.29	4.37e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CDH1,CXCL11,ANGPT2,ELN,CD47,AGTR1,VEGFA
PMID:34602858	(2021) Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.	10	94	1.09	4.37e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,CXCL10,CXCL9,PTGS2,BCL2,IRAK4,LTA,CCL5,VEGFA
PMID:34722319	(2021) Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies.	10	94	1.09	4.37e-05	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,THBS1,CCR5,CXCL10,MAP3K5,NFE2L2,BCL2,RHOA,CCL5,VEGFA
PMID:34830165	(2021) Secretome Analysis of Rabbit and Human Mesenchymal Stem and Endothelial Progenitor Cells: A Comparative Study.	8	47	1.29	4.37e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANGPT2,ANG,LTA,BDNF,CCL5,VEGFA
PMID:35127755	(2021) Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications.	8	47	1.29	4.37e-05	9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000419422,9606.ENSP00000478570	IGF1R,MAPK7,TXN,EDN1,JAK2,G6PD,AGTR1,VEGFA
PMID:32423112	(2020) The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids.	8	47	1.29	4.37e-05	9606.ENSP00000347041,9606.ENSP00000354511,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	FMOD,COMT,ABCG1,PTGS2,BMP2,NFE2L2,BCL2,VEGFA
PMID:32582693	(2020) Pro-angiogenic Activity Discriminates Human Adipose-Derived Stromal Cells From Retinal Pericytes: Considerations for Cell-Based Therapy of Diabetic Retinopathy.	8	47	1.29	4.37e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,THBS1,COL8A1,TIMP3,CD34,ANGPT2,EDN1,VEGFA
PMID:32751207	(2020) MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors.	8	47	1.29	4.37e-05	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000427424,9606.ENSP00000478570	CYP24A1,CDH1,TIMP3,PTEN,AR,JAK2,TNFAIP8,VEGFA
PMID:32957083	(2020) Alzheimers disease as a systems network disorder: chronic stressdyshomeostasis, innate immunity, and genetics.	10	94	1.09	4.37e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000352264,9606.ENSP00000354511,9606.ENSP00000356213,9606.ENSP00000365777,9606.ENSP00000369442,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CD2AP,COMT,VIP,MTHFR,KL,BDNF,CCL5,VEGFA
PMID:33379334	(2020) Role of Macrophages and RhoA Pathway in Atherosclerosis.	8	47	1.29	4.37e-05	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000477707	TIMP3,CCR5,MMP14,ABCG1,PTGS2,RHOA,CCL5,NR1H3
PMID:35185341	(2020) Social and Biological Parameters Involved in Suicide Ideation During the COVID-19 Pandemic: A Narrative Review.	8	47	1.29	4.37e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,PTGS2,NTF3,BDNF,VEGFA
PMID:30709025	(2019) The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.	8	47	1.29	4.37e-05	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,ANGPT2,SERPINF2,CAV1,HSPG2,EDN1,BDNF,VEGFA
PMID:30871956	(2019) The double edge sword of fibrosis in cancer.	8	47	1.29	4.37e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CD34,CAV1,RHOA,CCL5,VEGFA
PMID:31205572	(2019) BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.	10	94	1.09	4.37e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	CD38,ATM,ALDH1A1,CD34,NOX1,JAK2,NFE2L2,PROM1,VEGFA,UHRF1
PMID:31336890	(2019) Genetically Engineered-MSC Therapies for Non-unions, Delayed Unions and Critical-size Bone Defects.	8	47	1.29	4.37e-05	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CD34,ANG,PTEN,BMP2,BDNF,CCL5,VEGFA
PMID:31380247	(2019) The Chemopreventive Activity of Indonesia Medicinal Plants Targeting on Hallmarks of Cancer.	8	47	1.29	4.37e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,PTGS2,PTEN,TXN,AR,BCL2,VEGFA
PMID:31380270	(2019) PVT1 Promotes Cancer Progression via MicroRNAs.	8	47	1.29	4.37e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,IGF1R,ANGPT2,PTGS2,BMP2,BCL2,GREM1,VEGFA
PMID:31612014	(2019) Multiple roles of microRNA-146a in immune responses and hepatocellular carcinoma.	8	47	1.29	4.37e-05	9606.ENSP00000257430,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000479617	APC,PTGS2,IRAK4,MYD88,LTA,CCL5,VEGFA,UHRF1
PMID:31835751	(2019) Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development.	10	94	1.09	4.37e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CCR5,MMP14,PDGFB,ENTPD1,PTEN,JAK2,RHOA,PROM1,VEGFA
PMID:30154786	(2018) Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu.	10	94	1.09	4.37e-05	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CCR5,CXCL10,CXCL11,CXCL9,JAK2,FGFR1,MYD88,CCL5,VEGFA
PMID:25638213	(2015) Personalization of cancer treatment using predictive simulation.	8	47	1.29	4.37e-05	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CAV1,STAT5A,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:33869660	(2014) Exosomes in the Pathogenesis, Diagnosis and Treatment of Pancreatic Diseases.	8	47	1.29	4.37e-05	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000354782,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	CDH1,AMBP,VDAC1,CD247,RBP4,PTEN,BCL2,MYD88
PMID:23359810	(2013) Spindle shaped human mesenchymal stemstromal cells from amniotic fluid promote neovascularization.	8	47	1.29	4.37e-05	9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,AMBP,CD34,ANGPT2,ANG,EDN1,PROM1,VEGFA
PMID:23662201	(2013) Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension.	8	47	1.29	4.37e-05	9606.ENSP00000292303,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CCR5,VIP,BMP2,EDN1,RHOA,CCL5,GREM1,VEGFA
PMID:23973145	(2013) Osteoarthritis pain mechanisms: basic studies in animal models.	8	47	1.29	4.37e-05	9606.ENSP00000215832,9606.ENSP00000347041,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,FMOD,VIP,PTGS2,GAP43,NPY,CCL5,VEGFA
PMID:24024092	(2013) Involvement of free radicals in breast cancer.	8	47	1.29	4.37e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,ATM,SIRT6,NOX1,BCL2,RHOA,VEGFA
PMID:22189563	(2012) The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.	8	47	1.29	4.37e-05	9606.ENSP00000225275,9606.ENSP00000288266,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185	MPO,APPL1,MAPK7,PTEN,TXN,EDN1,NFE2L2,BCL2
PMID:22822401	(2012) Resveratrol: French paradox revisited.	8	47	1.29	4.37e-05	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,THBS1,LPL,CAV1,PTGS2,EDN1,BCL2,VEGFA
PMID:22942910	(2012) Genetic controls and cellular behaviors in branching morphogenesis of the renal collecting system.	10	94	1.09	4.37e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000478319,9606.ENSP00000478570,9606.ENSP00000480291	TGFB1,SOX9,MMP14,PTEN,BMP2,NPY,AGTR1,GREM1,VEGFA,HNF1B
PMID:18800074	(2008) The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system.	10	94	1.09	4.37e-05	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000444198	NOX4,ATM,MAP3K5,PTGS2,PTEN,NOX1,TXN,G6PD,BCL2,CITED2
PMID:18928341	(2008) Antiangiogenic therapy in brain tumors.	8	47	1.29	4.37e-05	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFB,ANG,PDGFA,CXCL9,BDNF,PROM1,VEGFA
PMID:35203463	(2022) The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.	9	69	1.18	4.47e-05	9606.ENSP00000221930,9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000419313,9606.ENSP00000419422	TGFB1,LPL,MAPK7,ELN,EDN1,NFE2L2,BDNF,TRPC1,AGTR1
PMID:34069147	(2021) MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer.	9	69	1.18	4.47e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	HSPB1,CDH1,ATM,MAPK7,CAV1,SREBF1,PTEN,AR,BCL2
PMID:34885056	(2021) The Serine Protease CD26DPP4 in Non-Transformed and Malignant T Cells.	9	69	1.18	4.47e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000354782,9606.ENSP00000384364,9606.ENSP00000474412	CD69,IFNG,CXCL10,MMP14,CD34,CAV1,CD247,NPY,CCL5
PMID:32148647	(2020) Antioxidant Effects and Mechanisms of Medicinal Plants and Their Bioactive Compounds for the Prevention and Treatment of Type 2 Diabetes: An Updated Review.	9	69	1.18	4.47e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,SIRT6,NOX1,TXN,EDN1,JAK2,BCL2,VEGFA
PMID:32806517	(2020) Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms.	9	69	1.18	4.47e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CD34,STAT5A,PDGFA,JAK2,NFE2L2,VEGFA
PMID:33412751	(2020) The nature of triple-negative breast cancer classification and antitumoral strategies.	9	69	1.18	4.47e-05	9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,PLIN1,CXCL10,CXCL11,AR,BMP2,BCL2,CCL5,VEGFA
PMID:35047982	(2020) The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities.	9	69	1.18	4.47e-05	9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ANG,CCL20,CD247,AR,EDN1,BCL2,CCL5,VEGFA
PMID:26997034	(2016) Gene-environment interactions and the enteric nervous system: Neural plasticity and Hirschsprung disease prevention.	9	69	1.18	4.47e-05	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	CNTF,VIP,RBP4,PTEN,BMP2,EDN1,LTA,BDNF,CCL5
PMID:24461730	(2014) New insights into molecular mechanisms of diabetic kidney disease.	9	69	1.18	4.47e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,NOX4,SIRT6,PTGS2,PTEN,NOX1,RHOA,VEGFA
PMID:34064589	(2021) AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review.	10	95	1.08	4.73e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000380365,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,IGF1R,CXCL10,PTEN,BMP2,EDN1,RGN,CCL5,VEGFA
PMID:34638913	(2021) Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives.	10	95	1.08	4.73e-05	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000480291	MAPK1,MPO,SOX9,ALDH1A1,CD34,SIRT6,PTEN,MYD88,PROM1,HNF1B
PMID:32174916	(2020) Glial Cells: Role of the Immune Response in Ischemic Stroke.	10	95	1.08	4.73e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,MAP3K5,CXCL9,CNTF,GAP43,MYD88,BDNF,VEGFA
PMID:32731422	(2020) The Emerging Role of Galectins and O-GlcNAc Homeostasis in Processes of Cellular Differentiation.	10	95	1.08	4.73e-05	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000414303	CD69,FABP4,PLIN1,CXCL11,CD34,STAT5A,SREBF1,BMP2,JAK2,BDNF
PMID:32793192	(2020) Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation.	10	95	1.08	4.73e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000401399,9606.ENSP00000427424,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,STAT5A,CD247,PTGS2,ENTPD1,MYD88,TNFAIP8,CCL5,VEGFA
PMID:32825443	(2020) Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis.	10	95	1.08	4.73e-05	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,MMP14,CD47,NOX1,MAFB,JAK2,IRAK4,MYD88,CCL5,VEGFA
PMID:25066777	(2015) Hepatic inflammation and fibrosis: functional links and key pathways.	10	95	1.08	4.73e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000364683,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412	THBS1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,BAMBI,FGFR1,MYD88,CCL5
PMID:34298199	(2021) Single cell functional genomics reveals plasticity of subcutaneous white adipose tissue (WAT) during early postnatal development.	11	124	1.01	4.77e-05	9606.ENSP00000256104,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000380252	FABP4,LAMC1,THBS1,CD34,STAT5A,CXCL9,PTGS2,EDN1,JAK2,GAP43,NFE2L2
PMID:34451824	(2021) Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update.	6	16	1.64	4.77e-05	9606.ENSP00000229135,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:34589625	(2021) Mesenchymal stem cells act as stimulators of neurogenesis and synaptic function in a rat model of Alzheimers disease.	6	16	1.64	4.77e-05	9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	GAP43,BDNF,MME,PROM1,CCL5,VEGFA
PMID:34609841	(2021) Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments.	6	16	1.64	4.77e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,BDNF,CCL5,VEGFA
PMID:34682413	(2021) Vascular Ageing and Aerobic Exercise.	6	16	1.64	4.77e-05	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,NOX4,EDNRA,ELN,EDN1,VEGFA
PMID:32107737	(2020) Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review.	6	16	1.64	4.77e-05	9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD34,TXN,GAP43,BCL2,BDNF,VEGFA
PMID:29409529	(2018) The JAK2 pathway is activated in idiopathic pulmonary fibrosis.	6	16	1.64	4.77e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,EDN1,JAK2,BCL2,VEGFA
PMID:30443207	(2018) CD34 and CD117 Stemness of Lineage-Negative Cells Reverses Memory Loss Induced by Amyloid Beta in Mouse Model.	6	16	1.64	4.77e-05	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CNTF,BDNF,MME,PROM1,VEGFA
PMID:28060893	(2017) Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis.	6	16	1.64	4.77e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000368683	TGFB1,THBS1,NOX4,CXCL10,EDNRA,EDN1
PMID:28603578	(2017) Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model.	6	16	1.64	4.77e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:28680562	(2017) Addressing the challenges of phenotyping pediatric pulmonary vascular disease.	6	16	1.64	4.77e-05	9606.ENSP00000229135,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,EDNRA,EDN1,LTA,CCL5,VEGFA
PMID:29312442	(2017) Mesenchymal Stem Cells Secretory Responses: Senescence Messaging Secretome and Immunomodulation Perspective.	13	191	0.89	4.77e-05	9606.ENSP00000278616,9606.ENSP00000281382,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	ATM,PIGF,CXCL10,CXCL11,PDGFB,PDGFA,CCL20,CXCL9,PTEN,BMP2,PLA2G2A,CCL5,VEGFA
PMID:29323053	(2017) Roles of neural stem cells in the repair of peripheral nerve injury.	6	16	1.64	4.77e-05	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,FGFR1,NTF3,BDNF,VEGFA
PMID:27774119	(2016) Role of Oxidative Stress in the Neurocognitive Dysfunction of Obstructive Sleep Apnea Syndrome.	6	16	1.64	4.77e-05	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PTGS2,TXN,NFE2L2,AGTR1,VEGFA
PMID:27776524	(2016) Pulsed high-dose dexamethasone modulates Th1-Th2-chemokine imbalance in immune thrombocytopenia.	6	16	1.64	4.77e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:25604905	(2015) Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.	6	16	1.64	4.77e-05	9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL11,CD34,ANG,CCL5,VEGFA
PMID:25972872	(2015) Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.	11	124	1.01	4.77e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CCR5,CXCL10,CD34,STAT5A,CXCL9,BCL2,RARRES2,CCL5,VEGFA
PMID:26094732	(2015) Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.	6	16	1.64	4.77e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412	MPO,IFNG,CCR5,CXCL10,CCL20,CCL5
PMID:26338015	(2015) Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway.	6	16	1.64	4.77e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:22616002	(2012) Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.	6	16	1.64	4.77e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL9,MME,CCL5
PMID:21756551	(2011) Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice.	6	16	1.64	4.77e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,PDGFB,PDGFA,CCL5,VEGFA
PMID:22184538	(2011) Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation.	6	16	1.64	4.77e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000418525	MPO,CD38,CD34,PDGFA,JAK2,MME
PMID:16721359	(2006) Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.	6	16	1.64	4.77e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000478570	IFNG,CXCL10,CD34,CXCL9,HSPG2,VEGFA
PMID:10430620	(1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.	6	16	1.64	4.77e-05	9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418525,9606.ENSP00000474412	CXCL10,EDN1,BCL2,NPY,MME,CCL5
PMID:34398443	(2022) Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?	7	30	1.43	4.87e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:35082907	(2022) Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.	9	70	1.17	4.87e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CDH1,NOX4,SREBF1,G6PD,NFE2L2,BCL2,MYD88,VEGFA
PMID:35236104	(2022) A Thromboxane A2 Receptor-Driven COX-2-Dependent Feedback Loop That Affects Endothelial Homeostasis and Angiogenesis.	7	30	1.43	4.87e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000339916,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CD34,LIMK2,PTGS2,FGFR1,RHOA,VEGFA
PMID:35397798	(2022) Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.	7	30	1.43	4.87e-05	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CXCL11,PDGFA,CXCL9,CCL5,VEGFA
PMID:33103852	(2021) The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.	8	48	1.28	4.87e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:33493334	(2021) Current knowledge of Kruppel-like factor 5 and vascular remodeling: providing insights for therapeutic strategies.	9	70	1.17	4.87e-05	9606.ENSP00000226279,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CD38,PDGFB,CAV1,PDGFA,ELN,PTEN,RHOA,AGTR1,VEGFA
PMID:33584979	(2021) Mesenchymal stem cell-derived small extracellular vesicles in the treatment of human diseases: Progress and prospect.	7	30	1.43	4.87e-05	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CD34,PTEN,BCL2,RHOA,BDNF,MME,VEGFA
PMID:33655898	(2021) T cell responses in respiratory viral infections and chronic obstructive pulmonary disease.	9	70	1.17	4.87e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,CXCL11,ELN,CD247,CXCL9,CCL5
PMID:33920534	(2021) New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis.	9	70	1.17	4.87e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495	MPO,CDH1,SIRT6,CAV1,TXN,NFE2L2,BCL2,MYD88,LTA
PMID:33922336	(2021) Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids.	8	48	1.28	4.87e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CXCL9,CD47,CCL5,VEGFA
PMID:34093545	(2021) Dickkopf-1: A Promising Target for Cancer Immunotherapy.	7	30	1.43	4.87e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000480291	IFNG,SOX9,ALDH1A1,HNF4A,PTGS2,RHOA,HNF1B
PMID:34105268	(2021) Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells.	8	48	1.28	4.87e-05	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000477707	FABP4,CD34,PDGFB,ELN,EDN1,JAK2,FGFR1,NR1H3
PMID:34215813	(2021) Distinct roles of androgen receptor, estrogen receptor alpha, and BCL6 in the establishment of sex-biased DNA methylation in mouse liver.	7	30	1.43	4.87e-05	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000363822,9606.ENSP00000369816	SOX9,ONECUT1,HNF4A,STAT5A,COMT,AR,SHBG
PMID:34217135	(2021) Natural killer cells and unconventional T cells in COVID-19.	7	30	1.43	4.87e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000354901	CD38,CD69,CCR5,CXCL10,EDNRA,CCL20,CXCL9
PMID:34281263	(2021) Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics.	8	48	1.28	4.87e-05	9606.ENSP00000225275,9606.ENSP00000265333,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MPO,VDAC1,SREBF1,ABCG1,JAK2,BCL2,PROM1,VEGFA
PMID:34627325	(2021) A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model.	7	30	1.43	4.87e-05	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,CD69,PTGS2,EDN1,NPY,BDNF,VEGFA
PMID:34685763	(2021) Role of Aldynoglia Cells in Neuroinflammatory and Neuroimmune Responses after Spinal Cord Injury.	9	70	1.17	4.87e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303	MPO,IFNG,SOX9,CXCL10,CNTF,VIP,GAP43,NTF3,BDNF
PMID:34943963	(2021) Senescence Alterations in Pulmonary Hypertension.	7	30	1.43	4.87e-05	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ELN,MAP3K5,PTEN,NOX1,BCL2,VEGFA
PMID:34950831	(2021) Vitamin D Endocrine System and COVID-19.	9	70	1.17	4.87e-05	9606.ENSP00000216862,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000419422,9606.ENSP00000474412	CYP24A1,CCR5,CXCL10,CCL20,CXCL9,PTGS2,KL,AGTR1,CCL5
PMID:34984016	(2021) Regulation of Methylase METTL3 on Fat Deposition.	8	48	1.28	4.87e-05	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000418823,9606.ENSP00000478570	FABP4,TIMP3,MAPK7,STAT5A,PTEN,EDN1,FTO,VEGFA
PMID:31997803	(2020) Multimodal treatment for spinal cord injury: a sword of neuroregeneration upon neuromodulation.	7	30	1.43	4.87e-05	9606.ENSP00000285407,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	KLF10,GAP43,NTF3,RHOA,BDNF,PROM1,VEGFA
PMID:32047730	(2020) Advantages and Limitations of the Neonatal Immune System.	8	48	1.28	4.87e-05	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	MPO,CXCL10,CXCL11,ELN,CXCL9,BCL2,BDNF,CCL5
PMID:32083086	(2020) Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases.	7	30	1.43	4.87e-05	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,NOX4,HNF4A,SREBF1,PTEN,MYD88,VEGFA
PMID:32189139	(2020) Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics.	7	30	1.43	4.87e-05	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000445772,9606.ENSP00000478570	NOX4,MAP3K5,NOX1,G6PD,NFE2L2,LTB4R2,VEGFA
PMID:32242330	(2020) Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.	9	70	1.17	4.87e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000364683,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CD34,ELN,HSPG2,BAMBI,MYD88,CCL5,VEGFA
PMID:32264958	(2020) Tumor microenvironment complexity and therapeutic implications at a glance.	9	70	1.17	4.87e-05	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,MMP14,ELN,CD47,PTEN,JAK2,MYD88,CCL5,VEGFA
PMID:32645995	(2020) Impact of Cholesterol Metabolism in Immune Cell Function and Atherosclerosis.	9	70	1.17	4.87e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000321334,9606.ENSP00000341208,9606.ENSP00000354995,9606.ENSP00000477707	CETP,MPO,CCR5,LPL,HNF4A,LPA,STAT5A,ABCG1,NR1H3
PMID:32698868	(2020) Therapeutic applications of adipose cell-free derivatives: a review.	8	48	1.28	4.87e-05	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	TIMP3,CD34,PDGFB,ELN,GAP43,BDNF,MME,VEGFA
PMID:32722203	(2020) MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value.	8	48	1.28	4.87e-05	9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	HSPB1,TIMP3,IGF1R,HNF4A,CCL20,PTEN,BCL2,PROM1
PMID:32821059	(2020) Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.	8	48	1.28	4.87e-05	9606.ENSP00000013807,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,CXCL10,CXCL11,ANG,CXCL9,BCL2,CCL5,VEGFA
PMID:33061451	(2020) IL-6STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells.	7	30	1.43	4.87e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,CD47,AR,BCL2,PROM1,VEGFA
PMID:33117153	(2020) Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials.	8	48	1.28	4.87e-05	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,HSPB1,ALDH1A1,HNF4A,PTGS2,AR,BCL2,VEGFA
PMID:33158122	(2020) Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression.	8	48	1.28	4.87e-05	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,MMP14,ANGPT2,EDNRA,PDGFB,SIRT6,PTEN,VEGFA
PMID:33322614	(2020) Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction.	7	30	1.43	4.87e-05	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,MAPK7,EDNRA,NOX1,EDN1,NFE2L2,VEGFA
PMID:33396566	(2020) What Can We Learn from FGF-2 Isoform-Specific Mouse Mutants? Differential Insights into FGF-2 Physiology In Vivo.	9	70	1.17	4.87e-05	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000355370,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,HSPB1,NOX4,CNTF,ALPL,BMP2,KL,FGFR1,VEGFA
PMID:30056769	(2019) Oncostatin M and its role in fibrosis.	8	48	1.28	4.87e-05	9606.ENSP00000255409,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,ANGPT2,CCL20,CNTF,EDN1,JAK2,CCL5,VEGFA
PMID:31323834	(2019) DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.	9	70	1.17	4.87e-05	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000479617	ERCC1,TGFB1,CDH1,TIMP3,ATM,PTEN,MTHFR,BCL2,UHRF1
PMID:31470642	(2019) Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML.	8	48	1.28	4.87e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000426809	CD38,IFNG,IGF1R,CD34,CD247,CD47,JAK2,PROM1
PMID:31612077	(2019) Euphorbia bicolor (Euphorbiaceae) Latex Extract Reduces Inflammatory Cytokines and Oxidative Stress in a Rat Model of Orofacial Pain.	7	30	1.43	4.87e-05	9606.ENSP00000263317,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CCL20,CXCL9,CNTF,NOX1,CCL5,VEGFA
PMID:31671654	(2019) Analysis of Transcriptome, Selected Intracellular Signaling Pathways, Proliferation and Apoptosis of LNCaP Cells Exposed to High Leptin Concentrations.	8	48	1.28	4.87e-05	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,STAT5A,CCL20,CNTF,AR,JAK2,BCL2,VEGFA
PMID:31795243	(2019) The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia.	8	48	1.28	4.87e-05	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185	NOX4,ATM,PRDX2,CD34,STAT5A,NOX1,JAK2,BCL2
PMID:31810265	(2019) Modifying the Tumour Microenvironment: Challenges and Future Perspectives for Anticancer Plasma Treatments.	8	48	1.28	4.87e-05	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ANGPT2,ANG,ELN,ENTPD1,HSPG2,CCL5,VEGFA
PMID:31871542	(2019) NOX2-Dependent Reactive Oxygen Species Regulate Formyl-Peptide Receptor 1-Mediated TrkA Transactivation in SH-SY5Y Cells.	8	48	1.28	4.87e-05	9606.ENSP00000263317,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000362057,9606.ENSP00000384906,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809	NOX4,CNTF,VIP,NOX1,SAA1,NTF3,BDNF,PROM1
PMID:29518696	(2018) EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.	7	30	1.43	4.87e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CXCL10,CD34,PTEN,EDN1,JAK2,CCL5
PMID:29588647	(2018) STAT3, stem cells, cancer stem cells and p63.	9	70	1.17	4.87e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,IGF1R,CD34,CNTF,PTEN,PROM1,CCL5,VEGFA
PMID:29849484	(2018) Wound Healing and Omega-6 Fatty Acids: From Inflammation to Repair.	7	30	1.43	4.87e-05	9606.ENSP00000225275,9606.ENSP00000246553,9606.ENSP00000278840,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	MPO,FFAR1,FADS2,ANGPT2,PTGS2,CCL5,VEGFA
PMID:29867053	(2018) Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.	9	70	1.17	4.87e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,GAS6,PTGS2,BMP2,EDN1,CCL5,VEGFA
PMID:30257724	(2018) Mechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disorders.	7	30	1.43	4.87e-05	9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,BMP2,BCL2,NTF3,RHOA,BDNF,VEGFA
PMID:30281213	(2018) Frontiers in pigment cell and melanoma research.	8	48	1.28	4.87e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412	IFNG,IGF1R,CXCL10,CXCL9,PTEN,EDN1,RHOA,CCL5
PMID:31360916	(2018) Recent advances in cerebral cavernous malformation research.	9	70	1.17	4.87e-05	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000362463,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,HSPB1,THBS1,NOX4,MAPK7,ANGPT2,GLO1,RHOA,VEGFA
PMID:28143649	(2017) Crosstalk between calcium and reactive oxygen species signaling in cancer.	9	70	1.17	4.87e-05	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000478570	NOX4,VDAC1,MAP3K5,PTEN,NOX1,TXN,BCL2,TRPC1,VEGFA
PMID:28299638	(2017) The impact of aging on cardiac extracellular matrix.	7	30	1.43	4.87e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,ELN,EDN1,AGTR1,CCL5,VEGFA
PMID:29095861	(2017) Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.	8	48	1.28	4.87e-05	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,IGF1R,ANGPT2,PDGFB,PDGFA,BMP2,BDNF,VEGFA
PMID:29253007	(2017) Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia.	8	48	1.28	4.87e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000317674,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000474412	CXCL10,CXCL11,APOL1,CCL20,CXCL9,JAK2,SAA1,CCL5
PMID:26731721	(2016) FOXP3+ Regulatory T Cells in Hepatic Fibrosis and Splenomegaly Caused by Schistosoma japonicum: The Spleen May Be a Major Source of Tregs in Subjects with Splenomegaly.	7	30	1.43	4.87e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000380365,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,RGN,CCL5
PMID:27143979	(2016) Dental and Nondental Stem Cell Based Regeneration of the Craniofacial Region: A Tissue Based Approach.	7	30	1.43	4.87e-05	9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000356515,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	ELN,VIP,UTRN,BMP2,BDNF,PROM1,VEGFA
PMID:27245276	(2016) Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.	9	70	1.17	4.87e-05	9606.ENSP00000222139,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,HSPB1,CDH1,IGF1R,CAV1,STAT5A,AR,BCL2,VEGFA
PMID:27376284	(2016) Effects and Mechanisms of Low-Intensity Pulsed Ultrasound for Chronic Prostatitis and Chronic Pelvic Pain Syndrome.	7	30	1.43	4.87e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,FABP4,CXCL10,PTGS2,RHOA,MYD88,VEGFA
PMID:27509527	(2016) Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting.	8	48	1.28	4.87e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL9,PTGS2,ENTPD1,BCL2,CCL5
PMID:27774507	(2016) Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease.	7	30	1.43	4.87e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000419422	MPO,NOX4,SIRT6,NOX1,MTHFR,EDN1,AGTR1
PMID:27902740	(2016) Extensive Characterization and Comparison of Endothelial Cells Derived from Dermis and Adipose Tissue: Potential Use in Tissue Engineering.	7	30	1.43	4.87e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANGPT2,CCL20,PTEN,CCL5,VEGFA
PMID:28005985	(2016) Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-alpha.	9	70	1.17	4.87e-05	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CXCL11,PDGFB,PDGFA,CCL20,CXCL9,CCL5,VEGFA
PMID:25548101	(2015) Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?	9	70	1.17	4.87e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,PDGFB,PDGFA,PTEN,PDGFD,RHOA,CCL5,VEGFA
PMID:26042506	(2015) Prostate cancer stroma: an important factor in cancer growth and progression.	7	30	1.43	4.87e-05	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,PDGFB,PDGFA,ELN,AR,BDNF,VEGFA
PMID:26462910	(2015) Biomarkers of severe dengue disease - a review.	8	48	1.28	4.87e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000360997,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,THBS1,CXCL10,ADAMTS13,BCL2,CCL5,VEGFA
PMID:25080108	(2014) The mammary cellular hierarchy and breast cancer.	9	70	1.17	4.87e-05	9606.ENSP00000216862,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809	CYP24A1,CD38,CDH1,ALDH1A1,CD34,STAT5A,BCL2,MME,PROM1
PMID:25162887	(2014) Two clinical phenotypes in polycythemia vera.	8	48	1.28	4.87e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000360997,9606.ENSP00000371067,9606.ENSP00000384262,9606.ENSP00000474412	TGFB1,THBS1,CD34,STAT5A,ADAMTS13,JAK2,HPSE,CCL5
PMID:25165728	(2014) The role of chemokines in breast cancer pathology and its possible use as therapeutic targets.	8	48	1.28	4.87e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,MMP14,CCL20,CXCL9,CCL5,VEGFA
PMID:22950383	(2013) NFAT gene family in inflammation and cancer.	9	70	1.17	4.87e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD69,IFNG,MAPK7,STAT5A,PTGS2,PTEN,EDN1,BCL2,VEGFA
PMID:23386906	(2013) The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.	9	70	1.17	4.87e-05	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,MMP14,CD34,STAT5A,CCL20,EDN1,BCL2,CCL5,VEGFA
PMID:23423565	(2013) Metabolic rescue of obese adipose-derived stem cells by Lin28Let7 pathway.	7	30	1.43	4.87e-05	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368104	FABP4,IGF1R,PLIN1,CD34,CAV1,PTEN,BMP2
PMID:23871589	(2013) Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration.	9	70	1.17	4.87e-05	9606.ENSP00000259486,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000322898,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000426809	ENPP2,MMP14,CD34,ANGPT2,EBF1,BMP2,EDN1,PDGFD,PROM1
PMID:23914259	(2013) Preconditioning strategy in stem cell transplantation therapy.	9	70	1.17	4.87e-05	9606.ENSP00000222139,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,NOX4,CXCL10,CD34,JAK2,BCL2,BDNF,PROM1,VEGFA
PMID:24307973	(2013) Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction.	7	30	1.43	4.87e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000384906,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,CDH1,CD34,SAA1,PROM1,VEGFA
PMID:22384256	(2012) Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase.	7	30	1.43	4.87e-05	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	MPO,CD34,STAT5A,JAK2,BCL2,FGFR1,MME
PMID:22617768	(2012) Endothelium under stress: local and systemic messages.	8	48	1.28	4.87e-05	9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ATM,ANGPT2,PDGFB,TXN,EDN1,BCL2,CCL5,VEGFA
PMID:23230436	(2012) CD8 T cell memory: it takes all kinds.	7	30	1.43	4.87e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CDH1,CXCL10,CXCL11,HNF4A,CXCL9,BCL2
PMID:21912642	(2011) Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.	8	48	1.28	4.87e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000474412	CD38,IFNG,CCR5,CXCL10,CXCL9,RHOA,MME,CCL5
PMID:22015690	(2011) Polyunsaturated fatty acid metabolism in prostate cancer.	9	70	1.17	4.87e-05	9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000383364,9606.ENSP00000393312,9606.ENSP00000478570	FADS2,LPL,PDGFB,PDGFA,PTGS2,PTEN,PLA2G2A,FGFR1,VEGFA
PMID:20498843	(2010) Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.	7	30	1.43	4.87e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CDH1,TIMP3,IGF1R,PTEN,BCL2,VEGFA
PMID:20692200	(2010) Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.	8	48	1.28	4.87e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,IGF1R,CD34,PTEN,PDGFD,BCL2,PROM1
PMID:19482623	(2009) Chemokines and angiogenesis in rheumatoid arthritis.	8	48	1.28	4.87e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5,VEGFA
PMID:19659647	(2009) Development, repair and fibrosis: what is common and why it matters.	8	48	1.28	4.87e-05	9606.ENSP00000293599,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478319	AQP5,HNF4A,PDGFB,PDGFA,FMOD,ELN,HSPG2,GREM1
PMID:15799695	(2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids.	7	30	1.43	4.87e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CAV1,CXCL9,CCL5
PMID:34970118	(2021) Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons.	10	96	1.08	4.91e-05	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CHI3L1,CXCL10,CD34,PTGS2,NFE2L2,LTA,BDNF,CCL5,VEGFA
PMID:33261147	(2020) Danger-SensingPatten Recognition Receptors and Neuroinflammation in Alzheimers Disease.	11	125	1.01	4.91e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000355361,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,LPL,CD47,NTF3,RHOA,MYD88,BDNF,MME,CCL5,VEGFA
PMID:28671573	(2017) Histone Deacetylase Inhibitors as Anticancer Drugs.	10	96	1.08	4.91e-05	9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	APC,THBS1,CDH1,ATM,TXN,JAK2,GAP43,BCL2,PROM1,VEGFA
PMID:26880981	(2016) Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance.	10	96	1.08	4.91e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,PDGFB,PTEN,BMP2,BCL2,BDNF,PROM1,VEGFA
PMID:35148789	(2022) Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment.	9	71	1.16	5.28e-05	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	MAPK1,CD69,ATM,CXCL10,PTEN,TXN,FGFR1,LTA,VEGFA
PMID:34208465	(2021) Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition.	9	71	1.16	5.28e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ATM,CCL20,PTEN,TXN,AR,JAK2,BCL2,PROM1
PMID:34359843	(2021) Extracellular Vesicles Derived from Endothelial Progenitor Cells Protect Human Glomerular Endothelial Cells and Podocytes from Complement- and Cytokine-Mediated Injury.	9	71	1.16	5.28e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000384262,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CD34,PDGFA,CXCL9,HPSE,PROM1,VEGFA
PMID:34680249	(2021) Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.	9	71	1.16	5.28e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,IGF1R,ALDH1A1,CD34,CD47,PTEN,AR,PROM1,CCL5
PMID:34681787	(2021) The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease.	9	71	1.16	5.28e-05	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000474412	NOX4,CXCL10,PRKCE,SIRT6,SREBF1,CXCL9,RBP4,EDN1,CCL5
PMID:34948368	(2021) Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment.	11	126	1.0	5.28e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,PTGS2,ENTPD1,PTEN,AR,BCL2,RHOA,MYD88,CCL5,VEGFA
PMID:32668602	(2020) The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management.	9	71	1.16	5.28e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000351807,9606.ENSP00000352264,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399	IFNG,CDH1,PLIN1,ELN,CD2AP,HSPG2,BCL2,NPY,MYD88
PMID:33076386	(2020) Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD.	9	71	1.16	5.28e-05	9606.ENSP00000246553,9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000348069,9606.ENSP00000358513,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422	FFAR1,CCR5,P2RY1,SREBF1,CNR1,TXN,JAK2,RHOA,AGTR1
PMID:33330442	(2020) Tumor Microenvironment Uses a Reversible Reprogramming of Mesenchymal Stromal Cells to Mediate Pro-tumorigenic Effects.	9	71	1.16	5.28e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CD34,CCL20,CXCL9,RARRES2,PROM1,CCL5,VEGFA
PMID:33597880	(2020) Tanshinone IIA: A Review of its Anticancer Effects.	9	71	1.16	5.28e-05	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,IGF1R,PTGS2,CYP2J2,PTEN,AR,BCL2,PROM1,VEGFA
PMID:31341421	(2019) Immunological Pathways Triggered by Porphyromonas gingivalis and Fusobacterium nucleatum: Therapeutic Possibilities?	9	71	1.16	5.28e-05	9606.ENSP00000216181,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000345708,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399	MYH9,P2RY1,CXCL10,CXCL11,KCNJ11,CXCL9,BCL2,RHOA,MYD88
PMID:31888477	(2019) Proximal femoral head transcriptome reveals novel candidate genes related to epiphysiolysis in broiler chickens.	11	126	1.0	5.28e-05	9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000347041,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185	THBS1,COL8A1,ALDH1A1,PLIN1,CD34,STAT5A,FMOD,SREBF1,ELN,JAK2,BCL2
PMID:29662489	(2018) Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.	11	126	1.0	5.28e-05	9606.ENSP00000261769,9606.ENSP00000345708,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,KCNJ11,MAP3K5,PTGS2,ENTPD1,PTEN,JAK2,NFE2L2,BCL2,MYD88,VEGFA
PMID:29743988	(2018) Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer.	9	71	1.16	5.28e-05	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	FABP4,LPL,SREBF1,MAP3K5,PTGS2,JAK2,BCL2,MYD88,VEGFA
PMID:29785138	(2018) A review of soft-tissue sarcomas: translation of biological advances into treatment measures.	11	126	1.0	5.28e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,PLIN1,CD34,CD47,PTEN,AR,G6PD,BCL2,VEGFA
PMID:27481707	(2017) Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets.	9	71	1.16	5.28e-05	9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,MMP14,HNF4A,STAT5A,PTEN,AR,JAK2,BCL2,VEGFA
PMID:27018053	(2016) Progression and metastasis of lung cancer.	11	126	1.0	5.28e-05	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,CDH1,MMP14,ANGPT2,FMOD,ELN,PTEN,HSPG2,FGFR1,PROM1,VEGFA
PMID:25954568	(2015) Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.	9	71	1.16	5.28e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ELN,CXCL9,PTGS2,NFE2L2,MYD88,CCL5,VEGFA
PMID:26220993	(2015) Fibroblast growth factor signaling in skeletal development and disease.	9	71	1.16	5.28e-05	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,HNF4A,STAT5A,PTGS2,HSPG2,KL,BCL2,FGFR1,VEGFA
PMID:26328267	(2015) Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals.	9	71	1.16	5.28e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	SOX9,CDH1,TIMP3,ATM,ALDH1A1,CXCL10,PTEN,AR,BCL2
PMID:26664907	(2015) Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues.	9	71	1.16	5.28e-05	9606.ENSP00000263774,9606.ENSP00000301522,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	NDUFS3,PRDX2,PRKCE,MAPK7,PDGFB,STAT5A,JAK2,BCL2,VEGFA
PMID:24978438	(2014) Cancer associated fibroblasts and tumor growth: focus on multiple myeloma.	9	71	1.16	5.28e-05	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD38,THBS1,CXCL10,CAV1,CXCL9,EDN1,RHOA,CCL5,VEGFA
PMID:21859497	(2011) Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.	9	71	1.16	5.28e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,IGF1R,PTGS2,PTEN,AR,BCL2,PROM1,VEGFA
PMID:20306120	(2010) Apigenin: a promising molecule for cancer prevention.	9	71	1.16	5.28e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	APC,CDH1,IGF1R,PTGS2,PTEN,AR,BCL2,CCL5,VEGFA
PMID:35128104	(2022) Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review.	10	97	1.07	5.32e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,NOX4,IGF1R,SIRT6,MAP3K5,PTGS2,PTEN,BCL2,VEGFA
PMID:33448320	(2021) Molecular mechanisms of astragaloside-IV in cancer therapy (Review).	10	97	1.07	5.32e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,TIMP3,SIRT6,CAV1,PTGS2,NOX1,BCL2,RHOA,VEGFA
PMID:32317939	(2020) Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions.	10	97	1.07	5.32e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303	CD38,CXCL10,LPL,GAS6,CD47,CNTF,EDN1,FGFR1,RHOA,BDNF
PMID:34610110	(2022) Targeting cholesterol homeostasis in hematopoietic malignancies.	8	49	1.27	5.33e-05	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399	IFNG,CD34,STAT5A,SREBF1,ABCG1,BCL2,RHOA,MYD88
PMID:35158846	(2022) Metformin as a Potential Treatment Option for Endometriosis.	8	49	1.27	5.33e-05	9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PDGFB,PTGS2,EDN1,JAK2,NFE2L2,BCL2,VEGFA
PMID:35299293	(2022) Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes.	8	49	1.27	5.33e-05	9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,ANGPT2,NFE2L2,FGFR1,RHOA,BDNF,CCL5,VEGFA
PMID:35352887	(2022) Chemokine Receptor Profiles of T Cells in Patients with Age-Related Macular Degeneration.	8	49	1.27	5.33e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:33511992	(2021) ACE2Ang-(1-7)Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.	8	49	1.27	5.33e-05	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422	NOX4,CD34,NOX1,KL,NFE2L2,RHOA,MME,AGTR1
PMID:33522929	(2021) Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer.	8	49	1.27	5.33e-05	9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000384262,9606.ENSP00000426809,9606.ENSP00000478570	CD69,IGF1R,ANGPT2,CD247,ENTPD1,HPSE,PROM1,VEGFA
PMID:33803151	(2021) The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.	8	49	1.27	5.33e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,CDH1,ALDH1A1,PTEN,G6PD,BCL2,PROM1,HNF1B
PMID:33920726	(2021) A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimers Disease, Aging, Cancer, Inflammation, and Diabetes.	8	49	1.27	5.33e-05	9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	SIRT6,SREBF1,PTGS2,PTEN,JAK2,NFE2L2,BCL2,VEGFA
PMID:34179307	(2021) Functional roles of lncRNAs in the pathogenesis and progression of cancer.	8	49	1.27	5.33e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,IGF1R,ATM,PTEN,AR,JAK2,BCL2,FGFR1
PMID:34335253	(2021) Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease.	8	49	1.27	5.33e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	MPO,IFNG,CHI3L1,CDH1,PTGS2,JAK2,BCL2,MYD88
PMID:34678727	(2021) Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19.	8	49	1.27	5.33e-05	9606.ENSP00000265333,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478319	VDAC1,CCR5,CD34,CD247,PTGS2,NOX1,CCL5,GREM1
PMID:34803491	(2021) Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4Pten mutant mice.	8	49	1.27	5.33e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL9,PTEN,NFE2L2,CCL5,VEGFA
PMID:32012885	(2020) Targeting the Immune system and Epigenetic Landscape of Urological Tumors.	8	49	1.27	5.33e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CXCL9,PTEN,AR,NFE2L2,VEGFA
PMID:32280305	(2020) Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches.	8	49	1.27	5.33e-05	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CDH1,ALDH1A1,CD34,PTEN,PROM1,VEGFA
PMID:32316469	(2020) Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.	8	49	1.27	5.33e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,PDGFA,CXCL9,PDGFD,BCL2,VEGFA
PMID:32679655	(2020) Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications.	8	49	1.27	5.33e-05	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CYP24A1,CDH1,HNF4A,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:32760219	(2020) Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review.	8	49	1.27	5.33e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000334329,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000480291	CDH1,IGF1R,ALDH1A1,MMP14,UNC5B,BCL2,PROM1,HNF1B
PMID:30724027	(2019) Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies.	8	49	1.27	5.33e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000426809	IGF1R,ATM,ALDH1A1,PRKAA1,PTEN,BCL2,AGTR1,PROM1
PMID:30791448	(2019) The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells.	8	49	1.27	5.33e-05	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000403495,9606.ENSP00000478570	ENPP2,THBS1,CDH1,MAP3K5,BCL2,NPY,LTA,VEGFA
PMID:31665139	(2019) Investigating the potential of the secretome of mesenchymal stem cells derived from sickle cell disease patients.	8	49	1.27	5.33e-05	9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,EPOR,THBS1,CD34,ANG,EDN1,BDNF,VEGFA
PMID:31810474	(2019) Ovarian cancer stem cells and targeted therapy.	8	49	1.27	5.33e-05	9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,CD34,HNF4A,PTEN,BCL2,MYD88,PROM1,VEGFA
PMID:30559739	(2018) Adipose Tissue T Cells in HIVSIV Infection.	8	49	1.27	5.33e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000381185,9606.ENSP00000474412	CD69,IFNG,CCR5,CXCL10,CCL20,RBP4,BCL2,CCL5
PMID:28567184	(2017) Molecular classifications of gastric cancers: Novel insights and possible future applications.	8	49	1.27	5.33e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,JAK2,FGFR1,RHOA,VEGFA
PMID:28115942	(2016) Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.	8	49	1.27	5.33e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,CD47,BMP2,BCL2,PROM1,VEGFA
PMID:25858952	(2015) New signaling pathways govern the host response to C. albicans infection in various niches.	8	49	1.27	5.33e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000366395,9606.ENSP00000376865	MAPK1,IFNG,CDH1,PDGFB,PDGFA,PTGS2,SYVN1,PDGFD
PMID:26693479	(2015) Oxidative Stress in Placenta: Health and Diseases.	8	49	1.27	5.33e-05	9606.ENSP00000265132,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	AMBP,ATM,MAP3K5,PTEN,TXN,NFE2L2,BCL2,VEGFA
PMID:27308453	(2015) Oncosuppressive functions of decorin.	8	49	1.27	5.33e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,TIMP3,IGF1R,CAV1,PDGFA,BCL2,RHOA,VEGFA
PMID:24267432	(2013) Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa.	8	49	1.27	5.33e-05	9606.ENSP00000278616,9606.ENSP00000278840,9606.ENSP00000317674,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000375844,9606.ENSP00000418823,9606.ENSP00000480291	ATM,FADS2,APOL1,KCNJ11,PTEN,CAPN10,FTO,HNF1B
PMID:21538852	(2011) Chemopreventive effects of tea in prostate cancer: green tea versus black tea.	8	49	1.27	5.33e-05	9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	HNF4A,ELN,COMT,PTGS2,AR,BCL2,PROM1,VEGFA
PMID:20531305	(2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.	8	49	1.27	5.33e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,HNF4A,PTEN,RHOA,PROM1
PMID:20824205	(2010) Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas.	13	194	0.89	5.33e-05	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000403495	MAPK1,CD69,CCR5,CXCL10,CXCL11,MAPK7,PDGFB,STAT5A,CXCL9,CD47,JAK2,RHOA,LTA
PMID:19890492	(2008) Angiogenesis, Kaposis Sarcoma and Kaposis Sarcoma-Associated Herpesvirus.	8	49	1.27	5.33e-05	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,MMP14,HNF4A,ANGPT2,CCL20,PTGS2,LTA,VEGFA
PMID:33572903	(2021) The Pancreatic beta-Cell: The Perfect Redox System.	12	159	0.94	5.39e-05	9606.ENSP00000246553,9606.ENSP00000259486,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000345708,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000419313	FFAR1,ENPP2,NOX4,PRDX2,LPL,SIRT6,KCNJ11,MAP3K5,TXN,NFE2L2,RHOA,TRPC1
PMID:34051847	(2021) Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.	12	159	0.94	5.39e-05	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CD38,APC,CDH1,ALDH1A1,CD34,BMP2,BCL2,MME,FTO,PROM1,VEGFA
PMID:35158927	(2022) Specialized Intercellular Communications via Tunnelling Nanotubes in Acute and Chronic Leukemia.	7	31	1.41	5.55e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	CD38,IFNG,CXCL10,CD34,STAT5A,JAK2,VEGFA
PMID:35304529	(2022) Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis.	7	31	1.41	5.55e-05	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	IFNG,MMP14,PDGFB,PDGFA,EDN1,BCL2,AGTR1
PMID:35328654	(2022) Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling.	7	31	1.41	5.55e-05	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,IFNG,SOX9,STAT5A,BMP2,JAK2,VEGFA
PMID:35432570	(2022) Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study.	7	31	1.41	5.55e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,CXCL10,PTGS2,JAK2,CCL5,VEGFA
PMID:34204735	(2021) Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk.	7	31	1.41	5.55e-05	9606.ENSP00000225275,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000419422	MPO,ELN,S100A12,EDN1,NFE2L2,MYD88,AGTR1
PMID:34607558	(2021) Expression of and correlational patterns among neuroinflammatory, neuropeptide, and neuroendocrine molecules from cerebrospinal fluid in cerebral palsy.	7	31	1.41	5.55e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CNTF,NPY,BDNF,CCL5,VEGFA
PMID:34680307	(2021) A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer Metastasis.	11	127	1.0	5.55e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,THBS1,TIMP3,ANGPT2,PDGFB,ELN,PTEN,AR,BMP2,EDN1,VEGFA
PMID:35052582	(2021) Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome.	7	31	1.41	5.55e-05	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,CD34,SIRT6,PTEN,NFE2L2,BCL2,VEGFA
PMID:31984665	(2020) Engineering a collagen matrix for cell-instructive regenerative angiogenesis.	7	31	1.41	5.55e-05	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000478570	IFNG,MMP14,ANG,ELN,HSPG2,BMP2,VEGFA
PMID:32085420	(2020) Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention.	7	31	1.41	5.55e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000381185	MPO,CDH1,ATM,COMT,MTHFR,SHBG,BCL2
PMID:32701678	(2020) Molecular profiling in sarcoidosis.	7	31	1.41	5.55e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185	CD69,CCR5,CXCL10,CXCL11,CXCL9,JAK2,BCL2
PMID:32962225	(2020) ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis.	7	31	1.41	5.55e-05	9606.ENSP00000229135,9606.ENSP00000284031,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000477707	IFNG,DDAH1,ABCG1,PTGS2,RHOA,CCL5,NR1H3
PMID:33375383	(2020) Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma.	7	31	1.41	5.55e-05	9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TIMP3,ATM,ALDH1A1,PTEN,BCL2,PROM1,VEGFA
PMID:30816803	(2019) DKK3 (Dikkopf-3) Transdifferentiates Fibroblasts Into Functional Endothelial Cells-Brief Report.	7	31	1.41	5.55e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,ANGPT2,ANG,EDN1,PROM1,VEGFA
PMID:31166464	(2019) The role of ischemic preconditioning in the expression of apoptosis-related genes in a rat model of intestinal ischemia-reperfusion injury.	7	31	1.41	5.55e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412	THBS1,CCR5,EDNRA,CAV1,EDN1,BCL2,CCL5
PMID:29449774	(2018) Reactive Oxygen Species: A Key Constituent in Cancer Survival.	7	31	1.41	5.55e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,NOX4,PTGS2,PTEN,TXN,NFE2L2,VEGFA
PMID:29651102	(2018) Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model.	7	31	1.41	5.55e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000380365,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX4,CD34,NOX1,RGN,PROM1,VEGFA
PMID:29936596	(2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.	7	31	1.41	5.55e-05	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000306124,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000477707	FABP4,CCR5,PRKCE,CAV1,SREBF1,MAP3K5,NR1H3
PMID:29953538	(2018) Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.	7	31	1.41	5.55e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:27653015	(2017) Peroxiredoxin 1 - an antioxidant enzyme in cancer.	7	31	1.41	5.55e-05	9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000478570	CDH1,PRDX2,MAP3K5,PTEN,TXN,AR,VEGFA
PMID:28748667	(2017) A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques.	7	31	1.41	5.55e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:29225709	(2017) Immunomodulatory Effects of Human Cryopreserved Viable Amniotic Membrane in a Pro-Inflammatory Environment In Vitro.	7	31	1.41	5.55e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363973,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,ANGPT2,PDGFB,ALPL,CCL5,VEGFA
PMID:27356868	(2016) Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts.	7	31	1.41	5.55e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,ANG,CXCL9,MYD88,CCL5,VEGFA
PMID:27522581	(2016) Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.	7	31	1.41	5.55e-05	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000354901,9606.ENSP00000474412	FABP4,CCR5,CXCL10,CXCL11,LPL,CXCL9,CCL5
PMID:24402967	(2014) Growth factor and signaling pathways and their relevance to prostate cancer therapeutics.	7	31	1.41	5.55e-05	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,IGF1R,PTEN,AR,EDN1,BCL2,VEGFA
PMID:24913676	(2014) Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.	7	31	1.41	5.55e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CDH1,EDNRA,PTGS2,PTEN,EDN1,VEGFA
PMID:23169287	(2013) Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.	7	31	1.41	5.55e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CD247,CXCL9,CCL5
PMID:23829793	(2013) Pulmonary arterial hypertension.	7	31	1.41	5.55e-05	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	EDNRA,CAV1,VIP,EDN1,RHOA,CCL5,VEGFA
PMID:23097661	(2012) Atherosclerosis: from biology to pharmacological treatment.	7	31	1.41	5.55e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CETP,MPO,IFNG,CCR5,ENTPD1,CCL5,VEGFA
PMID:23189073	(2012) Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina.	7	31	1.41	5.55e-05	9606.ENSP00000248553,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CNTF,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:20036813	(2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment.	7	31	1.41	5.55e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CDH1,CD34,PTGS2,PTEN,GREM1,VEGFA
PMID:34418449	(2022) Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities.	9	72	1.16	5.64e-05	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356213,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000419422	CXCL10,LPL,HNF4A,SREBF1,VIP,AR,NFE2L2,NPY,AGTR1
PMID:35203449	(2022) Quantitative Proteomics of Polarised Macrophages Derived from Induced Pluripotent Stem Cells.	10	98	1.07	5.64e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000478570	CD38,IFNG,TIMP3,CXCL10,CXCL11,GAS6,STAT5A,CXCL9,MYD88,VEGFA
PMID:35378955	(2022) Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine.	9	72	1.16	5.64e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,FABP4,LPL,CD34,ALPL,G6PD,BCL2,VEGFA,HNF1B
PMID:33397409	(2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.	10	98	1.07	5.64e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,CD34,HNF4A,ELN,JAK2,BCL2,PROM1,VEGFA
PMID:33640537	(2021) Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.	9	72	1.16	5.64e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,PTGS2,JAK2,MYD88,CCL5,VEGFA
PMID:33815388	(2021) Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS or Anti-CD3 and Anti-CD28.	10	98	1.07	5.64e-05	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000346148,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438	MAPK1,CD38,CD69,IFNG,CCR5,CXCL10,PRKAA1,CCL20,CXCL9,PTGS2
PMID:33937276	(2021) The Charming World of the Extracellular Matrix: A Dynamic and Protective Network of the Intestinal Wall.	9	72	1.16	5.64e-05	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	TIMP3,MMP14,ELN,PTGS2,ANGPTL2,HSPG2,BMP2,GREM1,VEGFA
PMID:33949207	(2021) Role of the Immune Microenvironment in SARS-CoV-2 Infection.	9	72	1.16	5.64e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	MPO,CD38,IFNG,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5
PMID:33959218	(2021) Calcium channels and their role in regenerative medicine.	10	98	1.07	5.64e-05	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000265333,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CD38,SOX9,VDAC1,CD34,BMP2,BDNF,TRPC1,PROM1,VEGFA,HNF1B
PMID:34059091	(2021) Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.	9	72	1.16	5.64e-05	9606.ENSP00000246553,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	FFAR1,CXCL10,CXCL9,PTGS2,TXN,JAK2,BCL2,MYD88,CCL5
PMID:34885091	(2021) Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma.	10	98	1.07	5.64e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,CXCL10,ANGPT2,STAT5A,CCL20,PTEN,JAK2,FGFR1,VEGFA
PMID:35281989	(2021) Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis.	10	98	1.07	5.64e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	TGFB1,IFNG,NOX4,ATM,CCR5,CXCL10,CD34,BCL2,LTA,VEGFA
PMID:32477114	(2020) Matrine: A Promising Natural Product With Various Pharmacological Activities.	9	72	1.16	5.64e-05	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,MMP14,PTEN,JAK2,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:32630699	(2020) The CCL5CCR5 Axis in Cancer Progression.	9	72	1.16	5.64e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CDH1,CCR5,CD34,STAT5A,AR,PROM1,CCL5,VEGFA
PMID:32894370	(2020) Gastric cancer: a comprehensive review of current and future treatment strategies.	10	98	1.07	5.64e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MAPK1,IFNG,CDH1,ATM,PDGFB,JAK2,BCL2,CCL5,GREM1,VEGFA
PMID:33262760	(2020) IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.	10	98	1.07	5.64e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,LPL,CXCL9,EDN1,MYD88,PROM1,VEGFA
PMID:30691108	(2019) Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications.	10	98	1.07	5.64e-05	9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,PLIN1,LPL,SIRT6,CAV1,SREBF1,PTEN,RHOA,PROM1,VEGFA
PMID:30867826	(2019) Immune targets in the tumor microenvironment treated by radiotherapy.	9	72	1.16	5.64e-05	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ATM,CXCL10,CCL20,ELN,CXCL9,CD47,CCL5,VEGFA
PMID:31080804	(2019) Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing.	9	72	1.16	5.64e-05	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399	TIMP3,CCR5,CXCL10,MMP14,SREBF1,ELN,PTGS2,BCL2,MYD88
PMID:31212734	(2019) Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases.	9	72	1.16	5.64e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,CDH1,ALDH1A1,CD34,ANG,CD47,MYD88,MME,VEGFA
PMID:31261963	(2019) Tumor Microenvironment as A Game Changer in Cancer Radiotherapy.	9	72	1.16	5.64e-05	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,ATM,CXCL10,ENTPD1,EDN1,RHOA,MYD88,CCL5,VEGFA
PMID:31287024	(2019) Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases.	9	72	1.16	5.64e-05	9606.ENSP00000225275,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	MPO,ONECUT1,CD34,HNF4A,EDN1,NFE2L2,BCL2,AGTR1,VEGFA
PMID:31319485	(2019) Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies.	10	98	1.07	5.64e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,NOX4,STAT5A,SREBF1,NOX1,TXN,JAK2,BCL2,VEGFA
PMID:31341493	(2019) In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells.	9	72	1.16	5.64e-05	9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,ALDH1A1,CD34,CD47,PTEN,BCL2,PROM1,CCL5,VEGFA
PMID:31571172	(2019) Roles of Drug Transporters in Blood-Retinal Barrier.	10	98	1.07	5.64e-05	9606.ENSP00000221930,9606.ENSP00000293599,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,AQP5,CAV1,VIP,PTGS2,AR,RHOA,AGTR1,CCL5,VEGFA
PMID:29915722	(2018) New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.	10	98	1.07	5.64e-05	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000474412	TGFB1,CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2,MME,CCL5
PMID:30206237	(2018) Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal.	9	72	1.16	5.64e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368104	CD38,ATM,CD34,HNF4A,STAT5A,ELN,PTEN,ALPL,BMP2
PMID:30559664	(2018) Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome.	9	72	1.16	5.64e-05	9606.ENSP00000200676,9606.ENSP00000259407,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000477707	CETP,BAAT,LPL,HNF4A,SREBF1,ABCG1,PTGS2,EDN1,NR1H3
PMID:30670929	(2018) Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage.	9	72	1.16	5.64e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,THBS1,CDH1,IGF1R,NOX1,EDN1,SAA1,CCL5,VEGFA
PMID:28108348	(2017) Epigenetic basis of cancer health disparities: Looking beyond genetic differences.	9	72	1.16	5.64e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CDH1,TIMP3,MMP14,CAV1,PTGS2,PTEN,AR,BCL2,MME
PMID:26342753	(2016) Microglia in the TBI brain: The good, the bad, and the dysregulated.	9	72	1.16	5.64e-05	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CXCL10,CXCL9,CD47,PTEN,BCL2,BDNF,CCL5,VEGFA
PMID:26771115	(2016) The Emerging Hallmarks of Cancer Metabolism.	9	72	1.16	5.64e-05	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000418823,9606.ENSP00000478570	FABP4,LPL,HNF4A,SIRT6,GFPT1,PTEN,G6PD,FTO,VEGFA
PMID:24715669	(2014) Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells.	9	72	1.16	5.64e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000304767,9606.ENSP00000312987,9606.ENSP00000383232,9606.ENSP00000478570,9606.ENSP00000480291	TGFB1,SOX9,CDH1,ONECUT1,P2RY1,HNF4A,GGT1,VEGFA,HNF1B
PMID:26813625	(2013) The role of microRNAs in prostate cancer progression.	9	72	1.16	5.64e-05	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,MAPK7,PTEN,AR,PDGFD,BCL2,FGFR1,RHOA,PROM1
PMID:20370557	(2010) Reactive oxygen species in cancer.	9	72	1.16	5.64e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	HSPB1,CDH1,ATM,MAP3K5,PTGS2,PTEN,NOX1,TXN,BCL2
PMID:19249983	(2009) Emerging therapies for multiple myeloma.	9	72	1.16	5.64e-05	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CD38,IGF1R,CD34,HNF4A,CCL20,PTEN,JAK2,RHOA,VEGFA
PMID:35185461	(2022) Plausible Mechanism of Sham Acupuncture Based on Biomarkers: A Systematic Review of Randomized Controlled Trials.	6	17	1.61	5.75e-05	9606.ENSP00000229135,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,VIP,NPY,LTA,BDNF,VEGFA
PMID:34322995	(2021) Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.	6	17	1.61	5.75e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,IGF1R,AR,JAK2,IRAK4,MYD88
PMID:30880689	(2019) Losartan improves erectile function through suppression of corporal apoptosis and oxidative stress in rats with cavernous nerve injury.	6	17	1.61	5.75e-05	9606.ENSP00000221930,9606.ENSP00000339916,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	TGFB1,LIMK2,NFE2L2,BCL2,RHOA,AGTR1
PMID:30985344	(2019) Electrical stimulation for neuroregeneration in urology: a new therapeutic paradigm.	6	17	1.61	5.75e-05	9606.ENSP00000221930,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000484631	TGFB1,GAP43,BCL2,BDNF,VEGFA,PMP22
PMID:30026579	(2018) Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function.	6	17	1.61	5.75e-05	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IGF1R,PTGS2,KL,CCL5,VEGFA
PMID:28300758	(2017) Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement.	6	17	1.61	5.75e-05	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IGF1R,PTGS2,JAK2,BCL2,VEGFA
PMID:26709781	(2016) TLR4 regulates pulmonary vascular homeostasis and remodeling via redox signaling.	6	17	1.61	5.75e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000401399	TGFB1,IFNG,NOX4,NOX1,BCL2,MYD88
PMID:26976446	(2016) EMD in periodontal regenerative surgery modulates cytokine profiles: A randomised controlled clinical trial.	6	17	1.61	5.75e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,PDGFA,CCL5,VEGFA
PMID:25606819	(2015) Proapoptotic effect of endocannabinoids in prostate cancer cells.	6	17	1.61	5.75e-05	9606.ENSP00000261769,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CNR1,PTEN,CNR2,BCL2,VEGFA
PMID:26219952	(2015) Inhibition of NOX14 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.	6	17	1.61	5.75e-05	9606.ENSP00000263317,9606.ENSP00000355370,9606.ENSP00000362057,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CNTF,NOX1,BDNF,CCL5,VEGFA
PMID:23383140	(2013) Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-alpha-induced damage.	6	17	1.61	5.75e-05	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,STAT5A,CNTF,JAK2,BDNF,VEGFA
PMID:22348081	(2012) Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFbeta activation.	6	17	1.61	5.75e-05	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000384906,9606.ENSP00000419422,9606.ENSP00000478570	CD69,THBS1,CDH1,SAA1,AGTR1,VEGFA
PMID:22461458	(2012) New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy.	6	17	1.61	5.75e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,CAV1,PTEN,FGFR1,VEGFA
PMID:21350645	(2010) Clinical and experimental advances in regeneration of spinal cord injury.	6	17	1.61	5.75e-05	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,GAP43,NTF3,RHOA,BDNF,VEGFA
PMID:18971436	(2008) Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes.	6	17	1.61	5.75e-05	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,HNF4A,KCNJ11,FTO,HNF1B
PMID:34298612	(2021) Oncogenic Functions and Clinical Significance of Circular RNAs in Colorectal Cancer.	11	128	1.0	5.77e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000479617	SOX9,CDH1,IGF1R,MMP14,PTEN,JAK2,BCL2,RHOA,CCL5,VEGFA,UHRF1
PMID:34944837	(2021) Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.	11	128	1.0	5.77e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,THBS1,CDH1,IGF1R,ALDH1A1,MMP14,ANGPT2,PTEN,HSPG2,PROM1,VEGFA
PMID:30857134	(2019) Monitoring of pH Using an i-Motif-Forming Sequence Containing a Fluorescent Cytosine Analogue, tC.	5	7	1.91	5.77e-05	9606.ENSP00000283928,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	JAZF1,PDGFA,BCL2,NPY,VEGFA
PMID:28599441	(2017) Effects of silencing endothelin-1 on invasion and vascular formation in lung cancer.	5	7	1.91	5.77e-05	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,PTGS2,EDN1,RHOA,VEGFA
PMID:24184161	(2014) Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.	5	7	1.91	5.77e-05	9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	EDNRA,PTGS2,EDN1,BCL2,VEGFA
PMID:22876248	(2012) Novel identified receptors on mast cells.	11	128	1.0	5.77e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000358513,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,STAT5A,CCL20,CXCL9,CNR1,IRAK4,MYD88,CCL5,VEGFA
PMID:23363796	(2012) [Blockage of Th17 cells differentiation exacerbated mouse acute intestine graft-versus-host disease following allogeneic bone marrow transplantation].	5	7	1.91	5.77e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CCL20,CXCL9
PMID:33513753	(2021) iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression.	8	50	1.27	5.82e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CCR5,CD34,ANGPT2,PDGFA,CCL5,GREM1,VEGFA
PMID:34193229	(2021) Molecular pathogenesis of the myeloproliferative neoplasms.	8	50	1.27	5.82e-05	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067	EPOR,CD38,IFNG,ATM,CD34,STAT5A,PTEN,JAK2
PMID:34234885	(2021) Roles of Dietary Bioactive Peptides in Redox Balance and Metabolic Disorders.	8	50	1.27	5.82e-05	9606.ENSP00000256104,9606.ENSP00000301522,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000419422	FABP4,PRDX2,LPL,SREBF1,JAK2,NFE2L2,NPY,AGTR1
PMID:35096588	(2021) Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment.	8	50	1.27	5.82e-05	9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	ONECUT1,CXCL10,HNF4A,BMP2,BCL2,PROM1,VEGFA,HNF1B
PMID:32265903	(2020) Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD).	8	50	1.27	5.82e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000478570	THBS1,TIMP3,CXCL10,CD247,CD47,PTGS2,NPY,VEGFA
PMID:32765418	(2020) Protective Effects of PACAP in Peripheral Organs.	8	50	1.27	5.82e-05	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,CXCL10,ANG,VIP,EDN1,BCL2,MYD88,VEGFA
PMID:32842503	(2020) Angiogenesis Inhibition in Prostate Cancer: An Update.	8	50	1.27	5.82e-05	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	TIMP3,IGF1R,CXCL10,MMP14,PTGS2,AR,FGFR1,VEGFA
PMID:33022979	(2020) Susceptibility Factors in Chronic Lung Inflammatory Responses to Engineered Nanomaterials.	8	50	1.27	5.82e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000474412	MPO,CCR5,CXCL10,PDGFB,PDGFA,CD47,PTGS2,CCL5
PMID:33281910	(2020) Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant.	8	50	1.27	5.82e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000414303	MAPK1,TGFB1,IFNG,IGF1R,PTGS2,PTEN,JAK2,BDNF
PMID:33424605	(2020) Natural Xanthones and Skin Inflammatory Diseases: Multitargeting Mechanisms of Action and Potential Application.	8	50	1.27	5.82e-05	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,MPO,CXCL10,CXCL9,NFE2L2,BCL2,CCL5,VEGFA
PMID:30638892	(2019) gRASping the redox lever to modulate cancer cell fate signaling.	8	50	1.27	5.82e-05	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185	MAPK1,NOX4,MAP3K5,PTEN,NOX1,TXN,G6PD,BCL2
PMID:31174392	(2019) Chemokines in COPD: From Implication to Therapeutic Use.	8	50	1.27	5.82e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,CXCL9,RHOA,CCL5,VEGFA
PMID:31358069	(2019) Epidermal stem cells in wound healing and their clinical applications.	8	50	1.27	5.82e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000479617	SOX9,CDH1,CD34,HNF4A,SIRT6,CAV1,ELN,UHRF1
PMID:28466274	(2018) Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.	8	50	1.27	5.82e-05	9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	CD34,BCL2,NTF3,BDNF,PROM1,CCL5,VEGFA,HNF1B
PMID:30035032	(2018) Molecular pathogenesis of fracture nonunion.	8	50	1.27	5.82e-05	9606.ENSP00000268035,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478319,9606.ENSP00000478570	IGF1R,FMOD,PTGS2,BAMBI,BMP2,FGFR1,GREM1,VEGFA
PMID:28435677	(2017) Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?	8	50	1.27	5.82e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,PTEN,EDN1,CCL5,VEGFA
PMID:27340271	(2016) Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.	8	50	1.27	5.82e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000478570	MPO,CCR5,PTGS2,BCL2,SAA1,RHOA,RARRES2,VEGFA
PMID:27477490	(2016) Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.	8	50	1.27	5.82e-05	9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	SIRT6,SGK1,PTEN,EDN1,KL,RHOA,CCL5,VEGFA
PMID:25663852	(2015) Emerging role of microRNA in hepatocellular carcinoma (Review).	8	50	1.27	5.82e-05	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000478570	TIMP3,IGF1R,HNF4A,PTEN,BCL2,RHOA,LTA,VEGFA
PMID:26016501	(2015) Whats New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment.	8	50	1.27	5.82e-05	9606.ENSP00000225275,9606.ENSP00000266085,9606.ENSP00000298352,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,TIMP3,NGB,COMT,PTEN,BCL2,BDNF,VEGFA
PMID:26464991	(2015) The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells	8	50	1.27	5.82e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,IGF1R,CNTF,PTEN,JAK2,BCL2,RHOA,BDNF
PMID:26556350	(2015) Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1DNA Minor Groove Adducts.	8	50	1.27	5.82e-05	9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	ATM,HNF4A,MAP3K5,PTGS2,AR,EDN1,BCL2,AGTR1
PMID:25566531	(2014) Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer.	8	50	1.27	5.82e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,IFNG,CDH1,CAV1,JAK2,BCL2,RHOA,VEGFA
PMID:23432874	(2013) Innate and adaptive anti-HIV immune responses in the female reproductive tract.	8	50	1.27	5.82e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5
PMID:25258675	(2013) Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.	8	50	1.27	5.82e-05	9606.ENSP00000248553,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,MMP14,CAV1,ELN,CD47,HSPG2,RHOA,VEGFA
PMID:23105975	(2012) Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases.	8	50	1.27	5.82e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,EDNRA,ANG,CCL20,NFE2L2,CCL5,VEGFA
PMID:23130099	(2012) Platelets in pulmonary vascular physiology and pathology.	8	50	1.27	5.82e-05	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,TGFB1,ELN,PTGS2,ENTPD1,ADAMTS13,CCL5,VEGFA
PMID:21342498	(2011) Metastasis: new perspectives on an old problem.	8	50	1.27	5.82e-05	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,HSPB1,CD34,PTEN,BCL2,PROM1,CCL5,VEGFA
PMID:15296517	(2004) Identification of genes differentially expressed in T cells following stimulation with the chemokines CXCL12 and CXCL10.	8	50	1.27	5.82e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000381185	CD38,CCR5,CXCL10,CXCL11,CD34,CXCL9,TXN,BCL2
PMID:29263927	(....) targeting cellular pathways in glioblastoma multiforme.	8	50	1.27	5.82e-05	9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,CXCL11,PDGFB,PDGFA,PTEN,PDGFD,FGFR1,VEGFA
PMID:28358273	(2017) New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets.	12	161	0.93	5.83e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000366395,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,IFNG,APC,CDH1,MAP3K5,PTGS2,PTEN,SYVN1,NFE2L2,BCL2,PROM1,VEGFA
PMID:28577489	(2017) European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).	12	161	0.93	5.83e-05	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000284031,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,VDAC1,ATM,DDAH1,SIRT6,CAV1,MAP3K5,PTEN,NOX1,AR,EDN1,VEGFA
PMID:32426372	(2020) A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature.	10	99	1.07	5.94e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	CXCL10,CD34,ANGPT2,PDGFB,CAV1,PDGFA,CCL20,CXCL9,EDN1,CCL5
PMID:30356678	(2018) The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity.	10	99	1.07	5.94e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000339916,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,FABP4,CDH1,IGF1R,MMP14,ANGPT2,LIMK2,ELN,RHOA,VEGFA
PMID:33478586	(2021) The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma.	9	73	1.15	6.07e-05	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,SOX9,THBS1,CDH1,CAV1,PTGS2,PTEN,BCL2,VEGFA
PMID:33670130	(2021) Oxidative Stress, Plant Natural Antioxidants, and Obesity.	9	73	1.15	6.07e-05	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000306124,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000384364,9606.ENSP00000419422	NOX4,PLIN1,PRKCE,LPL,PTGS2,NOX1,TXN,NPY,AGTR1
PMID:34384473	(2021) Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1alpha, HIF2alpha, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.	9	73	1.15	6.07e-05	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CD38,ALDH1A1,KCNJ11,PTEN,EDN1,NFE2L2,BCL2,VEGFA
PMID:34522580	(2021) Trends in the biological functions and medical applications of extracellular vesicles and analogues.	9	73	1.15	6.07e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000385834,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CD34,PDGFA,CD47,TF,PROM1,CCL5,VEGFA
PMID:34696321	(2021) The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.	11	129	0.99	6.07e-05	9606.ENSP00000222305,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	USF2,IFNG,THBS1,CDH1,ATM,MMP14,EDNRA,PTEN,EDN1,BCL2,VEGFA
PMID:34880853	(2021) The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?	9	73	1.15	6.07e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570,9606.ENSP00000483018	CD38,CXCL10,ANGPT2,PDGFB,CXCL9,EDN1,AGTR1,VEGFA,ABO
PMID:33041782	(2020) A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine.	9	73	1.15	6.07e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,MPO,PTGS2,PTEN,JAK2,BCL2,NTF3,BDNF,VEGFA
PMID:30148688	(2019) Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an Endotheliotropic Infection.	9	73	1.15	6.07e-05	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000377192,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,CAV1,CXCL9,G6PD,FGFR1,MYD88,CCL5,VEGFA
PMID:31130949	(2019) Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.	9	73	1.15	6.07e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CCR5,SIRT6,STAT5A,PTGS2,ENTPD1,CCL5,VEGFA
PMID:31515356	(2019) Updates on the hematologic tumor microenvironment and its therapeutic targeting.	9	73	1.15	6.07e-05	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CD38,FABP4,CDH1,CD34,GAS6,BCL2,FGFR1,CCL5,VEGFA
PMID:31555259	(2019) A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells.	9	73	1.15	6.07e-05	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CD34,CXCL9,CNTF,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:32038141	(2019) Overview of Crosstalk Between Multiple Factor of Transcytosis in Blood Brain Barrier.	9	73	1.15	6.07e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MPO,NOX4,PDGFB,CAV1,SREBF1,PDGFD,BCL2,RHOA,VEGFA
PMID:30517191	(2018) Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.	9	73	1.15	6.07e-05	9606.ENSP00000216181,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,CHI3L1,CDH1,ATM,CXCL10,LPL,MYD88,PROM1,VEGFA
PMID:30534057	(2018) Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System.	9	73	1.15	6.07e-05	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000365777,9606.ENSP00000384957,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CD47,MTHFR,F11,RHOA,BDNF,CCL5,VEGFA
PMID:27045805	(2016) Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades.	9	73	1.15	6.07e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021	MAPK1,FABP4,FADS2,PLIN1,LPL,HNF4A,CAV1,SREBF1,PTEN
PMID:24320956	(2014) Inflammatory and immune pathways in the pathogenesis of periodontal disease.	9	73	1.15	6.07e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,ELN,CXCL9,VIP,PTGS2,NPY,MYD88,CCL5
PMID:25347122	(2014) Standard of care and promising new agents for triple negative metastatic breast cancer.	9	73	1.15	6.07e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000478570	MAPK1,IFNG,CDH1,IGF1R,CAV1,PTEN,AR,MME,VEGFA
PMID:25415508	(2014) Remodelling the extracellular matrix in development and disease.	11	129	0.99	6.07e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000360997,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,TIMP3,CXCL10,MMP14,ELN,ADAMTS13,PTEN,HSPG2,RHOA,VEGFA
PMID:22202108	(2012) Differential roles of NADPH oxidases in vascular physiology and pathophysiology.	9	73	1.15	6.07e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MPO,NOX4,MAP3K5,NOX1,TXN,EDN1,BCL2,RHOA,VEGFA
PMID:35359972	(2022) Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells.	12	162	0.93	6.15e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000356213,9606.ENSP00000360250,9606.ENSP00000474412	CD69,CDH1,TIMP3,CCR5,CXCL10,CD34,STAT5A,CCL20,CD247,VIP,ENTPD1,CCL5
PMID:35190921	(2022) COVID-19 and cancer: start the resolution!	7	32	1.4	6.32e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CCL20,PTGS2,CCL5,VEGFA
PMID:35200568	(2022) Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?	7	32	1.4	6.32e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,PTEN,BCL2,PROM1,VEGFA
PMID:33558495	(2021) Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.	7	32	1.4	6.32e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	IFNG,IGF1R,CCR5,CXCL10,CXCL9,PTEN,CCL5
PMID:33842343	(2021) The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges.	7	32	1.4	6.32e-05	9606.ENSP00000200676,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000354995,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000478570	CETP,ATM,LPL,ABCG1,MAFB,BCL2,VEGFA
PMID:34198786	(2021) Role of Glucose-Lowering Medications in Erectile Dysfunction.	7	32	1.4	6.32e-05	9606.ENSP00000268035,9606.ENSP00000345708,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,KCNJ11,EDN1,SHBG,RHOA,BDNF,VEGFA
PMID:34249889	(2021) Engineering Breast Cancer On-chip-Moving Toward Subtype Specific Models.	7	32	1.4	6.32e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000478570	IFNG,THBS1,CD34,CAV1,ELN,AR,VEGFA
PMID:34869253	(2021) An ECHO of Cartilage: In Silico Prediction of Combinatorial Treatments to Switch Between Transient and Permanent Cartilage Phenotypes With Ex Vivo Validation.	7	32	1.4	6.32e-05	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478319	MAPK1,SOX9,IGF1R,HNF4A,BMP2,FGFR1,GREM1
PMID:31931138	(2020) Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis.	7	32	1.4	6.32e-05	9606.ENSP00000311005,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	MAPK7,CNTF,PTEN,NOX1,NTF3,RHOA,BDNF
PMID:32823572	(2020) Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?	7	32	1.4	6.32e-05	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000384906,9606.ENSP00000478570	CHI3L1,THBS1,CXCL10,PTEN,BMP2,SAA1,VEGFA
PMID:32913192	(2020) Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA.	7	32	1.4	6.32e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,FTO,PROM1,VEGFA
PMID:30970626	(2019) Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma in Vivo and in Vitro.	7	32	1.4	6.32e-05	9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,ATM,ALDH1A1,MAPK7,PTEN,BCL2,VEGFA
PMID:31911898	(2019) Polyunsaturated fatty acids and DNA methylation in colorectal cancer.	7	32	1.4	6.32e-05	9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,FADS2,PTGS2,PTEN,BCL2,VEGFA,UHRF1
PMID:32274260	(2019) DNA Methylation and Type 2 Diabetes: the Use of Mendelian Randomization to Assess Causality.	7	32	1.4	6.32e-05	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000418823,9606.ENSP00000478570	WFS1,JAZF1,KCNJ11,SREBF1,ABCG1,FTO,VEGFA
PMID:29492403	(2018) The Biological Role of Nestin((+))-Cells in Physiological and Pathological Cardiovascular Remodeling.	7	32	1.4	6.32e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000356515,9606.ENSP00000377372,9606.ENSP00000414303	TGFB1,SOX9,HSPB1,CDH1,UTRN,GAP43,BDNF
PMID:29519236	(2018) Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans.	7	32	1.4	6.32e-05	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CAV1,ELN,SGK1,NPY,CCL5,VEGFA
PMID:29755712	(2018) Lymphoproliferative Syndromes Associated with Human Herpesvirus-6A and Human Herpesvirus-6B.	7	32	1.4	6.32e-05	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000474412	MAPK1,CD38,CCR5,CXCL10,CXCL11,CD34,CCL5
PMID:29930512	(2018) Endothelial Mechanotransduction, Redox Signaling and the Regulation of Vascular Inflammatory Pathways.	7	32	1.4	6.32e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000419313,9606.ENSP00000478570	MPO,NOX4,PDGFB,CAV1,NOX1,TRPC1,VEGFA
PMID:30285678	(2018) N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer.	7	32	1.4	6.32e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	CD38,CDH1,CD34,HNF4A,BCL2,FGFR1,RHOA
PMID:30568652	(2018) Inflammatory Cytokine Profiles of Semen Influence Cytokine Responses of Cervicovaginal Epithelial Cells.	7	32	1.4	6.32e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:28282446	(2017) Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1.	7	32	1.4	6.32e-05	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000474412	MPO,CHI3L1,THBS1,CCR5,PDGFA,CCL20,CCL5
PMID:28912780	(2017) Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases.	7	32	1.4	6.32e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683	TGFB1,MPO,IFNG,ANGPT2,ELN,PTGS2,EDN1
PMID:29057791	(2017) Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.	7	32	1.4	6.32e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,EDNRA,AR,BCL2,VEGFA
PMID:27046197	(2016) Characterization of the MMPTIMP Imbalance and Collagen Production Induced by IL-1beta or TNF-alpha Release from Human Hepatic Stellate Cells.	7	32	1.4	6.32e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	CCR5,CXCL10,MMP14,PDGFB,CXCL9,EDN1,CCL5
PMID:27738312	(2016) IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin.	7	32	1.4	6.32e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	CXCL10,CD34,EDNRA,PDGFB,PDGFA,EDN1,VEGFA
PMID:26388155	(2015) Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.	7	32	1.4	6.32e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809	CD38,ATM,CD34,PTEN,BCL2,FGFR1,PROM1
PMID:26854164	(2015) When Prostate Cancer Circulates in the Bloodstream.	7	32	1.4	6.32e-05	9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	ALDH1A1,CAV1,CD47,PTEN,AR,BCL2,PROM1
PMID:24240679	(2014) Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.	7	32	1.4	6.32e-05	9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	CD34,EBF1,STAT5A,CD47,PTEN,JAK2,BCL2
PMID:25071581	(2014) ABC transporters in CSCs membranes as a novel target for treating tumor relapse.	7	32	1.4	6.32e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809	APC,CDH1,ALDH1A1,HNF4A,CD47,BCL2,PROM1
PMID:25309424	(2014) Abeta degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.	7	32	1.4	6.32e-05	9606.ENSP00000298352,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	NGB,MMP14,EDNRA,EDN1,MME,AGTR1,VEGFA
PMID:23731971	(2013) The E5 proteins.	7	32	1.4	6.32e-05	9606.ENSP00000222139,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185	EPOR,CCR5,PDGFB,CAV1,PTGS2,EDN1,BCL2
PMID:23880850	(2013) Role of cytokine signaling during nervous system development.	7	32	1.4	6.32e-05	9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000474412	STAT5A,CNTF,PTEN,JAK2,GAP43,BCL2,CCL5
PMID:22750474	(2012) Microvascular remodeling and wound healing: a role for pericytes.	7	32	1.4	6.32e-05	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CCR5,CD34,CXCL9,ENTPD1,CCL5,VEGFA
PMID:23486647	(2012) Nitrosothiol Signaling in Anoikis Resistance and Cancer Metastasis.	7	32	1.4	6.32e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,CAV1,ELN,PTEN,BCL2,VEGFA
PMID:21234405	(2010) Local bone marrow Renin-Angiotensin system and atherosclerosis.	7	32	1.4	6.32e-05	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PTGS2,NOX1,JAK2,RHOA,AGTR1,VEGFA
PMID:21368875	(2010) Mechanisms of HIV-associated lymphocyte apoptosis: 2010.	7	32	1.4	6.32e-05	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185	CD38,VDAC1,CCR5,CD34,MAP3K5,PTGS2,BCL2
PMID:18513389	(2008) New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.	7	32	1.4	6.32e-05	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000309757,9606.ENSP00000355370,9606.ENSP00000365777,9606.ENSP00000403495,9606.ENSP00000419422	CETP,PON2,LPL,CNTF,MTHFR,LTA,AGTR1
PMID:19133823	(2008) Melanoma biology and the promise of zebrafish.	7	32	1.4	6.32e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185	MAPK1,CDH1,EDNRA,PTEN,BMP2,EDN1,BCL2
PMID:33207733	(2020) Regulatory microRNAs in Brown, Brite and White Adipose Tissue.	10	100	1.06	6.33e-05	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000322898,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000480291	FABP4,LPL,MAPK7,EBF1,CAV1,PRKAA1,MAP3K5,PTEN,FGFR1,HNF1B
PMID:33375694	(2020) Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.	10	100	1.06	6.33e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000474412	MPO,CD69,HSPB1,CDH1,CD247,PTGS2,JAK2,BCL2,HPSE,CCL5
PMID:31063756	(2019) Metastasis Organotropism: Redefining the Congenial Soil.	10	100	1.06	6.33e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000384262,9606.ENSP00000384906,9606.ENSP00000478570	THBS1,CDH1,PRDX2,PTGS2,PTEN,AR,EDN1,HPSE,SAA1,VEGFA
PMID:24889528	(2014) Glial progenitors as targets for transformation in glioma.	10	100	1.06	6.33e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CDH1,ALDH1A1,PDGFB,PDGFA,PTEN,BMP2,FGFR1,PROM1,VEGFA
PMID:18612392	(2008) Identification of a common gene expression response in different lung inflammatory diseases in rodents and macaques.	11	130	0.99	6.42e-05	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	MPO,CHI3L1,CXCL10,CCL20,CXCL9,PTGS2,JAK2,SAA1,MYD88,BDNF,CCL5
PMID:35241146	(2022) Combination of stem cell therapy and acupuncture to treat ischemic stroke: a prospective review.	8	51	1.26	6.43e-05	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,PDGFB,ANG,PTGS2,CNR1,BCL2,BDNF,VEGFA
PMID:35386912	(2022) Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease.	8	51	1.26	6.43e-05	9606.ENSP00000245479,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CXCL11,CD34,ANG,SIRT6,EDN1,BCL2,VEGFA
PMID:34298636	(2021) Hypoxia in Lung Cancer Management: A Translational Approach.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,VDAC1,IGF1R,CD34,ANGPT2,PTEN,FGFR1,VEGFA
PMID:34611474	(2021) A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs.	8	51	1.26	6.43e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,PTEN,CCL5,VEGFA
PMID:34638467	(2021) Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis.	8	51	1.26	6.43e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412	CD38,IFNG,TIMP3,CXCL10,CCL20,PTEN,BCL2,CCL5
PMID:31342643	(2020) SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.	8	51	1.26	6.43e-05	9606.ENSP00000216181,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	MYH9,ANGPT2,EDNRA,MAP3K5,CD2AP,PTEN,EDN1,VEGFA
PMID:32029741	(2020) Lipid droplets: platforms with multiple functions in cancer hallmarks.	8	51	1.26	6.43e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000426809	FABP4,CDH1,PLIN1,SIRT6,SREBF1,PTGS2,PTEN,PROM1
PMID:32167126	(2020) Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,STAT5A,CNTF,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:32265721	(2020) Electrospun Nanofiber Meshes With Endometrial MSCs Modulate Foreign Body Response by Increased Angiogenesis, Matrix Synthesis, and Anti-Inflammatory Gene Expression in Mice: Implication in Pelvic Floor.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,CXCL10,PDGFA,ELN,CXCL9,CCL5,VEGFA
PMID:32660072	(2020) CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,CD34,HNF4A,PTEN,BCL2,PROM1,VEGFA
PMID:32842500	(2020) Murine Models of Myelofibrosis.	8	51	1.26	6.43e-05	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CD34,PDGFB,STAT5A,EDN1,JAK2,CCL5,VEGFA
PMID:33067577	(2020) DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000445772	CDH1,CD34,MAPK7,STAT5A,AR,JAK2,BCL2,LTB4R2
PMID:33110392	(2020) E3 Ubiquitin ligase NEDD4 family-regulatory network in cardiovascular disease.	8	51	1.26	6.43e-05	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,NOX4,SGK1,PTEN,TXN,BCL2,RHOA,VEGFA
PMID:33172038	(2020) Finding MEMO-Emerging Evidence for MEMO1s Function in Development and Disease.	8	51	1.26	6.43e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	APC,CDH1,IGF1R,NOX1,KL,FGFR1,RHOA,VEGFA
PMID:33425886	(2020) Expression and Function of WNT6: From Development to Disease.	8	51	1.26	6.43e-05	9606.ENSP00000248553,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303	HSPB1,APC,CDH1,CAV1,BCL2,RHOA,MYD88,BDNF
PMID:33681182	(2020) THBS1CD47 Modulates the Interaction of gamma-Catenin With E-Cadherin and Participates in Epithelial-Mesenchymal Transformation in Lipid Nephrotoxicity.	8	51	1.26	6.43e-05	9606.ENSP00000216862,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000348069,9606.ENSP00000355361,9606.ENSP00000381185	CYP24A1,THBS1,COL8A1,CDH1,VDAC1,SREBF1,CD47,BCL2
PMID:30894861	(2019) Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.	8	51	1.26	6.43e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:31148946	(2019) Application of Cerebrospinal Fluid Host Protein Biosignatures in the Diagnosis of Tuberculous Meningitis in Children from a High Burden Setting.	8	51	1.26	6.43e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360997,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL9,ADAMTS13,BDNF,CCL5,VEGFA
PMID:31357507	(2019) Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies.	8	51	1.26	6.43e-05	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000478570	NOX4,VDAC1,ANGPT2,PTEN,G6PD,NFE2L2,GGT1,VEGFA
PMID:31511825	(2019) Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology.	8	51	1.26	6.43e-05	9606.ENSP00000314897,9606.ENSP00000349860,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	ANGPT2,GFPT1,CNTF,PTGS2,TXN,BCL2,BDNF,VEGFA
PMID:31612118	(2019) Potential of Host Serum Protein Biomarkers in the Diagnosis of Tuberculous Meningitis in Children.	8	51	1.26	6.43e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360997,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL9,ADAMTS13,BDNF,CCL5,VEGFA
PMID:29115583	(2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.	8	51	1.26	6.43e-05	9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000478570	CYP24A1,TGFB1,THBS1,CDH1,MMP14,PDGFA,PTEN,VEGFA
PMID:29927962	(2018) Genome wide analysis of TLR12- and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands.	8	51	1.26	6.43e-05	9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000351671,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,APOL1,CCL20,ABCG1,PTGS2,SAA1,CCL5,VEGFA
PMID:30349361	(2018) Abnormal microRNA expression in the course of hematological malignancies.	8	51	1.26	6.43e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	CD38,ATM,CD34,PTEN,JAK2,BCL2,FGFR1,MME
PMID:30514962	(2018) PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia.	8	51	1.26	6.43e-05	9606.ENSP00000226279,9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000355361,9606.ENSP00000362524,9606.ENSP00000364683,9606.ENSP00000414303,9606.ENSP00000478570	CD38,TIMP3,CXCL11,CD47,ANGPTL2,BAMBI,BDNF,VEGFA
PMID:28676848	(2017) Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.	8	51	1.26	6.43e-05	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000390651,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANGPT2,PTGS2,EDN1,IRAK4,BDNF,CCL5,VEGFA
PMID:28729775	(2017) Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance.	8	51	1.26	6.43e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CDH1,AMBP,CAV1,ELN,PROM1,CCL5,VEGFA
PMID:28736230	(2017) Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration.	8	51	1.26	6.43e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000474412	CCR5,CXCL10,ANG,CCL20,ELN,BDNF,RARRES2,CCL5
PMID:28900507	(2017) Targeting MicroRNAs in Prostate Cancer Radiotherapy.	8	51	1.26	6.43e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	HSPB1,CDH1,ATM,PRKCE,PTEN,AR,BCL2,PROM1
PMID:35185340	(2017) Nicotinamide N-Methyltransferase in Health and Cancer.	8	51	1.26	6.43e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000263774,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000381185,9606.ENSP00000480291	TGFB1,CD38,IFNG,NDUFS3,IGF1R,SIRT6,BCL2,HNF1B
PMID:27618067	(2016) Targeting TRPM2 in ROS-Coupled Diseases.	8	51	1.26	6.43e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000401399	CD38,IFNG,NOX4,SIRT6,MAP3K5,NOX1,JAK2,MYD88
PMID:27941682	(2016) Cancer Preventive Activities of Tea Catechins.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000354511,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,COMT,JAK2,G6PD,NFE2L2,BCL2,VEGFA
PMID:25785244	(2015) Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?	8	51	1.26	6.43e-05	9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	ALDH1A1,CAV1,VIP,PTEN,AR,BCL2,NPY,VEGFA
PMID:25896391	(2015) Vascular biology of ageing-Implications in hypertension.	8	51	1.26	6.43e-05	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,SIRT6,ELN,NOX1,BMP2,EDN1,AGTR1,VEGFA
PMID:26370974	(2015) The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000403495	CDH1,NOX4,SIRT6,CAV1,NOX1,NFE2L2,BCL2,LTA
PMID:26462242	(2015) Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.	8	51	1.26	6.43e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000403495	HSPB1,CDH1,ATM,ERCC4,ELN,PTEN,MTHFR,LTA
PMID:23792225	(2013) mTOR kinase inhibitors as potential cancer therapeutic drugs.	8	51	1.26	6.43e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	ATM,CXCL10,CD34,CXCL9,SGK1,PTEN,JAK2,CCL5
PMID:23840100	(2013) Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.	8	51	1.26	6.43e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,MMP14,CD34,PDGFB,NOX1,RHOA,VEGFA
PMID:24319628	(2013) Angiogenic Factors and Cytokines in Diabetic Retinopathy.	8	51	1.26	6.43e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,CXCL10,CD34,ANGPT2,CXCL9,BDNF,VEGFA
PMID:22082163	(2011) Targeting airway smooth muscle in airways diseases: an old concept with new twists.	8	51	1.26	6.43e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CXCL10,ELN,PTGS2,HSPG2,EDN1,MYD88,CCL5
PMID:35222345	(2022) Modulation of Macrophage Polarization by Viruses: Turning OffOn Host Antiviral Responses.	9	74	1.15	6.48e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,GAS6,CD47,JAK2,IRAK4,MYD88,CCL5,VEGFA
PMID:35326441	(2022) Cardiac Cachexia: Unaddressed Aspect in Cancer Patients.	9	74	1.15	6.48e-05	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000384906,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	CD38,VDAC1,PTEN,BCL2,NPY,SAA1,AGTR1,APLNR,VEGFA
PMID:33718235	(2021) The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy.	9	74	1.15	6.48e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,CCL20,PTGS2,BCL2,FGFR1,CCL5,VEGFA
PMID:34200145	(2021) Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.	9	74	1.15	6.48e-05	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000393312	TIMP3,CXCL10,CXCL11,MMP14,CD34,CXCL9,PTEN,ANGPTL2,FGFR1
PMID:34440218	(2021) Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation.	9	74	1.15	6.48e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,NOX4,HNF4A,ELN,NOX1,FGFR1,RHOA,CCL5,VEGFA
PMID:34484116	(2021) GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer.	9	74	1.15	6.48e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,CDH1,TIMP3,IGF1R,PTGS2,PTEN,JAK2,VEGFA,HNF1B
PMID:34617419	(2021) Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer-Like Phenotype.	9	74	1.15	6.48e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000369816,9606.ENSP00000478570	MPO,THBS1,CDH1,TIMP3,ANGPT2,GAS6,ELN,SHBG,VEGFA
PMID:34788095	(2021) Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas.	9	74	1.15	6.48e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478319	TGFB1,SOX9,APC,CDH1,HNF4A,STAT5A,BMP2,PROM1,GREM1
PMID:32322199	(2020) Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma.	9	74	1.15	6.48e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CCR5,CXCL10,PDGFB,STAT5A,CXCL9,CD47,PROM1,VEGFA
PMID:30896792	(2019) Inductionreversal of drug resistance in gastric cancer by non-coding RNAs (Review).	9	74	1.15	6.48e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,TIMP3,IGF1R,CAV1,PTEN,BCL2,RHOA,VEGFA
PMID:30693344	(2018) Effects of three flavonoids from an ancient traditional Chinese medicine Radix puerariae on geriatric diseases.	9	74	1.15	6.48e-05	9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000354995,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,ATM,LPL,ABCG1,GAP43,BCL2,BDNF,PROM1,VEGFA
PMID:29249977	(2017) Response of Turkey Muscle Satellite Cells to Thermal Challenge. II. Transcriptome Effects in Differentiating Cells.	9	74	1.15	6.48e-05	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000384364,9606.ENSP00000419313,9606.ENSP00000478319	MYH9,TGFB1,FABP4,ENPP2,LPL,SREBF1,NPY,TRPC1,GREM1
PMID:27867775	(2016) Abstract: PRS PSRC Podium Proofs 2016.	9	74	1.15	6.48e-05	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,FABP4,NOX4,PLIN1,CD34,PTEN,BMP2,PROM1,VEGFA
PMID:26347709	(2015) The Role of Astrocytes in Multiple Sclerosis Progression.	9	74	1.15	6.48e-05	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CNTF,PTGS2,NTF3,RHOA,BDNF,CCL5,VEGFA
PMID:24966464	(2014) Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.	9	74	1.15	6.48e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5,VEGFA
PMID:12372143	(2002) Mining microarray expression data by literature profiling.	9	74	1.15	6.48e-05	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,CXCL11,MMP14,LPL,CCL20,CXCL9,CCL5,VEGFA
PMID:34371836	(2021) Systematic Bioinformatic Analyses of Nutrigenomic Modifications by Polyphenols Associated with Cardiometabolic Health in Humans-Evidence from Targeted Nutrigenomic Studies.	12	164	0.93	6.71e-05	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175	MYH9,TGFB1,CCR5,CXCL10,CD34,CCL20,CXCL9,ABCG1,PTEN,BCL2,NTF3,RHOA
PMID:33859752	(2021) Turning cold tumors into hot tumors by improving T-cell infiltration.	10	101	1.06	6.73e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,ANGPT2,CXCL9,CD47,ENTPD1,PTEN,CCL5,VEGFA
PMID:34163481	(2021) Metformin, Macrophage Dysfunction and Atherosclerosis.	10	101	1.06	6.73e-05	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000334329,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412	CETP,IFNG,FABP4,CXCL10,CXCL11,UNC5B,ABCG1,PTGS2,PTEN,CCL5
PMID:31825135	(2020) High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.	10	101	1.06	6.73e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067	TGFB1,CD38,IGF1R,CCR5,CXCL10,CXCL11,PDGFB,CCL20,CXCL9,JAK2
PMID:26046491	(2015) Mechanisms of Invasion in Head and Neck Cancer.	10	101	1.06	6.73e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,IGF1R,PRKCE,MMP14,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:24887580	(2014) Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications.	10	101	1.06	6.73e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CD34,CCL20,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:33463063	(2021) Research trends in pharmacological modulation of tumor-associated macrophages.	11	131	0.99	6.74e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,MAPK7,PDGFB,CXCL9,CD47,JAK2,RHOA,CCL5
PMID:34943797	(2021) An Insight into GPCR and G-Proteins as Cancer Drivers.	11	131	0.99	6.74e-05	9606.ENSP00000260356,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	THBS1,MAPK7,HNF4A,ANGPT2,EDNRA,EDN1,RHOA,AGTR1,CCL5,VEGFA,HNF1B
PMID:35163697	(2022) Mitochondrial Pathophysiology on Chronic Kidney Disease.	9	75	1.14	7.07e-05	9606.ENSP00000225275,9606.ENSP00000246553,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000426809	MPO,FFAR1,CDH1,NOX4,EDNRA,CNR2,EDN1,NFE2L2,PROM1
PMID:35216224	(2022) Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.	6	18	1.58	7.07e-05	9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175	ELN,PTGS2,NOX1,EDN1,BCL2,RHOA
PMID:35269807	(2022) The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair.	8	52	1.25	7.07e-05	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	LPL,CD34,ELN,ANGPTL2,EDN1,BCL2,PROM1,VEGFA
PMID:35327563	(2022) Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age.	9	75	1.14	7.07e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CCR5,CXCL10,SIRT6,COMT,PTGS2,PTEN,BDNF,VEGFA
PMID:33743810	(2021) Targeting chemokines for acute lymphoblastic leukemia therapy.	8	52	1.25	7.07e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	CCR5,CXCL10,CXCL11,STAT5A,CXCL9,PTEN,BCL2,RHOA
PMID:33917302	(2021) The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development.	9	75	1.14	7.07e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,MMP14,ANGPT2,PDGFB,ELN,JAK2,RHOA,VEGFA
PMID:33937077	(2021) Research Progress of Circular RNA in Gastrointestinal Tumors.	9	75	1.14	7.07e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,CXCL10,CAV1,STAT5A,PTEN,JAK2,RHOA,VEGFA
PMID:34067236	(2021) Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.	11	132	0.98	7.07e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,HNF4A,CCL20,PTGS2,BMP2,JAK2,BCL2,CCL5,VEGFA
PMID:34068728	(2021) Impact of Differentiated Macrophage-Like Cells on the Transcriptional Toxicity Profile of CuO Nanoparticles in Co-Cultured Lung Epithelial Cells.	8	52	1.25	7.07e-05	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185	TGFB1,ATM,ERCC4,PDGFA,MAP3K5,PTGS2,NFE2L2,BCL2
PMID:34571969	(2021) Molecular Markers and Targets in Melanoma.	9	75	1.14	7.07e-05	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000400175	IFNG,IGF1R,CCR5,CXCL10,CXCL11,HNF4A,CXCL9,PTEN,RHOA
PMID:34712244	(2021) Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.	8	52	1.25	7.07e-05	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412	IFNG,ATM,CCR5,CXCL10,CXCL11,CXCL9,SAA1,CCL5
PMID:34885108	(2021) Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment.	9	75	1.14	7.07e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CD247,CXCL9,BCL2,CCL5,VEGFA
PMID:34954691	(2021) Tertiary lymphoid structure stratifies glioma into three distinct tumor subtypes.	8	52	1.25	7.07e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL11,STAT5A,CCL20,CXCL9,CCL5
PMID:34970630	(2021) Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration.	6	18	1.58	7.07e-05	9606.ENSP00000221930,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,EDN1,NTF3,RHOA,BDNF,VEGFA
PMID:32329577	(2020) miR-322 treatment rescues cell apoptosis and neural tube defect formation through silencing NADPH oxidase 4.	6	18	1.58	7.07e-05	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000444198	NOX4,MAP3K5,TXN,BCL2,FGFR1,CITED2
PMID:32466429	(2020) Kidney Organoids and Tubuloids.	8	52	1.25	7.07e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000362410,9606.ENSP00000402152,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,HNF4A,PDGFB,MAFB,SLC12A3,PROM1,VEGFA
PMID:32948083	(2020) Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma.	9	75	1.14	7.07e-05	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD34,ANGPT2,JAK2,BCL2,FGFR1,RHOA,CCL5,VEGFA
PMID:33343297	(2020) Hypoxia-Ischemia Induced Age-Dependent Gene Transcription Effects at Two Development Stages in the Neonate Mouse Brain.	12	165	0.92	7.07e-05	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000339916,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000427424,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CHI3L1,CXCL10,SIRT6,LIMK2,CNTF,NTF3,MYD88,BDNF,TNFAIP8,CCL5,VEGFA
PMID:30049588	(2019) The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome.	8	52	1.25	7.07e-05	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000384364,9606.ENSP00000400175	MPO,IGF1R,LPL,HNF4A,CAV1,SREBF1,NPY,RHOA
PMID:30483778	(2019) Platelet-derived growth factor D promotes the angiogenic capacity of endothelial progenitor cells.	6	18	1.58	7.07e-05	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFB,PDGFA,PDGFD,PROM1,VEGFA
PMID:30691487	(2019) Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFRRASMAPK pathway in KRAS-mutated human colorectal cancer cell lines.	11	132	0.98	7.07e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,CDH1,IGF1R,ATM,GAS6,PTEN,JAK2,NFE2L2,FGFR1,RHOA,MYD88
PMID:30841577	(2019) The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients-Insights from Rodent-Based Animal Studies.	6	18	1.58	7.07e-05	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,ELN,PTEN,BCL2,AGTR1,VEGFA
PMID:30867745	(2019) Induction of entosis in prostate cancer cells by nintedanib and its therapeutic implications.	6	18	1.58	7.07e-05	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,PTEN,AR,FGFR1,RHOA,VEGFA
PMID:30909628	(2019) Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma.	8	52	1.25	7.07e-05	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,NOX4,ATM,PDGFB,CD247,PTEN,PROM1,VEGFA
PMID:31024541	(2019) Editorial: Orchestration of an Immune Response to Respiratory Pathogens.	6	18	1.58	7.07e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CXCL9,CCL5
PMID:31049830	(2019) Pigment Epithelium-Derived Factor Promotes Axon Regeneration and Functional Recovery After Spinal Cord Injury.	6	18	1.58	7.07e-05	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	CNTF,GAP43,BCL2,NTF3,BDNF,CCL5
PMID:31263531	(2019) Mesenchymal stem cell-based bioengineered constructs: foreign body response, cross-talk with macrophages and impact of biomaterial design strategies for pelvic floor disorders.	8	52	1.25	7.07e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,ELN,CXCL9,MYD88,CCL5,VEGFA
PMID:31281720	(2019) Insights into Hypoxia: Non-invasive Assessment through Imaging Modalities and Its Application in Breast Cancer.	6	18	1.58	7.07e-05	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	PTGS2,PTEN,EDN1,BCL2,PROM1,VEGFA
PMID:31476281	(2019) siRNA- and miRNA-based therapeutics for liver fibrosis.	8	52	1.25	7.07e-05	9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	MMP14,PDGFB,PDGFA,PDGFD,FGFR1,RHOA,GREM1,VEGFA
PMID:31514389	(2019) MicroRNA Networks Modulate Oxidative Stress in Cancer.	9	75	1.14	7.07e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,NOX4,ATM,PTGS2,PTEN,NOX1,NFE2L2,MYD88,VEGFA
PMID:31772577	(2019) The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression.	8	52	1.25	7.07e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,ATM,CXCL10,HNF4A,CCL20,MYD88,PROM1,CCL5
PMID:29557361	(2018) Dyslipidemia modulates Muller glial sensing and transduction of ambient information.	6	18	1.58	7.07e-05	9606.ENSP00000304767,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000419313,9606.ENSP00000478570	P2RY1,CXCL11,CAV1,ABCG1,TRPC1,VEGFA
PMID:29786051	(2018) Urinary Extracellular Vesicle: A Potential Source of Early Diagnostic and Therapeutic Biomarker in Diabetic Kidney Disease.	6	18	1.58	7.07e-05	9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000293599,9606.ENSP00000336762,9606.ENSP00000348069,9606.ENSP00000380365	AMBP,VDAC1,AQP5,ANG,SREBF1,RGN
PMID:29940987	(2018) Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.	8	52	1.25	7.07e-05	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175	NOX4,ATM,CD34,PTGS2,NOX1,TXN,NFE2L2,RHOA
PMID:30568659	(2018) Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections.	8	52	1.25	7.07e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:27661006	(2017) Type I insulin-like growth factor receptor signaling in hematological malignancies.	8	52	1.25	7.07e-05	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000400175	CD38,IGF1R,ATM,STAT5A,PTEN,SHBG,BCL2,RHOA
PMID:27920066	(2017) New concepts for an old problem: the diagnosis of endometrial hyperplasia.	6	18	1.58	7.07e-05	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185	CDH1,HNF4A,PTGS2,PTEN,SHBG,BCL2
PMID:28515147	(2017) Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.	6	18	1.58	7.07e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CCR5,CXCL10,MAPK7,CXCL9,PTEN,CCL5
PMID:28515944	(2017) Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.	8	52	1.25	7.07e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL11,CXCL9,ENTPD1,JAK2,CCL5
PMID:28599100	(2017) EMT and inflammation: inseparable actors of cancer progression.	9	75	1.14	7.07e-05	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412	MPO,THBS1,CDH1,CCR5,CCL20,PTEN,JAK2,PROM1,CCL5
PMID:28918499	(2017) The Levels of Circulating Proangiogenic Factors in Migraineurs.	6	18	1.58	7.07e-05	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000478570	MPO,ANGPT2,ANG,MTHFR,BCL2,VEGFA
PMID:29033948	(2017) Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes.	8	52	1.25	7.07e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CDH1,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,BCL2
PMID:29157300	(2017) Prospects for combined use of oncolytic viruses and CAR T-cells.	11	132	0.98	7.07e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CD247,CXCL9,CD47,PTGS2,MYD88,CCL5,VEGFA
PMID:26223803	(2016) Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury.	6	18	1.58	7.07e-05	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	PTGS2,PTEN,GAP43,BCL2,RHOA,BDNF
PMID:26907349	(2016) The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis.	6	18	1.58	7.07e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000354995,9606.ENSP00000418525,9606.ENSP00000426809	CD38,ALDH1A1,CD34,ABCG1,MME,PROM1
PMID:26956051	(2016) Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.	6	18	1.58	7.07e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CXCL10,CD34,CXCL9,PROM1,VEGFA
PMID:27117495	(2016) A framework for in vitro systems toxicology assessment of e-liquids.	6	18	1.58	7.07e-05	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ATM,CXCL10,CCL20,CCL5,VEGFA
PMID:27405802	(2016) Inactivation of Fam20B in Joint Cartilage Leads to Chondrosarcoma and Postnatal Ossification Defects.	6	18	1.58	7.07e-05	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CD34,HNF4A,BMP2,BCL2,VEGFA
PMID:27761468	(2016) Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.	6	18	1.58	7.07e-05	9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,ANGPT2,CAV1,CNTF,BDNF,VEGFA
PMID:26062132	(2015) Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.	9	75	1.14	7.07e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5,VEGFA
PMID:26208341	(2015) Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.	6	18	1.58	7.07e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000474412	CD38,IFNG,CCR5,CXCL10,BCL2,CCL5
PMID:26301087	(2015) Variability in vascular smooth muscle cell stretch-induced responses in 2D culture.	6	18	1.58	7.07e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000478570	THBS1,NOX4,IGF1R,SIRT6,NOX1,VEGFA
PMID:26560317	(2015) Characterization of secretomes provides evidence for adipose-derived mesenchymal stromal cells subtypes.	8	52	1.25	7.07e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000362524,9606.ENSP00000376865,9606.ENSP00000414303,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CD34,ANG,ANGPTL2,PDGFD,BDNF,GREM1,VEGFA
PMID:26564600	(2015) Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.	6	18	1.58	7.07e-05	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CD34,ANGPT2,ANG,EDN1,VEGFA
PMID:24616654	(2014) Diverse roles of prostaglandins in blastocyst implantation.	8	52	1.25	7.07e-05	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000419313,9606.ENSP00000478570	IFNG,TIMP3,ELN,PTGS2,BMP2,EDN1,TRPC1,VEGFA
PMID:24633153	(2014) Redox regulation of endothelial cell fate.	9	75	1.14	7.07e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,ATM,PTEN,TXN,EDN1,NFE2L2,BCL2,VEGFA
PMID:24976843	(2014) Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection.	8	52	1.25	7.07e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,CCL20,CXCL9,LTA,VEGFA
PMID:25538893	(2014) Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.	8	52	1.25	7.07e-05	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,STAT5A,CD247,PTGS2,JAK2,CCL5,VEGFA
PMID:23434273	(2013) Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokinechemokine production in macrophages.	8	52	1.25	7.07e-05	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD69,THBS1,CXCL10,CXCL11,CXCL9,JAK2,CCL5,VEGFA
PMID:23509770	(2013) Increasing hematopoietic stem cell yield to develop mice with human immune systems.	8	52	1.25	7.07e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000362524,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CXCL10,CD34,PDGFB,CD47,ANGPTL2,PROM1,VEGFA
PMID:23761784	(2013) Estrogens regulate the hepatic effects of growth hormone, a hormonal interplay with multiple fates.	8	52	1.25	7.07e-05	9606.ENSP00000232219,9606.ENSP00000302630,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000384364	RBP1,ONECUT1,LPL,HNF4A,STAT5A,SREBF1,JAK2,NPY
PMID:23869165	(2013) Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa.	6	18	1.58	7.07e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	MPO,IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:24381786	(2013) The enigmatic cytokine oncostatin m and roles in disease.	9	75	1.14	7.07e-05	9606.ENSP00000266085,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	TIMP3,LPL,ANGPT2,STAT5A,CNTF,PTEN,JAK2,BDNF,VEGFA
PMID:22481913	(2012) PPARgamma and Oxidative Stress: Con(beta) Catenating NRF2 and FOXO.	8	52	1.25	7.07e-05	9606.ENSP00000248553,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	HSPB1,HNF4A,PTGS2,PTEN,TXN,NFE2L2,BCL2,MYD88
PMID:22548060	(2012) Molecular Understanding of HIV-1 Latency.	8	52	1.25	7.07e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CCR5,CXCL10,CD34,STAT5A,CCL20,CXCL9,BCL2
PMID:22747567	(2012) Perinatal stress, brain inflammation and risk of autism-review and proposal.	6	18	1.58	7.07e-05	9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	PTEN,TXN,JAK2,NTF3,BDNF,VEGFA
PMID:24213462	(2012) Ovarian cancer stroma: pathophysiology and the roles in cancer development.	9	75	1.14	7.07e-05	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CXCL10,CXCL11,CCL20,CXCL9,PTEN,AR,CCL5,VEGFA
PMID:21359168	(2010) Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.	6	18	1.58	7.07e-05	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CNTF,NTF3,BDNF,PROM1,VEGFA
PMID:20374701	(2009) Progesterone receptor action in leiomyoma and endometrial cancer.	9	75	1.14	7.07e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,IGF1R,MMP14,STAT5A,PDGFA,FMOD,COMT,PTEN,BCL2
PMID:18929507	(2008) Colon cancer stem cells: implications for prevention and therapy.	6	18	1.58	7.07e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,HNF4A,PROM1,VEGFA
PMID:19087279	(2008) Attenuation of acute lung inflammation induced by cigarette smoke in CXCR3 knockout mice.	6	18	1.58	7.07e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:35056413	(2022) Case of Patient with AML with Complex Karyotype including Ultra-Rare t(4;8)(q32;q13), t(4;11)(q21;p15) and Familial Aggregation of Myeloid Malignancies.	7	33	1.39	7.09e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000371067	CD38,ATM,CD34,EBF1,ELN,PTEN,JAK2
PMID:35386146	(2022) Obesity: A Chronic Low-Grade Inflammation and Its Markers.	7	33	1.39	7.09e-05	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360522,9606.ENSP00000418009	IFNG,FABP4,CXCL10,CXCL11,CXCL9,RBP4,RARRES2
PMID:35399528	(2022) Periosteal Skeletal Stem Cells and Their Response to Bone Injury.	7	33	1.39	7.09e-05	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CCR5,ELN,CCL5,GREM1,VEGFA,HNF1B
PMID:33452734	(2021) Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology.	7	33	1.39	7.09e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000419422	MAPK1,IFNG,CXCL10,STAT5A,PTGS2,BCL2,AGTR1
PMID:34038417	(2021) Chemokines act as phosphatidylserine-bound find-me signals in apoptotic cell clearance.	7	33	1.39	7.09e-05	9606.ENSP00000265333,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	VDAC1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:34068096	(2021) Some Candidate Drugs for Pharmacotherapy of Alzheimers Disease.	7	33	1.39	7.09e-05	9606.ENSP00000310036,9606.ENSP00000354995,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ABCG1,CNTF,TXN,NTF3,BDNF,VEGFA
PMID:34193425	(2021) In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer.	7	33	1.39	7.09e-05	9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000480291	RBP4,AR,ALPL,EDN1,FGFR1,RHOA,HNF1B
PMID:34307011	(2021) In vitro three-dimensional cell cultures for bone sarcomas.	7	33	1.39	7.09e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,ALPL,BMP2,BCL2,PROM1,VEGFA
PMID:34630899	(2021) Cellular targets in diabetic retinopathy therapy.	7	33	1.39	7.09e-05	9606.ENSP00000263317,9606.ENSP00000349860,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,GFPT1,PTGS2,TXN,G6PD,NFE2L2,VEGFA
PMID:34815444	(2021) A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates.	7	33	1.39	7.09e-05	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000393312,9606.ENSP00000478570	TIMP3,CXCL10,CCL20,ELN,MAP3K5,FGFR1,VEGFA
PMID:34880922	(2021) Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review.	7	33	1.39	7.09e-05	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CXCL10,MAP3K5,PTGS2,PTEN,BCL2,VEGFA
PMID:32821382	(2020) Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.	7	33	1.39	7.09e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,ANGPT2,CXCL9,CCL5
PMID:32916783	(2020) Epitranscriptomics in Normal and Malignant Hematopoiesis.	7	33	1.39	7.09e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418823	CD38,CD34,ANG,PTEN,JAK2,BCL2,FTO
PMID:33038074	(2020) Depot and sex-specific implications for adipose tissue expandability and functional traits in adulthood of late prenatal and early postnatal malnutrition in a precocial sheep model.	7	33	1.39	7.09e-05	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000418823,9606.ENSP00000478570	TGFB1,FABP4,IGF1R,PLIN1,CD34,FTO,VEGFA
PMID:33187385	(2020) Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity.	7	33	1.39	7.09e-05	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,TGFB1,CDH1,PTEN,NFE2L2,BCL2,VEGFA
PMID:33344515	(2020) The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy.	7	33	1.39	7.09e-05	9606.ENSP00000225275,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000477707,9606.ENSP00000478570	MPO,PTEN,EDN1,MME,PROM1,NR1H3,VEGFA
PMID:30720765	(2019) Diabetes Impairs Angiogenesis and Induces Endothelial Cell Senescence by Up-Regulating Thrombospondin-CD47-Dependent Signaling.	7	33	1.39	7.09e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,NOX4,CD34,CD47,NOX1,FGFR1,VEGFA
PMID:30967632	(2019) Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation.	7	33	1.39	7.09e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067	TGFB1,IFNG,ATM,CXCL10,CD34,CXCL9,JAK2
PMID:31382593	(2019) Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression.	7	33	1.39	7.09e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,NOX4,PTGS2,NOX1,TXN,NFE2L2,VEGFA
PMID:31425636	(2019) A mechanistic evaluation of the angiogenic properties of a dehydrated amnion chorion membrane in vitro and in vivo.	7	33	1.39	7.09e-05	9606.ENSP00000215832,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000478570	MAPK1,CHI3L1,THBS1,ANGPT2,ANG,ELN,VEGFA
PMID:31569687	(2019) Nanoparticles Targeting STATs in Cancer Therapy.	7	33	1.39	7.09e-05	9606.ENSP00000226279,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,STAT5A,JAK2,NFE2L2,BCL2,PROM1,VEGFA
PMID:32082357	(2019) Epigenetics and In Utero Acquired Predisposition to Metabolic Disease.	10	102	1.05	7.09e-05	9606.ENSP00000215832,9606.ENSP00000306124,9606.ENSP00000322898,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,PRKCE,EBF1,PRKAA1,SREBF1,GFPT1,PTEN,NPY,FGFR1,VEGFA
PMID:35116904	(2019) The expression and role of trefoil factors in human tumors.	7	33	1.39	7.09e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,ANGPT2,PTGS2,PTEN,BCL2,VEGFA
PMID:28926101	(2018) The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.	7	33	1.39	7.09e-05	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL11,CAV1,PTGS2,PTEN,CCL5,VEGFA
PMID:29500688	(2018) Protective effects of PACAP in ischemia.	7	33	1.39	7.09e-05	9606.ENSP00000215832,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CNTF,VIP,BCL2,BDNF,CCL5,VEGFA
PMID:28792982	(2017) Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells.	7	33	1.39	7.09e-05	9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901	CD69,AMBP,CCR5,CXCL10,CXCL11,CD34,CXCL9
PMID:29254164	(2017) Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells.	7	33	1.39	7.09e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,PTGS2,JAK2,PROM1,VEGFA
PMID:27403320	(2016) A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects.	7	33	1.39	7.09e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,STAT5A,CXCL9,JAK2,CCL5
PMID:27639438	(2016) Heralding a new paradigm in 3D tumor modeling.	7	33	1.39	7.09e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000478570	CD38,IFNG,CD34,ELN,PTGS2,HSPG2,VEGFA
PMID:25721094	(2015) Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.	7	33	1.39	7.09e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000478570	FABP4,CDH1,ALDH1A1,CD34,PDGFA,FGFR1,VEGFA
PMID:24247562	(2014) Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.	7	33	1.39	7.09e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,IGF1R,MMP14,CD47,RHOA,VEGFA
PMID:24476686	(2014) The role of chemokines in severe malaria: more than meets the eye.	7	33	1.39	7.09e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:24724095	(2014) Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage.	7	33	1.39	7.09e-05	9606.ENSP00000298352,9606.ENSP00000315011,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000402152	NGB,EDNRA,TXN,EDN1,NFE2L2,BCL2,SLC12A3
PMID:25140325	(2014) Prevention and restoration of hearing loss associated with the use of cisplatin.	7	33	1.39	7.09e-05	9606.ENSP00000263317,9606.ENSP00000354511,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	NOX4,COMT,NOX1,NFE2L2,BCL2,NTF3,BDNF
PMID:26056585	(2014) Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment.	7	33	1.39	7.09e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000354995,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,MMP14,ABCG1,FGFR1,VEGFA
PMID:19120088	(2008) Identifying the stress transcriptome in the adrenal medulla following acute and repeated immobilization.	10	102	1.05	7.09e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000356213,9606.ENSP00000375844,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,TGFB1,IFNG,THBS1,MMP14,VIP,CAPN10,NPY,BDNF,VEGFA
PMID:32707662	(2020) Autophagy as a Potential Therapy for Malignant Glioma.	13	203	0.87	7.58e-05	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,HSPB1,IGF1R,ATM,CD34,CAV1,PTEN,CNR2,JAK2,NFE2L2,BCL2,PROM1,VEGFA
PMID:33477367	(2021) The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death.	9	76	1.13	7.60e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809	CD38,ALDH1A1,CD34,HNF4A,JAK2,NFE2L2,BCL2,MYD88,PROM1
PMID:33801741	(2021) Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.	9	76	1.13	7.60e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,ATM,CXCL10,CAV1,PTGS2,JAK2,BCL2,VEGFA
PMID:33916931	(2021) The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer.	9	76	1.13	7.60e-05	9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PRKCE,PTGS2,PTEN,AR,JAK2,NFE2L2,BCL2,VEGFA
PMID:33959500	(2021) Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1.	9	76	1.13	7.60e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000474412	IFNG,SOX9,FABP4,ATM,AQP5,CXCL10,HNF4A,PTEN,CCL5
PMID:33489906	(2020) The Metabolic Mechanisms of Breast Cancer Metastasis.	10	103	1.05	7.60e-05	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000363641,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,PLIN1,LPL,ANGPT2,SREBF1,CCL20,TXN,PLA2G2A,RHOA,VEGFA
PMID:30946477	(2019) The landscape of the mesenchymal signature in brain tumours.	10	103	1.05	7.60e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,SOX9,CHI3L1,THBS1,PDGFB,STAT5A,PDGFA,PTEN,PROM1,VEGFA
PMID:31208018	(2019) Costunolide-A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential.	9	76	1.13	7.60e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,STAT5A,MAP3K5,PTGS2,TXN,BCL2,CCL5,VEGFA
PMID:31579438	(2019) Emerging insights into the biology of metastasis: A review article.	9	76	1.13	7.60e-05	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	ENPP2,CDH1,ALDH1A1,CXCL10,ELN,CXCL9,PTEN,PROM1,VEGFA
PMID:31822804	(2019) Transcriptome analysis of human brain microvascular endothelial cells response to Neisseria meningitidis and its antigen MafA using RNA-seq.	10	103	1.05	7.60e-05	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000355361,9606.ENSP00000362410,9606.ENSP00000375844,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412	LAMC1,THBS1,CXCL10,CXCL11,CD47,MAFB,CAPN10,SAA1,MYD88,CCL5
PMID:29128673	(2018) Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.	9	76	1.13	7.60e-05	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CD34,PDGFB,CXCL9,MME,CCL5,VEGFA
PMID:29844272	(2018) The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function.	9	76	1.13	7.60e-05	9606.ENSP00000285407,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000381185	KLF10,CAV1,ELN,MAP3K5,NOX1,BMP2,KL,JAK2,BCL2
PMID:28275576	(2017) The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.	10	103	1.05	7.60e-05	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,ENPP2,CDH1,CCR5,CXCL10,STAT5A,CXCL9,PTEN,CCL5,VEGFA
PMID:28694706	(2017) Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.	9	76	1.13	7.60e-05	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,ATM,ANGPT2,ANG,STAT5A,CCL20,PTEN,FGFR1,VEGFA
PMID:26825686	(2016) MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases.	9	76	1.13	7.60e-05	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000478570	TGFB1,TIMP3,ANGPT2,EDNRA,STAT5A,PTEN,BCL2,IRAK4,VEGFA
PMID:27119356	(2016) Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.	10	103	1.05	7.60e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD38,ATM,CXCL10,CXCL9,PTEN,JAK2,BCL2,MME,CCL5,VEGFA
PMID:26441528	(2015) Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.	9	76	1.13	7.60e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,NTF3,BDNF,CCL5
PMID:26697428	(2015) Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?	9	76	1.13	7.60e-05	9606.ENSP00000222139,9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570,9606.ENSP00000479617	EPOR,TIMP3,CXCL11,PTEN,JAK2,BCL2,RHOA,VEGFA,UHRF1
PMID:25218581	(2014) A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.	9	76	1.13	7.60e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000369442,9606.ENSP00000369816	CD38,IFNG,TIMP3,IGF1R,MMP14,CD34,SERPINF2,KL,SHBG
PMID:25548518	(2014) Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.	9	76	1.13	7.60e-05	9606.ENSP00000200676,9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175	CETP,MAPK1,FABP4,IGF1R,PRDX2,TXN,JAK2,BCL2,RHOA
PMID:23401740	(2013) Reactive oxygen species in vascular formation and development.	9	76	1.13	7.60e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000478570	MPO,NOX4,ATM,CD34,STAT5A,NOX1,RHOA,RARRES2,VEGFA
PMID:21515361	(2011) Evidence demonstrating role of microRNAs in the etiopathology of major depression.	9	76	1.13	7.60e-05	9606.ENSP00000245479,9606.ENSP00000311005,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,MAPK7,CD2AP,PTEN,GAP43,BCL2,NPY,BDNF,VEGFA
PMID:34951691	(2022) Adipocytokines and disease progression in endometrial cancer: a systematic review.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ANG,CCL20,RBP4,BCL2,RARRES2,CCL5,VEGFA
PMID:34501271	(2021) Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential.	8	53	1.24	7.80e-05	9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412	ENPP2,CCR5,CXCL10,CXCL11,CCL20,ELN,CXCL9,CCL5
PMID:34789315	(2021) Mesenchymal stemstromal cells in cancer therapy.	8	53	1.24	7.80e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,STAT5A,JAK2,PROM1,CCL5,VEGFA
PMID:34944571	(2021) Endothelial Dysfunction in Pregnancy Complications.	8	53	1.24	7.80e-05	9606.ENSP00000229135,9606.ENSP00000284031,9606.ENSP00000308208,9606.ENSP00000334329,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,DDAH1,MMP14,UNC5B,TXN,EDN1,PROM1,VEGFA
PMID:35095518	(2021) Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice.	8	53	1.24	7.80e-05	9606.ENSP00000222139,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	EPOR,SIRT6,PTEN,JAK2,NPY,BDNF,AGTR1,VEGFA
PMID:31587329	(2020) Targeting MDM2 for novel molecular therapy: Beyond oncology.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,IGF1R,KLF10,SIRT6,STAT5A,PTEN,NFE2L2,VEGFA
PMID:32008371	(2020) Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases.	8	53	1.24	7.80e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000362057,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,CXCL10,NOX1,IRAK4,MYD88,CCL5,VEGFA
PMID:32052833	(2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.	8	53	1.24	7.80e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000368683	CETP,MPO,LPL,GAS6,CAV1,ELN,CD47,EDN1
PMID:32204455	(2020) Exosomes in Prostate Cancer Diagnosis, Prognosis and Therapy.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,MMP14,CAV1,CD47,AR,BCL2,VEGFA
PMID:32660101	(2020) Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,AQP5,PTGS2,PTEN,AR,EDN1,BCL2,VEGFA
PMID:33061498	(2020) The Mechanism of Traditional Chinese Medicine for the Treatment of Obesity.	8	53	1.24	7.80e-05	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000477707	FABP4,LPL,PRKAA1,SREBF1,JAK2,NPY,BDNF,NR1H3
PMID:33255794	(2020) Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.	8	53	1.24	7.80e-05	9606.ENSP00000259486,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000401399	ENPP2,HNF4A,ANGPT2,SREBF1,MAP3K5,PTEN,RHOA,MYD88
PMID:33324206	(2020) An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2.	8	53	1.24	7.80e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000377192,9606.ENSP00000381185	MPO,IFNG,CDH1,NOX4,CXCL10,SIRT6,G6PD,BCL2
PMID:30635789	(2019) Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis.	8	53	1.24	7.80e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,TIMP3,MMP14,STAT5A,BCL2,CCL5,GREM1,VEGFA
PMID:31174250	(2019) mTOR and Aging: An Old Fashioned Dress.	8	53	1.24	7.80e-05	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD34,STAT5A,SREBF1,PTEN,KL,BCL2,MYD88,VEGFA
PMID:31333641	(2019) Platelets in Skin Autoimmune Diseases.	8	53	1.24	7.80e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000304767,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,THBS1,P2RY1,PDGFA,EDN1,CCL5,VEGFA
PMID:32351905	(2019) Precision Medicine in Non Communicable Diseases.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,AR,MTHFR,JAK2,VEGFA
PMID:28292435	(2017) Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CD34,CD247,CXCL9,CCL5,VEGFA
PMID:28788092	(2017) Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment.	8	53	1.24	7.80e-05	9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MAP3K5,PTGS2,TXN,AR,NFE2L2,BCL2,VEGFA
PMID:27409608	(2016) Identification of Pathways in Liver Repair Potentially Targeted by Secretory Proteins from Human Mesenchymal Stem Cells.	8	53	1.24	7.80e-05	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000369816,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,THBS1,CD34,SHBG,MYD88,BDNF,CCL5,VEGFA
PMID:24775603	(2014) The multiple facets of drug resistance: one history, different approaches.	8	53	1.24	7.80e-05	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CD38,HSPB1,CDH1,ALDH1A1,CD34,PTEN,BCL2,PROM1
PMID:22085499	(2012) Cellular and molecular effects of vitamin D on carcinogenesis.	8	53	1.24	7.80e-05	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CYP24A1,CDH1,HNF4A,PTEN,AR,BCL2,RHOA,VEGFA
PMID:22410175	(2012) Endothelial progenitor cells and integrins: adhesive needs.	8	53	1.24	7.80e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CD34,CXCL9,HSPG2,PROM1,VEGFA
PMID:21300031	(2011) Dose-dependent differential effects of risedronate on gene expression in osteoblasts.	8	53	1.24	7.80e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,CDH1,PRKCE,PTGS2,ALPL,BMP2,FGFR1,VEGFA
PMID:21550393	(2011) Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications.	8	53	1.24	7.80e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,BMP2,MYD88,LTA,CCL5,VEGFA
PMID:22384440	(2011) Hormonal regulation of uterine chemokines and immune cells.	8	53	1.24	7.80e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,ANGPT2,CXCL9,CCL5,VEGFA
PMID:18200554	(2008) Lymphocytemacrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production.	8	53	1.24	7.80e-05	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,ELN,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:31001564	(2019) Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells.	11	134	0.98	7.87e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CD38,CD69,CCR5,CXCL10,CD34,STAT5A,PTEN,BCL2,MYD88,CCL5
PMID:29211816	(2017) Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.	11	134	0.98	7.87e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,IGF1R,ATM,GAS6,PTEN,JAK2,NFE2L2,FGFR1,RHOA,MYD88,VEGFA
PMID:22149093	(2012) Cancer cell signaling pathways targeted by spice-derived nutraceuticals.	11	134	0.98	7.87e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	APC,CDH1,IGF1R,ATM,SIRT6,STAT5A,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:35028016	(2022) Comparison of 2,3,5,4-tetrahydroxystilbene-2-O-b-D-glucoside-induced proliferation and differentiation of dental pulp stem cells in 2D and 3D culture systems-gene analysis.	7	34	1.37	8.16e-05	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CETP,LPL,CD34,PDGFB,JAK2,BCL2,PROM1
PMID:35241045	(2022) Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19).	7	34	1.37	8.16e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021	MAPK1,TGFB1,MPO,IFNG,CXCL10,PTGS2,PTEN
PMID:35406507	(2022) Kruppel-like Factor 9 (KLF9) Suppresses Hepatocellular Carcinoma (HCC)-Promoting Oxidative Stress and Inflammation in Mice Fed High-Fat Diet.	7	34	1.37	8.16e-05	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000480291	MPO,NOX4,HNF4A,NOX1,NFE2L2,BCL2,HNF1B
PMID:32817818	(2021) Ginseng gintonin, aging societies, and geriatric brain diseases.	7	34	1.37	8.16e-05	9606.ENSP00000246553,9606.ENSP00000259486,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	FFAR1,ENPP2,PTGS2,NFE2L2,BCL2,BDNF,VEGFA
PMID:33558334	(2021) Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.	7	34	1.37	8.16e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33688358	(2021) Network Pharmacology Interpretation of Fuzheng-Jiedu Decoction against Colorectal Cancer.	7	34	1.37	8.16e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IGF1R,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:33765610	(2021) An overview of some potential immunotherapeutic options against COVID-19.	9	77	1.13	8.16e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,ENTPD1,JAK2,VEGFA
PMID:33767633	(2021) Heterogeneity and Dynamics of Vasculature in the Endocrine System During Aging and Disease.	9	77	1.13	8.16e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,FABP4,THBS1,CDH1,PDGFB,PDGFA,EDN1,FGFR1,VEGFA
PMID:33849979	(2021) An Infection-Tolerant Mammalian Reservoir for Several Zoonotic Agents Broadly Counters the Inflammatory Effects of Endotoxin.	10	104	1.04	8.16e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000383364,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,CXCL9,NFE2L2,PLA2G2A,SAA1,MYD88,CCL5
PMID:33889151	(2021) Elevated Numbers of HIV-Specific Poly-Functional CD8(+) T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals.	7	34	1.37	8.16e-05	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:34272836	(2021) Upcoming treatments for morphea.	9	77	1.13	8.16e-05	9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	NOX4,CXCL11,ELN,NOX1,CNR2,EDN1,JAK2,BCL2,MYD88
PMID:34461565	(2021) Updated pharmacological effects of Lonicerae japonicae flos, with a focus on its potential efficacy on coronavirus disease-2019 (COVID-19).	7	34	1.37	8.16e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252	MPO,IFNG,HSPB1,ELN,PTGS2,JAK2,NFE2L2
PMID:34638620	(2021) Inhibition of APE1Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.	7	34	1.37	8.16e-05	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	ANGPT2,PDGFB,CCL20,TXN,EDN1,NFE2L2,VEGFA
PMID:34681202	(2021) Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease.	9	77	1.13	8.16e-05	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,ELN,CXCL9,TXN,NFE2L2,AGTR1,CCL5,VEGFA
PMID:34768814	(2021) The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors.	9	77	1.13	8.16e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000474412	CD38,CD69,CXCL10,CXCL11,CD247,CXCL9,PTGS2,PDGFD,CCL5
PMID:34829923	(2021) Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles.	5	8	1.86	8.16e-05	9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	CD47,PTEN,BMP2,BDNF,VEGFA
PMID:34948393	(2021) Three-Dimensional Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Promotes Matrix Metallopeptidase 13 (MMP13) Expression in Type I Collagen Hydrogels.	9	77	1.13	8.16e-05	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,SOX9,MMP14,CD34,PDGFA,ALPL,BMP2,FGFR1,VEGFA
PMID:32305401	(2020) Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.	7	34	1.37	8.16e-05	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000419422	MAPK1,IFNG,CXCL10,EDN1,JAK2,MME,AGTR1
PMID:32411805	(2020) Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis.	9	77	1.13	8.16e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478319	TGFB1,MPO,IFNG,CXCL10,CXCL11,CXCL9,EDN1,CCL5,GREM1
PMID:32908541	(2020) Involvement of Noncoding RNAs in the Differentiation of Osteoclasts.	10	104	1.04	8.16e-05	9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	APC,THBS1,IGF1R,CXCL11,MMP14,PTEN,MAFB,NFE2L2,BCL2,RHOA
PMID:33244513	(2020) Preclinical and Clinical Development of Therapeutic Antibodies Targeting Functions of CD47 in the Tumor Microenvironment.	7	34	1.37	8.16e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,THBS1,CD47,BCL2,PROM1,VEGFA
PMID:33381192	(2020) Humoral Influence of Repeated Lineage-Negative StemProgenitor Cell Administration on Articulatory Functions in ALS Patients.	5	8	1.86	8.16e-05	9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,NTF3,BDNF,PROM1,VEGFA
PMID:33552076	(2020) Tumor Hypoxia Regulates Immune EscapeInvasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.	7	34	1.37	8.16e-05	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,MMP14,ANGPT2,PDGFB,PTEN,PROM1,VEGFA
PMID:30728883	(2019) The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis.	7	34	1.37	8.16e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,ATM,NOX1,NFE2L2,BCL2,VEGFA
PMID:30884802	(2019) Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis.	9	77	1.13	8.16e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CCR5,CXCL10,STAT5A,CCL20,CXCL9,JAK2,MYD88,VEGFA
PMID:30992021	(2019) Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease.	5	8	1.86	8.16e-05	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,EDN1,PROM1,VEGFA
PMID:31060333	(2019) Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring.	10	104	1.04	8.16e-05	9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401720,9606.ENSP00000477707	CDH1,LPL,HNF4A,SIRT6,SREBF1,PTEN,NFE2L2,BCL2,GK,NR1H3
PMID:31109060	(2019) Cross-Talk between Inflammatory Mediators and the Epithelial Mesenchymal Transition Process in the Development of Thyroid Carcinoma.	9	77	1.13	8.16e-05	9606.ENSP00000261769,9606.ENSP00000288266,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,APPL1,HNF4A,STAT5A,PTEN,TXN,JAK2,BCL2,VEGFA
PMID:29594151	(2018) Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.	7	34	1.37	8.16e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000400175	IFNG,SOX9,ENPP2,ELN,PTGS2,KL,RHOA
PMID:29707149	(2018) Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression.	7	34	1.37	8.16e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	CDH1,ALDH1A1,CD34,HNF4A,PTEN,JAK2,CCL5
PMID:29783988	(2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinsons disease.	9	77	1.13	8.16e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,PTGS2,ENTPD1,MYD88,LTA,CCL5
PMID:30214103	(2018) Effects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane.	5	8	1.86	8.16e-05	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000478570	THBS1,ANGPT2,ANG,PTGS2,VEGFA
PMID:30255987	(2018) Higher Pericyte Content and Secretory Activity of Microfragmented Human Adipose Tissue Compared to Enzymatically Derived Stromal Vascular Fraction.	7	34	1.37	8.16e-05	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL10,CD34,ANG,CXCL9,CCL5,VEGFA
PMID:28253310	(2017) Petri net-based approach to modeling and analysis of selected aspects of the molecular regulation of angiogenesis.	7	34	1.37	8.16e-05	9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000478570	TGFB1,EPOR,MMP14,ANGPT2,PDGFB,CAV1,VEGFA
PMID:28445949	(2017) LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells.	9	77	1.13	8.16e-05	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD69,IFNG,CXCL10,STAT5A,EDN1,JAK2,BCL2,MYD88,MME
PMID:28670316	(2017) The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary Vasculature.	7	34	1.37	8.16e-05	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	NOX4,PTEN,NOX1,EDN1,RHOA,TRPC1,VEGFA
PMID:28789679	(2017) Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis.	10	104	1.04	8.16e-05	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000354782,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000478570	FABP4,THBS1,STAT5A,COMT,CD247,MTHFR,EDN1,JAK2,AGTR1,VEGFA
PMID:29213079	(2017) Human CD26(high) T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence.	9	77	1.13	8.16e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412	CD69,CCR5,CCL20,CD247,CXCL9,ENTPD1,BCL2,RHOA,CCL5
PMID:26967051	(2016) Lipidome in colorectal cancer.	7	34	1.37	8.16e-05	9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	LPL,LPA,SREBF1,PTGS2,BCL2,PROM1,VEGFA
PMID:27276710	(2016) Important molecular genetic markers of colorectal cancer.	9	77	1.13	8.16e-05	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,SOX9,ATM,HNF4A,PTGS2,PTEN,MTHFR,BCL2,VEGFA
PMID:27385915	(2016) Targeting MAPK Signaling in Age-Related Macular Degeneration.	7	34	1.37	8.16e-05	9606.ENSP00000200676,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000393312,9606.ENSP00000478570	CETP,COL8A1,TIMP3,MAPK7,MAP3K5,FGFR1,VEGFA
PMID:27579744	(2016) Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?	7	34	1.37	8.16e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	IFNG,CXCL10,VIP,NPY,BDNF,MME,VEGFA
PMID:25405932	(2015) The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.	7	34	1.37	8.16e-05	9606.ENSP00000257430,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000418009	APC,TIMP3,IGF1R,CAV1,PTGS2,AR,RARRES2
PMID:25622749	(2015) Profiling of cell stress protein expression in cardiac tissue of cardiosurgical patients undergoing remote ischemic preconditioning: implications for thioredoxin in cardioprotection.	7	34	1.37	8.16e-05	9606.ENSP00000222572,9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000444198	PON2,HSPB1,STAT5A,PTGS2,TXN,BCL2,CITED2
PMID:25890876	(2015) Resveratrol attenuates CXCL11 expression induced by proinflammatory cytokines in retinal pigment epithelial cells.	5	8	1.86	8.16e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:26044469	(2015) Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema.	5	8	1.86	8.16e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,PDGFA,VEGFA
PMID:24861084	(2014) Lipid biology of the podocyte--new perspectives offer new opportunities.	7	34	1.37	8.16e-05	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000317674,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000352264,9606.ENSP00000354995	CETP,PON2,APOL1,CAV1,SREBF1,CD2AP,ABCG1
PMID:23547922	(2013) Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models.	7	34	1.37	8.16e-05	9606.ENSP00000216181,9606.ENSP00000229135,9606.ENSP00000317674,9606.ENSP00000352264,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	MYH9,IFNG,APOL1,CD2AP,EDN1,RHOA,VEGFA
PMID:23922669	(2013) Cancer-associated fibroblasts promote proliferation of endometrial cancer cells.	7	34	1.37	8.16e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CCR5,PTEN,BCL2,CCL5,VEGFA
PMID:24129241	(2013) CXCR3CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.	5	8	1.86	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:24135786	(2013) Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.	5	8	1.86	8.16e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000478570	THBS1,CDH1,TIMP3,ANGPT2,VEGFA
PMID:24183943	(2013) Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.	10	104	1.04	8.16e-05	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,CDH1,CD34,PDGFB,PDGFA,PTEN,JAK2,PDGFD,PROM1,VEGFA
PMID:24349206	(2013) The transcriptomic response of rat hepatic stellate cells to endotoxin: implications for hepatic inflammation and immune regulation.	13	205	0.86	8.16e-05	9606.ENSP00000216181,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412	MYH9,COL8A1,TIMP3,CCR5,CXCL10,CXCL11,CCL20,ELN,CXCL9,BAMBI,EDN1,MYD88,CCL5
PMID:21193018	(2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer.	10	104	1.04	8.16e-05	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,CDH1,CD34,PDGFB,PDGFA,PTEN,JAK2,PDGFD,BCL2,VEGFA
PMID:21602838	(2011) The ClC-3 chloride channels in cardiovascular disease.	5	8	1.86	8.16e-05	9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	NOX1,EDN1,BCL2,RHOA,AGTR1
PMID:21644238	(2011) Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.	5	8	1.86	8.16e-05	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CD34,PTGS2,BCL2,VEGFA
PMID:22025564	(2011) PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.	7	34	1.37	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5,VEGFA
PMID:20042589	(2010) Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia.	7	34	1.37	8.16e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399	MPO,CD69,CXCL10,CCL20,CXCL9,IRAK4,MYD88
PMID:19040209	(2009) Prostate cancer stem cells.	7	34	1.37	8.16e-05	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ATM,CD34,PTEN,AR,BCL2,PROM1
PMID:17925429	(2008) CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.	5	8	1.86	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:18275612	(2008) Proteome analysis of human substantia nigra in Parkinsons disease.	7	34	1.37	8.16e-05	9606.ENSP00000232219,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000354511,9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000414303	RBP1,ALDH1A1,PRDX2,COMT,GLO1,TXN,BDNF
PMID:18613999	(2008) Malignant melanoma in the 21st century: the emerging molecular landscape.	10	104	1.04	8.16e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,CD34,HNF4A,EDNRA,PTEN,EDN1,BCL2,PROM1,VEGFA
PMID:15004722	(2005) The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.	5	8	1.86	8.16e-05	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:15888026	(2005) Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.	5	8	1.86	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:15213273	(2004) Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.	5	8	1.86	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:12544874	(2003) Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants.	5	8	1.86	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:12819030	(2003) Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTESCCL5 and IP-10CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.	5	8	1.86	8.16e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:12402142	(2002) Role of genetic polymorphisms in tumour angiogenesis.	7	34	1.37	8.16e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,CDH1,TIMP3,CXCL10,FGFR1,LTA,VEGFA
PMID:10209239	(1999) Growth factors effects on the expression of morphological and biochemical properties of avian embryonic sympathetic cells. Emphasis on NGF.	5	8	1.86	8.16e-05	9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,CNTF,NPY,NTF3,BDNF
PMID:7586498	(1995) Peptidergic, catecholaminergic and morphological properties of avian chromaffin cells are modulated distinctively by growth factors.	5	8	1.86	8.16e-05	9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,CNTF,NPY,NTF3,BDNF
PMID:31244652	(2019) Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.	11	135	0.97	8.23e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000444198,9606.ENSP00000478570	APC,CDH1,ATM,SIRT6,MAP3K5,PTEN,TXN,AR,BCL2,CITED2,VEGFA
PMID:33093441	(2020) Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.	12	169	0.91	8.36e-05	9606.ENSP00000216181,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,APC,CDH1,ALDH1A1,ANGPT2,SIRT6,SREBF1,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:35054828	(2022) Curcumin and Weight Loss: Does It Work?	8	54	1.23	8.46e-05	9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000393312	LPL,HNF4A,SREBF1,COMT,PTGS2,TXN,BCL2,FGFR1
PMID:35317173	(2022) Development of the nervous system in mouse liver.	6	19	1.56	8.46e-05	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,HNF4A,NPY,NTF3,BDNF,VEGFA
PMID:35327460	(2022) Inorganic Polymeric Materials for Injured Tissue Repair: Biocatalytic Formation and Exploitation.	6	19	1.56	8.46e-05	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000351807,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,FABP4,ELN,ALPL,BMP2,VEGFA
PMID:32972983	(2021) Targeting HIF2alpha-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.	8	54	1.23	8.46e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	MPO,IFNG,CD34,CAV1,ELN,EDN1,PROM1,VEGFA
PMID:33316289	(2021) Modulation of the chemokinechemokine receptor axis as a novel approach for glioma therapy.	8	54	1.23	8.46e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,PDGFB,CCL20,CXCL9,BCL2,CCL5
PMID:33510058	(2021) Astrocytes: a double-edged sword in neurodegenerative diseases.	8	54	1.23	8.46e-05	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CCL20,CNTF,PTGS2,NFE2L2,LTA,BDNF,VEGFA
PMID:33777201	(2021) Role of exosomes in the immune microenvironment of ovarian cancer.	10	105	1.04	8.46e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	HSPB1,CDH1,LPL,CAV1,CD247,ENTPD1,PTEN,BCL2,MYD88,VEGFA
PMID:33807355	(2021) The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer.	10	105	1.04	8.46e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CDH1,ATM,ALDH1A1,MAP3K5,SGK1,PTEN,NFE2L2,BCL2,VEGFA
PMID:33837221	(2021) Targets identified from exercised heart: killing multiple birds with one stone.	8	54	1.23	8.46e-05	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,IGF1R,PTEN,JAK2,G6PD,NFE2L2,BCL2,VEGFA
PMID:33981314	(2021) Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!	6	19	1.56	8.46e-05	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,JAK2,VEGFA
PMID:34072430	(2021) Elucidation of the Molecular Pathways Involved in the Protective Effects of AUY-922 in LPS-Induced Inflammation in Mouse Lungs.	8	54	1.23	8.46e-05	9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	ATM,ANGPT2,SIRT6,PTGS2,JAK2,RHOA,MYD88,VEGFA
PMID:34074330	(2021) Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.	8	54	1.23	8.46e-05	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000310036,9606.ENSP00000346148,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312	MAPK1,APC,CD34,PRKAA1,CD47,PTEN,JAK2,FGFR1
PMID:34208834	(2021) Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury.	10	105	1.04	8.46e-05	9606.ENSP00000260356,9606.ENSP00000301522,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,PRDX2,P2RY1,CXCL10,CNTF,TXN,EDN1,MYD88,BDNF,VEGFA
PMID:34300206	(2021) Genetic Susceptibility to Acute Kidney Injury.	8	54	1.23	8.46e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000317674,9606.ENSP00000354511,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	MPO,IFNG,APOL1,COMT,BCL2,LTA,AGTR1,VEGFA
PMID:34356845	(2021) Inflammatory Mechanisms Contributing to Endothelial Dysfunction.	8	54	1.23	8.46e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000401399	IFNG,NOX4,TIMP3,ANGPT2,NOX1,EDN1,NFE2L2,MYD88
PMID:34768479	(2021) Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment.	8	54	1.23	8.46e-05	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000478570	CHI3L1,CXCL10,CXCL11,ANGPT2,CCL20,ELN,CXCL9,VEGFA
PMID:34853306	(2021) Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids.	8	54	1.23	8.46e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303	IGF1R,ATM,PDGFB,GAS6,PDGFA,FGFR1,NTF3,BDNF
PMID:34856936	(2021) Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).	6	19	1.56	8.46e-05	9606.ENSP00000013807,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185	ERCC1,IFNG,ATM,CXCL10,CXCL9,BCL2
PMID:32467351	(2020) Metabolic Syndrome, Physical Activity, and Inflammation: A Cross-Sectional Analysis of 110 Circulating Biomarkers in Japanese Adults.	8	54	1.23	8.46e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000414303	CXCL10,CXCL11,CCL20,CXCL9,S100A12,SAA1,LTA,BDNF
PMID:32667137	(2020) Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity.	8	54	1.23	8.46e-05	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,AMBP,ATM,ALDH1A1,PTEN,BCL2,FGFR1,VEGFA
PMID:32764789	(2020) Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection.	6	19	1.56	8.46e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,ANGPT2,CCL20,CXCL9,CCL5
PMID:32848579	(2020) Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease.	6	19	1.56	8.46e-05	9606.ENSP00000298352,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	NGB,SIRT6,CNTF,NTF3,BDNF,VEGFA
PMID:33121141	(2020) Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology.	8	54	1.23	8.46e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,ATM,ELN,PTEN,TXN,BCL2,VEGFA
PMID:33124125	(2020) Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency.	6	19	1.56	8.46e-05	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CD34,ANG,EDN1,BCL2,VEGFA
PMID:30378501	(2019) Application of G-CSF in Congestive Heart Failure Treatment.	6	19	1.56	8.46e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419422	TGFB1,IFNG,CD34,EDN1,JAK2,AGTR1
PMID:30833142	(2019) Lipoxidation in cardiovascular diseases.	8	54	1.23	8.46e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000356438	MPO,IFNG,FABP4,NOX4,DDAH1,LPL,ELN,PTGS2
PMID:31055200	(2019) Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.	6	19	1.56	8.46e-05	9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000474412	IFNG,CD247,CXCL9,PTEN,NFE2L2,CCL5
PMID:31284512	(2019) Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.).	8	54	1.23	8.46e-05	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IFNG,CDH1,ATM,PLIN1,PTGS2,BCL2,VEGFA
PMID:31379856	(2019) Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms.	10	105	1.04	8.46e-05	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000474412	MPO,CD69,SOX9,HSPB1,CCR5,CCL20,BMP2,MYD88,RARRES2,CCL5
PMID:31402861	(2019) Formononetin: A Review of Its Anticancer Potentials and Mechanisms.	8	54	1.23	8.46e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTEN,JAK2,BCL2,FGFR1,VEGFA
PMID:31620092	(2019) Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications.	6	19	1.56	8.46e-05	9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	ATM,MAPK7,PTEN,TXN,BCL2,VEGFA
PMID:31766595	(2019) Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications.	6	19	1.56	8.46e-05	9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,NOX1,EDN1,RHOA,BDNF,VEGFA
PMID:31870101	(2019) JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.	6	19	1.56	8.46e-05	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000418525	EPOR,MPO,STAT5A,PTEN,JAK2,MME
PMID:31921154	(2019) Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack.	8	54	1.23	8.46e-05	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	ATM,CCR5,CXCL10,SREBF1,MAP3K5,CXCL9,MYD88,CCL5
PMID:29468140	(2018) Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer.	8	54	1.23	8.46e-05	9606.ENSP00000215832,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000477707	MAPK1,HNF4A,SIRT6,STAT5A,PTEN,JAK2,FGFR1,NR1H3
PMID:29497380	(2018) Triple-Gene Therapy for Stroke: A Proof-of-Concept in Vivo Study in Rats.	6	19	1.56	8.46e-05	9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CD34,CNTF,BCL2,BDNF,VEGFA
PMID:30097618	(2018) Enzyme-modified non-oxidized LDL (ELDL) induces human coronary artery smooth muscle cell transformation to a migratory and osteoblast-like phenotype.	6	19	1.56	8.46e-05	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000363973,9606.ENSP00000368104	MAPK1,FABP4,PLIN1,LPL,ALPL,BMP2
PMID:30186247	(2018) The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health.	6	19	1.56	8.46e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,NPY,CCL5
PMID:30356429	(2018) Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress.	6	19	1.56	8.46e-05	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000419422	PON2,NOX4,PTGS2,NOX1,TXN,AGTR1
PMID:30563247	(2018) Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.	8	54	1.23	8.46e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,CDH1,CXCL9,AR,EDN1,BCL2,VEGFA
PMID:30598575	(2018) Hepatitis C: From inflammatory pathogenesis to anti-inflammatoryhepatoprotective therapy.	8	54	1.23	8.46e-05	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000401399,9606.ENSP00000474412	NOX4,CXCL10,CXCL11,CCL20,CXCL9,NOX1,MYD88,CCL5
PMID:30619886	(2018) The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.	8	54	1.23	8.46e-05	9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000475344	CXCL10,EDNRA,EDN1,JAK2,BCL2,AGTR1,CCL5,APLNR
PMID:34171004	(2018) Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review.	6	19	1.56	8.46e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000360997,9606.ENSP00000478570	MPO,CD38,IFNG,CXCL10,ADAMTS13,VEGFA
PMID:27709799	(2017) Neurotrophic Factor-alpha1: A Key Wnt-beta-Catenin Dependent Anti-Proliferation Factor and ERK-Sox9 Activated Inducer of Embryonic Neural Stem Cell Differentiation to Astrocytes in Neurodevelopment.	6	19	1.56	8.46e-05	9606.ENSP00000245479,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	SOX9,CNTF,PTEN,BCL2,NTF3,BDNF
PMID:28123601	(2017) Human-derived normal mesenchymal stemstromal cells in anticancer therapies.	8	54	1.23	8.46e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CDH1,IGF1R,PTEN,BCL2,NTF3,BDNF,VEGFA
PMID:28255369	(2017) Prostate cancer between prognosis and adequateproper therapy.	8	54	1.23	8.46e-05	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000384364,9606.ENSP00000478570	CDH1,CAV1,VIP,PTEN,AR,SHBG,NPY,VEGFA
PMID:28367520	(2017) Therapeutic targets of renin-angiotensin system in ocular disorders.	6	19	1.56	8.46e-05	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000362463,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,CNTF,GLO1,BDNF,AGTR1,VEGFA
PMID:28542481	(2017) Effect of hyperbaric oxygen on BDNF-release and neuroprotection: Investigations with human mesenchymal stem cells and genetically modified NIH3T3 fibroblasts as putative cell therapeutics.	6	19	1.56	8.46e-05	9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CNTF,TXN,NTF3,BDNF,VEGFA
PMID:28744461	(2017) Integrating Genome-Wide Association and eQTLs Studies Identifies the Genes and Gene Sets Associated with Diabetes.	6	19	1.56	8.46e-05	9606.ENSP00000278840,9606.ENSP00000283928,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000477707	FADS2,JAZF1,SREBF1,PTEN,BCL2,NR1H3
PMID:28984359	(2017) Strategies to retain properties of bone marrow-derived mesenchymal stem cells ex vivo.	8	54	1.23	8.46e-05	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CXCL10,LPL,BMP2,EDN1,RHOA,CCL5,GREM1,VEGFA
PMID:27352979	(2016) PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease.	8	54	1.23	8.46e-05	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401720,9606.ENSP00000414303	SOX9,LPL,SIRT6,MAP3K5,BCL2,RHOA,GK,BDNF
PMID:27394680	(2016) Redox mechanisms in age-related lung fibrosis.	6	19	1.56	8.46e-05	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252	NOX4,CAV1,NOX1,TXN,EDN1,NFE2L2
PMID:27403169	(2016) Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimers Disease Treatment: An In Vitro Study.	6	19	1.56	8.46e-05	9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	GAP43,BCL2,BDNF,MME,CCL5,VEGFA
PMID:27932954	(2016) Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective.	6	19	1.56	8.46e-05	9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CCL20,CXCL9,JAK2,MYD88,BDNF,VEGFA
PMID:25501304	(2015) Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.	6	19	1.56	8.46e-05	9606.ENSP00000215832,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,HNF4A,PTEN,HSPG2,FGFR1,VEGFA
PMID:26117324	(2015) Signaling and stress: The redox landscape in NOS2 biology.	8	54	1.23	8.46e-05	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000478570	THBS1,ATM,SIRT6,CD47,NOX1,TXN,G6PD,VEGFA
PMID:26176954	(2015) Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome.	6	19	1.56	8.46e-05	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CXCL10,ANGPT2,EDNRA,EDN1,BCL2,VEGFA
PMID:26184171	(2015) Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells.	6	19	1.56	8.46e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,HNF4A,PROM1,VEGFA
PMID:26652025	(2015) Genetic modification of human mesenchymal stem cells helps to reduce adiposity and improve glucose tolerance in an obese diabetic mouse model.	6	19	1.56	8.46e-05	9606.ENSP00000256104,9606.ENSP00000263774,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000363973	FABP4,NDUFS3,PLIN1,CD34,SREBF1,ALPL
PMID:24855013	(2014) Microbiota and immune responses in colon cancer: more to learn.	6	19	1.56	8.46e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438	APC,CDH1,CXCL10,CD247,CXCL9,PTGS2
PMID:25193342	(2014) Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.	6	19	1.56	8.46e-05	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,MMP14,HNF4A,PTEN,PROM1,VEGFA
PMID:25311932	(2014) Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.	6	19	1.56	8.46e-05	9606.ENSP00000200676,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000345708,9606.ENSP00000477707	CETP,FADS2,LPL,APOL1,KCNJ11,NR1H3
PMID:25389900	(2014) Vitamin a deficiency and alterations in the extracellular matrix.	8	54	1.23	8.46e-05	9606.ENSP00000232219,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356515,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000478570	RBP1,LPL,STAT5A,ELN,UTRN,HSPG2,JAK2,VEGFA
PMID:23092791	(2013) Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy.	8	54	1.23	8.46e-05	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000363827,9606.ENSP00000475344,9606.ENSP00000478570	MMP14,CD34,ANGPT2,PDGFB,UNC5B,HSPG2,APLNR,VEGFA
PMID:23426401	(2013) Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.	8	54	1.23	8.46e-05	9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,ENPP2,CDH1,PTEN,AR,EDN1,JAK2,VEGFA
PMID:23725043	(2013) Macrophages and angiogenesis in rheumatic diseases.	8	54	1.23	8.46e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000478570	CXCL10,CD34,PDGFB,ANG,PDGFA,CXCL9,PDGFD,VEGFA
PMID:24259307	(2013) Chemokines in tumor progression and metastasis.	8	54	1.23	8.46e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,PROM1,CCL5,VEGFA
PMID:24558600	(2013) New therapeutic targets for intraocular pressure lowering.	8	54	1.23	8.46e-05	9606.ENSP00000260356,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478319	THBS1,HNF4A,EDNRA,ELN,ANGPTL2,EDN1,RHOA,GREM1
PMID:22065047	(2012) Regulatory dendritic cells in the tumor immunoenvironment.	8	54	1.23	8.46e-05	9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	EDNRA,STAT5A,PTGS2,ENTPD1,EDN1,BCL2,CCL5,VEGFA
PMID:22260501	(2012) Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells.	6	19	1.56	8.46e-05	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PDGFB,PTEN,JAK2,BCL2,VEGFA
PMID:22745769	(2012) Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions.	6	19	1.56	8.46e-05	9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,ANG,CNTF,GAP43,BDNF,VEGFA
PMID:21766027	(2011) Glial cells in amyotrophic lateral sclerosis.	6	19	1.56	8.46e-05	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CNTF,PTGS2,MYD88,BDNF,VEGFA
PMID:20212229	(2010) A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.	6	19	1.56	8.46e-05	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000478570	THBS1,TIMP3,ANGPT2,ANGPTL2,HSPG2,VEGFA
PMID:20406442	(2010) The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.	6	19	1.56	8.46e-05	9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,PTGS2,TXN,AR,BCL2,VEGFA
PMID:22043201	(2010) Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart.	6	19	1.56	8.46e-05	9606.ENSP00000248553,9606.ENSP00000345708,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,KCNJ11,PTGS2,TXN,BCL2,VEGFA
PMID:18631392	(2008) Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.	6	19	1.56	8.46e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000478570	SOX9,CDH1,IGF1R,AR,NPY,VEGFA
PMID:19039768	(2008) CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.	6	19	1.56	8.46e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:27999207	(2017) Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells.	11	136	0.97	8.58e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ALDH1A1,CD34,HNF4A,PTEN,KL,BCL2,PROM1,VEGFA
PMID:35053592	(2022) STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential.	9	78	1.12	8.67e-05	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,STAT5A,CNTF,PTGS2,PTEN,JAK2,AGTR1,PROM1,VEGFA
PMID:35418077	(2022) Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research.	9	78	1.12	8.67e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CDH1,MMP14,CD47,BCL2,RHOA,MYD88,CCL5,VEGFA
PMID:33918704	(2021) A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials.	9	78	1.12	8.67e-05	9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,ANGPT2,ENTPD1,PTEN,BMP2,JAK2,BCL2,FGFR1,VEGFA
PMID:34251745	(2021) Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study.	9	78	1.12	8.67e-05	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,ATM,CXCL10,CD34,PTEN,JAK2,FGFR1,LTA,VEGFA
PMID:34299604	(2021) Is Curcumin the Answer to Future Chemotherapy Cocktail?	9	78	1.12	8.67e-05	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,IGF1R,PTGS2,PTEN,AR,BCL2,PROM1,VEGFA
PMID:34611893	(2021) Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.	9	78	1.12	8.67e-05	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CXCL10,CXCL11,ANGPT2,PDGFB,CXCL9,IRAK4,MYD88,VEGFA
PMID:34639131	(2021) Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights.	9	78	1.12	8.67e-05	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	CDH1,STAT5A,MAP3K5,PTEN,JAK2,BCL2,FGFR1,LTA,VEGFA
PMID:32393771	(2020) Pancreatic cancer stroma: an update on therapeutic targeting strategies.	9	78	1.12	8.67e-05	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,IGF1R,GAS6,PTGS2,JAK2,IRAK4,CCL5,VEGFA
PMID:32456248	(2020) Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis.	9	78	1.12	8.67e-05	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000363827	THBS1,MMP14,ANGPT2,PDGFB,UNC5B,PDGFA,CD47,PTGS2,HSPG2
PMID:32486505	(2020) Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities.	9	78	1.12	8.67e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000426809,9606.ENSP00000474412	FABP4,CDH1,LPL,SIRT6,SREBF1,PTEN,TXN,PROM1,CCL5
PMID:32903669	(2020) Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders.	9	78	1.12	8.67e-05	9606.ENSP00000292303,9606.ENSP00000321853,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,SERPINF2,CAV1,HSPG2,NFE2L2,RHOA,BDNF,CCL5,VEGFA
PMID:33281727	(2020) The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury.	9	78	1.12	8.67e-05	9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,NOX1,EDN1,JAK2,NFE2L2,BCL2,RHOA,BDNF,VEGFA
PMID:33505596	(2020) Novel insights for improving the therapeutic safety and efficiency of mesenchymal stromal cells.	9	78	1.12	8.67e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CCL20,CXCL9,PTGS2,PTEN,LTB4R2,CCL5,VEGFA
PMID:30944599	(2019) Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches.	9	78	1.12	8.67e-05	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CXCL10,CD34,STAT5A,CCL20,PTEN,BCL2,PROM1,VEGFA
PMID:31881654	(2019) Antidiabetic Properties of Curcumin II: Evidence from In Vivo Studies.	9	78	1.12	8.67e-05	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,NOX4,LPL,CAV1,SREBF1,EDN1,NFE2L2,BCL2,VEGFA
PMID:31921852	(2019) Extracellular Matrix Composition and Remodeling: Current Perspectives on Secondary Palate Formation, Cleft LipPalate, and Palatal Reconstruction.	9	78	1.12	8.67e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,TIMP3,MMP14,FMOD,ELN,MAFB,BMP2,FGFR1,VEGFA
PMID:29507653	(2018) The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases.	9	78	1.12	8.67e-05	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000477707,9606.ENSP00000478570	CDH1,NOX4,SREBF1,PTEN,NFE2L2,BCL2,MYD88,NR1H3,VEGFA
PMID:28276486	(2017) A potential regulatory network underlying distinct fate commitment of myogenic and adipogenic cells in skeletal muscle.	9	78	1.12	8.67e-05	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809	LPL,CD34,CAV1,PDGFA,SREBF1,PDGFD,RHOA,AGTR1,PROM1
PMID:22581922	(2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.	9	78	1.12	8.67e-05	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,NOX4,STAT5A,MAP3K5,NOX1,EDN1,JAK2,RHOA,VEGFA
PMID:31900168	(2020) Tumor microenvironment differences between primary tumor and brain metastases.	10	106	1.04	9.07e-05	9606.ENSP00000013807,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	ERCC1,THBS1,CDH1,ANGPT2,PTGS2,PTEN,AR,BMP2,BDNF,VEGFA
PMID:33381036	(2020) The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus.	10	106	1.04	9.07e-05	9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,LPL,PDGFB,SREBF1,PTGS2,MAFB,NFE2L2,BCL2,BDNF,VEGFA
PMID:31354653	(2019) Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposis Sarcoma-Associated Herpesvirus.	10	106	1.04	9.07e-05	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ANGPT2,ANG,CCL20,PTGS2,PTEN,ANGPTL2,FGFR1,CCL5,VEGFA
PMID:30150991	(2018) Natural Killer Cells: Development, Maturation, and Clinical Utilization.	10	106	1.04	9.07e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412	CD38,CD69,CD34,STAT5A,CD247,JAK2,MYD88,MME,PROM1,CCL5
PMID:21437240	(2011) Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses.	10	106	1.04	9.07e-05	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	LAMC1,THBS1,CXCL10,STAT5A,CCL20,CXCL9,PTEN,BCL2,MYD88,CCL5
PMID:35220044	(2022) Alzheimers disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus.	11	137	0.97	9.12e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	TGFB1,IFNG,IGF1R,CXCL11,ANGPT2,PDGFB,CXCL9,CNTF,NTF3,BDNF,CCL5
PMID:33668160	(2021) Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.	11	137	0.97	9.12e-05	9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	ENPP2,CXCL10,CXCL11,CD34,CXCL9,PTGS2,PTEN,HSPG2,FGFR1,RHOA,VEGFA
PMID:29112161	(2017) Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.	11	137	0.97	9.12e-05	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,THBS1,CDH1,ALDH1A1,PRDX2,MMP14,ELN,HSPG2,BCL2,CCL5,VEGFA
PMID:34097193	(2022) Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?	7	35	1.36	9.18e-05	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384262,9606.ENSP00000478570	MPO,ANGPT2,ADAMTS13,EDN1,JAK2,HPSE,VEGFA
PMID:35197754	(2022) Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer.	7	35	1.36	9.18e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTEN,FGFR1,PROM1,VEGFA
PMID:33448312	(2021) Atrial fibrosis underlying atrial fibrillation (Review).	7	35	1.36	9.18e-05	9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,PDGFB,PDGFA,PDGFD,RHOA,AGTR1,VEGFA
PMID:33469052	(2021) Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles.	7	35	1.36	9.18e-05	9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000475344	CD69,AMBP,CXCL10,CXCL11,MMP14,CXCL9,APLNR
PMID:33541422	(2021) The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases.	7	35	1.36	9.18e-05	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000380252,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CD34,CCL20,NFE2L2,NTF3,BDNF,VEGFA
PMID:33805921	(2021) Revealing the Role of High-Density Lipoprotein in Colorectal Cancer.	7	35	1.36	9.18e-05	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000478570	CETP,MPO,CDH1,HNF4A,ABCG1,PTGS2,VEGFA
PMID:33821665	(2021) Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARalpha Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.	7	35	1.36	9.18e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,SIRT6,SREBF1,CXCL9,CCL5
PMID:34899707	(2021) Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea.	7	35	1.36	9.18e-05	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	SOX9,CCR5,CXCL10,CCL20,CXCL9,PTGS2,VEGFA
PMID:31699365	(2020) Current advances in ischemic stroke research and therapies.	7	35	1.36	9.18e-05	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809	MAPK1,CD34,PTGS2,EDN1,BCL2,BDNF,PROM1
PMID:32117287	(2020) Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.	7	35	1.36	9.18e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD34,CD47,PTGS2,PROM1,CCL5,VEGFA
PMID:32899775	(2020) Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.	7	35	1.36	9.18e-05	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,HNF4A,PTEN,BCL2,MYD88,PROM1
PMID:32923976	(2020) TRAIL signals, extracellular matrix and vessel remodelling.	7	35	1.36	9.18e-05	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000478570	TGFB1,THBS1,NOX4,IGF1R,PDGFB,ELN,VEGFA
PMID:30621039	(2019) Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer.	7	35	1.36	9.18e-05	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,AR,BCL2,CCL5,VEGFA
PMID:30720717	(2019) Potential of Schisandra chinensis (Turcz.) Baill. in Human Health and Nutrition: A Review of Current Knowledge and Therapeutic Perspectives.	7	35	1.36	9.18e-05	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000477707,9606.ENSP00000478570	SREBF1,PTGS2,NFE2L2,BCL2,RHOA,NR1H3,VEGFA
PMID:30880916	(2019) Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities.	7	35	1.36	9.18e-05	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CD34,STAT5A,ELN,PTGS2,JAK2,BCL2
PMID:31056763	(2019) Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care.	7	35	1.36	9.18e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000414303	CD38,CD69,CXCL10,CXCL11,CXCL9,VIP,BDNF
PMID:31221124	(2019) Analysis of the transcriptomic features of microsatellite instability subtype colon cancer.	7	35	1.36	9.18e-05	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL9,PTEN,JAK2,CCL5
PMID:31443386	(2019) Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.	7	35	1.36	9.18e-05	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,PTGS2,AR,G6PD,NFE2L2,BCL2,VEGFA
PMID:31636809	(2019) Emerging Perspective: Role of Increased ROS and Redox Imbalance in Skin Carcinogenesis.	7	35	1.36	9.18e-05	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTEN,NOX1,TXN,NFE2L2,BCL2,VEGFA
PMID:31666566	(2019) Using high-throughput sequencing to explore the anti-inflammatory effects of alpha-mangostin.	7	35	1.36	9.18e-05	9606.ENSP00000228434,9606.ENSP00000278840,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412	CD69,FADS2,CXCL10,CXCL11,CCL20,PTGS2,CCL5
PMID:31832112	(2019) Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles.	7	35	1.36	9.18e-05	9606.ENSP00000255409,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	CHI3L1,PTGS2,JAK2,BCL2,IRAK4,MYD88,VEGFA
PMID:32010138	(2019) Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged Sword.	7	35	1.36	9.18e-05	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL9,ENTPD1,PTEN,CCL5,VEGFA
PMID:28084682	(2018) Exogenous transforming growth factor-beta1 enhances smooth muscle differentiation in embryonic mouse jejunal explants.	7	35	1.36	9.18e-05	9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000376865	COL8A1,CDH1,PDGFB,PDGFA,ELN,PTEN,PDGFD
PMID:29490339	(2018) Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.	7	35	1.36	9.18e-05	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000278840,9606.ENSP00000339191,9606.ENSP00000478570	HSPB1,CDH1,IGF1R,ATM,FADS2,CAV1,VEGFA
PMID:29523133	(2018) Obesity as disruptor of the female fertility.	7	35	1.36	9.18e-05	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000478570	IGF1R,PTGS2,RBP4,SHBG,JAK2,RARRES2,VEGFA
PMID:29719227	(2018) A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism.	7	35	1.36	9.18e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000346148,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000480291	MAPK1,TGFB1,IFNG,PRKAA1,RBP4,AR,HNF1B
PMID:29936139	(2018) Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies.	7	35	1.36	9.18e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000418525	IFNG,CXCL10,CXCL11,CXCL9,CD47,PTGS2,MME
PMID:30135219	(2018) Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response.	7	35	1.36	9.18e-05	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:30240612	(2018) Nck1 Deficiency Impairs Adipogenesis by Activation of PDGFRalpha in Preadipocytes.	7	35	1.36	9.18e-05	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865	TGFB1,FABP4,PLIN1,CD34,PDGFB,PDGFA,PDGFD
PMID:30723697	(2018) CXCL13CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3KAKTmTOR Pathway in Clear Cell Renal Cell Carcinoma.	7	35	1.36	9.18e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2,CCL5
PMID:27916652	(2017) Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery.	7	35	1.36	9.18e-05	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IGF1R,CD34,ANGPT2,ANG,PROM1,VEGFA
PMID:27077889	(2016) Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases.	7	35	1.36	9.18e-05	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,NOX4,CD34,CAV1,EDN1,RHOA,VEGFA
PMID:27348748	(2016) A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin alpha4beta7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3.	7	35	1.36	9.18e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:27595115	(2016) T Helper Cell Subsets in Clinical Manifestations of Psoriasis.	7	35	1.36	9.18e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,VEGFA
PMID:26090665	(2015) Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.	7	35	1.36	9.18e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000393312	CCR5,CXCL10,CXCL11,STAT5A,CXCL9,JAK2,FGFR1
PMID:26239562	(2015) Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade.	7	35	1.36	9.18e-05	9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252	EDNRA,MAP3K5,NOX1,TXN,EDN1,JAK2,NFE2L2
PMID:26690200	(2015) From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis.	7	35	1.36	9.18e-05	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,CD34,CD47,BCL2,PROM1,VEGFA
PMID:24268694	(2014) Contractile forces sustain and polarize hematopoiesis from stem and progenitor cells.	7	35	1.36	9.18e-05	9606.ENSP00000216181,9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000426809	MYH9,CD38,ALDH1A1,CD34,ELN,CD47,PROM1
PMID:24904289	(2014) CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.	7	35	1.36	9.18e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,PROM1,CCL5,VEGFA
PMID:23806280	(2013) Bone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury.	7	35	1.36	9.18e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL11,CD34,GAS6,CCL5,VEGFA
PMID:22030746	(2012) Stem cells in liver diseases and cancer: recent advances on the path to new therapies.	7	35	1.36	9.18e-05	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000480291	CD38,SOX9,CD34,HNF4A,PTEN,PROM1,HNF1B
PMID:21552147	(2011) ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.	7	35	1.36	9.18e-05	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000362524,9606.ENSP00000393312,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,PDGFA,ANGPTL2,FGFR1,VEGFA
PMID:21624487	(2011) Tubulogenesis during blood vessel formation.	7	35	1.36	9.18e-05	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000478570	MYH9,CDH1,MMP14,CD34,PTEN,HSPG2,VEGFA
PMID:20979652	(2010) Treatment options for patients with triple-negative breast cancer.	7	35	1.36	9.18e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,ATM,CAV1,PTEN,AR,FGFR1,VEGFA
PMID:35158770	(2022) Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma.	8	55	1.22	9.24e-05	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,ATM,PTGS2,JAK2,BCL2,RHOA,MYD88,CCL5
PMID:33429918	(2021) Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms.	8	55	1.22	9.24e-05	9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	MPO,ATM,PTEN,EDN1,SHBG,BCL2,NPY,VEGFA
PMID:33836774	(2021) Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling.	8	55	1.22	9.24e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,CD34,PDGFB,ANG,PDGFA,BCL2,VEGFA
PMID:34071976	(2021) Therapies Targeted at Non-Coding RNAs in Prevention and Limitation of Myocardial Infarction and Subsequent Cardiac Remodeling-Current Experience and Perspectives.	8	55	1.22	9.24e-05	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	MAPK1,EPOR,TIMP3,MMP14,CD34,PTEN,BCL2,MYD88
PMID:34093183	(2021) Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause.	8	55	1.22	9.24e-05	9606.ENSP00000225275,9606.ENSP00000284031,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000414303	MPO,DDAH1,MAP3K5,PTGS2,AR,SHBG,BCL2,BDNF
PMID:34298809	(2021) The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy.	8	55	1.22	9.24e-05	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ALDH1A1,GAS6,PTEN,JAK2,NFE2L2,BCL2,PROM1
PMID:34512625	(2021) Identification of Genes Encoding Antimicrobial Proteins in Langerhans Cells.	8	55	1.22	9.24e-05	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000384906,9606.ENSP00000418009	CXCL10,CXCL11,CD34,CCL20,CXCL9,NPY,SAA1,RARRES2
PMID:34607951	(2021) Eicosanoid regulation of debris-stimulated metastasis.	8	55	1.22	9.24e-05	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,THBS1,CXCL10,ANGPT2,ANG,PTGS2,EDN1,VEGFA
PMID:34638893	(2021) Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature).	8	55	1.22	9.24e-05	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CHI3L1,PTGS2,AR,EDN1,LTA,BDNF,VEGFA
PMID:35011385	(2021) Macrophage-Mediated Immune Responses: From Fatty Acids to Oxylipins.	8	55	1.22	9.24e-05	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000383364	FFAR1,FABP4,CXCL10,CXCL11,EDNRA,CXCL9,PTGS2,PLA2G2A
PMID:31803974	(2020) PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours.	8	55	1.22	9.24e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901	CD69,CCR5,CXCL10,CXCL11,CD34,STAT5A,CD247,CXCL9
PMID:32267841	(2020) Influence of sickle cell disease on susceptibility to HIV infection.	8	55	1.22	9.24e-05	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	MPO,CD38,CCR5,CXCL11,CCL20,CXCL9,LTA,VEGFA
PMID:32650454	(2020) Inflammation Differentially Modulates the Biological Features of Adult Derived Human Liver StemProgenitor Cells.	8	55	1.22	9.24e-05	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,SOX9,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:32825112	(2020) The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies.	8	55	1.22	9.24e-05	9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000321853,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,EDNRA,SERPINF2,EDN1,RARRES2,AGTR1,CCL5,VEGFA
PMID:32967118	(2020) Microglia and Macrophages in the Pathological Central and Peripheral Nervous Systems.	8	55	1.22	9.24e-05	9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000377192,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303	MMP14,GAS6,STAT5A,CD47,G6PD,GAP43,BCL2,BDNF
PMID:33312397	(2020) Understanding cellular and molecular mechanisms of pathogenesis of diabetic tendinopathy.	8	55	1.22	9.24e-05	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,NOX4,IGF1R,FMOD,PTGS2,NOX1,BMP2,VEGFA
PMID:30860634	(2019) Cxcl17(--) mice develop exacerbated disease in a T cell-dependent autoimmune model.	8	55	1.22	9.24e-05	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:31422218	(2019) Immune profiles in primary squamous cell carcinoma of the head and neck.	8	55	1.22	9.24e-05	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,PTEN,JAK2,FGFR1,CCL5
PMID:29373606	(2018) Modulation of HIV replication in monocyte derived macrophages (MDM) by steroid hormones.	8	55	1.22	9.24e-05	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000369816,9606.ENSP00000474412	MAPK1,CCR5,CXCL10,CXCL11,CXCL9,TXN,SHBG,CCL5
PMID:27859310	(2017) The pathobiology of vascular malformations: insights from human and model organism genetics.	8	55	1.22	9.24e-05	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,TIMP3,ANGPT2,PDGFB,ELN,RHOA,AGTR1,VEGFA
PMID:28985567	(2017) Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.	8	55	1.22	9.24e-05	9606.ENSP00000322898,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	EBF1,SGK1,PTEN,JAK2,BCL2,RHOA,MYD88,MME
PMID:27242964	(2016) Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids.	8	55	1.22	9.24e-05	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,CAV1,PTEN,BCL2,VEGFA
PMID:27418953	(2016) Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.	8	55	1.22	9.24e-05	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000478570	ATM,PRDX2,MAP3K5,PTEN,TXN,G6PD,NFE2L2,VEGFA
PMID:25653535	(2015) Adiponectin as a potential biomarker of vascular disease.	8	55	1.22	9.24e-05	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000288266,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,FABP4,APPL1,CXCL10,CXCL11,CXCL9,MYD88,VEGFA
PMID:26073932	(2015) Pedican: an online gene resource for pediatric cancers with literature evidence.	8	55	1.22	9.24e-05	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000393312	IGF1R,ATM,PDGFB,PDGFA,PTEN,MTHFR,BCL2,FGFR1
PMID:24739658	(2014) Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Whartons jelly.	8	55	1.22	9.24e-05	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANG,ELN,CXCL9,HSPG2,CCL5,VEGFA
PMID:25361524	(2014) PPARgamma activation but not PPARgamma haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.	8	55	1.22	9.24e-05	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000478570	THBS1,NOX4,PLIN1,CD34,ANG,CAV1,STAT5A,VEGFA
PMID:24244384	(2013) Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells.	8	55	1.22	9.24e-05	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	SOX9,CCR5,CXCL10,CXCL11,CXCL9,MYD88,PROM1,CCL5
PMID:22201838	(2012) PPAR gamma, bioactive lipids, and cancer progression.	8	55	1.22	9.24e-05	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,IGF1R,APPL1,MAPK7,HNF4A,PTEN,BCL2,PROM1
PMID:22405985	(2012) Targeting NADPH oxidases in vascular pharmacology.	8	55	1.22	9.24e-05	9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,MMP14,CNR1,NOX1,EDN1,NFE2L2,AGTR1,VEGFA
PMID:22540255	(2012) New roles of HDL in inflammation and hematopoiesis.	8	55	1.22	9.24e-05	9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	APOL1,LPA,STAT5A,SREBF1,ABCG1,JAK2,BCL2,MYD88
PMID:24977105	(2012) Biomarkers to Target Heterogeneous Breast Cancer Stem Cells.	8	55	1.22	9.24e-05	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,PDGFB,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:19481138	(2010) Corneal transparency: genesis, maintenance and dysfunction.	8	55	1.22	9.24e-05	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000293599,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000478570	THBS1,CCR5,AQP5,ALDH1A1,ANGPT2,PTGS2,LTA,VEGFA
PMID:35144601	(2022) Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview.	9	79	1.12	9.25e-05	9606.ENSP00000248553,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,APC,CDH1,MMP14,MAPK7,HNF4A,BMP2,BCL2,VEGFA
PMID:35209140	(2022) Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease.	9	79	1.12	9.25e-05	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000477707	APC,ATM,SREBF1,PTGS2,MAFB,SHBG,BCL2,BDNF,NR1H3
PMID:35356799	(2022) STAT3 pathway in cancers: Past, present, and future.	9	79	1.12	9.25e-05	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CDH1,CXCL10,STAT5A,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:33919517	(2021) The Role of Macrophages in Cancer Development and Therapy.	9	79	1.12	9.25e-05	9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,P2RY1,CCL20,CD47,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:34006331	(2021) Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets.	9	79	1.12	9.25e-05	9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,CXCL11,HNF4A,GAS6,CD47,PTEN,JAK2,FGFR1,VEGFA
PMID:34299192	(2021) TGF-beta Signaling: From Tissue Fibrosis to Tumor Microenvironment.	9	79	1.12	9.25e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,CXCL11,CAV1,PTEN,BCL2,RHOA,CCL5,VEGFA
PMID:35047009	(2021) A Comprehensive Review of the Therapeutic Value of Urine-Derived Stem Cells.	9	79	1.12	9.25e-05	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CD34,ANG,PTEN,BCL2,BDNF,CCL5,VEGFA
PMID:31924786	(2020) Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice.	9	79	1.12	9.25e-05	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	APC,CDH1,ONECUT1,CXCL10,CXCL11,HNF4A,MYD88,PROM1,CCL5
PMID:31991604	(2020) Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.	9	79	1.12	9.25e-05	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,PROM1,CCL5,VEGFA
PMID:32937830	(2020) In Vitro Innovation of Tendon Tissue Engineering Strategies.	9	79	1.12	9.25e-05	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,THBS1,LPL,ANGPT2,FMOD,ELN,BMP2,RHOA,VEGFA
PMID:32937836	(2020) Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status.	9	79	1.12	9.25e-05	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,THBS1,STAT5A,MAP3K5,EDN1,BCL2,MYD88,AGTR1,VEGFA
PMID:28956065	(2018) The peritoneal soil for a cancerous seed: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases.	9	79	1.12	9.25e-05	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,ANG,CCL20,ELN,JAK2,MME,CCL5,VEGFA
PMID:29922331	(2018) Sex Differences in Neurotoxicogenetics.	9	79	1.12	9.25e-05	9606.ENSP00000221930,9606.ENSP00000222572,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303	TGFB1,PON2,IGF1R,CXCL10,COMT,PTGS2,G6PD,BCL2,BDNF
PMID:28659168	(2017) Gene expression profiles and signaling mechanisms in alpha2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.	9	79	1.12	9.25e-05	9606.ENSP00000222139,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	EPOR,MAPK7,CAV1,PTGS2,SGK1,JAK2,FGFR1,RHOA,VEGFA
PMID:28872613	(2017) Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells.	9	79	1.12	9.25e-05	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809	CD38,CDH1,ATM,ALDH1A1,CD34,PTEN,NTF3,BDNF,PROM1
PMID:26193078	(2016) Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.	9	79	1.12	9.25e-05	9606.ENSP00000216181,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MYH9,CD38,CD69,ATM,EDNRA,EDN1,BCL2,MYD88,VEGFA
PMID:26998193	(2016) ROS and ROS-Mediated Cellular Signaling.	9	79	1.12	9.25e-05	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,MAPK7,MAP3K5,PTEN,NOX1,TXN,NFE2L2,BCL2,VEGFA
PMID:27178410	(2016) COPD immunopathology.	9	79	1.12	9.25e-05	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,CXCL9,EDN1,NPY,CCL5,VEGFA
PMID:21248169	(2011) Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.	9	79	1.12	9.25e-05	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000362057,9606.ENSP00000478570,9606.ENSP00000480291	NOX4,MAPK7,ANGPT2,GAS6,CAV1,PDGFA,NOX1,VEGFA,HNF1B
PMID:33063247	(2020) Novel Analgesics with Peripheral Targets.	12	172	0.9	9.34e-05	9606.ENSP00000259486,9606.ENSP00000266085,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000445772	ENPP2,TIMP3,CAV1,STAT5A,VIP,PTGS2,ADAMTS13,EDN1,JAK2,BDNF,MME,LTB4R2
PMID:35335635	(2022) Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence.	11	138	0.96	9.44e-05	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000357726,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,CD38,IFNG,CXCL10,CD247,CXCL9,CD47,S100A12,CCL5,VEGFA
PMID:33599798	(2021) Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma.	10	107	1.03	9.49e-05	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000297785,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	CD38,HSPB1,NOX4,ALDH1A1,MAP3K5,PTEN,NOX1,TXN,BCL2,VEGFA
PMID:34069699	(2021) Enteral Feeding Interventions in the Prevention of Necrotizing Enterocolitis: A Systematic Review of Experimental and Clinical Studies.	10	107	1.03	9.49e-05	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	SOX9,CDH1,CAV1,VIP,PTGS2,EDN1,NFE2L2,BCL2,PROM1,CCL5
PMID:34522848	(2021) An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.	10	107	1.03	9.49e-05	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000377280,9606.ENSP00000384262,9606.ENSP00000474412	MPO,FABP4,CXCL10,CXCL11,CD34,CCL20,CXCL9,FBXO8,HPSE,CCL5
PMID:32820219	(2020) Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products.	10	107	1.03	9.49e-05	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000474412	TGFB1,CD38,IFNG,FABP4,CXCL10,CXCL11,GAS6,CXCL9,MME,CCL5
PMID:18794340	(2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.	10	107	1.03	9.49e-05	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000322898,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000418525,9606.ENSP00000480291	CD38,CHI3L1,ENPP2,ATM,CXCL10,EBF1,CXCL9,SGK1,MME,HNF1B
PMID:35409243	(2022) The Mammary Gland: Basic Structure and Molecular Signaling during Development.	12	173	0.9	9.89e-05	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,TIMP3,IGF1R,MMP14,CAV1,STAT5A,ELN,HSPG2,BMP2,JAK2,BCL2,FGFR1
PMID:35003899	(2022) Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.	8	56	1.22	0.00010	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000414303	TGFB1,IGF1R,CXCL10,CAV1,STAT5A,CXCL9,ENTPD1,BDNF
PMID:35035498	(2022) Pharmacological Mechanisms of Tinglizi against Chronic Heart Failure Determined by Network Pharmacology and Molecular Docking.	7	36	1.35	0.00010	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,IFNG,HSPB1,NFE2L2,BCL2,MME,VEGFA
PMID:35039055	(2022) Impaired JAK-STAT pathway signaling in leukocytes of the frail elderly.	7	36	1.35	0.00010	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CXCL9,AR,BDNF,CCL5
PMID:35204717	(2022) Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer.	8	56	1.22	0.00010	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,ANG,CNTF,JAK2,BCL2,PROM1,VEGFA
PMID:35252138	(2022) Effects of Mechanical Stress Stimulation on Function and Expression Mechanism of Osteoblasts.	8	56	1.22	0.00010	9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	ATM,MAPK7,HNF4A,PTGS2,BMP2,FGFR1,RHOA,VEGFA
PMID:35326607	(2022) Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer.	7	36	1.35	0.00010	9606.ENSP00000013807,9606.ENSP00000257430,9606.ENSP00000297785,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	ERCC1,APC,ALDH1A1,JAK2,BCL2,RHOA,PROM1
PMID:35366874	(2022) A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.	7	36	1.35	0.00010	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTGS2,NFE2L2,BCL2,PROM1,VEGFA
PMID:33027557	(2021) Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemiareperfusion model.	7	36	1.35	0.00010	9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CD34,MAPK7,GAP43,BCL2,RHOA,BDNF,VEGFA
PMID:33318872	(2021) Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential.	6	20	1.54	0.00010	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	PTGS2,PTEN,NFE2L2,BCL2,AGTR1,VEGFA
PMID:33435632	(2021) Signaling Pathway Mediating Myeloma Cell Growth and Survival.	9	80	1.11	0.00010	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CD38,IGF1R,PTEN,MAFB,JAK2,BCL2,RHOA,VEGFA
PMID:33519938	(2021) To Breathe or Not to Breathe: The Role of Oxygen in Bone Marrow-Derived Mesenchymal Stromal Cell Senescence.	7	36	1.35	0.00010	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,FABP4,CD34,ALPL,BCL2,VEGFA,HNF1B
PMID:33572780	(2021) MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.	9	80	1.11	0.00010	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,TIMP3,IGF1R,PTEN,EDN1,JAK2,BCL2,RHOA,VEGFA
PMID:33690604	(2021) Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohns colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.	7	36	1.35	0.00010	9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	ANG,CCL20,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:33922946	(2021) Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction.	7	36	1.35	0.00010	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412	ERCC1,CDH1,ATM,ANG,BCL2,LTA,CCL5
PMID:33967820	(2021) Mitochondrial Reactive Oxygen Species and Their Contribution in Chronic Kidney Disease Progression Through Oxidative Stress.	6	20	1.54	0.00010	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,MAP3K5,PTEN,NOX1,NFE2L2,BCL2
PMID:34025131	(2021) Effect of Korean Red Ginseng on metabolic syndrome.	7	36	1.35	0.00010	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000478570	FABP4,THBS1,LPL,STAT5A,SREBF1,PTGS2,VEGFA
PMID:34073352	(2021) In Vitro Framework to Assess the Anti-Helicobacter pylori Potential of Lactic Acid Bacteria Secretions as Alternatives to Antibiotics.	6	20	1.54	0.00010	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,CXCL9,CCL5,VEGFA
PMID:34137158	(2021) Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.	8	56	1.22	0.00010	9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CXCL11,PDGFA,CCL20,PTEN,JAK2,BCL2,VEGFA
PMID:34194399	(2021) Relationships Between Perivascular Adipose Tissue and Abdominal Aortic Aneurysms.	6	20	1.54	0.00010	9606.ENSP00000306124,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000376865,9606.ENSP00000402152,9606.ENSP00000474412	PRKCE,ELN,ANGPTL2,PDGFD,SLC12A3,CCL5
PMID:34194509	(2021) Characteristics, Classification, and Application of Stem Cells Derived from Human Teeth.	8	56	1.22	0.00010	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,CD34,ENTPD1,FGFR1,MME,PROM1,VEGFA
PMID:34219203	(2021) Stemprogenitor cells in fetuses and newborns: overview of immunohistochemical markers.	9	80	1.11	0.00010	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809	CD38,SOX9,ALDH1A1,CD34,HNF4A,PTEN,BCL2,MME,PROM1
PMID:34220864	(2021) The Role of Ageing and Parenchymal Senescence on Macrophage Function and Fibrosis.	8	56	1.22	0.00010	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,TGFB1,IFNG,CXCL10,CD47,KL,BCL2,VEGFA
PMID:34248961	(2021) Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?	11	140	0.96	0.00010	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000474412	MPO,FABP4,NOX4,CCR5,CXCL10,STAT5A,CCL20,PTGS2,ENTPD1,RHOA,CCL5
PMID:34299120	(2021) Evasion of the Host Immune Response by Betaherpesviruses.	11	139	0.96	0.00010	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	HSPB1,CXCL10,CXCL11,CD34,PTEN,JAK2,BCL2,IRAK4,RHOA,MYD88,CCL5
PMID:34301813	(2021) Neutrophils in the era of immune checkpoint blockade.	9	80	1.11	0.00010	9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,ANGPT2,STAT5A,CD247,CD47,PTEN,FGFR1,CCL5,VEGFA
PMID:34390393	(2021) New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.	6	20	1.54	0.00010	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185	CD38,IFNG,CCR5,CXCL10,CXCL9,BCL2
PMID:34576042	(2021) Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.	9	80	1.11	0.00010	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,SREBF1,PTGS2,PTEN,JAK2,NFE2L2,CCL5,VEGFA
PMID:34642376	(2021) Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.	7	36	1.35	0.00010	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IFNG,CXCL10,ANGPT2,CCL5,VEGFA
PMID:34651424	(2021) Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment.	9	80	1.11	0.00010	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,TIMP3,IGF1R,ALDH1A1,STAT5A,PTEN,JAK2,FGFR1,VEGFA
PMID:34681739	(2021) The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View.	8	56	1.22	0.00010	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD34,CNTF,PTEN,EDN1,NTF3,BDNF,CCL5,VEGFA
PMID:34685718	(2021) Sirtuins as Interesting Players in the Course of HIV Infection and Comorbidities.	11	140	0.96	0.00010	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412	CDH1,TIMP3,ATM,CCR5,SIRT6,CAV1,SREBF1,PTEN,BMP2,BCL2,CCL5
PMID:34733780	(2021) Case Report: Targeted Therapy for Metastatic Solid Pseudopapillary Neoplasm of the Pancreas With CTNNB1 and PTEN Mutations.	6	20	1.54	0.00010	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,ATM,PTEN,AR,MME,VEGFA
PMID:34786153	(2021) Retina stem cells, hopes and obstacles.	8	56	1.22	0.00010	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CD34,CNTF,JAK2,NTF3,BDNF,PROM1,VEGFA
PMID:34829586	(2021) Oxidative Stress and Energy Metabolism in the Brain: Midlife as a Turning Point.	7	36	1.35	0.00010	9606.ENSP00000013807,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000414303	ERCC1,NOX4,MAP3K5,PTGS2,TXN,G6PD,BDNF
PMID:34829831	(2021) Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors.	7	36	1.35	0.00010	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000477707	IFNG,NOX4,ELN,PTGS2,NOX1,NFE2L2,NR1H3
PMID:34831271	(2021) Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases.	8	56	1.22	0.00010	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,CXCL10,ELN,BMP2,BCL2,CCL5,VEGFA
PMID:35029792	(2021) The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.	11	140	0.96	0.00010	9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	VDAC1,IGF1R,ALDH1A1,SREBF1,ELN,SGK1,PTEN,BMP2,RHOA,PROM1,VEGFA
PMID:35046810	(2021) Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers.	11	140	0.96	0.00010	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,CDH1,MMP14,CAV1,CD47,PTEN,JAK2,BCL2,MYD88,PROM1,VEGFA
PMID:35052539	(2021) Usefulness of Melatonin and Other Compounds as Antioxidants and Epidrugs in the Treatment of Head and Neck Cancer.	9	80	1.11	0.00010	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,ATM,ANGPT2,PTEN,MTHFR,NFE2L2,BCL2,VEGFA
PMID:31894326	(2020) Role of microRNAs in remodeling the tumor microenvironment (Review).	8	56	1.22	0.00010	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,IGF1R,CD34,PTEN,JAK2,CCL5,VEGFA
PMID:32169396	(2020) Uncovering sex-specific mechanisms of action of testosterone and redox balance.	6	20	1.54	0.00010	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000380252	NOX4,PTGS2,NOX1,AR,SHBG,NFE2L2
PMID:32231294	(2020) Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential.	10	108	1.03	0.00010	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	SOX9,CDH1,CXCL11,HNF4A,CCL20,ELN,CD47,PTEN,BCL2,PROM1
PMID:32296030	(2020) Targeting cancer stem cell pathways for cancer therapy.	13	212	0.85	0.00010	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CXCL10,CD34,STAT5A,ELN,CXCL9,RBP4,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:32316408	(2020) Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis.	6	20	1.54	0.00010	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CXCL9,JAK2,CCL5
PMID:32334446	(2020) A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.	7	36	1.35	0.00010	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000478570	ERCC1,TGFB1,IGF1R,PTEN,AR,MTHFR,VEGFA
PMID:32443774	(2020) The NRF2KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives.	10	108	1.03	0.00010	9606.ENSP00000263317,9606.ENSP00000265132,9606.ENSP00000278840,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478253	NOX4,AMBP,FADS2,SIRT6,PTEN,TXN,G6PD,NFE2L2,BCL2,MTHFD1L
PMID:32509872	(2020) Significance of LL-37 on Immunomodulation and Disease Outcome.	9	80	1.11	0.00010	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CCL20,BMP2,BCL2,MYD88,LTA,CCL5,VEGFA
PMID:32562668	(2020) Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.	7	36	1.35	0.00010	9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,MAPK7,HSPG2,RHOA,BDNF,CCL5,VEGFA
PMID:32660524	(2020) High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.	9	80	1.11	0.00010	9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	HSPB1,CCR5,CD34,ANG,SIRT6,PTGS2,BCL2,MYD88,VEGFA
PMID:32724810	(2020) Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases.	8	56	1.22	0.00010	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,IGF1R,CD34,PTEN,PROM1,CCL5,VEGFA
PMID:32823992	(2020) Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies.	8	56	1.22	0.00010	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,ATM,CD34,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:32875727	(2020) Study and analysis of antitumor resistance mechanism of PD1PD-L1 immune checkpoint blocker.	11	139	0.96	0.00010	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CD247,CXCL9,PTGS2,ENTPD1,PTEN,MAFB,JAK2,CCL5,VEGFA
PMID:33015067	(2020) Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery.	8	56	1.22	0.00010	9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000380365,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD34,NOX1,NFE2L2,RGN,BCL2,MME,CCL5,VEGFA
PMID:33193581	(2020) MicroRNAs in Podocyte Injury in Diabetic Nephropathy.	7	36	1.35	0.00010	9606.ENSP00000263317,9606.ENSP00000317674,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175	NOX4,APOL1,CD2AP,PTEN,JAK2,BCL2,RHOA
PMID:33644032	(2020) Erythroblastic Island Macrophages Shape Normal Erythropoiesis and Drive Associated Disorders in Erythroid Hematopoietic Diseases.	8	56	1.22	0.00010	9606.ENSP00000222139,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000477707	EPOR,MMP14,CD34,STAT5A,CD47,JAK2,PROM1,NR1H3
PMID:30914056	(2019) Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.	7	36	1.35	0.00010	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,HSPB1,CDH1,PTGS2,BCL2,CCL5,VEGFA
PMID:30941350	(2019) Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy.	8	56	1.22	0.00010	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CD34,S100A12,JAK2,MYD88,VEGFA
PMID:31060341	(2019) The Role of Astrocytes in the Central Nervous System Focused on BK Channel and Heme Oxygenase Metabolites: A Review.	8	56	1.22	0.00010	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	NOX4,CAV1,PTGS2,NFE2L2,BCL2,BDNF,MME,VEGFA
PMID:31133987	(2019) Tanycyte Gene Expression Dynamics in the Regulation of Energy Homeostasis.	9	80	1.11	0.00010	9606.ENSP00000232219,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000418009,9606.ENSP00000478570	RBP1,SOX9,ALDH1A1,CAV1,CNTF,NPY,FGFR1,RARRES2,VEGFA
PMID:31296907	(2019) Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema.	7	36	1.35	0.00010	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CXCL10,CCL20,LTA,BDNF,CCL5,VEGFA
PMID:31374929	(2019) Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer.	7	36	1.35	0.00010	9606.ENSP00000200676,9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000478570	CETP,MAPK1,APC,HNF4A,ABCG1,PTGS2,VEGFA
PMID:31428038	(2019) Dental Pulp Stem Cells: An Attractive Alternative for Cell Therapy in Ischemic Stroke.	7	36	1.35	0.00010	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CD34,CNTF,BCL2,BDNF,CCL5,VEGFA
PMID:31768279	(2019) Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment.	8	56	1.22	0.00010	9606.ENSP00000260356,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,STAT5A,PTEN,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:31850325	(2019) Three-Layered Silk Fibroin Tubular Scaffold for the Repair and Regeneration of Small Caliber Blood Vessels: From Design to in vivo Pilot Tests.	6	20	1.54	0.00010	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ELN,LTA,CCL5,VEGFA
PMID:28891325	(2018) Epigenetics and Immunometabolism in Diabetes and Aging.	9	80	1.11	0.00010	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412	NOX4,CCR5,CXCL10,SIRT6,PTGS2,NOX1,EDN1,RHOA,CCL5
PMID:29565284	(2018) Phytochemicals in Skin Cancer Prevention and Treatment: An Updated Review.	7	36	1.35	0.00010	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,PTGS2,PTEN,NFE2L2,BCL2,VEGFA
PMID:29731393	(2018) NRF2 and the Hallmarks of Cancer.	11	140	0.96	0.00010	9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000477707,9606.ENSP00000478570	CDH1,ANG,CAV1,PTEN,TXN,G6PD,NFE2L2,BCL2,RHOA,NR1H3,VEGFA
PMID:29760743	(2018) Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis.	9	80	1.11	0.00010	9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ATM,MAPK7,MAP3K5,PTEN,NOX1,TXN,BCL2,PROM1,VEGFA
PMID:29799276	(2018) Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.	6	20	1.54	0.00010	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	THBS1,ATM,STAT5A,PTEN,JAK2,BCL2
PMID:29867149	(2018) Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.	7	36	1.35	0.00010	9606.ENSP00000258341,9606.ENSP00000306884,9606.ENSP00000321853,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	LAMC1,CXCL11,SERPINF2,HSPG2,BMP2,BDNF,VEGFA
PMID:29977307	(2018) Evaluation of Oxidative Stress and Mitophagy during Adipogenic Differentiation of Adipose-Derived Stem Cells Isolated from Equine Metabolic Syndrome (EMS) Horses.	7	36	1.35	0.00010	9606.ENSP00000245479,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,STAT5A,SREBF1,RBP4,BMP2,BCL2,VEGFA
PMID:30149671	(2018) Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling.	8	56	1.22	0.00010	9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,ELN,HSPG2,BMP2,MYD88,BDNF,AGTR1,VEGFA
PMID:30234009	(2018) Fructose 2,6-Bisphosphate in Cancer Cell Metabolism.	9	80	1.11	0.00010	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,MAPK1,ATM,CAV1,STAT5A,PTEN,AR,CCL5,VEGFA
PMID:30266096	(2018) Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing.	6	20	1.54	0.00010	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	MPO,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30309388	(2018) Schwann cell-like differentiated adipose stem cells promote neurite outgrowth via secreted exosomes and RNA transfer.	6	20	1.54	0.00010	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303	TIMP3,CD34,PTEN,GAP43,RHOA,BDNF
PMID:30322050	(2018) MicroRNAs in Autoimmunity and Hematological Malignancies.	11	139	0.96	0.00010	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000474412	MAPK1,CD69,IFNG,CXCL10,EBF1,STAT5A,CXCL9,PTEN,BCL2,IRAK4,CCL5
PMID:30567377	(2018) Using Mouse and Drosophila Models to Investigate the Mechanistic Links between Diet, Obesity, Type II Diabetes, and Cancer.	6	20	1.54	0.00010	9606.ENSP00000256104,9606.ENSP00000257430,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000478570	FABP4,APC,ALDH1A1,PTEN,G6PD,VEGFA
PMID:30631766	(2018) Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer.	9	80	1.11	0.00010	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CD247,CXCL9,ENTPD1,JAK2,CCL5
PMID:26719303	(2017) Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.	7	36	1.35	0.00010	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:27803950	(2017) Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy.	8	56	1.22	0.00010	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	MAPK1,HSPB1,CAV1,MAP3K5,PTGS2,EDN1,NFE2L2,VEGFA
PMID:27836101	(2017) Tumor necrosis factor-Alpha stimulates cytokine expression and transient sensitization of trigeminal nociceptive neurons.	6	20	1.54	0.00010	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:28255564	(2017) Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.	6	20	1.54	0.00010	9606.ENSP00000315011,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000483018	EDNRA,HSPG2,EDN1,BCL2,AGTR1,ABO
PMID:28335416	(2017) Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.	6	20	1.54	0.00010	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000477707	THBS1,NOX4,DDAH1,CD34,NTF3,NR1H3
PMID:28359741	(2017) Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.	7	36	1.35	0.00010	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:28400884	(2017) Effectiveness of Biologic Factors in Shoulder Disorders.	6	20	1.54	0.00010	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,MMP14,PDGFB,ELN,BMP2,VEGFA
PMID:28503090	(2017) Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.	8	56	1.22	0.00010	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,PRKCE,AR,BCL2,LTA,PROM1,VEGFA
PMID:28703764	(2017) Erythropoietin and Its Angiogenic Activity.	7	36	1.35	0.00010	9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,SOX9,EDN1,JAK2,BCL2,BDNF,VEGFA
PMID:28768485	(2017) A systematic review of genetic mutations in pulmonary arterial hypertension.	7	36	1.35	0.00010	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000419422	TGFB1,THBS1,EDNRA,CAV1,BMP2,EDN1,AGTR1
PMID:28775778	(2017) Redox Imbalance in the Development of Colorectal Cancer.	7	36	1.35	0.00010	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	MPO,PTGS2,PTEN,NOX1,TXN,BCL2,VEGFA
PMID:28915327	(2017) Adipose Tissue in HIV Infection.	8	56	1.22	0.00010	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000474412	CD69,IFNG,FABP4,CCR5,PLIN1,LPL,SREBF1,CCL5
PMID:29080633	(2017) Vitamin D Receptor Signaling and Cancer.	6	20	1.54	0.00010	9606.ENSP00000216862,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000363641,9606.ENSP00000381185	CYP24A1,APC,CDH1,CXCL11,TXN,BCL2
PMID:29158066	(2017) The potential role of leptin in tumor invasion and metastasis.	8	56	1.22	0.00010	9606.ENSP00000308208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	MMP14,CNTF,PTEN,AR,JAK2,BCL2,NPY,VEGFA
PMID:29163853	(2017) Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer.	8	56	1.22	0.00010	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,CDH1,IGF1R,ALDH1A1,GAS6,PTEN,BCL2,FGFR1
PMID:29265420	(2017) Tissue-specific endothelial cells: a promising approach for augmentation of soft tissue repair in orthopedics.	6	20	1.54	0.00010	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,BMP2,FGFR1,PROM1,VEGFA
PMID:29326641	(2017) The TGF-beta System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis.	7	36	1.35	0.00010	9606.ENSP00000229135,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,AMBP,CXCL10,CD34,SAA1,LTA,VEGFA
PMID:29391667	(2017) HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the InflammatoryRepair Response of Human Keratinocytes.	7	36	1.35	0.00010	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:26556395	(2016) Muller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy.	8	56	1.22	0.00010	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CHI3L1,CXCL10,CXCL11,ANG,CCL20,CCL5,VEGFA
PMID:26647161	(2016) Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.	9	80	1.11	0.00010	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,TIMP3,MMP14,PTGS2,PTEN,FGFR1,RHOA,MYD88,VEGFA
PMID:26697128	(2016) Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy.	7	36	1.35	0.00010	9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	ALDH1A1,PTEN,TXN,JAK2,NFE2L2,BCL2,PROM1
PMID:26817031	(2016) Prolonged Jaw Opening Promotes Nociception and Enhanced Cytokine Expression.	6	20	1.54	0.00010	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:27011179	(2016) Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis.	8	56	1.22	0.00010	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MPO,MMP14,CAV1,SREBF1,ABCG1,IRAK4,MYD88,CCL5
PMID:27211104	(2016) Interferon-gamma and Tumor Necrosis Factor-alpha Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype.	8	56	1.22	0.00010	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5
PMID:27354763	(2016) Molecular mechanisms of cisplatin resistance in cervical cancer.	8	56	1.22	0.00010	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000310520,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000427424,9606.ENSP00000444198	ERCC1,HSPB1,CDH1,ERCC4,MAP3K5,BCL2,TNFAIP8,CITED2
PMID:27933306	(2016) Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF.	8	56	1.22	0.00010	9606.ENSP00000221930,9606.ENSP00000339916,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	TGFB1,LIMK2,PTEN,JAK2,GAP43,BCL2,RHOA,BDNF
PMID:27993142	(2016) Identification and characterization of cancer stem cells in canine mammary tumors.	6	20	1.54	0.00010	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CDH1,CD34,BCL2,MME,PROM1
PMID:25608619	(2015) microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.	6	20	1.54	0.00010	9606.ENSP00000257430,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000400175,9606.ENSP00000478570,9606.ENSP00000479617	APC,CD34,HNF4A,RHOA,VEGFA,UHRF1
PMID:25810571	(2015) Harmful effects of nicotine.	6	20	1.54	0.00010	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,ELN,PTGS2,BCL2,VEGFA
PMID:26081571	(2015) Orchestrating liver development.	10	108	1.03	0.00010	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,CD34,HNF4A,BMP2,FGFR1,PROM1,VEGFA,HNF1B
PMID:26491226	(2015) Cancer Microenvironment and Endoplasmic Reticulum Stress Response.	7	36	1.35	0.00010	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CXCL10,PDGFB,PDGFA,MAP3K5,BCL2,VEGFA
PMID:26579420	(2015) Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemiareperfusion-induced cerebral microcirculatory disturbances and neuron damage.	7	36	1.35	0.00010	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CAV1,PTGS2,BCL2,BDNF,CCL5,VEGFA
PMID:26689699	(2015) LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis.	6	20	1.54	0.00010	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000418525,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,HNF4A,MME,HNF1B
PMID:27499904	(2015) The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives.	7	36	1.35	0.00010	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	SOX9,APC,ELN,BMP2,EDN1,RHOA,AGTR1
PMID:24646737	(2014) Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection.	7	36	1.35	0.00010	9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD247,CXCL9,PTGS2,MYD88,CCL5,VEGFA
PMID:24669294	(2014) The M1 and M2 paradigm of macrophage activation: time for reassessment.	9	80	1.11	0.00010	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000477707	CD38,CD69,THBS1,CXCL10,CXCL11,STAT5A,JAK2,MYD88,NR1H3
PMID:25058905	(2014) Cisplatin in cancer therapy: molecular mechanisms of action.	8	56	1.22	0.00010	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	HSPB1,CDH1,ATM,AQP5,PTEN,BCL2,RHOA,PROM1
PMID:25159167	(2014) Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.	6	20	1.54	0.00010	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CCR5,MMP14,PTGS2,PTEN,BCL2,VEGFA
PMID:25173872	(2014) Connecting the coronaries: how the coronary plexus develops and is functionalized.	6	20	1.54	0.00010	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000400175,9606.ENSP00000444198,9606.ENSP00000478570	CD34,PDGFB,PDGFA,RHOA,CITED2,VEGFA
PMID:25364264	(2014) Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.	8	56	1.22	0.00010	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CDH1,HNF4A,PTEN,EDN1,RHOA,PROM1,VEGFA
PMID:25383178	(2014) A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration.	6	20	1.54	0.00010	9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EBF1,PDGFA,BMP2,PROM1,VEGFA
PMID:22421507	(2013) Erythropoietin neuroprotection with traumatic brain injury.	6	20	1.54	0.00010	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,STAT5A,EDN1,JAK2,BCL2,VEGFA
PMID:23720326	(2013) Phenomics of cardiac chloride channels.	6	20	1.54	0.00010	9606.ENSP00000265333,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	VDAC1,EDNRA,EDN1,BCL2,RHOA,AGTR1
PMID:22168439	(2012) Vitamin D and cancer: a review of molecular mechanisms.	10	108	1.03	0.00010	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,PTEN,TXN,BMP2,G6PD,NFE2L2,BCL2,RHOA,VEGFA
PMID:22382702	(2012) The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.	6	20	1.54	0.00010	9606.ENSP00000221930,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,HNF4A,PTGS2,BCL2,PROM1,VEGFA
PMID:22723782	(2012) The role of chemokines in acute liver injury.	7	36	1.35	0.00010	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,PROM1,CCL5
PMID:19932197	(2011) Effect of aging on cellular mechanotransduction.	8	56	1.22	0.00010	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356515,9606.ENSP00000361021,9606.ENSP00000400175	MAPK1,TIMP3,IGF1R,MMP14,ELN,UTRN,PTEN,RHOA
PMID:21242808	(2011) Recombinant human erythropoietin suppresses endothelial cell apoptosis and reduces the ratio of Bax to Bcl-2 proteins in the aortas of apolipoprotein E-deficient mice.	6	20	1.54	0.00010	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,STAT5A,EDN1,JAK2,BCL2,VEGFA
PMID:21486047	(2011) Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.	6	20	1.54	0.00010	9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:21756134	(2011) Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimers, and other neurodegenerative diseases.	7	36	1.35	0.00010	9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000477707,9606.ENSP00000478570	HNF4A,SREBF1,CNTF,PTGS2,BCL2,NR1H3,VEGFA
PMID:21793836	(2011) Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism.	7	36	1.35	0.00010	9606.ENSP00000278616,9606.ENSP00000302630,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067	ATM,ONECUT1,LPL,HNF4A,STAT5A,AR,JAK2
PMID:22028149	(2011) Clinical implications of chemokines in acute and chronic hepatitis C virus infection.	6	20	1.54	0.00010	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:22162712	(2011) Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.	8	56	1.22	0.00010	9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,TIMP3,CCR5,CXCL10,PDGFB,PTGS2,CCL5,VEGFA
PMID:20979669	(2010) Living the high life: high-altitude adaptation.	6	20	1.54	0.00010	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,EDNRA,PRKAA1,PTEN,EDN1,VEGFA
PMID:21572574	(2010) Vascular Nitric Oxide: Formation and Function.	6	20	1.54	0.00010	9606.ENSP00000284031,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	DDAH1,CAV1,ENTPD1,PTEN,BCL2,RHOA
PMID:24281180	(2010) Interaction of stellate cells with pancreatic carcinoma cells.	8	56	1.22	0.00010	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,MMP14,CD34,CAV1,EDN1,BCL2,CCL5,VEGFA
PMID:18845187	(2009) The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.	7	36	1.35	0.00010	9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303	IFNG,SIRT6,PTGS2,BCL2,NTF3,LTA,BDNF
PMID:19525723	(2009) Friend or foe? Resolving the impact of glial responses in glaucoma.	7	36	1.35	0.00010	9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303	IFNG,ELN,PTGS2,AR,EDN1,BCL2,BDNF
PMID:19966906	(2009) Current and emerging treatments for amyotrophic lateral sclerosis.	6	20	1.54	0.00010	9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,PTGS2,CNR1,BCL2,BDNF,VEGFA
PMID:18725291	(2008) Mimicking stem cell niches to increase stem cell expansion.	6	20	1.54	0.00010	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,CD34,CNTF,PROM1,VEGFA
PMID:16725031	(2006) Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?	6	20	1.54	0.00010	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,EDN1,VEGFA
PMID:17116734	(2006) Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men.	7	36	1.35	0.00010	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5
PMID:35128491	(2022) Polygenic networks in peripheral leukocytes indicate patterns associated with HIV infection and context-dependent effects of cannabis use.	9	82	1.1	0.00011	9606.ENSP00000215832,9606.ENSP00000222305,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,USF2,CD38,CCR5,CNR1,BCL2,RHOA,MYD88,VEGFA
PMID:35133083	(2022) Ferroptosis in cancer and cancer immunotherapy.	9	81	1.11	0.00011	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252	CDH1,NOX4,ATM,PLIN1,SREBF1,PTGS2,PTEN,NOX1,NFE2L2
PMID:35159157	(2022) Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.	9	81	1.11	0.00011	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CDH1,CXCL10,STAT5A,ENTPD1,RHOA,MYD88,CCL5,VEGFA
PMID:35204498	(2022) Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.	10	109	1.02	0.00011	9606.ENSP00000255409,9606.ENSP00000259407,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000337332,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000369816,9606.ENSP00000427424	CHI3L1,BAAT,CXCL10,PRKCE,SIRT6,PDGFA,SREBF1,MAP3K5,SHBG,TNFAIP8
PMID:35214179	(2022) Lipoaspirate Shows In Vitro Potential for Wound Healing.	7	37	1.34	0.00011	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANG,CCL20,CXCL9,CCL5,VEGFA
PMID:35216086	(2022) Melatonin and the Programming of Stem Cells.	11	142	0.95	0.00011	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000418525	MYH9,SOX9,IGF1R,MMP14,CD34,PTEN,BMP2,NFE2L2,FGFR1,BDNF,MME
PMID:35256739	(2022) PPARgamma regulates the expression of genes involved in the DNA damage response in an inflamed endometrium.	10	109	1.02	0.00011	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000474412	ATM,PRDX2,CXCL10,CXCL11,CXCL9,PTGS2,BMP2,EDN1,NFE2L2,CCL5
PMID:35269896	(2022) Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.	11	141	0.95	0.00011	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	EPOR,CD38,ATM,HNF4A,EBF1,STAT5A,ELN,JAK2,BCL2,FGFR1,MME
PMID:35269941	(2022) Impact of Air Pollution in Airway Diseases: Role of the Epithelial Cells (Cell Models and Biomarkers).	7	37	1.34	0.00011	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000478319,9606.ENSP00000478570,9606.ENSP00000480291	NOX4,IGF1R,PTGS2,NFE2L2,GREM1,VEGFA,HNF1B
PMID:35328769	(2022) Pathophysiology of Atherosclerosis.	9	82	1.1	0.00011	9606.ENSP00000266085,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CAV1,ELN,ABCG1,PTEN,EDN1,LTA,CCL5,VEGFA
PMID:35386663	(2022) Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives.	8	57	1.21	0.00011	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,CXCL10,ANG,CXCL9,JAK2,RHOA,VEGFA
PMID:35530341	(2022) Exploring Tumor Immune Microenvironment and Its Associations With Molecular Characteristics in Melanoma.	5	9	1.81	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:31081293	(2021) Protein Fingerprinting of Seminal Plasma Reveals Dysregulation of Exosome-Associated Proteins in Infertile Men with Unilateral Varicocele.	7	37	1.34	0.00011	9606.ENSP00000216181,9606.ENSP00000301522,9606.ENSP00000321853,9606.ENSP00000362463,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000418525	MYH9,PRDX2,SERPINF2,GLO1,NFE2L2,GGT1,MME
PMID:33318869	(2021) Hydrogen sulfide and vascular regulation - An update.	9	81	1.11	0.00011	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000419422	NOX4,IGF1R,PTGS2,PTEN,TXN,NFE2L2,BCL2,NTF3,AGTR1
PMID:33401534	(2021) Role of Uremic Toxins in Early Vascular Ageing and Calcification.	8	57	1.21	0.00011	9606.ENSP00000216862,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000478570	CYP24A1,NOX4,NOX1,ALPL,BMP2,KL,NFE2L2,VEGFA
PMID:33406733	(2021) Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development.	10	109	1.02	0.00011	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,PDGFA,PTGS2,PTEN,NOX1,JAK2,RARRES2,CCL5,VEGFA
PMID:33576905	(2021) Targeting the purinergic pathway in breast cancer and its therapeutic applications.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000304767,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,P2RY1,ENTPD1,PTEN,BCL2,PROM1,VEGFA
PMID:33686198	(2021) Molecular biology of Hodgkin lymphoma.	10	110	1.02	0.00011	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412	CD38,CXCL10,MAPK7,STAT5A,CCL20,CXCL9,SGK1,ENTPD1,JAK2,CCL5
PMID:33796538	(2021) CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.	7	37	1.34	0.00011	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412	TGFB1,CD69,CXCL10,CXCL9,ENTPD1,PTEN,CCL5
PMID:33801921	(2021) Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions.	7	37	1.34	0.00011	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,ADAMTS13,EDN1,AGTR1,CCL5,VEGFA
PMID:33923599	(2021) The Potential Neuroprotective Role of Free and Encapsulated Quercetin Mediated by miRNA against Neurological Diseases.	7	37	1.34	0.00011	9606.ENSP00000222572,9606.ENSP00000229135,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	PON2,IFNG,JAK2,NFE2L2,BCL2,MYD88,BDNF
PMID:34012451	(2021) Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy.	11	141	0.95	0.00011	9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CD69,ATM,CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,CD47,CCL5,VEGFA
PMID:34064508	(2021) Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response.	8	57	1.21	0.00011	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,STAT5A,FGFR1,RHOA,VEGFA
PMID:34064635	(2021) Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells.	7	37	1.34	0.00011	9606.ENSP00000259486,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,ALDH1A1,PTEN,JAK2,PROM1,CCL5,VEGFA
PMID:34139255	(2021) Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.	10	109	1.02	0.00011	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000478570	MPO,CDH1,NOX4,TIMP3,HNF4A,ELN,BCL2,FGFR1,AGTR1,VEGFA
PMID:34202251	(2021) Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits.	7	37	1.34	0.00011	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CD34,SIRT6,CCL20,CCL5,VEGFA
PMID:34205534	(2021) Nutraceuticals and Enteric Glial Cells.	7	37	1.34	0.00011	9606.ENSP00000245479,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	SOX9,CXCL11,EDNRA,PTGS2,NPY,NTF3,BDNF
PMID:34248988	(2021) Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.	9	81	1.11	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CAV1,STAT5A,CXCL9,PTEN,CCL5,VEGFA
PMID:34262140	(2021) The glomerular filtration barrier: a structural target for novel kidney therapies.	8	57	1.21	0.00011	9606.ENSP00000216181,9606.ENSP00000315011,9606.ENSP00000317674,9606.ENSP00000352264,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	MYH9,EDNRA,APOL1,CD2AP,EDN1,NFE2L2,RHOA,VEGFA
PMID:34290401	(2021) DCision-making in tumors governs T cell anti-tumor immunity.	9	82	1.1	0.00011	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CD34,CXCL9,CD47,ENTPD1,CCL5,VEGFA
PMID:34322381	(2021) Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues.	10	109	1.02	0.00011	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000331831,9606.ENSP00000351908,9606.ENSP00000360997,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,THBS1,CDH1,GAS6,MAP3K5,ADAMTS13,PLA2G2A,RHOA,CCL5,VEGFA
PMID:34359681	(2021) Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells.	13	215	0.84	0.00011	9606.ENSP00000215832,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000334329,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000400175	MAPK1,MMP14,EDNRA,UNC5B,SREBF1,CCL20,PTGS2,SGK1,ENTPD1,PTEN,AR,JAK2,RHOA
PMID:34421351	(2021) ATM at the crossroads of reactive oxygen species and autophagy.	7	37	1.34	0.00011	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000377192,9606.ENSP00000381185	MPO,HSPB1,NOX4,ATM,PRDX2,G6PD,BCL2
PMID:34447243	(2021) Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.	8	57	1.21	0.00011	9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	SIRT6,MAP3K5,PTGS2,SGK1,NFE2L2,BCL2,BDNF,VEGFA
PMID:34485413	(2021) Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles.	9	82	1.1	0.00011	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000478570	IFNG,THBS1,CXCL10,PDGFB,PDGFA,PTEN,EDN1,PDGFD,VEGFA
PMID:34501239	(2021) Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia.	11	141	0.95	0.00011	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	EPOR,MPO,CD38,CD34,SREBF1,PTEN,BMP2,JAK2,BCL2,FGFR1,MME
PMID:34539647	(2021) Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer.	5	9	1.81	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34555221	(2021) CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance.	5	9	1.81	0.00011	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:34572373	(2021) The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis.	10	110	1.02	0.00011	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ALDH1A1,MMP14,PTEN,BCL2,PROM1,CCL5,VEGFA
PMID:34575965	(2021) Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.	8	57	1.21	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:34591416	(2021) The Wntbeta-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma.	9	81	1.11	0.00011	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,APC,CDH1,HNF4A,CCL20,ELN,PROM1,CCL5,VEGFA
PMID:34767039	(2021) The marriage of chemokines and galectins as functional heterodimers.	8	57	1.21	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000345708,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,KCNJ11,CCL20,CXCL9,CCL5,VEGFA
PMID:34769182	(2021) Survey of Molecular Mechanisms of Hyperbaric Oxygen in Tissue Repair.	7	37	1.34	0.00011	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CXCL10,ANG,PTGS2,TXN,BCL2,VEGFA
PMID:34829751	(2021) Immunomodulatory Effects of a Concoction of Natural Bioactive Compounds-Mechanistic Insights.	9	81	1.11	0.00011	9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	STAT5A,PTEN,TXN,JAK2,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:34831290	(2021) Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections.	8	57	1.21	0.00011	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CD34,CCL20,NFE2L2,RHOA,CCL5,VEGFA
PMID:34846108	(2021) Modulating microRNAs in cancer: Next-generation therapies.	7	37	1.34	0.00011	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,PTEN,BCL2,FGFR1,CCL5,VEGFA
PMID:34887836	(2021) Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling.	10	110	1.02	0.00011	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,FABP4,LPL,SREBF1,PTGS2,BMP2,EDN1,NFE2L2,BCL2,VEGFA
PMID:34905501	(2021) IGFBP-6sonic hedgehogTLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis.	7	37	1.34	0.00011	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000474412	CHI3L1,CDH1,IGF1R,CD34,BMP2,JAK2,CCL5
PMID:34966277	(2021) New Insights Into Cancer Chronotherapies.	7	37	1.34	0.00011	9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	ATM,PTGS2,BCL2,RHOA,BDNF,PROM1,VEGFA
PMID:32106609	(2020) Anticancer Potential of Raddeanin A, a Natural Triterpenoid Isolated from Anemone raddeana Regel.	7	37	1.34	0.00011	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MMP14,PTGS2,AR,JAK2,BCL2,VEGFA
PMID:32156052	(2020) Retinol-Binding Protein 4 Accelerates Metastatic Spread and Increases Impairment of Blood Flow in Mouse Mammary Gland Tumors.	7	37	1.34	0.00011	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,RBP4,EDN1,JAK2,RHOA,VEGFA
PMID:32166015	(2020) Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension.	10	109	1.02	0.00011	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	ANGPT2,PDGFB,CAV1,ELN,VIP,EDN1,FGFR1,RARRES2,APLNR,VEGFA
PMID:32290100	(2020) The Endothelium as a Driver of Liver Fibrosis and Regeneration.	8	57	1.21	0.00011	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,ANGPT2,CAV1,CXCL9,CD47,ADAMTS13,EDN1,VEGFA
PMID:32458441	(2020) The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.	8	57	1.21	0.00011	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418823,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ANGPT2,RHOA,MYD88,FTO,AGTR1,CCL5,VEGFA
PMID:32466434	(2020) The Influence of Supplementation of Anthocyanins on Obesity-Associated Comorbidities: A Concise Review.	8	57	1.21	0.00011	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000478570	FABP4,NOX4,LPL,SREBF1,NOX1,NPY,MYD88,VEGFA
PMID:32493414	(2020) Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.	9	81	1.11	0.00011	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,MAPK7,PTEN,AR,NFE2L2,BCL2,VEGFA
PMID:32508920	(2020) A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche.	9	81	1.11	0.00011	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000478570	MAPK1,CD38,IFNG,CXCL11,ANGPT2,ANG,CAV1,PTGS2,VEGFA
PMID:32509147	(2020) The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor.	9	82	1.1	0.00011	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,MAP3K5,TXN,EDN1,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:32575639	(2020) Therapeutic Functions of Stem Cells from Oral Cavity: An Update.	9	81	1.11	0.00011	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,CD34,PTGS2,ENTPD1,BMP2,MME,PROM1,VEGFA
PMID:32714944	(2020) Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish.	7	37	1.34	0.00011	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000401399,9606.ENSP00000474412	CETP,IFNG,CXCL11,LPL,LPA,MYD88,CCL5
PMID:32790806	(2020) Different types of cartilage neotissue fabricated from collagen hydrogels and mesenchymal stromal cells via SOX9, TGFB1 or BMP2 gene transfer.	5	9	1.81	0.00011	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000380365	TGFB1,SOX9,ALPL,BMP2,RGN
PMID:33062602	(2020) Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.	10	110	1.02	0.00011	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CD34,ANGPT2,GAS6,CCL20,CD47,PTEN,BCL2,CCL5,VEGFA
PMID:33117687	(2020) Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.	9	81	1.11	0.00011	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000268035,9606.ENSP00000357726,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,ENPP2,IGF1R,S100A12,BCL2,MYD88,LTA,CCL5,VEGFA
PMID:33178456	(2020) Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.	7	37	1.34	0.00011	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:33178597	(2020) Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer.	9	81	1.11	0.00011	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,MMP14,CCL20,ELN,JAK2,FGFR1,RHOA,VEGFA
PMID:33187200	(2020) Natural Health Products (NHPs) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends.	7	37	1.34	0.00011	9606.ENSP00000259486,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ENPP2,IGF1R,CD34,PTGS2,BCL2,RHOA,VEGFA
PMID:33243986	(2020) Head and neck squamous cell carcinoma.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTGS2,PTEN,NFE2L2,FGFR1,PROM1,VEGFA
PMID:33260746	(2020) Adipokines in the Skin and in Dermatological Diseases.	9	81	1.11	0.00011	9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	CXCL10,SREBF1,ELN,PTGS2,JAK2,RARRES2,AGTR1,APLNR,VEGFA
PMID:33312178	(2020) MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity.	7	37	1.34	0.00011	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000362410	FABP4,THBS1,CXCL10,CXCL11,GAS6,CXCL9,MAFB
PMID:33384688	(2020) Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-HaradaUveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.	8	57	1.21	0.00011	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33408525	(2020) The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence.	8	57	1.21	0.00011	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	ATM,ALDH1A1,CD34,PTEN,JAK2,BCL2,PROM1,CCL5
PMID:33986723	(2020) Immune Landscape of Thyroid Cancers: New Insights.	9	82	1.1	0.00011	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ATM,CXCL10,CCL20,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:30153900	(2019) A cycle involving HMGB1, IFN-gamma and dendritic cells plays a putative role in anti-tumor immunity.	5	9	1.81	0.00011	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CCL5
PMID:30531993	(2019) The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy.	7	37	1.34	0.00011	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,IGF1R,CXCL10,CXCL11,CD34,PTGS2,CCL5
PMID:30609771	(2019) Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations.	9	82	1.1	0.00011	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTGS2,JAK2,BCL2,RHOA,PROM1,VEGFA
PMID:30871063	(2019) Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.	9	81	1.11	0.00011	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000426809	MYH9,TGFB1,IFNG,CAV1,PDGFA,PTEN,BMP2,RHOA,PROM1
PMID:30944600	(2019) Inflammation: A key process in skin tumorigenesis.	10	110	1.02	0.00011	9606.ENSP00000216862,9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CYP24A1,CD69,SOX9,CDH1,CXCL10,EDNRA,PTGS2,NFE2L2,CCL5,VEGFA
PMID:30974901	(2019) Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.	7	37	1.34	0.00011	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	SREBF1,PTGS2,TXN,NFE2L2,BCL2,AGTR1,VEGFA
PMID:31150824	(2019) Targets of immunomodulation in bacterial endophthalmitis.	8	57	1.21	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,VIP,PTGS2,JAK2,MYD88,CCL5,VEGFA
PMID:31160393	(2019) Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.	9	81	1.11	0.00011	9606.ENSP00000245479,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,SREBF1,PTEN,FGFR1,RHOA,BDNF,FTO,PROM1,VEGFA
PMID:31165788	(2019) Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.	9	82	1.1	0.00011	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,SOX9,ONECUT1,CXCL10,HNF4A,IRAK4,MYD88,VEGFA,HNF1B
PMID:31205564	(2019) Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells.	9	81	1.11	0.00011	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000366395,9606.ENSP00000378046,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD38,CD69,CDH1,HNF4A,SYVN1,FKBP2,BCL2,RHOA,VEGFA
PMID:31581738	(2019) Classical Hodgkins Lymphoma in the Era of Immune Checkpoint Inhibition.	7	37	1.34	0.00011	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CD47,PTEN,JAK2,VEGFA
PMID:31597283	(2019) Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders.	9	82	1.1	0.00011	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,CCR5,CXCL10,SREBF1,MAP3K5,ABCG1,NFE2L2,LTA,VEGFA
PMID:31717621	(2019) Comprehensive In Vitro Testing of Calcium Phosphate-Based Bioceramics with Orthopedic and Dentistry Applications.	7	37	1.34	0.00011	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CD34,ALPL,BMP2,NFE2L2,BCL2,VEGFA
PMID:31749811	(2019) Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D.	7	37	1.34	0.00011	9606.ENSP00000216862,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CD38,CXCL10,CXCL9,PTEN,BCL2,VEGFA
PMID:31762718	(2019) Gene surgery: Potential applications for human diseases.	9	82	1.1	0.00011	9606.ENSP00000283928,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000418823	JAZF1,CCR5,CD34,HNF4A,KCNJ11,ABCG1,PTGS2,PTEN,FTO
PMID:31781608	(2019) Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review.	10	109	1.02	0.00011	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ALDH1A1,MMP14,HNF4A,PTEN,AR,BCL2,PROM1,VEGFA
PMID:31842336	(2019) TGF-beta and microRNA Interplay in Genitourinary Cancers.	10	110	1.02	0.00011	9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,COL8A1,CDH1,PTGS2,PTEN,AR,BAMBI,BMP2,RHOA,VEGFA
PMID:31866857	(2019) Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.	9	81	1.11	0.00011	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,ATM,PLIN1,PTGS2,NFE2L2,BCL2,RHOA,MYD88,VEGFA
PMID:31879572	(2019) Genetic links between endometriosis and cancers in women.	9	81	1.11	0.00011	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000383364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000474412	THBS1,TIMP3,CXCL9,CD47,PLA2G2A,NTF3,BDNF,AGTR1,CCL5
PMID:31993365	(2019) Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors.	9	82	1.1	0.00011	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,MMP14,PTGS2,BCL2,RHOA,PROM1,VEGFA
PMID:29301251	(2018) The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.	8	57	1.21	0.00011	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000362057,9606.ENSP00000478570	IFNG,CXCL10,ANGPT2,CXCL9,PTGS2,RBP4,NOX1,VEGFA
PMID:29436578	(2018) Protective effect of adenovirus-mediated erythropoietin expression on the spiral ganglion neurons in the rat inner ear.	5	9	1.81	0.00011	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BDNF,VEGFA
PMID:29691335	(2018) Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes.	5	9	1.81	0.00011	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:29726582	(2018) Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors.	9	82	1.1	0.00011	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,ANG,CCL20,CXCL9,S100A12,CCL5,VEGFA
PMID:29896199	(2018) Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33ST2 Axis and CD8(+) T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.	7	37	1.34	0.00011	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:29899293	(2018) Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer.	8	57	1.21	0.00011	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185	ATM,CXCL10,LPL,SIRT6,SREBF1,ABCG1,PTEN,BCL2
PMID:29941215	(2018) Effects of Non-thermal, Non-cavitational Ultrasound Exposure on Human Diabetic Ulcer Healing and Inflammatory Gene Expression in a Pilot Study.	5	9	1.81	0.00011	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,TIMP3,PDGFB,RHOA,VEGFA
PMID:30097061	(2018) Comparing atmospheric and hypoxic cultured mesenchymal stem cell transcriptome: implication for stem cell therapies targeting intervertebral discs.	7	37	1.34	0.00011	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363973,9606.ENSP00000478570	SOX9,FABP4,AMBP,CD34,ANGPT2,ALPL,VEGFA
PMID:30126117	(2018) Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site.	7	37	1.34	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,PTEN,CCL5,VEGFA
PMID:30271077	(2018) Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.	10	109	1.02	0.00011	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252	TGFB1,CDH1,LPL,HNF4A,CAV1,SREBF1,CCL20,PTEN,EDN1,NFE2L2
PMID:30274786	(2018) RNAi-Mediated beta-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade.	7	37	1.34	0.00011	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185	CXCL10,CXCL11,HNF4A,CD247,CXCL9,PTEN,BCL2
PMID:30323585	(2018) A review of using green chemistry methods for biomaterials in tissue engineering.	5	9	1.81	0.00011	9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ELN,BMP2,NTF3,BDNF,VEGFA
PMID:30534129	(2018) Leptin Functions in Infectious Diseases.	8	57	1.21	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,CNTF,TXN,JAK2,BCL2,CCL5
PMID:28013031	(2017) Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.	9	81	1.11	0.00011	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,ANG,SIRT6,SGK1,NFE2L2,BCL2,CCL5,VEGFA
PMID:28077237	(2017) Interplay of extracellular matrix and leukocytes in lung inflammation.	7	37	1.34	0.00011	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CXCL10,CCL20,ELN,HSPG2,CCL5,VEGFA
PMID:28234672	(2017) Vascular smooth muscle cell peroxisome proliferator-activated receptor gamma protects against endothelin-1-induced oxidative stress and inflammation.	7	37	1.34	0.00011	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683	CD69,FABP4,NOX4,EDNRA,PTGS2,NOX1,EDN1
PMID:28366820	(2017) Immune-related gene polymorphisms in pulmonary diseases.	8	57	1.21	0.00011	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412	TGFB1,IFNG,CDH1,CXCL10,PTGS2,EDN1,LTA,CCL5
PMID:28746417	(2017) Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.	7	37	1.34	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:28750661	(2017) Human dental pulp pluripotent-like stem cells promote wound healing and muscle regeneration.	8	57	1.21	0.00011	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANG,CCL20,LTA,BDNF,CCL5,VEGFA
PMID:28838042	(2017) The role of infiltrating immune cells in dysfunctional adipose tissue.	9	81	1.11	0.00011	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000474412	ATM,CCR5,CXCL10,CD34,ADAMTS13,EDN1,RHOA,RARRES2,CCL5
PMID:28974038	(2017) Chemokines from a Structural Perspective.	7	37	1.34	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,SAA1,CCL5
PMID:28978059	(2017) Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.	5	9	1.81	0.00011	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363641,9606.ENSP00000371067	EPOR,CD34,STAT5A,TXN,JAK2
PMID:29036837	(2017) Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinsons Disease: Rationale for Clinical Trial, and Current Progress.	7	37	1.34	0.00011	9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356213,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,SREBF1,VIP,NFE2L2,RHOA,BDNF,VEGFA
PMID:29472816	(2017) Disorders noticed during development of pancreatic cancer: potential opportunities for early and effective diagnostics and therapy.	7	37	1.34	0.00011	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,NOX4,CNTF,PTEN,NOX1,JAK2,VEGFA
PMID:27070595	(2016) Pathogens Use and Abuse MicroRNAs to Deceive the Immune System.	10	109	1.02	0.00011	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	TIMP3,CCR5,CXCL10,CXCL11,CD34,PTEN,BCL2,MYD88,LTA,CCL5
PMID:27117759	(2016) Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.	9	81	1.11	0.00011	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354511,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822	IFNG,CDH1,TIMP3,CXCL10,SIRT6,COMT,SGK1,PTEN,AR
PMID:27131432	(2016) Memory CD8(+) T Cells: Innate-Like Sensors and Orchestrators of Protection.	7	37	1.34	0.00011	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CXCL9,MYD88,CCL5
PMID:27376273	(2016) Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A Review.	8	57	1.21	0.00011	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000364683,9606.ENSP00000418823	FABP4,PLIN1,CD34,ELN,RBP4,AR,BAMBI,FTO
PMID:27918831	(2016) Induction of Chemokine Secretion and Monocyte Migration by Human Choroidal Melanocytes in Response to Proinflammatory Cytokines.	5	9	1.81	0.00011	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:25296095	(2015) Early HIV-1 infection is associated with reduced frequencies of cervical Th17 cells.	5	9	1.81	0.00011	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000474412	CD69,IFNG,CCR5,CCL20,CCL5
PMID:25547388	(2015) The biology of castration-resistant prostate cancer.	8	57	1.21	0.00011	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,CDH1,IGF1R,STAT5A,PTEN,AR,FGFR1,VEGFA
PMID:25867261	(2015) Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.	5	9	1.81	0.00011	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000478570	THBS1,CD34,ANGPT2,PDGFA,VEGFA
PMID:26197340	(2015) T-Cadherin Expression in Melanoma Cells Stimulates Stromal Cell Recruitment and Invasion by Regulating the Expression of Chemokines, Integrins and Adhesion Molecules.	7	37	1.34	0.00011	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000384262,9606.ENSP00000474412	CDH1,CXCL10,CXCL11,MMP14,ANGPT2,HPSE,CCL5
PMID:26217588	(2015) Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites.	9	81	1.11	0.00011	9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL11,CCL20,PTGS2,PTEN,BCL2,MYD88,CCL5,VEGFA
PMID:26464811	(2015) STATs: An Old Story, Yet Mesmerizing.	9	81	1.11	0.00011	9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,ATM,STAT5A,CNTF,PTEN,BMP2,JAK2,BCL2,VEGFA
PMID:26729182	(2015) The Effect of Marine Derived n-3 Fatty Acids on Adipose Tissue Metabolism and Function.	7	37	1.34	0.00011	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000363641	TGFB1,FABP4,PLIN1,LPL,CAV1,SREBF1,TXN
PMID:23957937	(2014) Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,CD34,PTEN,AR,PDGFD,PROM1,VEGFA
PMID:24398114	(2014) Tumour angiogenesis in Epstein-Barr virus-associated post-transplant smooth muscle tumours.	7	37	1.34	0.00011	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,CD34,ANGPT2,PTGS2,ANGPTL2,FGFR1,VEGFA
PMID:24498509	(2014) Introduction to personalized medicine in diabetes mellitus.	7	37	1.34	0.00011	9606.ENSP00000226760,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000418823	WFS1,ATM,HNF4A,KCNJ11,MTHFR,SHBG,FTO
PMID:24578018	(2014) Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.	7	37	1.34	0.00011	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,CHI3L1,CXCL11,ANGPT2,ELN,PTGS2,VEGFA
PMID:24801651	(2014) Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.	5	9	1.81	0.00011	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,ANG,CXCL9,VEGFA
PMID:24976757	(2014) The role of peroxiredoxin II in chemoresistance of breast cancer cells.	5	9	1.81	0.00011	9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252	PRDX2,MAP3K5,PTEN,TXN,NFE2L2
PMID:25074768	(2014) Inflammation-induced chemokine expression in uveal melanoma cell lines stimulates monocyte chemotaxis.	5	9	1.81	0.00011	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:25171153	(2014) Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease.	5	9	1.81	0.00011	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,EDN1,PROM1,VEGFA
PMID:25362644	(2014) Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.	7	37	1.34	0.00011	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,CXCL10,PDGFA,CXCL9,PROM1,VEGFA
PMID:23619968	(2013) Alarmin-induced cell migration.	8	57	1.21	0.00011	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,CXCL10,CCL20,CXCL9,RHOA,CCL5,VEGFA
PMID:23790730	(2013) Engineering peripheral nerve repair.	5	9	1.81	0.00011	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ELN,CNTF,BDNF,VEGFA
PMID:23847541	(2013) Macrophages and chemokines as mediators of angiogenesis.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CXCL9,FGFR1,CCL5,VEGFA
PMID:23902592	(2013) Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach.	7	37	1.34	0.00011	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,PTEN,BCL2,MYD88,PROM1
PMID:24228023	(2013) Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring.	10	110	1.02	0.00011	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,CCR5,CXCL10,CD34,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:24403841	(2013) Overview of diagnostictargeted treatment combinations in personalized medicine for breast cancer patients.	7	37	1.34	0.00011	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	EPOR,IFNG,CDH1,IGF1R,PTEN,BCL2,FGFR1
PMID:22146293	(2012) Progress of molecular targeted therapies for prostate cancers.	7	37	1.34	0.00011	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000478570	IGF1R,PDGFB,PDGFA,PTEN,AR,PDGFD,VEGFA
PMID:22511950	(2012) Focused examination of the intestinal lamina propria yields greater molecular insight into mechanisms underlying SIV induced immune dysfunction.	10	110	1.02	0.00011	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000363596,9606.ENSP00000393312	CD38,IFNG,THBS1,CCR5,CXCL11,HNF4A,PDGFB,STAT5A,CNR2,FGFR1
PMID:22634069	(2012) Redox balance dynamically regulates vascular growth and remodeling.	8	57	1.21	0.00011	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,MAP3K5,PTGS2,PTEN,NOX1,TXN,RHOA,VEGFA
PMID:22701492	(2012) Amniotic fluid and amniotic membrane stem cells: marker discovery.	12	177	0.89	0.00011	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000263774,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,NOX4,NDUFS3,PRDX2,CXCL10,CD34,HNF4A,CAV1,BMP2,MME,PROM1,VEGFA
PMID:22937121	(2012) Transcriptional profiling of bone marrow stromal cells in response to Porphyromonas gingivalis secreted products.	9	81	1.11	0.00011	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CAV1,ELN,CXCL9,JAK2,SAA1,MYD88,CCL5,VEGFA
PMID:22973234	(2012) Pancreatic stellate cells: a starring role in normal and diseased pancreas.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,MMP14,PTGS2,EDN1,BCL2,MME,CCL5,VEGFA
PMID:23251558	(2012) Molecular sex differences in human serum.	8	57	1.21	0.00011	9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000354901,9606.ENSP00000369816,9606.ENSP00000371067	CXCL11,LPL,ANGPT2,STAT5A,PRKAA1,CXCL9,SHBG,JAK2
PMID:24710543	(2012) Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.	10	109	1.02	0.00011	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,LPL,CD34,CXCL9,BMP2,MME,PROM1,CCL5,VEGFA
PMID:20500532	(2011) The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.	5	9	1.81	0.00011	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901	CD38,IFNG,CCR5,CXCL10,CXCL9
PMID:21199773	(2011) Molecular alterations in glioblastoma: potential targets for immunotherapy.	11	142	0.95	0.00011	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TIMP3,IGF1R,MMP14,CD34,CAV1,ELN,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:21439035	(2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimers disease.	7	37	1.34	0.00011	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,IFNG,CCR5,CD34,ANGPT2,JAK2,VEGFA
PMID:21863131	(2011) Management options in triple-negative breast cancer.	7	37	1.34	0.00011	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	MAPK1,CDH1,TIMP3,IGF1R,PTEN,AR,VEGFA
PMID:22174624	(2011) Bioengineering embryonic stem cell microenvironments for the study of breast cancer.	9	82	1.1	0.00011	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,TIMP3,ATM,HNF4A,ELN,PTEN,PROM1,GREM1,VEGFA
PMID:20459780	(2010) Transcriptome analysis of porcine PBMCs after in vitro stimulation by LPS or PMAionomycin using an expression array targeting the pig immune response.	9	81	1.11	0.00011	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000357726,9606.ENSP00000384906	TGFB1,CD69,IFNG,THBS1,CXCL10,MMP14,CD47,S100A12,SAA1
PMID:20664697	(2010) Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture.	10	109	1.02	0.00011	9606.ENSP00000216181,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000384906,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525	MYH9,CHI3L1,CDH1,CD34,FMOD,SAA1,FGFR1,NTF3,BDNF,MME
PMID:20804552	(2010) Protein targets of inflammatory serine proteases and cardiovascular disease.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,MMP14,CAV1,ELN,RHOA,CCL5,VEGFA
PMID:20827397	(2010) Catalpol increases brain angiogenesis and up-regulates VEGF and EPO in the rat after permanent middle cerebral artery occlusion.	5	9	1.81	0.00011	9606.ENSP00000222139,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,GAP43,BCL2,BDNF,VEGFA
PMID:20932934	(2010) Colorectal cancer cells - Proliferation, survival and invasion by lysophosphatidic acid.	7	37	1.34	0.00011	9606.ENSP00000257430,9606.ENSP00000259486,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	APC,ENPP2,CCL20,PTGS2,BCL2,RHOA,VEGFA
PMID:19114129	(2009) Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stemprogenitor cells and their therapeutic implications.	8	57	1.21	0.00011	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:19751821	(2009) Oxidative risk for atherothrombotic cardiovascular disease.	9	82	1.1	0.00011	9606.ENSP00000222572,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000321334,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000474412	PON2,IFNG,NOX4,CCR5,LPA,ELN,NOX1,RHOA,CCL5
PMID:20038496	(2009) Identifying positive selection candidate loci for high-altitude adaptation in Andean populations.	5	9	1.81	0.00011	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000346148,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,EDNRA,PRKAA1,EDN1,VEGFA
PMID:19125181	(2008) PPARs Mediate Lipid Signaling in Inflammation and Cancer.	7	37	1.34	0.00011	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,LPL,MAPK7,CAV1,PTEN,BCL2,VEGFA
PMID:17039239	(2007) Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes.	5	9	1.81	0.00011	9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	P2RY1,CXCL10,CXCL11,CXCL9,CCL5
PMID:17255201	(2007) Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.	5	9	1.81	0.00011	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067	IFNG,CXCL10,CXCL11,CXCL9,JAK2
PMID:15178708	(2004) I-TACCXCL11 is a natural antagonist for CCR5.	5	9	1.81	0.00011	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:15219783	(2004) Cell-surface peptidases.	9	81	1.11	0.00011	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,EDN1,NPY,MME,CCL5,VEGFA
PMID:35035667	(2022) Effects of Polyphenols on Oxidative Stress, Inflammation, and Interconnected Pathways during Spinal Cord Injury.	9	83	1.1	0.00012	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	MPO,SOX9,PTEN,TXN,JAK2,NFE2L2,BCL2,RHOA,BDNF
PMID:35250619	(2022) Mechanotransduction Regulates the Interplays Between Alveolar Epithelial and Vascular Endothelial Cells in Lung.	10	112	1.01	0.00012	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,NOX4,CAV1,PTEN,EDN1,BCL2,RHOA,TRPC1,CCL5,VEGFA
PMID:35409228	(2022) The Therapeutic Potential of Exosomes in Soft Tissue Repair and Regeneration.	8	58	1.2	0.00012	9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PTEN,GLO1,GAP43,BCL2,NTF3,RHOA,BDNF,VEGFA
PMID:33398113	(2021) Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.	10	111	1.02	0.00012	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CD69,CHI3L1,TIMP3,CXCL10,CXCL11,CXCL9,LTA,MME,VEGFA
PMID:33525511	(2021) Redox Homeostasis in Poultry: Regulatory Roles of NF-kappaB.	10	112	1.01	0.00012	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000401399,9606.ENSP00000474412	MPO,HSPB1,SIRT6,PTGS2,PTEN,TXN,BCL2,PLA2G2A,MYD88,CCL5
PMID:33532142	(2021) Melatonin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-related Diseases.	6	21	1.52	0.00012	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185	TGFB1,SOX9,ELN,PTGS2,BMP2,BCL2
PMID:33537252	(2021) Zebrafish as an Emerging Model for Dyslipidemia and Associated Diseases.	6	21	1.52	0.00012	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000354995,9606.ENSP00000477707	CETP,LPL,SREBF1,GFPT1,ABCG1,NR1H3
PMID:33559848	(2021) The cytokine storm and thyroid hormone changes in COVID-19.	6	21	1.52	0.00012	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:33572760	(2021) Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections.	11	143	0.95	0.00012	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000363641,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412	TGFB1,IFNG,ATM,CCR5,CXCL10,TXN,BAMBI,JAK2,MYD88,AGTR1,CCL5
PMID:33614926	(2021) Effects of Pelargonium sidoides extract vs roxithromycin on chemokine levels in nasal secretions of patients with uncomplicated acute rhinosinusitis.	6	21	1.52	0.00012	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33673398	(2021) Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy.	8	58	1.2	0.00012	9606.ENSP00000263317,9606.ENSP00000298352,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383232	NOX4,NGB,PTEN,NOX1,TXN,NFE2L2,BCL2,GGT1
PMID:33674596	(2021) KRAS drives immune evasion in a genetic model of pancreatic cancer.	8	58	1.2	0.00012	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	CD69,IFNG,SOX9,CCR5,CXCL10,CXCL9,PROM1,CCL5
PMID:33732706	(2021) Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.	9	83	1.1	0.00012	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000390651,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	IGF1R,ATM,MMP14,ELN,PTEN,IRAK4,MME,AGTR1,VEGFA
PMID:33817299	(2021) Iris metastasis of diffuse large B-cell lymphoma misdiagnosed as primary angle-closure glaucoma: A case report and review of the literature.	6	21	1.52	0.00012	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CD38,CD34,BCL2,MME,VEGFA
PMID:33841445	(2021) Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.	9	83	1.1	0.00012	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000478570	CD38,ATM,CXCL10,CXCL11,CXCL9,ENTPD1,BCL2,RARRES2,VEGFA
PMID:34031270	(2021) Platelet-Derived Growth Factor Receptor-alpha Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo.	6	21	1.52	0.00012	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000478570	CDH1,IGF1R,PDGFB,PDGFA,PDGFD,VEGFA
PMID:34054510	(2021) beta-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.	8	58	1.2	0.00012	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	MPO,CXCL10,PTGS2,CNR1,JAK2,NFE2L2,BCL2,MYD88
PMID:34055634	(2021) Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.	9	83	1.1	0.00012	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,SOX9,CDH1,IGF1R,CXCL10,PTEN,JAK2,BCL2,VEGFA
PMID:34113630	(2021) Pathergy Phenomenon.	6	21	1.52	0.00012	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000363822	IFNG,CXCL10,CXCL11,CCL20,CXCL9,AR
PMID:34164927	(2021) Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection.	6	21	1.52	0.00012	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CCR5,CXCL10,CCL5,VEGFA
PMID:34233729	(2021) Application of mesenchymal stem cell sheet to treatment of ischemic heart disease.	6	21	1.52	0.00012	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,BCL2,CCL5,VEGFA
PMID:34239870	(2021) Dental-Derived Mesenchymal Stem Cells: State of the Art.	9	83	1.1	0.00012	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,FABP4,HNF4A,SIRT6,BMP2,EDN1,NTF3,BDNF,VEGFA
PMID:34387402	(2021) Allogeneic mesenchymal stromal cells for cartilage regeneration: A review of in vitro evaluation, clinical experience, and translational opportunities.	6	21	1.52	0.00012	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,CXCL9,BMP2,CCL5,VEGFA
PMID:34609061	(2021) Roles of extracellular vesicles in the aging microenvironment and age-related diseases.	11	144	0.94	0.00012	9606.ENSP00000263774,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	NDUFS3,ATM,CXCL10,SIRT6,CAV1,PTEN,BMP2,BCL2,RHOA,CCL5,VEGFA
PMID:34641334	(2021) Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review.	9	83	1.1	0.00012	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,CXCL10,CXCL9,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:34696504	(2021) CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIVHCV-Coinfected Patients.	6	21	1.52	0.00012	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34746878	(2021) Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions.	8	58	1.2	0.00012	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,VIP,EDN1,NPY,CCL5,VEGFA
PMID:34868078	(2021) Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.	6	21	1.52	0.00012	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067	CDH1,CXCL10,CXCL11,STAT5A,CXCL9,JAK2
PMID:31906916	(2020) Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls.	6	21	1.52	0.00012	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,BCL2,MME,PROM1,VEGFA
PMID:32028725	(2020) Antitumoral Properties of Natural Products.	6	21	1.52	0.00012	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ATM,ALDH1A1,SREBF1,BCL2,PROM1,VEGFA
PMID:32094357	(2020) Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000478570	CDH1,ALDH1A1,ANGPT2,PDGFB,FMOD,ELN,SGK1,VEGFA
PMID:32197476	(2020) The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer.	8	58	1.2	0.00012	9606.ENSP00000215832,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,TIMP3,ATM,HNF4A,PTEN,BCL2,RHOA,VEGFA
PMID:32210969	(2020) Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis.	10	111	1.02	0.00012	9606.ENSP00000225275,9606.ENSP00000259407,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000383232,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	MPO,BAAT,CXCL10,ELN,PTGS2,EDN1,GGT1,CCL5,APLNR,VEGFA
PMID:32256949	(2020) Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation.	8	58	1.2	0.00012	9606.ENSP00000229135,9606.ENSP00000246553,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,FFAR1,ANGPT2,PTGS2,NFE2L2,BCL2,BDNF,VEGFA
PMID:32536032	(2020) Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies.	8	58	1.2	0.00012	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,ELN,PTGS2,NOX1,EDN1,NPY,RHOA,VEGFA
PMID:32708855	(2020) Cellular Mechanisms of Circulating Tumor Cells During Breast Cancer Metastasis.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	CDH1,ATM,MMP14,PTEN,NOX1,G6PD,NFE2L2,BCL2
PMID:32751163	(2020) Role of MSC in the Tumor Microenvironment.	8	58	1.2	0.00012	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,ANG,ELN,PTGS2,BMP2,RHOA,VEGFA
PMID:32811507	(2020) Discovery of the possible mechanisms in kouyanqing granule for treatment of oral ulcers based on network pharmacology.	6	21	1.52	0.00012	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412	MAPK1,IFNG,PTGS2,EDN1,BCL2,CCL5
PMID:32952861	(2020) Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine.	10	111	1.02	0.00012	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	IFNG,SOX9,CD34,ELN,CNTF,PTEN,BCL2,NTF3,RHOA,BDNF
PMID:33042113	(2020) Communications Between Peripheral and the Brain-Resident Immune System in Neuronal Regeneration After Stroke.	8	58	1.2	0.00012	9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	CCR5,CCL20,PTEN,JAK2,GAP43,NTF3,RHOA,BDNF
PMID:33049989	(2020) Regulation of Vascular Calcification by Reactive Oxygen Species.	8	58	1.2	0.00012	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000380252	SOX9,NOX4,MAPK7,HNF4A,S100A12,NOX1,BMP2,NFE2L2
PMID:33163007	(2020) Editorial: Atypical Functions of Leukocyte Chemoattractant Receptors.	6	21	1.52	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906	CCR5,CXCL10,CXCL11,CCL20,CXCL9,SAA1
PMID:33187272	(2020) The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC).	9	83	1.1	0.00012	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CAV1,PTGS2,PTEN,NOX1,TXN,NFE2L2,BCL2,VEGFA
PMID:33312400	(2020) Stem cell quiescence and its clinical relevance.	11	143	0.95	0.00012	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,CD34,EBF1,ANG,STAT5A,ENTPD1,JAK2,NFE2L2,NPY,RHOA,PROM1
PMID:33326796	(2020) Endothelial Reprogramming by Disturbed Flow Revealed by Single-Cell RNA and Chromatin Accessibility Study.	9	83	1.1	0.00012	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	MYH9,TGFB1,TIMP3,CD34,ANGPT2,ELN,PTGS2,EDN1,VEGFA
PMID:33396739	(2020) Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases.	11	143	0.95	0.00012	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,TGFB1,SOX9,CDH1,IGF1R,ATM,MMP14,SIRT6,PTEN,CCL5,VEGFA
PMID:30809220	(2019) Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?	8	58	1.2	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CXCL9,PTGS2,CCL5,VEGFA
PMID:30819129	(2019) Molecular Pathogenesis of Cholangiocarcinoma.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTGS2,PTEN,PDGFD,BCL2,VEGFA
PMID:30924280	(2019) Understanding the marvels behind liver regeneration.	10	112	1.01	0.00012	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,SOX9,ONECUT1,CD34,HNF4A,NTF3,BDNF,PROM1,VEGFA,HNF1B
PMID:30962863	(2019) Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health.	8	58	1.2	0.00012	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,PLIN1,SREBF1,MAP3K5,G6PD,BCL2,BDNF,VEGFA
PMID:30979057	(2019) Dendritic Cells and Cancer: From Biology to Therapeutic Intervention.	9	83	1.1	0.00012	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CD34,CCL20,CXCL9,MYD88,CCL5,VEGFA
PMID:31159489	(2019) Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.	8	58	1.2	0.00012	9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000363596,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CD34,SREBF1,CCL20,MAP3K5,CNR2,TXN,NFE2L2,VEGFA
PMID:31269734	(2019) Cytokine Storm Combined with Humoral Immune Response Defect in Fatal Hemorrhagic Fever with Renal Syndrome Case, Tatarstan, Russia.	6	21	1.52	0.00012	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,LTA,PROM1,CCL5,VEGFA
PMID:31467935	(2019) Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.	6	21	1.52	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:31611950	(2019) CAR-T 19 combined with reduced-dose PD-1 blockade therapy for treatment of refractory follicular lymphoma: A case report.	6	21	1.52	0.00012	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,CD34,CD247,BCL2,MYD88,MME
PMID:31686866	(2019) Functional aspects, phenotypic heterogeneity, and tissue immune response of macrophages in infectious diseases.	12	178	0.89	0.00012	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD38,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,ABCG1,JAK2,MYD88,CCL5,VEGFA
PMID:29437272	(2018) Bioactivity and composition of a preserved connective tissue matrix derived from human placental tissue.	6	21	1.52	0.00012	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,IFNG,PDGFB,PDGFA,BMP2,VEGFA
PMID:29562608	(2018) Health Risks of Hypovitaminosis D: A Review of New Molecular Insights.	8	58	1.2	0.00012	9606.ENSP00000339191,9606.ENSP00000354511,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000478570	CAV1,COMT,TXN,KL,NFE2L2,NTF3,MYD88,VEGFA
PMID:29844207	(2018) Cardiometabolic risk in polycystic ovary syndrome.	6	21	1.52	0.00012	9606.ENSP00000225275,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000375844,9606.ENSP00000478570	MPO,AR,MTHFR,SHBG,CAPN10,VEGFA
PMID:30310078	(2018) GSK3beta: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?	6	21	1.52	0.00012	9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	EPOR,SOX9,STAT5A,JAK2,BCL2,BDNF
PMID:28012875	(2017) Advances in understanding and management of retinopathy of prematurity.	6	21	1.52	0.00012	9606.ENSP00000222139,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,THBS1,NOX4,NOX1,BDNF,VEGFA
PMID:28062199	(2017) MicroRNAs and the metabolic hallmarks of aging.	8	58	1.2	0.00012	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303	ERCC1,IGF1R,HNF4A,SIRT6,ABCG1,PTEN,BCL2,BDNF
PMID:28433655	(2017) Targeting sarcoma tumor-initiating cells through differentiation therapy.	6	21	1.52	0.00012	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000339191,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000426809	SOX9,ONECUT1,CAV1,ALPL,BMP2,PROM1
PMID:28610419	(2017) Gene Expression Profiling of Chemokines and Their Receptors in Low and High Grade Astrocytoma	6	21	1.52	0.00012	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,PTEN,VEGFA
PMID:28748217	(2017) Mechanisms and applications of the anti-inflammatory effects of photobiomodulation.	8	58	1.2	0.00012	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL11,PTGS2,BCL2,FGFR1,BDNF,CCL5,VEGFA
PMID:28878776	(2017) Interferon-lambdas and Plasmacytoid Dendritic Cells: A Close Relationship.	8	58	1.2	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,EDNRA,STAT5A,CXCL9,JAK2,CCL5
PMID:28978186	(2017) The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.	9	83	1.1	0.00012	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,IFNG,THBS1,NOX4,MMP14,PDGFB,STAT5A,JAK2,VEGFA
PMID:29463952	(2017) Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.	8	58	1.2	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,ENTPD1,PTEN,CCL5,VEGFA
PMID:26755644	(2016) IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.	6	21	1.52	0.00012	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,IGF1R,CD34,STAT5A,JAK2,VEGFA
PMID:26859576	(2016) Targeting hypoxic response for cancer therapy.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,CAV1,PRKAA1,PTEN,EDN1,PROM1,VEGFA
PMID:27027682	(2016) Glomerular cell crosstalk.	6	21	1.52	0.00012	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,MAPK7,SREBF1,EDN1,BCL2,VEGFA
PMID:27039259	(2016) TGF-beta signaling in liver and gastrointestinal cancers.	8	58	1.2	0.00012	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	IFNG,CDH1,ALDH1A1,BMP2,BCL2,PROM1,GREM1,VEGFA
PMID:27436075	(2016) Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.	6	21	1.52	0.00012	9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	AR,EDN1,BCL2,NPY,RHOA,VEGFA
PMID:27790220	(2016) T Cell Interstitial Migration: Motility Cues from the Inflamed Tissue for Micro- and Macro-Positioning.	6	21	1.52	0.00012	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901	CDH1,CXCL10,CXCL11,CCL20,ELN,CXCL9
PMID:25970778	(2015) CEMTDD: The database for elucidating the relationships among herbs, compounds, targets and related diseases for Chinese ethnic minority traditional drugs.	6	21	1.52	0.00012	9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	NOX4,DDAH1,PTGS2,BCL2,MME,VEGFA
PMID:26120272	(2015) Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.	6	21	1.52	0.00012	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CD34,ANG,CD47,EDN1,VEGFA
PMID:26301222	(2015) Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease.	6	21	1.52	0.00012	9606.ENSP00000229135,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,CAV1,PDGFA,ELN,PTGS2,VEGFA
PMID:26545368	(2015) Network analysis of microRNA and mRNA seasonal dynamics in a highly plastic sensorimotor neural circuit.	6	21	1.52	0.00012	9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	MAPK7,SIRT6,PTEN,NPY,BDNF,VEGFA
PMID:26640323	(2015) Acute Respiratory Distress Syndrome: Role of Oleic Acid-Triggered Lung Injury and Inflammation.	6	21	1.52	0.00012	9606.ENSP00000246553,9606.ENSP00000260356,9606.ENSP00000293599,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000475344	FFAR1,THBS1,AQP5,PTEN,BCL2,APLNR
PMID:26696896	(2015) H2S- and NO-Signaling Pathways in Alzheimers Amyloid Vasculopathy: Synergism or Antagonism?	6	21	1.52	0.00012	9606.ENSP00000226279,9606.ENSP00000336762,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CD38,ANG,TXN,EDN1,RHOA,VEGFA
PMID:24670365	(2014) MicroRNAs in the Regulation of MMPs and Metastasis.	8	58	1.2	0.00012	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	TIMP3,IGF1R,MMP14,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:25091702	(2014) Soluble biglycan as a biomarker of inflammatory renal diseases.	8	58	1.2	0.00012	9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000360522,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,MMP14,FMOD,ELN,RBP4,MYD88,CCL5,VEGFA
PMID:25298902	(2014) Walking along the Fibroblast Growth Factor 10 Route: A Key Pathway to Understand the Control and Regulation of Epithelial and Mesenchymal Cell-Lineage Formation during Lung Development and Repair after Injury.	8	58	1.2	0.00012	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000393312	SOX9,APC,CDH1,AQP5,CD34,PDGFA,ELN,FGFR1
PMID:23290997	(2013) Physiological and molecular determinants of embryo implantation.	10	112	1.01	0.00012	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000368104,9606.ENSP00000474412	CDH1,CXCL10,HNF4A,CXCL9,PTGS2,SGK1,CNR1,CNR2,BMP2,CCL5
PMID:23301078	(2013) Expansion of activated memory CD4+ T cells affects infectivity of CCR5-tropic HIV-1 in humanized NODSCIDJAK3null mice.	6	21	1.52	0.00012	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809	CD38,CD69,AMBP,CCR5,CD34,PROM1
PMID:23351585	(2013) Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.	9	83	1.1	0.00012	9606.ENSP00000226760,9606.ENSP00000278616,9606.ENSP00000283928,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000346148,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000418823	WFS1,ATM,JAZF1,LPL,KCNJ11,PRKAA1,CNTF,BDNF,FTO
PMID:23401782	(2013) Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,CAV1,JAK2,BCL2,FGFR1,VEGFA
PMID:23434930	(2013) Functional redundancy of CXCR3CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes model.	6	21	1.52	0.00012	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:23474584	(2013) CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.	6	21	1.52	0.00012	9606.ENSP00000259486,9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000426809,9606.ENSP00000478570	ENPP2,P2RY1,CD34,ENTPD1,PROM1,VEGFA
PMID:23797537	(2013) Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus.	6	21	1.52	0.00012	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,CXCL9,CCL5,VEGFA
PMID:23899291	(2013) Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines.	8	58	1.2	0.00012	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CXCL10,IRAK4,MYD88,LTA,CCL5,VEGFA
PMID:23928100	(2013) Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.	6	21	1.52	0.00012	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000478570	CD69,IFNG,CXCL10,CXCL9,MYD88,VEGFA
PMID:24130912	(2013) CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathytropical spastic paraparesis.	6	21	1.52	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:24319678	(2013) Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice.	6	21	1.52	0.00012	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,CD34,PDGFA,CNTF,NTF3,BDNF
PMID:22236028	(2012) Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.	6	21	1.52	0.00012	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,CD34,CNTF,BDNF,PROM1,VEGFA
PMID:22666281	(2012) Cellular and humoral mechanisms involved in the control of tuberculosis.	8	58	1.2	0.00012	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000363641,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	CD69,CCR5,CXCL10,TXN,IRAK4,MYD88,LTA,CCL5
PMID:21196205	(2011) Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,MMP14,HNF4A,ELN,CXCL9,VEGFA
PMID:21321078	(2011) Role for miR-204 in human pulmonary arterial hypertension.	6	21	1.52	0.00012	9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	EDNRA,PDGFB,EDN1,JAK2,RHOA,VEGFA
PMID:21412436	(2011) Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis.	8	58	1.2	0.00012	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CCR5,CXCL10,CD47,BDNF,CCL5,VEGFA
PMID:21668411	(2011) Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.	9	83	1.1	0.00012	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,HNF4A,EDNRA,PTGS2,PTEN,AR,EDN1,RHOA,VEGFA
PMID:21742796	(2011) Normalization of the vasculature for treatment of cancer and other diseases.	8	58	1.2	0.00012	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,PDGFB,CCL20,PTGS2,PDGFD,BCL2,VEGFA
PMID:20210685	(2010) Pharmacotherapy of systemic sclerosis.	8	58	1.2	0.00012	9606.ENSP00000259486,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	ENPP2,CD34,PDGFB,PDGFA,VIP,EDN1,JAK2,VEGFA
PMID:18363841	(2008) Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimers disease.	8	58	1.2	0.00012	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD47,PTGS2,EDN1,MME,CCL5,VEGFA
PMID:18708172	(2008) HIF-1 and ventilatory acclimatization to chronic hypoxia.	6	21	1.52	0.00012	9606.ENSP00000222139,9606.ENSP00000298352,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,NGB,EDNRA,EDN1,BDNF,VEGFA
PMID:27102705	(....) effects of tea catechins on cancer signaling pathways.	8	58	1.2	0.00012	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000354511,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,COMT,JAK2,G6PD,NFE2L2,BCL2,VEGFA
PMID:35216131	(2022) Glucose-6-Phosphate Dehydrogenase, Redox Homeostasis and Embryogenesis.	7	38	1.33	0.00013	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	CDH1,NOX4,PRDX2,MAP3K5,NOX1,TXN,NFE2L2
PMID:35252807	(2022) A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease.	7	38	1.33	0.00013	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000474412	TGFB1,HSPB1,CXCL10,CXCL11,CNTF,NFE2L2,CCL5
PMID:35285685	(2022) Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection.	7	38	1.33	0.00013	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,STAT5A,CXCL9,CCL5
PMID:35293942	(2022) Effects of systemic inflammation due to hepatic ischemia-reperfusion injury upon lean or obese visceral adipose tissue.	7	38	1.33	0.00013	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:35317831	(2022) Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.	10	113	1.01	0.00013	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000427424,9606.ENSP00000478570	TGFB1,CDH1,IGF1R,CAV1,SGK1,PTEN,AR,BCL2,TNFAIP8,VEGFA
PMID:33230600	(2021) Pathological angiogenesis and inflammation in tissues.	8	59	1.19	0.00013	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,ANGPT2,EDNRA,CXCL9,EDN1,CCL5,VEGFA
PMID:33337480	(2021) IL-6 in inflammation, autoimmunity and cancer.	9	84	1.09	0.00013	9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	STAT5A,CCL20,CNTF,JAK2,BCL2,MYD88,AGTR1,CCL5,VEGFA
PMID:33639960	(2021) The impact of reactive oxygen species in the development of cardiometabolic disorders: a review.	8	59	1.19	0.00013	9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000284031,9606.ENSP00000351908,9606.ENSP00000360522,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000419422	PON2,MPO,DDAH1,MAP3K5,RBP4,NOX1,TXN,AGTR1
PMID:33707239	(2021) Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus.	7	38	1.33	0.00013	9606.ENSP00000245479,9606.ENSP00000293599,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000475344,9606.ENSP00000478570	SOX9,AQP5,HNF4A,PDGFA,ELN,APLNR,VEGFA
PMID:33920819	(2021) Multifaceted Roles of CD5L in Infectious and Sterile Inflammation.	7	38	1.33	0.00013	9606.ENSP00000225275,9606.ENSP00000300055,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000362410,9606.ENSP00000390651,9606.ENSP00000478570	MPO,PLIN1,STAT5A,SREBF1,MAFB,IRAK4,VEGFA
PMID:33935970	(2021) Cytokines as Targets of Novel Therapies for Graves Ophthalmopathy.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,IGF1R,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:33985562	(2021) Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.	8	59	1.19	0.00013	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	CD69,SOX9,CXCL10,CXCL11,CCL20,CXCL9,BDNF,CCL5
PMID:34039998	(2021) Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation.	7	38	1.33	0.00013	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000380252,9606.ENSP00000383232,9606.ENSP00000426809	SOX9,ONECUT1,CD34,HNF4A,NFE2L2,GGT1,PROM1
PMID:34165702	(2021) Biology of primary breast cancer in older women beyond routine biomarkers.	7	38	1.33	0.00013	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ALDH1A1,PTEN,AR,BCL2,CCL5,VEGFA
PMID:34185424	(2021) Emerging roles of exosomal miRNAs in diabetes mellitus.	7	38	1.33	0.00013	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000403495,9606.ENSP00000478570	THBS1,ATM,CD34,PTEN,GAP43,LTA,VEGFA
PMID:34209845	(2021) Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.	9	84	1.09	0.00013	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CD38,CD69,FABP4,CXCL10,CXCL11,CXCL9,MYD88,VEGFA
PMID:34220868	(2021) NLRC5: A Potential Target for Central Nervous System Disorders.	8	59	1.19	0.00013	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000345708,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	CXCL10,CXCL11,KCNJ11,JAK2,NFE2L2,BCL2,MYD88,BDNF
PMID:34222419	(2021) Roles of vitamin A in the regulation of fatty acid synthesis.	7	38	1.33	0.00013	9606.ENSP00000232219,9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000297785,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000360522	RBP1,FABP4,FADS2,ALDH1A1,SIRT6,SREBF1,RBP4
PMID:34326390	(2021) Ontology of the apelinergic system in mouse pancreas during pregnancy and relationship with beta-cell mass.	7	38	1.33	0.00013	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000362410,9606.ENSP00000363827,9606.ENSP00000475344	FABP4,THBS1,EDNRA,ELN,MAFB,HSPG2,APLNR
PMID:34440695	(2021) The Molecular Aspect of Nephrolithiasis Development.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:34443563	(2021) Biological Activities of Paeonol in Cardiovascular Diseases: A Review.	7	38	1.33	0.00013	9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000477707	ABCG1,PTGS2,PTEN,EDN1,NFE2L2,BCL2,NR1H3
PMID:34445701	(2021) CAR T-Cell Therapy in Hematological Malignancies.	7	38	1.33	0.00013	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	CD38,CD34,STAT5A,CD247,BCL2,PROM1,CCL5
PMID:34502424	(2021) The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb-A Summary Update.	8	59	1.19	0.00013	9606.ENSP00000013807,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,MPO,CDH1,PTGS2,NFE2L2,BCL2,RHOA,VEGFA
PMID:34627721	(2021) The role of NADPH oxidases in infectious and inflammatory diseases.	9	84	1.09	0.00013	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,CD247,CXCL9,NOX1,G6PD,MYD88,CCL5,VEGFA
PMID:34638506	(2021) Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma.	10	113	1.01	0.00013	9606.ENSP00000013807,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399	ERCC1,APC,IGF1R,ATM,CXCL11,PTEN,AR,JAK2,FGFR1,MYD88
PMID:34680193	(2021) (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers.	10	113	1.01	0.00013	9606.ENSP00000221930,9606.ENSP00000246553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,FFAR1,CXCL10,CXCL11,MMP14,SIRT6,PTEN,ANGPTL2,BDNF,VEGFA
PMID:34721017	(2021) Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach.	7	38	1.33	0.00013	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,MPO,IFNG,VDAC1,PTGS2,PTEN,BCL2
PMID:34769341	(2021) New Insight into Molecular and Hormonal Connection in Andrology.	7	38	1.33	0.00013	9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CD34,GAS6,ELN,AR,MYD88,PROM1,VEGFA
PMID:34775964	(2021) How cancer cells remodel lipid metabolism: strategies targeting transcription factors.	8	59	1.19	0.00013	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021	FABP4,ENPP2,THBS1,LPL,SREBF1,ABCG1,PTGS2,PTEN
PMID:34803430	(2021) Role of ginseng in the neurovascular unit of neuroinflammatory diseases focused on the blood-brain barrier.	8	59	1.19	0.00013	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	IGF1R,PDGFB,PTGS2,GAP43,NFE2L2,BDNF,MME,VEGFA
PMID:34836155	(2021) Beneficial Effects of Ursolic Acid and Its Derivatives-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.	8	59	1.19	0.00013	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000321334,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185	CETP,MPO,NOX4,LPA,ELN,PTEN,EDN1,BCL2
PMID:34858421	(2021) Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies.	7	38	1.33	0.00013	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,CAV1,ELN,BMP2,JAK2,BCL2,VEGFA
PMID:34917122	(2021) Non-Coding RNA Networks in Pulmonary Hypertension.	7	38	1.33	0.00013	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185	TIMP3,IGF1R,EDNRA,ELN,PTEN,EDN1,BCL2
PMID:34945101	(2021) Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells.	8	59	1.19	0.00013	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	CD38,ATM,CD34,HNF4A,STAT5A,PTEN,JAK2,BCL2
PMID:35011444	(2021) The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.	7	38	1.33	0.00013	9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000475344	CCR5,EDNRA,EDN1,NPY,AGTR1,CCL5,APLNR
PMID:35187110	(2021) Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.	8	59	1.19	0.00013	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000419422	NOX4,PLIN1,MAP3K5,PTGS2,AR,EDN1,G6PD,AGTR1
PMID:32040857	(2020) Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment.	7	38	1.33	0.00013	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CXCL10,CXCL11,CD34,CXCL9,MYD88,PROM1,CCL5
PMID:32133008	(2020) CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,PTGS2,EDN1,MYD88,CCL5
PMID:32458269	(2020) Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer.	8	59	1.19	0.00013	9606.ENSP00000259407,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000419313	BAAT,CDH1,VDAC1,HNF4A,CAV1,PTGS2,RHOA,TRPC1
PMID:32466439	(2020) The Use of Euterpe oleracea Mart. As a New Perspective for Disease Treatment and Prevention.	7	38	1.33	0.00013	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MPO,FABP4,LPL,SREBF1,PTGS2,BCL2,VEGFA
PMID:32511247	(2020) iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,EDN1,LTA,CCL5
PMID:32548074	(2020) Idiopathic CD4 Lymphocytopenia: Current Insights.	8	59	1.19	0.00013	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000418525	CD38,CD69,IFNG,CD34,STAT5A,BCL2,LTA,MME
PMID:32594047	(2020) Hub genes and key pathways of traumatic brain injury: bioinformatics analysis and in vivo validation.	7	38	1.33	0.00013	9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000368104	CYP24A1,TGFB1,CD38,NOX4,CXCL10,HNF4A,BMP2
PMID:32635472	(2020) Interleukin-1beta and Cancer.	10	113	1.01	0.00013	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000390651,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	PTGS2,PTEN,AR,EDN1,IRAK4,FGFR1,MYD88,PROM1,CCL5,VEGFA
PMID:32867057	(2020) Polyphenols by Generating H2O2, Affect Cell Redox Signaling, Inhibit PTPs and Activate Nrf2 Axis for Adaptation and Cell Surviving: In Vitro, In Vivo and Human Health.	7	38	1.33	0.00013	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000414303	NOX4,PTGS2,PTEN,NOX1,TXN,NFE2L2,BDNF
PMID:33062666	(2020) Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer.	9	84	1.09	0.00013	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,ATM,PTEN,NOX1,TXN,AR,BCL2,CCL5,VEGFA
PMID:33087723	(2020) Early-onset autoimmunity associated with SOCS1 haploinsufficiency.	8	59	1.19	0.00013	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000321853,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412	CD69,CXCL10,SERPINF2,STAT5A,CXCL9,JAK2,LTA,CCL5
PMID:33324646	(2020) Fibroblast Senescence in Idiopathic Pulmonary Fibrosis.	8	59	1.19	0.00013	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000381185	NOX4,CAV1,PTGS2,PTEN,NOX1,KL,JAK2,BCL2
PMID:30488311	(2019) A Review of Integrin-Mediated Endothelial Cell Phenotype in the Design of Cardiovascular Devices.	7	38	1.33	0.00013	9606.ENSP00000261037,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000360997,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	COL8A1,IGF1R,ELN,ADAMTS13,HSPG2,RHOA,VEGFA
PMID:30828977	(2019) An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.	7	38	1.33	0.00013	9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	FABP4,ATM,CXCL10,CD34,PTGS2,PROM1,VEGFA
PMID:31059004	(2019) Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells.	7	38	1.33	0.00013	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,TIMP3,ALDH1A1,CD34,ANG,PTEN,VEGFA
PMID:31110513	(2019) Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes.	10	113	1.01	0.00013	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,TIMP3,ANGPT2,CAV1,PTEN,AR,BCL2,RHOA,VEGFA
PMID:31300673	(2019) Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.	7	38	1.33	0.00013	9606.ENSP00000265132,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000477707	AMBP,CXCL9,S100A12,NOX1,TXN,NFE2L2,NR1H3
PMID:31410189	(2019) CD36 tango in cancer: signaling pathways and functions.	8	59	1.19	0.00013	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CAV1,CD47,PTEN,PROM1,VEGFA
PMID:31620359	(2019) Exosomes in Head and Neck Squamous Cell Carcinoma.	7	38	1.33	0.00013	9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CAV1,ENTPD1,PTEN,JAK2,RHOA,VEGFA
PMID:31720047	(2019) Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy.	7	38	1.33	0.00013	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL10,CXCL11,CD34,BCL2,CCL5,VEGFA
PMID:31798777	(2019) Non-coding RNA in drug resistance of gastric cancer.	9	84	1.09	0.00013	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,SOX9,CDH1,TIMP3,IGF1R,CAV1,PTEN,BCL2,RHOA
PMID:29346331	(2018) Growth Hormone (GH) and Cardiovascular System.	8	59	1.19	0.00013	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,CD34,EDN1,KL,NFE2L2,BDNF,PROM1,VEGFA
PMID:29562770	(2018) Human Amniotic Membrane and Amniotic Membrane-Derived Cells: How Far Are We from Their Use in Regenerative and Reconstructive Urology?	8	59	1.19	0.00013	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,TIMP3,CD34,ANGPT2,MME,PROM1,VEGFA
PMID:29651130	(2018) Targeting the tumour stroma to improve cancer therapy.	8	59	1.19	0.00013	9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	GAS6,CAV1,ELN,PTEN,AR,FGFR1,CCL5,VEGFA
PMID:29670239	(2018) Resistance of HIV-infected macrophages to CD8(+) T lymphocyte-mediated killing drives activation of the immune system.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,BCL2,CCL5
PMID:29970158	(2018) Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.	8	59	1.19	0.00013	9606.ENSP00000266085,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000363827,9606.ENSP00000478570	TIMP3,FMOD,ELN,CXCL9,PTGS2,ADAMTS13,HSPG2,VEGFA
PMID:30042330	(2018) Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?	8	59	1.19	0.00013	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,HNF4A,PTEN,JAK2,MYD88,PROM1
PMID:30079404	(2018) A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.	8	59	1.19	0.00013	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000298352,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,ATM,NGB,PTGS2,TXN,BCL2,BDNF,VEGFA
PMID:30257339	(2018) Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors.	7	38	1.33	0.00013	9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000380365,9606.ENSP00000381185	IGF1R,SREBF1,PTGS2,PTEN,NFE2L2,RGN,BCL2
PMID:30275839	(2018) Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics.	7	38	1.33	0.00013	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CD34,ANG,CXCL9,BMP2,BDNF,VEGFA
PMID:30619850	(2018) The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment.	9	84	1.09	0.00013	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,CCR5,STAT5A,CD247,G6PD,NFE2L2,CCL5,VEGFA
PMID:28154097	(2017) Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.	8	59	1.19	0.00013	9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,DDAH1,CAV1,ELN,EDN1,NTF3,RHOA,VEGFA
PMID:28538690	(2017) Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment.	9	84	1.09	0.00013	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412	CDH1,TIMP3,HNF4A,PDGFB,SREBF1,PTEN,BCL2,FGFR1,CCL5
PMID:28538838	(2017) Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer.	7	38	1.33	0.00013	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000376865,9606.ENSP00000478570	CDH1,TIMP3,MMP14,HNF4A,ELN,PDGFD,VEGFA
PMID:28576253	(2017) Stem Cells and Tissue Engineering: Regeneration of the Skin and Its Contents.	7	38	1.33	0.00013	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,ELN,BMP2,CCL5,VEGFA
PMID:28683107	(2017) Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues.	8	59	1.19	0.00013	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000363973,9606.ENSP00000397297,9606.ENSP00000414303	SOX9,CDH1,AMBP,CD34,CNTF,ALPL,NTF3,BDNF
PMID:28698459	(2017) Dietary Natural Products for Prevention and Treatment of Breast Cancer.	9	84	1.09	0.00013	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,CDH1,IGF1R,MMP14,SIRT6,JAK2,BCL2,RHOA,VEGFA
PMID:28729958	(2017) Mutational analysis of driver genes with tumor suppressive and oncogenic roles in gastric cancer.	8	59	1.19	0.00013	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,TIMP3,PTEN,AR,JAK2,RHOA,VEGFA
PMID:29140271	(2017) Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms.	7	38	1.33	0.00013	9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	GAS6,PTGS2,PTEN,JAK2,BCL2,FGFR1,VEGFA
PMID:27143920	(2016) Esophageal cancer stem cells and implications for future therapeutics.	7	38	1.33	0.00013	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809	TGFB1,SOX9,CDH1,ALDH1A1,PTGS2,BCL2,PROM1
PMID:27578545	(2016) Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis.	7	38	1.33	0.00013	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,PDGFB,CXCL9,CCL5
PMID:27641646	(2016) Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors.	8	59	1.19	0.00013	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CXCL11,CCL20,CXCL9,LTA,VEGFA
PMID:31656694	(2016) Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.	8	59	1.19	0.00013	9606.ENSP00000257430,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	APC,ALDH1A1,HNF4A,CD47,BCL2,RHOA,PROM1,VEGFA
PMID:25993296	(2015) A review of the pathophysiology and potential biomarkers for peripheral artery disease.	7	38	1.33	0.00013	9606.ENSP00000222572,9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000321334,9606.ENSP00000426809,9606.ENSP00000478570	PON2,CHI3L1,CD34,ANGPT2,LPA,PROM1,VEGFA
PMID:26414534	(2015) Skin telocytes versus fibroblasts: two distinct dermal cell populations.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ANG,CCL20,CXCL9,BDNF,CCL5,VEGFA
PMID:24336328	(2014) Protein kinase C and cancer: what we know and what we do not.	7	38	1.33	0.00013	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,CDH1,ATM,PTEN,BCL2,RHOA,VEGFA
PMID:24465925	(2014) From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract.	7	38	1.33	0.00013	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,NFE2L2,RHOA,CCL5,VEGFA
PMID:24778633	(2014) Neuro-endocrine networks controlling immune system in health and disease.	8	59	1.19	0.00013	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	CD38,CD69,IFNG,STAT5A,VIP,BCL2,NPY,BDNF
PMID:24812504	(2014) Cytokine inhibition in the treatment of COPD.	9	84	1.09	0.00013	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,CCL20,CXCL9,BAMBI,EDN1,FGFR1,VEGFA
PMID:24886588	(2014) Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-kappaB inhibition.	7	38	1.33	0.00013	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,NFE2L2,MYD88,CCL5,VEGFA
PMID:24974178	(2014) Reactive oxygen species in normal and tumor stem cells.	10	113	1.01	0.00013	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	CD38,NOX4,ATM,CD34,ELN,MAP3K5,PTEN,NOX1,TXN,BCL2
PMID:23435093	(2013) From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.	7	38	1.33	0.00013	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000354995	CETP,LPL,SIRT6,CAV1,PRKAA1,SREBF1,ABCG1
PMID:23766565	(2013) Pathogenesis of the metabolic syndrome: insights from monogenic disorders.	7	38	1.33	0.00013	9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000369816,9606.ENSP00000384364,9606.ENSP00000414303	PLIN1,HNF4A,CAV1,KCNJ11,SHBG,NPY,BDNF
PMID:23986795	(2013) T-Cell Signaling in HIV-1 Infection.	8	59	1.19	0.00013	9606.ENSP00000228434,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CHI3L1,CCR5,MAP3K5,PTEN,TXN,BCL2,CCL5
PMID:24119288	(2013) Sustained, neuron-specific IKKNF-kappaB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging.	7	38	1.33	0.00013	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	MAPK1,CXCL10,PTGS2,BCL2,NTF3,BDNF,CCL5
PMID:24353900	(2013) Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.	8	59	1.19	0.00013	9606.ENSP00000330382,9606.ENSP00000349860,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PDGFB,GFPT1,MAP3K5,PTEN,TXN,BCL2,BDNF,VEGFA
PMID:24649216	(2013) The biology of uterine sarcomas: A review and update.	8	59	1.19	0.00013	9606.ENSP00000261769,9606.ENSP00000283928,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,JAZF1,PTEN,AR,BCL2,FGFR1,MME,VEGFA
PMID:21669034	(2012) Stem cells decreased neuronal cell death after hypoxic stress in primary fetal rat neurons in vitro.	7	38	1.33	0.00013	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CXCL10,NTF3,BDNF,PROM1,CCL5,VEGFA
PMID:22247596	(2012) Physiological roles of NOXNADPH oxidase, the superoxide-generating enzyme.	9	84	1.09	0.00013	9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363596,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000445772,9606.ENSP00000478570	NOX4,STAT5A,PTEN,NOX1,CNR2,JAK2,BCL2,LTB4R2,VEGFA
PMID:22815692	(2012) Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever.	7	38	1.33	0.00013	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL11,CXCL9,BCL2,CCL5
PMID:22929101	(2012) Airway smooth muscle in asthma: just a target for bronchodilation?	7	38	1.33	0.00013	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000474412	CD38,CXCL10,ELN,VIP,HSPG2,RHOA,CCL5
PMID:21765856	(2011) Estrogen action and prostate cancer.	7	38	1.33	0.00013	9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	STAT5A,COMT,PTEN,AR,SHBG,BCL2,VEGFA
PMID:22096655	(2011) Using molecular markers to help predict who will fail after radical prostatectomy.	7	38	1.33	0.00013	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CDH1,CAV1,PTEN,AR,BCL2,VEGFA
PMID:22319466	(2011) gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.	7	38	1.33	0.00013	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303	CNTF,VIP,JAK2,GAP43,NPY,RHOA,BDNF
PMID:20627072	(2010) Tumors as organs: complex tissues that interface with the entire organism.	8	59	1.19	0.00013	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,CD34,PDGFB,PTEN,MYD88,PROM1,GREM1,VEGFA
PMID:20848566	(2010) Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation.	7	38	1.33	0.00013	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,RARRES2,CCL5
PMID:21383957	(2010) Deciphering the nuclear bile acid receptor FXR paradigm.	9	84	1.09	0.00013	9606.ENSP00000248553,9606.ENSP00000259407,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	HSPB1,BAAT,LPL,HNF4A,SREBF1,PTGS2,EDN1,BCL2,AGTR1
PMID:18684337	(2008) New molecular targets in angiogenic vessels of glioblastoma tumours.	8	59	1.19	0.00013	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,ANGPT2,PTGS2,HSPG2,FGFR1,PROM1,VEGFA
PMID:17183687	(2006) Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity.	7	38	1.33	0.00013	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000362463,9606.ENSP00000368104,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,GLO1,BMP2,CCL5
PMID:11733577	(2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.	7	38	1.33	0.00013	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000347041,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418525	TGFB1,CD38,CD69,FMOD,ENTPD1,BCL2,MME
PMID:34657251	(2022) The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword.	9	86	1.08	0.00014	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,PTGS2,PTEN,JAK2,BCL2,IRAK4,CCL5,VEGFA
PMID:34982799	(2022) Insertive condom-protected and condomless vaginal sex both have a profound impact on the penile immune correlates of HIV susceptibility.	6	22	1.5	0.00014	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901	CD69,CDH1,CCR5,CXCL10,CCL20,CXCL9
PMID:35053500	(2022) High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.	6	22	1.5	0.00014	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	ATM,PTEN,JAK2,BCL2,MYD88,MME
PMID:35159174	(2022) BMP9 Promotes an Epithelial Phenotype and a Hepatocyte-like Gene Expression Profile in Adult Hepatic Progenitor Cells.	6	22	1.5	0.00014	9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000383232,9606.ENSP00000480291	CDH1,ONECUT1,CD34,HNF4A,GGT1,HNF1B
PMID:35160284	(2022) Non-HLA Antibodies in Hand Transplant Recipients Are Connected to Multiple Acute Rejection Episodes and Endothelial Activation.	5	10	1.76	0.00014	9606.ENSP00000229135,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,EDNRA,EDN1,AGTR1,VEGFA
PMID:35214076	(2022) Manipulating MacrophageMicroglia Polarization to Treat Glioblastoma or Multiple Sclerosis.	8	60	1.19	0.00014	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IGF1R,CXCL10,ANGPT2,CD47,CCL5,VEGFA
PMID:35250546	(2022) Is Immune Suppression Involved in the Ischemic Stroke? A Study Based on Computational Biology.	7	39	1.32	0.00014	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000371067	MAPK1,IFNG,THBS1,STAT5A,PTEN,MAFB,JAK2
PMID:35252131	(2022) Decellularized Tissues for Wound Healing: Towards Closing the Gap Between Scaffold Design and Effective Extracellular Matrix Remodeling.	8	60	1.19	0.00014	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000321853,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478570	TGFB1,IFNG,THBS1,MMP14,SERPINF2,ELN,HSPG2,VEGFA
PMID:35269470	(2022) Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.	8	60	1.19	0.00014	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067	MPO,IFNG,CCR5,CXCL10,CCL20,CXCL9,EDN1,JAK2
PMID:35273595	(2022) The Lineage Differentiation and Dynamic Heterogeneity of Thymic Epithelial Cells During Thymus Organogenesis.	12	182	0.88	0.00014	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354511,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	SOX9,IGF1R,AQP5,CXCL10,CD34,CAV1,PDGFA,CCL20,COMT,CD247,CXCL9,CCL5
PMID:35408920	(2022) Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside.	6	22	1.5	0.00014	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000310520,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,ATM,LPL,ERCC4,BCL2,VEGFA
PMID:33429982	(2021) Cellular and Molecular Mechanisms of RS-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells.	9	86	1.08	0.00014	9606.ENSP00000228434,9606.ENSP00000301522,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CD69,PRDX2,LPL,STAT5A,EDN1,BCL2,MYD88,BDNF,VEGFA
PMID:33456775	(2021) Arrested development: suppression of NK cell function in the tumor microenvironment.	9	86	1.08	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD247,CXCL9,PTGS2,ENTPD1,CCL5,VEGFA
PMID:33567654	(2021) Pathological Circulating Factors in Moyamoya Disease.	6	22	1.5	0.00014	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CAV1,ELN,PTEN,PROM1,VEGFA
PMID:33716791	(2021) The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling.	7	39	1.32	0.00014	9606.ENSP00000360247,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CYP2J2,EDN1,JAK2,BCL2,RHOA,CCL5,VEGFA
PMID:33728021	(2021) Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application.	7	39	1.32	0.00014	9606.ENSP00000229135,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000477707	IFNG,HNF4A,SREBF1,NFE2L2,BCL2,MYD88,NR1H3
PMID:33808001	(2021) Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,PTEN,G6PD,NFE2L2,BCL2,RHOA,VEGFA
PMID:33816501	(2021) Non-Coding RNAs Steering the Senescence-Related Progress, Properties, and Application of Mesenchymal Stem Cells.	9	86	1.08	0.00014	9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000347041,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ATM,STAT5A,FMOD,PTEN,BMP2,NFE2L2,BCL2,RHOA,VEGFA
PMID:33852855	(2021) Chronic stress physically spares but functionally impairs innate-like invariant T cells.	9	86	1.08	0.00014	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CCL20,CD247,CXCL9,BCL2,NPY,CCL5,VEGFA
PMID:33863385	(2021) Signaling pathways governing breast cancer stem cells behavior.	9	86	1.08	0.00014	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,CD47,PTEN,BMP2,BCL2,PROM1,VEGFA
PMID:33917315	(2021) The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis.	7	39	1.32	0.00014	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478253,9606.ENSP00000478570	ATM,CD34,PDGFB,PTEN,BCL2,MTHFD1L,VEGFA
PMID:34068954	(2021) Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.	10	114	1.0	0.00014	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000363827,9606.ENSP00000369442,9606.ENSP00000377372,9606.ENSP00000393312	THBS1,CDH1,PRKCE,STAT5A,PTEN,AR,HSPG2,KL,GAP43,FGFR1
PMID:34124265	(2021) PD-1 Coexpression Gene Analysis and the Regulatory Network in Endometrial Cancer Based on Bioinformatics Analysis.	6	22	1.5	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD247,CXCL9,CCL5
PMID:34178980	(2021) Biological Function of Long Non-coding RNA (LncRNA) Xist.	11	147	0.94	0.00014	9606.ENSP00000215832,9606.ENSP00000312987,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,HNF4A,SGK1,PTEN,AR,ALPL,BMP2,JAK2,BCL2,VEGFA,HNF1B
PMID:34188448	(2021) Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,GAS6,JAK2,BCL2,PROM1,VEGFA
PMID:34207163	(2021) The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer.	10	114	1.0	0.00014	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000255409,9606.ENSP00000297785,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD69,CHI3L1,ALDH1A1,PDGFB,ANG,PTEN,RHOA,CCL5,VEGFA
PMID:34209703	(2021) Macrophage Polarization States in the Tumor Microenvironment.	9	86	1.08	0.00014	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,CD47,PTEN,MYD88,CCL5,VEGFA
PMID:34354950	(2021) Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.	10	115	1.0	0.00014	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ATM,ALDH1A1,CD34,ANGPT2,CD247,BCL2,MME,PROM1,VEGFA
PMID:34367778	(2021) Transformation of Polycythemia Vera to Pure Erythroid Leukemia.	5	10	1.76	0.00014	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000371067	MPO,CDH1,CD34,ELN,JAK2
PMID:34382326	(2021) Dehydrozingerone inhibits renal lipotoxicity in high-fat diet-induced obese mice.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,NOX4,SREBF1,NFE2L2,BCL2,VEGFA
PMID:34439112	(2021) Genetic Suppressor Element 1 (GSE1) Promotes the Oncogenic and Recurrent Phenotypes of Castration-Resistant Prostate Cancer by Targeting Tumor-Associated Calcium Signal Transducer 2 (TACSTD2).	7	39	1.32	0.00014	9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ANGPT2,PTEN,AR,ALPL,BCL2,PROM1,VEGFA
PMID:34439477	(2021) Proanthocyanidins and Where to Find Them: A Meta-Analytic Approach to Investigate Their Chemistry, Biosynthesis, Distribution, and Effect on Human Health.	9	85	1.09	0.00014	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000477707	FABP4,PLIN1,LPL,LPA,SREBF1,GFPT1,PTGS2,NFE2L2,NR1H3
PMID:34439492	(2021) Peroxiredoxins as Potential Targets for Cardiovascular Disease.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	IFNG,NOX4,PRDX2,NOX1,TXN,NFE2L2
PMID:34441754	(2021) Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,ANGPT2,PTEN,BCL2,VEGFA
PMID:34559064	(2021) Role of adipokines in embryo implantation.	7	39	1.32	0.00014	9606.ENSP00000225275,9606.ENSP00000346148,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	MPO,PRKAA1,CCL20,RBP4,RARRES2,APLNR,VEGFA
PMID:34692785	(2021) Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis.	9	85	1.09	0.00014	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,IGF1R,ATM,STAT5A,PDGFA,PTEN,IRAK4,MYD88,VEGFA
PMID:34712615	(2021) NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma.	8	60	1.19	0.00014	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:34760707	(2021) Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer.	10	114	1.0	0.00014	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CDH1,ATM,ALDH1A1,CAV1,JAK2,BCL2,RHOA,PROM1,VEGFA
PMID:34790572	(2021) Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA.	8	60	1.19	0.00014	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000297785,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000379256,9606.ENSP00000381185,9606.ENSP00000426809	ERCC1,MAPK1,ALDH1A1,ELN,PTEN,NCALD,BCL2,PROM1
PMID:34885161	(2021) Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology.	7	39	1.32	0.00014	9606.ENSP00000228434,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000360250,9606.ENSP00000426809,9606.ENSP00000478570	CD69,CHI3L1,CDH1,IGF1R,ENTPD1,PROM1,VEGFA
PMID:34943045	(2021) Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.	8	60	1.19	0.00014	9606.ENSP00000263317,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,ALDH1A1,PRDX2,PTEN,NOX1,TXN,NFE2L2,BCL2
PMID:34943879	(2021) Growth Hormone and IGF1 Actions in Kidney Development and Function.	7	39	1.32	0.00014	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000419422	EPOR,IGF1R,STAT5A,KL,JAK2,NPY,AGTR1
PMID:34944738	(2021) Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts.	8	60	1.19	0.00014	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,CAV1,AR,BAMBI,BCL2,LTA,MME,VEGFA
PMID:34956857	(2021) MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,ANGPT2,PDGFB,BCL2,FGFR1,VEGFA
PMID:34956981	(2021) An Overview of Vascular Dysfunction and Determinants: The Case of Children of African Ancestry.	6	22	1.5	0.00014	9606.ENSP00000309757,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	LPL,EDNRA,ELN,PTGS2,EDN1,VEGFA
PMID:34966385	(2021) Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19.	9	86	1.08	0.00014	9606.ENSP00000284031,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000478570,9606.ENSP00000484631	DDAH1,CD34,ANGPT2,SERPINF2,ANG,CAV1,ELN,VEGFA,PMP22
PMID:35096858	(2021) Oxidative Stress in Intestinal Ischemia-Reperfusion.	6	22	1.5	0.00014	9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	HNF4A,SIRT6,TXN,JAK2,BCL2,MYD88
PMID:35155408	(2021) Interleukin-1beta More Than Mechanical Loading Induces a Degenerative Phenotype in Human Annulus Fibrosus Cells, Partially Impaired by Anti-Proteolytic Activity of Mesenchymal Stem Cell Secretome.	7	39	1.32	0.00014	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000474412	TIMP3,CXCL10,CXCL11,CCL20,ELN,BCL2,CCL5
PMID:31483915	(2020) Redox control of vascular biology.	7	39	1.32	0.00014	9606.ENSP00000232219,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	RBP1,ELN,NOX1,TXN,EDN1,NFE2L2,VEGFA
PMID:31926020	(2020) Experimental animal models of coronary microvascular dysfunction.	6	22	1.5	0.00014	9606.ENSP00000221930,9606.ENSP00000309757,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000419422	TGFB1,LPL,EDNRA,PTGS2,EDN1,AGTR1
PMID:32103637	(2020) Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis.	7	39	1.32	0.00014	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000478570	CHI3L1,THBS1,CXCL10,ANGPT2,CXCL9,SAA1,VEGFA
PMID:32103897	(2020) Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases.	8	60	1.19	0.00014	9606.ENSP00000225275,9606.ENSP00000336762,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MPO,ANG,PRKAA1,PTEN,NFE2L2,MYD88,BDNF,VEGFA
PMID:32104185	(2020) Mesenchymal Stem Cells Combined with Tissue Fusion Technology Promoted Wound Healing in Porcine Bowel Anastomosis.	9	85	1.09	0.00014	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,IFNG,CXCL11,CD34,PTGS2,PTEN,ALPL,EDN1,VEGFA
PMID:32153726	(2020) Mitotic quiescence in hepatic cancer stem cells: An incognito mode.	6	22	1.5	0.00014	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000426809	CD38,ALDH1A1,CD34,GAS6,CD47,PROM1
PMID:32252490	(2020) Impact of Type 2 Diabetes Mellitus on Human Bone Marrow Stromal Cell Number and Phenotypic Characteristics.	7	39	1.32	0.00014	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CD34,ANGPT2,ANG,CCL20,CXCL9,CCL5
PMID:32273686	(2020) Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration.	6	22	1.5	0.00014	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PDGFB,PDGFA,BMP2,BCL2,BDNF,VEGFA
PMID:32274960	(2020) The role of TRPV1 channels in atherosclerosis.	7	39	1.32	0.00014	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000477707	NOX4,EDNRA,SIRT6,ELN,ABCG1,EDN1,NR1H3
PMID:32471255	(2020) The Proliferation and Differentiation of Adipose-Derived Stem Cells in Neovascularization and Angiogenesis.	9	85	1.09	0.00014	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000384364,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,FABP4,LPL,CD34,ANG,STAT5A,NPY,PROM1,VEGFA
PMID:32484226	(2020) Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats.	6	22	1.5	0.00014	9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,CCL20,CNTF,PROM1,CCL5,VEGFA
PMID:32549388	(2020) Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,GAS6,PTEN,JAK2,FGFR1,VEGFA
PMID:32595638	(2020) Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages.	9	86	1.08	0.00014	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,IGF1R,CXCL10,CCL20,PTEN,EDN1,JAK2,CCL5,VEGFA
PMID:32640839	(2020) Titanium dioxide nanoparticles exaggerate respiratory syncytial virus-induced airway epithelial barrier dysfunction.	7	39	1.32	0.00014	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:32678432	(2020) Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.	6	22	1.5	0.00014	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	MPO,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:32686306	(2020) The emerging role of fibroblast-like synoviocytes-mediated synovitis in osteoarthritis: An update.	9	85	1.09	0.00014	9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	APC,HNF4A,CCL20,MAP3K5,PTGS2,EDN1,JAK2,BDNF,VEGFA
PMID:32731620	(2020) Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers.	8	60	1.19	0.00014	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,LPL,STAT5A,SREBF1,JAK2,BCL2,RHOA,VEGFA
PMID:32798764	(2020) Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment.	9	86	1.08	0.00014	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,MMP14,ANG,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:32825327	(2020) Melatonins Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease.	6	22	1.5	0.00014	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	TGFB1,CXCL10,NFE2L2,BCL2,BDNF,CCL5
PMID:32843934	(2020) MicroRNA sequences modulating inflammation and lipid accumulation in macrophage foam cells: Implications for atherosclerosis.	10	115	1.0	0.00014	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MPO,MMP14,LPL,PRKAA1,SREBF1,PTGS2,NFE2L2,IRAK4,MYD88,CCL5
PMID:32875248	(2020) Dual Switch Mechanism of Erythropoietin as an Antiapoptotic and Pro-Angiogenic Determinant in the Retina.	7	39	1.32	0.00014	9606.ENSP00000222139,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,PTEN,TXN,JAK2,NFE2L2,BCL2,VEGFA
PMID:32887262	(2020) Lipid Phosphate Phosphatases and Cancer.	8	60	1.19	0.00014	9606.ENSP00000259486,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ENPP2,ALDH1A1,CAV1,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:32962103	(2020) Zoledronic Acid Abrogates Restraint Stress-Induced Macrophage Infiltration, PDGF-AA Expression, and Ovarian Cancer Growth.	6	22	1.5	0.00014	9606.ENSP00000255409,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,ANG,PDGFA,CCL20,CCL5,VEGFA
PMID:32998289	(2020) Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma.	11	147	0.94	0.00014	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000385834,9606.ENSP00000393312,9606.ENSP00000426809	TGFB1,MPO,CHI3L1,THBS1,TIMP3,ATM,PTGS2,PTEN,TF,FGFR1,PROM1
PMID:33042108	(2020) Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.	7	39	1.32	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,RARRES2,CCL5
PMID:33071776	(2020) Phytochemistry and Pharmacological Activities of Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb.	7	39	1.32	0.00014	9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495	CXCL10,GAS6,PTGS2,PTEN,BCL2,MYD88,LTA
PMID:33147758	(2020) Ocular Manifestations of West Nile Virus.	5	10	1.76	0.00014	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000364683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,BAMBI,CCL5,VEGFA
PMID:33194371	(2020) Differentially expressed serum proteins in children with or without asthma as determined using isobaric tags for relative and absolute quantitation proteomics.	7	39	1.32	0.00014	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000360997,9606.ENSP00000363973,9606.ENSP00000377192,9606.ENSP00000474412	MPO,CDH1,CCR5,ADAMTS13,ALPL,G6PD,CCL5
PMID:33291665	(2020) LKB1 Differently Regulates Adipogenesis in Intramuscular and Subcutaneous Adipocytes through Metabolic and Cytokine-Related Signaling Pathways.	10	114	1.0	0.00014	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000346148,9606.ENSP00000357726,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478319	TGFB1,FABP4,TIMP3,PLIN1,HNF4A,PRKAA1,S100A12,BMP2,JAK2,GREM1
PMID:33302608	(2020) Cannabinoids in Glaucoma Patients: The Never-Ending Story.	5	10	1.76	0.00014	9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000478570	PTGS2,CNR1,CNR2,EDN1,VEGFA
PMID:33327433	(2020) The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment.	9	85	1.09	0.00014	9606.ENSP00000226279,9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412	CD38,ENPP2,CCR5,CXCL10,STAT5A,CCL20,JAK2,LTA,CCL5
PMID:33376956	(2020) Cell-mediated immunity to SARS-CoV-2.	8	60	1.19	0.00014	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000474412	CD38,CXCL10,CXCL11,CD34,CCL20,ENTPD1,JAK2,CCL5
PMID:33456300	(2020) Osmotic regulation of aquaporin-8 expression in retinal pigment epithelial cells in vitro: Dependence on KATP channel activation.	7	39	1.32	0.00014	9606.ENSP00000221930,9606.ENSP00000293599,9606.ENSP00000345708,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000478570	TGFB1,AQP5,KCNJ11,PTGS2,SGK1,JAK2,VEGFA
PMID:30503767	(2019) Intratunical Injection of Human Adipose Tissue-Derived Stem Cells Restores Collagen IIII Ratio in a Rat Model of Chronic Peyronies Disease.	7	39	1.32	0.00014	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478319,9606.ENSP00000478570	TGFB1,THBS1,TIMP3,ELN,EDN1,GREM1,VEGFA
PMID:30565732	(2019) Minimally Invasive and Regenerative Therapeutics.	6	22	1.5	0.00014	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,IFNG,ELN,CNTF,BMP2,VEGFA
PMID:30827071	(2019) Mesenchymal stem cells for restoration of ovarian function.	6	22	1.5	0.00014	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,CD34,ANG,PTEN,EDN1,VEGFA
PMID:30941660	(2019) A Short Bout of Exercise Prior to Stroke Improves Functional Outcomes by Enhancing Angiogenesis.	5	10	1.76	0.00014	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANGPT2,EDN1,BDNF,VEGFA
PMID:30945363	(2019) Deciphering role of FGFR signalling pathway in pancreatic cancer.	8	60	1.19	0.00014	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,CDH1,MMP14,PTEN,KL,BCL2,FGFR1,VEGFA
PMID:31097342	(2019) Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.	7	39	1.32	0.00014	9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021	AMBP,CCR5,CXCL10,CXCL11,CXCL9,ENTPD1,PTEN
PMID:31276061	(2019) Significance of Cyclooxygenase-2 in Oncogenesis.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ANGPT2,ANG,CAV1,PTGS2,BCL2,VEGFA
PMID:31359618	(2019) Risk factors for hemorrhage of brain arteriovenous malformation.	6	22	1.5	0.00014	9606.ENSP00000248553,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000478570	HSPB1,ANGPT2,PDGFB,HSPG2,NFE2L2,VEGFA
PMID:31408324	(2019) Nanoparticle Interactions with the Tumor Microenvironment.	8	60	1.19	0.00014	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000360522,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,IGF1R,STAT5A,PTGS2,ENTPD1,RBP4,PROM1,VEGFA
PMID:31438555	(2019) Effect of Diet and Type of Pregnancy on Transcriptional Expression of Selected Genes in Sheep Mammary Gland.	6	22	1.5	0.00014	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IGF1R,ANGPT2,SREBF1,BCL2,VEGFA
PMID:31614569	(2019) Contextual Regulation of TGF-beta Signaling in Liver Cancer.	10	115	1.0	0.00014	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,MMP14,PDGFB,CAV1,STAT5A,PTEN,BAMBI,RHOA,PROM1,VEGFA
PMID:31658621	(2019) The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA.	6	22	1.5	0.00014	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000363973,9606.ENSP00000478570	CXCL10,CXCL11,ANG,CXCL9,ALPL,VEGFA
PMID:31683697	(2019) Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment.	8	60	1.19	0.00014	9606.ENSP00000215832,9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,ENPP2,THBS1,CAV1,NOX1,EDN1,RHOA,VEGFA
PMID:31712384	(2019) Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections.	6	22	1.5	0.00014	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412	CD69,IFNG,CCR5,CXCL10,CXCL11,CCL5
PMID:31817990	(2019) Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review.	8	60	1.19	0.00014	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,ATM,CCR5,SIRT6,SREBF1,NFE2L2,BCL2,VEGFA
PMID:31835680	(2019) Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases.	9	86	1.08	0.00014	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CDH1,ANGPT2,PTEN,NFE2L2,BCL2,BDNF,MME,VEGFA
PMID:31861720	(2019) Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.	9	86	1.08	0.00014	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	CD34,STAT5A,PTEN,JAK2,BCL2,PROM1,LTB4R2,CCL5,VEGFA
PMID:28290053	(2018) Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment.	6	22	1.5	0.00014	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000426809	CD38,THBS1,CD34,CD247,CD47,PROM1
PMID:29140564	(2018) beta-Catenin and interleukin-1beta-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis.	7	39	1.32	0.00014	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438	IFNG,CDH1,CXCL10,CXCL11,STAT5A,CXCL9,PTGS2
PMID:29500454	(2018) The effects of angiotensin receptor neprilysin inhibition by sacubitrilvalsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients.	6	22	1.5	0.00014	9606.ENSP00000200676,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000418525,9606.ENSP00000419422	CETP,FABP4,PLIN1,LPL,MME,AGTR1
PMID:29545397	(2018) Molecular transitions in early progenitors during human cord blood hematopoiesis.	8	60	1.19	0.00014	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000418525	MPO,CD38,AMBP,CD34,EBF1,STAT5A,CD247,MME
PMID:29629372	(2018) Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early [corrected] Diabetic Kidney Disease.	7	39	1.32	0.00014	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,EDNRA,PDGFB,SIRT6,NOX1,EDN1,VEGFA
PMID:29690901	(2018) CXCL91011, a regulator of PD-L1 expression in gastric cancer.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399	IFNG,CXCL10,CXCL11,CXCL9,PTEN,MYD88
PMID:29740333	(2018) Flavonoids in Kidney Health and Disease.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,PTGS2,EDN1,NFE2L2,BCL2,RHOA,PROM1
PMID:29871520	(2018) The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets.	7	39	1.32	0.00014	9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,CNTF,NFE2L2,BCL2,IRAK4,BDNF,VEGFA
PMID:29891783	(2018) Neuroprotective and Cognitive Enhancement Potentials of Baicalin: A Review.	8	60	1.19	0.00014	9606.ENSP00000225275,9606.ENSP00000355370,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	MPO,CNTF,SGK1,JAK2,NFE2L2,BCL2,MYD88,BDNF
PMID:29892750	(2018) An integrated global regulatory network of hematopoietic precursor cell self-renewal and differentiation.	8	60	1.19	0.00014	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000426809	MAPK1,TGFB1,MPO,CD34,MAPK7,PDGFA,BCL2,PROM1
PMID:30015675	(2018) Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis.	6	22	1.5	0.00014	9606.ENSP00000200676,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	CETP,CXCL10,CCL20,NOX1,CCL5,VEGFA
PMID:30093732	(2018) Diabetes induces fibrotic changes in the lung through the activation of TGF-beta signaling pathways.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412	CDH1,CXCL10,CAV1,CXCL9,BCL2,LTA,CCL5
PMID:30369883	(2018) Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity.	7	39	1.32	0.00014	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000477707	MAPK1,THBS1,TIMP3,PTEN,MYD88,AGTR1,NR1H3
PMID:30380628	(2018) Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression.	9	85	1.09	0.00014	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CDH1,CXCL10,PTGS2,JAK2,BCL2,MME,CCL5,VEGFA
PMID:30386740	(2018) CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors.	7	39	1.32	0.00014	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CD247,CXCL9,CCL5,VEGFA
PMID:30441761	(2018) Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment.	6	22	1.5	0.00014	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,JAK2,BCL2,PROM1,VEGFA
PMID:30505341	(2018) Pharmacological effects of medicinal components of Atractylodes lancea (Thunb.) DC.	8	60	1.19	0.00014	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000419313,9606.ENSP00000478570	MPO,PTGS2,PTEN,JAK2,BCL2,MYD88,TRPC1,VEGFA
PMID:30525080	(2018) Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CD34,BCL2,CCL5,VEGFA
PMID:30533416	(2018) Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges.	6	22	1.5	0.00014	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000321334,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368104	SOX9,ENPP2,LPA,ELN,PTEN,BMP2
PMID:30719023	(2018) Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.	8	60	1.19	0.00014	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000477707	CYP24A1,CDH1,IGF1R,CAV1,AR,JAK2,BCL2,NR1H3
PMID:28386296	(2017) High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study.	6	22	1.5	0.00014	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000381185	CXCL10,CD34,PDGFB,PDGFA,CXCL9,BCL2
PMID:28413025	(2017) Biochemical and Biological Attributes of Matrix Metalloproteinases.	9	85	1.09	0.00014	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,MMP14,ANG,ELN,PTGS2,NOX1,CCL5,VEGFA
PMID:28500309	(2017) Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.	6	22	1.5	0.00014	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000354511,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	TIMP3,MMP14,COMT,TXN,EDN1,VEGFA
PMID:28604601	(2017) Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases.	8	60	1.19	0.00014	9606.ENSP00000216181,9606.ENSP00000292303,9606.ENSP00000317674,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000474412	MYH9,CCR5,APOL1,MTHFR,JAK2,LTA,MME,CCL5
PMID:28736547	(2017) Thyroid Involvement in Hepatitis C Virus-Infected Patients withwithout Mixed Cryoglobulinemia.	5	10	1.76	0.00014	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185	IFNG,CXCL10,CXCL11,CXCL9,BCL2
PMID:28811575	(2017) Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency.	7	39	1.32	0.00014	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000474412	CD38,CXCL10,CD34,CXCL9,ALPL,BMP2,CCL5
PMID:28864539	(2017) Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.	7	39	1.32	0.00014	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	CD69,IFNG,CHI3L1,LPL,PTGS2,JAK2,VEGFA
PMID:28869579	(2017) Exploring the Role of RGD-Recognizing Integrins in Cancer.	8	60	1.19	0.00014	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,MMP14,CAV1,CCL20,BCL2,RHOA,VEGFA
PMID:28903453	(2017) The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.	10	114	1.0	0.00014	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570,9606.ENSP00000480291	HSPB1,CDH1,ATM,MAPK7,MAP3K5,TXN,BCL2,RHOA,VEGFA,HNF1B
PMID:28904399	(2017) Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells.	7	39	1.32	0.00014	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,AR,PROM1,VEGFA
PMID:29018573	(2017) How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.	7	39	1.32	0.00014	9606.ENSP00000228434,9606.ENSP00000297785,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000363822,9606.ENSP00000478570	CD69,ALDH1A1,CXCL9,CD47,ENTPD1,AR,VEGFA
PMID:29085221	(2017) Road to stemness in hepatocellular carcinoma.	10	115	1.0	0.00014	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CDH1,IGF1R,ALDH1A1,CD34,HNF4A,BCL2,PROM1,VEGFA,HNF1B
PMID:29088306	(2017) Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.	6	22	1.5	0.00014	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:29181035	(2017) The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche.	8	60	1.19	0.00014	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CD34,ANGPT2,CCL20,CCL5,VEGFA
PMID:29229985	(2017) Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm.	6	22	1.5	0.00014	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CCL20,ELN,CCL5,VEGFA
PMID:29348826	(2017) Interaction of macrophages with apoptotic cells inhibits transdifferentiation and invasion of lung fibroblasts.	8	60	1.19	0.00014	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000475344,9606.ENSP00000478570	THBS1,MMP14,CD47,PTGS2,PTEN,RHOA,APLNR,VEGFA
PMID:29375564	(2017) New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases.	9	86	1.08	0.00014	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CCL20,CXCL9,ABCG1,ENTPD1,BCL2,CCL5,VEGFA
PMID:32962323	(2017) Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes.	7	39	1.32	0.00014	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000354511,9606.ENSP00000362057,9606.ENSP00000368683	CETP,MPO,NOX4,EDNRA,COMT,NOX1,EDN1
PMID:26745377	(2016) Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain.	6	22	1.5	0.00014	9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	ANG,PTGS2,NTF3,LTA,BDNF,VEGFA
PMID:26880988	(2016) Glioma Stem Cells: Signaling, Microenvironment, and Therapy.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,CD34,PTEN,BMP2,PROM1,GREM1,VEGFA
PMID:26959737	(2016) MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.	6	22	1.5	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,IGF1R,MMP14,PTGS2,PTEN,BCL2
PMID:27000769	(2016) Emerging therapeutic targets in metastatic progression: A focus on breast cancer.	8	60	1.19	0.00014	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,CXCL10,PTEN,AR,FGFR1,CCL5,VEGFA
PMID:27026202	(2016) Targeting astrocytes in CNS injury and disease: A translational research approach.	7	39	1.32	0.00014	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303	IFNG,CXCL10,CNTF,PTEN,EDN1,NTF3,BDNF
PMID:27186261	(2016) Human lung cancer-derived microparticles enhanced angiogenesis and growth of hepatoma cells in rodent lung parenchyma.	5	10	1.76	0.00014	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTEN,BMP2,BCL2,VEGFA
PMID:27239288	(2016) Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances.	9	85	1.09	0.00014	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,ATM,HNF4A,PTEN,NFE2L2,FGFR1,PROM1,VEGFA
PMID:27651766	(2016) Treating spinal cord injury via sustained drug delivery from calcium phosphate coatings.	5	10	1.76	0.00014	9606.ENSP00000221930,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,BMP2,NTF3,BDNF,VEGFA
PMID:27658533	(2016) Mitigation of indomethacin-induced gastrointestinal damages in fat-1 transgenic mice via gate-keeper action of omega-3-polyunsaturated fatty acids.	7	39	1.32	0.00014	9606.ENSP00000246553,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185	FFAR1,NOX4,CAV1,CXCL9,PTGS2,NOX1,BCL2
PMID:27679576	(2016) Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells.	6	22	1.5	0.00014	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000426809	SOX9,ALDH1A1,ELN,VIP,BMP2,PROM1
PMID:27738492	(2016) Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes.	6	22	1.5	0.00014	9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	IGF1R,MAPK7,PTEN,AR,JAK2,BCL2
PMID:27847404	(2016) Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat.	5	10	1.76	0.00014	9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,BCL2,NTF3,BDNF,VEGFA
PMID:27872865	(2016) CXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimotos Thyroiditis Obtained by Fine Needle Aspiration Biopsy.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:27941650	(2016) Roles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin Diseases.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,CD34,CCL20,BCL2,VEGFA
PMID:28955931	(2016) Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema.	6	22	1.5	0.00014	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CXCL10,STAT5A,ELN,MYD88,CCL5
PMID:25634527	(2015) Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.	8	60	1.19	0.00014	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CCR5,ANGPT2,ANGPTL2,HSPG2,CCL5,VEGFA
PMID:25666933	(2015) Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.	6	22	1.5	0.00014	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000363596,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CNR2,RHOA,CCL5,VEGFA
PMID:25820137	(2015) Matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate inflammation and fever.	7	39	1.32	0.00014	9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	CXCL10,ELN,CXCL9,PLA2G2A,CCL5,NR1H3,VEGFA
PMID:25821590	(2015) Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.	7	39	1.32	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:25912019	(2015) Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.	6	22	1.5	0.00014	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CD34,STAT5A,CXCL9,JAK2,VEGFA
PMID:25961742	(2015) Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.	11	147	0.94	0.00014	9606.ENSP00000013807,9606.ENSP00000216181,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,MYH9,LAMC1,CDH1,ATM,CXCL10,CXCL11,PTEN,BCL2,FGFR1,VEGFA
PMID:25968128	(2015) Pathogenic pathways are activated in each major cell type of the glomerulus in the Cd2ap mutant mouse model of focal segmental glomerulosclerosis.	9	86	1.08	0.00014	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000352264,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CXCL10,PDGFB,PDGFA,ELN,CD2AP,CXCL9,EDN1,VEGFA
PMID:26000021	(2015) Endothelial progenitor cells in tumor angiogenesis: another brick in the wall.	8	60	1.19	0.00014	9606.ENSP00000216862,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CYP24A1,TGFB1,IFNG,CCR5,CD34,PROM1,CCL5,VEGFA
PMID:26346739	(2015) Deciphering Asthma Biomarkers with Protein Profiling Technology.	7	39	1.32	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ANG,CCL20,BDNF,CCL5,VEGFA
PMID:26369691	(2015) Wnt3a: functions and implications in cancer.	9	85	1.09	0.00014	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,CDH1,CD34,MAP3K5,AR,BCL2,MME,PROM1,VEGFA
PMID:26441489	(2015) Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.	7	39	1.32	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5,VEGFA
PMID:29051464	(2015) Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.	7	39	1.32	0.00014	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000310520,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	ERCC1,HSPB1,VDAC1,ERCC4,BCL2,NTF3,BDNF
PMID:23988267	(2014) Molecular mechanisms underlying chronic inflammation-associated cancers.	7	39	1.32	0.00014	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,CAV1,PTGS2,NOX1,BCL2,MYD88,VEGFA
PMID:24530608	(2014) Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies.	6	22	1.5	0.00014	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,MME,PROM1,VEGFA
PMID:24679494	(2014) Pathophysiology of portal hypertension.	5	10	1.76	0.00014	9606.ENSP00000339191,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000478570	CAV1,CNR2,EDN1,NPY,VEGFA
PMID:24713433	(2014) Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets.	7	39	1.32	0.00014	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CD34,CD47,PTEN,AR,BCL2,PROM1
PMID:24727247	(2014) The Multifunctional Protein Kinase C-epsilon in Cancer Development and Progression.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000306124,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,VDAC1,PRKCE,CD34,CAV1,BCL2,RHOA
PMID:24743778	(2014) Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.	8	60	1.19	0.00014	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,CXCL10,STAT5A,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:24744125	(2014) Hypothalamic subependymal niche: a novel site of the adult neurogenesis.	7	39	1.32	0.00014	9606.ENSP00000245479,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000426809	SOX9,CNTF,PTGS2,HSPG2,NPY,BDNF,PROM1
PMID:24787290	(2014) Interferons and their stimulated genes in the tumor microenvironment.	9	86	1.08	0.00014	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,JAK2,BCL2,MYD88,CCL5,VEGFA
PMID:24959828	(2014) Genetic association study with metabolic syndrome and metabolic-related traits in a cross-sectional sample and a 10-year longitudinal sample of chinese elderly population.	6	22	1.5	0.00014	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000418823	WFS1,JAZF1,LPL,KCNJ11,MTHFR,FTO
PMID:25025934	(2014) Endothelial cells in dengue hemorrhagic fever.	7	39	1.32	0.00014	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,CXCL9,RHOA,CCL5,VEGFA
PMID:25163502	(2014) Mammalian gut immunity.	8	60	1.19	0.00014	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,CXCL10,CCL20,CXCL9,CD47,PTGS2,MYD88,CCL5
PMID:25243154	(2014) Noncoding RNAs as novel biomarkers in prostate cancer.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	CDH1,PRKCE,MAPK7,CAV1,PTEN,AR,BCL2
PMID:25919031	(2014) Human adipose-tissue derived stromal cells in combination with hypoxia effectively support ex vivo expansion of cord blood haematopoietic progenitors.	6	22	1.5	0.00014	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	CD38,CXCL10,CD34,CXCL9,PROM1,CCL5
PMID:23316962	(2013) Matrix metalloproteinases: drug targets for myocardial infarction.	7	39	1.32	0.00014	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000478570	MPO,THBS1,TIMP3,MMP14,CD34,ELN,VEGFA
PMID:23351141	(2013) Radiosensitization in prostate cancer: mechanisms and targets.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTGS2,PTEN,BCL2,VEGFA
PMID:23431350	(2013) Predicting in silico which mixtures of the natural products of plants might most effectively kill human leukemia cells?	6	22	1.5	0.00014	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,IGF1R,MMP14,AR,BCL2,RHOA
PMID:23800466	(2013) In vitro models of angiogenesis and vasculogenesis in fibrin gel.	5	10	1.76	0.00014	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,PDGFB,PROM1,VEGFA
PMID:23843792	(2013) Surgical Approaches Based on Biological Objectives: GTR versus GBR Techniques.	5	10	1.76	0.00014	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,PDGFB,BMP2,BDNF,VEGFA
PMID:23852423	(2013) Chemoprevention of colon and small intestinal tumorigenesis in APC(min+) mice by SHetA2 (NSC721689) without toxicity.	5	10	1.76	0.00014	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	APC,CDH1,PTGS2,BCL2,VEGFA
PMID:23878592	(2013) BlueBerry Isolate, Pterostilbene, Functions as a Potential Anticancer Stem Cell Agent in Suppressing Irradiation-Mediated Enrichment of Hepatoma Stem Cells.	5	10	1.76	0.00014	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,CD34,BCL2,PROM1
PMID:23890064	(2013) Deciphering and reversing tumor immune suppression.	8	60	1.19	0.00014	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,EDNRA,CXCL9,EDN1,CCL5,VEGFA
PMID:23903048	(2013) Angiogenesis-related pathways in the pathogenesis of ovarian cancer.	7	39	1.32	0.00014	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	ANGPT2,PDGFB,STAT5A,PDGFA,PDGFD,FGFR1,VEGFA
PMID:24015303	(2013) The interaction of endothelin-1 and TGF-beta1 mediates vascular cell remodeling.	5	10	1.76	0.00014	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683	MAPK1,TGFB1,EDNRA,PTGS2,EDN1
PMID:24069584	(2013) Melanoma biomolecules: independently identified but functionally intertwined.	8	60	1.19	0.00014	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,ENPP2,CAV1,ELN,PTEN,BCL2,RHOA,VEGFA
PMID:24189842	(2013) Immune mechanisms in medium and large-vessel vasculitis.	7	39	1.32	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,EDN1,CCL5
PMID:24422025	(2013) MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas.	8	60	1.19	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	CDH1,IGF1R,CXCL11,MAPK7,PTEN,BCL2,RHOA,AGTR1
PMID:21466438	(2012) The chemopreventive and chemotherapeutic potentials of tea polyphenols.	9	86	1.08	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,MMP14,COMT,PTGS2,PTEN,EDN1,BCL2,VEGFA
PMID:22113482	(2012) An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155.	5	10	1.76	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:22426080	(2012) Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.	8	60	1.19	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CXCL9,VIP,MYD88,CCL5,VEGFA
PMID:22503040	(2012) Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis.	5	10	1.76	0.00014	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,CCL5,VEGFA
PMID:22633458	(2012) The chemokine superfamily revisited.	8	60	1.19	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,RARRES2,CCL5,VEGFA
PMID:22640827	(2012) Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.	7	39	1.32	0.00014	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,TIMP3,CXCL10,CXCL9,CCL5,VEGFA
PMID:22768217	(2012) Microarray analyses of inflammation response of human dermal fibroblasts to different strains of Borrelia burgdorferi sensu stricto.	7	39	1.32	0.00014	9606.ENSP00000261037,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	COL8A1,CXCL10,CCL20,ELN,CXCL9,CCL5,VEGFA
PMID:22811904	(2012) Extracellular matrix proteins modulate antimigratory and apoptotic effects of Doxorubicin.	6	22	1.5	0.00014	9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CD47,PTEN,AR,RHOA,VEGFA
PMID:22969117	(2012) Paracrine signaling between carcinoma cells and mesenchymal stem cells generates cancer stem cell niche via epithelial-mesenchymal transition.	6	22	1.5	0.00014	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,HNF4A,PTGS2,PROM1,VEGFA
PMID:23087045	(2012) Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinsons disease.	6	22	1.5	0.00014	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	IFNG,CNTF,GAP43,BCL2,RHOA,BDNF
PMID:24791250	(2012) Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	CDH1,CXCL10,CD34,ANGPT2,CXCL9,PTGS2,VEGFA
PMID:21552384	(2011) Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.	6	22	1.5	0.00014	9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000418525,9606.ENSP00000478570	PTGS2,AR,BCL2,HPSE,MME,VEGFA
PMID:21687401	(2011) Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?	8	60	1.19	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CXCL9,PTGS2,MYD88,CCL5,VEGFA
PMID:21840986	(2011) Comparison of increased aromatase versus ERalpha in the generation of mammary hyperplasia and cancer.	6	22	1.5	0.00014	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185	CDH1,IGF1R,STAT5A,PTGS2,G6PD,BCL2
PMID:22558051	(2011) Implication of stem cells in the biology and therapy of head and neck cancer.	7	39	1.32	0.00014	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,ALDH1A1,CD34,MME,PROM1,VEGFA
PMID:23154658	(2011) Correlative studies on the effects of obesity, diabetes and hypertension on gene expression in omental adipose tissue of obese women.	8	60	1.19	0.00014	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,PLIN1,LPL,RBP4,EDN1,PLA2G2A,CCL5,VEGFA
PMID:20022691	(2010) Cross-talk between miRNA and Notch signaling pathways in tumor development and progression.	7	39	1.32	0.00014	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PTEN,AR,PDGFD,BCL2,PROM1,VEGFA
PMID:20161779	(2010) Investigation of type 2 diabetes risk alleles support CDKN2AB, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.	6	22	1.5	0.00014	9606.ENSP00000226760,9606.ENSP00000264717,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,GCKR,JAZF1,KCNJ11,FTO,HNF1B
PMID:20409732	(2010) Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.	7	39	1.32	0.00014	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:20493838	(2010) Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy.	5	10	1.76	0.00014	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,TIMP3,CD34,PROM1,VEGFA
PMID:20576802	(2010) Novel targets for prostate cancer chemoprevention.	8	60	1.19	0.00014	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CDH1,IGF1R,CXCL9,PTEN,AR,BCL2,VEGFA
PMID:20671917	(2010) Extracellular matrix proteins and tumor angiogenesis.	7	39	1.32	0.00014	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,TIMP3,MMP14,ELN,CD47,PTEN,VEGFA
PMID:20688584	(2010) Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.	6	22	1.5	0.00014	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CD34,PTEN,AR,BCL2,PROM1
PMID:20727227	(2010) Bench to bedside: A role for erythropoietin in sepsis.	6	22	1.5	0.00014	9606.ENSP00000222139,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	EPOR,MAP3K5,EDN1,JAK2,BCL2,PROM1
PMID:20862220	(2010) Contrasting roles for TLR ligands in HIV-1 pathogenesis.	6	22	1.5	0.00014	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,ENTPD1,CCL5
PMID:20977782	(2010) Growth factor regulation of proliferation and survival of multipotential stromal cells.	8	60	1.19	0.00014	9606.ENSP00000257430,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	APC,PDGFB,PDGFA,BMP2,PDGFD,BCL2,BDNF,VEGFA
PMID:21078198	(2010) Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma.	7	39	1.32	0.00014	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185	TGFB1,CDH1,IGF1R,STAT5A,CD47,PTEN,BCL2
PMID:21081221	(2010) Cardiovascular effects of erythropoietin an update.	6	22	1.5	0.00014	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,CD34,EDN1,JAK2,PROM1,VEGFA
PMID:19462957	(2009) Pharmacologic and chemical adjuvants in tumor virotherapy.	7	39	1.32	0.00014	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ATM,CXCL11,CXCL9,MYD88,CCL5,VEGFA
PMID:18316578	(2008) Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.	5	10	1.76	0.00014	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	THBS1,ANGPT2,PDGFB,PDGFA,VEGFA
PMID:18640567	(2008) The E. Donnall Thomas lecture: normal and neoplastic stem cells.	6	22	1.5	0.00014	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CD34,HNF4A,CD47,JAK2,BCL2
PMID:18704688	(2008) Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge.	6	22	1.5	0.00014	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MPO,THBS1,PTGS2,CCL5,GREM1,VEGFA
PMID:18728788	(2008) Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.	9	85	1.09	0.00014	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CD34,STAT5A,CXCL9,LTA,PROM1,CCL5,VEGFA
PMID:18941244	(2008) Differential regulation of chemokines by IL-17 in colonic epithelial cells.	5	10	1.76	0.00014	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CCL5
PMID:17404688	(2007) Progesterone regulation of implantation-related genes: new insights into the role of oestrogen.	8	60	1.19	0.00014	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000474412	CXCL10,MMP14,PDGFB,PDGFA,PTGS2,EDN1,FGFR1,CCL5
PMID:17026465	(2006) Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.	5	10	1.76	0.00014	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CCL5,VEGFA
PMID:17118216	(2006) Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.	7	39	1.32	0.00014	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000403495,9606.ENSP00000478570	TGFB1,IFNG,LPL,ELN,HSPG2,LTA,VEGFA
PMID:10992426	(2000) CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.	5	10	1.76	0.00014	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTEN,AR,BCL2,VEGFA
PMID:35020865	(2022) Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.	9	87	1.08	0.00015	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000403495	CD69,CDH1,CXCL10,CXCL11,CXCL9,EDN1,JAK2,NPY,LTA
PMID:35251985	(2022) The Role of Mesenchymal Stem Cells in the Induction of Cancer-Stem Cell Phenotype.	8	61	1.18	0.00015	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000474412	MPO,CDH1,CXCL10,PTGS2,AR,BMP2,PROM1,CCL5
PMID:35309354	(2022) Role of the CXCL13CXCR5 Axis in Autoimmune Diseases.	9	87	1.08	0.00015	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	CD38,CCR5,CXCL10,CXCL11,HNF4A,CCL20,CXCL9,PTEN,VEGFA
PMID:33199179	(2021) Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19.	9	87	1.08	0.00015	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CCR5,CXCL10,CXCL11,CXCL9,AGTR1,CCL5,VEGFA
PMID:33214719	(2021) Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.	9	87	1.08	0.00015	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CDH1,CCR5,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:33477916	(2021) The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.	9	87	1.08	0.00015	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	MPO,CD34,PTGS2,PTEN,BMP2,JAK2,BCL2,VEGFA,HNF1B
PMID:33669749	(2021) Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer.	9	87	1.08	0.00015	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,ATM,PRKCE,PTEN,AR,BCL2,RHOA,VEGFA
PMID:33736695	(2021) Mesenchymal stemstromal cells as a valuable source for the treatment of immune-mediated disorders.	9	87	1.08	0.00015	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,CXCL10,MMP14,CD34,PDGFA,PTGS2,CCL5,VEGFA
PMID:33748128	(2021) Role of Lipid Metabolism and Signaling in Mammalian Oocyte Maturation, Quality, and Acquisition of Competence.	8	61	1.18	0.00015	9606.ENSP00000348069,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000369442,9606.ENSP00000369816,9606.ENSP00000375844,9606.ENSP00000381185,9606.ENSP00000418823	SREBF1,CD47,AR,KL,SHBG,CAPN10,BCL2,FTO
PMID:34041240	(2021) Macro, Micro, and Molecular. Changes of the Osteochondral Interface in Osteoarthritis Development.	8	61	1.18	0.00015	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,THBS1,TIMP3,CD34,PDGFA,NTF3,BDNF,VEGFA
PMID:34168918	(2021) miR-940 is a new biomarker with tumor diagnostic and prognostic value.	8	61	1.18	0.00015	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,CDH1,STAT5A,PTEN,BCL2,RHOA,MYD88,VEGFA
PMID:34199761	(2021) The Many Faces of Innate Immunity in SARS-CoV-2 Infection.	8	61	1.18	0.00015	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000419422,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL11,CXCL9,ENTPD1,AGTR1,VEGFA
PMID:34220496	(2021) The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.	8	61	1.18	0.00015	9606.ENSP00000221930,9606.ENSP00000321853,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000384957,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422	TGFB1,SERPINF2,NOX1,EDN1,F11,RHOA,MME,AGTR1
PMID:34278470	(2021) Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review).	9	87	1.08	0.00015	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	SOX9,NOX4,CD34,PTGS2,NOX1,BMP2,IRAK4,RHOA,MYD88
PMID:34336089	(2021) Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits.	11	149	0.93	0.00015	9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,ENPP2,CDH1,ATM,PTEN,AR,BCL2,MYD88,BDNF,PROM1,VEGFA
PMID:34337083	(2021) Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.	9	87	1.08	0.00015	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CAV1,CXCL9,PTGS2,BCL2,FGFR1,MME,CCL5,VEGFA
PMID:34360720	(2021) Signals and Mechanisms Regulating Monocyte and Macrophage Activation in the Pathogenesis of Juvenile Idiopathic Arthritis.	8	61	1.18	0.00015	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,CCL20,S100A12,JAK2,MYD88,CCL5,VEGFA
PMID:34540684	(2021) The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma.	10	116	1.0	0.00015	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000360997,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312	MAPK1,CDH1,TIMP3,CXCL10,HNF4A,ADAMTS13,PTEN,AR,JAK2,FGFR1
PMID:34603210	(2021) The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium.	8	61	1.18	0.00015	9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356729,9606.ENSP00000358513,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,LPL,SREBF1,FMO3,CNR1,EDN1,MYD88,VEGFA
PMID:34831211	(2021) Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs.	9	87	1.08	0.00015	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CDH1,IGF1R,PTGS2,PTEN,BMP2,RHOA,AGTR1,VEGFA
PMID:34895148	(2021) Regulatory modules of human thermogenic adipocytes: functional genomics of large cohort and Meta-analysis derived marker-genes.	10	116	1.0	0.00015	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000477707	TGFB1,NOX4,ALDH1A1,PLIN1,LPL,PTEN,AR,BDNF,FTO,NR1H3
PMID:34900955	(2021) Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering.	8	61	1.18	0.00015	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANG,CD47,ENTPD1,ADAMTS13,BMP2,PROM1,VEGFA
PMID:32503281	(2020) Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions.	8	61	1.18	0.00015	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,CAV1,PTGS2,EDN1,RHOA,MME,AGTR1,VEGFA
PMID:32649623	(2020) Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.	8	61	1.18	0.00015	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175	NOX4,ELN,PTGS2,NOX1,TXN,EDN1,NFE2L2,RHOA
PMID:32963568	(2020) Deciphering the Underlying Mechanism of Eucommiae Cortex against Osteoporotic Fracture by Network Pharmacology.	8	61	1.18	0.00015	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000474412	MAPK1,IFNG,PDGFB,GAS6,STAT5A,EDN1,NFE2L2,CCL5
PMID:33035814	(2020) Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2M in HepG2 hepatocarcinoma cells.	9	87	1.08	0.00015	9606.ENSP00000227868,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000278840,9606.ENSP00000301522,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252	PDHX,NOX4,ATM,FADS2,PRDX2,NOX1,TXN,JAK2,NFE2L2
PMID:33060592	(2020) Transplantation of hPSC-derived pericyte-like cells promotes functional recovery in ischemic stroke mice.	9	87	1.08	0.00015	9606.ENSP00000216181,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000355370,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MYH9,EDNRA,PDGFB,CNTF,HSPG2,EDN1,NTF3,BDNF,VEGFA
PMID:33110061	(2020) Progress in the mechanism and targeted drug therapy for COPD.	9	87	1.08	0.00015	9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000356213,9606.ENSP00000363641,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	SIRT6,ELN,MAP3K5,VIP,TXN,BAMBI,EDN1,CCL5,VEGFA
PMID:33193730	(2020) Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases.	11	149	0.93	0.00015	9606.ENSP00000200676,9606.ENSP00000256104,9606.ENSP00000306124,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000345708,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000418823	CETP,FABP4,PRKCE,LPL,HNF4A,SIRT6,KCNJ11,PDGFA,SREBF1,NOX1,FTO
PMID:33211409	(2020) Gene expression responses to Zika virus infection in peripheral blood mononuclear cells from pregnant and non-pregnant women.	11	148	0.93	0.00015	9606.ENSP00000221930,9606.ENSP00000306884,9606.ENSP00000346148,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000477707	TGFB1,CXCL11,PRKAA1,CCL20,CXCL9,EDN1,JAK2,BCL2,MYD88,CCL5,NR1H3
PMID:33212873	(2020) Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies.	8	61	1.18	0.00015	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CD34,CNTF,GAP43,NTF3,MYD88,BDNF,VEGFA
PMID:33327496	(2020) Examination of Oral Squamous Cell Carcinoma and Precancerous Lesions Using Proximity Extension Assay and Salivary RNA Quantification.	8	61	1.18	0.00015	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,SAA1,BDNF,CCL5
PMID:30332889	(2019) Resveratrol: Twenty Years of Growth, Development and Controversy.	8	61	1.18	0.00015	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,CAV1,PTGS2,PTEN,NOX1,BCL2,VEGFA
PMID:30669615	(2019) Facets of Theilers Murine Encephalomyelitis Virus-Induced Diseases: An Update.	9	87	1.08	0.00015	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL9,ENTPD1,HSPG2,BCL2,MYD88,CCL5,VEGFA
PMID:31003534	(2019) The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents.	9	87	1.08	0.00015	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,ATM,PTEN,AR,JAK2,BCL2,RHOA,VEGFA
PMID:31092698	(2019) Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response.	8	61	1.18	0.00015	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,CD34,ALPL,PROM1,CCL5,VEGFA
PMID:31440236	(2019) Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies.	8	61	1.18	0.00015	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,HSPB1,CDH1,IGF1R,ELN,PTEN,BCL2,VEGFA
PMID:31805958	(2019) Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.	10	116	1.0	0.00015	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000258341,9606.ENSP00000265333,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000363641	MAPK1,MPO,CHI3L1,LAMC1,VDAC1,ALDH1A1,PRDX2,GAS6,CAV1,TXN
PMID:31921102	(2019) More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.	9	87	1.08	0.00015	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,HSPB1,CCR5,CXCL10,STAT5A,JAK2,BCL2,CCL5,VEGFA
PMID:29389895	(2018) Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.	12	185	0.87	0.00015	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,CDH1,ATM,ALDH1A1,HNF4A,PTEN,AR,BMP2,MYD88,PROM1,VEGFA,HNF1B
PMID:29477046	(2018) Redox control of cancer cell destruction.	8	61	1.18	0.00015	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,MAP3K5,CD47,PTEN,NOX1,TXN,NFE2L2,VEGFA
PMID:29568199	(2018) Functional macrophages and gastrointestinal disorders.	8	61	1.18	0.00015	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000478570	MPO,CHI3L1,CXCL10,VIP,BMP2,MYD88,LTA,VEGFA
PMID:29568751	(2018) Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action.	8	61	1.18	0.00015	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ALDH1A1,HNF4A,MAP3K5,PTGS2,PTEN,BCL2,VEGFA
PMID:29946544	(2018) Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.	9	87	1.08	0.00015	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,ANGPT2,PTEN,HSPG2,JAK2,MYD88,CCL5,VEGFA
PMID:30061485	(2018) The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer.	9	87	1.08	0.00015	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PTGS2,PTEN,TXN,BMP2,BCL2,RHOA,PROM1,VEGFA
PMID:30208623	(2018) Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling.	8	61	1.18	0.00015	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,CD34,HNF4A,STAT5A,JAK2,BCL2,VEGFA
PMID:27872477	(2017) The role of GATA2 in lethal prostate cancer aggressiveness.	8	61	1.18	0.00015	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000479617	MAPK1,IGF1R,PTEN,AR,BMP2,EDN1,BCL2,UHRF1
PMID:28154473	(2017) Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.	9	87	1.08	0.00015	9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000356213,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	HSPB1,STAT5A,VIP,JAK2,NPY,MYD88,BDNF,MME,CCL5
PMID:28418909	(2017) Pathogenesis of ETV6RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.	8	61	1.18	0.00015	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	EPOR,CD38,CD34,EBF1,STAT5A,JAK2,BCL2,MME
PMID:28421078	(2017) Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.	9	87	1.08	0.00015	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,STAT5A,CXCL9,MTHFR,BCL2,HPSE,CCL5
PMID:28008279	(2016) Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment.	8	61	1.18	0.00015	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CD34,CXCL9,PTGS2,CCL5,VEGFA
PMID:25887408	(2015) Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinoma.	10	116	1.0	0.00015	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000444198,9606.ENSP00000478570	CDH1,TIMP3,ATM,MMP14,CCL20,PTEN,MYD88,PROM1,CITED2,VEGFA
PMID:26177309	(2015) Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.	9	87	1.08	0.00015	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	THBS1,TIMP3,IGF1R,HNF4A,CAV1,HSPG2,RHOA,MYD88,CCL5
PMID:26313265	(2015) High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.	8	61	1.18	0.00015	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,BCL2,VEGFA
PMID:24467887	(2014) Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?	8	61	1.18	0.00015	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,MMP14,CCL20,ELN,CXCL9,CCL5,VEGFA
PMID:24722453	(2014) The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.	8	61	1.18	0.00015	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CDH1,IGF1R,CNTF,PTEN,AR,BCL2,VEGFA
PMID:24924700	(2014) Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.	9	87	1.08	0.00015	9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,VDAC1,IGF1R,MAPK7,MAP3K5,EDN1,BCL2,RHOA,VEGFA
PMID:24949228	(2014) Childhood B-acute lymphoblastic leukemia: a genetic update.	8	61	1.18	0.00015	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	EPOR,CD38,CD34,EBF1,STAT5A,JAK2,BCL2,MME
PMID:25483671	(2014) CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6-8 2014, Mainz, Germany.	8	61	1.18	0.00015	9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,GAS6,CCL20,CD247,CXCL9,MYD88,CCL5,VEGFA
PMID:25484899	(2014) Emerging Targets in Pituitary Adenomas: Role of the CXCL12CXCR4-R7 System.	8	61	1.18	0.00015	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,CXCL9,VIP,RHOA,VEGFA
PMID:25526965	(2014) Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells.	8	61	1.18	0.00015	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANG,ELN,CXCL9,HSPG2,CCL5,VEGFA
PMID:23918298	(2013) Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.	8	61	1.18	0.00015	9606.ENSP00000215832,9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,EDNRA,AR,BMP2,EDN1,NPY,BDNF,VEGFA
PMID:22634835	(2012) Embryonic stem cell markers.	9	87	1.08	0.00015	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CD38,CDH1,IGF1R,ALDH1A1,CD34,HNF4A,PROM1,VEGFA,HNF1B
PMID:22683550	(2012) Role of apoptosis in disease.	8	61	1.18	0.00015	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495	MAPK1,CCR5,MAP3K5,PTGS2,PTEN,BCL2,MYD88,LTA
PMID:19876833	(2010) Critical growth factors and signalling pathways controlling human trophoblast invasion.	9	87	1.08	0.00015	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,MMP14,MAPK7,STAT5A,PTEN,JAK2,RHOA,VEGFA
PMID:34523036	(2022) Leptin as a key regulator of the adipose organ.	7	40	1.3	0.00016	9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000384364,9606.ENSP00000478570	PLIN1,LPL,ANGPT2,CAV1,SREBF1,NPY,VEGFA
PMID:35033157	(2022) Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension.	9	88	1.07	0.00016	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	EDNRA,CAV1,STAT5A,MAP3K5,EDN1,BCL2,RHOA,GREM1,VEGFA
PMID:35055129	(2022) Secretome from Human Mesenchymal Stem Cells-Derived Endothelial Cells Promotes Wound Healing in a Type-2 Diabetes Mouse Model.	6	23	1.48	0.00016	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	CD34,ANGPT2,ANG,ELN,EDN1,VEGFA
PMID:35159244	(2022) Tendon Immune Regeneration: Insights on the Synergetic Role of Stem and Immune Cells during Tendon Regeneration.	9	88	1.07	0.00016	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CD69,TIMP3,CXCL10,CD34,ELN,CXCL9,PTGS2,CCL5,VEGFA
PMID:35163420	(2022) Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer.	10	117	0.99	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,GAS6,CXCL9,CD47,PTGS2,JAK2,MYD88,CCL5,VEGFA
PMID:35203661	(2022) Functional Phenotypes of Intraplaque Macrophages and Their Distinct Roles in Atherosclerosis Development and Atheroinflammation.	9	88	1.07	0.00016	9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000334329,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000362410,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,GAS6,UNC5B,ABCG1,CD47,MAFB,NFE2L2,CCL5,VEGFA
PMID:35222703	(2022) Inhibition of thioredoxin-interacting protein may enhance the therapeutic effect of dehydrocostus lactone in cardiomyocytes under doxorubicin stimulation via the inhibition of the inflammatory response.	6	23	1.48	0.00016	9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000401399	CXCL11,CXCL9,PTGS2,TXN,NFE2L2,MYD88
PMID:35248081	(2022) The importance of miRNA-630 in human diseases with an especial focus on cancers.	7	40	1.3	0.00016	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	TGFB1,CDH1,IGF1R,ATM,PTEN,JAK2,BCL2
PMID:35267480	(2022) Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy.	8	62	1.17	0.00016	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000393312,9606.ENSP00000478570,9606.ENSP00000480291	CHI3L1,CCR5,ANGPT2,PDGFB,CD47,FGFR1,VEGFA,HNF1B
PMID:35270026	(2022) Prenatal Hypoxia Affects Foetal Cardiovascular Regulatory Mechanisms in a Sex- and Circadian-Dependent Manner: A Review.	7	40	1.3	0.00016	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,NOX4,AR,EDN1,NFE2L2,AGTR1,VEGFA
PMID:35327584	(2022) Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.	9	88	1.07	0.00016	9606.ENSP00000255409,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,ATM,CCR5,STAT5A,SREBF1,CD47,PTEN,CCL5,VEGFA
PMID:35348977	(2022) Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,P2RY1,PTGS2,MTHFR,BCL2,BDNF,CCL5
PMID:35360215	(2022) Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review.	8	62	1.17	0.00016	9606.ENSP00000221930,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000351671,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,AMBP,CXCL10,LPA,CCL20,GAP43,BDNF,VEGFA
PMID:35422689	(2022) The Obese Brain: Mechanisms of Systemic and Local Inflammation, and Interventions to Reverse the Cognitive Deficit.	8	62	1.17	0.00016	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,CXCL10,CXCL9,PTGS2,NOX1,JAK2,BDNF,VEGFA
PMID:33336112	(2021) Challenges and strategies for in situ endothelialization and long-term lumen patency of vascular grafts.	6	23	1.48	0.00016	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ELN,PTEN,LTA,PROM1,VEGFA
PMID:33482868	(2021) Obesity, leptin, and deregulation of microRNA in lipid metabolisms: their contribution to breast cancer prognosis.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,MAPK7,PTEN,SHBG,JAK2,BCL2,VEGFA
PMID:33507685	(2021) EZB-ICR Cell Line: A New Established and Characterized Oral Squamous Cell Carcinoma Cell Line From Tongue.	6	23	1.48	0.00016	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000474412	CD69,CCR5,CXCL10,CD34,MME,CCL5
PMID:33672590	(2021) Molecular and Biochemical Pathways of Catalpol in Alleviating Diabetes Mellitus and Its Complications.	9	88	1.07	0.00016	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000475344,9606.ENSP00000478570	THBS1,NOX4,IGF1R,CAV1,PTEN,BCL2,RHOA,APLNR,VEGFA
PMID:33753717	(2021) Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis.	9	88	1.07	0.00016	9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,PDGFB,UNC5B,CAV1,PTGS2,BMP2,RHOA,GREM1,VEGFA
PMID:33802077	(2021) Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.	7	40	1.3	0.00016	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000354782,9606.ENSP00000478570	CD69,CCR5,CXCL10,ANGPT2,ANG,CD247,VEGFA
PMID:33807389	(2021) miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.	8	62	1.17	0.00016	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	APC,CDH1,TIMP3,MMP14,PTGS2,PTEN,BCL2,VEGFA
PMID:33859619	(2021) Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells.	8	62	1.17	0.00016	9606.ENSP00000221930,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000427424	TGFB1,KLF10,CXCL10,HNF4A,PDGFB,CCL20,PTGS2,TNFAIP8
PMID:33907575	(2021) Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development.	6	23	1.48	0.00016	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057	TGFB1,IFNG,CDH1,PTGS2,PTEN,NOX1
PMID:33918297	(2021) Comprehensive Profiling of Secretome Formulations from Fetal- and Perinatal Human Amniotic Fluid Stem Cells.	7	40	1.3	0.00016	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000363827,9606.ENSP00000377192,9606.ENSP00000414303	THBS1,MMP14,ANGPT2,ANG,HSPG2,G6PD,BDNF
PMID:33921348	(2021) The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer.	8	62	1.17	0.00016	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,CDH1,IGF1R,HNF4A,PTEN,BCL2,FGFR1,VEGFA
PMID:33924941	(2021) The Endothelium Is Both a Target and a Barrier of HDLs Protective Functions.	7	40	1.3	0.00016	9606.ENSP00000225275,9606.ENSP00000304767,9606.ENSP00000321334,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000478570	MPO,P2RY1,LPA,CAV1,ABCG1,PTGS2,VEGFA
PMID:33925380	(2021) Polysaccharide-Based Materials Created by Physical Processes: From Preparation to Biomedical Applications.	6	23	1.48	0.00016	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478570	PDGFB,PDGFA,ELN,BMP2,FGFR1,VEGFA
PMID:33937352	(2021) Chronic Thromboembolic Pulmonary Hypertension - What Have We Learned From Large Animal Models.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175	IFNG,NOX4,EDNRA,NOX1,BCL2,RHOA
PMID:33946224	(2021) SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,HNF4A,PTEN,MAFB,AR,NFE2L2,BCL2,VEGFA
PMID:33972733	(2021) A biomechanical switch regulates the transition towards homeostasis in oesophageal epithelium.	8	62	1.17	0.00016	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000356438	SOX9,THBS1,CDH1,IGF1R,MMP14,CAV1,PDGFA,PTGS2
PMID:34007408	(2021) Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent Prostates.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000418525	CDH1,NOX4,DDAH1,PTGS2,RHOA,MME
PMID:34020704	(2021) Mesenchymal stemstromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.	9	88	1.07	0.00016	9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000402152,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	ANG,PTGS2,PTEN,PDGFD,BCL2,SLC12A3,BDNF,CCL5,VEGFA
PMID:34064823	(2021) Modulations of Cardiac Functions and Pathogenesis by Reactive Oxygen Species and Natural Antioxidants.	7	40	1.3	0.00016	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	NOX4,NOX1,TXN,EDN1,NFE2L2,BCL2,MYD88
PMID:34072636	(2021) Bee Pollen: Current Status and Therapeutic Potential.	6	23	1.48	0.00016	9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000477707	SREBF1,EDN1,NFE2L2,BCL2,BDNF,NR1H3
PMID:34073983	(2021) Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System.	8	62	1.17	0.00016	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363641,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	IFNG,PTGS2,CNR1,TXN,GAP43,NFE2L2,BCL2,BDNF
PMID:34147519	(2021) Interferon-Gamma-Producing CD8(+) Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.	8	62	1.17	0.00016	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CD69,IFNG,STAT5A,CCL20,JAK2,BCL2,CCL5
PMID:34149462	(2021) Modeling the Glomerular Filtration Barrier and Intercellular Crosstalk.	6	23	1.48	0.00016	9606.ENSP00000311005,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000352264,9606.ENSP00000368683,9606.ENSP00000478570	MAPK7,EDNRA,PDGFB,CD2AP,EDN1,VEGFA
PMID:34169095	(2021) An Overview of RNA-Based Scaffolds for Osteogenesis.	6	23	1.48	0.00016	9606.ENSP00000245479,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,ELN,BMP2,JAK2,VEGFA,HNF1B
PMID:34258292	(2021) Association of HLA-B Gene Polymorphisms with Type 2 Diabetes in Pashtun Ethnic Population of Khyber Pakhtunkhwa, Pakistan.	6	23	1.48	0.00016	9606.ENSP00000226760,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,HNF4A,KCNJ11,CAPN10,FTO,HNF1B
PMID:34276353	(2021) Protective Effects and Network Analysis of Ginsenoside Rb1 Against Cerebral Ischemia Injury: A Pharmacological Review.	6	23	1.48	0.00016	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000414303	NOX4,MAP3K5,PTEN,NOX1,BCL2,BDNF
PMID:34279440	(2021) Targeting the PI3KAKTmTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CAV1,SGK1,PTEN,BCL2,PROM1,VEGFA
PMID:34335703	(2021) Th2Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726	IFNG,CXCL10,CXCL11,CCL20,CXCL9,S100A12
PMID:34341712	(2021) Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimers Disease and Its Neuropsychiatric Symptoms.	8	62	1.17	0.00016	9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,PTGS2,AR,G6PD,NFE2L2,LTA,BDNF,VEGFA
PMID:34356321	(2021) Oxidative-Signaling in Neural Stem Cell-Mediated Plasticity: Implications for Neurodegenerative Diseases.	8	62	1.17	0.00016	9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,PTEN,JAK2,NFE2L2,BCL2,NTF3,BDNF,VEGFA
PMID:34445479	(2021) The CellBox-2 Mission to the International Space Station: Thyroid Cancer Cells in Space.	8	62	1.17	0.00016	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,IFNG,FABP4,CXCL11,ANGPT2,CAV1,RHOA,VEGFA
PMID:34497344	(2021) Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.	6	23	1.48	0.00016	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000368104	SOX9,NOX4,CAV1,S100A12,NOX1,BMP2
PMID:34608214	(2021) Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops.	7	40	1.3	0.00016	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000357726,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,SGK1,S100A12,CCL5
PMID:34715776	(2021) ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,IGF1R,ATM,ANGPT2,PTEN,BCL2
PMID:34762274	(2021) The aging venous system: from varicosities to vascular cognitive impairment.	7	40	1.3	0.00016	9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384957,9606.ENSP00000478570	TIMP3,SIRT6,ELN,NFE2L2,BCL2,F11,VEGFA
PMID:34766151	(2021) Current therapeutic strategies for respiratory diseases using mesenchymal stem cells.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL11,CXCL9,EDN1,CCL5,VEGFA
PMID:34776000	(2021) Bone regeneration in rat calvarial defects using dissociated or spheroid mesenchymal stromal cells in scaffold-hydrogel constructs.	6	23	1.48	0.00016	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,ALPL,BMP2,CCL5,VEGFA
PMID:34776968	(2021) The Impact of Inflammatory Immune Reactions of the Vascular Niche on Organ Fibrosis.	8	62	1.17	0.00016	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478570	SOX9,NOX4,MMP14,PDGFB,SIRT6,BMP2,EDN1,VEGFA
PMID:34884604	(2021) Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.	6	23	1.48	0.00016	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419422	NOX4,CD34,EDN1,RHOA,MME,AGTR1
PMID:34885647	(2021) Cynanchum auriculatum Royle ex Wight., Cynanchum bungei Decne. and Cynanchum wilfordii (Maxim.) Hemsl.: Current Research and Prospects.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,MAPK7,VIP,EDN1,BCL2,MYD88,VEGFA
PMID:34916489	(2021) COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors.	7	40	1.3	0.00016	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000475344	MPO,FABP4,SREBF1,RBP4,SHBG,BDNF,APLNR
PMID:35004308	(2021) HIF-1alpha Is a Rational Target for Future Ovarian Cancer Therapies.	7	40	1.3	0.00016	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	ENPP2,CDH1,ATM,MMP14,PTEN,JAK2,VEGFA
PMID:31852220	(2020) Retinoids Repress Human Cardiovascular Cell Calcification With Evidence for Distinct Selective Retinoid Modulator Effects.	6	23	1.48	0.00016	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000321334,9606.ENSP00000363973	SOX9,ALDH1A1,LPL,HNF4A,LPA,ALPL
PMID:32381656	(2020) Epigenetic Attire in Ovarian Cancer: The Emperors New Clothes.	7	40	1.3	0.00016	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,ALDH1A1,CXCL10,STAT5A,CXCL9,CCL5,VEGFA
PMID:32397183	(2020) Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.	8	62	1.17	0.00016	9606.ENSP00000216181,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000418525	MYH9,THBS1,CDH1,CAV1,PTEN,G6PD,BCL2,MME
PMID:32439888	(2020) Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.	7	40	1.3	0.00016	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:32486019	(2020) The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin.	7	40	1.3	0.00016	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,CD47,PTGS2,NFE2L2,BCL2,VEGFA
PMID:32509781	(2020) Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer.	9	88	1.07	0.00016	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000427424,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,GAS6,STAT5A,PTGS2,JAK2,TNFAIP8,CCL5,VEGFA
PMID:32562483	(2020) Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.	7	40	1.3	0.00016	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	CD38,CD69,FABP4,CXCL10,CD34,STAT5A,JAK2
PMID:32577155	(2020) microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance.	8	62	1.17	0.00016	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000477707	IGF1R,ATM,SREBF1,ABCG1,PTGS2,PTEN,BCL2,NR1H3
PMID:32587858	(2020) Use of Stem Cell Extracellular Vesicles as a Holistic Approach to CNS Repair.	10	117	0.99	0.00016	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CD34,PTEN,GAP43,NPY,RHOA,MYD88,BDNF,MME,VEGFA
PMID:32704466	(2020) Picornavirus Cellular Remodeling: Doubling Down in Response to Viral-Induced Inflammation.	7	40	1.3	0.00016	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CXCL11,CXCL9,HSPG2,CCL5,VEGFA
PMID:32793228	(2020) Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade.	9	88	1.07	0.00016	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,CD247,CXCL9,PTGS2,CCL5,GREM1,VEGFA
PMID:32843914	(2020) Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species.	9	88	1.07	0.00016	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000426809	MPO,CDH1,VDAC1,CXCL10,CAV1,CD47,NOX1,BCL2,PROM1
PMID:32847060	(2020) Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors.	9	88	1.07	0.00016	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000347041,9606.ENSP00000351671,9606.ENSP00000363827,9606.ENSP00000478570	IFNG,CDH1,IGF1R,MMP14,STAT5A,FMOD,CCL20,HSPG2,VEGFA
PMID:32855763	(2020) Detrimental Effects of UVB on Retinal Pigment Epithelial Cells and Its Role in Age-Related Macular Degeneration.	8	62	1.17	0.00016	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000347041,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,ATM,PRDX2,FMOD,PTEN,JAK2,BCL2,VEGFA
PMID:32903374	(2020) Therapeutic Effects and Mechanisms of Herbal Medicines for Treating Polycystic Ovary Syndrome: A Review.	7	40	1.3	0.00016	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,PTEN,AR,SHBG,BCL2,BDNF,VEGFA
PMID:32917932	(2020) A comprehensive p75 neurotrophin receptor gene network and pathway analyses identifying new target genes.	7	40	1.3	0.00016	9606.ENSP00000215832,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,CNTF,PTEN,JAK2,NTF3,RHOA,BDNF
PMID:32973458	(2020) Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis.	9	88	1.07	0.00016	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000419422,9606.ENSP00000474412	MPO,CD38,CCR5,CXCL10,GAS6,CXCL9,CNTF,AGTR1,CCL5
PMID:32974219	(2020) CD103 Promotes the Pro-inflammatory Response of Gastric Resident CD4(+) T Cell in Helicobacter pylori-Positive Gastritis.	7	40	1.3	0.00016	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901	CD69,CDH1,CCR5,CXCL10,CXCL11,CD247,CXCL9
PMID:33114738	(2020) ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance.	7	40	1.3	0.00016	9606.ENSP00000226279,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000418525,9606.ENSP00000478570	CD38,PRDX2,CD34,NOX1,TXN,MME,VEGFA
PMID:33121202	(2020) Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy.	7	40	1.3	0.00016	9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	TIMP3,ANGPT2,ANG,PTEN,JAK2,FGFR1,VEGFA
PMID:33142233	(2020) Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses.	9	88	1.07	0.00016	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000426809	MYH9,SOX9,CDH1,ATM,AR,BCL2,FGFR1,MME,PROM1
PMID:33266427	(2020) Rubi Fructus Water Extract Alleviates LPS-Stimulated Macrophage Activation via an ER Stress-Induced CalciumCHOP Signaling Pathway.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,JAK2,CCL5,VEGFA
PMID:33370269	(2020) Increased prostaglandin-D2 in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation.	7	40	1.3	0.00016	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000322898,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000480291	FABP4,PLIN1,EBF1,PTGS2,AR,BMP2,HNF1B
PMID:33376577	(2020) A Positive Feed Forward Loop between Wntbeta-Catenin and NOX4 Promotes Silicon Dioxide-Induced Epithelial-Mesenchymal Transition of Lung Epithelial Cells.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185	CDH1,NOX4,HNF4A,NOX1,NFE2L2,BCL2
PMID:33553157	(2020) Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy.	9	88	1.07	0.00016	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,IGF1R,CXCL10,PTGS2,AR,JAK2,MME,CCL5,VEGFA
PMID:33604295	(2020) Obesity, Type 2 Diabetes, and Cancer Risk.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,CD34,SREBF1,ABCG1,SHBG,BCL2,VEGFA
PMID:30149103	(2019) Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.	9	88	1.07	0.00016	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,NOX4,TIMP3,MMP14,STAT5A,ELN,EDN1,CCL5,VEGFA
PMID:30392076	(2019) The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.	6	23	1.48	0.00016	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CDH1,CD47,NOX1,EDN1,VEGFA
PMID:30705774	(2019) Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,TXN,EDN1,JAK2,BCL2,BDNF,VEGFA
PMID:30836719	(2019) Comprehensive Analysis of Differentially Expressed mRNA, lncRNA and circRNA and Their ceRNA Networks in the Longissimus Dorsi Muscle of Two Different Pig Breeds.	7	40	1.3	0.00016	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000322898,9606.ENSP00000349860,9606.ENSP00000381185,9606.ENSP00000480291	TGFB1,FABP4,IGF1R,EBF1,GFPT1,BCL2,HNF1B
PMID:30887097	(2019) Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.	8	62	1.17	0.00016	9606.ENSP00000245479,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000381185	SOX9,GAS6,ELN,SGK1,ALPL,BMP2,KL,BCL2
PMID:30923583	(2019) Transcriptional response of cultured porcine intestinal epithelial cells to micro algae extracts in the presence and absence of enterotoxigenic Escherichia coli.	8	62	1.17	0.00016	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000474412	IFNG,THBS1,AMBP,CCL20,ELN,PTGS2,NFE2L2,CCL5
PMID:30931508	(2019) Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.	9	88	1.07	0.00016	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,CCR5,CD34,CD47,ENTPD1,PTEN,CCL5,VEGFA
PMID:30934676	(2019) Mechanisms of Adiponectin Action in Fertility: An Overview from Gametogenesis to Gestation in Humans and Animal Models in Normal and Pathological Conditions.	8	62	1.17	0.00016	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000288266,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000369816	IFNG,CDH1,APPL1,LPL,STAT5A,SREBF1,PTEN,SHBG
PMID:30971897	(2019) Emerging Role of Schwann Cells in Neuropathic Pain: Receptors, Glial Mediators and Myelination.	6	23	1.48	0.00016	9606.ENSP00000222139,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000397297,9606.ENSP00000414303	EPOR,MMP14,PTGS2,NOX1,NTF3,BDNF
PMID:31136958	(2019) Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer.	6	23	1.48	0.00016	9606.ENSP00000301522,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252	PRDX2,SGK1,PTEN,TXN,AR,NFE2L2
PMID:31187898	(2019) Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.	8	62	1.17	0.00016	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000369442,9606.ENSP00000478570	NOX4,ANGPT2,PDGFB,NOX1,TXN,MTHFR,KL,VEGFA
PMID:31266770	(2019) Innate alphabeta T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming.	9	88	1.07	0.00016	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000322898,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CD38,CD69,AMBP,CCR5,CXCL10,EBF1,CXCL9,ENTPD1,CCL5
PMID:31323735	(2019) HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension.	6	23	1.48	0.00016	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000321853,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000384957	CETP,LPL,SERPINF2,ABCG1,EDN1,F11
PMID:31416282	(2019) Endothelial Ca(2+) Signaling, Angiogenesis and Vasculogenesis: just What It Takes to Make a Blood Vessel.	9	88	1.07	0.00016	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000419313,9606.ENSP00000478570	CD38,THBS1,CXCL10,CAV1,CD47,KL,FGFR1,TRPC1,VEGFA
PMID:31547472	(2019) CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.	9	88	1.07	0.00016	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000401399	CD38,CXCL10,CD34,STAT5A,CD247,CXCL9,CD47,JAK2,MYD88
PMID:31642043	(2019) An Overview of Novel Unconventional Mechanisms of Hematopoietic Development and Regulators of Hematopoiesis - a Roadmap for Future Investigations.	7	40	1.3	0.00016	9606.ENSP00000222139,9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,P2RY1,CD34,BMP2,NPY,PROM1,VEGFA
PMID:31766220	(2019) Deciphering Molecular Mechanism of the Neuropharmacological Action of Fucosterol through Integrated System Pharmacology and In Silico Analysis.	7	40	1.3	0.00016	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	MAPK1,TGFB1,SREBF1,ABCG1,NFE2L2,BCL2,BDNF
PMID:27777083	(2018) Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.	8	62	1.17	0.00016	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,STAT5A,CD247,PTGS2,PTEN,JAK2,MYD88,VEGFA
PMID:28965082	(2018) Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.	6	23	1.48	0.00016	9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	CD34,MAP3K5,PTGS2,TXN,BCL2,VEGFA
PMID:29416702	(2018) Drug resistance related to aberrant glycosylation in colorectal cancer.	9	88	1.07	0.00016	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000349860,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,ALDH1A1,GFPT1,MTHFR,NFE2L2,BCL2,PROM1,VEGFA
PMID:29514202	(2018) Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness.	8	62	1.17	0.00016	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000368104,9606.ENSP00000369442	MYH9,SOX9,FABP4,NOX4,ELN,S100A12,BMP2,KL
PMID:29522457	(2018) Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.	7	40	1.3	0.00016	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,CDH1,PTEN,ANGPTL2,JAK2,RHOA,VEGFA
PMID:29662007	(2018) MicroRNAs as Potential Regulators of Glutathione Peroxidases Expression and Their Role in Obesity and Related Pathologies.	7	40	1.3	0.00016	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175	FABP4,IGF1R,MAPK7,PTGS2,TXN,NFE2L2,RHOA
PMID:29719625	(2018) Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions.	6	23	1.48	0.00016	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,RARRES2,CCL5
PMID:30013421	(2018) Decidualization of the human endometrium.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000478570	IFNG,ANGPT2,ANG,ELN,SGK1,VEGFA
PMID:30040046	(2018) Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity.	9	88	1.07	0.00016	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000384906	MAPK1,HSPB1,ATM,SIRT6,MAP3K5,TXN,G6PD,BCL2,SAA1
PMID:30087224	(2018) Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis.	7	40	1.3	0.00016	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000478570	MPO,CD38,CAV1,SREBF1,ABCG1,EDN1,VEGFA
PMID:30165256	(2018) Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection.	7	40	1.3	0.00016	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CXCL9,JAK2,BCL2,VEGFA
PMID:30355249	(2018) Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.	8	62	1.17	0.00016	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000475344,9606.ENSP00000478570	FABP4,THBS1,IGF1R,CAV1,ABCG1,EDN1,APLNR,VEGFA
PMID:30387323	(2018) The peripheral immune response after stroke-A double edge sword for blood-brain barrier integrity.	8	62	1.17	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000321853,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CCR5,CXCL10,SERPINF2,CAV1,CXCL9,BCL2,RHOA,VEGFA
PMID:30406100	(2018) StemProgenitor Cells and Their Therapeutic Application in Cardiovascular Disease.	6	23	1.48	0.00016	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,CD34,EDN1,JAK2,PROM1,VEGFA
PMID:30410607	(2018) Roles of Smads Family and Alternative Splicing Variants of Smad4 in Different Cancers.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,PTEN,AR,BMP2,BCL2,VEGFA
PMID:30417008	(2018) The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.	7	40	1.3	0.00016	9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000352264,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,CAV1,CCL20,CD2AP,BCL2,RHOA,VEGFA
PMID:30425237	(2018) Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000366395,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,CD34,CCL20,PTEN,SYVN1,CCL5,VEGFA
PMID:30475828	(2018) Compensatory regrowth of the mouse bladder after partial cystectomy.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CD34,CXCL9,LTA,CCL5
PMID:30483151	(2018) Regulation of Renal Differentiation by Trophic Factors.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478319,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,MAPK7,ANGPT2,PTEN,FGFR1,GREM1,VEGFA,HNF1B
PMID:30544955	(2018) Nutrition and Cardiovascular Health.	8	62	1.17	0.00016	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CETP,MPO,IFNG,PTGS2,RBP4,LTA,CCL5,VEGFA
PMID:30622654	(2018) Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.	9	88	1.07	0.00016	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,HNF4A,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:27717961	(2017) Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.	8	62	1.17	0.00016	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,CCL20,CXCL9,PTGS2,LTA,VEGFA
PMID:28251486	(2017) The 23 (rd) Scientific Conference of the Society on Neuroimmune Pharmacology: Program and Abstracts.	13	225	0.82	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000383232,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,SREBF1,PTGS2,CNR2,BCL2,GGT1,SAA1,IRAK4,MYD88,BDNF,CCL5,VEGFA
PMID:28396037	(2017) Antecedents and correlates of blood concentrations of neurotrophic growth factors in very preterm newborns.	6	23	1.48	0.00016	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,ANGPT2,SAA1,BDNF,CCL5,VEGFA
PMID:28532298	(2017) CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.	8	62	1.17	0.00016	9606.ENSP00000215832,9606.ENSP00000227868,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000285407,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,PDHX,APC,CDH1,ATM,KLF10,PTEN,BCL2
PMID:28740436	(2017) The effect of apatinib in the treatment of metastatic renal cell carcinoma: a case report and review of the literature.	6	23	1.48	0.00016	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	CD34,PDGFB,PTGS2,RHOA,MME,VEGFA
PMID:28757546	(2017) Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.	8	62	1.17	0.00016	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,MMP14,CD34,CD47,PTGS2,EDN1,PROM1,VEGFA
PMID:28783167	(2017) Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTEN,BCL2,VEGFA
PMID:29245915	(2017) Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen nitrogen species.	8	62	1.17	0.00016	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,STAT5A,CXCL9,PTEN,TXN,CCL5,VEGFA
PMID:29259984	(2017) mTOR-Dependent Cell Proliferation in the Brain.	7	40	1.3	0.00016	9606.ENSP00000245479,9606.ENSP00000348069,9606.ENSP00000355370,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,SREBF1,CNTF,SGK1,PTEN,BDNF,VEGFA
PMID:29359013	(2017) Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.	7	40	1.3	0.00016	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,ANGPT2,SREBF1,PTGS2,BCL2,VEGFA
PMID:26820564	(2016) Redox homeostasis: The Golden Mean of healthy living.	6	23	1.48	0.00016	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,SIRT6,MAP3K5,PTEN,TXN,NFE2L2
PMID:26902783	(2016) C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,PDGFA,CCL5,VEGFA
PMID:27049720	(2016) Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,MMP14,PTEN,AR,BCL2,PROM1
PMID:27146311	(2016) The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches.	7	40	1.3	0.00016	9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,ATM,PLIN1,CD34,BMP2,CCL5,VEGFA
PMID:27367735	(2016) Mechanisms of TGFbeta-Induced Epithelial-Mesenchymal Transition.	12	187	0.87	0.00016	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000445772	CDH1,MMP14,HNF4A,CAV1,CXCL9,PTEN,TXN,BMP2,KL,PDGFD,RHOA,LTB4R2
PMID:27424223	(2016) Role of lipids in the metabolism and activation of immune cells.	8	62	1.17	0.00016	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000278840,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000354995	CD38,CD69,ATM,FADS2,CXCL10,SREBF1,CXCL9,ABCG1
PMID:27459703	(2016) Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.	8	62	1.17	0.00016	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CD34,CAV1,PTGS2,ENTPD1,PTEN,BCL2,VEGFA
PMID:27481042	(2016) Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.	6	23	1.48	0.00016	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356213	CD38,CD69,IFNG,CXCL10,CD34,VIP
PMID:27498551	(2016) Combined Detection of Serum IL-10, IL-17, and CXCL10 Predicts Acute Rejection Following Adult Liver Transplantation.	6	23	1.48	0.00016	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CD69,IFNG,CXCL10,CXCL11,CCL20,CXCL9
PMID:27721617	(2016) Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update.	8	62	1.17	0.00016	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,PTEN,BMP2,BCL2,MME,PROM1,VEGFA
PMID:27765909	(2016) In pursuit of synergy: An investigation of the PI3KmTORMEK co-targeted inhibition strategy in NSCLC.	7	40	1.3	0.00016	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,HSPB1,PTEN,JAK2,BCL2,RHOA,MYD88
PMID:27793274	(2016) Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000384906	IFNG,CXCL10,CXCL11,CCL20,PTGS2,SAA1
PMID:27822457	(2016) Targeting SOX2 as a Therapeutic Strategy in Glioblastoma.	7	40	1.3	0.00016	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CHI3L1,IGF1R,PTEN,RHOA,PROM1,VEGFA
PMID:25506896	(2015) Role of epithelial mesenchymal transition in prostate tumorigenesis.	8	62	1.17	0.00016	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,HSPB1,CDH1,PTEN,AR,PDGFD,FGFR1,VEGFA
PMID:25725623	(2015) Pathophysiology of diabetic dyslipidaemia: where are we?	7	40	1.3	0.00016	9606.ENSP00000200676,9606.ENSP00000215832,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000360522	CETP,MAPK1,LPL,LPA,SREBF1,ABCG1,RBP4
PMID:25811194	(2015) Macrophages modulate migration and invasion of human tongue squamous cell carcinoma.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CCR5,ANG,CCL20,CXCL9,MYD88,CCL5
PMID:25922572	(2015) Gene delivery strategies to promote spinal cord repair.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,ELN,BCL2,NTF3,BDNF,VEGFA
PMID:26256211	(2015) An Integrated Transcriptome Atlas of Embryonic Hair Follicle Progenitors, Their Niche, and the Developing Skin.	9	88	1.07	0.00016	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000334329,9606.ENSP00000377372,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,ENPP2,CDH1,UNC5B,GAP43,FGFR1,BDNF,GREM1,VEGFA
PMID:26258407	(2015) Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,IGF1R,ANG,PDGFA,EDN1,VEGFA
PMID:26347327	(2015) Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease.	6	23	1.48	0.00016	9606.ENSP00000216862,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000419313	CYP24A1,EDNRA,EDN1,KL,FGFR1,TRPC1
PMID:26382622	(2015) Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.	6	23	1.48	0.00016	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525	EPOR,MPO,CD38,CD34,JAK2,MME
PMID:26572250	(2015) Deep sequencing of the uterine immune response to bacteria during the equine oestrous cycle.	8	62	1.17	0.00016	9606.ENSP00000229135,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360522,9606.ENSP00000383364	IFNG,AQP5,CXCL10,CXCL11,CCL20,CXCL9,RBP4,PLA2G2A
PMID:26712794	(2015) MicroRNA Regulation of Human Breast Cancer Stem Cells.	9	88	1.07	0.00016	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,APC,CDH1,TIMP3,ALDH1A1,PTEN,BCL2,PROM1,VEGFA
PMID:24170546	(2014) AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,GAS6,JAK2,PROM1,VEGFA
PMID:24643902	(2014) Diabetes and associated complications in the South Asian population.	7	40	1.3	0.00016	9606.ENSP00000292303,9606.ENSP00000349860,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	CCR5,GFPT1,COMT,MTHFR,LTA,AGTR1,VEGFA
PMID:24672551	(2014) 2-cys peroxiredoxins: emerging hubs determining redox dependency of Mammalian signaling networks.	7	40	1.3	0.00016	9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000363822	ATM,PDGFB,MAP3K5,PTEN,NOX1,TXN,AR
PMID:24862542	(2014) Phagocyte-myocyte interactions and consequences during hypoxic wound healing.	8	62	1.17	0.00016	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,GAS6,CD47,PTGS2,CCL5,VEGFA
PMID:24940911	(2014) Regulation of chemokine expression in the tumor microenvironment.	8	62	1.17	0.00016	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:24944034	(2014) Autonomic nervous system and immune system interactions.	7	40	1.3	0.00016	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000419422	TGFB1,MPO,CNTF,PTGS2,JAK2,NPY,AGTR1
PMID:24971028	(2014) Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.	7	40	1.3	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,AR,BCL2,MYD88,CCL5,VEGFA
PMID:24991086	(2014) Novel insights into miRNA in lung and heart inflammatory diseases.	8	62	1.17	0.00016	9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,PTEN,MTHFR,RHOA,MYD88,AGTR1,CCL5,VEGFA
PMID:25068296	(2014) Lymphatic endothelial cells support tumor growth in breast cancer.	6	23	1.48	0.00016	9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	PDGFB,ANG,HSPG2,EDN1,FGFR1,VEGFA
PMID:25353372	(2014) Mesenchymal stem-cell potential in cartilage repair: an update.	8	62	1.17	0.00016	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000478570	SOX9,MMP14,CD34,ELN,BMP2,FGFR1,LTA,VEGFA
PMID:23063463	(2013) TGF-beta signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities.	6	23	1.48	0.00016	9606.ENSP00000222305,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000400175	USF2,NOX4,ATM,CAV1,NOX1,RHOA
PMID:23230897	(2013) Endothelial progenitor cells: therapeutic perspective for ischemic stroke.	7	40	1.3	0.00016	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,ANGPT2,AGTR1,PROM1,CCL5,VEGFA
PMID:23281051	(2013) Retinoids: Potent regulators of metabolism.	7	40	1.3	0.00016	9606.ENSP00000232219,9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000358513,9606.ENSP00000371067	RBP1,FABP4,ALDH1A1,LPL,STAT5A,CNR1,JAK2
PMID:23370117	(2013) Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.	8	62	1.17	0.00016	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000474412	NOX4,VDAC1,ATM,CXCL10,SIRT6,PTEN,NOX1,CCL5
PMID:23840269	(2013) A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent.	6	23	1.48	0.00016	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,HNF4A,PROM1
PMID:23867518	(2013) Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics.	9	88	1.07	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,STAT5A,CCL20,CXCL9,ENTPD1,TXN,CCL5,VEGFA
PMID:23901022	(2013) Genetic factors and pathogenesis of Waldenstroems macroglobulinemia.	7	40	1.3	0.00016	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	CD38,ATM,BCL2,IRAK4,MYD88,MME,VEGFA
PMID:23922675	(2013) Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,HNF4A,PTEN,BCL2,VEGFA
PMID:24090040	(2013) Rat pulmonary responses to inhaled nano-TiO2: effect of primary particle size and agglomeration state.	6	23	1.48	0.00016	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:24179490	(2013) A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).	7	40	1.3	0.00016	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,BCL2,PROM1,VEGFA
PMID:22290824	(2012) Novel pathways to erythropoiesis induced by dimerization of intracellular C-Mpl in human hematopoietic progenitors.	8	62	1.17	0.00016	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000478570	EPOR,CD38,CDH1,CD34,STAT5A,JAK2,MME,VEGFA
PMID:22421969	(2012) Mesenchymal stem cells: a double-edged sword in regulating immune responses.	6	23	1.48	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:22565047	(2012) Chronic inflammation and aging: DNA damage tips the balance.	6	23	1.48	0.00016	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000418525	CD38,ATM,CD34,EBF1,STAT5A,MME
PMID:22763855	(2012) Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,ALDH1A1,HNF4A,PTGS2,PROM1,CCL5
PMID:22819144	(2012) Pathogenesis and pathophysiology of endometriosis.	6	23	1.48	0.00016	9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ANG,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:22860018	(2012) Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells.	6	23	1.48	0.00016	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000474412	CDH1,IGF1R,PDGFB,PDGFA,PDGFD,CCL5
PMID:23316217	(2012) PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma.	6	23	1.48	0.00016	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000478570	CD38,CDH1,TIMP3,CD34,HNF4A,VEGFA
PMID:23403960	(2012) The molecular pathways underlying host resistance and tolerance to pathogens.	6	23	1.48	0.00016	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000317674,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CCR5,APOL1,BCL2,MYD88,VEGFA
PMID:23788861	(2012) Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma - apoptosis-regulating factors.	6	23	1.48	0.00016	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CD34,CAV1,PTEN,AR,BCL2,VEGFA
PMID:21146954	(2011) Genes and abdominal aortic aneurysm.	9	88	1.07	0.00016	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000222572,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000365777,9606.ENSP00000419422	CETP,TGFB1,PON2,TIMP3,ELN,PTGS2,HSPG2,MTHFR,AGTR1
PMID:21497747	(2011) Anti-fibrogenic strategies and the regression of fibrosis.	7	40	1.3	0.00016	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,SREBF1,ELN,BCL2,PROM1,VEGFA
PMID:21645207	(2011) 15th International Symposium on Cells of the Hepatic Sinusoid, 2010.	9	88	1.07	0.00016	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CD34,FMOD,CNR2,EDN1,PROM1,CCL5,VEGFA
PMID:20071192	(2010) IGF-1, oxidative stress and atheroprotection.	6	23	1.48	0.00016	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000368683	MPO,IGF1R,LPL,EDNRA,PDGFB,EDN1
PMID:20195532	(2010) Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes.	7	40	1.3	0.00016	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,PDGFA,PTGS2,CCL5,VEGFA
PMID:20339586	(2010) PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.	6	23	1.48	0.00016	9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000426809,9606.ENSP00000478570	PTEN,GAP43,BCL2,NPY,PROM1,VEGFA
PMID:20935203	(2010) Host genes associated with HIV-1 replication in lymphatic tissue.	7	40	1.3	0.00016	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,KLF10,CXCL10,CXCL11,CXCL9,CCL5
PMID:19570510	(2009) Control of stem cell fate by physical interactions with the extracellular matrix.	6	23	1.48	0.00016	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,RHOA,TRPC1,PROM1,VEGFA
PMID:19669186	(2009) Myelofibrosis involving lymph node: a novel cytogenetic abnormality in a mimicker of mesenchymal neoplasm.	6	23	1.48	0.00016	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525	CD38,CD34,JAK2,BCL2,FGFR1,MME
PMID:19846892	(2009) A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer.	8	62	1.17	0.00016	9606.ENSP00000259486,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000478570	ENPP2,IGF1R,ATM,MMP14,HNF4A,CAV1,BCL2,VEGFA
PMID:19912656	(2009) MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.	7	40	1.3	0.00016	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	THBS1,CDH1,TIMP3,IGF1R,PTGS2,PTEN,BCL2
PMID:18590522	(2008) Meta-analysis approach identifies candidate genes and associated molecular networks for type-2 diabetes mellitus.	9	88	1.07	0.00016	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000285407,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000418823,9606.ENSP00000480291	MAPK1,FABP4,KLF10,ONECUT1,HNF4A,KCNJ11,SREBF1,FTO,HNF1B
PMID:18629371	(2008) High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.	6	23	1.48	0.00016	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000400175	CETP,LPL,LPA,SREBF1,ABCG1,RHOA
PMID:17233909	(2007) Differential role of ICAM ligands in determination of human memory T cell differentiation.	8	62	1.17	0.00016	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,BCL2,CCL5
PMID:35153781	(2022) Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer.	8	63	1.16	0.00017	9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	SREBF1,PTEN,JAK2,NFE2L2,BCL2,MYD88,PROM1,VEGFA
PMID:35186768	(2022) Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions.	8	63	1.16	0.00017	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CCR5,CD34,STAT5A,JAK2,CCL5,VEGFA
PMID:35205732	(2022) Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment.	8	63	1.16	0.00017	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000378046,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,CD34,JAK2,FKBP2,CCL5,VEGFA
PMID:35273209	(2022) Causal biological network models for reactive astrogliosis: a systems approach to neuroinflammation.	8	63	1.16	0.00017	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000401399	TGFB1,IFNG,THBS1,PTGS2,PTEN,NFE2L2,RHOA,MYD88
PMID:35292083	(2022) Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes.	7	41	1.29	0.00017	9606.ENSP00000226760,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000393312,9606.ENSP00000414303	WFS1,FADS2,LPL,CAV1,KCNJ11,FGFR1,BDNF
PMID:35311116	(2022) New Advances in Targeted Therapy of HER2-Negative Breast Cancer.	8	63	1.16	0.00017	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,PTEN,AR,JAK2,FGFR1,PROM1,VEGFA
PMID:35328780	(2022) Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas.	8	63	1.16	0.00017	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ALDH1A1,MMP14,PTEN,BCL2,RHOA,PROM1,CCL5,VEGFA
PMID:33377452	(2021) The Effects of Human Bone Marrow-Derived Mesenchymal Stem Cell Conditioned Media Produced with Fetal Bovine Serum or Human Platelet Lysate on Skin Rejuvenation Characteristics.	7	41	1.29	0.00017	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,THBS1,ANG,ELN,BDNF,CCL5,VEGFA
PMID:33413653	(2021) Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury.	7	41	1.29	0.00017	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CXCL10,CNTF,PTGS2,NTF3,BDNF,VEGFA
PMID:33499208	(2021) Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases.	8	63	1.16	0.00017	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CXCL10,CD34,PTGS2,NFE2L2,NTF3,BDNF,CCL5
PMID:33548859	(2021) Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia.	7	41	1.29	0.00017	9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,DDAH1,PTEN,NOX1,EDN1,AGTR1,VEGFA
PMID:33708222	(2021) Identification of a Novel Serum Proteomic Signature for Primary Sjoegrens Syndrome.	8	63	1.16	0.00017	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303	IFNG,CHI3L1,FABP4,CXCL10,CXCL11,CCL20,CXCL9,BDNF
PMID:33789681	(2021) An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.	9	89	1.07	0.00017	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,SOX9,HSPB1,MAP3K5,PTGS2,EDN1,NFE2L2,BCL2,VEGFA
PMID:33816403	(2021) Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250	CD38,CDH1,CXCL10,CXCL11,CCL20,CXCL9,ENTPD1
PMID:33827905	(2021) Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CD38,IFNG,CDH1,CXCL10,CXCL9,ENTPD1,CCL5
PMID:33880430	(2021) The aging endothelium.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD38,THBS1,PDGFB,ANGPTL2,EDN1,BCL2,VEGFA
PMID:33968034	(2021) Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.	9	89	1.07	0.00017	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,SREBF1,CCL20,CXCL9,CD47,AR,CCL5,VEGFA
PMID:33980266	(2021) Immunotherapies targeting stimulatory pathways and beyond.	9	89	1.07	0.00017	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,SIRT6,CXCL9,PTEN,BCL2,CCL5,VEGFA
PMID:33986184	(2021) Regulatory Role of Zinc in Immune Cell Signaling.	7	41	1.29	0.00017	9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399	CD69,STAT5A,CD247,PTEN,JAK2,IRAK4,MYD88
PMID:34026749	(2021) Bone Cells Differentiation: How CFTR Mutations May Rule the Game of Stem Cells Commitment?	10	119	0.99	0.00017	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,CD34,HNF4A,PTEN,ALPL,BMP2,FGFR1,CCL5,GREM1,VEGFA
PMID:34039257	(2021) Role of long noncoding RNA taurine-upregulated gene 1 in cancers.	9	89	1.07	0.00017	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,HSPB1,MMP14,HNF4A,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:34045585	(2021) Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.	7	41	1.29	0.00017	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	MAPK1,CXCL10,PDGFB,CCL20,JAK2,BCL2,CCL5
PMID:34063238	(2021) Immune Checkpoint Inhibitors in Prostate Cancer.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	CD38,CD69,ATM,ENTPD1,PTEN,AR,VEGFA
PMID:34067089	(2021) Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity.	8	63	1.16	0.00017	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,CCL5,VEGFA
PMID:34267669	(2021) Single-Cell RNA Sequencing Analysis of Chicken Anterior Pituitary: A Birds-Eye View on Vertebrate Pituitary.	11	152	0.92	0.00017	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000427424,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,AR,BMP2,NPY,NTF3,BDNF,RARRES2,TNFAIP8,VEGFA
PMID:34286174	(2021) Engineering skeletal muscle tissues with advanced maturity improves synapse formation with human induced pluripotent stem cell-derived motor neurons.	7	41	1.29	0.00017	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000375844,9606.ENSP00000393312,9606.ENSP00000414303	MYH9,TGFB1,CNTF,EDN1,CAPN10,FGFR1,BDNF
PMID:34409033	(2021) Neural Tissue Homeostasis and Repair Is Regulated via CS and DS Proteoglycan Motifs.	11	151	0.92	0.00017	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,AMBP,IGF1R,MMP14,CD47,HSPG2,MYD88,BDNF,CCL5,VEGFA
PMID:34588957	(2021) Role of Exosomes in Brain Diseases.	10	119	0.99	0.00017	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,THBS1,TIMP3,IGF1R,KLF10,PTEN,GAP43,BCL2,BDNF,VEGFA
PMID:34679688	(2021) Preclinical and Clinical Antioxidant Effects of Natural Compounds against Oxidative Stress-Induced Epigenetic Instability in Tumor Cells.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,MAP3K5,PTEN,NOX1,TXN,NFE2L2,VEGFA
PMID:34691253	(2021) Exosomal circular RNAs: A new frontier in the metastasis of digestive system tumors.	7	41	1.29	0.00017	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,PTEN,JAK2,RHOA,PROM1,VEGFA
PMID:34769288	(2021) Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis.	9	89	1.07	0.00017	9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000358513,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,KLF10,CNR1,BMP2,EDN1,JAK2,NFE2L2,FGFR1,VEGFA
PMID:34771577	(2021) Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment.	7	41	1.29	0.00017	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,ANGPT2,AR,MME,PROM1,VEGFA
PMID:34829820	(2021) Targeted Therapies in Cancer: To Be or Not to Be, Selective.	8	63	1.16	0.00017	9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,STAT5A,AR,JAK2,BCL2,IRAK4,MYD88,VEGFA
PMID:34922551	(2021) Roles of ferroptosis in urologic malignancies.	8	63	1.16	0.00017	9606.ENSP00000216075,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000278840,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000380252	MIOX,IFNG,HSPB1,NOX4,FADS2,SREBF1,NOX1,NFE2L2
PMID:34975475	(2021) Tetramethylpyrazine: A Review of Its Antitumor Potential and Mechanisms.	9	89	1.07	0.00017	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,CD34,PRKAA1,MAP3K5,PTEN,JAK2,NFE2L2,BCL2,VEGFA
PMID:34984074	(2021) Understanding Pattern Hair Loss-Hair Biology Impacted by Genes, Androgens, Prostaglandins and Epigenetic Factors.	7	41	1.29	0.00017	9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	ATM,PTGS2,SHBG,JAK2,LTA,BDNF,VEGFA
PMID:35237130	(2021) Vav3-Deficient Astrocytes Enhance the Dendritic Development of Hippocampal Neurons in an Indirect Co-culture System.	7	41	1.29	0.00017	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL11,CNTF,NTF3,RHOA,BDNF,CCL5
PMID:31925333	(2020) IGFBP2: integrative hub of developmental and oncogenic signaling network.	7	41	1.29	0.00017	9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CHI3L1,IGF1R,PDGFB,PTEN,AR,BCL2,VEGFA
PMID:32143355	(2020) Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid Cells.	8	63	1.16	0.00017	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000426809	CD69,CXCL10,PTGS2,ENTPD1,AR,JAK2,MYD88,PROM1
PMID:32253828	(2020) Genetic and molecular biology of bladder cancer among Iranian patients.	8	63	1.16	0.00017	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,ALDH1A1,S100A12,PTEN,MTHFR,BCL2,FGFR1,VEGFA
PMID:32272767	(2020) Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000356213,9606.ENSP00000358513,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	IFNG,LPL,VIP,CNR1,NPY,NTF3,BDNF
PMID:32382280	(2020) Role of Resveratrol in Regulating Cutaneous Functions.	7	41	1.29	0.00017	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000478570	TGFB1,HSPB1,CXCL10,ELN,PTGS2,NFE2L2,VEGFA
PMID:32466129	(2020) Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.	8	63	1.16	0.00017	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000393312,9606.ENSP00000478570	TIMP3,CXCL10,CXCL11,MMP14,ELN,CXCL9,FGFR1,VEGFA
PMID:32582698	(2020) Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy.	10	119	0.99	0.00017	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD69,CCR5,CXCL10,CCL20,CXCL9,ENTPD1,MME,PROM1,VEGFA
PMID:32630301	(2020) Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances.	7	41	1.29	0.00017	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	MAPK1,IFNG,ABCG1,PTGS2,NFE2L2,BCL2,BDNF
PMID:32664529	(2020) Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives.	8	63	1.16	0.00017	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,SOX9,ENPP2,ELN,BMP2,BCL2,RHOA,VEGFA
PMID:32705508	(2020) Activity of the human immortalized endothelial progenitor cell line HEPC-CB.1 supporting in vitro angiogenesis.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CXCL10,CD34,ANG,CNTF,PROM1,VEGFA
PMID:33169785	(2020) Abstract: Posters: 13th Clinical Trials on Alzheimers Disease (CTAD) November 4-7, 2020.	9	89	1.07	0.00017	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000363973,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CDH1,PRDX2,CXCL10,LPA,ALPL,BDNF,CCL5,VEGFA
PMID:33328998	(2020) Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications.	7	41	1.29	0.00017	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000384262,9606.ENSP00000478570	MPO,IFNG,LPL,ANGPT2,ELN,HPSE,VEGFA
PMID:33383852	(2020) From Preclinical Stroke Models to Humans: Polyphenols in the Prevention and Treatment of Stroke.	7	41	1.29	0.00017	9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	SIRT6,CAV1,PTGS2,TXN,BCL2,BDNF,VEGFA
PMID:33419310	(2020) Mechanisms of Immunosuppression in Colorectal Cancer.	9	89	1.07	0.00017	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CCL20,CD247,CXCL9,ENTPD1,CCL5,VEGFA
PMID:30221358	(2019) Generic chemoprevention of hepatocellular carcinoma.	7	41	1.29	0.00017	9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000419422,9606.ENSP00000478570	ENPP2,CCR5,SREBF1,MAP3K5,PTGS2,AGTR1,VEGFA
PMID:30531002	(2019) Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury.	7	41	1.29	0.00017	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,PTEN,NTF3,RHOA,MYD88,BDNF,VEGFA
PMID:30775250	(2019) Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics.	8	63	1.16	0.00017	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000363827,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ELN,AR,HSPG2,BDNF,CCL5,VEGFA
PMID:30781344	(2019) Targeting Tumor Microenvironment for Cancer Therapy.	8	63	1.16	0.00017	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,MMP14,ANGPT2,PDGFB,PDGFA,ELN,LTA,VEGFA
PMID:30813267	(2019) Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy.	9	89	1.07	0.00017	9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185	CXCL10,MAP3K5,CXCL9,CD47,PTGS2,S100A12,ENTPD1,PTEN,BCL2
PMID:30862995	(2019) Integrated network analysis of transcriptomic and protein-protein interaction data in taurine-treated hepatic stellate cells.	7	41	1.29	0.00017	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000285407,9606.ENSP00000311005,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,TIMP3,KLF10,MAPK7,JAK2,BDNF,VEGFA
PMID:30917628	(2019) Medicinal Herbs Effective Against Atherosclerosis: Classification According to Mechanism of Action.	8	63	1.16	0.00017	9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000477707	NOX4,CXCL11,CXCL9,ABCG1,JAK2,BCL2,RHOA,NR1H3
PMID:30919407	(2019) The oral Janus kinasespleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled ...	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067	CD38,IFNG,CXCL10,CXCL11,CCL20,CXCL9,JAK2
PMID:31052435	(2019) Focus on Formononetin: Anticancer Potential and Molecular Targets.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTGS2,PTEN,BCL2,VEGFA
PMID:31294333	(2019) Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia.	8	63	1.16	0.00017	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000371067,9606.ENSP00000384957,9606.ENSP00000474412	MPO,CCR5,ANGPT2,ENTPD1,ADAMTS13,JAK2,F11,CCL5
PMID:31374852	(2019) Galactosaminoglycans: Medical Applications and Drawbacks.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000265132,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,AMBP,HSPG2,BCL2,HPSE,CCL5,VEGFA
PMID:31406672	(2019) Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation.	8	63	1.16	0.00017	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD247,CXCL9,CD47,CCL5,VEGFA
PMID:31412566	(2019) The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.	10	118	0.99	0.00017	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:31614481	(2019) The Regulation of Lipokines by Environmental Factors.	7	41	1.29	0.00017	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000259407,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000474412	FFAR1,FABP4,BAAT,SREBF1,PTGS2,NFE2L2,CCL5
PMID:31752925	(2019) Distinct functions of AKT isoforms in breast cancer: a comprehensive review.	9	89	1.07	0.00017	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,NOX4,IGF1R,SIRT6,CAV1,PTEN,BCL2,BDNF,VEGFA
PMID:29245123	(2018) The GDNF Family: A Role in Cancer?	9	89	1.07	0.00017	9606.ENSP00000261769,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CNTF,PTEN,BCL2,RHOA,LTA,BDNF,PROM1,VEGFA
PMID:29301792	(2018) Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.	7	41	1.29	0.00017	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000426809	MPO,CXCL10,CXCL11,CCL20,CXCL9,BDNF,PROM1
PMID:29511710	(2018) Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,PDGFB,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:29599799	(2018) Peroxisome Proliferator-Activated Receptor gamma and PGC-1alpha in Cancer: Dual Actions as Tumor Promoter and Suppressor.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,HNF4A,STAT5A,PTEN,NOX1,BCL2,VEGFA
PMID:29623912	(2018) Cerebral ischemia and neuroregeneration.	7	41	1.29	0.00017	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,PTGS2,BCL2,NTF3,RHOA,BDNF,VEGFA
PMID:29677116	(2018) Human Cancer and Platelet Interaction, a Potential Therapeutic Target.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000304767,9606.ENSP00000306884,9606.ENSP00000351908,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,P2RY1,CXCL11,MAP3K5,PDGFD,RHOA,VEGFA
PMID:29770323	(2018) Dental Mesenchymal Stem Cell-Based Translational Regenerative Dentistry: From Artificial to Biological Replacement.	7	41	1.29	0.00017	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,SOX9,ANGPT2,ANG,EDN1,BDNF,VEGFA
PMID:29966369	(2018) Recent Progress in Gene Therapy for Ovarian Cancer.	9	89	1.07	0.00017	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,CD47,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:30515411	(2018) Survival Mechanisms and Influence Factors of Circulating Tumor Cells.	8	63	1.16	0.00017	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,CD47,PTEN,BCL2,PROM1,VEGFA
PMID:28154736	(2017) Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology.	7	41	1.29	0.00017	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,IGF1R,CD34,TXN,BCL2,PROM1,VEGFA
PMID:28178443	(2017) Abstracts from the Thirteenth Rambam Research Day, December 22, 2016.	7	41	1.29	0.00017	9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000384262,9606.ENSP00000478570	IGF1R,MMP14,CD34,BMP2,EDN1,HPSE,VEGFA
PMID:28303857	(2017) Research Progress on the Risk Factors and Outcomes of Human Carotid Atherosclerotic Plaques.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000357726	IFNG,CHI3L1,TIMP3,MMP14,ELN,PTGS2,S100A12
PMID:28328745	(2017) G Protein-Coupled Receptor Signaling Through beta-Arrestin-Dependent Mechanisms.	10	119	0.99	0.00017	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	IGF1R,CCR5,HNF4A,EDNRA,MAP3K5,PTGS2,EDN1,BCL2,RHOA,AGTR1
PMID:28357082	(2017) The role of peroxiredoxins in cancer.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PRDX2,MAP3K5,PTEN,TXN,PROM1,VEGFA
PMID:28590292	(2017) Transcriptome profiles in sarcoidosis and their potential role in disease prediction.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,JAK2,CCL5
PMID:28642237	(2017) Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.	7	41	1.29	0.00017	9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	HNF4A,PDGFB,ABCG1,PTGS2,BCL2,PROM1,CCL5
PMID:28933365	(2017) Milks Role as an Epigenetic Regulator in Health and Disease.	9	89	1.07	0.00017	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000418823	FABP4,LPL,SREBF1,COMT,PTEN,BMP2,NFE2L2,NPY,FTO
PMID:28969616	(2017) Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,LTA,BDNF,CCL5,VEGFA
PMID:29026007	(2017) Milk fat components with potential anticancer activity-a review.	8	63	1.16	0.00017	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185	FABP4,LPL,CD34,SIRT6,SREBF1,PTEN,G6PD,BCL2
PMID:26539643	(2016) The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,MMP14,HNF4A,PTEN,PROM1,VEGFA
PMID:26906720	(2016) Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.	10	119	0.99	0.00017	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	CD38,CDH1,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,LTA,VEGFA
PMID:27242392	(2016) Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems.	7	41	1.29	0.00017	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CD34,CXCL9,NPY,MYD88,BDNF,CCL5
PMID:27445820	(2016) Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis.	7	41	1.29	0.00017	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,MMP14,ANGPT2,CCL20,PTGS2,CCL5,VEGFA
PMID:27624340	(2016) In Vitro Effects of Hollow Gold Nanoshells on Human Aortic Endothelial Cells.	7	41	1.29	0.00017	9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAP3K5,PTGS2,TXN,EDN1,BCL2,RHOA,VEGFA
PMID:28074098	(2016) Human Cord Blood-Derived CD133(+)C-Kit(+)Lin(-) Cells Have Bipotential Ability to Differentiate into Mesenchymal Stem Cells and Outgrowth Endothelial Cells.	7	41	1.29	0.00017	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,LPL,CCL20,BMP2,EDN1,PROM1,VEGFA
PMID:25717174	(2015) Atherosclerosis.	7	41	1.29	0.00017	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000334329,9606.ENSP00000354995,9606.ENSP00000362524,9606.ENSP00000474412	MPO,IGF1R,CCR5,UNC5B,ABCG1,ANGPTL2,CCL5
PMID:25783564	(2015) Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000418525	CD38,FABP4,CDH1,LPL,CD34,ALPL,MME
PMID:25962947	(2015) Stroke genomics in people of African ancestry: charting new paths.	7	41	1.29	0.00017	9606.ENSP00000216181,9606.ENSP00000317674,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000375844,9606.ENSP00000377192,9606.ENSP00000480291	MYH9,APOL1,PTEN,MTHFR,CAPN10,G6PD,HNF1B
PMID:26171944	(2015) The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,CXCL10,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:26264608	(2015) Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.	11	151	0.92	0.00017	9606.ENSP00000222139,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CD69,CCR5,CXCL10,CXCL11,GAS6,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:26325610	(2015) Modulatory effects of bortezomib on host immune cell functions.	8	63	1.16	0.00017	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CD247,CXCL9,PTGS2,CCL5,VEGFA
PMID:28210697	(2015) Angiogenesis and Fibrogenesis in Chronic Liver Diseases.	7	41	1.29	0.00017	9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000475344,9606.ENSP00000478570	CCR5,CAV1,CXCL9,BMP2,EDN1,APLNR,VEGFA
PMID:24732754	(2014) HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy.	7	41	1.29	0.00017	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000381185	MAPK1,CCR5,CXCL10,CAV1,CXCL9,TXN,BCL2
PMID:24901012	(2014) The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000363641,9606.ENSP00000474412	IFNG,CXCL10,CCL20,PTGS2,S100A12,TXN,CCL5
PMID:24981363	(2014) Tackling the cancer stem cells - what challenges do they pose?	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478319	CDH1,ALDH1A1,CD34,HNF4A,PROM1,CCL5,GREM1
PMID:23168041	(2013) Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.	7	41	1.29	0.00017	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,CXCL10,PTEN,BCL2,PROM1,VEGFA
PMID:23772224	(2013) Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance.	7	41	1.29	0.00017	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000300055,9606.ENSP00000360522,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	FABP4,CCR5,PLIN1,RBP4,CCL5,APLNR,VEGFA
PMID:24079748	(2013) MicroRNAmRNA profiling and regulatory network of intracranial aneurysm.	7	41	1.29	0.00017	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,THBS1,MMP14,ELN,JAK2,BCL2,VEGFA
PMID:24344983	(2013) Comparison of upstream regulators in human ex vivo cultured cornea limbal epithelial stem cells and differentiated corneal epithelial cells.	10	118	0.99	0.00017	9606.ENSP00000245479,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,LAMC1,THBS1,CXCL10,CAV1,CD47,CNTF,EDN1,CCL5,VEGFA
PMID:22364136	(2012) Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.	7	41	1.29	0.00017	9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CAV1,ENTPD1,TXN,RHOA,AGTR1,CCL5,VEGFA
PMID:22581366	(2012) Targeting NADPH oxidases for the treatment of cancer and inflammation.	7	41	1.29	0.00017	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,ANGPT2,MAP3K5,PTEN,NOX1,RHOA,VEGFA
PMID:22820962	(2012) Acute and impaired wound healing:  pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing:  therapeutic potential and methods of delivery.	7	41	1.29	0.00017	9606.ENSP00000260356,9606.ENSP00000321853,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000376865,9606.ENSP00000478570	THBS1,SERPINF2,PDGFB,PDGFA,BMP2,PDGFD,VEGFA
PMID:23085539	(2012) RasRafMEKERK and PI3KPTENAktmTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.	9	89	1.07	0.00017	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,ATM,CD34,MAPK7,PTGS2,PTEN,BCL2,FGFR1,VEGFA
PMID:23133672	(2012) Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IFNG,CXCL10,BCL2,CCL5,VEGFA
PMID:21248162	(2011) Regulation of blood pressure and salt homeostasis by endothelin.	8	63	1.16	0.00017	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000356832,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000418525	MAPK1,IFNG,MAPK7,SGK1,GAP43,NPY,RHOA,MME
PMID:21654676	(2011) D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.	8	63	1.16	0.00017	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,THBS1,TIMP3,PDGFB,PDGFA,HSPG2,BCL2,VEGFA
PMID:21912722	(2011) ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?	7	41	1.29	0.00017	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000478570	NOX4,SIRT6,MAP3K5,NOX1,TXN,KL,VEGFA
PMID:19968738	(2010) The vicious circle between oxidative stress and inflammation in atherosclerosis.	7	41	1.29	0.00017	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000331831,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000383364,9606.ENSP00000478570	MPO,LPL,GAS6,ABCG1,NOX1,PLA2G2A,VEGFA
PMID:20022228	(2010) Gastrointestinal lymphatics in health and disease.	9	89	1.07	0.00017	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000356213	FABP4,CDH1,TIMP3,CD34,ANGPT2,ANG,CCL20,ELN,VIP
PMID:20184544	(2010) Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTEN,AR,BCL2,PROM1,VEGFA
PMID:20370703	(2010) Cancer stem cells: a novel paradigm for cancer prevention and treatment.	7	41	1.29	0.00017	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,ALDH1A1,PTEN,PROM1,VEGFA
PMID:20835362	(2010) HSV Recombinant Vectors for Gene Therapy.	8	63	1.16	0.00017	9606.ENSP00000226279,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CNTF,BCL2,NTF3,BDNF,MME,PROM1,VEGFA
PMID:22399922	(2010) Transcriptional regulation of glucose sensors in pancreatic beta-cells and liver: an update.	7	41	1.29	0.00017	9606.ENSP00000222305,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000362410,9606.ENSP00000477707,9606.ENSP00000480291	USF2,ONECUT1,HNF4A,SREBF1,MAFB,NR1H3,HNF1B
PMID:24281076	(2010) Current research and development of chemotherapeutic agents for melanoma.	7	41	1.29	0.00017	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,CD34,PTGS2,PTEN,BCL2,VEGFA
PMID:18053092	(2008) Cancer stem cells: the lessons from pre-cancerous stem cells.	7	41	1.29	0.00017	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:35039221	(2022) Before the cytokine storm: Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications.	8	64	1.16	0.00018	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,GAS6,CXCL9,CD47,PTGS2,CCL5,VEGFA
PMID:35203268	(2022) Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.	6	24	1.46	0.00018	9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:35208526	(2022) Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study.	6	24	1.46	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CCR5,CD34,CCL5,VEGFA
PMID:35308726	(2022) Multisystem Inflammatory Syndrome in Adults or Hemophagocytic Lymphohistiocytosis: A Clinical Conundrum in Fully Vaccinated Adults With Breakthrough COVID-19 Infections.	5	11	1.72	0.00018	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000418525	CD38,IFNG,CXCL10,CXCL9,MME
PMID:35819552	(2022) Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model.	5	11	1.72	0.00018	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000377372,9606.ENSP00000384364	CCR5,CXCL10,CCL20,GAP43,NPY
PMID:33024271	(2021) Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma.	6	24	1.46	0.00018	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,CXCL9,CCL5,VEGFA
PMID:33148506	(2021) Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.	6	24	1.46	0.00018	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000480291	CD34,PDGFA,PTEN,FGFR1,PROM1,HNF1B
PMID:33179080	(2021) Role of hypoxia inducible factor-1 in cancer stem cells (Review).	8	64	1.16	0.00018	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,SIRT6,CCL20,CD47,AR,PROM1,VEGFA
PMID:33186704	(2021) CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.	8	64	1.16	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CCR5,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:33302033	(2021) The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.	9	90	1.06	0.00018	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	CD38,CXCL10,STAT5A,ENTPD1,BCL2,IRAK4,MYD88,AGTR1,VEGFA
PMID:33456711	(2021) Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000426809	CDH1,STAT5A,PTEN,AR,FGFR1,PROM1
PMID:33481318	(2021) The phenotypic and functional study of tissue B cells in respiratory system provided important information for diseases and development of vaccines.	6	24	1.46	0.00018	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD38,CD69,CCR5,CXCL10,CXCL11,CXCL9
PMID:33567616	(2021) Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.	8	64	1.16	0.00018	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310520,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,IGF1R,ALDH1A1,ERCC4,PTEN,BCL2,PROM1,VEGFA
PMID:33614752	(2021) Advanced Research of Abdominal Aortic Aneurysms on Metabolism.	6	24	1.46	0.00018	9606.ENSP00000225275,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000384906,9606.ENSP00000478570	MPO,ELN,PTGS2,CYP2J2,SAA1,VEGFA
PMID:33646290	(2021) Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.	5	11	1.72	0.00018	9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	ANGPT2,ANG,BDNF,CCL5,VEGFA
PMID:33668112	(2021) Signaling Pathways That Control Apoptosis in Prostate Cancer.	9	90	1.06	0.00018	9606.ENSP00000215832,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,PRKCE,MAPK7,SGK1,PTEN,AR,BCL2,FGFR1,VEGFA
PMID:33744858	(2021) Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial-mesenchymal transition and stem-like reprogram.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CD34,PROM1,CCL5,VEGFA
PMID:33794993	(2021) Sodium alginate-bioglass-encapsulated hAECs restore ovarian function in premature ovarian failure by stimulating angiogenic factor secretion.	6	24	1.46	0.00018	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CDH1,CD34,ANG,EDN1,VEGFA
PMID:33802575	(2021) LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells.	10	120	0.98	0.00018	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000426809	APC,CDH1,ATM,ALDH1A1,STAT5A,PTGS2,PTEN,JAK2,MME,PROM1
PMID:33807314	(2021) Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke.	8	64	1.16	0.00018	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,TIMP3,ANGPT2,ANG,JAK2,RHOA,BDNF,VEGFA
PMID:33964953	(2021) Hypoxia-dependent drivers of melanoma progression.	9	90	1.06	0.00018	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,MMP14,ANGPT2,EDNRA,PTEN,EDN1,BCL2,CCL5,VEGFA
PMID:34026650	(2021) Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights.	6	24	1.46	0.00018	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,BCL2,PROM1
PMID:34064933	(2021) Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice.	6	24	1.46	0.00018	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34203461	(2021) Effects of Dietary n-3 and n-6 Polyunsaturated Fatty Acids in Inflammation and Cancerogenesis.	8	64	1.16	0.00018	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,FADS2,ANGPT2,PTGS2,CNR1,PTEN,BCL2,VEGFA
PMID:34396426	(2021) Phylogenetic analysis of combined lobular and ductal carcinoma of the breast.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000377192	CDH1,TIMP3,SGK1,PTEN,AR,G6PD
PMID:34440080	(2021) TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy.	8	64	1.16	0.00018	9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	ATM,PDGFB,PDGFA,PTEN,AR,PDGFD,FGFR1,VEGFA
PMID:34512156	(2021) Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations.	8	64	1.16	0.00018	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000478570	IFNG,IGF1R,SIRT6,CCL20,ABCG1,NFE2L2,NPY,VEGFA
PMID:34781643	(2021) Modeling of endothelial cell dysfunction using human induced pluripotent stem cells derived from patients with end-stage renal disease.	8	64	1.16	0.00018	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANGPT2,EDN1,MME,PROM1,CCL5,VEGFA
PMID:34827174	(2021) Cell-Based Neuroprotection of Retinal Ganglion Cells in Animal Models of Optic Neuropathies.	6	24	1.46	0.00018	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,GAP43,NTF3,BDNF,VEGFA
PMID:34831452	(2021) From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma.	9	90	1.06	0.00018	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,ATM,CXCL10,CXCL9,CD47,ENTPD1,CCL5,VEGFA
PMID:34867394	(2021) Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway.	6	24	1.46	0.00018	9606.ENSP00000284031,9606.ENSP00000315011,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000475344	DDAH1,EDNRA,BMP2,EDN1,MME,APLNR
PMID:34899757	(2021) Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications.	10	120	0.98	0.00018	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000401399,9606.ENSP00000418823,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CXCL9,PTGS2,S100A12,MYD88,FTO,CCL5,VEGFA
PMID:34912224	(2021) Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?	5	11	1.72	0.00018	9606.ENSP00000222139,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,JAK2,BCL2,BDNF,VEGFA
PMID:34948209	(2021) Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting.	8	64	1.16	0.00018	9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000478570	FABP4,ENPP2,CD34,GAS6,ELN,CXCL9,IRAK4,VEGFA
PMID:35070963	(2021) Ovarian Biomechanics: From Health to Disease.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,MMP14,ELN,RHOA,VEGFA
PMID:35096795	(2021) Exosomes: Biological Pharmaceutical Nanovectors for Theranostics.	8	64	1.16	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,IFNG,HSPB1,CXCL10,CAV1,CD47,BDNF,VEGFA
PMID:30989489	(2020) Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy.	5	11	1.72	0.00018	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTGS2,AR,BCL2,VEGFA
PMID:31669080	(2020) The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature.	5	11	1.72	0.00018	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000357726	MPO,FABP4,CXCL10,CCL20,S100A12
PMID:31733132	(2020) Cell-line-based assay for the toxicitybenefit analysis of lipopolysaccharides in plants.	5	11	1.72	0.00018	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,PTGS2,MYD88,CCL5
PMID:31816057	(2020) Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling.	8	64	1.16	0.00018	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,CXCL9,CD47,PTGS2,PTEN,CCL5,VEGFA
PMID:31947935	(2020) Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer.	9	90	1.06	0.00018	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,TIMP3,ATM,PTGS2,PTEN,G6PD,NFE2L2,BCL2,VEGFA
PMID:31952147	(2020) Antitumor Features of Vegetal Protein-Based Nanotherapeutics.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ELN,AR,BCL2,RHOA,VEGFA
PMID:32013028	(2020) Lung Macrophage Functional Properties in Chronic Obstructive Pulmonary Disease.	8	64	1.16	0.00018	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000362410,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,MAFB,NFE2L2,RHOA,CCL5
PMID:32093391	(2020) Hyperbaric Oxygen Therapy Improves the Osteogenic and Vasculogenic Properties of Mesenchymal Stem Cells in the Presence of Inflammation In Vitro.	6	24	1.46	0.00018	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000363973,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD34,HNF4A,ALPL,EDN1,BCL2,VEGFA
PMID:32205838	(2020) Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stemprogenitor cells.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CDH1,VIP,PTEN,AR,BCL2,MME
PMID:32212784	(2020) The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma.	6	24	1.46	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000418009,9606.ENSP00000478570	TGFB1,IFNG,SREBF1,RBP4,RARRES2,VEGFA
PMID:32259636	(2020) Exposure to growth hormone is associated with hepatic up-regulation of cPLA2alpha and COX.	5	11	1.72	0.00018	9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000383364	IGF1R,STAT5A,PTGS2,JAK2,PLA2G2A
PMID:32266141	(2020) NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.	8	64	1.16	0.00018	9606.ENSP00000226279,9606.ENSP00000304767,9606.ENSP00000337332,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000401399,9606.ENSP00000478570	CD38,P2RY1,SIRT6,ENTPD1,TXN,G6PD,MYD88,VEGFA
PMID:32309444	(2020) Effects of Mesenchymal Stem Cell Coculture on Human Lung Small Airway Epithelial Cells.	6	24	1.46	0.00018	9606.ENSP00000229135,9606.ENSP00000293599,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000418525,9606.ENSP00000478570	IFNG,AQP5,CD34,ANGPT2,MME,VEGFA
PMID:32320382	(2020) Swimming exercise stimulates IGF1 PI3KAkt and AMPKSIRT1PGC1alpha survival signaling to suppress apoptosis and inflammation in aging hippocampus.	6	24	1.46	0.00018	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,PTGS2,AR,BCL2,BDNF,VEGFA
PMID:32332711	(2020) Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis.	8	64	1.16	0.00018	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067	CDH1,CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2
PMID:32391382	(2020) Cellular Plasticity in Breast Cancer Progression and Therapy.	9	90	1.06	0.00018	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,APC,CDH1,ALDH1A1,HNF4A,CD47,JAK2,PROM1,VEGFA
PMID:32461855	(2020) The Relationship between Chemokine Ligand 3 and Allergic Rhinitis.	5	11	1.72	0.00018	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CD34,CCL5
PMID:32577235	(2020) Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer.	6	24	1.46	0.00018	9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252	FADS2,PLIN1,SREBF1,TXN,AR,NFE2L2
PMID:32599451	(2020) MicroRNA-19a-PTEN Axis Is Involved in the Developmental Decline of Axon Regenerative Capacity in Retinal Ganglion Cells.	6	24	1.46	0.00018	9606.ENSP00000265132,9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000414303	AMBP,IGF1R,CNTF,PTEN,GAP43,BDNF
PMID:32630372	(2020) The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.	11	153	0.92	0.00018	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175	MAPK1,APC,CDH1,MAPK7,HNF4A,CAV1,PRKAA1,SGK1,PTEN,AR,RHOA
PMID:32632400	(2020) Tumor dormancy in bone.	8	64	1.16	0.00018	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,HSPB1,THBS1,CD34,GAS6,PROM1,CCL5,VEGFA
PMID:32669966	(2020) PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1Akt pathway.	6	24	1.46	0.00018	9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809	ALDH1A1,CD34,PTEN,RHOA,AGTR1,PROM1
PMID:32717819	(2020) Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.	8	64	1.16	0.00018	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,ALDH1A1,MAPK7,PTEN,BMP2,PROM1,CCL5,VEGFA
PMID:32726968	(2020) More Than Resveratrol: New Insights into Stilbene-Based Compounds.	8	64	1.16	0.00018	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	PTGS2,PTEN,AR,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:32823961	(2020) Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad.	10	120	0.98	0.00018	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000478570	CCR5,CXCL10,LPL,STAT5A,CD247,CXCL9,ABCG1,CD47,ENTPD1,VEGFA
PMID:32867371	(2020) iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine.	8	64	1.16	0.00018	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,CD34,HNF4A,CD47,PTEN,BMP2,FGFR1,VEGFA
PMID:32942544	(2020) Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes.	5	11	1.72	0.00018	9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	PTEN,GAP43,BDNF,MME,VEGFA
PMID:33256225	(2020) Good Cop, Bad Cop: The Opposing Effects of Macrophage Activation State on Maintaining or Damaging Functional beta-Cell Mass.	8	64	1.16	0.00018	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000345708,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CHI3L1,CXCL10,KCNJ11,CCL20,CXCL9,CCL5,VEGFA
PMID:33261069	(2020) Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages.	8	64	1.16	0.00018	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	IGF1R,ATM,CAV1,PTGS2,PDGFD,BCL2,FGFR1,RHOA
PMID:33364397	(2020) The role of vitamin D in head and neck cancer.	6	24	1.46	0.00018	9606.ENSP00000216862,9606.ENSP00000228434,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185	CYP24A1,CD69,PTGS2,PTEN,TXN,BCL2
PMID:33505964	(2020) Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming.	10	120	0.98	0.00018	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,EDNRA,CCL20,CD47,PTGS2,EDN1,IRAK4,MYD88,CCL5,VEGFA
PMID:30413411	(2019) Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.	6	24	1.46	0.00018	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000400175	CD34,STAT5A,CXCL9,PTEN,FGFR1,RHOA
PMID:30688888	(2019) Injectable Allograft Adipose Matrix Supports Adipogenic Tissue Remodeling in the Nude Mouse and Human.	5	11	1.72	0.00018	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000351807,9606.ENSP00000478570	TGFB1,FABP4,PLIN1,ELN,VEGFA
PMID:30825284	(2019) The Expression of Microvesicles in Leukemia: Prognostic Approaches.	8	64	1.16	0.00018	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CD34,ENTPD1,PTEN,BCL2,RHOA,MME,VEGFA
PMID:30944604	(2019) Vascular patterns in basal cell carcinoma: Dermoscopic, confocal and histopathological perspectives.	5	11	1.72	0.00018	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CD34,PDGFB,BCL2,VEGFA
PMID:30970537	(2019) Sustained Human Hair Follicle Growth Ex Vivo in a Glycosaminoglycan Hydrogel Matrix.	6	24	1.46	0.00018	9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000478570	CD34,FMOD,ELN,HSPG2,BMP2,VEGFA
PMID:30986934	(2019) LOXL2-A New Target in Antifibrogenic Therapy?	6	24	1.46	0.00018	9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	CXCL10,ELN,MAP3K5,CXCL9,EDN1,CCL5
PMID:31024546	(2019) HGMB1 and RAGE as Essential Components of Ti Osseointegration Process in Mice.	8	64	1.16	0.00018	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000363973,9606.ENSP00000474412	TIMP3,CCR5,CXCL10,CXCL11,CD34,CCL20,ALPL,CCL5
PMID:31026414	(2019) Neuroinflammation During RNA Viral Infections.	8	64	1.16	0.00018	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412	CD38,CD69,CXCL10,CXCL9,PTGS2,BCL2,RHOA,CCL5
PMID:31057536	(2019) Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.	9	90	1.06	0.00018	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000478570	CD38,CD69,MMP14,ANG,CD247,PTGS2,ENTPD1,JAK2,VEGFA
PMID:31115532	(2019) Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data.	8	64	1.16	0.00018	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IFNG,LPL,PTEN,ANGPTL2,AR,BCL2,VEGFA
PMID:31523137	(2019) Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies.	5	11	1.72	0.00018	9606.ENSP00000256104,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000418823	FABP4,RBP4,AR,SHBG,FTO
PMID:31537512	(2019) Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice.	6	24	1.46	0.00018	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901	CD38,CD69,CCR5,CXCL10,CD34,CXCL9
PMID:31546924	(2019) FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response.	9	90	1.06	0.00018	9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000444198,9606.ENSP00000478570	VDAC1,ATM,MAPK7,SIRT6,SGK1,PTEN,BCL2,CITED2,VEGFA
PMID:31652910	(2019) The Hedgehog Signaling Pathway in Ischemic Tissues.	6	24	1.46	0.00018	9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478319,9606.ENSP00000478570	NOX1,BCL2,RHOA,BDNF,GREM1,VEGFA
PMID:31703458	(2019) Systematic Elucidation of the Mechanism of Genistein against Pulmonary Hypertension via Network Pharmacology Approach.	6	24	1.46	0.00018	9606.ENSP00000215832,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,PTGS2,PTEN,EDN1,MYD88,VEGFA
PMID:31815635	(2019) Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.	9	90	1.06	0.00018	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,PTGS2,JAK2,VEGFA
PMID:31885816	(2019) Imbalance of Homocysteine and H2S: Significance, Mechanisms, and Therapeutic Promise in Vascular Injury.	6	24	1.46	0.00018	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000419422	NOX4,CAV1,TXN,MTHFR,EDN1,AGTR1
PMID:31921140	(2019) Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion.	9	90	1.06	0.00018	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,CD34,CXCL9,CD47,PTGS2,JAK2,CCL5,VEGFA
PMID:29444487	(2018) Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFRSrc Transformation in Prostate Tumor Progression.	6	24	1.46	0.00018	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312	MAPK1,CDH1,CAV1,PTEN,AR,FGFR1
PMID:29580274	(2018) Chronic obstructive pulmonary disease (COPD): neutrophils, macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD.	5	11	1.72	0.00018	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901	MPO,IFNG,CXCL10,ELN,CXCL9
PMID:29588317	(2018) Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease.	10	120	0.98	0.00018	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000363973,9606.ENSP00000383364	MPO,FABP4,THBS1,TIMP3,PRDX2,CAV1,ELN,ANGPTL2,ALPL,PLA2G2A
PMID:29672868	(2018) Fetal Cerebral Circulation as Target of Maternal Alcohol Consumption.	6	24	1.46	0.00018	9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000358513,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ELN,VIP,CNR1,NTF3,BDNF,VEGFA
PMID:29785172	(2018) Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.	8	64	1.16	0.00018	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,ATM,CXCL10,CXCL11,CXCL9,HSPG2,EDN1,VEGFA
PMID:30006759	(2018) Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives.	6	24	1.46	0.00018	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000426809	CD38,IFNG,CD34,STAT5A,CD47,PROM1
PMID:30078142	(2018) Vasa vasorum inside outoutside in communication: a potential role in the patency of saphenous vein coronary artery bypass grafts.	5	11	1.72	0.00018	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,EDN1,VEGFA
PMID:30267158	(2018) The Role of Accessory Cells in Islet Homeostasis.	6	24	1.46	0.00018	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000478570	THBS1,CD34,VIP,EDN1,NPY,VEGFA
PMID:30427932	(2018) A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.	6	24	1.46	0.00018	9606.ENSP00000229135,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,SREBF1,ELN,CNTF,PTEN,VEGFA
PMID:30464459	(2018) Pulmonary impact of titanium dioxide nanorods: examination of nanorod-exposed rat lungs and human alveolar cells.	6	24	1.46	0.00018	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:31406390	(2018) Additive manufacturing of biomaterials.	5	11	1.72	0.00018	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,CDH1,ELN,BMP2,VEGFA
PMID:27232854	(2017) PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.	5	11	1.72	0.00018	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:28067804	(2017) Stromal Modulators of TGF-beta in Cancer.	8	64	1.16	0.00018	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000478570	THBS1,CDH1,KLF10,MMP14,CAV1,FMOD,BMP2,VEGFA
PMID:28116550	(2017) Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction.	5	11	1.72	0.00018	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,ELN,JAK2,BCL2,VEGFA
PMID:28261155	(2017) Environmental Factors Impacting Bone-Relevant Chemokines.	8	64	1.16	0.00018	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MPO,CXCL10,CCL20,BMP2,LTA,CCL5,GREM1,VEGFA
PMID:28394276	(2017) Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,HNF4A,RHOA,PROM1,VEGFA
PMID:28821884	(2017) The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.	9	90	1.06	0.00018	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000403495	FABP4,CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,S100A12,LTA
PMID:29135921	(2017) Nox, Reactive Oxygen Species and Regulation of Vascular Cell Fate.	8	64	1.16	0.00018	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000400175	NOX4,ELN,PTEN,NOX1,TXN,JAK2,NFE2L2,RHOA
PMID:29152213	(2017) The role of nitric oxide in stroke.	5	11	1.72	0.00018	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252	EDNRA,CAV1,PTGS2,EDN1,NFE2L2
PMID:29180963	(2017) Spinal Cord Molecular and Cellular Changes Induced by Adenoviral Vector- and Cell-Mediated Triple Gene Therapy after Severe Contusion.	6	24	1.46	0.00018	9606.ENSP00000248553,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,ANG,CNTF,BCL2,BDNF,VEGFA
PMID:29240722	(2017) G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.	8	64	1.16	0.00018	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,ANGPT2,CCL20,AGTR1,PROM1,CCL5,VEGFA
PMID:29258182	(2017) Tumor Microenvironment and Metabolism.	6	24	1.46	0.00018	9606.ENSP00000351807,9606.ENSP00000358513,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	ELN,CNR1,MTHFR,EDN1,PROM1,VEGFA
PMID:29259353	(2017) Effects of Extremely Low-Frequency Electromagnetic Fields on Neurogenesis and Cognitive Behavior in an Experimental Model of Hippocampal Injury.	5	11	1.72	0.00018	9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000403495,9606.ENSP00000414303	CAV1,BCL2,NPY,LTA,BDNF
PMID:26904322	(2016) Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.	5	11	1.72	0.00018	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525	MPO,CD38,CD34,JAK2,MME
PMID:26931436	(2016) Flow Cytometric Evaluation of DoubleTriple Hit Lymphoma.	5	11	1.72	0.00018	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MME
PMID:26982980	(2016) Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy.	5	11	1.72	0.00018	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	PTGS2,PTEN,AR,BCL2,VEGFA
PMID:27169994	(2016) Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.	6	24	1.46	0.00018	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	CD69,IFNG,CXCL10,CXCL11,CXCL9,VEGFA
PMID:27171110	(2016) The Potential Protective Effects of Polyphenols in Asbestos-Mediated Inflammation and Carcinogenesis of Mesothelium.	8	64	1.16	0.00018	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,PTGS2,BCL2,MYD88,LTA,CCL5,VEGFA
PMID:27623753	(2016) The extracellular matrix - the under-recognized element in lung disease?	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000400175	CDH1,CD34,ELN,PTGS2,HSPG2,RHOA
PMID:27731420	(2016) Whole Chromosome Instability induces senescence and promotes SASP.	8	64	1.16	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412	TGFB1,IFNG,ATM,CXCL10,PDGFB,CXCL9,RHOA,CCL5
PMID:27775600	(2016) Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide.	6	24	1.46	0.00018	9606.ENSP00000306884,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185	CXCL11,MAP3K5,PTGS2,PTEN,TXN,BCL2
PMID:27800506	(2016) Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice.	5	11	1.72	0.00018	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BCL2,VEGFA
PMID:27987541	(2016) Developing Treatments for Chronic Kidney Disease in the 21st Century.	6	24	1.46	0.00018	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000371067	TGFB1,CCR5,EDNRA,MAP3K5,NOX1,JAK2
PMID:28304186	(2016) miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.	5	11	1.72	0.00018	9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	PRKCE,PTEN,BCL2,AGTR1,VEGFA
PMID:28348774	(2016) Latent infection of human bocavirus accompanied by flare of chronic cough, fatigue and episodes of viral replication in an immunocompetent adult patient, Cologne, Germany.	8	64	1.16	0.00018	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,CCL20,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:28868235	(2016) Design of Injectable Materials to Improve Stem Cell Transplantation.	5	11	1.72	0.00018	9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	PDGFA,BMP2,NTF3,BDNF,VEGFA
PMID:30276271	(2016) Amnion-derived stem cell transplantation: A novel treatment for neurological disorders.	6	24	1.46	0.00018	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,HSPB1,CNTF,NTF3,BDNF,VEGFA
PMID:25545344	(2015) Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjoegrens syndrome.	5	11	1.72	0.00018	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,HSPB1,CXCL10,BCL2,CCL5
PMID:25616591	(2015) Vascularization in bone tissue engineering constructs.	5	11	1.72	0.00018	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,CD34,ELN,BMP2,VEGFA
PMID:25793578	(2015) Tenascin-X: beyond the architectural function.	6	24	1.46	0.00018	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,FMOD,ELN,RHOA,VEGFA
PMID:25937189	(2015) Adversomics: a new paradigm for vaccine safety and design.	6	24	1.46	0.00018	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000354901,9606.ENSP00000365777,9606.ENSP00000403495,9606.ENSP00000474412	CD69,CCR5,CXCL9,MTHFR,LTA,CCL5
PMID:25955299	(2015) Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.	6	24	1.46	0.00018	9606.ENSP00000226279,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000426809	CD38,MMP14,CD34,STAT5A,PTEN,PROM1
PMID:26048575	(2015) Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.	6	24	1.46	0.00018	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,PTEN,CCL5
PMID:26082926	(2015) Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair.	5	11	1.72	0.00018	9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CD34,SERPINF2,BMP2,CCL5,VEGFA
PMID:26492267	(2015) Longitudinal Study of Cytokine Expression, Lipid Profile and Neuronal Growth Factors in Human Breast Milk from Term and Preterm Deliveries.	6	24	1.46	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000414303	TGFB1,IFNG,ANG,CCL20,CNTF,BDNF
PMID:26579470	(2015) Mechanisms of resistance to EGFR tyrosine kinase inhibitors.	8	64	1.16	0.00018	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,IGF1R,GAS6,PTEN,JAK2,BCL2,VEGFA
PMID:24281852	(2014) Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.	5	11	1.72	0.00018	9606.ENSP00000013807,9606.ENSP00000225275,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000369816	ERCC1,MPO,COMT,MTHFR,SHBG
PMID:24437600	(2014) Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000363827	CDH1,TIMP3,IGF1R,MMP14,CD34,HSPG2
PMID:24527460	(2014) Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,HNF4A,PTEN,PROM1,VEGFA
PMID:24667266	(2014) [Advances in hypoxia microenvironment and chemotherapy-resistant of lung cancer].	6	24	1.46	0.00018	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,VDAC1,IGF1R,PROM1,VEGFA
PMID:24719869	(2014) Stem cell-based therapies for ischemic stroke.	8	64	1.16	0.00018	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,MPO,IFNG,CD34,BCL2,NTF3,BDNF,VEGFA
PMID:24798639	(2014) Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia.	6	24	1.46	0.00018	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000426809	CDH1,CD34,HNF4A,ELN,FGFR1,PROM1
PMID:24927147	(2014) Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.	8	64	1.16	0.00018	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,STAT5A,CCL20,BCL2,FGFR1,CCL5,VEGFA
PMID:24976841	(2014) Portal hypertension as immune mediate disease.	8	64	1.16	0.00018	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	CHI3L1,CCR5,EDNRA,ELN,VIP,EDN1,MYD88,VEGFA
PMID:25505471	(2014) M1M2 macrophage polarity in normal and complicated pregnancy.	8	64	1.16	0.00018	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,VIP,PTGS2,PROM1,CCL5
PMID:25905011	(2014) A review of experimental studies of hydrogen as a new therapeutic agent in emergency and critical care medicine.	5	11	1.72	0.00018	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000380365,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,RGN,BDNF,VEGFA
PMID:23551971	(2013) Effects of traumatic brain injury on intestinal contractility.	6	24	1.46	0.00018	9606.ENSP00000229135,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:24202338	(2013) Leptins Pro-Angiogenic Signature in Breast Cancer.	8	64	1.16	0.00018	9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	IGF1R,MMP14,CD34,ANG,SREBF1,PTGS2,JAK2,VEGFA
PMID:24223781	(2013) RTKERK pathway under natural selection associated with prostate cancer.	6	24	1.46	0.00018	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	IGF1R,PDGFB,AR,BCL2,MME,VEGFA
PMID:22934547	(2012) The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.	9	90	1.06	0.00018	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CCL20,ENTPD1,TXN,BCL2,LTA,CCL5,VEGFA
PMID:21490770	(2011) Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response.	6	24	1.46	0.00018	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000383364	CETP,MPO,LPL,LPA,ABCG1,PLA2G2A
PMID:21629653	(2011) Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis infection.	8	64	1.16	0.00018	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,MMP14,PDGFB,BCL2,MYD88,VEGFA
PMID:21647363	(2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.	6	24	1.46	0.00018	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,IGF1R,CCR5,MME,CCL5,VEGFA
PMID:21787235	(2011) Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease.	6	24	1.46	0.00018	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:22005287	(2011) Dietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins.	6	24	1.46	0.00018	9606.ENSP00000225275,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,TXN,EDN1,NFE2L2,BCL2,VEGFA
PMID:22025201	(2011) Mucosal macrophages in intestinal homeostasis and inflammation.	8	64	1.16	0.00018	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,CCR5,CXCL10,CCL20,VIP,PTGS2,MYD88,VEGFA
PMID:22048864	(2011) Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors.	8	64	1.16	0.00018	9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,FADS2,SREBF1,JAK2,GAP43,BCL2,MYD88,VEGFA
PMID:20028757	(2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.	5	11	1.72	0.00018	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ALDH1A1,CAV1,BCL2,PROM1
PMID:20050630	(2010) Signaling functions of reactive oxygen species.	6	24	1.46	0.00018	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641	NOX4,PRDX2,MAP3K5,PTEN,NOX1,TXN
PMID:20177380	(2010) High-density lipoprotein and the acute phase response.	6	24	1.46	0.00018	9606.ENSP00000200676,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000383364,9606.ENSP00000401399	CETP,LPA,ABCG1,JAK2,PLA2G2A,MYD88
PMID:20478049	(2010) Stat3: linking inflammation to epithelial cancer - more than a gut feeling?	8	64	1.16	0.00018	9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCL20,CNTF,JAK2,BCL2,MYD88,CCL5,VEGFA
PMID:20599443	(2010) Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.	6	24	1.46	0.00018	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000480291	IFNG,CD34,MME,AGTR1,APLNR,HNF1B
PMID:21209923	(2010) Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study.	5	11	1.72	0.00018	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000360997,9606.ENSP00000478570	IFNG,CXCL10,ANGPT2,ADAMTS13,VEGFA
PMID:19497108	(2009) Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a.	8	64	1.16	0.00018	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CXCL11,CD34,JAK2,BCL2,SAA1,MME,CCL5,VEGFA
PMID:19037210	(2008) Considerations regarding the genetics of obesity.	6	24	1.46	0.00018	9606.ENSP00000226760,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000384364,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,KCNJ11,CAPN10,NPY,FTO,HNF1B
PMID:19043603	(2008) PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.	8	64	1.16	0.00018	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,PRKAA1,PTEN,TXN,BCL2,RHOA,VEGFA
PMID:19079610	(2008) Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours.	6	24	1.46	0.00018	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CD34,MME,CCL5,VEGFA
PMID:17016617	(2006) Genetic risk for atherothrombotic cerebral infarction in individuals stratified by sex or conventional risk factors for atherosclerosis.	5	11	1.72	0.00018	9606.ENSP00000315011,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000474412	EDNRA,COMT,MTHFR,EDN1,CCL5
PMID:17319453	(2006) Clinical implications of angiogenesis in cancers.	6	24	1.46	0.00018	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000478570	THBS1,CD34,ANGPT2,ANG,PTGS2,VEGFA
PMID:11909910	(2002) Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.	5	11	1.72	0.00018	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:31069161	(....) immune mediator expression signatures are associated with improved outcome in ovarian carcinoma.	6	24	1.46	0.00018	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,CXCL11,PDGFA,CXCL9,LTA,VEGFA
PMID:35198545	(2022) Understanding Reactive Oxygen Species in Bone Regeneration: A Glance at Potential Therapeutics and Bioengineering Applications.	7	42	1.28	0.00019	9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,HNF4A,NOX1,TXN,BMP2,NFE2L2,VEGFA
PMID:35328637	(2022) Gene Expression over Time during Cell Transformation Due to Non-Genotoxic Carcinogen Treatment of Bhas 42 Cells.	11	155	0.91	0.00019	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000478253,9606.ENSP00000478570	IFNG,SOX9,THBS1,ATM,STAT5A,PTGS2,PTEN,JAK2,NFE2L2,MTHFD1L,VEGFA
PMID:35359949	(2022) Stem Cell-Derived Extracellular Vesicles as Potential Therapeutic Approach for Acute Kidney Injury.	7	42	1.28	0.00019	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,NOX4,CD47,PTEN,KL,FGFR1,VEGFA
PMID:33361384	(2021) Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.	7	42	1.28	0.00019	9606.ENSP00000255409,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,ATM,CD34,SREBF1,PTEN,PROM1,VEGFA
PMID:33420256	(2021) Hypoxia-induced amniotic fluid stem cell secretome augments cardiomyocyte proliferation and enhances cardioprotective effects under hypoxic-ischemic conditions.	7	42	1.28	0.00019	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000362524,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CXCL9,ANGPTL2,BDNF,CCL5,VEGFA
PMID:33670730	(2021) Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders.	7	42	1.28	0.00019	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000478570	FABP4,LPL,LPA,SREBF1,BDNF,FTO,VEGFA
PMID:33807174	(2021) Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance.	7	42	1.28	0.00019	9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CAV1,PTGS2,AR,BCL2,PROM1,VEGFA
PMID:33842514	(2021) Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease.	7	42	1.28	0.00019	9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000364683,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ANGPT2,EDNRA,BAMBI,EDN1,BCL2,RHOA,VEGFA
PMID:33902539	(2021) Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.	11	154	0.91	0.00019	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000264717,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000347041,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000364683,9606.ENSP00000376865,9606.ENSP00000401720	THBS1,NOX4,GCKR,ANGPT2,EDNRA,FMOD,SREBF1,MAP3K5,BAMBI,PDGFD,GK
PMID:34063955	(2021) Simulated Microgravity Remodels Extracellular Matrix of Osteocommitted Mesenchymal Stromal Cells.	10	121	0.98	0.00019	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000360997,9606.ENSP00000363973,9606.ENSP00000418525,9606.ENSP00000478570	LAMC1,THBS1,COL8A1,CDH1,TIMP3,ELN,ADAMTS13,ALPL,MME,VEGFA
PMID:34067630	(2021) The PI3KAkt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders.	7	42	1.28	0.00019	9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CD34,SREBF1,PTEN,NFE2L2,BCL2,VEGFA
PMID:34087197	(2021) The lipid biology of sepsis.	7	42	1.28	0.00019	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000259486,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000383364	CETP,MPO,ENPP2,ANGPT2,PTGS2,CNR1,PLA2G2A
PMID:34199319	(2021) Endothelial Cell Participation in Inflammatory Reaction.	7	42	1.28	0.00019	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,ANGPT2,SERPINF2,S100A12,EDN1,FGFR1,VEGFA
PMID:34204085	(2021) Post-Effort Changes in Autophagy- and Inflammation-Related Gene Expression in White Blood Cells of Healthy Young Men.	7	42	1.28	0.00019	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,BCL2,CCL5,VEGFA
PMID:34267760	(2021) The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures.	7	42	1.28	0.00019	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CD69,CXCL10,CXCL11,CXCL9,BCL2,CCL5
PMID:34422833	(2021) Physiological Signaling Functions of Reactive Oxygen Species in Stem Cells: From Flies to Man.	9	91	1.06	0.00019	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000363641	MPO,CDH1,NOX4,ATM,PRDX2,CD34,SIRT6,PTEN,TXN
PMID:34603321	(2021) Pulmonary-Resident Memory Lymphocytes: Pivotal Orchestrators of Local Immunity Against Respiratory Infections.	7	42	1.28	0.00019	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901	CD69,CDH1,CCR5,CXCL10,CXCL11,STAT5A,CXCL9
PMID:34671031	(2021) Extracellular vesicles in pancreatic cancer progression and therapies.	10	121	0.98	0.00019	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,ALDH1A1,CCL20,CD47,PTEN,RHOA,PROM1,CCL5,VEGFA
PMID:34733317	(2021) Integrated Network Analysis to Identify Key Modules and Potential Hub Genes Involved in Bovine Respiratory Disease: A Systems Biology Approach.	9	91	1.06	0.00019	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CCR5,STAT5A,PTGS2,SGK1,PTEN,JAK2,MYD88,CCL5
PMID:34771745	(2021) In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling.	10	121	0.98	0.00019	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	MPO,IFNG,APC,LAMC1,CDH1,CD34,SREBF1,PTEN,BCL2,FGFR1
PMID:34830952	(2021) Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?	7	42	1.28	0.00019	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,PDGFB,STAT5A,PDGFA,PTEN,FGFR1,VEGFA
PMID:34926607	(2021) Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling.	7	42	1.28	0.00019	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IFNG,NOX4,PTGS2,EDN1,BCL2,VEGFA
PMID:34965886	(2021) Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies.	9	91	1.06	0.00019	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CXCL9,CD47,PTGS2,JAK2,CCL5,VEGFA
PMID:34975877	(2021) The Immuno-Modulation Effect of Macrophage-Derived Extracellular Vesicles in Chronic Inflammatory Diseases.	9	91	1.06	0.00019	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000480291	IGF1R,ATM,CD47,PTGS2,PTEN,BMP2,BCL2,BDNF,HNF1B
PMID:34975885	(2021) Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.	11	154	0.91	0.00019	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD38,CD69,IFNG,CXCL10,CCL20,PTEN,TXN,RHOA,CCL5,VEGFA
PMID:35052770	(2021) The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?	9	91	1.06	0.00019	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CXCL11,GAS6,CXCL9,PTEN,PROM1,VEGFA
PMID:31918173	(2020) Molecular biology of oral cavity squamous cell carcinoma.	7	42	1.28	0.00019	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000376865,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL9,NOX1,PDGFD,VEGFA
PMID:32121067	(2020) Advances in Research on the Bioactivity of Alginate Oligosaccharides.	7	42	1.28	0.00019	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000362463,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	MPO,LPL,PTGS2,GLO1,NFE2L2,CCL5,VEGFA
PMID:32314127	(2020) The Complexity of Targeting Chemokines to Promote a Tumor Immune Response.	7	42	1.28	0.00019	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,PTEN,CCL5,VEGFA
PMID:32340220	(2020) The Relevance of Oxidative Stress in the Pathogenesis and Therapy of Retinal Dystrophies.	7	42	1.28	0.00019	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252	TGFB1,IFNG,NOX4,PRDX2,PTGS2,TXN,NFE2L2
PMID:32604738	(2020) Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination.	9	91	1.06	0.00019	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,IGF1R,MMP14,CD34,CAV1,PTEN,CCL5,VEGFA
PMID:32635637	(2020) Role of Curcumin and (-)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review.	7	42	1.28	0.00019	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,MAPK7,BCL2,PROM1,VEGFA
PMID:32760209	(2020) The Roles of Noncardiomyocytes in Cardiac Remodeling.	9	91	1.06	0.00019	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,NOX4,CCR5,CXCL10,CXCL11,CXCL9,EDN1,MYD88,VEGFA
PMID:32776013	(2020) Stem Cells in Ovarian Cancer and Potential Therapies.	7	42	1.28	0.00019	9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	ALDH1A1,CD34,STAT5A,ABCG1,PTEN,JAK2,PROM1
PMID:32824813	(2020) Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer.	9	91	1.06	0.00019	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ATM,CCR5,CXCL10,CXCL11,CCL20,PTEN,CCL5,VEGFA
PMID:32849557	(2020) Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies.	7	42	1.28	0.00019	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000478570	CD38,CCR5,CXCL10,CXCL9,PTGS2,ENTPD1,VEGFA
PMID:32903501	(2020) Contributions of IL-33 in Non-hematopoietic Lung Cells to Obstructive Lung Disease.	7	42	1.28	0.00019	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,IFNG,ANG,EDN1,JAK2,MYD88,VEGFA
PMID:33062639	(2020) Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer.	10	121	0.98	0.00019	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412	CD38,IFNG,CXCL10,CXCL11,STAT5A,CXCL9,PTGS2,ENTPD1,PTEN,CCL5
PMID:33066509	(2020) Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.	11	154	0.91	0.00019	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,CDH1,IGF1R,STAT5A,PTGS2,PTEN,NFE2L2,BCL2,MYD88,VEGFA,HNF1B
PMID:33142794	(2020) Bee Venom: An Updating Review of Its Bioactive Molecules and Its Health Applications.	7	42	1.28	0.00019	9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	STAT5A,PTGS2,PTEN,JAK2,BCL2,MYD88,VEGFA
PMID:30833362	(2019) The role of miRNAs in the invasion and metastasis of cervical cancer.	9	91	1.06	0.00019	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,TIMP3,IGF1R,CCR5,PTGS2,PTEN,BCL2,VEGFA
PMID:31049023	(2019) The Association between Depression and Type 1 Diabetes Mellitus: Inflammatory Cytokines as Ferrymen in between?	7	42	1.28	0.00019	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399	HSPB1,CXCL10,CXCL11,CCL20,CXCL9,JAK2,MYD88
PMID:31223427	(2019) Antioxidant and Anti-inflammatory Mechanisms of Neuroprotection by Ursolic Acid: Addressing Brain Injury, Cerebral Ischemia, Cognition Deficit, Anxiety, and Depression.	7	42	1.28	0.00019	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303	MPO,PTGS2,KL,GAP43,NFE2L2,MYD88,BDNF
PMID:31398325	(2019) Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis.	9	91	1.06	0.00019	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412	FABP4,CXCL10,EDNRA,GAS6,CXCL9,VIP,EDN1,AGTR1,CCL5
PMID:31426611	(2019) Cancer Stem Cells and Targeting Strategies.	7	42	1.28	0.00019	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ATM,CD34,CD47,BCL2,PROM1,VEGFA
PMID:31442675	(2019) Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.	7	42	1.28	0.00019	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,TIMP3,MMP14,ALPL,BMP2,GREM1,VEGFA
PMID:29805774	(2018) p53 and metabolism: from mechanism to therapeutics.	10	121	0.98	0.00019	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000400175	MAPK1,IGF1R,ATM,PTEN,NOX1,TXN,NFE2L2,BCL2,PLA2G2A,RHOA
PMID:30246025	(2018) Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma.	7	42	1.28	0.00019	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFB,CXCL9,LTA,PROM1,CCL5,VEGFA
PMID:30258937	(2018) Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.	9	91	1.06	0.00019	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000418525	CDH1,IGF1R,ATM,ALDH1A1,HNF4A,PTEN,JAK2,FGFR1,MME
PMID:30266897	(2018) USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and beta-TrCP and promotes cancer malignancy.	7	42	1.28	0.00019	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000479617	THBS1,CDH1,ANGPT2,SAA1,CCL5,VEGFA,UHRF1
PMID:29081515	(2017) Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.	9	91	1.06	0.00019	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD38,NOX4,EDNRA,CAV1,PTGS2,NOX1,EDN1,BCL2,VEGFA
PMID:29326752	(2017) The Dynamics of microRNA Transcriptome in Bovine Corpus Luteum during Its Formation, Function, and Regression.	7	42	1.28	0.00019	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,THBS1,ANGPT2,PTEN,BCL2,VEGFA
PMID:26836372	(2016) MicroRNA-27b Enhances the Hepatic Regenerative Properties of Adipose-Derived Mesenchymal Stem Cells.	7	42	1.28	0.00019	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000306124,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000397297,9606.ENSP00000478570	TGFB1,NOX4,PRKCE,CAV1,PRKAA1,NTF3,VEGFA
PMID:27110066	(2016) Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.	7	42	1.28	0.00019	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000368683,9606.ENSP00000400175	CETP,TGFB1,IFNG,CXCL10,SIRT6,EDN1,RHOA
PMID:25713706	(2015) Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration.	7	42	1.28	0.00019	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000352264,9606.ENSP00000402152,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,AMBP,VDAC1,CD2AP,SLC12A3,PROM1,VEGFA
PMID:25765115	(2015) Transcriptome analysis of hen preadipocytes treated with an adipogenic cocktail (DMIOA) with or without 20(S)-hydroxylcholesterol.	10	121	0.98	0.00019	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000419422	CD38,FABP4,ENPP2,FADS2,LPL,SREBF1,CCL20,AR,FGFR1,AGTR1
PMID:24780245	(2014) Updates of reactive oxygen species in melanoma etiology and progression.	7	42	1.28	0.00019	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000400175	SOX9,NOX4,IGF1R,PTEN,NOX1,TXN,RHOA
PMID:24904424	(2014) Fibroblasts in fibrosis: novel roles and mediators.	7	42	1.28	0.00019	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000478570	NOX4,TIMP3,EDNRA,CAV1,ELN,PTGS2,VEGFA
PMID:25009722	(2014) Inflammatory response in maternal serum during preterm labour.	7	42	1.28	0.00019	9606.ENSP00000229135,9606.ENSP00000259407,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,BAAT,TIMP3,CXCL10,CXCL9,CCL5,VEGFA
PMID:26770737	(2014) Natural products as potential cancer therapy enhancers: A preclinical update.	7	42	1.28	0.00019	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,PTEN,AR,BCL2,PROM1,VEGFA
PMID:23554249	(2013) Perivascular cells in blood vessel regeneration.	7	42	1.28	0.00019	9606.ENSP00000232219,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	RBP1,CD34,ANGPT2,PDGFB,ELN,RHOA,VEGFA
PMID:24288571	(2013) Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.	7	42	1.28	0.00019	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000345708,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	MPO,HSPB1,KCNJ11,EDN1,BCL2,LTA,VEGFA
PMID:24455420	(2013) Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines.	7	42	1.28	0.00019	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000478570	ATM,CCR5,CD34,RBP4,JAK2,RARRES2,VEGFA
PMID:22781158	(2012) Genetics of type 2 diabetes in European populations.	7	42	1.28	0.00019	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,HNF4A,KCNJ11,BCL2,FTO,HNF1B
PMID:23284726	(2012) Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A.	7	42	1.28	0.00019	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,SAA1,MYD88,CCL5
PMID:25977900	(2012) Oncolytic virotherapy for ovarian cancer.	7	42	1.28	0.00019	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CXCL10,CXCL9,PTGS2,MYD88,PROM1,VEGFA
PMID:21422497	(2011) Roles of the RafMEKERK and PI3KPTENAktmTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.	9	91	1.06	0.00019	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,IGF1R,HNF4A,PTGS2,PTEN,AR,BCL2,FGFR1,VEGFA
PMID:19800967	(2010) Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.	7	42	1.28	0.00019	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000362057	IFNG,THBS1,CDH1,NOX4,TIMP3,PTEN,NOX1
PMID:20138013	(2010) FcRgamma activation regulates inflammation-associated squamous carcinogenesis.	7	42	1.28	0.00019	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,PTGS2,MYD88,VEGFA
PMID:19628034	(2009) NOX and inflammation in the vascular adventitia.	7	42	1.28	0.00019	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	MAPK1,IFNG,NOX4,MAPK7,NOX1,EDN1,VEGFA
PMID:18790444	(2008) Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.	7	42	1.28	0.00019	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000354782,9606.ENSP00000381185	CD38,CD69,IFNG,CD34,FMOD,CD247,BCL2
PMID:18001488	(2007) Cells of the synovium in rheumatoid arthritis. Chondrocytes.	9	91	1.06	0.00019	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SOX9,CHI3L1,THBS1,MMP14,FMOD,PLA2G2A,CCL5,VEGFA
PMID:35269828	(2022) Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets.	8	65	1.15	0.00020	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,S100A12,JAK2,LTA,CCL5
PMID:33289908	(2021) An evaluation of the molecular mode of action of trans-resveratrol in the Porphyromonas gingivalis lipopolysaccharide challenged neuronal cell model.	8	65	1.15	0.00020	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000418823,9606.ENSP00000478570	TGFB1,IGF1R,PTGS2,PTEN,JAK2,MYD88,FTO,VEGFA
PMID:33669611	(2021) RNA-Seq Analysis Reveals CCR5 as a Key Target for CRISPR Gene Editing to Regulate In Vivo NK Cell Trafficking.	8	65	1.15	0.00020	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,JAK2,RARRES2,CCL5,VEGFA
PMID:33800266	(2021) The Two-Faced Role of SIRT6 in Cancer.	8	65	1.15	0.00020	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,CYP24A1,CDH1,IGF1R,CD34,SIRT6,JAK2,BCL2
PMID:33917037	(2021) Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer.	8	65	1.15	0.00020	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,CD34,CXCL9,CD47,PTEN,CCL5,VEGFA
PMID:33919211	(2021) Vitamin E beyond Its Antioxidant Label.	8	65	1.15	0.00020	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,LPL,SREBF1,PTEN,JAK2,BCL2,VEGFA
PMID:34118939	(2021) Molecular and cellular pathways contributing to brain aging.	8	65	1.15	0.00020	9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,SIRT6,EDN1,NFE2L2,BCL2,NTF3,BDNF,VEGFA
PMID:34177893	(2021) Inflammasomes and Fibrosis.	8	65	1.15	0.00020	9606.ENSP00000263317,9606.ENSP00000345708,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412	NOX4,KCNJ11,TXN,NFE2L2,IRAK4,MYD88,AGTR1,CCL5
PMID:34645669	(2021) Immunological configuration of ovarian carcinoma: features and impact on disease outcome.	10	122	0.97	0.00020	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CD38,IFNG,FABP4,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:34842660	(2021) Exploring the Inflammatory Pathogenesis of Colorectal Cancer.	8	65	1.15	0.00020	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000418823,9606.ENSP00000478570	MPO,CDH1,CCL20,PTGS2,JAK2,MYD88,FTO,VEGFA
PMID:34899318	(2021) Effects of Berberine on Atherosclerosis.	8	65	1.15	0.00020	9606.ENSP00000263317,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	NOX4,PDGFA,MAP3K5,PTGS2,PTEN,MYD88,LTA,CCL5
PMID:34925351	(2021) Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups.	8	65	1.15	0.00020	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,NOX1,BMP2,MYD88,CCL5
PMID:35002759	(2021) Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation.	8	65	1.15	0.00020	9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000419422,9606.ENSP00000478570	MAPK7,ANGPT2,ELN,EDN1,RHOA,TRPC1,AGTR1,VEGFA
PMID:35059451	(2021) Targeting Epigenetic Mechanisms in Vascular Aging.	10	122	0.97	0.00020	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000418823,9606.ENSP00000479617	CD38,ATM,GAS6,SIRT6,SREBF1,ABCG1,PTGS2,NOX1,FTO,UHRF1
PMID:35070038	(2021) Macrophages play a role in inflammatory transformation of colorectal cancer.	8	65	1.15	0.00020	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL9,PTEN,KL,MYD88,CCL5,VEGFA
PMID:30535469	(2019) PI3KAkt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review).	8	65	1.15	0.00020	9606.ENSP00000222139,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,APC,ATM,PTGS2,PTEN,EDN1,JAK2,VEGFA
PMID:30964207	(2019) MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.	8	65	1.15	0.00020	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354901	MPO,IFNG,IGF1R,CXCL10,CXCL11,HNF4A,SREBF1,CXCL9
PMID:31178825	(2019) Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.	11	156	0.91	0.00020	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,ALDH1A1,STAT5A,PTEN,JAK2,NFE2L2,BCL2,FGFR1,PROM1,VEGFA
PMID:31827525	(2019) Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids.	12	192	0.86	0.00020	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000258341,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,LAMC1,VDAC1,ATM,MMP14,SIRT6,SREBF1,GFPT1,G6PD,BCL2,VEGFA
PMID:32038494	(2019) Transcriptional Analysis of Sepsis-Induced Activation and Damage of the Adrenal Endothelial Microvascular Cells.	8	65	1.15	0.00020	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,CXCL9,PTGS2,CCL5,VEGFA
PMID:29872724	(2018) Role of nonresolving inflammation in hepatocellular carcinoma development and progression.	8	65	1.15	0.00020	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ANGPT2,PTEN,JAK2,BCL2,LTA,PROM1,VEGFA
PMID:30279347	(2018) Oncogenic Signaling Induced by HCV Infection.	8	65	1.15	0.00020	9606.ENSP00000257430,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	APC,CD34,ANGPT2,STAT5A,PTGS2,BCL2,PROM1,VEGFA
PMID:25306501	(2017) Cellular and Molecular Mediators of Intestinal Fibrosis.	8	65	1.15	0.00020	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	CD34,PDGFA,CCL20,EDN1,BCL2,FGFR1,MYD88,VEGFA
PMID:28275390	(2017) Dual role of inflammatory mediators in cancer.	8	65	1.15	0.00020	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:28408751	(2017) MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells.	8	65	1.15	0.00020	9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	AMBP,CCR5,CXCL10,CD34,CXCL9,BCL2,PROM1,CCL5
PMID:28497350	(2017) Synovial cellular and molecular markers in rheumatoid arthritis.	8	65	1.15	0.00020	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CD69,CCR5,MMP14,CD34,CCL20,CXCL9,PTGS2,CCL5
PMID:27208212	(2016) The arterial microenvironment: the where and why of atherosclerosis.	8	65	1.15	0.00020	9606.ENSP00000292303,9606.ENSP00000311005,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,MAPK7,ELN,ENTPD1,BCL2,FGFR1,RHOA,CCL5
PMID:27590516	(2016) On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer.	8	65	1.15	0.00020	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252	TGFB1,IGF1R,ATM,SIRT6,CAV1,PTGS2,PTEN,NFE2L2
PMID:28050120	(2016) Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays.	8	65	1.15	0.00020	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,ANGPT2,ANG,CXCL9,CCL5,VEGFA
PMID:30159411	(2016) Non-coding RNAmicroRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins.	8	65	1.15	0.00020	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185	SOX9,CDH1,ALDH1A1,PTGS2,PTEN,AR,NFE2L2,BCL2
PMID:24950699	(2014) Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.	8	65	1.15	0.00020	9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000376865,9606.ENSP00000414303	FABP4,ALDH1A1,PLIN1,LPL,CD34,ELN,PDGFD,BDNF
PMID:23633288	(2013) How stem cells speak with host immune cells in inflammatory brain diseases.	8	65	1.15	0.00020	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000478570	CD38,CD69,CCR5,CXCL10,STAT5A,CXCL9,BDNF,VEGFA
PMID:24058791	(2013) STAT3 activation: A key factor in tumor immunoescape.	8	65	1.15	0.00020	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,ENTPD1,PTEN,JAK2,MYD88,CCL5,VEGFA
PMID:24348712	(2013) Curcumin and diabetes: a systematic review.	8	65	1.15	0.00020	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000478570	IFNG,HSPB1,LPL,PTGS2,EDN1,G6PD,NFE2L2,VEGFA
PMID:24416650	(2013) IL-6-STAT3 signaling and premature senescence.	8	65	1.15	0.00020	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ATM,STAT5A,CNTF,PTEN,JAK2,BCL2,VEGFA
PMID:22481923	(2012) Matricellular proteins: a sticky affair with cancers.	8	65	1.15	0.00020	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,EDNRA,CD47,PTGS2,EDN1,RHOA,VEGFA
PMID:22504887	(2012) Molecular markers of adrenocortical tumors.	8	65	1.15	0.00020	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000418009,9606.ENSP00000477707,9606.ENSP00000478570	ERCC1,IGF1R,ALDH1A1,SREBF1,ABCG1,RARRES2,NR1H3,VEGFA
PMID:22417140	(2011) Hypothalamic inflammation: a double-edged sword to nutritional diseases.	8	65	1.15	0.00020	9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303	LPL,SIRT6,CNTF,PTGS2,JAK2,NPY,MYD88,BDNF
PMID:20525361	(2010) Intrinsic response of thoracic propriospinal neurons to axotomy.	8	65	1.15	0.00020	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	HSPB1,ATM,CNTF,TXN,GAP43,BCL2,NPY,BDNF
PMID:18662800	(2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.	8	65	1.15	0.00020	9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	ELN,PTGS2,EDN1,NFE2L2,BCL2,LTA,CCL5,VEGFA
PMID:17222352	(2007) Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.	8	65	1.15	0.00020	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	CD69,CXCL10,STAT5A,CD247,CXCL9,JAK2,BCL2,MYD88
PMID:34953040	(2022) Roles of mesenchymal stem cells and exosomes in interstitial cystitisbladder pain syndrome.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,ELN,VIP,BCL2,VEGFA
PMID:34984803	(2022) Biological and molecular profile of fracture non-union tissue: A systematic review and an update on current insights.	6	25	1.44	0.00021	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	CD34,PDGFA,ALPL,BMP2,GREM1,VEGFA
PMID:35017150	(2022) Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000478570	CD38,CD69,CCL20,CD47,ENTPD1,VEGFA
PMID:35054151	(2022) Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician.	8	66	1.14	0.00021	9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000478570	TIMP3,ANGPT2,MAP3K5,PTEN,NFE2L2,BCL2,IRAK4,VEGFA
PMID:35163326	(2022) Colon Expression of Chemokines and Their Receptors Depending on the Stage of Colitis and Oat Beta-Glucan Dietary Intervention-Crohns Disease Model Study.	7	43	1.27	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5
PMID:35207132	(2022) Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding.	8	66	1.14	0.00021	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,TIMP3,MMP14,PTEN,NFE2L2,RHOA,VEGFA
PMID:35222035	(2022) Resveratrol: Potential Application in Sepsis.	7	43	1.27	0.00021	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CXCL10,PTGS2,JAK2,RHOA,MYD88,CCL5
PMID:35251337	(2022) Role of melatonin in respiratory diseases (Review).	6	25	1.44	0.00021	9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,EDN1,NFE2L2,BCL2,BDNF,VEGFA
PMID:35265535	(2022) miR-548d-3p Is Up-Regulated in Human Visceral Leishmaniasis and Suppresses Parasite Growth in Macrophages.	6	25	1.44	0.00021	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	MAPK1,IGF1R,CXCL10,CXCL9,PTGS2,CCL5
PMID:35269779	(2022) Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.	6	25	1.44	0.00021	9606.ENSP00000221930,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368683	TGFB1,HNF4A,SIRT6,SREBF1,PTGS2,EDN1
PMID:35321240	(2022) Oxidative Stress and Gut Microbiome in Inflammatory Skin Diseases.	7	43	1.27	0.00021	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000478570	MPO,THBS1,NOX4,ATM,CXCL9,NOX1,VEGFA
PMID:35326408	(2022) New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.	9	92	1.05	0.00021	9606.ENSP00000288266,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	APPL1,SIRT6,PTGS2,JAK2,BCL2,FGFR1,RARRES2,APLNR,VEGFA
PMID:35327514	(2022) Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights.	7	43	1.27	0.00021	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000474412	CHI3L1,CDH1,CXCL10,CAV1,ELN,JAK2,CCL5
PMID:35327629	(2022) Y It Matters-Sex Differences in Fetal Lung Development.	6	25	1.44	0.00021	9606.ENSP00000215832,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000478570	MAPK1,PDGFA,ELN,AR,SHBG,VEGFA
PMID:35408440	(2022) The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer.	7	43	1.27	0.00021	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	CXCL10,CXCL11,MMP14,CCL20,CXCL9,PTEN,VEGFA
PMID:35409420	(2022) Physical Forces in Glioblastoma Migration: A Systematic Review.	6	25	1.44	0.00021	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CAV1,PTEN,RHOA,PROM1,VEGFA
PMID:33401654	(2021) Molecular Mechanisms of Renal Progenitor Regulation: How Many Pieces in the Puzzle?	8	66	1.14	0.00021	9606.ENSP00000245479,9606.ENSP00000315011,9606.ENSP00000317674,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,EDNRA,APOL1,ANG,EDN1,SAA1,PROM1,VEGFA
PMID:33436830	(2021) Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.	6	25	1.44	0.00021	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CCL20,BCL2,CCL5,VEGFA
PMID:33505588	(2021) Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimers Disease: A Narrative Review.	6	25	1.44	0.00021	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000354995,9606.ENSP00000363641,9606.ENSP00000384906	CETP,PON2,MPO,ABCG1,TXN,SAA1
PMID:33537076	(2021) Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.	8	66	1.14	0.00021	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	ATM,CCR5,CXCL10,CXCL11,CCL20,CD247,CXCL9,CCL5
PMID:33605033	(2021) The functions of autophagy at the tumour-immune interface.	7	43	1.27	0.00021	9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD47,PTEN,BCL2,MYD88,CCL5,VEGFA
PMID:33671514	(2021) Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease DevelopmentProgression, and Potential as Therapeutic Targets.	7	43	1.27	0.00021	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	ERCC1,MAPK1,CDH1,STAT5A,PTEN,JAK2,VEGFA
PMID:33801451	(2021) Intracellular Responses Triggered by Cold Atmospheric Plasma and Plasma-Activated Media in Cancer Cells.	8	66	1.14	0.00021	9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000426809	HSPB1,CHI3L1,CDH1,ATM,MAP3K5,NOX1,BCL2,PROM1
PMID:33803804	(2021) New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics.	7	43	1.27	0.00021	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,PDGFB,PTEN,BCL2,CCL5,VEGFA
PMID:33805763	(2021) Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out?	7	43	1.27	0.00021	9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD34,BMP2,EDN1,BCL2,MME,CCL5,VEGFA
PMID:33808737	(2021) Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection.	7	43	1.27	0.00021	9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,NFE2L2,BCL2,NPY,MYD88,BDNF,VEGFA
PMID:33920054	(2021) From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy.	9	92	1.05	0.00021	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	APC,CDH1,HNF4A,PTEN,AR,BCL2,IRAK4,MYD88,VEGFA
PMID:34025826	(2021) Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles.	8	66	1.14	0.00021	9606.ENSP00000013807,9606.ENSP00000310520,9606.ENSP00000337332,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000383232,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,ERCC4,SIRT6,AR,BCL2,GGT1,PROM1,VEGFA
PMID:34064375	(2021) Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?	8	66	1.14	0.00021	9606.ENSP00000263317,9606.ENSP00000351671,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CCL20,BAMBI,JAK2,FGFR1,MYD88,CCL5,VEGFA
PMID:34162860	(2021) Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.	8	66	1.14	0.00021	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	TGFB1,CD38,IFNG,CD34,CNTF,BDNF,MME,CCL5
PMID:34209636	(2021) Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties.	7	43	1.27	0.00021	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	PON2,NOX4,LPL,SREBF1,PTGS2,BCL2,VEGFA
PMID:34298815	(2021) Lineage Plasticity in Cancer: The Tale of a Skin-Walker.	8	66	1.14	0.00021	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000322898,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	SOX9,CDH1,EBF1,GAS6,PTEN,BCL2,PROM1,CCL5
PMID:34299048	(2021) Adipose-Derived Exosomes as Possible Players in the Development of Insulin Resistance.	8	66	1.14	0.00021	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000393312,9606.ENSP00000418009	FABP4,IGF1R,ATM,CAV1,SREBF1,RBP4,FGFR1,RARRES2
PMID:34335050	(2021) The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes?	7	43	1.27	0.00021	9606.ENSP00000216862,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000360247,9606.ENSP00000419422,9606.ENSP00000474412	CYP24A1,CD38,IFNG,CCR5,CYP2J2,AGTR1,CCL5
PMID:34359938	(2021) Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases.	8	66	1.14	0.00021	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000321334,9606.ENSP00000321853,9606.ENSP00000363827,9606.ENSP00000384364,9606.ENSP00000384906,9606.ENSP00000478570	MPO,MMP14,LPA,SERPINF2,HSPG2,NPY,SAA1,VEGFA
PMID:34572013	(2021) Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages.	10	123	0.97	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ANGPT2,GAS6,CXCL9,CD47,PTGS2,JAK2,CCL5,VEGFA
PMID:34572562	(2021) Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk.	6	25	1.44	0.00021	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000369816,9606.ENSP00000478570	MAPK1,MAPK7,AR,ALPL,SHBG,VEGFA
PMID:34671561	(2021) The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?	9	92	1.05	0.00021	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185	SOX9,CDH1,ATM,CXCL10,ANGPT2,SIRT6,CXCL9,PTEN,BCL2
PMID:34760623	(2021) Potential of different cells-derived exosomal microRNA cargos for treating spinal cord injury.	7	43	1.27	0.00021	9606.ENSP00000216181,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	MYH9,CNTF,PTEN,GAP43,BCL2,RHOA,BDNF
PMID:34764955	(2021) Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.	6	25	1.44	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:34777336	(2021) PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer.	7	43	1.27	0.00021	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000474412	TGFB1,CXCL10,CXCL11,CCL20,PTGS2,AR,CCL5
PMID:34804970	(2021) Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer.	6	25	1.44	0.00021	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,CAV1,PTEN,PROM1,VEGFA
PMID:34847773	(2021) Expression and function of PDGF-C in development and stem cells.	6	25	1.44	0.00021	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000419422,9606.ENSP00000426809	CD34,PDGFB,STAT5A,PDGFA,AGTR1,PROM1
PMID:34944415	(2021) MicroRNAs Regulating Renin-Angiotensin-Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension.	7	43	1.27	0.00021	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	TIMP3,MMP14,SIRT6,EDN1,BCL2,AGTR1,VEGFA
PMID:35052595	(2021) Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.	8	66	1.14	0.00021	9606.ENSP00000200676,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	CETP,NOX4,SREBF1,GFPT1,PTEN,NOX1,TXN,NFE2L2
PMID:35118091	(2021) Hantavirus Induced Kidney Disease.	6	25	1.44	0.00021	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CDH1,CXCL10,APOL1,CCL5,VEGFA
PMID:35198435	(2021) Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients Stratification.	8	66	1.14	0.00021	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,MMP14,HNF4A,CCL20,PTGS2,PLA2G2A,MYD88,VEGFA
PMID:30632783	(2020) Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.	7	43	1.27	0.00021	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,CDH1,ALDH1A1,VIP,PTEN,PROM1,VEGFA
PMID:31884477	(2020) Decay in Retinoic Acid Signaling in Varied Models of Alzheimers Disease and In-Vitro Test of Novel Retinoic Acid Receptor Ligands (RAR-Ms) to Regulate Protective Genes.	7	43	1.27	0.00021	9606.ENSP00000232219,9606.ENSP00000341208,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412	RBP1,STAT5A,ABCG1,JAK2,BDNF,MME,CCL5
PMID:32012983	(2020) Endocrine Disruptor Bisphenol A (BPA) Triggers Systemic Para-Inflammation and is Sufficient to Induce Airway Allergic Sensitization in Mice.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000377192	IFNG,CDH1,CXCL10,CXCL11,CXCL9,G6PD
PMID:32092864	(2020) Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective.	7	43	1.27	0.00021	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CCR5,ELN,NFE2L2,CCL5,VEGFA
PMID:32093140	(2020) Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.	8	66	1.14	0.00021	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303	CCR5,CD34,ELN,CD47,PTEN,BMP2,BCL2,BDNF
PMID:32110861	(2020) Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000368683	MPO,LPL,LPA,CAV1,ABCG1,EDN1
PMID:32133350	(2020) Targeted Drug Delivery via the Use of ECM-Mimetic Materials.	7	43	1.27	0.00021	9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	PDGFB,CAV1,ELN,BMP2,BCL2,RHOA,VEGFA
PMID:32161595	(2020) Chemokine Receptors and Phagocyte Biology in Zebrafish.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399	IFNG,CCR5,CXCL10,CXCL11,CXCL9,MYD88
PMID:32164715	(2020) Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance.	8	66	1.14	0.00021	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185	IGF1R,ATM,CD34,HNF4A,STAT5A,CD47,PTEN,BCL2
PMID:32210799	(2020) Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology-Based Identification.	8	66	1.14	0.00021	9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MMP14,PTGS2,PTEN,BCL2,MYD88,BDNF,CCL5,VEGFA
PMID:32233938	(2020) Matrix Metalloproteinases and Glaucoma Treatment.	6	25	1.44	0.00021	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000393312	CDH1,TIMP3,MMP14,ELN,PTGS2,FGFR1
PMID:32375354	(2020) Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.	9	92	1.05	0.00021	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	CD38,ATM,CD34,STAT5A,JAK2,BCL2,MYD88,MME,VEGFA
PMID:32429787	(2020) Polygala tenuifolia: a source for anti-Alzheimers disease drugs.	6	25	1.44	0.00021	9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	MAP3K5,PTGS2,GAP43,BCL2,MYD88,BDNF
PMID:32470547	(2020) Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.	7	43	1.27	0.00021	9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	CXCL10,PTGS2,EDN1,NFE2L2,MME,AGTR1,VEGFA
PMID:32545552	(2020) Eicosanoids and Oxidative Stress in Diabetic Retinopathy.	6	25	1.44	0.00021	9606.ENSP00000246553,9606.ENSP00000314897,9606.ENSP00000360247,9606.ENSP00000362057,9606.ENSP00000445772,9606.ENSP00000478570	FFAR1,ANGPT2,CYP2J2,NOX1,LTB4R2,VEGFA
PMID:32595946	(2020) Cell plasticity in cancer cell populations.	8	66	1.14	0.00021	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CDH1,HNF4A,GAS6,AR,BMP2,BDNF,CCL5
PMID:32642732	(2020) Genetics of human malignant peripheral nerve sheath tumors.	9	92	1.05	0.00021	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000393312	SOX9,THBS1,TIMP3,PDGFB,PDGFA,PTEN,GAP43,BCL2,FGFR1
PMID:32655851	(2020) Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance.	7	43	1.27	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:32674405	(2020) The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis.	8	66	1.14	0.00021	9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,ANGPT2,RBP4,ANGPTL2,JAK2,FGFR1,RARRES2,VEGFA
PMID:32699181	(2020) M1(hot) tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer.	7	43	1.27	0.00021	9606.ENSP00000256104,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	FABP4,AMBP,CXCL10,CXCL11,CXCL9,PROM1,CCL5
PMID:32722054	(2020) Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma.	9	92	1.05	0.00021	9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,SIRT6,SREBF1,ELN,CXCL9,PTGS2,BCL2,CCL5,VEGFA
PMID:32722151	(2020) Atherosclerotic Pre-Conditioning Affects the Paracrine Role of Circulating Angiogenic Cells Ex-Vivo.	7	43	1.27	0.00021	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363827,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,THBS1,CD34,ANGPT2,HSPG2,PROM1,VEGFA
PMID:32832403	(2020) Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000351908,9606.ENSP00000358513,9606.ENSP00000381185	IFNG,CCR5,EDNRA,MAP3K5,CNR1,BCL2
PMID:32909687	(2020) The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancerstromal cell cooperation.	7	43	1.27	0.00021	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000393312	MYH9,CDH1,GAS6,CAV1,PTEN,EDN1,FGFR1
PMID:32962005	(2020) P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.	8	66	1.14	0.00021	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFB,ENTPD1,EDN1,RHOA,AGTR1,PROM1,VEGFA
PMID:33033248	(2020) Two distinct immunopathological profiles in autopsy lungs of COVID-19.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	MPO,CD38,CCR5,CXCL10,CXCL11,CXCL9
PMID:33171872	(2020) Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype.	8	66	1.14	0.00021	9606.ENSP00000215832,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000400175	MAPK1,LAMC1,CDH1,PLIN1,PTEN,AR,JAK2,RHOA
PMID:30259383	(2019) Mechanisms of Resistance to Immune Checkpoint Blockade.	7	43	1.27	0.00021	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CXCL9,PTEN,JAK2,VEGFA
PMID:30383238	(2019) Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility.	6	25	1.44	0.00021	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901	CD69,IFNG,CCR5,CXCL10,CCL20,CXCL9
PMID:30651611	(2019) Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications.	9	92	1.05	0.00021	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000479617,9606.ENSP00000480291	THBS1,CXCL10,SIRT6,PTEN,KL,BCL2,CCL5,UHRF1,HNF1B
PMID:30675202	(2019) Orbital precursor B-lymphoblastic lymphoma involving the extraocular muscles in a 56-year-old male and a review of the literature.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,EBF1,BCL2,MME
PMID:30733831	(2019) A patient with a diagnosis of nodal marginal zone B-cell lymphoma and a t(2;14)(p24;q32) involving MYCN and IGH.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,ATM,JAK2,BCL2,MYD88,MME
PMID:30781519	(2019) Integrated MicroRNA and mRNA Profiling in Zika Virus-Infected Neurons.	8	66	1.14	0.00021	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CXCL9,PTGS2,MYD88,CCL5,VEGFA
PMID:30913246	(2019) Socioeconomic status and early blood concentrations of inflammation-related and neurotrophic proteins among extremely preterm newborns.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000336762,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,ANG,SAA1,BDNF,CCL5,VEGFA
PMID:30948622	(2019) Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance.	7	43	1.27	0.00021	9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000369816,9606.ENSP00000384906,9606.ENSP00000384957,9606.ENSP00000385834	LPL,APOL1,LPA,SHBG,SAA1,F11,TF
PMID:31014399	(2019) Multiple antigen-engineered DC vaccines with or without IFNalpha to promote antitumor immunity in melanoma.	9	92	1.05	0.00021	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CCL20,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:31139179	(2019) Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?	6	25	1.44	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252	CCR5,CXCL10,CXCL11,CXCL9,PTGS2,NFE2L2
PMID:31169198	(2019) Differences in pathological changes between two rat models of severe traumatic brain injury.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:31248452	(2019) Harnessing the secretome of adipose-derived stem cells in the treatment of ischemic heart diseases.	8	66	1.14	0.00021	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,CD34,PDGFA,MAP3K5,PDGFD,BCL2,MME,VEGFA
PMID:31277498	(2019) Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development.	6	25	1.44	0.00021	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,CAV1,PTGS2,BCL2,MYD88,VEGFA
PMID:31284524	(2019) Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges.	7	43	1.27	0.00021	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CHI3L1,THBS1,TIMP3,PTEN,PROM1,VEGFA
PMID:31443240	(2019) NF-kappaB Signaling in Ovarian Cancer.	7	43	1.27	0.00021	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,PTEN,BCL2,MYD88,PROM1,VEGFA
PMID:31514409	(2019) Conflicting Roles of 20-HETE in Hypertension and Stroke.	6	25	1.44	0.00021	9606.ENSP00000215832,9606.ENSP00000246553,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,FFAR1,EDNRA,PTGS2,CCL5,VEGFA
PMID:31614572	(2019) Antioxidant Therapies for Neuroprotection-A Review.	6	25	1.44	0.00021	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000414303	NOX4,PTGS2,NOX1,TXN,EDN1,BDNF
PMID:31618961	(2019) Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.	6	25	1.44	0.00021	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000478570	TGFB1,IFNG,PDGFB,PDGFA,PDGFD,VEGFA
PMID:31680976	(2019) Notoginsenoside R1 for Organs IschemiaReperfusion Injury: A Preclinical Systematic Review.	7	43	1.27	0.00021	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CAV1,PTEN,NFE2L2,BCL2,BDNF,VEGFA
PMID:31745084	(2019) HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition.	7	43	1.27	0.00021	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:31759347	(2019) Different Role of Caveolin-1 Gene in the Progression of Gynecological Tumors.	6	25	1.44	0.00021	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000369816	CDH1,MMP14,HNF4A,CAV1,PTEN,SHBG
PMID:31773065	(2019) Central regulation of breast cancer growth and metastasis.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000478570	MPO,IFNG,PTGS2,NPY,MYD88,VEGFA
PMID:31814865	(2019) Psychological Stress and Cellular Aging in Cancer: A Meta-Analysis.	6	25	1.44	0.00021	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000478570	NOX4,MAP3K5,PTGS2,NOX1,TXN,VEGFA
PMID:31817606	(2019) Pathogenomics of Uterine Fibroids Development.	8	66	1.14	0.00021	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000354511,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CCR5,CD34,HNF4A,COMT,NFE2L2,CCL5,VEGFA
PMID:31920952	(2019) Novel Neuropathic Pain Mechanisms Associated With Allergic Inflammation.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000414303	CD38,EDNRA,VIP,PTGS2,EDN1,BDNF
PMID:28793782	(2018) Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis.	6	25	1.44	0.00021	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,ANGPT2,CAV1,NOX1,NFE2L2,VEGFA
PMID:29413878	(2018) Neonatal systemic inflammation and the risk of low scores on measures of reading and mathematics achievement at age 10 years among children born extremely preterm.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,ANGPT2,SAA1,BDNF,CCL5,VEGFA
PMID:29420211	(2018) Translational Implications of Platelets as Vascular First Responders.	9	92	1.05	0.00021	9606.ENSP00000225275,9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,P2RY1,CD34,GAS6,PTGS2,ADAMTS13,MYD88,CCL5,VEGFA
PMID:29545965	(2018) Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.	8	66	1.14	0.00021	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,MAPK1,CDH1,MAPK7,PTGS2,PTEN,BCL2,VEGFA
PMID:29724198	(2018) The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial.	6	25	1.44	0.00021	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CD34,EDN1,BCL2,PROM1,VEGFA
PMID:29767367	(2018) A Review of Transcriptome Analysis in Pulmonary Vascular Diseases.	7	43	1.27	0.00021	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,ANGPT2,CAV1,VIP,EDN1,AGTR1,VEGFA
PMID:29796019	(2018) Cinnamon in Anticancer Armamentarium: A Molecular Approach.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CXCL11,CXCL9,PTGS2,BCL2,VEGFA
PMID:29921789	(2018) Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity.	9	92	1.05	0.00021	9606.ENSP00000246553,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	FFAR1,THBS1,LPL,SIRT6,SREBF1,PTGS2,NOX1,TXN,BCL2
PMID:30050659	(2018) Therapeutic Potential of Salviae Miltiorrhizae Radix et Rhizoma against Human Diseases Based on Activation of Nrf2-Mediated Antioxidant Defense System: Bioactive Constituents and Mechanism of Action.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000380252	IFNG,NOX4,ABCG1,PTGS2,G6PD,NFE2L2
PMID:30060755	(2018) Tumor microenvironment participates in metastasis of pancreatic cancer.	9	92	1.05	0.00021	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CCL20,CD247,PTEN,MME,PROM1,CCL5,VEGFA
PMID:30181337	(2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection.	7	43	1.27	0.00021	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	TGFB1,CXCL10,CXCL9,CD47,PTEN,JAK2,CCL5
PMID:30283138	(2018) Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD38,CD69,CCR5,CXCL10,CXCL11,CXCL9
PMID:30400241	(2018) Transcriptional Landscape of PARs in Epithelial Malignancies.	7	43	1.27	0.00021	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000384262,9606.ENSP00000478570	TGFB1,CDH1,PDGFA,PTEN,AR,HPSE,VEGFA
PMID:30413079	(2018) Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.	8	66	1.14	0.00021	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000363827,9606.ENSP00000384262,9606.ENSP00000474412	CD69,THBS1,IGF1R,CXCL10,MMP14,HSPG2,HPSE,CCL5
PMID:30564236	(2018) Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.	7	43	1.27	0.00021	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,CDH1,ANG,BCL2,BDNF,CCL5,VEGFA
PMID:30595701	(2018) Human Pluripotent Stem Cell Culture: Current Status, Challenges, and Advancement.	7	43	1.27	0.00021	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	CDH1,IGF1R,BMP2,FGFR1,NTF3,RHOA,BDNF
PMID:31930188	(2018) Cancer prevention through miRNAs: miR-206 prevents the initiation and progression of hepatocellular carcinoma by attenuating c-MET signaling and cell-cycle progression via cyclin D1 and CDK6.	6	25	1.44	0.00021	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	TIMP3,IGF1R,PTEN,BCL2,RHOA,VEGFA
PMID:32258418	(2018) The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma.	7	43	1.27	0.00021	9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000426809	ATM,ANG,STAT5A,PTEN,RHOA,AGTR1,PROM1
PMID:27860287	(2017) Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.	7	43	1.27	0.00021	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,TIMP3,CD47,HSPG2,MYD88,CCL5,VEGFA
PMID:28095367	(2017) MicroRNAs are important regulators of drug resistance in colorectal cancer.	7	43	1.27	0.00021	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,ATM,MAPK7,PTGS2,PTEN,BCL2,VEGFA
PMID:28356110	(2017) Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets?	7	43	1.27	0.00021	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000400175	MAPK1,CD38,CD34,STAT5A,JAK2,G6PD,RHOA
PMID:28464443	(2017) The Drug Discovery and Development Industry in India-Two Decades of Proprietary Small-Molecule R&D.	8	66	1.14	0.00021	9606.ENSP00000200676,9606.ENSP00000246553,9606.ENSP00000268035,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000390651,9606.ENSP00000419422	CETP,FFAR1,IGF1R,VIP,PTGS2,HSPG2,IRAK4,AGTR1
PMID:28629479	(2017) Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.	7	43	1.27	0.00021	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412	CD69,IFNG,CXCL10,CXCL11,ELN,CXCL9,CCL5
PMID:28928631	(2017) Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.	6	25	1.44	0.00021	9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000414303	CNTF,PTGS2,CNR1,PTEN,EDN1,BDNF
PMID:29085362	(2017) Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency.	7	43	1.27	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,RHOA,CCL5
PMID:29127334	(2017) Biological assessments of multifunctional hydrogel-decorated implantable neural cuff electrode for clinical neurology application.	6	25	1.44	0.00021	9606.ENSP00000355370,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000484631	CNTF,CNR1,CNR2,GAP43,BDNF,PMP22
PMID:29162599	(2017) Redox Control of Vascular Function.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000362057	MPO,THBS1,NOX4,CAV1,CD47,NOX1
PMID:29170667	(2017) Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,CD47,PROM1,VEGFA
PMID:29312286	(2017) Emerging Concepts in the Resolution of Periodontal Inflammation: A Role for Resolvin E1.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000418009,9606.ENSP00000478570	MPO,IFNG,P2RY1,PTGS2,RARRES2,VEGFA
PMID:26649049	(2016) Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases.	7	43	1.27	0.00021	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,CD34,CNTF,PTEN,NTF3,BDNF,VEGFA
PMID:27070575	(2016) MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.	6	25	1.44	0.00021	9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	EDN1,BCL2,RHOA,BDNF,CCL5,VEGFA
PMID:27141352	(2016) CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy.	6	25	1.44	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,PTGS2,CCL5
PMID:27403037	(2016) Chemokines and Chemokine Receptors in the Development of Lupus Nephritis.	8	66	1.14	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,MYD88,CCL5
PMID:27417066	(2016) Cell-microenvironment interactions and architectures in microvascular systems.	6	25	1.44	0.00021	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000478570	TIMP3,MMP14,ANGPT2,PDGFB,ELN,VEGFA
PMID:27540349	(2016) Different anti-adipogenic effects of bio-compounds on primary visceral pre-adipocytes and adipocytes.	9	92	1.05	0.00021	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000477707	SOX9,FABP4,PLIN1,LPL,ANGPT2,PRKAA1,SREBF1,BMP2,NR1H3
PMID:27589890	(2016) A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.	6	25	1.44	0.00021	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:27632174	(2016) New Insights into the Pro-Inflammatory Activities of Ang1 on Neutrophils: Induction of MIP-1beta Synthesis and Release.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CCR5,CXCL10,ANGPT2,CXCL9,VEGFA
PMID:28691104	(2016) Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.	7	43	1.27	0.00021	9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000375844,9606.ENSP00000419422,9606.ENSP00000478570	HNF4A,KCNJ11,TXN,EDN1,CAPN10,AGTR1,VEGFA
PMID:25220353	(2015) Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.	9	92	1.05	0.00021	9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,PRKCE,MAPK7,ANG,PTEN,BCL2,NTF3,MYD88,CCL5
PMID:25371494	(2015) Versican in inflammation and tissue remodeling: the impact on lung disorders.	7	43	1.27	0.00021	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000347041,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000363827	THBS1,CDH1,HNF4A,FMOD,CCL20,ELN,HSPG2
PMID:25505290	(2015) CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:25807521	(2015) Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000381185	CD38,CD34,HNF4A,PTEN,ANGPTL2,BCL2
PMID:25815110	(2015) Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.	7	43	1.27	0.00021	9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	PTEN,TXN,EDN1,NTF3,BDNF,MME,VEGFA
PMID:25893478	(2015) New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?	6	25	1.44	0.00021	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525	EDNRA,ELN,VIP,EDN1,BCL2,MME
PMID:26082624	(2015) Novel aspects of pathogenesis and regeneration mechanisms in COPD.	7	43	1.27	0.00021	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,ELN,CXCL9,PTEN,VEGFA
PMID:26109963	(2015) Ligustrazine monomer against cerebral ischemiareperfusion injury.	6	25	1.44	0.00021	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,PTGS2,BCL2,RHOA,BDNF,VEGFA
PMID:26168983	(2015) Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.	7	43	1.27	0.00021	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,ANGPT2,EDNRA,ELN,EDN1,AGTR1,VEGFA
PMID:26175869	(2015) Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.	6	25	1.44	0.00021	9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,STAT5A,MAP3K5,AR,BCL2,VEGFA
PMID:26217233	(2015) NOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasis.	6	25	1.44	0.00021	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,EDNRA,NOX1,EDN1,RHOA,AGTR1
PMID:26346347	(2015) Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis.	6	25	1.44	0.00021	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	CD34,PDGFB,PDGFA,PDGFD,FGFR1,VEGFA
PMID:26440592	(2015) Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders.	7	43	1.27	0.00021	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFB,CXCL9,NPY,LTA,CCL5,VEGFA
PMID:26793165	(2015) The PI3KAkt Pathway in Tumors of Endocrine Tissues.	9	92	1.05	0.00021	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356213,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,VIP,SGK1,PTEN,BCL2,BDNF,PROM1,VEGFA
PMID:24682974	(2014) Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.	7	43	1.27	0.00021	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,STAT5A,ELN,PTEN,HSPG2,JAK2,VEGFA
PMID:24872814	(2014) Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes.	8	66	1.14	0.00021	9606.ENSP00000259407,9606.ENSP00000284031,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000477707	BAAT,DDAH1,LPL,HNF4A,CAV1,SREBF1,ABCG1,NR1H3
PMID:24918289	(2014) Erythropoietin action in stress response, tissue maintenance and metabolism.	8	66	1.14	0.00021	9606.ENSP00000222139,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	EPOR,HNF4A,PDGFB,STAT5A,JAK2,BCL2,NPY,VEGFA
PMID:25196434	(2014) Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.	8	66	1.14	0.00021	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000384262,9606.ENSP00000401399,9606.ENSP00000474412	CD69,THBS1,CCR5,CXCL10,CXCL9,HPSE,MYD88,CCL5
PMID:23383236	(2013) Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CD34,PROM1,CCL5,VEGFA
PMID:23520144	(2013) The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.	8	66	1.14	0.00021	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,CDH1,PTGS2,PTEN,EDN1,BCL2,VEGFA
PMID:23703386	(2013) Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.	7	43	1.27	0.00021	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CDH1,CXCL10,CXCL9,BCL2,CCL5,VEGFA
PMID:23752182	(2013) Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.	8	66	1.14	0.00021	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,CAV1,PTEN,AR,FGFR1,VEGFA
PMID:23839247	(2013) The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.	8	66	1.14	0.00021	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CCL20,CXCL9,BDNF,CCL5,VEGFA
PMID:24120657	(2013) Can nanomedicines kill cancer stem cells?	7	43	1.27	0.00021	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,BCL2,PROM1,VEGFA
PMID:24204127	(2013) Obstructive sleep apnea and endothelial progenitor cells.	6	25	1.44	0.00021	9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,MAP3K5,PTGS2,BCL2,PROM1,VEGFA
PMID:22185446	(2012) The epicardium as a candidate for heart regeneration.	8	66	1.14	0.00021	9606.ENSP00000222139,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000478570	EPOR,THBS1,CDH1,PDGFB,PDGFA,ELN,FGFR1,VEGFA
PMID:22398146	(2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.	8	66	1.14	0.00021	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MMP14,ANGPT2,PDGFB,TXN,EDN1,BCL2,VEGFA
PMID:22525850	(2012) The role of vitamin D in cancer prevention and treatment.	6	25	1.44	0.00021	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:22962432	(2012) PPARgamma regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.	6	25	1.44	0.00021	9606.ENSP00000256104,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000419422	FABP4,ELN,EDN1,RHOA,TRPC1,AGTR1
PMID:23251084	(2012) Salinomycin as a drug for targeting human cancer stem cells.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,PTEN,PROM1
PMID:24179404	(2012) Treatment of recurrent metastatic head and neck cancer: focus on cetuximab.	6	25	1.44	0.00021	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:31380106	(2012) TIMP-2: An Endogenous Angiogenesis Inhibitor with Distinct Antitumoral Properties.	6	25	1.44	0.00021	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000363827,9606.ENSP00000478570	THBS1,TIMP3,IGF1R,MMP14,HSPG2,VEGFA
PMID:21085979	(2011) Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines.	6	25	1.44	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:21334249	(2011) Regulation of hepatocyte fate by interferon-gamma.	7	43	1.27	0.00021	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185	CD69,CCR5,CXCL10,CXCL11,CXCL9,JAK2,BCL2
PMID:21610146	(2011) Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.	6	25	1.44	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD247,CXCL9,CCL5
PMID:21701683	(2011) Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine.	6	25	1.44	0.00021	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:21703360	(2011) Attenuation of multi-targeted proliferation-linked signaling by 3,3-diindolylmethane (DIM): from bench to clinic.	9	92	1.05	0.00021	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,HNF4A,COMT,PTGS2,PTEN,AR,PDGFD,BCL2,VEGFA
PMID:21742790	(2011) CaMKII in the cardiovascular system: sensing redox states.	7	43	1.27	0.00021	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000368683	HSPB1,NOX4,CAV1,KCNJ11,MAP3K5,TXN,EDN1
PMID:19854168	(2010) The extracellular matrix in development and morphogenesis: a dynamic view.	7	43	1.27	0.00021	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,STAT5A,PDGFA,ELN,HSPG2,RHOA,VEGFA
PMID:20018250	(2010) Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.	7	43	1.27	0.00021	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000478570	CD38,CD69,CXCL10,CD34,CXCL9,MYD88,VEGFA
PMID:20072701	(2010) Antivascular therapy for epithelial ovarian cancer.	7	43	1.27	0.00021	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CD34,EDNRA,PTGS2,PTEN,EDN1,VEGFA
PMID:20511060	(2010) The role of vitamin D in cancer prevention and treatment.	6	25	1.44	0.00021	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:20545606	(2010) Targeting the perpetrator: breast cancer stem cell therapeutics.	8	66	1.14	0.00021	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CD38,CDH1,ATM,CD34,PTEN,PROM1,GREM1,VEGFA
PMID:20552555	(2010) New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.	7	43	1.27	0.00021	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,PTEN,BCL2,PROM1,VEGFA
PMID:20716925	(2010) Redox regulation in cancer: a double-edged sword with therapeutic potential.	7	43	1.27	0.00021	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,MAP3K5,PTGS2,TXN,AR,NFE2L2,BCL2
PMID:21317461	(2010) Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.	6	25	1.44	0.00021	9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,CD47,HSPG2,BCL2,FGFR1,VEGFA
PMID:19084067	(2009) Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.	6	25	1.44	0.00021	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,CXCL10,CD34,CXCL9,PROM1,VEGFA
PMID:19482709	(2009) Chemokines and cardiac fibrosis.	6	25	1.44	0.00021	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CD34,CXCL9,CCL5
PMID:19826427	(2009) Side population cells have the characteristics of cancer stem-like cellscancer-initiating cells in bone sarcomas.	6	25	1.44	0.00021	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000317674,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,APOL1,BCL2,PROM1,VEGFA
PMID:19064699	(2008) MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries.	6	25	1.44	0.00021	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000401399	CXCL10,CAV1,ELN,CXCL9,TXN,MYD88
PMID:19675766	(2007) New therapeutic targets in the treatment of prostate cancer.	6	25	1.44	0.00021	9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	EDNRA,PTEN,AR,EDN1,BCL2,VEGFA
PMID:12740039	(2003) Molecular responses to hypoxia in tumor cells.	7	43	1.27	0.00021	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CXCL10,ANG,PTGS2,PTEN,BCL2,VEGFA
PMID:11352941	(2001) Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body.	6	25	1.44	0.00021	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000480291	CDH1,HNF4A,HSPG2,BMP2,FGFR1,HNF1B
PMID:34635621	(2022) Concomitant Diagnosis of Primary Bone Marrow B-Cell Non-Hodgkin Lymphoma and Essential Thrombocythemia: A Case Report.	5	12	1.68	0.00022	9606.ENSP00000226279,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,JAK2,BCL2,MYD88,MME
PMID:33525388	(2021) CD123 Is Consistently Expressed on NPM1-Mutated AML Cells.	5	12	1.68	0.00022	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	CD38,IFNG,CD34,STAT5A,JAK2
PMID:33680881	(2021) Inhibition of Fatty Acid Binding Protein 4 in Obese Male Mice Adversely Affects Reproductive Parameters.	5	12	1.68	0.00022	9606.ENSP00000256104,9606.ENSP00000356438,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000477707	FABP4,PTGS2,SHBG,BCL2,NR1H3
PMID:33718169	(2021) Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers.	10	124	0.97	0.00022	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	ERCC1,IGF1R,ALDH1A1,PTEN,JAK2,NFE2L2,BCL2,FGFR1,MYD88,VEGFA
PMID:33909827	(2021) Estradiol prevented intestinal ischemia and reperfusion-induced changes in intestinal permeability and motility in male rats.	5	12	1.68	0.00022	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,CXCL10,EDNRA,EDN1,VEGFA
PMID:34131397	(2021) MicroRNA-135bCAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling.	5	12	1.68	0.00022	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384262	CDH1,IGF1R,PTEN,JAK2,HPSE
PMID:34367476	(2021) Stem cell therapies in tendon-bone healing.	5	12	1.68	0.00022	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000478570	MMP14,CD34,PDGFB,BMP2,VEGFA
PMID:34559465	(2021) Oxidative Stress Induced Osteocyte Apoptosis in Steroid-Induced Femoral Head Necrosis.	5	12	1.68	0.00022	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000381185	NOX4,MAP3K5,NOX1,BMP2,BCL2
PMID:34778245	(2021) Targeting Phosphatases and Kinases: How to Checkmate Cancer.	9	93	1.05	0.00022	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	SOX9,HSPB1,CDH1,ATM,ALDH1A1,MAPK7,PTEN,JAK2,PROM1
PMID:34830951	(2021) FGFFGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance.	10	124	0.97	0.00022	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,CDH1,IGF1R,MMP14,STAT5A,AR,JAK2,BCL2,FGFR1,VEGFA
PMID:34835969	(2021) Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.	10	124	0.97	0.00022	9606.ENSP00000256104,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000479617	FABP4,COL8A1,CDH1,TIMP3,ATM,ALDH1A1,PTEN,BCL2,CCL5,UHRF1
PMID:32704047	(2020) Autophagy in kidney homeostasis and disease.	9	93	1.05	0.00022	9606.ENSP00000216075,9606.ENSP00000266085,9606.ENSP00000317674,9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000371067,9606.ENSP00000380252	MIOX,TIMP3,APOL1,SIRT6,SGK1,PTEN,BAMBI,JAK2,NFE2L2
PMID:32742977	(2020) Endometrial and Menstrual Blood Mesenchymal StemStromal Cells: Biological Properties and Clinical Application.	10	124	0.97	0.00022	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000384262,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,THBS1,CDH1,CD34,ANG,PTGS2,ALPL,HPSE,MME,VEGFA
PMID:33817212	(2020) Neurotrophin-3 accelerates reendothelialization through inducing EPC mobilization and homing.	5	12	1.68	0.00022	9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,NTF3,BDNF,PROM1,VEGFA
PMID:30739387	(2019) Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.	5	12	1.68	0.00022	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000383232	CXCL10,CXCL11,ELN,CXCL9,GGT1
PMID:31244820	(2019) Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.	9	93	1.05	0.00022	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD38,CD69,THBS1,CXCL10,ANGPT2,ENTPD1,BCL2,RHOA,VEGFA
PMID:31315063	(2019) Age-dependent dysregulation of redox genes may contribute to fibrotic pulmonary disease susceptibility.	5	12	1.68	0.00022	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000363641,9606.ENSP00000377192	TGFB1,THBS1,NOX4,TXN,G6PD
PMID:31754391	(2019) Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis.	5	12	1.68	0.00022	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,CD34,CAV1,PTEN,VEGFA
PMID:29123257	(2018) Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.	5	12	1.68	0.00022	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:29220201	(2018) Engineering Hydrogel Microenvironments to Recapitulate the Stem Cell Niche.	5	12	1.68	0.00022	9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ELN,BMP2,RHOA,VEGFA
PMID:29593789	(2018) Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.	9	93	1.05	0.00022	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361883,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000474412	FABP4,PLIN1,LPL,SREBF1,PTGS2,CAP1,EDN1,FGFR1,CCL5
PMID:29882416	(2018) Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy.	5	12	1.68	0.00022	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,IGF1R,HNF4A,BDNF,VEGFA
PMID:29984752	(2018) Central Nervous System Lymphoma Harboring the JAK2 V617F Mutation That Developed after a 20-year History of Polycythemia Vera.	5	12	1.68	0.00022	9606.ENSP00000226279,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000418525	CD38,JAK2,G6PD,BCL2,MME
PMID:30258764	(2018) 3D tissue engineering, an emerging technique for pharmaceutical research.	5	12	1.68	0.00022	9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000478570	ELN,CNTF,PTGS2,BDNF,VEGFA
PMID:30361676	(2018) Hyperhomocysteinemia Causes Chorioretinal Angiogenesis with Placental Growth Factor Upregulation.	5	12	1.68	0.00022	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000365777,9606.ENSP00000376865,9606.ENSP00000478570	ANGPT2,PDGFB,MTHFR,PDGFD,VEGFA
PMID:30455412	(2018) Leucine-Rich Alpha-2-Glycoprotein1 Gene Interferes with Regulation of Apoptosis in Leukemia KASUMI-1 Cells.	5	12	1.68	0.00022	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CD34,ENTPD1,JAK2,BCL2
PMID:28375674	(2017) The Inflammatory CXC Chemokines, GROalpha(high), IP-10(low), and MIG(low), in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression.	5	12	1.68	0.00022	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:28522946	(2017) Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells.	5	12	1.68	0.00022	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,PTGS2,BCL2,VEGFA
PMID:28592701	(2017) Thrombospondin-1 contributes to slower aortic aneurysm growth by inhibiting maladaptive remodeling of extracellular matrix.	5	12	1.68	0.00022	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000355361	IFNG,THBS1,CXCL10,ELN,CD47
PMID:28933211	(2017) Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors.	5	12	1.68	0.00022	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BDNF,VEGFA
PMID:29047089	(2017) Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.	5	12	1.68	0.00022	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000368683	NOX4,EDNRA,CAV1,TXN,EDN1
PMID:26883105	(2016) An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.	5	12	1.68	0.00022	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,PROM1,CCL5
PMID:26904026	(2016) Ocular Immune Privilege and Transplantation.	5	12	1.68	0.00022	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000474412	CD38,THBS1,VIP,NPY,CCL5
PMID:27217773	(2016) Prognostic significance of miR-126 in various cancers: a meta-analysis.	5	12	1.68	0.00022	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,GAS6,RHOA,VEGFA
PMID:27455221	(2016) Qingxuan Jiangya Decoction Reverses Vascular Remodeling by Inducing Vascular Smooth Muscle Cell Apoptosis in Spontaneously Hypertensive Rats.	5	12	1.68	0.00022	9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	PTEN,NFE2L2,BCL2,RHOA,AGTR1
PMID:25475596	(2015) Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.	5	12	1.68	0.00022	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683	NOX4,CAV1,PTEN,NOX1,EDN1
PMID:25708927	(2015) Expression of Interferon-gamma Receptor Genes in Peripheral Blood Mononuclear Cells Is Associated With Rheumatoid Arthritis and Its Radiographic Severity in African Americans.	5	12	1.68	0.00022	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,JAK2,CCL5
PMID:26096795	(2015) Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.	10	124	0.97	0.00022	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,ATM,CAV1,STAT5A,PTGS2,FGFR1,BDNF,PROM1,VEGFA
PMID:26596048	(2015) [the role of cytokines and chemokines in laboratory diagnostic of chronic viral hepatitis c].	5	12	1.68	0.00022	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:24314868	(2014) Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.	5	12	1.68	0.00022	9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	COMT,PTEN,AR,BCL2,VEGFA
PMID:24551834	(2014) Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate.	5	12	1.68	0.00022	9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ENTPD1,EDN1,PROM1,VEGFA
PMID:24634581	(2014) Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells.	5	12	1.68	0.00022	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,MMP14,PTGS2,RHOA,PROM1
PMID:23359148	(2013) Immunohistochemistry of pancreatic neoplasia.	5	12	1.68	0.00022	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CD34,PTGS2,BCL2,VEGFA
PMID:23443167	(2013) Interplay between Hepatitis C Virus and Redox Cell Signaling.	5	12	1.68	0.00022	9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252	SREBF1,MAP3K5,PTEN,TXN,NFE2L2
PMID:23881914	(2013) DEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses.	5	12	1.68	0.00022	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:22086127	(2012) Erythropoietin promotes the growth of pituitary adenomas by enhancing             angiogenesis.	5	12	1.68	0.00022	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,EPOR,STAT5A,JAK2,VEGFA
PMID:22388732	(2012) Gene therapy for cisplatin-induced ototoxicity: a systematic review of in vitro and experimental animal studies.	5	12	1.68	0.00022	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297	NOX4,NOX1,NFE2L2,BCL2,NTF3
PMID:22685558	(2012) A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.	5	12	1.68	0.00022	9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	APC,HNF4A,PTGS2,PTEN,BCL2
PMID:21743803	(2011) Angiogenin as a molecular target for the treatment of prostate cancer.	5	12	1.68	0.00022	9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	ANG,PTEN,AR,BCL2,VEGFA
PMID:20668147	(2010) Neonatal diabetes caused by pancreatic agenesia: which other genes should be used for diagnosis?	5	12	1.68	0.00022	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000480291	SOX9,ONECUT1,HNF4A,KCNJ11,HNF1B
PMID:20959486	(2010) CediranibAZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer.	5	12	1.68	0.00022	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,ANG,VEGFA
PMID:21318146	(2010) Cancer stem cells and epithelial ovarian cancer.	5	12	1.68	0.00022	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000401399,9606.ENSP00000426809	CD38,ALDH1A1,CD34,MYD88,PROM1
PMID:19383129	(2009) No evidence for protective erythropoietin alpha signalling in rat hepatocytes.	5	12	1.68	0.00022	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BCL2,VEGFA
PMID:19800444	(2009) Local cytokine and inflammatory responses to candidate vaginal adjuvants in mice.	5	12	1.68	0.00022	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CCL20,CXCL9
PMID:19806208	(2009) Vasoregression linked to neuronal damage in the rat with defect of polycystin-2.	5	12	1.68	0.00022	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	ANGPT2,PDGFB,CNTF,BDNF,VEGFA
PMID:20027220	(2009) Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice.	5	12	1.68	0.00022	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,LTA,CCL5,VEGFA
PMID:18334583	(2008) Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements.	5	12	1.68	0.00022	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CXCL11,ANGPT2,BDNF,VEGFA
PMID:17363704	(2007) Switching on reparative angiogenesis: essential role of the vascular erythropoietin receptor.	5	12	1.68	0.00022	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CD34,STAT5A,JAK2,VEGFA
PMID:34979906	(2022) The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.	9	94	1.04	0.00023	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383232,9606.ENSP00000426809	ERCC1,CDH1,PTEN,TXN,AR,NFE2L2,BCL2,GGT1,PROM1
PMID:35053521	(2022) Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions.	7	44	1.26	0.00023	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ELN,PTEN,HSPG2,PROM1,VEGFA
PMID:35054835	(2022) Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing.	8	67	1.14	0.00023	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,MAPK1,TGFB1,ATM,PRKCE,BMP2,BCL2,VEGFA
PMID:35250621	(2022) Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.	9	94	1.04	0.00023	9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,EDNRA,STAT5A,CCL20,CXCL9,RHOA,LTA,CCL5,VEGFA
PMID:35281017	(2022) The Roles of Mesenchymal Stem Cells in Gastrointestinal Cancers.	8	67	1.14	0.00023	9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,HNF4A,PTEN,JAK2,BCL2,RARRES2,CCL5,VEGFA
PMID:35281941	(2022) Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.	8	67	1.14	0.00023	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,PTEN,NOX1,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:35281942	(2022) Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.	8	67	1.14	0.00023	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	IFNG,THBS1,CXCL11,CD34,ANGPT2,PDGFB,PDGFA,VEGFA
PMID:35326121	(2022) Shedding a New Light on Skin Aging, Iron- and Redox-Homeostasis and Emerging Natural Antioxidants.	8	67	1.14	0.00023	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	IFNG,CXCL10,SIRT6,ELN,PTGS2,TXN,NFE2L2,VEGFA
PMID:35378831	(2022) Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.	7	44	1.26	0.00023	9606.ENSP00000215832,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,CAV1,PTGS2,PTEN,KL,JAK2,VEGFA
PMID:35401529	(2022) Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy.	7	44	1.26	0.00023	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,PROM1,CCL5
PMID:35409010	(2022) Vascular Permeability in Diseases.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000400175,9606.ENSP00000478570	MPO,IFNG,PTGS2,EDN1,SAA1,RHOA,VEGFA
PMID:33087432	(2021) Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL9,SAA1,CCL5,VEGFA
PMID:33422149	(2021) Deconstructing transcriptional variations and their effects on immunomodulatory function among human mesenchymal stromal cells.	8	67	1.14	0.00023	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,BMP2,JAK2,CCL5,VEGFA
PMID:33520115	(2021) Reversing oncogenic transformation with iron chelation.	8	67	1.14	0.00023	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,HNF4A,PTEN,TXN,BCL2,PROM1,VEGFA
PMID:33533957	(2021) Extracellular vesicles as mediators and markers of acute organ injury: current concepts.	9	94	1.04	0.00023	9606.ENSP00000222572,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	PON2,CCL20,ENTPD1,PTEN,PDGFD,BCL2,MYD88,CCL5,VEGFA
PMID:33670885	(2021) Crosstalk between MicroRNA and Oxidative Stress in Primary Open-Angle Glaucoma.	7	44	1.26	0.00023	9606.ENSP00000258341,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175	LAMC1,EDNRA,PTGS2,PTEN,EDN1,NFE2L2,RHOA
PMID:33717092	(2021) Adipose Extracellular Vesicles in Intercellular and Inter-Organ Crosstalk in Metabolic Health and Diseases.	7	44	1.26	0.00023	9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000360522,9606.ENSP00000362410,9606.ENSP00000377192,9606.ENSP00000393312	FABP4,ATM,LPL,RBP4,MAFB,G6PD,FGFR1
PMID:33799880	(2021) Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments.	7	44	1.26	0.00023	9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000400175	IGF1R,APPL1,SREBF1,JAK2,BCL2,PLA2G2A,RHOA
PMID:33809620	(2021) Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.	7	44	1.26	0.00023	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PTGS2,EDN1,NFE2L2,MME,AGTR1,VEGFA
PMID:33816320	(2021) Defining Immunogenic and Radioimmunogenic Tumors.	7	44	1.26	0.00023	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000371067	CCR5,CXCL10,CXCL11,GAS6,CXCL9,CD47,JAK2
PMID:33918154	(2021) The Ambivalent Role of miRNAs in Carcinogenesis: Involvement in Renal Cell Carcinoma and Their Clinical Applications.	7	44	1.26	0.00023	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,CAV1,PTEN,KL,BCL2,VEGFA,UHRF1
PMID:33995371	(2021) Innate Immune Cells in the Esophageal Tumor Microenvironment.	9	94	1.04	0.00023	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000393312,9606.ENSP00000478570	MPO,CD38,CDH1,CXCL10,CCL20,CXCL9,CD47,FGFR1,VEGFA
PMID:34017247	(2021) Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,PTGS2,EDN1,NFE2L2,BCL2,BDNF,VEGFA
PMID:34062992	(2021) Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.	7	44	1.26	0.00023	9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000478570	MMP14,ANG,STAT5A,CD47,ENTPD1,PTEN,VEGFA
PMID:34072790	(2021) Astrocytes in Multiple Sclerosis-Essential Constituents with Diverse Multifaceted Functions.	8	67	1.14	0.00023	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000360250,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CNTF,ENTPD1,NFE2L2,BDNF,CCL5,VEGFA
PMID:34211477	(2021) Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis.	8	67	1.14	0.00023	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	ALDH1A1,CXCL10,STAT5A,CCL20,RBP4,BCL2,MYD88,VEGFA
PMID:34285903	(2021) Impact of human immunodeficiency virus on pulmonary vascular disease.	7	44	1.26	0.00023	9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CXCL11,CD34,VIP,EDN1,CCL5,VEGFA
PMID:34289845	(2021) Genistein as a regulator of signaling pathways and microRNAs in different types of cancers.	8	67	1.14	0.00023	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,HNF4A,SGK1,PTEN,JAK2,BCL2,VEGFA
PMID:34344870	(2021) Pattern recognition receptors in health and diseases.	9	94	1.04	0.00023	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	MPO,NOX4,MAP3K5,PTGS2,JAK2,SAA1,IRAK4,MYD88,VEGFA
PMID:34349753	(2021) Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis.	7	44	1.26	0.00023	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354901	TGFB1,IGF1R,CCR5,CXCL10,STAT5A,SREBF1,CXCL9
PMID:34566988	(2021) Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.	7	44	1.26	0.00023	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,SOX9,CXCL10,PTEN,CCL5,VEGFA
PMID:34572776	(2021) Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers.	9	94	1.04	0.00023	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,ALDH1A1,HNF4A,CD47,PTEN,BCL2,FGFR1,PROM1,HNF1B
PMID:34575678	(2021) Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma.	10	125	0.96	0.00023	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,THBS1,CDH1,CXCL10,CD34,SIRT6,CCL20,CXCL9,BCL2,VEGFA
PMID:34830491	(2021) Hypoxia: The Cornerstone of Glioblastoma.	8	67	1.14	0.00023	9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD47,ENTPD1,PTEN,EDN1,BCL2,PROM1,VEGFA
PMID:34912707	(2021) Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies.	8	67	1.14	0.00023	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,STAT5A,ELN,JAK2,BCL2,MME
PMID:34943928	(2021) Therapeutic Potential of Annexin A1 Modulation in Kidney and Cardiovascular Disorders.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	MPO,MMP14,ELN,PTGS2,RHOA,AGTR1,VEGFA
PMID:35115946	(2021) Traditional Chinese Medicine Targeting Heat Shock Proteins as Therapeutic Strategy for Heart Failure.	7	44	1.26	0.00023	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	HSPB1,NOX4,MAP3K5,BCL2,MYD88,MME,VEGFA
PMID:31791885	(2020) Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes.	7	44	1.26	0.00023	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFB,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:31928443	(2020) Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,SAA1,LTA,CCL5,VEGFA
PMID:32238918	(2020) Neutrophil chemoattractant receptors in health and disease: double-edged swords.	9	94	1.04	0.00023	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000384906,9606.ENSP00000445772,9606.ENSP00000474412	MPO,CCR5,CXCL10,CXCL11,CXCL9,PTEN,SAA1,LTB4R2,CCL5
PMID:32266222	(2020) MicroRNA Mediated Cardioprotection - Is There a Path to Clinical Translation?	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,TIMP3,PTEN,CNR2,BCL2,VEGFA
PMID:32377537	(2020) Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:32392899	(2020) Mesenchymal StemStromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration.	9	94	1.04	0.00023	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	IGF1R,ATM,ELN,PTGS2,MAFB,NFE2L2,MYD88,MME,VEGFA
PMID:32553695	(2020) Cytochrome P4501B1 in bone marrow is co-expressed with key markers of mesenchymal stem cells. BMS2 cell line models PAH disruption of bone marrow niche development functions.	8	67	1.14	0.00023	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000381185	IFNG,THBS1,ATM,CXCL10,GAS6,PDGFA,PTGS2,BCL2
PMID:32661325	(2020) Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.	7	44	1.26	0.00023	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000444198	TGFB1,CD38,CD34,STAT5A,JAK2,BCL2,CITED2
PMID:32670895	(2020) Dysregulation of Stemness Pathways in HPV Mediated Cervical Malignant Transformation Identifies Potential Oncotherapy Targets.	7	44	1.26	0.00023	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000330382,9606.ENSP00000426809,9606.ENSP00000478570	LAMC1,THBS1,CDH1,ALDH1A1,PDGFB,PROM1,VEGFA
PMID:32679249	(2020) Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000400175	IFNG,THBS1,ATM,MMP14,HNF4A,BCL2,RHOA
PMID:32695831	(2020) Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.	8	67	1.14	0.00023	9606.ENSP00000263317,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570	NOX4,CD2AP,PTEN,NOX1,JAK2,BCL2,GREM1,VEGFA
PMID:32724338	(2020) Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity.	7	44	1.26	0.00023	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,MAPK1,ATM,MAPK7,NFE2L2,BCL2,VEGFA
PMID:32751846	(2020) Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions.	8	67	1.14	0.00023	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000478570	SOX9,ATM,ALDH1A1,ANGPT2,PTEN,AR,JAK2,VEGFA
PMID:32754163	(2020) Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.	8	67	1.14	0.00023	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CXCL10,STAT5A,CXCL9,PTGS2,NFE2L2,MYD88,CCL5
PMID:32824846	(2020) Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.	7	44	1.26	0.00023	9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000478570	ENPP2,ATM,CXCL10,LPL,PTGS2,PLA2G2A,VEGFA
PMID:32854444	(2020) Fatty Acids and Membrane Lipidomics in Oncology: A Cross-Road of Nutritional, Signaling and Metabolic Pathways.	7	44	1.26	0.00023	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000478570	FABP4,IGF1R,FADS2,ALDH1A1,SREBF1,JAK2,VEGFA
PMID:33005474	(2020) MiR-22 as a metabolic silencer and liver tumor suppressor.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478319	IFNG,ALDH1A1,SREBF1,MTHFR,NFE2L2,FGFR1,GREM1
PMID:33061527	(2020) Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33202963	(2020) Insights into Potential Targets for Therapeutic Intervention in Epilepsy.	9	94	1.04	0.00023	9606.ENSP00000222139,9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000356213,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,APC,HNF4A,VIP,JAK2,BCL2,NPY,BDNF,VEGFA
PMID:33258056	(2020) Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives.	8	67	1.14	0.00023	9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,LPL,CD34,EDNRA,PDGFB,CAV1,AGTR1,VEGFA
PMID:33292459	(2020) Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.	8	67	1.14	0.00023	9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CXCL11,CD34,CAV1,ELN,PTEN,BCL2,VEGFA
PMID:33321934	(2020) Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota.	8	67	1.14	0.00023	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CXCL10,CD34,BCL2,IRAK4,MYD88,PROM1,VEGFA
PMID:33322216	(2020) Pro-Inflammatory Cytokines in the Formation of the Pre-Metastatic Niche.	7	44	1.26	0.00023	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL9,JAK2,SAA1,CCL5,VEGFA
PMID:33391033	(2020) Perivascular Adipose Tissue as an Indication, Contributor to, and Therapeutic Target for Atherosclerosis.	7	44	1.26	0.00023	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,ANGPT2,PDGFB,CAV1,AGTR1,CCL5,VEGFA
PMID:33396653	(2020) Synovial Tissue Proteins and Patient-Specific Variables as Predictive Factors for Temporomandibular Joint Surgery.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000360997,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,ADAMTS13,LTA,CCL5,VEGFA
PMID:27561663	(2019) CD26 and Asthma: a Comprehensive Review.	9	94	1.04	0.00023	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CAV1,CCL20,CXCL9,VIP,NPY,CCL5
PMID:30867161	(2019) Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors.	7	44	1.26	0.00023	9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	IGF1R,STAT5A,SGK1,PTEN,JAK2,BCL2,FGFR1
PMID:31178859	(2019) Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages.	11	159	0.9	0.00023	9606.ENSP00000226279,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CD38,P2RY1,CXCL10,CXCL11,STAT5A,CXCL9,JAK2,BCL2,MYD88,PROM1,CCL5
PMID:31275169	(2019) RNA-Seq Analysis Reveals Spatial and Sex Differences in Pectoralis Major Muscle of Broiler Chickens Contributing to Difference in Susceptibility to Wooden Breast Disease.	8	67	1.14	0.00023	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000347041,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000380252	FABP4,THBS1,PLIN1,LPL,FMOD,TXN,KL,NFE2L2
PMID:31334144	(2019) Role of microRNAs in stroke recovery.	7	44	1.26	0.00023	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,THBS1,PTEN,GAP43,BCL2,BDNF,VEGFA
PMID:31379869	(2019) Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250	MPO,CHI3L1,THBS1,CXCL10,CXCL11,CXCL9,ENTPD1
PMID:31410045	(2019) The regenerative potential of skin and the immune system.	9	94	1.04	0.00023	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5,VEGFA
PMID:31417109	(2019) Bioinformatics Unmasks the Maneuverers of Pain Pathways in Acute Kidney Injury.	7	44	1.26	0.00023	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IFNG,PTGS2,CNR2,EDN1,BCL2,VEGFA
PMID:31417650	(2019) Multifaceted Mechanisms of Areca Nuts in Oral Carcinogenesis: the Molecular Pathology from Precancerous Condition to Malignant Transformation.	7	44	1.26	0.00023	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000297785,9606.ENSP00000362057,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,NOX4,ALDH1A1,NOX1,PROM1,VEGFA
PMID:31452720	(2019) Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000478570	IFNG,CDH1,IGF1R,PDGFB,CAV1,ELN,VEGFA
PMID:31523027	(2019) Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense.	8	67	1.14	0.00023	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	SOX9,ENPP2,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:31708793	(2019) Cerebral Small Vessel Disease (CSVD) - Lessons From the Animal Models.	7	44	1.26	0.00023	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303	TIMP3,IGF1R,ELN,PTGS2,EDN1,BCL2,BDNF
PMID:31718044	(2019) TGF-beta in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.	10	125	0.96	0.00023	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000478319	CDH1,NOX4,PDGFB,CAV1,ELN,NOX1,BAMBI,BMP2,NFE2L2,GREM1
PMID:31781501	(2019) RAS as Supporting Actor in Breast Cancer.	7	44	1.26	0.00023	9606.ENSP00000013807,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000445772	ERCC1,CXCL10,CAV1,PTGS2,PTEN,JAK2,LTB4R2
PMID:31970155	(2019) Differential Regulation of LPS-Mediated VE-Cadherin Disruption in Human Endothelial Cells and the Underlying Signaling Pathways: A Mini Review.	7	44	1.26	0.00023	9606.ENSP00000248553,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419313,9606.ENSP00000478570	HSPB1,HNF4A,CAV1,RHOA,MYD88,TRPC1,VEGFA
PMID:32009958	(2019) Saussureae Involucratae Herba (Snow Lotus): Review of Chemical Compositions and Pharmacological Properties.	7	44	1.26	0.00023	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	SREBF1,PTGS2,TXN,EDN1,BCL2,CCL5,VEGFA
PMID:32923966	(2019) GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	MPO,NOX4,CAV1,NOX1,EDN1,RHOA,AGTR1
PMID:29435195	(2018) Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.	7	44	1.26	0.00023	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,MMP14,CAV1,VEGFA
PMID:29479354	(2018) Withaferin A Associated Differential Regulation of Inflammatory Cytokines.	7	44	1.26	0.00023	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000369816,9606.ENSP00000414303	MPO,THBS1,CXCL10,ANG,CCL20,SHBG,BDNF
PMID:29562686	(2018) Profiling Prostate Cancer Therapeutic Resistance.	8	67	1.14	0.00023	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,AR,BCL2,PROM1,VEGFA
PMID:30534080	(2018) Plasticity of Adipose Tissue-Derived Stem Cells and Regulation of Angiogenesis.	8	67	1.14	0.00023	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000360250,9606.ENSP00000418525,9606.ENSP00000478570	CD38,THBS1,CD34,ANG,SIRT6,ENTPD1,MME,VEGFA
PMID:27926493	(2017) Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.	7	44	1.26	0.00023	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,ATM,STAT5A,PTEN,JAK2,FGFR1,VEGFA
PMID:28154552	(2017) Chemokines Associated with Pathologic Responses to Orthopedic Implant Debris.	7	44	1.26	0.00023	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:28161916	(2017) The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.	7	44	1.26	0.00023	9606.ENSP00000215832,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,CAV1,CNTF,BMP2,RHOA,BDNF,VEGFA
PMID:28607629	(2017) The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System.	8	67	1.14	0.00023	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MPO,NOX4,SIRT6,NOX1,TXN,BCL2,RHOA,VEGFA
PMID:28724427	(2017) Curcumin: the spicy modulator of breast carcinogenesis.	7	44	1.26	0.00023	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:28895880	(2017) The Role of Vitamin D in Thyroid Diseases.	7	44	1.26	0.00023	9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,IFNG,CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:26706194	(2016) Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.	8	67	1.14	0.00023	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,THBS1,IGF1R,CD34,ANGPT2,PTGS2,LTA,VEGFA
PMID:26784894	(2016) Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimers Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease.	8	67	1.14	0.00023	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303	MAPK1,NOX4,VDAC1,TIMP3,PTEN,JAK2,NFE2L2,BDNF
PMID:27391151	(2016) MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem progenitor cells.	7	44	1.26	0.00023	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000426809	CD38,HSPB1,CD34,STAT5A,CD47,PTEN,PROM1
PMID:27891540	(2016) Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.	8	67	1.14	0.00023	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175	THBS1,CDH1,ATM,ALDH1A1,CXCL10,PTEN,AR,RHOA
PMID:25710020	(2015) MicroRNAs and cardiovascular diseases.	8	67	1.14	0.00023	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,IGF1R,PTEN,EDN1,BCL2,RHOA,AGTR1,VEGFA
PMID:25771509	(2015) Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset.	7	44	1.26	0.00023	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,PDGFB,CXCL9,LTA,CCL5,VEGFA
PMID:26380295	(2015) Gene Network Analysis of Glucose Linked Signaling Pathways and Their Role in Human Hepatocellular Carcinoma Cell Growth and Survival in HuH7 and HepG2 Cell Lines.	7	44	1.26	0.00023	9606.ENSP00000312987,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252	HNF4A,PRKAA1,SREBF1,PTGS2,PTEN,NOX1,NFE2L2
PMID:26404259	(2015) PI3K and AKT: Unfaithful Partners in Cancer.	7	44	1.26	0.00023	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	IGF1R,ATM,STAT5A,SGK1,PTEN,JAK2,BCL2
PMID:26816842	(2015) Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.	8	67	1.14	0.00023	9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000349860,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,PDGFB,GFPT1,AR,EDN1,JAK2,BCL2,VEGFA
PMID:24531241	(2014) New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.	8	67	1.14	0.00023	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,CXCL9,CD47,BCL2,CCL5,VEGFA
PMID:24598793	(2014) A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.	8	67	1.14	0.00023	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,TGFB1,CCR5,HNF4A,ELN,AR,CCL5,VEGFA
PMID:24672487	(2014) Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases.	7	44	1.26	0.00023	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000348069,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CCR5,P2RY1,SREBF1,ENTPD1,BCL2,VEGFA
PMID:24945092	(2014) CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV.	7	44	1.26	0.00023	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,BCL2,SAA1,CCL5
PMID:25258717	(2014) The role of microRNAs in diabetic nephropathy.	7	44	1.26	0.00023	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000419313,9606.ENSP00000478570	NOX4,TIMP3,PTGS2,PTEN,NFE2L2,TRPC1,VEGFA
PMID:25324141	(2014) New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.	7	44	1.26	0.00023	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ATM,ALDH1A1,CD34,CD47,BCL2,PROM1
PMID:23397329	(2013) Accumulation of CD11b+Gr-1+ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses.	7	44	1.26	0.00023	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	THBS1,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:23764061	(2013) beta-Arrestins in the immune system.	9	94	1.04	0.00023	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412	MAPK1,CCR5,CXCL10,MAP3K5,CXCL9,BMP2,BCL2,AGTR1,CCL5
PMID:23922777	(2013) A strong anti-inflammatory signature revealed by liver transcription profiling of Tmprss6-- mice.	8	67	1.14	0.00023	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399	IFNG,CXCL10,CXCL11,CXCL9,PTGS2,JAK2,SAA1,MYD88
PMID:24093097	(2013) Progress of molecular targeted therapies for advanced renal cell carcinoma.	7	44	1.26	0.00023	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,EDN1,BCL2,FGFR1,PROM1,VEGFA
PMID:24348218	(2013) Microvascular targets for anti-fibrotic therapeutics.	7	44	1.26	0.00023	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,PDGFB,PDGFA,PDGFD,CCL5,VEGFA
PMID:22201936	(2012) Obesity-related glomerulopathy and podocyte injury: a mini review.	7	44	1.26	0.00023	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000288266,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,NOX4,APPL1,SREBF1,SGK1,AGTR1,VEGFA
PMID:22366328	(2012) VEGF signaling inside vascular endothelial cells and beyond.	7	44	1.26	0.00023	9606.ENSP00000288266,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000355361,9606.ENSP00000478570	APPL1,MMP14,ANGPT2,PDGFB,UNC5B,CD47,VEGFA
PMID:22391302	(2012) Identification, functional characterization, and pathobiological significance of GLI1 isoforms in human cancers.	7	44	1.26	0.00023	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,PDGFB,PDGFA,PTEN,PROM1,VEGFA
PMID:22746994	(2012) Overcoming drug resistance and treating advanced prostate cancer.	7	44	1.26	0.00023	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,PTEN,AR,EDN1,BCL2,PROM1,VEGFA
PMID:22830335	(2012) Natural product MDM2 inhibitors: anticancer activity and mechanisms of action.	7	44	1.26	0.00023	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,AR,BCL2,VEGFA
PMID:23055713	(2012) Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.	7	44	1.26	0.00023	9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000380365	IGF1R,SIRT6,STAT5A,PTEN,KL,NFE2L2,RGN
PMID:21593863	(2011) Lessons on the pathogenesis of aneurysm from heritable conditions.	7	44	1.26	0.00023	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,THBS1,CXCL10,ELN,S100A12,RHOA,AGTR1
PMID:21829704	(2011) TIRAP, an adaptor protein for TLR24, transduces a signal from RAGE phosphorylated upon ligand binding.	7	44	1.26	0.00023	9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	ANG,CCL20,S100A12,IRAK4,MYD88,BDNF,CCL5
PMID:22190971	(2011) From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors.	7	44	1.26	0.00023	9606.ENSP00000315011,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	EDNRA,STAT5A,PTGS2,EDN1,BCL2,IRAK4,MYD88
PMID:20193003	(2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.	10	125	0.96	0.00023	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	TIMP3,CCR5,CXCL10,PTEN,JAK2,BCL2,MYD88,CCL5,VEGFA,HNF1B
PMID:21040832	(2010) Molecular biology of Kaposis sarcoma-associated herpesvirus and related oncogenesis.	8	67	1.14	0.00023	9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000478570	HNF4A,ANGPT2,PTGS2,JAK2,BCL2,RHOA,LTA,VEGFA
PMID:24281035	(2010) Angiogenesis and melanoma.	7	44	1.26	0.00023	9606.ENSP00000260356,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,PDGFA,EDN1,PDGFD,AGTR1,CCL5,VEGFA
PMID:18626063	(2008) LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.	8	67	1.14	0.00023	9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,LPL,PDGFB,PDGFA,PDGFD,RHOA,MME,VEGFA
PMID:18691016	(2008) Therapeutic potential of autotaxinlysophospholipase d inhibitors.	7	44	1.26	0.00023	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	ENPP2,THBS1,P2RY1,PTGS2,EDN1,RHOA,VEGFA
PMID:34826215	(2022) In vitro evaluation of periapical lesion-derived stem cells for dental pulp tissue engineering.	6	26	1.42	0.00024	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,CD34,BDNF,CCL5,VEGFA,HNF1B
PMID:34115984	(2021) Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,THBS1,PTEN,PDGFD,BCL2,VEGFA
PMID:34122421	(2021) Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.	6	26	1.42	0.00024	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	THBS1,CXCL10,CXCL11,CXCL9,EDN1,CCL5
PMID:34200323	(2021) Exosome-Derived MicroRNAs of Human Milk and Their Effects on Infant Health and Development.	10	126	0.96	0.00024	9606.ENSP00000256104,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	FABP4,STAT5A,PRKAA1,SREBF1,PTEN,MAFB,NPY,MYD88,PROM1,CCL5
PMID:34209857	(2021) Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments.	9	95	1.04	0.00024	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,HNF4A,ANGPT2,PTEN,EDN1,BCL2,VEGFA
PMID:34248946	(2021) Cytokine Imprint in Preeclampsia.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CXCL9,LTA,VEGFA
PMID:34307349	(2021) Uniaxial Cyclic Stretching Promotes Chromatin Accessibility of Gene Loci Associated With Mesenchymal Stem Cells Morphogenesis and Osteogenesis.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000400175	TGFB1,SOX9,FABP4,ALPL,BMP2,RHOA
PMID:34407830	(2021) Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment.	9	95	1.04	0.00024	9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,CXCL11,LPL,SREBF1,PTGS2,JAK2,BCL2,MYD88,VEGFA
PMID:34440909	(2021) Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine.	6	26	1.42	0.00024	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,STAT5A,EDN1,JAK2,BCL2,VEGFA
PMID:34768747	(2021) Scaffold-Free Retinal Pigment Epithelium Microtissues Exhibit Increased Release of PEDF.	6	26	1.42	0.00024	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000331831,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,TIMP3,GAS6,CNTF,BDNF,VEGFA
PMID:34803160	(2021) 3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice.	6	26	1.42	0.00024	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,NTF3,BDNF,CCL5,VEGFA
PMID:34804009	(2021) Splenic Transcriptional Responses in Severe Visceral Leishmaniasis: Impaired Leukocyte Chemotaxis and Cell Cycle Arrest.	6	26	1.42	0.00024	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:34830354	(2021) Metalloproteinases in Endometrial Cancer-Are They Worth Measuring?	6	26	1.42	0.00024	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000361021	CDH1,TIMP3,MMP14,ANG,ELN,PTEN
PMID:35008602	(2021) Personalized Nutrition as a Key Contributor to Improving Radiation Response in Breast Cancer.	6	26	1.42	0.00024	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,PTEN,BCL2,CCL5,VEGFA
PMID:35069120	(2021) Mechanism and Prevention of Spiral Ganglion Neuron Degeneration in the Cochlea.	6	26	1.42	0.00024	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303	CXCL10,CXCL9,CNTF,PTEN,NTF3,BDNF
PMID:31444950	(2020) Essential roles of interstitial cells in testicular development and function.	6	26	1.42	0.00024	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	SOX9,IGF1R,CD34,AR,EDN1,VEGFA
PMID:31811565	(2020) Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis.	9	95	1.04	0.00024	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000477707	TGFB1,THBS1,ATM,CAV1,PTGS2,PTEN,BCL2,MME,NR1H3
PMID:32246572	(2020) Interstitial cystitisbladder pain syndrome: The evolving landscape, animal models and future perspectives.	6	26	1.42	0.00024	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000419422,9606.ENSP00000478570	CHI3L1,CDH1,CXCL10,CXCL9,AGTR1,VEGFA
PMID:32431596	(2020) Identification of Differentially Expressed Genes and Key Pathways in the Dorsal Root Ganglion After Chronic Compression.	6	26	1.42	0.00024	9606.ENSP00000215832,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000414303	MAPK1,PDGFA,PTGS2,JAK2,NPY,BDNF
PMID:32547545	(2020) CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.	6	26	1.42	0.00024	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,STAT5A,CXCL9,CCL5
PMID:32872119	(2020) Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.	6	26	1.42	0.00024	9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	CAV1,EDN1,JAK2,NPY,RHOA,VEGFA
PMID:33021426	(2020) Emerging therapeutic targets for neuroblastoma.	10	126	0.96	0.00024	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809	SOX9,CDH1,VDAC1,IGF1R,STAT5A,PTEN,GAP43,BCL2,BDNF,PROM1
PMID:33023532	(2020) TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.	6	26	1.42	0.00024	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000371067,9606.ENSP00000426809	ERCC1,CDH1,TIMP3,MMP14,JAK2,PROM1
PMID:33132854	(2020) Pain in Endometriosis.	6	26	1.42	0.00024	9606.ENSP00000358513,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	CNR1,AR,EDN1,NPY,CCL5,VEGFA
PMID:33193295	(2020) Tuning Cancer Fate: Tumor Microenvironments Role in Cancer Stem Cell Quiescence and Reawakening.	9	95	1.04	0.00024	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000331831,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,THBS1,TIMP3,IGF1R,ALDH1A1,GAS6,BCL2,PROM1,VEGFA
PMID:33305187	(2020) SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations.	9	95	1.04	0.00024	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000393312	MAPK1,TGFB1,IGF1R,PDGFA,MAP3K5,PTEN,JAK2,PDGFD,FGFR1
PMID:33316986	(2020) ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer.	6	26	1.42	0.00024	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809	SOX9,ALDH1A1,CD34,PTEN,MYD88,PROM1
PMID:33371425	(2020) Phytochemicals with Added Value from Morella and Myrica Species.	6	26	1.42	0.00024	9606.ENSP00000225275,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,SREBF1,PTGS2,BCL2,MYD88,VEGFA
PMID:33552068	(2020) Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,IGF1R,BCL2,CCL5,VEGFA
PMID:33634031	(2020) Game of Bones: How Myeloma Manipulates Its Microenvironment.	10	126	0.96	0.00024	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CDH1,TIMP3,IGF1R,CCR5,ANGPT2,MAFB,BMP2,BCL2,VEGFA
PMID:33718332	(2020) Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells.	6	26	1.42	0.00024	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,ELN,PTEN,PROM1,VEGFA
PMID:30419314	(2019) Unraveling the journey of cancer stem cells from origin to metastasis.	9	95	1.04	0.00024	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,ALDH1A1,CD34,PTEN,BCL2,MME,PROM1,VEGFA
PMID:31394732	(2019) Gingers and Their Purified Components as Cancer Chemopreventative Agents.	9	95	1.04	0.00024	9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000383232,9606.ENSP00000384906,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,JAK2,BCL2,GGT1,SAA1,FGFR1,RHOA,MYD88,VEGFA
PMID:31423178	(2019) Identification of a miRNA-mRNA network associated with lymph node metastasis in colorectal cancer.	6	26	1.42	0.00024	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	CXCL10,CXCL11,MMP14,CXCL9,EDN1,CCL5
PMID:31780824	(2019) Cytokinechemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stage.	6	26	1.42	0.00024	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:31857597	(2019) Comprehensive expression patterns of inflammatory cytokines in aqueous humor of patients with neovascular age-related macular degeneration.	6	26	1.42	0.00024	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANG,CXCL9,CCL5,VEGFA
PMID:29134515	(2018) Neuroprotective Potential and Paracrine Activity of Stromal Vs. Culture-Expanded hMSC Derived from Wharton Jelly under Co-Cultured with Hippocampal Organotypic Slices.	6	26	1.42	0.00024	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,GAP43,BCL2,NTF3,BDNF,VEGFA
PMID:29671772	(2018) Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms.	6	26	1.42	0.00024	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ATM,CD34,PTGS2,PROM1,VEGFA
PMID:29679617	(2018) Retinopathy of prematurity: a review of risk factors and their clinical significance.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IGF1R,ANGPT2,BDNF,AGTR1,VEGFA
PMID:29738484	(2018) Human Macrophages Preferentially Infiltrate the Superficial Adipose Tissue.	6	26	1.42	0.00024	9606.ENSP00000256104,9606.ENSP00000265132,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000418009	FABP4,AMBP,PLIN1,CD34,PDGFA,RARRES2
PMID:29760725	(2018) The Effects of Hyperacute Serum on the Elements of the Human Subchondral Bone Marrow Niche.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,FABP4,CD34,ALPL,BCL2,VEGFA
PMID:30050455	(2018) Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia.	6	26	1.42	0.00024	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,PDGFB,NOX1,EDN1,MYD88,VEGFA
PMID:30271757	(2018) Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy.	6	26	1.42	0.00024	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000418525,9606.ENSP00000478570	MPO,IFNG,CXCL10,PTGS2,MME,VEGFA
PMID:28240383	(2017) Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model.	6	26	1.42	0.00024	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,PTEN,VEGFA
PMID:28370981	(2017) In vitro assessment of a novel, hypothermically stored amniotic membrane for use in a chronic wound environment.	6	26	1.42	0.00024	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,ELN,CXCL9,CCL5,VEGFA
PMID:28533907	(2017) Novel treatment options for portal hypertension.	6	26	1.42	0.00024	9606.ENSP00000284031,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	DDAH1,EDNRA,EDN1,NPY,RHOA,VEGFA
PMID:28758328	(2017) The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore.	6	26	1.42	0.00024	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000380365,9606.ENSP00000381185	CD38,VDAC1,SIRT6,TXN,RGN,BCL2
PMID:26992918	(2016) Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.	6	26	1.42	0.00024	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,SAA1,CCL5,HNF1B
PMID:27207143	(2016) Genome-wide analysis of the transcriptional response to porcine reproductive and respiratory syndrome virus infection at the maternalfetal interface and in the fetus.	9	95	1.04	0.00024	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000357726	TGFB1,MPO,CHI3L1,CCR5,CXCL10,PDGFB,PDGFA,CXCL9,S100A12
PMID:27284266	(2016) Triple-negative breast cancer: treatment challenges and solutions.	6	26	1.42	0.00024	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,CAV1,PTEN,AR,FGFR1,VEGFA
PMID:25810725	(2015) Neuroprotective and antiapoptotic activity of lineage-negative bone marrow cells after intravitreal injection in a mouse model of acute retinal injury.	6	26	1.42	0.00024	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809	MAPK1,CD34,CNTF,BCL2,BDNF,PROM1
PMID:26507949	(2015) Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities.	6	26	1.42	0.00024	9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000478570	ANGPT2,EDNRA,CAV1,PDGFD,RHOA,VEGFA
PMID:26510438	(2015) Enzymatic regulation and functional relevance of NOX5.	6	26	1.42	0.00024	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067	NOX4,CAV1,STAT5A,NOX1,EDN1,JAK2
PMID:26512646	(2015) Diabetic Cardiovascular Disease Induced by Oxidative Stress.	6	26	1.42	0.00024	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683	SOX9,NOX4,MAP3K5,NOX1,TXN,EDN1
PMID:26512920	(2015) A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells.	6	26	1.42	0.00024	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL9,PROM1,CCL5,VEGFA
PMID:24322659	(2014) Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.	6	26	1.42	0.00024	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067	MAPK1,CDH1,IGF1R,ALDH1A1,PTEN,JAK2
PMID:24523323	(2014) CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.	6	26	1.42	0.00024	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:24661782	(2014) Overproduction of Toxoplasma gondii cyclophilin-18 regulates host cell migration and enhances parasite dissemination in a CCR5-independent manner.	6	26	1.42	0.00024	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,MYD88,CCL5
PMID:24782986	(2014) Targeted Disruption of the JAK2STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.	6	26	1.42	0.00024	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000426809	ERCC1,CDH1,ALDH1A1,CD34,JAK2,PROM1
PMID:26316944	(2014) Alveolar Macrophage Polarisation in Lung Cancer.	6	26	1.42	0.00024	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ELN,CXCL9,CCL5,VEGFA
PMID:23341976	(2013) Polymorphism in the ELOVL6 gene is associated with a major QTL effect on fatty acid composition in pigs.	6	26	1.42	0.00024	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000285407,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000477707	FABP4,FADS2,KLF10,HNF4A,SREBF1,NR1H3
PMID:23624605	(2013) Targeting the redox balance in inflammatory skin conditions.	6	26	1.42	0.00024	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,VDAC1,NOX1,TXN,NFE2L2,VEGFA
PMID:23637986	(2013) Prominin 1CD133 endothelium sustains growth of proneural glioma.	6	26	1.42	0.00024	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	PDGFB,PDGFA,EDN1,BDNF,PROM1,VEGFA
PMID:23864030	(2013) Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.	6	26	1.42	0.00024	9606.ENSP00000265333,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000381185	VDAC1,ANG,PTGS2,CNR1,CNR2,BCL2
PMID:23889988	(2013) AEG-1MTDHLYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.	10	126	0.96	0.00024	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,MMP14,LPL,HNF4A,ANGPT2,PTEN,EDN1,BCL2,VEGFA
PMID:24034904	(2013) rAAV-mediated overexpression of TGF-beta stably restructures human osteoarthritic articular cartilage in situ.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	TGFB1,SOX9,TIMP3,BMP2,GREM1,VEGFA
PMID:24113173	(2013) ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis.	6	26	1.42	0.00024	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000381185	NOX4,VDAC1,MAP3K5,NOX1,G6PD,BCL2
PMID:24307888	(2013) Honokiol as a Radiosensitizing Agent for Colorectal cancers.	6	26	1.42	0.00024	9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ATM,STAT5A,JAK2,BCL2,PROM1,VEGFA
PMID:24340223	(2013) astrocytes: emerging stars in leukodystrophy pathogenesis.	6	26	1.42	0.00024	9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CAV1,CNTF,NTF3,BDNF,VEGFA
PMID:22173163	(2012) The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis.	6	26	1.42	0.00024	9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	CD34,SREBF1,ELN,BCL2,PROM1,CCL5
PMID:22509804	(2012) PDGF and PDGF receptors in glioma.	6	26	1.42	0.00024	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000478570	IGF1R,PDGFB,PDGFA,PTEN,PDGFD,VEGFA
PMID:22514701	(2012) Comparative transcriptional network modeling of three PPAR-alphagamma co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes.	6	26	1.42	0.00024	9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000380252	FADS2,PLIN1,LPL,ABCG1,PTEN,NFE2L2
PMID:22579961	(2012) The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.	9	95	1.04	0.00024	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ANGPT2,PTGS2,PTEN,AR,EDN1,BCL2,PROM1,VEGFA
PMID:22666217	(2012) Emerging targeted therapies for castration-resistant prostate cancer.	6	26	1.42	0.00024	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,EDNRA,AR,EDN1,BCL2,VEGFA
PMID:22761039	(2012) The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal origin.	6	26	1.42	0.00024	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,HNF4A,PROM1,HNF1B
PMID:23249408	(2012) The arthritis severity locus Cia5a regulates the expression of inflammatory mediators including Syk pathway genes and proteases in pristane-induced arthritis.	9	95	1.04	0.00024	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000300055,9606.ENSP00000308208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000477707	FABP4,TIMP3,PLIN1,MMP14,SREBF1,PTGS2,IRAK4,MYD88,NR1H3
PMID:21345246	(2011) Role of cancer stem cells in hepatocarcinogenesis.	6	26	1.42	0.00024	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809	CD38,ALDH1A1,CD34,HNF4A,PTEN,PROM1
PMID:21527746	(2011) Triglycerides and heart disease: still a hypothesis?	6	26	1.42	0.00024	9606.ENSP00000200676,9606.ENSP00000264717,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000362524	CETP,GCKR,FADS2,LPL,SREBF1,ANGPTL2
PMID:20210774	(2010) Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000369816	TGFB1,EDNRA,ELN,COMT,EDN1,SHBG
PMID:20426842	(2010) Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.	6	26	1.42	0.00024	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,EDNRA,CAV1,BCL2,CCL5,VEGFA
PMID:20484034	(2010) Persistent cyclooxygenase-2 inhibition downregulates NF-kappaB, resulting in chronic intestinal inflammation in the min+ mouse model of colon tumorigenesis.	6	26	1.42	0.00024	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CD34,PTGS2,RHOA,MYD88,VEGFA
PMID:21151968	(2010) TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.	6	26	1.42	0.00024	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CXCL10,CD34,MYD88,CCL5,VEGFA
PMID:19041853	(2009) Adenosine receptor agonists for promotion of dermal wound healing.	6	26	1.42	0.00024	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,THBS1,ANGPT2,ENTPD1,MYD88,VEGFA
PMID:19490417	(2009) The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis.	6	26	1.42	0.00024	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,SAA1,CCL5
PMID:19754664	(2009) Genetic characterization of breast cancer and implications for clinical management.	6	26	1.42	0.00024	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312	CDH1,IGF1R,ATM,PTEN,AR,FGFR1
PMID:18566695	(2008) The role of erythropoietin as an inhibitor of tissue ischemia.	6	26	1.42	0.00024	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BCL2,RHOA,VEGFA
PMID:18695004	(2008) Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection.	6	26	1.42	0.00024	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,LTA,CCL5
PMID:18076762	(2007) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors.	6	26	1.42	0.00024	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CCR5,CXCL10,NPY,BDNF,CCL5
PMID:11602641	(2001) Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase.	6	26	1.42	0.00024	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL9,TXN,JAK2,MYD88,CCL5
PMID:10934220	(2000) Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes.	6	26	1.42	0.00024	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000474412	MAPK1,CCR5,CXCL10,CD34,CCL20,CCL5
PMID:34875482	(2022) The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy.	8	68	1.13	0.00025	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CDH1,IGF1R,CCR5,BCL2,NPY,BDNF,VEGFA
PMID:35082276	(2022) JAK2 inhibitor persistence in MPN: uncovering a central role of ERK activation.	7	45	1.25	0.00025	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,EPOR,CD34,STAT5A,JAK2,BCL2,VEGFA
PMID:33277742	(2021) Understanding the tumor microenvironment for effective immunotherapy.	8	68	1.13	0.00025	9606.ENSP00000258341,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	LAMC1,CCR5,CD34,CD247,JAK2,CCL5,APLNR,VEGFA
PMID:33390834	(2021) Role of hydrogen sulfide donors in cancer development and progression.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,PTGS2,PTEN,JAK2,NFE2L2,BCL2,VEGFA
PMID:33557173	(2021) The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.	10	127	0.96	0.00025	9606.ENSP00000216181,9606.ENSP00000228434,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,CD69,PLIN1,CXCL10,PTGS2,AR,JAK2,LTA,CCL5,VEGFA
PMID:33604758	(2021) The pulmonary pathology of COVID-19.	7	45	1.25	0.00025	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000360250,9606.ENSP00000478570	TGFB1,MPO,CXCL10,ANGPT2,SERPINF2,ENTPD1,VEGFA
PMID:33661132	(2021) Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study.	7	45	1.25	0.00025	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CXCL10,CXCL9,JAK2,CCL5,VEGFA
PMID:33664848	(2021) The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.	7	45	1.25	0.00025	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	THBS1,CCR5,PDGFB,CD247,BCL2,MYD88,VEGFA
PMID:33748199	(2021) The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity.	7	45	1.25	0.00025	9606.ENSP00000263317,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000364683,9606.ENSP00000418009,9606.ENSP00000478570	NOX4,ALDH1A1,SREBF1,NOX1,BAMBI,RARRES2,VEGFA
PMID:33771989	(2021) P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.	8	68	1.13	0.00025	9606.ENSP00000226279,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412	CD38,TIMP3,CXCL10,PDGFB,PDGFA,CXCL9,EDN1,CCL5
PMID:33806258	(2021) The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412	CDH1,ALDH1A1,CD34,ANGPT2,GAS6,AR,BCL2,CCL5
PMID:33809718	(2021) Key Signaling Pathways in Aging and Potential Interventions for Healthy Aging.	8	68	1.13	0.00025	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000414303	ERCC1,CD38,ATM,SIRT6,SGK1,BMP2,NFE2L2,BDNF
PMID:33854987	(2021) NAFLD-Associated HCC: Progress and Opportunities.	7	45	1.25	0.00025	9606.ENSP00000221930,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,SREBF1,PTGS2,AR,MYD88,CCL5,VEGFA
PMID:33922465	(2021) Mast Cells and Skin and Breast Cancers: A Complicated and Microenvironment-Dependent Role.	8	68	1.13	0.00025	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CD34,ANGPT2,ENTPD1,EDN1,CCL5,VEGFA
PMID:34062950	(2021) Exosomes and Cancer Stem Cells in Cancer Immunity: Current Reports and Future Directions.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,SOX9,CAV1,ABCG1,BCL2,PROM1,VEGFA
PMID:34271980	(2021) Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.	7	45	1.25	0.00025	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303	TGFB1,IFNG,STAT5A,SGK1,IRAK4,MYD88,BDNF
PMID:34349805	(2021) The Effects of Mesenchymal Stem Cell on Colorectal Cancer.	7	45	1.25	0.00025	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,CCR5,CD34,JAK2,CCL5,VEGFA
PMID:34399615	(2021) Hofbauer Cells Spread Listeria monocytogenes among Placental Cells and Undergo Pro-Inflammatory Reprogramming while Retaining Production of Tolerogenic Factors.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,AMBP,CXCL10,CXCL11,CD34,CXCL9,MYD88,CCL5
PMID:34440160	(2021) The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions.	8	68	1.13	0.00025	9606.ENSP00000306124,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	PRKCE,SIRT6,STAT5A,CNTF,JAK2,BCL2,AGTR1,VEGFA
PMID:34456867	(2021) Role of Inflammation in Vascular Disease-Related Perivascular Adipose Tissue Dysfunction.	7	45	1.25	0.00025	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000474412	NOX4,PLIN1,PTGS2,NOX1,EDN1,PDGFD,CCL5
PMID:34503180	(2021) Sterculic Acid Alters Adhesion Molecules Expression and Extracellular Matrix Compounds to Regulate Migration of Lung Cancer Cells.	8	68	1.13	0.00025	9606.ENSP00000258341,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000351807	LAMC1,COL8A1,CDH1,TIMP3,PDGFB,CAV1,SREBF1,ELN
PMID:34547545	(2021) Understanding the cross-talk between mediators of infertility and COVID-19.	8	68	1.13	0.00025	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000401399	TGFB1,CDH1,PTGS2,NOX1,NFE2L2,SAA1,IRAK4,MYD88
PMID:34625124	(2021) Next frontier in tumor immunotherapy: macrophage-mediated immune evasion.	10	127	0.96	0.00025	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CD47,ENTPD1,PTEN,MAFB,MYD88,CCL5,VEGFA
PMID:34638338	(2021) Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000306124,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	IFNG,PRKCE,STAT5A,PTEN,AR,JAK2,BCL2
PMID:34663639	(2021) Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CCL20,PTGS2,PROM1,CCL5,VEGFA
PMID:34679735	(2021) Anthocyanins in Colorectal Cancer Prevention Review.	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,IGF1R,COMT,PTGS2,NFE2L2,BCL2,PROM1
PMID:34681231	(2021) Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer.	7	45	1.25	0.00025	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000474412	IGF1R,ATM,CXCL9,PTEN,AR,FGFR1,CCL5
PMID:34744690	(2021) From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum.	7	45	1.25	0.00025	9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000478319,9606.ENSP00000478570	FABP4,ANGPT2,CAV1,COMT,EDN1,GREM1,VEGFA
PMID:34778071	(2021) Immune Evasion Mechanism and AXL.	7	45	1.25	0.00025	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000369816,9606.ENSP00000474412	CXCL10,CXCL11,CD34,GAS6,CXCL9,SHBG,CCL5
PMID:34795764	(2021) Classification and Characteristics of Mesenchymal Stem Cells and Its Potential Therapeutic Mechanisms and Applications against Ischemic Stroke.	7	45	1.25	0.00025	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	TIMP3,CD34,ANGPT2,ANG,BMP2,BDNF,VEGFA
PMID:34960102	(2021) Microbiome and Human Aging: Probiotic and Prebiotic Potentials in Longevity, Skin Health and Cellular Senescence.	7	45	1.25	0.00025	9606.ENSP00000013807,9606.ENSP00000226279,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185	ERCC1,CD38,SIRT6,ELN,CXCL9,JAK2,BCL2
PMID:34970257	(2021) CD8(+) T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma.	7	45	1.25	0.00025	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CXCL9,PTGS2,PTEN,VEGFA
PMID:35004784	(2021) Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity.	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,EDNRA,PDGFB,EDN1,BCL2,CCL5,VEGFA
PMID:35052592	(2021) Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.	7	45	1.25	0.00025	9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000362057,9606.ENSP00000478570	PON2,MPO,IFNG,NOX4,ANGPT2,NOX1,VEGFA
PMID:31845391	(2020) The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond.	7	45	1.25	0.00025	9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	CCR5,HNF4A,CAV1,AR,RHOA,MYD88,VEGFA
PMID:31979318	(2020) Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.	8	68	1.13	0.00025	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,ATM,CD247,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:32430627	(2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000475344,9606.ENSP00000478570	IFNG,CXCL10,EDN1,NFE2L2,BCL2,APLNR,VEGFA
PMID:32437299	(2020) Metabolic Inflammation and Insulin Resistance in Obesity.	8	68	1.13	0.00025	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,CCR5,CXCL10,CXCL11,JAK2,CCL5,VEGFA
PMID:32503267	(2020) Small Ones to Fight a Big Problem-Intervention of Cancer Metastasis by Small Molecules.	8	68	1.13	0.00025	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,TIMP3,HNF4A,GAS6,FGFR1,RHOA,VEGFA
PMID:32669297	(2020) Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.	7	45	1.25	0.00025	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CXCL10,CXCL9,ENTPD1,CCL5,VEGFA
PMID:32680511	(2020) Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.	10	127	0.96	0.00025	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,STAT5A,SREBF1,CCL20,ENTPD1,PTEN,CCL5,VEGFA
PMID:32728529	(2020) CITED2 and the modulation of the hypoxic response in cancer.	7	45	1.25	0.00025	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000363822,9606.ENSP00000444198,9606.ENSP00000478570	CD38,IFNG,CD34,CCL20,AR,CITED2,VEGFA
PMID:32869704	(2020) Deoxycholic Acid Upregulates the Reprogramming Factors KFL4 and OCT4 Through the IL-6STAT3 Pathway in Esophageal Adenocarcinoma Cells.	7	45	1.25	0.00025	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CD38,CD34,JAK2,BCL2,PROM1,VEGFA
PMID:32982731	(2020) The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action.	8	68	1.13	0.00025	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	FABP4,NOX4,LPL,SREBF1,NFE2L2,BCL2,NPY,VEGFA
PMID:32983162	(2020) Remodeling the Bone Marrow Microenvironment - A Proposal for Targeting Pro-inflammatory Contributors in MPN.	7	45	1.25	0.00025	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD34,STAT5A,BMP2,EDN1,JAK2,CCL5,VEGFA
PMID:33054110	(2020) Pediatric acute lymphoblastic leukemia.	10	127	0.96	0.00025	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000480291	EPOR,MPO,CD38,CD247,PTEN,JAK2,BCL2,FGFR1,MME,HNF1B
PMID:33203146	(2020) Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,ALDH1A1,MMP14,PTEN,BCL2,VEGFA
PMID:30834247	(2019) Meeting the Challenge of Targeting Cancer Stem Cells.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,PTGS2,BCL2,RHOA,PROM1,VEGFA
PMID:30977196	(2019) G-protein coupled receptors and ligands that organize humoral immune responses.	8	68	1.13	0.00025	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361	CD69,SOX9,ENPP2,CXCL10,CXCL11,CCL20,CXCL9,CD47
PMID:30987378	(2019) Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy.	8	68	1.13	0.00025	9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	SIRT6,STAT5A,SREBF1,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:31130916	(2019) Obesity May Accelerate the Aging Process.	7	45	1.25	0.00025	9606.ENSP00000248553,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,SIRT6,MAP3K5,BDNF,RARRES2,CCL5,VEGFA
PMID:31223280	(2019) Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MAP3K5,PTGS2,PTEN,AR,JAK2,BCL2,VEGFA
PMID:31341222	(2019) Plasticity of patient-matched normal mammary epithelial cells is dependent on autologous adipose-derived stem cells.	7	45	1.25	0.00025	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000474412	ENPP2,THBS1,CDH1,CD34,LTA,MME,CCL5
PMID:31514268	(2019) Non-Coding RNAs in Cartilage Development: An Updated Review.	8	68	1.13	0.00025	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,IFNG,SOX9,IGF1R,KLF10,PTGS2,BMP2,VEGFA
PMID:31681160	(2019) Thyroid Hormones in the Brain and Their Impact in Recovery Mechanisms After Stroke.	7	45	1.25	0.00025	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,IFNG,ANGPT2,BCL2,RHOA,BDNF,VEGFA
PMID:31774816	(2019) Mesenchymal Stem Stromal Cells metabolomic and bioactive factors profiles: A comparative analysis on the umbilical cord and dental pulp derived Stem Stromal Cells secretome.	8	68	1.13	0.00025	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CD34,ANGPT2,EDN1,LTA,CCL5,VEGFA
PMID:31817583	(2019) Mapping Research in the Obesity, Adipose Tissue, and MicroRNA Field: A Bibliometric Analysis.	7	45	1.25	0.00025	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,MMP14,SIRT6,SREBF1,VEGFA
PMID:32642651	(2019) Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects.	7	45	1.25	0.00025	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000478570	CHI3L1,THBS1,CXCL10,ANG,PTEN,BMP2,VEGFA
PMID:29416873	(2018) Biomarker discovery for renal cancer stem cells.	7	45	1.25	0.00025	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,ELN,PROM1,VEGFA
PMID:29641459	(2018) An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.	7	45	1.25	0.00025	9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000339191,9606.ENSP00000368683	CHI3L1,FABP4,PLIN1,LPL,LPA,CAV1,EDN1
PMID:29774056	(2018) Epigenetic regulation of inflammation in stroke.	8	68	1.13	0.00025	9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,PTGS2,MTHFR,NFE2L2,BCL2,MYD88,BDNF,VEGFA
PMID:29904155	(2018) Moringin Induces Neural Differentiation in the Stem Cell of the Human Periodontal Ligament.	7	45	1.25	0.00025	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	FABP4,CD34,SREBF1,GAP43,BCL2,NTF3,BDNF
PMID:30087893	(2018) Stem Cells From the Apical Papilla (SCAP) as a Tool for Endogenous Tissue Regeneration.	7	45	1.25	0.00025	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,THBS1,LPL,CD34,EDN1,BDNF,VEGFA
PMID:30250564	(2018) Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer.	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,PTEN,AR,FGFR1,VEGFA
PMID:30251564	(2018) Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke.	7	45	1.25	0.00025	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CD34,ANGPT2,ANG,NTF3,BDNF,MME,VEGFA
PMID:30513833	(2018) GPCR Modulation in Breast Cancer.	8	68	1.13	0.00025	9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CCR5,EDNRA,EDN1,JAK2,AGTR1,CCL5,VEGFA
PMID:27610554	(2017) Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Whartons Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.	8	68	1.13	0.00025	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525	TGFB1,IFNG,CXCL10,CD34,STAT5A,PTEN,BCL2,MME
PMID:27888331	(2017) The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.	10	127	0.96	0.00025	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,CD34,STAT5A,CCL20,CXCL9,ENTPD1,CCL5
PMID:28137309	(2017) Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.	10	127	0.96	0.00025	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ATM,ALDH1A1,CD34,CAV1,PTEN,BCL2,PROM1,VEGFA
PMID:28174535	(2017) Emergency Spatiotemporal Shift: The Response of Protein Kinase D to Stress Signals in the Cardiovascular System.	7	45	1.25	0.00025	9606.ENSP00000246553,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	FFAR1,LPL,HNF4A,MAP3K5,BCL2,RHOA,VEGFA
PMID:28623955	(2017) Precision medicine in breast cancer: reality or utopia?	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CXCL9,PTEN,AR,CCL5,VEGFA
PMID:26807786	(2016) Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In Vitro.	8	68	1.13	0.00025	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,CCL20,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:27044487	(2016) VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.	7	45	1.25	0.00025	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000362524,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANGPT2,ANG,ANGPTL2,PROM1,CCL5,VEGFA
PMID:27690014	(2016) New Treatment Strategies for Alcohol-Induced Heart Damage.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175	IFNG,NOX4,SIRT6,ELN,EDN1,BCL2,RHOA
PMID:25965831	(2015) Geneticmolecular alterations of meningiomas and the signaling pathways targeted.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,PTGS2,PTEN,ALPL,BCL2,VEGFA
PMID:26101460	(2015) Harnessing the Therapeutic Potential of Th17 Cells.	7	45	1.25	0.00025	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,ENTPD1,JAK2,VEGFA
PMID:26123869	(2015) Relationship between synovial fluid ARGS-aggrecan fragments, cytokines, MMPs, and TIMPs following acute ACL injury: A cross-sectional study.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,FGFR1,LTA,CCL5,VEGFA
PMID:26610602	(2015) Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function.	8	68	1.13	0.00025	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CCL20,AR,BMP2,BDNF,CCL5,VEGFA
PMID:26694366	(2015) Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CD34,PTEN,BMP2,BCL2,LTA,CCL5,VEGFA
PMID:26702828	(2015) Regulation of Cellular Identity in Cancer.	7	45	1.25	0.00025	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,ALDH1A1,ONECUT1,HNF4A,PTEN,PROM1,HNF1B
PMID:29051866	(2015) Mechanisms navigating the TGF-beta pathway in prostate cancer.	7	45	1.25	0.00025	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,PTEN,AR,BCL2,RHOA,VEGFA
PMID:24526695	(2014) Regulation of an inflammatory disease: Kruppel-like factors and atherosclerosis.	8	68	1.13	0.00025	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000285407,9606.ENSP00000292303,9606.ENSP00000311005,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000474412	CD69,FABP4,KLF10,CCR5,MAPK7,PDGFA,EDN1,CCL5
PMID:24859987	(2014) Peripheral changes in endometriosis-associated pain.	7	45	1.25	0.00025	9606.ENSP00000310036,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,VIP,PTGS2,NPY,NTF3,BDNF,VEGFA
PMID:25371905	(2014) Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.	7	45	1.25	0.00025	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CD34,ANGPT2,EDN1,RHOA,AGTR1,CCL5,VEGFA
PMID:25525301	(2014) Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.	8	68	1.13	0.00025	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CCR5,CXCL10,CCL20,CXCL9,ENTPD1,BCL2,CCL5
PMID:26436133	(2014) NADPH Oxidases in Chronic Liver Diseases.	7	45	1.25	0.00025	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252	NOX4,TIMP3,STAT5A,NOX1,TXN,EDN1,NFE2L2
PMID:26932379	(2014) The significance of macrophage phenotype in cancer and biomaterials.	8	68	1.13	0.00025	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:23313965	(2013) Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.	8	68	1.13	0.00025	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANGPT2,CCL20,PTEN,NFE2L2,PROM1,CCL5,VEGFA
PMID:24384839	(2013) Chemokine receptors in epithelial ovarian cancer.	7	45	1.25	0.00025	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:22321604	(2012) Monocytes conditioned media stimulate fibronectin expression and spreading of inflammatory breast cancer cells in three-dimensional culture: A mechanism mediated by IL-8 signaling pathway.	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000474412	CDH1,CXCL10,CAV1,CXCL9,RHOA,LTA,CCL5
PMID:22605974	(2012) Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health.	7	45	1.25	0.00025	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000478570	SOX9,TIMP3,SIRT6,FMOD,PTGS2,AR,VEGFA
PMID:22666523	(2012) Anticancer activity of green tea polyphenols in prostate gland.	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,COMT,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:22802911	(2012) Role of MicroRNAs in Fibrosis.	7	45	1.25	0.00025	9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,COL8A1,CDH1,PDGFB,PTEN,EDN1,VEGFA
PMID:23009917	(2012) Immune and inflammatory mechanisms in pulmonary arterial hypertension.	7	45	1.25	0.00025	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	PDGFB,PDGFA,VIP,EDN1,BCL2,CCL5,VEGFA
PMID:23209336	(2012) Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice.	7	45	1.25	0.00025	9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,PLIN1,PTEN,AR,BCL2,MME,VEGFA
PMID:20946957	(2011) The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CDH1,TIMP3,MMP14,PTEN,MYD88,VEGFA
PMID:21547001	(2011) Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.	7	45	1.25	0.00025	9606.ENSP00000216181,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	MYH9,IGF1R,ATM,PTEN,BCL2,VEGFA,HNF1B
PMID:21715071	(2011) Podocyte biology for the bedside.	7	45	1.25	0.00025	9606.ENSP00000263317,9606.ENSP00000317674,9606.ENSP00000352264,9606.ENSP00000356832,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	NOX4,APOL1,CD2AP,SGK1,RHOA,PROM1,VEGFA
PMID:21892159	(2011) Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.	8	68	1.13	0.00025	9606.ENSP00000222139,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	EPOR,CD69,CD34,STAT5A,PTEN,JAK2,BCL2,MME
PMID:22096557	(2011) IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase III study.	7	45	1.25	0.00025	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000474412	CD69,IFNG,CCR5,CXCL10,CD34,LTA,CCL5
PMID:20690004	(2010) Intestinal mesenchymal cells.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	IFNG,CD34,PTGS2,BDNF,CCL5,GREM1,VEGFA
PMID:20923405	(2010) Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.	8	68	1.13	0.00025	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000321853,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,EDNRA,SERPINF2,COMT,EDN1,RHOA,AGTR1,VEGFA
PMID:16691187	(2006) Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.	7	45	1.25	0.00025	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,MYD88,CCL5
PMID:35335873	(2022) Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer.	9	96	1.03	0.00026	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000339916,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	HSPB1,ATM,LIMK2,STAT5A,PTGS2,PTEN,AR,JAK2,BCL2
PMID:33808627	(2021) The Role of Cancer-Associated Fibroblasts in Tumor Progression.	9	96	1.03	0.00026	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	CD69,CDH1,IGF1R,CD34,CAV1,PTEN,AR,PROM1,VEGFA
PMID:34235155	(2021) Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.	9	96	1.03	0.00026	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CHI3L1,ALDH1A1,CD34,CD47,FTO,PROM1,CCL5,VEGFA
PMID:33294746	(2020) Long non-coding RNAs in breast cancer metastasis.	9	96	1.03	0.00026	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000334329,9606.ENSP00000363822,9606.ENSP00000366395,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,UNC5B,AR,SYVN1,JAK2,BCL2,VEGFA
PMID:31554173	(2019) Autophagy and Its Relationship to Epithelial to Mesenchymal Transition: When Autophagy Inhibition for Cancer Therapy Turns Counterproductive.	9	96	1.03	0.00026	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,JAK2,BCL2,PROM1,CCL5,VEGFA
PMID:28730968	(2018) Modulation of the Immune System for the Treatment of Glaucoma.	9	96	1.03	0.00026	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000267484,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495	IFNG,HSPB1,VDAC1,RTN1,PTGS2,GAP43,BCL2,MYD88,LTA
PMID:29351723	(2018) Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling.	9	96	1.03	0.00026	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384364	FFAR1,FABP4,NOX4,SREBF1,PTGS2,TXN,EDN1,JAK2,NPY
PMID:27128908	(2016) New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.	9	96	1.03	0.00026	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	LAMC1,THBS1,TIMP3,IGF1R,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:25609920	(2015) Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.	12	200	0.84	0.00026	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000263774,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383364	MAPK1,MYH9,CDH1,NOX4,NDUFS3,VDAC1,SIRT6,SHBG,JAK2,NFE2L2,BCL2,PLA2G2A
PMID:26649299	(2015) Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.	9	96	1.03	0.00026	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD38,IFNG,IGF1R,CD34,PTEN,MAFB,BCL2,MYD88,VEGFA
PMID:24723924	(2014) Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues.	9	96	1.03	0.00026	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,ATM,CCR5,MMP14,ANGPT2,CCL20,CD47,CCL5,VEGFA
PMID:20981323	(2009) Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNTPCP, Flt-3LFlt-3 and CXCL9CXCR3 as Regulators of Cell Proliferation, Survival and Migration.	9	96	1.03	0.00026	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000312987,9606.ENSP00000347041,9606.ENSP00000354901,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412	CD38,IFNG,HNF4A,FMOD,CXCL9,MAFB,JAK2,RHOA,CCL5
PMID:34117484	(2022) Natural killer cells in antiviral immunity.	8	69	1.13	0.00027	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CD69,IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:35203510	(2022) Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View.	8	69	1.13	0.00027	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CDH1,CD34,PTEN,PROM1,CCL5,VEGFA
PMID:35236304	(2022) Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis.	8	69	1.13	0.00027	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,CD34,ANG,AR,JAK2,BCL2,VEGFA
PMID:32920752	(2021) COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.	8	69	1.13	0.00027	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,STAT5A,CXCL9,PTGS2,CCL5,VEGFA
PMID:33500480	(2021) Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma.	9	97	1.03	0.00027	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399	ERCC1,CDH1,IGF1R,ATM,PTGS2,PTEN,JAK2,FGFR1,MYD88
PMID:33504575	(2021) Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer.	10	128	0.95	0.00027	9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,MAPK7,CD247,CXCL9,CD47,PTEN,JAK2,MYD88,CCL5,VEGFA
PMID:33763992	(2021) Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis.	8	69	1.13	0.00027	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,CCR5,MMP14,CD34,CAV1,BCL2,VEGFA
PMID:33794890	(2021) Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment.	8	69	1.13	0.00027	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,ATM,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:33925827	(2021) Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.	8	69	1.13	0.00027	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000360522,9606.ENSP00000369442,9606.ENSP00000474412	FABP4,CCR5,SREBF1,ELN,MAP3K5,RBP4,KL,CCL5
PMID:33946986	(2021) PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis.	9	97	1.03	0.00027	9606.ENSP00000232219,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	RBP1,THBS1,NOX4,ANGPT2,CAV1,PTGS2,PTEN,BCL2,VEGFA
PMID:34145432	(2021) Noncoding RNA therapeutics - challenges and potential solutions.	8	69	1.13	0.00027	9606.ENSP00000265333,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	VDAC1,CCR5,CD34,CD47,BCL2,MYD88,BDNF,VEGFA
PMID:34168400	(2021) Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.	9	97	1.03	0.00027	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000474412	MPO,IFNG,CXCL10,CCL20,TXN,G6PD,NFE2L2,AGTR1,CCL5
PMID:34257817	(2021) The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence.	8	69	1.13	0.00027	9606.ENSP00000225275,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000477707,9606.ENSP00000478570	MPO,SREBF1,COMT,PTGS2,G6PD,BCL2,NR1H3,VEGFA
PMID:34359674	(2021) Heterogeneous Myeloid Cells in Tumors.	9	97	1.03	0.00027	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CXCL10,STAT5A,CCL20,CD247,CXCL9,BCL2,MME,VEGFA
PMID:34426741	(2021) Maxillofacial-Derived Mesenchymal Stem Cells: Characteristics and Progress in Tissue Regeneration.	9	97	1.03	0.00027	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,LPL,CD34,ANGPT2,PTGS2,BMP2,BDNF,CCL5,VEGFA
PMID:34439102	(2021) Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.	8	69	1.13	0.00027	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CDH1,PDGFA,JAK2,BDNF,AGTR1,PROM1,VEGFA
PMID:34447800	(2021) Transcriptome Analysis Identifies Strategies Targeting Immune Response-Related Pathways to Control Enterotoxigenic Escherichia coli Infection in Porcine Intestinal Epithelial Cells.	8	69	1.13	0.00027	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000403495	CXCL10,CXCL11,CCL20,CXCL9,PTGS2,EDN1,MYD88,LTA
PMID:34504417	(2021) Current Therapies for Neonatal Hypoxic-Ischaemic and Infection-Sensitised Hypoxic-Ischaemic Brain Damage.	8	69	1.13	0.00027	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	EPOR,IFNG,MAP3K5,NFE2L2,BCL2,MYD88,VEGFA,HNF1B
PMID:34686542	(2021) (68)Ga-DOTATOC PETCT to detect immune checkpoint inhibitor-related myocarditis.	8	69	1.13	0.00027	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:34733609	(2021) Relationship between Th17 immune response and cancer.	8	69	1.13	0.00027	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ALDH1A1,CXCL10,CCL20,CXCL9,JAK2,PROM1,CCL5,VEGFA
PMID:34820325	(2021) Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets.	8	69	1.13	0.00027	9606.ENSP00000256104,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	FABP4,STAT5A,SREBF1,ABCG1,PTEN,BCL2,PROM1,VEGFA
PMID:35008569	(2021) Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.	11	163	0.89	0.00027	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,CXCL10,CXCL11,MMP14,ANG,CAV1,CXCL9,HSPG2,RHOA,VEGFA
PMID:35048056	(2021) Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.	8	69	1.13	0.00027	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CCL20,ENTPD1,BCL2,MYD88,CCL5,VEGFA
PMID:32183376	(2020) Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review.	8	69	1.13	0.00027	9606.ENSP00000229135,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,PLIN1,PTGS2,PTEN,NFE2L2,BCL2,MYD88,CCL5
PMID:32272677	(2020) Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription.	9	97	1.03	0.00027	9606.ENSP00000232219,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000477707	RBP1,ALDH1A1,HNF4A,SREBF1,ABCG1,RBP4,AR,BCL2,NR1H3
PMID:32357493	(2020) Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.	8	69	1.13	0.00027	9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MMP14,STAT5A,MAP3K5,PTEN,TXN,AR,BCL2,VEGFA
PMID:32670883	(2020) Metabolic Adaptations in Cancer Stem Cells.	8	69	1.13	0.00027	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,HNF4A,G6PD,BCL2,PROM1
PMID:32779878	(2020) The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.	8	69	1.13	0.00027	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5,VEGFA
PMID:32872365	(2020) Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.	9	97	1.03	0.00027	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CD38,SOX9,FABP4,CD34,SIRT6,ENTPD1,PTEN,RHOA,VEGFA
PMID:32883003	(2020) Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells.	9	97	1.03	0.00027	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	CDH1,IGF1R,ALDH1A1,PDGFB,CAV1,CD47,PTEN,AR,BCL2
PMID:33240882	(2020) Epidermal Stem Cells in Hair Follicle Cycling and Skin Regeneration: A View From the Perspective of Inflammation.	10	128	0.95	0.00027	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	SOX9,CDH1,TIMP3,MMP14,CD34,CCL20,EDN1,BCL2,MME,VEGFA
PMID:33246471	(2020) Long noncoding RNAs: functions and mechanisms in colon cancer.	8	69	1.13	0.00027	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	HSPB1,CDH1,MMP14,PTEN,BCL2,PROM1,VEGFA,UHRF1
PMID:33321708	(2020) Carotenoids in Cancer Metastasis-Status Quo and Outlook.	8	69	1.13	0.00027	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX4,TIMP3,MMP14,JAK2,RHOA,PROM1,VEGFA
PMID:33370234	(2020) Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.	8	69	1.13	0.00027	9606.ENSP00000255409,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,NOX4,CXCL10,CAV1,CCL20,CXCL9,CCL5,VEGFA
PMID:30927908	(2019) Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.	8	69	1.13	0.00027	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000418525	THBS1,CDH1,IGF1R,CAV1,ELN,JAK2,IRAK4,MME
PMID:30927923	(2019) Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review.	11	163	0.89	0.00027	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,ELN,CXCL9,PTEN,EDN1,PDGFD,BDNF,CCL5,VEGFA
PMID:31083442	(2019) Vascular Dysfunction in Alzheimers Disease: A Prelude to the Pathological Process or a Consequence of It?	8	69	1.13	0.00027	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,EDN1,FGFR1,MME,CCL5,VEGFA
PMID:31109063	(2019) Bone Marrow Adipocytes: The Enigmatic Components of the Hematopoietic Stem Cell Niche.	8	69	1.13	0.00027	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000444198	FABP4,CD34,STAT5A,PTGS2,JAK2,BCL2,PROM1,CITED2
PMID:31143113	(2019) Modulation of the Endocannabinoid System as a Potential Anticancer Strategy.	8	69	1.13	0.00027	9606.ENSP00000232219,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000478570	RBP1,FABP4,ENPP2,CDH1,VDAC1,PTGS2,PLA2G2A,VEGFA
PMID:31288837	(2019) An update on reactive astrocytes in chronic pain.	8	69	1.13	0.00027	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,CNTF,EDN1,JAK2,RHOA,CCL5,VEGFA
PMID:31992984	(2019) Scaffold-Based Gene Therapeutics for Osteochondral Tissue Engineering.	8	69	1.13	0.00027	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,SOX9,IGF1R,PTEN,MAFB,BMP2,MYD88,VEGFA
PMID:29506506	(2018) Cancer stem cells as key drivers of tumour progression.	8	69	1.13	0.00027	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	IGF1R,CD34,CCL20,PTGS2,BCL2,PROM1,GREM1,VEGFA
PMID:29552625	(2018) Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).	8	69	1.13	0.00027	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000300055,9606.ENSP00000306124,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185	TGFB1,MPO,PLIN1,PRKCE,SREBF1,PTGS2,NFE2L2,BCL2
PMID:29628997	(2018) Cancer metabolism: New insights into classic characteristics.	9	97	1.03	0.00027	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,SIRT6,SREBF1,PTEN,NFE2L2,FGFR1,RHOA,VEGFA
PMID:29755289	(2018) Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.	8	69	1.13	0.00027	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000379256,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,TIMP3,IGF1R,PTEN,NCALD,BCL2,VEGFA
PMID:29941024	(2018) Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweightobese adolescents from Bogota, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial.	8	69	1.13	0.00027	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,ANG,CCL20,CXCL9,NTF3,LTA,BDNF,CCL5
PMID:30168075	(2018) Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression.	8	69	1.13	0.00027	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,CDH1,MMP14,CAV1,PTGS2,FGFR1,MME,VEGFA
PMID:30215857	(2018) Immunobiology of Inherited Muscular Dystrophies.	8	69	1.13	0.00027	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000356515,9606.ENSP00000369442,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,UTRN,KL,MYD88,AGTR1,CCL5,VEGFA
PMID:28930164	(2017) Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.	11	163	0.89	0.00027	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,ATM,ALDH1A1,HNF4A,CD47,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:27588490	(2016) MicroRNAs and epithelial-mesenchymal transition in prostate cancer.	8	69	1.13	0.00027	9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PRKCE,PTEN,PDGFD,FGFR1,RHOA,PROM1,VEGFA
PMID:28185585	(2016) How interacting pathways are regulated by miRNAs in breast cancer subtypes.	8	69	1.13	0.00027	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000304767,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	IGF1R,ATM,ALDH1A1,P2RY1,PTEN,FGFR1,RHOA,VEGFA
PMID:26007179	(2015) Curcumin, inflammation, and chronic diseases: how are they linked?	8	69	1.13	0.00027	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,FABP4,SREBF1,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:24967356	(2014) Cell communication in a coculture system consisting of outgrowth endothelial cells and primary osteoblasts.	9	97	1.03	0.00027	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	IFNG,SOX9,THBS1,TIMP3,ANGPT2,PDGFA,ALPL,BMP2,VEGFA
PMID:25076948	(2014) Organ-specific and memory treg cells: specificity, development, function, and maintenance.	8	69	1.13	0.00027	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000381185	CD38,CD69,CXCL10,STAT5A,CCL20,CXCL9,ENTPD1,BCL2
PMID:23644076	(2013) Microglia during development and aging.	8	69	1.13	0.00027	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303	IFNG,CHI3L1,CXCL10,CD47,ENTPD1,NTF3,LTA,BDNF
PMID:22467146	(2012) Immune markers and differential signaling networks in ulcerative colitis and Crohns disease.	8	69	1.13	0.00027	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,STAT5A,CCL20,PTGS2,JAK2,BCL2,MYD88,CCL5
PMID:24392268	(2012) Gene-Diet Interactions on Colorectal Cancer Risk.	8	69	1.13	0.00027	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000445772	NOX4,PDGFB,MAP3K5,PTGS2,PTEN,NOX1,TXN,LTB4R2
PMID:24970128	(2012) Oxysterols and their cellular effectors.	8	69	1.13	0.00027	9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000477707	CDH1,LPL,SREBF1,ABCG1,JAK2,BCL2,MYD88,NR1H3
PMID:21939239	(2011) Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.	8	69	1.13	0.00027	9606.ENSP00000228434,9606.ENSP00000259486,9606.ENSP00000310036,9606.ENSP00000321334,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD69,ENPP2,CD34,LPA,PTEN,RHOA,CCL5,VEGFA
PMID:20070897	(2010) 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1.	8	69	1.13	0.00027	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CDH1,HNF4A,GAS6,G6PD,NFE2L2,BCL2,VEGFA
PMID:20671809	(2010) The phosphatidylinositol 3-kinaseAktmTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.	8	69	1.13	0.00027	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000478570	CD38,IGF1R,ATM,CD34,MAP3K5,SGK1,PTEN,VEGFA
PMID:20959622	(2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.	9	97	1.03	0.00027	9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,VDAC1,MAPK7,MAP3K5,EDN1,BCL2,FGFR1,RHOA,VEGFA
PMID:34669097	(2022) Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease.	9	98	1.02	0.00028	9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	IGF1R,HNF4A,MAP3K5,PTEN,EDN1,BCL2,RHOA,MYD88,VEGFA
PMID:35053430	(2022) Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight.	8	70	1.12	0.00028	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809	SOX9,HSPB1,IGF1R,ALDH1A1,CD47,BCL2,MME,PROM1
PMID:35056157	(2022) Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review.	9	98	1.02	0.00028	9606.ENSP00000263317,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,ANG,CAV1,ABCG1,PTGS2,NFE2L2,BCL2,CCL5,VEGFA
PMID:35076142	(2022) Role of extracellular matrix proteoglycans in immune cell recruitment.	6	27	1.41	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,HSPG2,BDNF,CCL5
PMID:35116110	(2022) Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.	5	13	1.65	0.00028	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,CDH1,JAK2,RHOA,VEGFA
PMID:35158892	(2022) Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances.	8	70	1.12	0.00028	9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,ANGPT2,ANG,NFE2L2,BCL2,FGFR1,CCL5,VEGFA
PMID:35163131	(2022) Clinical Implication of Phosphodiesterase-4-Inhibition.	8	70	1.12	0.00028	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CCL20,CXCL9,S100A12,RHOA,CCL5,VEGFA
PMID:35204185	(2022) Antiangiogenic Phytochemicals Constituent of Diet as Promising Candidates for Chemoprevention of Cancer.	6	27	1.41	0.00028	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,ATM,HNF4A,PTGS2,BCL2,VEGFA
PMID:35217004	(2022) Transforming growth factor-beta1Thrombospondin-1CD47 axis mediates dysfunction in CD34(+) cells derived from diabetic older adults.	4	4	2.06	0.00028	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000355361	TGFB1,THBS1,CD34,CD47
PMID:35252166	(2022) The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets.	8	70	1.12	0.00028	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,MAPK7,PTEN,BCL2,PROM1,VEGFA
PMID:35269843	(2022) NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation.	6	27	1.41	0.00028	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,NOX1,TXN,G6PD,NFE2L2,VEGFA
PMID:35278793	(2022) Improving the role of immune checkpoint inhibitors in the management of advanced urothelial carcinoma, where do we stand?	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,ATM,CXCL10,CXCL9,PTEN,VEGFA
PMID:35294666	(2022) Omega-9 fatty acids: potential roles in inflammation and cancer management.	7	46	1.24	0.00028	9606.ENSP00000225275,9606.ENSP00000246553,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,FFAR1,CCL20,PTEN,NFE2L2,BCL2,VEGFA
PMID:35328639	(2022) Tumor-Mediated Neutrophil Polarization and Therapeutic Implications.	8	70	1.12	0.00028	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CD34,CXCL9,MME,CCL5,VEGFA
PMID:35328686	(2022) Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling.	7	46	1.24	0.00028	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,FABP4,CDH1,ELN,BCL2,CCL5,VEGFA
PMID:35358850	(2022) The amyloid peptide beta disrupts intercellular junctions and increases endothelial permeability in a NADPH oxidase 1-dependent manner.	6	27	1.41	0.00028	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000474412	NOX4,CXCL10,PTGS2,NOX1,NFE2L2,CCL5
PMID:33129107	(2021) HPV(+ve-ve) oral-tongue cancer stem cells: A potential target for relapse-free therapy.	7	46	1.24	0.00028	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IGF1R,ALDH1A1,CD34,BCL2,PROM1,VEGFA
PMID:33139798	(2021) A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,PTEN,MYD88,CCL5
PMID:33402737	(2021) The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1(+) tumour-infiltrating lymphocytes.	7	46	1.24	0.00028	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250	CD38,THBS1,ATM,CCR5,CD247,CXCL9,ENTPD1
PMID:33406104	(2021) Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNgammaCXCL10-dependent peripheral T cell recruitment in humanized murine model.	6	27	1.41	0.00028	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000475344	CD69,CXCL10,CXCL11,CD34,CXCL9,APLNR
PMID:33438104	(2021) Neutrophil-derived granule cargoes: paving the way for tumor growth and progression.	8	70	1.12	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CXCL10,STAT5A,ELN,CXCL9,CCL5,VEGFA
PMID:33467521	(2021) Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CD34,CCL5,VEGFA
PMID:33498928	(2021) Therapeutic Application of Exosomes in Inflammatory Diseases.	8	70	1.12	0.00028	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000426809,9606.ENSP00000474412	MPO,IFNG,CXCL10,CXCL9,PTGS2,KL,PROM1,CCL5
PMID:33519208	(2021) Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets.	8	70	1.12	0.00028	9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	ALDH1A1,ANGPT2,STAT5A,SREBF1,PTGS2,PTEN,JAK2,VEGFA
PMID:33530406	(2021) What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?	7	46	1.24	0.00028	9606.ENSP00000306124,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000358513,9606.ENSP00000384364,9606.ENSP00000418823	PRKCE,PDGFA,SREBF1,ABCG1,CNR1,NPY,FTO
PMID:33562161	(2021) Therapeutic Single Compounds for Osteoarthritis Treatment.	7	46	1.24	0.00028	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,SOX9,PTGS2,NFE2L2,BCL2,MYD88,VEGFA
PMID:33570672	(2021) Morphogens and growth factor signalling in the myeloma bone-lining niche.	7	46	1.24	0.00028	9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570	HNF4A,GAS6,MAFB,BMP2,BCL2,GREM1,VEGFA
PMID:33585615	(2021) Review of Diagnostic Tests for Detection of Mycobacterium bovis Infection in South African Wildlife.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:33650320	(2021) Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.	9	98	1.02	0.00028	9606.ENSP00000013807,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000478570	ERCC1,IFNG,CDH1,ATM,PTGS2,PTEN,BCL2,PLA2G2A,VEGFA
PMID:33671427	(2021) Peripheral Nerve Regeneration Using a Cytokine Cocktail Secreted by Skeletal Muscle-Derived Stem Cells in a Mouse Model.	6	27	1.41	0.00028	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000360522,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CD34,CNTF,RBP4,BDNF,VEGFA
PMID:33671779	(2021) Vitamin D Deficiency Cause Gender Specific Alterations of Renal Arterial Function in a Rodent Model.	5	13	1.65	0.00028	9606.ENSP00000216862,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000419422	CYP24A1,ELN,PTGS2,AR,AGTR1
PMID:33779796	(2021) Distinct genomic features across cytolytic subgroups in skin melanoma.	11	164	0.89	0.00028	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412	ATM,CCR5,CXCL10,CXCL11,CD247,CXCL9,ENTPD1,PTEN,JAK2,RARRES2,CCL5
PMID:33790810	(2021) Biological Functions of RBP4 and Its Relevance for Human Diseases.	6	27	1.41	0.00028	9606.ENSP00000200676,9606.ENSP00000232219,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000360522,9606.ENSP00000371067	CETP,RBP1,LPL,STAT5A,RBP4,JAK2
PMID:33807742	(2021) MicroRNA Signatures Associated with Bronchopulmonary Dysplasia Severity in Tracheal Aspirates of Preterm Infants.	5	13	1.65	0.00028	9606.ENSP00000245479,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,PTGS2,AR,RHOA,VEGFA
PMID:33897292	(2021) Immunological and molecular basics of the primary open angle glaucoma pathomechanism.	7	46	1.24	0.00028	9606.ENSP00000248553,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CNTF,EDN1,BCL2,RHOA,BDNF,VEGFA
PMID:33925337	(2021) Ultrashort Peptide Hydrogels Display Antimicrobial Activity and Enhance Angiogenic Growth Factor Release by Dental Pulp StemStromal Cells.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL11,ANGPT2,ANG,CCL5,VEGFA
PMID:33939261	(2021) Functional differences of Toll-like receptor 4 in osteogenesis, adipogenesis and chondrogenesis in human bone marrow-derived mesenchymal stem cells.	6	27	1.41	0.00028	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000368104,9606.ENSP00000401399	SOX9,FABP4,CXCL10,LPL,BMP2,MYD88
PMID:33945643	(2021) Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies.	6	27	1.41	0.00028	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906	CD69,CXCL10,ANGPT2,CXCL9,JAK2,SAA1
PMID:33979613	(2021) Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells.	6	27	1.41	0.00028	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000360250,9606.ENSP00000474412	CD38,CD69,IFNG,CCR5,ENTPD1,CCL5
PMID:34060407	(2021) Extracellular vesicles derived from lipoaspirate fluid promote fat graft survival.	6	27	1.41	0.00028	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000336762,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,PLIN1,LPL,ANG,RHOA,VEGFA
PMID:34063061	(2021) Genetic and Epigenomic Modifiers of Diabetic Neuropathy.	7	46	1.24	0.00028	9606.ENSP00000278616,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000375844,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ATM,KCNJ11,MTHFR,CAPN10,NTF3,BDNF,VEGFA
PMID:34069890	(2021) Insulin Resistance and Diabetes Mellitus in Alzheimers Disease.	10	129	0.95	0.00028	9606.ENSP00000215832,9606.ENSP00000265333,9606.ENSP00000300055,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	MAPK1,VDAC1,PLIN1,MAPK7,MAP3K5,SGK1,PTEN,NFE2L2,BCL2,BDNF
PMID:34112258	(2021) Metastasis-associated fibroblasts: an emerging target for metastatic cancer.	7	46	1.24	0.00028	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,THBS1,CXCL10,CXCL9,PTGS2,CCL5,VEGFA
PMID:34204038	(2021) Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications.	9	98	1.02	0.00028	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000477707	MPO,FABP4,EDNRA,SREBF1,ABCG1,RBP4,EDN1,JAK2,NR1H3
PMID:34210658	(2021) Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma.	8	70	1.12	0.00028	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,IGF1R,ATM,PTEN,JAK2,NFE2L2,FGFR1,RHOA
PMID:34235102	(2021) A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer.	8	70	1.12	0.00028	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ANGPT2,PTEN,AR,BCL2,FGFR1,RHOA,VEGFA
PMID:34297787	(2021) Perception of breast cancer risk factors: Dysregulation of TGF-betamiRNA axis in Pakistani females.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000381185	MAPK1,TGFB1,THBS1,IGF1R,BAMBI,BMP2,BCL2
PMID:34298679	(2021) Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy.	7	46	1.24	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CXCL11,EDNRA,CCL20,PTEN,BDNF,VEGFA
PMID:34360658	(2021) The Role of Supplementation with Natural Compounds in Post-Stroke Patients.	7	46	1.24	0.00028	9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	SIRT6,PTGS2,EDN1,NFE2L2,BCL2,BDNF,VEGFA
PMID:34367477	(2021) Exosomal microRNAs from mesenchymal stemstromal cells: Biology and applications in neuroprotection.	7	46	1.24	0.00028	9606.ENSP00000245479,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,PTEN,GAP43,BCL2,RHOA,BDNF,VEGFA
PMID:34445359	(2021) From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy.	7	46	1.24	0.00028	9606.ENSP00000268035,9606.ENSP00000352264,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525	IGF1R,CD2AP,TXN,BCL2,RHOA,BDNF,MME
PMID:34457051	(2021) Cancer-associated fibroblast-derived CCL5 contributes to cisplatin resistance in A549 NSCLC cells partially through upregulation of lncRNA HOTAIR expression.	5	13	1.65	0.00028	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000474412	CDH1,CCR5,CAV1,BCL2,CCL5
PMID:34490235	(2021) The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings.	8	70	1.12	0.00028	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CD34,ANGPT2,ENTPD1,BCL2,MYD88,CCL5,VEGFA
PMID:34502281	(2021) Network Pharmacology Study on Morus alba L. Leaves: Pivotal Functions of Bioactives on RAS Signaling Pathway and Its Associated Target Proteins against Gout.	6	27	1.41	0.00028	9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000384262,9606.ENSP00000475344,9606.ENSP00000478570	PTGS2,BCL2,PLA2G2A,HPSE,APLNR,VEGFA
PMID:34571733	(2021) The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation.	10	129	0.95	0.00028	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ALDH1A1,CXCL10,CXCL11,STAT5A,CXCL9,BCL2,MYD88,PROM1,CCL5,VEGFA
PMID:34587172	(2021) Role of T cells during the cerebral infection with Trypanosoma brucei.	6	27	1.41	0.00028	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000478570	CD69,IFNG,CDH1,CXCL10,CXCL9,VEGFA
PMID:34599188	(2021) Tendon and multiomics: advantages, advances, and opportunities.	9	98	1.02	0.00028	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000285407,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,HSPB1,THBS1,KLF10,FMOD,ELN,FGFR1,PROM1,VEGFA
PMID:34611806	(2021) Unboxing the molecular modalities of mutagens in cancer.	10	129	0.95	0.00028	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,MAPK1,MPO,APC,ATM,CXCL10,BCL2,MYD88,CCL5,VEGFA
PMID:34674640	(2021) Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro.	6	27	1.41	0.00028	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,THBS1,TIMP3,PDGFD,CCL5,VEGFA
PMID:34680266	(2021) Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.	10	129	0.95	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,IGF1R,ATM,HNF4A,VIP,PTEN,BCL2,FGFR1,MME,VEGFA
PMID:34680295	(2021) Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers.	8	70	1.12	0.00028	9606.ENSP00000226279,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000478570	CD38,STAT5A,JAK2,BCL2,IRAK4,MYD88,LTA,VEGFA
PMID:34744762	(2021) Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin.	8	70	1.12	0.00028	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175	SOX9,FABP4,EDNRA,SREBF1,PTGS2,EDN1,NPY,RHOA
PMID:34746010	(2021) Target-Based Radiosensitization Strategies: Concepts and Companion Animal Model Outlook.	6	27	1.41	0.00028	9606.ENSP00000278616,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CD47,ENTPD1,PTEN,BCL2,VEGFA
PMID:34771671	(2021) Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells.	7	46	1.24	0.00028	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000418525	CD38,CD34,EBF1,STAT5A,ELN,JAK2,MME
PMID:34833007	(2021) New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies.	5	13	1.65	0.00028	9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CD47,PTEN,AR,BCL2,VEGFA
PMID:34848989	(2021) Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimers Disease.	8	70	1.12	0.00028	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000322898,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000403495	CHI3L1,CCR5,PRDX2,EBF1,TXN,NFE2L2,RHOA,LTA
PMID:34873252	(2021) Higher mucosal antibody concentrations in women with genital tract inflammation.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:34884723	(2021) Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.	7	46	1.24	0.00028	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000478570	CD38,CD69,IFNG,CD34,CD47,ENTPD1,VEGFA
PMID:34938381	(2021) H2A.X Phosphorylation in Oxidative Stress and Risk Assessment in Plasma Medicine.	6	27	1.41	0.00028	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185	ATM,PRDX2,MAP3K5,NOX1,NFE2L2,BCL2
PMID:35008675	(2021) Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.	8	70	1.12	0.00028	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ANGPT2,ANG,PTEN,BMP2,BCL2,CCL5,VEGFA
PMID:35024507	(2021) Platelets: Implications in Aortic Valve Stenosis and Bioprosthetic Valve Dysfunction From Pathophysiology to Clinical Care.	6	27	1.41	0.00028	9606.ENSP00000259486,9606.ENSP00000304767,9606.ENSP00000309757,9606.ENSP00000360997,9606.ENSP00000368104,9606.ENSP00000400175	ENPP2,P2RY1,LPL,ADAMTS13,BMP2,RHOA
PMID:35047557	(2021) Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.	7	46	1.24	0.00028	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000474412	NOX4,ATM,CXCL10,STAT5A,NOX1,JAK2,CCL5
PMID:35173663	(2021) Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations.	7	46	1.24	0.00028	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,TIMP3,CD34,CAV1,PTEN,BCL2,VEGFA
PMID:31196739	(2020) Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:31820492	(2020) Epigeneticsepigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer.	7	46	1.24	0.00028	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252	APC,IGF1R,PTGS2,PTEN,NOX1,EDN1,NFE2L2
PMID:32070157	(2020) Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.	6	27	1.41	0.00028	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	EDNRA,ELN,VIP,EDN1,RHOA,VEGFA
PMID:32075964	(2020) Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CD247,CXCL9,CCL5
PMID:32082484	(2020) Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo.	5	13	1.65	0.00028	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478570	PDGFB,PDGFA,BMP2,EDN1,VEGFA
PMID:32175277	(2020) An Overview of Vasculogenic Mimicry in Breast Cancer.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000284031,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,DDAH1,ALDH1A1,MMP14,PTGS2,PROM1,VEGFA
PMID:32300778	(2020) Role of S-Equol, Indoxyl Sulfate, and Trimethylamine N-Oxide on Vascular Function.	7	46	1.24	0.00028	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	NOX4,PTGS2,EDN1,KL,NFE2L2,BCL2,RHOA
PMID:32326111	(2020) Role of Genetic Variations in the Hepatic Handling of Drugs.	8	70	1.12	0.00028	9606.ENSP00000013807,9606.ENSP00000200676,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000354511,9606.ENSP00000354995,9606.ENSP00000360247,9606.ENSP00000478570	ERCC1,CETP,ATM,ANGPT2,COMT,ABCG1,CYP2J2,VEGFA
PMID:32671039	(2020) Influence of Microenvironment on Mesenchymal Stem Cell Therapeutic Potency: From Planar Culture to Microcarriers.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,SOX9,CD34,ALPL,RHOA,BDNF,VEGFA
PMID:32723695	(2020) Role of non-coding-RNAs in response to environmental stressors and consequences on human health.	8	70	1.12	0.00028	9606.ENSP00000013807,9606.ENSP00000265333,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	ERCC1,VDAC1,HNF4A,SIRT6,PTEN,NFE2L2,BDNF,VEGFA
PMID:32747663	(2020) MethylResolver-a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:32751137	(2020) From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective.	9	98	1.02	0.00028	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,IGF1R,ATM,PTGS2,PTEN,JAK2,FGFR1,RHOA,VEGFA
PMID:32775470	(2020) Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis.	7	46	1.24	0.00028	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,IRAK4,MYD88,LTA,VEGFA
PMID:32825277	(2020) Targeting the Calcium Signalling Machinery in Cancer.	8	70	1.12	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,PTEN,BCL2,TRPC1,CCL5,VEGFA
PMID:32998687	(2020) Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,LTA,CCL5,VEGFA
PMID:33003572	(2020) Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation.	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCL20,PTEN,RARRES2,CCL5,VEGFA
PMID:33071712	(2020) A Patch of Detachable Hybrid Microneedle Depot for Localized Delivery of Mesenchymal Stem Cells in Regeneration Therapy.	5	13	1.65	0.00028	9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000478570	COL8A1,TIMP3,CD34,ELN,VEGFA
PMID:33081260	(2020) The Benefits of Flavonoids in Diabetic Retinopathy.	8	70	1.12	0.00028	9606.ENSP00000232219,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	RBP1,NOX4,PTGS2,PTEN,NFE2L2,BCL2,BDNF,VEGFA
PMID:33132848	(2020) Beyond the Hippocampus and the SVZ: Adult Neurogenesis Throughout the Brain.	8	70	1.12	0.00028	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000246553,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,FFAR1,CNTF,BCL2,NPY,BDNF,VEGFA
PMID:33143013	(2020) On a Beam of Light: Photoprotective Activities of the Marine Carotenoids Astaxanthin and Fucoxanthin in Suppression of Inflammation and Cancer.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000478570	MPO,THBS1,PTGS2,NFE2L2,MME,VEGFA
PMID:33177176	(2020) Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000478570	IFNG,THBS1,CD34,PTGS2,ENTPD1,VEGFA
PMID:33178814	(2020) Pulmonary hypertension: Proteins in the blood.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CXCL10,ANGPT2,EDN1,CCL5,VEGFA
PMID:33203443	(2020) Environmental chemicals, breast cancer progression and drug resistance.	8	70	1.12	0.00028	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000478570	MAPK1,CDH1,CD34,PTGS2,PTEN,NOX1,BMP2,VEGFA
PMID:33277571	(2020) Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATXLPALPA1 signaling axis.	6	27	1.41	0.00028	9606.ENSP00000259486,9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000474412	ENPP2,ONECUT1,CXCL10,CXCL11,PTGS2,CCL5
PMID:33321877	(2020) The Role of the Adipokines in the Most Common Gestational Complications.	6	27	1.41	0.00028	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000475344	MAPK1,FABP4,STAT5A,JAK2,RARRES2,APLNR
PMID:33335518	(2020) COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.	10	129	0.95	0.00028	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CXCL10,CXCL11,EDNRA,CCL20,CXCL9,S100A12,BCL2,MYD88,CCL5
PMID:33364196	(2020) How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer.	7	46	1.24	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,PTEN,CCL5,VEGFA
PMID:30422673	(2019) Restoration of skeletal muscle homeostasis by hydrogen sulfide during hyperhomocysteinemia-mediated oxidativeER stress condition (1).	7	46	1.24	0.00028	9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PRDX2,MAP3K5,TXN,MTHFR,BCL2,BDNF,VEGFA
PMID:30485762	(2019) Cell Death in the Lung: The Apoptosis-Necroptosis Axis.	9	98	1.02	0.00028	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IFNG,CHI3L1,NOX4,MAP3K5,PTEN,EDN1,BCL2,VEGFA
PMID:30594446	(2019) Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.	5	13	1.65	0.00028	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CCL20,CCL5
PMID:30624253	(2019) One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000317674,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,APOL1,CXCL9
PMID:30692642	(2019) Autophagy in endothelial cells and tumor angiogenesis.	7	46	1.24	0.00028	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,ANGPT2,PTEN,HSPG2,EDN1,BCL2,VEGFA
PMID:30703735	(2019) Asymmetrical 3D Nanoceria Channel for Severe Neurological Defect Regeneration.	5	13	1.65	0.00028	9606.ENSP00000310036,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	CD34,GAP43,NFE2L2,BDNF,VEGFA
PMID:30841549	(2019) Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy.	8	70	1.12	0.00028	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	IGF1R,ATM,ALDH1A1,SIRT6,STAT5A,PTEN,AR,BCL2
PMID:30853891	(2019) Natrium Benzoate Alleviates Neuronal Apoptosis via the DJ-1-Related Anti-oxidative Stress Pathway Involving Akt Phosphorylation in a Rat Model of Traumatic Spinal Cord Injury.	5	13	1.65	0.00028	9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	PRDX2,MAP3K5,NFE2L2,BCL2,BDNF
PMID:30905621	(2019) O-GlcNAcylation disrupts STRA6-retinol signals in kidneys of diabetes.	5	13	1.65	0.00028	9606.ENSP00000232219,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000349860,9606.ENSP00000371067	RBP1,ALDH1A1,STAT5A,GFPT1,JAK2
PMID:30959772	(2019) Platelet-Rich Fibrin Scaffolds for Cartilage and Tendon Regenerative Medicine: From Bench to Bedside.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	MPO,SOX9,CD34,PTGS2,BMP2,VEGFA
PMID:30967156	(2019) Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial.	8	70	1.12	0.00028	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000478570	CD69,TIMP3,IGF1R,PDGFB,CCL20,PTGS2,FGFR1,VEGFA
PMID:31077226	(2019) Colon adenoma and adenocarcinoma with clear cell components - two case reports.	5	13	1.65	0.00028	9606.ENSP00000257430,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000418525	APC,PLIN1,PTGS2,AR,MME
PMID:31080827	(2019) Toxoplasma gondii Modulates the Host Cell Responses: An Overview of Apoptosis Pathways.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000360997,9606.ENSP00000381185,9606.ENSP00000401399	MAPK1,IFNG,NOX4,MAP3K5,ADAMTS13,BCL2,MYD88
PMID:31113756	(2019) What role do fat cells play in pancreatic tissue?	8	70	1.12	0.00028	9606.ENSP00000200676,9606.ENSP00000246553,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CETP,FFAR1,LPL,KCNJ11,ANGPTL2,JAK2,CCL5,VEGFA
PMID:31185026	(2019) Clinical and molecular markers in retinal detachment-From hyperreflective points to stem cells and inflammation.	7	46	1.24	0.00028	9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000478570	CHI3L1,CD34,ANG,CD47,SHBG,BDNF,VEGFA
PMID:31244609	(2019) Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds.	6	27	1.41	0.00028	9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	PDGFA,CNTF,PTEN,NTF3,BDNF,VEGFA
PMID:31247903	(2019) Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer.	8	70	1.12	0.00028	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000314897,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,ALDH1A1,ANGPT2,TXN,BCL2,PROM1,VEGFA,HNF1B
PMID:31395836	(2019) The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.	7	46	1.24	0.00028	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,CCL20,CXCL9,PTEN,CCL5,VEGFA
PMID:31396083	(2019) Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review.	8	70	1.12	0.00028	9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	LPL,HNF4A,SIRT6,SREBF1,RBP4,NFE2L2,BCL2,MYD88
PMID:31417646	(2019) The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL9,CCL5,VEGFA
PMID:31485289	(2019) Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases.	7	46	1.24	0.00028	9606.ENSP00000248553,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000478570	HSPB1,SIRT6,ELN,PTEN,TXN,G6PD,VEGFA
PMID:31495720	(2019) Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2ROS and Nrf2PD-L1 signaling.	6	27	1.41	0.00028	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185	ERCC1,CDH1,ATM,NOX1,NFE2L2,BCL2
PMID:31531025	(2019) Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists.	6	27	1.41	0.00028	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANG,MYD88,CCL5,VEGFA
PMID:31634377	(2019) An ex vivo tissue model of cartilage degradation suggests that cartilage state can be determined from secreted key protein patterns.	6	27	1.41	0.00028	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000368104,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,BMP2,CCL5
PMID:31637219	(2019) Transcriptional Analysis of Human Skin Lesions Identifies Tryptophan-2,3-Deoxygenase as a Restriction Factor for Cutaneous Leishmania.	7	46	1.24	0.00028	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000354901,9606.ENSP00000384262,9606.ENSP00000474412	TGFB1,MPO,FABP4,CCR5,CXCL9,HPSE,CCL5
PMID:31640258	(2019) The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.	7	46	1.24	0.00028	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CCR5,MMP14,CD34,ELN,CCL5,VEGFA
PMID:31683684	(2019) Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000330382,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000419422	MAPK1,PDGFB,CNR1,CNR2,AR,JAK2,AGTR1
PMID:31710714	(2019) THE CONCISE GUIDE TO PHARMACOLOGY 201920: Enzymes.	14	287	0.75	0.00028	9606.ENSP00000216862,9606.ENSP00000225275,9606.ENSP00000259486,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000284031,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000354511,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000383364,9606.ENSP00000400175	CYP24A1,MPO,ENPP2,TIMP3,ATM,DDAH1,MMP14,SIRT6,COMT,ENTPD1,PTEN,JAK2,PLA2G2A,RHOA
PMID:31731180	(2019) ROCK inhibitor increases proacinar cells in adult salivary gland organoids.	5	13	1.65	0.00028	9606.ENSP00000245479,9606.ENSP00000293599,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809	SOX9,AQP5,PTEN,RHOA,PROM1
PMID:31731545	(2019) Recent Advances in Basic Research for Brain Arteriovenous Malformation.	6	27	1.41	0.00028	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000478570	LPL,CD34,MAPK7,PDGFB,PTEN,VEGFA
PMID:32010194	(2019) Biology of Tendon Stem Cells and Tendon in Aging.	8	70	1.12	0.00028	9606.ENSP00000245479,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000444198,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,FMOD,ELN,BMP2,RHOA,CITED2,CCL5,VEGFA
PMID:28745329	(2018) Involvement of MAFSPP1 axis in the development of bone marrow fibrosis in PMF patients.	6	27	1.41	0.00028	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	ENPP2,THBS1,CD34,STAT5A,JAK2,VEGFA
PMID:28964716	(2018) Delayed Hair Follicle Morphogenesis and Hair Follicle Dystrophy in a Lipoatrophy Mouse Model of Pparg Total Deletion.	6	27	1.41	0.00028	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104	FABP4,PLIN1,CAV1,PDGFA,ALPL,BMP2
PMID:29228279	(2018) In Vitro Model of Fully Differentiated Human Nasal Epithelial Cells Infected With Rhinovirus Reveals Epithelium-Initiated Immune Responses.	4	4	2.06	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:29455667	(2018) Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.	9	98	1.02	0.00028	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,IGF1R,ATM,CD34,CAV1,STAT5A,JAK2,BCL2,VEGFA
PMID:29615075	(2018) Lipid accumulation in human breast cancer cells injured by iron depletors.	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000349860,9606.ENSP00000381185	CDH1,VDAC1,FADS2,PLIN1,GFPT1,BCL2
PMID:29616218	(2018) Recent Insights into the Contribution of the Changing Hypertrophic Chondrocyte Phenotype in the Development and Progression of Osteoarthritis.	9	98	1.02	0.00028	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,HNF4A,SIRT6,ALPL,BMP2,KL,FGFR1,GREM1,VEGFA
PMID:29682351	(2018) Comparative Analysis of Cellular and Growth Factor Composition in Bone Marrow Aspirate Concentrate and Platelet-Rich Plasma.	5	13	1.65	0.00028	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,IFNG,CD34,BMP2,VEGFA
PMID:29768965	(2018) The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.	7	46	1.24	0.00028	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANGPT2,ANG,CNTF,NTF3,BDNF,VEGFA
PMID:29874834	(2018) Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.	6	27	1.41	0.00028	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,EDN1,CCL5,VEGFA
PMID:29876339	(2018) Steroid Hormones and Their Action in Womens Brains: The Importance of Hormonal Balance.	5	13	1.65	0.00028	9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000484631	AR,SHBG,BCL2,BDNF,PMP22
PMID:29983921	(2018) Role of extracellular matrix in breast cancer development: a brief update.	8	70	1.12	0.00028	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,STAT5A,ELN,CXCL9,JAK2,RHOA,VEGFA
PMID:30003089	(2018) Advantages of Graphene Biosensors for Human Stem Cell Therapy Potency Assays.	5	13	1.65	0.00028	9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,BMP2,BCL2,PROM1,VEGFA
PMID:30208590	(2018) Fish Oil Supplementation Reduces Inflammation but Does Not Restore Renal Function and Klotho Expression in an Adenine-Induced CKD Model.	5	13	1.65	0.00028	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000369442	CDH1,CXCL10,CXCL9,PTGS2,KL
PMID:30323626	(2018) Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,JAK2,CCL5,VEGFA
PMID:30442178	(2018) Computational analysis reveals histotype-dependent molecular profile and actionable mutation effects across cancers.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,ATM,CAV1,STAT5A,PTEN,BCL2,FGFR1
PMID:30455858	(2018) Hydrogel-assisted neuroregeneration approaches towards brain injury therapy: A state-of-the-art review.	6	27	1.41	0.00028	9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	PDGFA,ELN,CNTF,NTF3,BDNF,VEGFA
PMID:30555478	(2018) Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction.	8	70	1.12	0.00028	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,CD34,ANGPT2,PDGFA,PTGS2,ANGPTL2,RHOA,VEGFA
PMID:30622670	(2018) Apigenin Protects the Brain against IschemiaReperfusion Injury via Caveolin-1VEGF In Vitro and In Vivo.	5	13	1.65	0.00028	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,CAV1,JAK2,BCL2,VEGFA
PMID:27592626	(2017) Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor Angiopoietin-2Thrombospondin-1 Signaling.	4	4	2.06	0.00028	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000478570	THBS1,CD34,ANGPT2,VEGFA
PMID:27768230	(2017) An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.	5	13	1.65	0.00028	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000474412	CD38,CXCL10,CXCL9,S100A12,CCL5
PMID:28125639	(2017) NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.	5	13	1.65	0.00028	9606.ENSP00000314897,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000419313,9606.ENSP00000478570	ANGPT2,VIP,EDN1,TRPC1,VEGFA
PMID:28134850	(2017) CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,CXCL10,PTGS2,PTEN,AR,EDN1,VEGFA
PMID:28167942	(2017) Distinct Cytokine and Chemokine Profiles in Autism Spectrum Disorders.	5	13	1.65	0.00028	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CCR5,CXCL10,CXCL9,CCL5
PMID:28188431	(2017) Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000474412	IFNG,CXCL10,LPA,PTGS2,RHOA,CCL5
PMID:28208771	(2017) Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility.	8	70	1.12	0.00028	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000365256,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CHI3L1,THBS1,CLCN5,EDN1,BCL2,PROM1,VEGFA
PMID:28218908	(2017) Cell-matrix signals specify bone endothelial cells during developmental osteogenesis.	7	46	1.24	0.00028	9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,PDGFB,UNC5B,CAV1,PDGFA,BMP2,VEGFA
PMID:28279813	(2017) The role of chemokines in hypertension and consequent target organ damage.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:28321184	(2017) The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000346508,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,TGFB1,PDGFA,SGK1,PTEN,RHOA,BDNF
PMID:28352326	(2017) Genetic variants in KCNJ11, TCF7L2 and HNF4A are associated with type 2 diabetes, BMI and dyslipidemia in families of Northeastern Mexico: A pilot study.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000375844,9606.ENSP00000418823	MAPK1,JAZF1,HNF4A,KCNJ11,MTHFR,CAPN10,FTO
PMID:28415635	(2017) Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355370,9606.ENSP00000363822,9606.ENSP00000426809	CDH1,TIMP3,ALDH1A1,HNF4A,CNTF,AR,PROM1
PMID:28588064	(2017) Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways.	7	46	1.24	0.00028	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412	ENPP2,CDH1,CXCL10,CXCL9,PTGS2,EDN1,CCL5
PMID:28596936	(2017) New Bioengineering Breakthroughs and Enabling Tools in Regenerative Medicine.	5	13	1.65	0.00028	9606.ENSP00000351807,9606.ENSP00000356515,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	ELN,UTRN,BMP2,RHOA,VEGFA
PMID:28714932	(2017) Thrombospondins: A Role in Cardiovascular Disease.	8	70	1.12	0.00028	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,CXCL10,CD34,ELN,CD47,NOX1,BCL2,VEGFA
PMID:28814293	(2017) Regulation of human airway smooth muscle cell migration and relevance to asthma.	8	70	1.12	0.00028	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000445772,9606.ENSP00000474412	HSPB1,CXCL10,MMP14,CD34,ELN,PTEN,LTB4R2,CCL5
PMID:28890835	(2017) Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation andor Conventional Chemotherapy: Report of a Case.	5	13	1.65	0.00028	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000418525	MPO,CD38,CD34,ELN,MME
PMID:28973175	(2017) Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.	5	13	1.65	0.00028	9606.ENSP00000265333,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303	VDAC1,CNTF,PTEN,BCL2,BDNF
PMID:28974019	(2017) A Review of the Biomedical Applications of Zerumbone and the Techniques for Its Extraction from Ginger Rhizomes.	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000478570	CDH1,ATM,NFE2L2,BCL2,PLA2G2A,VEGFA
PMID:28983249	(2017) Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin.	7	46	1.24	0.00028	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,CXCL10,PTEN,JAK2,BCL2,VEGFA
PMID:29109329	(2017) Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins.	5	13	1.65	0.00028	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995	CETP,LPL,LPA,SREBF1,ABCG1
PMID:29404441	(2017) The role of human cytochrome P450 2E1 in liver inflammation and fibrosis.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252	MPO,NOX4,SREBF1,PTGS2,NOX1,NFE2L2
PMID:29662799	(2017) Ultrasound as a stimulus for musculoskeletal disorders.	5	13	1.65	0.00028	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,PTGS2,BMP2,RHOA,VEGFA
PMID:30258909	(2017) Ultrasound-targeted microbubble destruction in gene therapy: A new tool to cure human diseases.	6	27	1.41	0.00028	9606.ENSP00000266085,9606.ENSP00000298352,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TIMP3,NGB,AR,BCL2,BDNF,VEGFA
PMID:25893296	(2016) XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.	6	27	1.41	0.00028	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,PDGFA,EDN1,BCL2,VEGFA
PMID:26197028	(2016) Prenatal Maternal Physical Activity and Stem Cells in Umbilical Cord Blood.	5	13	1.65	0.00028	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,EDN1,PROM1,VEGFA
PMID:26462417	(2016) Characterization and Comparison of Canine Multipotent Stromal Cells Derived from Liver and Bone Marrow.	7	46	1.24	0.00028	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,ONECUT1,CD34,PTGS2,BMP2,PROM1,VEGFA
PMID:26522384	(2016) Decorin as a multivalent therapeutic agent against cancer.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,VDAC1,TIMP3,IGF1R,CAV1,BCL2,RHOA
PMID:26653885	(2016) Nanotechnology-Based Approaches for Guiding Neural Regeneration.	4	4	2.06	0.00028	9606.ENSP00000245479,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000414303	SOX9,CAV1,ELN,BDNF
PMID:26682011	(2016) High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.	8	70	1.12	0.00028	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CDH1,NOX4,PTEN,NOX1,NFE2L2,BCL2,VEGFA
PMID:26881043	(2016) A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000414303	MPO,PTGS2,SGK1,KL,BCL2,BDNF
PMID:26909869	(2016) Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.	10	129	0.95	0.00028	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000355361,9606.ENSP00000385834,9606.ENSP00000401399,9606.ENSP00000478570	EPOR,MPO,CD38,CXCL10,ANGPT2,EDNRA,CD47,TF,MYD88,VEGFA
PMID:26988558	(2016) Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.	8	70	1.12	0.00028	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809	ERCC1,TGFB1,SOX9,CDH1,IGF1R,PTEN,AR,PROM1
PMID:27038129	(2016) DMSO- and Serum-Free Cryopreservation of Whartons Jelly Tissue Isolated From Human Umbilical Cord.	6	27	1.41	0.00028	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185	SOX9,FABP4,LPL,CD34,BMP2,BCL2
PMID:27042198	(2016) Cul3-KLHL20 ubiquitin ligase: physiological functions, stress responses, and disease implications.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,PTEN,AR,NTF3,RHOA,BDNF,VEGFA
PMID:27070705	(2016) Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.	4	4	2.06	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,CCL5
PMID:27143978	(2016) Endothelial-Mesenchymal Transition in Regenerative Medicine.	7	46	1.24	0.00028	9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000419422	EDNRA,PTEN,BMP2,EDN1,FGFR1,RHOA,AGTR1
PMID:27313492	(2016) Vitamin K2 Ameliorates Damage of Blood Vessels by Glucocorticoid: a Potential Mechanism for Its Protective Effects in Glucocorticoid-induced Osteonecrosis of the Femoral Head in a Rat Model.	5	13	1.65	0.00028	9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000356832,9606.ENSP00000368104,9606.ENSP00000478570	PDGFB,GAS6,SGK1,BMP2,VEGFA
PMID:27343361	(2016) O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,SREBF1,GFPT1,PTEN,G6PD,BCL2,VEGFA
PMID:27461979	(2016) Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.	8	70	1.12	0.00028	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000351908	MAPK1,HSPB1,THBS1,COL8A1,CDH1,ATM,MAPK7,MAP3K5
PMID:27490540	(2016) Salvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in Vitro.	5	13	1.65	0.00028	9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	EDNRA,PTEN,EDN1,AGTR1,VEGFA
PMID:27595927	(2016) The functional interplay between systemic cancer and the hematopoietic stem cell niche.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,CXCL9,JAK2,VEGFA
PMID:27607584	(2016) Adipose-derived mesenchymal stem cells promote the survival of fat grafts via crosstalk between the Nrf2 and TLR4 pathways.	6	27	1.41	0.00028	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,CD34,SIRT6,NOX1,NFE2L2,VEGFA
PMID:27655701	(2016) Native and bone marrow-derived cell mosaicism in gastric carcinoma in H. pylori-infected p27-deficient mice.	5	13	1.65	0.00028	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL9,CCL5
PMID:27758098	(2016) Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth.	7	46	1.24	0.00028	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000300055,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000478570	FABP4,THBS1,PLIN1,PDGFA,SREBF1,EDN1,VEGFA
PMID:27845488	(2016) Contact dermatitis and interferon-gamma dependent chemokines.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:28450798	(2016) Elevated level of some chemokines in plasma of gastric cancer patients.	5	13	1.65	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:28894804	(2016) Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.	8	70	1.12	0.00028	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,ALDH1A1,AR,BCL2,FGFR1,BDNF,PROM1,VEGFA
PMID:24968203	(2015) Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury.	5	13	1.65	0.00028	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDN1,BDNF,PROM1,VEGFA
PMID:25183023	(2015) Placental lesions associated with acute atherosis.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:25854108	(2015) [Battle with herpes for 37 years].	4	4	2.06	0.00028	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CCL20,CXCL9,CCL5
PMID:25877879	(2015) Host gene expression for Mycobacterium avium subsp. paratuberculosis infection in human THP-1 macrophages.	5	13	1.65	0.00028	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	MPO,IFNG,CXCL10,CXCL9,CCL5
PMID:25949069	(2015) Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.	6	27	1.41	0.00028	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,MAP3K5,NOX1,TXN,BDNF,VEGFA
PMID:26134897	(2015) miR-135 family members mediate podocyte injury through the activation of Wntbeta-catenin signaling.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,APC,CDH1,BCL2,VEGFA
PMID:26216636	(2015) Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment.	7	46	1.24	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,PTEN,CCL5,VEGFA
PMID:26462272	(2015) Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.	8	70	1.12	0.00028	9606.ENSP00000221930,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000365777,9606.ENSP00000419422	TGFB1,LPL,HNF4A,SREBF1,CNR1,CNR2,MTHFR,AGTR1
PMID:26478910	(2015) Developing Extracellular Matrix Technology to Treat Retinal or Optic Nerve Injury(1,2,3).	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CXCL10,CNTF,BDNF,PROM1,VEGFA
PMID:26578855	(2015) Hypothalamic tanycytes-masters and servants of metabolic, neuroendocrine, and neurogenic functions.	7	46	1.24	0.00028	9606.ENSP00000232219,9606.ENSP00000304767,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000418009	RBP1,P2RY1,CNTF,NPY,FGFR1,BDNF,RARRES2
PMID:24445379	(2014) An oral mixed fat load is followed by a modest anti-inflammatory adipocytokine response in overweight patients with metabolic syndrome.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000360522,9606.ENSP00000384906,9606.ENSP00000418009	IFNG,CXCL10,RBP4,SAA1,RARRES2
PMID:24971349	(2014) CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.	7	46	1.24	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,MMP14,CXCL9,RARRES2,CCL5,VEGFA
PMID:25110709	(2014) The impact of simulated and real microgravity on bone cells and mesenchymal stem cells.	6	27	1.41	0.00028	9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CNTF,BMP2,RHOA,BDNF,PROM1,VEGFA
PMID:25113844	(2014) Transcriptome profiling of CTLs regulated by rapamycin using RNA-Seq.	7	46	1.24	0.00028	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185	IFNG,TIMP3,CXCL10,CXCL11,STAT5A,CXCL9,BCL2
PMID:25242112	(2014) Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasiadysplasianeoplasia in the hamster uterus.	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000381185	CDH1,IGF1R,HNF4A,STAT5A,AR,BCL2
PMID:25290689	(2014) Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injury.	5	13	1.65	0.00028	9606.ENSP00000221930,9606.ENSP00000232219,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683	TGFB1,RBP1,EDNRA,PTEN,EDN1
PMID:25342915	(2014) Diabetic nephropathy - complications and treatment.	7	46	1.24	0.00028	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CCR5,EDNRA,EDN1,MME,GREM1,VEGFA
PMID:25344858	(2014) Axl as a mediator of cellular growth and survival.	8	70	1.12	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,CD34,PTEN,KL,SHBG,BCL2,VEGFA
PMID:25486901	(2014) In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.	6	27	1.41	0.00028	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000484631	MAPK1,TGFB1,IFNG,CXCL11,CXCL9,PMP22
PMID:27355071	(2014) Ethnopharmacological Significance of Eclipta alba (L.) Hassk. (Asteraceae).	7	46	1.24	0.00028	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,IGF1R,PTGS2,AR,NFE2L2,BCL2,VEGFA
PMID:23353703	(2013) Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.	7	46	1.24	0.00028	9606.ENSP00000256104,9606.ENSP00000308208,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,MMP14,AR,SHBG,JAK2,BCL2,VEGFA
PMID:23382852	(2013) Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000265132,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000393312	MPO,HSPB1,AMBP,S100A12,JAK2,FGFR1
PMID:23447114	(2013) The role of chemokines in Guillain-Barre syndrome.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:23514336	(2013) Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery.	8	70	1.12	0.00028	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641	NOX4,ATM,PRDX2,CAV1,PTGS2,PTEN,NOX1,TXN
PMID:23613347	(2013) From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.	5	13	1.65	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185	CCR5,CXCL10,CCL20,CXCL9,BCL2
PMID:23710823	(2013) Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.	5	13	1.65	0.00028	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,CAV1,EDN1,RHOA,AGTR1
PMID:23762126	(2013) MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet.	5	13	1.65	0.00028	9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000478570	MAPK7,PDGFB,ELN,BCL2,VEGFA
PMID:23833638	(2013) Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines.	5	13	1.65	0.00028	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,STAT5A,PTEN,JAK2,VEGFA
PMID:23967200	(2013) STAT3 regulates MMP3 in heme-induced endothelial cell apoptosis.	7	46	1.24	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,CXCL10,CD34,JAK2,MYD88,PROM1,VEGFA
PMID:24151615	(2013) The role of osteoimmunology in periodontal disease.	6	27	1.41	0.00028	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000474412	MPO,CCR5,ELN,PTGS2,LTA,CCL5
PMID:24267290	(2013) How to utilize Ca(2)+ signals to rejuvenate the repairative phenotype of senescent endothelial progenitor cells in elderly patients affected by cardiovascular diseases: a useful therapeutic support of surgical approach?	6	27	1.41	0.00028	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,EDN1,TRPC1,PROM1,VEGFA
PMID:24308813	(2013) Does Metformin affect ER, PR, IGF-1R, beta-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTEN,SHBG,VEGFA
PMID:24324296	(2013) Chemokines and neurodegeneration in the early stage of experimental ischemic stroke.	6	27	1.41	0.00028	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,EDN1,BDNF,CCL5,VEGFA
PMID:24490159	(2013) Novel strategies for the treatment of chondrosarcomas: targeting integrins.	7	46	1.24	0.00028	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,PTGS2,BMP2,BDNF,CCL5,VEGFA
PMID:24961316	(2013) NADPH oxidase and angiogenesis following endothelin-1 induced stroke in rats: role for nox2 in brain repair.	5	13	1.65	0.00028	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,NOX1,EDN1,BDNF,VEGFA
PMID:25206518	(2013) Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo.	6	27	1.41	0.00028	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CD34,CNTF,NTF3,BDNF,VEGFA
PMID:22215192	(2012) Curcumin treatment provides protection against Trypanosoma cruzi infection.	6	27	1.41	0.00028	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CAV1,SREBF1,EDN1,BCL2,CCL5
PMID:22319577	(2012) Accumulation of CCR4+CTLA-4 FOXP3+CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells.	6	27	1.41	0.00028	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD69,CDH1,CCR5,CXCL10,CXCL11,CXCL9
PMID:22382178	(2012) Stem cell therapy: a novel & futuristic treatment modality for disaster injuries.	6	27	1.41	0.00028	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,BMP2,BDNF,PROM1,VEGFA
PMID:22462028	(2012) The diabetic heart: too sweet for its own good?	5	13	1.65	0.00028	9606.ENSP00000306124,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	PRKCE,JAK2,BCL2,AGTR1,VEGFA
PMID:22498582	(2012) New therapeutic targets in soft tissue sarcoma.	7	46	1.24	0.00028	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,THBS1,IGF1R,PDGFB,PTEN,BCL2,VEGFA
PMID:22536488	(2012) Diet, genetics, and disease: a focus on the middle East and north Africa region.	6	27	1.41	0.00028	9606.ENSP00000216862,9606.ENSP00000309757,9606.ENSP00000365777,9606.ENSP00000375844,9606.ENSP00000414303,9606.ENSP00000418823	CYP24A1,LPL,MTHFR,CAPN10,BDNF,FTO
PMID:22576456	(2012) Immunotherapy of cancer in 2012.	7	46	1.24	0.00028	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:22661950	(2012) Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.	5	13	1.65	0.00028	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	EDNRA,CAV1,NOX1,EDN1,VEGFA
PMID:22664457	(2012) 1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, Israel.	7	46	1.24	0.00028	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,CXCL10,APOL1,CD247,CXCL9,BCL2,VEGFA
PMID:22737659	(2012) Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factors.	6	27	1.41	0.00028	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000474412	WFS1,JAZF1,HNF4A,KCNJ11,FTO,CCL5
PMID:22895640	(2012) Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal             cancer.	5	13	1.65	0.00028	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ALDH1A1,CD34,BCL2,PROM1
PMID:23145368	(2012) The Role of EMT in Pancreatic Cancer Progression.	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CAV1,PDGFD,FGFR1,PROM1,VEGFA
PMID:23162750	(2012) High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.	6	27	1.41	0.00028	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:23271906	(2012) Minimally invasive cell-seeded biomaterial systems for injectableepicardial implantation in ischemic heart disease.	6	27	1.41	0.00028	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CAV1,ELN,BMP2,PROM1,VEGFA
PMID:21222121	(2011) Roles and mechanisms of microRNAs in pancreatic cancer.	6	27	1.41	0.00028	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,PTEN,BCL2,PROM1,VEGFA
PMID:21228060	(2011) Phosphatase and tensin homologueprotein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.	7	46	1.24	0.00028	9606.ENSP00000306124,9606.ENSP00000336762,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	PRKCE,ANG,MAP3K5,PTEN,BCL2,RHOA,VEGFA
PMID:21430069	(2011) Molecular classification of gastric cancer: a new paradigm.	6	27	1.41	0.00028	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000383364	CXCL10,CXCL9,S100A12,CYP2J2,PTEN,PLA2G2A
PMID:21463523	(2011) Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.	5	13	1.65	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:21501493	(2011) Expression patterns of microRNAs associated with CML phases and their disease related targets.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000362410,9606.ENSP00000381185	MAPK1,MYH9,TGFB1,KLF10,CD34,MAFB,BCL2
PMID:21830940	(2011) Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000418525	IFNG,CXCL10,CD247,CXCL9,MME
PMID:21912077	(2011) The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.	4	4	2.06	0.00028	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000478570	CD34,PTGS2,AR,VEGFA
PMID:22030551	(2011) Central nervous system pericytes in health and disease.	7	46	1.24	0.00028	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,TIMP3,MMP14,ANGPT2,PDGFB,EDN1,VEGFA
PMID:22121495	(2011) Lipid chaperones and metabolic inflammation.	6	27	1.41	0.00028	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067	IFNG,FABP4,ANGPT2,PTGS2,PTEN,JAK2
PMID:22197976	(2011) B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.	8	70	1.12	0.00028	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000297785,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	MPO,CD38,IFNG,ALDH1A1,JAK2,BCL2,MYD88,MME
PMID:22384430	(2011) Role of endometrial immune cells in implantation.	7	46	1.24	0.00028	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,ANGPT2,CXCL9,CCL5,VEGFA
PMID:28781583	(2011) Cathepsin B: Basis Sequence: Mouse.	7	46	1.24	0.00028	9606.ENSP00000222305,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000478570	USF2,IFNG,CDH1,AMBP,CAV1,BCL2,VEGFA
PMID:19875106	(2010) I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft.	5	13	1.65	0.00028	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:20029966	(2010) Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data.	6	27	1.41	0.00028	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000376865,9606.ENSP00000478570	THBS1,IGF1R,CD34,PDGFB,PDGFD,VEGFA
PMID:20224526	(2010) Cellular and molecular mechanisms of venous leg ulcers development--the puzzle theory.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:20512918	(2010) Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes.	7	46	1.24	0.00028	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000400175	MAPK1,SOX9,TIMP3,IGF1R,MMP14,PTEN,RHOA
PMID:20565710	(2010) Interleukin-17 regulation: an attractive therapeutic approach for asthma.	7	46	1.24	0.00028	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD34,PTGS2,PTEN,JAK2,MYD88,CCL5,VEGFA
PMID:22043207	(2010) Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis.	8	70	1.12	0.00028	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,CAV1,ABCG1,PTGS2,NOX1,TXN,EDN1,VEGFA
PMID:23776353	(2010) Genetic contribution and associated pathophysiology in end-stage renal disease.	9	98	1.02	0.00028	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000352264,9606.ENSP00000365777,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570,9606.ENSP00000480291	IGF1R,CCR5,HNF4A,CD2AP,MTHFR,AGTR1,CCL5,VEGFA,HNF1B
PMID:24281171	(2010) A quest for initiating cells of head and neck cancer and their treatment.	6	27	1.41	0.00028	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,BCL2,PROM1
PMID:19265149	(2009) Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection.	5	13	1.65	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19344719	(2009) Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.	5	13	1.65	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19442199	(2009) Targeting stem cells-clinical implications for cancer therapy.	6	27	1.41	0.00028	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PTEN,BMP2,PROM1,VEGFA
PMID:19463170	(2009) A transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor.	8	70	1.12	0.00028	9606.ENSP00000216181,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000285407,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	MYH9,THBS1,NOX4,ATM,KLF10,EDN1,MYD88,VEGFA
PMID:19472429	(2009) Cancer prevention by tea: animal  studies, molecular mechanisms and  human relevance.	7	46	1.24	0.00028	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000354511,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	CDH1,IGF1R,MMP14,COMT,G6PD,NFE2L2,BCL2
PMID:19539835	(2009) Gene therapy targeting glaucoma: where are we?	6	27	1.41	0.00028	9606.ENSP00000215832,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,CNTF,PTGS2,BCL2,BDNF,VEGFA
PMID:19804625	(2009) Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis.	6	27	1.41	0.00028	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:18772110	(2008) Calcification of multipotent prostate tumor endothelium.	6	27	1.41	0.00028	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,CD34,AR,PROM1,VEGFA
PMID:18952314	(2008) Type 2 diabetes: new genes, new understanding.	6	27	1.41	0.00028	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,KCNJ11,CAPN10,FTO,HNF1B
PMID:17525185	(2007) Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL6 mice: effects of desiccating stress.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:17579721	(2007) Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.	5	13	1.65	0.00028	9606.ENSP00000222139,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,ANGPT2,STAT5A,JAK2,VEGFA
PMID:15655045	(2005) Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:15746677	(2005) Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.	4	4	2.06	0.00028	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTGS2,BCL2,VEGFA
PMID:16118671	(2005) Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CCL5
PMID:15116331	(2004) Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue.	4	4	2.06	0.00028	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTGS2,BCL2,VEGFA
PMID:15526056	(2004) An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.	6	27	1.41	0.00028	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901	CD69,CCR5,CXCL10,CXCL11,ELN,CXCL9
PMID:14551243	(2003) Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on TRPC1.	4	4	2.06	0.00028	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000419313	EDNRA,CAV1,EDN1,TRPC1
PMID:14613530	(2003) Chemokines in the corpus luteum: implications of leukocyte chemotaxis.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,CCL5,VEGFA
PMID:11869363	(2002) Recruitment of lymphocytes to the human liver.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:12162873	(2002) Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis.	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:11310827	(2001) Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris.	5	13	1.65	0.00028	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901	IFNG,CDH1,CCR5,CXCL10,CXCL9
PMID:10828609	(2000) Cloning, genomic sequence, and chromosome mapping of Scyb11, the murine homologue of SCYB11 (alias betaR1H174SCYB9BI-TACIP-9CXCL11).	4	4	2.06	0.00028	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:10971326	(2000) Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts.	4	4	2.06	0.00028	9606.ENSP00000221930,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,EDN1,MME,VEGFA
PMID:25705263	(....) the mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis.	8	70	1.12	0.00028	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399	CXCL10,LPL,SREBF1,CXCL9,ABCG1,JAK2,SAA1,MYD88
PMID:27657690	(....) prognostic values of vimentin expression and its clinicopathological significance in non-small cell lung cancer: a meta-analysis of observational studies with 4118 cases.	5	13	1.65	0.00028	9606.ENSP00000221930,9606.ENSP00000297785,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,ALDH1A1,FGFR1,PROM1,VEGFA
PMID:35406692	(2022) Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies.	10	130	0.95	0.00029	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000414303,9606.ENSP00000478570	CD38,THBS1,IGF1R,CAV1,ENTPD1,PTEN,BCL2,HPSE,BDNF,VEGFA
PMID:34722637	(2021) Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages.	10	130	0.95	0.00029	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175	MAPK1,CDH1,CXCL10,MMP14,CAV1,CXCL9,CD47,PTEN,JAK2,RHOA
PMID:23526956	(2013) Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States.	11	165	0.88	0.00029	9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000402152,9606.ENSP00000427424,9606.ENSP00000478570	IFNG,ENPP2,ATM,ANGPT2,CAV1,CYP2J2,PTEN,EDN1,SLC12A3,TNFAIP8,VEGFA
PMID:35027930	(2022) Dental Pulp Stem Cell Heterogeneity: Finding Superior Quality Needles in a Dental Pulpal Haystack for Regenerative Medicine-Based Applications.	9	99	1.02	0.00030	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,IGF1R,ALDH1A1,LPL,CD34,BMP2,MME,PROM1,VEGFA
PMID:35187013	(2022) Novel Potential Biomarkers for Retinopathy of Prematurity.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD69,IFNG,ANG,BDNF,CCL5,VEGFA
PMID:35193549	(2022) The role of lipopolysaccharides in diabetic retinopathy.	7	47	1.23	0.00030	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,JAK2,MYD88,BDNF,VEGFA
PMID:35248049	(2022) MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTGS2,PTEN,BCL2,VEGFA
PMID:35301416	(2022) Antifungals influence the immune-related transcriptomic landscape of human monocytes after Aspergillus fumigatus infection.	7	47	1.23	0.00030	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:35409229	(2022) The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.	7	47	1.23	0.00030	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,CCL20,CXCL9,PTGS2,CCL5,VEGFA
PMID:33318418	(2021) Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes.	7	47	1.23	0.00030	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL9,CNTF,EDN1,NTF3,BDNF,CCL5
PMID:33432484	(2021) Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.	8	71	1.11	0.00030	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CD34,PTGS2,ADAMTS13,BCL2,CCL5,VEGFA
PMID:33508232	(2021) Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.	8	71	1.11	0.00030	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000321853,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CD38,ATM,CCR5,SERPINF2,CXCL9,PTEN,JAK2,VEGFA
PMID:33532135	(2021) A Comprehensive Summary of the Knowledge on COVID-19 Treatment.	7	47	1.23	0.00030	9606.ENSP00000292303,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000384957,9606.ENSP00000419422,9606.ENSP00000478570	CCR5,TXN,AR,NFE2L2,F11,AGTR1,VEGFA
PMID:33546241	(2021) MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000322898,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	CD38,ATM,LPL,EBF1,PTEN,BCL2,MYD88
PMID:33565332	(2021) Stem cells as therapeutic targets in colorectal cancer.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,JAK2,PROM1,VEGFA
PMID:33586908	(2021) Nerve growth factor (NGF) and NGF receptors in mesenchymal stemstromal cells: Impact on potential therapies.	7	47	1.23	0.00030	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	IFNG,SOX9,CD34,PDGFB,BDNF,MME,VEGFA
PMID:33689121	(2021) The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target?	8	71	1.11	0.00030	9606.ENSP00000225275,9606.ENSP00000259486,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	MPO,ENPP2,CCR5,CXCL10,HSPG2,RHOA,MYD88,CCL5
PMID:33802841	(2021) FGFFGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention.	8	71	1.11	0.00030	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,CDH1,ANGPT2,PTEN,KL,JAK2,FGFR1,VEGFA
PMID:33806895	(2021) The Role of Innate and Adaptive Immune Cells in Skeletal Muscle Regeneration.	8	71	1.11	0.00030	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CD69,IFNG,CXCL10,TXN,CCL5,VEGFA
PMID:33807872	(2021) The Unique Biology behind the Early Onset of Breast Cancer.	8	71	1.11	0.00030	9606.ENSP00000227868,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000393312	PDHX,SOX9,CDH1,IGF1R,ATM,STAT5A,PTEN,FGFR1
PMID:33808599	(2021) The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ATM,CD34,SIRT6,G6PD,BCL2,PROM1
PMID:33854765	(2021) 2020 Annual World Congress of the Pulmonary Vascular Research Institute.	10	131	0.94	0.00030	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000371067,9606.ENSP00000478570	TGFB1,PDGFB,CAV1,ELN,CXCL9,VIP,PTEN,GLO1,JAK2,VEGFA
PMID:33902630	(2021) Is immunotherapy in the future of therapeutic management of sarcomas?	7	47	1.23	0.00030	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	IGF1R,CCR5,CXCL10,CD247,CXCL9,BCL2,CCL5
PMID:33918986	(2021) The Role of Toxic Metals and Metalloids in Nrf2 Signaling.	7	47	1.23	0.00030	9606.ENSP00000245479,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	SOX9,CAV1,PTEN,TXN,G6PD,NFE2L2,BCL2
PMID:34112175	(2021) Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer.	7	47	1.23	0.00030	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000426809	SOX9,IGF1R,ALDH1A1,HNF4A,AR,FGFR1,PROM1
PMID:34202537	(2021) Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions.	8	71	1.11	0.00030	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CD34,PDGFB,CXCL9,EDN1,VEGFA
PMID:34203813	(2021) Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000301522,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412	MPO,PRDX2,ELN,PTGS2,NFE2L2,MYD88,CCL5
PMID:34204341	(2021) The Angiogenic Switch and Functional Resources in Cyclic Sports Athletes.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,ANGPT2,PDGFB,PDGFA,PDGFD,FGFR1,VEGFA
PMID:34298870	(2021) Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance.	8	71	1.11	0.00030	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000362410,9606.ENSP00000364683,9606.ENSP00000401399,9606.ENSP00000474412	CETP,IFNG,CCR5,HNF4A,MAFB,BAMBI,MYD88,CCL5
PMID:34417463	(2021) Tet2 Controls the Responses of beta cells to Inflammation in Autoimmune Diabetes.	8	71	1.11	0.00030	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	CD69,CXCL10,CXCL11,GAS6,CXCL9,PTEN,JAK2,BCL2
PMID:34445756	(2021) The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina.	7	47	1.23	0.00030	9606.ENSP00000314897,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	ANGPT2,CNTF,PTEN,GAP43,BCL2,BDNF,VEGFA
PMID:34563684	(2021) A hitchhikers guide through the COVID-19 galaxy.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000478570	MPO,CCR5,ANGPT2,JAK2,MYD88,AGTR1,VEGFA
PMID:34576107	(2021) Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.	7	47	1.23	0.00030	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312	TIMP3,CXCL10,MMP14,PTGS2,AR,BCL2,FGFR1
PMID:34645281	(2021) Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis.	8	71	1.11	0.00030	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000401399,9606.ENSP00000444198,9606.ENSP00000474412,9606.ENSP00000477707,9606.ENSP00000478570	IFNG,THBS1,CXCL10,MYD88,CITED2,CCL5,NR1H3,VEGFA
PMID:34679777	(2021) Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422	MPO,CD38,SREBF1,NFE2L2,BCL2,BDNF,AGTR1
PMID:34831463	(2021) The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration.	7	47	1.23	0.00030	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570,9606.ENSP00000479617	MAPK1,CDH1,KL,BCL2,FGFR1,VEGFA,UHRF1
PMID:34880756	(2021) Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000337332,9606.ENSP00000377192,9606.ENSP00000426809	CD38,CDH1,ATM,ALDH1A1,SIRT6,G6PD,PROM1
PMID:34900673	(2021) Biological Adaptations of Tumor Cells to Radiation Therapy.	9	99	1.02	0.00030	9606.ENSP00000261769,9606.ENSP00000263774,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NDUFS3,ATM,CXCL10,CAV1,ELN,GAP43,BCL2,VEGFA
PMID:34912809	(2021) Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases.	8	71	1.11	0.00030	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000360997,9606.ENSP00000371067,9606.ENSP00000384262,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,PTGS2,ADAMTS13,JAK2,HPSE,CCL5,VEGFA
PMID:34944550	(2021) Liver Regeneration and Cell Transplantation for End-Stage Liver Disease.	7	47	1.23	0.00030	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,HNF4A,PDGFA,ENTPD1,PTEN,MYD88,VEGFA
PMID:34977027	(2021) Myeloid Immune Cells CARrying a New Weapon Against Cancer.	9	99	1.02	0.00030	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000362410,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CD34,CD247,CXCL9,MAFB,CCL5,VEGFA
PMID:34988010	(2021) Chronic Stress Effects on Tumor: Pathway and Mechanism.	8	71	1.11	0.00030	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	CD69,CDH1,IGF1R,ALDH1A1,GAS6,PTGS2,JAK2,VEGFA
PMID:31746390	(2020) Molecular basis of degenerative spinal disorders from a proteomic perspective (Review).	7	47	1.23	0.00030	9606.ENSP00000245479,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000377192	SOX9,APOL1,LPA,FMOD,ELN,BMP2,G6PD
PMID:32127290	(2020) Exercise, redox homeostasis and the epigenetic landscape.	9	99	1.02	0.00030	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000283928,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303	NOX4,ATM,JAZF1,CAV1,PTEN,TXN,JAK2,NFE2L2,BDNF
PMID:32252341	(2020) Failure to Down-Regulate miR-154 Expression in Early Postnatal Mouse Lung Epithelium Suppresses Alveologenesis, with Changes in Tgf-beta Signaling Similar to those Induced by Exposure to Hyperoxia.	7	47	1.23	0.00030	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000393312	APC,CDH1,AQP5,CXCL11,CAV1,ELN,FGFR1
PMID:32256352	(2020) Ferroptosis and Its Potential Role in Human Diseases.	8	71	1.11	0.00030	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	HSPB1,CDH1,VDAC1,SIRT6,TXN,G6PD,NFE2L2,BCL2
PMID:32290052	(2020) PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD38,CD247,PTEN,JAK2,BCL2,MYD88,VEGFA
PMID:32666711	(2020) Genetics and signaling mechanisms of orofacial clefts.	12	205	0.83	0.00030	9606.ENSP00000222572,9606.ENSP00000232219,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000362410,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175	PON2,RBP1,SOX9,APC,CDH1,ALDH1A1,HNF4A,MAFB,MTHFR,JAK2,FGFR1,RHOA
PMID:32718047	(2020) Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,ATM,ANGPT2,GAS6,PTEN,NFE2L2,VEGFA
PMID:32768490	(2020) Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.	7	47	1.23	0.00030	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,PTEN,NFE2L2,BCL2,MYD88,CCL5
PMID:32878347	(2020) Genetic and Epigenetic Mechanisms Underlying Vascular Smooth Muscle Cell Phenotypic Modulation in Abdominal Aortic Aneurysm.	10	131	0.94	0.00030	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185	CHI3L1,THBS1,NOX4,TIMP3,ELN,MAP3K5,PTEN,NOX1,JAK2,BCL2
PMID:32974337	(2020) Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives.	8	71	1.11	0.00030	9606.ENSP00000216862,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	CYP24A1,CXCL10,CXCL11,CD34,ANGPT2,EDN1,FGFR1,VEGFA
PMID:32984222	(2020) Molecular and Mechanical Mechanisms Regulating Ductus Arteriosus Closure in Preterm Infants.	8	71	1.11	0.00030	9606.ENSP00000229135,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,EDNRA,PDGFB,ELN,PTGS2,EDN1,AGTR1,VEGFA
PMID:33059766	(2020) Application of human amniotic epithelial cells in regenerative medicine: a systematic review.	7	47	1.23	0.00030	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,SOX9,PDGFB,ANG,NTF3,BDNF,VEGFA
PMID:33101293	(2020) Immunomodulatory Effects of Diterpenes and Their Derivatives Through NLRP3 Inflammasome Pathway: A Review.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399	MPO,SREBF1,MAP3K5,PTGS2,PTEN,JAK2,MYD88
PMID:33203135	(2020) Cardiac ECM: Its Epigenetic Regulation and Role in Heart Development and Repair.	7	47	1.23	0.00030	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000368683	TGFB1,THBS1,COL8A1,MMP14,ELN,CD47,EDN1
PMID:33243251	(2020) Insulin inhibits inflammation-induced cone death in retinal detachment.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,IGF1R,CXCL10,CD47,TXN,CCL5,VEGFA
PMID:33384547	(2020) Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies.	7	47	1.23	0.00030	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CD34,STAT5A,ELN,PTGS2,BCL2,VEGFA
PMID:33419318	(2020) Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.	9	99	1.02	0.00030	9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CCR5,CXCL10,CXCL9,CD47,PTGS2,NPY,CCL5,VEGFA
PMID:33748193	(2020) Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy.	7	47	1.23	0.00030	9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,LPL,ELN,BMP2,EDN1,RHOA,CCL5
PMID:30451357	(2019) Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer.	7	47	1.23	0.00030	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:30467381	(2019) Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTEN,AR,RHOA,PROM1,VEGFA
PMID:31242602	(2019) In Search of Panacea-Review of Recent Studies Concerning Nature-Derived Anticancer Agents.	8	71	1.11	0.00030	9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	VDAC1,TIMP3,PTEN,AR,JAK2,BCL2,VEGFA,HNF1B
PMID:31379821	(2019) Striking a Balance-Cellular and Molecular Drivers of Memory T Cell Development and Responses to Chronic Stimulation.	8	71	1.11	0.00030	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000352264,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CD69,CDH1,CCR5,CD2AP,ENTPD1,BCL2,CCL5
PMID:31480477	(2019) Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,BCL2,RHOA,PROM1,VEGFA
PMID:31521169	(2019) The role of collagen in cancer: from bench to bedside.	9	99	1.02	0.00030	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	MAPK1,CYP24A1,CDH1,MMP14,HNF4A,STAT5A,PTGS2,PTEN,VEGFA
PMID:31533268	(2019) S-Nitrosylation: An Emerging Paradigm of Redox Signaling.	8	71	1.11	0.00030	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000363596,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,VDAC1,IGF1R,CNR2,TXN,BCL2,VEGFA
PMID:31546724	(2019) Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms.	9	99	1.02	0.00030	9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,SIRT6,CXCL9,PTGS2,TXN,JAK2,BCL2,LTA,VEGFA
PMID:31575075	(2019) Exportin-1-Dependent Nuclear Export of DEAD-box Helicase DDX3X is Central to its Role in Antiviral Immunity.	7	47	1.23	0.00030	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000384906,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,PTGS2,SAA1,CCL5
PMID:31627295	(2019) Hydroxytyrosol Modulates Adipocyte Gene and miRNA Expression Under Inflammatory Condition.	7	47	1.23	0.00030	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,FABP4,CXCL10,LPL,SREBF1,PTGS2,VEGFA
PMID:31686890	(2019) Impact of polyphenols in phagocyte functions.	7	47	1.23	0.00030	9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,PTGS2,AR,JAK2,BCL2,MYD88,VEGFA
PMID:28757325	(2018) Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.	7	47	1.23	0.00030	9606.ENSP00000257430,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000478570	APC,NOX4,HNF4A,ELN,PTGS2,NOX1,VEGFA
PMID:29063730	(2018) Fibroblast growth factors in the management of spinal cord injury.	7	47	1.23	0.00030	9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	CAV1,CNTF,GAP43,FGFR1,NTF3,RHOA,BDNF
PMID:29148847	(2018) Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.	8	71	1.11	0.00030	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000403495	EPOR,IFNG,ATM,CD34,STAT5A,JAK2,RHOA,LTA
PMID:29290585	(2018) A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.	7	47	1.23	0.00030	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000418525	EPOR,MPO,CD38,CD34,EBF1,STAT5A,MME
PMID:29334991	(2018) Role of the nervous system in cancer metastasis.	7	47	1.23	0.00030	9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	AR,JAK2,BCL2,NPY,RHOA,BDNF,VEGFA
PMID:29415727	(2018) New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,CDH1,IGF1R,ANG,CD47,PTEN,VEGFA
PMID:29681985	(2018) Natural Products for the Management and Prevention of Breast Cancer.	8	71	1.11	0.00030	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000383364	SOX9,TIMP3,IGF1R,ATM,PTGS2,AR,BCL2,PLA2G2A
PMID:29866769	(2018) Innate Immunity to Staphylococcus aureus: Evolving Paradigms in Soft Tissue and Invasive Infections.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399	MPO,CXCL10,CXCL11,CCL20,CXCL9,IRAK4,MYD88
PMID:30211115	(2018) The Network of Non-coding RNAs in Cancer Drug Resistance.	9	99	1.02	0.00030	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000426809	IGF1R,ATM,EDNRA,PTEN,MTHFR,PDGFD,BCL2,AGTR1,PROM1
PMID:30305178	(2018) Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword.	8	71	1.11	0.00030	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000418009,9606.ENSP00000474412	FABP4,CCR5,CD34,ANGPTL2,EDN1,PLA2G2A,RARRES2,CCL5
PMID:30420728	(2018) Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis.	8	71	1.11	0.00030	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,TGFB1,ATM,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:30428522	(2018) TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,AR,JAK2,BCL2,PROM1,VEGFA
PMID:28108739	(2017) Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.	7	47	1.23	0.00030	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,ATM,MAPK7,PTEN,AR,FGFR1,VEGFA
PMID:28223985	(2017) Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity.	8	71	1.11	0.00030	9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000444198,9606.ENSP00000474412,9606.ENSP00000478570	CD69,STAT5A,CD247,PTGS2,MYD88,CITED2,CCL5,VEGFA
PMID:28292312	(2017) Comprehensive discovery of subsample gene expression components by information explanation: therapeutic implications in cancer.	7	47	1.23	0.00030	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	TGFB1,CXCL10,CXCL11,MAP3K5,CXCL9,JAK2,CCL5
PMID:28300841	(2017) Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,HNF4A,PTEN,BCL2,RHOA,MYD88,PROM1
PMID:28466561	(2017) Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000403495,9606.ENSP00000478570	CD38,CD69,IFNG,CXCL10,CCL20,LTA,VEGFA
PMID:28570941	(2017) Diet-dependent retinoid effects on liver gene expression include stellate and inflammation markers and parallel effects of the nuclear repressor Shp.	7	47	1.23	0.00030	9606.ENSP00000232219,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000360522	RBP1,ALDH1A1,CXCL10,LPL,HNF4A,SREBF1,RBP4
PMID:28785215	(2017) Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us.	8	71	1.11	0.00030	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000474412	TGFB1,CD69,CXCL10,MMP14,PDGFB,GAS6,PDGFA,CCL5
PMID:28785589	(2017) Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,MMP14,ELN,PROM1,CCL5,VEGFA
PMID:28829353	(2017) Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.	8	71	1.11	0.00030	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412	CCR5,CXCL10,CD34,STAT5A,CCL20,CXCL9,BMP2,CCL5
PMID:28937044	(2017) Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy.	8	71	1.11	0.00030	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,CDH1,MMP14,CD34,BDNF,AGTR1,PROM1,VEGFA
PMID:28951873	(2017) Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.	7	47	1.23	0.00030	9606.ENSP00000310036,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000352264,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000478570	CD34,APOL1,LPA,CD2AP,CNTF,JAK2,VEGFA
PMID:29147648	(2017) Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer.	8	71	1.11	0.00030	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000480291	CDH1,MMP14,MAPK7,CCL20,PTEN,BCL2,FGFR1,HNF1B
PMID:29156578	(2017) Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.	12	204	0.83	0.00030	9606.ENSP00000222572,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000426809	PON2,SOX9,CDH1,NOX4,IGF1R,ATM,ALDH1A1,HNF4A,CD47,PTEN,FGFR1,PROM1
PMID:29228930	(2017) Gene expression analysis in asthma using a targeted multiplex array.	8	71	1.11	0.00030	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000393312	MAPK1,CD38,HSPB1,CHI3L1,CDH1,STAT5A,BMP2,FGFR1
PMID:29259202	(2017) Identification of new genes associated to senescent and tumorigenic phenotypes in mesenchymal stem cells.	9	99	1.02	0.00030	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412	TGFB1,CD38,THBS1,TIMP3,ALDH1A1,CD34,EDN1,AGTR1,CCL5
PMID:29348758	(2017) Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy.	8	71	1.11	0.00030	9606.ENSP00000228434,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL11,STAT5A,CXCL9,ENTPD1,LTA,CCL5,VEGFA
PMID:30159416	(2017) Interactions between anticancer active platinum complexes and non-coding RNAsmicroRNAs.	10	131	0.94	0.00030	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185	ERCC1,CDH1,IGF1R,ATM,CXCL11,EDNRA,PTGS2,EDN1,NFE2L2,BCL2
PMID:26682014	(2016) The Tumorigenic Roles of the Cellular REDOX Regulatory Systems.	7	47	1.23	0.00030	9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	SIRT6,MAP3K5,PTEN,NOX1,TXN,NFE2L2,BCL2
PMID:26778458	(2016) Extracellular matrix-mediated cellular communication in the heart.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412	THBS1,MMP14,CAV1,CD47,PTEN,RHOA,CCL5
PMID:26808628	(2016) Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.	7	47	1.23	0.00030	9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000401399	AMBP,CCR5,CXCL10,CD34,CXCL9,ENTPD1,MYD88
PMID:27145373	(2016) Optical imaging probes in oncology.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	MPO,IGF1R,MMP14,EDNRA,PTGS2,EDN1,VEGFA
PMID:27240340	(2016) The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression.	8	71	1.11	0.00030	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,PTEN,BCL2,AGTR1,PROM1,VEGFA
PMID:27348007	(2016) The IL-8IL-8R Axis: A Double Agent in Tumor Immune Resistance.	8	71	1.11	0.00030	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,ANG,CXCL9,JAK2,RHOA,CCL5,VEGFA
PMID:27350037	(2016) Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.	8	71	1.11	0.00030	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,IGF1R,CXCL10,ANGPT2,ANG,EDN1,FGFR1,VEGFA
PMID:27445824	(2016) Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives.	7	47	1.23	0.00030	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	PTGS2,PTEN,AR,JAK2,BCL2,MYD88,VEGFA
PMID:27509260	(2016) Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.	8	71	1.11	0.00030	9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	COL8A1,CDH1,PDGFA,PTEN,EDN1,MME,PROM1,VEGFA
PMID:27703487	(2016) Anti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral Ischemia.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,STAT5A,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:27735847	(2016) Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans.	7	47	1.23	0.00030	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000418009	FABP4,FADS2,PLIN1,EDNRA,CAV1,SREBF1,RARRES2
PMID:27763252	(2016) Myeloid Cell Origins, Differentiation, and Clinical Implications.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CD34,CD47,JAK2,BCL2,MME,CCL5
PMID:27773999	(2016) Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer.	7	47	1.23	0.00030	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	APC,ATM,PTEN,AR,EDN1,BCL2,VEGFA
PMID:25613728	(2015) Epstein-Barr virus latent genes.	10	131	0.94	0.00030	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000322898,9606.ENSP00000346148,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000379256,9606.ENSP00000418525	ATM,CXCL10,CXCL11,EBF1,PRKAA1,CCL20,CXCL9,PTEN,NCALD,MME
PMID:25999952	(2015) Chemokine function in periodontal disease and oral cavity cancer.	8	71	1.11	0.00030	9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	HSPB1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:26273419	(2015) Controlling Redox Status for Stem Cell Survival, Expansion, and Differentiation.	7	47	1.23	0.00030	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	SOX9,NOX4,ATM,NOX1,TXN,NFE2L2,VEGFA
PMID:24424267	(2014) Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells.	8	71	1.11	0.00030	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,CAV1,SREBF1,PTGS2,SHBG,BCL2,VEGFA
PMID:24828484	(2014) Human antimicrobial peptides and proteins.	8	71	1.11	0.00030	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000418009	CXCL10,ANG,CCL20,CXCL9,S100A12,NPY,MYD88,RARRES2
PMID:25429431	(2014) Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.	7	47	1.23	0.00030	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,MAPK1,SREBF1,PTGS2,JAK2,BCL2,VEGFA
PMID:26770714	(2014) MicroRNAs and cardiovascular medicine.	7	47	1.23	0.00030	9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	SIRT6,SREBF1,ELN,PTEN,RHOA,AGTR1,VEGFA
PMID:23434903	(2013) Plant sterols as anticancer nutrients: evidence for their role in breast cancer.	7	47	1.23	0.00030	9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000477707,9606.ENSP00000478570	CAV1,SREBF1,PTEN,SHBG,BCL2,NR1H3,VEGFA
PMID:23576873	(2013) The influence of perivascular adipose tissue on vascular homeostasis.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000478570	THBS1,PLIN1,LPL,EDN1,BDNF,RARRES2,VEGFA
PMID:23698776	(2013) Obesity-associated oxidative stress: strategies finalized to improve redox state.	8	71	1.11	0.00030	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000418823	FABP4,LPL,SIRT6,SREBF1,TXN,EDN1,RARRES2,FTO
PMID:23846224	(2013) ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation.	7	47	1.23	0.00030	9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000426809,9606.ENSP00000478570	PRDX2,CD34,STAT5A,NOX1,TXN,PROM1,VEGFA
PMID:23889992	(2013) AEG-1MTDHLYRIC in liver cancer.	9	99	1.02	0.00030	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,ATM,ANG,PTEN,BCL2,AGTR1,VEGFA
PMID:24124379	(2013) Emerging targets in cancer management: role of the CXCL12CXCR4 axis.	7	47	1.23	0.00030	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000426809	CD38,IGF1R,CCR5,CXCL11,CD34,RHOA,PROM1
PMID:24206916	(2013) Noncoding RNAs in cancer and cancer stem cells.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000361883,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ALDH1A1,PTEN,CAP1,AR,BCL2,PROM1
PMID:23226636	(2012) Aberrant angiogenesis: The gateway to diabetic complications.	7	47	1.23	0.00030	9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	DDAH1,CXCL10,CD34,ANGPT2,FGFR1,CCL5,VEGFA
PMID:23798298	(2012) Lack of exercise is a major cause of chronic diseases.	7	47	1.23	0.00030	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000478570	MAPK1,APC,SIRT6,NOX1,BDNF,FTO,VEGFA
PMID:22000009	(2011) Tumor metastasis: molecular insights and evolving paradigms.	7	47	1.23	0.00030	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,ANGPT2,CAV1,PTGS2,RHOA,VEGFA
PMID:22737441	(2011) Genetic and epigenetic changes in human prostate cancer.	7	47	1.23	0.00030	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CAV1,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:20228847	(2010) Viral hepatocarcinogenesis.	8	71	1.11	0.00030	9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000356729,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,SREBF1,MAP3K5,PTGS2,FMO3,BCL2,PROM1,VEGFA
PMID:19343061	(2009) Gene expression profiles of human liver cells mediated by hepatitis B virus X protein.	7	47	1.23	0.00030	9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412	HNF4A,CAV1,ELN,PTGS2,BMP2,BCL2,CCL5
PMID:19635926	(2009) Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.	7	47	1.23	0.00030	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:19638242	(2009) Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.	7	47	1.23	0.00030	9606.ENSP00000256104,9606.ENSP00000258341,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000478570	FABP4,LAMC1,NOX4,HNF4A,NOX1,JAK2,VEGFA
PMID:20032877	(2009) Neuroprotection by radical avoidance: search for suitable agents.	7	47	1.23	0.00030	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000384364,9606.ENSP00000414303	NOX4,SIRT6,NOX1,JAK2,G6PD,NPY,BDNF
PMID:18752467	(2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.	7	47	1.23	0.00030	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185	MPO,LPL,MAPK7,MAP3K5,TXN,EDN1,BCL2
PMID:35159278	(2022) How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span.	9	100	1.02	0.00031	9606.ENSP00000305651,9606.ENSP00000321853,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000365777,9606.ENSP00000376865,9606.ENSP00000418823	CXCL10,SERPINF2,SIRT6,SREBF1,CXCL9,ABCG1,MTHFR,PDGFD,FTO
PMID:35205692	(2022) The Bright and the Dark Side of TGF-beta Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.	12	206	0.83	0.00031	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000285407,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418823,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX4,KLF10,MMP14,CAV1,ELN,PTEN,BCL2,RHOA,FTO,PROM1,VEGFA
PMID:33562534	(2021) Epigenetics: New Insights into Mammary Gland Biology.	10	132	0.94	0.00031	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000477707	FABP4,CDH1,IGF1R,KLF10,STAT5A,SREBF1,PTGS2,PTEN,BCL2,NR1H3
PMID:33671187	(2021) Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides.	6	28	1.39	0.00031	9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	TIMP3,ELN,AR,JAK2,MYD88,VEGFA
PMID:33672937	(2021) Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000418525	MPO,CD34,ELN,JAK2,FGFR1,MME
PMID:33746783	(2021) Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome.	6	28	1.39	0.00031	9606.ENSP00000268035,9606.ENSP00000356832,9606.ENSP00000363822,9606.ENSP00000369442,9606.ENSP00000369816,9606.ENSP00000381185	IGF1R,SGK1,AR,KL,SHBG,BCL2
PMID:33800340	(2021) Young at Gut-Turning Back the Clock with the Gut Microbiome.	6	28	1.39	0.00031	9606.ENSP00000337332,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000474412	SIRT6,COMT,PTGS2,BCL2,FTO,CCL5
PMID:33815682	(2021) Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy.	9	100	1.02	0.00031	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,CAV1,PTGS2,PTEN,AR,EDN1,BCL2,VEGFA
PMID:33816595	(2021) Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495	IFNG,CXCL10,CXCL11,CCL20,CXCL9,LTA
PMID:33861416	(2021) Anesthesia Medications and Interaction with Chemotherapeutic Agents.	6	28	1.39	0.00031	9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD69,CD34,PTGS2,JAK2,BCL2,VEGFA
PMID:33889575	(2021) Retinoic Acid Inhibits Tumor-Associated Mesenchymal Stromal Cell Transformation in Melanoma.	6	28	1.39	0.00031	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:34070757	(2021) Effects of Anthocyanins on Vascular Health.	6	28	1.39	0.00031	9606.ENSP00000200676,9606.ENSP00000226279,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000384364	CETP,CD38,ELN,PTGS2,EDN1,NPY
PMID:34202907	(2021) Myeloid-Derived Suppressor Cells and Mesenchymal StemStromal Cells in Myeloid Malignancies.	9	100	1.02	0.00031	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CXCL10,CD34,STAT5A,CD247,PTGS2,ENTPD1,JAK2,BCL2
PMID:34305576	(2021) Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction.	6	28	1.39	0.00031	9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303	PTGS2,JAK2,BCL2,NPY,MYD88,BDNF
PMID:34415890	(2021) Oxidative stress in leukemia and antioxidant treatment.	6	28	1.39	0.00031	9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185	ATM,STAT5A,TXN,JAK2,NFE2L2,BCL2
PMID:34827970	(2021) Beta-Sitosterol Promotes Milk Protein and Fat Syntheses-Related Genes in Bovine Mammary Epithelial Cells.	6	28	1.39	0.00031	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067	EPOR,IGF1R,LPL,STAT5A,SREBF1,JAK2
PMID:34899727	(2021) Increased Ratio of CD14(++)CD80(+) CellsCD14(++)CD163(+) Cells in the Infrapatellar Fat Pad of End-Stage Arthropathy Patients.	6	28	1.39	0.00031	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000477707	ATM,CXCL10,STAT5A,SREBF1,JAK2,NR1H3
PMID:34947237	(2021) Bioactives from Mushroom: Health Attributes and Food Industry Applications.	6	28	1.39	0.00031	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000474412	FABP4,CCR5,LPL,STAT5A,SREBF1,CCL5
PMID:35069521	(2021) Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.	6	28	1.39	0.00031	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CCL20,CXCL9,CCL5
PMID:32296014	(2020) Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3ITD(+) acute myeloid leukemia.	6	28	1.39	0.00031	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901	CD38,CXCL10,CXCL11,CD34,STAT5A,CXCL9
PMID:32347309	(2020) The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.	6	28	1.39	0.00031	9606.ENSP00000266085,9606.ENSP00000281382,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000478570	TIMP3,PIGF,PTGS2,CNR1,CNR2,VEGFA
PMID:32349263	(2020) Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme.	9	100	1.02	0.00031	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,SOX9,TIMP3,MMP14,PDGFB,PTEN,BCL2,BDNF,VEGFA
PMID:32457139	(2020) Inflammation-related plasma and CSF biomarkers for multiple sclerosis.	6	28	1.39	0.00031	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BDNF
PMID:32643971	(2020) Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MYD88,MME
PMID:32731406	(2020) Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CD34,CXCL9,VEGFA
PMID:32796813	(2020) FBX8 promotes metastatic dormancy of colorectal cancer in liver.	6	28	1.39	0.00031	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000377280,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,CD34,FBXO8,PROM1,VEGFA
PMID:33081785	(2020) Role of extracellular vesicles in tumour microenvironment.	9	100	1.02	0.00031	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000321853,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD69,CDH1,MMP14,SERPINF2,CAV1,PTEN,CCL5,VEGFA
PMID:33117353	(2020) Extracellular DNA-A Danger Signal Triggering Immunothrombosis.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000261037,9606.ENSP00000304767,9606.ENSP00000360997,9606.ENSP00000384957,9606.ENSP00000474412	MPO,COL8A1,P2RY1,ADAMTS13,F11,CCL5
PMID:33193339	(2020) Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.	6	28	1.39	0.00031	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000478570	CD38,CD69,CD34,ENTPD1,JAK2,VEGFA
PMID:33261156	(2020) Early CSF Biomarkers and Late Functional Outcomes in Spinal Cord Injury. A Pilot Study.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	MPO,CXCL10,PDGFA,CXCL9,BDNF,CCL5
PMID:30621735	(2019) The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis.	9	100	1.02	0.00031	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000426809	MAPK1,CDH1,SIRT6,CAV1,STAT5A,SGK1,PTEN,EDN1,PROM1
PMID:30916045	(2019) Bioinformatics Analysis and Identification of Genes and Molecular Pathways Involved in Synovial Inflammation in Rheumatoid Arthritis.	6	28	1.39	0.00031	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL9,BCL2,CCL5,VEGFA
PMID:30984420	(2019) The Mechanism of Acupuncture in Treating Essential Hypertension: A Narrative Review.	6	28	1.39	0.00031	9606.ENSP00000248553,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	HSPB1,EDNRA,PTGS2,EDN1,BCL2,AGTR1
PMID:31044029	(2019) Prospects for repurposing CNS drugs for cancer treatment.	6	28	1.39	0.00031	9606.ENSP00000222572,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000381185,9606.ENSP00000478570	PON2,CDH1,STAT5A,PRKAA1,BCL2,VEGFA
PMID:31183428	(2019) Angiogenic properties of dental pulp stem cells conditioned medium on endothelial cells in vitro and in rodent orthotopic dental pulp regeneration.	6	28	1.39	0.00031	9606.ENSP00000215832,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,ANG,BCL2,BDNF,CCL5,VEGFA
PMID:31185618	(2019) Role of Cytosolic 2-Cys Prx1 and Prx2 in Redox Signaling.	6	28	1.39	0.00031	9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067	HNF4A,MAP3K5,PTEN,TXN,AR,JAK2
PMID:31186548	(2019) Mechanisms underlying T cell ageing.	6	28	1.39	0.00031	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067	CD38,ATM,STAT5A,ENTPD1,PTEN,JAK2
PMID:31530419	(2019) The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,PTGS2,CCL5,VEGFA
PMID:31708781	(2019) Targeting Macrophages: Friends or Foes in Disease?	6	28	1.39	0.00031	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000478570	IGF1R,CCR5,ANGPT2,CAV1,CD47,VEGFA
PMID:31847229	(2019) The IkappaB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells.	6	28	1.39	0.00031	9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:31861404	(2019) microRNA: The Impact on Cancer Stemness and Therapeutic Resistance.	9	100	1.02	0.00031	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000480291	CD38,ALDH1A1,PRDX2,CD34,HNF4A,PTEN,AR,PROM1,HNF1B
PMID:29079596	(2018) Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway.	6	28	1.39	0.00031	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000371067	EPOR,CD38,CD34,HNF4A,BMP2,JAK2
PMID:29352188	(2018) Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells.	6	28	1.39	0.00031	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	CHI3L1,CXCL10,CCL20,BMP2,BDNF,VEGFA
PMID:29452207	(2018) Glycogen synthase kinase 3beta promotes liver innate immune activation by restraining AMP-activated protein kinase activation.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000403495,9606.ENSP00000477707	MPO,CXCL10,HNF4A,PTEN,LTA,NR1H3
PMID:29670919	(2018) Dysregulated Functions of Lung Macrophage Populations in COPD.	9	100	1.02	0.00031	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412	MPO,CHI3L1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,RHOA,CCL5
PMID:30002127	(2018) Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185	MPO,CD38,CD34,TXN,JAK2,BCL2
PMID:30060505	(2018) Phycochemical Constituents and Biological Activities of Fucus spp.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185	IFNG,CXCL11,SREBF1,PTGS2,G6PD,BCL2
PMID:27458171	(2017) Capsazepine inhibits JAKSTAT3 signaling, tumor growth, and cell survival in prostate cancer.	6	28	1.39	0.00031	9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	STAT5A,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:28062508	(2017) Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.	6	28	1.39	0.00031	9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000368104	GAS6,ELN,S100A12,AR,ALPL,BMP2
PMID:28107581	(2017) MicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cells.	6	28	1.39	0.00031	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185	CD38,CDH1,CD34,STAT5A,PTEN,BCL2
PMID:28264810	(2017) Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers.	6	28	1.39	0.00031	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000403495	CD69,CXCL10,CXCL11,CXCL9,PTEN,LTA
PMID:28274817	(2017) Microvascular NADPH oxidase in health and disease.	6	28	1.39	0.00031	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,PTEN,NOX1,EDN1,RHOA,VEGFA
PMID:28366734	(2017) SP and KLF Transcription Factors in Digestive Physiology and Diseases.	10	132	0.94	0.00031	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000302630,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,SOX9,CDH1,KLF10,ONECUT1,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:28903328	(2017) CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via AktmTOR signaling.	6	28	1.39	0.00031	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809	SOX9,CDH1,ALDH1A1,CD34,PTEN,PROM1
PMID:29201269	(2017) Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000368683	MPO,NOX4,IGF1R,ATM,MAP3K5,EDN1
PMID:29255458	(2017) PD-1PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?	9	100	1.02	0.00031	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000475344	CD38,CD69,HNF4A,CD47,PTEN,JAK2,BCL2,MYD88,APLNR
PMID:29379508	(2017) Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:26515267	(2016) Human haematopoietic stemprogenitor cells express several functional sex hormone receptors.	6	28	1.39	0.00031	9606.ENSP00000222139,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,AMBP,CD34,AR,PROM1,VEGFA
PMID:26578439	(2016) Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.	6	28	1.39	0.00031	9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000418525,9606.ENSP00000478570	ELN,VIP,PTEN,TXN,MME,VEGFA
PMID:26762579	(2016) Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.	6	28	1.39	0.00031	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000363822,9606.ENSP00000478570	THBS1,IGF1R,ANGPT2,GAS6,AR,VEGFA
PMID:26769713	(2016) Genetic polymorphisms associated with heart failure: A literature review.	6	28	1.39	0.00031	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IFNG,EDNRA,EDN1,AGTR1,VEGFA
PMID:26811493	(2016) Lentivirus-mediated PLCgamma1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.	6	28	1.39	0.00031	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,CD34,BCL2,FGFR1,BDNF,VEGFA
PMID:27447661	(2016) KSHV-Mediated Angiogenesis in Tumor Progression.	9	100	1.02	0.00031	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,CD34,ANGPT2,ANG,STAT5A,CCL20,PTGS2,PTEN,VEGFA
PMID:27529234	(2016) The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke.	6	28	1.39	0.00031	9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,MMP14,ELN,EDN1,FGFR1,VEGFA
PMID:27843613	(2016) Mechanisms of resistance to EGFR-targeted drugs: lung cancer.	6	28	1.39	0.00031	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,IGF1R,GAS6,PTEN,BCL2,FGFR1
PMID:27886180	(2016) MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment.	6	28	1.39	0.00031	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,CD34,CXCL9,CCL5,VEGFA
PMID:27960084	(2016) Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.	9	100	1.02	0.00031	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,IFNG,THBS1,MMP14,CAV1,PTEN,MYD88,CCL5,VEGFA
PMID:25431829	(2015) Genetic variants and risk of esophageal squamous cell carcinoma: a GWAS-based pathway analysis.	6	28	1.39	0.00031	9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ATM,HNF4A,PTEN,BCL2,RHOA,VEGFA
PMID:25674762	(2015) Aberrant expression of COT is related to recurrence of papillary thyroid cancer.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000361021	IFNG,IGF1R,CXCL10,CXCL11,CD247,PTEN
PMID:25923423	(2015) Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer?	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360522	IFNG,FABP4,ATM,CXCL10,CXCL9,RBP4
PMID:25940549	(2015) Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000362057	MPO,THBS1,CXCL10,ELN,CD47,NOX1
PMID:26260145	(2015) Metabolic functions of FABPs--mechanisms and therapeutic implications.	6	28	1.39	0.00031	9606.ENSP00000200676,9606.ENSP00000256104,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067	CETP,FABP4,CAV1,SREBF1,PTGS2,JAK2
PMID:26696750	(2015) Correlation Network Analysis Reveals Relationships between MicroRNAs, Transcription Factor T-bet, and Deregulated CytokineChemokine-Receptor Network in Pulmonary Sarcoidosis.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:24386892	(2014) The potential of adeno-associated viral vectors for gene delivery to muscle tissue.	6	28	1.39	0.00031	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,LPL,CCL20,CXCL9,MYD88,CCL5
PMID:28548071	(2014) The Pathogenetic Role of the HGFc-Met System in Papillary Carcinoma of the Thyroid.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,CXCL10,PTGS2,CCL5,VEGFA
PMID:23041058	(2013) Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.	9	100	1.02	0.00031	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	MAPK1,CD38,CD34,MAPK7,MAP3K5,TXN,BCL2,RHOA,PROM1
PMID:23114843	(2013) Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.	6	28	1.39	0.00031	9606.ENSP00000245479,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312	SOX9,CAV1,PTEN,AR,BCL2,FGFR1
PMID:23527042	(2013) Replication of type 2 diabetes candidate genes variations in three geographically unrelated Indian population groups.	6	28	1.39	0.00031	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823	WFS1,JAZF1,HNF4A,KCNJ11,CAPN10,FTO
PMID:23626764	(2013) CD271 defines a stem cell-like population in hypopharyngeal cancer.	6	28	1.39	0.00031	9606.ENSP00000226279,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809	CD38,MMP14,CD34,NTF3,BDNF,PROM1
PMID:23792201	(2013) Cdc42 coordinates proliferation, polarity, migration, and differentiation of small intestinal epithelial cells in mice.	6	28	1.39	0.00031	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000426809	MPO,CDH1,PTEN,RHOA,MME,PROM1
PMID:23849222	(2013) Tofacitinab in renal transplantation.	6	28	1.39	0.00031	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CD69,CXCL10,STAT5A,CXCL9,JAK2,CCL5
PMID:23874342	(2013) Home sweet home: the tumor microenvironment as a haven for regulatory T cells.	6	28	1.39	0.00031	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:23938132	(2013) Metabolic actions of Rho-kinase in periphery and brain.	6	28	1.39	0.00031	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000400175	EPOR,STAT5A,PTEN,JAK2,NPY,RHOA
PMID:24386599	(2013) Suppression of in vitro murine T cell proliferation by human adipose tissue-derived mesenchymal stem cells is dependent mainly on cyclooxygenase-2 expression.	6	28	1.39	0.00031	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250	CXCL10,CXCL11,CD34,CXCL9,PTGS2,ENTPD1
PMID:22431312	(2012) Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.	6	28	1.39	0.00031	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000383364	CETP,MPO,CAV1,ABCG1,EDN1,PLA2G2A
PMID:22754349	(2012) Design and synthesis of binding growth factors.	6	28	1.39	0.00031	9606.ENSP00000321853,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SERPINF2,ELN,BMP2,NTF3,BDNF,VEGFA
PMID:21179030	(2011) CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells.	6	28	1.39	0.00031	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:22027691	(2011) Therapeutic potential of AZD1480 for the treatment of human glioblastoma.	6	28	1.39	0.00031	9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CNTF,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:20396973	(2010) HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.	6	28	1.39	0.00031	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000414303,9606.ENSP00000474412	CD69,CCR5,CXCL10,MAP3K5,BDNF,CCL5
PMID:20861812	(2010) Promoter hypermethylation in prostate cancer.	6	28	1.39	0.00031	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363822	CDH1,TIMP3,LPL,CAV1,PTGS2,AR
PMID:19010784	(2009) Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets.	6	28	1.39	0.00031	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000321853,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CXCL10,CXCL11,SERPINF2,CXCL9,RARRES2,CCL5
PMID:19216842	(2009) Angiopoietin-2: development of inhibitors for cancer therapy.	6	28	1.39	0.00031	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000478570	THBS1,CDH1,CD34,ANGPT2,PTGS2,VEGFA
PMID:19745170	(2009) Cardiovascular consequences when nitric oxide and lipid signaling converge.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000284031,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252	IFNG,DDAH1,PTGS2,TXN,EDN1,NFE2L2
PMID:19941816	(2009) EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.	6	28	1.39	0.00031	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000361021	MAPK1,APC,CDH1,MAPK7,CAV1,PTEN
PMID:18404505	(2005) Purinergic mechanism in the immune system: A signal of danger for dendritic cells.	6	28	1.39	0.00031	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000474412	IFNG,CCR5,P2RY1,CXCL10,ENTPD1,CCL5
PMID:31637019	(....) demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.	10	132	0.94	0.00031	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000479617	ATM,CXCL10,PTGS2,NOX1,AR,NPY,SAA1,MYD88,VEGFA,UHRF1
PMID:34518975	(2022) Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimers Disease.	7	48	1.22	0.00032	9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000475344,9606.ENSP00000478570	ABCG1,NFE2L2,BCL2,BDNF,MME,APLNR,VEGFA
PMID:34931503	(2022) Transcriptome profiling identifies immune response genes against porcine reproductive and respiratory syndrome virus and Haemophilus parasuis co-infection in the lungs of piglets.	8	72	1.11	0.00032	9606.ENSP00000229135,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000477707	IFNG,FADS2,PLIN1,CXCL10,CXCL11,CCL20,CXCL9,NR1H3
PMID:35056657	(2022) Inflammaging and Brain: Curcumin and Its Beneficial Potential as Regulator of Microglia Activation.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,PTGS2,NFE2L2,BCL2,MYD88,BDNF,CCL5
PMID:35151223	(2022) Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy.	8	72	1.11	0.00032	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000403495,9606.ENSP00000419422	MAPK1,MPO,CXCL10,ELN,PTGS2,G6PD,LTA,AGTR1
PMID:35236376	(2022) The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells?	8	72	1.11	0.00032	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000381185,9606.ENSP00000478570	CD38,IFNG,IGF1R,CXCL10,CD34,GAS6,BCL2,VEGFA
PMID:35327461	(2022) Extracellular Vesicles Derived from Acidified Metastatic Melanoma Cells Stimulate Growth, Migration, and Stemness of Normal Keratinocytes.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,PTEN,EDN1,BDNF,PROM1,VEGFA
PMID:35328824	(2022) Molecular Processes in Stress Urinary Incontinence: A Systematic Review of Human and Animal Studies.	7	48	1.22	0.00032	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,CCR5,FMOD,ELN,NFE2L2,BCL2,VEGFA
PMID:35406662	(2022) Activation of the Renin-Angiotensin System Disrupts the Cytoskeletal Architecture of Human Urine-Derived Podocytes.	8	72	1.11	0.00032	9606.ENSP00000339191,9606.ENSP00000352264,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CAV1,CD2AP,RBP4,EDN1,BDNF,AGTR1,PROM1,VEGFA
PMID:35408871	(2022) Mesenchymal Stromal Cells from Healthy and Inflamed Human Gingiva Respond Differently to Porphyromonas gingivalis.	7	48	1.22	0.00032	9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	AMBP,CXCL10,CD34,ENTPD1,BMP2,CCL5,VEGFA
PMID:35418981	(2022) Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147EMMPRIN to Prevent Tumor Recurrence?	8	72	1.11	0.00032	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,CDH1,ATM,GAS6,JAK2,CCL5,VEGFA
PMID:33525407	(2021) CAPE and Neuroprotection: A Review.	7	48	1.22	0.00032	9606.ENSP00000225275,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	MPO,COMT,PTGS2,JAK2,NFE2L2,BCL2,BDNF
PMID:33553708	(2021) Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CCR5,CXCL10,ANGPT2,CCL5,VEGFA
PMID:33866463	(2021) New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction.	7	48	1.22	0.00032	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,IRAK4,MYD88,VEGFA
PMID:33885811	(2021) Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.	8	72	1.11	0.00032	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA,VEGFA
PMID:33920288	(2021) Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,JAK2,CCL5
PMID:33971957	(2021) Oxidant therapy improves adipogenic differentiation of adipose-derived stem cells in human wound healing.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000360522	IFNG,FABP4,PLIN1,CXCL10,SREBF1,CCL20,RBP4
PMID:34026439	(2021) Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.	8	72	1.11	0.00032	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	CDH1,CXCL10,CXCL9,CD47,PTGS2,PTEN,BCL2,MYD88
PMID:34063506	(2021) Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000419313,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL9,PTGS2,TRPC1,VEGFA
PMID:34073629	(2021) The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.	8	72	1.11	0.00032	9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MMP14,CAV1,STAT5A,PTGS2,PTEN,BCL2,MYD88,VEGFA
PMID:34145279	(2021) Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells.	7	48	1.22	0.00032	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185	CD38,CD69,IFNG,CXCL10,CXCL11,CXCL9,BCL2
PMID:34429399	(2021) Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,BDNF,CCL5
PMID:34629548	(2021) Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation.	8	72	1.11	0.00032	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185	THBS1,ATM,CAV1,KCNJ11,SREBF1,ABCG1,PTEN,BCL2
PMID:34702860	(2021) Macrophages in heterotopic ossification: from mechanisms to therapy.	7	48	1.22	0.00032	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000397297,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CCR5,ANG,CD47,NTF3,CCL5,VEGFA
PMID:34885241	(2021) Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity.	8	72	1.11	0.00032	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,ENTPD1,CCL5,VEGFA
PMID:35008723	(2021) Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes.	7	48	1.22	0.00032	9606.ENSP00000226760,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000369816,9606.ENSP00000380252,9606.ENSP00000418823	WFS1,KCNJ11,SREBF1,ABCG1,SHBG,NFE2L2,FTO
PMID:31812277	(2020) Migration and Function of Memory CD8(+) T Cells in Skin.	7	48	1.22	0.00032	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067	CD69,FABP4,CDH1,CCR5,CXCL10,CXCL9,JAK2
PMID:31941075	(2020) Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.	7	48	1.22	0.00032	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,THBS1,PTGS2,PTEN,MTHFR,BCL2,VEGFA
PMID:32290543	(2020) EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAKSTAT, Wntbeta-Catenin, TGFSMAD, NOTCH, SHHGLI, and TRAIL Mediated Signaling Pathways.	8	72	1.11	0.00032	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,TIMP3,HNF4A,STAT5A,JAK2,BCL2,VEGFA,UHRF1
PMID:32466591	(2020) Emerging Therapeutic RNAs for the Targeting of Cancer Associated Fibroblasts.	7	48	1.22	0.00032	9606.ENSP00000263317,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,GAS6,CXCL9,PTEN,FGFR1,CCL5,VEGFA
PMID:32518769	(2020) Prophylactic and therapeutic roles of oleanolic acid and its derivatives in several diseases.	8	72	1.11	0.00032	9606.ENSP00000216862,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CYP24A1,NOX4,CXCL10,CXCL9,NFE2L2,BDNF,CCL5,VEGFA
PMID:32582159	(2020) Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated Naive-Like Cells Capable of Restricting Mycobacteria Growth.	7	48	1.22	0.00032	9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	AMBP,CCR5,CXCL10,CD34,LTA,CCL5,VEGFA
PMID:32630531	(2020) The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.	7	48	1.22	0.00032	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000478570	MAPK1,TGFB1,CDH1,MMP14,ELN,PTGS2,VEGFA
PMID:32635646	(2020) Immune Dysfunction in Uremia 2020.	7	48	1.22	0.00032	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000384364	MPO,IFNG,RBP4,EDN1,KL,NFE2L2,NPY
PMID:32785018	(2020) PPARs and Angiogenesis-Implications in Pathology.	7	48	1.22	0.00032	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CXCL10,PTGS2,PTEN,NOX1,EDN1,VEGFA
PMID:32899187	(2020) Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?	7	48	1.22	0.00032	9606.ENSP00000258341,9606.ENSP00000266085,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	LAMC1,TIMP3,CAV1,HSPG2,EDN1,BCL2,VEGFA
PMID:32972405	(2020) Targeting STAT3 in Cancer Immunotherapy.	8	72	1.11	0.00032	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,PTGS2,AR,JAK2,BCL2,CCL5,VEGFA
PMID:32977499	(2020) Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis.	8	72	1.11	0.00032	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CD38,IFNG,NOX4,CD34,STAT5A,PTGS2,BCL2,VEGFA
PMID:33080891	(2020) Curcumin: Could This Compound Be Useful in Pregnancy and Pregnancy-Related Complications?	7	48	1.22	0.00032	9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,SREBF1,EDN1,JAK2,BCL2,BDNF,VEGFA
PMID:33311428	(2020) Cell Sources and Influencing Factors of Liver Regeneration: A Review.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,SOX9,CD34,HNF4A,ANGPT2,LTA,VEGFA
PMID:30700305	(2019) The spleen may be an important target of stem cell therapy for stroke.	7	48	1.22	0.00032	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CD34,CCL20,PTGS2,CCL5,VEGFA
PMID:31043378	(2019) Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.	7	48	1.22	0.00032	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,ALDH1A1,CXCL10,CCL20,JAK2,PROM1,CCL5
PMID:31066193	(2019) Recent insights on the role and regulation of retinoic acid signaling during epicardial development.	8	72	1.11	0.00032	9606.ENSP00000222139,9606.ENSP00000232219,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000475344,9606.ENSP00000478570	EPOR,RBP1,IGF1R,LPL,FGFR1,RHOA,APLNR,VEGFA
PMID:31173222	(2019) Pathway and network analysis of genes related to osteoporosis.	7	48	1.22	0.00032	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000393312	TGFB1,SOX9,TIMP3,HNF4A,PTGS2,BMP2,FGFR1
PMID:31205106	(2019) Application and prospects of butylphthalide for the treatment of neurologic diseases.	7	48	1.22	0.00032	9606.ENSP00000221930,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,TXN,KL,NFE2L2,BCL2,BDNF,VEGFA
PMID:31284389	(2019) A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.	7	48	1.22	0.00032	9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000474412	CYP24A1,IFNG,CXCL10,TXN,JAK2,NFE2L2,CCL5
PMID:31350446	(2019) Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer.	7	48	1.22	0.00032	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CD34,CD47,JAK2,CCL5,VEGFA
PMID:31496355	(2019) Exosomes in head and neck cancer. Updating and revisiting.	7	48	1.22	0.00032	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,CAV1,ENTPD1,PTEN,BCL2,VEGFA
PMID:31500822	(2019) MAIT cells in metabolic diseases.	7	48	1.22	0.00032	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185	CD38,CD69,CCR5,CXCL10,CCL20,CXCL9,BCL2
PMID:31507535	(2019) The Role of the CXCL12CXCR4ACKR3 Axis in Autoimmune Diseases.	7	48	1.22	0.00032	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:31652837	(2019) Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.	7	48	1.22	0.00032	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000380252,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CDH1,NFE2L2,PLA2G2A,RHOA,CCL5,VEGFA
PMID:32063863	(2019) Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.	7	48	1.22	0.00032	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000478570	ATM,CD34,STAT5A,JAK2,RHOA,RARRES2,VEGFA
PMID:29330447	(2018) Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-alpha and IFN-gamma Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.	7	48	1.22	0.00032	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL11,CD34,CXCL9,PTEN,LTA,CCL5,VEGFA
PMID:29706964	(2018) Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNTbeta-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.	7	48	1.22	0.00032	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,HNF4A,PTGS2,PTEN,BCL2,VEGFA
PMID:29847580	(2018) AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection.	7	48	1.22	0.00032	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CD69,IFNG,CHI3L1,CCL20,CXCL9,PTGS2,CCL5
PMID:30009170	(2018) The Signaling Pathways Involved in the Antiatherosclerotic Effects Produced by Chinese Herbal Medicines.	8	72	1.11	0.00032	9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,SREBF1,ABCG1,NFE2L2,BCL2,RHOA,MYD88,VEGFA
PMID:30123354	(2018) The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma.	8	72	1.11	0.00032	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000322898,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,IGF1R,ATM,CXCL11,EBF1,MAP3K5,PTEN,BCL2
PMID:30593276	(2018) Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.	8	72	1.11	0.00032	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000358513,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,HNF4A,CCL20,CNR1,CCL5,VEGFA
PMID:30746323	(2018) EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.	8	72	1.11	0.00032	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,MMP14,MAPK7,STAT5A,PTEN,RHOA,VEGFA
PMID:28328747	(2017) In Development-A New Paradigm for Understanding Vascular Disease.	7	48	1.22	0.00032	9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	ANGPT2,ELN,PTEN,NOX1,EDN1,RHOA,VEGFA
PMID:28457748	(2017) Gli1(+) Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target.	7	48	1.22	0.00032	9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185	AMBP,CD34,STAT5A,CXCL9,EDN1,JAK2,BCL2
PMID:28667255	(2017) Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,CXCL9,BDNF,CCL5,VEGFA
PMID:28723893	(2017) In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.	7	48	1.22	0.00032	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CD47,PTEN,JAK2,CCL5
PMID:28785557	(2017) The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.	7	48	1.22	0.00032	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,PTEN,BCL2,PROM1,VEGFA
PMID:27070592	(2016) Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells.	7	48	1.22	0.00032	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354995,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185	CD38,CD34,STAT5A,ABCG1,SGK1,PTEN,BCL2
PMID:27427759	(2016) Transcriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus Macaques.	11	168	0.88	0.00032	9606.ENSP00000228434,9606.ENSP00000246553,9606.ENSP00000260356,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD69,FFAR1,THBS1,PRDX2,CXCL10,CXCL11,STAT5A,CXCL9,BDNF,CCL5,VEGFA
PMID:27738435	(2016) Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells.	7	48	1.22	0.00032	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CHI3L1,CD34,PDGFB,PTEN,PROM1,VEGFA
PMID:27847522	(2016) Mesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis Progression.	8	72	1.11	0.00032	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000478570	CD69,CCR5,CXCL10,CD34,CCL20,CXCL9,ENTPD1,VEGFA
PMID:27898034	(2016) Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.	8	72	1.11	0.00032	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:25446259	(2015) The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.	8	72	1.11	0.00032	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,APC,MAPK7,HNF4A,MAP3K5,PTEN,BCL2,VEGFA
PMID:25795503	(2015) Renal endothelial injury and microvascular dysfunction in acute kidney injury.	7	48	1.22	0.00032	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	TIMP3,CD34,ANGPT2,CAV1,EDN1,MYD88,VEGFA
PMID:25849621	(2015) Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.	7	48	1.22	0.00032	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175	EPOR,CDH1,TIMP3,PTEN,JAK2,BCL2,RHOA
PMID:26184238	(2015) Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin.	7	48	1.22	0.00032	9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	LPL,STAT5A,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:26261901	(2015) Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.	7	48	1.22	0.00032	9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,DDAH1,NOX1,TXN,EDN1,RHOA,AGTR1
PMID:23848204	(2014) beta2-Microglobulin-mediated signaling as a target for cancer therapy.	7	48	1.22	0.00032	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,SREBF1,PTGS2,AR,BCL2,VEGFA
PMID:24291532	(2014) Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.	8	72	1.11	0.00032	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	CXCL10,CD34,PDGFB,UNC5B,ELN,CXCL9,PTEN,VEGFA
PMID:24356096	(2014) Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.	7	48	1.22	0.00032	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312	CDH1,IGF1R,ATM,PTEN,AR,JAK2,FGFR1
PMID:24392122	(2014) Secretome analysis of human oligodendrocytes derived from neural stem cells.	7	48	1.22	0.00032	9606.ENSP00000258341,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	LAMC1,CXCL10,PDGFA,BAMBI,BCL2,PROM1,CCL5
PMID:24393708	(2014) mTOR pathway in colorectal cancer: an update.	7	48	1.22	0.00032	9606.ENSP00000297785,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,SGK1,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:24419232	(2014) Paradoxic effects of metformin on endothelial cells and angiogenesis.	7	48	1.22	0.00032	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000478570	CD34,ANGPT2,ANG,PTGS2,EDN1,G6PD,VEGFA
PMID:24799765	(2014) Adipokines as potential biomarkers in rheumatoid arthritis.	7	48	1.22	0.00032	9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	PTGS2,JAK2,SAA1,MYD88,RARRES2,APLNR,VEGFA
PMID:24938765	(2014) Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response.	7	48	1.22	0.00032	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,STAT5A,JAK2,CCL5,VEGFA
PMID:25097473	(2014) Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis.	8	72	1.11	0.00032	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:25102061	(2014) Profiling of luteal transcriptome during prostaglandin F2-alpha treatment in buffalo cows: analysis of signaling pathways associated with luteolysis.	7	48	1.22	0.00032	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000419422	FABP4,TIMP3,IGF1R,PTGS2,BMP2,BCL2,AGTR1
PMID:23358390	(2013) HCV and oxidative stress in the liver.	7	48	1.22	0.00032	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000478570	THBS1,NOX4,FMOD,PTGS2,NOX1,TXN,VEGFA
PMID:23530840	(2013) Advances in medical diagnosis of intra-amniotic infection.	7	48	1.22	0.00032	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000357726,9606.ENSP00000360522,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CDH1,S100A12,RBP4,NTF3,BDNF,CCL5
PMID:23945296	(2013) Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.	7	48	1.22	0.00032	9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000478570	ATM,MMP14,CAV1,PTEN,JAK2,G6PD,VEGFA
PMID:23995626	(2013) Macrophages in atherosclerosis: a dynamic balance.	8	72	1.11	0.00032	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000354995,9606.ENSP00000383364,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MPO,IFNG,CCR5,ABCG1,PLA2G2A,IRAK4,MYD88,CCL5
PMID:24605290	(2013) Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.	7	48	1.22	0.00032	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641	NOX4,ATM,CD34,MAP3K5,PTEN,NOX1,TXN
PMID:22406924	(2012) Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.	7	48	1.22	0.00032	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000352264,9606.ENSP00000356438,9606.ENSP00000371067	MAPK1,EPOR,MAPK7,STAT5A,CD2AP,PTGS2,JAK2
PMID:23700507	(2012) Brown adipose tissue: Recent insights into development, metabolic function and therapeutic potential.	7	48	1.22	0.00032	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000414303	FABP4,PLIN1,SIRT6,PTGS2,BMP2,NPY,BDNF
PMID:21521165	(2011) Central nervous system agents for ischemic stroke: neuroprotection mechanisms.	7	48	1.22	0.00032	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	CD34,PTGS2,PTEN,BCL2,BDNF,AGTR1,VEGFA
PMID:21609465	(2011) Endothelial progenitor cell biology in disease and tissue regeneration.	7	48	1.22	0.00032	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CD34,ANG,PROM1,CCL5,VEGFA
PMID:22091432	(2011) Innovative Therapies against Human Glioblastoma Multiforme.	7	48	1.22	0.00032	9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,CNTF,PTEN,BCL2,FGFR1,PROM1,VEGFA
PMID:22180737	(2011) The nuclear events guiding successful nerve regeneration.	7	48	1.22	0.00032	9606.ENSP00000248553,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525	HSPB1,CNTF,VIP,GAP43,NTF3,BDNF,MME
PMID:20214479	(2010) Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine.	7	48	1.22	0.00032	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:16765573	(2006) Natural killer cells as an initial defense against pathogens.	7	48	1.22	0.00032	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CD247,MYD88,CCL5
PMID:34846534	(2022) A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15.	10	133	0.94	0.00033	9606.ENSP00000256104,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000477707	FABP4,HNF4A,GAS6,STAT5A,PRKAA1,ABCG1,PTGS2,NFE2L2,MYD88,NR1H3
PMID:35172892	(2022) Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.	9	101	1.01	0.00033	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000357726,9606.ENSP00000474412	CD69,IFNG,THBS1,CCR5,CXCL10,CD34,CD47,S100A12,CCL5
PMID:33868315	(2021) Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction.	9	101	1.01	0.00033	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CCR5,CXCL10,ANGPT2,PTGS2,ENTPD1,EDN1,MME,VEGFA
PMID:31936346	(2020) Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.	9	101	1.01	0.00033	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,CDH1,IGF1R,ALDH1A1,COMT,PTEN,BCL2,PROM1,VEGFA
PMID:32012718	(2020) Toll-like Receptors from the Perspective of Cancer Treatment.	10	133	0.94	0.00033	9606.ENSP00000228434,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD69,HSPB1,ATM,CXCL10,CD34,MAPK7,MAP3K5,BCL2,MYD88,VEGFA
PMID:32900991	(2020) Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications.	10	133	0.94	0.00033	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000480291	ERCC1,CDH1,ATM,GAS6,SGK1,PTEN,AR,BCL2,FTO,HNF1B
PMID:33081387	(2020) Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets.	9	101	1.01	0.00033	9606.ENSP00000245479,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	SOX9,SREBF1,PTEN,TXN,AR,NFE2L2,BCL2,RHOA,PROM1
PMID:33256814	(2020) Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications.	9	101	1.01	0.00033	9606.ENSP00000261769,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000331831,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,VDAC1,IGF1R,ATM,GAS6,SREBF1,GFPT1,PTEN,VEGFA
PMID:29456536	(2018) Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.	9	101	1.01	0.00033	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,CXCL10,STAT5A,CD47,ENTPD1,PTEN,BCL2,VEGFA
PMID:30109213	(2018) Do We Know Jack About JAK? A Closer Look at JAKSTAT Signaling Pathway.	9	101	1.01	0.00033	9606.ENSP00000222139,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000478570	EPOR,CCR5,PTGS2,PTEN,JAK2,BCL2,FGFR1,AGTR1,VEGFA
PMID:24806461	(2014) Epithelial SCAPINSIGSREBP signaling regulates multiple biological processes during perinatal lung maturation.	9	101	1.01	0.00033	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252	TGFB1,IFNG,HNF4A,STAT5A,PDGFA,SREBF1,PTGS2,PTEN,NFE2L2
PMID:21152443	(2010) Molecular characterization of c-Ablc-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers.	10	133	0.94	0.00033	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,CD34,CAV1,STAT5A,CCL20,PTGS2,PROM1,CCL5,VEGFA
PMID:21339979	(2010) Cell surface markers in colorectal cancer prognosis.	9	101	1.01	0.00033	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD69,THBS1,CDH1,CCR5,MMP14,MME,PROM1,VEGFA
PMID:35149705	(2022) Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics.	5	14	1.61	0.00034	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000418525	CD38,AMBP,CD34,PTEN,MME
PMID:35287653	(2022) Antioxidant effect of nicotinamide mononucleotide in tendinopathy.	5	14	1.61	0.00034	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000381185	CD38,NOX4,SIRT6,NOX1,BCL2
PMID:35340424	(2022) Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives.	5	14	1.61	0.00034	9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	GAP43,NTF3,BDNF,PROM1,VEGFA
PMID:35384373	(2022) Targeting transforming growth factor-beta signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin.	8	73	1.1	0.00034	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,CXCL11,CAV1,PTGS2,BCL2,RHOA,VEGFA
PMID:35386346	(2022) Rational design of biodegradable thermoplastic polyurethanes for tissue repair.	5	14	1.61	0.00034	9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	ELN,BMP2,GAP43,BDNF,VEGFA
PMID:33510172	(2021) CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis.	8	73	1.1	0.00034	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000381185,9606.ENSP00000403495	CD69,CXCL10,STAT5A,MAP3K5,CXCL9,SGK1,BCL2,LTA
PMID:33625674	(2021) Remote Ischemic Postconditioning vs. Physical Exercise After Stroke: an Alternative Rehabilitation Strategy?	5	14	1.61	0.00034	9606.ENSP00000314897,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	ANGPT2,GAP43,BCL2,BDNF,VEGFA
PMID:33923200	(2021) Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress.	8	73	1.1	0.00034	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,CD34,SGK1,PTEN,BCL2,PROM1,VEGFA
PMID:34069133	(2021) Ambient Particulate Matter Induces Vascular Smooth Muscle Cell Phenotypic Changes via NOX1ROSNF-kappaB Dependent and Independent Pathways: Protective Effects of Polyphenols.	5	14	1.61	0.00034	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,ELN,NOX1,RHOA,VEGFA
PMID:34155448	(2021) Differences in the reaction of hyperlipidemia on different endothelial progenitor cells based on sex.	5	14	1.61	0.00034	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000426809,9606.ENSP00000478570	NOX4,CD34,NOX1,PROM1,VEGFA
PMID:34178620	(2021) TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.	8	73	1.1	0.00034	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000419313	CDH1,AQP5,CAV1,KCNJ11,PTEN,FGFR1,RHOA,TRPC1
PMID:34210364	(2021) Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitors-time for new definitions.	10	134	0.93	0.00034	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000376865	FABP4,TIMP3,PLIN1,CD34,PDGFB,PDGFA,FMOD,ELN,BMP2,PDGFD
PMID:34367949	(2021) The Provocative Roles of Platelets in Liver Disease and Cancer.	8	73	1.1	0.00034	9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000321853,9606.ENSP00000331831,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000474412	CXCL11,MMP14,SERPINF2,GAS6,ADAMTS13,EDN1,MYD88,CCL5
PMID:34721005	(2021) Saikosaponin D Inhibits Peritoneal Fibrosis in Rats With Renal Failure by Regulation of TGFbeta1 BMP7  Gremlin1 Smad Pathway.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478319	IFNG,CDH1,BMP2,RHOA,GREM1
PMID:34944856	(2021) The Complex Network between Inflammation and Colorectal Cancer: A Systematic Review of the Literature.	8	73	1.1	0.00034	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,MPO,CCL20,ENTPD1,JAK2,BCL2,CCL5,VEGFA
PMID:35008330	(2021) Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer.	5	14	1.61	0.00034	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312	IGF1R,PTEN,AR,BCL2,FGFR1
PMID:26218314	(2020) Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,PTGS2,BCL2,VEGFA
PMID:31467431	(2020) Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1.	5	14	1.61	0.00034	9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901	PRDX2,CXCL10,CXCL11,CAV1,CXCL9
PMID:32131693	(2020) Endothelium-Targeted Deletion of microRNA-15a16-1 Promotes Poststroke Angiogenesis and Improves Long-Term Neurological Recovery.	5	14	1.61	0.00034	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	PDGFB,PDGFA,BCL2,FGFR1,VEGFA
PMID:32143579	(2020) An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report.	5	14	1.61	0.00034	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000258341,9606.ENSP00000310036,9606.ENSP00000418525	MPO,CD38,LAMC1,CD34,MME
PMID:32265714	(2020) The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.	8	73	1.1	0.00034	9606.ENSP00000013807,9606.ENSP00000263317,9606.ENSP00000310520,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000444198	ERCC1,NOX4,ERCC4,STAT5A,PTEN,JAK2,BCL2,CITED2
PMID:32384763	(2020) Identifying the Therapeutic Significance of Mesenchymal Stem Cells.	8	73	1.1	0.00034	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000474412	NOX4,CXCL10,CXCL11,CD34,CXCL9,PTGS2,BDNF,CCL5
PMID:32423475	(2020) Gene modification strategies for next-generation CAR T cells against solid cancers.	8	73	1.1	0.00034	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,CD247,CXCL9,PROM1,CCL5,VEGFA
PMID:32527062	(2020) Switching Homes: How Cancer Moves to Bone.	8	73	1.1	0.00034	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CCR5,CD34,ELN,AR,EDN1,CCL5,VEGFA
PMID:32765291	(2020) Physical Exercise Exacerbates Acute Kidney Injury Induced by LPS via Toll-Like Receptor 4.	5	14	1.61	0.00034	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000401399	MPO,CXCL10,ALPL,BCL2,MYD88
PMID:32858050	(2020) Melatonin as a protective agent in cardiac ischemia-reperfusion injury: VisionIllusion?	8	73	1.1	0.00034	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,VDAC1,PTEN,TXN,JAK2,NFE2L2,BCL2,VEGFA
PMID:32958359	(2020) The complexity of neutrophils in health and disease: Focus on cancer.	8	73	1.1	0.00034	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	MPO,THBS1,CCR5,CXCL10,CXCL9,MYD88,MME,VEGFA
PMID:32989390	(2020) Pretreatment with human urine-derived stem cells protects neurological function in rats following cardiopulmonary resuscitation after cardiac arrest.	5	14	1.61	0.00034	9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000383232,9606.ENSP00000414303,9606.ENSP00000478570	CD34,BCL2,GGT1,BDNF,VEGFA
PMID:33239867	(2020) Loxoprofen Sodium Alleviates Oxidative Stress and Apoptosis Induced by Angiotensin II in Human Umbilical Vein Endothelial Cells (HUVECs).	5	14	1.61	0.00034	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	NOX4,NOX1,EDN1,BCL2,AGTR1
PMID:33383973	(2020) Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches.	8	73	1.1	0.00034	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,PTEN,TXN,JAK2,BCL2,RHOA,VEGFA
PMID:33419373	(2020) The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.	8	73	1.1	0.00034	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000403495,9606.ENSP00000478570	CDH1,TIMP3,MMP14,ELN,PTEN,SHBG,LTA,VEGFA
PMID:33911720	(2020) Exploratory Study of Epidermis, Basement Membrane Zone, Upper Dermis Alterations and Wnt Pathway Activation in Melasma Compared to Adjacent and Retroauricular Skin.	5	14	1.61	0.00034	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	CD34,ELN,PTGS2,EDN1,VEGFA
PMID:30886905	(2019) Mesenchymal actomyosin contractility is required for androgen-driven urethral masculinization in mice.	5	14	1.61	0.00034	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000362410,9606.ENSP00000363822,9606.ENSP00000400175	MYH9,CDH1,MAFB,AR,RHOA
PMID:31076601	(2019) Human adipose stromal-vascular fraction self-organizes to form vascularized adipose tissue in 3D cultures.	5	14	1.61	0.00034	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000478570	FABP4,PLIN1,LPL,CD34,VEGFA
PMID:31387282	(2019) Current Strategies to Enhance Adipose Stem Cell Function: An Update.	8	73	1.1	0.00034	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,CXCL10,CD34,CXCL9,PTGS2,PTEN,MME,VEGFA
PMID:31391918	(2019) PKM2, function and expression and regulation.	8	73	1.1	0.00034	9606.ENSP00000215832,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,HNF4A,SIRT6,PTEN,JAK2,BCL2,FGFR1,VEGFA
PMID:31528854	(2019) Vaginal endometrial stromal sarcoma: A literature review.	5	14	1.61	0.00034	9606.ENSP00000268035,9606.ENSP00000283928,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	IGF1R,JAZF1,CD34,BCL2,MME
PMID:31547062	(2019) The Emerging Roles of Cancer Stem Cells and WntBeta-Catenin Signaling in Hepatoblastoma.	8	73	1.1	0.00034	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	IFNG,CDH1,ALDH1A1,HNF4A,AR,NFE2L2,BCL2,PROM1
PMID:28819864	(2018) Molecular processes involved in B cell acute lymphoblastic leukaemia.	10	134	0.93	0.00034	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809	EPOR,CD38,ATM,CD34,EBF1,STAT5A,JAK2,BCL2,MME,PROM1
PMID:29351204	(2018) mTOR Cross-Talk in Cancer and Potential for Combination Therapy.	8	73	1.1	0.00034	9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	STAT5A,SREBF1,SGK1,PTEN,JAK2,FGFR1,RHOA,VEGFA
PMID:29371248	(2018) From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.	5	14	1.61	0.00034	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995	CETP,MPO,APOL1,LPA,ABCG1
PMID:29559910	(2018) Liposome-Encapsulated Baicalein Suppressed Lipogenesis and Extracellular Matrix Formation in Hs68 Human Dermal Fibroblasts.	5	14	1.61	0.00034	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000478570	FABP4,LPL,ELN,PTGS2,VEGFA
PMID:29805645	(2018) Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,MME,PROM1,VEGFA
PMID:29883409	(2018) Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review.	8	73	1.1	0.00034	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,STAT5A,CCL20,ELN,LTA,CCL5,VEGFA
PMID:29986768	(2018) A team effort: natural killer cells on the first leg of the tumor immunity relay race.	5	14	1.61	0.00034	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,PTGS2,CCL5
PMID:30050416	(2018) Is Environmental Enrichment Ready for Clinical Application in Human Post-stroke Rehabilitation?	5	14	1.61	0.00034	9606.ENSP00000260356,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,GAP43,NTF3,BDNF,VEGFA
PMID:30301974	(2018) The oral microbiota: dynamic communities and host interactions.	5	14	1.61	0.00034	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000383364,9606.ENSP00000401399	CXCL10,CXCL11,CXCL9,PLA2G2A,MYD88
PMID:30310855	(2018) Cancer stem cells and tumorigenesis.	8	73	1.1	0.00034	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,HNF4A,PTEN,MME,PROM1,VEGFA
PMID:30593195	(2018) A case report of cerebral infarction caused by polycythemia vera.	5	14	1.61	0.00034	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525	MPO,CD38,CD34,JAK2,MME
PMID:28259923	(2017) Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wntbeta-catenin signaling pathway in human colorectal adenocarcinoma.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,HNF4A,FGFR1,RHOA,VEGFA
PMID:28260009	(2017) Molecular profile of major growth factors in lumbar intervertebral disc herniation: Correlation with patient clinical and epidemiological characteristics.	5	14	1.61	0.00034	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000478570	TGFB1,PDGFB,PDGFA,PDGFD,VEGFA
PMID:28293259	(2017) Influence of Normo- and Hypogonadal Condition, Hyperuricemia, and High-Fructose Diet on Renal Changes in Male Rats.	5	14	1.61	0.00034	9606.ENSP00000309757,9606.ENSP00000346508,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000369816	LPL,PDGFA,AR,EDN1,SHBG
PMID:28419100	(2017) Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000478570	IFNG,CHI3L1,CXCL10,ANGPT2,VEGFA
PMID:28444967	(2017) Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,PTEN,BCL2,VEGFA
PMID:28910446	(2017) Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRalpha: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA.	5	14	1.61	0.00034	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000376865,9606.ENSP00000414303	PDGFB,PDGFA,CNTF,PDGFD,BDNF
PMID:29118542	(2017) The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,EDNRA,AR,EDN1,VEGFA
PMID:29312482	(2017) Assessment of doxorubicin-induced mouse testicular damage by the novel second-harmonic generation microscopy.	5	14	1.61	0.00034	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363822	NOX4,ATM,PTEN,NOX1,AR
PMID:26808525	(2016) ECM-Regulator timp Is Required for Stem Cell Niche Organization and Cyst Production in the Drosophila Ovary.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000363827,9606.ENSP00000380365	CDH1,TIMP3,SIRT6,HSPG2,RGN
PMID:26918392	(2016) RES-529: a PI3KAKTmTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.	8	73	1.1	0.00034	9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SREBF1,SGK1,PTEN,AR,BCL2,RHOA,PROM1,VEGFA
PMID:27634756	(2016) RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTEN,AR,BCL2,VEGFA
PMID:27965774	(2016) CXC chemokine superfamily induced by Interferon-gamma in asthma: a cross-sectional observational study.	5	14	1.61	0.00034	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000414303	CXCL10,CXCL11,CCL20,CXCL9,BDNF
PMID:25307081	(2015) Endothelial cells enhance the migration of bovine meniscus cells.	5	14	1.61	0.00034	9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	EDNRA,PDGFB,PDGFA,EDN1,VEGFA
PMID:25446141	(2015) Role of microRNAs in maintaining cancer stem cells.	8	73	1.1	0.00034	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000426809	CD38,SOX9,CDH1,ALDH1A1,CD34,PTGS2,PTEN,PROM1
PMID:25802865	(2015) Characterization of bone marrow mononuclear cells on biomaterials for bone tissue engineering in vitro.	5	14	1.61	0.00034	9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,SERPINF2,BMP2,PROM1,VEGFA
PMID:26498168	(2015) Isolation and characteristics of CD133-A2B5+ and CD133-A2B5- cells from the SHG139s cell line.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,CD34,PROM1,VEGFA
PMID:26612085	(2015) Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,PTGS2,BCL2,BDNF,VEGFA
PMID:23660230	(2014) Differential regulation of BDNF, synaptic plasticity and sprouting in the hippocampal mossy fiber pathway of male and female rats.	5	14	1.61	0.00034	9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	AR,NPY,NTF3,BDNF,VEGFA
PMID:24498100	(2014) Trkb signaling in pericytes is required for cardiac microvessel stabilization.	5	14	1.61	0.00034	9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PDGFB,HSPG2,RHOA,BDNF,VEGFA
PMID:24524446	(2014) Pathogenesis and prevention of intraventricular hemorrhage.	5	14	1.61	0.00034	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000365777,9606.ENSP00000478570	ANGPT2,PDGFB,HSPG2,MTHFR,VEGFA
PMID:24528626	(2014) Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.	8	73	1.1	0.00034	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,IGF1R,PRKCE,SGK1,EDN1,BCL2,RHOA,VEGFA
PMID:24608803	(2014) Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension.	5	14	1.61	0.00034	9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	EDN1,FGFR1,AGTR1,APLNR,VEGFA
PMID:24671264	(2014) High-dimensional single-cell cancer biology.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000426809	IFNG,CD34,STAT5A,BCL2,PROM1
PMID:24700364	(2014) The biliary epithelium gives rise to liver progenitor cells.	5	14	1.61	0.00034	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,ONECUT1,HNF4A,PROM1,HNF1B
PMID:24722571	(2014) Oxidative stress in cardiovascular disease.	5	14	1.61	0.00034	9606.ENSP00000284031,9606.ENSP00000362057,9606.ENSP00000362463,9606.ENSP00000380365,9606.ENSP00000478570	DDAH1,NOX1,GLO1,RGN,VEGFA
PMID:25157370	(2014) Progress in the identification of dengue virus entryfusion inhibitors.	5	14	1.61	0.00034	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000331831	CCR5,CXCL10,CXCL11,CD34,GAS6
PMID:25180681	(2014) CAV1 promotes HCC cell progression and metastasis through Wntbeta-catenin pathway.	5	14	1.61	0.00034	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000478570	CDH1,MMP14,HNF4A,CAV1,VEGFA
PMID:25522391	(2014) Cellular and molecular mechanisms of action of transcranial direct current stimulation: evidence from in vitro and in vivo models.	5	14	1.61	0.00034	9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	PRKCE,PTGS2,GAP43,BDNF,VEGFA
PMID:23859799	(2013) Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy.	5	14	1.61	0.00034	9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000414303	HSPB1,TIMP3,MAP3K5,CNTF,BDNF
PMID:23998913	(2013) Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.	8	73	1.1	0.00034	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PDGFB,STAT5A,PTEN,JAK2,RHOA,PROM1,VEGFA
PMID:24205233	(2013) Augmented dried versus cryopreserved amniotic membrane as an ocular surface dressing.	5	14	1.61	0.00034	9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CNTF,NTF3,BDNF,CCL5,VEGFA
PMID:21945521	(2012) Redox modification of cell signaling in the cardiovascular system.	5	14	1.61	0.00034	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000414303	NOX4,MAP3K5,TXN,EDN1,BDNF
PMID:22150570	(2012) Chronic alcohol exposure alters gene expression in HepG2 cells.	8	73	1.1	0.00034	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000401720	TGFB1,IGF1R,SREBF1,EDN1,JAK2,NFE2L2,FGFR1,GK
PMID:22210636	(2012) Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.	5	14	1.61	0.00034	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IFNG,CCL5,VEGFA
PMID:22570603	(2012) Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study.	5	14	1.61	0.00034	9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	MMP14,ANGPT2,ELN,EDN1,VEGFA
PMID:22593752	(2012) Preclinical models to investigate retinal ischemia: advances and drawbacks.	5	14	1.61	0.00034	9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,TXN,EDN1,BDNF,VEGFA
PMID:22815815	(2012) Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384364	IFNG,CXCL10,CXCL11,CXCL9,NPY
PMID:22954171	(2012) Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.	5	14	1.61	0.00034	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CD34,EDN1,JAK2,VEGFA
PMID:23060792	(2012) The role of the neuro-astro-vascular unit in the etiology of ataxia telangiectasia.	5	14	1.61	0.00034	9606.ENSP00000278616,9606.ENSP00000315011,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ATM,EDNRA,NTF3,BDNF,VEGFA
PMID:23272142	(2012) Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c.	5	14	1.61	0.00034	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000400175	ENPP2,CDH1,EDNRA,EDN1,RHOA
PMID:21274647	(2011) HIV-1 Tat-mediated neurotoxicity in retinal cells.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:21896157	(2011) Polymicrobial periodontal pathogen transcriptomes in calvarial bone and soft tissue.	8	73	1.1	0.00034	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906	TGFB1,THBS1,TIMP3,MMP14,FMOD,CCL20,CXCL9,SAA1
PMID:20546613	(2010) Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.	5	14	1.61	0.00034	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000478570	THBS1,CD34,ANG,PTEN,VEGFA
PMID:19249645	(2009) Therapeutic implications of the cancer stem cell hypothesis.	5	14	1.61	0.00034	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000377192	CD38,ALDH1A1,CD34,PTEN,G6PD
PMID:19309513	(2009) Identifying disease-specific genes based on their topological significance in protein networks.	5	14	1.61	0.00034	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067	IFNG,CXCL10,CXCL11,CXCL9,JAK2
PMID:19492418	(2009) Prostate cancer regulatory networks.	5	14	1.61	0.00034	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CD34,AR,EDN1,BCL2,VEGFA
PMID:19923455	(2009) Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.	5	14	1.61	0.00034	9606.ENSP00000215832,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000418525,9606.ENSP00000474412	MAPK1,CXCL9,PTGS2,MME,CCL5
PMID:17702963	(2007) An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke.	5	14	1.61	0.00034	9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	PTGS2,NPY,BDNF,AGTR1,VEGFA
PMID:28424744	(....) oxidative stress in retinal diseases.	5	14	1.61	0.00034	9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	SIRT6,MAP3K5,NFE2L2,BDNF,VEGFA
PMID:33960101	(2022) Construction of circRNA-miRNA-mRNA network in the pathogenesis of recurrent implantation failure using integrated bioinformatics study.	6	29	1.38	0.00035	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000478570	MAPK1,CXCL10,CXCL11,PTGS2,AR,VEGFA
PMID:34963058	(2022) The imprinted Igf2-Igf2r axis is critical for matching placental microvasculature expansion to fetal growth.	7	49	1.22	0.00035	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,IGF1R,CXCL10,CD34,ANGPT2,EDN1,VEGFA
PMID:35008966	(2022) Mast Cells Differentiated in Synovial Fluid and Resident in Osteophytes Exalt the Inflammatory Pathology of Osteoarthritis.	7	49	1.22	0.00035	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000368104,9606.ENSP00000383364	SOX9,CXCL10,CXCL11,CXCL9,S100A12,BMP2,PLA2G2A
PMID:35059992	(2022) Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.	9	102	1.01	0.00035	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,SOX9,TIMP3,ATM,CXCL11,CD34,PTEN,FGFR1,VEGFA
PMID:35135866	(2022) Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000478570	MAPK1,CD38,CD47,PTGS2,ENTPD1,PTEN,VEGFA
PMID:35205842	(2022) Glioblastoma Microenvironment and Cellular Interactions.	9	102	1.01	0.00035	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	MPO,CDH1,ALDH1A1,MMP14,HNF4A,CD47,RHOA,PROM1,VEGFA
PMID:35206286	(2022) Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.	7	49	1.22	0.00035	9606.ENSP00000268035,9606.ENSP00000360522,9606.ENSP00000368104,9606.ENSP00000369816,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000478319	IGF1R,RBP4,BMP2,SHBG,NPY,RARRES2,GREM1
PMID:35223493	(2022) Tertiary Lymphoid Structures and Chemokine Landscape in Virus-Positive and Virus-Negative Merkel Cell Carcinoma.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,PTGS2,G6PD,CCL5
PMID:35277461	(2022) Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ATM,CXCL10,CXCL9,AR,CCL5,VEGFA
PMID:35281084	(2022) Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering.	6	29	1.38	0.00035	9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478570	CD34,ENTPD1,BMP2,EDN1,MME,VEGFA
PMID:35327322	(2022) Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity.	7	49	1.22	0.00035	9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	TXN,EDN1,KL,NFE2L2,BCL2,MME,VEGFA
PMID:35421091	(2022) Network pharmacology and in vitro testing of Theobroma cacao extracts antioxidative activity and its effects on cancer cell survival.	6	29	1.38	0.00035	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000336762,9606.ENSP00000383364,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,EDNRA,ANG,PLA2G2A,FGFR1,VEGFA
PMID:33413329	(2021) Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.	6	29	1.38	0.00035	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399	MAPK1,CXCL10,PDGFB,PTGS2,JAK2,MYD88
PMID:33436065	(2021) Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD).	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,TGFB1,MPO,CD34,PTGS2,CCL5,VEGFA
PMID:33505474	(2021) An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CXCL9,PTEN,BCL2,CCL5,VEGFA
PMID:33510842	(2021) Hydrogen Gas: A Novel Type of Antioxidant in Modulating Sexual Organs Homeostasis.	6	29	1.38	0.00035	9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	PTGS2,EDN1,NFE2L2,BCL2,RHOA,VEGFA
PMID:33540711	(2021) Inflammatory Response Mechanisms of the Dentine-Pulp Complex and the Periapical Tissues.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,BMP2,NPY,BDNF,CCL5,VEGFA
PMID:33544228	(2021) The links between diabetes mellitus and amyotrophic lateral sclerosis.	6	29	1.38	0.00035	9606.ENSP00000226760,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000345708,9606.ENSP00000360522,9606.ENSP00000375844	WFS1,HNF4A,SIRT6,KCNJ11,RBP4,CAPN10
PMID:33717128	(2021) The Immunopathology of Giant Cell Arteritis Across Disease Spectra.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,ELN,CXCL9,EDN1,VEGFA
PMID:33777158	(2021) Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine.	7	49	1.22	0.00035	9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000393312	LPL,STAT5A,RBP4,EDN1,SHBG,JAK2,FGFR1
PMID:33833895	(2021) Biological and Therapeutic Effects of Troxerutin: Molecular Signaling Pathways Come into View.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	IFNG,PTGS2,PTEN,TXN,G6PD,NFE2L2,BCL2
PMID:33842835	(2021) Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.	7	49	1.22	0.00035	9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	VIP,PTEN,AR,BCL2,NPY,RHOA,VEGFA
PMID:33843223	(2021) GPR120FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000246553,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	IFNG,FFAR1,SREBF1,PTGS2,BCL2,NPY,VEGFA
PMID:33867892	(2021) Possible Potential Effects of Honey and Its Main Components Against Covid-19 Infection.	6	29	1.38	0.00035	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	CD38,IFNG,PTGS2,NFE2L2,BCL2,CCL5
PMID:33918941	(2021) Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:33953710	(2021) Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.	7	49	1.22	0.00035	9606.ENSP00000228434,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CD69,ANG,STAT5A,ENTPD1,RARRES2,CCL5,VEGFA
PMID:34064579	(2021) Metabolic Reprogramming: Strategy for Ischemic Stroke Treatment by Ischemic Preconditioning.	6	29	1.38	0.00035	9606.ENSP00000200676,9606.ENSP00000222572,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000377192	CETP,PON2,PTGS2,TXN,MTHFR,G6PD
PMID:34084749	(2021) Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CD34,JAK2,CCL5,VEGFA
PMID:34095095	(2021) Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration.	7	49	1.22	0.00035	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000356515,9606.ENSP00000361883,9606.ENSP00000478570	TGFB1,THBS1,IGF1R,CD34,UTRN,CAP1,VEGFA
PMID:34187362	(2021) Genome wide effects of oleic acid on cultured bovine granulosa cells: evidence for the activation of pathways favoring folliculo-luteal transition.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683	TGFB1,SOX9,ALDH1A1,EDNRA,PTGS2,EDN1
PMID:34261470	(2021) Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000293599,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,AQP5,ELN,PTEN,BCL2,MYD88,VEGFA
PMID:34277453	(2021) Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling.	7	49	1.22	0.00035	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000474412	NOX4,PTEN,TXN,NFE2L2,BCL2,AGTR1,CCL5
PMID:34466409	(2021) Molecular Targets of Ferroptosis in Hepatocellular Carcinoma.	7	49	1.22	0.00035	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,HSPB1,SREBF1,PTGS2,NFE2L2,PROM1,VEGFA
PMID:34502043	(2021) Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CXCL10,CD34,CXCL9,PTEN,JAK2,BCL2,VEGFA
PMID:34576209	(2021) Mesenchymal StemStromal Cell Therapy in Blood-Brain Barrier Preservation Following Ischemia: Molecular Mechanisms and Prospects.	7	49	1.22	0.00035	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,TIMP3,PTEN,NFE2L2,BCL2,RHOA,VEGFA
PMID:34733464	(2021) Physoxia alters human mesenchymal stem cell secretome.	7	49	1.22	0.00035	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,CD34,ANG,CCL5,VEGFA
PMID:34803375	(2021) A New Strategy for the Rapid Identification and Validation of the Direct Targets of Aconitine-Induced Cardiotoxicity.	6	29	1.38	0.00035	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000403495,9606.ENSP00000478570	MAPK1,TGFB1,PTGS2,PLA2G2A,LTA,VEGFA
PMID:34831726	(2021) Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000321334,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185	MPO,NOX4,ATM,LPA,PTEN,BMP2,BCL2
PMID:34884550	(2021) Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update.	7	49	1.22	0.00035	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CYP24A1,CDH1,ALDH1A1,JAK2,BCL2,PROM1,VEGFA
PMID:34901070	(2021) Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,BDNF,CCL5,VEGFA
PMID:34909644	(2021) Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,ALDH1A1,PTGS2,NOX1,NFE2L2,BCL2,VEGFA
PMID:35069985	(2021) Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine.	7	49	1.22	0.00035	9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303	ENPP2,CXCL10,CD34,SIRT6,BMP2,BCL2,BDNF
PMID:35096624	(2021) The Emerging Role of Tissue-Resident Memory CD8(+) T Lymphocytes in Human Digestive Tract Cancers.	7	49	1.22	0.00035	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250	CD69,FABP4,CDH1,CXCL10,CXCL11,CXCL9,ENTPD1
PMID:31936853	(2020) Iridoids: Research Advances in Their Phytochemistry, Biological Activities, and Pharmacokinetics.	6	29	1.38	0.00035	9606.ENSP00000268035,9606.ENSP00000345708,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	IGF1R,KCNJ11,GAP43,BCL2,RHOA,BDNF
PMID:31941015	(2020) Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.	7	49	1.22	0.00035	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000419422	CD38,IGF1R,PLIN1,SREBF1,AR,JAK2,AGTR1
PMID:31983537	(2020) Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth.	7	49	1.22	0.00035	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,PDGFA,CXCL9,JAK2,CCL5,VEGFA
PMID:32111002	(2020) snoRNAs Offer Novel Insight and Promising Perspectives for Lung Cancer Understanding and Management.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000480291	MAPK1,CDH1,IGF1R,ALDH1A1,BCL2,PROM1,HNF1B
PMID:32194856	(2020) An evolving paradigm of cancer stem cell hierarchies: therapeutic implications.	7	49	1.22	0.00035	9606.ENSP00000255409,9606.ENSP00000297785,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CHI3L1,ALDH1A1,BMP2,JAK2,PROM1,GREM1,VEGFA
PMID:32243381	(2020) Cell-Block cytology in diagnosis of primary central nervous system lymphoma: A case report.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000418525	MPO,ATM,CD34,PTEN,JAK2,MYD88,MME
PMID:32267550	(2020) Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism.	6	29	1.38	0.00035	9606.ENSP00000265333,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000414303	VDAC1,ALDH1A1,SREBF1,CXCL9,BCL2,BDNF
PMID:32290082	(2020) Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.	7	49	1.22	0.00035	9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000358513,9606.ENSP00000474412	LPL,APOL1,LPA,SREBF1,ABCG1,CNR1,CCL5
PMID:32290431	(2020) Effects of Oxidative Stress on Protein Translation: Implications for Cardiovascular Diseases.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,PTEN,NOX1,TXN,BCL2,VEGFA
PMID:32325892	(2020) Both Human Hematoma Punctured from Pelvic Fractures and Serum Increase Muscle Resident Stem Cells Response to BMP9: A Multivariate Statistical Approach.	6	29	1.38	0.00035	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CD34,ANGPT2,BMP2,BDNF,VEGFA
PMID:32358507	(2020) Effective combinatorial immunotherapy for penile squamous cell carcinoma.	7	49	1.22	0.00035	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822	CDH1,IGF1R,HNF4A,CCL20,PTGS2,PTEN,AR
PMID:32409632	(2020) Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,SGK1,PTEN,AR,G6PD,BCL2,FGFR1
PMID:32498325	(2020) Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,SOX9,CXCL10,MMP14,AR,BCL2,VEGFA
PMID:32531951	(2020) Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells.	6	29	1.38	0.00035	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,AR,PROM1,VEGFA
PMID:32547552	(2020) Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles.	7	49	1.22	0.00035	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CCL20,MYD88,CCL5,VEGFA
PMID:32663498	(2020) Composition, structure and function of the corneal stroma.	6	29	1.38	0.00035	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478570	THBS1,CD34,FMOD,ELN,HSPG2,VEGFA
PMID:32666137	(2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.	6	29	1.38	0.00035	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000360997,9606.ENSP00000390651,9606.ENSP00000401399	MPO,CD38,CD69,ADAMTS13,IRAK4,MYD88
PMID:32764978	(2020) HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity.	7	49	1.22	0.00035	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,CXCL11,BCL2,MYD88,CCL5,VEGFA
PMID:32824407	(2020) Evolution of the Experimental Models of Cholangiocarcinoma.	7	49	1.22	0.00035	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,ALDH1A1,ELN,PTEN,BCL2,PROM1,VEGFA
PMID:32832649	(2020) Beyond the cell factory: Homeostatic regulation of and by the UPR(ER).	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000366395,9606.ENSP00000380252,9606.ENSP00000381185	IFNG,PLIN1,SREBF1,MAP3K5,SYVN1,NFE2L2,BCL2
PMID:32855752	(2020) Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects.	7	49	1.22	0.00035	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,BCL2,NPY,MME,CCL5,VEGFA
PMID:32872203	(2020) Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1beta and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,STAT5A,CXCL9,JAK2,CCL5,VEGFA
PMID:32899709	(2020) An Extra Breath of Fresh Air: Hyperbaric Oxygenation as a Stroke Therapeutic.	7	49	1.22	0.00035	9606.ENSP00000298352,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	NGB,PTGS2,TXN,G6PD,BCL2,BDNF,VEGFA
PMID:32906784	(2020) The Beneficial Effects of Morusin, an Isoprene Flavonoid Isolated from the Root Bark of Morus.	7	49	1.22	0.00035	9606.ENSP00000265333,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	VDAC1,ALDH1A1,PLIN1,PTGS2,BCL2,CCL5,VEGFA
PMID:32916794	(2020) Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics.	7	49	1.22	0.00035	9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422	SIRT6,NOX1,BMP2,KL,NFE2L2,BCL2,AGTR1
PMID:32999709	(2020) Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension.	7	49	1.22	0.00035	9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000475344,9606.ENSP00000478570	COMT,PTGS2,NOX1,EDN1,RHOA,APLNR,VEGFA
PMID:33061569	(2020) Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites.	6	29	1.38	0.00035	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,CXCL10,CXCL9,PTGS2,MYD88,CCL5
PMID:33062143	(2020) The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms.	7	49	1.22	0.00035	9606.ENSP00000228434,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000401399	CD69,NOX4,CXCL10,EDNRA,EDN1,JAK2,MYD88
PMID:33076918	(2020) Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.	6	29	1.38	0.00035	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252	CXCL10,CXCL11,ELN,CXCL9,PTGS2,NFE2L2
PMID:33082511	(2020) Formyl peptide receptors in the mucosal immune system.	7	49	1.22	0.00035	9606.ENSP00000248553,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000384906,9606.ENSP00000478570	HSPB1,CCL20,PTGS2,PTEN,NOX1,SAA1,VEGFA
PMID:33092220	(2020) Microglia in Prion Diseases: Angels or Demons?	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,BDNF,CCL5
PMID:33121114	(2020) Effects of Human Endothelial Progenitor Cell and Its Conditioned Medium on Oocyte Development and Subsequent Embryo Development.	6	29	1.38	0.00035	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,IGF1R,PTGS2,BCL2,PROM1,VEGFA
PMID:33133058	(2020) Cluster Analysis of Dry Eye Disease Models Based on Immune Cell Parameters - New Insight Into Therapeutic Perspective.	7	49	1.22	0.00035	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399	CD69,THBS1,CCR5,CXCL10,CCL20,CXCL9,MYD88
PMID:33193355	(2020) Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.	6	29	1.38	0.00035	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185	CD38,CXCL10,CXCL11,STAT5A,CXCL9,BCL2
PMID:33202575	(2020) Health Effects of Grape Seed and Skin Extracts and Their Influence on Biochemical Markers.	6	29	1.38	0.00035	9606.ENSP00000200676,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185	CETP,SREBF1,PTGS2,EDN1,NFE2L2,BCL2
PMID:33317050	(2020) Adiponectin in Chronic Kidney Disease.	7	49	1.22	0.00035	9606.ENSP00000263317,9606.ENSP00000288266,9606.ENSP00000348069,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000474412	NOX4,APPL1,SREBF1,KL,JAK2,NPY,CCL5
PMID:33329752	(2020) In silico Prediction of miRNA Interactions With Candidate Atherosclerosis Gene mRNAs.	7	49	1.22	0.00035	9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000314897,9606.ENSP00000317674,9606.ENSP00000331831,9606.ENSP00000365777,9606.ENSP00000380252	IGF1R,FADS2,ANGPT2,APOL1,GAS6,MTHFR,NFE2L2
PMID:33335095	(2020) Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.	9	102	1.01	0.00035	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185	CD38,FABP4,ATM,CD34,GAS6,STAT5A,CD47,JAK2,BCL2
PMID:33374952	(2020) The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CAV1,PTGS2,BCL2,BDNF,VEGFA
PMID:33376724	(2020) Pathway Maps of Orphan and Complex Diseases Using an Integrative Computational Approach.	6	29	1.38	0.00035	9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000393312	ATM,PTGS2,PTEN,MTHFR,BCL2,FGFR1
PMID:33396584	(2020) Markers Associated with COVID-19 Susceptibility, Resistance, and Severity.	6	29	1.38	0.00035	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000384906,9606.ENSP00000483018	CD69,IFNG,CXCL10,CCL20,SAA1,ABO
PMID:30592976	(2019) Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury.	7	49	1.22	0.00035	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,IGF1R,CXCL10,CXCL9,PTEN,CCL5,VEGFA
PMID:30605676	(2019) Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD.	7	49	1.22	0.00035	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000418009	NOX4,CXCL10,CAV1,SREBF1,CXCL9,SAA1,RARRES2
PMID:31050207	(2019) The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.	6	29	1.38	0.00035	9606.ENSP00000225275,9606.ENSP00000265132,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	MPO,AMBP,CD247,BCL2,MME,VEGFA
PMID:31159859	(2019) Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,CD34,PDGFA,PTEN,BCL2,VEGFA
PMID:31191805	(2019) Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases.	6	29	1.38	0.00035	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000368683,9606.ENSP00000371067	NOX4,NOX1,TXN,MTHFR,EDN1,JAK2
PMID:31652503	(2019) Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells.	7	49	1.22	0.00035	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000380252	TGFB1,CDH1,PDGFB,SIRT6,SREBF1,TXN,NFE2L2
PMID:31847428	(2019) The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,PTGS2,CCL5
PMID:31920963	(2019) Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes.	6	29	1.38	0.00035	9606.ENSP00000315011,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	EDNRA,CNTF,PTGS2,EDN1,BDNF,VEGFA
PMID:28736792	(2018) Double-Injected Human Stem Cells Enhance Rehabilitation in TBI Mice Via Modulation of Survival and Inflammation.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,BCL2,BDNF,CCL5,VEGFA
PMID:29310800	(2018) Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.	9	102	1.01	0.00035	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363827,9606.ENSP00000365777,9606.ENSP00000478570	CDH1,TIMP3,MMP14,ANG,ELN,NOX1,HSPG2,MTHFR,VEGFA
PMID:29346311	(2018) Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer.	7	49	1.22	0.00035	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ATM,PTEN,AR,NFE2L2,BCL2,PROM1
PMID:29397935	(2018) The dichotomous role of H2S in cancer cell biology? Deja vu all over again.	7	49	1.22	0.00035	9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CAV1,PTEN,TXN,NFE2L2,BCL2,RHOA,VEGFA
PMID:29448962	(2018) Non-viral gene delivery systems for tissue repair and regeneration.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,SOX9,PDGFB,FMOD,BMP2,VEGFA
PMID:29739970	(2018) Identifying microRNA determinants of human myelopoiesis.	7	49	1.22	0.00035	9606.ENSP00000222305,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809	USF2,CD38,IFNG,CD34,BCL2,MME,PROM1
PMID:29868027	(2018) Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity.	6	29	1.38	0.00035	9606.ENSP00000263317,9606.ENSP00000360250,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185	NOX4,ENTPD1,NOX1,TXN,G6PD,BCL2
PMID:29967585	(2018) A Rising Star in Pancreatic Diseases: Pancreatic Stellate Cells.	7	49	1.22	0.00035	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000419313,9606.ENSP00000426809	THBS1,CDH1,CD34,PTEN,MME,TRPC1,PROM1
PMID:29967760	(2018) Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.	6	29	1.38	0.00035	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000362057	CD38,THBS1,NOX4,AMBP,CD34,NOX1
PMID:30091812	(2018) Assessing recrudescence of photoregressed Siberian hamster ovaries using in vitro whole ovary culture.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,ANGPT2,PTGS2,NTF3,BDNF,VEGFA
PMID:30185627	(2018) A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.	7	49	1.22	0.00035	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	CD38,AMBP,CD34,PTEN,JAK2,BCL2,MYD88
PMID:30210493	(2018) The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30323661	(2018) Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I-III patients with colorectal cancer after operation.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30328953	(2018) Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis.	7	49	1.22	0.00035	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,IGF1R,CD34,STAT5A,PTEN,JAK2,BCL2
PMID:30524653	(2018) Biological Effects of Tetrahydroxystilbene Glucoside: An Active Component of a Rhizome Extracted from Polygonum multiflorum.	7	49	1.22	0.00035	9606.ENSP00000221930,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,ABCG1,PTGS2,KL,BCL2,BDNF,VEGFA
PMID:27084354	(2017) HIVneuroAIDS biomarkers.	6	29	1.38	0.00035	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000414303,9606.ENSP00000418525	CD69,IFNG,CHI3L1,CXCL10,BDNF,MME
PMID:27890867	(2017) Obesity-Related Digestive Diseases and Their Pathophysiology.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,RBP4,JAK2,RARRES2,CCL5,VEGFA
PMID:28401256	(2017) Immune-mediated cytokine storm and its role in severe dengue.	6	29	1.38	0.00035	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000474412	CD38,CD69,CXCL10,CXCL11,ANGPT2,CCL5
PMID:28525507	(2017) Subcellular Energetics and Metabolism: A Cross-Species Framework.	6	29	1.38	0.00035	9606.ENSP00000298352,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	NGB,ANGPT2,PDGFB,BCL2,BDNF,VEGFA
PMID:28616250	(2017) Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000380365,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,AMBP,VDAC1,RGN,AGTR1,VEGFA
PMID:28618138	(2017) Expansion of Umbilical Cord Blood Aldehyde Dehydrogenase Expressing Cells Generates Myeloid Progenitor Cells that Stimulate Limb Revascularization.	6	29	1.38	0.00035	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CD34,ANGPT2,PROM1,CCL5,VEGFA
PMID:28642578	(2017) Human endothelial cells secrete neurotropic factors to direct axonal growth of peripheral nerves.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CXCL10,CCL20,NTF3,BDNF,VEGFA
PMID:28819419	(2017) Osteopontin -- a promising biomarker for cancer therapy.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,IFNG,CDH1,HNF4A,BCL2,CCL5,VEGFA
PMID:28955330	(2017) Perturbation of B Cell Gene Expression Persists in HIV-Infected Children Despite Effective Antiretroviral Therapy and Predicts H1N1 Response.	7	49	1.22	0.00035	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,CD69,CAV1,STAT5A,BCL2,MYD88,MME
PMID:29050279	(2017) SSeCKSAKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL910 secretion by resident fibroblasts.	7	49	1.22	0.00035	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	ATM,CXCL10,CXCL11,STAT5A,CXCL9,PTEN,VEGFA
PMID:29075193	(2017) Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed.	6	29	1.38	0.00035	9606.ENSP00000225275,9606.ENSP00000284031,9606.ENSP00000337332,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000363822	MPO,DDAH1,SIRT6,ABCG1,PTGS2,AR
PMID:29430083	(2017) Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.	7	49	1.22	0.00035	9606.ENSP00000259486,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000478570	ENPP2,ALDH1A1,STAT5A,PTGS2,PLA2G2A,RHOA,VEGFA
PMID:26300002	(2016) Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.	6	29	1.38	0.00035	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	SOX9,APC,ALDH1A1,PTGS2,PTEN,BCL2
PMID:26891293	(2016) Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer.	6	29	1.38	0.00035	9606.ENSP00000227868,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000478570	PDHX,CDH1,IGF1R,ATM,BCL2,VEGFA
PMID:26905303	(2016) Repair of liver mediated by adult mouse liver neuro-glia antigen 2-positive progenitor cell transplantation in a mouse model of cirrhosis.	6	29	1.38	0.00035	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,ONECUT1,CD34,HNF4A,PROM1,HNF1B
PMID:27126646	(2016) Systems Analysis of Thrombus Formation.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000304767,9606.ENSP00000331831,9606.ENSP00000384957,9606.ENSP00000400175	IFNG,THBS1,P2RY1,GAS6,F11,RHOA
PMID:27659519	(2016) Profiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000349860,9606.ENSP00000356832,9606.ENSP00000381185	MAPK1,CDH1,IGF1R,PRKCE,GFPT1,SGK1,BCL2
PMID:27829982	(2016) New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000403495	MPO,PTGS2,NOX1,TXN,KL,NFE2L2,LTA
PMID:27879287	(2016) Tissue-specific programming of memory CD8 T cell subsets impacts protection against lethal respiratory virus infection.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CD34,CCL20,CXCL9,CCL5
PMID:28053983	(2016) A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives.	6	29	1.38	0.00035	9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,GAP43,NFE2L2,BCL2,BDNF,VEGFA
PMID:25601205	(2015) Endothelial cells control pancreatic cell fate at defined stages through EGFL7 signaling.	6	29	1.38	0.00035	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382	SOX9,CDH1,ONECUT1,HNF4A,ANGPT2,PDGFB
PMID:25671296	(2015) Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.	6	29	1.38	0.00035	9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	AMBP,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:25747479	(2015) CD47-dependent regulation of H2S biosynthesis and signaling in T cells.	7	49	1.22	0.00035	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363641	CD69,IFNG,HSPB1,THBS1,CD47,PTEN,TXN
PMID:25770816	(2015) Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions.	6	29	1.38	0.00035	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	CXCL10,PDGFB,ELN,CXCL9,PTEN,VEGFA
PMID:25860801	(2015) Melanocortins contribute to sequential differentiation and enucleation of human erythroblasts via melanocortin receptors 1, 2 and 5.	6	29	1.38	0.00035	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000400175	MAPK1,EPOR,CD34,STAT5A,JAK2,RHOA
PMID:26085348	(2015) Impact Assessment of Cigarette Smoke Exposure on Organotypic Bronchial Epithelial Tissue Cultures: A Comparison of Mono-Culture and Coculture Model Containing Fibroblasts.	6	29	1.38	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,NFE2L2,CCL5,VEGFA
PMID:26207932	(2015) Differential regulation of pericyte function by the CXC receptor 3.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:26264833	(2015) Controlled release strategies for modulating immune responses to promote tissue regeneration.	7	49	1.22	0.00035	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MPO,CXCL10,ENTPD1,BDNF,CCL5,GREM1,VEGFA
PMID:26300921	(2015) Analysis of the Pro- and Anti-Inflammatory Cytokines Secreted by Adult Stem Cells during Differentiation.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368104	IFNG,FABP4,CXCL10,LPL,CD34,PTGS2,BMP2
PMID:26369565	(2015) Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy.	6	29	1.38	0.00035	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,BCL2,RHOA,PROM1,VEGFA
PMID:26510617	(2015) HIF-2alpha-induced chemokines stimulate motility of fibroblast-like synoviocytes and chondrocytes into the cartilage-pannus interface in experimental rheumatoid arthritis mouse models.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:26525644	(2015) Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest.	7	49	1.22	0.00035	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,MMP14,CXCL9,JAK2,CCL5,VEGFA
PMID:26594215	(2015) The Ins and Outs of B Cells in Multiple Sclerosis.	6	29	1.38	0.00035	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000403495	CD38,CCR5,CXCL10,CCL20,BCL2,LTA
PMID:26664893	(2015) Accentuating and Opposing Factors Leading to Development of Thoracic Aortic Aneurysms Not Due to Genetic or Inherited Conditions.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000400175	CXCL10,CXCL11,MMP14,ELN,CXCL9,S100A12,RHOA
PMID:24439810	(2014) The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000426809	IFNG,SOX9,CD34,HNF4A,PTGS2,LTA,PROM1
PMID:24516581	(2014) Growth factor priming differentially modulates components of the extracellular matrix proteome in chondrocytes and synovium-derived stem cells.	7	49	1.22	0.00035	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104	TGFB1,HSPB1,THBS1,CD34,FMOD,ELN,BMP2
PMID:24654626	(2014) Neutropenia during HIV infection: adverse consequences and remedies.	6	29	1.38	0.00035	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000474412	MPO,CD38,CCR5,CD34,STAT5A,CCL5
PMID:25050322	(2014) Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.	6	29	1.38	0.00035	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTEN,MYD88,PROM1,VEGFA
PMID:25247155	(2014) Microarray Analysis of Gene Expression Reveals that Cyclo-oxygenase-2 Gene Therapy Up-regulates Hematopoiesis and Down-regulates Inflammation During Endochondral Bone Fracture Healing.	6	29	1.38	0.00035	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,CXCL10,CXCL9,PTGS2,BMP2,VEGFA
PMID:25347773	(2014) Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy.	6	29	1.38	0.00035	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,PTEN,BCL2,BDNF,VEGFA
PMID:25480554	(2014) Chemokines in cancer.	7	49	1.22	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,BCL2,CCL5,VEGFA
PMID:22445908	(2013) Pancreatic cancer stem cells: emerging target for designing novel therapy.	7	49	1.22	0.00035	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,HNF4A,BCL2,PROM1
PMID:23106593	(2013) Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,PTGS2,BCL2,CCL5
PMID:23509802	(2013) Ovarian cancer stem cells: a new target for cancer therapy.	6	29	1.38	0.00035	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000444198,9606.ENSP00000474412	CDH1,ALDH1A1,CD34,PROM1,CITED2,CCL5
PMID:23571738	(2013) miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.	6	29	1.38	0.00035	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000363822,9606.ENSP00000368683	CDH1,IGF1R,PDGFA,CCL20,AR,EDN1
PMID:23799363	(2013) Hormesis in aging and neurodegeneration-a prodigy awaiting dissection.	6	29	1.38	0.00035	9606.ENSP00000248553,9606.ENSP00000298352,9606.ENSP00000337332,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	HSPB1,NGB,SIRT6,NFE2L2,BCL2,BDNF
PMID:24057238	(2013) Susceptibility gene search for nephropathy and related traits in Mexican-Americans.	6	29	1.38	0.00035	9606.ENSP00000216181,9606.ENSP00000222572,9606.ENSP00000312987,9606.ENSP00000317674,9606.ENSP00000419422,9606.ENSP00000478319	MYH9,PON2,HNF4A,APOL1,AGTR1,GREM1
PMID:24168184	(2013) Regulation of EMT by KLF4 in gastrointestinal cancer.	7	49	1.22	0.00035	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,APC,CDH1,HNF4A,EDN1,RHOA,VEGFA
PMID:24210793	(2013) GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	CCR5,CXCL10,JAK2,BCL2,BDNF,CCL5
PMID:25984323	(2013) Restoration versus reconstruction: cellular mechanisms of skin, nerve and muscle regeneration compared.	6	29	1.38	0.00035	9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,ELN,CNTF,NTF3,BDNF,VEGFA
PMID:22649567	(2012) Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA.	7	49	1.22	0.00035	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,BCL2,LTA,AGTR1,CCL5
PMID:22928087	(2012) Regulation of ROS production and vascular function by carbon monoxide.	7	49	1.22	0.00035	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,CAV1,NOX1,TXN,BCL2,MYD88,VEGFA
PMID:23034637	(2012) Age-related changes in expression and function of Toll-like receptors in human skin.	7	49	1.22	0.00035	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,EDN1,MYD88,VEGFA
PMID:23120745	(2012) Integrins and p53 pathways in glioblastoma resistance to temozolomide.	6	29	1.38	0.00035	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,CAV1,PTEN,BCL2,FGFR1,VEGFA
PMID:23129956	(2012) MicroRNAs as newer therapeutic targets: A big hope from a tiny player.	7	49	1.22	0.00035	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,TGFB1,IGF1R,MAPK7,PTEN,BCL2,VEGFA
PMID:20936110	(2011) Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance.	7	49	1.22	0.00035	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,CD34,HNF4A,CAV1,BCL2,PROM1
PMID:21110043	(2011) Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.	6	29	1.38	0.00035	9606.ENSP00000216181,9606.ENSP00000317674,9606.ENSP00000352264,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000426809	MYH9,APOL1,CD2AP,HSPG2,RHOA,PROM1
PMID:21150694	(2011) Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation.	6	29	1.38	0.00035	9606.ENSP00000225275,9606.ENSP00000306884,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL11,SAA1,LTA,CCL5,VEGFA
PMID:21672282	(2011) Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.	7	49	1.22	0.00035	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,CCR5,ALDH1A1,HNF4A,PTEN,PROM1,CCL5
PMID:21691304	(2011) Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?	7	49	1.22	0.00035	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000393312	SOX9,CDH1,MMP14,PTEN,AR,PDGFD,FGFR1
PMID:21712022	(2011) Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice.	6	29	1.38	0.00035	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,IRAK4,MYD88,CCL5,VEGFA
PMID:21747703	(2011) Sulfotyrosine recognition as marker for druggable sites in the extracellular space.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:21946665	(2011) Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.	6	29	1.38	0.00035	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067	CD38,CD34,ANGPT2,STAT5A,ELN,JAK2
PMID:22035745	(2011) JAK2 inhibitors: are they the solution?	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	TGFB1,EPOR,CD34,STAT5A,JAK2,VEGFA
PMID:22203846	(2011) Endometriosis gene expression heterogeneity and biosignature: a phylogenetic analysis.	6	29	1.38	0.00035	9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303	CAV1,PTGS2,CNR2,JAK2,RHOA,BDNF
PMID:19717225	(2010) Novel targeted therapeutics for metastatic castration-resistant prostate cancer.	6	29	1.38	0.00035	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,PTEN,AR,EDN1,BCL2,VEGFA
PMID:20427772	(2010) The role of the CCL2CCR2 axis in mouse mast cell migration in vitro and in vivo.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:18548352	(2009) Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,EDNRA,EDN1,NPY,BDNF,VEGFA
PMID:19104910	(2009) Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice.	6	29	1.38	0.00035	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000348069	FABP4,PLIN1,LPL,HNF4A,CAV1,SREBF1
PMID:19267855	(2009) Potential of adipose-derived stem cells for treatment of erectile dysfunction.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000418525	TGFB1,IGF1R,CD34,ANGPT2,BDNF,MME
PMID:19296922	(2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.	6	29	1.38	0.00035	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,IFNG,ANGPT2,BCL2,BDNF,VEGFA
PMID:18232728	(2008) Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.	6	29	1.38	0.00035	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	ANGPT2,PDGFB,PDGFA,PDGFD,FGFR1,VEGFA
PMID:18509496	(2008) Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer.	6	29	1.38	0.00035	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,MAPK7,PTGS2,PTEN,CCL5,VEGFA
PMID:17367501	(2007) Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.	6	29	1.38	0.00035	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000478570	CCR5,CD34,ANGPT2,AR,NPY,VEGFA
PMID:34686988	(2022) Remote but not Distant: a Review on Experimental Models and Clinical Trials in Remote Ischemic Conditioning as Potential Therapy in Ischemic Stroke.	8	74	1.09	0.00036	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000298352,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	MPO,HSPB1,NGB,PTEN,GAP43,NFE2L2,BCL2,BDNF
PMID:35055149	(2022) Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging.	8	74	1.09	0.00036	9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000384906,9606.ENSP00000419422,9606.ENSP00000478570	SIRT6,ELN,PTGS2,EDN1,KL,SAA1,AGTR1,VEGFA
PMID:35433477	(2022) Integrative Analyses of Circulating mRNA and lncRNA Expression Profile in Plasma of Lung Cancer Patients.	8	74	1.09	0.00036	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000366395,9606.ENSP00000380252,9606.ENSP00000478570	TGFB1,ATM,ERCC4,PTGS2,PTEN,SYVN1,NFE2L2,VEGFA
PMID:32981205	(2021) Cellular senescence in cancer: from mechanisms to detection.	8	74	1.09	0.00036	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000478570	THBS1,CDH1,ATM,CD47,PTEN,BCL2,RARRES2,VEGFA
PMID:33800000	(2021) Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.	8	74	1.09	0.00036	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,CD34,STAT5A,AR,BCL2,VEGFA
PMID:33865984	(2021) A single cell atlas of human cornea that defines its development, limbal progenitor cells and their interactions with the immune cells.	10	135	0.93	0.00036	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,COL8A1,TIMP3,CD34,BMP2,SAA1,BDNF,CCL5,VEGFA
PMID:33883002	(2021) Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.	8	74	1.09	0.00036	9606.ENSP00000263317,9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000380252	NOX4,ANG,SIRT6,PTEN,ANGPTL2,KL,JAK2,NFE2L2
PMID:33995422	(2021) Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.	8	74	1.09	0.00036	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	TGFB1,CD69,CCR5,CXCL10,CD34,CXCL9,ENTPD1,CCL5
PMID:34178692	(2021) Tumor-Associated Macrophages: A Potential Target for Cancer Therapy.	8	74	1.09	0.00036	9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	MAPK7,ANGPT2,CCL20,CD247,CD47,PTGS2,JAK2,VEGFA
PMID:34228239	(2021) CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.	8	74	1.09	0.00036	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,CDH1,TIMP3,IGF1R,ANGPT2,CCL20,BMP2,VEGFA
PMID:34262673	(2021) Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.	8	74	1.09	0.00036	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000360997	MPO,CHI3L1,AMBP,CXCL10,CXCL11,CXCL9,S100A12,ADAMTS13
PMID:34660589	(2021) The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications.	8	74	1.09	0.00036	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478319,9606.ENSP00000478570	IGF1R,CD34,MAPK7,PTEN,MYD88,MME,GREM1,VEGFA
PMID:34876936	(2021) Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.	8	74	1.09	0.00036	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000383364,9606.ENSP00000474412	IFNG,HSPB1,CXCL10,CXCL11,CXCL9,VIP,PLA2G2A,CCL5
PMID:32462405	(2020) Heparanase, cell signaling, and viral infections.	8	74	1.09	0.00036	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000384262,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,CXCL10,PTEN,HSPG2,HPSE,IRAK4,MYD88,VEGFA
PMID:32641978	(2020) Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells.	8	74	1.09	0.00036	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,SREBF1,ABCG1,PTEN,JAK2,PROM1
PMID:32752143	(2020) Emerging Roles of Long Non-Coding RNAs in Renal Fibrosis.	8	74	1.09	0.00036	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,CDH1,MAP3K5,SGK1,KL,BCL2,VEGFA,HNF1B
PMID:33149603	(2020) MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications.	8	74	1.09	0.00036	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,HNF4A,ELN,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:33244139	(2020) UBC9 coordinates inflammation affecting development of bladder cancer.	8	74	1.09	0.00036	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,ANG,CCL20,CXCL9,PTGS2,LTA,BDNF,CCL5
PMID:30267742	(2019) Therapeutic strategies for enhancing angiogenesis in wound healing.	8	74	1.09	0.00036	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,ELN,VIP,BMP2,PROM1,VEGFA
PMID:30797519	(2019) Molecular regulation of mammalian hepatic architecture.	8	74	1.09	0.00036	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000478570	TGFB1,SOX9,APC,CDH1,ONECUT1,HNF4A,SREBF1,VEGFA
PMID:31131326	(2019) Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease.	8	74	1.09	0.00036	9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418823	ATM,SIRT6,PDGFA,SREBF1,PTEN,JAK2,BCL2,FTO
PMID:31781488	(2019) The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy.	8	74	1.09	0.00036	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185	IFNG,FABP4,CXCL10,STAT5A,ELN,CXCL9,JAK2,BCL2
PMID:31969876	(2019) Transcriptome Profiling of Bovine Macrophages Infected by Mycobacterium avium spp. paratuberculosis Depicts Foam Cell and Innate Immune Tolerance Phenotypes.	10	135	0.93	0.00036	9606.ENSP00000226279,9606.ENSP00000322898,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412	CD38,EBF1,PDGFB,PDGFA,SREBF1,CCL20,ABCG1,PTGS2,EDN1,CCL5
PMID:30687561	(2018) Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment.	8	74	1.09	0.00036	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399	ERCC1,SOX9,IGF1R,PTEN,JAK2,BCL2,FGFR1,MYD88
PMID:28356139	(2017) Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.	8	74	1.09	0.00036	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,ANGPT2,ELN,PTGS2,PTEN,CCL5,VEGFA
PMID:28752248	(2017) Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?	8	74	1.09	0.00036	9606.ENSP00000215832,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CD69,THBS1,CDH1,IGF1R,ANG,CCL5,VEGFA
PMID:27929432	(2016) Integrins in the Spotlight of Cancer.	8	74	1.09	0.00036	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,CXCL11,ANGPT2,BCL2,FGFR1,RHOA,VEGFA
PMID:26217336	(2015) Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.	8	74	1.09	0.00036	9606.ENSP00000331831,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000393312,9606.ENSP00000419422	GAS6,CNR1,NOX1,BMP2,EDN1,KL,FGFR1,AGTR1
PMID:26215705	(2014) Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach.	10	135	0.93	0.00036	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000346148,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	MAPK1,THBS1,PRKAA1,CD247,CD47,SGK1,PTEN,JAK2,BCL2,CCL5
PMID:24069208	(2013) Identification of multipath genes differentially expressed in pathway-targeted microarrays in zebrafish infected and surviving spring viremia carp virus (SVCV) suggest preventive drug candidates.	8	74	1.09	0.00036	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	MAPK1,IFNG,CXCL10,CXCL11,NTF3,MYD88,BDNF,CCL5
PMID:24416653	(2013) STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.	8	74	1.09	0.00036	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,EPOR,ATM,CD34,EBF1,STAT5A,JAK2,BCL2
PMID:23106210	(2012) Cytokines in radiobiological responses: a review.	8	74	1.09	0.00036	9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000478570	ATM,MAP3K5,CNTF,PTEN,TXN,NFE2L2,MYD88,VEGFA
PMID:21253495	(2011) Pathobiology of hodgkin lymphoma.	8	74	1.09	0.00036	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CCR5,ALDH1A1,CCL20,JAK2,BCL2,MME,CCL5
PMID:21677293	(2011) Monocyte and macrophage dynamics during atherogenesis.	8	74	1.09	0.00036	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL9,ABCG1,JAK2,MYD88,CCL5,VEGFA
PMID:19527773	(2009) ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.	8	74	1.09	0.00036	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354511,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	CDH1,CXCL10,CXCL11,COMT,CXCL9,PTEN,AR,BCL2
PMID:33923108	(2021) The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.	9	103	1.0	0.00037	9606.ENSP00000222572,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000403495	PON2,THBS1,CDH1,NOX4,CXCL10,CXCL9,PTGS2,BCL2,LTA
PMID:34357048	(2021) Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review.	9	103	1.0	0.00037	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000384957,9606.ENSP00000426809,9606.ENSP00000478570	MPO,CD34,ANGPT2,ANG,EDN1,JAK2,F11,PROM1,VEGFA
PMID:35008832	(2021) Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics.	9	103	1.0	0.00037	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,CD247,CXCL9,CD47,BCL2,MME,CCL5,VEGFA
PMID:33747899	(2020) Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response.	9	103	1.0	0.00037	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	ATM,CD34,ANGPT2,GAS6,CCL20,PTEN,AR,EDN1,VEGFA
PMID:31817676	(2019) Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.	9	103	1.0	0.00037	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,IGF1R,SIRT6,SREBF1,GFPT1,SGK1,PTEN,BCL2,VEGFA
PMID:29862288	(2018) Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7.	9	103	1.0	0.00037	9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354995,9606.ENSP00000356832,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,AMBP,CAV1,SREBF1,CCL20,ABCG1,SGK1,BCL2,VEGFA
PMID:20473358	(2010) Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.	9	103	1.0	0.00037	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	CD38,SOX9,APC,CDH1,AR,BCL2,RHOA,MME,VEGFA
PMID:19262752	(2009) A functional and regulatory network associated with PIP expression in human breast cancer.	9	103	1.0	0.00037	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000477707	TGFB1,IFNG,CCR5,MMP14,HNF4A,STAT5A,AR,BCL2,NR1H3
PMID:34406416	(2021) Transcriptome programs involved in the development and structure of the cerebellum.	10	136	0.93	0.00038	9606.ENSP00000216181,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000418823	MYH9,HSPB1,CDH1,HNF4A,PTEN,BCL2,NPY,FGFR1,BDNF,FTO
PMID:34440265	(2021) Exosomes: Potential Disease Biomarkers and New Therapeutic Targets.	11	172	0.87	0.00038	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	MPO,SOX9,TIMP3,CXCL11,VIP,PTEN,GAP43,BCL2,RHOA,MME,VEGFA
PMID:29199959	(2017) Single-cell transcriptome analysis of avian neural crest migration reveals signatures of invasion and molecular transitions.	10	136	0.93	0.00038	9606.ENSP00000293599,9606.ENSP00000322898,9606.ENSP00000334329,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	AQP5,EBF1,UNC5B,BAMBI,BMP2,EDN1,GAP43,RHOA,BDNF,VEGFA
PMID:34962450	(2022) The attenuation effect of low piperine Piper nigrum extract on doxorubicin-induced toxicity of blood chemical and immunological properties in mammary tumour rats.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:35059465	(2022) A Comparative Study of Gene Expression in Menstrual Blood-Derived Stromal Cells between Endometriosis and Healthy Women.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,BCL2,MME,PROM1,VEGFA
PMID:35147163	(2022) RAS-mediated tumor stress adaptation and the targeting opportunities it presents.	7	50	1.21	0.00039	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTGS2,SGK1,NOX1,NFE2L2,BCL2,VEGFA
PMID:35177125	(2022) Identification of functional pathways for regenerative bioactivity of selected renal cells.	6	30	1.36	0.00039	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000393312	THBS1,TIMP3,ANGPT2,GAS6,PDGFA,FGFR1
PMID:35207558	(2022) The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance.	6	30	1.36	0.00039	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185	HSPB1,CDH1,ATM,SREBF1,PTEN,BCL2
PMID:35250997	(2022) Chemokine-Driven Migration of Pro-Inflammatory CD4(+) T Cells in CNS Autoimmune Disease.	8	75	1.09	0.00039	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2,CCL5
PMID:35407148	(2022) Polyphenols and Their Metabolites in Renal Diseases: An Overview.	6	30	1.36	0.00039	9606.ENSP00000263317,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,JAK2,NFE2L2,BCL2,AGTR1,VEGFA
PMID:35432337	(2022) Donor-Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms.	6	30	1.36	0.00039	9606.ENSP00000315011,9606.ENSP00000317674,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000419422	EDNRA,APOL1,CAV1,HSPG2,EDN1,AGTR1
PMID:31900460	(2021) Inflammation-induced inhibition of chaperone-mediated autophagy maintains the immunosuppressive function of murine mesenchymal stromal cells.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,PTGS2,PTEN,CCL5
PMID:32381570	(2021) Acute myeloid leukemia shapes the bone marrow stromal niche in vivo.	6	30	1.36	0.00039	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000363973	MPO,SOX9,FABP4,PLIN1,LPL,ALPL
PMID:33191170	(2021) Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,JAK2,VEGFA
PMID:33401767	(2021) Colored Corn: An Up-Date on Metabolites Extraction, Health Implication, and Potential Use.	6	30	1.36	0.00039	9606.ENSP00000246553,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	FFAR1,SREBF1,GFPT1,PTGS2,BCL2,VEGFA
PMID:33440689	(2021) Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.	7	50	1.21	0.00039	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,MAPK7,MAP3K5,BCL2,RHOA,VEGFA
PMID:33450900	(2021) Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.	7	50	1.21	0.00039	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	MPO,CHI3L1,CDH1,STAT5A,PTEN,JAK2,PROM1
PMID:33498887	(2021) MSC Based Therapies to Prevent or Treat BPD-A Narrative Review on Advances and Ongoing Challenges.	6	30	1.36	0.00039	9606.ENSP00000225275,9606.ENSP00000293599,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,AQP5,ELN,BCL2,CCL5,VEGFA
PMID:33521688	(2021) COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777	CD38,IFNG,CHI3L1,PTGS2,PTEN,MTHFR
PMID:33525498	(2021) Age-Related Macular Degeneration: Role of Oxidative Stress and Blood Vessels.	7	50	1.21	0.00039	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,TIMP3,PTGS2,NOX1,NFE2L2,BCL2,VEGFA
PMID:33535416	(2021) Melanoma Single-Cell Biology in Experimental and Clinical Settings.	9	104	1.0	0.00039	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000426809	CD38,SOX9,CXCL10,CXCL9,ENTPD1,PTEN,JAK2,FGFR1,PROM1
PMID:33668583	(2021) Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312	IFNG,IGF1R,PTGS2,PTEN,JAK2,FGFR1
PMID:33681216	(2021) Regulation of the Migration of Distinct Dendritic Cell Subsets.	9	104	1.0	0.00039	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ATM,CCR5,CXCL10,CD34,CXCL9,RARRES2,CCL5,VEGFA
PMID:33681228	(2021) Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective.	7	50	1.21	0.00039	9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,CDH1,CD34,AR,BCL2,PROM1,VEGFA
PMID:33717656	(2021) Tumor-intrinsic determinants of immunogenic cell death modalities.	8	75	1.09	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	CXCL10,CXCL11,CXCL9,CD47,ENTPD1,PTEN,BCL2,MYD88
PMID:33777671	(2021) Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.	7	50	1.21	0.00039	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,NOX4,CXCL10,CXCL9,BCL2,PROM1,VEGFA
PMID:33803326	(2021) Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas.	7	50	1.21	0.00039	9606.ENSP00000263317,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,TXN,G6PD,NFE2L2,BCL2,RHOA,VEGFA
PMID:33804765	(2021) Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?	7	50	1.21	0.00039	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384364	CD38,CD69,CXCL10,CNTF,PTGS2,JAK2,NPY
PMID:33805807	(2021) The Vesicular Intelligence Strategy of Blood Cancers.	9	104	1.0	0.00039	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	CD38,CXCL10,CD34,ANGPTL2,JAK2,BCL2,FGFR1,MYD88,VEGFA
PMID:33936109	(2021) Gingiva-Derived Mesenchymal Stem Cells: Potential Application in Tissue Engineering and Regenerative Medicine - A Comprehensive Review.	8	75	1.09	0.00039	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000414303	CD69,SOX9,CD34,PTGS2,ENTPD1,BMP2,GAP43,BDNF
PMID:34054953	(2021) Evaluation of Important Molecular Pathways and Candidate Diagnostic Biomarkers of Noninvasive to Invasive Stages in Gastric Cancer by In Silico Analysis.	6	30	1.36	0.00039	9606.ENSP00000221930,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000478319	TGFB1,COL8A1,CDH1,TIMP3,ELN,GREM1
PMID:34064859	(2021) The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PTGS2,ANGPTL2,AR,CCL5,VEGFA
PMID:34199763	(2021) Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance.	9	104	1.0	0.00039	9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000480291	CDH1,CXCL11,HNF4A,EDNRA,PTEN,AR,EDN1,RHOA,HNF1B
PMID:34200820	(2021) Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.	9	104	1.0	0.00039	9606.ENSP00000256104,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000478253,9606.ENSP00000478570	FABP4,CAV1,SREBF1,PTEN,MTHFR,G6PD,RHOA,MTHFD1L,VEGFA
PMID:34209041	(2021) Achievements and Challenges in Transplantation of Mesenchymal Stem Cells in Otorhinolaryngology.	7	50	1.21	0.00039	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,CD34,PDGFB,ELN,NTF3,BDNF,VEGFA
PMID:34259916	(2021) Cannabinoids in the landscape of cancer.	8	75	1.09	0.00039	9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	PTGS2,CNR1,PTEN,AR,BCL2,RHOA,PROM1,VEGFA
PMID:34271224	(2021) Ileal Derived Organoids From Crohns Disease Patients Show Unique Transcriptomic and Secretomic Signatures.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,CXCL9,CCL5,VEGFA
PMID:34284780	(2021) Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment.	8	75	1.09	0.00039	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,CD34,PTGS2,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:34299272	(2021) Breast Cancer and Anaesthesia: Genetic Influence.	7	50	1.21	0.00039	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,MPO,CDH1,CAV1,PTEN,BCL2,VEGFA
PMID:34358116	(2021) Dietary Effects of Anthocyanins in Human Health: A Comprehensive Review.	7	50	1.21	0.00039	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	TGFB1,EDNRA,PTGS2,EDN1,NFE2L2,BCL2,CCL5
PMID:34359588	(2021) Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade.	8	75	1.09	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,CXCL9,PTEN,PROM1,VEGFA
PMID:34405870	(2021) Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia.	7	50	1.21	0.00039	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000363827,9606.ENSP00000384906,9606.ENSP00000418525	CETP,MPO,CD38,CHI3L1,HSPG2,SAA1,MME
PMID:34444030	(2021) Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans.	7	50	1.21	0.00039	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000346148,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	THBS1,CDH1,EDNRA,PRKAA1,EDN1,NFE2L2,VEGFA
PMID:34445646	(2021) Radiotherapy of High-Grade Gliomas: First Half of 2021 Update with Special Reference to Radiosensitization Studies.	6	30	1.36	0.00039	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809	ATM,CXCL10,MMP14,CD34,PTEN,PROM1
PMID:34480296	(2021) Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis.	7	50	1.21	0.00039	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000478570	TGFB1,HSPB1,AMBP,VDAC1,RBP4,PTEN,VEGFA
PMID:34513596	(2021) Roles of microRNAs in tumorigenesis and metastasis of esophageal squamous cell carcinoma.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,MMP14,STAT5A,PTEN,G6PD,PROM1,VEGFA
PMID:34620838	(2021) Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer.	10	137	0.92	0.00039	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000478570	CCR5,CD34,STAT5A,PRKAA1,CD247,PTGS2,ENTPD1,JAK2,NFE2L2,VEGFA
PMID:34630328	(2021) Expression of Sex Hormone Receptor and Immune Response Genes in Peripheral Blood Mononuclear Cells During the Menstrual Cycle.	6	30	1.36	0.00039	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000403495	TGFB1,IFNG,STAT5A,AR,SHBG,LTA
PMID:34638411	(2021) Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.	8	75	1.09	0.00039	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,ATM,PTEN,BCL2,FGFR1,VEGFA
PMID:34669475	(2021) Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,RARRES2,CCL5,VEGFA
PMID:34680276	(2021) Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes.	8	75	1.09	0.00039	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,CXCL10,MMP14,CD247,PTGS2,CCL5,VEGFA
PMID:34681219	(2021) Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach.	7	50	1.21	0.00039	9606.ENSP00000260356,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,KLF10,CD34,ANGPT2,PTEN,AGTR1,VEGFA
PMID:34707779	(2021) Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?	7	50	1.21	0.00039	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,ATM,SIRT6,NOX1,JAK2,CCL5,VEGFA
PMID:34812408	(2021) Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways.	6	30	1.36	0.00039	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000478570	MAPK1,FABP4,LPL,SREBF1,PTGS2,VEGFA
PMID:34894313	(2021) Patho-mechanisms of the origins of bronchopulmonary dysplasia.	6	30	1.36	0.00039	9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ANGPT2,ELN,MAP3K5,NFE2L2,BCL2,VEGFA
PMID:34909118	(2021) Regulation of the mesenchymal stem cell fate by interleukin-17: Implications in osteogenic differentiation.	9	104	1.0	0.00039	9606.ENSP00000245479,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,KLF10,CD34,MAPK7,PTGS2,BMP2,JAK2,GREM1,VEGFA
PMID:34930441	(2021) Sex differences in the immune response to acute COVID-19 respiratory tract infection.	7	50	1.21	0.00039	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,EDN1,LTA,CCL5,VEGFA
PMID:34940677	(2021) Anti-Inflammatory Mechanisms of Fucoidans to Treat Inflammatory Diseases: A Review.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,CXCL10,CCL20,PTGS2,JAK2,CCL5
PMID:34944829	(2021) The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.	7	50	1.21	0.00039	9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,HNF4A,PTEN,AR,BCL2,PROM1,VEGFA
PMID:35111041	(2021) Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.	7	50	1.21	0.00039	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,NOX4,IGF1R,ANG,JAK2,BDNF,VEGFA
PMID:35116481	(2021) Current research progress in the role of reactive oxygen species in esophageal adenocarcinoma.	6	30	1.36	0.00039	9606.ENSP00000261769,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,NOX1,NFE2L2,BCL2,PROM1,VEGFA
PMID:29879890	(2020) Pathophysiology of Type 2 Diabetes in Children and Adolescents.	6	30	1.36	0.00039	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000418823	WFS1,JAZF1,LPL,HNF4A,KCNJ11,FTO
PMID:31683318	(2020) Mechanotransduction in Liver Diseases.	7	50	1.21	0.00039	9606.ENSP00000259407,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000400175	BAAT,CDH1,HNF4A,PDGFA,ELN,JAK2,RHOA
PMID:32123313	(2020) Gastric cancer: genome damaged by bugs.	7	50	1.21	0.00039	9606.ENSP00000216181,9606.ENSP00000232219,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	MYH9,RBP1,CDH1,PTGS2,PTEN,JAK2,BCL2
PMID:32194860	(2020) PI3KAKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.	6	30	1.36	0.00039	9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000426809	ALDH1A1,CD34,CD47,PTEN,FGFR1,PROM1
PMID:32245498	(2020) The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment.	8	75	1.09	0.00039	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,HNF4A,PTEN,AR,ALPL,BMP2,BCL2,VEGFA
PMID:32256028	(2020) The association between intravitreal ranibizumab therapy and serum cytokine concentrations in patients with diabetic macular edema.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANGPT2,PDGFB,CCL5,VEGFA
PMID:32258104	(2020) Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition.	7	50	1.21	0.00039	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252	APC,CDH1,SIRT6,PTGS2,PTEN,NOX1,NFE2L2
PMID:32325715	(2020) Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis.	6	30	1.36	0.00039	9606.ENSP00000259486,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CXCL9,PTGS2,LTA,CCL5,VEGFA
PMID:32354143	(2020) Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient.	6	30	1.36	0.00039	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:32354170	(2020) Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CD34,BMP2,BCL2,PROM1,VEGFA
PMID:32410111	(2020) MDA-9SynteninSDCBP: new insights into a unique multifunctional scaffold protein.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,MMP14,PTEN,BCL2,RHOA,VEGFA
PMID:32470399	(2020) Molecular Choreography of Acute Exercise.	7	50	1.21	0.00039	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000403495	MPO,FABP4,IGF1R,ADAMTS13,EDN1,SAA1,LTA
PMID:32526973	(2020) Dietary Fat and Cancer-Which Is Good, Which Is Bad, and the Body of Evidence.	8	75	1.09	0.00039	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,FABP4,CDH1,LPL,PTEN,NFE2L2,PROM1,VEGFA
PMID:32544459	(2020) BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment.	8	75	1.09	0.00039	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000360522,9606.ENSP00000418525,9606.ENSP00000480291	CD38,IFNG,CD34,CCL20,S100A12,RBP4,MME,HNF1B
PMID:32547404	(2020) Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,PTGS2,CCL5,VEGFA
PMID:32685936	(2020) Nonalcoholic fatty liver disease and portal hypertension.	6	30	1.36	0.00039	9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000478570	ANGPT2,ELN,EDN1,RHOA,LTA,VEGFA
PMID:32732949	(2020) Molecular and metabolomic changes in the proximal colon of pigs infected with Trichuris suis.	9	104	1.0	0.00039	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000383364	IFNG,CHI3L1,CXCL10,CXCL11,SREBF1,CXCL9,PTGS2,S100A12,PLA2G2A
PMID:32764460	(2020) Emerging Insights on the Biological Impact of Extracellular Vesicle-Associated ncRNAs in Multiple Myeloma.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,ALPL,BCL2,CCL5,VEGFA
PMID:32784680	(2020) Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions.	7	50	1.21	0.00039	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000426809	CD38,IFNG,CDH1,CD34,BCL2,HPSE,PROM1
PMID:32794189	(2020) The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vdelta2(+) gammadelta T cells in the modulation of immune response to tumour?	6	30	1.36	0.00039	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:32818797	(2020) Complex interplay between autophagy and oxidative stress in the development of pulmonary disease.	8	75	1.09	0.00039	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	NOX4,VDAC1,ATM,MAP3K5,NOX1,NFE2L2,BCL2,RHOA
PMID:32899833	(2020) Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System.	7	50	1.21	0.00039	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261037,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000419422	CD38,IFNG,COL8A1,CXCL10,AR,MME,AGTR1
PMID:32923972	(2020) Induced pluripotent stem cell-derived vascular smooth muscle cells.	7	50	1.21	0.00039	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000475344,9606.ENSP00000478570	PDGFB,PDGFA,ELN,EDN1,BDNF,APLNR,VEGFA
PMID:32937891	(2020) The Impact of Herbal Infusion Consumption on Oxidative Stress and Cancer: The Good, the Bad, the Misunderstood.	6	30	1.36	0.00039	9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PTEN,NOX1,NFE2L2,BCL2,BDNF,VEGFA
PMID:32989174	(2020) MAIT cell activation and dynamics associated with COVID-19 disease severity.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671	CD38,CD69,CCR5,CXCL10,CXCL11,CCL20
PMID:32994405	(2020) The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties.	7	50	1.21	0.00039	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000222305,9606.ENSP00000278616,9606.ENSP00000278840,9606.ENSP00000297785,9606.ENSP00000480291	MAPK1,CYP24A1,USF2,ATM,FADS2,ALDH1A1,HNF1B
PMID:33013406	(2020) Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review.	9	104	1.0	0.00039	9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,LPL,PTGS2,BMP2,NFE2L2,BCL2,RHOA,BDNF,VEGFA
PMID:33035434	(2020) Extracellular vesicles: new players in regulating vascular barrier function.	8	75	1.09	0.00039	9606.ENSP00000225275,9606.ENSP00000321853,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,SERPINF2,GAS6,CAV1,RHOA,MYD88,CCL5,VEGFA
PMID:33076306	(2020) Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice.	6	30	1.36	0.00039	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000393312	ERCC1,TGFB1,CXCL10,CXCL9,BCL2,FGFR1
PMID:33132633	(2020) Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,NOX4,HNF4A,PTEN,NOX1,NFE2L2,VEGFA
PMID:33204324	(2020) Novel insights into ferroptosis: Implications for age-related diseases.	7	50	1.21	0.00039	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	ENPP2,CDH1,NOX4,VDAC1,NOX1,TXN,NFE2L2
PMID:33371482	(2020) Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants.	8	75	1.09	0.00039	9606.ENSP00000263317,9606.ENSP00000264717,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000400175	NOX4,GCKR,SIRT6,SREBF1,CYP2J2,PTEN,NOX1,RHOA
PMID:33371511	(2020) Mitochondrial microRNAs: A Putative Role in Tissue Regeneration.	7	50	1.21	0.00039	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,CDH1,BMP2,EDN1,BCL2,RHOA,AGTR1
PMID:33613564	(2020) A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000393312	CXCL10,CXCL11,MAP3K5,CXCL9,CD47,FGFR1
PMID:33628175	(2020) Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials.	7	50	1.21	0.00039	9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	LPL,PTGS2,AR,G6PD,NFE2L2,BCL2,MYD88
PMID:29512466	(2019) Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw.	6	30	1.36	0.00039	9606.ENSP00000304767,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000414303	P2RY1,COMT,PTGS2,MTHFR,BCL2,BDNF
PMID:29758244	(2019) Neural stem cell therapies and hypoxic-ischemic brain injury.	7	50	1.21	0.00039	9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,SOX9,PTEN,EDN1,BCL2,BDNF,VEGFA
PMID:30334629	(2019) Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease.	6	30	1.36	0.00039	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252	NOX4,CAV1,NOX1,EDN1,JAK2,NFE2L2
PMID:30728419	(2019) Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.	6	30	1.36	0.00039	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823	WFS1,JAZF1,HNF4A,KCNJ11,CAPN10,FTO
PMID:30735831	(2019) IGF-1 and cardiovascular disease.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000371067	IFNG,NOX4,IGF1R,PDGFB,CD47,JAK2
PMID:31096567	(2019) The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.	9	104	1.0	0.00039	9606.ENSP00000259486,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000478570	ENPP2,THBS1,CDH1,CD34,CCL20,CD47,PTEN,MME,VEGFA
PMID:31133802	(2019) MicroRNAs in Microglia: How do MicroRNAs Affect Activation, Inflammation, Polarization of Microglia and Mediate the Interaction Between Microglia and Glioma?	7	50	1.21	0.00039	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,MAP3K5,IRAK4,RHOA,MYD88,BDNF,VEGFA
PMID:31211759	(2019) Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis.	7	50	1.21	0.00039	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CXCL10,LTA,BDNF,CCL5,VEGFA
PMID:31248102	(2019) Kaempferol: A Key Emphasis to Its Anticancer Potential.	8	75	1.09	0.00039	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ATM,PTGS2,PTEN,TXN,BCL2,RHOA,VEGFA
PMID:31340532	(2019) Novel Insights on the Toxicity of Phycotoxins on the Gut through the Targeting of Enteric Glial Cells.	6	30	1.36	0.00039	9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303	NFE2L2,BCL2,NPY,RHOA,MYD88,BDNF
PMID:31340863	(2019) RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000339916,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CAV1,LIMK2,RHOA,PROM1,VEGFA
PMID:31481963	(2019) Microglia in Retinal Degeneration.	8	75	1.09	0.00039	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,MMP14,CNTF,PTGS2,NTF3,BDNF,CCL5,VEGFA
PMID:31565447	(2019) Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis.	6	30	1.36	0.00039	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CDH1,CD34,BCL2,MME
PMID:31647026	(2019) Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312	IFNG,CXCL10,PTEN,AR,JAK2,FGFR1
PMID:32818162	(2019) Redox Regulation of Metabolic Syndrome: Recent Developments in Skeletal Muscle Insulin Resistance and Non-alcoholic Fatty Liver Disease (NAFLD).	6	30	1.36	0.00039	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000380252	NOX4,LPL,SREBF1,MAP3K5,NOX1,NFE2L2
PMID:28974520	(2018) Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.	6	30	1.36	0.00039	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000356213,9606.ENSP00000356438	CETP,TGFB1,ANGPT2,SERPINF2,VIP,PTGS2
PMID:29207157	(2018) Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.	6	30	1.36	0.00039	9606.ENSP00000245479,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,STAT5A,JAK2,NFE2L2,CCL5,VEGFA
PMID:29308206	(2018) SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.	8	75	1.09	0.00039	9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	THBS1,AMBP,CD34,EBF1,SGK1,PTEN,BCL2,PROM1
PMID:29337890	(2018) Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology.	6	30	1.36	0.00039	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000419422,9606.ENSP00000478570	MPO,NOX4,MAP3K5,NOX1,AGTR1,VEGFA
PMID:29593724	(2018) miRNome Expression Analysis Reveals New Players on Leprosy Immune Physiopathology.	9	104	1.0	0.00039	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	TGFB1,SOX9,CDH1,IGF1R,PRKCE,PTEN,BCL2,RHOA,BDNF
PMID:29615071	(2018) Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.	6	30	1.36	0.00039	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000400175,9606.ENSP00000478570	TIMP3,MMP14,CD34,SERPINF2,RHOA,VEGFA
PMID:29726819	(2018) Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ALDH1A1,CXCL10,CXCL9,PTEN,BCL2,VEGFA
PMID:29910810	(2018) Adaptive Regulation of Osteopontin Production by Dendritic Cells Through the Bidirectional Interaction With Mesenchymal Stromal Cells.	6	30	1.36	0.00039	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000474412	MPO,CD38,FABP4,CDH1,CD34,CCL5
PMID:30149591	(2018) RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact.	8	75	1.09	0.00039	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CDH1,PTEN,AR,BCL2,PROM1,CCL5,VEGFA
PMID:30275402	(2018) Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.	7	50	1.21	0.00039	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CCL20,CXCL9,EDN1,VEGFA
PMID:30416700	(2018) Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver.	8	75	1.09	0.00039	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000321853,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CD34,SERPINF2,ELN,JAK2,CCL5,VEGFA
PMID:30424016	(2018) Peroxisome Proliferator-Activated Receptors (PPAR)gamma Agonists as Master Modulators of Tumor Tissue.	6	30	1.36	0.00039	9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021	THBS1,LPL,HNF4A,STAT5A,PTGS2,PTEN
PMID:30460245	(2018) Cell Sources for Tissue Engineering Strategies to Treat Calcific Valve Disease.	6	30	1.36	0.00039	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,SOX9,ELN,BMP2,PROM1,VEGFA
PMID:30552021	(2018) Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells.	6	30	1.36	0.00039	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD69,IFNG,CDH1,CXCL10,CXCL11,CXCL9
PMID:30564199	(2018) Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.	7	50	1.21	0.00039	9606.ENSP00000283928,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000357726,9606.ENSP00000365777,9606.ENSP00000418823,9606.ENSP00000478570	JAZF1,SREBF1,ABCG1,S100A12,MTHFR,FTO,VEGFA
PMID:27480216	(2017) Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.	6	30	1.36	0.00039	9606.ENSP00000200676,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CETP,LPA,ABCG1,TXN,NFE2L2,VEGFA
PMID:27939939	(2017) CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000474412	CD38,CXCL10,PTEN,EDN1,RARRES2,CCL5
PMID:28198592	(2017) Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms.	6	30	1.36	0.00039	9606.ENSP00000228434,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000426809	CD69,CNTF,PTEN,GAP43,BDNF,PROM1
PMID:28430130	(2017) Timp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma.	6	30	1.36	0.00039	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,TIMP3,ATM,SGK1,PTEN,VEGFA
PMID:28626344	(2017) Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro.	6	30	1.36	0.00039	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:28698765	(2017) Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy.	6	30	1.36	0.00039	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTEN,NOX1,NFE2L2,BCL2,VEGFA
PMID:28704922	(2017) Transcriptome Differences in Porcine Alveolar Macrophages from Tongcheng and Large White Pigs in Response to Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection.	10	137	0.92	0.00039	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412	TGFB1,CCR5,PLIN1,CXCL10,CXCL11,CCL20,CD247,EDN1,BCL2,CCL5
PMID:28717401	(2017) Novel therapeutic strategies in the treatment of triple-negative breast cancer.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,CAV1,PTEN,AR,JAK2,FGFR1,VEGFA
PMID:28933369	(2017) Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.	8	75	1.09	0.00039	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,ATM,SIRT6,PTEN,PROM1,VEGFA
PMID:29025601	(2017) A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemialymphoma without eosinophilia.	7	50	1.21	0.00039	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312	MPO,CD38,STAT5A,PDGFA,PTEN,JAK2,FGFR1
PMID:29088737	(2017) Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating AktNF-kappaB signaling by paracrine CCL5.	6	30	1.36	0.00039	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CD34,PROM1,CCL5,VEGFA
PMID:26577614	(2016) Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.	6	30	1.36	0.00039	9606.ENSP00000300055,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000380252	PLIN1,CAV1,SREBF1,COMT,EDN1,NFE2L2
PMID:26909338	(2016) Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer.	7	50	1.21	0.00039	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,IGF1R,ATM,PTEN,AR,BCL2,VEGFA
PMID:26952935	(2016) Interplay between cardiac function and heart development.	6	30	1.36	0.00039	9606.ENSP00000311005,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	MAPK7,EDNRA,ELN,EDN1,RHOA,VEGFA
PMID:27120467	(2016) Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.	6	30	1.36	0.00039	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000426809	CDH1,ALDH1A1,PTEN,AR,MME,PROM1
PMID:27213331	(2016) Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.	8	75	1.09	0.00039	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,IGF1R,PRKCE,ELN,PTEN,EDN1,BCL2,RHOA
PMID:27247702	(2016) ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases.	6	30	1.36	0.00039	9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641	ATM,PRKCE,CAV1,PTEN,NOX1,TXN
PMID:27293463	(2016) Medical Application of Spirulina platensis Derived C-Phycocyanin.	6	30	1.36	0.00039	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CDH1,PTGS2,BCL2,BDNF,VEGFA
PMID:27344175	(2016) PDGFRalpha depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PDGFB,PDGFA,EDN1,PDGFD,BCL2,VEGFA
PMID:27621061	(2016) beta-catenin activity in late hypertrophic chondrocytes locally orchestrates osteoblastogenesis and osteoclastogenesis.	6	30	1.36	0.00039	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000478570	SOX9,FABP4,TIMP3,MMP14,HNF4A,VEGFA
PMID:27696124	(2016) Peripheral blood mononuclear cell secretome for tissue repair.	6	30	1.36	0.00039	9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CD34,BCL2,BDNF,CCL5,VEGFA
PMID:27775593	(2016) Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression.	6	30	1.36	0.00039	9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	CD69,STAT5A,ENTPD1,PTEN,BCL2,MYD88
PMID:27795960	(2016) Immunomodulatory Effects Mediated by Dopamine.	8	75	1.09	0.00039	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000354511,9606.ENSP00000478570	CD38,CD69,IFNG,IGF1R,CCR5,CD34,COMT,VEGFA
PMID:27886133	(2016) Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.	9	104	1.0	0.00039	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	TGFB1,THBS1,TIMP3,ATM,CXCL11,CAV1,PTGS2,PTEN,BCL2
PMID:25092249	(2015) Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.	6	30	1.36	0.00039	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000321334,9606.ENSP00000336762	CHI3L1,THBS1,CXCL10,CXCL11,LPA,ANG
PMID:25418030	(2015) Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD38,KLF10,CD34,MME,PROM1,VEGFA
PMID:25482829	(2015) Tenascin-C: Form versus function.	7	50	1.21	0.00039	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000281382,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,TIMP3,PIGF,HSPG2,BCL2,BDNF,VEGFA
PMID:25534849	(2015) Cyclooxygenase-2 or tumor necrosis factor-alpha inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle.	6	30	1.36	0.00039	9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,CXCL9,PTGS2,PROM1,CCL5,VEGFA
PMID:25544368	(2015) Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.	8	75	1.09	0.00039	9606.ENSP00000215832,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,ANGPT2,PDGFB,PDGFA,PDGFD,BCL2,FGFR1,VEGFA
PMID:25609980	(2015) Advances in the targeted therapy of liposarcoma.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,SREBF1,MAP3K5,PROM1,VEGFA
PMID:25634974	(2015) Cellular origin and developmental program of coronary angiogenesis.	6	30	1.36	0.00039	9606.ENSP00000222139,9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000393312,9606.ENSP00000475344,9606.ENSP00000478570	EPOR,FABP4,ANGPT2,FGFR1,APLNR,VEGFA
PMID:25674855	(2015) Fatty acid signaling: the new function of intracellular lipases.	7	50	1.21	0.00039	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000477707,9606.ENSP00000478570	FABP4,PLIN1,HNF4A,SREBF1,NFE2L2,NR1H3,VEGFA
PMID:25719334	(2015) The role of perivascular adipose tissue in vasoconstriction, arterial stiffness, and aneurysm.	6	30	1.36	0.00039	9606.ENSP00000221930,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000418009	TGFB1,CAV1,ELN,ANGPTL2,EDN1,RARRES2
PMID:25733103	(2015) The HIV-1 transgenic rat model of neuroHIV.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CCR5,CNTF,NFE2L2,BDNF,CCL5
PMID:25784858	(2015) Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimers disease.	7	50	1.21	0.00039	9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	CCR5,ANGPT2,CD47,PTGS2,NFE2L2,RHOA,VEGFA
PMID:25788267	(2015) Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel.	6	30	1.36	0.00039	9606.ENSP00000330382,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	PDGFB,CNTF,JAK2,BCL2,CCL5,VEGFA
PMID:25808641	(2015) Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.	6	30	1.36	0.00039	9606.ENSP00000221930,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000478570	TGFB1,CXCL11,CD34,CXCL9,CNTF,VEGFA
PMID:25834307	(2015) Effect of crossing C57BL6 and FVB mouse strains on basal cytokine expression.	6	30	1.36	0.00039	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,NFE2L2,CCL5,VEGFA
PMID:26152369	(2015) Pro-inflammatory TNFalpha and IL-1beta differentially regulate the inflammatory phenotype of brain microvascular endothelial cells.	7	50	1.21	0.00039	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5,VEGFA
PMID:26236568	(2015) Recent Developments in Understanding the Role of Aqueous Humor Outflow in Normal and Primary Open Angle Glaucoma.	6	30	1.36	0.00039	9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CAV1,ELN,BMP2,RHOA,VEGFA
PMID:26300924	(2015) Cell Therapy in Patients with Critical Limb Ischemia.	6	30	1.36	0.00039	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000478570	CCR5,MMP14,CD34,ELN,CXCL9,VEGFA
PMID:26356073	(2015) EMT-Inducing Molecular Factors in Gynecological Cancers.	9	104	1.0	0.00039	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000414303,9606.ENSP00000478570	ENPP2,CDH1,IGF1R,EDNRA,PTEN,EDN1,KL,BDNF,VEGFA
PMID:26373931	(2015) Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives.	6	30	1.36	0.00039	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000346148,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,EDNRA,PRKAA1,EDN1,AGTR1,VEGFA
PMID:26379491	(2015) A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis.	6	30	1.36	0.00039	9606.ENSP00000246553,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	FFAR1,BCL2,FGFR1,NTF3,BDNF,VEGFA
PMID:26415051	(2015) Pharmacology and Clinical Drug Candidates in Redox Medicine.	6	30	1.36	0.00039	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000419422	NOX4,PTEN,NOX1,TXN,BCL2,AGTR1
PMID:26530042	(2015) Using mesenchymal stem cells as a therapy for bone regeneration and repairing.	6	30	1.36	0.00039	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CD34,ANGPT2,PDGFB,CCL5,VEGFA
PMID:26602923	(2015) MicroRNAs: Clinical Relevance in Colorectal Cancer.	7	50	1.21	0.00039	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	APC,CDH1,IGF1R,ATM,PTEN,BCL2,VEGFA
PMID:27867838	(2015) Advances in miRNA-Mediated Mucin Regulation.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:24434519	(2014) Molecular mechanisms of hepatic apoptosis.	7	50	1.21	0.00039	9606.ENSP00000292303,9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,ONECUT1,CXCL10,SREBF1,ELN,BCL2,CCL5
PMID:24495169	(2014) Engineering anisotropic biomimetic fibrocartilage microenvironment by bioprinting mesenchymal stem cells in nanoliter gel droplets.	8	75	1.09	0.00039	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IFNG,SOX9,BMP2,RHOA,BDNF,PROM1,VEGFA
PMID:24856117	(2014) Chemokines and chemokine receptors: update on utility and challenges for the clinician.	6	30	1.36	0.00039	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:25032678	(2014) The impact of the human genome project on complex disease.	6	30	1.36	0.00039	9606.ENSP00000200676,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000284031,9606.ENSP00000352264,9606.ENSP00000478570	CETP,COL8A1,TIMP3,DDAH1,CD2AP,VEGFA
PMID:25033178	(2014) Glial development: the crossroads of regeneration and repair in the CNS.	8	75	1.09	0.00039	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,IGF1R,PDGFA,CNTF,EDN1,FGFR1,BDNF,VEGFA
PMID:25184116	(2014) SRC: marker or actor in prostate cancer aggressiveness.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTEN,AR,BCL2,VEGFA
PMID:25236925	(2014) The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.	6	30	1.36	0.00039	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000478570	IGF1R,CD34,ANGPT2,PDGFB,ANG,VEGFA
PMID:25268360	(2014) Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:23434665	(2013) NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicity.	7	50	1.21	0.00039	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTGS2,PTEN,NOX1,JAK2,BCL2,VEGFA
PMID:23533994	(2013) The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.	8	75	1.09	0.00039	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CDH1,CCL20,PTGS2,JAK2,FGFR1,MYD88,VEGFA
PMID:23734203	(2013) Gene expression profiling of solitary fibrous tumors.	8	75	1.09	0.00039	9606.ENSP00000221930,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	TGFB1,ALDH1A1,CD34,PDGFB,BMP2,JAK2,BCL2,FGFR1
PMID:23738043	(2013) Reactive oxygen species and the cardiovascular system.	6	30	1.36	0.00039	9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAP3K5,PTEN,EDN1,BCL2,RHOA,VEGFA
PMID:23797033	(2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.	6	30	1.36	0.00039	9606.ENSP00000222572,9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000377192,9606.ENSP00000478570	PON2,IFNG,ANG,CNTF,G6PD,VEGFA
PMID:23799579	(2013) Understanding vascular development.	8	75	1.09	0.00039	9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000475344,9606.ENSP00000478570	TGFB1,ANGPT2,PDGFB,UNC5B,ELN,RHOA,APLNR,VEGFA
PMID:23989721	(2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.	7	50	1.21	0.00039	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CD38,MMP14,CD34,BCL2,PROM1,VEGFA
PMID:24156623	(2013) Pubertal high fat diet: effects on mammary cancer development.	8	75	1.09	0.00039	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,IGF1R,CCL20,BMP2,NTF3,LTA,BDNF,VEGFA
PMID:24184186	(2013) Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions?	6	30	1.36	0.00039	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,BCL2,CCL5
PMID:24252550	(2013) Molecular signatures of chronic myeloid leukemia stem cells.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000257430,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CD38,APC,CD34,PTEN,BCL2,PROM1
PMID:24359404	(2013) Targeting the PDGF signaling pathway in tumor treatment.	7	50	1.21	0.00039	9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000478570	PDGFB,STAT5A,PDGFA,PTEN,JAK2,PDGFD,VEGFA
PMID:24665208	(2013) The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.	7	50	1.21	0.00039	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,IGF1R,CXCL11,PTEN,BMP2,EDN1,VEGFA
PMID:21898543	(2012) Erythropoietin mediated bone formation is regulated by mTOR signaling.	6	30	1.36	0.00039	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,STAT5A,MAFB,BMP2,JAK2,BCL2
PMID:22325146	(2012) Wnt signaling pathways in urological cancers: past decades and still growing.	8	75	1.09	0.00039	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,MMP14,PTGS2,AR,PDGFD,BCL2,VEGFA
PMID:22654484	(2012) Inference of tumor phylogenies from genomic assays on heterogeneous samples.	6	30	1.36	0.00039	9606.ENSP00000216862,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000427424	CYP24A1,IGF1R,STAT5A,BCL2,FGFR1,TNFAIP8
PMID:22863788	(2012) A comparison of epithelial-to-mesenchymal transition and re-epithelialization.	7	50	1.21	0.00039	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000478570	TGFB1,IGF1R,MMP14,MAPK7,HNF4A,PDGFB,VEGFA
PMID:22906922	(2012) Anti-angiogenic gene therapy in the treatment of malignant gliomas.	6	30	1.36	0.00039	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,NOX4,TIMP3,PTEN,BCL2,VEGFA
PMID:23443123	(2012) The implications of cancer stem cells for cancer therapy.	6	30	1.36	0.00039	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809	CD38,ALDH1A1,CD34,HNF4A,PTEN,PROM1
PMID:24278677	(2012) Stress in obesity and associated metabolic and cardiovascular disorders.	8	75	1.09	0.00039	9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000478570	LPL,SIRT6,STAT5A,ANGPTL2,JAK2,NPY,AGTR1,VEGFA
PMID:21249426	(2011) Tumor immunosurveillance in human cancers.	6	30	1.36	0.00039	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000478570	CD69,IFNG,CXCL10,CD247,CXCL9,VEGFA
PMID:21709278	(2011) Diabetes complications: the microRNA perspective.	6	30	1.36	0.00039	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,ELN,PTEN,RHOA,VEGFA
PMID:21802343	(2011) CXCL10IP-10 in infectious diseases pathogenesis and potential therapeutic implications.	6	30	1.36	0.00039	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,JAK2,MYD88,VEGFA
PMID:20716126	(2010) The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease.	6	30	1.36	0.00039	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000383364,9606.ENSP00000414303,9606.ENSP00000474412	FABP4,CXCL10,LPL,PLA2G2A,BDNF,CCL5
PMID:19258507	(2009) Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.	6	30	1.36	0.00039	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,STAT5A,CXCL9,CCL5,VEGFA
PMID:19453519	(2009) Cartilage repair: past and future--lessons for regenerative medicine.	6	30	1.36	0.00039	9606.ENSP00000245479,9606.ENSP00000301522,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,PRDX2,FMOD,BMP2,BCL2,VEGFA
PMID:19012726	(2008) Expression profiles in surgically-induced carotid stenosis: a combined transcriptomic and proteomic investigation.	8	75	1.09	0.00039	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000285407,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000377372,9606.ENSP00000478570	TGFB1,HSPB1,KLF10,MMP14,ELN,TXN,GAP43,VEGFA
PMID:11748287	(2001) CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720.	6	30	1.36	0.00039	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:35409206	(2022) Metastasis and MAPK Pathways.	11	174	0.86	0.00040	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,MAP3K5,PTGS2,PTEN,HSPG2,PDGFD,BCL2,FGFR1,RHOA,VEGFA
PMID:34693660	(2021) Parallels between the Developing Vascular and Neural Systems: Signaling Pathways and Future Perspectives for Regenerative Medicine.	11	174	0.86	0.00040	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	ANGPT2,PDGFB,UNC5B,CNTF,BMP2,BCL2,NTF3,BDNF,AGTR1,PROM1,VEGFA
PMID:35000673	(2022) Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases.	5	15	1.58	0.00041	9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CAV1,CD47,BDNF,MME,VEGFA
PMID:35158943	(2022) Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.	7	51	1.2	0.00041	9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,AR,EDN1,NFE2L2,BCL2,PROM1,VEGFA
PMID:35159202	(2022) Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review.	8	76	1.08	0.00041	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000347041,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000381185	IFNG,SOX9,TIMP3,FMOD,MAP3K5,TXN,BMP2,BCL2
PMID:35256933	(2022) Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions.	8	76	1.08	0.00041	9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,HNF4A,CD47,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:35267626	(2022) Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.	8	76	1.08	0.00041	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IGF1R,CXCL10,CXCL9,CD47,MYD88,CCL5,VEGFA
PMID:35303879	(2022) Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.	7	51	1.2	0.00041	9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CD34,GAS6,CAV1,CD47,AR,BCL2,VEGFA
PMID:35315698	(2022) Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:35321703	(2022) Polyphenols in Ilex latifolia Thunb. inhibit human lung cancer cell line A549 by regulation of the PI3K-Akt signaling pathway.	5	15	1.58	0.00041	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:35328633	(2022) Mitochondrial Sirtuins in Chronic Degenerative Diseases: New Metabolic Targets in Colorectal Cancer.	9	105	0.99	0.00041	9606.ENSP00000216862,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822	CYP24A1,FABP4,CDH1,KLF10,SIRT6,SREBF1,PTGS2,PTEN,AR
PMID:35337154	(2022) Novel In Vivo Assessment of Antimicrobial Efficacy of Ciprofloxacin Loaded Mesoporous Silica Nanoparticles against Salmonella typhimurium Infection.	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000381185	MPO,CXCL10,CXCL11,PTGS2,BCL2
PMID:35341590	(2022) CC group of chemokines and associated gene expression of transcription factors: Deciphering immuno-pathogenetic aspect of oral submucous fibrosis.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:35346303	(2022) Cellular stress signaling and the unfolded protein response in retinal degeneration: mechanisms and therapeutic implications.	7	51	1.2	0.00041	9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,ELN,EDN1,NFE2L2,RHOA,BDNF,VEGFA
PMID:35399432	(2022) A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000360997	CD38,IFNG,CHI3L1,CD34,ADAMTS13
PMID:35409117	(2022) Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	MPO,IFNG,ATM,JAK2,NFE2L2,BCL2,MYD88
PMID:35487305	(2022) Naltrexone protects against BDL-induced cirrhosis in Wistar rats by attenuating thrombospondin-1 and enhancing antioxidant defense system via Nrf-2.	4	5	1.96	0.00041	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000362057,9606.ENSP00000380252	TGFB1,THBS1,NOX1,NFE2L2
PMID:36091020	(2022) Association between frontal fibrosing Alopecia and Rosacea: Results from clinical observational studies and gene expression profiles.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD38,CCR5,CXCL10,CXCL11,CXCL9
PMID:36231038	(2022) Baicalin Modulates Inflammatory Response of Macrophages Activated by LPS via Calcium-CHOP Pathway.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,CCL5,VEGFA
PMID:32810267	(2021) Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.	5	15	1.58	0.00041	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000478570	CHI3L1,CXCL10,ANGPT2,CXCL9,VEGFA
PMID:32978039	(2021) Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.	7	51	1.2	0.00041	9606.ENSP00000215832,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,COMT,PTGS2,G6PD,BCL2,MYD88,CCL5
PMID:33691172	(2021) Contribution of STAT3 to the pathogenesis of COVID-19.	7	51	1.2	0.00041	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,CXCL10,STAT5A,CCL20,CCL5,VEGFA
PMID:33708350	(2021) Adult human liver slice cultures: Modelling of liver fibrosis and evaluation of new anti-fibrotic drugs.	5	15	1.58	0.00041	9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000478570,9606.ENSP00000480291	CCR5,HNF4A,MAP3K5,VEGFA,HNF1B
PMID:33806846	(2021) Silk Fibroin: An Ancient Material for Repairing the Injured Nervous System.	5	15	1.58	0.00041	9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ELN,CNTF,NTF3,BDNF,VEGFA
PMID:33850656	(2021) Ameliorative effect of apelin-13 against renal complications in L-NAME-induced preeclampsia in rats.	5	15	1.58	0.00041	9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	EDN1,NFE2L2,AGTR1,APLNR,VEGFA
PMID:33919150	(2021) Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes.	5	15	1.58	0.00041	9606.ENSP00000248553,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,PTEN,AR,BCL2,VEGFA
PMID:33953756	(2021) Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412	CXCL10,AR,MYD88,AGTR1,CCL5
PMID:33978185	(2021) Regenerative medicine for radiation emergencies.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,FABP4,CD34,PROM1,VEGFA
PMID:33995938	(2021) MicroRNAs may provide new strategies in the treatment and diagnosis of diabetic retinopathy: Importance of VEGF.	8	76	1.08	0.00041	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000478570	TIMP3,IGF1R,CD34,CAV1,S100A12,PTEN,MYD88,VEGFA
PMID:34026558	(2021) Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview.	8	76	1.08	0.00041	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252	FABP4,IGF1R,CXCL10,CAV1,SREBF1,PTEN,JAK2,NFE2L2
PMID:34068618	(2021) Neuroendocrine Factors in Melanoma Pathogenesis.	8	76	1.08	0.00041	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	IFNG,CDH1,VIP,PTGS2,EDN1,BCL2,NPY,VEGFA
PMID:34071245	(2021) Planet of the AAVs: The Spinal Cord Injury Episode.	7	51	1.2	0.00041	9606.ENSP00000229135,9606.ENSP00000298352,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	IFNG,NGB,CNTF,PTEN,NTF3,RHOA,BDNF
PMID:34095461	(2021) Angiogenesis-related non-coding RNAs and gastrointestinal cancer.	8	76	1.08	0.00041	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,EDN1,BCL2,FGFR1,AGTR1,PROM1,VEGFA
PMID:34123451	(2021) Orbital Swelling and Ptosis as an Initial Presentation of Childhood Acute Lymphoblastic Leukaemia: A Case Report and Review of the Literature.	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000377192,9606.ENSP00000418525	MPO,CD38,CD34,G6PD,MME
PMID:34136201	(2021) Nephroprotective activity of natural products against chemical toxicants: The role of Nrf2ARE signaling pathway.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185	MPO,NOX4,SIRT6,TXN,G6PD,NFE2L2,BCL2
PMID:34204362	(2021) Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000419422,9606.ENSP00000474412	CXCL10,CCL20,PTEN,NOX1,TXN,AGTR1,CCL5
PMID:34277111	(2021) Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CHI3L1,PTGS2,ENTPD1,PTEN,MME,VEGFA
PMID:34282706	(2021) Potential of thrombospondin-1 in treatment of polycystic ovary syndrome rat model: a preliminary study.	4	5	1.96	0.00041	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000376865	THBS1,ANGPT2,PDGFB,PDGFD
PMID:34321839	(2021) Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CD69,CCR5,CXCL10,ENTPD1,BCL2,CCL5
PMID:34326930	(2021) Novel Treatment Pathways in Pulmonary Arterial Hypertension.	5	15	1.58	0.00041	9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356213,9606.ENSP00000380252	EDNRA,PDGFB,PDGFA,VIP,NFE2L2
PMID:34390226	(2021) Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients-A prospective controlled study.	4	5	1.96	0.00041	9606.ENSP00000354511,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000414303	COMT,AR,SHBG,BDNF
PMID:34440119	(2021) Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development.	7	51	1.2	0.00041	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000401399	IFNG,THBS1,CXCL10,CXCL9,ABCG1,NFE2L2,MYD88
PMID:34440245	(2021) Thioredoxin-1 and Correlations of the Plasma Cytokines Regarding Aortic Valve Stenosis Severity.	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000363641,9606.ENSP00000418009,9606.ENSP00000478570	MPO,ANGPT2,TXN,RARRES2,VEGFA
PMID:34457021	(2021) Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein.	8	76	1.08	0.00041	9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	CDH1,SREBF1,MAP3K5,KL,NFE2L2,BCL2,MYD88,BDNF
PMID:34502310	(2021) The Role of ER Stress-Related Phenomena in the Biology of Malignant Peripheral Nerve Sheath Tumors.	7	51	1.2	0.00041	9606.ENSP00000265333,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	VDAC1,PTEN,TXN,G6PD,NFE2L2,BCL2,VEGFA
PMID:34557105	(2021) Editorial: Applications of Herbal Medicine to Control Chronic Kidney Disease.	5	15	1.58	0.00041	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000478319	NOX4,PTEN,TXN,KL,GREM1
PMID:34566499	(2021) Efficacy of Platelet-Rich Plasma on Symptom Reduction in Patellar Tendinopathy.	4	5	1.96	0.00041	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	TGFB1,PDGFB,PDGFA,VEGFA
PMID:34571964	(2021) Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Glucose Homeostasis and Diabetes-Related Endothelial Cell Dysfunction.	7	51	1.2	0.00041	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,IGF1R,ELN,NOX1,EDN1,NFE2L2,VEGFA
PMID:34572923	(2021) Prostate Cancer-Focus on Cholesterol.	8	76	1.08	0.00041	9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816	ATM,SIRT6,SREBF1,ABCG1,SGK1,PTEN,AR,SHBG
PMID:34639186	(2021) Adipokines as Immune Cell Modulators in Multiple Sclerosis.	7	51	1.2	0.00041	9606.ENSP00000341208,9606.ENSP00000361883,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000475344	STAT5A,CAP1,JAK2,NFE2L2,BDNF,RARRES2,APLNR
PMID:34696395	(2021) Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418525	CD38,CD69,CXCL10,CXCL11,CCL20,CXCL9,MME
PMID:34720877	(2021) Microglia Regulate Neuronal Circuits in Homeostatic and High-Fat Diet-Induced Inflammatory Conditions.	7	51	1.2	0.00041	9606.ENSP00000221930,9606.ENSP00000246553,9606.ENSP00000309757,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303	TGFB1,FFAR1,LPL,CNTF,NPY,MYD88,BDNF
PMID:34829539	(2021) Mechanism, Prevention, and Treatment of Radiation-Induced Salivary Gland Injury Related to Oxidative Stress.	8	76	1.08	0.00041	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CD38,HSPB1,ATM,AQP5,BCL2,BDNF,VEGFA
PMID:34858499	(2021) Function of N6-Methyladenosine Modification in Tumors.	8	76	1.08	0.00041	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418823,9606.ENSP00000478570	CDH1,CXCL10,STAT5A,CXCL9,PTEN,BCL2,FTO,VEGFA
PMID:34893070	(2021) Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CCL20,CXCL9
PMID:34893580	(2021) Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000478570	CD38,CD69,CDH1,CXCL10,ANGPT2,CXCL9,VEGFA
PMID:34945227	(2021) The Role of the Stromal Extracellular Matrix in the Development of Pterygium Pathology: An Update.	7	51	1.2	0.00041	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,MMP14,ELN,PTEN,BCL2,VEGFA
PMID:35052581	(2021) New Discoveries and Ambiguities of Nrf2 and ATF3 Signaling in Environmental Arsenic-Induced Carcinogenesis.	8	76	1.08	0.00041	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000380252	ALDH1A1,CXCL10,CXCL11,PDGFB,CAV1,CXCL9,PDGFD,NFE2L2
PMID:32021397	(2020) Electroacupuncture Inhibits Hyperalgesia by Alleviating Inflammatory Factors in a Rat Model of Migraine.	5	15	1.58	0.00041	9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303	VIP,PTGS2,EDN1,NPY,BDNF
PMID:32111081	(2020) Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells.	7	51	1.2	0.00041	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,IGF1R,ATM,MAP3K5,NFE2L2,RHOA,VEGFA
PMID:32168908	(2020) Reactive Oxygen Species in Venous Thrombosis.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000384957,9606.ENSP00000401399,9606.ENSP00000478570	MPO,NOX4,NOX1,TXN,F11,MYD88,VEGFA
PMID:32257947	(2020) Novel Therapeutic Strategies for Ovarian Cancer Stem Cells.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ATM,ALDH1A1,CD34,PROM1,VEGFA
PMID:32280836	(2020) Bioactive polymeric materials and electrical stimulation strategies for musculoskeletal tissue repair and regeneration.	5	15	1.58	0.00041	9606.ENSP00000351807,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ELN,GAP43,NTF3,BDNF,VEGFA
PMID:32368055	(2020) PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.	5	15	1.58	0.00041	9606.ENSP00000215832,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,PTGS2,PTEN,BCL2,VEGFA
PMID:32411336	(2020) Evolution of the Knowledge of Free Radicals and Other Oxidants.	5	15	1.58	0.00041	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,MAP3K5,PTEN,TXN,NFE2L2
PMID:32424297	(2020) Risk of cancer in patients with glaucoma: A nationwide population-based cohort study.	4	5	1.96	0.00041	9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,EDN1,BDNF,VEGFA
PMID:32466585	(2020) Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies.	7	51	1.2	0.00041	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000400175	THBS1,IGF1R,EDNRA,PTEN,EDN1,FGFR1,RHOA
PMID:32494661	(2020) Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1PD-L1 immunotherapy.	7	51	1.2	0.00041	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,PTEN,JAK2,CCL5
PMID:32517213	(2020) Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.	8	76	1.08	0.00041	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000475344,9606.ENSP00000478570	TGFB1,CXCL10,CXCL11,CXCL9,PTEN,JAK2,APLNR,VEGFA
PMID:32533883	(2020) Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.	5	15	1.58	0.00041	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000474412	CD69,IFNG,ATM,CCR5,CCL5
PMID:32542038	(2020) Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.	7	51	1.2	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,LTA,CCL5,VEGFA
PMID:32576889	(2020) Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CXCL10,CD34,LTA,CCL5,VEGFA
PMID:32629875	(2020) Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000478570	CXCL10,CD34,ANGPT2,EDN1,JAK2,AGTR1,VEGFA
PMID:32679703	(2020) Biomimetic Aspects of Restorative Dentistry Biomaterials.	5	15	1.58	0.00041	9606.ENSP00000260356,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	THBS1,PDGFA,ELN,BMP2,VEGFA
PMID:32733242	(2020) Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling.	7	51	1.2	0.00041	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CETP,MPO,PTGS2,EDN1,BCL2,MYD88,CCL5
PMID:32821333	(2020) Oxidative stress in alcohol-related liver disease.	7	51	1.2	0.00041	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000401399	NOX4,SIRT6,MAP3K5,PTEN,NOX1,TXN,MYD88
PMID:32823683	(2020) Non-pharmacological Treatment of Refractory Angina and Microvascular Angina.	4	5	1.96	0.00041	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDN1,PROM1,VEGFA
PMID:32872338	(2020) Transient Receptor Potential Canonical (TRPC) Channels: Then and Now.	7	51	1.2	0.00041	9606.ENSP00000246553,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000478570	FFAR1,NOX4,PTEN,TXN,RHOA,TRPC1,VEGFA
PMID:32911852	(2020) Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA.	7	51	1.2	0.00041	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000418009	TIMP3,IGF1R,CAV1,SREBF1,PTEN,SHBG,RARRES2
PMID:32930334	(2020) Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression.	4	5	1.96	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901	CXCL10,CXCL11,ANGPT2,CXCL9
PMID:32952149	(2020) The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseases.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	MPO,IGF1R,MAP3K5,PTGS2,PTEN,NFE2L2,VEGFA
PMID:32989051	(2020) Secretory galectin-3 induced by glucocorticoid stress triggers stemness exhaustion of hepatic progenitor cells.	5	15	1.58	0.00041	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000380365,9606.ENSP00000426809	SOX9,CD34,HNF4A,RGN,PROM1
PMID:32998363	(2020) Angiotensin Inhibition, TGF-beta and EMT in Cancer.	8	76	1.08	0.00041	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,SOX9,THBS1,CDH1,ELN,HSPG2,BCL2,VEGFA
PMID:32999525	(2020) Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?	8	76	1.08	0.00041	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000484631	IFNG,HSPB1,CNTF,PTEN,GAP43,BDNF,VEGFA,PMP22
PMID:33003981	(2020) HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor-Dependent Increases in NADPH Oxidase 1 (Nox1), C-C Chemokine Receptor Type 5 (CCR5), and Inflammation.	5	15	1.58	0.00041	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000474412	NOX4,CCR5,NOX1,EDN1,CCL5
PMID:33014312	(2020) Appropriate Scaffold Selection for CNS Tissue Engineering.	5	15	1.58	0.00041	9606.ENSP00000355370,9606.ENSP00000363827,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,HSPG2,NTF3,BDNF,VEGFA
PMID:33032611	(2020) Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000393312	CDH1,ATM,ALDH1A1,PTEN,AR,NPY,FGFR1
PMID:33072673	(2020) Host-Based Prognostic Biomarkers to Improve Risk Stratification and Outcome of Febrile Children in Low- and Middle-Income Countries.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000478570	IFNG,CHI3L1,CXCL10,ANGPT2,VEGFA
PMID:33095554	(2020) Progress in Natural CompoundssiRNA Co-delivery Employing Nanovehicles for Cancer Therapy.	7	51	1.2	0.00041	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,HSPB1,PTEN,KL,BCL2,PROM1,VEGFA
PMID:33117713	(2020) Emerging Landscapes of Tumor Immunity and Metabolism.	8	76	1.08	0.00041	9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,MAPK7,STAT5A,CCL20,CD47,PTEN,BCL2,CCL5
PMID:33143144	(2020) Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report.	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000284031,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	MPO,DDAH1,TXN,NFE2L2,VEGFA
PMID:33220234	(2020) Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,PTGS2,MYD88,CCL5,VEGFA
PMID:33302580	(2020) Inhibition of NADPH Oxidases Activity by Diphenyleneiodonium Chloride as a Mechanism of Senescence Induction in Human Cancer Cells.	5	15	1.58	0.00041	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTEN,NOX1,BCL2,VEGFA
PMID:33339267	(2020) Multi-Therapeutic Potential of Naringenin (4,5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms.	7	51	1.2	0.00041	9606.ENSP00000260356,9606.ENSP00000311005,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,MAPK7,EDNRA,SREBF1,BCL2,AGTR1,VEGFA
PMID:33352789	(2020) Psychobiotics: Mechanisms of Action, Evaluation Methods and Effectiveness in Applications with Food Products.	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	MPO,IFNG,NPY,NTF3,BDNF
PMID:33584695	(2020) Moonlighting Proteins Are Important Players in Cancer Immunology.	10	138	0.92	0.00041	9606.ENSP00000228434,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD69,HSPB1,IGF1R,STAT5A,CD247,CD47,PTGS2,JAK2,BCL2,VEGFA
PMID:30788342	(2019) Coordinating Development: How Do Animals Integrate Plastic and Robust Developmental Processes?	4	5	1.96	0.00041	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000361021,9606.ENSP00000368104	SOX9,APC,PTEN,BMP2
PMID:30873580	(2019) Mechanosensing and Mechanoregulation of Endothelial Cell Functions.	10	138	0.92	0.00041	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,HSPB1,NOX4,MMP14,ELN,PTGS2,HSPG2,EDN1,RHOA,VEGFA
PMID:30906568	(2019) Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy.	8	76	1.08	0.00041	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	IGF1R,ATM,CD34,SIRT6,STAT5A,PTEN,JAK2,BCL2
PMID:31013625	(2019) RNA-Binding Proteins HuB, HuC, and HuD are Distinctly Regulated in Dorsal Root Ganglia Neurons from STZ-Sensitive Compared to STZ-Resistant Diabetic Mice.	5	15	1.58	0.00041	9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	PTGS2,GAP43,BDNF,MME,VEGFA
PMID:31031622	(2019) Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CHI3L1,CDH1,ANGPT2,NFE2L2,BCL2,VEGFA
PMID:31042345	(2019) The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000419422,9606.ENSP00000478570	CD38,CD34,ANGPT2,AGTR1,VEGFA
PMID:31067776	(2019) Effects of Intestinal Microbial-Elaborated Butyrate on Oncogenic Signaling Pathways.	8	76	1.08	0.00041	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CDH1,SIRT6,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:31108964	(2019) Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.	8	76	1.08	0.00041	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,CD47,PTEN,BCL2,FGFR1,PROM1,VEGFA
PMID:31124204	(2019) Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.	8	76	1.08	0.00041	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000371067	CD69,CXCL10,CXCL11,CCL20,ELN,CXCL9,S100A12,JAK2
PMID:31311204	(2019) Targeting the Canonical WNTbeta-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.	7	51	1.2	0.00041	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,PTGS2,PTEN,NFE2L2,BCL2,VEGFA
PMID:31334229	(2019) The Role of the Extracellular Matrix in Cancer Stemness.	7	51	1.2	0.00041	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,MMP14,HNF4A,CD47,CNTF,RHOA,VEGFA
PMID:31335473	(2019) Pivotal micro factors associated with endothelial cells.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,MMP14,CD34,ANG,PTGS2,PROM1,VEGFA
PMID:31422044	(2019) Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,S100A12,SAA1,LTA,CCL5,VEGFA
PMID:31450621	(2019) TGFbetaBMP Signaling Pathway in Cartilage Homeostasis.	8	76	1.08	0.00041	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000363827,9606.ENSP00000363973,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478319	SOX9,TIMP3,HSPG2,ALPL,BAMBI,BMP2,RHOA,GREM1
PMID:31472696	(2019) Pioglitazone suppresses excessive follicular development in murine preantral follicles.	5	15	1.58	0.00041	9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000369816,9606.ENSP00000478570	PTEN,AR,BMP2,SHBG,VEGFA
PMID:31475778	(2019) Protective role of melatonin in early-stage and end-stage liver cirrhosis.	7	51	1.2	0.00041	9606.ENSP00000259486,9606.ENSP00000284031,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	ENPP2,DDAH1,BMP2,NFE2L2,BCL2,BDNF,VEGFA
PMID:31578376	(2019) Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice.	5	15	1.58	0.00041	9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	EDNRA,PTGS2,EDN1,AGTR1,VEGFA
PMID:31622015	(2019) Coptisine from Coptis chinensis exerts diverse beneficial properties: A concise review.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000321334,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495	MPO,CDH1,LPA,EDN1,BCL2,MYD88,LTA
PMID:31623280	(2019) Mitochondrial Dysfunction in the Transition from NASH to HCC.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CDH1,HNF4A,SIRT6,SREBF1,JAK2,BCL2
PMID:31694146	(2019) Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000474412	CXCL10,CAV1,SREBF1,EDN1,JAK2,RARRES2,CCL5
PMID:31698726	(2019) The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma.	7	51	1.2	0.00041	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,ATM,CXCL10,PTEN,BCL2,CCL5,VEGFA
PMID:31717832	(2019) Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells.	8	76	1.08	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,ABCG1,NFE2L2,CCL5,VEGFA
PMID:31777543	(2019) Comparison of cytokine profiles induced by nonlethal and lethal doses of influenza A virus in mice.	7	51	1.2	0.00041	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:31781593	(2019) Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000419422	CXCL10,CXCL11,CXCL9,RHOA,AGTR1
PMID:31788367	(2019) Navigating oxygen deprivation: liver transcriptomic responses of the red eared slider turtle to environmental anoxia.	4	5	1.96	0.00041	9606.ENSP00000013807,9606.ENSP00000264717,9606.ENSP00000310520,9606.ENSP00000362057	ERCC1,GCKR,ERCC4,NOX1
PMID:31840081	(2019) Synchronous inhibition of mTOR and VEGFNRP1 axis impedes tumor growth and metastasis in renal cancer.	5	15	1.58	0.00041	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	TGFB1,CXCL10,CXCL11,CXCL9,VEGFA
PMID:31859460	(2019) MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.	8	76	1.08	0.00041	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,TIMP3,IGF1R,PTEN,BCL2,RHOA,VEGFA
PMID:31905766	(2019) Hematopoietic Cells Derived from Cancer Stem Cells Generated from Mouse Induced Pluripotent Stem Cells.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,ALDH1A1,CD34,MME,PROM1
PMID:32038244	(2019) Ginsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells.	7	51	1.2	0.00041	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000478570	CD34,ELN,SGK1,BMP2,GAP43,BCL2,VEGFA
PMID:28637080	(2018) The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:29239137	(2018) Medical management of gastric cancer: a 2017 update.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,JAK2,RHOA,VEGFA
PMID:29719539	(2018) Natural Killer Cell Recruitment to the Lung During Influenza A Virus Infection Is Dependent on CXCR3, CCR5, and Virus Exposure Dose.	5	15	1.58	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:29795466	(2018) Upregulation of angiostatic chemokines IP-10CXCL10 and I-TACCXCL11 in human obesity and their implication for adipose tissue angiogenesis.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:29867026	(2018) The Pattern of Signatures in Gastric Cancer Prognosis.	8	76	1.08	0.00041	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,PTGS2,PTEN,JAK2,BCL2,RHOA,MME,VEGFA
PMID:29867567	(2018) Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol.	5	15	1.58	0.00041	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995	CETP,MPO,LPL,LPA,ABCG1
PMID:29907133	(2018) Emerging role of lipid metabolism alterations in Cancer stem cells.	8	76	1.08	0.00041	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,SREBF1,PTEN,NFE2L2,PROM1,VEGFA
PMID:29954076	(2018) GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000304767,9606.ENSP00000315011,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175	CDH1,P2RY1,EDNRA,CNR1,PTEN,JAK2,RHOA
PMID:29992751	(2018) Emerging findings into molecular mechanism of brain metastasis.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000478570	CDH1,CD34,PTGS2,PTEN,BCL2,HPSE,VEGFA
PMID:30038574	(2018) Physiological and Biological Responses to Short-Term Intermittent Hypobaric Hypoxia Exposure: From Sports and Mountain Medicine to New Biomedical Applications.	5	15	1.58	0.00041	9606.ENSP00000222139,9606.ENSP00000298352,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,NGB,BCL2,BDNF,VEGFA
PMID:30052066	(2018) The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000360522,9606.ENSP00000384906,9606.ENSP00000418009	IFNG,CXCL10,RBP4,SAA1,RARRES2
PMID:30087852	(2018) Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?	9	105	0.99	0.00041	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTEN,NFE2L2,BCL2,FGFR1,PROM1,VEGFA
PMID:30513940	(2018) Reconstructing Bone with Natural Bone Graft: A Review of In Vivo Studies in Bone Defect Animal Model.	5	15	1.58	0.00041	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,CD34,ELN,BMP2,VEGFA
PMID:27741508	(2017) Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,STAT5A,PTEN,AR,JAK2,BCL2,PROM1
PMID:27742621	(2017) TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.	4	5	1.96	0.00041	9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000355361,9606.ENSP00000368683	THBS1,EDNRA,CD47,EDN1
PMID:28180980	(2017) Myofibroblast in the ligamentum flavum hypertrophic activity.	4	5	1.96	0.00041	9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000478570	TGFB1,ELN,ANGPTL2,VEGFA
PMID:28264489	(2017) Tenebrio molitor Larvae Inhibit Adipogenesis through AMPK and MAPKs Signaling in 3T3-L1 Adipocytes and Obesity in High-Fat Diet-Induced Obese Mice.	5	15	1.58	0.00041	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000384364	MAPK1,FABP4,LPL,SREBF1,NPY
PMID:28276820	(2017) Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000363596	MPO,IFNG,PTGS2,CNR1,CNR2
PMID:28285686	(2017) Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer.	5	15	1.58	0.00041	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000478570	TGFB1,THBS1,ANGPT2,PDGFB,VEGFA
PMID:28373915	(2017) Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.	8	76	1.08	0.00041	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CXCL10,CCL20,CNTF,NPY,NTF3,BDNF,VEGFA
PMID:28383628	(2017) Interferon-gamma-induced protein 10 in Lyme disease.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:28422089	(2017) Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport.	5	15	1.58	0.00041	9606.ENSP00000200676,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995	CETP,FABP4,LPL,LPA,ABCG1
PMID:28433542	(2017) Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.	5	15	1.58	0.00041	9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	THBS1,EDNRA,PDGFB,PDGFA,VEGFA
PMID:28496437	(2017) Bacillus anthracis Peptidoglycan Integrity Is Disrupted by the Chemokine CXCL10 through the FtsEX Complex.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:28553016	(2017) Urinary Levels of IL-1beta and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,BDNF,CCL5
PMID:28662830	(2017) Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.	8	76	1.08	0.00041	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,MMP14,EDNRA,ELN,NOX1,RHOA,AGTR1,VEGFA
PMID:28686641	(2017) The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:28708082	(2017) Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases.	8	76	1.08	0.00041	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,STAT5A,CCL20,CXCL9,RARRES2,CCL5,VEGFA
PMID:28757878	(2017) Neuroprotective Effects of Stem Cells in Ischemic Stroke.	5	15	1.58	0.00041	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANGPT2,BCL2,BDNF,VEGFA
PMID:28775934	(2017) Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells.	7	51	1.2	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,CXCL9,CNTF,CCL5,VEGFA
PMID:28796257	(2017) LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTENPI3KAKT pathway in multiple myeloma.	5	15	1.58	0.00041	9606.ENSP00000285407,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	KLF10,PTEN,BCL2,AGTR1,VEGFA
PMID:28865990	(2017) ECM turnover-stimulated gene delivery through collagen-mimetic peptide-plasmid integration in collagen.	4	5	1.96	0.00041	9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000478570	PDGFB,CAV1,BMP2,VEGFA
PMID:28878685	(2017) Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies.	7	51	1.2	0.00041	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000360522,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	PON2,NOX4,RBP4,NOX1,TXN,NFE2L2,BCL2
PMID:29039473	(2017) Altered expression profiles of circular RNA in colorectal cancer tissues from patients with lung metastasis.	5	15	1.58	0.00041	9606.ENSP00000013807,9606.ENSP00000227868,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000363822	ERCC1,PDHX,ATM,CCR5,AR
PMID:29163802	(2017) Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.	5	15	1.58	0.00041	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000478570	CD34,ANGPT2,EDNRA,EDN1,VEGFA
PMID:29284412	(2017) CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFNRBV.	5	15	1.58	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:29440984	(2017) The Optimal Timing for Pancreatic Islet Transplantation into Subcutaneous Scaffolds Assessed by Multimodal Imaging.	5	15	1.58	0.00041	9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000478570	FABP4,ANGPT2,ELN,CNTF,VEGFA
PMID:26709763	(2016) Regulation and involvement of matrix metalloproteinases in vascular diseases.	8	76	1.08	0.00041	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000478570	THBS1,ATM,MMP14,CAV1,ELN,PTGS2,HSPG2,VEGFA
PMID:26757984	(2016) On the Utility of ToxCast(TM) and ToxPi as Methods for Identifying New Obesogens.	5	15	1.58	0.00041	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000402152	FABP4,LPL,HNF4A,SREBF1,SLC12A3
PMID:26850040	(2016) Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing ...	5	15	1.58	0.00041	9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	PTEN,SHBG,BCL2,LTA,VEGFA
PMID:26869447	(2016) miRNAs and High-Density Lipoprotein metabolism.	7	51	1.2	0.00041	9606.ENSP00000200676,9606.ENSP00000317674,9606.ENSP00000337332,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000384906	CETP,APOL1,SIRT6,PRKAA1,SREBF1,ABCG1,SAA1
PMID:27031164	(2016) Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.	8	76	1.08	0.00041	9606.ENSP00000013807,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,HNF4A,PTEN,MTHFR,JAK2,FGFR1,PROM1,VEGFA
PMID:27042837	(2016) Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources.	4	5	1.96	0.00041	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CD34,MME,PROM1
PMID:27045355	(2016) Comprehensive Genome-Wide Transcriptomic Analysis of Immature Articular Cartilage following Ischemic Osteonecrosis of the Femoral Head in Piglets.	7	51	1.2	0.00041	9606.ENSP00000245479,9606.ENSP00000306884,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,CXCL11,MAP3K5,CXCL9,PTGS2,BMP2,VEGFA
PMID:27091078	(2016) Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats.	4	5	1.96	0.00041	9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	EDNRA,PTGS2,EDN1,VEGFA
PMID:27124451	(2016) Hypoxic control of metastasis.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CD47,PTEN,EDN1,CCL5,VEGFA
PMID:27211546	(2016) Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000474412	CD38,CD69,CCR5,PRDX2,TXN,G6PD,CCL5
PMID:27484185	(2016) CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.	5	15	1.58	0.00041	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000361021	CDH1,ATM,HNF4A,CAV1,PTEN
PMID:27651793	(2016) Early Vascular Damage in Young Women with DM-1 and Its Relation to Anti-Mullerian Hormone: A Cross-Sectional Study.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CXCL10,CD34,PROM1,VEGFA
PMID:27671821	(2016) Celastrol and Its Role in Controlling Chronic Diseases.	7	51	1.2	0.00041	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,CXCL10,NOX1,JAK2,NFE2L2,BCL2,VEGFA
PMID:27825319	(2016) Growth hormone is increased in the lungs and enhances experimental lung metastasis of melanoma in DJ-1 KO mice.	5	15	1.58	0.00041	9606.ENSP00000225275,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067	MPO,STAT5A,PTEN,AR,JAK2
PMID:27886147	(2016) Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.	5	15	1.58	0.00041	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,PTGS2,BCL2,VEGFA
PMID:27899964	(2016) Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000371067,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,JAK2,PROM1
PMID:28051834	(2016) Interferon-gamma-induced protein 10 in Dengue Virus infection.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:25469849	(2015) RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,EDN1,AGTR1,CCL5,VEGFA
PMID:25574918	(2015) CXCR3 ligands as clinical markers for pulmonary tuberculosis.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:25688242	(2015) Urinary extracellular vesicles as source of biomarkers in kidney diseases.	7	51	1.2	0.00041	9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000352264,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000402152,9606.ENSP00000426809	AMBP,VDAC1,CD2AP,HSPG2,BCL2,SLC12A3,PROM1
PMID:25794049	(2015) Effects of Alpha Particle and Proton Beam Irradiation as Putative Cross-Talk between A549 Cancer Cells and the Endothelial Cells in a Co-Culture System.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFB,BCL2,CCL5,VEGFA
PMID:25795373	(2015) Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.	4	5	1.96	0.00041	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000478570	TGFB1,PDGFB,PTGS2,VEGFA
PMID:25802721	(2015) Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes.	5	15	1.58	0.00041	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,NTF3,BDNF,VEGFA
PMID:25995986	(2015) Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients.	5	15	1.58	0.00041	9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356213,9606.ENSP00000384364	PLIN1,LPL,SREBF1,VIP,NPY
PMID:26024523	(2015) MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809	CD38,AMBP,CXCL10,CD34,PROM1
PMID:26044102	(2015) Impaired pulmonary vascular development in bronchopulmonary dysplasia.	5	15	1.58	0.00041	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,EDN1,PROM1,VEGFA
PMID:26064956	(2015) MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.	7	51	1.2	0.00041	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,IGF1R,STAT5A,PTEN,RHOA,VEGFA
PMID:26098852	(2015) The Axolotl Fibula as a Model for the Induction of Regeneration across Large Segment Defects in Long Bones of the Extremities.	5	15	1.58	0.00041	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000376865,9606.ENSP00000478570	PDGFB,PDGFA,BMP2,PDGFD,VEGFA
PMID:26236231	(2015) Protective effects of ginseng on neurological disorders.	7	51	1.2	0.00041	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000384364,9606.ENSP00000414303	IFNG,PTGS2,NFE2L2,BCL2,PLA2G2A,NPY,BDNF
PMID:26359669	(2015) Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates Direct Antimicrobial Activity against Mastitis Causing Bacteria.	4	5	1.96	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CXCL10,CXCL11,CCL20,CXCL9
PMID:26447543	(2015) Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.	7	51	1.2	0.00041	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000368104	TGFB1,SOX9,CDH1,MMP14,PTEN,BAMBI,BMP2
PMID:26557038	(2015) Cathelicidin impact on inflammatory cells.	7	51	1.2	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5,VEGFA
PMID:26584646	(2015) The twisted survivin connection to angiogenesis.	7	51	1.2	0.00041	9606.ENSP00000222305,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000478570	USF2,HNF4A,PTEN,BCL2,NPY,MYD88,VEGFA
PMID:26629397	(2015) A comprehensive review of amyotrophic lateral sclerosis.	5	15	1.58	0.00041	9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	ANG,CNTF,AR,BCL2,VEGFA
PMID:26770026	(2015) Primary ovarian cancer cell inhibition by human Whartons Jelly stem cells (hWJSCs): Mapping probable mechanisms and targets using systems oncology.	5	15	1.58	0.00041	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PTEN,JAK2,BCL2,VEGFA
PMID:26818606	(2015) Mesenchymal stem cells for treating ocular surface diseases.	7	51	1.2	0.00041	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,LTA,BDNF,PROM1,VEGFA
PMID:23816560	(2014) Vasculogenic mimicry: a novel target for glioma therapy.	5	15	1.58	0.00041	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,PTGS2,PROM1,VEGFA
PMID:24154640	(2014) Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:24331662	(2014) A critical role of the PTENPDGF signaling network for the regulation of radiosensitivity in adenocarcinoma of the prostate.	4	5	1.96	0.00041	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865	PDGFB,PDGFA,PTEN,PDGFD
PMID:24626192	(2014) Expression of miR-33 from an SREBF2 intron targets the FTO gene in the chicken.	5	15	1.58	0.00041	9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000358513,9606.ENSP00000418823,9606.ENSP00000480291	SREBF1,ABCG1,CNR1,FTO,HNF1B
PMID:24627643	(2014) Brain repair: cell therapy in stroke.	5	15	1.58	0.00041	9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,NTF3,BDNF,PROM1,VEGFA
PMID:24660852	(2014) Characterization of gammadeltaT cells in naive and HIV-infected chimpanzees and their responses to T-cell activators in vitro.	7	51	1.2	0.00041	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:24874729	(2014) Systems biology of cisplatin resistance: past, present and future.	9	105	0.99	0.00041	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,HSPB1,VDAC1,ATM,PRKCE,MAPK7,PTEN,BCL2,VEGFA
PMID:24971315	(2014) Prostate cancer and bone: the elective affinities.	8	76	1.08	0.00041	9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	HNF4A,ANGPT2,PTGS2,AR,BMP2,EDN1,CCL5,VEGFA
PMID:25122689	(2014) Different culture conditions modulate the immunological properties of adipose stem cells.	5	15	1.58	0.00041	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL9,CCL5
PMID:25140302	(2014) The motile breast cancer phenotype roles of proteoglycansglycosaminoglycans.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000384262,9606.ENSP00000401399	CDH1,IGF1R,MMP14,FMOD,ELN,HPSE,MYD88
PMID:25197575	(2014) ApoA-IHDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes.	5	15	1.58	0.00041	9606.ENSP00000321334,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995	LPA,ANG,CAV1,SREBF1,ABCG1
PMID:25204993	(2014) Osteoblasts: a novel source of erythropoietin.	5	15	1.58	0.00041	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,STAT5A,BMP2,JAK2,VEGFA
PMID:25228925	(2014) A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,CNTF,CCL5,VEGFA
PMID:25271422	(2014) BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.	5	15	1.58	0.00041	9606.ENSP00000261769,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL9,BMP2,CCL5,VEGFA
PMID:25750744	(2014) Characterization of in vitro transcriptional responses of dorsal root ganglia cultured in the presence and absence of blastema cells from regenerating salamander limbs.	7	51	1.2	0.00041	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000331831,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,THBS1,GAS6,BMP2,NPY,NTF3,BDNF
PMID:25949190	(2014) A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-kappaB Signaling Cascade.	8	76	1.08	0.00041	9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,MAPK7,EDN1,BCL2,SAA1,MYD88,CCL5,VEGFA
PMID:23225891	(2013) Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.	5	15	1.58	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399	CCR5,CXCL10,CXCL9,PTEN,MYD88
PMID:23360828	(2013) Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors.	5	15	1.58	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:23388331	(2013) [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-gamma].	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:23472861	(2013) Platelet-rich plasma enhances autograft revascularization and reinnervation in a dog model of anterior cruciate ligament reconstruction.	4	5	1.96	0.00041	9606.ENSP00000260356,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000478570	THBS1,GAP43,NTF3,VEGFA
PMID:23536722	(2013) Endothelial cells enhance prostate cancer metastasis via IL-6-->androgen receptor-->TGF-beta-->MMP-9 signals.	5	15	1.58	0.00041	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CD34,AR,CCL5,VEGFA
PMID:23536776	(2013) Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker.	7	51	1.2	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000478319	IFNG,CXCL10,CXCL11,EDNRA,CCL20,CXCL9,GREM1
PMID:23544998	(2013) Association of TRPC1 gene polymorphisms with type 2 diabetes and diabetic nephropathy in Han Chinese population.	4	5	1.96	0.00041	9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000402152,9606.ENSP00000419313	HNF4A,KCNJ11,SLC12A3,TRPC1
PMID:23915095	(2013) Bone marrow-derived progenitor cells in end-stage lung disease patients.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CD34,CXCL9,CCL5
PMID:24063376	(2013) Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.	7	51	1.2	0.00041	9606.ENSP00000304767,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000419422,9606.ENSP00000478570	P2RY1,ANGPT2,EDNRA,PDGFB,PDGFA,AGTR1,VEGFA
PMID:24082215	(2013) Multiple familial trichoepithelioma with malignant transformation.	4	5	1.96	0.00041	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CD34,AR,BCL2,MME
PMID:24113581	(2013) Non-coding RNAs: the dark matter of cardiovascular pathophysiology.	8	76	1.08	0.00041	9606.ENSP00000215832,9606.ENSP00000306124,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,PRKCE,MAP3K5,PTEN,TXN,EDN1,RHOA,VEGFA
PMID:24376714	(2013) Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma.	5	15	1.58	0.00041	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,CAV1,VEGFA
PMID:25070783	(2013) MicroRNA and HER2-overexpressing cancer.	7	51	1.2	0.00041	9606.ENSP00000215832,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,LAMC1,CDH1,TIMP3,PTEN,BCL2,RHOA
PMID:22299021	(2012) Thrombospondin-1 and VEGF in inflammatory bowel disease.	4	5	1.96	0.00041	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000478570	TGFB1,IFNG,THBS1,VEGFA
PMID:22358057	(2012) Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:22497828	(2012) Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase Cnicotinamide adenine dinucleotide phosphate oxidase-dependent manner.	5	15	1.58	0.00041	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	NOX4,NOX1,EDN1,BCL2,AGTR1
PMID:22508840	(2012) Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.	5	15	1.58	0.00041	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995	CETP,MPO,LPL,LPA,ABCG1
PMID:22520846	(2012) Janus kinase deregulation in leukemia and lymphoma.	7	51	1.2	0.00041	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	EPOR,CD34,STAT5A,JAK2,BCL2,IRAK4,MYD88
PMID:22611498	(2012) Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.	7	51	1.2	0.00041	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CD34,CAV1,EDN1,PROM1,CCL5,VEGFA
PMID:22717583	(2012) Intrinsic regulation of hemangioma involution by platelet-derived growth factor.	5	15	1.58	0.00041	9606.ENSP00000256104,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000426809	FABP4,PDGFB,PDGFA,PDGFD,PROM1
PMID:22880047	(2012) MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.	7	51	1.2	0.00041	9606.ENSP00000261037,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000376865,9606.ENSP00000384364,9606.ENSP00000478570	COL8A1,MMP14,CD34,ELN,PDGFD,NPY,VEGFA
PMID:23369699	(2012) Dose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,VEGFA
PMID:21183928	(2011) Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.	4	5	1.96	0.00041	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	CD34,EDN1,AGTR1,VEGFA
PMID:21200283	(2011) Hyperbaric oxygen: its mechanisms and efficacy.	5	15	1.58	0.00041	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000363641,9606.ENSP00000478570	TGFB1,MPO,ANGPT2,TXN,VEGFA
PMID:21302177	(2011) Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	IFNG,IGF1R,PTGS2,PTEN,BCL2
PMID:21314431	(2011) Myocardial remodeling: cellular and extracellular events and targets.	5	15	1.58	0.00041	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000426809	TIMP3,MMP14,CD34,CXCL9,PROM1
PMID:21569306	(2011) Lipid phosphate phosphatase-3 regulates tumor growth via beta-catenin and CYCLIN-D1 signaling.	5	15	1.58	0.00041	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,HNF4A,PROM1,VEGFA
PMID:21597472	(2011) Fibrocytes: emerging effector cells in chronic inflammation.	7	51	1.2	0.00041	9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478570	CHI3L1,CD34,STAT5A,HSPG2,EDN1,MME,VEGFA
PMID:21665990	(2011) Common variants near FRKCOL10A1 and VEGFA are associated with advanced age-related macular degeneration.	5	15	1.58	0.00041	9606.ENSP00000200676,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000478570	CETP,THBS1,COL8A1,TIMP3,VEGFA
PMID:21696410	(2011) Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates.	5	15	1.58	0.00041	9606.ENSP00000298352,9606.ENSP00000354511,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525	NGB,COMT,BCL2,BDNF,MME
PMID:21930768	(2011) Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation.	7	51	1.2	0.00041	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:20019195	(2010) Aberrant inflammatory response to Streptococcus pyogenes in mice lacking myeloid differentiation factor 88.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399	IFNG,CXCL10,CXCL9,MYD88
PMID:20164683	(2010) Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.	7	51	1.2	0.00041	9606.ENSP00000216862,9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,APC,THBS1,CDH1,PTEN,BCL2,VEGFA
PMID:20379873	(2010) Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:20805442	(2010) Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.	5	15	1.58	0.00041	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175	NOX4,NOX1,EDN1,JAK2,RHOA
PMID:20827338	(2010) Toll-like Receptor3-mediated Induction of Chemokines in Salivary Epithelial Cells.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL5
PMID:20851072	(2010) Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000418525	CD38,CD69,AMBP,CD34,MME
PMID:21151606	(2010) High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.	4	5	1.96	0.00041	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000426809	CD34,AR,JAK2,PROM1
PMID:23082307	(2010) Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.	7	51	1.2	0.00041	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,ANGPT2,PTGS2,BCL2,CCL5,VEGFA
PMID:18789927	(2009) Biological properties of trabecular meshwork cells.	5	15	1.58	0.00041	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000368104,9606.ENSP00000368683	THBS1,MMP14,EDNRA,BMP2,EDN1
PMID:19155265	(2009) The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor.	4	5	1.96	0.00041	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067	MAPK1,EPOR,STAT5A,JAK2
PMID:19336372	(2009) Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants.	5	15	1.58	0.00041	9606.ENSP00000229135,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,LTA,BDNF,CCL5,VEGFA
PMID:19577709	(2009) Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.	5	15	1.58	0.00041	9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	EDNRA,VIP,PTGS2,EDN1,VEGFA
PMID:19629358	(2009) [Inflammatory cells and their mediators in COPD pathogenesis].	4	5	1.96	0.00041	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:19735711	(2009) Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2STAT5 signaling pathway.	4	5	1.96	0.00041	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	EPOR,CD34,STAT5A,JAK2
PMID:19923899	(2009) Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.	5	15	1.58	0.00041	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ATM,CD34,BCL2,PROM1
PMID:18092321	(2008) The twenty-second Aspen Cancer Conference: Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and Cancer Therapy, 2007.	8	76	1.08	0.00041	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,CDH1,PTGS2,PTEN,AR,BCL2,MME,VEGFA
PMID:18821591	(2008) Molecular targeted therapies in hepatocellular carcinoma.	7	51	1.2	0.00041	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,MMP14,ANGPT2,PTEN,BCL2,VEGFA
PMID:17414926	(2007) Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virusHIV-coinfected patients.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:17475924	(2007) Role of chemokines in endocrine autoimmune diseases.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:17875002	(2007) The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.	4	5	1.96	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,CCL5
PMID:18038413	(2007) Effects of surface-modified scaffolds on the growth and differentiation of mouse adipose-derived stromal cells.	4	5	1.96	0.00041	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PTGS2,PROM1,VEGFA
PMID:16923831	(2006) Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways.	7	51	1.2	0.00041	9606.ENSP00000215832,9606.ENSP00000356438,9606.ENSP00000384262,9606.ENSP00000414303,9606.ENSP00000419313,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,PTGS2,HPSE,BDNF,TRPC1,PROM1,VEGFA
PMID:16930512	(2006) Role of platelet-derived growth factor-B, vascular endothelial growth factor, insulin-like growth factor-II, mitogen-activated protein kinase and transforming growth factor-beta1 in expansion-induced lung growth in fetal sheep.	4	5	1.96	0.00041	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000478570	TGFB1,IGF1R,PDGFB,VEGFA
PMID:17114340	(2006) Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells.	4	5	1.96	0.00041	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000478570	THBS1,CDH1,CAV1,VEGFA
PMID:15621055	(2005) Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:15755293	(2005) Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia.	4	5	1.96	0.00041	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036	CD38,CD69,IFNG,CD34
PMID:15805997	(2005) Asthmatic bronchial epithelium activated by the proteolytic allergen Der p 1 increases selective dendritic cell recruitment.	4	5	1.96	0.00041	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000474412	CXCL10,CD34,CCL20,CCL5
PMID:15863363	(2005) Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000371067,9606.ENSP00000383364,9606.ENSP00000400175	IFNG,JAK2,PLA2G2A,RHOA
PMID:15548973	(2004) CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.	4	5	1.96	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL5
PMID:12417585	(2003) Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:12629513	(2003) PDGF-D is a potent transforming and angiogenic growth factor.	4	5	1.96	0.00041	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000478570	PDGFB,PDGFA,PDGFD,VEGFA
PMID:12739748	(2003) Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:14763503	(2003) Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells.	4	5	1.96	0.00041	9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809	CD34,NTF3,BDNF,PROM1
PMID:12517732	(2002) A CXC chemokine sequence isolated from the rainbow trout Oncorhynchus mykiss resembles the closely related interferon-gamma-inducible chemokines CXCL9, CXCL10 and CXCL11.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:11259614	(2001) Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:11085753	(2000) Requirement of the chemokine receptor CXCR3 for acute allograft rejection.	5	15	1.58	0.00041	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:10233762	(1999) Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10Mig receptor (CXCR3).	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:10601272	(1999) Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats.	4	5	1.96	0.00041	9606.ENSP00000229135,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000341208	IFNG,ONECUT1,HNF4A,STAT5A
PMID:8477446	(1993) The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis.	4	5	1.96	0.00041	9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	CNTF,BCL2,NTF3,BDNF
PMID:29399410	(....) poly(i:c) primes primary human glioblastoma cells for an immune response invigorated by pd-l1 blockade.	5	15	1.58	0.00041	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL9,CCL5
PMID:35276890	(2022) Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications.	9	106	0.99	0.00042	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,NOX4,MMP14,PTEN,JAK2,BCL2,FGFR1,RHOA,VEGFA
PMID:33869048	(2021) Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis.	10	139	0.92	0.00042	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000418823,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,KLF10,PTEN,BCL2,HPSE,FTO,VEGFA
PMID:34578166	(2021) Molecular Pathogenesis and Immune Evasion of Vesicular Stomatitis New Jersey Virus Inferred from Genes Expression Changes in Infected Porcine Macrophages.	9	106	0.99	0.00042	9606.ENSP00000292303,9606.ENSP00000304767,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000362410,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,P2RY1,CCL20,PTGS2,SGK1,MAFB,MYD88,CCL5,VEGFA
PMID:31730279	(2020) Immune modulation by mesenchymal stem cells.	9	106	0.99	0.00042	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412	CD69,CCR5,CXCL10,CD34,CCL20,CXCL9,PTGS2,ENTPD1,CCL5
PMID:32712221	(2020) The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease.	9	106	0.99	0.00042	9606.ENSP00000255409,9606.ENSP00000259486,9606.ENSP00000264717,9606.ENSP00000278840,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000360522,9606.ENSP00000369816,9606.ENSP00000474412	CHI3L1,ENPP2,GCKR,FADS2,SIRT6,MAP3K5,RBP4,SHBG,CCL5
PMID:32982772	(2020) The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver.	9	106	0.99	0.00042	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	FABP4,CCR5,CXCL10,CD34,ANGPT2,CCL20,CXCL9,EDN1,VEGFA
PMID:30578870	(2019) 17beta-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.	9	106	0.99	0.00042	9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000306124,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000444198,9606.ENSP00000474412	CD69,THBS1,TIMP3,PRKCE,JAK2,BCL2,SAA1,CITED2,CCL5
PMID:23744510	(2013) Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108.	9	106	0.99	0.00042	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	MAPK1,THBS1,TIMP3,IGF1R,ATM,ANGPT2,BCL2,LTA,VEGFA
PMID:35105853	(2022) EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.	6	31	1.35	0.00043	9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865	CHI3L1,IGF1R,PDGFB,PDGFA,PTEN,PDGFD
PMID:35163485	(2022) Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma.	6	31	1.35	0.00043	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	THBS1,CDH1,PTEN,BCL2,LTA,VEGFA
PMID:35164215	(2022) Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes.	6	31	1.35	0.00043	9606.ENSP00000263317,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,GFPT1,PTEN,EDN1,NFE2L2,VEGFA
PMID:35205812	(2022) Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond.	6	31	1.35	0.00043	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,ALDH1A1,CD34,BCL2,FGFR1,VEGFA
PMID:33177060	(2021) Lower Airway Dysbiosis Affects Lung Cancer Progression.	6	31	1.35	0.00043	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL9,PTEN,CCL5,VEGFA
PMID:33273682	(2021) CXCR4 in Waldenstroems Macroglobulinema: chances and challenges.	6	31	1.35	0.00043	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,CD38,BCL2,IRAK4,MYD88,VEGFA
PMID:33530550	(2021) The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL9,MYD88,CCL5
PMID:33584134	(2021) The role of oxidative stress in the development of obesity and obesity-related metabolic disorders.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000375844,9606.ENSP00000383232,9606.ENSP00000478570	TGFB1,LPL,SREBF1,CAPN10,GGT1,VEGFA
PMID:33776489	(2021) Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy.	8	77	1.08	0.00043	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,IGF1R,CCL20,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:33778136	(2021) New insight of immuno-engineering in osteoimmunomodulation for bone regeneration.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,BMP2,LTA,VEGFA
PMID:33800156	(2021) Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer.	8	77	1.08	0.00043	9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,CD247,PTEN,AR,NFE2L2,NPY,MYD88,VEGFA
PMID:33802083	(2021) Danegaptide Prevents TGFbeta1-Induced Damage in Human Proximal Tubule Epithelial Cells of the Kidney.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000369442,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,HNF4A,KL,CCL5,VEGFA
PMID:33803671	(2021) Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas.	8	77	1.08	0.00043	9606.ENSP00000322898,9606.ENSP00000355361,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	EBF1,CD47,SGK1,PTEN,BCL2,RHOA,MYD88,MME
PMID:33805687	(2021) Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach.	8	77	1.08	0.00043	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000337332,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,MMP14,SIRT6,SGK1,PTEN,NFE2L2,BCL2,FGFR1
PMID:33995278	(2021) Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,STAT5A,PTEN,BCL2,RHOA,VEGFA
PMID:34178997	(2021) Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers.	6	31	1.35	0.00043	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	SOX9,ATM,STAT5A,PTEN,JAK2,BCL2
PMID:34203742	(2021) Gene Expression Profiling Reveals New Pathways and Genes Associated with VisnaMaedi Viral Disease.	8	77	1.08	0.00043	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000356515,9606.ENSP00000368683,9606.ENSP00000474412	TIMP3,CCR5,CAV1,CCL20,PTGS2,UTRN,EDN1,CCL5
PMID:34262796	(2021) Double-edged effects of interferons on the regulation of cancer-immunity cycle.	8	77	1.08	0.00043	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,ATM,CXCL10,CXCL9,JAK2,CCL5,VEGFA
PMID:34360964	(2021) Role of GPR39 in Neurovascular Homeostasis and Disease.	6	31	1.35	0.00043	9606.ENSP00000346508,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PDGFA,CNR1,BCL2,RHOA,BDNF,VEGFA
PMID:34414175	(2021) The Tyrosine Kinase-Driven Networks of Novel Long Non-coding RNAs and Their Molecular Targets in Myeloproliferative Neoplasms.	6	31	1.35	0.00043	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CXCL11,CD34,STAT5A,PTEN,JAK2,VEGFA
PMID:34577576	(2021) Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTKmTORVEGF Signaling.	6	31	1.35	0.00043	9606.ENSP00000314897,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ANGPT2,SGK1,JAK2,BCL2,PROM1,VEGFA
PMID:34631676	(2021) Effect of Microgravity on Endothelial Cell Function, Angiogenesis, and Vessel Remodeling During Wound Healing.	6	31	1.35	0.00043	9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	MMP14,ANGPT2,CAV1,HSPG2,RHOA,VEGFA
PMID:34946778	(2021) Withaferin A: From Ancient Remedy to Potential Drug Candidate.	8	77	1.08	0.00043	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000381185	TGFB1,FABP4,ALDH1A1,CD34,PTEN,ANGPTL2,EDN1,BCL2
PMID:34959716	(2021) The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence.	6	31	1.35	0.00043	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ATM,PTEN,NFE2L2,BCL2,CCL5,VEGFA
PMID:35003080	(2021) The Effects of Porphyromonas gingivalis on Atherosclerosis-Related Cells.	8	77	1.08	0.00043	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000401399	CXCL10,ANGPT2,GAS6,ELN,ABCG1,HSPG2,BCL2,MYD88
PMID:35087972	(2021) A review of neovascular glaucoma. Etiopathogenesis and treatment.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,MMP14,ANGPT2,PDGFB,EDN1,VEGFA
PMID:31642363	(2020) Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells.	6	31	1.35	0.00043	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,JAK2,RHOA,VEGFA
PMID:32038501	(2020) The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer.	6	31	1.35	0.00043	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000362057,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,CXCL10,NOX1,FGFR1,PROM1,VEGFA
PMID:32080959	(2020) Chemokines and galectins form heterodimers to modulate inflammation.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,CXCL11,CXCL9,TXN,BCL2,CCL5
PMID:32085474	(2020) Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors.	6	31	1.35	0.00043	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000478570	PTGS2,PTEN,AR,NFE2L2,MME,VEGFA
PMID:32368302	(2020) Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma.	8	77	1.08	0.00043	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,HNF4A,PTEN,BCL2,PROM1,VEGFA
PMID:32372860	(2020) Ginsenosides: potential therapeutic source for fibrosis-associated human diseases.	6	31	1.35	0.00043	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000369442,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CDH1,CAV1,KL,AGTR1,VEGFA
PMID:32398324	(2020) Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,ATM,CXCL10,CXCL9,CCL5,VEGFA
PMID:32514239	(2020) Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.	6	31	1.35	0.00043	9606.ENSP00000222572,9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000356832,9606.ENSP00000478570	PON2,CHI3L1,IGF1R,ALDH1A1,SGK1,VEGFA
PMID:32599910	(2020) An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.	6	31	1.35	0.00043	9606.ENSP00000246553,9606.ENSP00000259486,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000474412	FFAR1,ENPP2,PTGS2,EDN1,PLA2G2A,CCL5
PMID:32662111	(2020) COVID-19 and TregTh17 imbalance: Potential relationship to pregnancy outcomes.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CD38,CXCL10,CCL20,CXCL9,CCL5
PMID:32744067	(2020) Role of platelet-derived growth factor in type II diabetes mellitus and its complications.	6	31	1.35	0.00043	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PDGFB,PDGFA,PDGFD,BCL2,BDNF,VEGFA
PMID:32784481	(2020) Notch Transduction in Non-Small Cell Lung Cancer.	8	77	1.08	0.00043	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ALDH1A1,PDGFA,BCL2,PROM1,VEGFA
PMID:32863874	(2020) Anaesthesia and cancer: can anaesthetic drugs modify gene expression?	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000478570	IFNG,CDH1,IGF1R,ANGPT2,AR,VEGFA
PMID:32872192	(2020) The Impact of Ang-(1-9) and Ang-(3-7) on the Biological Properties of Prostate Cancer Cells by Modulation of Inflammatory and Steroidogenesis Pathway Genes.	6	31	1.35	0.00043	9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	STAT5A,AR,BCL2,RHOA,MME,VEGFA
PMID:32921312	(2020) Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis.	6	31	1.35	0.00043	9606.ENSP00000200676,9606.ENSP00000265132,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000360522,9606.ENSP00000384906	CETP,AMBP,APOL1,LPA,RBP4,SAA1
PMID:33144895	(2020) Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000356438	IFNG,CXCL10,CXCL11,HNF4A,CCL20,PTGS2
PMID:33193331	(2020) A 21st Century Evil: Immunopathology and New Therapies of COVID-19.	8	77	1.08	0.00043	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000419422,9606.ENSP00000478570	MPO,CD38,CD69,CCR5,CXCL10,CD34,AGTR1,VEGFA
PMID:33204331	(2020) Theta-burst transcranial magnetic stimulation promotes stroke recovery by vascular protection and neovascularization.	6	31	1.35	0.00043	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CAV1,CCL20,CXCL9,CCL5,VEGFA
PMID:33396745	(2020) Glyoxalase System in the Progression of Skin Aging and Skin Malignancies.	6	31	1.35	0.00043	9606.ENSP00000351807,9606.ENSP00000362463,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ELN,GLO1,EDN1,NFE2L2,BCL2,VEGFA
PMID:33408476	(2020) Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges.	6	31	1.35	0.00043	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,JAK2,CCL5,VEGFA
PMID:33519525	(2020) Links Between Testosterone, Oestrogen, and the Growth HormoneInsulin-Like Growth Factor Axis and Resistance Exercise Muscle Adaptations.	6	31	1.35	0.00043	9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000400175	IGF1R,STAT5A,AR,SHBG,JAK2,RHOA
PMID:33574820	(2020) Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Fas(lprlpr) Mice.	6	31	1.35	0.00043	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,BCL2,CCL5
PMID:30194990	(2019) Ras homolog family member ARho-associated protein kinase 1 signaling modulates lineage commitment of mesenchymal stem cells in asthmatic patients through lymphoid enhancer-binding factor 1.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,CD34,HNF4A,PTGS2,RHOA,VEGFA
PMID:30549207	(2019) Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors.	6	31	1.35	0.00043	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000426809	CD38,CD69,CDH1,CXCL10,ENTPD1,PROM1
PMID:30834271	(2019) New Gene Markers of Angiogenesis and Blood Vessels Development in Porcine Ovarian Granulosa Cells during Short-Term Primary Culture In Vitro.	6	31	1.35	0.00043	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000478570	CHI3L1,CXCL10,EDNRA,CAV1,ELN,VEGFA
PMID:30881959	(2019) Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000259486,9606.ENSP00000321334,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000400175	TGFB1,ENPP2,LPA,ALPL,BMP2,RHOA
PMID:30949450	(2019) Lysosomal Pathways and Autophagy Distinctively Control Endothelial Cell Behavior to Affect Tumor Vasculature.	6	31	1.35	0.00043	9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	IGF1R,ANGPT2,PDGFB,PDGFA,EDN1,VEGFA
PMID:30977191	(2019) T-cell positioning by chemokines in autoimmune skin diseases.	8	77	1.08	0.00043	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,ELN,CXCL9,JAK2,CCL5
PMID:31035408	(2019) Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects.	8	77	1.08	0.00043	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	MPO,CD38,ATM,CD34,CD2AP,PTEN,BCL2,RHOA
PMID:31134077	(2019) Nrf2 Involvement in Chemical-Induced Skin Innate Immunity.	8	77	1.08	0.00043	9606.ENSP00000265333,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	VDAC1,CD34,CCL20,PTGS2,NFE2L2,BCL2,MYD88,CCL5
PMID:31423451	(2019) RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung reveals unique pathway regulation.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CXCL9,VEGFA
PMID:31427916	(2019) Therapeutic Potential of Neurotrophins for Repair After Brain Injury: A Helping Hand From Biomaterials.	6	31	1.35	0.00043	9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	HSPG2,EDN1,NTF3,RHOA,BDNF,VEGFA
PMID:31435482	(2019) Traditional Oriental Medicines and Alzheimers Disease.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,BCL2,BDNF,VEGFA
PMID:31543756	(2019) Involvement of Epigenetic Mechanisms and Non-coding RNAs in Blood-Brain Barrier and Neurovascular Unit Injury and Recovery After Stroke.	8	77	1.08	0.00043	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,CXCL10,SIRT6,HSPG2,NFE2L2,MYD88,BDNF,VEGFA
PMID:31998297	(2019) New Insights on the Role of Lipid Metabolism in the Metabolic Reprogramming of Macrophages.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,NOX4,PLIN1,SREBF1,PTGS2,VEGFA
PMID:28540715	(2018) The role of endothelial lipase in lipid metabolism, inflammation, and cancer.	6	31	1.35	0.00043	9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000383364,9606.ENSP00000477707	LPL,LPA,STAT5A,JAK2,PLA2G2A,NR1H3
PMID:29229607	(2018) Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000300055,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000363822	CDH1,IGF1R,PLIN1,CXCL9,TXN,AR
PMID:29495622	(2018) Minoxidil Promotes Hair Growth through Stimulation of Growth Factor Release from Adipose-Derived Stem Cells.	6	31	1.35	0.00043	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PDGFA,AR,PDGFD,BCL2,VEGFA
PMID:29667012	(2018) Bone Marrow Adipocyte Developmental Origin and Biology.	6	31	1.35	0.00043	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000371067	SOX9,FABP4,PLIN1,LPL,CD34,JAK2
PMID:29670618	(2018) BCG and Adverse Events in the Context of Leprosy.	6	31	1.35	0.00043	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,ENTPD1,LTA,CCL5,VEGFA
PMID:29681903	(2018) Inflammatory Mediator Profiles Differ in Sepsis Patients With and Without Bacteremia.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,CXCL11,CCL5,VEGFA
PMID:29731655	(2018) Immune-regulating effects of exercise on cigarette smoke-induced inflammation.	8	77	1.08	0.00043	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,MMP14,PTGS2,EDN1,BCL2,BDNF,CCL5,VEGFA
PMID:29731721	(2018) Endothelial AIP1 Regulates Vascular Remodeling by Suppressing NADPH Oxidase-2.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000478570	IFNG,NOX4,ELN,MAP3K5,NOX1,VEGFA
PMID:29874886	(2018) The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications.	6	31	1.35	0.00043	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000478570	CETP,MPO,LPA,ABCG1,PTGS2,VEGFA
PMID:29875383	(2018) A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.	8	77	1.08	0.00043	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,IGF1R,ALDH1A1,CXCL10,CXCL11,CD34,MME,PROM1
PMID:30347782	(2018) Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.	8	77	1.08	0.00043	9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,MAP3K5,PTGS2,PTEN,BCL2,BDNF,CCL5,VEGFA
PMID:30524292	(2018) Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics.	6	31	1.35	0.00043	9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	HSPB1,CD34,CAV1,MME,AGTR1,VEGFA
PMID:30586399	(2018) Pulmonary toxicity and lung tumorigenic potential of surrogate metal oxides in gas metal arc welding-stainless steel fume: Iron as a primary mediator versus chromium and nickel.	6	31	1.35	0.00043	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,CXCL9,SAA1,CCL5,VEGFA
PMID:27901498	(2017) Targeting the VEGF-CVEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRASYAP1 signaling.	6	31	1.35	0.00043	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,ALDH1A1,CD34,PROM1,VEGFA
PMID:28163789	(2017) A porcine gluteus medius muscle genome-wide transcriptome analysis: dietary effects of omega-6 and omega-3 fatty acids on biological mechanisms.	6	31	1.35	0.00043	9606.ENSP00000215832,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000360522,9606.ENSP00000474412	MAPK1,FADS2,LPL,LPA,RBP4,CCL5
PMID:28367247	(2017) Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CXCL11,CAV1,EDN1,PROM1,VEGFA
PMID:28588507	(2017) Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CDH1,COMT,MTHFR,BDNF,VEGFA
PMID:28642697	(2017) Targeting Microglial Activation States as a Therapeutic Avenue in Parkinsons Disease.	8	77	1.08	0.00043	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,STAT5A,PTGS2,PTEN,JAK2,MYD88,BDNF,CCL5
PMID:28874759	(2017) Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:28880206	(2017) Comparative Response of Brain to Chronic Hypoxia and Hyperoxia.	6	31	1.35	0.00043	9606.ENSP00000222139,9606.ENSP00000298352,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,NGB,CD34,BCL2,BDNF,VEGFA
PMID:28983804	(2017) Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.	6	31	1.35	0.00043	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021	FABP4,CDH1,PLIN1,HNF4A,SREBF1,PTEN
PMID:29230082	(2017) Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.	8	77	1.08	0.00043	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000414303	IFNG,TIMP3,IGF1R,MMP14,GAS6,KL,JAK2,BDNF
PMID:26323267	(2016) Dysfunctional HDL and atherosclerotic cardiovascular disease.	6	31	1.35	0.00043	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000383364,9606.ENSP00000384906	CETP,LPL,LPA,ABCG1,PLA2G2A,SAA1
PMID:27297561	(2016) Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,BMP2,PROM1,CCL5,VEGFA
PMID:27357191	(2016) VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.	6	31	1.35	0.00043	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356213,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,VIP,CCL5
PMID:27514667	(2016) Gastric biomarkers: a global review.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,JAK2,FGFR1,RHOA,VEGFA
PMID:27832807	(2016) Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise.	6	31	1.35	0.00043	9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IGF1R,CXCL10,BDNF,CCL5,VEGFA
PMID:25673085	(2015) Triple-negative breast cancer in African-American women: disparities versus biology.	6	31	1.35	0.00043	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	IGF1R,ATM,ALDH1A1,PTGS2,PTEN,VEGFA
PMID:26074921	(2015) Regulation of NKT Cell Localization in Homeostasis and Infection.	8	77	1.08	0.00043	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CCL20,CXCL9,BCL2,CCL5
PMID:26180515	(2015) Cyclooxygeanse-2 promotes metastasis in osteosarcoma.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,IGF1R,CXCL9,PTGS2,BDNF,VEGFA
PMID:26351461	(2015) Physical, Spatial, and Molecular Aspects of Extracellular Matrix of In Vivo Niches and Artificial Scaffolds Relevant to Stem Cells Research.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000400175	CDH1,CD34,STAT5A,ELN,HSPG2,RHOA
PMID:26389893	(2015) Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy.	6	31	1.35	0.00043	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,CD34,STAT5A,JAK2,BDNF,VEGFA
PMID:26465138	(2015) Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model.	6	31	1.35	0.00043	9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000426809	CD69,AMBP,CD34,CXCL9,LTA,PROM1
PMID:26694467	(2015) Oncogenic MicroRNAs: Key Players in Malignant Transformation.	8	77	1.08	0.00043	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185	TGFB1,IFNG,CDH1,TIMP3,ATM,MMP14,PTEN,BCL2
PMID:24457954	(2014) Nox4 and redox signaling mediate TGF-beta-induced endothelial cell apoptosis and phenotypic switch.	6	31	1.35	0.00043	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,MAP3K5,PTEN,NOX1,BCL2,VEGFA
PMID:24524450	(2014) Pharmacologic neuroprotective strategies in neonatal brain injury.	6	31	1.35	0.00043	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BCL2,BDNF,VEGFA
PMID:24632571	(2014) Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1.	6	31	1.35	0.00043	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,IGF1R,CD34,BCL2,PROM1
PMID:24959422	(2014) Regulation of Metastasis by microRNAs in Ovarian Cancer.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,TIMP3,ALDH1A1,PTEN,PROM1,VEGFA
PMID:25230753	(2014) IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation.	6	31	1.35	0.00043	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CXCL9,CCL5,VEGFA
PMID:25528160	(2014) Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus.	6	31	1.35	0.00043	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:25529562	(2014) Mast cells and neuroinflammation.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CD34,VIP,BCL2,BDNF,VEGFA
PMID:27471701	(2014) Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab.	6	31	1.35	0.00043	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000418525	CD69,IFNG,CD34,PTEN,JAK2,MME
PMID:23307733	(2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.	6	31	1.35	0.00043	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000334329,9606.ENSP00000354995,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,UNC5B,ABCG1,CCL5,VEGFA
PMID:23429503	(2013) Simian immunodeficiency virus infection potently modulates chemokine networks and immune environments in hilar lymph nodes of cynomolgus macaques.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:23550937	(2013) Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties.	6	31	1.35	0.00043	9606.ENSP00000215832,9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000346148,9606.ENSP00000390651,9606.ENSP00000478570	MAPK1,VDAC1,IGF1R,PRKAA1,IRAK4,VEGFA
PMID:23555076	(2013) Vasculogenic cytokines in wound healing.	6	31	1.35	0.00043	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000426809	CD34,PDGFB,PDGFA,PDGFD,FGFR1,PROM1
PMID:21917410	(2012) Alcohol and inflammation and infection: clinical and experimental systems--summary of the 2010 Alcohol and Immunology Research Interest Group Meeting.	6	31	1.35	0.00043	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000401399,9606.ENSP00000474412	NOX4,CXCL10,CXCL9,NOX1,MYD88,CCL5
PMID:22249946	(2012) CD34 marks angiogenic tip cells in human vascular endothelial cell cultures.	6	31	1.35	0.00043	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,UNC5B,PROM1,VEGFA
PMID:22312192	(2012) TCCRWSX-1 is a novel angiogenic factor in age-related macular degeneration.	6	31	1.35	0.00043	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,CXCL9,CNTF,VEGFA
PMID:22421313	(2012) Prostate cancer stem cells.	6	31	1.35	0.00043	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809	CD34,PTEN,AR,PDGFD,BCL2,PROM1
PMID:22457230	(2012) Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000341208,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,STAT5A,S100A12,EDN1,MYD88,VEGFA
PMID:22474423	(2012) Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?	6	31	1.35	0.00043	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185	PON2,NOX4,MAP3K5,NOX1,EDN1,BCL2
PMID:22482452	(2012) The complex molecular biology of amyotrophic lateral sclerosis (ALS).	6	31	1.35	0.00043	9606.ENSP00000336762,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303	ANG,MAP3K5,CNTF,PTGS2,BCL2,BDNF
PMID:22496888	(2012) Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CD34,CCL20,CCL5,VEGFA
PMID:22567318	(2012) Erythropoietin in brain development and beyond.	6	31	1.35	0.00043	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,STAT5A,CNTF,JAK2,BDNF,VEGFA
PMID:22919381	(2012) Drug-induced oxidative stress and toxicity.	6	31	1.35	0.00043	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	NOX4,ATM,MAP3K5,NOX1,TXN,BCL2
PMID:23243586	(2012) Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice.	6	31	1.35	0.00043	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:21143185	(2011) Radiation induced non-targeted response: mechanism and potential clinical implications.	6	31	1.35	0.00043	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	IGF1R,ATM,PTGS2,PTEN,JAK2,BCL2
PMID:21253475	(2011) Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma.	6	31	1.35	0.00043	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,PDGFB,PDGFA,PDGFD,FGFR1,VEGFA
PMID:21308863	(2011) Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation.	6	31	1.35	0.00043	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809	APC,CDH1,HNF4A,PTEN,AR,PROM1
PMID:21708280	(2011) Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis.	6	31	1.35	0.00043	9606.ENSP00000200676,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000478570	CETP,CCR5,PTGS2,PTEN,SHBG,VEGFA
PMID:21725736	(2011) Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.	6	31	1.35	0.00043	9606.ENSP00000225275,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000426809,9606.ENSP00000478570	MPO,TIMP3,ANGPT2,PDGFB,PROM1,VEGFA
PMID:21935537	(2011) Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,PTGS2,AR,NFE2L2,BCL2,VEGFA
PMID:21991325	(2011) RSPO1beta-catenin signaling pathway regulates oogonia differentiation and entry into meiosis in the mouse fetal ovary.	6	31	1.35	0.00043	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000363973,9606.ENSP00000368104	SOX9,CDH1,HNF4A,PDGFB,ALPL,BMP2
PMID:22125537	(2011) Diabetes and alpha lipoic Acid.	6	31	1.35	0.00043	9606.ENSP00000256104,9606.ENSP00000284031,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000397297	FABP4,DDAH1,MAP3K5,TXN,NFE2L2,NTF3
PMID:20012482	(2010) Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?	6	31	1.35	0.00043	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	ANGPT2,PDGFB,PDGFA,PDGFD,BCL2,VEGFA
PMID:20022538	(2010) New insights in synovial angiogenesis.	8	77	1.08	0.00043	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CD34,CXCL9,PTGS2,EDN1,VEGFA
PMID:20419111	(2010) Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.	6	31	1.35	0.00043	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	EDNRA,ELN,COMT,EDN1,RHOA,VEGFA
PMID:18419795	(2009) Mouse models with human immunity and their application in biomedical research.	6	31	1.35	0.00043	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000418525	CD38,CD69,CCR5,CD34,CD47,MME
PMID:19317920	(2009) Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling.	6	31	1.35	0.00043	9606.ENSP00000229135,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,SREBF1,CCL20,CNTF,BCL2,VEGFA
PMID:19337719	(2009) Regulation of vascular integrity.	6	31	1.35	0.00043	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,PDGFB,ELN,HSPG2,RHOA,VEGFA
PMID:19442151	(2009) Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.	6	31	1.35	0.00043	9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000400175	TGFB1,ELN,COMT,EDN1,SHBG,RHOA
PMID:19522842	(2009) Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.	6	31	1.35	0.00043	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,CD34,STAT5A,JAK2,BCL2,VEGFA
PMID:15955837	(2005) Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors.	6	31	1.35	0.00043	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,CCL5,VEGFA
PMID:35055176	(2022) CRLF1 and CLCF1 in Development, Health and Disease.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000414303	IFNG,SOX9,CNTF,VIP,BMP2,JAK2,BDNF
PMID:35106465	(2022) A gradient tree boosting and network propagation derived pan-cancer survival network of the tumor microenvironment.	7	52	1.19	0.00044	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,TGFB1,MMP14,CAV1,PTEN,JAK2,VEGFA
PMID:35164167	(2022) Medicine-Food Herbs against Alzheimers Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action.	7	52	1.19	0.00044	9606.ENSP00000222572,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	PON2,PTGS2,BCL2,FGFR1,MYD88,BDNF,VEGFA
PMID:35173539	(2022) Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,IGF1R,MAPK7,CAV1,AR,BCL2,RHOA
PMID:35399416	(2022) Curcumin as a Potential Therapeutic Agent in Certain Cancer Types.	7	52	1.19	0.00044	9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTGS2,PTEN,AR,JAK2,BCL2,VEGFA
PMID:35406570	(2022) Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis.	10	140	0.91	0.00044	9606.ENSP00000215832,9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000288266,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000418823	MAPK1,WFS1,JAZF1,APPL1,ONECUT1,HNF4A,KCNJ11,MAFB,BCL2,FTO
PMID:33215738	(2021) Decreased blood vessel density and endothelial cell subset dynamics during ageing of the endocrine system.	7	52	1.19	0.00044	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000478570	FABP4,CD34,PDGFB,UNC5B,CAV1,PDGFA,VEGFA
PMID:33467722	(2021) The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.	7	52	1.19	0.00044	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000478570	IGF1R,CXCL10,CXCL11,CD34,PDGFA,CXCL9,VEGFA
PMID:33553683	(2021) More attention on glial cells to have better recovery after spinal cord injury.	7	52	1.19	0.00044	9606.ENSP00000245479,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303	SOX9,PDGFA,CNTF,BMP2,EDN1,NTF3,BDNF
PMID:33574085	(2021) Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.	7	52	1.19	0.00044	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,PTEN,PROM1,CCL5
PMID:33828258	(2021) Vascular normalisation as the stepping stone into tumour microenvironment transformation.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000381185,9606.ENSP00000475344,9606.ENSP00000478570	IFNG,THBS1,CXCL10,CXCL11,BCL2,APLNR,VEGFA
PMID:33898874	(2021) Small extracellular vesicles in cancer.	11	177	0.85	0.00044	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,ANG,CAV1,CD47,PTEN,AR,RHOA,PROM1,CCL5,VEGFA
PMID:34041023	(2021) Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,PTGS2,PTEN,TXN,BCL2,VEGFA
PMID:34095008	(2021) The Role of Vitamin D in Adipose Tissue Biology: Adipocyte Differentiation, Energy Metabolism, and Inflammation.	7	52	1.19	0.00044	9606.ENSP00000216862,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000474412	CYP24A1,FABP4,CXCL10,CXCL11,LPL,SREBF1,CCL5
PMID:34140495	(2021) Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.	7	52	1.19	0.00044	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,CXCL10,CCL20,CXCL9,CD47,PROM1,VEGFA
PMID:34232958	(2021) Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000284031,9606.ENSP00000300055,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CDH1,DDAH1,PLIN1,PDGFB,CXCL9,PTEN,CCL5
PMID:34430782	(2021) Transcriptional Analysis of Liver Tissue Identifies Distinct Phenotypes of Indeterminate Pediatric Acute Liver Failure.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495	IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA
PMID:34440460	(2021) Genetic Determinants of Inherited Endocrine Tumors: Do They Have a Direct Role in Bone Metabolism Regulation and Osteoporosis?	7	52	1.19	0.00044	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000257430,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000480291	SOX9,FABP4,APC,CXCL10,PTEN,BMP2,HNF1B
PMID:34456875	(2021) Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications.	7	52	1.19	0.00044	9606.ENSP00000265132,9606.ENSP00000265333,9606.ENSP00000293599,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	AMBP,VDAC1,AQP5,STAT5A,PTEN,RHOA,VEGFA
PMID:34497832	(2021) Possible Immunotherapeutic Strategies Based on Carcinogen-Dependent Subgroup Classification for Oral Cancer.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,GAS6,CCL20,PTGS2,CCL5,VEGFA
PMID:34572572	(2021) Beyond the GFAP-Astrocyte Protein Markers in the Brain.	10	140	0.91	0.00044	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000401720,9606.ENSP00000414303,9606.ENSP00000474412	SOX9,HSPB1,THBS1,CXCL10,PTGS2,GAP43,NFE2L2,GK,BDNF,CCL5
PMID:34684698	(2021) Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.	7	52	1.19	0.00044	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000419422,9606.ENSP00000477707	SREBF1,PTGS2,MYD88,BDNF,FTO,AGTR1,NR1H3
PMID:34771615	(2021) Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy.	7	52	1.19	0.00044	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,PTEN,BCL2,CCL5
PMID:34830489	(2021) Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5.	10	140	0.91	0.00044	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000261037,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000363596,9606.ENSP00000419422	MAPK1,CD38,THBS1,COL8A1,ANGPT2,CAV1,STAT5A,CCL20,CNR2,AGTR1
PMID:34884848	(2021) Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics.	7	52	1.19	0.00044	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:34895058	(2021) Herpes simplex virus interference with immunity: Focus on dendritic cells.	10	140	0.91	0.00044	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CDH1,CCR5,CXCL10,CAV1,STAT5A,JAK2,BCL2,MYD88,CCL5
PMID:34925435	(2021) Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.	7	52	1.19	0.00044	9606.ENSP00000263317,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	NOX4,HNF4A,MAP3K5,SGK1,JAK2,BCL2,MYD88
PMID:34944027	(2021) Dual Role of p73 in Cancer Microenvironment and DNA Damage Response.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,THBS1,CDH1,IGF1R,ATM,BCL2,VEGFA
PMID:35006432	(2021) Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways.	10	140	0.91	0.00044	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,THBS1,CDH1,CCR5,CD34,PTGS2,PTEN,SAA1,CCL5,VEGFA
PMID:32012717	(2020) A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells.	9	107	0.99	0.00044	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,HSPB1,CCR5,MMP14,CAV1,PTEN,RHOA,PROM1,VEGFA
PMID:32218342	(2020) Regenerative Potential of Carbon Monoxide in Adult Neural Circuits of the Central Nervous System.	7	52	1.19	0.00044	9606.ENSP00000334329,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	UNC5B,CNTF,PTEN,GAP43,NFE2L2,BDNF,VEGFA
PMID:32331364	(2020) The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond.	7	52	1.19	0.00044	9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	LPL,HNF4A,SREBF1,ABCG1,PTEN,BCL2,MYD88
PMID:32759728	(2020) The Prowess of Andrographolide as a Natural Weapon in the War against Cancer.	7	52	1.19	0.00044	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	SOX9,TIMP3,ALDH1A1,HNF4A,PTEN,JAK2,VEGFA
PMID:32855630	(2020) The Emerging Role of PPAR BetaDelta in Tumor Angiogenesis.	7	52	1.19	0.00044	9606.ENSP00000232219,9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000478570	RBP1,FABP4,THBS1,ANGPT2,PDGFB,PTGS2,VEGFA
PMID:32934709	(2020) Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,AQP5,HNF4A,PTGS2,PTEN,BCL2,VEGFA
PMID:33014105	(2020) An Overview of the Mechanism of Penthorum chinense Pursh on Alcoholic Fatty Liver.	7	52	1.19	0.00044	9606.ENSP00000215832,9606.ENSP00000265333,9606.ENSP00000311005,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	MAPK1,VDAC1,MAPK7,SREBF1,NFE2L2,BCL2,MYD88
PMID:33028105	(2020) The Paracrine Function of Mesenchymal Stem Cells in Response to Pulsed Focused Ultrasound.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:33187148	(2020) Trop2: Jack of All Trades, Master of None.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:33260759	(2020) Natural Salicylates and Their Roles in Human Health.	7	52	1.19	0.00044	9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CCL20,PTGS2,PTEN,AR,JAK2,BCL2,VEGFA
PMID:33613533	(2020) Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks.	7	52	1.19	0.00044	9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,ATM,ALDH1A1,CXCL10,MYD88,CCL5,VEGFA
PMID:33644030	(2020) Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches.	9	107	0.99	0.00044	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,CXCL10,EDNRA,SREBF1,NFE2L2,BCL2,RHOA,PROM1,VEGFA
PMID:30800125	(2019) Cold Tumors: A Therapeutic Challenge for Immunotherapy.	7	52	1.19	0.00044	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,CD247,CXCL9,PTEN,JAK2,CCL5
PMID:30863527	(2019) Checkpoint inhibition of PD-L1 and CTLA-4 in a child with refractory acute leukemia.	7	52	1.19	0.00044	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CXCL10,CD34,LTA,CCL5,VEGFA
PMID:30898137	(2019) Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma.	7	52	1.19	0.00044	9606.ENSP00000013807,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,IFNG,ATM,CXCL10,PTEN,BCL2,VEGFA
PMID:31127882	(2019) A Review on Dietary Intervention in Obesity Associated Colon Cancer	7	52	1.19	0.00044	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000418823,9606.ENSP00000478570	IGF1R,PTGS2,BCL2,NPY,RHOA,FTO,VEGFA
PMID:31277278	(2019) Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting.	7	52	1.19	0.00044	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,PTEN,PROM1,VEGFA
PMID:31311935	(2019) Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction.	7	52	1.19	0.00044	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000478570	TGFB1,IFNG,THBS1,TIMP3,CD34,ANGPT2,VEGFA
PMID:31331376	(2019) Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNTbeta-catenin pathway.	7	52	1.19	0.00044	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,PTGS2,PTEN,NFE2L2,BCL2,VEGFA
PMID:31334678	(2019) Roles of omental and bone marrow adipocytes in tumor biology.	7	52	1.19	0.00044	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000478570	FABP4,CD34,PTGS2,JAK2,BCL2,RARRES2,VEGFA
PMID:31366178	(2019) The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis.	7	52	1.19	0.00044	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809	CD38,FABP4,ALDH1A1,CD34,PTEN,MYD88,PROM1
PMID:31367615	(2019) Role of the brain-gut axis in gastrointestinal cancer.	7	52	1.19	0.00044	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,PTGS2,BCL2,FGFR1,RHOA,BDNF,VEGFA
PMID:31368612	(2019) EGFR signaling pathway occupies an important position in cancer-related downstream signaling pathways of Pyk2.	7	52	1.19	0.00044	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,ALDH1A1,PTEN,AR,VEGFA
PMID:31484463	(2019) Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity.	7	52	1.19	0.00044	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,CD34,G6PD,BCL2,AGTR1,PROM1,VEGFA
PMID:31523371	(2019) Linking stemness with colorectal cancer initiation, progression, and therapy.	7	52	1.19	0.00044	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,ALDH1A1,PTGS2,BCL2,PROM1,VEGFA
PMID:31598386	(2019) Targeting cancer stem cells in squamous cell carcinoma.	7	52	1.19	0.00044	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000306124,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,PRKCE,CD34,HNF4A,PROM1
PMID:31652497	(2019) The ST2Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox.	7	52	1.19	0.00044	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000362410,9606.ENSP00000390651,9606.ENSP00000401399	CD69,CXCL10,CD34,STAT5A,MAFB,IRAK4,MYD88
PMID:31827423	(2019) Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets.	7	52	1.19	0.00044	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BCL2,RHOA,BDNF,VEGFA
PMID:29066510	(2018) Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.	7	52	1.19	0.00044	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANGPT2,EDNRA,FGFR1,CCL5,VEGFA
PMID:29415476	(2018) The Impact of Aging on Cardio and Cerebrovascular Diseases.	7	52	1.19	0.00044	9606.ENSP00000200676,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000474412	CETP,NOX4,SIRT6,ELN,EDN1,KL,CCL5
PMID:29566757	(2018) Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.	7	52	1.19	0.00044	9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000356832,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IGF1R,CXCL11,SGK1,NFE2L2,BCL2,RHOA,VEGFA
PMID:29732735	(2018) Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CD34,ELN,EDN1,NFE2L2,PROM1,VEGFA
PMID:29887862	(2018) Emerging Functions of Regulatory T Cells in Tissue Homeostasis.	9	107	0.99	0.00044	9606.ENSP00000228434,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000478570	CD69,CCL20,ELN,ENTPD1,PTEN,NFE2L2,NTF3,MYD88,VEGFA
PMID:30250013	(2018) Curcumin, Cardiometabolic Health and Dementia.	9	107	0.99	0.00044	9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000477707,9606.ENSP00000478570	LPL,SREBF1,PTGS2,EDN1,NFE2L2,BDNF,MME,NR1H3,VEGFA
PMID:28173864	(2017) Macrophage activation and polarization in post-infarction cardiac remodeling.	7	52	1.19	0.00044	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000478570	CXCL10,CXCL11,ELN,CXCL9,PTEN,MAFB,VEGFA
PMID:28223148	(2017) STAT3 activation in infection and infection-associated cancer.	7	52	1.19	0.00044	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,JAK2,BCL2,PLA2G2A,CCL5,VEGFA
PMID:28322920	(2017) Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke.	7	52	1.19	0.00044	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,IFNG,CD34,EDN1,BCL2,BDNF,VEGFA
PMID:28649187	(2017) Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus.	9	107	0.99	0.00044	9606.ENSP00000216181,9606.ENSP00000226279,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000384906,9606.ENSP00000400175,9606.ENSP00000427424	MYH9,CD38,GAS6,CD47,TXN,G6PD,SAA1,RHOA,TNFAIP8
PMID:28950947	(2017) G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling.	7	52	1.19	0.00044	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000400175,9606.ENSP00000474412	IGF1R,CCR5,CAV1,PTGS2,CNR2,RHOA,CCL5
PMID:27349385	(2016) Targeting microRNAs as key modulators of tumor immune response.	7	52	1.19	0.00044	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,PTGS2,PTEN,MYD88,CCL5,VEGFA
PMID:25307620	(2015) Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative omic profiling of affected neuroendocrine carcinomas.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000304767,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000385834,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,P2RY1,PTEN,AR,TF,FGFR1,VEGFA
PMID:26078352	(2015) Reactive oxygen species a double-edged sword for mesothelioma.	7	52	1.19	0.00044	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,NOX4,ELN,PTGS2,PTEN,BCL2,VEGFA
PMID:26635606	(2015) The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease.	7	52	1.19	0.00044	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000339916,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	LPL,CD34,LIMK2,PTEN,EDN1,RHOA,VEGFA
PMID:27227071	(2015) Central mediators involved in the febrile response: effects of antipyretic drugs.	7	52	1.19	0.00044	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412	MPO,CCR5,CXCL10,CNTF,PTGS2,EDN1,CCL5
PMID:23859619	(2014) AMPK as a potential anticancer target - friend or foe?	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,HNF4A,SREBF1,AR,BCL2,VEGFA
PMID:24447924	(2014) Molecular basis of cardiac myxomas.	7	52	1.19	0.00044	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,CD34,FMOD,EDN1,PLA2G2A,FGFR1,VEGFA
PMID:24751526	(2014) Circulating membrane-derived microvesicles in redox biology.	7	52	1.19	0.00044	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000478570	MPO,NOX4,PRDX2,PTGS2,NOX1,TXN,VEGFA
PMID:24798211	(2014) Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.	7	52	1.19	0.00044	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	MPO,NOX4,PTGS2,NOX1,TXN,NFE2L2,BCL2
PMID:25190145	(2014) Roles of tumor suppressors in regulating tumor-associated inflammation.	7	52	1.19	0.00044	9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	APC,THBS1,CD34,PTGS2,PTEN,BCL2,VEGFA
PMID:23161445	(2013) Inflammation and colorectal cancer: colitis-associated neoplasia.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,TIMP3,ATM,PTEN,BCL2,MYD88,VEGFA
PMID:23591842	(2013) Ovarian cancer: can proteomics give new insights for therapy and diagnosis?	7	52	1.19	0.00044	9606.ENSP00000232219,9606.ENSP00000255409,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	RBP1,CHI3L1,ALDH1A1,PRDX2,PTEN,JAK2,VEGFA
PMID:23865481	(2013) Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins.	7	52	1.19	0.00044	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000381185,9606.ENSP00000426809	ERCC1,TGFB1,ATM,PTGS2,SGK1,BCL2,PROM1
PMID:24063382	(2013) Cerebral artery signal transduction mechanisms: developmental changes in dynamics and Ca2+ sensitivity.	7	52	1.19	0.00044	9606.ENSP00000221930,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,VIP,EDN1,NPY,RHOA,BDNF,VEGFA
PMID:22033227	(2012) Molecular functions of syndecan-1 in disease.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,MMP14,PDGFB,CXCL9,RHOA,CCL5,VEGFA
PMID:22245898	(2012) Development of the bile ducts: essentials for the clinical hepatologist.	7	52	1.19	0.00044	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,HNF4A,BCL2,VEGFA,HNF1B
PMID:22261334	(2012) Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185	IFNG,CDH1,IGF1R,STAT5A,PTGS2,JAK2,BCL2
PMID:22262158	(2012) Early alterations of the immune transcriptome in cultured progenitor cells from obese African-American women.	7	52	1.19	0.00044	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000426809	CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,PROM1
PMID:22295241	(2012) The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the Seed and the Soil?	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,TIMP3,CD34,PDGFA,PTGS2,BCL2,PROM1
PMID:22348396	(2012) MicroRNA in cancer: new hopes for antineoplastic chemotherapy.	7	52	1.19	0.00044	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	CDH1,TIMP3,HNF4A,PTEN,BCL2,FGFR1,RHOA
PMID:23000686	(2012) Targeting the TGFbeta signalling pathway in disease.	7	52	1.19	0.00044	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000419422	THBS1,CDH1,ATM,CD34,FMOD,ELN,AGTR1
PMID:23788862	(2012) Comparative proteomics in acute myeloid leukemia.	7	52	1.19	0.00044	9606.ENSP00000225275,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	MPO,PRDX2,CD34,STAT5A,PTEN,JAK2,PROM1
PMID:21036194	(2011) Is HCMV a tumor promoter?	7	52	1.19	0.00044	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,ATM,BCL2,PROM1,CCL5,VEGFA
PMID:22194660	(2011) Beyond fat mass: exploring the role of adipokines in rheumatic diseases.	7	52	1.19	0.00044	9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000384906,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	PTGS2,JAK2,NPY,SAA1,RARRES2,APLNR,VEGFA
PMID:20414842	(2010) Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.	9	107	0.99	0.00044	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CXCL10,PDGFB,PDGFA,PDGFD,BCL2,CCL5,VEGFA
PMID:20729908	(2010) Up for Mischief? IL-17Th17 in the tumour microenvironment.	7	52	1.19	0.00044	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000478570	MPO,CCR5,CXCL10,STAT5A,CCL20,CXCL9,VEGFA
PMID:19138453	(2009) Inflammation and neuropeptides: the connection in diabetic wound healing.	7	52	1.19	0.00044	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,NPY,MME,CCL5,VEGFA
PMID:33491070	(2021) Noncoding RNAs: modulators and modulatable players during infection-induced stress response.	8	78	1.07	0.00046	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	NOX4,CXCL10,CXCL9,PTGS2,NFE2L2,BCL2,MYD88,CCL5
PMID:33562324	(2021) Recent Advancements in the Mechanisms Underlying Resistance to PD-1PD-L1 Blockade Immunotherapy.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CXCL9,PTEN,JAK2,CCL5,VEGFA
PMID:33814008	(2021) The m(6)A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis.	10	141	0.91	0.00046	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000418823	APC,IGF1R,ATM,MAPK7,HNF4A,STAT5A,MAP3K5,SGK1,PTEN,FTO
PMID:33995478	(2021) Construction of Unified Human Antimicrobial and Immunomodulatory Peptide Database and Examination of Antimicrobial and Immunomodulatory Peptides in Alzheimers Disease Using Network Analysis of Proteomics Datasets.	8	78	1.07	0.00046	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000321853,9606.ENSP00000357726,9606.ENSP00000384364,9606.ENSP00000478570	MAPK1,THBS1,IGF1R,CXCL10,SERPINF2,S100A12,NPY,VEGFA
PMID:34079555	(2021) Interleukin-27 and Its Diverse Effects on Bacterial Infections.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000360250,9606.ENSP00000401399,9606.ENSP00000418525	CD38,CD69,CXCL10,STAT5A,CNTF,ENTPD1,MYD88,MME
PMID:34150747	(2021) Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions.	8	78	1.07	0.00046	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CD34,EBF1,CXCL9,CCL5,VEGFA
PMID:34202940	(2021) Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury.	8	78	1.07	0.00046	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000478570	SOX9,CDH1,CD34,ANG,BCL2,RHOA,LTA,VEGFA
PMID:34831182	(2021) The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD38,THBS1,CCR5,CXCL10,PTGS2,ENTPD1,CCL5,VEGFA
PMID:32102186	(2020) G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits.	8	78	1.07	0.00046	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000337332,9606.ENSP00000356213,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	CETP,TGFB1,SIRT6,VIP,CNR1,BCL2,NPY,BDNF
PMID:32751786	(2020) Models Contribution to the Understanding of Sarcoidosis Pathogenesis: Are There Good Models of Sarcoidosis?	8	78	1.07	0.00046	9606.ENSP00000256104,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	FABP4,EBF1,STAT5A,CCL20,ABCG1,JAK2,MYD88,CCL5
PMID:32961745	(2020) Nasal Polyposis: Insights in Epithelial-Mesenchymal Transition and Differentiation of Polyp Mesenchymal Stem Cells.	8	78	1.07	0.00046	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809	MPO,SOX9,FABP4,CDH1,CD34,PTEN,BMP2,PROM1
PMID:33585187	(2020) Research Progress of Sirtuin4 in Cancer.	8	78	1.07	0.00046	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000334329,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,CD34,UNC5B,SIRT6,SREBF1,JAK2,VEGFA,UHRF1
PMID:31317205	(2019) Stem cells in tissues, organoids, and cancers.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,IGF1R,CD34,BMP2,BDNF,PROM1,VEGFA
PMID:31887997	(2019) Angioregulatory microRNAs in Colorectal Cancer.	8	78	1.07	0.00046	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,IGF1R,MMP14,ANGPT2,PTEN,BCL2,RHOA,VEGFA
PMID:29222693	(2018) Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CDH1,CD34,HNF4A,FGFR1,PROM1,VEGFA
PMID:29701666	(2018) TGF-beta and the Tissue Microenvironment: Relevance in Fibrosis and Cancer.	8	78	1.07	0.00046	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000474412	SOX9,THBS1,CDH1,NOX4,ELN,PTEN,RHOA,CCL5
PMID:30064463	(2018) Function and clinical significance of circRNAs in solid tumors.	8	78	1.07	0.00046	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000384262,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,FADS2,PTEN,AR,HPSE,VEGFA
PMID:27678246	(2017) Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000363641,9606.ENSP00000381185	CD38,ATM,ALDH1A1,CD34,STAT5A,CD47,TXN,BCL2
PMID:28662828	(2017) Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.	8	78	1.07	0.00046	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000365777,9606.ENSP00000478570	MPO,CDH1,TIMP3,ANG,ELN,HSPG2,MTHFR,VEGFA
PMID:26306748	(2016) Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.	8	78	1.07	0.00046	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000426809	MAPK1,TGFB1,CD38,ALDH1A1,CD34,STAT5A,JAK2,PROM1
PMID:25876649	(2015) Melatonin: an inhibitor of breast cancer.	8	78	1.07	0.00046	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000444198	CDH1,TIMP3,IGF1R,ATM,HNF4A,CAV1,BCL2,CITED2
PMID:26323406	(2015) RNA-seq Profiles of Immune Related Genes in the Spleen of Necrotic Enteritis-afflicted Chicken Lines.	10	141	0.91	0.00046	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000355370,9606.ENSP00000376865,9606.ENSP00000427424	CD38,CD69,IFNG,CXCL11,CD34,CCL20,CD247,CNTF,PDGFD,TNFAIP8
PMID:25025370	(2014) Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic.	8	78	1.07	0.00046	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CD38,CDH1,CD34,HNF4A,STAT5A,PTEN,JAK2,VEGFA
PMID:20368795	(2010) Molecular profiling of endometrial malignancies.	8	78	1.07	0.00046	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CDH1,IGF1R,JAZF1,HNF4A,PTEN,AR,BCL2,MME
PMID:18922967	(2008) Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.	8	78	1.07	0.00046	9606.ENSP00000222139,9606.ENSP00000354511,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,COMT,G6PD,BCL2,NPY,NTF3,BDNF,VEGFA
PMID:33435246	(2021) Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials.	9	108	0.98	0.00047	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CAV1,SREBF1,MAP3K5,PTGS2,BCL2,BDNF,CCL5,VEGFA
PMID:33743212	(2021) COVID-19 and the human innate immune system.	9	108	0.98	0.00047	9606.ENSP00000200676,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412	CETP,CCR5,CXCL10,CCL20,CXCL9,JAK2,SAA1,MYD88,CCL5
PMID:32349983	(2020) Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth.	9	108	0.98	0.00047	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	ANGPT2,PDGFB,GAS6,PDGFA,CCL20,CXCL9,CNTF,NTF3,BDNF
PMID:32561709	(2020) Noncoding RNAs: the shot callers in tumor immune escape.	9	108	0.98	0.00047	9606.ENSP00000215832,9606.ENSP00000227868,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,PDHX,THBS1,CDH1,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:32932969	(2020) Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.	9	108	0.98	0.00047	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CD34,STAT5A,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:32982967	(2020) Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.	9	108	0.98	0.00047	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,CD47,PTEN,FGFR1,PROM1,CCL5,VEGFA
PMID:31067680	(2019) Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy.	9	108	0.98	0.00047	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000474412	CD38,THBS1,CXCL10,SIRT6,CXCL9,PTEN,TXN,BCL2,CCL5
PMID:31202359	(2019) Immunometabolism: A new target for improving cancer immunotherapy.	9	108	0.98	0.00047	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000478570	NOX4,LPL,STAT5A,SREBF1,GFPT1,CD247,PTEN,G6PD,VEGFA
PMID:30254638	(2018) The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review.	9	108	0.98	0.00047	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,CNTF,PTGS2,BCL2,NTF3,BDNF,CCL5,VEGFA
PMID:25936818	(2015) Broad targeting of resistance to apoptosis in cancer.	9	108	0.98	0.00047	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,HSPB1,AR,JAK2,NFE2L2,BCL2,CCL5,VEGFA
PMID:25973901	(2015) Changes in transcriptome of macrophages in atherosclerosis.	9	108	0.98	0.00047	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL10,CXCL11,CXCL9,ABCG1,PTGS2,MAFB,CCL5,VEGFA
PMID:24231048	(2013) Stemness of T cells and the hematopoietic stem cells: fate, memory, niche, cytokines.	9	108	0.98	0.00047	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CD34,HNF4A,STAT5A,PTEN,ANGPTL2,JAK2,BCL2,PROM1
PMID:35130955	(2022) Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease.	10	142	0.91	0.00048	9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,TIMP3,MMP14,ANGPT2,PDGFB,PTGS2,BCL2,FGFR1,PROM1,VEGFA
PMID:33435156	(2021) The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.	10	142	0.91	0.00048	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422	MAPK1,SOX9,APC,CDH1,IGF1R,MMP14,CAV1,PTEN,BCL2,AGTR1
PMID:32733474	(2020) High-Resolution Profiling of Innate Immune Responses by Porcine Dendritic Cell Subsets in vitro and in vivo.	10	142	0.91	0.00048	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000418009,9606.ENSP00000474412	CXCL10,CXCL11,CD34,CCL20,CXCL9,MAFB,JAK2,IRAK4,RARRES2,CCL5
PMID:33363031	(2020) Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics.	10	142	0.91	0.00048	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MPO,CD38,CD34,ELN,CD47,PTEN,JAK2,BCL2,IRAK4,MYD88
PMID:28346400	(2017) T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.	10	142	0.91	0.00048	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CDH1,CCR5,CXCL10,CXCL11,CD34,CD247,CXCL9,CCL5,VEGFA
PMID:21261944	(2011) Caries induced cytokine network in the odontoblast layer of human teeth.	10	142	0.91	0.00048	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,JAK2,MYD88,LTA,CCL5,VEGFA
PMID:35106623	(2022) Effect of expansion of human umbilical cord blood CD34 + cells on neurotrophic and angiogenic factor expression and function.	6	32	1.33	0.00049	9606.ENSP00000310036,9606.ENSP00000362524,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPTL2,NTF3,BDNF,PROM1,VEGFA
PMID:35159113	(2022) The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.	7	53	1.18	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,RARRES2,CCL5
PMID:35163066	(2022) Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,NFE2L2,BCL2,MYD88,VEGFA
PMID:35172901	(2022) A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:35213966	(2022) The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimers Disease.	7	53	1.18	0.00049	9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000419422	EDN1,NFE2L2,BCL2,NTF3,BDNF,MME,AGTR1
PMID:35255964	(2022) Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CCR5,CD34,EDN1,BCL2,PROM1,VEGFA
PMID:35269712	(2022) Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	CD38,ATM,CD247,ENTPD1,PTEN,AR,VEGFA
PMID:35317197	(2022) Neuroprotective Effect of Physical Activity in Ischemic Stroke: Focus on the Neurovascular Unit.	6	32	1.33	0.00049	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CAV1,EDN1,BCL2,BDNF,VEGFA
PMID:35326390	(2022) Failure Analysis of TEVGs II: Late Failure and Entering the Regeneration Pathway.	8	79	1.07	0.00049	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,THBS1,CD34,ANGPT2,BMP2,EDN1,PROM1,VEGFA
PMID:35350538	(2022) HDL Composition, Heart Failure, and Its Comorbidities.	6	32	1.33	0.00049	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000419422,9606.ENSP00000478570	CETP,MPO,LPA,ABCG1,AGTR1,VEGFA
PMID:35422984	(2022) Delivery of Wnt inhibitor WIF1 via engineered polymeric microspheres promotes nerve regeneration after sciatic nerve crush.	5	16	1.56	0.00049	9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	BMP2,GAP43,RHOA,BDNF,VEGFA
PMID:36036015	(2022) Exercise-induced signaling pathways to counteracting cardiac apoptotic processes.	6	32	1.33	0.00049	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175	HSPB1,IGF1R,PTEN,JAK2,BCL2,RHOA
PMID:36208271	(2022) [Transcriptional Modification and Potential Intracellular Signaling Mechanisms in Human Macrophages Primed by Interferon-gamma].	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000317674,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,APOL1,CXCL9
PMID:33430105	(2021) The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment.	8	79	1.07	0.00049	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000478570	MPO,CCR5,CD34,PTGS2,ENTPD1,CCL5,GREM1,VEGFA
PMID:33445810	(2021) Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.	6	32	1.33	0.00049	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:33495827	(2021) miR-140-5p regulates vascular smooth muscle cell viability, migration and apoptosis by targeting ROBO4 gene expression in atherosclerosis.	5	16	1.56	0.00049	9606.ENSP00000268035,9606.ENSP00000334329,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,UNC5B,NFE2L2,BCL2,VEGFA
PMID:33503200	(2021) Transcriptomic markers in pediatric septic shock prognosis: an integrative analysis of gene expression profiles.	5	16	1.56	0.00049	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000259486,9606.ENSP00000418525,9606.ENSP00000479617	MPO,CD69,ENPP2,MME,UHRF1
PMID:33602249	(2021) Effect of docosahexaenoic acid plus insulin on atherosclerotic human endothelial cells.	6	32	1.33	0.00049	9606.ENSP00000215832,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000477707	MAPK1,LPL,PDGFB,PDGFA,ELN,NR1H3
PMID:33607779	(2021) Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.	5	16	1.56	0.00049	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MME
PMID:33671829	(2021) Aerosolized Exposure to H5N1 Influenza Virus Causes Less Severe Disease Than Infection via Combined Intrabronchial, Oral, and Nasal Inoculation in Cynomolgus Macaques.	5	16	1.56	0.00049	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,CCL5
PMID:33718595	(2021) Molecular profiles of small cell lung cancer subtypes: therapeutic implications.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CD38,SOX9,IGF1R,TXN,BCL2,FGFR1,VEGFA
PMID:33758415	(2021) Autophagy in tumour immunity and therapy.	8	79	1.07	0.00049	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	ATM,CXCL10,CXCL9,CD47,TXN,NFE2L2,BCL2,CCL5
PMID:33764858	(2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.	6	32	1.33	0.00049	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000474412	CXCL10,CXCL11,LPL,CXCL9,NPY,CCL5
PMID:33767987	(2021) CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment.	8	79	1.07	0.00049	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	MAPK1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5
PMID:33815418	(2021) Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.	10	143	0.91	0.00049	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000357726,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,THBS1,ALDH1A1,CD34,CD47,S100A12,NFE2L2,PROM1,VEGFA
PMID:33840389	(2021) Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides.	5	16	1.56	0.00049	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000265132,9606.ENSP00000292303	MPO,CD69,IFNG,AMBP,CCR5
PMID:33848273	(2021) Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000360250	CD69,CDH1,AMBP,CCR5,CCL20,ENTPD1
PMID:33897696	(2021) Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,ANG,CXCL9,MYD88,CCL5,VEGFA
PMID:33920160	(2021) Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview.	8	79	1.07	0.00049	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,MAP3K5,PTEN,TXN,JAK2,NFE2L2,BCL2,VEGFA
PMID:33928351	(2021) Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000479617	CDH1,ATM,PTEN,AR,JAK2,BCL2,UHRF1
PMID:33935784	(2021) Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review.	7	53	1.18	0.00049	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:33937049	(2021) Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors.	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000426809	CDH1,ALDH1A1,MMP14,PTEN,AR,BCL2,LTA,PROM1
PMID:33937351	(2021) Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease.	5	16	1.56	0.00049	9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021	CHI3L1,TIMP3,ELN,PTGS2,PTEN
PMID:33957948	(2021) Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression.	7	53	1.18	0.00049	9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CXCL10,HNF4A,CD247,PTGS2,CCL5,VEGFA
PMID:33981232	(2021) Natural-Derived Polysaccharides From Plants, Mushrooms, and Seaweeds for the Treatment of Inflammatory Bowel Disease.	8	79	1.07	0.00049	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	MPO,CDH1,HNF4A,PTGS2,EDN1,JAK2,BCL2,CCL5
PMID:33983615	(2021) Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.	7	53	1.18	0.00049	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,IRAK4,MYD88,CCL5
PMID:34045653	(2021) IL-30(+) (IL-27A): a familiar stranger in immunity, inflammation, and cancer.	7	53	1.18	0.00049	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000360250,9606.ENSP00000401399,9606.ENSP00000478570	TIMP3,CXCL10,CXCL9,CNTF,ENTPD1,MYD88,VEGFA
PMID:34046337	(2021) Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CDH1,CD34,PROM1,CCL5,VEGFA
PMID:34093855	(2021) The utility of biomedical scaffolds laden with spheroids in various tissue engineering applications.	5	16	1.56	0.00049	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,CDH1,ELN,BMP2,VEGFA
PMID:34104079	(2021) Inhibition of Lipopolysaccharide-Induced Inflammatory and Oxidative Responses by Trans-cinnamaldehyde in C2C12 Myoblasts.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000401399	IFNG,NOX4,PTGS2,NOX1,MYD88
PMID:34131444	(2021) Identification of key candidate genes in local dorsal root ganglion inflammation by integrated bioinformatics analysis.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:34165252	(2021) Advancing to the era of cancer immunotherapy.	8	79	1.07	0.00049	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000478570	IGF1R,CXCL10,CXCL11,GAS6,CXCL9,CD47,ENTPD1,VEGFA
PMID:34168976	(2021) Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies.	9	109	0.98	0.00049	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,ANGPT2,PDGFB,CD47,PTEN,BCL2,PROM1,VEGFA
PMID:34198742	(2021) Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success.	8	79	1.07	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,CD247,CD47,PTEN,BCL2,PROM1,VEGFA
PMID:34201840	(2021) Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis.	9	109	0.98	0.00049	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412	MAPK1,IGF1R,CCR5,MMP14,CAV1,PTEN,BCL2,FGFR1,CCL5
PMID:34202203	(2021) New Insights into Molecular Mechanism behind Anti-Cancer Activities of Lycopene.	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NOX4,IGF1R,CXCL10,CXCL9,PTGS2,BCL2,VEGFA
PMID:34327781	(2021) Current progress and future perspectives of research on intravascular large B-cell lymphoma.	6	32	1.33	0.00049	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000356832,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	ATM,CD34,SGK1,BCL2,MYD88,MME
PMID:34359596	(2021) Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,CD34,CAV1,PTEN,AR,BCL2,RHOA
PMID:34380571	(2021) A systematic summary of survival and death signalling during the life of hair follicle stem cells.	8	79	1.07	0.00049	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,CD34,HNF4A,PTEN,AR,BMP2,BCL2,VEGFA
PMID:34400611	(2021) Spatially defined single-cell transcriptional profiling characterizes diverse chondrocyte subtypes and nucleus pulposus progenitors in human intervertebral discs.	8	79	1.07	0.00049	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,SOX9,CHI3L1,CD34,PDGFA,ALPL,BMP2,VEGFA
PMID:34421318	(2021) Nestin Expression as a Diagnostic and Prognostic Marker in Colorectal Cancer and Other Tumors.	5	16	1.56	0.00049	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,NFE2L2,PROM1,VEGFA
PMID:34422919	(2021) Inhibition of Rac1 GTPase Decreases Vascular Oxidative Stress, Improves Endothelial Function, and Attenuates Atherosclerosis Development in Mice.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,NOX1,EDN1,RHOA,VEGFA
PMID:34440585	(2021) Impact of Physical Activity and Natural Bioactive Compounds on Endothelial Dysfunction in Chronic Kidney Disease.	6	32	1.33	0.00049	9606.ENSP00000221930,9606.ENSP00000284031,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000426809	TGFB1,DDAH1,CD34,TXN,MTHFR,PROM1
PMID:34445193	(2021) Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,CCR5,CCL20,JAK2,MYD88,CCL5,VEGFA
PMID:34471106	(2021) Integrin-alphaV-mediated activation of TGF-beta regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade.	6	32	1.33	0.00049	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000360250,9606.ENSP00000371067	TGFB1,CD69,CDH1,MMP14,ENTPD1,JAK2
PMID:34512715	(2021) Epigenetic Regulation of the Vascular Endothelium by Angiogenic LncRNAs.	7	53	1.18	0.00049	9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570,9606.ENSP00000480291	MAPK7,ANGPT2,PDGFB,PTGS2,EDN1,VEGFA,HNF1B
PMID:34539793	(2021) An In Vitro and In Vivo Comparison of Osteogenic Differentiation of Human Mesenchymal StromalStem Cells.	7	53	1.18	0.00049	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	LPL,CD34,HNF4A,PTGS2,BMP2,GREM1,VEGFA
PMID:34601190	(2021) Role of microRNAs in COVID-19 with implications for therapeutics.	7	53	1.18	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356832,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,SGK1,BCL2,FGFR1,MYD88,CCL5
PMID:34679122	(2021) Upregulation of a nuclear factor-kappa B-interacting immune gene network in mice cochleae with age-related hearing loss.	6	32	1.33	0.00049	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CCL20,CXCL9,PTGS2,LTA,CCL5
PMID:34703268	(2021) The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy.	7	53	1.18	0.00049	9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000369442,9606.ENSP00000384262,9606.ENSP00000393312,9606.ENSP00000478570	NOX4,STAT5A,MAP3K5,KL,HPSE,FGFR1,VEGFA
PMID:34721056	(2021) Hypoxia-Induced Neuroinflammation in Alzheimers Disease: Potential Neuroprotective Effects of Centella asiatica.	7	53	1.18	0.00049	9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525	PTGS2,NFE2L2,BCL2,SAA1,MYD88,BDNF,MME
PMID:34722553	(2021) Epigenetic Signaling of Cancer Stem Cells During Inflammation.	7	53	1.18	0.00049	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	SOX9,ALDH1A1,STAT5A,JAK2,BCL2,PROM1,CCL5
PMID:34746014	(2021) Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis.	6	32	1.33	0.00049	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ANGPT2,PDGFB,SIRT6,BCL2,RHOA,VEGFA
PMID:34754365	(2021) Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,HNF4A,PTGS2,PTEN,BCL2,FGFR1,VEGFA
PMID:34778088	(2021) Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CD34,STAT5A,ELN,PTEN,JAK2,BCL2
PMID:34830179	(2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models).	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418009	CDH1,ATM,CXCL11,PTEN,AR,JAK2,BCL2,RARRES2
PMID:34831420	(2021) Mitochondrial Metabolism in Melanoma.	7	53	1.18	0.00049	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000480291	MAPK1,IGF1R,MAPK7,PTEN,BCL2,RHOA,HNF1B
PMID:34833360	(2021) The Role of Chemokines in Cervical Cancers.	8	79	1.07	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,STAT5A,CCL20,BCL2,CCL5,VEGFA
PMID:34842843	(2021) Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches.	8	79	1.07	0.00049	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000325548,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	ALDH1A1,CXCL10,CNDP2,ELN,JAK2,BCL2,LTA,VEGFA
PMID:34869001	(2021) Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues.	7	53	1.18	0.00049	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CD34,ANGPT2,PDGFA,CXCL9,CCL5
PMID:34869592	(2021) Atheroprotective Effects and Molecular Mechanism of Berberine.	7	53	1.18	0.00049	9606.ENSP00000222572,9606.ENSP00000315011,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000356729,9606.ENSP00000400175,9606.ENSP00000477707	PON2,EDNRA,ABCG1,PTGS2,FMO3,RHOA,NR1H3
PMID:34915908	(2021) Abstracts from the Virtual Symposium Signal Transduction at the Blood-Brain Barriers.	8	79	1.07	0.00049	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000376865,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	CD38,CD69,CD34,ANGPT2,PDGFD,NPY,RHOA,VEGFA
PMID:34944973	(2021) Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers.	7	53	1.18	0.00049	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,ATM,PTEN,NFE2L2,MME,VEGFA,HNF1B
PMID:34959486	(2021) CD4 T Cell-Mediated Immune Control of Cytomegalovirus Infection in Murine Salivary Glands.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:34988104	(2021) TRIM29 in Cutaneous Squamous Cell Carcinoma.	7	53	1.18	0.00049	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252	SOX9,CDH1,ATM,HNF4A,PTEN,JAK2,NFE2L2
PMID:35011819	(2021) Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features-What Do We Already Know?	6	32	1.33	0.00049	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000478570	CHI3L1,CXCL10,CXCL11,CXCL9,EDN1,VEGFA
PMID:35048028	(2021) Oral Cancer Stem Cells: Therapeutic Implications and Challenges.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PRKCE,PTGS2,MME,PROM1,VEGFA
PMID:30607565	(2020) Kidney and organoid single-cell transcriptomics: the end of the beginning.	7	53	1.18	0.00049	9606.ENSP00000245479,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000339191,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,PDGFB,UNC5B,CAV1,BDNF,PROM1,VEGFA
PMID:31241018	(2020) Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?	5	16	1.56	0.00049	9606.ENSP00000266085,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000418525,9606.ENSP00000419422	TIMP3,EDN1,NPY,MME,AGTR1
PMID:31679840	(2020) Evasins: Tick Salivary Proteins that Inhibit Mammalian Chemokines.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:31789409	(2020) Expression profile of Toll-like receptors in human breast cancer.	6	32	1.33	0.00049	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,MYD88,CCL5,VEGFA
PMID:31892981	(2020) Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45(+)CD19(-) cells but in the ALDH(high) Cells.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ALDH1A1,CD34,BCL2,PROM1
PMID:31963513	(2020) Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,BCL2,FGFR1,LTA,PROM1,VEGFA
PMID:31963581	(2020) Immunological Memory of Psoriatic Lesions.	7	53	1.18	0.00049	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000381185	CD69,FABP4,CDH1,CCR5,LPL,CCL20,BCL2
PMID:31969705	(2020) Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8(+) cells.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000272645,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208	CD38,CD69,POLR2D,CCR5,CD34,STAT5A
PMID:31980503	(2020) Functional characterization of two rare BCR-FGFR1(+) leukemias.	6	32	1.33	0.00049	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000418525	IGF1R,ATM,CD34,JAK2,FGFR1,MME
PMID:31985699	(2020) Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,CCL5,VEGFA
PMID:32081834	(2020) Identification of biomarkers related to CD8(+) T cell infiltration with gene co-expression network in clear cell renal cell carcinoma.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	IFNG,CCR5,CXCL9,PTEN,CCL5
PMID:32131560	(2020) Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,HNF4A,PTEN,MAFB,AR,BCL2,PROM1,VEGFA
PMID:32150875	(2020) A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs.	7	53	1.18	0.00049	9606.ENSP00000285407,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	KLF10,ALDH1A1,CAV1,ABCG1,PTGS2,PTEN,VEGFA
PMID:32166899	(2020) Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase-4 inhibitor Linagliptin: A subanalysis from a randomized, placebo-controlled trial (RELEASE study).	5	16	1.56	0.00049	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,PROM1,CCL5,VEGFA
PMID:32192892	(2020) The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370	IFNG,CXCL10,CCL20,CXCL9,CNTF
PMID:32194403	(2020) The Vascular Consequences of Metabolic Syndrome: Rodent Models, Endothelial Dysfunction, and Current Therapies.	6	32	1.33	0.00049	9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000418009	PTGS2,RBP4,NOX1,EDN1,RHOA,RARRES2
PMID:32197355	(2020) Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimers Disease.	5	16	1.56	0.00049	9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000384364,9606.ENSP00000418525,9606.ENSP00000478570	LPL,ANGPT2,NPY,MME,VEGFA
PMID:32238357	(2020) Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy.	7	53	1.18	0.00049	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000474412	MPO,CD69,CXCL10,ANG,CCL20,CD247,CCL5
PMID:32279119	(2020) Caveolin-1, a master regulator of cellular senescence.	7	53	1.18	0.00049	9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000478570	ATM,CAV1,CCL20,PTGS2,PTEN,TXN,VEGFA
PMID:32296423	(2020) Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.	7	53	1.18	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:32300100	(2020) CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating beta-cateninSTAT3 signaling.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000474412	CDH1,CCR5,ALDH1A1,AR,PROM1,CCL5
PMID:32379588	(2020) Recent Findings on the Effects of Pharmacological Agents on the Nerve Regeneration after Peripheral Nerve Injury.	5	16	1.56	0.00049	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000484631	CNTF,GAP43,BDNF,VEGFA,PMP22
PMID:32391124	(2020) Lack of CD8(+) T-cell co-localization with Kaposis sarcoma-associated herpesvirus infected cells in Kaposis sarcoma tumors.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CD34,CXCL9
PMID:32391790	(2020) Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.	7	53	1.18	0.00049	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	MPO,IFNG,CXCL10,CXCL9,PTGS2,MYD88,CCL5
PMID:32494745	(2020) Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy.	7	53	1.18	0.00049	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	MAPK1,CCR5,GAS6,PTEN,CCL5,APLNR,VEGFA
PMID:32532960	(2020) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.	8	79	1.07	0.00049	9606.ENSP00000216181,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570	MYH9,SOX9,HSPB1,CD47,AR,NFE2L2,PROM1,VEGFA
PMID:32564247	(2020) Is Porphyromonas gingivalis involved in Parkinsons disease?	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:32664207	(2020) Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells.	7	53	1.18	0.00049	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901	CD69,CCR5,CXCL10,CXCL11,CD34,STAT5A,CXCL9
PMID:32669286	(2020) PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2(V617F)-Mutant MPN.	7	53	1.18	0.00049	9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000474412	EPOR,ATM,CXCL10,CD34,STAT5A,JAK2,CCL5
PMID:32731349	(2020) miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain.	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,PTGS2,PTEN,BCL2,HPSE,NTF3,RHOA,VEGFA
PMID:32751905	(2020) Combined Treatment with Fasudil and Menthol Improves Functional Recovery in Rat Spinal Cord Injury Model.	5	16	1.56	0.00049	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303	PTGS2,PTEN,GAP43,RHOA,BDNF
PMID:32760726	(2020) Fibroblast Reprogramming in Gastrointestinal Cancer.	7	53	1.18	0.00049	9606.ENSP00000259486,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478319	ENPP2,CAV1,PTEN,JAK2,IRAK4,MYD88,GREM1
PMID:32825247	(2020) Caveolin-1-Mediated Tumor Suppression Is Linked to Reduced HIF1alpha S-Nitrosylation and Transcriptional Activity in Hypoxia.	5	16	1.56	0.00049	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000478570	CDH1,HNF4A,CAV1,PTGS2,VEGFA
PMID:32884030	(2020) Deciphering the secretome of leukocyte-platelet rich fibrin: towards a better understanding of its wound healing properties.	7	53	1.18	0.00049	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000301522,9606.ENSP00000346508,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,MPO,THBS1,PRDX2,PDGFA,NTF3,BDNF
PMID:32948210	(2020) Thrombospondin-1CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells.	5	16	1.56	0.00049	9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000360997,9606.ENSP00000362057,9606.ENSP00000381185	THBS1,CD47,ADAMTS13,NOX1,BCL2
PMID:33020443	(2020) Regulation of Obesity by Antiangiogenic Herbal Medicines.	7	53	1.18	0.00049	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000384364,9606.ENSP00000478570	THBS1,TIMP3,MMP14,PDGFB,ELN,NPY,VEGFA
PMID:33046994	(2020) MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers.	8	79	1.07	0.00049	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,PTGS2,PTEN,EDN1,JAK2,NFE2L2,BCL2,RHOA
PMID:33082354	(2020) Importance of cholesterol-rich microdomains in the regulation of Nox isoforms and redox signaling in human vascular smooth muscle cells.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252	NOX4,CAV1,NOX1,EDN1,NFE2L2
PMID:33093883	(2020) Human umbilical cord-derived mesenchymal stem cells and human cord blood mononuclear cells protect against cisplatin-induced acute kidney injury in rat models.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,BCL2,PROM1,VEGFA
PMID:33096815	(2020) The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000362524,9606.ENSP00000363596,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,ANGPTL2,CNR2,RHOA,CCL5,VEGFA
PMID:33116629	(2020) Novel Therapeutic Strategies for CDK46 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer.	7	53	1.18	0.00049	9606.ENSP00000278616,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	ATM,SGK1,PTEN,AR,BCL2,FGFR1,VEGFA
PMID:33118708	(2020) Alterations in the phosphodiesterase type 5 pathway and oxidative stress correlate with erectile function in spontaneously hypertensive rats.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175	NOX4,NOX1,EDN1,BCL2,RHOA
PMID:33138205	(2020) Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease.	6	32	1.33	0.00049	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,PTGS2,NOX1,JAK2,NFE2L2,BCL2
PMID:33204320	(2020) Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.	5	16	1.56	0.00049	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PTEN,NFE2L2,BCL2,VEGFA
PMID:33224897	(2020) Mobilization and Activation of the Innate Immune Response to Dengue Virus.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CCR5,CD34,CCL20,CCL5,VEGFA
PMID:33264334	(2020) Genetic factors contributing to extensive variability of sex-specific hepatic gene expression in Diversity Outbred mice.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000302630,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000426809	NOX4,ONECUT1,STAT5A,JAK2,PROM1
PMID:33291236	(2020) Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives.	9	109	0.98	0.00049	9606.ENSP00000297785,9606.ENSP00000306124,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000419422	ALDH1A1,PRKCE,CD34,PTGS2,PTEN,NFE2L2,BCL2,MME,AGTR1
PMID:33330380	(2020) The Relationship Between Reactive Oxygen Species and Endothelial Cell Metabolism.	7	53	1.18	0.00049	9606.ENSP00000263317,9606.ENSP00000349860,9606.ENSP00000362057,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,GFPT1,NOX1,MTHFR,NFE2L2,RHOA,VEGFA
PMID:33375065	(2020) Anti-Ageing Protein beta-Klotho Rejuvenates Diabetic Stem Cells for Improved Gene-Activated Scaffold Based Wound Healing.	5	16	1.56	0.00049	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000369442,9606.ENSP00000478570	THBS1,ANGPT2,ANG,KL,VEGFA
PMID:33381084	(2020) FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases.	8	79	1.07	0.00049	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000393312	NOX4,CXCL10,HNF4A,SREBF1,MAP3K5,KL,NFE2L2,FGFR1
PMID:33381498	(2020) Stem Cell Mechanobiology and the Role of Biomaterials in Governing Mechanotransduction and Matrix Production for Tissue Regeneration.	7	53	1.18	0.00049	9606.ENSP00000300055,9606.ENSP00000311005,9606.ENSP00000351807,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000418525	PLIN1,MAPK7,ELN,ALPL,BMP2,NPY,MME
PMID:33543036	(2020) Alterations in extracellular matrix composition during aging and photoaging of the skin.	8	79	1.07	0.00049	9606.ENSP00000258341,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000321853,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000383364	LAMC1,COL8A1,TIMP3,SERPINF2,FMOD,ELN,HSPG2,PLA2G2A
PMID:30151880	(2019) Roles of microRNAs in mammalian reproduction: from the commitment of germ cells to peri-implantation embryos.	11	180	0.85	0.00049	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000414303	TGFB1,SOX9,IGF1R,ATM,SREBF1,ABCG1,PTGS2,PTEN,AR,BCL2,BDNF
PMID:30696040	(2019) 5p and 3p Strands of miR-34 Family Members Have Differential Effects in Cell Proliferation, Migration, and Invasion in Cervical Cancer Cells.	7	53	1.18	0.00049	9606.ENSP00000215832,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185	MAPK1,MMP14,HNF4A,PDGFB,PDGFA,PDGFD,BCL2
PMID:30709791	(2019) Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics.	8	79	1.07	0.00049	9606.ENSP00000268035,9606.ENSP00000284031,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000478570	IGF1R,DDAH1,HNF4A,PTEN,TXN,G6PD,RHOA,VEGFA
PMID:30934943	(2019) Anti-Obesity and Anti-Diabetic Effects of Ishige okamurae.	5	16	1.56	0.00049	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185	FABP4,PLIN1,SREBF1,PTGS2,BCL2
PMID:31105939	(2019) Endometrial polyps: Pathogenesis, sequelae and treatment.	5	16	1.56	0.00049	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,PTGS2,BCL2,VEGFA
PMID:31189952	(2019) Migrant memory B cells secrete luminal antibody in the vagina.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CD38,CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9
PMID:31212642	(2019) NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management.	6	32	1.33	0.00049	9606.ENSP00000259407,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000478570	BAAT,STAT5A,SREBF1,SHBG,JAK2,VEGFA
PMID:31330086	(2019) Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.	7	53	1.18	0.00049	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,CAV1,PTEN,BCL2,RHOA,VEGFA
PMID:31352198	(2019) Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,HNF4A,PTEN,BCL2,VEGFA
PMID:31369569	(2019) Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity.	5	16	1.56	0.00049	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000380252	EPOR,CD34,STAT5A,JAK2,NFE2L2
PMID:31401304	(2019) Pyruvate kinase M2: A simple molecule with complex functions.	8	79	1.07	0.00049	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,SIRT6,SREBF1,PTEN,JAK2,BCL2,VEGFA
PMID:31417869	(2019) Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.	7	53	1.18	0.00049	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,PTEN,MME,PROM1,CCL5,VEGFA
PMID:31442666	(2019) Fate Distribution and Regulatory Role of Human Mesenchymal Stromal Cells in Engineered Hematopoietic Bone Organs.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000478570	CD38,SOX9,CD34,BMP2,VEGFA
PMID:31546913	(2019) Dynamic Interplay between Pericytes and Endothelial Cells during Sprouting Angiogenesis.	5	16	1.56	0.00049	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000478570	ANGPT2,PDGFB,HSPG2,EDN1,VEGFA
PMID:31591326	(2019) The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL9,BMP2,BCL2,CCL5,VEGFA
PMID:31683538	(2019) The Role of MicroRNAs in Diabetes-Related Oxidative Stress.	7	53	1.18	0.00049	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,TIMP3,PTEN,MAFB,TXN,NFE2L2,BCL2
PMID:31684142	(2019) On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective.	8	79	1.07	0.00049	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CXCL10,STAT5A,PTGS2,PTEN,BCL2,BDNF,VEGFA
PMID:31699883	(2019) Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000349860,9606.ENSP00000377192,9606.ENSP00000381185	CD69,IFNG,VDAC1,GFPT1,G6PD,BCL2
PMID:31712626	(2019) Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683	NOX4,EDNRA,PTGS2,NOX1,EDN1
PMID:31729368	(2019) A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.	6	32	1.33	0.00049	9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000478570	HSPB1,CAV1,VIP,EDN1,GAP43,VEGFA
PMID:31766423	(2019) Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis.	5	16	1.56	0.00049	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000321334,9606.ENSP00000351807,9606.ENSP00000368104	SOX9,ENPP2,LPA,ELN,BMP2
PMID:31771653	(2019) The immune landscape of esophageal cancer.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,ALDH1A1,CCL20,CD47,CCL5,VEGFA
PMID:31840053	(2019) Single-cell connectomic analysis of adult mammalian lungs.	7	53	1.18	0.00049	9606.ENSP00000245479,9606.ENSP00000293599,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,AQP5,GAS6,PDGFA,ELN,BDNF,VEGFA
PMID:31885471	(2019) Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventiveanticancer agent: Chemistry and biological effects.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,ANG,AR,JAK2,BCL2,VEGFA
PMID:31930139	(2019) Noncoding RNAs in Steroid-Induced Osteonecrosis of the Femoral Head.	6	32	1.33	0.00049	9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570	PTEN,BMP2,NFE2L2,BCL2,GREM1,VEGFA
PMID:29194760	(2018) Hepatic Fibrosis in Dogs.	6	32	1.33	0.00049	9606.ENSP00000255409,9606.ENSP00000263317,9606.ENSP00000347041,9606.ENSP00000362057,9606.ENSP00000363827,9606.ENSP00000368683	CHI3L1,NOX4,FMOD,NOX1,HSPG2,EDN1
PMID:29280568	(2018) Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.	9	109	0.98	0.00049	9606.ENSP00000216862,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	CYP24A1,THBS1,CDH1,ANGPT2,CAV1,ELN,PTGS2,PTEN,VEGFA
PMID:29396371	(2018) Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.	7	53	1.18	0.00049	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000345708,9606.ENSP00000362410,9606.ENSP00000418823,9606.ENSP00000480291	TGFB1,SOX9,ONECUT1,KCNJ11,MAFB,FTO,HNF1B
PMID:29429153	(2018) Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,BCL2,PROM1,VEGFA
PMID:29440427	(2018) Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.	5	16	1.56	0.00049	9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	ALPL,BMP2,EDN1,RHOA,VEGFA
PMID:29455669	(2018) EGFR-TKIs resistance via EGFR-independent signaling pathways.	6	32	1.33	0.00049	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000331831,9606.ENSP00000361021,9606.ENSP00000393312	MAPK1,CDH1,IGF1R,GAS6,PTEN,FGFR1
PMID:29500637	(2018) RNA-Seq Profile Reveals Th-1 and Th-17-Type of Immune Responses in Mice Infected Systemically with Aspergillus fumigatus.	7	53	1.18	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:29617404	(2018) Angiogenic role of miR-20a in breast cancer.	5	16	1.56	0.00049	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000325548,9606.ENSP00000346508,9606.ENSP00000478570	THBS1,CD34,CNDP2,PDGFA,VEGFA
PMID:29747461	(2018) Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases.	6	32	1.33	0.00049	9606.ENSP00000268035,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000474412	IGF1R,EDNRA,PTGS2,EDN1,BDNF,CCL5
PMID:29755358	(2018) Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.	6	32	1.33	0.00049	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000393312,9606.ENSP00000478570	LPL,CD34,ANGPT2,PDGFB,FGFR1,VEGFA
PMID:29799862	(2018) Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.	6	32	1.33	0.00049	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,MYD88,CCL5,VEGFA
PMID:29871521	(2018) Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,BCL2,BDNF,PROM1,VEGFA
PMID:29925765	(2018) Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.	7	53	1.18	0.00049	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,IGF1R,SIRT6,PTEN,BCL2,MYD88,VEGFA
PMID:29939854	(2018) Chemokine Signaling in Allergic Contact Dermatitis: Toward Targeted Therapies.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:30135489	(2018) Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET-1Nox4 signal pathway in diabetic rats.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185	NOX4,EDNRA,NOX1,EDN1,BCL2
PMID:30140283	(2018) Smooth Muscle-Specific BCL6+- Knockout Abrogates Sex Bias in Chronic Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.	5	16	1.56	0.00049	9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000368683	ONECUT1,HNF4A,STAT5A,ELN,EDN1
PMID:30186406	(2018) Downregulation of microRNA-1 attenuates glucose-induced apoptosis by regulating the liver X receptor alpha in cardiomyocytes.	5	16	1.56	0.00049	9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000477707	SREBF1,ABCG1,EDN1,BCL2,NR1H3
PMID:30200235	(2018) Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na+K+-ATPase.	6	32	1.33	0.00049	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL9,PTGS2,BCL2,MYD88,CCL5
PMID:30294285	(2018) Current Perspectives on Role of MSC in Renal Pathophysiology.	5	16	1.56	0.00049	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	CXCL11,CD34,BCL2,LTA,VEGFA
PMID:30323672	(2018) Monitoring of tumor vascular normalization: the key points from basic research to clinical application.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000475344,9606.ENSP00000478570	IFNG,CD34,ANGPT2,APLNR,VEGFA
PMID:30387077	(2018) Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,ANGPT2,CXCL9,VEGFA
PMID:30467502	(2018) A Co-culture Model of PBMC and Stem Cell Derived Human Nasal Epithelium Reveals Rapid Activation of NK and Innate T Cells Upon Influenza A Virus Infection of the Nasal Epithelium.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000414303	CD38,CD69,CXCL10,CXCL11,CXCL9,BDNF
PMID:30774650	(2018) Metastatic tumor cells - genotypes and phenotypes.	7	53	1.18	0.00049	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	CD38,CDH1,ATM,CD34,PTEN,JAK2,PROM1
PMID:27922978	(2017) Significance of Monocyte Counts at Recurrence on Survival Outcome of Women With Endometrial Cancer.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCL20,PTEN,CCL5,VEGFA
PMID:28089339	(2017) Discovery of a murine model of clinical PAH: Mission impossible?	6	32	1.33	0.00049	9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000475344	CAV1,ELN,PTEN,EDN1,PROM1,APLNR
PMID:28185790	(2017) Immune Regulation of Antibody Access to Neuronal Tissues.	7	53	1.18	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000400175	CCR5,CXCL10,GAS6,CCL20,CD247,CXCL9,RHOA
PMID:28190711	(2017) CD8(+) T Cells Orchestrate pDC-XCR1(+) Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000349860,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,GFPT1,CXCL9,CCL5
PMID:28221004	(2017) Systems biology of oxygen homeostasis.	7	53	1.18	0.00049	9606.ENSP00000222139,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000377192,9606.ENSP00000418823,9606.ENSP00000478253,9606.ENSP00000478570	EPOR,ANGPT2,PDGFB,G6PD,FTO,MTHFD1L,VEGFA
PMID:28232735	(2017) Accelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000401399,9606.ENSP00000474412	CD38,IFNG,CCR5,CXCL10,MYD88,CCL5
PMID:28270908	(2017) Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.	5	16	1.56	0.00049	9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412	MAP3K5,TXN,NFE2L2,BDNF,CCL5
PMID:28346397	(2017) The Process and Regulatory Components of Inflammation in Brain Oncogenesis.	9	109	0.98	0.00049	9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MMP14,ANGPT2,PTGS2,PTEN,JAK2,BCL2,BDNF,CCL5,VEGFA
PMID:28377586	(2017) Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CCL20,CXCL9,VEGFA
PMID:28421069	(2017) Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Dont Forget the Fuel.	8	79	1.07	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412	CCR5,CXCL10,STAT5A,CD247,CXCL9,PTGS2,ENTPD1,CCL5
PMID:28425456	(2017) Salt suppresses IFNgamma inducible chemokines through the IFNgamma-JAK1-STAT1 signaling pathway in proximal tubular cells.	5	16	1.56	0.00049	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000402152	CXCL10,CXCL11,CXCL9,JAK2,SLC12A3
PMID:28435278	(2017) Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation.	7	53	1.18	0.00049	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823,9606.ENSP00000474412	WFS1,JAZF1,HNF4A,KCNJ11,CAPN10,FTO,CCL5
PMID:28487510	(2017) Influence of depression on genetic predisposition to type 2 diabetes in a multiethnic longitudinal study.	5	16	1.56	0.00049	9606.ENSP00000226760,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000381185,9606.ENSP00000418823	WFS1,HNF4A,KCNJ11,BCL2,FTO
PMID:28496985	(2017) The effects of dietary macronutrient composition on lipid metabolism-associated factor gene expression in the adipose tissue of chickens are influenced by fasting and refeeding.	5	16	1.56	0.00049	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000384364	FABP4,PLIN1,LPL,SREBF1,NPY
PMID:28512447	(2017) Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy.	5	16	1.56	0.00049	9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000484631	CNTF,JAK2,GAP43,BDNF,PMP22
PMID:28521856	(2017) Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.	10	143	0.91	0.00049	9606.ENSP00000216181,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000419422	MYH9,IFNG,TIMP3,MMP14,ELN,PTGS2,S100A12,EDN1,MYD88,AGTR1
PMID:28596300	(2017) Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000369442	CDH1,TIMP3,MMP14,GAS6,CAV1,KL
PMID:28754556	(2017) Kidney function is associated with an altered protein composition of high-density lipoprotein.	5	16	1.56	0.00049	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000360522,9606.ENSP00000384906	CETP,LPL,APOL1,RBP4,SAA1
PMID:28771176	(2017) Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000474412	CCR5,CXCL11,CCL20,CXCL9,HSPG2,CCL5
PMID:28878218	(2017) Lack of Evidence for Vasoactive and Inflammatory Mediators in the Promotion of Macular Edema Associated with Epiretinal Membranes.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,ANGPT2,SHBG,BDNF,VEGFA
PMID:28887549	(2017) SATB2beta-cateninTCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,MAPK7,HNF4A,BCL2,PROM1,VEGFA
PMID:28892299	(2017) Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,PTGS2,PTEN,VEGFA
PMID:28938694	(2017) Preclinical evidence of ghrelin as a therapeutic target in epilepsy.	5	16	1.56	0.00049	9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,BCL2,NPY,BDNF,VEGFA
PMID:29050362	(2017) miR-708-5p: a microRNA with emerging roles in cancer.	8	79	1.07	0.00049	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000381185	CD38,CDH1,TIMP3,CXCL10,CXCL11,CD34,CXCL9,BCL2
PMID:29056974	(2017) Avoidance of Total Knee Arthroplasty in Early Osteoarthritis of the Knee with Intra-Articular Implantation of Autologous Activated Peripheral Blood Stem Cells versus Hyaluronic Acid: A Randomized Controlled Trial with Differential Effects of ...	5	16	1.56	0.00049	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,BDNF,PROM1,VEGFA
PMID:29078819	(2017) Cytokines associated with Burkitts lymphoma in western Kenya.	5	16	1.56	0.00049	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000381185,9606.ENSP00000418525	TGFB1,CD38,IFNG,BCL2,MME
PMID:29084988	(2017) Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax - a liver transcriptomics approach.	6	32	1.33	0.00049	9606.ENSP00000200676,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000419422,9606.ENSP00000444198,9606.ENSP00000478570	CETP,ATM,PTEN,AGTR1,CITED2,VEGFA
PMID:29286303	(2017) Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).	7	53	1.18	0.00049	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000371067	SOX9,ALDH1A1,HNF4A,STAT5A,SREBF1,RBP4,JAK2
PMID:29375316	(2017) Biomaterial-Supported Cell Transplantation Treatments for Spinal Cord Injury: Challenges and Perspectives.	5	16	1.56	0.00049	9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303	PDGFA,CNTF,GAP43,NTF3,BDNF
PMID:25779598	(2016) Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis.	5	16	1.56	0.00049	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ANGPT2,PDGFB,JAK2,BCL2,VEGFA
PMID:26486634	(2016) Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,MYD88,CCL5
PMID:26526143	(2016) Cerebral Response to Peripheral Challenge with a Viral Mimetic.	6	32	1.33	0.00049	9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	HSPB1,CCR5,CXCL10,CXCL9,BCL2,CCL5
PMID:26558730	(2016) Distinct cytokinechemokine network in semen and blood characterize different stages of HIV infection.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:26798416	(2016) Role of Natural Stilbenes in the Prevention of Cancer.	6	32	1.33	0.00049	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	PTGS2,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:26887821	(2016) At the interface of antioxidant signalling and cellular function: Key polyphenol effects.	8	79	1.07	0.00049	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	CD38,HSPB1,SIRT6,CAV1,NOX1,EDN1,NFE2L2,VEGFA
PMID:26943181	(2016) Roles of the kidney in the formation, remodeling and repair of bone.	6	32	1.33	0.00049	9606.ENSP00000216862,9606.ENSP00000222139,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000478570	CYP24A1,EPOR,BMP2,KL,JAK2,VEGFA
PMID:26962117	(2016) Deletion of Arid1a in Reproductive Tract Mesenchymal Cells Reduces Fertility in Female Mice.	7	53	1.18	0.00049	9606.ENSP00000257430,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000478570	APC,PTGS2,PTEN,BMP2,BCL2,TRPC1,VEGFA
PMID:26988916	(2016) Emerging preclinical pharmacological targets for Parkinsons disease.	7	53	1.18	0.00049	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000354511,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	MPO,IFNG,COMT,NFE2L2,BCL2,RHOA,BDNF
PMID:27132116	(2016) Myeloid-derived suppressor cells: The green light for myeloma immune escape.	6	32	1.33	0.00049	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD34,STAT5A,CD247,BCL2,CCL5,VEGFA
PMID:27133824	(2016) The concept of treatment-free remission in chronic myeloid leukemia.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067	CD38,CD34,STAT5A,ELN,JAK2
PMID:27148161	(2016) Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders.	7	53	1.18	0.00049	9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000478570	MPO,ATM,PLIN1,CD34,SREBF1,RBP4,VEGFA
PMID:27215705	(2016) Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.	7	53	1.18	0.00049	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CD34,CCL20,ENTPD1,CCL5,VEGFA
PMID:27292642	(2016) Threshold-Dependent Cooperativity of Pdx1 and Oc1 in Pancreatic Progenitors Establishes Competency for Endocrine Differentiation and beta-Cell Function.	6	32	1.33	0.00049	9606.ENSP00000246553,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000362410,9606.ENSP00000384364	FFAR1,ONECUT1,HNF4A,KCNJ11,MAFB,NPY
PMID:27366312	(2016) New Developments in Chronic Myeloid Leukemia: Implications for Therapy.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067	CD38,CD34,STAT5A,ELN,JAK2
PMID:27446920	(2016) p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story.	5	16	1.56	0.00049	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,HSPB1,THBS1,BCL2,VEGFA
PMID:27586591	(2016) Identification and functional characterization of the miRNA-gene regulatory network in chronic myeloid leukemia lineage negative cells.	5	16	1.56	0.00049	9606.ENSP00000222305,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	USF2,CD38,CD34,STAT5A,JAK2
PMID:27597870	(2016) Cancer Stem Cells and Radioresistance: RhoROCK Pathway Plea Attention.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PTEN,RHOA,PROM1,VEGFA
PMID:27975071	(2016) New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCL20,PTGS2,CNR2,BCL2,CCL5,VEGFA
PMID:27990285	(2016) Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.	7	53	1.18	0.00049	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,PDGFB,CCL20,CXCL9,CCL5,VEGFA
PMID:28154781	(2016) Properties and feasibility of using cancer stem cells in clinical cancer treatment.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000426809	CD38,SOX9,ALDH1A1,CD34,CD47,PROM1
PMID:28539803	(2016) Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy.	6	32	1.33	0.00049	9606.ENSP00000222139,9606.ENSP00000263317,9606.ENSP00000334329,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000478570	EPOR,NOX4,UNC5B,STAT5A,NOX1,VEGFA
PMID:25861671	(2015) ERK5 Mediated Signalling in Diabetic Retinopathy.	6	32	1.33	0.00049	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,MAPK7,SGK1,EDN1,BCL2,VEGFA
PMID:25928540	(2015) A Novobiocin Derivative, XN4, Inhibits the Proliferation of Chronic Myeloid Leukemia Cells by Inducing Oxidative DNA Damage.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000362057	CD38,NOX4,ATM,CD34,NOX1
PMID:25950480	(2015) Arachidonic acid promotes skin wound healing through induction of human MSC migration by MT3-MMP-mediated fibronectin degradation.	6	32	1.33	0.00049	9606.ENSP00000245479,9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000360247	SOX9,FFAR1,FABP4,MMP14,CD34,CYP2J2
PMID:25982381	(2015) DNA methylation changes in the placenta are associated with fetal manganese exposure.	6	32	1.33	0.00049	9606.ENSP00000356515,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000418823,9606.ENSP00000478570	UTRN,PTEN,BMP2,NTF3,FTO,VEGFA
PMID:26102214	(2015) Mechanistic Effects of Calcitriol in Cancer Biology.	7	53	1.18	0.00049	9606.ENSP00000216862,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,THBS1,CDH1,MAPK7,PTGS2,BCL2,VEGFA
PMID:26104528	(2015) Effects of Dietary Restriction on the Expression of Lipid Metabolism and Growth Hormone Signaling Genes in the Longissimus dorsi Muscle of Korean Cattle Steers.	5	16	1.56	0.00049	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067	FABP4,LPL,STAT5A,AR,JAK2
PMID:26121213	(2015) The Androgen Receptor Antagonizes Wntbeta-Catenin Signaling in Epidermal Stem Cells.	6	32	1.33	0.00049	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368104	SOX9,FABP4,HNF4A,PTGS2,AR,BMP2
PMID:26170839	(2015) Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.	7	53	1.18	0.00049	9606.ENSP00000300055,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000414303,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000475344	PLIN1,EDN1,SAA1,BDNF,RARRES2,AGTR1,APLNR
PMID:26192455	(2015) Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth Muscle.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD38,EDN1,BCL2,BDNF,VEGFA
PMID:26207031	(2015) Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000383364	IFNG,CXCL10,LPL,ABCG1,NOX1,PLA2G2A
PMID:26300976	(2015) Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression.	6	32	1.33	0.00049	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,JAK2,BCL2,MME
PMID:26416448	(2015) MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.	5	16	1.56	0.00049	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,IGF1R,PTEN,BCL2,VEGFA
PMID:26684789	(2015) Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:26690128	(2015) Mast Cell-Mediated Mechanisms of Nociception.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356213,9606.ENSP00000358513,9606.ENSP00000368683,9606.ENSP00000474412	CDH1,CD34,VIP,CNR1,EDN1,CCL5
PMID:26843836	(2015) Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MAPK7,PTEN,AR,BCL2,VEGFA
PMID:27019614	(2015) The Role of miRNAs in Cartilage Homeostasis.	8	79	1.07	0.00049	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,TIMP3,PTGS2,PTEN,BMP2,BCL2,CCL5,VEGFA
PMID:27417759	(2015) NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for Prevention.	5	16	1.56	0.00049	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000365777	NOX4,ELN,MAP3K5,NOX1,MTHFR
PMID:24313723	(2014) Resolution of acute inflammation in the lung.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000418009,9606.ENSP00000445772	CD38,CCR5,CXCL9,PTGS2,RARRES2,LTB4R2
PMID:24745023	(2014) MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,SREBF1,ABCG1,PTEN,PROM1,VEGFA
PMID:24758278	(2014) Fat body, fat pad and adipose tissues in invertebrates and vertebrates: the nexus.	7	53	1.18	0.00049	9606.ENSP00000200676,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000380365,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	CETP,PLIN1,LPL,RGN,IRAK4,MYD88,VEGFA
PMID:24782825	(2014) Endothelial progenitor cells in diabetic retinopathy.	6	32	1.33	0.00049	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,TIMP3,CD34,BDNF,PROM1,VEGFA
PMID:24788775	(2014) Mapping the homodimer interface of an optimized, artificial, transmembrane protein activator of the human erythropoietin receptor.	5	16	1.56	0.00049	9606.ENSP00000222139,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	EPOR,CCR5,CD34,STAT5A,JAK2
PMID:24832597	(2014) ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS.	6	32	1.33	0.00049	9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	CNTF,PTEN,GAP43,BCL2,RHOA,BDNF
PMID:24908616	(2014) The role of BMPs in endothelial cell function and dysfunction.	7	53	1.18	0.00049	9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	PTGS2,NOX1,BAMBI,BMP2,EDN1,RHOA,VEGFA
PMID:24970330	(2014) Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis.	5	16	1.56	0.00049	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000400175	MPO,CCR5,CXCL10,CXCL9,RHOA
PMID:25071162	(2014) Fibroblast heterogeneity in the cancer wound.	7	53	1.18	0.00049	9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,ALDH1A1,MMP14,CAV1,PTGS2,CCL5,VEGFA
PMID:25237831	(2014) EZH2 promotes angiogenesis through inhibition of miR-1Endothelin-1 axis in nasopharyngeal carcinoma.	5	16	1.56	0.00049	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,CD34,EDNRA,EDN1,VEGFA
PMID:25397683	(2014) Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression.	6	32	1.33	0.00049	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000371067,9606.ENSP00000380252	ATM,PRDX2,CD34,SIRT6,JAK2,NFE2L2
PMID:25431758	(2014) Immune responses to non-tumor antigens in the central nervous system.	7	53	1.18	0.00049	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	MPO,CCR5,CXCL10,CXCL11,CXCL9,BDNF,CCL5
PMID:25520921	(2014) Personalized medicine in Type 2 Diabetes.	7	53	1.18	0.00049	9606.ENSP00000226760,9606.ENSP00000278616,9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000478570,9606.ENSP00000480291	WFS1,ATM,LPL,KCNJ11,MTHFR,VEGFA,HNF1B
PMID:25551605	(2014) Accelerating in situ endothelialisation of cardiovascular bypass grafts.	6	32	1.33	0.00049	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ELN,EDN1,BDNF,PROM1,VEGFA
PMID:25628089	(2014) New therapeutic modalities to modulate orthodontic tooth movement.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,PTGS2,CCL5,VEGFA
PMID:25977681	(2014) The many roles of statins in ischemic stroke.	6	32	1.33	0.00049	9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	NOX1,EDN1,RHOA,BDNF,CCL5,VEGFA
PMID:22982587	(2013) Signaling mechanisms regulating adult neural stem cells and neurogenesis.	8	79	1.07	0.00049	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,HNF4A,PTEN,FGFR1,NTF3,BDNF,PROM1,VEGFA
PMID:23358247	(2013) Neurodegeneration and neuroprotection in  diabetic retinopathy.	5	16	1.56	0.00049	9606.ENSP00000355370,9606.ENSP00000365777,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,MTHFR,NTF3,BDNF,VEGFA
PMID:23483225	(2013) Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.	5	16	1.56	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:23509712	(2013) The importance of the nurse cells and regulatory cells in the control of T lymphocyte responses.	8	79	1.07	0.00049	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000356213,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000384364	TGFB1,CD38,CD69,IFNG,VIP,ENTPD1,BCL2,NPY
PMID:23717153	(2013) A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.	7	53	1.18	0.00049	9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	STAT5A,PTGS2,BCL2,NPY,BDNF,MME,VEGFA
PMID:23720280	(2013) Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.	9	109	0.98	0.00049	9606.ENSP00000256104,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000474412	FABP4,CAV1,STAT5A,SREBF1,PTEN,JAK2,NPY,RARRES2,CCL5
PMID:23758954	(2013) Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?	5	16	1.56	0.00049	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,BCL2,PROM1,VEGFA
PMID:24012543	(2013) Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokinechemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.	6	32	1.33	0.00049	9606.ENSP00000216862,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000474412	CYP24A1,ALDH1A1,CXCL10,CXCL11,PTEN,CCL5
PMID:24147217	(2013) Stem cell transplantation for neuroprotection in stroke.	6	32	1.33	0.00049	9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,BCL2,BDNF,PROM1,CCL5,VEGFA
PMID:24167471	(2013) Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells.	6	32	1.33	0.00049	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANG,BMP2,BDNF,PROM1,VEGFA
PMID:21826801	(2012) A systems biology approach to synovial joint lubrication in health, injury, and disease.	8	79	1.07	0.00049	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000301522,9606.ENSP00000336762,9606.ENSP00000357726,9606.ENSP00000363827,9606.ENSP00000478570	SOX9,CHI3L1,TIMP3,PRDX2,ANG,S100A12,HSPG2,VEGFA
PMID:21924222	(2012) Trpc2 depletion protects red blood cells from oxidative stress-induced hemolysis.	5	16	1.56	0.00049	9606.ENSP00000222139,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000419313,9606.ENSP00000478570	EPOR,BDNF,MME,TRPC1,VEGFA
PMID:22030901	(2012) Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,MYD88,CCL5
PMID:22210319	(2012) Expression and regulation of chemokines in murine and human type 1 diabetes.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:22229096	(2012) Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.	6	32	1.33	0.00049	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	PTGS2,PTEN,AR,BCL2,PROM1,VEGFA
PMID:22233170	(2012) A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.	5	16	1.56	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901	CCR5,CXCL10,CXCL11,ELN,CXCL9
PMID:22235369	(2012) The carnivore connection hypothesis: revisited.	5	16	1.56	0.00049	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823	WFS1,JAZF1,KCNJ11,CAPN10,FTO
PMID:22326260	(2012) Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.	5	16	1.56	0.00049	9606.ENSP00000200676,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000354995	CETP,CCR5,CD34,SREBF1,ABCG1
PMID:22359619	(2012) Hemagglutinin from the H5N1 virus activates Janus kinase 3 to dysregulate innate immunity.	6	32	1.33	0.00049	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,STAT5A,CXCL9,PTGS2,JAK2,CCL5
PMID:22363134	(2012) Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.	5	16	1.56	0.00049	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000478570	TGFB1,IFNG,CXCL11,ANG,VEGFA
PMID:22423039	(2012) A2 adenosine receptors and vascular pathologies.	6	32	1.33	0.00049	9606.ENSP00000260356,9606.ENSP00000304767,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000478570	THBS1,P2RY1,SREBF1,ELN,ENTPD1,VEGFA
PMID:22433783	(2012) Growth factor delivery: how surface interactions modulate release in vitro and in vivo.	5	16	1.56	0.00049	9606.ENSP00000261769,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303	CDH1,HSPG2,BMP2,NTF3,BDNF
PMID:22645613	(2012) Epigenetic dysregulation in laryngeal squamous cell carcinoma.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,MTHFR,VEGFA
PMID:22748184	(2012) Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice.	6	32	1.33	0.00049	9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	ANG,ELN,CXCL9,EDN1,CCL5,VEGFA
PMID:22787334	(2012) Biologically based strategies to augment rotator cuff tears.	6	32	1.33	0.00049	9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,MMP14,ELN,PTGS2,BMP2,VEGFA
PMID:22815773	(2012) Altered microRNA expression in bovine subcutaneous and visceral adipose tissues from cattle under different diet.	6	32	1.33	0.00049	9606.ENSP00000306124,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000381185	PRKCE,PDGFB,CAV1,PTGS2,SGK1,BCL2
PMID:22920724	(2012) Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration.	5	16	1.56	0.00049	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,SOX9,PDGFA,BCL2,VEGFA
PMID:22927833	(2012) The common C49620T polymorphism in the sulfonylurea receptor gene SUR1 (ABCC8) in patients with gestational diabetes and subsequent glucose metabolism abnormalities.	5	16	1.56	0.00049	9606.ENSP00000226760,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,HNF4A,KCNJ11,FTO,HNF1B
PMID:22988495	(2012) Ductal carcinoma in situ of the breast: a surgical perspective.	5	16	1.56	0.00049	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000478570	CDH1,PTGS2,AR,SHBG,VEGFA
PMID:23049603	(2012) Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation.	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,LTA,CCL5
PMID:23150618	(2012) Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells.	5	16	1.56	0.00049	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:23236355	(2012) Age-dependent modulation of cortical transcriptomes in spinal cord injury and repair.	6	32	1.33	0.00049	9606.ENSP00000311005,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303	MAPK7,ELN,CNTF,JAK2,RHOA,BDNF
PMID:24383043	(2012) Targeting Cancer Stem Cells with Nanoparticle-Enabled Therapies.	5	16	1.56	0.00049	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000306124,9606.ENSP00000310036,9606.ENSP00000426809	CD38,ALDH1A1,PRKCE,CD34,PROM1
PMID:21284992	(2011) HIV reservoirs and latency models.	5	16	1.56	0.00049	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000381185	CD69,CCR5,CXCL10,CCL20,BCL2
PMID:21337461	(2011) Beta-catenin signaling in hepatic development and progenitors: which way does the WNT blow?	8	79	1.07	0.00049	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000380365,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000480291	APC,CDH1,ONECUT1,HNF4A,RGN,FGFR1,PROM1,HNF1B
PMID:21717064	(2011) Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CD69,CXCL10,CD247,BCL2,MYD88,CCL5
PMID:21717071	(2011) Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?	6	32	1.33	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:21731663	(2011) Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,VEGFA
PMID:21829703	(2011) Sox9-haploinsufficiency causes glucose intolerance in mice.	5	16	1.56	0.00049	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,HNF4A,HNF1B
PMID:21896560	(2011) Contemporary genetic technologies and female reproduction.	8	79	1.07	0.00049	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000345708,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000478319	HSPB1,CXCL10,KCNJ11,PTGS2,BCL2,BDNF,FTO,GREM1
PMID:21952300	(2011) Forming functional fat: a growing understanding of adipocyte differentiation.	8	79	1.07	0.00049	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067	FABP4,TIMP3,MMP14,CD34,HNF4A,STAT5A,BMP2,JAK2
PMID:22125567	(2011) Angiogenesis and Proteinases: Influence on Vascular Morphogenesis, Stabilization and Regression.	6	32	1.33	0.00049	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000478570	THBS1,TIMP3,MMP14,CD47,HSPG2,VEGFA
PMID:22150304	(2011) Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.	6	32	1.33	0.00049	9606.ENSP00000222139,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067	EPOR,HNF4A,EBF1,STAT5A,PTEN,JAK2
PMID:24212647	(2011) Inflammation and tumor microenvironment in lymph node metastasis.	7	53	1.18	0.00049	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CXCL10,PTGS2,PROM1,CCL5,VEGFA
PMID:20128875	(2010) Roles of endothelin signaling in melanocyte development and melanoma.	6	32	1.33	0.00049	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,EDNRA,PTEN,EDN1,PROM1,VEGFA
PMID:20175905	(2010) Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide.	5	16	1.56	0.00049	9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFA,CXCL9,CCL5,VEGFA
PMID:20398931	(2010) Cellular chemotaxis induced by wear particles from joint replacements.	6	32	1.33	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:20499882	(2010) Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation.	5	16	1.56	0.00049	9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ATM,HNF4A,PTEN,BCL2,VEGFA
PMID:20532174	(2010) Topological significance analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.	6	32	1.33	0.00049	9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	IGF1R,HNF4A,SREBF1,PTEN,AR,VEGFA
PMID:20665377	(2010) Macrophages: master regulators of inflammation and fibrosis.	6	32	1.33	0.00049	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,IFNG,CHI3L1,CCR5,MYD88,CCL5
PMID:21152281	(2010) Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the niche of endothelial progenitor cells.	5	16	1.56	0.00049	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD34,PTGS2,PROM1,VEGFA
PMID:24281089	(2010) Role of inflammation and oxidative stress mediators in gliomas.	7	53	1.18	0.00049	9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,ANGPT2,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:19110052	(2009) Function of AktPKB signaling to cell motility, invasion and the tumor stroma in cancer.	6	32	1.33	0.00049	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,PTGS2,PTEN,CCL5,VEGFA
PMID:19414191	(2009) Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH).	5	16	1.56	0.00049	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	MPO,CD38,CD34,MME,PROM1
PMID:19529959	(2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.	6	32	1.33	0.00049	9606.ENSP00000226279,9606.ENSP00000317674,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CD38,APOL1,ENTPD1,BCL2,MME,VEGFA
PMID:19575365	(2009) Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.	5	16	1.56	0.00049	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000474412	CDH1,CXCL10,CXCL11,CCL20,CCL5
PMID:19767105	(2009) T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor.	6	32	1.33	0.00049	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19815822	(2009) ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.	5	16	1.56	0.00049	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185	MAPK1,MAPK7,MAP3K5,TXN,BCL2
PMID:18081553	(2008) Paracrinicity: the story of 30 years of cellular pituitary crosstalk.	10	143	0.91	0.00049	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000356213,9606.ENSP00000363822,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000419422,9606.ENSP00000475344	THBS1,CDH1,VIP,AR,HSPG2,EDN1,NPY,FGFR1,AGTR1,APLNR
PMID:19090991	(2008) The potential of hematopoietic growth factors for treatment of Alzheimers disease: a mini-review.	5	16	1.56	0.00049	9606.ENSP00000222139,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000414303	EPOR,CNTF,BMP2,JAK2,BDNF
PMID:17403935	(2007) Repression of BCL-6 is required for the formation of human memory B cells in vitro.	8	79	1.07	0.00049	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000418525	CD38,CD69,CXCL10,HNF4A,EBF1,STAT5A,BCL2,MME
PMID:17603905	(2007) Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiation.	5	16	1.56	0.00049	9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,BMP2,BCL2,BDNF,VEGFA
PMID:19305741	(2007) The ERK 1 and 2 pathway in the nervous system: from basic aspects to possible clinical applications in pain and visceral dysfunction.	6	32	1.33	0.00049	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	MAPK1,MAPK7,PTGS2,BCL2,NPY,BDNF
PMID:16219708	(2006) Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.	5	16	1.56	0.00049	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:16940167	(2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.	5	16	1.56	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356213	CCR5,CXCL10,CXCL11,CXCL9,VIP
PMID:16238103	(2005) In vivo and in vitro estrogenic and progestagenic actions of Tibolone.	5	16	1.56	0.00049	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,STAT5A,AR,BCL2,VEGFA
PMID:15582161	(2004) Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes.	5	16	1.56	0.00049	9606.ENSP00000248553,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364	HSPB1,VIP,GAP43,BCL2,NPY
PMID:11806848	(2002) Growth factors in idiopathic pulmonary fibrosis: relative roles.	6	32	1.33	0.00049	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CXCL10,PDGFB,PTGS2,EDN1,VEGFA
PMID:11465103	(2001) Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-- mice and Rag-2-- mice reconstituted with CD4+CD45RBhigh T cells.	5	16	1.56	0.00049	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:34033001	(2022) The Beneficial Potential of Genetically Modified Stem Cells in the Treatment of Stroke: a Review.	7	54	1.17	0.00052	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,BCL2,NTF3,MYD88,BDNF,VEGFA
PMID:34782555	(2022) All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimers disease.	8	80	1.06	0.00052	9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000363827,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	THBS1,CAV1,CD47,HSPG2,NFE2L2,BDNF,MME,VEGFA
PMID:35015114	(2022) Role of Curcumin in Retinal Diseases-A review.	7	54	1.17	0.00052	9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ELN,PTGS2,TXN,EDN1,NFE2L2,BCL2,VEGFA
PMID:35053302	(2022) Generation of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000293599,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000400175	IFNG,APC,AQP5,PTGS2,PTEN,BMP2,RHOA
PMID:35168143	(2022) The PI3KAktmTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles.	7	54	1.17	0.00052	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,CD34,PTEN,BCL2,RHOA,VEGFA
PMID:35203272	(2022) Potential Therapeutic Effects of PPAR Ligands in Glioblastoma.	7	54	1.17	0.00052	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,PTGS2,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:35203550	(2022) Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension.	7	54	1.17	0.00052	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000426809	NOX4,EDNRA,PTEN,NOX1,TXN,EDN1,PROM1
PMID:35203580	(2022) Emerging Therapeutic Strategies for Parkinsons Disease and Future Prospects: A 2021 Update.	8	80	1.06	0.00052	9606.ENSP00000339191,9606.ENSP00000354511,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303	CAV1,COMT,CNTF,VIP,PTEN,RHOA,MYD88,BDNF
PMID:35269711	(2022) Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells.	7	54	1.17	0.00052	9606.ENSP00000216862,9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000363973	CYP24A1,FABP4,FADS2,PLIN1,LPL,CD34,ALPL
PMID:35388304	(2022) Biogenic Phytochemicals Modulating Obesity: From Molecular Mechanism to Preventive and Therapeutic Approaches.	7	54	1.17	0.00052	9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000418823	PLIN1,LPL,STAT5A,SREBF1,JAK2,NPY,FTO
PMID:35408800	(2022) How miRNAs Regulate Schwann Cells during Peripheral Nerve Regeneration-A Systemic Review.	7	54	1.17	0.00052	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000484631	TGFB1,TIMP3,CNTF,PTEN,BCL2,BDNF,PMP22
PMID:33029758	(2021) Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.	7	54	1.17	0.00052	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	CDH1,PTGS2,JAK2,MYD88,AGTR1,APLNR,VEGFA
PMID:33558455	(2021) Viral vector platforms within the gene therapy landscape.	8	80	1.06	0.00052	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,LPL,CD34,CXCL9,PTGS2,NTF3,MYD88,VEGFA
PMID:33656139	(2021) Biomarkers of severity and chronification in chikungunya fever: a systematic review and meta-analysis.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360997,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,ADAMTS13,LTA,BDNF,CCL5,VEGFA
PMID:33671568	(2021) Chemically Defined Xeno- and Serum-Free Cell Culture Medium to Grow Human Adipose Stem Cells.	8	80	1.06	0.00052	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000362524,9606.ENSP00000369442,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,FABP4,CDH1,CD34,ANGPTL2,KL,CCL5,VEGFA
PMID:33768115	(2021) Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma.	7	54	1.17	0.00052	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,CD47,PTGS2,PTEN,BCL2,VEGFA
PMID:33918883	(2021) Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.	9	110	0.97	0.00052	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,ENTPD1,EDN1,BCL2,RHOA,PROM1,VEGFA
PMID:33919512	(2021) Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives.	7	54	1.17	0.00052	9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MMP14,ANG,PTGS2,NFE2L2,BCL2,CCL5,VEGFA
PMID:34055195	(2021) Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments.	7	54	1.17	0.00052	9606.ENSP00000222572,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	PON2,NOX4,MAP3K5,PTEN,NOX1,TXN,BCL2
PMID:34063627	(2021) JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation.	7	54	1.17	0.00052	9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ALDH1A1,CCL20,MAP3K5,PTGS2,BCL2,CCL5,VEGFA
PMID:34098945	(2021) EstrogenER in anti-tumor immunity regulation to tumor cell and tumor microenvironment.	8	80	1.06	0.00052	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,IGF1R,CXCL11,AR,BCL2,FGFR1,CCL5,VEGFA
PMID:34202238	(2021) The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities.	7	54	1.17	0.00052	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,ANGPT2,STAT5A,ANGPTL2,BCL2,VEGFA
PMID:34281281	(2021) The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis.	8	80	1.06	0.00052	9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	EDNRA,VIP,EDN1,JAK2,BCL2,NPY,BDNF,VEGFA
PMID:34356891	(2021) Emerging Evidence of the Functional Impact of the miR379miR656 Cluster (C14MC) in Breast Cancer.	7	54	1.17	0.00052	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	MAPK1,CDH1,PTGS2,PTEN,BCL2,LTA,VEGFA
PMID:34385994	(2021) Mesenchymal Stromal Cell-Derived Tailored Exosomes Treat Bacteria-Associated Diabetes Foot Ulcers: A Customized Approach From Bench to Bed.	7	54	1.17	0.00052	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	MAPK1,MPO,CD34,PTEN,BDNF,MME,VEGFA
PMID:34445235	(2021) Roles of CCL2-CCR2 Axis in the Tumor Microenvironment.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CCL20,PTGS2,AR,CCL5,VEGFA
PMID:34451874	(2021) Mechanistic Insight into the Effects of Curcumin on Neuroinflammation-Driven Chronic Pain.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,STAT5A,JAK2,NFE2L2,MYD88,BDNF,CCL5
PMID:34471502	(2021) The molecular feature of macrophages in tumor immune microenvironment of glioma patients.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067	IFNG,CHI3L1,CXCL10,MMP14,CXCL9,PTEN,JAK2
PMID:34482756	(2021) ASNTR Abstracts 2021.	8	80	1.06	0.00052	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303	TGFB1,IFNG,HSPB1,CHI3L1,CD34,JAK2,NFE2L2,BDNF
PMID:34513956	(2021) Cardioprotective Roles of Endothelial Progenitor Cell-Derived Exosomes.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,THBS1,NOX4,CD34,CXCL9,FGFR1,VEGFA
PMID:34571965	(2021) The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: Crafting a Microenvironment That Matters.	7	54	1.17	0.00052	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000360997,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,MPO,CCR5,CD34,ADAMTS13,JAK2,VEGFA
PMID:34613483	(2021) 3D tumor angiogenesis models: recent advances and challenges.	7	54	1.17	0.00052	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000346508,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	THBS1,MMP14,PDGFA,HSPG2,BCL2,NPY,VEGFA
PMID:34680566	(2021) The Role of Microglia in the Development of Neurodegenerative Diseases.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,KL,JAK2,BCL2,BDNF,CCL5,VEGFA
PMID:34681633	(2021) Organ Specificity and Heterogeneity of Cancer-Associated Fibroblasts in Colorectal Cancer.	7	54	1.17	0.00052	9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000478319,9606.ENSP00000478570	CHI3L1,CD34,CAV1,BMP2,JAK2,GREM1,VEGFA
PMID:34707127	(2021) Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	CXCL10,STAT5A,CXCL9,PTGS2,JAK2,MYD88,VEGFA
PMID:34869378	(2021) Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments.	7	54	1.17	0.00052	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000384364,9606.ENSP00000478570	THBS1,CDH1,IGF1R,ANG,PTGS2,NPY,VEGFA
PMID:34940041	(2021) A Synopsis of Signaling Crosstalk of Pericytes and Endothelial Cells in Salivary Gland.	9	110	0.97	0.00052	9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,APC,CDH1,CD34,HNF4A,PDGFB,PTEN,BCL2,VEGFA
PMID:34944870	(2021) Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.	10	144	0.9	0.00052	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000354782,9606.ENSP00000356832,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000371067	ATM,CXCL10,PDGFB,PRKAA1,PDGFA,CD247,SGK1,CNR1,PTEN,JAK2
PMID:35127725	(2021) Ferroptosis: A Potential Target in Cardiovascular Disease.	7	54	1.17	0.00052	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252	HSPB1,NOX4,VDAC1,SREBF1,ELN,PTGS2,NFE2L2
PMID:31571662	(2020) Protein microarray analysis of cytokine expression changes in distal stumps after sciatic nerve transection.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000474412	IFNG,TIMP3,CXCL11,CXCL9,CNTF,JAK2,CCL5
PMID:31935965	(2020) Redox Signaling from Mitochondria: Signal Propagation and Its Targets.	8	80	1.06	0.00052	9606.ENSP00000246553,9606.ENSP00000265333,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175	FFAR1,VDAC1,MAP3K5,PTEN,NOX1,TXN,BCL2,RHOA
PMID:32157087	(2020) Cancer associated fibroblast FAK regulates malignant cell metabolism.	8	80	1.06	0.00052	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000377192,9606.ENSP00000400175	CD69,CDH1,CCR5,CXCL11,HNF4A,CCL20,G6PD,RHOA
PMID:32324526	(2020) Chronic Pancreatitis and the Development of Pancreatic Cancer.	10	144	0.9	0.00052	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CDH1,CCR5,ALDH1A1,CXCL10,CCL20,MYD88,PROM1,CCL5,VEGFA
PMID:32403085	(2020) Therapeutic potential of lipids obtained from gamma-irradiated PBMCs in dendritic cell-mediated skin inflammation.	7	54	1.17	0.00052	9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000474412	CCL20,CXCL9,CNTF,PTGS2,NFE2L2,LTA,CCL5
PMID:32459397	(2020) Establishment and characterization of a novel double-hit follicular lymphoma cell line, FL-SJC.	7	54	1.17	0.00052	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,ATM,PTEN,JAK2,BCL2,MYD88,MME
PMID:32545470	(2020) Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.	8	80	1.06	0.00052	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,CXCL11,CXCL9,MYD88,CCL5,VEGFA
PMID:32602047	(2020) The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,COL8A1,CDH1,JAK2,CCL5,VEGFA
PMID:32722137	(2020) Friend or Foe: S100 Proteins in Cancer.	8	80	1.06	0.00052	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000365256,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CXCL10,MMP14,PTGS2,S100A12,CLCN5,BCL2,VEGFA
PMID:32911833	(2020) Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimers Disease.	9	110	0.97	0.00052	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000478570	NOX4,CD34,ANGPT2,GAS6,ELN,PTGS2,NOX1,BMP2,VEGFA
PMID:32932720	(2020) The Role of Sirtuins in Kidney Diseases.	7	54	1.17	0.00052	9606.ENSP00000337332,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	SIRT6,NOX1,KL,NFE2L2,BCL2,AGTR1,VEGFA
PMID:33004861	(2020) Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000401399	CXCL10,CXCL11,HNF4A,CCL20,CXCL9,AR,MYD88
PMID:33007997	(2020) Bioactive Properties of Marine Phenolics.	7	54	1.17	0.00052	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,PLIN1,SREBF1,PTGS2,BCL2,BDNF,VEGFA
PMID:33015098	(2020) Bile Acids and FXR: Novel Targets for Liver Diseases.	7	54	1.17	0.00052	9606.ENSP00000259407,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000393312	BAAT,SREBF1,PTGS2,KL,NFE2L2,NPY,FGFR1
PMID:33066016	(2020) Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma.	9	110	0.97	0.00052	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	APC,CDH1,HNF4A,PTGS2,PTEN,JAK2,BCL2,RHOA,VEGFA
PMID:33076269	(2020) Post-Transcriptional Expression Control in Platelet Biogenesis and Function.	8	80	1.06	0.00052	9606.ENSP00000216181,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000384957	MYH9,THBS1,TIMP3,IGF1R,CD34,PTGS2,MAFB,F11
PMID:33255985	(2020) The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections.	8	80	1.06	0.00052	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,STAT5A,CXCL9,JAK2,MYD88,CCL5
PMID:33304777	(2020) Manipulation of immune-vascular crosstalk: new strategies towards cancer treatment.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,CXCL11,PDGFB,CXCL9,EDN1,LTA,VEGFA
PMID:33362554	(2020) Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.	7	54	1.17	0.00052	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	NOX4,ATM,EDN1,KL,NFE2L2,BCL2,MYD88
PMID:30196070	(2019) Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight.	7	54	1.17	0.00052	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5
PMID:30898146	(2019) The effect of type 2 diabetes mellitus and obesity on muscle progenitor cell function.	7	54	1.17	0.00052	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000356515,9606.ENSP00000361021,9606.ENSP00000478570	FABP4,TIMP3,MMP14,CD34,UTRN,PTEN,VEGFA
PMID:30970564	(2019) Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CCR5,MMP14,PDGFB,CCL5,VEGFA
PMID:30971831	(2019) Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes.	7	54	1.17	0.00052	9606.ENSP00000221930,9606.ENSP00000285407,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,KLF10,PTGS2,PTEN,AR,RHOA,VEGFA
PMID:31129149	(2019) Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2STAT3 pathway.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,ANGPT2,ANG,JAK2,LTA,BDNF,CCL5
PMID:31156649	(2019) Immune Control by TRAF6-Mediated Pathways of Epithelial Cells in the EIME (Epithelial Immune Microenvironment).	9	110	0.97	0.00052	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,IFNG,MAPK7,CCL20,MAP3K5,TXN,SAA1,IRAK4,MYD88
PMID:31187890	(2019) Doxorubicin-Induced Cardiomyopathy in Children.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000477707	MPO,HSPB1,TIMP3,ATM,EDN1,BCL2,NR1H3
PMID:31572387	(2019) Tumors vs. Chronic Wounds: An Immune Cells Perspective.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANGPT2,PDGFB,CXCL9,CD47,CCL5,VEGFA
PMID:31662821	(2019) Precision medicine in gastric cancer.	7	54	1.17	0.00052	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	APC,CDH1,ATM,PTEN,JAK2,RHOA,VEGFA
PMID:31721726	(2019) Aging and stress induced beta cell senescence and its implication in diabetes development.	7	54	1.17	0.00052	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000380252,9606.ENSP00000380365,9606.ENSP00000381185	IGF1R,CXCL10,CAV1,PDGFA,NFE2L2,RGN,BCL2
PMID:29559981	(2018) Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.	8	80	1.06	0.00052	9606.ENSP00000229135,9606.ENSP00000258341,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399	IFNG,LAMC1,CXCL10,CXCL11,PDGFA,EDN1,BCL2,MYD88
PMID:29566770	(2018) Stem cell properties of human clonal salivary gland stem cells are enhanced by three-dimensional priming culture in nanofibrous microwells.	7	54	1.17	0.00052	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,CDH1,AQP5,HNF4A,BCL2,BDNF,VEGFA
PMID:29616091	(2018) Molecular and cellular mechanisms of castration resistant prostate cancer.	7	54	1.17	0.00052	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,PTEN,AR,BCL2,PROM1,VEGFA
PMID:29760813	(2018) Protective and Restorative Effects of Nutrients and Phytochemicals.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,IGF1R,PTGS2,BCL2,CCL5,VEGFA
PMID:29778695	(2018) Corticosteroids and perinatal hypoxic-ischemic brain injury.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MPO,EDNRA,EDN1,BCL2,NTF3,BDNF,VEGFA
PMID:29876507	(2018) Angiotensin, transforming growth factor beta and aortic dilatation in Marfan syndrome: Of mice and humans.	7	54	1.17	0.00052	9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000418525	THBS1,CAV1,ELN,NOX1,BMP2,RHOA,MME
PMID:29910742	(2018) Obesity, Fat Mass and Immune System: Role for Leptin.	8	80	1.06	0.00052	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,SREBF1,JAK2,BCL2,NPY,CCL5,VEGFA
PMID:29983715	(2018) SHP2-Mediated Signal Networks in Stem Cell Homeostasis and Dysfunction.	7	54	1.17	0.00052	9606.ENSP00000245479,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	SOX9,MAPK7,STAT5A,PTEN,BCL2,RHOA,PROM1
PMID:30158978	(2018) MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer.	7	54	1.17	0.00052	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	TGFB1,CDH1,IGF1R,ATM,PTEN,BCL2,PROM1
PMID:30294272	(2018) Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000475344	CXCL10,CXCL9,PTGS2,ENTPD1,PTEN,JAK2,APLNR
PMID:30544653	(2018) miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis.	7	54	1.17	0.00052	9606.ENSP00000215832,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000477707	MAPK1,ONECUT1,HNF4A,SREBF1,PTEN,BCL2,NR1H3
PMID:33418763	(2018) Regenerative Engineering of the Rotator Cuff of the Shoulder.	7	54	1.17	0.00052	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,SOX9,FABP4,FMOD,ELN,BMP2,VEGFA
PMID:28251903	(2017) Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,PTEN,CCL5
PMID:28555670	(2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.	8	80	1.06	0.00052	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,STAT5A,CCL20,CXCL9,JAK2,CCL5,VEGFA
PMID:29018797	(2017) microRNAs Make the Call in Cancer Personalized Medicine.	7	54	1.17	0.00052	9606.ENSP00000013807,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,LAMC1,CDH1,PTEN,BMP2,BCL2,VEGFA
PMID:26662846	(2016) Systems Toxicology of Male Reproductive Development: Profiling 774 Chemicals for Molecular Targets and Adverse Outcomes.	9	110	0.97	0.00052	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354511,9606.ENSP00000354901,9606.ENSP00000360247,9606.ENSP00000380252,9606.ENSP00000384906,9606.ENSP00000402152	TGFB1,CD69,CXCL10,COMT,CXCL9,CYP2J2,NFE2L2,SAA1,SLC12A3
PMID:26954942	(2016) MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.	8	80	1.06	0.00052	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CD69,CXCL10,CXCL11,STAT5A,JAK2,MYD88,CCL5
PMID:26079210	(2015) Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damagerepair.	8	80	1.06	0.00052	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310520,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525	ERCC1,CDH1,NOX4,ERCC4,TXN,EDN1,BCL2,MME
PMID:26416427	(2015) MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management.	8	80	1.06	0.00052	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CD34,STAT5A,SGK1,PTEN,BCL2,MME,VEGFA
PMID:25501580	(2014) Lymphotoxin beta receptor signaling induces IL-8 production in human bronchial epithelial cells.	8	80	1.06	0.00052	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANG,CCL20,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:25533351	(2014) ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages.	7	54	1.17	0.00052	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000381185	MAPK1,MYH9,PDGFB,CAV1,PDGFA,PTGS2,BCL2
PMID:28890954	(2014) Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration.	8	80	1.06	0.00052	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,THBS1,TIMP3,CCR5,CD34,BCL2,CCL5,VEGFA
PMID:23954997	(2013) Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,JAK2,MYD88,CCL5
PMID:23170260	(2012) Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations.	7	54	1.17	0.00052	9606.ENSP00000248553,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000362410,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CCR5,ANGPT2,CCL20,MAFB,CCL5,VEGFA
PMID:23207606	(2012) Discovering the route from inflammation to pancreatic cancer.	7	54	1.17	0.00052	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000351671,9606.ENSP00000360522,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IGF1R,CCL20,RBP4,MYD88,CCL5,VEGFA
PMID:23552603	(2012) COX-2PGE2: molecular ambassadors of Kaposis sarcoma-associated herpes virus oncoprotein-v-FLIP.	8	80	1.06	0.00052	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CCL20,PTGS2,BCL2,RHOA,CCL5,VEGFA
PMID:21628403	(2011) Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice.	7	54	1.17	0.00052	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000363596,9606.ENSP00000418525	EPOR,MPO,CD38,CD34,EBF1,CNR2,MME
PMID:21826013	(2011) Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIVMTB coinfection.	7	54	1.17	0.00052	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:20600632	(2010) Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.	7	54	1.17	0.00052	9606.ENSP00000013807,9606.ENSP00000222139,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,EPOR,CDH1,PTEN,AR,BCL2,VEGFA
PMID:24281116	(2010) Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin.	7	54	1.17	0.00052	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,SIRT6,MAP3K5,NOX1,TXN,BCL2,VEGFA
PMID:19002158	(2009) Signaling cross-talk between TGF-betaBMP and other pathways.	8	80	1.06	0.00052	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000285407,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000403495,9606.ENSP00000478319	IFNG,IGF1R,KLF10,STAT5A,PTEN,AR,LTA,GREM1
PMID:19100241	(2009) AHR-mediated immunomodulation: the role of altered gene transcription.	8	80	1.06	0.00052	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000285407,9606.ENSP00000292303,9606.ENSP00000371067,9606.ENSP00000474412	TGFB1,MPO,CD38,THBS1,KLF10,CCR5,JAK2,CCL5
PMID:19500073	(2009) Vascular and cellular calcium in normal and hypertensive pregnancy.	7	54	1.17	0.00052	9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	EDNRA,CAV1,ELN,EDN1,RHOA,AGTR1,VEGFA
PMID:19534570	(2009) Transcriptional targets in adipocyte biology.	7	54	1.17	0.00052	9606.ENSP00000256104,9606.ENSP00000322898,9606.ENSP00000348069,9606.ENSP00000358513,9606.ENSP00000360522,9606.ENSP00000384364,9606.ENSP00000401720	FABP4,EBF1,SREBF1,CNR1,RBP4,NPY,GK
PMID:18670616	(2008) PPAR Regulation of Inflammatory Signaling in CNS Diseases.	7	54	1.17	0.00052	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CXCL9,JAK2,BCL2,CCL5
PMID:18799141	(2008) Mechanisms and consequences of dendritic cell migration.	8	80	1.06	0.00052	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000400175,9606.ENSP00000418009,9606.ENSP00000474412	CDH1,CCR5,CCL20,CXCL9,CD47,RHOA,RARRES2,CCL5
PMID:18855619	(2008) Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.	7	54	1.17	0.00052	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,THBS1,CD47,PTEN,EDN1,BCL2,VEGFA
PMID:17442097	(2007) Developments in the synovial biology field 2006.	7	54	1.17	0.00052	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	TIMP3,CCR5,MMP14,VIP,PTEN,BCL2,RHOA
PMID:18060066	(2007) Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow.	7	54	1.17	0.00052	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000363827,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,LPL,CD34,CNTF,HSPG2,BDNF,VEGFA
PMID:17090326	(2006) The hepatic transcriptome in human liver disease.	9	110	0.97	0.00052	9606.ENSP00000222305,9606.ENSP00000228434,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000474412	USF2,CD69,CHI3L1,CDH1,CXCL10,CXCL11,HNF4A,CXCL9,CCL5
PMID:15219236	(2004) Antiangiogenic gene therapy of cancer: recent developments.	7	54	1.17	0.00052	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CXCL10,ANGPT2,ANG,PTEN,EDN1,VEGFA
PMID:35163198	(2022) microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,BCL2,RHOA,PROM1
PMID:35164569	(2022) The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:35184271	(2022) Hypertension and COVID-19: Current Evidence and Perspectives.	6	33	1.32	0.00054	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000419422	IGF1R,CXCL10,ANGPT2,JAK2,MME,AGTR1
PMID:35215280	(2022) Potential Therapeutic Effects of Citrus hystrix DC and Its Bioactive Compounds on Metabolic Disorders.	6	33	1.32	0.00054	9606.ENSP00000200676,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000400175,9606.ENSP00000478570	CETP,NOX4,LPL,SREBF1,RHOA,VEGFA
PMID:35281903	(2022) Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies.	6	33	1.32	0.00054	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,VIP,BCL2,NTF3,BDNF,VEGFA
PMID:35406116	(2022) Diabetes and Familial Hypercholesterolemia: Interplay between Lipid and Glucose Metabolism.	6	33	1.32	0.00054	9606.ENSP00000200676,9606.ENSP00000226760,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000480291	CETP,WFS1,HNF4A,KCNJ11,PTEN,HNF1B
PMID:32680434	(2021) Clinically Relevant Molecular Biomarkers for Use in Human Knee Osteoarthritis: A Systematic Review.	6	33	1.32	0.00054	9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000478570	CHI3L1,FABP4,ANGPT2,PTGS2,BDNF,VEGFA
PMID:32870433	(2021) Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.	6	33	1.32	0.00054	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	MPO,IFNG,CXCL10,CXCL9,PTGS2,VEGFA
PMID:33469989	(2021) REST promotes ETS1-dependent vascular growth in medulloblastoma.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000346508,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,ANGPT2,ANG,PDGFA,GREM1,VEGFA
PMID:33783686	(2021) A bi-directional dialog between vascular cells and monocytesmacrophages regulates tumor progression.	9	111	0.97	0.00054	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ANGPT2,PDGFB,MAP3K5,PTGS2,EDN1,RHOA,CCL5,VEGFA
PMID:34035459	(2021) Novel immune engagers and cellular therapies for metastatic castration-resistant prostate cancer: do we take a BiTe or ride BiKEs, TriKEs, and CARs?	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000354782,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000426809	IFNG,ATM,CD247,AR,MYD88,PROM1
PMID:34067499	(2021) Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering.	6	33	1.32	0.00054	9606.ENSP00000225275,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,ANGPT2,PTGS2,BCL2,BDNF,VEGFA
PMID:34079802	(2021) The Inhibition of B7H3 by 2-HG Accumulation Is Associated With Downregulation of VEGFA in IDH Mutated Gliomas.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000478570	THBS1,PDGFB,PDGFA,CXCL9,PDGFD,VEGFA
PMID:34099022	(2021) NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,HNF4A,PTGS2,BCL2,PROM1,VEGFA
PMID:34137513	(2021) Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CXCL10,CXCL11,CD34,RHOA,VEGFA
PMID:34193756	(2021) Significance of trogocytosis and exosome-mediated transport in establishing and maintaining the tumor microenvironment in lymphoid malignancies.	6	33	1.32	0.00054	9606.ENSP00000226279,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000401399,9606.ENSP00000474412	CD38,MMP14,CD34,CD47,MYD88,CCL5
PMID:34293006	(2021) Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,S100A12,JAK2,CCL5
PMID:34326871	(2021) Current and Emerging Approaches for Hepatic Fibrosis Treatment.	6	33	1.32	0.00054	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000478570	NOX4,CCR5,HNF4A,MAP3K5,NOX1,VEGFA
PMID:34360735	(2021) Secretome and Tunneling Nanotubes: A Multilevel Network for Long Range Intercellular Communication between Endothelial Cells and Distant Cells.	9	111	0.97	0.00054	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000355361,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000390651,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANGPT2,CD47,ADAMTS13,EDN1,IRAK4,CCL5,VEGFA
PMID:34417157	(2021) Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.	6	33	1.32	0.00054	9606.ENSP00000256104,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,ANGPT2,PTGS2,TXN,BDNF,VEGFA
PMID:34573282	(2021) SALL4 and microRNA: The Role of Let-7.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,CD34,HNF4A,SREBF1,PTEN,BCL2
PMID:34576594	(2021) Lipid-Based Drug Delivery Systems in Regenerative Medicine.	6	33	1.32	0.00054	9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	PDGFA,ELN,BMP2,GAP43,BDNF,VEGFA
PMID:34579002	(2021) Potential Health Benefits of Curcumin on Female Reproductive Disorders: A Review.	6	33	1.32	0.00054	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,NFE2L2,BCL2,CCL5,VEGFA
PMID:34649377	(2021) Mechanisms of Preconditioning Exercise-Induced Neurovascular Protection in Stroke.	6	33	1.32	0.00054	9606.ENSP00000248553,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	HSPB1,CAV1,EDN1,BCL2,BDNF,VEGFA
PMID:34680177	(2021) Coffee Bioactive N-Methylpyridinium Attenuates Tumor Necrosis Factor (TNF)-alpha-Mediated Insulin Resistance and Inflammation in Human Adipocytes.	6	33	1.32	0.00054	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000401720	MAPK1,NOX4,ATM,CXCL10,SREBF1,GK
PMID:34715028	(2021) Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.	10	145	0.9	0.00054	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD69,IFNG,CD34,CD247,PTGS2,S100A12,ENTPD1,CCL5,VEGFA
PMID:34731090	(2021) New tale on LianHuaQingWen: IL6RIL6IL6ST complex is a potential target for COVID-19 treatment.	6	33	1.32	0.00054	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185	MAPK1,IFNG,CXCL10,CNTF,PTGS2,BCL2
PMID:34771558	(2021) Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions.	6	33	1.32	0.00054	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000400175	MYH9,CDH1,PTEN,AR,FGFR1,RHOA
PMID:34840808	(2021) Challenges and strategy in treatment with exosomes for cell-free-based tissue engineering in dentistry.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,IFNG,ELN,BMP2,BDNF,VEGFA
PMID:34930338	(2021) NOX4: a potential therapeutic target for pancreatic cancer and its mechanism.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,NOX4,MAP3K5,NOX1,JAK2,VEGFA
PMID:35003391	(2021) Role of Biomarkers in the Integrated Management of Melanoma.	6	33	1.32	0.00054	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,MMP14,PTGS2,MME,PROM1,VEGFA
PMID:35141256	(2021) Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-beta Superfamily Signaling.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000475344,9606.ENSP00000478319	THBS1,CAV1,PTEN,EDN1,APLNR,GREM1
PMID:31715336	(2020) No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing.	6	33	1.32	0.00054	9606.ENSP00000245479,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,VIP,BMP2,NTF3,BDNF,VEGFA
PMID:32117953	(2020) The Secretome Derived From Mesenchymal Stromal Cells Cultured in a Xeno-Free Medium Promotes Human Cartilage Recovery in vitro.	6	33	1.32	0.00054	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000478570	CHI3L1,THBS1,CD34,ANG,PTGS2,VEGFA
PMID:32235006	(2020) Indian Hedgehog regulates senescence in bone marrow-derived mesenchymal stem cell through modulation of ROSmTOR4EBP1, p70S6K12 pathway.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000371067	TGFB1,FABP4,LPL,CD34,PTGS2,JAK2
PMID:32258038	(2020) Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067	CXCL10,CXCL11,ANGPT2,CXCL9,PTEN,JAK2
PMID:32352658	(2020) The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cells.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,CD34,PTEN,PROM1,GREM1,VEGFA
PMID:32411704	(2020) Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?	6	33	1.32	0.00054	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CDH1,CAV1,PTEN,CCL5,VEGFA
PMID:32483112	(2020) Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,THBS1,CDH1,KLF10,PTEN,VEGFA
PMID:32545342	(2020) Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance.	6	33	1.32	0.00054	9606.ENSP00000268035,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000480291	IGF1R,ONECUT1,HNF4A,SREBF1,PTEN,HNF1B
PMID:32570707	(2020) Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model.	6	33	1.32	0.00054	9606.ENSP00000284031,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384262	DDAH1,HNF4A,SREBF1,JAK2,BCL2,HPSE
PMID:32588163	(2020) Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.	6	33	1.32	0.00054	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,PDGFB,CXCL9,CCL5,VEGFA
PMID:32603362	(2020) High-throughput sequencing analysis of a hit and run cell and animal model of KSHV tumorigenesis.	6	33	1.32	0.00054	9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000401399,9606.ENSP00000478570	HNF4A,ANGPT2,PDGFB,PDGFA,MYD88,VEGFA
PMID:32620113	(2020) Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology.	6	33	1.32	0.00054	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252	MPO,IFNG,COMT,PTGS2,JAK2,NFE2L2
PMID:32764454	(2020) SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306124,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000419422	IFNG,CXCL10,PRKCE,ELN,AR,AGTR1
PMID:32784499	(2020) Emerging Therapeutic Modalities against COVID-19.	6	33	1.32	0.00054	9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000325548,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,ANGPT2,CNDP2,JAK2,CCL5,VEGFA
PMID:32842664	(2020) Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis.	6	33	1.32	0.00054	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000478570	MPO,NOX4,PDGFB,ELN,NFE2L2,VEGFA
PMID:33171100	(2020) Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.	9	111	0.97	0.00054	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000357726,9606.ENSP00000383232,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CXCL10,CD34,S100A12,GGT1,LTA,CCL5,VEGFA
PMID:33233546	(2020) Expression of Pro-Angiogenic Markers Is Enhanced by Blue Light in Human RPE Cells.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,PDGFB,EDN1,RHOA,VEGFA
PMID:33281808	(2020) Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.	6	33	1.32	0.00054	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,PTGS2,CCL5
PMID:33330432	(2020) De novo Vessel Formation Through Cross-Talk of Blood-Derived Cells and Mesenchymal Stromal Cells in the Absence of Pre-existing Vascular Structures.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,ANG,CCL20,CCL5,VEGFA
PMID:33519923	(2020) Identification of Common Genes and Pathways in Eight Fibrosis Diseases.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000400175,9606.ENSP00000474412	TGFB1,IFNG,NOX4,MMP14,RHOA,CCL5
PMID:30617265	(2019) Cell migration: implications for repair and regeneration in joint disease.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,BMP2,RHOA,CCL5,VEGFA
PMID:30909895	(2019) The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.	6	33	1.32	0.00054	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,CXCL10,EDN1,MME,AGTR1,VEGFA
PMID:30949485	(2019) Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation.	6	33	1.32	0.00054	9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000414303,9606.ENSP00000478570	TIMP3,ANGPT2,PDGFB,PDGFA,BDNF,VEGFA
PMID:30956175	(2019) IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,HSPB1,CXCL11,STAT5A,CXCL9,CCL5
PMID:30978005	(2019) Characterization of Lipid-Protein Interactions and Lipid-Mediated Modulation of Membrane Protein Function through Molecular Simulation.	10	145	0.9	0.00054	9606.ENSP00000200676,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000293599,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000383364,9606.ENSP00000427424	CETP,THBS1,CCR5,AQP5,CAV1,ABCG1,CYP2J2,PTEN,PLA2G2A,TNFAIP8
PMID:30982492	(2019) The Roles of Plant-Derived Triptolide on Non-Small Cell Lung Cancer.	6	33	1.32	0.00054	9606.ENSP00000308208,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	MMP14,MAPK7,PTEN,NFE2L2,BCL2,PROM1
PMID:31040788	(2019) Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000354511,9606.ENSP00000362057,9606.ENSP00000478570	TGFB1,NOX4,EDNRA,COMT,NOX1,VEGFA
PMID:31114575	(2019) Immunopathogenesis of Pediatric Localized Scleroderma.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:31159345	(2019) Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CNTF,BCL2,NTF3,BDNF,VEGFA
PMID:31387182	(2019) Low dose of chronic ethanol exposure in adult zebrafish induces hepatic steatosis and injury.	6	33	1.32	0.00054	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192	NOX4,LPL,SREBF1,NOX1,TXN,G6PD
PMID:31395351	(2019) The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases.	9	111	0.97	0.00054	9606.ENSP00000225275,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000381185	MPO,APC,CDH1,TIMP3,ATM,ALDH1A1,SIRT6,PTEN,BCL2
PMID:31412678	(2019) Mesenchymal Stem Cells for Regenerative Medicine.	6	33	1.32	0.00054	9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,BMP2,JAK2,NTF3,BDNF,VEGFA
PMID:31623356	(2019) Vitamin D as A Protector of Arterial Health: Potential Role in Peripheral Arterial Disease Formation.	6	33	1.32	0.00054	9606.ENSP00000216862,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000478570	CYP24A1,ANG,ELN,EDN1,KL,VEGFA
PMID:31627390	(2019) Highly Selective Cleavage of TH2-Promoting Cytokines by the Human and the Mouse Mast Cell Tryptases, Indicating a Potent Negative Feedback Loop on TH2 Immunity.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000418009	CXCL10,PDGFB,PDGFA,CCL20,VIP,RARRES2
PMID:31801938	(2019) Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,JAK2,CCL5,VEGFA
PMID:31849640	(2019) Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:28592707	(2018) Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice.	6	33	1.32	0.00054	9606.ENSP00000301522,9606.ENSP00000311005,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	PRDX2,MAPK7,PDGFA,BCL2,RHOA,VEGFA
PMID:29051279	(2018) Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models.	6	33	1.32	0.00054	9606.ENSP00000222139,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	EPOR,CXCL10,CD34,CXCL9,JAK2,CCL5
PMID:29140729	(2018) Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,MMP14,EDNRA,EDN1,AGTR1,VEGFA
PMID:29176657	(2018) Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.	6	33	1.32	0.00054	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000356438	CETP,LPL,APOL1,LPA,ABCG1,PTGS2
PMID:29247045	(2018) The immunology of hypertension.	6	33	1.32	0.00054	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000354782,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000474412	CD69,CCR5,CD247,SGK1,EDN1,CCL5
PMID:29740591	(2018) Postnatal and Adult Aortic Heart Valves Have Distinctive Transcriptional Profiles Associated With Valve Tissue Growth and Maintenance Respectively.	6	33	1.32	0.00054	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000418009	NOX4,TIMP3,ELN,CXCL9,PTGS2,RARRES2
PMID:29755667	(2018) A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids.	6	33	1.32	0.00054	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,BCL2,PROM1
PMID:29783680	(2018) Copaifera of the Neotropics: A Review of the Phytochemistry and Pharmacology.	6	33	1.32	0.00054	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000390651	MAPK1,MPO,IGF1R,PTGS2,AR,IRAK4
PMID:30034877	(2018) Ageing: Is there a role for arachidonic acid and other bioactive lipids? A review.	6	33	1.32	0.00054	9606.ENSP00000225275,9606.ENSP00000348069,9606.ENSP00000383364,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412	MPO,SREBF1,PLA2G2A,NPY,BDNF,CCL5
PMID:30035030	(2018) The roles of inflammatory mediators and immunocytes in tendinopathy.	6	33	1.32	0.00054	9606.ENSP00000347041,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	FMOD,CNTF,VIP,PTGS2,BMP2,VEGFA
PMID:30061536	(2018) Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders.	6	33	1.32	0.00054	9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412	CCR5,ALDH1A1,CD34,BMP2,BCL2,CCL5
PMID:30077720	(2018) Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412	CXCL10,CD34,CCL20,CXCL9,CNTF,CCL5
PMID:30122551	(2018) Opportunities for Host-targeted Therapies for Malaria.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422	CXCL10,ANGPT2,G6PD,NFE2L2,BCL2,AGTR1
PMID:30283745	(2018) Mycobacterium tuberculosis Virulent Factor ESAT-6 Drives Macrophage Differentiation Toward the Pro-inflammatory M1 Phenotype and Subsequently Switches It to the Anti-inflammatory M2 Phenotype.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000401399	CXCL10,CXCL11,CXCL9,PTGS2,IRAK4,MYD88
PMID:32745368	(2018) Abstracts for the 32nd European Immunogenetics and Histocompatibility Conference and the 25th Annual Meeting of the Italian Society for Immunogenetics and Transplantation Biology (AIBT) Venice Lido, Italy May 9-12, 2018.	10	145	0.9	0.00054	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	TGFB1,MPO,CD38,CCR5,CD34,EDNRA,HSPG2,EDN1,BCL2,AGTR1
PMID:27748194	(2017) Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.	6	33	1.32	0.00054	9606.ENSP00000263317,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000419313,9606.ENSP00000478570	NOX4,TXN,EDN1,NFE2L2,TRPC1,VEGFA
PMID:28122577	(2017) The Id-protein family in developmental and cancer-associated pathways.	9	111	0.97	0.00054	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,CD34,CAV1,PTEN,AR,BMP2,BCL2,VEGFA
PMID:28202507	(2017) YAPTAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.	6	33	1.32	0.00054	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,CDH1,IGF1R,CAV1,PTEN,BCL2
PMID:28210260	(2017) From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis.	6	33	1.32	0.00054	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000377192	EPOR,IFNG,GAS6,CD47,JAK2,G6PD
PMID:28402337	(2017) Bone Marrow Adipose Tissue Deficiency Increases Disuse-Induced Bone Loss in Male Mice.	6	33	1.32	0.00054	9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000403495	COMT,MTHFR,SHBG,NPY,FGFR1,LTA
PMID:28445781	(2017) Mitochondrial ROS control of cancer.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000478570	CDH1,NOX4,MAP3K5,PTEN,TXN,VEGFA
PMID:28594389	(2017) The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk.	6	33	1.32	0.00054	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,MAP3K5,NOX1,TXN,BDNF,VEGFA
PMID:28698718	(2017) The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications.	6	33	1.32	0.00054	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570,9606.ENSP00000484631	MMP14,CD34,PTGS2,BMP2,VEGFA,PMP22
PMID:28727780	(2017) Comparative analysis of signature genes in PRRSV-infected porcine monocyte-derived cells to different stimuli.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000354901	IFNG,THBS1,CXCL10,CAV1,FMOD,CXCL9
PMID:28840540	(2017) A more tubulocentric view of diabetic kidney disease.	6	33	1.32	0.00054	9606.ENSP00000351671,9606.ENSP00000356832,9606.ENSP00000360522,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CCL20,SGK1,RBP4,AGTR1,CCL5,VEGFA
PMID:29076267	(2017) Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine.	6	33	1.32	0.00054	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,PDGFB,PDGFA,PROM1,CCL5,VEGFA
PMID:29085205	(2017) Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.	6	33	1.32	0.00054	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363596	CCR5,CXCL10,CCL20,MAP3K5,NOX1,CNR2
PMID:29150694	(2017) Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,ELN,PTGS2,IRAK4,MYD88,CCL5
PMID:26675546	(2016) A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma.	6	33	1.32	0.00054	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185	ERCC1,HSPB1,CDH1,ALDH1A1,PTEN,BCL2
PMID:26871601	(2016) Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stemprogenitor cells through Oct-4 hyperexpression.	6	33	1.32	0.00054	9606.ENSP00000268035,9606.ENSP00000293599,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,AQP5,ANGPT2,PDGFA,PROM1,VEGFA
PMID:26998837	(2016) MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells.	6	33	1.32	0.00054	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,PTEN,RARRES2,CCL5,VEGFA
PMID:27634890	(2016) Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cells.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	THBS1,CDH1,ALDH1A1,PTEN,BCL2,PROM1
PMID:25005927	(2015) Memory CD4 T cells in influenza.	6	33	1.32	0.00054	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CXCL9,CCL5
PMID:25661523	(2015) Pivotal role for decorin in angiogenesis.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000347041,9606.ENSP00000363827,9606.ENSP00000478570	IFNG,TIMP3,IGF1R,FMOD,HSPG2,VEGFA
PMID:26052064	(2015) Characterization of chemokine and chemokine receptor expression during Pneumocystis infection in healthy and immunodeficient mice.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:26753010	(2015) Myeloid Proliferations Associated with Down Syndrome.	6	33	1.32	0.00054	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525	EPOR,MPO,CD38,CD34,JAK2,MME
PMID:24095954	(2014) Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis.	6	33	1.32	0.00054	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000400175,9606.ENSP00000478570	CETP,LPL,LPA,ABCG1,RHOA,VEGFA
PMID:24386936	(2014) Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions.	6	33	1.32	0.00054	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	IGF1R,CD34,AR,BCL2,MYD88,VEGFA
PMID:24463459	(2014) Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,PTEN,CCL5
PMID:24467841	(2014) Comprehensive analysis of beta-catenin target genes in colorectal carcinoma cell lines with deregulated Wntbeta-catenin signaling.	6	33	1.32	0.00054	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	APC,IGF1R,HNF4A,PTEN,RHOA,VEGFA
PMID:24808821	(2014) Neurogenic and non-neurogenic functions of endogenous neural stem cells.	6	33	1.32	0.00054	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,CCR5,CXCL10,CNTF,BDNF,VEGFA
PMID:24886974	(2014) Transcription factors involved in prostate gland adaptation to androgen deprivation.	6	33	1.32	0.00054	9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399	HNF4A,PDGFB,PTEN,AR,BCL2,MYD88
PMID:25043127	(2014) NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.	6	33	1.32	0.00054	9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000478570	CXCL11,CD34,ANGPT2,PDGFB,CXCL9,VEGFA
PMID:25043950	(2014) High-density lipoprotein: a novel target for antirestenosis therapy.	6	33	1.32	0.00054	9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	ELN,ABCG1,PTGS2,JAK2,MYD88,VEGFA
PMID:25132857	(2014) The Secretome of Bone Marrow and Wharton Jelly Derived Mesenchymal Stem Cells Induces Differentiation and Neurite Outgrowth in SH-SY5Y Cells.	6	33	1.32	0.00054	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANGPT2,CNTF,NTF3,BDNF,VEGFA
PMID:25219761	(2014) Neural crest development in fetal alcohol syndrome.	6	33	1.32	0.00054	9606.ENSP00000232219,9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000397297	RBP1,SOX9,HNF4A,PDGFA,CNTF,NTF3
PMID:25229406	(2014) Liver X receptor regulation of thyrotropin-releasing hormone transcription in mouse hypothalamus is dependent on thyroid status.	6	33	1.32	0.00054	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000414303	CETP,LPL,SREBF1,ABCG1,PTGS2,BDNF
PMID:25278877	(2014) Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle.	6	33	1.32	0.00054	9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CAV1,PDGFA,BMP2,AGTR1,PROM1,VEGFA
PMID:26605353	(2014) Practical issues concerning tear protein assays in dry eye.	6	33	1.32	0.00054	9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	AQP5,CXCL10,CXCL9,NPY,CCL5,VEGFA
PMID:23568032	(2013) Lack of Cyp1b1 promotes the proliferative and migratory phenotype of perivascular supporting cells.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000360247,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,THBS1,CD47,CYP2J2,BCL2,VEGFA
PMID:23997993	(2013) Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.	6	33	1.32	0.00054	9606.ENSP00000232219,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000426809	RBP1,CDH1,CD34,ELN,EDN1,PROM1
PMID:24276378	(2013) The inhibition of stat5 by a Peptide aptamer ligand specific for the DNA binding domain prevents target gene transactivation and the growth of breast and prostate tumor cells.	6	33	1.32	0.00054	9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	STAT5A,PTEN,TXN,AR,JAK2,BCL2
PMID:24330528	(2013) Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.	6	33	1.32	0.00054	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	MAPK1,IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:24427166	(2013) Stress-induced ECM alteration modulates cellular microRNAs that feedback to readjust the extracellular environment and cell behavior.	6	33	1.32	0.00054	9606.ENSP00000266085,9606.ENSP00000347041,9606.ENSP00000356515,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000478570	TIMP3,FMOD,UTRN,HSPG2,BMP2,VEGFA
PMID:24860613	(2013) Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.	6	33	1.32	0.00054	9606.ENSP00000200676,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000365777,9606.ENSP00000478570	CETP,COL8A1,TIMP3,ELN,MTHFR,VEGFA
PMID:22902093	(2012) Mast cell chymase and tryptase in abdominal aortic aneurysm formation.	6	33	1.32	0.00054	9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000477707,9606.ENSP00000478570	CD34,SREBF1,ELN,ABCG1,NR1H3,VEGFA
PMID:23084749	(2012) Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809	TGFB1,LAMC1,CDH1,CD34,HNF4A,PROM1
PMID:23202964	(2012) A systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease.	6	33	1.32	0.00054	9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	PTGS2,AR,EDN1,JAK2,BCL2,VEGFA
PMID:21213373	(2011) MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype.	6	33	1.32	0.00054	9606.ENSP00000309757,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000478570	LPL,MAPK7,PTGS2,PTEN,MTHFR,VEGFA
PMID:21622183	(2011) Protective role of heme oxygenase-1 against inflammation in atherosclerosis.	6	33	1.32	0.00054	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL11,CAV1,CXCL9,MYD88,CCL5
PMID:21886885	(2011) Spinal cord injury: From inflammation to glial scar.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303	IFNG,CNTF,JAK2,GAP43,BCL2,BDNF
PMID:21951628	(2011) Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.	6	33	1.32	0.00054	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000419422	TGFB1,EDNRA,AR,EDN1,MME,AGTR1
PMID:23667383	(2011) Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis.	6	33	1.32	0.00054	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000363822	SOX9,CDH1,MMP14,HNF4A,CAV1,AR
PMID:19995751	(2010) Go upstream, young man: lessons learned from the p38 saga.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399	IFNG,CD247,PTGS2,JAK2,IRAK4,MYD88
PMID:20624114	(2010) Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.	6	33	1.32	0.00054	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CXCL9,CCL5
PMID:21030723	(2010) Oxidative stress and diabetic complications.	6	33	1.32	0.00054	9606.ENSP00000314897,9606.ENSP00000349860,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	ANGPT2,GFPT1,S100A12,EDN1,AGTR1,VEGFA
PMID:19266198	(2009) The immunologic aspects of poxvirus oncolytic therapy.	6	33	1.32	0.00054	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:19400868	(2009) Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.	6	33	1.32	0.00054	9606.ENSP00000292303,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000479617	CCR5,CXCL9,JAK2,MYD88,VEGFA,UHRF1
PMID:19421322	(2009) Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohns disease.	6	33	1.32	0.00054	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19526209	(2009) Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants?	6	33	1.32	0.00054	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000414303,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,KCNJ11,BDNF,FTO,HNF1B
PMID:27789987	(2009) Recent advances in neutralizing the IL-6 pathway in arthritis.	9	111	0.97	0.00054	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CHI3L1,TIMP3,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:18506144	(2008) Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness.	6	33	1.32	0.00054	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000401399,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,CD34,HNF4A,MYD88,GREM1,VEGFA
PMID:27688600	(....) doxycycline and benznidazole reduce the profile of th1, th2, and th17 chemokines and chemokine receptors in cardiac tissue from chronic trypanosoma cruzi-infected dogs.	6	33	1.32	0.00054	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33401460	(2021) Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression.	8	81	1.06	0.00055	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000362410,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,CD247,CXCL9,ENTPD1,MAFB,CCL5,VEGFA
PMID:33466236	(2021) The Network of Cytokines in Brain Metastases.	8	81	1.06	0.00055	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,ANGPT2,PTGS2,PTEN,HPSE,CCL5,VEGFA
PMID:33662042	(2021) The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.	8	81	1.06	0.00055	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000278840,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000361021,9606.ENSP00000381185	FABP4,CDH1,ATM,FADS2,ALDH1A1,PLIN1,PTEN,BCL2
PMID:34359821	(2021) The Role of Chronic Inflammation in the Development of Breast Cancer.	8	81	1.06	0.00055	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CAV1,CXCL9,PTGS2,CCL5,VEGFA
PMID:34480337	(2021) Role of the PD-1PD-L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions.	8	81	1.06	0.00055	9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	CD69,STAT5A,CD247,CD47,PTEN,JAK2,BCL2,BDNF
PMID:34572399	(2021) Macrophages in Atherosclerosis, First or Second Row Players?	8	81	1.06	0.00055	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368104	CETP,MPO,CCR5,ANGPT2,ELN,ABCG1,PTGS2,BMP2
PMID:34737957	(2021) Targeting Sphingolipids for Cancer Therapy.	8	81	1.06	0.00055	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,AR,SHBG,BCL2,RHOA,VEGFA
PMID:32084275	(2020) Fibrocytes, Wound Healing, and Corneal Fibrosis.	8	81	1.06	0.00055	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CD34,HSPG2,EDN1,MME,CCL5,VEGFA
PMID:32472114	(2020) Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.	8	81	1.06	0.00055	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412	IFNG,ATM,CD34,CD247,CXCL9,PTGS2,PTEN,CCL5
PMID:33171792	(2020) The Influence of Tumor Microenvironment on Immune Escape of Melanoma.	8	81	1.06	0.00055	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,PTGS2,ENTPD1,PTEN,BCL2,CCL5,VEGFA
PMID:33193725	(2020) Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.	8	81	1.06	0.00055	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000418009,9606.ENSP00000478570	MAPK1,CD38,ATM,CD34,MAPK7,PDGFB,RARRES2,VEGFA
PMID:33240892	(2020) Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells.	8	81	1.06	0.00055	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CD34,CCL20,PTGS2,ENTPD1,PTEN,MYD88,CCL5
PMID:33384962	(2020) Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.	8	81	1.06	0.00055	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,STAT5A,PTGS2,JAK2,BCL2,CCL5,VEGFA
PMID:30105672	(2019) Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARgamma Activation.	8	81	1.06	0.00055	9606.ENSP00000311005,9606.ENSP00000336762,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000419422	MAPK7,ANG,ABCG1,PTGS2,EDN1,NFE2L2,MYD88,AGTR1
PMID:30602375	(2019) Exosomes of pasteurized milk: potential pathogens of Western diseases.	8	81	1.06	0.00055	9606.ENSP00000341208,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000418823	STAT5A,PRKAA1,SREBF1,PTEN,MAFB,BCL2,NPY,FTO
PMID:30736372	(2019) Podoplanin in Inflammation and Cancer.	8	81	1.06	0.00055	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,CD34,RHOA,PROM1,CCL5,VEGFA
PMID:30927928	(2019) Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment.	8	81	1.06	0.00055	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,ATM,CXCL10,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:30999909	(2019) Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers.	8	81	1.06	0.00055	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,PTEN,BCL2,HPSE,PROM1,VEGFA
PMID:29991872	(2018) Apoptosis and non-alcoholic fatty liver diseases.	8	81	1.06	0.00055	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000380365,9606.ENSP00000381185	MPO,NOX4,ATM,CXCL10,MAP3K5,NOX1,RGN,BCL2
PMID:30404206	(2018) Signaling Pathways Induced by Leptin during Epithelial-Mesenchymal Transition in Breast Cancer.	8	81	1.06	0.00055	9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000478570	CDH1,LPL,HNF4A,STAT5A,PTEN,JAK2,NPY,VEGFA
PMID:27370713	(2016) Mouse models of Hirschsprung disease and other developmental disorders of the enteric nervous system: Old and new players.	8	81	1.06	0.00055	9606.ENSP00000245479,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000400175	SOX9,CD47,PTGS2,RBP4,PTEN,BMP2,NTF3,RHOA
PMID:27486746	(2016) Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review.	8	81	1.06	0.00055	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000362524,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL10,CD34,ANGPT2,ANGPTL2,PLA2G2A,CCL5,VEGFA
PMID:28083515	(2016) Genome-Wide Transcriptional and Post-transcriptional Regulation of Innate Immune and Defense Responses of Bovine Mammary Gland to Staphylococcus aureus.	8	81	1.06	0.00055	9606.ENSP00000229135,9606.ENSP00000261037,9606.ENSP00000293599,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000371067	IFNG,COL8A1,AQP5,CD34,CCL20,ELN,S100A12,JAK2
PMID:21403879	(2011) Modulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock.	8	81	1.06	0.00055	9606.ENSP00000225275,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MPO,SIRT6,MAP3K5,PTEN,TXN,BCL2,IRAK4,MYD88
PMID:34981659	(2022) The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IGF1R,SREBF1,CCL20,CXCL9,BCL2,VEGFA
PMID:35327404	(2022) Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies.	7	55	1.17	0.00056	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000418525	NOX4,VDAC1,SIRT6,TXN,EDN1,BCL2,MME
PMID:35401516	(2022) Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000356832,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412	TGFB1,SGK1,ENTPD1,BCL2,MYD88,MME,CCL5
PMID:33524787	(2021) Diabetes and hypertension: Pivotal involvement of purinergic signaling.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	TGFB1,IFNG,ENPP2,ENTPD1,EDN1,AGTR1,VEGFA
PMID:33567774	(2021) Cell Membrane Theory of Senescence and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications.	7	55	1.17	0.00056	9606.ENSP00000278840,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000381185,9606.ENSP00000383364	FADS2,SIRT6,SREBF1,PTGS2,CYP2J2,BCL2,PLA2G2A
PMID:33762949	(2021) The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer.	7	55	1.17	0.00056	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,NFE2L2,BCL2,FGFR1,RHOA,VEGFA
PMID:33799966	(2021) Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.	7	55	1.17	0.00056	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,CD34,CXCL9,CD47,CCL5,VEGFA
PMID:33972681	(2021) The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance.	7	55	1.17	0.00056	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175	HSPB1,ATM,MAP3K5,SGK1,AR,BCL2,RHOA
PMID:34294146	(2021) Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment.	7	55	1.17	0.00056	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000478570	THBS1,CXCL10,CXCL11,ANGPT2,PDGFB,CXCL9,VEGFA
PMID:34394377	(2021) Data Mining, Network Pharmacology, and Molecular Docking Explore the Effects of Core Traditional Chinese Medicine Prescriptions in Patients with Rectal Cancer and Qi and Blood Deficiency Syndrome.	7	55	1.17	0.00056	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,TGFB1,MPO,IFNG,PTGS2,BCL2,VEGFA
PMID:34456581	(2021) Localized and Systemic Inflammatory Mediators in a Murine Acute Mastitis Model.	7	55	1.17	0.00056	9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	DDAH1,CXCL10,CXCL11,CCL20,CXCL9,BCL2,CCL5
PMID:34571731	(2021) Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment.	10	146	0.9	0.00056	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000365777,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,ATM,ALDH1A1,CCL20,MTHFR,NFE2L2,BCL2,PROM1,VEGFA
PMID:34572406	(2021) Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis.	7	55	1.17	0.00056	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000477707	CXCL10,CXCL11,CXCL9,ABCG1,PTGS2,BCL2,NR1H3
PMID:34646847	(2021) Mitochondrial Regulation of Diabetic Kidney Disease.	7	55	1.17	0.00056	9606.ENSP00000216075,9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641	MIOX,NOX4,VDAC1,SIRT6,PTEN,NOX1,TXN
PMID:34777681	(2021) Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival.	7	55	1.17	0.00056	9606.ENSP00000265333,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	VDAC1,MAP3K5,PTEN,NOX1,TXN,BCL2,VEGFA
PMID:34785890	(2021) A review on the molecular basis underlying the protective effects of Andrographis paniculata and andrographolide against myocardial injury.	7	55	1.17	0.00056	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185	MPO,NOX4,IGF1R,CAV1,PTGS2,EDN1,BCL2
PMID:34887680	(2021) How Well Do Current Laboratory Biomarkers Inform Clinical Decision-Making in Chronic Pain Management?	7	55	1.17	0.00056	9606.ENSP00000259486,9606.ENSP00000317674,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,APOL1,PTGS2,LTA,BDNF,CCL5,VEGFA
PMID:34912237	(2021) A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative Medicine.	7	55	1.17	0.00056	9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD34,PDGFA,PTGS2,AR,JAK2,CCL5,VEGFA
PMID:34961815	(2021) An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH-Mutant Lower-Grade Gliomas.	7	55	1.17	0.00056	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BMP2,CCL5
PMID:35008500	(2021) Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target.	7	55	1.17	0.00056	9606.ENSP00000222572,9606.ENSP00000256104,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000363641,9606.ENSP00000381185	PON2,FABP4,SIRT6,ELN,ABCG1,TXN,BCL2
PMID:35008679	(2021) Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight.	7	55	1.17	0.00056	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000478570	CD38,CDH1,ATM,CXCL11,CCL20,PTEN,VEGFA
PMID:35096289	(2021) Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend.	7	55	1.17	0.00056	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,PTEN,BCL2,PROM1,CCL5,VEGFA
PMID:32252330	(2020) The Role of Vitamin D in Modulating Mesenchymal Stem Cells and Endothelial Progenitor Cells for Vascular Calcification.	7	55	1.17	0.00056	9606.ENSP00000222572,9606.ENSP00000310036,9606.ENSP00000356832,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	PON2,CD34,SGK1,BMP2,MME,PROM1,VEGFA
PMID:32295518	(2020) Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome.	7	55	1.17	0.00056	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,SAA1,LTA,CCL5
PMID:32481582	(2020) An Evidence-Based Update on the Molecular Mechanisms Underlying Periodontal Diseases.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000474412	TGFB1,IFNG,PTGS2,TXN,BMP2,RHOA,CCL5
PMID:32575923	(2020) Glia-Derived Extracellular Vesicles in Parkinsons Disease.	7	55	1.17	0.00056	9606.ENSP00000292303,9606.ENSP00000298352,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	CCR5,NGB,CXCL10,CXCL11,NFE2L2,BCL2,BDNF
PMID:32606809	(2020) Targeting IFNSTAT1 Pathway as a Promising Strategy to Overcome Radioresistance.	7	55	1.17	0.00056	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067	THBS1,CXCL10,CXCL11,STAT5A,CXCL9,PTGS2,JAK2
PMID:32642003	(2020) Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cellstissues.	7	55	1.17	0.00056	9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000360522,9606.ENSP00000377192	ATM,AQP5,CXCL10,MMP14,CAV1,RBP4,G6PD
PMID:32659896	(2020) Insight into the Role of Dental Pulp Stem Cells in Regenerative Therapy.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368104	IFNG,SOX9,CDH1,IGF1R,LPL,CD34,BMP2
PMID:32664226	(2020) Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?	7	55	1.17	0.00056	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	MPO,NOX4,PTGS2,TXN,NFE2L2,BDNF,VEGFA
PMID:32717640	(2020) Network Approaches for Dissecting the Immune System.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000474412,9606.ENSP00000477707	TGFB1,CCR5,CXCL10,CD34,EBF1,CCL5,NR1H3
PMID:32731512	(2020) Inflammatory Cells in Diffuse Large B Cell Lymphoma.	7	55	1.17	0.00056	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000478570	CXCL10,CCL20,CD247,CXCL9,JAK2,IRAK4,VEGFA
PMID:32742246	(2020) Proteomic approaches for characterizing renal cell carcinoma.	10	146	0.9	0.00056	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000265333,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000321334,9606.ENSP00000325548,9606.ENSP00000418525,9606.ENSP00000478570	MAPK1,HSPB1,THBS1,VDAC1,ALDH1A1,PRDX2,LPA,CNDP2,MME,VEGFA
PMID:32905015	(2020) Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,JAK2,LTA,CCL5
PMID:32971931	(2020) IL-21 in Homeostasis of Resident Memory and Exhausted CD8 T Cells during Persistent Infection.	7	55	1.17	0.00056	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CDH1,CXCL10,HNF4A,STAT5A,CXCL9,BCL2
PMID:33194756	(2020) Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer.	7	55	1.17	0.00056	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,CDH1,SREBF1,PTGS2,BCL2,RHOA,VEGFA
PMID:30568223	(2019) An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,FABP4,CXCL10,CD34,PROM1,CCL5,VEGFA
PMID:30930851	(2019) The Uncovered Role of Immune Cells and NK Cells in the Regulation of Bone Metastasis.	7	55	1.17	0.00056	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000474412	CD69,CCR5,CXCL10,CD34,CXCL9,HSPG2,CCL5
PMID:30995715	(2019) LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.	7	55	1.17	0.00056	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,HNF4A,SREBF1,NOX1,CCL5,VEGFA
PMID:31069617	(2019) Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.	7	55	1.17	0.00056	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,HNF4A,PTEN,EDN1,VEGFA
PMID:31133019	(2019) Microfluidics for studying metastatic patterns of lung cancer.	7	55	1.17	0.00056	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ANGPT2,ANG,CD47,PTEN,RHOA,VEGFA
PMID:31208080	(2019) Epigenetics: A Potential Mechanism Involved in the Pathogenesis of Various Adverse Consequences of Obstructive Sleep Apnea.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185	IFNG,PRKCE,PTEN,NOX1,TXN,EDN1,BCL2
PMID:29495967	(2018) Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:29559224	(2018) ROS signaling and ER stress in cardiovascular disease.	7	55	1.17	0.00056	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,VDAC1,MAP3K5,NOX1,TXN,RHOA,VEGFA
PMID:30322213	(2018) Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases.	7	55	1.17	0.00056	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,CD34,ELN,CD47,PTGS2,MYD88,VEGFA
PMID:30360455	(2018) Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CAV1,CXCL9,NPY,CCL5
PMID:28220123	(2017) Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.	7	55	1.17	0.00056	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000351671,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,ALDH1A1,CCL20,MME,CCL5,VEGFA
PMID:28874954	(2017) Aging: Molecular Pathways and Implications on the Cardiovascular System.	7	55	1.17	0.00056	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,SIRT6,ELN,PTGS2,NOX1,NFE2L2,VEGFA
PMID:28974990	(2017) Role of microRNAs in obesity and obesity-related diseases.	7	55	1.17	0.00056	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000302630,9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000477707	FABP4,IGF1R,ONECUT1,LPL,SIRT6,PTEN,NR1H3
PMID:29295482	(2017) Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells.	7	55	1.17	0.00056	9606.ENSP00000278840,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	FADS2,ALDH1A1,PLIN1,SREBF1,PTEN,BCL2,VEGFA
PMID:27164089	(2016) Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.	7	55	1.17	0.00056	9606.ENSP00000278616,9606.ENSP00000322898,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000401399	ATM,EBF1,PTEN,JAK2,NFE2L2,FGFR1,MYD88
PMID:27411480	(2016) MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis.	7	55	1.17	0.00056	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:27487181	(2016) Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response.	7	55	1.17	0.00056	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000360997,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,CXCL10,ADAMTS13,LTA,BDNF,VEGFA
PMID:27529216	(2016) The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.	7	55	1.17	0.00056	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000393312,9606.ENSP00000426809	CDH1,ALDH1A1,MAPK7,CAV1,CD47,FGFR1,PROM1
PMID:26075284	(2015) Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000384364	IFNG,CCR5,CD34,CAV1,ENTPD1,BCL2,NPY
PMID:26697426	(2015) G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling.	7	55	1.17	0.00056	9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	HNF4A,ELN,EDN1,RHOA,AGTR1,APLNR,VEGFA
PMID:24498071	(2014) Nur77 decreases atherosclerosis progression in apoE(--) mice fed a high-fathigh-cholesterol diet.	7	55	1.17	0.00056	9606.ENSP00000200676,9606.ENSP00000256104,9606.ENSP00000263774,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995	CETP,FABP4,NDUFS3,LPL,CAV1,SREBF1,ABCG1
PMID:25346724	(2014) The Role of SIRT1 in Diabetic Kidney Disease.	7	55	1.17	0.00056	9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000478570	MMP14,ANGPT2,PTGS2,SGK1,RARRES2,AGTR1,VEGFA
PMID:23434668	(2013) Crosstalk between Oxidative Stress and SIRT1:  Impact on the Aging Process.	7	55	1.17	0.00056	9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185	ATM,SIRT6,MAP3K5,PTEN,NOX1,TXN,BCL2
PMID:23639323	(2013) Protein phosphatase 2A: a target for anticancer therapy.	7	55	1.17	0.00056	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	ATM,CD34,HNF4A,STAT5A,PTEN,JAK2,BCL2
PMID:23774812	(2013) Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.	7	55	1.17	0.00056	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PTGS2,SGK1,EDN1,G6PD,AGTR1,VEGFA
PMID:21941553	(2012) The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000418525	TGFB1,IFNG,ATM,CD34,STAT5A,BCL2,MME
PMID:22168167	(2012) Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.	7	55	1.17	0.00056	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,PDGFB,PDGFA,AR,PDGFD,FGFR1,VEGFA
PMID:22406271	(2012) Crosstalk between reverse cholesterol transport and innate immunity.	7	55	1.17	0.00056	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000317674,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000383364,9606.ENSP00000401399	CETP,MPO,APOL1,ABCG1,JAK2,PLA2G2A,MYD88
PMID:22582993	(2012) Organotypic liver culture models: meeting current challenges in toxicity testing.	7	55	1.17	0.00056	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412	CDH1,CCR5,ELN,HSPG2,EDN1,RHOA,CCL5
PMID:22837040	(2012) Immune surveillance in the central nervous system.	7	55	1.17	0.00056	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	CD69,CCR5,CXCL10,CCL20,CNTF,NTF3,BDNF
PMID:24040506	(2012) Next-generation therapeutic solutions for age-related macular degeneration.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CXCL10,FMOD,ELN,CNTF,BDNF,VEGFA
PMID:19854201	(2010) Structural analysis of cysteine S-nitrosylation: a modified acid-based motif and the emerging role of trans-nitrosylation.	7	55	1.17	0.00056	9606.ENSP00000216181,9606.ENSP00000284031,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000401399	MYH9,DDAH1,PRDX2,MAP3K5,TXN,BCL2,MYD88
PMID:20386472	(2010) Cancer and inflammation: promise for biologic therapy.	7	55	1.17	0.00056	9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000445772,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,STAT5A,BCL2,MYD88,LTB4R2,VEGFA,HNF1B
PMID:21085494	(2010) Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.	7	55	1.17	0.00056	9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	AMBP,CXCL10,CD34,CXCL9,BMP2,CCL5,VEGFA
PMID:24281073	(2010) The two-faced effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer.	7	55	1.17	0.00056	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,THBS1,CDH1,ATM,NOX1,BCL2,VEGFA
PMID:19034000	(2008) Endothelial cells in allograft rejection.	7	55	1.17	0.00056	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,BCL2,CCL5,VEGFA
PMID:34617205	(2022) Molecular implications of HOX genes targeting multiple signaling pathways in cancer.	9	112	0.97	0.00057	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CD34,ANGPT2,STAT5A,PDGFA,PTEN,ANGPTL2,BCL2,VEGFA
PMID:34843718	(2022) CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.	4	6	1.88	0.00057	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000362057,9606.ENSP00000474412	NOX4,CCR5,NOX1,CCL5
PMID:34981815	(2022) [Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKTmTOR pathway.	4	6	1.88	0.00057	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,CD34,RHOA,VEGFA
PMID:35154709	(2022) Inflammatory marker trajectories associated with frailty and ageing in a 20-year longitudinal study.	5	17	1.53	0.00057	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,BDNF,CCL5
PMID:35155701	(2022) The Efficacy of Platelet-Rich Plasma for Ligament Injuries: A Systematic Review of Basic Science Literature With Protocol Quality Assessment.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000478570	TGFB1,THBS1,GAP43,NTF3,VEGFA
PMID:35163629	(2022) Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa.	9	112	0.97	0.00057	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495	MAPK1,HSPB1,ATM,STAT5A,MAP3K5,CXCL9,PTEN,BCL2,LTA
PMID:35189948	(2022) Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy.	4	6	1.88	0.00057	9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	CNTF,NPY,NTF3,BDNF
PMID:35215625	(2022) Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review.	5	17	1.53	0.00057	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CAV1,PTEN,PROM1,VEGFA
PMID:35308286	(2022) Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality.	4	6	1.88	0.00057	9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	PTGS2,NFE2L2,BCL2,VEGFA
PMID:35369062	(2022) Chemistry and Pharmacological Actions of Delphinidin, a Dietary Purple Pigment in Anthocyanidin and Anthocyanin Forms.	9	112	0.97	0.00057	9606.ENSP00000261769,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000362463,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,COMT,PTGS2,GLO1,BCL2,RHOA,BDNF,AGTR1,VEGFA
PMID:35926563	(2022) Activation of aryl hydrocarbon receptor ameliorates rosacea-like eruptions in mice and suppresses the TLR signaling pathway in LL-37-induced HaCaT cells.	4	6	1.88	0.00057	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:32299902	(2021) Myeloidlymphoid neoplasms with eosinophilia basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000393312	CD38,CD34,STAT5A,JAK2,FGFR1
PMID:33352047	(2021) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.	5	17	1.53	0.00057	9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	PDGFB,STAT5A,JAK2,BCL2,VEGFA
PMID:33541390	(2021) Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	CD38,ATM,CD34,BCL2,MME
PMID:33586033	(2021) Study on the Correlation Between NF-kappaB and Central Fatigue.	5	17	1.53	0.00057	9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,JAK2,BCL2,BDNF,VEGFA
PMID:33603470	(2021) PRDX6 Overexpression Promotes Proliferation, Invasion, and Migration of A549 Cells in vitro and in vivo.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000371067,9606.ENSP00000474412	CDH1,MMP14,HNF4A,JAK2,CCL5
PMID:33672734	(2021) Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence.	4	6	1.88	0.00057	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000426809	ALDH1A1,MMP14,CAV1,PROM1
PMID:33685048	(2021) [Angiopoietin-2 regulates vessels encapsulated by tumor clusters positive hepatocellular carcinoma nest-type metastasis via integrin alpha5beta1].	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000356438	CD34,ANGPT2,ANG,PTGS2
PMID:33726849	(2021) Analyses of the pericyte transcriptome in ischemic skeletal muscles.	9	112	0.97	0.00057	9606.ENSP00000216181,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	MYH9,PLIN1,CXCL10,MMP14,CD34,PDGFB,ALPL,BMP2,VEGFA
PMID:33738994	(2021) Biomaterial-based platforms for cancer stem cell enrichment and study.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,PROM1,VEGFA
PMID:33744829	(2021) The chemotactic cytokines in the cerebrospinal fluid of patients with neuroborreliosis.	4	6	1.88	0.00057	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:33771659	(2021) Histological evaluation of extraction sites grafted with Bio-Oss Collagen: Randomized controlled trial.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000363973,9606.ENSP00000478570	CD34,CAV1,ALPL,VEGFA
PMID:33807271	(2021) High-Density Lipoproteins and the Kidney.	5	17	1.53	0.00057	9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000384906	APOL1,LPA,SREBF1,RBP4,SAA1
PMID:33888767	(2021) Vegfa promoter gene hypermethylation at HIF1alpha binding site is an early contributor to CKD progression after renal ischemia.	5	17	1.53	0.00057	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,EDNRA,EDN1,NFE2L2,VEGFA
PMID:33946931	(2021) Angiogenic Properties of Concentrated Growth Factors (CGFs): The Role of Soluble Factors and Cellular Components.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PDGFB,BMP2,PROM1,VEGFA
PMID:33994432	(2021) Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2(V617F)-myeloproliferative neoplasm.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	CD38,CD34,JAK2,BCL2,MME
PMID:34063635	(2021) Beneficial Effects of Green Tea Catechins on Female Reproductive Disorders: A Review.	5	17	1.53	0.00057	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000369816,9606.ENSP00000478570	MAPK1,IFNG,CD34,SHBG,VEGFA
PMID:34105799	(2021) Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,PTGS2,BDNF,VEGFA
PMID:34122558	(2021) Long-Term Effects of Adjuvant Intravitreal Treatment with Autologous Bone Marrow-Derived Lineage-Negative Cells in Retinitis Pigmentosa.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,NTF3,BDNF,VEGFA
PMID:34135982	(2021) Mechanism of Yifei Decoction Combined with MitoQ on Inhibition of TGFbeta1NOX4 and PDGFROCK Signal Pathway in Idiopathic Pulmonary Fibrosis.	5	17	1.53	0.00057	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000401399	NOX4,ELN,NOX1,RHOA,MYD88
PMID:34141739	(2021) Xenogeneic stem cell transplantation: Research progress and clinical prospects.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000368104	IFNG,CD34,CD47,BMP2
PMID:34162919	(2021) Serum protein triplet TGF-beta1, TIMP-1, and YKL-40 serve as diagnostic and prognostic profile for astrocytoma.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000368104	TGFB1,IFNG,CHI3L1,CXCL10,BMP2
PMID:34195238	(2021) Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000363822	CD34,HNF4A,ELN,AR
PMID:34222308	(2021) Polyphenol-Rich Aronia melanocarpa Juice Consumption Affects LINE-1 DNA Methylation in Peripheral Blood Leukocytes in Dyslipidemic Women.	4	6	1.88	0.00057	9606.ENSP00000278840,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000380252	FADS2,COMT,MTHFR,NFE2L2
PMID:34234602	(2021) Are Anti-Inflammatory Cytokines Associated with Cognitive Impairment in Patients with Insomnia Comorbid with Depression? A Pilot Study.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	TGFB1,IFNG,LTA,BDNF,CCL5
PMID:34239574	(2021) Influence of Dental Pulp Harvesting Method on the Viability and Differentiation Capacity of Adult Dental Pulp-Derived Mesenchymal Stem Cells.	5	17	1.53	0.00057	9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	AMBP,CD34,CNTF,BDNF,VEGFA
PMID:34294622	(2021) Diagnostic Performance of Erythropoietin and Erythropoietin Receptors Levels in Children with Attention Deficit Hyperactivity Disorder.	4	6	1.88	0.00057	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,MPO,JAK2,BCL2
PMID:34461635	(2021) IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:34501934	(2021) Interferon-gamma-Inducible Chemokines as Prognostic Markers for Lung Cancer.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:34577153	(2021) Gas Plasma-Augmented Wound Healing in Animal Models and Veterinary Medicine.	4	6	1.88	0.00057	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000380252,9606.ENSP00000478570	MPO,CDH1,NFE2L2,VEGFA
PMID:34579015	(2021) Dietary Lipids and Dyslipidemia in Chronic Kidney Disease.	5	17	1.53	0.00057	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000477707	CETP,LPL,SREBF1,RBP4,NR1H3
PMID:34656059	(2021) Alpinia officinarum water extract inhibits the atopic dermatitis-like responses in NCNga mice by regulation of inflammatory chemokine production.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL5
PMID:34736527	(2021) The telomere complex and the origin of the cancer stem cell.	10	147	0.89	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495	CD38,CD34,HNF4A,ANGPT2,EBF1,STAT5A,CD47,PTEN,BCL2,LTA
PMID:34950027	(2021) In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L.	4	6	1.88	0.00057	9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	ALDH1A1,CXCL10,CXCL9,CCL5
PMID:35087536	(2021) Natural Killer Cells in the Malignant Niche of Multiple Myeloma.	10	147	0.89	0.00057	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CD34,STAT5A,CXCL9,MME,PROM1,CCL5,VEGFA
PMID:31435034	(2020) Allogeneic transplantation of peripheral blood stem cell grafts results in a massive decrease of primitive hematopoietic progenitor frequencies in reconstituted bone marrows.	4	6	1.88	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CD34,MME,PROM1
PMID:31789672	(2020) Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CCL20,CXCL9,CCL5
PMID:31836883	(2020) Losartan protects against intermittent hypoxia-induced peritubular capillary loss by modulating the renal renin-angiotensin system and angiogenesis factors.	4	6	1.88	0.00057	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,CD34,AGTR1,VEGFA
PMID:32252351	(2020) Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.	9	112	0.97	0.00057	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,SIRT6,CAV1,PTGS2,PTEN,G6PD,NFE2L2,BCL2,VEGFA
PMID:32316287	(2020) Differential Activation of Glioprotective Intracellular Signaling Pathways in Primary Optic Nerve Head Astrocytes after Treatment with Different Classes of Antioxidants.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000380252,9606.ENSP00000381185	TGFB1,HSPB1,NOX4,NFE2L2,BCL2
PMID:32358340	(2020) Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia: A case report.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000418525	CD38,IFNG,CD34,EBF1,MME
PMID:32398729	(2020) Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418525	CD38,CD34,ENTPD1,BCL2,MME
PMID:32426049	(2020) Predicting STAT1 as a prognostic marker in patients with solid cancer.	5	17	1.53	0.00057	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185	CXCL10,CXCL11,STAT5A,CXCL9,BCL2
PMID:32454973	(2020) Male mammary myofibroblastoma: Two case reports and brief review of literature.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CD34,AR,BCL2,MME
PMID:32686598	(2020) Gut microbiota regulate tumor metastasis via circRNAmiRNA networks.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,PROM1,VEGFA
PMID:32751679	(2020) Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma.	9	112	0.97	0.00057	9606.ENSP00000013807,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310520,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,SOX9,CDH1,ALDH1A1,ERCC4,PTGS2,BCL2,PROM1,VEGFA
PMID:32821513	(2020) microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy.	4	6	1.88	0.00057	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000478570	ANGPT2,PDGFB,BMP2,VEGFA
PMID:32847144	(2020) Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides.	5	17	1.53	0.00057	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,CAV1,AR,BCL2,VEGFA
PMID:32874588	(2020) Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsedrefractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report.	5	17	1.53	0.00057	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000418525	MPO,CD38,IFNG,CD34,MME
PMID:33071752	(2020) Mutation-Independent Therapies for Retinal Diseases: Focus on Gene-Based Approaches.	5	17	1.53	0.00057	9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,BCL2,RHOA,BDNF,VEGFA
PMID:33139646	(2020) Mycotoxin Occurrence, Exposure and Health Implications in Infants and Young Children in Sub-Saharan Africa: A Review.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000380252,9606.ENSP00000381185	CCR5,CXCL10,HNF4A,NFE2L2,BCL2
PMID:33178387	(2020) Mechanisms of Acupuncture in the Regulation of Oxidative Stress in Treating Ischemic Stroke.	5	17	1.53	0.00057	9606.ENSP00000263317,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,CNR1,NOX1,TXN,NFE2L2
PMID:33339902	(2020) Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.	4	6	1.88	0.00057	9606.ENSP00000315011,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185	EDNRA,AR,EDN1,BCL2
PMID:30840669	(2019) Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia.	4	6	1.88	0.00057	9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,EDN1,CCL5,VEGFA
PMID:30944034	(2019) Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis.	5	17	1.53	0.00057	9606.ENSP00000265333,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000377192	VDAC1,CXCL10,CXCL11,CXCL9,G6PD
PMID:30972164	(2019) Catalpol improves axonal outgrowth and reinnervation of injured sciatic nerve by activating AktmTOR pathway and regulating BDNF and PTEN expression.	4	6	1.88	0.00057	9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303	PTEN,GAP43,BCL2,BDNF
PMID:31119475	(2019) Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms.	5	17	1.53	0.00057	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CD34,CXCL9,JAK2,VEGFA
PMID:31142342	(2019) The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.	5	17	1.53	0.00057	9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412	CXCL10,SREBF1,PTGS2,PTEN,CCL5
PMID:31151929	(2019) Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.	5	17	1.53	0.00057	9606.ENSP00000225275,9606.ENSP00000358513,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CNR1,SHBG,BDNF,VEGFA
PMID:31341423	(2019) Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000403495,9606.ENSP00000478570	CDH1,PTEN,AR,LTA,VEGFA
PMID:31428150	(2019) Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,BDNF,PROM1,VEGFA
PMID:31475784	(2019) Absence of estrogen receptor beta leads to abnormal adipogenesis during early tendon healing by an up-regulation of PPARgamma signalling.	5	17	1.53	0.00057	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000361021	FABP4,PLIN1,LPL,CD34,PTEN
PMID:31581603	(2019) Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD.	5	17	1.53	0.00057	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD69,IFNG,CXCL10,CXCL11,CXCL9
PMID:31788302	(2019) Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis.	5	17	1.53	0.00057	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525	MPO,CDH1,CD34,JAK2,MME
PMID:31949512	(2019) The Role of VEGF and TNF-Alpha on Epithelialization of Diabetic Foot Ulcers after Hyperbaric Oxygen Therapy.	5	17	1.53	0.00057	9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000478570	PTGS2,TXN,EDN1,LTA,VEGFA
PMID:28829757	(2018) Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:29191392	(2018) Cold atmospheric plasma (CAP) activates angiogenesis-related molecules in skin keratinocytes, fibroblasts and endothelial cells and improves wound angiogenesis in an autocrine and paracrine mode.	5	17	1.53	0.00057	9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	ANGPT2,ANG,EDN1,FGFR1,VEGFA
PMID:29581858	(2018) Depleting ovarian cancer stem cells with calcitriol.	5	17	1.53	0.00057	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000401399,9606.ENSP00000426809	CYP24A1,CDH1,HNF4A,MYD88,PROM1
PMID:29605557	(2018) Nitrolipids in kidney physiology and disease.	5	17	1.53	0.00057	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000474412	NOX4,PTGS2,NFE2L2,AGTR1,CCL5
PMID:29687874	(2018) Effects of platelet-rich plasma on angiogenesis and osteogenesis-associated factors in rabbits with avascular necrosis of the femoral head.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,PDGFB,BMP2,VEGFA
PMID:29701676	(2018) Anti-Inflammatory Effect of Baicalein on Polyinosinic-Polycytidylic Acid-Induced RAW 264.7 Mouse Macrophages.	5	17	1.53	0.00057	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,CCL5,VEGFA
PMID:29709093	(2018) Magnesium sulfate differentially modulates fetal membrane inflammation in a time-dependent manner.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000362463,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,GLO1,CCL5,VEGFA
PMID:29722145	(2018) High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,LTA,CCL5,VEGFA
PMID:29725393	(2018) Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CCL5,VEGFA
PMID:29772461	(2018) Quickening: Translational design of resorbable synthetic vascular grafts.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ELN,PROM1,VEGFA
PMID:29804281	(2018) Interferon-gamma and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:29893515	(2018) CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:30038466	(2018) Multiparametric analysis of colorectal cancer immune responses.	5	17	1.53	0.00057	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000478570	MPO,IFNG,CD34,ENTPD1,VEGFA
PMID:30042332	(2018) Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review.	5	17	1.53	0.00057	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,VDAC1,NFE2L2,AGTR1,VEGFA
PMID:30096912	(2018) Differential and Interactive Effects of Substrate Topography and Chemistry on Human Mesenchymal Stem Cell Gene Expression.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,FABP4,ALPL,BMP2,VEGFA
PMID:30111800	(2018) Complex bile duct network formation within liver decellularized extracellular matrix hydrogels.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CDH1,ELN,VEGFA,HNF1B
PMID:30513080	(2018) Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:30973277	(2018) Quantitative proteomics reveals the mechanisms of hydrogen-conferred protection against hyperoxia-induced injury in type II alveolar epithelial cells.	4	6	1.88	0.00057	9606.ENSP00000293599,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000381185	AQP5,PDGFB,EDN1,BCL2
PMID:27253191	(2017) Association of type 2 diabetes susceptibility loci with peripheral nerve function in a Chinese population with diabetes.	5	17	1.53	0.00057	9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000365777,9606.ENSP00000418823,9606.ENSP00000480291	JAZF1,KCNJ11,MTHFR,FTO,HNF1B
PMID:28057939	(2017) Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm.	5	17	1.53	0.00057	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	EPOR,IGF1R,CD34,STAT5A,JAK2
PMID:28073888	(2017) Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000480291	TGFB1,CDH1,HNF4A,ELN,HNF1B
PMID:28092180	(2017) N-acetylcysteine a possible protector against indomethacin-induced peptic ulcer: crosstalk between antioxidant, anti-inflammatory, and antiapoptotic mechanisms.	4	6	1.88	0.00057	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000377192,9606.ENSP00000381185	MPO,IFNG,G6PD,BCL2
PMID:28203223	(2017) Impaired Axonal Regeneration in Diabetes. Perspective on the Underlying Mechanism from In Vivo and In Vitro Experimental Studies.	5	17	1.53	0.00057	9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	PTEN,NTF3,RHOA,BDNF,VEGFA
PMID:28320472	(2017) Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(-) endothelial progenitor cells in systemic sclerosis.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDNRA,EDN1,PROM1,VEGFA
PMID:28362700	(2017) Dermatofibrosarcoma Protuberans: An Immunomarker Study of 57 Cases That Included Putative Mesenchymal Stem Cell Markers.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000418525,9606.ENSP00000426809	CD34,PDGFB,MME,PROM1
PMID:28418843	(2017) CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ATM,CXCL11,BCL2,PROM1
PMID:28461757	(2017) Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185	CDH1,STAT5A,PTGS2,JAK2,BCL2
PMID:28649635	(2017) Gravireceptors in eukaryotes-a comparison of case studies on the cellular level.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000419313	TGFB1,SOX9,BMP2,TRPC1
PMID:29042859	(2017) Associations between Systemic Sclerosis and Thyroid Diseases.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:29090279	(2017) Selenium nanoparticles induce suppressed function of tumor associated macrophages and inhibit Daltons lymphoma proliferation.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000478570	CD34,CD47,PTGS2,LTA,VEGFA
PMID:29165316	(2017) Residual gammaH2AX foci induced by low dose x-ray radiation in bone marrow mesenchymal stem cells do not cause accelerated senescence in the progeny of irradiated cells.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000426809	CD38,CD69,ATM,CD34,PROM1
PMID:29218106	(2017) Extracorporeal shock wave therapy effectively protects brain against chronic cerebral hypo-perfusion-induced neuropathological changes.	5	17	1.53	0.00057	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,NOX1,BMP2,BCL2,VEGFA
PMID:26448099	(2016) Integrin alphavbeta6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,HNF4A,LTA,PROM1,HNF1B
PMID:26553462	(2016) Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:26748988	(2016) NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study.	4	6	1.88	0.00057	9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,NPY,BDNF,VEGFA
PMID:26799921	(2016) The plastic cellular states of liver cells: Are EpCAM and Lgr5 fit for purpose?	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809	SOX9,CDH1,CD34,HNF4A,PROM1
PMID:27062839	(2016) [expressions of ligament remodeling related genes in rabbit model of anterior cruciate ligament reconstruction with preserving tibial residual fibers].	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000478570	TGFB1,GAP43,NTF3,VEGFA
PMID:27140846	(2016) Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000401399,9606.ENSP00000426809	CD38,CDH1,CD34,MYD88,PROM1
PMID:27215129	(2016) Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages.	4	6	1.88	0.00057	9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000380252,9606.ENSP00000381185	CNR1,CNR2,NFE2L2,BCL2
PMID:27297729	(2016) Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis.	5	17	1.53	0.00057	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000362057,9606.ENSP00000478570	THBS1,NOX4,CXCL10,NOX1,VEGFA
PMID:27382979	(2016) The GG genotype of the -152 GA vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANG,PROM1,VEGFA
PMID:27440106	(2016) Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:27504534	(2016) The Effect of Platform Switching on Periimplant Crevicular Fluid Content During Early Wound Healing.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CCL5,VEGFA
PMID:27551316	(2016) Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:28127486	(2016) Trichoepithelioma Arising in an Ovarian Mature Cystic Teratoma.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CD34,AR,BCL2,MME
PMID:25756272	(2015) Sarcoidosis and Th1 chemokines.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:25849939	(2015) Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,BCL2,PROM1,VEGFA
PMID:25887432	(2015) Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy.	4	6	1.88	0.00057	9606.ENSP00000321853,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252	SERPINF2,PTGS2,EDN1,NFE2L2
PMID:25896668	(2015) Paired design study by real-time PCR: miR-378* and miR-145 are potent early diagnostic biomarkers of human colorectal cancer.	4	6	1.88	0.00057	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000478570	MAPK1,SOX9,BMP2,VEGFA
PMID:25922643	(2015) Oxidative stress in myopia.	5	17	1.53	0.00057	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000381185	ANGPT2,PDGFB,VIP,EDN1,BCL2
PMID:25973012	(2015) Biocompatibility of porcine small intestinal submucosa and rat endothelial progenitor cells in vitro.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANG,PROM1,VEGFA
PMID:26059451	(2015) STAT5A regulates DNMT3A in CD34(+)CD38(-) AML cells.	4	6	1.88	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021	CD38,CD34,STAT5A,PTEN
PMID:26124844	(2015) Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,GAP43,NTF3,BDNF,VEGFA
PMID:26188246	(2015) Cadherin-11 coordinates cellular migration and extracellular matrix remodeling during aortic valve maturation.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,CDH1,ELN,RHOA,VEGFA
PMID:26316489	(2015) Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000478570	TGFB1,CD34,JAK2,VEGFA
PMID:26439689	(2015) Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization.	5	17	1.53	0.00057	9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CD34,PDGFB,PROM1,VEGFA
PMID:26517517	(2015) Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000478319,9606.ENSP00000478570	TGFB1,ANGPT2,EDN1,GREM1,VEGFA
PMID:26560478	(2015) Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:26722382	(2015) Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model.	4	6	1.88	0.00057	9606.ENSP00000225275,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,RHOA,BDNF,VEGFA
PMID:26729707	(2015) DNA repair in species with extreme lifespan differences.	5	17	1.53	0.00057	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000337332,9606.ENSP00000361021	ERCC1,ATM,ERCC4,SIRT6,PTEN
PMID:24520395	(2014) A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000360522,9606.ENSP00000418009,9606.ENSP00000474412	IFNG,CXCL10,RBP4,RARRES2,CCL5
PMID:24574151	(2014) Multiplexed measurements of immunomodulator levels in peripheral blood of healthy subjects: Effects of analytical variables based on anticoagulants, age, and gender.	5	17	1.53	0.00057	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:24890045	(2014) Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets.	5	17	1.53	0.00057	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:24914197	(2014) Down but not out: an emerging role for the B-type endothelin receptor in placental ischemia-induced hypertension.	4	6	1.88	0.00057	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	EDNRA,ELN,EDN1,VEGFA
PMID:25001926	(2014) [PPAR-gamma agonist inhibits the expressions of chemokines induced by IFN-gamma and TNF-alpha in renal tubular epithelial cells].	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:25058515	(2014) The semen microbiome and its relationship with local immunology and viral load in HIV infection.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CCL20,CXCL9,CCL5
PMID:25105998	(2014) Testosterone and weight loss: the evidence.	5	17	1.53	0.00057	9606.ENSP00000309757,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000363822,9606.ENSP00000369816	LPL,RBP4,ANGPTL2,AR,SHBG
PMID:25309050	(2014) Markers of inflammation and fibrosis in the orbital fatconnective tissue of patients with Graves orbitopathy: clinical implications.	5	17	1.53	0.00057	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	PDGFB,PDGFA,PTGS2,CCL5,VEGFA
PMID:23383116	(2013) Analysis of CD45- [CD34+KDR+] endothelial progenitor cells as juvenile protective factors in a rat model of ischemic-hemorrhagic stroke.	4	6	1.88	0.00057	9606.ENSP00000200676,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000478570	CETP,CD34,EDN1,VEGFA
PMID:23476102	(2013) Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ALPL,BMP2,PROM1,VEGFA
PMID:23483579	(2013) An overview of underlying causes and animal models for the study of age-related degenerative disorders of the spine and synovial joints.	5	17	1.53	0.00057	9606.ENSP00000013807,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000347041,9606.ENSP00000369442	ERCC1,TIMP3,ATM,FMOD,KL
PMID:23505438	(2013) Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CCL20,CCL5,VEGFA
PMID:23524956	(2013) miRNA-Based Therapeutic Strategies.	5	17	1.53	0.00057	9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	SREBF1,ABCG1,PTEN,AR,BCL2
PMID:23560534	(2013) Inhibition of related JAKSTAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.	4	6	1.88	0.00057	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	EPOR,CD34,STAT5A,JAK2
PMID:23601622	(2013) Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,EDN1,PROM1,VEGFA
PMID:23762293	(2013) Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDN1,PROM1,VEGFA
PMID:23940720	(2013) Contribution of NADPH oxidase to membrane CD38 internalization and activation in coronary arterial myocytes.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683	CD38,NOX4,EDNRA,NOX1,EDN1
PMID:24052896	(2013) Loss of menin mediated by endothelial cells treated with CoPP is associated with increased maturation of adipocytes.	5	17	1.53	0.00057	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000478570	FABP4,LPL,ANG,EDN1,VEGFA
PMID:24309935	(2013) Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors.	5	17	1.53	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,NFE2L2,BCL2,VEGFA
PMID:22056785	(2012) Competence of failed endocrine progenitors to give rise to acinar but not ductal cells is restricted to early pancreas development.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000362410,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,MAFB,HNF1B
PMID:22432006	(2012) Inhibition of intestinal adenoma formation in APC(Min+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CD34,HNF4A,PTGS2,BCL2,VEGFA
PMID:22509308	(2012) Erythropoietin receptor signaling is membrane raft dependent.	5	17	1.53	0.00057	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000400175	EPOR,CD34,STAT5A,JAK2,RHOA
PMID:22536411	(2012) Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,PDGFB,ANG,CCL5,VEGFA
PMID:22558525	(2012) Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000368683	CD34,ELN,VIP,EDN1
PMID:22658713	(2012) Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:22675614	(2012) Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,JAK2,PROM1,VEGFA
PMID:22809140	(2012) Intraoperative stem cell therapy.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,BMP2,PROM1,VEGFA
PMID:22890131	(2012) Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:22929118	(2012) Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial.	5	17	1.53	0.00057	9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000383364	PLIN1,LPL,SREBF1,PTGS2,PLA2G2A
PMID:22969821	(2012) Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic dbdb Mice.	5	17	1.53	0.00057	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185	TGFB1,NOX4,PTGS2,NFE2L2,BCL2
PMID:23272637	(2012) Adenovirus-mediated delivery of interferon-gamma gene inhibits the growth of nasopharyngeal carcinoma.	4	6	1.88	0.00057	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000478570	CXCL10,CXCL9,HSPG2,VEGFA
PMID:23507864	(2012) Functionalization of biomaterial surfaces using artificial extracellular matrices.	5	17	1.53	0.00057	9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368104,9606.ENSP00000478570	FMOD,ELN,HSPG2,BMP2,VEGFA
PMID:25317141	(2012) Biomechanical analysis of optic nerve injury treated by compound light granules and ciliary neurotrophic factor.	4	6	1.88	0.00057	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303	CNTF,GAP43,BCL2,BDNF
PMID:20843569	(2011) Effect of enhanced external counterpulsation on circulating CD34+ progenitor cell subsets.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDN1,PROM1,VEGFA
PMID:20966394	(2011) S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program.	5	17	1.53	0.00057	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000368104	MPO,NOX4,S100A12,NOX1,BMP2
PMID:21296375	(2011) Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-beta1: role of TGF-beta1 in HCV replication.	5	17	1.53	0.00057	9606.ENSP00000260356,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000403495,9606.ENSP00000478570	THBS1,ANG,STAT5A,LTA,VEGFA
PMID:21330473	(2011) Overexpression of IL-3Ralpha on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML.	4	6	1.88	0.00057	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	CD38,CD34,STAT5A,JAK2
PMID:21354137	(2011) Evidence of hematopoietic differentiation, vasculogenesis and angiogenesis in the formation of human choroidal blood vessels.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ENTPD1,PROM1,VEGFA
PMID:21391226	(2011) A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis.	5	17	1.53	0.00057	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,HNF4A,HNF1B
PMID:21421859	(2011) Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma.	4	6	1.88	0.00057	9606.ENSP00000331831,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	GAS6,RHOA,BDNF,VEGFA
PMID:21498912	(2011) Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease.	4	6	1.88	0.00057	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000478570	CD34,EDNRA,EDN1,VEGFA
PMID:21538855	(2011) Green tea and breast cancer.	5	17	1.53	0.00057	9606.ENSP00000354511,9606.ENSP00000363822,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000478570	COMT,AR,MTHFR,SHBG,VEGFA
PMID:21554191	(2011) Gene regulation of extracellular matrix remodeling in human bone marrow stem cell-seeded tissue-engineered grafts.	4	6	1.88	0.00057	9606.ENSP00000245479,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000368683	SOX9,ALPL,BMP2,EDN1
PMID:21645215	(2011) Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:21904548	(2011) Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000377280,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,FBXO8,MYD88,PROM1
PMID:21946269	(2011) A mouse model of blast-induced mild traumatic brain injury.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:21978170	(2011) Branched alpha-(1,4) glucans from Lentinula edodes (L10) in combination with radiation enhance cytotoxic effect on human lung adenocarcinoma through the Toll-like receptor 4 mediated induction of THP-1 differentiationactivation.	4	6	1.88	0.00057	9606.ENSP00000336762,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ANG,MYD88,CCL5,VEGFA
PMID:19924133	(2010) Possible roles of IL-27 in the pathogenesis of psoriasis.	4	6	1.88	0.00057	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CXCL10,CXCL11,CCL20,CXCL9
PMID:20122881	(2010) Mechanical stretch induces nerve sprouting in rat sympathetic neurocytes.	4	6	1.88	0.00057	9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000419422	CNTF,NTF3,BDNF,AGTR1
PMID:20368766	(2010) Advances in the Development of Microbicides for the Prevention of HIV Infection.	4	6	1.88	0.00057	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000474412	CDH1,CCR5,CCL20,CCL5
PMID:20459657	(2010) Identification of genetic modifiers of behavioral phenotypes in serotonin transporter knockout rats.	5	17	1.53	0.00057	9606.ENSP00000268035,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000414303	IGF1R,COMT,PTEN,CNR2,BDNF
PMID:20626297	(2010) Predominant interferon-gamma-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALBc mice resistant to development of toxoplasmic encephalitis.	4	6	1.88	0.00057	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:20664591	(2010) Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.	5	17	1.53	0.00057	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000393312	IGF1R,PDGFB,PDGFA,PTEN,FGFR1
PMID:20942936	(2010) Chemokine control of HIV-1 infection: beyond a binding competition.	5	17	1.53	0.00057	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901	CD69,CCR5,CXCL10,CCL20,CXCL9
PMID:21054962	(2010) [Enhance effort for study of neuroprotection of degenerative fundus disease].	4	6	1.88	0.00057	9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	CNTF,BCL2,NTF3,BDNF
PMID:18843284	(2009) Bone marrow microenvironment and the identification of new targets for myeloma therapy.	9	112	0.97	0.00057	9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,ATM,CD34,HNF4A,CAV1,JAK2,BCL2,RHOA,VEGFA
PMID:19276231	(2009) Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:20032541	(2009) Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,CCL5
PMID:20409980	(2009) O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.	5	17	1.53	0.00057	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000349860,9606.ENSP00000368683,9606.ENSP00000400175	MAPK1,TGFB1,GFPT1,EDN1,RHOA
PMID:18560148	(2008) Structure of mouse IP-10, a chemokine.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:18775511	(2008) ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: implications for vascular repair.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000478570	CD34,LPA,ABCG1,JAK2,VEGFA
PMID:19011631	(2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.	5	17	1.53	0.00057	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478319	CDH1,HNF4A,BMP2,RHOA,GREM1
PMID:17351619	(2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:17383622	(2007) Laminar flow attenuates interferon-induced inflammatory responses in endothelial cells.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:17703315	(2007) The proinflammatory CXC-chemokines GRO-alphaCXCL1 and MIGCXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:15536145	(2005) NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:15841074	(2005) Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	CD34,EDNRA,EDN1,FGFR1,VEGFA
PMID:16319316	(2005) Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimers disease.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,PTGS2,EDN1,VEGFA
PMID:15063730	(2004) Nitric oxide differentially regulates pro- and anti-angiogenic markers in DLD-1 colon carcinoma cells.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,VEGFA
PMID:15526047	(2004) Characterization of T lymphocytes in chronic obstructive pulmonary disease.	5	17	1.53	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,ELN,CXCL9
PMID:12529425	(2003) STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA.	4	6	1.88	0.00057	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000400175	CDH1,STAT5A,JAK2,RHOA
PMID:10790287	(2000) Developmental profiles of growth-associated protein (Gap43), Ngfb, Bndf and Ntf4 mRNA levels in the rat forebrain after exposure to 60 Hz magnetic fields.	4	6	1.88	0.00057	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303	CNTF,GAP43,NTF3,BDNF
PMID:10867504	(2000) Regulation of CD69 expression on eosinophil precursors by interferon-gamma.	4	6	1.88	0.00057	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000371067	CD69,IFNG,CD34,JAK2
PMID:10027074	(1999) Endothelial cell responses to hypoxic stress.	4	6	1.88	0.00057	9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,PDGFB,EDN1,VEGFA
PMID:10194423	(1999) Differential chemokine expression in tissues involved by Hodgkins disease: direct correlation of eotaxin expression and tissue eosinophilia.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:10477104	(1999) Age-related decrease in brain-derived neurotrophic factor gene expression in the brain of the zitter rat with genetic spongiform encephalopathy.	4	6	1.88	0.00057	9606.ENSP00000215832,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	MAPK1,CNTF,NTF3,BDNF
PMID:9847285	(1998) Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807	TGFB1,PDGFB,PDGFA,ELN
PMID:9850741	(1998) Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).	4	6	1.88	0.00057	9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,PTGS2,EDN1,VEGFA
PMID:9027719	(1997) Effects of hypoxia on growth factor expression in the rat kidney in vivo.	4	6	1.88	0.00057	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	PDGFB,PDGFA,EDN1,VEGFA
PMID:8738162	(1996) BDNF increases the expression of neuropeptide Y mRNA and promotes differentiationmaturation of neuropeptide Y-positive cultured cortical neurons from embryonic and postnatal rats.	4	6	1.88	0.00057	9606.ENSP00000229135,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303	IFNG,NPY,NTF3,BDNF
PMID:8866133	(1996) Neurotrophic factors as pharmacological agents for the treatment of injured auditory neurons.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,CNTF,NTF3,BDNF
PMID:25599002	(....) application of umbilical cord blood derived stem cells in diseases of the nervous system.	5	17	1.53	0.00057	9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD34,BDNF,PROM1,CCL5,VEGFA
PMID:34949918	(....) chinese medical injections for acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.	4	6	1.88	0.00057	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000381185	TGFB1,MPO,PTGS2,BCL2
PMID:33416083	(2021) Inflammation: a putative link between phosphate metabolism and cardiovascular disease.	8	82	1.05	0.00058	9606.ENSP00000216862,9606.ENSP00000278616,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000363973,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000418009	CYP24A1,ATM,ELN,SGK1,ALPL,NFE2L2,FGFR1,RARRES2
PMID:33466626	(2021) The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.	8	82	1.05	0.00058	9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	GLO1,TXN,EDN1,G6PD,NFE2L2,BCL2,RHOA,VEGFA
PMID:33668707	(2021) Mesenchymal Stem Cell-Derived Extracellular Vesicles: Regenerative Potential and Challenges.	8	82	1.05	0.00058	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000377372,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,IFNG,ANG,ELN,CD47,GAP43,MME,VEGFA
PMID:34065048	(2021) Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis.	8	82	1.05	0.00058	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363827	IFNG,THBS1,CXCL10,HNF4A,FMOD,ELN,PTGS2,HSPG2
PMID:35046800	(2021) Natural AMPK Activators in Cardiovascular Disease Prevention.	8	82	1.05	0.00058	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	NOX4,MAPK7,HNF4A,SIRT6,SREBF1,PTEN,BCL2,RHOA
PMID:32194669	(2020) IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence.	8	82	1.05	0.00058	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CHI3L1,CXCL10,CXCL11,CCL20,CD247,CXCL9,CCL5
PMID:32775327	(2020) Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs.	8	82	1.05	0.00058	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ALDH1A1,CD34,ANGPT2,STAT5A,PROM1,VEGFA
PMID:33066148	(2020) Genetic Alterations of Metastatic Colorectal Cancer.	8	82	1.05	0.00058	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,ATM,HNF4A,PTEN,JAK2,FGFR1,GREM1,VEGFA
PMID:30656775	(2019) Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinsons disease.	8	82	1.05	0.00058	9606.ENSP00000297785,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000351908,9606.ENSP00000401399,9606.ENSP00000414303	ALDH1A1,MAPK7,SIRT6,CAV1,KCNJ11,MAP3K5,MYD88,BDNF
PMID:31674938	(2019) Perivascular adipose tissue in cardiovascular diseases-an update.	8	82	1.05	0.00058	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000474412	FABP4,PLIN1,LPL,CD34,ANGPTL2,EDN1,RARRES2,CCL5
PMID:29996499	(2018) Implications of Angiogenesis Involvement in Arthritis.	8	82	1.05	0.00058	9606.ENSP00000255409,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,CD34,ANGPT2,JAK2,BCL2,SAA1,PROM1,VEGFA
PMID:30249004	(2018) Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?	8	82	1.05	0.00058	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000322898,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777	THBS1,CDH1,TIMP3,ATM,EBF1,PTGS2,PTEN,MTHFR
PMID:28626501	(2017) NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells.	8	82	1.05	0.00058	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,NOX4,MAPK7,PTEN,NOX1,PROM1,VEGFA
PMID:21852555	(2011) The regulation of valvular and vascular sclerosis by osteogenic morphogens.	8	82	1.05	0.00058	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,HNF4A,GAS6,ELN,ALPL,BMP2,GREM1,VEGFA
PMID:24212955	(2011) Aberrant signaling pathways in glioma.	8	82	1.05	0.00058	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,ATM,PDGFB,PDGFA,PTEN,RHOA,PROM1,VEGFA
PMID:19455193	(2009) Autosomal dominant polycystic kidney disease: the last 3 years.	8	82	1.05	0.00058	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000284031,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000419313,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,IGF1R,DDAH1,EDN1,JAK2,TRPC1,VEGFA,HNF1B
PMID:19534815	(2009) Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.	8	82	1.05	0.00058	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,CCL5,VEGFA
PMID:18781150	(2008) Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.	8	82	1.05	0.00058	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000475344	CCR5,CXCL10,CXCL11,CXCL9,MYD88,BDNF,CCL5,APLNR
PMID:35155683	(2022) Transcript Expression Profiles and MicroRNA Regulation Indicate an Upregulation of Processes Linked to Oxidative Stress, DNA Repair, Cell Death, and Inflammation in Type 1 Diabetes Mellitus Patients.	6	34	1.31	0.00059	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185	CD69,IFNG,ATM,CCL20,PTGS2,BCL2
PMID:35281064	(2022) Crosstalk Between the Oxidative Stress and Glia Cells After Stroke: From Mechanism to Therapies.	7	56	1.16	0.00059	9606.ENSP00000263317,9606.ENSP00000298352,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,NGB,BCL2,IRAK4,MYD88,BDNF,VEGFA
PMID:35299751	(2022) Modulation of TLRNF-kappaBNLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.	10	148	0.89	0.00059	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000477707,9606.ENSP00000478570	CDH1,CXCL10,PTGS2,PTEN,JAK2,BCL2,IRAK4,MYD88,NR1H3,VEGFA
PMID:35327504	(2022) Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	MPO,IFNG,CXCL10,LPA,MME,AGTR1,VEGFA
PMID:32001529	(2021) The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CD34,STAT5A,BMP2,JAK2,BCL2
PMID:33368269	(2021) Macrophage reprogramming for therapy.	7	56	1.16	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CCR5,CXCL10,CD47,PTGS2,NFE2L2,BCL2,VEGFA
PMID:33391520	(2021) The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction.	6	34	1.31	0.00059	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000478570	TGFB1,IFNG,APC,CD34,PTEN,VEGFA
PMID:33398248	(2021) Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAKSTAT and TGFB signaling pathways.	7	56	1.16	0.00059	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067	MAPK1,CXCL10,CXCL11,MAPK7,CXCL9,PTEN,JAK2
PMID:33416116	(2021) Platelet-derived growth factor-BB mediates pancreatic cancer malignancy via regulation of the HippoYes-associated protein signaling pathway.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ANGPT2,PDGFA,BCL2,RHOA,VEGFA
PMID:33416119	(2021) Fangchinoline exerts antitumour activity by suppressing the EGFR-PI3KAKT signalling pathway in colon adenocarcinoma.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,BCL2,MYD88,PROM1,VEGFA
PMID:33499258	(2021) Primary Pulmonary B-Cell Lymphoma: A Review and Update.	7	56	1.16	0.00059	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CD34,CXCL9,BCL2,MYD88,MME,VEGFA
PMID:33650759	(2021) Gynaecological cancers and their cell lines.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000480291	CDH1,PRDX2,ENTPD1,PTEN,FGFR1,HNF1B
PMID:33718459	(2021) The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,PTGS2,EDN1,BCL2,CCL5,VEGFA
PMID:33757544	(2021) Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks.	7	56	1.16	0.00059	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000346148,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,PRKAA1,PTGS2,PTEN,BCL2,VEGFA
PMID:33761979	(2021) Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors.	6	34	1.31	0.00059	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000381185	IGF1R,ATM,CXCL10,CXCL9,AR,BCL2
PMID:33802091	(2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.	10	148	0.89	0.00059	9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000354511,9606.ENSP00000356213,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CD69,ATM,STAT5A,COMT,VIP,JAK2,SAA1,MYD88,BDNF,VEGFA
PMID:33806335	(2021) Emerging Role of Pericytes and Their Secretome in the Heart.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFB,PTGS2,HSPG2,CCL5,VEGFA
PMID:33817342	(2021) Engineering precision therapies: lessons and motivations from the clinic.	6	34	1.31	0.00059	9606.ENSP00000222139,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000355361	EPOR,CCR5,LPL,CD34,CD247,CD47
PMID:33916641	(2021) Colorectal Cancer and Immunity: From the Wet Lab to Individuals.	7	56	1.16	0.00059	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,CD34,CXCL9,CD47,CCL5,VEGFA
PMID:33935782	(2021) Role of Leptin in the Digestive System.	6	34	1.31	0.00059	9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	STAT5A,SREBF1,PTGS2,JAK2,BCL2,VEGFA
PMID:33946480	(2021) Cancer Stem Cells and Neovascularization.	6	34	1.31	0.00059	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,MMP14,CD34,PDGFB,PROM1,VEGFA
PMID:33964940	(2021) Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations.	6	34	1.31	0.00059	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000381185	THBS1,CD34,PDGFB,PDGFA,PTEN,BCL2
PMID:33967772	(2021) SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000371067,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,CXCL10,APOL1,JAK2,AGTR1,VEGFA
PMID:33996157	(2021) Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment.	6	34	1.31	0.00059	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000384906	CETP,MPO,APOL1,LPA,ABCG1,SAA1
PMID:34001236	(2021) Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer.	6	34	1.31	0.00059	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000310520,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312	ERCC1,TGFB1,ERCC4,PTEN,AR,FGFR1
PMID:34025430	(2021) Cellular Mechanisms of Liver Fibrosis.	9	113	0.96	0.00059	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478319	NOX4,CCR5,CXCL10,ELN,CXCL9,NOX1,AGTR1,CCL5,GREM1
PMID:34071012	(2021) Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,SGK1,CCL5,VEGFA
PMID:34095116	(2021) Integrating Spatial Transcriptomics and Single-Cell RNA-seq Reveals the Gene Expression Profling of the Human Embryonic Liver.	7	56	1.16	0.00059	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000419422,9606.ENSP00000474412	TGFB1,THBS1,IGF1R,HNF4A,CAV1,AGTR1,CCL5
PMID:34135773	(2021) Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?	6	34	1.31	0.00059	9606.ENSP00000222572,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000474412	PON2,COMT,PTGS2,EDN1,MME,CCL5
PMID:34277474	(2021) Upregulated Intrathecal Expression of VEGF-A and Long Lasting Global Upregulation of Proinflammatory Immune Mediators in Vaccine Breakthrough Tick-Borne Encephalitis.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL11,CXCL9,VEGFA
PMID:34287859	(2021) Neutrophils in pregnancy: New insights into innate and adaptive immune regulation.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000403495	MPO,CD69,CXCL10,STAT5A,CCL20,VIP,LTA
PMID:34330764	(2021) Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.	7	56	1.16	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,CXCL10,STAT5A,CXCL9,ENTPD1,RHOA,CCL5
PMID:34415457	(2021) A Narrative Review of the Renin-Angiotensin-Aldosterone System in the Placenta and Placental Bed of HIV Infected Women of African Ancestry with Preeclampsia.	6	34	1.31	0.00059	9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	PTGS2,EDN1,JAK2,MME,AGTR1,VEGFA
PMID:34422902	(2021) Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications.	7	56	1.16	0.00059	9606.ENSP00000261769,9606.ENSP00000283928,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,JAZF1,PTGS2,PTEN,BCL2,RHOA,VEGFA
PMID:34440150	(2021) Intrauterine Hypoxia and Epigenetic Programming in Lung Development and Disease.	6	34	1.31	0.00059	9606.ENSP00000245479,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,ELN,BCL2,RHOA,CCL5,VEGFA
PMID:34440851	(2021) Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.	7	56	1.16	0.00059	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000401399	TGFB1,CD69,MMP14,CD34,CD47,JAK2,MYD88
PMID:34457119	(2021) Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.	7	56	1.16	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000380252,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ANGPT2,NFE2L2,AGTR1,CCL5,VEGFA
PMID:34557402	(2021) Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma.	6	34	1.31	0.00059	9606.ENSP00000278616,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412	ATM,BMP2,BCL2,MYD88,MME,CCL5
PMID:34565215	(2021) Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective.	6	34	1.31	0.00059	9606.ENSP00000314897,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	ANGPT2,CD247,PTEN,JAK2,PROM1,VEGFA
PMID:34586841	(2021) G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000474412	MPO,CD69,SOX9,CXCL10,CD34,PDGFB,CCL5
PMID:34589747	(2021) Blood cytokines differentiate bipolar disorder and major depressive disorder during a major depressive episode: Initial discovery and independent sample replication.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000369442,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,KL,LTA,CCL5
PMID:34638361	(2021) The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma.	6	34	1.31	0.00059	9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MAPK7,ANGPT2,CCL20,PROM1,CCL5,VEGFA
PMID:34671362	(2021) Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment.	9	113	0.96	0.00059	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,MMP14,STAT5A,CD247,CD47,PTEN,BCL2,CCL5,VEGFA
PMID:34671431	(2021) Circular RNA regulates the onset and progression of cancer through the mitogen-activated protein kinase signaling pathway.	6	34	1.31	0.00059	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570,9606.ENSP00000480291	MAPK1,MAPK7,FGFR1,MYD88,VEGFA,HNF1B
PMID:34691284	(2021) Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors.	7	56	1.16	0.00059	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,IGF1R,ATM,MMP14,PTEN,JAK2,VEGFA
PMID:34745357	(2021) Possible impact of neutrophils on immune responses during early pregnancy in ruminants.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:34769099	(2021) Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies.	9	113	0.96	0.00059	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,PTEN,JAK2,BCL2,LTA,PROM1,VEGFA
PMID:34778334	(2021) An Overview of Registered Clinical Trials on Glucosinolates and Human Health: The Current Situation.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000380252	IFNG,HSPB1,CXCL10,PTGS2,AR,NFE2L2
PMID:34796337	(2021) Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity.	7	56	1.16	0.00059	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,ANGPT2,CXCL9,CCL5,VEGFA
PMID:34830132	(2021) Effect of Cold Atmospheric Plasma on Epigenetic Changes, DNA Damage, and Possibilities for Its Use in Synergistic Cancer Therapy.	7	56	1.16	0.00059	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,PRDX2,CXCL10,PTEN,BCL2,VEGFA
PMID:34831436	(2021) Stem Cell Secretome for Spinal Cord Repair: Is It More than Just a Random Baseline Set of Factors?	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CD34,CNTF,NTF3,BDNF,VEGFA
PMID:34841367	(2021) The role played by bacterial infections in the onset and metastasis of cancer.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000478570	MPO,IFNG,CDH1,ATM,PTGS2,RHOA,VEGFA
PMID:34867473	(2021) Supraphysiological Role of Melatonin Over Vascular Dysfunction of Pregnancy, a New Therapeutic Agent?	7	56	1.16	0.00059	9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000444198,9606.ENSP00000478570	HSPB1,CD34,PRKAA1,PTEN,HPSE,CITED2,VEGFA
PMID:34887766	(2021) Recent Advances in Pharmacological Intervention of Osteoarthritis: A Biological Aspect.	7	56	1.16	0.00059	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000419422	SOX9,CHI3L1,CCL20,PTGS2,JAK2,NPY,AGTR1
PMID:34899389	(2021) Sirtuin Oxidative Post-translational Modifications.	6	34	1.31	0.00059	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000377192	MPO,NOX4,SIRT6,SREBF1,TXN,G6PD
PMID:34941738	(2021) The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins.	7	56	1.16	0.00059	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,IFNG,CDH1,CCL20,PTGS2,BCL2,RHOA
PMID:34957111	(2021) Low Dose Chronic Angiotensin II Induces Selective Senescence of Kidney Endothelial Cells.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000380252	NOX4,ATM,CD34,ANGPT2,JAK2,NFE2L2
PMID:35111787	(2021) Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine.	6	34	1.31	0.00059	9606.ENSP00000293599,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000474412,9606.ENSP00000478570	AQP5,CXCL9,BCL2,NPY,CCL5,VEGFA
PMID:35173760	(2021) Single-Cell RNA Sequencing of Human Pluripotent Stem Cell-Derived Macrophages for Quality Control of The Cell Therapy Product.	6	34	1.31	0.00059	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000478570	TGFB1,CD38,IFNG,CCR5,CD34,VEGFA
PMID:31973059	(2020) Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma.	7	56	1.16	0.00059	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CXCL10,MMP14,ENTPD1,PTEN,CCL5,VEGFA
PMID:32032302	(2020) Persistent Immune Activation in HIV-1-Infected Ex Vivo Model Tissues Subjected to Antiretroviral Therapy: Soluble and Extracellular Vesicle-Associated Cytokines.	6	34	1.31	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:32060308	(2020) Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures.	6	34	1.31	0.00059	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	MAPK1,ATM,JAK2,NFE2L2,BCL2,PROM1
PMID:32071927	(2020) Oncolytic Viruses and the Immune System: The Dynamic Duo.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:32098620	(2020) Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL11,CCL20,CXCL9,CCL5
PMID:32120334	(2020) Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma.	6	34	1.31	0.00059	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,ATM,CD34,PDGFA,BCL2,VEGFA
PMID:32235364	(2020) Therapy-Induced Senescence: An Old Friend Becomes the Enemy.	7	56	1.16	0.00059	9606.ENSP00000013807,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CD34,PTEN,AR,BCL2,PROM1,VEGFA
PMID:32312307	(2020) High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injury.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	CXCL10,CD34,CXCL9,MYD88,PROM1,CCL5
PMID:32375250	(2020) Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.	7	56	1.16	0.00059	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PTGS2,BCL2,FGFR1,PROM1,VEGFA
PMID:32409991	(2020) Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000363596,9606.ENSP00000414303	CD38,CCR5,CXCL10,STAT5A,CNR2,BDNF
PMID:32429348	(2020) Nutraceutical Activity in Osteoarthritis Biology: A Focus on the Nutrigenomic Role.	7	56	1.16	0.00059	9606.ENSP00000245479,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,SIRT6,PTGS2,JAK2,NFE2L2,MYD88,VEGFA
PMID:32455916	(2020) Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,LTA,CCL5
PMID:32496453	(2020) Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma.	7	56	1.16	0.00059	9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	CD47,JAK2,BCL2,IRAK4,RHOA,MYD88,MME
PMID:32630640	(2020) Perivascular Adipose Tissue as a Target for Antioxidant Therapy for Cardiovascular Complications.	7	56	1.16	0.00059	9606.ENSP00000263317,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000418009,9606.ENSP00000419422	NOX4,PRKCE,PTGS2,EDN1,NFE2L2,RARRES2,AGTR1
PMID:32637451	(2020) Circular RNAs: Promising Molecular Biomarkers of Human Aging-Related Diseases via Functioning as an miRNA Sponge.	7	56	1.16	0.00059	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,PTGS2,PTEN,BCL2,BDNF,VEGFA,HNF1B
PMID:32714862	(2020) The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,ANGPT2,AR,VEGFA
PMID:32723566	(2020) Vascular mimicry: Triggers, molecular interactions and in vivo models.	7	56	1.16	0.00059	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,MMP14,CD34,ANGPT2,BCL2,PROM1,VEGFA
PMID:32738920	(2020) The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome.	6	34	1.31	0.00059	9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	PTGS2,MYD88,BDNF,AGTR1,CCL5,VEGFA
PMID:32752274	(2020) Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000331831,9606.ENSP00000337332,9606.ENSP00000354511,9606.ENSP00000362057,9606.ENSP00000478570	NOX4,GAS6,SIRT6,COMT,NOX1,VEGFA
PMID:32757303	(2020) Cellular scars and local crosstalk in relapsing psoriasis: an example of a skin sticking disease.	6	34	1.31	0.00059	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:32791489	(2020) Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.	6	34	1.31	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,STAT5A,CXCL9,CCL5
PMID:32974308	(2020) Xeno-Free Spheroids of Human Gingiva-Derived Progenitor Cells for Bone Tissue Engineering.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,LPL,CD34,BMP2,CCL5,VEGFA
PMID:33123088	(2020) The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer.	7	56	1.16	0.00059	9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	IFNG,LPL,CAV1,SREBF1,PTEN,BCL2,FGFR1
PMID:33235460	(2020) Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report.	6	34	1.31	0.00059	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	MPO,CD34,STAT5A,PTEN,JAK2,VEGFA
PMID:33363148	(2020) An Intrinsic Oscillation of Gene Networks Inside Hair Follicle Stem Cells: An Additional Layer That Can Modulate Hair Stem Cell Activities.	9	113	0.96	0.00059	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478319	SOX9,TIMP3,CD34,HNF4A,STAT5A,PTEN,BMP2,PROM1,GREM1
PMID:33381038	(2020) TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.	6	34	1.31	0.00059	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,MMP14,PTEN,RHOA,PROM1,VEGFA
PMID:33424775	(2020) Nutrition and Metabolic Adaptations in Physiological and Complicated Pregnancy: Focus on Obesity and Gestational Diabetes.	6	34	1.31	0.00059	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000418009	FABP4,LPL,SREBF1,EDN1,NPY,RARRES2
PMID:33716731	(2020) Advanced Approaches to Breast Cancer Classification and Diagnosis.	7	56	1.16	0.00059	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	ATM,ALDH1A1,ELN,CD47,PTEN,AR,VEGFA
PMID:30572753	(2019) CD4(+) Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II-Induced Hypertension.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,NOX1,CCL5,VEGFA
PMID:30641476	(2019) MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.	6	34	1.31	0.00059	9606.ENSP00000221930,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,LPL,PTEN,BMP2,PROM1,VEGFA
PMID:30655509	(2019) Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000384906,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,SAA1,LTA,VEGFA
PMID:30728081	(2019) Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,ENTPD1,CCL5
PMID:30739275	(2019) Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome.	6	34	1.31	0.00059	9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	AMBP,CD34,PTGS2,BDNF,PROM1,VEGFA
PMID:30781581	(2019) The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.	6	34	1.31	0.00059	9606.ENSP00000222572,9606.ENSP00000284031,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000365777,9606.ENSP00000368683	PON2,DDAH1,SREBF1,TXN,MTHFR,EDN1
PMID:30863394	(2019) GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CCR5,CD34,PTGS2,CCL5,VEGFA
PMID:30915333	(2019) How HSCs Colonize and Expand in the Fetal Niche of the Vertebrate Embryo: An Evolutionary Perspective.	7	56	1.16	0.00059	9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000330382,9606.ENSP00000362524	LAMC1,CDH1,LPL,CD34,EBF1,PDGFB,ANGPTL2
PMID:30977255	(2019) Concise Review: Mesenchymal Stem Cells: From Roots to Boost.	7	56	1.16	0.00059	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CD34,HNF4A,CXCL9,BMP2,BDNF,CCL5,VEGFA
PMID:31002835	(2019) Tissue engineered models of healthy and malignant human bone marrow.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	CD38,IGF1R,CD34,BMP2,BCL2,VEGFA
PMID:31093312	(2019) Exercise for Prevention and Relief of Cardiovascular Disease: Prognoses, Mechanisms, and Approaches.	6	34	1.31	0.00059	9606.ENSP00000225275,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000478570	MPO,SIRT6,ELN,TXN,G6PD,VEGFA
PMID:31176993	(2019) The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review.	9	113	0.96	0.00059	9606.ENSP00000228434,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000426809	CD69,IGF1R,CXCL10,CCL20,CD247,CXCL9,AR,FGFR1,PROM1
PMID:31214203	(2019) Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.	6	34	1.31	0.00059	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000354901,9606.ENSP00000478570	TIMP3,CXCL10,CXCL11,MMP14,CXCL9,VEGFA
PMID:31242034	(2019) Metabolism, Obesity, and Diabetes Mellitus.	7	56	1.16	0.00059	9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000478570	FABP4,NOX4,CAV1,SREBF1,ADAMTS13,EDN1,VEGFA
PMID:31247027	(2019) Blood brain barrier disruption in cerebral malaria: Beyond endothelial cell activation.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,BDNF,AGTR1,VEGFA
PMID:31308736	(2019) Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment.	7	56	1.16	0.00059	9606.ENSP00000260356,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,HNF4A,PTGS2,BCL2,MYD88,CCL5,VEGFA
PMID:31337120	(2019) Acute Lymphoblastic Leukaemia Cells Impair Dendritic Cell and Macrophage Differentiation: Role of BMP4.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,PTGS2,BMP2,CCL5,VEGFA
PMID:31395050	(2019) Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:31540200	(2019) Disparate Entry of Adenoviruses Dictates Differential Innate Immune Responses on the Ocular Surface.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	MPO,CXCL10,CXCL11,CCL20,CXCL9,MYD88,CCL5
PMID:31600937	(2019) Tumor Endothelial Heterogeneity in Cancer Progression.	7	56	1.16	0.00059	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,CD34,EDN1,BCL2,FGFR1,PROM1,VEGFA
PMID:31689522	(2019) Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MPO,IFNG,CXCL10,SIRT6,IRAK4,MYD88,CCL5
PMID:31695781	(2019) betaKlotho is identified as a target for theranostics in non-small cell lung cancer.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809	CDH1,PTEN,KL,BCL2,FGFR1,PROM1
PMID:31766196	(2019) The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications.	6	34	1.31	0.00059	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,IGF1R,ALDH1A1,PTGS2,BCL2,VEGFA
PMID:32047496	(2019) Macrophage Phenotype and Function in Liver Disorder.	7	56	1.16	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363596,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL9,CNR2,MYD88,CCL5,VEGFA
PMID:32337482	(2019) Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma.	7	56	1.16	0.00059	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312	THBS1,IGF1R,HNF4A,PTEN,NFE2L2,BCL2,FGFR1
PMID:29332937	(2018) Improving immune-vascular crosstalk for cancer immunotherapy.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000478570	CXCL10,CXCL11,CD34,ANGPT2,CXCL9,VEGFA
PMID:29465830	(2018) Toll-like receptor 3 signal augments radiation-induced tumor growth retardation in a murine model.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,MYD88,CCL5
PMID:29731007	(2018) Chemokines: Critical Regulators of Memory T Cell Development, Maintenance, and Function.	6	34	1.31	0.00059	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:29783691	(2018) Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.	7	56	1.16	0.00059	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CDH1,CD47,PTEN,NFE2L2,BCL2,VEGFA
PMID:29785126	(2018) Impact of targeting transforming growth factor beta-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer.	7	56	1.16	0.00059	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,MYD88,LTA,BDNF,CCL5,VEGFA
PMID:29807688	(2018) Baboon CD8 T cells suppress SIVmac infection in CD4 T cells through contact-dependent production of MIP-1alpha, MIP-1beta, and RANTES.	6	34	1.31	0.00059	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL9,LTA,CCL5
PMID:30028342	(2018) Stem cells: a promising candidate to treat neurological disorders.	6	34	1.31	0.00059	9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CD34,BCL2,BDNF,MME,PROM1,VEGFA
PMID:30057551	(2018) Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,NOX4,ANGPT2,NOX1,BCL2,VEGFA
PMID:30272265	(2018) A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363596,9606.ENSP00000478570	CDH1,CXCL10,CXCL11,CXCL9,CNR2,VEGFA
PMID:30320048	(2018) Children With Autism Spectrum Disorder With Regression Exhibit a Different Profile in Plasma Cytokines and Adhesion Molecules Compared to Children Without Such Regression.	6	34	1.31	0.00059	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000474412	MPO,IFNG,CXCL10,CXCL9,BDNF,CCL5
PMID:30320116	(2018) The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer.	6	34	1.31	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,VEGFA
PMID:30352099	(2018) Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:30400212	(2018) PGC-1alpha as a Pivotal Factor in Lipid and Metabolic Regulation.	7	56	1.16	0.00059	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000477707,9606.ENSP00000478570	CDH1,HNF4A,EDN1,BCL2,BDNF,NR1H3,VEGFA
PMID:30402122	(2018) Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD34,ANGPT2,CNR2,BCL2,CCL5,VEGFA
PMID:30559931	(2018) Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,IGF1R,PRKCE,CAV1,PTEN,VEGFA
PMID:30564132	(2018) Vascular Oxidative Stress: Impact and Therapeutic Approaches.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252	NOX4,ELN,NOX1,TXN,EDN1,NFE2L2
PMID:28043948	(2017) ANGPTL2 expression in the intestinal stem cell niche controls epithelial regeneration and homeostasis.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,PTEN,ANGPTL2,BMP2,GREM1,VEGFA
PMID:28049494	(2017) Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response.	6	34	1.31	0.00059	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:28108555	(2017) Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice.	7	56	1.16	0.00059	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL9,BCL2,LTA,CCL5,VEGFA
PMID:28146084	(2017) Role of Aquaporin 1 Signalling in Cancer Development and Progression.	6	34	1.31	0.00059	9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	APC,HNF4A,PTGS2,BCL2,RHOA,VEGFA
PMID:28212800	(2017) Vascular Cells in Blood Vessel Wall Development and Disease.	6	34	1.31	0.00059	9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000478570	TIMP3,PDGFB,ELN,HSPG2,EDN1,VEGFA
PMID:28245631	(2017) Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.	6	34	1.31	0.00059	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,TIMP3,PTEN,NTF3,BDNF,VEGFA
PMID:28303152	(2017) Promising Therapeutic Strategies for Mesenchymal Stem Cell-Based Cardiovascular Regeneration: From Cell Priming to Tissue Engineering.	7	56	1.16	0.00059	9606.ENSP00000246553,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000478570	FFAR1,LPL,CD34,PDGFB,PTEN,BMP2,VEGFA
PMID:28540086	(2017) Diabetic nephropathy: Time to withhold development and progression - A review.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000419422	IFNG,CXCL10,EDN1,KL,NFE2L2,AGTR1
PMID:28588581	(2017) Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA.	6	34	1.31	0.00059	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000419313,9606.ENSP00000474412,9606.ENSP00000478570	CD34,PTEN,RHOA,TRPC1,CCL5,VEGFA
PMID:28594363	(2017) Alteration of SHP-1p-STAT3 Signaling: A Potential Target for Anticancer Therapy.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,STAT5A,JAK2,BCL2,FGFR1,VEGFA
PMID:28615804	(2017) The neurochemistry of peripheral nerve regeneration.	7	56	1.16	0.00059	9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CNTF,VIP,TXN,BCL2,BDNF,VEGFA
PMID:28746882	(2017) A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.	7	56	1.16	0.00059	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,HSPB1,IGF1R,MAPK7,NFE2L2,BCL2,FGFR1
PMID:28762014	(2017) Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.	6	34	1.31	0.00059	9606.ENSP00000336762,9606.ENSP00000337332,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ANG,SIRT6,G6PD,BCL2,CCL5,VEGFA
PMID:28768501	(2017) Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer steminitiating cells.	6	34	1.31	0.00059	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809	SOX9,CDH1,ALDH1A1,CD34,PTGS2,PROM1
PMID:28776551	(2017) Advances in Pathobiology of Primary Central Nervous System Lymphoma.	7	56	1.16	0.00059	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000322898,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,ATM,EBF1,PTEN,BCL2,MYD88,MME
PMID:28827386	(2017) Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.	6	34	1.31	0.00059	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CCR5,MME,CCL5,VEGFA
PMID:28974047	(2017) Heparin Mimetics: Their Therapeutic Potential.	7	56	1.16	0.00059	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000384957,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,IGF1R,CCR5,CCL20,F11,CCL5,VEGFA
PMID:29029547	(2017) Nanoformulations of curcumin: an emerging paradigm for improved remedial application.	6	34	1.31	0.00059	9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495	IGF1R,SREBF1,PTGS2,JAK2,BCL2,LTA
PMID:29051489	(2017) Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000393312	IFNG,CXCL10,CXCL9,CD47,PTEN,FGFR1
PMID:29552372	(2017) Cellular crosstalk during cholestatic liver injury.	6	34	1.31	0.00059	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CD34,ELN,CXCL9,EDN1,RHOA,VEGFA
PMID:26269128	(2016) The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor.	7	56	1.16	0.00059	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000345708,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,CDH1,CD34,KCNJ11,BCL2,FGFR1,VEGFA
PMID:26788252	(2016) Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000297785,9606.ENSP00000301522,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641	NOX4,ALDH1A1,PRDX2,SREBF1,PTEN,TXN
PMID:26836231	(2016) Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment.	7	56	1.16	0.00059	9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CCR5,CXCL10,LTA,PROM1,CCL5,VEGFA
PMID:26937756	(2016) Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.	6	34	1.31	0.00059	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,ATM,PTEN,JAK2,FGFR1,VEGFA
PMID:27156077	(2016) Oncomirs miRNA-221222 and Tumor Suppressors miRNA-199a195 Are Crucial miRNAs in Liver Cancer: A Systematic Analysis.	6	34	1.31	0.00059	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,IGF1R,CXCL11,PTEN,BCL2,VEGFA
PMID:27184417	(2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.	7	56	1.16	0.00059	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,ATM,PTEN,AR,JAK2,FGFR1,VEGFA
PMID:27207308	(2016) Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:27256979	(2016) Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.	7	56	1.16	0.00059	9606.ENSP00000222139,9606.ENSP00000283928,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000478570	EPOR,JAZF1,PDGFB,BCL2,FGFR1,BDNF,VEGFA
PMID:27493632	(2016) Decoding Angiogenesis: New Facets Controlling Endothelial Cell Behavior.	6	34	1.31	0.00059	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000330382,9606.ENSP00000478570	FFAR1,FABP4,NOX4,PRDX2,PDGFB,VEGFA
PMID:27547038	(2016) MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000414303	IFNG,PDGFB,CD47,PTGS2,PTEN,BDNF
PMID:27549123	(2016) VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma.	7	56	1.16	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,LTA,PROM1,CCL5,VEGFA
PMID:27965958	(2016) A Dormant Microbial Component in the Development of Preeclampsia.	6	34	1.31	0.00059	9606.ENSP00000354511,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000478570	COMT,EDN1,NPY,RARRES2,AGTR1,VEGFA
PMID:25853700	(2015) Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endothelial cell injury.	7	56	1.16	0.00059	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000384262,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,CXCL9,PTGS2,HPSE,VEGFA
PMID:25902704	(2015) Interventions to Slow Aging in Humans: Are We Ready?	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000349860,9606.ENSP00000419422	CD38,IGF1R,ATM,SIRT6,GFPT1,AGTR1
PMID:25913718	(2015) Human platelets and their capacity of binding viruses: meaning and challenges?	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CD34,JAK2,CCL5,VEGFA
PMID:26104296	(2015) The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.	7	56	1.16	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,RARRES2,CCL5
PMID:26170166	(2015) The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000301522,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CDH1,PRDX2,PTEN,TXN,NFE2L2,VEGFA
PMID:26175718	(2015) Host-pathogen interactions between the human innate immune system and Candida albicans-understanding and modeling defense and evasion strategies.	7	56	1.16	0.00059	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000361883,9606.ENSP00000363641,9606.ENSP00000403495,9606.ENSP00000474412	MPO,CDH1,CCL20,CAP1,TXN,LTA,CCL5
PMID:26183159	(2015) PDGFRbeta signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CXCL9,JAK2,CCL5
PMID:26268554	(2015) Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.	6	34	1.31	0.00059	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,CD34,ANG,FGFR1,PROM1,VEGFA
PMID:26648938	(2015) The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CXCL9,ENTPD1,CCL5
PMID:28536400	(2015) HGFc-MET Axis in Tumor Microenvironment and Metastasis Formation.	7	56	1.16	0.00059	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,TIMP3,PTGS2,ENTPD1,RHOA,CCL5,VEGFA
PMID:24327602	(2014) Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGFc-Met signaling.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000363973,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,CAV1,ALPL,PROM1,VEGFA
PMID:24398857	(2014) Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.	6	34	1.31	0.00059	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,CDH1,CD34,PTGS2,BCL2,VEGFA
PMID:24713578	(2014) BMP signaling in axon regeneration.	6	34	1.31	0.00059	9606.ENSP00000215832,9606.ENSP00000368104,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,BMP2,NPY,NTF3,RHOA,BDNF
PMID:24787299	(2014) Tumor macroenvironment and metabolism.	7	56	1.16	0.00059	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,FABP4,ABCG1,PTGS2,BCL2,RHOA,VEGFA
PMID:24959337	(2014) Pathobiology of hodgkin lymphoma.	7	56	1.16	0.00059	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CCR5,CCL20,JAK2,BCL2,MME,CCL5
PMID:25056707	(2014) Non-small-cell lung cancers: a heterogeneous set of diseases.	7	56	1.16	0.00059	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,IGF1R,CD47,PTEN,BCL2,FGFR1,VEGFA
PMID:25294814	(2014) Functional modification of adipocytes by grape seed extract impairs their pro-tumorigenic signaling on colon cancer stem cells and the daughter cancer cells.	7	56	1.16	0.00059	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000426809	FABP4,CDH1,PLIN1,LPL,SREBF1,BMP2,PROM1
PMID:25306249	(2014) The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.	6	34	1.31	0.00059	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412	TGFB1,IFNG,CDH1,CXCL10,CCL20,CCL5
PMID:25320277	(2014) CXCL12CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,MYD88,PROM1,VEGFA
PMID:25717380	(2014) Therapeutic Opportunities for Targeting microRNAs in Cancer.	7	56	1.16	0.00059	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	IFNG,THBS1,CDH1,ATM,PTEN,BCL2,RHOA
PMID:23121619	(2013) Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,STAT5A,JAK2,BCL2,VEGFA
PMID:23819113	(2013) Emerging therapeutic biomarkers in endometrial cancer.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,PTGS2,PTEN,PROM1,VEGFA
PMID:23993726	(2013) Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structuralelectrical remodeling.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,PDGFB,PDGFA,PTGS2,EDN1,VEGFA
PMID:24084056	(2013) Molecular link between vitamin D and cancer prevention.	7	56	1.16	0.00059	9606.ENSP00000216862,9606.ENSP00000261769,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,CDH1,TXN,EDN1,G6PD,BCL2,VEGFA
PMID:24120656	(2013) Nanomedicine therapeutic approaches to overcome cancer drug resistance.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IGF1R,CD34,BCL2,PROM1,VEGFA
PMID:24132149	(2013) The epidermal growth factor receptor and its ligands in cardiovascular disease.	6	34	1.31	0.00059	9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CAV1,PTGS2,NOX1,EDN1,BCL2,VEGFA
PMID:24276377	(2013) Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.	6	34	1.31	0.00059	9606.ENSP00000225275,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MPO,HNF4A,PTEN,AR,BCL2,VEGFA
PMID:24392351	(2013) The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors.	6	34	1.31	0.00059	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000363827,9606.ENSP00000478570	CDH1,IGF1R,MMP14,FMOD,HSPG2,VEGFA
PMID:21704731	(2012) The contribution of vitamin A to autocrine regulation of fat depots.	6	34	1.31	0.00059	9606.ENSP00000297785,9606.ENSP00000309757,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067	ALDH1A1,LPL,EBF1,STAT5A,SREBF1,JAK2
PMID:22209517	(2012) Redox regulation of cell migration and adhesion.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000301522,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,PRDX2,NOX1,TXN,RHOA,VEGFA
PMID:22448089	(2012) Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.	7	56	1.16	0.00059	9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000478570	PRDX2,MAP3K5,PTEN,TXN,AR,MYD88,VEGFA
PMID:22733998	(2012) The impact of the unfolded protein response on human disease.	6	34	1.31	0.00059	9606.ENSP00000226760,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000384364,9606.ENSP00000478570	WFS1,LPL,SREBF1,MAP3K5,NPY,VEGFA
PMID:22745913	(2012) Ultraviolet radiation and the slug transcription factor induce proinflammatory and immunomodulatory mediator expression in melanocytes.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000321853,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CXCL10,CXCL11,SERPINF2,CXCL9,PTGS2,CCL5
PMID:22859966	(2012) Stimulation of Wntbeta-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared youngmemory phenotype.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,BCL2,PROM1,CCL5,VEGFA
PMID:22913454	(2012) Analysis of in vitro secretion profiles from adipose-derived cell populations.	6	34	1.31	0.00059	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,PLIN1,CXCL10,CD34,CCL5,VEGFA
PMID:22935090	(2012) Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines.	6	34	1.31	0.00059	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:22942256	(2012) Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000478570	CXCL10,HNF4A,ANGPT2,ANGPTL2,BCL2,VEGFA
PMID:23074383	(2012) Cell-free Circulating miRNA Biomarkers in Cancer.	7	56	1.16	0.00059	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185	TGFB1,CDH1,TIMP3,MMP14,CD34,PTEN,BCL2
PMID:21105689	(2011) Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential.	6	34	1.31	0.00059	9606.ENSP00000226279,9606.ENSP00000259486,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185	CD38,ENPP2,ATM,CD34,AR,BCL2
PMID:21267013	(2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells.	7	56	1.16	0.00059	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	TGFB1,CD69,CCR5,CXCL10,CXCL11,CCL20,CXCL9
PMID:24212666	(2011) Breast cancer-initiating cells: insights into novel treatment strategies.	7	56	1.16	0.00059	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTEN,BCL2,MME,PROM1,VEGFA
PMID:20053773	(2010) Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.	7	56	1.16	0.00059	9606.ENSP00000232219,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000363822	RBP1,THBS1,TIMP3,PDGFB,STAT5A,PTGS2,AR
PMID:20975842	(2010) The protein cargo of HDL: implications for vascular wall biology and therapeutics.	6	34	1.31	0.00059	9606.ENSP00000200676,9606.ENSP00000265132,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000321853,9606.ENSP00000354995	CETP,AMBP,APOL1,LPA,SERPINF2,ABCG1
PMID:21159253	(2010) [PI3KAktmTOR signaling pathway and non-small cell lung cancer].	6	34	1.31	0.00059	9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MMP14,PTEN,BCL2,CCL5,VEGFA
PMID:21187959	(2010) Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair.	6	34	1.31	0.00059	9606.ENSP00000336762,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	ANG,VIP,GAP43,NTF3,BDNF,CCL5
PMID:18692159	(2009) Molecular inflammation: underpinnings of aging and age-related diseases.	7	56	1.16	0.00059	9606.ENSP00000216181,9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MYH9,MPO,PTGS2,TXN,LTA,CCL5,VEGFA
PMID:19581417	(2009) Gene profiling of human adipose tissue during evoked inflammation in vivo.	7	56	1.16	0.00059	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000317674,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000371067	IFNG,CXCL10,CXCL11,APOL1,CXCL9,BMP2,JAK2
PMID:19836265	(2009) Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.	6	34	1.31	0.00059	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,CCL5
PMID:19907660	(2009) Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17IL-6 axis.	6	34	1.31	0.00059	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	LPL,CD34,ANG,PTGS2,CCL5,VEGFA
PMID:20057951	(2009) ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.	6	34	1.31	0.00059	9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,ELN,NPY,RHOA,BDNF,VEGFA
PMID:19325820	(2008) Broad-spectrum drugs against viral agents.	6	34	1.31	0.00059	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,MYD88,LTA,CCL5,VEGFA
PMID:15353555	(2004) Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.	7	56	1.16	0.00059	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,MPO,CD34,STAT5A,JAK2,BCL2,VEGFA
PMID:27668035	(....) therapeutic strategies for oxidative stress-related cardiovascular diseases: removal of excess reactive oxygen species in adult stem cells.	6	34	1.31	0.00059	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000381185	NOX4,ATM,PRDX2,CD34,TXN,BCL2
PMID:34957918	(2022) Long-term in vivo survival of 3D-bioprinted human lipoaspirate-derived adipose tissue: proteomic signature and cellular content.	8	83	1.05	0.00061	9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000360522,9606.ENSP00000362524,9606.ENSP00000363827,9606.ENSP00000376865,9606.ENSP00000418009,9606.ENSP00000478570	ALDH1A1,CD34,RBP4,ANGPTL2,HSPG2,PDGFD,RARRES2,VEGFA
PMID:35014178	(2022) MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.	8	83	1.05	0.00061	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	CDH1,IGF1R,ABCG1,PTEN,AR,BCL2,FGFR1,RHOA
PMID:35163380	(2022) Tumor-Derived Exosomes in Tumor-Induced Immune Suppression.	8	83	1.05	0.00061	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CD69,THBS1,CD34,PTGS2,PTEN,MYD88,VEGFA
PMID:35237156	(2022) Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease.	8	83	1.05	0.00061	9606.ENSP00000260356,9606.ENSP00000315011,9606.ENSP00000317674,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,EDNRA,APOL1,SIRT6,ELN,EDN1,AGTR1,VEGFA
PMID:35243248	(2022) Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques.	8	83	1.05	0.00061	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,PDGFB,CXCL9,RARRES2,CCL5,VEGFA
PMID:35267408	(2022) Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review.	9	114	0.96	0.00061	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,HSPB1,STAT5A,MAP3K5,PTEN,TXN,JAK2,BCL2,VEGFA
PMID:33800865	(2021) Functions of Dendritic Cells and Its Association with Intestinal Diseases.	9	114	0.96	0.00061	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CD34,CXCL9,BMP2,MYD88,CCL5,VEGFA
PMID:33805488	(2021) Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.	8	83	1.05	0.00061	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,MPO,CXCL10,G6PD,NFE2L2,BCL2,MYD88,CCL5
PMID:33927896	(2021) Metabolic Consequences of Efferocytosis and its Impact on Atherosclerosis.	8	83	1.05	0.00061	9606.ENSP00000256104,9606.ENSP00000331831,9606.ENSP00000337332,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000356832,9606.ENSP00000400175,9606.ENSP00000474412	FABP4,GAS6,SIRT6,ABCG1,CD47,SGK1,RHOA,CCL5
PMID:34209038	(2021) The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.	8	83	1.05	0.00061	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,STAT5A,CXCL9,BCL2,MYD88,CCL5,VEGFA
PMID:34248996	(2021) Current Understanding of IL-37 in Human Health and Disease.	8	83	1.05	0.00061	9606.ENSP00000226279,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCL20,PTEN,BMP2,BCL2,MYD88,CCL5,VEGFA
PMID:34502117	(2021) Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis.	8	83	1.05	0.00061	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,TIMP3,CCR5,CNTF,PTGS2,JAK2,CCL5,VEGFA
PMID:34925466	(2021) SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.	8	83	1.05	0.00061	9606.ENSP00000226760,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000480291	WFS1,LPL,PTEN,NFE2L2,BCL2,RHOA,AGTR1,HNF1B
PMID:35006441	(2021) Targeting cardiomyocyte proliferation as a key approach of promoting heart repair after injury.	8	83	1.05	0.00061	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000393312,9606.ENSP00000478570	APC,IGF1R,PDGFB,PDGFA,BMP2,GAP43,FGFR1,VEGFA
PMID:32604954	(2020) Newly Identified Regulators of Ovarian Folliculogenesis and Ovulation.	8	83	1.05	0.00061	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000418009,9606.ENSP00000478570	THBS1,CD34,PDGFB,SREBF1,PTGS2,PTEN,RARRES2,VEGFA
PMID:32752107	(2020) Rewiring of Lipid Metabolism in Adipose Tissue Macrophages in Obesity: Impact on Insulin Resistance and Type 2 Diabetes.	8	83	1.05	0.00061	9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000383364,9606.ENSP00000401399	FABP4,ATM,PLIN1,LPL,SREBF1,ABCG1,PLA2G2A,MYD88
PMID:32937758	(2020) Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia.	8	83	1.05	0.00061	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000478570	CD38,THBS1,CXCL10,PTEN,BCL2,MYD88,LTA,VEGFA
PMID:33271979	(2020) How Far Are We from Prescribing Fasting as Anticancer Medicine?	8	83	1.05	0.00061	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,NFE2L2,NPY,BDNF,VEGFA
PMID:33392174	(2020) Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature.	9	114	0.96	0.00061	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000384262,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	CD38,CDH1,CD34,EDN1,HPSE,MME,PROM1,GREM1,VEGFA
PMID:31671842	(2019) Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.	8	83	1.05	0.00061	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,MMP14,CD34,HNF4A,BCL2,PROM1,CCL5,VEGFA
PMID:31701394	(2019) JMJD3 in the regulation of human diseases.	8	83	1.05	0.00061	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000384906,9606.ENSP00000474412	MAPK1,NOX4,CD34,PTGS2,PTEN,AR,SAA1,CCL5
PMID:29617291	(2018) Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma.	8	83	1.05	0.00061	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000478570	CD38,THBS1,CDH1,ATM,CXCL10,CCL20,PTEN,VEGFA
PMID:28497213	(2017) Bone Pain and Muscle Weakness in Cancer Patients.	8	83	1.05	0.00061	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,EDNRA,NOX1,AR,BMP2,EDN1,RHOA,VEGFA
PMID:29264822	(2017) In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.	8	83	1.05	0.00061	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,PTGS2,TXN,AR,NFE2L2,BCL2,VEGFA
PMID:26756522	(2016) Inside-Out Signaling Pathways from Nuclear Reactive Oxygen Species Control Pulmonary Innate Immunity.	8	83	1.05	0.00061	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000401399,9606.ENSP00000474412	NOX4,ATM,CXCL11,CCL20,NOX1,TXN,MYD88,CCL5
PMID:27148255	(2016) Regulation of Natural Killer Cell Function by STAT3.	9	114	0.96	0.00061	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CD34,STAT5A,CXCL9,CNTF,JAK2,CCL5,VEGFA
PMID:27230643	(2016) Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.	9	114	0.96	0.00061	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000357726,9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185	NOX4,SIRT6,SREBF1,GFPT1,S100A12,GLO1,TXN,EDN1,BCL2
PMID:28450803	(2016) Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.	8	83	1.05	0.00061	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,IGF1R,ATM,CXCL10,RBP4,PTEN,BCL2,VEGFA
PMID:25386819	(2015) Targeting the NFkappaB signaling pathways for breast cancer prevention and therapy.	8	83	1.05	0.00061	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000478570	CDH1,ATM,PTGS2,PTEN,TXN,BCL2,NTF3,VEGFA
PMID:26216631	(2015) Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.	8	83	1.05	0.00061	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD34,STAT5A,CD247,PTGS2,PTEN,BCL2,MYD88,VEGFA
PMID:24429391	(2014) Kruppel-like factors in cancer progression: three fingers on the steering wheel.	8	83	1.05	0.00061	9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000474412	CDH1,KLF10,ALDH1A1,MMP14,PTEN,AR,EDN1,CCL5
PMID:24628328	(2014) The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis.	8	83	1.05	0.00061	9606.ENSP00000292303,9606.ENSP00000331831,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,GAS6,ABCG1,CD47,NFE2L2,BCL2,MYD88,CCL5
PMID:23970935	(2013) Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition.	8	83	1.05	0.00061	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTEN,TXN,NFE2L2,BCL2,VEGFA
PMID:18648529	(2008) Type I interferon: potential therapeutic target for psoriasis?	8	83	1.05	0.00061	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000401399	CD69,TIMP3,CXCL10,CXCL11,CXCL9,PTEN,HPSE,MYD88
PMID:34838588	(2022) Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications.	7	57	1.15	0.00065	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,ANGPT2,AGTR1,CCL5,VEGFA
PMID:35142668	(2022) Recent developments of neuroprotective agents for degenerative retinal disorders.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,TIMP3,CNTF,BCL2,NPY,BDNF,VEGFA
PMID:35211759	(2022) Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer (Review).	7	57	1.15	0.00065	9606.ENSP00000278616,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000426809	ATM,CXCL9,PTEN,TXN,G6PD,BCL2,PROM1
PMID:35232486	(2022) Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination.	7	57	1.15	0.00065	9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000475344,9606.ENSP00000478570	DDAH1,CXCL10,CNTF,EDN1,BDNF,APLNR,VEGFA
PMID:35267569	(2022) The Biology of Ocular Adnexal Marginal Zone Lymphomas.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,CD34,BCL2,RHOA,MYD88,MME,VEGFA
PMID:35288707	(2022) Immunomodulation by endothelial cells - partnering up with the immune system?	8	84	1.04	0.00065	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,THBS1,CXCL10,CD34,GAS6,CXCL9,MYD88,VEGFA
PMID:35326105	(2022) Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma.	7	57	1.15	0.00065	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,STAT5A,JAK2,NFE2L2,BCL2,VEGFA
PMID:35331296	(2022) Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.	7	57	1.15	0.00065	9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175	APC,IGF1R,STAT5A,FMOD,ELN,PTEN,RHOA
PMID:33087588	(2021) Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?	8	84	1.04	0.00065	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CXCL10,CD47,PTEN,JAK2,MYD88,CCL5,VEGFA
PMID:33499277	(2021) Profilin 1 and Mitochondria-Partners in the Pathogenesis of Coronary Artery Disease?	7	57	1.15	0.00065	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,ELN,JAK2,BCL2,CCL5,VEGFA
PMID:33537099	(2021) Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.	7	57	1.15	0.00065	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IGF1R,CD34,CCL20,CD47,PROM1,VEGFA
PMID:33546172	(2021) Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,CCL20,CXCL9,CD47,CCL5,VEGFA
PMID:33649314	(2021) Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression.	8	84	1.04	0.00065	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000403495	CD38,CCR5,CXCL10,CXCL11,CCL20,CXCL9,ENTPD1,LTA
PMID:33807260	(2021) The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy.	8	84	1.04	0.00065	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185	CXCL10,CXCL11,MAPK7,CD247,CXCL9,CD47,ENTPD1,BCL2
PMID:33815672	(2021) Molecular pathways of liver regeneration: A comprehensive review.	9	115	0.95	0.00065	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,THBS1,ONECUT1,HNF4A,PTEN,NFE2L2,PROM1,VEGFA,HNF1B
PMID:33917482	(2021) Roles of microRNAs in Regulating Cancer Stemness in Head and Neck Cancers.	8	84	1.04	0.00065	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,ALDH1A1,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:33948974	(2021) Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.	7	57	1.15	0.00065	9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	HNF4A,MAP3K5,PTEN,NFE2L2,BCL2,RHOA,VEGFA
PMID:34069422	(2021) MicroRNAs and Oxidative Stress: An Intriguing Crosstalk to Be Exploited in the Management of Type 2 Diabetes.	7	57	1.15	0.00065	9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000400175	IGF1R,PRDX2,MAP3K5,PTEN,TXN,EDN1,RHOA
PMID:34177928	(2021) Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools.	7	57	1.15	0.00065	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000363827,9606.ENSP00000383364,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,HSPG2,PLA2G2A,MYD88,CCL5,VEGFA
PMID:34202411	(2021) Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells.	8	84	1.04	0.00065	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	FABP4,IGF1R,ALDH1A1,ANG,STAT5A,MYD88,PROM1,VEGFA
PMID:34295336	(2021) Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC(+) and SPP1(+) TAMs in Cervical Cancer.	8	84	1.04	0.00065	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,CXCL10,CXCL11,MMP14,CCL20,CXCL9,CCL5
PMID:34360975	(2021) New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351908,9606.ENSP00000355361,9606.ENSP00000356438	CDH1,TIMP3,CXCL10,MMP14,MAP3K5,CD47,PTGS2
PMID:34367185	(2021) Cell Fate Reprogramming in the Era of Cancer Immunotherapy.	9	115	0.95	0.00065	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000478570	SOX9,CCR5,CXCL10,HNF4A,EBF1,CXCL9,BMP2,MME,VEGFA
PMID:34376140	(2021) Characterization and comparative analysis of transcriptional profiles of porcine colostrum and mature milk at different parities.	7	57	1.15	0.00065	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067	FABP4,IGF1R,CXCL10,CXCL11,STAT5A,CXCL9,JAK2
PMID:34403220	(2021) Targeting myeloid-derived suppressor cells for cancer therapy.	7	57	1.15	0.00065	9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD247,PTGS2,PTEN,NFE2L2,LTA,CCL5,VEGFA
PMID:34414192	(2021) Role of Autophagy in the Maintenance of Stemness in Adult Stem Cells: A Disease-Relevant Mechanism of Action.	7	57	1.15	0.00065	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,BMP2,JAK2,PROM1,CCL5,VEGFA
PMID:34502094	(2021) Extracellular Matrix Biomarkers in Colorectal Cancer.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000376865,9606.ENSP00000426809	THBS1,CDH1,FMOD,ELN,NOX1,PDGFD,PROM1
PMID:34548907	(2021) The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis.	7	57	1.15	0.00065	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000418009,9606.ENSP00000444198,9606.ENSP00000478570	CXCL10,CAV1,CXCL9,PTEN,RARRES2,CITED2,VEGFA
PMID:34571848	(2021) Extracellular Vehicles of Oxygen-Depleted Mesenchymal Stromal Cells: Route to Off-Shelf Cellular Therapeutics?	7	57	1.15	0.00065	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000400175,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,ATM,CD34,ALPL,RHOA,VEGFA,HNF1B
PMID:34573120	(2021) Transcriptomics Underlying Pulmonary Ozone Pathogenesis Regulated by Inflammatory Mediators in Mice.	10	150	0.88	0.00065	9606.ENSP00000222139,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000356729,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	EPOR,HSPB1,THBS1,MMP14,CCL20,FMO3,EDN1,MYD88,LTA,CCL5
PMID:34576226	(2021) From Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques.	7	57	1.15	0.00065	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000381185,9606.ENSP00000401399	CD38,ATM,CCR5,CD34,GAS6,BCL2,MYD88
PMID:34594426	(2021) An overview of mesenchymal stem cells and their potential therapeutic benefits in cancer therapy.	7	57	1.15	0.00065	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,IGF1R,LPL,CD34,CXCL9,CCL5,VEGFA
PMID:34641969	(2021) Current knowledge and challenges associated with targeted delivery of neurotrophic factors into the central nervous system: focus on available approaches.	7	57	1.15	0.00065	9606.ENSP00000311005,9606.ENSP00000355370,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MAPK7,CNTF,TXN,BCL2,NTF3,BDNF,VEGFA
PMID:34803167	(2021) Circulating tumor cells: biology and clinical significance.	8	84	1.04	0.00065	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809	TGFB1,CHI3L1,CDH1,ALDH1A1,CD47,PTEN,AR,PROM1
PMID:34885015	(2021) Is There an Interplay between Oral Microbiome, Head and Neck Carcinoma and Radiation-Induced Oral Mucositis?	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412	IFNG,HSPB1,CDH1,PTGS2,BCL2,RHOA,CCL5
PMID:34909117	(2021) Effects of immune cells on mesenchymal stem cells during fracture healing.	8	84	1.04	0.00065	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CD34,STAT5A,PTGS2,BMP2,FGFR1,CCL5,VEGFA
PMID:34916492	(2021) Targeting PI3KAkt signal transduction for cancer therapy.	8	84	1.04	0.00065	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:34948097	(2021) Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer.	7	57	1.15	0.00065	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000478570	HSPB1,CDH1,CXCL10,ANG,PTEN,TXN,VEGFA
PMID:35127859	(2021) Andrographolide Promotes Interaction Between Endothelin-Dependent EDNRAEDNRB and Myocardin-SRF to Regulate Pathological Vascular Remodeling.	7	57	1.15	0.00065	9606.ENSP00000216181,9606.ENSP00000266085,9606.ENSP00000315011,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	MYH9,TIMP3,EDNRA,PTEN,EDN1,MYD88,VEGFA
PMID:31566705	(2020) Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.	7	57	1.15	0.00065	9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CHI3L1,TIMP3,PTGS2,PTEN,BCL2,MYD88,VEGFA
PMID:31819191	(2020) Metabolic rewiring and redox alterations in malignant pleural mesothelioma.	7	57	1.15	0.00065	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	MPO,THBS1,CDH1,NOX4,PTEN,NFE2L2,VEGFA
PMID:32169087	(2020) Vasculogenic mimicry in carcinogenesis and clinical applications.	8	84	1.04	0.00065	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000284031,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,DDAH1,CXCL11,MMP14,CD34,PROM1,VEGFA
PMID:32226771	(2020) Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal-Maternal Interface.	8	84	1.04	0.00065	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,ANG,ENTPD1,PTEN,BCL2,CCL5,VEGFA
PMID:32273976	(2020) JAKSTAT signaling in hepatocellular carcinoma.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,STAT5A,JAK2,BCL2,FGFR1,PROM1,VEGFA
PMID:32331221	(2020) Nicotine in Senescence and Atherosclerosis.	8	84	1.04	0.00065	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000478570	THBS1,NOX4,ATM,SIRT6,PTEN,NOX1,JAK2,VEGFA
PMID:32371195	(2020) Danger signals in liver injury and restoration of homeostasis.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252	IFNG,NOX4,PTGS2,ENTPD1,PTEN,NOX1,NFE2L2
PMID:32390843	(2020) Traditional Chinese Medicine: Role in Reducing beta-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimers Disease.	7	57	1.15	0.00065	9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525	PTGS2,TXN,JAK2,BCL2,MYD88,BDNF,MME
PMID:32455989	(2020) Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell lymphomas.	8	84	1.04	0.00065	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000426809	CD38,ATM,CXCL10,PTEN,BCL2,IRAK4,MYD88,PROM1
PMID:32456160	(2020) Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer-Implications for Pathogenesis and Therapy.	7	57	1.15	0.00065	9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185	CYP24A1,IFNG,CDH1,IGF1R,PTGS2,G6PD,BCL2
PMID:32477322	(2020) Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,TIMP3,PTGS2,EDN1,BCL2,VEGFA
PMID:32685145	(2020) Dietary plant extracts modulate gene expression profiles in alveolar macrophages of pigs experimentally infected with porcine reproductive and respiratory syndrome virus.	8	84	1.04	0.00065	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000354782,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,CD69,FABP4,CCR5,CD247,JAK2,MYD88,CCL5
PMID:32849880	(2020) Molecular Mechanism of Stem Cell Differentiation into Adipocytes and Adipocyte Differentiation of Malignant Tumor.	9	115	0.95	0.00065	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000285407,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000400175	IFNG,FABP4,CDH1,NOX4,KLF10,SIRT6,STAT5A,BMP2,RHOA
PMID:32882823	(2020) Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2.	7	57	1.15	0.00065	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	MAPK1,IFNG,CXCL10,CXCL11,CXCL9,PTEN,CCL5
PMID:32916872	(2020) Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,ELN,HSPG2,FGFR1,CCL5,VEGFA
PMID:32929364	(2020) Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.	10	150	0.88	0.00065	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312	IGF1R,CAV1,STAT5A,PDGFA,AR,BMP2,JAK2,PDGFD,BCL2,FGFR1
PMID:33005291	(2020) Notch signalling pathway in development of cholangiocarcinoma.	7	57	1.15	0.00065	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,CDH1,CXCL10,PTEN,BCL2,VEGFA,HNF1B
PMID:33013822	(2020) TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals.	7	57	1.15	0.00065	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD247,CXCL9,ENTPD1,CCL5,VEGFA
PMID:33182676	(2020) Electrophile Modulation of Inflammation: A Two-Hit Approach.	7	57	1.15	0.00065	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000401399	MPO,CXCL10,CXCL9,G6PD,NFE2L2,IRAK4,MYD88
PMID:33183321	(2020) Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells.	8	84	1.04	0.00065	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	TIMP3,IGF1R,P2RY1,PTGS2,PTEN,BCL2,RHOA,VEGFA
PMID:33292604	(2020) Complex roles of cAMP-PKA-CREB signaling in cancer.	8	84	1.04	0.00065	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	HSPB1,IGF1R,ATM,SIRT6,VIP,PTEN,AR,BCL2
PMID:33302971	(2020) Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,CAV1,ENTPD1,PTEN,RHOA,VEGFA
PMID:33584245	(2020) The Neuroimmunology of Guillain-Barre Syndrome and the Potential Role of an Aging Immune System.	7	57	1.15	0.00065	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412	MPO,CD69,CCR5,CXCL10,BCL2,LTA,CCL5
PMID:33681821	(2020) The current paradigm and challenges ahead for the dormancy of disseminated tumor cells.	7	57	1.15	0.00065	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000474412	MAPK1,IFNG,SOX9,CDH1,AR,JAK2,CCL5
PMID:33718121	(2020) Complimenting the Complement: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma.	10	150	0.88	0.00065	9606.ENSP00000226279,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CHI3L1,CDH1,CCL20,ENTPD1,BMP2,JAK2,SAA1,CCL5,VEGFA
PMID:29848834	(2019) Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CD47,PTEN,AR,BCL2,RHOA,VEGFA
PMID:30999581	(2019) Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.	8	84	1.04	0.00065	9606.ENSP00000222305,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525	USF2,CD69,CCR5,CCL20,CXCL9,PTEN,BCL2,MME
PMID:31100937	(2019) Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.	8	84	1.04	0.00065	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000363822,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,PDGFA,AR,ALPL,BCL2,PROM1,VEGFA
PMID:31225500	(2019) Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma.	9	115	0.95	0.00065	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000474412	CD69,CXCL10,MMP14,CCL20,CD247,ENTPD1,PTEN,PROM1,CCL5
PMID:31275385	(2019) CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer?	7	57	1.15	0.00065	9606.ENSP00000285407,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	KLF10,CXCL11,CCL20,JAK2,PROM1,CCL5,VEGFA
PMID:31485227	(2019) Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment.	7	57	1.15	0.00065	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,CD34,STAT5A,CD47,ENTPD1,BCL2,VEGFA
PMID:31546818	(2019) NK Cell Plasticity in Cancer.	7	57	1.15	0.00065	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,ANG,CXCL9,CCL5,VEGFA
PMID:31614690	(2019) Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000478570	THBS1,CDH1,LPL,LPA,PTEN,NOX1,VEGFA
PMID:31637214	(2019) Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target.	8	84	1.04	0.00065	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	APC,CDH1,MMP14,HNF4A,STAT5A,PTEN,FGFR1,VEGFA
PMID:31817726	(2019) The Influence of Dietary Fatty Acids on Immune Responses.	8	84	1.04	0.00065	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000478570	MPO,CD69,FFAR1,FABP4,CXCL10,STAT5A,PTGS2,VEGFA
PMID:31849522	(2019) Overview of microRNA-199a Regulation in Cancer.	7	57	1.15	0.00065	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,ATM,CAV1,KL,BCL2,VEGFA
PMID:28889951	(2018) Pancreatic beta Cell Regeneration as a Possible Therapy for Diabetes.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000355370,9606.ENSP00000426809,9606.ENSP00000480291	IFNG,SOX9,ALDH1A1,HNF4A,CNTF,PROM1,HNF1B
PMID:29462936	(2018) New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,ANGPT2,EDN1,BCL2,RHOA,AGTR1,VEGFA
PMID:29673549	(2018) Tau and neuroinflammation: What impact for Alzheimers Disease and Tauopathies?	7	57	1.15	0.00065	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000352264,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CD2AP,PTGS2,PTEN,LTA,CCL5
PMID:29747682	(2018) The biology and role of CD44 in cancer progression: therapeutic implications.	8	84	1.04	0.00065	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,HNF4A,PTEN,AR,BCL2,PROM1,VEGFA
PMID:30513991	(2018) Innate Immunity Cells and the Neurovascular Unit.	8	84	1.04	0.00065	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000355361,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000478570	MAPK1,CCR5,CXCL10,CAV1,CD47,VIP,PTGS2,VEGFA
PMID:30619088	(2018) Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment.	7	57	1.15	0.00065	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,IGF1R,ANGPT2,STAT5A,JAK2,BCL2,VEGFA
PMID:28115020	(2017) Cerebral ischemic damage in diabetes: an inflammatory perspective.	7	57	1.15	0.00065	9606.ENSP00000225275,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCL20,PTGS2,EDN1,BCL2,CCL5,VEGFA
PMID:28187289	(2017) Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,CXCL10,ANG,PTEN,BCL2,VEGFA
PMID:28628092	(2017) Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.	7	57	1.15	0.00065	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000278616,9606.ENSP00000355361,9606.ENSP00000360250	CD38,CD69,CDH1,AMBP,ATM,CD47,ENTPD1
PMID:28688452	(2017) Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.	8	84	1.04	0.00065	9606.ENSP00000255409,9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	CHI3L1,THBS1,NOX4,EDNRA,NOX1,EDN1,AGTR1,VEGFA
PMID:28912209	(2017) Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification.	7	57	1.15	0.00065	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000400175	TGFB1,SOX9,ELN,PTGS2,BMP2,KL,RHOA
PMID:29034071	(2017) Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.	8	84	1.04	0.00065	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD38,ATM,CD34,STAT5A,JAK2,BCL2,CCL5,VEGFA
PMID:29312345	(2017) Abnormal Complement Activation and Inflammation in the Pathogenesis of Retinopathy of Prematurity.	7	57	1.15	0.00065	9606.ENSP00000200676,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CETP,CXCL10,ANGPT2,BDNF,AGTR1,CCL5,VEGFA
PMID:29326672	(2017) HHV-6A Infection of Endometrial Epithelial Cells Induces Increased Endometrial NK Cell-Mediated Cytotoxicity.	7	57	1.15	0.00065	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,TIMP3,CCR5,CXCL10,ANG,CCL5,VEGFA
PMID:26551552	(2016) Leukocyte Trafficking to the Small Intestine and Colon.	7	57	1.15	0.00065	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	TGFB1,CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9
PMID:27025211	(2016) Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications.	7	57	1.15	0.00065	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,MAP3K5,BCL2,RHOA,PROM1,VEGFA
PMID:27036015	(2016) The emerging role of FTY720 (Fingolimod) in cancer treatment.	8	84	1.04	0.00065	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ENPP2,CDH1,STAT5A,AR,JAK2,BCL2,RHOA,VEGFA
PMID:27340270	(2016) The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.	8	84	1.04	0.00065	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,MPO,IFNG,CCR5,CXCL10,ELN,MYD88,VEGFA
PMID:27539668	(2016) Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.	7	57	1.15	0.00065	9606.ENSP00000292303,9606.ENSP00000356213,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,VIP,PTGS2,MYD88,LTA,CCL5,VEGFA
PMID:27775562	(2016) Protective Role of Dietary Berries in Cancer.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,SIRT6,PTGS2,NFE2L2,BCL2,VEGFA
PMID:27833527	(2016) Intrinsic Axonal Growth and the Drive for Regeneration.	7	57	1.15	0.00065	9606.ENSP00000285407,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	KLF10,CNTF,PTEN,BMP2,BCL2,NTF3,BDNF
PMID:25763353	(2015) From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies.	7	57	1.15	0.00065	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185	CD38,ATM,CD34,STAT5A,PTGS2,JAK2,BCL2
PMID:26105538	(2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.	7	57	1.15	0.00065	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANGPT2,CXCL9,FGFR1,CCL5,VEGFA
PMID:26594173	(2015) MicroRNAs as potential targets for progressive pulmonary fibrosis.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570	IFNG,CDH1,CAV1,PTEN,BCL2,GREM1,VEGFA
PMID:24484528	(2014) The hepatic sinusoid classic and contemporary: a report on the 17th international symposium on cells of the hepatic sinusoid (ISCHS).	8	84	1.04	0.00065	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000363596,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,CDH1,MAPK7,PTGS2,CNR2,NFE2L2,MYD88,VEGFA
PMID:24891760	(2014) Two faces of TGF-beta1 in breast cancer.	9	115	0.95	0.00065	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,THBS1,CDH1,ATM,PTGS2,PTEN,BCL2,RHOA,VEGFA
PMID:24971332	(2014) Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy.	7	57	1.15	0.00065	9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,PDGFB,PDGFA,EDN1,PDGFD,CCL5,VEGFA
PMID:25136294	(2014) Astrocytic modulation of blood brain barrier: perspectives on Parkinsons disease.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,PDGFB,PTEN,BCL2,RHOA,BDNF,VEGFA
PMID:25227753	(2014) Current siRNA targets in the prevention and treatment of intimal hyperplasia.	7	57	1.15	0.00065	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000419422	IFNG,IGF1R,CXCL10,MMP14,CAV1,NOX1,AGTR1
PMID:25360510	(2014) n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.	7	57	1.15	0.00065	9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PTGS2,PTEN,SHBG,JAK2,BCL2,VEGFA
PMID:25443348	(2014) Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.	7	57	1.15	0.00065	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,IGF1R,ATM,PTGS2,CCL5,VEGFA
PMID:25548754	(2014) Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.	8	84	1.04	0.00065	9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000384957,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL11,CD34,STAT5A,JAK2,F11,CCL5,VEGFA
PMID:23432060	(2013) Transient receptor potential (TRP) channels and cardiac fibrosis.	7	57	1.15	0.00065	9606.ENSP00000308208,9606.ENSP00000345708,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000419313,9606.ENSP00000478570	MMP14,KCNJ11,PDGFA,EDN1,PDGFD,TRPC1,VEGFA
PMID:24098824	(2013) MicroRNA expression profile in human macrophages in response to Leishmania major infection.	7	57	1.15	0.00065	9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	HSPB1,CXCL10,CXCL11,PTEN,BCL2,MYD88,CCL5
PMID:22127890	(2012) Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.	8	84	1.04	0.00065	9606.ENSP00000225275,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MPO,SIRT6,MAP3K5,PTEN,TXN,BCL2,IRAK4,MYD88
PMID:22357101	(2012) Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems.	7	57	1.15	0.00065	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000355370,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185	NOX4,MAPK7,CNTF,NOX1,TXN,EDN1,BCL2
PMID:22481932	(2012) Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000268035,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,AMBP,IGF1R,ABCG1,PTEN,BCL2,VEGFA
PMID:21182948	(2011) Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.	7	57	1.15	0.00065	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000380365,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,HNF4A,PTEN,RGN,PROM1,VEGFA
PMID:21466483	(2011) Adult neural stem cells: response to stroke injury and potential for therapeutic applications.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,RHOA,BDNF,CCL5,VEGFA
PMID:22076154	(2011) Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment.	7	57	1.15	0.00065	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000478570	TGFB1,TIMP3,ATM,PDGFB,PTEN,GLO1,VEGFA
PMID:22216249	(2011) Differential gene expression from microarray analysis distinguishes woven and lamellar bone formation in the rat ulna following mechanical loading.	8	84	1.04	0.00065	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000401399,9606.ENSP00000478319,9606.ENSP00000478570	TGFB1,CXCL10,CCL20,PTGS2,BMP2,MYD88,GREM1,VEGFA
PMID:22523638	(2011) Above genetics: lessons from cerebral development in autism.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,PTEN,AR,BDNF,VEGFA
PMID:19948237	(2010) Tumor-stroma co-evolution in prostate cancer progression and metastasis.	7	57	1.15	0.00065	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,IGF1R,NOX1,AR,EDN1,CCL5,VEGFA
PMID:20230744	(2010) Cellular plasticity within the pancreas--lessons learned from development.	7	57	1.15	0.00065	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000362410,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,ONECUT1,HNF4A,PDGFB,MAFB,VEGFA,HNF1B
PMID:19099182	(2009) Modulation of chemokine receptor activity through dimerization and crosstalk.	7	57	1.15	0.00065	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CCR5,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:19560734	(2009) Molecular epigenetics and genetics in neuro-oncology.	7	57	1.15	0.00065	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000426809	THBS1,TIMP3,PDGFB,SIRT6,CNTF,PTEN,PROM1
PMID:19729072	(2009) Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes.	7	57	1.15	0.00065	9606.ENSP00000258341,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412	LAMC1,TIMP3,CXCL10,ELN,EDN1,RHOA,CCL5
PMID:20003277	(2009) Early pregnancy peripheral blood gene expression and risk of preterm delivery: a nested case control study.	7	57	1.15	0.00065	9606.ENSP00000228434,9606.ENSP00000308208,9606.ENSP00000346148,9606.ENSP00000351807,9606.ENSP00000383232,9606.ENSP00000400175,9606.ENSP00000478570	CD69,MMP14,PRKAA1,ELN,GGT1,RHOA,VEGFA
PMID:34716428	(2022) Obesity and Roux-en-Y gastric bypass drive changes in miR-31 and miR-215 expression in the human rectal mucosa.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000480291	IGF1R,CAV1,PRKAA1,JAK2,BCL2,HNF1B
PMID:35015744	(2022) Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000478570	CD38,ATM,SIRT6,ANGPTL2,BCL2,VEGFA
PMID:35115489	(2022) An instructive role for Interleukin-7 receptor alpha in the development of human B-cell precursor leukemia.	6	35	1.3	0.00066	9606.ENSP00000222572,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000418525	PON2,CD38,CD34,STAT5A,BCL2,MME
PMID:35134057	(2022) In silico prediction of HIV-1-host molecular interactions and their directionality.	5	18	1.5	0.00066	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000317674,9606.ENSP00000390651	IFNG,CCR5,CXCL10,APOL1,IRAK4
PMID:35163418	(2022) MAPKERK Pathway as a Central Regulator in Vertebrate Organ Regeneration.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,BCL2,FGFR1,NTF3,BDNF,VEGFA
PMID:35207660	(2022) Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.	5	18	1.5	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,PTGS2,CCL5
PMID:35269694	(2022) Evaluation of Myeloperoxidase as Target for Host-Directed Therapy in Tuberculosis In Vivo.	6	35	1.3	0.00066	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,IFNG,CXCL10,CCL20,CXCL9,CCL5
PMID:35269824	(2022) Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.	6	35	1.3	0.00066	9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PRKCE,ELN,NFE2L2,BCL2,VEGFA
PMID:35326604	(2022) DLBCL 1L-What to Expect beyond R-CHOP?	6	35	1.3	0.00066	9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	CD247,CD47,BCL2,MYD88,MME,VEGFA
PMID:35359832	(2022) A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,IGF1R,HNF4A,PTGS2,PTEN,BCL2
PMID:35371043	(2022) Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.	5	18	1.5	0.00066	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,CCL5
PMID:35387325	(2022) Effect of Traditional Chinese Medicine on the Cardiovascular Diseases.	6	35	1.3	0.00066	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185	CETP,MPO,FABP4,PTGS2,JAK2,BCL2
PMID:35409214	(2022) Hippo Signaling in the Endometrium.	6	35	1.3	0.00066	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,PTEN,JAK2,BCL2,VEGFA
PMID:32525774	(2021) Protective Effects of Polydatin Against Dementia-Related Disorders.	5	18	1.5	0.00066	9606.ENSP00000363641,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303	TXN,BMP2,NFE2L2,BCL2,BDNF
PMID:32870390	(2021) Cellular responses to deproteinized bovine bone mineral biofunctionalized with bone-conditioned medium.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,NOX4,ALPL,BMP2,VEGFA
PMID:33152664	(2021) Silencing COX-2 blocks PDK1TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000384906,9606.ENSP00000478570	NOX4,CXCL11,PTGS2,SAA1,VEGFA
PMID:33155660	(2021) Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5cyclin D1 and STAT5Bcl-xL signaling pathways.	5	18	1.5	0.00066	9606.ENSP00000215832,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000480291	MAPK1,STAT5A,JAK2,PROM1,HNF1B
PMID:33442417	(2021) Research progress in the role and mechanism of Cadherin-11 in different diseases.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000480291	SOX9,CDH1,HNF4A,AR,RHOA,HNF1B
PMID:33467066	(2021) Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CDH1,PTGS2,AR,BCL2,VEGFA
PMID:33478512	(2021) Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,PTEN,TXN,NFE2L2,BCL2,RHOA
PMID:33573134	(2021) Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.	5	18	1.5	0.00066	9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	ANGPT2,ENTPD1,EDN1,CCL5,VEGFA
PMID:33573220	(2021) Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000360997	TGFB1,THBS1,CDH1,MMP14,ELN,ADAMTS13
PMID:33628765	(2021) The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000380252,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,NFE2L2,PROM1
PMID:33728712	(2021) Age-related changes in cerebrovascular health and their effects on neural function and cognition: A comprehensive review.	5	18	1.5	0.00066	9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000478570	SIRT6,ELN,EDN1,BDNF,VEGFA
PMID:33752736	(2021) Diet-induced obesity leads to behavioral indicators of pain preceding structural joint damage in wild-type mice.	6	35	1.3	0.00066	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,BDNF,CCL5,VEGFA
PMID:33832087	(2021) Long-term survival in an acute promyelocytic leukemia patient with recurrent granulocytic sarcomas: A case report.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MME
PMID:33869221	(2021) BMSC-Derived Small Extracellular Vesicles Induce Cartilage Reconstruction of Temporomandibular Joint Osteoarthritis via Autotaxin-YAP Signaling Axis.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000480291	SOX9,ENPP2,PTGS2,BMP2,RHOA,HNF1B
PMID:33893069	(2021) Redox regulation of the insulin signalling pathway.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000380252	NOX4,IGF1R,PRDX2,SREBF1,G6PD,NFE2L2
PMID:33898307	(2021) Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	CD38,AMBP,CD34,BCL2,MME
PMID:34023385	(2021) NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185	NOX4,VDAC1,MAP3K5,PTEN,BCL2
PMID:34067485	(2021) Molecular Mechanisms of PD-1 and PD-L1 Activity on a Pan-Cancer Basis: A Bioinformatic Exploratory Study.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	MAPK1,CCR5,JAK2,BCL2,LTA,VEGFA
PMID:34187415	(2021) CypB promotes cell proliferation and metastasis in endometrial carcinoma.	5	18	1.5	0.00066	9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000478570	ANGPT2,STAT5A,SREBF1,PTEN,VEGFA
PMID:34200256	(2021) Involvement of Microglia in the Pathophysiology of Intracranial Aneurysms and Vascular Malformations-A Short Overview.	6	35	1.3	0.00066	9606.ENSP00000222139,9606.ENSP00000301522,9606.ENSP00000311005,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,PRDX2,MAPK7,EDN1,JAK2,VEGFA
PMID:34210107	(2021) Molecular and Circulating Biomarkers of Brain Tumors.	6	35	1.3	0.00066	9606.ENSP00000255409,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	CHI3L1,TIMP3,PTEN,NPY,BDNF,VEGFA
PMID:34257802	(2021) Role of Polyphenols as Antioxidant Supplementation in Ischemic Stroke.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000301522,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419422	MPO,PRDX2,TXN,BCL2,RHOA,AGTR1
PMID:34323647	(2021) The effect of propofol on the proliferation and apoptosis of hepatocellular carcinoma cells through TGF-Beta1Smad2 signaling pathway.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,PTEN,BCL2,VEGFA
PMID:34360786	(2021) Clinical Proteomics of Biofluids in Haematological Malignancies.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000259486,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000414303	TGFB1,IFNG,ENPP2,CXCL10,CD34,BDNF
PMID:34366884	(2021) Effects of Genetic Variation on Endurance Performance, Muscle Strength, and Injury Susceptibility in Sports: A Systematic Review.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000325548,9606.ENSP00000393312,9606.ENSP00000418823,9606.ENSP00000478570	TGFB1,IGF1R,CNDP2,FGFR1,FTO,VEGFA
PMID:34367971	(2021) Effects of Inflammation on the Immune Microenvironment in Gastric Cancer.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,THBS1,CXCL10,CXCL9,CCL5
PMID:34451902	(2021) Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000419422	MAPK1,NOX4,PTGS2,BCL2,MME,AGTR1
PMID:34490084	(2021) Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling.	10	151	0.88	0.00066	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000478570	APC,CDH1,ATM,CXCL10,PTEN,JAK2,NFE2L2,NPY,FGFR1,VEGFA
PMID:34503214	(2021) Molecular Mechanisms of Alcohol-Induced Colorectal Carcinogenesis.	6	35	1.3	0.00066	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000474412	HSPB1,CDH1,CCR5,PTEN,MTHFR,CCL5
PMID:34532315	(2021) Boost TendonLigament Repair With Biomimetic and Smart Cellular Constructs.	5	18	1.5	0.00066	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,MMP14,ELN,BMP2,VEGFA
PMID:34754377	(2021) Diabetic kidney disease: Are the reported associations with single-nucleotide polymorphisms disease-specific?	5	18	1.5	0.00066	9606.ENSP00000200676,9606.ENSP00000221930,9606.ENSP00000222572,9606.ENSP00000365777,9606.ENSP00000419422	CETP,TGFB1,PON2,MTHFR,AGTR1
PMID:34831021	(2021) Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,IGF1R,CXCL10,BCL2,CCL5,VEGFA
PMID:34831217	(2021) Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models.	6	35	1.3	0.00066	9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	ANG,BCL2,NTF3,RHOA,BDNF,VEGFA
PMID:34836410	(2021) Chlorogenic Acid Protects against Advanced Alcoholic Steatohepatitis in Rats via Modulation of Redox Homeostasis, Inflammation, and Lipogenesis.	5	18	1.5	0.00066	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000478570	SREBF1,PTGS2,NFE2L2,LTA,VEGFA
PMID:34847640	(2021) Obesity, Diabetes, and Increased Cancer Progression.	6	35	1.3	0.00066	9606.ENSP00000256104,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000351807,9606.ENSP00000377192,9606.ENSP00000478570	FABP4,IGF1R,APPL1,ELN,G6PD,VEGFA
PMID:34899325	(2021) Biejiajian Pill Promotes the Infiltration of CD8(+) T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,RHOA,CCL5
PMID:34903915	(2021) Efficacy of bubaline blood derived fibrin glue in silk ligature-induced acute periodontitis in Wistar rats.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	TGFB1,IFNG,PDGFB,PDGFA,VEGFA
PMID:34912294	(2021) Emerging Antioxidant Paradigm of Mesenchymal Stem Cell-Derived Exosome Therapy.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CAV1,BMP2,NFE2L2,BCL2,VEGFA
PMID:35010907	(2021) Curcumin May Prevent Basement Membrane Disassembly by Matrix Metalloproteinases and Progression of the Bladder Cancer.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,MMP14,HSPG2,BCL2,VEGFA,HNF1B
PMID:35058774	(2021) Perilla Leaf Extract (PLE) Attenuates COPD Airway Inflammation via the TLR4SykPKCNF-kappaB Pathway In Vivo and In Vitro.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,MAPK7,CXCL9,CCL5
PMID:35155416	(2021) Intervertebral Disc-on-a-Chip as Advanced In Vitro Model for Mechanobiology Research and Drug Testing: A Review and Perspective.	5	18	1.5	0.00066	9606.ENSP00000013807,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000478570	ERCC1,CXCL9,PTGS2,RHOA,VEGFA
PMID:35155445	(2021) Segmentally Demineralized Cortical Bone With Stem Cell-Derived Matrix Promotes Proliferation, Migration and Differentiation of Stem Cells in vitro.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,SOX9,FMOD,BMP2,VEGFA
PMID:30457046	(2020) Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.	6	35	1.3	0.00066	9606.ENSP00000292303,9606.ENSP00000321853,9606.ENSP00000351807,9606.ENSP00000384957,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,SERPINF2,ELN,F11,CCL5,VEGFA
PMID:31468264	(2020) Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.	5	18	1.5	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,CCL5
PMID:31657086	(2020) PRRX1-induced epithelial-to-mesenchymal transition in salivary adenoid cystic carcinoma activates the metabolic reprogramming of free fatty acids to promote invasion and metastasis.	6	35	1.3	0.00066	9606.ENSP00000246553,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000418009,9606.ENSP00000478570	FFAR1,FABP4,CDH1,STAT5A,RARRES2,VEGFA
PMID:31915068	(2020) Neurovascular effects of umbilical cord blood-derived stem cells in growth-restricted newborn lambs : UCBCs for perinatal brain injury.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000414303,9606.ENSP00000478570	CXCL10,EDNRA,CXCL9,BDNF,VEGFA
PMID:32092433	(2020) Characterization of gene expression changes in human neural stem cells and endothelial cells modeling a neurovascular microenvironment.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,ANGPT2,PDGFB,PDGFA,BDNF,VEGFA
PMID:32116075	(2020) miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.	5	18	1.5	0.00066	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	TIMP3,IGF1R,PTEN,RHOA,VEGFA
PMID:32154191	(2020) Hematopoietic StemProgenitor Cells and the Pathogenesis of HIVAIDS.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412	CD38,IFNG,CCR5,CD34,PROM1,CCL5
PMID:32158615	(2020) Decursin negatively regulates LPS-induced upregulation of the TLR4 and JNK signaling stimulated by the expression of PRP4 in vitro.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,MAPK7,PTGS2,MYD88,VEGFA
PMID:32184801	(2020) Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma.	5	18	1.5	0.00066	9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000426809	SOX9,ALDH1A1,CD34,CD47,PROM1
PMID:32200439	(2020) A comprehensive analysis to understand the mechanism of action of balneotherapy: why, how, and where they can be used? Evidence from in vitro studies performed on human and animal samples.	6	35	1.3	0.00066	9606.ENSP00000228434,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CD69,MMP14,PTGS2,NFE2L2,CCL5,VEGFA
PMID:32251307	(2020) Effect of the deuterium on efficiency and type of adipogenic differentiation of human adipose-derived stem cells in vitro.	5	18	1.5	0.00066	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000418009	FABP4,PLIN1,CXCL10,LPL,RARRES2
PMID:32296387	(2020) Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000419422,9606.ENSP00000478570,9606.ENSP00000480291	NOX4,IGF1R,AGTR1,VEGFA,HNF1B
PMID:32324828	(2020) Compromised angiogenesis and vascular Integrity in impaired diabetic wound healing.	5	18	1.5	0.00066	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000478570	THBS1,CXCL10,ANGPT2,PDGFB,VEGFA
PMID:32368082	(2020) Grainyhead-Like Genes Family May Act as Novel Biomarkers in Colon Cancer.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000444198	CDH1,PTEN,BCL2,PROM1,CITED2
PMID:32432046	(2020) Effects of BMPER, CXCL10, and HOXA9 on Neovascularization During Early-Growth Stage of Primary High-Grade Glioma and Their Corresponding MRI Biomarkers.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CD34,ANGPT2,PROM1,VEGFA
PMID:32596244	(2020) The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399	MPO,CDH1,CXCL10,PTGS2,NFE2L2,MYD88
PMID:32624507	(2020) Pim-1 Protects Retinal Ganglion Cells by Enhancing Their Regenerative Ability Following Optic Nerve Crush.	6	35	1.3	0.00066	9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	STAT5A,CNTF,PTEN,JAK2,BCL2,BDNF
PMID:32635162	(2020) Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.	6	35	1.3	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,MME,CCL5
PMID:32713346	(2020) Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	CD38,AMBP,CD34,BCL2,MME
PMID:32873828	(2020) Co-targeting PIM and PI3KmTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,PRKAA1,MAP3K5,PTEN,JAK2,BCL2
PMID:32961812	(2020) Potential Therapeutic Benefit of NAD(+) Supplementation for Glaucoma and Age-Related Macular Degeneration.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	CD38,SIRT6,CNTF,NFE2L2,BDNF,VEGFA
PMID:32963574	(2020) Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology.	6	35	1.3	0.00066	9606.ENSP00000339191,9606.ENSP00000362463,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000403495,9606.ENSP00000478570	CAV1,GLO1,EDN1,NFE2L2,LTA,VEGFA
PMID:32974181	(2020) Case Report: Concomitant Diagnosis of Plasma Cell Leukemia in Patient With JAK2 Positive Myeloproliferative Neoplasm.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CD34,JAK2,MME,VEGFA
PMID:32982165	(2020) Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration.	5	18	1.5	0.00066	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000355370,9606.ENSP00000478570	TIMP3,CD34,ANGPT2,CNTF,VEGFA
PMID:32990600	(2020) Pregnancy success in mice requires appropriate cannabinoid receptor signaling for primary decidua formation.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000478570	CDH1,ANGPT2,PTGS2,BMP2,VEGFA
PMID:33049923	(2020) Circulating microRNAs in Breast Milk and Their Potential Impact on the Infant.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000418823	MPO,FABP4,CAV1,STAT5A,SREBF1,FTO
PMID:33096803	(2020) Injectables and Depots to Prolong Drug Action of Proteins and Peptides.	6	35	1.3	0.00066	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	ANGPT2,PDGFB,ELN,CNTF,BDNF,VEGFA
PMID:33117427	(2020) Oxidative stress and antioxidant defense in detoxification systems of snake venom-induced toxicity.	6	35	1.3	0.00066	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000383364,9606.ENSP00000384906	CETP,MPO,MAP3K5,TXN,PLA2G2A,SAA1
PMID:33176601	(2020) RAI14 Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric Cancer.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185	TGFB1,CDH1,CXCL10,CXCL9,PTGS2,BCL2
PMID:33209511	(2020) Effects of Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitis.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:33256096	(2020) Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function.	6	35	1.3	0.00066	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000477707	CETP,MPO,APOL1,LPA,ABCG1,NR1H3
PMID:33291663	(2020) Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000354995,9606.ENSP00000371067	CDH1,IGF1R,ATM,STAT5A,ABCG1,JAK2
PMID:33426228	(2020) Gaps between Asian regulations for eligibility of human mesenchymal stromal cells as starting materials of cell therapy products and comparability of mesenchymal stromal cell-based products subject to changes in their manufacturing process.	5	18	1.5	0.00066	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CD34,CXCL9
PMID:33520964	(2020) Sub-Regional Differences of the Human Amniotic Membrane and Their Potential Impact on Tissue Regeneration Application.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000336762,9606.ENSP00000356438	MAPK1,TGFB1,CDH1,HNF4A,ANG,PTGS2
PMID:33543037	(2020) Native extracellular matrix, synthesized ex vivo by bone marrow or adipose stromal cells, faithfully directs mesenchymal stem cell differentiation.	6	35	1.3	0.00066	9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000363827,9606.ENSP00000363973,9606.ENSP00000478319	THBS1,LPL,CD34,HSPG2,ALPL,GREM1
PMID:30553823	(2019) Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.	6	35	1.3	0.00066	9606.ENSP00000314897,9606.ENSP00000360250,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	ANGPT2,ENTPD1,NOX1,EDN1,RHOA,AGTR1
PMID:30669689	(2019) An Exonic Switch Regulates Differential Accession of microRNAs to the Cd34 Transcript in Atherosclerosis Progression.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ELN,BCL2,PROM1,VEGFA
PMID:30679323	(2019) Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000310520,9606.ENSP00000371067,9606.ENSP00000426809	CD38,ATM,CD34,ERCC4,JAK2,PROM1
PMID:30763910	(2019) Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000381185	NOX4,CD34,MAPK7,PRKAA1,PTEN,BCL2
PMID:30782046	(2019) Dietary fish oil supplementation alters liver gene expressions to protect against LPS-induced liver injury in weanling piglets.	6	35	1.3	0.00066	9606.ENSP00000278840,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399	FADS2,CXCL10,CXCL11,CXCL9,IRAK4,MYD88
PMID:30783513	(2019) Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and gamma-irradiation in human glioblastoma cells.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	MAPK1,IFNG,ATM,PTEN,JAK2,PROM1
PMID:30803933	(2019) FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis.	5	18	1.5	0.00066	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419313,9606.ENSP00000478570	PTGS2,PTEN,BCL2,TRPC1,VEGFA
PMID:30809507	(2019) Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412	IGF1R,CD247,CD47,MYD88,PROM1,CCL5
PMID:30842338	(2019) Modified lipoproteins in periodontitis: a link to cardiovascular disease?	6	35	1.3	0.00066	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000384906	CETP,IFNG,LPL,APOL1,LPA,SAA1
PMID:30842808	(2019) Triple-modal imaging of stem-cells labeled with multimodal nanoparticles, applied in a stroke model.	5	18	1.5	0.00066	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	ATM,CD34,NTF3,BDNF,VEGFA
PMID:31010242	(2019) Tumor-Associated Neutrophils in Cancer: Going Pro.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,THBS1,CDH1,CCL5,VEGFA
PMID:31013694	(2019) Curcumin: New Insights into an Ancient Ingredient against Cancer.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,PTGS2,BCL2,PROM1,VEGFA
PMID:31191666	(2019) Employing Endogenous NSCs to Promote Recovery of Spinal Cord Injury.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	MPO,SOX9,CNTF,BDNF,PROM1,VEGFA
PMID:31243897	(2019) Reduced m6A modification predicts malignant phenotypes and augmented WntPI3K-Akt signaling in gastric cancer.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418823	CDH1,PTEN,AR,BCL2,RHOA,FTO
PMID:31303976	(2019) Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000356832,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000381185	SOX9,ATM,SGK1,BMP2,KL,BCL2
PMID:31352001	(2019) Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000393312	TGFB1,IFNG,SREBF1,CXCL9,PTGS2,FGFR1
PMID:31402170	(2019) Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000384262,9606.ENSP00000478570	CDH1,EDNRA,EDN1,HPSE,VEGFA
PMID:31460807	(2019) Emerging molecular therapeutic targets for spinal cord injury.	10	151	0.88	0.00066	9606.ENSP00000285407,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000479617	KLF10,CCR5,CXCL10,CNTF,PTEN,NTF3,RHOA,BDNF,CCL5,UHRF1
PMID:31464900	(2019) Clinical characteristics and management of primary granulocytic sarcoma of the breast: A case report.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CDH1,CD34,BCL2,MME
PMID:31467899	(2019) Potential Anticancer Properties and Mechanisms of Action of Formononetin.	5	18	1.5	0.00066	9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	MAPK7,STAT5A,PTEN,JAK2,BCL2
PMID:31500829	(2019) Epigenetic disturbances in obesity and diabetes: Epidemiological and functional insights.	6	35	1.3	0.00066	9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000418823	HNF4A,SREBF1,ABCG1,PTGS2,PTEN,FTO
PMID:31608227	(2019) Angiogenesis in Gynecological Cancers: Role of Neurotrophins.	5	18	1.5	0.00066	9606.ENSP00000215832,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,BCL2,NTF3,BDNF,VEGFA
PMID:31649684	(2019) Functional Change of Effector Tumor-Infiltrating CCR5(+)CD38(+)HLA-DR(+)CD8(+) T Cells in Glioma Microenvironment.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412	CD38,CCR5,CD34,BCL2,PROM1,CCL5
PMID:31801887	(2019) The human tissue-resident CCR5(+) T cell compartment maintains protective and functional properties during inflammation.	5	18	1.5	0.00066	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000474412	CD69,IFNG,CCR5,PDGFB,CCL5
PMID:31861663	(2019) Anti-Obesity Effects of Microalgae.	6	35	1.3	0.00066	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000478570	FABP4,PLIN1,LPL,SREBF1,G6PD,VEGFA
PMID:31866833	(2019) Pericytes: Problems and Promises for CNS Repair.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,ANGPT2,EDNRA,PDGFB,BDNF,VEGFA
PMID:31942539	(2019) Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?	6	35	1.3	0.00066	9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000478570	CD247,PTEN,BCL2,MYD88,MME,VEGFA
PMID:32309625	(2019) Acute exposure to air pollution is associated with novel changes in blood levels of endothelin-1 and circulating angiogenic cells in young, healthy adults.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDNRA,EDN1,PROM1,VEGFA
PMID:29084920	(2018) CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas.	6	35	1.3	0.00066	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CD34,ANGPT2,TXN,EDN1,VEGFA
PMID:29127031	(2018) Sulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,CXCL10,CCL5,VEGFA
PMID:29348435	(2018) Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,MYD88,CCL5
PMID:29351986	(2018) A phase II study of the oral JAK1JAK2 inhibitor ruxolitinib in advanced relapsedrefractory Hodgkin lymphoma.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,JAK2,BCL2,CCL5,VEGFA
PMID:29490284	(2018) Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:29494553	(2018) Comparison of Tumor- and Bone Marrow-Derived Mesenchymal StromalStem Cells from Patients with High-Grade Osteosarcoma.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000310520,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CD34,ERCC4,PTEN,CCL5,VEGFA
PMID:29515107	(2018) PARK2 inhibits osteosarcoma cell growth through the JAK2STAT3VEGF signaling pathway.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTEN,JAK2,BCL2,VEGFA
PMID:29523594	(2018) Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000361021,9606.ENSP00000363822	MAPK1,CDH1,IGF1R,APPL1,PTEN,AR
PMID:29548337	(2018) The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,MAP3K5,PTEN,NOX1,NFE2L2,VEGFA
PMID:29642635	(2018) CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,MPO,CXCL10,CXCL9,CCL5
PMID:29669555	(2018) The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.	6	35	1.3	0.00066	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000419422,9606.ENSP00000474412	CD34,ELN,EDN1,KL,AGTR1,CCL5
PMID:29735645	(2018) Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.	5	18	1.5	0.00066	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000478570	THBS1,CDH1,TIMP3,ELN,VEGFA
PMID:29755893	(2018) Policing the intestinal epithelial barrier: Innate immune functions of intraepithelial lymphocytes.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,MYD88,CCL5
PMID:29844144	(2018) Vascular Nox (NADPH Oxidase) Compartmentalization, Protein Hyperoxidation, and Endoplasmic Reticulum Stress Response in Hypertension.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,MAP3K5,NOX1,TXN,NFE2L2
PMID:29844613	(2018) Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000393312	CDH1,CD34,PDGFB,PTEN,FGFR1
PMID:29853174	(2018) The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000368104	CDH1,MMP14,STAT5A,PDGFA,ELN,BMP2
PMID:29868516	(2018) Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,LTA,CCL5
PMID:29925409	(2018) Sexual dimorphism in bacterial infections.	6	35	1.3	0.00066	9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	PDGFB,CXCL9,AR,MYD88,LTA,CCL5
PMID:29947533	(2018) Nephron prorenin receptor deficiency alters renal medullary endothelin-1 and endothelin receptor expression.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000368683	NOX4,EDNRA,PTGS2,SGK1,EDN1
PMID:29984620	(2018) Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu Treatment After Focal Cerebral Ischemia in Mice.	5	18	1.5	0.00066	9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,JAK2,NFE2L2,BDNF,VEGFA
PMID:29986413	(2018) Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within.	6	35	1.3	0.00066	9606.ENSP00000200676,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000383364,9606.ENSP00000384906	CETP,LPA,ABCG1,PTGS2,PLA2G2A,SAA1
PMID:29987877	(2018) Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC(+) CD4(+) cell levels: a surrogate marker candidate of HIV-induced intestinal damage.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30192802	(2018) EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	NOX4,CXCL10,MAPK7,CXCL9,PTEN,CCL5
PMID:30205595	(2018) Resveratrol: A Double-Edged Sword in Health Benefits.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,PTGS2,BCL2,MYD88,BDNF,VEGFA
PMID:30394782	(2018) Precision behavioral medicine: Implications of genetic and genomic discoveries for behavioral weight loss treatment.	5	18	1.5	0.00066	9606.ENSP00000200676,9606.ENSP00000345708,9606.ENSP00000354995,9606.ENSP00000414303,9606.ENSP00000418823	CETP,KCNJ11,ABCG1,BDNF,FTO
PMID:30459931	(2018) NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000288266,9606.ENSP00000362057,9606.ENSP00000478570	TGFB1,NOX4,APPL1,NOX1,VEGFA
PMID:30545286	(2018) Comparative evaluation of mesenchymal stromal cells from umbilical cord and amniotic membrane in xeno-free conditions.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000478570	TGFB1,IFNG,SOX9,CD34,VEGFA
PMID:27739069	(2017) The Signature of Maternal Social Rank in Placenta Deoxyribonucleic Acid Methylation Profiles in Rhesus Monkeys.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000346508	TGFB1,TIMP3,CD34,HNF4A,PDGFA
PMID:28035069	(2017) PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1Twist1 pathway.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PDGFA,PDGFD,BCL2,VEGFA
PMID:28036294	(2017) Hsp90 N- and C-terminal double inhibition synergistically suppresses Bcr-Abl-positive human leukemia cells.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000341208	CD38,HSPB1,IGF1R,CD34,STAT5A
PMID:28091403	(2017) Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,ATM,BCL2,MYD88,MME
PMID:28272447	(2017) Eggshell membrane powder ameliorates intestinal inflammation by facilitating the restitution of epithelial injury and alleviating microbial dysbiosis.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000368683	MPO,TIMP3,CXCL11,PDGFA,CXCL9,EDN1
PMID:28386230	(2017) Role of NADPH Oxidase-4 in Human Endothelial Progenitor Cells.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000426809,9606.ENSP00000478570	NOX4,CD34,NOX1,PROM1,VEGFA
PMID:28587319	(2017) Seawater-drowning-induced acute lung injury: From molecular mechanisms to potential treatments.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000400175,9606.ENSP00000478570	MPO,ATM,AQP5,RHOA,VEGFA
PMID:28604744	(2017) EMP2 is a novel therapeutic target for endometrial cancer stem cells.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000484631	CDH1,ALDH1A1,PROM1,VEGFA,PMP22
PMID:28800782	(2017) Effects of Chinese medicinal herbs on expression of brain-derived Neurotrophic factor (BDNF) and its interaction with human breast cancer MDA-MB-231 cells and endothelial HUVECs.	5	18	1.5	0.00066	9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000414303	PTGS2,AR,JAK2,RHOA,BDNF
PMID:28804608	(2017) Remyelination improvement after neurotrophic factors secreting cells transplantation in rat spinal cord injury.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,NTF3,BDNF,VEGFA
PMID:28924035	(2017) STAT1 modulates tissue wasting or overgrowth downstream from PDGFRbeta.	6	35	1.3	0.00066	9606.ENSP00000300055,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000354901	PLIN1,CXCL10,CXCL11,PDGFB,STAT5A,CXCL9
PMID:28962005	(2017) Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252	MAPK1,MPO,IFNG,PTGS2,JAK2,NFE2L2
PMID:29047079	(2017) Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175	NOX4,CAV1,NOX1,EDN1,RHOA
PMID:29089889	(2017) Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000477707,9606.ENSP00000478570	MAPK1,FABP4,ABCG1,BCL2,NR1H3,VEGFA
PMID:29109908	(2017) Extraocular Muscle Repair and Regeneration.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000356515,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,CD34,UTRN,NTF3,BDNF
PMID:29213245	(2017) Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000478570	IFNG,CXCL10,ELN,CXCL9,CNTF,VEGFA
PMID:29262570	(2017) DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy.	5	18	1.5	0.00066	9606.ENSP00000215832,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,EDNRA,EDN1,RHOA,AGTR1
PMID:29422831	(2017) Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MME
PMID:33225060	(2017) Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks.	6	35	1.3	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,TXN,CCL5
PMID:26757406	(2016) Fit for the Eye: Aptamers in Ocular Disorders.	5	18	1.5	0.00066	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000478570	ANGPT2,PDGFB,PDGFA,PDGFD,VEGFA
PMID:26882564	(2016) microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.	5	18	1.5	0.00066	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000478570	SOX9,IGF1R,ALDH1A1,CD34,VEGFA
PMID:26905827	(2016) ROS-activated calcium signaling mechanisms regulating endothelial barrier function.	6	35	1.3	0.00066	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419313	NOX4,CAV1,NOX1,RHOA,MYD88,TRPC1
PMID:26933731	(2016) The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods.	5	18	1.5	0.00066	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278840,9606.ENSP00000310036,9606.ENSP00000426809	SOX9,IGF1R,FADS2,CD34,PROM1
PMID:26966697	(2016) Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	CD38,IFNG,CXCL10,CXCL11,CXCL9,VEGFA
PMID:27035118	(2016) Whole-genome re-sequencing for the identification of high contribution susceptibility gene variants in patients with type 2 diabetes.	6	35	1.3	0.00066	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,HNF4A,KCNJ11,FTO,HNF1B
PMID:27051596	(2016) Implication of hepatokines in metabolic disorders and cardiovascular diseases.	6	35	1.3	0.00066	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000414303,9606.ENSP00000478570	FABP4,LPL,SREBF1,RBP4,BDNF,VEGFA
PMID:27098664	(2016) Alveologenesis: key cellular players and fibroblast growth factor 10 signaling.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,SOX9,PDGFA,ELN,FGFR1,VEGFA
PMID:27101285	(2016) Circulating Tumor Cell Composition in Renal Cell Carcinoma.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PDGFA,FGFR1,PROM1,VEGFA
PMID:27141455	(2016) Clinical applications of low-intensity pulsed ultrasound and its potential role in urology.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,FABP4,CXCL10,PTGS2,MYD88,VEGFA
PMID:27158466	(2016) Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CAV1,EDN1,PROM1,VEGFA
PMID:27166858	(2016) Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MPO,PTGS2,BCL2,NTF3,BDNF,VEGFA
PMID:27213590	(2016) RhoEROCK2 regulates chemoresistance through NF-kappaBIL-6 STAT3 signaling in hepatocellular carcinoma.	5	18	1.5	0.00066	9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	JAK2,BCL2,RHOA,PROM1,VEGFA
PMID:27221472	(2016) Improving Adherence to Post-Cervical Biopsy Sexual Abstinence in Kenyan Female Sex Workers.	5	18	1.5	0.00066	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901	CD69,CCR5,CXCL10,CCL20,CXCL9
PMID:27273720	(2016) Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.	6	35	1.3	0.00066	9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PDGFB,PDGFA,LTA,CCL5,VEGFA
PMID:27287409	(2016) Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.	6	35	1.3	0.00066	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD69,IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:27385910	(2016) Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension.	5	18	1.5	0.00066	9606.ENSP00000336762,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	ANG,CAV1,ELN,EDN1,VEGFA
PMID:27431370	(2016) Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.	6	35	1.3	0.00066	9606.ENSP00000257430,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	APC,TIMP3,HNF4A,PTGS2,PTEN,BCL2
PMID:27432323	(2016) Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,PDGFB,PDGFA,FGFR1,VEGFA
PMID:27577048	(2016) The oncometabolite R-2-hydroxyglutarate activates NF-kappaB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000371067	IFNG,CXCL10,CD34,GAS6,PTGS2,JAK2
PMID:27642277	(2016) Blockade of Apoptosis Signal-Regulating Kinase 1 Attenuates Matrix Metalloproteinase 9 Activity in Brain Endothelial Cells and the Subsequent Apoptosis in Neurons after Ischemic Injury.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MAP3K5,PTGS2,BCL2,VEGFA
PMID:27806334	(2016) MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3zetaSTAT3HIF-1alphaVEGF signaling.	5	18	1.5	0.00066	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,HSPB1,ANGPT2,BCL2,VEGFA
PMID:27807472	(2016) Oxidative Stress and Salvia miltiorrhiza in Aging-Associated Cardiovascular Diseases.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,NOX4,EDN1,JAK2,BCL2,VEGFA
PMID:27875520	(2016) The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000346148,9606.ENSP00000349860,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,ATM,PRKAA1,GFPT1,BCL2,VEGFA
PMID:25227937	(2015) Macrophage-sensory neuronal interaction in HIV-1 gp120-induced neurotoxicity++.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:25565910	(2015) Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes.	6	35	1.3	0.00066	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CD38,CD34,STAT5A,JAK2,VEGFA
PMID:25737954	(2015) High-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor gene.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	SOX9,CDH1,SREBF1,PTEN,AR,VEGFA
PMID:26009251	(2015) Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.	6	35	1.3	0.00066	9606.ENSP00000200676,9606.ENSP00000265132,9606.ENSP00000314897,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000384906	CETP,AMBP,ANGPT2,LPA,ABCG1,SAA1
PMID:26042473	(2015) Kinase-Independent Small-Molecule Inhibition of JAK-STAT Signaling.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CXCL9,JAK2,BCL2,CCL5
PMID:26075202	(2015) A top-down view of the tumor microenvironment: structure, cells and signaling.	6	35	1.3	0.00066	9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CD34,ELN,PTEN,CCL5,VEGFA
PMID:26078822	(2015) The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,MPO,NOX4,JAK2,BCL2,VEGFA
PMID:26167492	(2015) Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-MycCyclin D1 and Elevation of BaxBcl-2 Ratio.	5	18	1.5	0.00066	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000426809	IGF1R,CD34,HNF4A,BCL2,PROM1
PMID:26249339	(2015) Peripheral blood derived mononuclear cells enhance osteoarthritic human chondrocyte migration.	6	35	1.3	0.00066	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CXCL10,CXCL11,BMP2,CCL5,VEGFA
PMID:26500761	(2015) Vascularization mediated by mesenchymal stem cells from bone marrow and adipose tissue: a comparison.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000363827,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,MMP14,CD34,HSPG2,PROM1,VEGFA
PMID:26609237	(2015) Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809	CD38,ALDH1A1,CD34,PTEN,PROM1
PMID:26627480	(2015) Genetic predisposition to acute kidney injury--a systematic review.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000354511,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	MPO,COMT,BCL2,LTA,AGTR1,VEGFA
PMID:27127405	(2015) Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,IGF1R,STAT5A,JAK2,FGFR1,VEGFA
PMID:24416262	(2014) Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000261037,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,COL8A1,CD34,MME,CCL5,VEGFA
PMID:24488807	(2014) Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury.	5	18	1.5	0.00066	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000426809	SOX9,CDH1,HNF4A,ELN,PROM1
PMID:24563071	(2014) Angiopoietin-like protein 2 regulates endothelial colony forming cell vasculogenesis.	5	18	1.5	0.00066	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000362524,9606.ENSP00000478570	TIMP3,MMP14,ANGPT2,ANGPTL2,VEGFA
PMID:24595981	(2014) Erythropoietin: powerful protection of ischemic and post-ischemic brain.	6	35	1.3	0.00066	9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	STAT5A,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:24683432	(2014) How Gene Networks Can Uncover Novel CVD Players.	6	35	1.3	0.00066	9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356729,9606.ENSP00000356832,9606.ENSP00000384906	LPL,SREBF1,ABCG1,FMO3,SGK1,SAA1
PMID:24876950	(2014) Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?	6	35	1.3	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ELN,CXCL9,CCL5,VEGFA
PMID:25013801	(2014) The increased type-1 and type-2 chemokine levels in children with acute RSV infection alter the development of adaptive immune responses.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:25174308	(2014) Engineering strategies to mimic the glioblastoma microenvironment.	5	18	1.5	0.00066	9606.ENSP00000308208,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MMP14,RHOA,PROM1,CCL5,VEGFA
PMID:25365322	(2014) Fibroblast growth factor 21 improves insulin sensitivity and synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes.	6	35	1.3	0.00066	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000300055,9606.ENSP00000377280,9606.ENSP00000393312	HSPB1,IGF1R,ATM,PLIN1,FBXO8,FGFR1
PMID:25389390	(2014) The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TIMP3,ANGPT2,CAV1,CCL5,VEGFA
PMID:25395868	(2014) Fibroblasts and myofibroblasts in wound healing.	6	35	1.3	0.00066	9606.ENSP00000216181,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MYH9,ELN,EDN1,RHOA,BDNF,VEGFA
PMID:25561233	(2014) Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000419422	MPO,NOX4,MAP3K5,EDN1,AGTR1
PMID:25653923	(2014) New approaches to radiation protection.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000380252,9606.ENSP00000381185	IFNG,IGF1R,ATM,CD34,NFE2L2,BCL2
PMID:25995969	(2014) Delivering Oxidation Resistance-1 (OXR1) to Mouse Kidney by Genetic Modified Mesenchymal Stem Cells Exhibited Enhanced Protection against Nephrotoxic Serum Induced Renal Injury and Lupus Nephritis.	6	35	1.3	0.00066	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CXCL9,BCL2,CCL5,VEGFA
PMID:23220072	(2013) Identification of avian RIG-I responsive genes during influenza infection.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,CCL20,PTGS2,MYD88,CCL5
PMID:23324661	(2013) Persistent immune activation in chronic HIV infection: do any interventions work?	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000474412	TGFB1,CD38,CCR5,PTGS2,CCL5
PMID:23333872	(2013) Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR.	6	35	1.3	0.00066	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,LPL,CD34,AR,BCL2,VEGFA
PMID:23509696	(2013) Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	CD34,EDN1,BCL2,AGTR1,VEGFA
PMID:23545087	(2013) Naturally Leishmania infantum-infected dogs display an overall impairment of chemokine and chemokine receptor expression during visceral leishmaniasis.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:23653634	(2013) Biomarkers for gastroesophageal reflux in respiratory diseases.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000397297,9606.ENSP00000414303	MPO,IFNG,CDH1,NTF3,BDNF
PMID:23776480	(2013) The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.	6	35	1.3	0.00066	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:23806781	(2013) Inflammatory cytokine-specific alterations in retinal endothelial cell function.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,THBS1,CDH1,CAV1,PTGS2,VEGFA
PMID:23919981	(2013) Pharmacological targeting of the PI3KmTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,VEGFA
PMID:23922745	(2013) Induction of an inflammatory loop by interleukin-1beta and tumor necrosis factor-alpha involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells.	6	35	1.3	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,JAK2,CCL5
PMID:23923986	(2013) Oxidative stress and hepatitis C virus.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000363641	NOX4,ATM,HNF4A,SIRT6,TXN
PMID:24041156	(2013) Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	IGF1R,ALDH1A1,STAT5A,PTEN,JAK2,PROM1
PMID:24063378	(2013) Role of endothelin in uteroplacental circulation and fetal vascular function.	5	18	1.5	0.00066	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000418525,9606.ENSP00000478570	EDNRA,ELN,VIP,MME,VEGFA
PMID:24077122	(2013) Molecular research in penile cancer-lessons learned from the past and bright horizons of the future?	6	35	1.3	0.00066	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CDH1,PTGS2,PTEN,BCL2,VEGFA
PMID:24091671	(2013) Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000418525,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,CD47,MME,PROM1
PMID:24165569	(2013) miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2HER2 expression.	5	18	1.5	0.00066	9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,ATM,STAT5A,JAK2,BCL2
PMID:24274066	(2013) IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,STAT5A,PTGS2,JAK2,VEGFA
PMID:24322672	(2013) Transcriptional signaling pathways inversely regulated in Alzheimers disease and glioblastoma multiform.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CD34,ANGPT2,PTEN,BCL2,VEGFA
PMID:24386282	(2013) Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000284031,9606.ENSP00000365777,9606.ENSP00000478570	NOX4,TIMP3,DDAH1,MTHFR,VEGFA
PMID:24489574	(2013) Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase 1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CCL5,VEGFA
PMID:26816736	(2013) Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation.	5	18	1.5	0.00066	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816	IGF1R,CAV1,PTEN,AR,SHBG
PMID:21749581	(2012) Caloric restriction and chronic inflammatory diseases.	6	35	1.3	0.00066	9606.ENSP00000266085,9606.ENSP00000321334,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,LPA,TXN,EDN1,CCL5,VEGFA
PMID:22128761	(2012) Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	CD34,ANGPT2,STAT5A,JAK2,VEGFA
PMID:22258328	(2012) Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000426809	CD38,AMBP,ATM,CD34,PROM1
PMID:22276189	(2012) Proteomic analysis of aortae from human lipoprotein(a) transgenic mice shows an early metabolic response independent of atherosclerosis.	5	18	1.5	0.00066	9606.ENSP00000256104,9606.ENSP00000321334,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000377192	FABP4,LPA,ELN,TXN,G6PD
PMID:22359637	(2012) Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,PROM1
PMID:22375168	(2012) The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CD38,ALDH1A1,CD34,PTEN,BCL2,PROM1
PMID:22573336	(2012) Insights into the genetic architecture of diabetic nephropathy.	6	35	1.3	0.00066	9606.ENSP00000216181,9606.ENSP00000317674,9606.ENSP00000325548,9606.ENSP00000339916,9606.ENSP00000379256,9606.ENSP00000478319	MYH9,APOL1,CNDP2,LIMK2,NCALD,GREM1
PMID:22594894	(2012) New vitamin D analogs as potential therapeutics in melanoma.	6	35	1.3	0.00066	9606.ENSP00000216862,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CYP24A1,THBS1,CDH1,PTEN,BCL2,VEGFA
PMID:22648069	(2012) Estrogen receptors and human disease: an update.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,PTGS2,AR,PROM1,VEGFA
PMID:22689130	(2012) Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.	5	18	1.5	0.00066	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000478570	PDGFB,PDGFA,PTEN,PDGFD,VEGFA
PMID:22690122	(2012) Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.	5	18	1.5	0.00066	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000478570	THBS1,ATM,MMP14,CD34,VEGFA
PMID:22929887	(2012) Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CXCL10,CD34,PROM1,VEGFA
PMID:22953080	(2012) Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD34,JAK2,BCL2,MME
PMID:23071493	(2012) TLR-4 signalling accelerates colon cancer cell adhesion via NF-kappaB mediated transcriptional up-regulation of Nox-1.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,PTEN,NOX1,MYD88,VEGFA
PMID:23118928	(2012) In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.	5	18	1.5	0.00066	9606.ENSP00000215832,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,PTGS2,PTEN,BCL2,VEGFA
PMID:23293636	(2012) Structural perspectives on antimicrobial chemokines.	6	35	1.3	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:23316315	(2012) Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in dbdb mice.	5	18	1.5	0.00066	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000478570	NOX4,PLIN1,CD34,NOX1,VEGFA
PMID:23503323	(2012) The cell-matrix interface: a possible target for treating retinal vascular related pathologies.	5	18	1.5	0.00066	9606.ENSP00000229135,9606.ENSP00000258341,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	IFNG,LAMC1,PDGFB,PDGFA,VEGFA
PMID:21199330	(2011) Methyl deficient diet aggravates experimental colitis in rats.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000381185	CDH1,TIMP3,PTGS2,MTHFR,BCL2
PMID:21258854	(2011) A broad upregulation of cerebral chemokine genes by peripherally-generated inflammatory mediators.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:21358326	(2011) HIV-associated nephropathy: pathogenesis.	5	18	1.5	0.00066	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000292303,9606.ENSP00000317674,9606.ENSP00000400175	MAPK1,MYH9,CCR5,APOL1,RHOA
PMID:21362080	(2011) Dynamic reciprocity in the wound microenvironment.	6	35	1.3	0.00066	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000478570	THBS1,CDH1,MMP14,PDGFB,ELN,VEGFA
PMID:21424917	(2011) Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.	5	18	1.5	0.00066	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	MPO,IFNG,CD34,PROM1,VEGFA
PMID:21429183	(2011) Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia.	5	18	1.5	0.00066	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000474412	CD69,IFNG,CCR5,CXCL10,CCL5
PMID:21512135	(2011) Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.	5	18	1.5	0.00066	9606.ENSP00000222139,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,CXCL10,STAT5A,JAK2,VEGFA
PMID:21513708	(2011) Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation.	6	35	1.3	0.00066	9606.ENSP00000221930,9606.ENSP00000293599,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000478570	TGFB1,AQP5,CAV1,PDGFA,ELN,VEGFA
PMID:21707946	(2011) Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction.	5	18	1.5	0.00066	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,CD34,STAT5A,JAK2,BCL2
PMID:22082357	(2011) Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.	5	18	1.5	0.00066	9606.ENSP00000315011,9606.ENSP00000321334,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000426809	EDNRA,LPA,EDN1,AGTR1,PROM1
PMID:22111002	(2011) Mouse models of prostate cancer.	6	35	1.3	0.00066	9606.ENSP00000257430,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000426809	APC,STAT5A,PTEN,AR,FGFR1,PROM1
PMID:22649375	(2011) Neuroprotective actions of neurosteroids.	5	18	1.5	0.00066	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303	IGF1R,PTGS2,GAP43,BCL2,BDNF
PMID:19838113	(2010) Susceptibility genes in common complex kidney disease.	6	35	1.3	0.00066	9606.ENSP00000216181,9606.ENSP00000325548,9606.ENSP00000352264,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478319	MYH9,CNDP2,CD2AP,AGTR1,CCL5,GREM1
PMID:20089354	(2010) Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals.	5	18	1.5	0.00066	9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ALDH1A1,PTGS2,NFE2L2,BCL2,VEGFA
PMID:20142250	(2010) Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.	5	18	1.5	0.00066	9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000377192,9606.ENSP00000418823	JAZF1,KCNJ11,CAPN10,G6PD,FTO
PMID:20179298	(2010) Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.	5	18	1.5	0.00066	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000384262,9606.ENSP00000401399	CDH1,CD34,PTGS2,HPSE,MYD88
PMID:20370625	(2010) The pathogenesis of murine coronavirus infection of the central nervous system.	6	35	1.3	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,CNTF,NTF3,CCL5
PMID:20535745	(2010) Oxidative stress promotes myofibroblast differentiation and tumour spreading.	6	35	1.3	0.00066	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175	MAPK1,CDH1,NOX4,ELN,PTEN,RHOA
PMID:20616715	(2010) Marked HDL deficiency and premature coronary heart disease.	5	18	1.5	0.00066	9606.ENSP00000200676,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000383364	CETP,APOL1,LPA,ABCG1,PLA2G2A
PMID:20619313	(2010) The cytokinechemokine pattern in the bone marrow environment of multiple myeloma patients.	5	18	1.5	0.00066	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CCL20,CXCL9,CCL5
PMID:20699227	(2010) Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.	5	18	1.5	0.00066	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000478570	CXCL10,CXCL11,CD34,CXCL9,VEGFA
PMID:20717114	(2010) Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells.	6	35	1.3	0.00066	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,HNF4A,PTGS2,CCL5,VEGFA
PMID:19107756	(2009) Expression of the regeneration-associated protein SPRR1A in primary sensory neurons and spinal cord of the adult mouse following peripheral and central injury.	5	18	1.5	0.00066	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000414303	CNTF,VIP,GAP43,NPY,BDNF
PMID:19383550	(2009) G2A and LPC: regulatory functions in immunity.	5	18	1.5	0.00066	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000259486,9606.ENSP00000383364,9606.ENSP00000400175	MAPK1,MPO,ENPP2,PLA2G2A,RHOA
PMID:19414117	(2009) Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CD34,AR,BCL2,PROM1
PMID:19572804	(2009) Mechanism of human natural killer cell activation by Haemophilus ducreyi.	6	35	1.3	0.00066	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:20003325	(2009) Inhibition of SOCCa2+NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells.	5	18	1.5	0.00066	9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000419313	EDNRA,EDN1,BCL2,RHOA,TRPC1
PMID:20017978	(2009) Influence of control selection in genome-wide association studies: the example of diabetes in the Framingham Heart Study.	5	18	1.5	0.00066	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,KCNJ11,FTO,HNF1B
PMID:20111736	(2009) Identification of compounds that inhibit IGF-I signaling in hyperglycemia.	5	18	1.5	0.00066	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000355361,9606.ENSP00000478570	THBS1,IGF1R,MMP14,CD47,VEGFA
PMID:18377664	(2008) Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination.	6	35	1.3	0.00066	9606.ENSP00000259486,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000484631	ENPP2,GAP43,NPY,RHOA,BDNF,PMP22
PMID:18423023	(2008) Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.	5	18	1.5	0.00066	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000478570	CD38,THBS1,CD34,BCL2,VEGFA
PMID:18554315	(2008) The microRNAs involved in human myeloid differentiation and myelogenousmyeloblastic leukemia.	6	35	1.3	0.00066	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000362410,9606.ENSP00000381185,9606.ENSP00000419422	CD38,CD34,PDGFB,MAFB,BCL2,AGTR1
PMID:18604295	(2008) Preclinical evidence for the benefits of penile rehabilitation therapy following nerve-sparing radical prostatectomy.	5	18	1.5	0.00066	9606.ENSP00000221930,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,EDN1,NTF3,BDNF,VEGFA
PMID:18627346	(2008) Oxidative stress impairs endothelial progenitor cell function.	5	18	1.5	0.00066	9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000426809,9606.ENSP00000478570	CD34,MAP3K5,TXN,PROM1,VEGFA
PMID:18671680	(2008) The roles of CD8 central and effector memory T-cell subsets in allograft rejection.	5	18	1.5	0.00066	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:18678732	(2008) Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	MPO,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:18974148	(2008) Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.	5	18	1.5	0.00066	9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	PRKCE,PTGS2,AR,BCL2,VEGFA
PMID:19112152	(2008) Chemistry and antihypertensive effects of tempol and other nitroxides.	6	35	1.3	0.00066	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000419422	MPO,PTGS2,NOX1,EDN1,G6PD,AGTR1
PMID:17979881	(2007) Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.	6	35	1.3	0.00066	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CCR5,CD34,EDN1,CCL5,VEGFA
PMID:15661933	(2005) A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis.	6	35	1.3	0.00066	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:9733590	(1998) The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells.	6	35	1.3	0.00066	9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000393312,9606.ENSP00000478570	IGF1R,PDGFB,PDGFA,CNTF,FGFR1,VEGFA
PMID:32222998	(2021) Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived Organoids.	9	116	0.95	0.00067	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000384957,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,HSPB1,ONECUT1,HNF4A,PDGFA,ALPL,F11,PROM1,HNF1B
PMID:33763422	(2021) MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.	9	116	0.95	0.00067	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:33979628	(2021) Integrated OMICs unveil the bone-marrow microenvironment in human leukemia.	9	116	0.95	0.00067	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000363973,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478319	MPO,THBS1,CD34,PDGFB,CXCL9,ALPL,AGTR1,CCL5,GREM1
PMID:34638302	(2021) Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation.	9	116	0.95	0.00067	9606.ENSP00000278616,9606.ENSP00000310520,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000418823,9606.ENSP00000426809	ATM,ERCC4,STAT5A,PTEN,NOX1,JAK2,NFE2L2,FTO,PROM1
PMID:32466294	(2020) Transcriptomic Response of Breast Cancer Cells MDA-MB-231 to Docosahexaenoic Acid: Downregulation of Lipid and Cholesterol Metabolism Genes and Upregulation of Genes of the Pro-Apoptotic ER-Stress Pathway.	9	116	0.95	0.00067	9606.ENSP00000221930,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000334329,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185	TGFB1,FADS2,LPL,CD34,UNC5B,SREBF1,PTGS2,NFE2L2,BCL2
PMID:32760201	(2020) The Role of Interleukins in Colorectal Cancer.	9	116	0.95	0.00067	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,CDH1,STAT5A,CNTF,PTEN,JAK2,BCL2,MYD88,VEGFA
PMID:26421274	(2015) An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.	9	116	0.95	0.00067	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000385834,9606.ENSP00000393312,9606.ENSP00000478570	MPO,CDH1,TIMP3,STAT5A,PDGFA,PTEN,TF,FGFR1,VEGFA
PMID:27600067	(2015) SNP Array in Hematopoietic Neoplasms: A Review.	9	116	0.95	0.00067	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185	TGFB1,ATM,CD34,EBF1,PTEN,MAFB,BMP2,JAK2,BCL2
PMID:35047109	(2022) The Oxidative Balance Orchestrates the Main Keystones of the Functional Activity of Cardiomyocytes.	8	85	1.03	0.00068	9606.ENSP00000215832,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356515,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252	MAPK1,NOX4,ELN,UTRN,NOX1,TXN,EDN1,NFE2L2
PMID:35062368	(2022) Immune Profiling of COVID-19 in Correlation with SARS and MERS.	8	85	1.03	0.00068	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CCL20,CXCL9,JAK2,MYD88,CCL5,VEGFA
PMID:35432323	(2022) Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.	8	85	1.03	0.00068	9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000334329,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	HSPB1,VDAC1,LPL,UNC5B,ABCG1,BCL2,MYD88,VEGFA
PMID:33746673	(2021) Role and application of stem cells in dental regeneration: A comprehensive overview.	8	85	1.03	0.00068	9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	HNF4A,BMP2,FGFR1,NTF3,RHOA,BDNF,MME,VEGFA
PMID:34199169	(2021) The Role of Prostaglandins in Different Types of Cancer.	8	85	1.03	0.00068	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000444198	CDH1,STAT5A,PTGS2,CYP2J2,PTEN,AR,BCL2,CITED2
PMID:32560120	(2020) Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia.	8	85	1.03	0.00068	9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	ONECUT1,CXCL10,SIRT6,SREBF1,CCL20,CXCL9,MYD88,CCL5
PMID:33172072	(2020) The Roles of Non-Coding RNAs in Tumor-Associated Lymphangiogenesis.	8	85	1.03	0.00068	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,ANGPT2,PTGS2,PTEN,BMP2,JAK2,BDNF,VEGFA
PMID:33246476	(2020) Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine.	8	85	1.03	0.00068	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CD34,ELN,PTGS2,PTEN,BMP2,BCL2,MME,VEGFA
PMID:31198853	(2019) Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes.	8	85	1.03	0.00068	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,NOX4,IGF1R,CAV1,ELN,FGFR1,CCL5,VEGFA
PMID:31396666	(2019) Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimers disease.	8	85	1.03	0.00068	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000331831,9606.ENSP00000358513,9606.ENSP00000360250,9606.ENSP00000401399	TGFB1,CHI3L1,CXCL10,LPL,GAS6,CNR1,ENTPD1,MYD88
PMID:31861484	(2019) Molecular Signaling Regulating Endometrium-Blastocyst Crosstalk.	8	85	1.03	0.00068	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,TIMP3,IGF1R,PTGS2,BMP2,BCL2,VEGFA
PMID:29459857	(2018) Genome-Wide Bimolecular Fluorescence Complementation-Based Proteomic Analysis of Toxoplasma gondii ROP18s Human Interactome Shows Its Key Role in Regulation of Cell Immunity and Apoptosis.	8	85	1.03	0.00068	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000357726,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000384906	IGF1R,ATM,CXCL10,CXCL11,S100A12,BCL2,NPY,SAA1
PMID:29462882	(2018) Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling.	8	85	1.03	0.00068	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	TGFB1,CDH1,IGF1R,CAV1,AR,JAK2,FGFR1,VEGFA
PMID:29766399	(2018) Consensus guidelines for the use and interpretation of angiogenesis assays.	8	85	1.03	0.00068	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CD38,IFNG,CD34,ANGPT2,PDGFB,BCL2,FGFR1,VEGFA
PMID:29928478	(2018) An NFkappaB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features.	8	85	1.03	0.00068	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000477707	IFNG,CDH1,ALDH1A1,AR,JAK2,PROM1,CCL5,NR1H3
PMID:28141856	(2017) Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.	8	85	1.03	0.00068	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000474412	CHI3L1,CCR5,CXCL10,CXCL11,STAT5A,CXCL9,NFE2L2,CCL5
PMID:29085361	(2017) Disease-Associated Plasmacytoid Dendritic Cells.	8	85	1.03	0.00068	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000401399,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,VIP,MYD88,RARRES2,CCL5,VEGFA
PMID:27058560	(2016) The NF-kappaB Pathway and Cancer Stem Cells.	8	85	1.03	0.00068	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD34,PTEN,BCL2,MYD88,PROM1,CCL5,VEGFA
PMID:26000333	(2015) Strategies to minimize hypertrophy in cartilage engineering and regeneration.	8	85	1.03	0.00068	9606.ENSP00000245479,9606.ENSP00000356438,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,PTGS2,ALPL,BMP2,BCL2,RHOA,GREM1,VEGFA
PMID:26556341	(2015) Alzheimers Disease: Mechanism and Approach to Cell Therapy.	8	85	1.03	0.00068	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	HSPB1,IGF1R,MAP3K5,BCL2,MYD88,BDNF,MME,VEGFA
PMID:26635790	(2015) The Interplay Between MonocytesMacrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis.	8	85	1.03	0.00068	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CCL20,ENTPD1,BCL2,CCL5,VEGFA
PMID:22979947	(2012) Nuclear Factor kappa B is central to Mareks disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.	8	85	1.03	0.00068	9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,HNF4A,STAT5A,CCL20,PTEN,BCL2,CCL5,VEGFA
PMID:23728973	(2012) Peripheral chemoreceptors: function and plasticity of the carotid body.	8	85	1.03	0.00068	9606.ENSP00000263317,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000419313,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,EDN1,NPY,BDNF,MME,TRPC1,AGTR1,VEGFA
PMID:19937461	(2010) CAS proteins in normal and pathological cell growth control.	8	85	1.03	0.00068	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412	CDH1,MMP14,CAV1,CCL20,PTEN,JAK2,RHOA,CCL5
PMID:34534372	(2022) Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection.	7	58	1.14	0.00069	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000390651,9606.ENSP00000480291	IFNG,CXCL10,CD34,CAV1,AR,IRAK4,HNF1B
PMID:34908111	(2022) Circular RNAs in stem cells: from basic research to clinical implications.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000363973,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,SIRT6,SREBF1,ALPL,JAK2,PROM1,VEGFA
PMID:35251314	(2022) Molecular imaging of tumor-associated macrophages in cancer immunotherapy.	7	58	1.14	0.00069	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,ANGPT2,CCL20,CD47,CCL5,VEGFA
PMID:35310965	(2022) Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000383364,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000478570	MPO,LPL,ELN,PLA2G2A,SAA1,MYD88,VEGFA
PMID:33526969	(2021) Macrophage Polarization and Liver Ischemia-Reperfusion Injury.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000403495	MPO,CXCL10,CXCL11,CXCL9,NFE2L2,MYD88,LTA
PMID:33672062	(2021) Lipotoxic Impairment of Mitochondrial Function in beta-Cells: A Review.	7	58	1.14	0.00069	9606.ENSP00000246553,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185	FFAR1,SIRT6,CAV1,SREBF1,PTEN,TXN,BCL2
PMID:33673612	(2021) Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000297785,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809	SOX9,APC,ALDH1A1,NOX1,BCL2,MYD88,PROM1
PMID:33853929	(2021) Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.	7	58	1.14	0.00069	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000322898,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525	CD38,CD69,EBF1,CD247,PTEN,BCL2,MME
PMID:33920898	(2021) The Impact of the Ca(2+)-Independent Phospholipase A2beta (iPLA2beta) on Immune Cells.	7	58	1.14	0.00069	9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000383364,9606.ENSP00000403495,9606.ENSP00000445772	NOX4,SREBF1,PTGS2,NOX1,PLA2G2A,LTA,LTB4R2
PMID:34063253	(2021) Preventive Healthcare and Management for Acute Lymphoblastic Leukaemia in Adults: Case Report and Literature Review.	7	58	1.14	0.00069	9606.ENSP00000222139,9606.ENSP00000265333,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	EPOR,VDAC1,CD34,PTEN,JAK2,BCL2,MME
PMID:34246984	(2021) Plasma proteome alterations by MAPK inhibitors in BRAF(V600)-mutated metastatic cutaneous melanoma.	7	58	1.14	0.00069	9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,CHI3L1,CXCL10,CXCL11,ANGPT2,CCL20,CXCL9
PMID:34281192	(2021) The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease.	7	58	1.14	0.00069	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ANGPT2,PDGFB,PDGFA,EDN1,CCL5,VEGFA
PMID:34359633	(2021) Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression.	7	58	1.14	0.00069	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,CD47,PTEN,CCL5
PMID:34447368	(2021) IP-10 Promotes Latent HIV Infection in Resting Memory CD4(+) T Cells via LIMK-Cofilin Pathway.	7	58	1.14	0.00069	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CD69,IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9
PMID:34571905	(2021) The Interplay between Glioblastoma and Its Microenvironment.	7	58	1.14	0.00069	9606.ENSP00000292303,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL9,CD47,PDGFD,PROM1,CCL5,VEGFA
PMID:34572948	(2021) The Role of Extracellular HSP70 in the Function of Tumor-Associated Immune Cells.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,STAT5A,BCL2,MYD88,CCL5,VEGFA
PMID:34580816	(2021) mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication.	7	58	1.14	0.00069	9606.ENSP00000278840,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	FADS2,HNF4A,SREBF1,SGK1,PTEN,NFE2L2,VEGFA
PMID:34685572	(2021) Lymphatic Clearance of Immune Cells in Cardiovascular Disease.	7	58	1.14	0.00069	9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	ANGPT2,CCL20,ELN,HSPG2,MYD88,CCL5,VEGFA
PMID:34778084	(2021) Long Non-Coding RNA: A Potential Strategy for the Diagnosis and Treatment of Colorectal Cancer.	7	58	1.14	0.00069	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000479617	TGFB1,CDH1,ALDH1A1,HNF4A,NFE2L2,RHOA,UHRF1
PMID:34830398	(2021) Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?	7	58	1.14	0.00069	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,TGFB1,ATM,CD34,PTEN,JAK2,BCL2
PMID:35008644	(2021) Mechanisms of Melatonin in Obesity: A Review.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000380252	MPO,FABP4,PLIN1,SREBF1,MAP3K5,PTGS2,NFE2L2
PMID:35069173	(2021) Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods.	7	58	1.14	0.00069	9606.ENSP00000013807,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000362410,9606.ENSP00000414303,9606.ENSP00000478570	ERCC1,IFNG,CD34,GAS6,MAFB,BDNF,VEGFA
PMID:32050423	(2020) Differential Regulation of circRNA, miRNA, and piRNA during Early Osteogenic and Chondrogenic Differentiation of Human Mesenchymal Stromal Cells.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000261037,9606.ENSP00000278840,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000393312	SOX9,COL8A1,FADS2,CD34,ALPL,BMP2,FGFR1
PMID:32210335	(2020) OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine.	7	58	1.14	0.00069	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,ATM,PTEN,JAK2,BCL2,BDNF,VEGFA
PMID:32244804	(2020) Tumor Milieu Controlled by RB Tumor Suppressor.	7	58	1.14	0.00069	9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	CXCL10,PTGS2,PTEN,AR,CCL5,APLNR,VEGFA
PMID:32435657	(2020) Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies.	7	58	1.14	0.00069	9606.ENSP00000200676,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000478570	CETP,IFNG,HSPB1,PLIN1,SREBF1,BCL2,VEGFA
PMID:32824702	(2020) Stemness Potency of Human Gingival Cells-Application in Anticancer Therapies and Clinical Trials.	7	58	1.14	0.00069	9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,SREBF1,ENTPD1,BCL2,NTF3,BDNF,VEGFA
PMID:33053909	(2020) p38beta and Cancer: The Beginning of the Road.	7	58	1.14	0.00069	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000478570	ERCC1,HSPB1,ATM,PRKCE,MAPK7,MAP3K5,VEGFA
PMID:33117340	(2020) Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.	7	58	1.14	0.00069	9606.ENSP00000256104,9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683	FABP4,DDAH1,CXCL10,CXCL11,ELN,CXCL9,EDN1
PMID:33195249	(2020) Integrin-Ligand Interactions in Inflammation, Cancer, and Metabolic Disease: Insights Into the Multifaceted Roles of an Emerging Ligand Irisin.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CDH1,CD47,PDGFD,BCL2,MYD88,VEGFA
PMID:33240441	(2020) The influence of secreted factors and extracellular vesicles in ovarian cancer metastasis.	7	58	1.14	0.00069	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	FABP4,CDH1,ANGPT2,JAK2,BCL2,RHOA,VEGFA
PMID:33292283	(2020) Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3KAktmTOR pathway: go four better to treat bladder cancer.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,SREBF1,SGK1,PTEN,BCL2,VEGFA
PMID:30328686	(2019) Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success.	7	58	1.14	0.00069	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ALDH1A1,CD34,CD47,BCL2,PROM1,VEGFA
PMID:30531065	(2019) Peripheral nerve regeneration and intraneural revascularization.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000284031,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000484631	MPO,DDAH1,CNTF,VIP,BDNF,VEGFA,PMP22
PMID:30984006	(2019) Emerging Roles of miRNAs in Brain Development and Perinatal Brain Injury.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000361021,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,PTEN,IRAK4,RHOA,MYD88,BDNF,VEGFA
PMID:29332042	(2018) Protective Effects of Indian Spice Curcumin Against Amyloid-beta in Alzheimers Disease.	7	58	1.14	0.00069	9606.ENSP00000306884,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525	CXCL11,CD2AP,PTEN,NFE2L2,BCL2,BDNF,MME
PMID:29523213	(2018) Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine.	7	58	1.14	0.00069	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000418525,9606.ENSP00000478570	IGF1R,CD34,PTEN,BCL2,LTA,MME,VEGFA
PMID:29616220	(2018) The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.	7	58	1.14	0.00069	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,ELN,CXCL9,CCL5,VEGFA
PMID:30155439	(2018) Computational Structural Biology of S-nitrosylation of Cancer Targets.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CAV1,PTEN,CNR2,TXN,BCL2,VEGFA
PMID:30180883	(2018) Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD47,PTEN,AR,BCL2,PROM1,VEGFA
PMID:30233418	(2018) Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis.	7	58	1.14	0.00069	9606.ENSP00000222572,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000478570	PON2,CXCL10,ANGPT2,PTGS2,RBP4,EDN1,VEGFA
PMID:28137265	(2017) Targeting acute myeloid leukemia stem cell signaling by natural products.	7	58	1.14	0.00069	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD34,STAT5A,CD47,PTEN,BCL2,VEGFA
PMID:28167649	(2017) Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses.	7	58	1.14	0.00069	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,GAS6,ENTPD1,BCL2,CCL5,VEGFA
PMID:28487653	(2017) Chinese Herbal Medicines Attenuate Acute Pancreatitis: Pharmacological Activities and Mechanisms.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000293599,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000383364	MPO,AQP5,CAV1,MAP3K5,PTGS2,BCL2,PLA2G2A
PMID:28567372	(2017) Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000368104,9606.ENSP00000369442,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,IGF1R,BMP2,KL,JAK2,MYD88,VEGFA
PMID:28758305	(2017) Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.	7	58	1.14	0.00069	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000400175	TGFB1,MPO,CD38,IFNG,CCL20,PTGS2,RHOA
PMID:29137331	(2017) HDAC inhibitors enhance the immunotherapy response of melanoma cells.	7	58	1.14	0.00069	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CD69,IFNG,HSPB1,STAT5A,CXCL9,PTEN,CCL5
PMID:29379583	(2017) Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.	7	58	1.14	0.00069	9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,MAPK7,HNF4A,SREBF1,PTEN,BCL2,VEGFA
PMID:27598148	(2016) Melanoma Brain Metastasis: Mechanisms, Models, and Medicine.	7	58	1.14	0.00069	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000384262,9606.ENSP00000397297,9606.ENSP00000478570	CXCL10,ANGPT2,PTEN,HSPG2,HPSE,NTF3,VEGFA
PMID:27608835	(2016) Interaction of MSC with tumor cells.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CCL20,ELN,PROM1,CCL5,VEGFA
PMID:25571978	(2015) Biological targets and mechanisms of action of natural products from marine cyanobacteria.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000401720,9606.ENSP00000478570	CDH1,IGF1R,SIRT6,BMP2,BCL2,GK,VEGFA
PMID:25703786	(2015) Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system.	7	58	1.14	0.00069	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000477707	CCR5,CXCL10,LPL,LPA,JAK2,MYD88,NR1H3
PMID:25797907	(2015) Human mesenchymal stem cells - current trends and future prospective.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000478570	SOX9,LPL,CD34,HNF4A,BMP2,NTF3,VEGFA
PMID:25934522	(2015) Molecular staging of gynecological cancer: What is the future?	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	CDH1,PTGS2,PTEN,BCL2,PROM1,VEGFA,HNF1B
PMID:25965781	(2015) An ex vivo model for studying hepatic schistosomiasis and the effect of released protein from dying eggs.	7	58	1.14	0.00069	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000474412	CXCL10,LPL,CCL20,CXCL9,SAA1,IRAK4,CCL5
PMID:26528540	(2015) Identification of Pathways Mediating Growth Differentiation Factor5-Induced Tenogenic Differentiation in Human Bone Marrow Stromal Cells.	7	58	1.14	0.00069	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,ATM,CD34,ALPL,PLA2G2A,RHOA,VEGFA
PMID:24719615	(2014) Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies.	7	58	1.14	0.00069	9606.ENSP00000226760,9606.ENSP00000264717,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823	WFS1,GCKR,JAZF1,HNF4A,KCNJ11,CAPN10,FTO
PMID:27774466	(2014) HIF-mediated innate immune responses: cell signaling and therapeutic implications.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000356438,9606.ENSP00000478570	MPO,THBS1,CCR5,PDGFB,UNC5B,PTGS2,VEGFA
PMID:23360156	(2013) Dry eye as a mucosal autoimmune disease.	7	58	1.14	0.00069	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CXCL9,BCL2,CCL5,VEGFA
PMID:23983766	(2013) The controversial role of microglia in malignant gliomas.	7	58	1.14	0.00069	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,MMP14,STAT5A,JAK2,MYD88,PROM1,VEGFA
PMID:24066673	(2013) FGF2-induced effects on transcriptome associated with regeneration competence in adult human fibroblasts.	7	58	1.14	0.00069	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000356438,9606.ENSP00000363827	MAPK1,TGFB1,LAMC1,COL8A1,TIMP3,PTGS2,HSPG2
PMID:24228024	(2013) Anti-cancer Therapies in High Grade Gliomas.	7	58	1.14	0.00069	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,ANGPT2,PTEN,PROM1,VEGFA
PMID:23319948	(2012) Early detection biomarkers for ovarian cancer.	7	58	1.14	0.00069	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CHI3L1,CDH1,ALDH1A1,CAV1,PTEN,BCL2,PROM1
PMID:21461315	(2011) Aging of the Innate Immune System: An Update.	7	58	1.14	0.00069	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CD34,STAT5A,MYD88,CCL5,VEGFA
PMID:18632600	(2008) XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from molecular pathogenesis to targeted therapy in leukemia and solid tumors.	7	58	1.14	0.00069	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,CDH1,CD34,STAT5A,TXN,JAK2,BCL2
PMID:10974036	(2000) Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.	7	58	1.14	0.00069	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CD34,CCL20,CXCL9,CCL5
PMID:33891889	(2021) Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.	9	117	0.95	0.00070	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000363641	CD38,IFNG,CHI3L1,CCR5,CXCL10,CXCL11,CXCL9,S100A12,TXN
PMID:34283060	(2021) Molecular Update and Evolving Classification of Large B-Cell Lymphoma.	9	117	0.95	0.00070	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	CD38,CD69,SGK1,PTEN,JAK2,BCL2,RHOA,MYD88,MME
PMID:34325734	(2021) Cellular senescence or stemness: hypoxia flips the coin.	9	117	0.95	0.00070	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,ATM,CD34,CAV1,SREBF1,PTEN,BCL2,PROM1,VEGFA
PMID:28445439	(2017) HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.	9	117	0.95	0.00070	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000426809	APC,CDH1,ALDH1A1,HNF4A,STAT5A,PTEN,JAK2,RHOA,PROM1
PMID:24864266	(2014) Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.	9	117	0.95	0.00070	9606.ENSP00000226760,9606.ENSP00000278616,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000351908,9606.ENSP00000375844,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,ATM,JAZF1,HNF4A,KCNJ11,MAP3K5,CAPN10,FTO,HNF1B
PMID:33723519	(2022) Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,LTA,BDNF,CCL5,VEGFA
PMID:34617194	(2022) Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	CD38,THBS1,CXCL9,EDN1,FGFR1,VEGFA
PMID:34846222	(2022) The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185	MPO,CDH1,NOX4,JAK2,NFE2L2,BCL2
PMID:35055049	(2022) Changes in the Transcriptome Profiles of Human Amnion-Derived Mesenchymal StromalStem Cells Induced by Three-Dimensional Culture: A Potential Priming Strategy to Improve Their Properties.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000414303	TGFB1,CHI3L1,CCL20,PTGS2,BMP2,BDNF
PMID:35163279	(2022) Wnt and PI3KAktmTOR Survival Pathways as Therapeutic Targets in Glioblastoma.	8	86	1.03	0.00073	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,MAPK7,STAT5A,PTEN,BCL2,RHOA,PROM1,VEGFA
PMID:35205744	(2022) Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses.	8	86	1.03	0.00073	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000426809	ERCC1,CDH1,ATM,ALDH1A1,CD47,PTEN,TXN,PROM1
PMID:35228642	(2022) STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,IGF1R,STAT5A,JAK2,BCL2,FGFR1
PMID:33477354	(2021) The Multifaced Actions of Curcumin in Pregnancy Outcome.	6	36	1.28	0.00073	9606.ENSP00000256104,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,PTGS2,JAK2,NFE2L2,BCL2,VEGFA
PMID:33582384	(2021) Assessing the effect of human mesenchymal stem cell-derived conditioned media on human cancer cell lines: A systematic review.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,CXCL9,JAK2,CCL5,VEGFA
PMID:33628741	(2021) Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.	6	36	1.28	0.00073	9606.ENSP00000257430,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000360250	APC,CCR5,CXCL10,CXCL9,PTGS2,ENTPD1
PMID:33681210	(2021) Tendon StemProgenitor Cell Subpopulations and Their Implications in Tendon Biology.	6	36	1.28	0.00073	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000444198	SOX9,TIMP3,CD34,FMOD,BMP2,CITED2
PMID:33777815	(2021) Hypoxia in Breast Cancer-Scientific Translation to Therapeutic and Diagnostic Clinical Applications.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,MMP14,BCL2,CCL5,VEGFA
PMID:33801899	(2021) Anti-Tumor Drug Discovery Based on Natural Product beta-Elemene: Anti-Tumor Mechanisms and Structural Modification.	8	86	1.03	0.00073	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CDH1,ATM,CD34,PTEN,JAK2,BCL2,VEGFA
PMID:33808631	(2021) Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,PTGS2,CCL5
PMID:33810515	(2021) Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia.	8	86	1.03	0.00073	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000478570	CD38,IGF1R,CXCL10,CD247,CD47,JAK2,MME,VEGFA
PMID:33923318	(2021) Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4).	6	36	1.28	0.00073	9606.ENSP00000246553,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000401399	FFAR1,NOX4,SREBF1,NOX1,KL,MYD88
PMID:33953223	(2021) Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,PTGS2,BCL2,BDNF,CCL5,VEGFA
PMID:33968752	(2021) Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,TIMP3,MMP14,ELN,PTEN,VEGFA
PMID:34012921	(2021) Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia.	8	86	1.03	0.00073	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000357726,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CD69,FABP4,CD34,S100A12,PTEN,BCL2,VEGFA
PMID:34072943	(2021) Proangiogenic Effect of 2A-Peptide Based Multicistronic Recombinant Constructs Encoding VEGF and FGF2 Growth Factors.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,BCL2,FGFR1,LTA,CCL5,VEGFA
PMID:34122342	(2021) Current and Future Roles of Circular RNAs in Normal and Pathological Endometrium.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,ENTPD1,BCL2,VEGFA
PMID:34206588	(2021) Anthocyanins: Promising Natural Products with Diverse Pharmacological Activities.	6	36	1.28	0.00073	9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303	FABP4,CDH1,IGF1R,EDN1,BCL2,BDNF
PMID:34206761	(2021) Quercetin: A Bioactive Compound Imparting Cardiovascular and Neuroprotective Benefits: Scope for Exploring Fresh Produce, Their Wastes, and By-Products.	6	36	1.28	0.00073	9606.ENSP00000222572,9606.ENSP00000351908,9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303	PON2,MAP3K5,GLO1,TXN,BCL2,BDNF
PMID:34209376	(2021) Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?	8	86	1.03	0.00073	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185	CD38,IFNG,CD34,HNF4A,STAT5A,BMP2,JAK2,BCL2
PMID:34217971	(2021) Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.	6	36	1.28	0.00073	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000356515,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000400175	ERCC1,ATM,UTRN,PTEN,AR,RHOA
PMID:34278852	(2021) The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067	CDH1,CXCL10,HNF4A,STAT5A,PTEN,JAK2
PMID:34337369	(2021) Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.	6	36	1.28	0.00073	9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	JAK2,NFE2L2,NPY,RHOA,CCL5,VEGFA
PMID:34361788	(2021) Pharmacoinformatics and UPLC-QTOFESI-MS-Based Phytochemical Screening of Combretum indicum against Oxidative Stress and Alloxan-Induced Diabetes in Long-Evans Rats.	6	36	1.28	0.00073	9606.ENSP00000013807,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310520,9606.ENSP00000351671,9606.ENSP00000384364	ERCC1,CXCL10,CXCL11,ERCC4,CCL20,NPY
PMID:34371691	(2021) Hydroxycinnamic Acids and Derivatives Formulations for Skin Damages and Disorders: A Review.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000390651,9606.ENSP00000401399	TGFB1,PTGS2,JAK2,NFE2L2,IRAK4,MYD88
PMID:34466225	(2021) The immunological link between neonatal lung and eye disease.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,ELN,BCL2,BDNF,VEGFA
PMID:34528694	(2021) Abnormally elevated ubiquilin-1 expression in breast cancer regulates metastasis and stemness via AKT signaling.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,IGF1R,ALDH1A1,CD47,PTEN,BCL2
PMID:34646394	(2021) Proteomic analysis of lung cancer cells reveals a critical role of BCAT1 in cancer cell metastasis.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000321334,9606.ENSP00000361021,9606.ENSP00000426809	IFNG,FABP4,CDH1,LPA,PTEN,PROM1
PMID:34745420	(2021) The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD.	8	86	1.03	0.00073	9606.ENSP00000263317,9606.ENSP00000302630,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000418823	NOX4,ONECUT1,SIRT6,SREBF1,NOX1,AR,NFE2L2,FTO
PMID:34760005	(2021) Anti-angiogenic peptides application in cancer therapy; a review.	6	36	1.28	0.00073	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,MMP14,ANGPT2,BCL2,CCL5,VEGFA
PMID:34765268	(2021) Recent advances in research on vine tea, a potential and functional herbal tea with dihydromyricetin and myricetin as major bioactive compounds.	6	36	1.28	0.00073	9606.ENSP00000354511,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	COMT,ABCG1,PTGS2,JAK2,BCL2,BDNF
PMID:34769176	(2021) Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,NOX4,CD34,ELN,RHOA,VEGFA
PMID:34778803	(2021) NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000418525	CD38,AMBP,CD34,CD247,ENTPD1,MME
PMID:34884842	(2021) An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Stills Disease.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000357726	MPO,IFNG,CXCL10,CXCL11,CXCL9,S100A12
PMID:34948455	(2021) Molecular Targets of Natural Compounds with Anti-Cancer Properties.	8	86	1.03	0.00073	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CDH1,CXCL10,STAT5A,PTGS2,PTEN,BCL2,VEGFA
PMID:35004698	(2021) CCRL2 Modulates Physiological and Pathological Angiogenesis During Retinal Development.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000445772	IFNG,CXCL10,CXCL11,CXCL9,RARRES2,LTB4R2
PMID:32053875	(2020) MAIT Cells Come to the Rescue in Cancer Immunotherapy?	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000330382,9606.ENSP00000360250,9606.ENSP00000478570	TGFB1,CD38,CD69,PDGFB,ENTPD1,VEGFA
PMID:32060354	(2020) ROS in cancer therapy: the bright side of the moon.	6	36	1.28	0.00073	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PTEN,TXN,NFE2L2,BCL2,VEGFA
PMID:32148497	(2020) Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,ENTPD1,CCL5,VEGFA
PMID:32184663	(2020) The Role of Inhaled Anesthetics in Tumorigenesis and Tumor Immunity.	6	36	1.28	0.00073	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CAV1,BCL2,RHOA,CCL5,VEGFA
PMID:32199248	(2020) Profiling inflammatory response in lesions of cutaneous leishmaniasis patients using a non-invasive sampling method combined with a high-throughput protein detection assay.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000403495	CXCL10,CXCL11,CCL20,CXCL9,S100A12,LTA
PMID:32260071	(2020) The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance.	8	86	1.03	0.00073	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000305651,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CXCL10,GAS6,CD47,BCL2,PROM1,VEGFA
PMID:32274319	(2020) Smart Hydrogels for the Augmentation of Bone Regeneration by Endogenous Mesenchymal Progenitor Cell Recruitment.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ALPL,BMP2,CCL5,VEGFA
PMID:32489469	(2020) The Power of Phytochemicals Combination in Cancer Chemoprevention.	6	36	1.28	0.00073	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	PTGS2,PTEN,AR,BCL2,MYD88,VEGFA
PMID:32574710	(2020) Psoriatic arthritis under the influence of IFNgamma.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067	CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2
PMID:32685487	(2020) Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.	6	36	1.28	0.00073	9606.ENSP00000261037,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	COL8A1,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:32759751	(2020) Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders.	8	86	1.03	0.00073	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,IFNG,NOX4,LPL,SREBF1,BCL2,BDNF,VEGFA
PMID:32849585	(2020) The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.	8	86	1.03	0.00073	9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,MMP14,STAT5A,ENTPD1,PTEN,NFE2L2,CCL5,VEGFA
PMID:32933002	(2020) Altered Secretome and ROS Production in Olfactory Mucosa Stem Cells Derived from Friedreichs Ataxia Patients.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000351671,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,SOX9,CCL20,BDNF,PROM1,VEGFA
PMID:33042011	(2020) Circadian Genes as Therapeutic Targets in Pancreatic Cancer.	8	86	1.03	0.00073	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000363641,9606.ENSP00000426809	CD38,CDH1,ATM,ALDH1A1,HNF4A,KCNJ11,TXN,PROM1
PMID:33096812	(2020) Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,PTGS2,LTA,CCL5,VEGFA
PMID:33167307	(2020) Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses.	6	36	1.28	0.00073	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,TIMP3,MMP14,MME,AGTR1,VEGFA
PMID:33177244	(2020) CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.	6	36	1.28	0.00073	9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	PDGFB,STAT5A,PDGFA,CD47,CCL5,VEGFA
PMID:33209218	(2020) Role of Obesity in the Tumorigenesis of Gastric Cancer.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000418823,9606.ENSP00000478570	CDH1,IGF1R,STAT5A,JAK2,FTO,VEGFA
PMID:33265993	(2020) Peroxiredoxins in Neurodegenerative Diseases.	6	36	1.28	0.00073	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000414303	ATM,PRDX2,MAP3K5,PTEN,TXN,BDNF
PMID:33276687	(2020) The Cellular Prion Protein: A Promising Therapeutic Target for Cancer.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,BCL2,RHOA,PROM1
PMID:33348563	(2020) Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.	6	36	1.28	0.00073	9606.ENSP00000257430,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	APC,CCR5,PTGS2,PTEN,CCL5,VEGFA
PMID:33364931	(2020) The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimers Disease.	8	86	1.03	0.00073	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,SOX9,CXCL10,LPL,VIP,NPY,BDNF,VEGFA
PMID:33584259	(2020) Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CDH1,PTGS2,RHOA,BDNF,VEGFA
PMID:33859967	(2020) Biomarkers in COVID-19: An Up-To-Date Review.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,EDN1,SAA1,AGTR1,CCL5,VEGFA
PMID:28875842	(2019) Targeting CXCL12CXCR4 Axis in Tumor Immunotherapy.	6	36	1.28	0.00073	9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	CXCL11,MMP14,CD34,RHOA,PROM1,VEGFA
PMID:30259123	(2019) Molecular markers in bladder cancer.	6	36	1.28	0.00073	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,TGFB1,CDH1,ATM,BCL2,VEGFA
PMID:30526771	(2019) Cellular senescence: a promising strategy for cancer therapy.	6	36	1.28	0.00073	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	IGF1R,ATM,CAV1,PTEN,BCL2,FGFR1
PMID:30744168	(2019) The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer.	6	36	1.28	0.00073	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,PTEN,JAK2,CCL5
PMID:30823403	(2019) Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimers Disease and Cerebral Ischemic Events.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303	MPO,IGF1R,CNTF,EDN1,BCL2,BDNF
PMID:30881112	(2019) The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix.	6	36	1.28	0.00073	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	TIMP3,MMP14,RHOA,MYD88,PROM1,VEGFA
PMID:31085588	(2019) CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.	6	36	1.28	0.00073	9606.ENSP00000228434,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185	CD69,STAT5A,CD247,ENTPD1,PTEN,BCL2
PMID:31130914	(2019) Potential Applications of Remote Limb Ischemic Conditioning for Chronic Cerebral Circulation Insufficiency.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MPO,CD34,PTEN,JAK2,BCL2,VEGFA
PMID:31205619	(2019) Application of PD-1 Blockade in Cancer Immunotherapy.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CD47,PTEN,VEGFA
PMID:31216637	(2019) Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,PTEN,MTHFR,BCL2,BDNF,VEGFA
PMID:31275532	(2019) Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment.	6	36	1.28	0.00073	9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,ANG,PTEN,NTF3,PROM1,VEGFA
PMID:31480505	(2019) Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels.	6	36	1.28	0.00073	9606.ENSP00000246553,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000400175	FFAR1,PTEN,KL,G6PD,BCL2,RHOA
PMID:31534956	(2019) Effect of Hypoxia on Gene Expression in Cell Populations Involved in Wound Healing.	8	86	1.03	0.00073	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,CXCL10,HNF4A,PDGFA,ELN,CXCL9,BCL2,VEGFA
PMID:31638227	(2019) Gene expression profiling analysis reveals that the long non-coding RNA uc.412 is involved in mesangial cell proliferation.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000304767,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000383364	TGFB1,P2RY1,EDNRA,PTGS2,AR,PLA2G2A
PMID:31781640	(2019) Immunological Aspects of Graves Ophthalmopathy.	6	36	1.28	0.00073	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	IGF1R,CXCL10,CXCL11,CXCL9,PTGS2,CCL5
PMID:31803711	(2019) The Play of Genes and Non-genetic Factors on Type 2 Diabetes.	6	36	1.28	0.00073	9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000418823,9606.ENSP00000480291	JAZF1,HNF4A,KCNJ11,SREBF1,FTO,HNF1B
PMID:31878047	(2019) HB-EGF Improves the Hair Regenerative Potential of Adipose-Derived Stem Cells via ROS Generation and Hck Phosphorylation.	6	36	1.28	0.00073	9606.ENSP00000263317,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000362057,9606.ENSP00000376865,9606.ENSP00000478570	NOX4,PDGFB,PDGFA,NOX1,PDGFD,VEGFA
PMID:29416775	(2018) The DNA methyl-transferase protein DNMT1 enhances tumor-promoting properties of breast stromal fibroblasts.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000371067	CDH1,ALDH1A1,HNF4A,PDGFB,PTEN,JAK2
PMID:29771921	(2018) Mosquito saliva alone has profound effects on the human immune system.	6	36	1.28	0.00073	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CD34,LTA,CCL5,VEGFA
PMID:29790245	(2018) P465L-PPARgamma mutation confers partial resistance to the hypolipidaemic action of fibrates.	6	36	1.28	0.00073	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000384906	FABP4,FADS2,LPL,HNF4A,SREBF1,SAA1
PMID:29869753	(2018) The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone.	6	36	1.28	0.00073	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185	FABP4,FADS2,PLIN1,SREBF1,PTEN,BCL2
PMID:30348892	(2018) Bacterial infections and cancer.	6	36	1.28	0.00073	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	APC,CDH1,ATM,RHOA,MYD88,CCL5
PMID:30361682	(2018) Repression of Mcl-1 expression by the CDC7CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000381185,9606.ENSP00000474412	CD38,CXCL10,CD34,ANGPT2,BCL2,CCL5
PMID:30400641	(2018) Adipose Stem Cell Translational Applications: From Bench-to-Bedside.	6	36	1.28	0.00073	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	LPL,CD34,ELN,PTGS2,EDN1,VEGFA
PMID:30505350	(2018) Advances in therapeutic options for portal hypertension.	6	36	1.28	0.00073	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	EDNRA,ELN,MAP3K5,JAK2,RHOA,VEGFA
PMID:30619298	(2018) Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?	6	36	1.28	0.00073	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000478570	IGF1R,CD34,PDGFB,CAV1,PDGFA,VEGFA
PMID:30648113	(2018) Preserved Expression of Skin Neurotrophic Factors in Advanced Diabetic Neuropathy Does Not Lead to Neural Regeneration despite Pancreas and Kidney Transplantation.	6	36	1.28	0.00073	9606.ENSP00000355370,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,NPY,FGFR1,NTF3,BDNF,VEGFA
PMID:28098771	(2017) Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.	6	36	1.28	0.00073	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000397297	THBS1,ATM,PTGS2,PTEN,HPSE,NTF3
PMID:28102325	(2017) Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses.	6	36	1.28	0.00073	9606.ENSP00000222139,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067	EPOR,THBS1,CXCL10,STAT5A,PTEN,JAK2
PMID:28464824	(2017) Growth and stress response mechanisms underlying post-feeding regenerative organ growth in the Burmese python.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000311005,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252	TGFB1,MAPK7,SREBF1,PTEN,TXN,NFE2L2
PMID:28487844	(2017) Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.	6	36	1.28	0.00073	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	PTGS2,PTEN,AR,BCL2,CCL5,VEGFA
PMID:28630088	(2017) The islet-resident macrophage is in an inflammatory state and senses microbial products in blood.	8	86	1.03	0.00073	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CCR5,PRDX2,CXCL10,CXCL9,PTGS2,MYD88,CCL5
PMID:28783169	(2017) Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.	6	36	1.28	0.00073	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,PDGFB,PTEN,PROM1,VEGFA
PMID:28962587	(2017) Comparative characteristics of laryngeal-resident mesenchymal stromal cell populations isolated from distinct sites in the rat larynx.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,AQP5,CD34,ELN,PROM1,VEGFA
PMID:29022912	(2017) Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000347041,9606.ENSP00000351807	TGFB1,FABP4,PLIN1,LPL,FMOD,ELN
PMID:29152153	(2017) Molecular determinants of prostate cancer metastasis.	10	153	0.88	0.00073	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000480291	SOX9,CDH1,IGF1R,ATM,HNF4A,SREBF1,PTEN,AR,JAK2,HNF1B
PMID:29160038	(2017) Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000371067	MPO,THBS1,ELN,PTGS2,TXN,JAK2
PMID:26062519	(2016) Serum concentrations of HGF and IL-8 in patients with active Graves orbitopathy before and after methylprednisolone therapy.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IGF1R,CXCL10,ANGPT2,CCL5,VEGFA
PMID:26654978	(2016) Role of redoximiRs in fibrogenesis.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000400175	CDH1,NOX4,PTEN,NOX1,NFE2L2,RHOA
PMID:27239103	(2016) Effects of Acute Endurance Exercise on Plasma Protein Profiles of Endurance-Trained and Untrained Individuals over Time.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000357726,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,S100A12,BDNF,CCL5,VEGFA
PMID:27388124	(2016) Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression.	6	36	1.28	0.00073	9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000383364	ATM,PRDX2,MAP3K5,PTEN,TXN,PLA2G2A
PMID:27528260	(2016) Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus.	6	36	1.28	0.00073	9606.ENSP00000222139,9606.ENSP00000266085,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,TIMP3,CNTF,BDNF,PROM1,VEGFA
PMID:27737716	(2016) Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,LTA,CCL5,VEGFA
PMID:27922003	(2016) Blood flow controls bone vascular function and osteogenesis.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,SOX9,ANGPT2,PDGFB,BMP2,VEGFA
PMID:28066424	(2016) Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356438	CD38,CD69,IFNG,CXCL10,CCL20,PTGS2
PMID:25387248	(2015) Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175	IFNG,PTGS2,EDN1,NFE2L2,BCL2,RHOA
PMID:25405367	(2015) Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000419422	CDH1,HNF4A,ANG,STAT5A,PTEN,AGTR1
PMID:25468272	(2015) Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma.	8	86	1.03	0.00073	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,BMP2,LTA,CCL5
PMID:25656826	(2015) Adipocytokines and hepatic fibrosis.	6	36	1.28	0.00073	9606.ENSP00000288266,9606.ENSP00000348069,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000418009,9606.ENSP00000475344	APPL1,SREBF1,RBP4,JAK2,RARRES2,APLNR
PMID:25702227	(2015) Neuroprotection for traumatic brain injury.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,IGF1R,CD47,BCL2,BDNF,VEGFA
PMID:25786132	(2015) Endothelial nitric oxide synthase deficient mice are protected from lipopolysaccharide induced acute lung injury.	6	36	1.28	0.00073	9606.ENSP00000284031,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	DDAH1,CXCL10,CXCL9,RHOA,CCL5,VEGFA
PMID:26097877	(2015) Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD38,SOX9,CD34,PTEN,PROM1,VEGFA
PMID:26113847	(2015) Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:26177468	(2015) Redox implications in adipose tissue (dys)function--A new look at old acquaintances.	6	36	1.28	0.00073	9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,LPL,SREBF1,NOX1,TXN,NFE2L2
PMID:26184557	(2015) Redox regulation of FoxO transcription factors.	8	86	1.03	0.00073	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356832,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000444198	CDH1,NOX4,SIRT6,SREBF1,SGK1,NOX1,TXN,CITED2
PMID:26225992	(2015) Immune Modulation by Vitamin D and Its Relevance to Food Allergy.	6	36	1.28	0.00073	9606.ENSP00000216862,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000360247,9606.ENSP00000369442	CYP24A1,IFNG,CDH1,MAPK7,CYP2J2,KL
PMID:26504486	(2015) Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.	6	36	1.28	0.00073	9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303	MAPK7,PTEN,AR,BCL2,NTF3,BDNF
PMID:24394191	(2014) Signal transduction in podocytes--spotlight on receptor tyrosine kinases.	6	36	1.28	0.00073	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000352264,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000478570	PDGFB,PDGFA,CD2AP,PDGFD,FGFR1,VEGFA
PMID:24518612	(2014) STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,PTEN,JAK2,BCL2,CCL5,VEGFA
PMID:24519699	(2014) Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	CDH1,IGF1R,CAV1,PTEN,BCL2,RHOA
PMID:24599128	(2014) Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000310036,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	CD38,HSPB1,CD34,TXN,NFE2L2,BCL2
PMID:24676492	(2014) New concepts in white adipose tissue physiology.	8	86	1.03	0.00073	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000475344	FABP4,PLIN1,LPL,STAT5A,SREBF1,EDN1,NPY,APLNR
PMID:24807488	(2014) Bladder afferent hyperexcitability in bladder pain syndromeinterstitial cystitis.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000397297	CXCL10,CXCL11,CXCL9,CNTF,PTGS2,NTF3
PMID:24811731	(2014) Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CCR5,ALDH1A1,PLIN1,PROM1,VEGFA
PMID:24934597	(2014) Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000474412	CD38,CD69,CXCL10,CXCL11,STAT5A,CCL5
PMID:25019218	(2014) Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,PTGS2,BCL2,MME
PMID:25054122	(2014) The living aortic valve: From molecules to function.	6	36	1.28	0.00073	9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,BMP2,EDN1,NPY,RHOA,VEGFA
PMID:25277175	(2014) Molecular pathways and targets in prostate cancer.	11	192	0.82	0.00073	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,CDH1,IGF1R,ATM,STAT5A,PTEN,AR,JAK2,FGFR1,MYD88,VEGFA
PMID:25309903	(2014) MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients samples.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312	CDH1,TIMP3,PTEN,AR,BCL2,FGFR1
PMID:25503635	(2014) Eggshell membrane ameliorates hepatic fibrogenesis in human C3A cells and rats through changes in PPARgamma-Endothelin 1 signaling.	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000385834,9606.ENSP00000478570	TGFB1,EDNRA,ELN,EDN1,TF,VEGFA
PMID:22968420	(2013) Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.	6	36	1.28	0.00073	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,MYD88,CCL5
PMID:23862980	(2013) Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.	6	36	1.28	0.00073	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL9,BCL2,CCL5,VEGFA
PMID:24286369	(2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.	6	36	1.28	0.00073	9606.ENSP00000278616,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312,9606.ENSP00000478570	ATM,CD47,PTEN,AR,FGFR1,VEGFA
PMID:24382971	(2013) Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets.	6	36	1.28	0.00073	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:25031656	(2013) Stromal Vascular Cells and Adipogenesis: Cells within Adipose Depots Regulate Adipogenesis.	6	36	1.28	0.00073	9606.ENSP00000256104,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000478570	FABP4,THBS1,CD34,ANGPT2,PDGFB,VEGFA
PMID:22460584	(2012) Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium.	6	36	1.28	0.00073	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	EPOR,CD38,CXCL10,CD34,STAT5A,JAK2
PMID:22899914	(2012) The Redox System in C. elegans, a Phylogenetic Approach.	6	36	1.28	0.00073	9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	PRDX2,MAP3K5,PTEN,NOX1,TXN,NFE2L2
PMID:21302282	(2011) Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress.	6	36	1.28	0.00073	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,NOX4,MMP14,VIP,EDN1,VEGFA
PMID:21788406	(2011) Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration.	6	36	1.28	0.00073	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CCR5,CXCL10,CXCL11,CXCL9,BCL2
PMID:21906447	(2011) [Expressions of receptor tyrosine kinases mRNA and protein in carcinoma of bladder].	6	36	1.28	0.00073	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000478570	TGFB1,IGF1R,ANGPT2,CXCL9,PDGFD,VEGFA
PMID:22087835	(2011) The emerging role of large immunophilin FK506 binding protein 51 in cancer.	6	36	1.28	0.00073	9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	ATM,STAT5A,PTEN,AR,JAK2,BCL2
PMID:22246171	(2011) Is human cytomegalovirus a target in cancer therapy?	6	36	1.28	0.00073	9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,PTGS2,BCL2,PROM1,CCL5,VEGFA
PMID:22259633	(2011) Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,P2RY1,CXCL10,MMP14,CCL5,VEGFA
PMID:22829197	(2011) Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cellprogenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CD69,AMBP,CD34,MME,PROM1
PMID:24212957	(2011) Therapeutic approaches to target cancer stem cells.	6	36	1.28	0.00073	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PTEN,BCL2,PROM1,VEGFA
PMID:20153821	(2010) Roles for the type III TGF-beta receptor in human cancer.	6	36	1.28	0.00073	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000484631	CDH1,MMP14,PTEN,BMP2,PROM1,PMP22
PMID:20339534	(2010) Dissecting interferon-induced transcriptional programs in human peripheral blood cells.	10	153	0.88	0.00073	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000352264,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399	CD38,CD69,CCR5,CXCL10,CXCL11,STAT5A,CD2AP,CXCL9,JAK2,MYD88
PMID:20815913	(2010) Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis.	6	36	1.28	0.00073	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,BCL2,LTA,CCL5,VEGFA
PMID:21105121	(2010) Targeted inhibition of kinases in cancer therapy.	6	36	1.28	0.00073	9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,IGF1R,PTEN,JAK2,FGFR1,VEGFA
PMID:19700031	(2009) Green tea and bone metabolism.	6	36	1.28	0.00073	9606.ENSP00000248553,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	HSPB1,PTGS2,EDN1,BCL2,VEGFA,HNF1B
PMID:19014650	(2008) Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis.	6	36	1.28	0.00073	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,PDGFB,ELN,BCL2,VEGFA
PMID:16846534	(2006) MUC1 alters oncogenic events and transcription in human breast cancer cells.	6	36	1.28	0.00073	9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000478570	TIMP3,PDGFB,PDGFA,MAP3K5,PTGS2,VEGFA
PMID:12370242	(2002) TGFbeta induces GDNF responsiveness in neurons by recruitment of GFRalpha1 to the plasma membrane.	6	36	1.28	0.00073	9606.ENSP00000229135,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000368104,9606.ENSP00000414303	IFNG,CAV1,CNTF,VIP,BMP2,BDNF
PMID:33301129	(2022) The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic Review.	7	59	1.14	0.00074	9606.ENSP00000216862,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	CYP24A1,HSPB1,VDAC1,G6PD,BCL2,MYD88,BDNF
PMID:35011701	(2022) Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias.	9	118	0.94	0.00074	9606.ENSP00000226279,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000390651,9606.ENSP00000401399	CD38,THBS1,CD34,STAT5A,CD247,CD47,PTEN,IRAK4,MYD88
PMID:35163777	(2022) Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.	7	59	1.14	0.00074	9606.ENSP00000013807,9606.ENSP00000297785,9606.ENSP00000345708,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,ALDH1A1,KCNJ11,PTEN,BCL2,PROM1,VEGFA
PMID:35310030	(2022) Nature against Diabetic Retinopathy: A Review on Antiangiogenic, Antioxidant, and Anti-Inflammatory Phytochemicals.	7	59	1.14	0.00074	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:35406748	(2022) Comparative Proteomic Profiling of Ectosomes Derived from Thyroid Carcinoma and Normal Thyroid Cells Uncovers Multiple Proteins with Functional Implications in Cancer.	7	59	1.14	0.00074	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000265333,9606.ENSP00000478570	MPO,CD69,IFNG,HSPB1,THBS1,VDAC1,VEGFA
PMID:35409080	(2022) Transcription Factors with Targeting Potential in Gliomas.	9	118	0.94	0.00074	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384262,9606.ENSP00000400175,9606.ENSP00000477707,9606.ENSP00000478570	MAPK1,IGF1R,PTEN,JAK2,BCL2,HPSE,RHOA,NR1H3,VEGFA
PMID:33077904	(2021) Implications of metabolism-driven myeloid dysfunctions in cancer therapy.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000369816,9606.ENSP00000401399,9606.ENSP00000478570	CD38,IGF1R,ATM,CD34,SHBG,MYD88,VEGFA
PMID:33562380	(2021) Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.	7	59	1.14	0.00074	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000478570	CHI3L1,CDH1,PTEN,SHBG,BCL2,RARRES2,VEGFA
PMID:33748165	(2021) Whats New in the Treatment of Systemic Lupus Erythematosus.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000390651	CD38,IFNG,CXCL10,CXCL11,ANGPT2,JAK2,IRAK4
PMID:33762019	(2021) Perspective of mesenchymal transformation in glioblastoma.	7	59	1.14	0.00074	9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000351671,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,CHI3L1,IGF1R,CCL20,JAK2,RHOA,VEGFA
PMID:33804511	(2021) Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs.	7	59	1.14	0.00074	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000480291	IFNG,SOX9,CDH1,HNF4A,PTEN,PROM1,HNF1B
PMID:33807043	(2021) Articular Chondrocyte Phenotype Regulation through the Cytoskeleton and the Signaling Processes That Originate from or Converge on the Cytoskeleton: Towards a Novel Understanding of the Intersection between Actin Dynamics and Chondrogenic ...	9	118	0.94	0.00074	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000312987,9606.ENSP00000339916,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,SOX9,HSPB1,HNF4A,LIMK2,BMP2,FGFR1,RHOA,VEGFA
PMID:34072312	(2021) Multiple Myeloma Inhibitory Activity of Plant Natural Products.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,ALDH1A1,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:34256839	(2021) Progress in molecular feature of smoldering mantle cell lymphoma.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525	CD38,ATM,CD34,PDGFA,PTEN,BCL2,MME
PMID:34466686	(2021) Reactive oxygen and nitrogen species regulate porcine embryo development during pre-implantation period: A mini-review.	7	59	1.14	0.00074	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,PTGS2,CCL5
PMID:34551771	(2021) Genetic profiling of human bone marrow and adipose tissue-derived mesenchymal stem cells reveals differences in osteogenic signaling mediated by graphene.	7	59	1.14	0.00074	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,SOX9,IGF1R,PDGFA,ALPL,BMP2,VEGFA
PMID:34572387	(2021) New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology.	7	59	1.14	0.00074	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000401399	EPOR,CD38,CD69,CD34,CD247,BCL2,MYD88
PMID:34578920	(2021) The Pro-Health Benefits of Morusin Administration-An Update Review.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,PLIN1,PTGS2,JAK2,BCL2,CCL5,VEGFA
PMID:34621747	(2021) Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy.	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000358513,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412	NOX4,MAP3K5,CNR1,NOX1,BCL2,FGFR1,CCL5
PMID:34676881	(2021) Multi-faceted role of cancer-associated adipocytes in the tumor microenvironment (Review).	7	59	1.14	0.00074	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,FABP4,CCR5,SREBF1,PTGS2,CCL5,VEGFA
PMID:34745048	(2021) Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD38,IFNG,CDH1,CXCL10,CXCL9,CCL5,VEGFA
PMID:34830856	(2021) The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,MMP14,ANGPT2,PTGS2,BCL2,VEGFA
PMID:34903555	(2021) Combinatorial immunotherapy induces tumor-infiltrating CD8(+) T cells with distinct functional, migratory, and stem-like properties.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000383232	CD38,CCR5,CXCL11,HNF4A,CXCL9,ENTPD1,GGT1
PMID:34938184	(2021) Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis.	7	59	1.14	0.00074	9606.ENSP00000225275,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000419422	MPO,PTGS2,PTEN,JAK2,FGFR1,MYD88,AGTR1
PMID:34944732	(2021) Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.	7	59	1.14	0.00074	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185	CXCL10,STAT5A,SREBF1,CCL20,PTEN,NFE2L2,BCL2
PMID:34975465	(2021) Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids.	7	59	1.14	0.00074	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CD69,CD34,HNF4A,PTEN,BCL2,VEGFA
PMID:34987512	(2021) Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000292303,9606.ENSP00000337332,9606.ENSP00000351671,9606.ENSP00000474412	CD38,CD69,AMBP,CCR5,SIRT6,CCL20,CCL5
PMID:35002720	(2021) Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment.	7	59	1.14	0.00074	9606.ENSP00000260356,9606.ENSP00000311005,9606.ENSP00000346148,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000371067	THBS1,MAPK7,PRKAA1,ELN,CD47,EDN1,JAK2
PMID:31399003	(2020) Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns.	7	59	1.14	0.00074	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,ONECUT1,CD34,HNF4A,PTEN,PROM1,HNF1B
PMID:32102237	(2020) Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.	7	59	1.14	0.00074	9606.ENSP00000248553,9606.ENSP00000283928,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399	HSPB1,JAZF1,CXCL10,SREBF1,AR,BCL2,MYD88
PMID:32123491	(2020) Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring.	7	59	1.14	0.00074	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	ATM,PTEN,JAK2,BCL2,RHOA,MYD88,MME
PMID:32185403	(2020) Building sophisticated sensors of extracellular cues that enable mammalian cells to work as doctors in the body.	7	59	1.14	0.00074	9606.ENSP00000222139,9606.ENSP00000246553,9606.ENSP00000354782,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	EPOR,FFAR1,CD247,FGFR1,RHOA,MYD88,VEGFA
PMID:32194404	(2020) Fat Therapeutics: The Clinical Capacity of Adipose-Derived Stem Cells and Exosomes for Human Disease and Tissue Regeneration.	7	59	1.14	0.00074	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	SOX9,CD34,PTEN,BCL2,BDNF,MME,VEGFA
PMID:32215170	(2020) The Emerging Role of Senescence in Ocular Disease.	7	59	1.14	0.00074	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,ATM,CCL20,PTEN,BCL2,CCL5,VEGFA
PMID:32231131	(2020) Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach.	7	59	1.14	0.00074	9606.ENSP00000226760,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	WFS1,CNTF,NFE2L2,MYD88,BDNF,PROM1,VEGFA
PMID:32296643	(2020) Cancer Stem Cells and Its Role in Angiogenesis and Vasculogenic Mimicry in Gastrointestinal Cancers.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,ALDH1A1,CD34,PROM1,CCL5,VEGFA
PMID:32323760	(2020) Modulators of microglia activation and polarization in ischemic stroke (Review).	7	59	1.14	0.00074	9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418009	SIRT6,PTGS2,JAK2,NFE2L2,MYD88,BDNF,RARRES2
PMID:32391363	(2020) Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,PTEN,JAK2,PROM1
PMID:32612615	(2020) Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000419422	CD38,CD69,FABP4,CCR5,CXCL10,CXCL9,AGTR1
PMID:32785109	(2020) Metabolic and Molecular Mechanisms of Macrophage Polarisation and Adipose Tissue Insulin Resistance.	7	59	1.14	0.00074	9606.ENSP00000256104,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000371067,9606.ENSP00000401399	FABP4,ATM,STAT5A,SREBF1,ABCG1,JAK2,MYD88
PMID:32875103	(2020) Actomyosin contractility confers mechanoprotection against TNFalpha-induced disruption of the intervertebral disc.	7	59	1.14	0.00074	9606.ENSP00000216181,9606.ENSP00000266085,9606.ENSP00000347041,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000474412	MYH9,TIMP3,FMOD,CCL20,ELN,RHOA,CCL5
PMID:33396628	(2020) MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance.	7	59	1.14	0.00074	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185	ERCC1,CDH1,IGF1R,HNF4A,PTEN,NFE2L2,BCL2
PMID:33425768	(2020) The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,SIRT6,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:35117938	(2020) Role of microenvironmental acidity and tumor exosomes in cancer immunomodulation.	7	59	1.14	0.00074	9606.ENSP00000266085,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TIMP3,CXCL11,STAT5A,PTEN,BCL2,CCL5,VEGFA
PMID:30836718	(2019) Dietary Phytochemicals Targeting Cancer Stem Cells.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,PTGS2,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:30925927	(2019) Extracellular vesicles in the tumor microenvironment: old stories, but new tales.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,GAS6,CAV1,ENTPD1,PTEN,MYD88,VEGFA
PMID:31122291	(2019) MicroRNA-655-3p and microRNA-497-5p inhibit cell proliferation in cultured human lip cells through the regulation of genes related to human cleft lip.	7	59	1.14	0.00074	9606.ENSP00000245479,9606.ENSP00000362410,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478253,9606.ENSP00000478319	SOX9,MAFB,MTHFR,BCL2,FGFR1,MTHFD1L,GREM1
PMID:31212697	(2019) The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000351807	CDH1,CCR5,CXCL10,CXCL11,EDNRA,CCL20,ELN
PMID:31467634	(2019) ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells.	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000381185	NOX4,ELN,PTGS2,PTEN,NOX1,G6PD,BCL2
PMID:29342287	(2018) To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.	7	59	1.14	0.00074	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000380252,9606.ENSP00000418009,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,NFE2L2,RARRES2,CCL5
PMID:30037144	(2018) The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.	7	59	1.14	0.00074	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	MPO,NOX4,CCR5,PTGS2,EDN1,CCL5,VEGFA
PMID:30261606	(2018) Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.	7	59	1.14	0.00074	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ELN,CXCL9,MYD88,CCL5,VEGFA
PMID:27307150	(2017) Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CDH1,CD34,PTEN,BMP2,JAK2,BCL2
PMID:27837475	(2017) Pericytes in Brain Injury and Repair After Ischemic Stroke.	7	59	1.14	0.00074	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,TIMP3,CNTF,EDN1,NTF3,BDNF,VEGFA
PMID:27923196	(2017) Environmental preconditioning rejuvenates adult stem cells proliferation and chondrogenic potential.	7	59	1.14	0.00074	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	SOX9,THBS1,ELN,BCL2,PROM1,GREM1,VEGFA
PMID:28265339	(2017) Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy.	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,ANGPT2,ELN,NOX1,NFE2L2,BCL2,VEGFA
PMID:28422730	(2017) miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	CDH1,IGF1R,MMP14,AR,BCL2,FGFR1,RHOA
PMID:28524175	(2017) Modulators of microglial activation and polarization after intracerebral haemorrhage.	7	59	1.14	0.00074	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000401399	MPO,CXCL10,CCL20,CD47,PTGS2,NFE2L2,MYD88
PMID:29225627	(2017) Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD34,ANG,PROM1,CCL5,VEGFA
PMID:27379204	(2016) Rationally Repurposing Ruxolitinib (Jakafi ((R))) as a Solid Tumor Therapeutic.	7	59	1.14	0.00074	9606.ENSP00000248553,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,STAT5A,CCL20,PTEN,JAK2,BCL2,VEGFA
PMID:27418931	(2016) Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy.	7	59	1.14	0.00074	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CDH1,ATM,ALDH1A1,CD34,BCL2,PROM1
PMID:27429002	(2016) Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,HNF4A,PDGFB,BCL2,VEGFA
PMID:25179475	(2015) P2Y receptors in Alzheimers disease.	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000304767,9606.ENSP00000355361,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,P2RY1,CD47,NOX1,EDN1,BCL2,VEGFA
PMID:25450578	(2015) Regulation of cancer metastasis by cell-free miRNAs.	7	59	1.14	0.00074	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,TIMP3,MMP14,PTEN,BCL2,VEGFA
PMID:25598425	(2015) Advanced research on vasculogenic mimicry in cancer.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,CD34,EDN1,BCL2,PROM1,VEGFA
PMID:25691826	(2015) Regulation of breast cancer stem cell features.	7	59	1.14	0.00074	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000368104,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ALDH1A1,HNF4A,BMP2,NFE2L2,BCL2,PROM1
PMID:25838429	(2015) Nonclassical patrolling monocyte function in the vasculature.	7	59	1.14	0.00074	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000321334,9606.ENSP00000381185,9606.ENSP00000474412	FABP4,CCR5,CXCL10,ANGPT2,LPA,BCL2,CCL5
PMID:26282885	(2015) Tissue instruction for migration and retention of TRM cells.	7	59	1.14	0.00074	9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CDH1,CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:26807113	(2015) Repair, protection and regeneration of peripheral nerve injury.	7	59	1.14	0.00074	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303	TIMP3,IGF1R,SIRT6,CNTF,PTEN,NTF3,BDNF
PMID:26814148	(2015) Mechanisms of resistance in castration-resistant prostate cancer (CRPC).	7	59	1.14	0.00074	9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,IGF1R,PTEN,AR,SHBG,BCL2,VEGFA
PMID:24374228	(2014) Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair.	7	59	1.14	0.00074	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000414303,9606.ENSP00000474412	CD69,CCR5,CNTF,PTGS2,EDN1,BDNF,CCL5
PMID:24555469	(2014) The basic biology of redoxosomes in cytokine-mediated signal transduction and implications for disease-specific therapies.	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000401399	NOX4,NOX1,TXN,EDN1,G6PD,RHOA,MYD88
PMID:24744783	(2014) The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings.	7	59	1.14	0.00074	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000312987,9606.ENSP00000339916,9606.ENSP00000345708,9606.ENSP00000375844,9606.ENSP00000418823	WFS1,JAZF1,HNF4A,LIMK2,KCNJ11,CAPN10,FTO
PMID:24976593	(2014) Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,IGF1R,CCR5,PTGS2,NFE2L2,CCL5,VEGFA
PMID:25262780	(2014) NF-kappaB and STAT3 in glioblastoma: therapeutic targets coming of age.	7	59	1.14	0.00074	9606.ENSP00000255409,9606.ENSP00000306124,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CHI3L1,PRKCE,PDGFB,STAT5A,PTEN,JAK2,VEGFA
PMID:23114846	(2013) Stromal cells in tumor microenvironment and breast cancer.	7	59	1.14	0.00074	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CD34,CAV1,CD247,PTEN,FGFR1,CCL5,VEGFA
PMID:23165235	(2013) The role of microRNAs in cancers of the upper gastrointestinal tract.	7	59	1.14	0.00074	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	MYH9,CDH1,IGF1R,CD47,PTEN,JAK2,BCL2
PMID:23560233	(2013) Molecular regulation of kidney development.	7	59	1.14	0.00074	9606.ENSP00000330382,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000444198,9606.ENSP00000478319,9606.ENSP00000478570	PDGFB,BMP2,EDN1,FGFR1,CITED2,GREM1,VEGFA
PMID:23689081	(2013) MicroRNAs in liver disease.	7	59	1.14	0.00074	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175	CHI3L1,CDH1,PTGS2,PTEN,EDN1,BCL2,RHOA
PMID:23762566	(2013) Trans-10, cis 12-Conjugated Linoleic Acid-Induced Milk Fat Depression Is Associated with Inhibition of PPARgamma Signaling and Inflammation in Murine Mammary Tissue.	7	59	1.14	0.00074	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000356729,9606.ENSP00000381185,9606.ENSP00000384906	FABP4,FADS2,CAV1,SREBF1,FMO3,BCL2,SAA1
PMID:23862137	(2013) Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome.	7	59	1.14	0.00074	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000478570	TIMP3,IGF1R,MMP14,ELN,PTGS2,NFE2L2,VEGFA
PMID:22161147	(2012) Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.	7	59	1.14	0.00074	9606.ENSP00000315011,9606.ENSP00000354511,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000402152,9606.ENSP00000419422,9606.ENSP00000475344	EDNRA,COMT,SGK1,EDN1,SLC12A3,AGTR1,APLNR
PMID:22298653	(2012) Epoxides and soluble epoxide hydrolase in cardiovascular physiology.	7	59	1.14	0.00074	9606.ENSP00000301522,9606.ENSP00000339191,9606.ENSP00000345708,9606.ENSP00000360247,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	PRDX2,CAV1,KCNJ11,CYP2J2,EDN1,BCL2,VEGFA
PMID:22363839	(2012) The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-beta-Induced Epithelial-Mesenchymal Transition.	7	59	1.14	0.00074	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000400175	MAPK1,HSPB1,CDH1,MAPK7,HNF4A,MAP3K5,RHOA
PMID:20962773	(2011) Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin.	7	59	1.14	0.00074	9606.ENSP00000263317,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000384906	NOX4,CXCL11,CCL20,PTGS2,S100A12,NOX1,SAA1
PMID:21058931	(2010) Mesenchymal stem cells at the intersection of cell and gene therapy.	7	59	1.14	0.00074	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000414303	SOX9,MMP14,CD34,PDGFB,ANG,BCL2,BDNF
PMID:21189220	(2010) Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.	7	59	1.14	0.00074	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CD69,CCR5,CXCL10,SIRT6,CXCL9,JAK2,CCL5
PMID:19838819	(2009) The role of tenascin-C in tissue injury and tumorigenesis.	7	59	1.14	0.00074	9606.ENSP00000260356,9606.ENSP00000312987,9606.ENSP00000315011,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	THBS1,HNF4A,EDNRA,HSPG2,RHOA,AGTR1,VEGFA
PMID:19057661	(2008) Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles.	7	59	1.14	0.00074	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,PTGS2,MYD88,CCL5,VEGFA
PMID:34220859	(....) myeloid-derived suppressor cells as a potential biomarker and therapeutic target in covid-19.	7	59	1.14	0.00074	9606.ENSP00000265333,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356438,9606.ENSP00000478570	VDAC1,CCR5,CXCL10,STAT5A,CD247,PTGS2,VEGFA
PMID:34572312	(2021) Alzheimers Disease: A Molecular View of beta-Amyloid Induced Morbific Events.	11	193	0.82	0.00075	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000355361,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525	MAPK1,MAPK7,SIRT6,MAP3K5,CD47,NFE2L2,BCL2,NTF3,RHOA,BDNF,MME
PMID:21678067	(2011) Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells.	10	154	0.87	0.00075	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000474412	MAPK1,IFNG,THBS1,TIMP3,MAPK7,CAV1,PDGFA,EDN1,NFE2L2,CCL5
PMID:34152084	(2022) Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021	CD38,CD34,CD47,PTEN
PMID:34783169	(2022) Multiplex Single-Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B-ALL.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	CD38,CD34,BCL2,MME
PMID:34808537	(2022) Hypertensive effects of transforming growth factor-beta1 in vascular smooth muscles cells from spontaneously hypertensive rats are mediated by sulfatase 2.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000284031,9606.ENSP00000368683,9606.ENSP00000419422	TGFB1,DDAH1,EDN1,AGTR1
PMID:35115784	(2022) Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia.	5	19	1.48	0.00077	9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185	HNF4A,STAT5A,ELN,JAK2,BCL2
PMID:35203638	(2022) The Role of Mitochondrial miRNAs in the Development of Radon-Induced Lung Cancer.	8	87	1.02	0.00077	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	SOX9,IGF1R,CXCL10,PDGFB,PTEN,BCL2,MYD88,VEGFA
PMID:35214186	(2022) Latest Trends in Surface Modification for Dental Implantology: Innovative Developments and Analytical Applications.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	MPO,MMP14,ELN,BMP2,VEGFA
PMID:35386842	(2022) Redox signaling at the crossroads of human health and disease.	8	87	1.02	0.00077	9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000354995,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	NOX4,MAP3K5,ABCG1,NOX1,TXN,NFE2L2,BCL2,PROM1
PMID:35409276	(2022) A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics.	5	19	1.48	0.00077	9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000403495,9606.ENSP00000419422	PTGS2,EDN1,KL,LTA,AGTR1
PMID:35618744	(2022) Development and verification of the nomogram for dilated cardiomyopathy gene diagnosis.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000384906	CXCL10,CXCL11,CXCL9,SAA1
PMID:33301921	(2021) New lathyrane diterpenoids with anti-inflammatory activity isolated from the roots of Jatropha curcas L.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,PTGS2,EDN1,LTA,CCL5
PMID:33303990	(2021) The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOSNO signaling in mice.	4	7	1.82	0.00077	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	NOX4,NOX1,EDN1,VEGFA
PMID:33338877	(2021) Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000478570	IFNG,THBS1,CD34,ANGPT2,VEGFA
PMID:33469123	(2021) Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:33484732	(2021) Machine Learning Approach for Intraocular Disease Prediction Based on Aqueous Humor Immune Mediator Profiles.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901	IFNG,CXCL10,ANG,CXCL9
PMID:33643504	(2021) Bone Marrow Involvement by Aggressive B Cell Lymphoma Undetected by Aspirate Immunophenotyping.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000418525	CD38,CDH1,CD34,MME
PMID:33725263	(2021) Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?	9	119	0.94	0.00077	9606.ENSP00000263317,9606.ENSP00000356213,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000384957,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000419313,9606.ENSP00000478570	NOX4,VIP,NOX1,EDN1,F11,RHOA,MME,TRPC1,VEGFA
PMID:33763426	(2021) In situ Adipogenesis in Biomaterials Without Cell Seeds: Current Status and Perspectives.	5	19	1.48	0.00077	9606.ENSP00000309757,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000478570	LPL,ANG,ELN,FGFR1,VEGFA
PMID:33776471	(2021) The Diabetes Syndrome - A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms.	5	19	1.48	0.00077	9606.ENSP00000268035,9606.ENSP00000283928,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000480291	IGF1R,JAZF1,PTEN,SHBG,HNF1B
PMID:33787578	(2021) Myeloid sarcoma of the pancreas: A case report and literature review.	4	7	1.82	0.00077	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD34,BCL2,MME
PMID:33836805	(2021) DNA methylation and gene expression integration in cardiovascular disease.	5	19	1.48	0.00077	9606.ENSP00000278616,9606.ENSP00000283928,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000362524	ATM,JAZF1,SGK1,PTEN,ANGPTL2
PMID:33922974	(2021) The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.	8	87	1.02	0.00077	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478319,9606.ENSP00000478570	CDH1,TIMP3,P2RY1,PTGS2,PTEN,BCL2,GREM1,VEGFA
PMID:33974005	(2021) Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model.	5	19	1.48	0.00077	9606.ENSP00000215832,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,PTGS2,AR,BCL2,VEGFA
PMID:33993051	(2021) Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target.	8	87	1.02	0.00077	9606.ENSP00000215832,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000478570	MAPK1,CHI3L1,CDH1,PDGFB,CCL20,CD47,PTEN,VEGFA
PMID:34035320	(2021) Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture.	5	19	1.48	0.00077	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000312987,9606.ENSP00000321334	LAMC1,THBS1,TIMP3,HNF4A,LPA
PMID:34050774	(2021) TARP as antigen in cancer immunotherapy.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000381185	CD38,CD34,CAV1,AR,BCL2
PMID:34066744	(2021) Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.	5	19	1.48	0.00077	9606.ENSP00000278840,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	FADS2,SREBF1,PTGS2,BCL2,VEGFA
PMID:34067832	(2021) Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,PTEN,AR,EDN1,VEGFA
PMID:34150725	(2021) Enlightenment of Growth Plate Regeneration Based on Cartilage Repair Theory: A Review.	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000478570	TGFB1,SOX9,BMP2,NTF3,VEGFA
PMID:34188955	(2021) The influence of reduced graphene oxide on stem cells: a perspective in peripheral nerve regeneration.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000484631	MPO,CDH1,BMP2,GAP43,PMP22
PMID:34193832	(2021) A narrative overview of utilizing biomaterials to recapitulate the salient regenerative features of dental-derived mesenchymal stem cells.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,SOX9,CD34,BDNF,CCL5
PMID:34195162	(2021) sVEGFR1 Is Enriched in Hepatic Vein Blood-Evidence for a Provisional Hepatic Factor Candidate?	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANGPT2,LTA,BDNF,VEGFA
PMID:34235345	(2021) A rat model to investigate quality of recovery after abdominal surgery.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCL20,PTGS2,CCL5,VEGFA
PMID:34246267	(2021) Integrative analysis the characterization of peroxiredoxins in pan-cancer.	5	19	1.48	0.00077	9606.ENSP00000301522,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	PRDX2,AR,JAK2,BCL2,VEGFA
PMID:34257616	(2021) MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-beta-Treated Endometrial Stromal Cells via the MAPK and Wntbeta-Catenin Signaling Pathways.	5	19	1.48	0.00077	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000361021	MAPK1,CDH1,HNF4A,ANGPT2,PTEN
PMID:34299344	(2021) Cutting Edge Endogenous Promoting and Exogenous Driven Strategies for Bone Regeneration.	5	19	1.48	0.00077	9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478570	ANGPT2,ELN,BMP2,RHOA,VEGFA
PMID:34305943	(2021) Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.	4	7	1.82	0.00077	9606.ENSP00000315011,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000419422	EDNRA,HSPG2,EDN1,AGTR1
PMID:34327849	(2021) Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000426809	CD38,CDH1,AMBP,CD34,PROM1
PMID:34336976	(2021) Whole-Transcriptome Analysis of LncRNAs Mediated ceRNA Regulation in Granulosa Cells Isolated From Healthy and Atresia Follicles of Chinese Buffalo.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000356832,9606.ENSP00000393312,9606.ENSP00000478570	SOX9,THBS1,SGK1,FGFR1,VEGFA
PMID:34356869	(2021) Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality.	5	19	1.48	0.00077	9606.ENSP00000200676,9606.ENSP00000225275,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000360522	CETP,MPO,LPA,ABCG1,RBP4
PMID:34359786	(2021) Cancer Stem Cells in Oropharyngeal Cancer.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000480291	CD38,ALDH1A1,CD34,PROM1,HNF1B
PMID:34373557	(2021) Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901	TGFB1,IFNG,CXCL10,STAT5A,CXCL9
PMID:34452386	(2021) Cannabis and Inflammation in HIV: A Review of Human and Animal Studies.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000358513,9606.ENSP00000478570	CD38,CXCL10,PTGS2,CNR1,VEGFA
PMID:34503477	(2021) Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418525	CD38,CD34,ENTPD1,BCL2,MME
PMID:34608862	(2021) HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD38,AMBP,CXCL10,CXCL11,CXCL9
PMID:34611514	(2021) Biological modulations to facilitate graft healing in anterior cruciate ligament reconstruction (ACLR), when and where to apply? A systematic review.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,CD34,BMP2,VEGFA
PMID:34691031	(2021) Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,SAA1,VEGFA
PMID:34698278	(2021) The Limbal Niche and Regenerative Strategies.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000478570	MPO,IFNG,ELN,CNTF,VEGFA
PMID:34766149	(2021) Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.	8	87	1.02	0.00077	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809	ERCC1,CDH1,ATM,PTGS2,PTEN,JAK2,BCL2,PROM1
PMID:34771482	(2021) Targeting Tumor-Associated Macrophages in Cancer Immunotherapy.	8	87	1.02	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CD247,CXCL9,CD47,CCL5,VEGFA
PMID:34901292	(2021) High Variability of Mesenchymal Stem Cells Obtained via Bone Marrow Aspirate Concentrate Compared With Traditional Bone Marrow Aspiration Technique.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000360522,9606.ENSP00000369816,9606.ENSP00000478570	CD34,ANG,RBP4,SHBG,VEGFA
PMID:34944564	(2021) Is the Macrophage Phenotype Determinant for Fibrosis Development?	9	119	0.94	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356832,9606.ENSP00000358513,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,SGK1,CNR1,MYD88,AGTR1,CCL5,VEGFA
PMID:31256391	(2020) Lentinula edodes as a Source of Bioelements Released into Artificial Digestive Juices and Potential Anti-inflammatory Material.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000356438,9606.ENSP00000380252	IFNG,FABP4,PTGS2,NFE2L2
PMID:31726870	(2020) Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice.	5	19	1.48	0.00077	9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	NOX1,BCL2,BDNF,AGTR1,VEGFA
PMID:31906560	(2020) Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis Patients: A Cross-Sectional Study.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000426809	CD34,STAT5A,PTGS2,JAK2,PROM1
PMID:31925976	(2020) High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:31996229	(2020) Physical resistance training-induced changes in lipids metabolism pathways and apoptosis in prostate.	5	19	1.48	0.00077	9606.ENSP00000260356,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	THBS1,SREBF1,PTEN,AR,BCL2
PMID:32151958	(2020) Synergistic induction of CCL5, CXCL9 and CXCL10 by IFN-gamma and NLRs ligands on human fibroblast-like synoviocytes-A potential immunopathological mechanism for joint inflammation in rheumatoid arthritis.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:32158229	(2020) Entire ABL1 Gene Deletion Without BCRABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.	5	19	1.48	0.00077	9606.ENSP00000222139,9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000418525	EPOR,MPO,CD34,JAK2,MME
PMID:32183259	(2020) Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRLLpr Mouse Model of Lupus Nephritis.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CCL20,CXCL9,JAK2,CCL5
PMID:32196567	(2020) Effect of NT-3 on repair of spinal cord injury through the MAPK signaling pathway.	4	7	1.82	0.00077	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000397297,9606.ENSP00000403495	MAPK1,MPO,NTF3,LTA
PMID:32256958	(2020) G9a Suppression Alleviates Corneal Neovascularization through Blocking Nox4-Mediated Oxidative Stress.	5	19	1.48	0.00077	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000362057,9606.ENSP00000478570	NOX4,CD34,ANG,NOX1,VEGFA
PMID:32277808	(2020) Lung Cancer Inhibition by Betulinic Acid Nanoparticles via Adenosine 5-Triphosphate (ATP)-Binding Cassette Transporter G1 Gene Downregulation.	4	7	1.82	0.00077	9606.ENSP00000297785,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000426809	ALDH1A1,ABCG1,BCL2,PROM1
PMID:32290862	(2020) Effect of cold stress on ovarian & uterine microcirculation in rats and the role of endothelin system.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000418525	CD34,EDNRA,EDN1,MME
PMID:32351973	(2020) Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure.	8	87	1.02	0.00077	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,HSPB1,TIMP3,ELN,EDN1,MME,CCL5,VEGFA
PMID:32430093	(2020) Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo.	5	19	1.48	0.00077	9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PRKCE,STAT5A,BCL2,VEGFA
PMID:32471105	(2020) Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Transection is Driven by Cellular Intravitreal Sciatic Nerve Grafts.	5	19	1.48	0.00077	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	CNTF,GAP43,BCL2,RHOA,BDNF
PMID:32503618	(2020) MiR-9-5p promotes rabbit preadipocyte differentiation by suppressing leptin gene expression.	5	19	1.48	0.00077	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000361021	MAPK1,FABP4,NOX4,SREBF1,PTEN
PMID:32575396	(2020) Deep Learning of Cancer Stem Cell Morphology Using Conditional Generative Adversarial Networks.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000426809	CD38,CD34,ELN,PROM1
PMID:32607768	(2020) Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,CCL5,VEGFA
PMID:32774430	(2020) Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial.	4	7	1.82	0.00077	9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	EDN1,BCL2,BDNF,VEGFA
PMID:32787520	(2020) Loss of Down Syndrome Critical Region-1 Mediated-Hypercholesterolemia Accelerates Corneal Opacity Via Pathological Neovessel Formation.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000384906,9606.ENSP00000475344,9606.ENSP00000478570	CD34,ANGPT2,SAA1,APLNR,VEGFA
PMID:32795116	(2020) Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review.	5	19	1.48	0.00077	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252	NOX4,PTGS2,NOX1,TXN,NFE2L2
PMID:32957381	(2020) Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis.	4	7	1.82	0.00077	9606.ENSP00000325548,9606.ENSP00000365777,9606.ENSP00000402152,9606.ENSP00000419422	CNDP2,MTHFR,SLC12A3,AGTR1
PMID:32992956	(2020) Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:33003392	(2020) Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354782,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CD247,CXCL9
PMID:33021505	(2020) The N-terminal length and side-chain composition of CXCL13 affect crystallization, structure and functional activity.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:33081056	(2020) MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.	8	87	1.02	0.00077	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,SREBF1,ELN,CD47,ENTPD1,RHOA,VEGFA
PMID:33116592	(2020) Wogonoside Attenuates Cutaneous Squamous Cell Carcinoma by Reducing Epithelial-Mesenchymal TransitionInvasion and Cancer Stem-Like Cell Property.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,BCL2,PROM1,VEGFA
PMID:33133043	(2020) Potent Restriction of Sexual Zika Virus Infection by the Lipid Fraction of Extracellular Vesicles in Semen.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,GAS6,CXCL9,CCL5
PMID:33143283	(2020) Cannabidiol (CBD) as a Promising Anti-Cancer Drug.	8	87	1.02	0.00077	9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,ATM,PTEN,TXN,AR,BCL2,MYD88,VEGFA
PMID:33171811	(2020) Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.	8	87	1.02	0.00077	9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	TIMP3,IGF1R,PTEN,JAK2,NFE2L2,BCL2,RHOA,VEGFA
PMID:33391925	(2020) Flow Cytometric Analysis of ZAP-70 Protein Expression for B-Cell Chronic Lymphocytic Leukemia Prognostication: Usefulness and Limitations.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MME
PMID:34138062	(2020) Insights into Theranostic Properties of Titanium Dioxide for Nanomedicine.	4	7	1.82	0.00077	9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000418823,9606.ENSP00000426809	BMP2,RHOA,FTO,PROM1
PMID:30361931	(2019) Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPOEPORJAK2 Signaling Pathway and Increasing the Serum Estradiol Level.	4	7	1.82	0.00077	9606.ENSP00000222139,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	EPOR,JAK2,BCL2,BDNF
PMID:30411783	(2019) Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,ANGPT2,PDGFB,CCL5,VEGFA
PMID:30558832	(2019) The Role of Immature and Mature Adipocytes in Hair Cycling.	5	19	1.48	0.00077	9606.ENSP00000300055,9606.ENSP00000322898,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000368104	PLIN1,EBF1,CAV1,PDGFA,BMP2
PMID:30601239	(2019) Tissue issues: mucosal T-cell responses in HIV-1 infection.	5	19	1.48	0.00077	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL9,CCL5
PMID:30671548	(2019) Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation.	5	19	1.48	0.00077	9606.ENSP00000222139,9606.ENSP00000265333,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,VDAC1,STAT5A,JAK2,BCL2
PMID:30813187	(2019) Association between CXCL910 polymorphisms and acute rejection of liver allograft.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:30925081	(2019) Apoptosis signal-regulating kinase 1 activation by Nox1-derived oxidants is required for TNFalpha receptor endocytosis.	4	7	1.82	0.00077	9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641	CAV1,MAP3K5,NOX1,TXN
PMID:30928625	(2019) Variable chemokine expression in porcine trophoblasts and endometrium during the peri-implantation period.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:30982733	(2019) Epigenetics in Human Obesity and Type 2 Diabetes.	8	87	1.02	0.00077	9606.ENSP00000200676,9606.ENSP00000226279,9606.ENSP00000278840,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000414303,9606.ENSP00000418823	CETP,CD38,FADS2,KCNJ11,SREBF1,ABCG1,BDNF,FTO
PMID:31013257	(2019) Biomarkers of endothelial activationdysfunction distinguish sub-groups of Ugandan patients with sepsis and differing mortality risks.	4	7	1.82	0.00077	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000478570	CHI3L1,CXCL10,ANGPT2,VEGFA
PMID:31049575	(2019) MOSClip: multi-omic and survival pathway analysis for the identification of survival associated gene and modules.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021	CDH1,IGF1R,PDGFB,PDGFA,PTEN
PMID:31170889	(2019) Immunophenotyping of Murine Precursor B-Cell LeukemiaLymphoma: A Comparison of Immunohistochemistry and Flow Cytometry.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000418525	MPO,CD34,STAT5A,ELN,MME
PMID:31351238	(2019) Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-beta1 secretion.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000478570	CDH1,CAV1,ELN,HSPG2,VEGFA
PMID:31419975	(2019) Exosomes released from neural progenitor cells and induced neural progenitor cells regulate neurogenesis through miR-21a.	5	19	1.48	0.00077	9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303	CD47,PTEN,BCL2,RHOA,BDNF
PMID:31470689	(2019) A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction.	4	7	1.82	0.00077	9606.ENSP00000356213,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	VIP,RHOA,BDNF,VEGFA
PMID:31541683	(2019) Endogenous ET-1 promotes ANP secretion through activation of COX2-L-PGDS-PPARgamma signaling in hypoxic beating rat atria.	4	7	1.82	0.00077	9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000380252	EDNRA,PTGS2,EDN1,NFE2L2
PMID:31545956	(2019) Reducing PRLR expression and JAK2 activity results in an increase in BDNF expression and inhibits the apoptosis of CA3 hippocampal neurons in a chronic mild stress model of depression.	4	7	1.82	0.00077	9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	STAT5A,JAK2,BCL2,BDNF
PMID:31569444	(2019) Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link.	8	87	1.02	0.00077	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000426809	MAPK1,SOX9,CDH1,MAP3K5,PTEN,PDGFD,BCL2,PROM1
PMID:31662991	(2019) Cell Chromatography-Based Screening of the Active Components in Buyang Huanwu Decoction Promoting Axonal Regeneration.	4	7	1.82	0.00077	9606.ENSP00000339191,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	CAV1,GAP43,BDNF,VEGFA
PMID:31819639	(2019) STIP1 Regulates Proliferation and Migration of Lung Adenocarcinoma Through JAK2STAT3 Signaling Pathway.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,HNF4A,JAK2,BCL2,VEGFA
PMID:28597850	(2018) The role of peroxisome proliferator-activated receptor gamma in prostate cancer.	5	19	1.48	0.00077	9606.ENSP00000256104,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	FABP4,PTEN,AR,BCL2,VEGFA
PMID:28845522	(2018) Adipochemokines induced by ultraviolet irradiation contribute to impaired fat metabolism in subcutaneous fat cells.	4	7	1.82	0.00077	9606.ENSP00000292303,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000474412	CCR5,SREBF1,CCL20,CCL5
PMID:28958974	(2018) Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	MPO,CD34,JAK2,BCL2,FGFR1
PMID:29191928	(2018) Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.	5	19	1.48	0.00077	9606.ENSP00000232219,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000418525	RBP1,EDNRA,EDN1,RHOA,MME
PMID:29499628	(2018) In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-IILDLR(--)ApoB(100100) mice.	5	19	1.48	0.00077	9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000362463	NOX4,ELN,PTGS2,NOX1,GLO1
PMID:29524300	(2018) Estrogen receptor-beta of microglia underlies sexual differentiation of neuronal protection via ginsenosides in mice brain.	4	7	1.82	0.00077	9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303	STAT5A,JAK2,BCL2,BDNF
PMID:29526178	(2018) [Mechanisms of Resistance to the Third-generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer].	5	19	1.48	0.00077	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,IGF1R,PTEN,BCL2,FGFR1
PMID:29566069	(2018) Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.	5	19	1.48	0.00077	9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	STAT5A,BCL2,RHOA,PROM1,VEGFA
PMID:29852748	(2018) Enhancing the Therapeutic Potential of Olfactory Ensheathing Cells in Spinal Cord Repair Using Neurotrophins.	5	19	1.48	0.00077	9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	FGFR1,NTF3,RHOA,BDNF,VEGFA
PMID:29896263	(2018) Nimesulide inhibits proliferation and induces apoptosis of pancreatic cancer cells by enhancing expression of PTEN.	4	7	1.82	0.00077	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	PTGS2,PTEN,BCL2,VEGFA
PMID:30054761	(2018) Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000268035,9606.ENSP00000362057,9606.ENSP00000362463,9606.ENSP00000478570	MPO,IGF1R,NOX1,GLO1,VEGFA
PMID:30057275	(2018) Defining Lineage Potential and Fate Behavior of Precursors during Pancreas Development.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000336762,9606.ENSP00000480291	SOX9,CDH1,ALDH1A1,ANG,HNF1B
PMID:30179996	(2018) Effect of intranasal administration of neurotrophic factors on regeneration of chemically degenerated olfactory epithelium in aging mice.	4	7	1.82	0.00077	9606.ENSP00000268035,9606.ENSP00000377372,9606.ENSP00000393312,9606.ENSP00000414303	IGF1R,GAP43,FGFR1,BDNF
PMID:30181917	(2018) Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30258629	(2018) CD38 is methylated in prostate cancer and regulates extracellular NAD.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185	CD38,SIRT6,PTGS2,AR,BCL2
PMID:30388621	(2018) lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221SOCS3 in Pancreatic Cancer.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809	CDH1,CCL20,PTEN,JAK2,PROM1
PMID:30402637	(2018) Inhibition of perilipin 2 expression reduces pro-inflammatory gene expression and increases lipid droplet size.	5	19	1.48	0.00077	9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000351671,9606.ENSP00000356832,9606.ENSP00000362410	PLIN1,LPL,CCL20,SGK1,MAFB
PMID:30479719	(2018) Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD.	5	19	1.48	0.00077	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000478570	THBS1,TIMP3,CD47,CNTF,VEGFA
PMID:31414076	(2018) The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:33102918	(2018) Bioprinting of artificial blood vessels.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,ELN,EDN1,VEGFA
PMID:33467316	(2018) Detraining and Anabolic-Androgenic Steroid Discontinuation Change Calcaneal Tendon Morphology.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000363822,9606.ENSP00000418009,9606.ENSP00000478570	TGFB1,AR,RARRES2,VEGFA
PMID:28081931	(2017) Neurogenin-2-transduced human neural progenitor cells attenuate neonatal hypoxic-ischemic brain injury.	4	7	1.82	0.00077	9606.ENSP00000260356,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	THBS1,CNTF,NTF3,BDNF
PMID:28111237	(2017) Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance.	5	19	1.48	0.00077	9606.ENSP00000200676,9606.ENSP00000292303,9606.ENSP00000321334,9606.ENSP00000384906,9606.ENSP00000474412	CETP,CCR5,LPA,SAA1,CCL5
PMID:28112237	(2017) Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance.	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000363822,9606.ENSP00000478570	TGFB1,CDH1,CAV1,AR,VEGFA
PMID:28216616	(2017) CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5STAT5CCND1 signaling pathway.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000474412	CCR5,CXCL10,STAT5A,AR,CCL5
PMID:28386173	(2017) Analysis on regulatory network linked to Hpa gene in invasion and metastasis of colon cancer.	4	7	1.82	0.00077	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000478570	PTGS2,PTEN,HPSE,VEGFA
PMID:28415561	(2017) Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000248553,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809	CD38,HSPB1,ALDH1A1,CD34,PROM1
PMID:28469654	(2017) Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective.	5	19	1.48	0.00077	9606.ENSP00000337332,9606.ENSP00000355370,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000478570	SIRT6,CNTF,NFE2L2,BDNF,VEGFA
PMID:28524540	(2017) Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma.	5	19	1.48	0.00077	9606.ENSP00000266085,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,ALDH1A1,PTGS2,BCL2,VEGFA
PMID:28819416	(2017) Expression of CD133 in endometrial cancer cells and its implications.	5	19	1.48	0.00077	9606.ENSP00000268035,9606.ENSP00000297785,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000426809	IGF1R,ALDH1A1,PDGFB,PDGFA,PROM1
PMID:28825045	(2017) Targeting the duality of cancer.	5	19	1.48	0.00077	9606.ENSP00000265333,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	VDAC1,ANGPT2,PTEN,RHOA,VEGFA
PMID:28859287	(2017) Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:28873441	(2017) A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495	CXCL10,CXCL11,CCL20,CXCL9,LTA
PMID:28904337	(2017) Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.	8	87	1.02	0.00077	9606.ENSP00000229135,9606.ENSP00000317674,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000377372,9606.ENSP00000390651,9606.ENSP00000478570	IFNG,APOL1,PTGS2,PTEN,EDN1,GAP43,IRAK4,VEGFA
PMID:28984832	(2017) The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review.	5	19	1.48	0.00077	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995	CETP,LPL,HNF4A,SREBF1,ABCG1
PMID:29164064	(2017) Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.	5	19	1.48	0.00077	9606.ENSP00000265132,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000385834	AMBP,PTEN,AR,NPY,TF
PMID:29332450	(2017) Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics.	5	19	1.48	0.00077	9606.ENSP00000248553,9606.ENSP00000301522,9606.ENSP00000385834,9606.ENSP00000400175,9606.ENSP00000478570	HSPB1,PRDX2,TF,RHOA,VEGFA
PMID:29390349	(2017) Sjoegrens syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000478570	CD38,IFNG,CXCL10,VEGFA
PMID:26447506	(2016) The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL9,CCL5
PMID:26463919	(2016) Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.	5	19	1.48	0.00077	9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000478570	TIMP3,ANGPT2,PDGFB,PDGFA,VEGFA
PMID:26555377	(2016) Engineering growth factors for regenerative medicine applications.	5	19	1.48	0.00077	9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000414303	ANGPT2,SERPINF2,BMP2,JAK2,BDNF
PMID:26612594	(2016) Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:26698852	(2016) Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:26775693	(2016) P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,PTEN,BMP2,CCL5,VEGFA
PMID:26856660	(2016) Role of beta-catenin in development of bile ducts.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000480291	SOX9,CDH1,ONECUT1,HNF4A,HNF1B
PMID:26914908	(2016) Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CCL5
PMID:26955396	(2016) Primary ovarian non-Hodgkin lymphoma: Diagnosis of two cases on fine needle aspiration cytology.	4	7	1.82	0.00077	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD34,BCL2,MME
PMID:26981875	(2016) Sustained Elevated Cytokine Levels during Recovery Phase of Mayaro Virus Infection.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,CCL5,VEGFA
PMID:27069746	(2016) Glomangiopericytoma simulating an intracavernous meningioma.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000363822,9606.ENSP00000381185	CD34,ELN,AR,BCL2
PMID:27177227	(2016) Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model.	5	19	1.48	0.00077	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,CCL5
PMID:27246398	(2016) Functional validation of tensin2 SH2-PTB domain by CRISPRCas9-mediated genome editing.	5	19	1.48	0.00077	9606.ENSP00000216181,9606.ENSP00000229135,9606.ENSP00000352264,9606.ENSP00000361021,9606.ENSP00000400175	MYH9,IFNG,CD2AP,PTEN,RHOA
PMID:27447865	(2016) An integrated genomic and transcriptomic survey of mucormycosis-causing fungi.	5	19	1.48	0.00077	9606.ENSP00000215832,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000366395,9606.ENSP00000376865	MAPK1,PDGFB,PDGFA,SYVN1,PDGFD
PMID:27517091	(2016) Non-Cell-Autonomous Regulation of Retrograde Motoneuronal Axonal Transport in an SBMA Mouse Model.	4	7	1.82	0.00077	9606.ENSP00000355370,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,AR,BDNF,VEGFA
PMID:27527764	(2016) Equine herpesvirus type 1 modulates inflammatory host immune response genes in equine endothelial cells.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:27579295	(2016) Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy.	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000426809	TGFB1,IFNG,CDH1,CAV1,PROM1
PMID:27585950	(2016) Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185	CD38,CD34,ELN,PTEN,BCL2
PMID:27746098	(2016) Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFAAKT-Signaling Axis.	5	19	1.48	0.00077	9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865	PLIN1,CD34,PDGFB,PDGFA,PDGFD
PMID:27781068	(2016) Chondrogenic Potency Analyses of Donor-Matched Chondrocytes and Mesenchymal Stem Cells Derived from Bone Marrow, Infrapatellar Fat Pad, and Subcutaneous Fat.	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000360250	TGFB1,SOX9,AMBP,CD34,ENTPD1
PMID:27895465	(2016) Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000478570	CXCL10,ANG,CXCL9,VEGFA
PMID:27898732	(2016) Chemokine Levels in the Penile Coronal Sulcus Correlate with HIV-1 Acquisition and Are Reduced by Male Circumcision in Rakai, Uganda.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,CCL5
PMID:30167505	(2016) Better Blood Flow Delivered: Extracellular Matrix-Derived Hydrogels for the Induction of Arteriogenesis in Peripheral Artery Disease?	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANGPT2,CCL5,VEGFA
PMID:25370311	(2015) Vascular patterning sets the stage for macro and micro hepatic architecture.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,ONECUT1,HNF4A,VEGFA,HNF1B
PMID:25537642	(2015) Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:25542189	(2015) Role of Mesenchymal Stem Cells Transfected With Vascular Endothelial Growth Factor in Maintaining Renal Structure and Function in Rats with Unilateral Ureteral Obstruction.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000478570	TGFB1,MPO,CDH1,VEGFA
PMID:25571952	(2015) Adenovirus-mediated ING4PTEN double tumor suppressor gene co-transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTEN,BCL2,VEGFA
PMID:25595970	(2015) Fibroblast growth factor and endothelin-1 receptors mediate the response of human striatal precursor cells to hypoxia.	4	7	1.82	0.00077	9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000393312,9606.ENSP00000478570	EDNRA,EDN1,FGFR1,VEGFA
PMID:25647305	(2015) Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PTEN,JAK2,BCL2,VEGFA
PMID:25654121	(2015) Blunted activation of Rho-kinase in yak pulmonary circulation.	4	7	1.82	0.00077	9606.ENSP00000284031,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000400175	DDAH1,ELN,EDN1,RHOA
PMID:25701227	(2015) Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.	9	119	0.94	0.00077	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000363827,9606.ENSP00000478570	IFNG,THBS1,AMBP,TIMP3,IGF1R,MMP14,FMOD,HSPG2,VEGFA
PMID:25829425	(2015) MYC Drives PtenTrp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412	IFNG,CXCL10,PTEN,AR,CCL5
PMID:25843671	(2015) Janus kinase 2signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,CNTF,JAK2,LTA,VEGFA
PMID:25856523	(2015) Signals mediating Klotho-induced neuroprotection in hippocampal neuronal cells.	4	7	1.82	0.00077	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000369442,9606.ENSP00000371067	EPOR,STAT5A,KL,JAK2
PMID:25972230	(2015) Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.	4	7	1.82	0.00077	9606.ENSP00000200676,9606.ENSP00000278840,9606.ENSP00000414303,9606.ENSP00000418823	CETP,FADS2,BDNF,FTO
PMID:26134008	(2015) [Effects of stromal cells on sentitivity to imatinib in Sup-B15 Philadelphia chromosome positive acute lymphoblastic leukemia cells].	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809	CD38,ALDH1A1,CD34,PROM1
PMID:26195481	(2015) Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene Expression.	5	19	1.48	0.00077	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412	NOX4,CXCL10,MYD88,AGTR1,CCL5
PMID:26204886	(2015) CDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000368104,9606.ENSP00000474412	SOX9,CDH1,CCR5,BMP2,CCL5
PMID:26238857	(2015) MiR-106b induces cell radioresistance via the PTENPI3KAKT pathways and p21 in colorectal cancer.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,ATM,PTEN,BCL2,PROM1
PMID:26239915	(2015) The cnidarian origin of the proto-oncogenes NF-kappaBSTAT and WNT-like oncogenic pathway drives the ctenophores (Review).	8	87	1.02	0.00077	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000478570	APC,CDH1,ATM,STAT5A,PTEN,MYD88,PROM1,VEGFA
PMID:26292361	(2015) Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809	SOX9,HNF4A,PTEN,AR,PROM1
PMID:26317771	(2015) The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control.	5	19	1.48	0.00077	9606.ENSP00000260356,9606.ENSP00000321853,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,SERPINF2,ANG,EDN1,VEGFA
PMID:26428954	(2015) The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000357726	IFNG,CXCL10,CXCL9,S100A12
PMID:26435634	(2015) Tissue Engineering: Step Ahead in Maxillofacial Reconstruction.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000293599,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,AQP5,BMP2,VEGFA
PMID:26788151	(2015) Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CD34,AR,BCL2,MME
PMID:26889193	(2015) Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy?	5	19	1.48	0.00077	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,CD34,BCL2,BDNF,VEGFA
PMID:23761196	(2014) Hsp70 regulation on Nox4p22phox and cytoskeletal integrity as an effect of losartan in vascular smooth muscle cells.	4	7	1.82	0.00077	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000400175,9606.ENSP00000419422	NOX4,CAV1,RHOA,AGTR1
PMID:24267605	(2014) Anorectal physiology and pathophysiology in the elderly.	4	7	1.82	0.00077	9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000369442	CAV1,ELN,VIP,KL
PMID:24363404	(2014) Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CD34,MME,PROM1
PMID:24574518	(2014) DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,BCL2,MYD88,PROM1
PMID:24628910	(2014) Bone regenerative medicine: classic options, novel strategies, and future directions.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000403495,9606.ENSP00000478570	IFNG,ELN,BMP2,LTA,VEGFA
PMID:24658076	(2014) New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.	4	7	1.82	0.00077	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000377192,9606.ENSP00000381185	CD69,CCR5,G6PD,BCL2
PMID:24761846	(2014) Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2STAT5 signalling pathway in the TF-1 Epo human leukemia cell line.	4	7	1.82	0.00077	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,STAT5A,JAK2,BCL2
PMID:24773320	(2014) Age-related macular degeneration: genetics and biology coming together.	5	19	1.48	0.00077	9606.ENSP00000200676,9606.ENSP00000261037,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000478570	CETP,COL8A1,TIMP3,ELN,VEGFA
PMID:24829581	(2014) Controlled release of granulocyte colony-stimulating factor enhances osteoconductive and biodegradable properties of Beta-tricalcium phosphate in a rat calvarial defect model.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000478570	TGFB1,CD34,BMP2,VEGFA
PMID:24859629	(2014) Chemokine receptor CXCR3 ligands in bronchoalveolar lavage fluid: associations with radiological pattern, clinical course, and prognosis in sarcoidosis.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:24886434	(2014) Inhibition of the JAK2STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.	5	19	1.48	0.00077	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000371067,9606.ENSP00000426809	ERCC1,CDH1,ALDH1A1,JAK2,PROM1
PMID:24966836	(2014) Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis.	5	19	1.48	0.00077	9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000478570	FABP4,CCR5,CAV1,PDGFA,VEGFA
PMID:25111578	(2014) Stromal nodules in benign prostatic hyperplasia: morphologic and immunohistochemical characteristics.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	CD34,AR,PROM1,VEGFA
PMID:25120561	(2014) HumanViCe: host ceRNA network in virus infected cells in human.	4	7	1.82	0.00077	9606.ENSP00000260356,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000361021	THBS1,CXCL11,ELN,PTEN
PMID:25181353	(2014) Hematopoietic stem cells in neonates: any differences between very preterm and term neonates?	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CD34,MME,PROM1
PMID:25598773	(2014) Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration?	4	7	1.82	0.00077	9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	ELN,CNTF,NTF3,BDNF
PMID:26056586	(2014) Improvements in biomaterial matrices for neural precursor cell transplantation.	5	19	1.48	0.00077	9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000480291	CNTF,NTF3,BDNF,VEGFA,HNF1B
PMID:27574640	(2014) Chronic allograft rejection: A significant hurdle to transplant success.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CD34,ELN,RHOA,VEGFA
PMID:22975872	(2013) Plasmacytoid dendritic cells in HIV infection.	8	87	1.02	0.00077	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	CD38,CCR5,CXCL10,CCL20,CXCL9,IRAK4,MYD88,CCL5
PMID:23319010	(2013) Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.	4	7	1.82	0.00077	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTGS2,BCL2,VEGFA
PMID:23328683	(2013) Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13CD33CD19 expression and immunoglobulin heavy chain gene rearrangement.	4	7	1.82	0.00077	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000393312,9606.ENSP00000418525	MPO,CD34,FGFR1,MME
PMID:23337718	(2013) Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester.	4	7	1.82	0.00077	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000369816	CETP,LPL,SREBF1,SHBG
PMID:23419732	(2013) Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.	5	19	1.48	0.00077	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	PTGS2,PTEN,BCL2,CCL5,VEGFA
PMID:23501697	(2013) Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.	5	19	1.48	0.00077	9606.ENSP00000263317,9606.ENSP00000321334,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000384906	NOX4,LPA,CAV1,ABCG1,SAA1
PMID:23505219	(2013) Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000400175	CDH1,PDGFB,PDGFA,PDGFD,RHOA
PMID:23554274	(2013) Uterine vasculature remodeling in human pregnancy involves functional macrochimerism by endothelial colony forming cells of fetal origin.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CCR5,CD34,PROM1,VEGFA
PMID:23564444	(2013) IL-1beta inhibits self-renewal capacity of dormant CD34+CD38- acute myelogenous leukemia cells in vitro and in vivo.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	CD38,CD34,STAT5A,JAK2
PMID:23601240	(2013) Biological functions of decorin in cancer.	5	19	1.48	0.00077	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000478570	THBS1,CDH1,TIMP3,IGF1R,VEGFA
PMID:23827112	(2013) [Effect of VE-cadherin on sensitivity to Imatinib in Sup-B15 Philadelphia chromosome positive acute lymphoblastic leukemia cells].	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809	CD38,ALDH1A1,CD34,PROM1
PMID:23878188	(2013) Redox imbalance and biochemical changes in cancer.	5	19	1.48	0.00077	9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000380252	ATM,SIRT6,CAV1,TXN,NFE2L2
PMID:24137452	(2013) U87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissues.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CCL5,VEGFA
PMID:24280306	(2013) Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,CD34,MYD88,PROM1
PMID:24326543	(2013) Alopecia areata: updates from the mouse perspective.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:24385810	(2013) Significance of neuropilin-1 expression in acute myeloid leukemia.	5	19	1.48	0.00077	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000393312,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CD34,FGFR1,MME,VEGFA
PMID:25095525	(2013) Role of alloimmunity and autoimmunity in allograft rejection.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	IFNG,HSPG2,EDN1,BCL2,AGTR1
PMID:22179420	(2012) Heavy and moderate interval exercise training alters low-flow-mediated constriction but does not increase circulating progenitor cells in healthy humans.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDN1,PROM1,VEGFA
PMID:22201929	(2012) Sex hormones, aging, and Alzheimers disease.	5	19	1.48	0.00077	9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525	AR,SHBG,BCL2,BDNF,MME
PMID:22268587	(2012) Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PROM1,VEGFA
PMID:22545050	(2012) Angiogenesis in Pagets Disease of the Vulva and the Breast: Correlation with Microvessel Density.	4	7	1.82	0.00077	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000478570	THBS1,CDH1,CD34,VEGFA
PMID:22619504	(2012) Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16.	4	7	1.82	0.00077	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409	MPO,CD69,IFNG,CHI3L1
PMID:22649204	(2012) CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:22733553	(2012) Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185	CD38,CDH1,ATM,PTEN,BCL2
PMID:22954273	(2012) Can nitric oxide-based therapy prevent bronchopulmonary dysplasia?	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	TGFB1,ELN,PTGS2,EDN1,VEGFA
PMID:23155238	(2012) Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CD34,CXCL9,CCL5
PMID:23226759	(2012) Experimental studies of erythropoietin protection following traumatic brain injury in rats.	5	19	1.48	0.00077	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	EPOR,STAT5A,JAK2,BCL2,VEGFA
PMID:24058786	(2012) Screening approaches to generating STAT inhibitors: Allowing the hits to identify the targets.	5	19	1.48	0.00077	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	IFNG,CD34,STAT5A,JAK2,BCL2
PMID:24710552	(2012) Macro and microfluidic flows for skeletal regenerative medicine.	5	19	1.48	0.00077	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000400175	SOX9,LPL,PTGS2,BMP2,RHOA
PMID:25317143	(2012) Secretion of nerve growth factor, brain-derived neurotrophic factor, and glial cell-line derived neurotrophic factor in co-culture of four cell types in cerebrospinal fluid-containing medium.	4	7	1.82	0.00077	9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,NTF3,BDNF,VEGFA
PMID:20232397	(2011) Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment.	4	7	1.82	0.00077	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000414303,9606.ENSP00000478570	PDGFB,PDGFA,BDNF,VEGFA
PMID:20720219	(2011) Different populations of circulating endothelial cells in patients with age-related macular degeneration: a novel insight into pathogenesis.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CD34,EDN1,PROM1,VEGFA
PMID:21076298	(2011) New insights into angiotensin receptor actions: from blood pressure to aging.	5	19	1.48	0.00077	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000419422	THBS1,CXCL10,JAK2,RHOA,AGTR1
PMID:21150020	(2011) Neuroprotection in glaucoma.	5	19	1.48	0.00077	9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000397297	CNTF,PTGS2,EDN1,BCL2,NTF3
PMID:21171080	(2011) Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.	4	7	1.82	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,CCL5
PMID:21273392	(2011) Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL9
PMID:21437259	(2011) Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells.	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809	CD38,AMBP,CXCL10,CD34,PROM1
PMID:21863242	(2011) Expression of the progenitor marker NG2CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.	5	19	1.48	0.00077	9606.ENSP00000265132,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000426809	AMBP,ATM,MAP3K5,TXN,PROM1
PMID:21869887	(2011) Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CNR1,PTEN,PROM1,VEGFA
PMID:21953501	(2011) Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.	5	19	1.48	0.00077	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000478570	THBS1,ANGPT2,PDGFA,FGFR1,VEGFA
PMID:21990094	(2011) A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis.	4	7	1.82	0.00077	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067	EPOR,STAT5A,CXCL9,JAK2
PMID:21992896	(2011) Salvianolic acid B suppresses IFN-gamma-induced JAKSTAT1 activation in endothelial cells.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067	CXCL10,CXCL11,CXCL9,JAK2
PMID:22107808	(2011) Adaptation to statins restricts human tumour growth in Nude mice.	5	19	1.48	0.00077	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,SREBF1,BCL2,VEGFA
PMID:22279463	(2011) CD10 expression helps to differentiate basal cell carcinoma from trichoepithelioma.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525	CD34,AR,BCL2,MME
PMID:19836390	(2010) Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD).	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000478570	CD34,CAV1,VIP,VEGFA
PMID:19944411	(2010) In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.	4	7	1.82	0.00077	9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000477707,9606.ENSP00000478570	PTGS2,S100A12,NR1H3,VEGFA
PMID:20075975	(2010) Development of the human choriocapillaris.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000478570	CD34,ELN,ENTPD1,VEGFA
PMID:20178043	(2010) Angiogenesis, neurogenesis and brain recovery of function following injury.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	CD34,BMP2,BDNF,AGTR1,VEGFA
PMID:20298532	(2010) Endothelial progenitor cells: what use for the cardiologist?	5	19	1.48	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,AGTR1,PROM1,VEGFA
PMID:20298566	(2010) Proteome differences associated with fat accumulation in bovine subcutaneous adipose tissues.	5	19	1.48	0.00077	9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000385834,9606.ENSP00000401720	FABP4,SREBF1,G6PD,TF,GK
PMID:20373263	(2010) siRNA-based topical microbicides targeting sexually transmitted infections.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,CCL20,CCL5,VEGFA
PMID:20416033	(2010) Partial pulmonary embolization disrupts alveolarization in fetal sheep.	4	7	1.82	0.00077	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000478570	PDGFB,PDGFA,ELN,VEGFA
PMID:20417684	(2010) Bone marrow stem cells and liver regeneration.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,PROM1,VEGFA
PMID:20461084	(2010) STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.	5	19	1.48	0.00077	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,STAT5A,JAK2,BCL2,VEGFA
PMID:20487305	(2010) Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:20806819	(2010) [Molecular predictors in head and neck tumours].	4	7	1.82	0.00077	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,BCL2,VEGFA
PMID:20856926	(2010) CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.	5	19	1.48	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:22043205	(2010) The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress.	5	19	1.48	0.00077	9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683	EDNRA,PTGS2,NOX1,TXN,EDN1
PMID:19290007	(2009) Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells.	4	7	1.82	0.00077	9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,STAT5A,BCL2,VEGFA
PMID:19323909	(2009) Knockout of the tumor necrosis factor a receptor 1 gene can up-regulate erythropoietin receptor during myocardial ischemia-reperfusion injury in mice.	4	7	1.82	0.00077	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,STAT5A,JAK2,BCL2
PMID:19343207	(2009) Loss of the transcriptional repressor PAG-3Gfi-1 results in enhanced neurosecretion that is dependent on the dense-core vesicle membrane protein IDA-1IA-2.	5	19	1.48	0.00077	9606.ENSP00000300055,9606.ENSP00000321853,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000356213	PLIN1,SERPINF2,EBF1,STAT5A,VIP
PMID:19356234	(2009) A novel liver specific isoform of the rat LAR transcript is expressed as a truncated isoform encoded from a 5UTR located within intron 11.	5	19	1.48	0.00077	9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000414303	IGF1R,HNF4A,SREBF1,CCL20,BDNF
PMID:19403382	(2009) [Effect of sinomenine on the expression of chemokines and chemokine receptors in dendritic cells from patients with rheumatoid arthritis].	4	7	1.82	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CCR5,CXCL10,CXCL11,CXCL9
PMID:19426609	(2009) Polymeric materials for tissue engineering of arterial substitutes.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	CD34,ELN,EDN1,VEGFA
PMID:19502020	(2009) Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation.	4	7	1.82	0.00077	9606.ENSP00000228434,9606.ENSP00000278840,9606.ENSP00000312987,9606.ENSP00000380252	CD69,FADS2,HNF4A,NFE2L2
PMID:19545356	(2009) Direct cord implantation in brachial plexus avulsions: revised technique using a single stage combined anterior (first) posterior (second) approach and end-to-side side-to-side grafting neurorrhaphy.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	IFNG,CNTF,NTF3,BDNF
PMID:19553463	(2009) FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.	5	19	1.48	0.00077	9606.ENSP00000355370,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000414303	CNTF,SGK1,PTEN,AR,BDNF
PMID:19558500	(2009) Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:19602701	(2009) Underlying genetic models of inheritance in established type 2 diabetes associations.	5	19	1.48	0.00077	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,KCNJ11,FTO,HNF1B
PMID:19636412	(2009) CD47 regulates collagen I-induced cyclooxygenase-2 expression and intestinal epithelial cell migration.	4	7	1.82	0.00077	9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000400175	THBS1,CD47,PTGS2,RHOA
PMID:19638592	(2009) Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000474412	TGFB1,CDH1,CCR5,CCL5
PMID:20169144	(2009) Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,VEGFA
PMID:24198504	(2009) Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809	CD38,CD34,PTEN,PROM1
PMID:17991878	(2008) Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399	CXCL10,CXCL11,CXCL9,MYD88
PMID:18320471	(2008) Mechanical stretch induced interleukin-18 (IL-18) expression through Angiotensin subtype 1 receptor (AT1R) and endothelin-1 in cardiomyocytes.	4	7	1.82	0.00077	9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000419422	EDNRA,EDN1,RHOA,AGTR1
PMID:18364728	(2008) Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000478570	TGFB1,CCR5,PDGFA,ELN,VEGFA
PMID:18514095	(2008) TH1TH2 immune response in lung fibroblasts in interstitial lung disease.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:18596134	(2008) 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAKSTAT1 signalling pathway activation and IP-10CXCL10 expression in mesangial cells.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067	CXCL10,CXCL11,CXCL9,JAK2
PMID:18612312	(2008) Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.	4	7	1.82	0.00077	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,VEGFA
PMID:18644457	(2008) Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:18817543	(2008) Rho kinase inhibitors Y27632 and H1152 augment neurite extension in the presence of cultured Schwann cells.	4	7	1.82	0.00077	9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	CNTF,NTF3,RHOA,BDNF
PMID:17192467	(2007) Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:17569210	(2007) Antitumor, anti-invasion, and antimetastatic effects of curcumin.	4	7	1.82	0.00077	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PTGS2,BCL2,VEGFA
PMID:17717633	(2007) Tumour vascularization: sprouting angiogenesis and beyond.	8	87	1.02	0.00077	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,THBS1,MMP14,CD34,ANGPT2,PTGS2,PROM1,VEGFA
PMID:16397045	(2006) Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,VEGFA
PMID:16551362	(2006) 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.	5	19	1.48	0.00077	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000356832	TIMP3,MMP14,HNF4A,CAV1,SGK1
PMID:16575871	(2006) Antagonist of interferon-inducible protein 10CXCL10 ameliorates the progression of autoimmune sialadenitis in MRLlpr mice.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:16597412	(2006) [Endothelin-1, angiotensin II and cancer].	4	7	1.82	0.00077	9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	EDNRA,EDN1,AGTR1,VEGFA
PMID:16613997	(2006) Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:16889103	(2006) Changes in the immune system in depression and dementia: causal or coincidental effects?	5	19	1.48	0.00077	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303	TGFB1,IFNG,PTGS2,BCL2,BDNF
PMID:17056573	(2006) Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	CXCL10,CXCL11,CCL20,CXCL9
PMID:15937690	(2005) Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:16248895	(2005) Regulation of soluble vascular endothelial growth factor receptor (sFlt-1sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells.	4	7	1.82	0.00077	9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000478570	ANGPT2,ANG,ELN,VEGFA
PMID:15507231	(2004) Early chemokine expression induced by interferon-gamma in a murine model of Hashimotos thyroiditis.	4	7	1.82	0.00077	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,CCL5
PMID:12555203	(2003) Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000475344	CCR5,CXCL10,CXCL9,CCL5,APLNR
PMID:12932287	(2003) High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.	5	19	1.48	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000354901	CCR5,CXCL10,CD34,CD247,CXCL9
PMID:11912115	(2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL9
PMID:11600578	(2001) Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.	4	7	1.82	0.00077	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,CCL5
PMID:11714827	(2001) A functional IFN-gamma-inducible protein-10CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CXCL9
PMID:11091274	(2000) CXC chemokines Gro(alpha)IL-8 and IP-10MIG in Helicobacter pylori gastritis.	4	7	1.82	0.00077	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,CCL5
PMID:10029585	(1999) Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression.	4	7	1.82	0.00077	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,STAT5A,JAK2,BCL2
PMID:10521580	(1999) Transforming growth factor-beta1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,CNTF,NTF3,BDNF
PMID:9180296	(1997) Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501.	4	7	1.82	0.00077	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185	MPO,CD38,CD34,BCL2
PMID:8814243	(1996) Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization.	4	7	1.82	0.00077	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000360250,9606.ENSP00000418525	CD38,CD69,ENTPD1,MME
PMID:26097496	(....) human parvovirus b19: a mechanistic overview of infection and dna replication.	5	19	1.48	0.00077	9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067	EPOR,ATM,CD34,STAT5A,JAK2
PMID:28255425	(....) oxidative stress in infection and consequent disease.	4	7	1.82	0.00077	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057	TGFB1,NOX4,PTGS2,NOX1
PMID:35053485	(2022) Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer.	7	60	1.13	0.00079	9606.ENSP00000227868,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	PDHX,CAV1,SREBF1,G6PD,RHOA,CCL5,VEGFA
PMID:35054837	(2022) The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease.	6	37	1.27	0.00079	9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000312987,9606.ENSP00000362524,9606.ENSP00000380365,9606.ENSP00000381185	ATM,PRKCE,HNF4A,ANGPTL2,RGN,BCL2
PMID:35067158	(2022) Adipose endothelial cells mastering adipose tissues metabolic fate.	6	37	1.27	0.00079	9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000475344,9606.ENSP00000478570	ATM,PDGFB,EDN1,MYD88,APLNR,VEGFA
PMID:35073970	(2022) The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review.	7	60	1.13	0.00079	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	IGF1R,CD34,ANGPT2,STAT5A,PTGS2,PTEN,VEGFA
PMID:35103937	(2022) Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy.	6	37	1.27	0.00079	9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CNTF,BCL2,NTF3,BDNF,PROM1,VEGFA
PMID:35154701	(2022) Advances in research on the effects of platelet activation in acute lung injury (Review).	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000304767,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,P2RY1,PTGS2,BCL2,CCL5,VEGFA
PMID:35216243	(2022) Lymphatics in Tumor Progression and Immunomodulation.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,ANGPT2,CXCL9,PTEN,CCL5,VEGFA
PMID:35216294	(2022) Effect of Multiple Sclerosis Cerebrospinal Fluid and Oligodendroglia Cell Line Environment on Human Whartons Jelly Mesenchymal Stem Cells Secretome.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CD34,BDNF,CCL5,VEGFA
PMID:35251963	(2022) Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies.	7	60	1.13	0.00079	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,HNF4A,CCL20,PTEN,JAK2,PROM1,VEGFA
PMID:35260172	(2022) An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.	6	37	1.27	0.00079	9606.ENSP00000222572,9606.ENSP00000248553,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000444198,9606.ENSP00000480291	PON2,HSPB1,BCL2,PROM1,CITED2,HNF1B
PMID:35267606	(2022) Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma.	7	60	1.13	0.00079	9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000393312	TGFB1,LAMC1,CDH1,TIMP3,IGF1R,ELN,FGFR1
PMID:35269466	(2022) Regulating Endogenous Neural Stem Cell Activation to Promote Spinal Cord Injury Repair.	7	60	1.13	0.00079	9606.ENSP00000245479,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000480291	SOX9,PTEN,NTF3,BDNF,PROM1,VEGFA,HNF1B
PMID:35269956	(2022) Dysregulation of mTOR Signaling after Brain Ischemia.	6	37	1.27	0.00079	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000414303,9606.ENSP00000478570	SREBF1,PTGS2,SGK1,PTEN,BDNF,VEGFA
PMID:35280538	(2022) Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review.	6	37	1.27	0.00079	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,PTEN,GLO1,NFE2L2,BCL2,VEGFA
PMID:35282365	(2022) Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice.	6	37	1.27	0.00079	9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	PLIN1,LPL,PDGFB,CCL20,CXCL9,CCL5
PMID:35291649	(2022) Immunopathology and Immunotherapy of Inflammatory Skin Diseases.	7	60	1.13	0.00079	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000371067	CXCL10,CXCL11,STAT5A,CCL20,CD247,CXCL9,JAK2
PMID:35400817	(2022) Amelioration of cancer cachexia with preemptive administration of tumor necrosis factor-alpha blocker.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000300055,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067	IFNG,PLIN1,SREBF1,PTEN,AR,JAK2
PMID:35432447	(2022) Applications of Non-Coding RNAs in Patients With Retinoblastoma.	6	37	1.27	0.00079	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000479617	IGF1R,ATM,PTEN,BCL2,BDNF,UHRF1
PMID:33247906	(2021) Description of the Follicular Fluid Cytokine and Hormone Profiles in Human Physiological Natural Cycles.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,LTA,BDNF,CCL5,VEGFA
PMID:33391542	(2021) Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000427424,9606.ENSP00000474412	MAPK1,CXCL10,CCL20,BCL2,TNFAIP8,CCL5
PMID:33393902	(2021) Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease.	7	60	1.13	0.00079	9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000393312,9606.ENSP00000478319	PDGFB,CXCL9,BMP2,EDN1,SAA1,FGFR1,GREM1
PMID:33425248	(2021) Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000321853,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000354901,9606.ENSP00000368104	CCR5,CXCL10,SERPINF2,STAT5A,PDGFA,CXCL9,BMP2
PMID:33436050	(2021) Cholangiogenic potential of human deciduous pulp stem cell-converted hepatocyte-like cells.	6	37	1.27	0.00079	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000418525,9606.ENSP00000426809	SOX9,ONECUT1,CD34,HNF4A,MME,PROM1
PMID:33562328	(2021) Human Paraoxonase-2 (PON2): Protein Functions and Modulation.	7	60	1.13	0.00079	9606.ENSP00000222572,9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000380252	PON2,MPO,NOX4,CAV1,MAP3K5,TXN,NFE2L2
PMID:33604794	(2021) Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors.	11	195	0.81	0.00079	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000478570,9606.ENSP00000479617	ERCC1,CDH1,TIMP3,IGF1R,HNF4A,SREBF1,PTGS2,SGK1,PTEN,VEGFA,UHRF1
PMID:33622377	(2021) A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease.	7	60	1.13	0.00079	9606.ENSP00000309757,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	LPL,SIRT6,SREBF1,PTEN,NFE2L2,BCL2,VEGFA
PMID:33684837	(2021) Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?	10	156	0.87	0.00079	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000336762,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MAPK1,HSPB1,ATM,ANG,SGK1,PTEN,JAK2,BCL2,MYD88,VEGFA
PMID:33735664	(2021) Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenstroem macroglobulinemia.	7	60	1.13	0.00079	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000418525	MAPK1,ATM,JAK2,BCL2,IRAK4,MYD88,MME
PMID:33794574	(2021) Exploring the differentially expressed genes in human lymphocytes upon response to ionizing radiation: a network biology approach.	6	37	1.27	0.00079	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	ERCC1,IGF1R,ATM,PTGS2,PTEN,BCL2
PMID:33796062	(2021) Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412	CXCL10,CNTF,EDN1,NTF3,BDNF,CCL5
PMID:33807461	(2021) Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?	6	37	1.27	0.00079	9606.ENSP00000292303,9606.ENSP00000330382,9606.ENSP00000351908,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000477707	CCR5,PDGFB,MAP3K5,PDGFD,CCL5,NR1H3
PMID:33809543	(2021) The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness.	7	60	1.13	0.00079	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,MMP14,ANGPT2,ANGPTL2,BCL2,VEGFA
PMID:33869200	(2021) Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies.	7	60	1.13	0.00079	9606.ENSP00000225275,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CXCL11,CD34,BCL2,LTA,BDNF,VEGFA
PMID:33909153	(2021) The role of redox system in metastasis formation.	7	60	1.13	0.00079	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000427424,9606.ENSP00000478570	CDH1,NOX4,NOX1,TXN,NFE2L2,TNFAIP8,VEGFA
PMID:33927608	(2021) Mechanism of White Matter Injury and Promising Therapeutic Strategies of MSCs After Intracerebral Hemorrhage.	6	37	1.27	0.00079	9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CCR5,PTEN,GAP43,MYD88,BDNF,VEGFA
PMID:33928081	(2021) Immune Response: A Missed Opportunity Between Vitamin D and Radiotherapy.	6	37	1.27	0.00079	9606.ENSP00000216862,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CYP24A1,CXCL10,CXCL9,JAK2,BCL2,CCL5
PMID:33946541	(2021) MicroRNAs in Acute ST Elevation Myocardial Infarction-A New Tool for Diagnosis and Prognosis: Therapeutic Implications.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,ATM,ELN,PTEN,BCL2,VEGFA
PMID:34040696	(2021) Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CD47,PTGS2,ENTPD1,CCL5,VEGFA
PMID:34054832	(2021) Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:34065010	(2021) Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy.	7	60	1.13	0.00079	9606.ENSP00000260356,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CD247,CD47,PTGS2,ENTPD1,GREM1,VEGFA
PMID:34072544	(2021) Erythrocytes: Central Actors in Multiple Scenes of Atherosclerosis.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,THBS1,ABCG1,CD47,EDN1,VEGFA
PMID:34106380	(2021) Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases.	6	37	1.27	0.00079	9606.ENSP00000246553,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000477707	FFAR1,SREBF1,JAK2,NFE2L2,BCL2,NR1H3
PMID:34163000	(2021) Targeting therapy-resistant lung cancer stem cells via disruption of the AKTTSPYL5PTEN positive-feedback loop.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000426809	CD38,CDH1,ALDH1A1,CD34,PTEN,PROM1
PMID:34203086	(2021) The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.	7	60	1.13	0.00079	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570,9606.ENSP00000479617	CXCL10,CAV1,RBP4,PTEN,PROM1,VEGFA,UHRF1
PMID:34277620	(2021) The Genomic Response to TGF-beta1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney.	7	60	1.13	0.00079	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000400175,9606.ENSP00000426809	THBS1,CDH1,ATM,EDN1,KL,RHOA,PROM1
PMID:34345178	(2021) Identification of Key Candidate Genes Related to Inflammatory Osteolysis Associated with Vitamin E-Blended UHMWPE Debris of Orthopedic Implants by Integrated Bioinformatics Analysis and Experimental Confirmation.	6	37	1.27	0.00079	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	THBS1,CXCL10,CCL20,CXCL9,PTGS2,CCL5
PMID:34371753	(2021) Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL.	9	120	0.94	0.00079	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,NOX4,TIMP3,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:34388961	(2021) Interleukin-22: a potential therapeutic target in atherosclerosis.	7	60	1.13	0.00079	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2,CCL5
PMID:34439810	(2021) Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases.	7	60	1.13	0.00079	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,PTEN,NOX1,TXN,KL,NFE2L2,BCL2
PMID:34479599	(2021) TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000401399	CDH1,CCL20,PTGS2,NOX1,BCL2,MYD88
PMID:34490133	(2021) Inflammatory Amplification: A Central Tenet of Uterine Transition for Labor.	6	37	1.27	0.00079	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412	TIMP3,CXCL10,ELN,PTGS2,EDN1,CCL5
PMID:34572794	(2021) Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185	CD38,ATM,CD34,ELN,JAK2,BCL2
PMID:34573095	(2021) Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress.	6	37	1.27	0.00079	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,NOX1,TXN,EDN1,NFE2L2,VEGFA
PMID:34575833	(2021) Molecular Interactions of Arterial Hypertension in Its Target Organs.	6	37	1.27	0.00079	9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	ANG,ELN,EDN1,AGTR1,CCL5,VEGFA
PMID:34638258	(2021) Molecular Characterization of Prostate Cancers in the Precision Medicine Era.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822	CD38,ATM,CD34,CAV1,PTEN,AR
PMID:34638469	(2021) Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis.	8	88	1.02	0.00079	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000400175,9606.ENSP00000426809	ENPP2,CDH1,ATM,ALDH1A1,MMP14,CD34,RHOA,PROM1
PMID:34642818	(2021) Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function.	8	88	1.02	0.00079	9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000301522,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,VDAC1,PRDX2,STAT5A,PTGS2,JAK2,BCL2,VEGFA
PMID:34646551	(2021) Myricetin: A comprehensive review on its biological potentials.	8	88	1.02	0.00079	9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	LPL,SREBF1,PTGS2,BMP2,EDN1,G6PD,BCL2,VEGFA
PMID:34680363	(2021) Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View.	6	37	1.27	0.00079	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	ATM,PTEN,JAK2,FGFR1,RHOA,VEGFA
PMID:34712243	(2021) Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000380252	CD38,CCR5,CXCL10,CXCL9,TXN,NFE2L2
PMID:34733419	(2021) Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	MPO,IFNG,PTGS2,BCL2,AGTR1,VEGFA
PMID:34769021	(2021) Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis.	7	60	1.13	0.00079	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412	MPO,CCR5,CXCL10,CD34,CXCL9,JAK2,CCL5
PMID:34771532	(2021) Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CAV1,CCL20,CXCL9,CCL5
PMID:34795999	(2021) Apoptosis and Cell Proliferation Markers in Inflammatory-Fibroproliferative Diseases of the Vessel Wall (Review).	6	37	1.27	0.00079	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	TIMP3,CXCL10,PTGS2,BCL2,MYD88,VEGFA
PMID:34805157	(2021) Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer.	7	60	1.13	0.00079	9606.ENSP00000216181,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067	MYH9,CDH1,IGF1R,MMP14,PTGS2,PTEN,JAK2
PMID:34830207	(2021) Nuclear Receptors in Myocardial and Cerebral Ischemia-Mechanisms of Action and Therapeutic Strategies.	7	60	1.13	0.00079	9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SIRT6,PTGS2,BCL2,BDNF,CCL5,VEGFA
PMID:34831048	(2021) Modulation of Immune Components on Stem Cell and Dormancy in Cancer.	8	88	1.02	0.00079	9606.ENSP00000225275,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000355361,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412	MPO,ALDH1A1,CD34,GAS6,CD47,MME,PROM1,CCL5
PMID:34866972	(2021) Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects.	7	60	1.13	0.00079	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000351908,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,ATM,ALDH1A1,MAP3K5,G6PD,BCL2,VEGFA
PMID:34877297	(2021) T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,PTEN,BCL2,MME
PMID:34885024	(2021) Review: Challenges of In Vitro CAF Modelling in Liver Cancers.	6	37	1.27	0.00079	9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000400175,9606.ENSP00000478319,9606.ENSP00000478570	ELN,BCL2,SAA1,RHOA,GREM1,VEGFA
PMID:34885698	(2021) Gallic Acid and Diabetes Mellitus: Its Association with Oxidative Stress.	6	37	1.27	0.00079	9606.ENSP00000263317,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,SREBF1,PTGS2,TXN,NFE2L2,BCL2
PMID:35087885	(2021) Mechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis.	6	37	1.27	0.00079	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	HSPB1,CDH1,CAV1,ELN,BMP2,VEGFA
PMID:31256327	(2020) Role of Mast Cells in Shaping the Tumor Microenvironment.	8	88	1.02	0.00079	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000445772,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,STAT5A,CCL20,CXCL9,LTB4R2,CCL5,VEGFA
PMID:31887849	(2020) Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CXCL10,MMP14,CD34,CXCL9,ENTPD1,CCL5
PMID:31939724	(2020) Role of microRNA and Long Non-Coding RNA in Hepatocellular Carcinoma.	7	60	1.13	0.00079	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	HSPB1,CDH1,HNF4A,PTEN,BCL2,FGFR1,VEGFA
PMID:31988296	(2020) Human BCL-G regulates secretion of inflammatory chemokines but is dispensable for induction of apoptosis by IFN-gamma and TNF-alpha in intestinal epithelial cells.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,BCL2,CCL5
PMID:32033591	(2020) Skeletal muscle as an experimental model of choice to study tissue aging and rejuvenation.	7	60	1.13	0.00079	9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CAV1,ELN,HSPG2,LTA,PROM1,VEGFA
PMID:32127922	(2020) Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial.	7	60	1.13	0.00079	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CD38,CD69,CXCL10,CCL20,CXCL9,ENTPD1,CCL5
PMID:32178321	(2020) Application of Adult and Pluripotent Stem Cells in Interstitial CystitisBladder Pain Syndrome Therapy: Methods and Perspectives.	8	88	1.02	0.00079	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,NOX4,CD34,BCL2,FGFR1,CCL5,VEGFA
PMID:32195169	(2020) Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,CDH1,IGF1R,PTEN,FGFR1,VEGFA
PMID:32210188	(2020) A Wnt-BMP4 Signaling Axis Induces MSX and NOTCH Proteins and Promotes Growth Suppression and Differentiation in Neuroblastoma.	6	37	1.27	0.00079	9606.ENSP00000257430,9606.ENSP00000312987,9606.ENSP00000362410,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000478319	APC,HNF4A,MAFB,BAMBI,BMP2,GREM1
PMID:32300641	(2020) The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth.	8	88	1.02	0.00079	9606.ENSP00000268035,9606.ENSP00000301522,9606.ENSP00000308208,9606.ENSP00000334329,9606.ENSP00000346508,9606.ENSP00000354511,9606.ENSP00000363641,9606.ENSP00000401399	IGF1R,PRDX2,MMP14,UNC5B,PDGFA,COMT,TXN,MYD88
PMID:32309787	(2020) Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000403495,9606.ENSP00000478570	CD38,CD34,CD47,ENTPD1,LTA,VEGFA
PMID:32365809	(2020) Targeting GSK3 and Associated Signaling Pathways Involved in Cancer.	7	60	1.13	0.00079	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	CDH1,IGF1R,CD34,HNF4A,PTEN,AR,BCL2
PMID:32386458	(2020) Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,MYD88,CCL5,VEGFA
PMID:32462078	(2020) Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000418525	CD38,AMBP,CD34,STAT5A,CD247,MME
PMID:32481590	(2020) Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000265333,9606.ENSP00000300055,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000381185	MPO,VDAC1,PLIN1,CAV1,SREBF1,BCL2
PMID:32535032	(2020) Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000369442,9606.ENSP00000419422,9606.ENSP00000474412	CXCL10,ANGPT2,CXCL9,KL,AGTR1,CCL5
PMID:32599870	(2020) The Double-Edged Sword Role of Viruses in Gastric Cancer.	7	60	1.13	0.00079	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000427424,9606.ENSP00000478570	THBS1,CDH1,ANGPT2,JAK2,BCL2,TNFAIP8,VEGFA
PMID:32733268	(2020) The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction.	6	37	1.27	0.00079	9606.ENSP00000315011,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000477707	EDNRA,SREBF1,ABCG1,PTEN,EDN1,NR1H3
PMID:32823812	(2020) Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action.	7	60	1.13	0.00079	9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,MAPK7,COMT,PTEN,BCL2,RHOA,VEGFA
PMID:32850829	(2020) Hepatic Stellate Cells and Hepatocarcinogenesis.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000478570	IFNG,THBS1,CDH1,ANG,PTEN,VEGFA
PMID:32916911	(2020) Cranial Neural Crest Cells and Their Role in the Pathogenesis of Craniofacial Anomalies and Coronal Craniosynostosis.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000363973,9606.ENSP00000393312,9606.ENSP00000478570	MAPK1,SOX9,CDH1,ALPL,FGFR1,VEGFA
PMID:32927696	(2020) Small Heat Shock Proteins in Cancers: Functions and Therapeutic Potential for Cancer Therapy.	6	37	1.27	0.00079	9606.ENSP00000248553,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,G6PD,NFE2L2,BCL2,PROM1,VEGFA
PMID:32947237	(2020) Identification of clinical molecular targets for childhood Burkitt lymphoma.	6	37	1.27	0.00079	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000418525	ATM,PTEN,BCL2,RHOA,MYD88,MME
PMID:32983976	(2020) Knockout of EGFL6 by CRISPRCas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CXCL10,HNF4A,PDGFB,BCL2,VEGFA
PMID:33008022	(2020) Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma.	7	60	1.13	0.00079	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000381185,9606.ENSP00000384906	TGFB1,CD38,AMBP,IGF1R,CCR5,BCL2,SAA1
PMID:33092038	(2020) Modeling Adipogenesis: Current and Future Perspective.	6	37	1.27	0.00079	9606.ENSP00000351807,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418823	ELN,RBP4,AR,RHOA,BDNF,FTO
PMID:33113418	(2020) Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.	8	88	1.02	0.00079	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000419422,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,NFE2L2,BCL2,MYD88,AGTR1,CCL5,VEGFA
PMID:33153118	(2020) Prolonged Effect of Seminal Plasma on Global Gene Expression in Porcine Endometrium.	7	60	1.13	0.00079	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000357726,9606.ENSP00000365256,9606.ENSP00000477707	MAPK1,IFNG,CXCL11,STAT5A,S100A12,CLCN5,NR1H3
PMID:33182840	(2020) The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:33193350	(2020) Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,ELN,CXCL9,EDN1,CCL5,VEGFA
PMID:33203195	(2020) Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?	6	37	1.27	0.00079	9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000384906,9606.ENSP00000474412	PTGS2,PTEN,BMP2,EDN1,SAA1,CCL5
PMID:33291743	(2020) Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy.	7	60	1.13	0.00079	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	ERCC1,ATM,PTEN,NFE2L2,BCL2,FGFR1,VEGFA
PMID:33324210	(2020) Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,JAK2,LTA,RARRES2,CCL5,VEGFA
PMID:33324416	(2020) Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation.	8	88	1.02	0.00079	9606.ENSP00000229135,9606.ENSP00000232219,9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,RBP1,SOX9,CD34,PDGFA,ELN,LTA,CCL5
PMID:33335962	(2020) ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells.	6	37	1.27	0.00079	9606.ENSP00000256104,9606.ENSP00000297785,9606.ENSP00000300055,9606.ENSP00000317674,9606.ENSP00000381185,9606.ENSP00000426809	FABP4,ALDH1A1,PLIN1,APOL1,BCL2,PROM1
PMID:33537342	(2020) Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS).	6	37	1.27	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412	CCR5,CXCL10,ENTPD1,EDN1,AGTR1,CCL5
PMID:33569382	(2020) MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.	7	60	1.13	0.00079	9606.ENSP00000263317,9606.ENSP00000285407,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175	NOX4,KLF10,CXCL10,STAT5A,TXN,NFE2L2,RHOA
PMID:30588884	(2019) Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000478570	MAPK1,IFNG,BCL2,NPY,NTF3,VEGFA
PMID:30705711	(2019) Human adult pluripotency: Facts and questions.	6	37	1.27	0.00079	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000426809	TGFB1,IFNG,CD34,HNF4A,SIRT6,PROM1
PMID:30717356	(2019) Curbing Lipids: Impacts ON Cancer and Viral Infection.	7	60	1.13	0.00079	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570,9606.ENSP00000480291	SREBF1,PTGS2,PTEN,SHBG,BCL2,VEGFA,HNF1B
PMID:30976106	(2019) Metabolic regulation of cell growth and proliferation.	7	60	1.13	0.00079	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000478570	FABP4,LPL,PTEN,TXN,G6PD,NFE2L2,VEGFA
PMID:30977203	(2019) Concepts of GPCR-controlled navigation in the immune system.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000400175,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,RHOA,CCL5
PMID:31014119	(2019) Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000475344	CXCL10,CCL20,CXCL9,PTEN,MYD88,APLNR
PMID:31027362	(2019) Interplay Between SOX9, Wntbeta-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer.	6	37	1.27	0.00079	9606.ENSP00000245479,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822	SOX9,HSPB1,CDH1,HNF4A,PTEN,AR
PMID:31137568	(2019) Paralogous HOX13 Genes in Human Cancers.	7	60	1.13	0.00079	9606.ENSP00000222139,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	EPOR,ALDH1A1,HNF4A,PTEN,AR,PROM1,VEGFA
PMID:31231385	(2019) Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFkappaB to Enhance Pro-inflammatory Transcription.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000384906,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL9,JAK2,SAA1,MYD88,CCL5
PMID:31247937	(2019) Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.	8	88	1.02	0.00079	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000426809	ERCC1,CDH1,ATM,CD34,HNF4A,STAT5A,BCL2,PROM1
PMID:31320999	(2019) CD90(low) MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer.	6	37	1.27	0.00079	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000474412	CD69,CCR5,CXCL10,CD34,CD247,CCL5
PMID:31336893	(2019) The Role of In Vitro Immune Response Assessment for Biomaterials.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351807,9606.ENSP00000377192,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,ELN,G6PD,CCL5,VEGFA
PMID:31349902	(2019) Cancer stem cells in breast and prostate: Fact or fiction?	6	37	1.27	0.00079	9606.ENSP00000297785,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,AR,BCL2,FGFR1,PROM1,VEGFA
PMID:31379474	(2019) Genome-Wide DNA Methylation Analysis Reveals Epigenetic Pattern of SH2B1 in Chinese Monozygotic Twins Discordant for Autism Spectrum Disorder.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000397297,9606.ENSP00000414303	MAPK1,MAPK7,BCL2,IRAK4,NTF3,BDNF
PMID:31387614	(2019) Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.	6	37	1.27	0.00079	9606.ENSP00000222139,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	EPOR,IGF1R,MMP14,FGFR1,RHOA,VEGFA
PMID:31403867	(2019) Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000478570	IFNG,CXCL10,CD34,CXCL9,PTGS2,VEGFA
PMID:31492821	(2019) International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that ElabelaToddler Is a Second Endogenous Peptide Ligand.	6	37	1.27	0.00079	9606.ENSP00000292303,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000419422,9606.ENSP00000475344,9606.ENSP00000478570	CCR5,EDN1,MME,AGTR1,APLNR,VEGFA
PMID:31579085	(2019) Prospective applications of microRNAs in oral cancer.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,PDGFA,PTEN,VEGFA
PMID:31588228	(2019) Role of FOXC1 in regulating APSCs self-renewal via STI-1PrP(C) signaling.	7	60	1.13	0.00079	9606.ENSP00000221930,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TGFB1,CD34,PTEN,JAK2,BCL2,BDNF,VEGFA
PMID:31684858	(2019) An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,THBS1,STAT5A,JAK2,BCL2,VEGFA
PMID:31717629	(2019) Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia.	8	88	1.02	0.00079	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000445772	CD38,CD34,GAS6,STAT5A,BMP2,JAK2,BCL2,LTB4R2
PMID:31921705	(2019) Persistent Exposure to Fusobacterium nucleatum Triggers ChemokineCytokine Release and Inhibits the Proliferation and Osteogenic Differentiation Capabilities of Human Gingiva-Derived Mesenchymal Stem Cells.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412	CDH1,CCL20,PTGS2,BMP2,BCL2,CCL5
PMID:29426834	(2018) Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic EncephalomyelitisChronic Fatigue Syndrome.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,LTA,CCL5,VEGFA
PMID:29552328	(2018) The role of exosomal non-coding RNAs in cancer metastasis.	7	60	1.13	0.00079	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,HNF4A,ENTPD1,PTEN,BCL2,MYD88,VEGFA
PMID:29713744	(2018) Skin neurogenic inflammation.	6	37	1.27	0.00079	9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	VIP,EDN1,NPY,BDNF,CCL5,VEGFA
PMID:29959723	(2018) Origin of Reparative Stem Cells in Fracture Healing.	6	37	1.27	0.00079	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,CD34,PDGFB,ELN,BMP2,VEGFA
PMID:30036185	(2018) Implementation of environmental enrichment after middle age promotes healthy aging.	6	37	1.27	0.00079	9606.ENSP00000306124,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000384364,9606.ENSP00000414303	PRKCE,LPL,SREBF1,PTEN,NPY,BDNF
PMID:30134800	(2018) Effects of radiation on the metastatic process.	8	88	1.02	0.00079	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,MMP14,PTGS2,PTEN,BCL2,RHOA,VEGFA
PMID:30254608	(2018) Cholesterol as an Endogenous ERRalpha Agonist: A New Perspective to Cancer Treatment.	6	37	1.27	0.00079	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	IGF1R,CXCL10,HNF4A,CXCL9,PTEN,VEGFA
PMID:30369881	(2018) P311, Friend, or Foe of Tissue Fibrosis?	6	37	1.27	0.00079	9606.ENSP00000216181,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000400175	MYH9,TGFB1,IFNG,THBS1,CDH1,RHOA
PMID:30420855	(2018) Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.	7	60	1.13	0.00079	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30463587	(2018) Human menstrual blood: a renewable and sustainable source of stem cells for regenerative medicine.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000426809,9606.ENSP00000478570	CD38,IFNG,CD34,ANGPT2,PROM1,VEGFA
PMID:30483271	(2018) Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000444198,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CCL20,CXCL9,CITED2,CCL5,VEGFA
PMID:30505270	(2018) Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia.	8	88	1.02	0.00079	9606.ENSP00000284031,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	DDAH1,CAV1,MAP3K5,EDN1,RHOA,MYD88,BDNF,VEGFA
PMID:30618774	(2018) Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications.	7	60	1.13	0.00079	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CCR5,ABCG1,PTGS2,NOX1,EDN1,VEGFA
PMID:27534926	(2017) A systems approach to renal inflammation in SLE.	7	60	1.13	0.00079	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000317674,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CXCL10,MMP14,APOL1,MYD88,CCL5,VEGFA
PMID:27873219	(2017) Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,STAT5A,LTA,BDNF,CCL5,VEGFA
PMID:27909729	(2017) Self-renewal molecular mechanisms of colorectal cancer stem cells.	9	120	0.94	0.00079	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	APC,CDH1,ALDH1A1,STAT5A,PTGS2,PTEN,BCL2,RHOA,PROM1
PMID:27916613	(2017) Leptin in inflammation and autoimmunity.	6	37	1.27	0.00079	9606.ENSP00000228434,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412	CD69,PTGS2,ENTPD1,JAK2,BCL2,CCL5
PMID:28099143	(2017) Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:28123515	(2017) Genetic alterations and epigenetic alterations of cancer-associated fibroblasts.	6	37	1.27	0.00079	9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	CAV1,PTGS2,PTEN,FGFR1,CCL5,VEGFA
PMID:28392501	(2017) Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.	7	60	1.13	0.00079	9606.ENSP00000227868,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	PDHX,CDH1,CCR5,ANG,BCL2,CCL5,VEGFA
PMID:28400597	(2017) Indicators of responsiveness to immune checkpoint inhibitors.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CDH1,CCR5,CXCL10,CXCL9,RARRES2,CCL5
PMID:28410147	(2017) The roles of microgliamacrophages in tumor progression of brain cancer and metastatic disease.	7	60	1.13	0.00079	9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MMP14,PTGS2,PTEN,MYD88,PROM1,CCL5,VEGFA
PMID:28439256	(2017) The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression.	7	60	1.13	0.00079	9606.ENSP00000261769,9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	CDH1,EDNRA,PTGS2,EDN1,BCL2,AGTR1,VEGFA
PMID:28572804	(2017) Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,CXCL9,LTA,CCL5,VEGFA
PMID:28627612	(2017) Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis (Review).	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000352264,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000381185	CDH1,NOX4,CD2AP,NOX1,KL,BCL2
PMID:28790817	(2017) Emerging pharmaceutical therapies for COPD.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000351807,9606.ENSP00000356213,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000474412	IFNG,ELN,VIP,NFE2L2,BDNF,CCL5
PMID:28804688	(2017) Pivotal regulators of tissue homeostasis and cancer: macrophages.	7	60	1.13	0.00079	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000478570	TGFB1,IFNG,CHI3L1,CCR5,CXCL10,PTGS2,VEGFA
PMID:28848709	(2017) New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTENFocal Adhesion Kinase Pathway.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,IGF1R,PTEN,JAK2,RHOA,VEGFA
PMID:28966630	(2017) Neurotrophic factors and corneal nerve regeneration.	6	37	1.27	0.00079	9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,GAP43,NPY,NTF3,BDNF,VEGFA
PMID:29109374	(2017) Therapeutic Versatility of Resveratrol Derivatives.	7	60	1.13	0.00079	9606.ENSP00000263317,9606.ENSP00000265333,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,VDAC1,PTEN,EDN1,NFE2L2,BCL2,VEGFA
PMID:29143805	(2017) Mechanisms of Acupuncture Therapy in Ischemic Stroke Rehabilitation: A Literature Review of Basic Studies.	6	37	1.27	0.00079	9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	TXN,EDN1,JAK2,BCL2,BDNF,VEGFA
PMID:29250169	(2017) Therapeutic strategies against cancer stem cells in human colorectal cancer.	7	60	1.13	0.00079	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,ALDH1A1,HNF4A,BCL2,PROM1,VEGFA
PMID:29379802	(2017) Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers.	7	60	1.13	0.00079	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412	CD38,CDH1,CCR5,CCL20,PTEN,AR,CCL5
PMID:30035270	(2017) Regulation of gene expression in ischemic preconditioning in the brain.	6	37	1.27	0.00079	9606.ENSP00000260356,9606.ENSP00000265333,9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000380252	THBS1,VDAC1,PRDX2,PTGS2,AR,NFE2L2
PMID:26830766	(2016) Enhanced renoprotective effect of IGF-1 modified human umbilical cord-derived mesenchymal stem cells on gentamicin-induced acute kidney injury.	6	37	1.27	0.00079	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CD34,PDGFB,BCL2,CCL5,VEGFA
PMID:26989787	(2016) Effects of intratracheally instilled laser printer-emitted engineered nanoparticles in a mouse model: A case study of toxicological implications from nanomaterials released during consumer use.	6	37	1.27	0.00079	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,MPO,CXCL9,BCL2,CCL5,VEGFA
PMID:27187332	(2016) Effects of Brassicaceae Isothiocyanates on Prostate Cancer.	8	88	1.02	0.00079	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ALDH1A1,MMP14,AR,JAK2,BCL2,PROM1,VEGFA
PMID:27304054	(2016) Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.	7	60	1.13	0.00079	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000426809	MAPK1,CDH1,ALDH1A1,PTGS2,EDN1,JAK2,PROM1
PMID:27379019	(2016) Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells.	7	60	1.13	0.00079	9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000478570	CD34,STAT5A,CCL20,PTEN,MAFB,JAK2,VEGFA
PMID:27556950	(2016) HER2 expression identifies dynamic functional states within circulating breast cancer cells.	6	37	1.27	0.00079	9606.ENSP00000265132,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000380252,9606.ENSP00000383232	AMBP,IGF1R,ATM,ALDH1A1,NFE2L2,GGT1
PMID:27693002	(2016) The role of miRNAs in cardiovascular disease risk factors.	7	60	1.13	0.00079	9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000363822	IGF1R,CAV1,STAT5A,SREBF1,ABCG1,PTEN,AR
PMID:27697548	(2016) Alteration in cellular turnover and progenitor cell population in lacrimal glands from thrombospondin 1(--) mice, a model of dry eye.	6	37	1.27	0.00079	9606.ENSP00000245479,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000355361,9606.ENSP00000480291	SOX9,THBS1,CDH1,AQP5,CD47,HNF1B
PMID:28115943	(2016) Acute Hypoxic Stress Affects Migration Machinery of Tissue O2-Adapted Adipose Stromal Cells.	7	60	1.13	0.00079	9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CD69,CD34,MAPK7,PDGFB,PTEN,RHOA,VEGFA
PMID:25370680	(2015) Palatogenesis and cutaneous repair: A two-headed coin.	7	60	1.13	0.00079	9606.ENSP00000225275,9606.ENSP00000351807,9606.ENSP00000362410,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	MPO,ELN,MAFB,BMP2,FGFR1,RHOA,VEGFA
PMID:25417704	(2015) A stress-induced early innate response causes multidrug tolerance in melanoma.	6	37	1.27	0.00079	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000381185	IFNG,IGF1R,ATM,ANGPT2,ANG,BCL2
PMID:25665458	(2015) Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries.	7	60	1.13	0.00079	9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000380365,9606.ENSP00000401399	NOX4,MMP14,PDGFB,ELN,NOX1,RGN,MYD88
PMID:26036250	(2015) Characterization of bursa subacromialis-derived mesenchymal stem cells.	6	37	1.27	0.00079	9606.ENSP00000245479,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000368104,9606.ENSP00000426809	SOX9,LPL,CD34,FMOD,BMP2,PROM1
PMID:26106641	(2015) Exhaled Breath Condensate: Technical and Diagnostic Aspects.	7	60	1.13	0.00079	9606.ENSP00000013807,9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,MPO,IFNG,PTGS2,EDN1,CCL5,VEGFA
PMID:26137468	(2015) MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics.	6	37	1.27	0.00079	9606.ENSP00000260356,9606.ENSP00000311005,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	THBS1,MAPK7,ANG,PTEN,BCL2,RHOA
PMID:26253932	(2015) Menstrual physiology: implications for endometrial pathology and beyond.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CXCL10,ANGPT2,EDN1,BCL2,VEGFA
PMID:26261700	(2015) The Newly Identified T Helper 22 Cells Lodge in Leukemia.	7	60	1.13	0.00079	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067	CD38,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,JAK2
PMID:26416208	(2015) MicroRNAs; easy and potent targets in optimizing therapeutic methods in reparative angiogenesis.	7	60	1.13	0.00079	9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	ATM,CAV1,PTEN,AR,BCL2,FGFR1,VEGFA
PMID:26483618	(2015) Characterizing autism spectrum disorders by key biochemical pathways.	6	37	1.27	0.00079	9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,CNTF,PTEN,NTF3,BDNF,VEGFA
PMID:26517240	(2015) Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.	6	37	1.27	0.00079	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000330382,9606.ENSP00000371067,9606.ENSP00000381185	ERCC1,CDH1,ATM,PDGFB,JAK2,BCL2
PMID:26543328	(2015) Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms.	7	60	1.13	0.00079	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,STAT5A,CXCL9,JAK2,CCL5,VEGFA
PMID:26674248	(2015) Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.	6	37	1.27	0.00079	9606.ENSP00000221930,9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000477707	TGFB1,FABP4,SREBF1,NFE2L2,MYD88,NR1H3
PMID:27595061	(2015) Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000426809	CD38,CDH1,IGF1R,CD34,CAV1,PROM1
PMID:28936238	(2015) Biodistribution, Uptake and Effects Caused by Cancer-Derived Extracellular Vesicles.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000478570	CDH1,ANG,CD247,ENTPD1,PTEN,VEGFA
PMID:32226725	(2015) Chemopreventive Effects of Licorice and Its Components.	7	60	1.13	0.00079	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,TIMP3,ATM,PTGS2,BCL2,VEGFA
PMID:24390922	(2014) Fetal immune response to chorioamnionitis.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000354901	MPO,CD69,CXCL10,CAV1,ELN,CXCL9
PMID:24494192	(2014) New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate.	6	37	1.27	0.00079	9606.ENSP00000256104,9606.ENSP00000337332,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185	FABP4,SIRT6,TXN,EDN1,NFE2L2,BCL2
PMID:24550933	(2014) Utility of network integrity methods in therapeutic target identification.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067	MAPK1,MAPK7,MAP3K5,PTGS2,AR,JAK2
PMID:24555688	(2014) Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.	6	37	1.27	0.00079	9606.ENSP00000245479,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,ABCG1,PTEN,BCL2,BDNF,VEGFA
PMID:24769259	(2014) Effect of ozone exposure and infection on bronchoalveolar lavage: sex differences in response patterns.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,LPA,EDN1,CCL5,VEGFA
PMID:24857913	(2014) Enamel matrix derivative promote primary human pulp cell differentiation and mineralization.	7	60	1.13	0.00079	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,BMP2,PDGFD,CCL5,VEGFA
PMID:25137043	(2014) Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.	9	120	0.94	0.00079	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CHI3L1,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:25329450	(2014) Mutational analysis of merkel cell carcinoma.	6	37	1.27	0.00079	9606.ENSP00000257430,9606.ENSP00000266085,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	APC,TIMP3,PDGFA,PTEN,JAK2,VEGFA
PMID:25514634	(2014) Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells.	7	60	1.13	0.00079	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,ANG,BCL2,LTA,CCL5,VEGFA
PMID:25547723	(2014) Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses.	6	37	1.27	0.00079	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,FABP4,PTGS2,NFE2L2,BCL2,VEGFA
PMID:23041649	(2013) Modulation of signaling pathways in prostate cancer by green tea polyphenols.	6	37	1.27	0.00079	9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,MAPK7,PTGS2,AR,BCL2,VEGFA
PMID:23168132	(2013) Chemokines shape the immune responses to tuberculosis.	6	37	1.27	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:23371049	(2013) TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherinbeta-catenin complex expression in A549 lung cancer cells.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000393312	CDH1,IGF1R,MMP14,CAV1,PTGS2,FGFR1
PMID:23431463	(2013) MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.	11	195	0.81	0.00079	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	CD69,TIMP3,IGF1R,SGK1,PTEN,TXN,JAK2,BCL2,RHOA,BDNF,VEGFA
PMID:23516571	(2013) Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.	6	37	1.27	0.00079	9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	IGF1R,HNF4A,PTEN,BCL2,NPY,VEGFA
PMID:23622130	(2013) A starring role for stellate cells in the pancreatic cancer microenvironment.	6	37	1.27	0.00079	9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,PTGS2,BDNF,MME,CCL5,VEGFA
PMID:23785504	(2013) Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.	6	37	1.27	0.00079	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CXCL9,CCL5,VEGFA
PMID:23935844	(2013) Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress.	6	37	1.27	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CXCL9,CCL5,VEGFA
PMID:23951090	(2013) Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CXCL10,CD34,CCL5,VEGFA
PMID:24066945	(2013) FSH in vitro versus LH in vivo: similar genomic effects on the cumulus.	6	37	1.27	0.00079	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000364683,9606.ENSP00000400175,9606.ENSP00000478570	TGFB1,PTGS2,SGK1,BAMBI,RHOA,VEGFA
PMID:24081948	(2013) Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000368104,9606.ENSP00000418525,9606.ENSP00000426809	CD38,CD34,EBF1,BMP2,MME,PROM1
PMID:24098347	(2013) Association between inflammatory infiltrates and isolated monosomy 22del(22q) in meningiomas.	9	120	0.94	0.00079	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000351807,9606.ENSP00000351908,9606.ENSP00000363973,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	CD38,CD69,TIMP3,ELN,MAP3K5,ALPL,BCL2,MYD88,VEGFA
PMID:24367332	(2013) DNA methylation, a hand behind neurodegenerative diseases.	7	60	1.13	0.00079	9606.ENSP00000298352,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	NGB,PTGS2,PTEN,MTHFR,BDNF,MME,VEGFA
PMID:28989865	(2013) Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.	7	60	1.13	0.00079	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000376865,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,PDGFB,PTGS2,PDGFD,CCL5,VEGFA
PMID:22007304	(2012) The chylomicron: relationship to atherosclerosis.	6	37	1.27	0.00079	9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000380252	LPL,HNF4A,LPA,SREBF1,ABCG1,NFE2L2
PMID:22187650	(2012) Signaling required for blood vessel maintenance: molecular basis and pathological manifestations.	7	60	1.13	0.00079	9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000351807,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	ANGPT2,PDGFB,UNC5B,ELN,FGFR1,RHOA,VEGFA
PMID:22424216	(2012) Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes.	6	37	1.27	0.00079	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000377192,9606.ENSP00000478570,9606.ENSP00000480291	CD38,CD34,HNF4A,G6PD,VEGFA,HNF1B
PMID:22479258	(2012) KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes.	6	37	1.27	0.00079	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	THBS1,CD34,ANG,PTGS2,JAK2,VEGFA
PMID:22503691	(2012) How does the macula protect itself from oxidative stress?	6	37	1.27	0.00079	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	CETP,LPL,ELN,TXN,NFE2L2,VEGFA
PMID:22505934	(2012) Prostaglandins in cancer cell adhesion, migration, and invasion.	8	88	1.02	0.00079	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,HNF4A,CAV1,FMOD,PTGS2,HSPG2,RHOA,VEGFA
PMID:22542780	(2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptorretinal pigment epitheliumBruchs membranechoriocapillaris complex.	6	37	1.27	0.00079	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000355370,9606.ENSP00000478570	THBS1,TIMP3,IGF1R,ELN,CNTF,VEGFA
PMID:22698182	(2012) Chemokines and NK cells: regulators of development, trafficking and functions.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000418009,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,CXCL9,RARRES2,CCL5
PMID:22878108	(2012) Cell biology of ischemiareperfusion injury.	9	120	0.94	0.00079	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	MPO,THBS1,CD47,PTEN,TXN,EDN1,BCL2,CCL5,VEGFA
PMID:23186290	(2012) Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation.	6	37	1.27	0.00079	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000393312,9606.ENSP00000478570	NOX4,PTEN,NOX1,TXN,FGFR1,VEGFA
PMID:23610686	(2012) A systematic review of the histological and molecular changes in rotator cuff disease.	6	37	1.27	0.00079	9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	FMOD,ELN,GAP43,BCL2,NPY,VEGFA
PMID:24710545	(2012) Surface markers for chondrogenic determination: a highlight of synovium-derived stem cells.	6	37	1.27	0.00079	9606.ENSP00000228434,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	CD69,SOX9,ALDH1A1,CD34,MME,PROM1
PMID:21439758	(2011) Vascular biology of metabolic syndrome.	7	60	1.13	0.00079	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000360522,9606.ENSP00000368683,9606.ENSP00000418009,9606.ENSP00000475344,9606.ENSP00000478570	THBS1,ANGPT2,RBP4,EDN1,RARRES2,APLNR,VEGFA
PMID:21660237	(2011) Cell-specific dual role of caveolin-1 in pulmonary hypertension.	6	37	1.27	0.00079	9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MMP14,CAV1,EDN1,BCL2,RHOA,VEGFA
PMID:21880980	(2011) Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection.	6	37	1.27	0.00079	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	CD69,CCR5,CXCL10,CXCL9,BCL2,CCL5
PMID:22076424	(2011) Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368104	MPO,NOX4,MAPK7,CAV1,NOX1,BMP2
PMID:22814423	(2011) MicroRNA-503 and the extended microRNA-16 family in angiogenesis.	6	37	1.27	0.00079	9606.ENSP00000222305,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	USF2,PDGFB,ELN,NFE2L2,FGFR1,VEGFA
PMID:19830599	(2010) A clear and present danger: endogenous ligands of Toll-like receptors.	7	60	1.13	0.00079	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	TGFB1,CCR5,CXCL10,CCL20,IRAK4,MYD88,CCL5
PMID:20422780	(2010) Aldosterone and inflammation.	6	37	1.27	0.00079	9606.ENSP00000263317,9606.ENSP00000306124,9606.ENSP00000356832,9606.ENSP00000377192,9606.ENSP00000418009,9606.ENSP00000419422	NOX4,PRKCE,SGK1,G6PD,RARRES2,AGTR1
PMID:20585340	(2010) Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.	6	37	1.27	0.00079	9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000478570	PDGFB,HSPG2,BAMBI,BMP2,EDN1,VEGFA
PMID:20599773	(2010) Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.	7	60	1.13	0.00079	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000381185	IFNG,CDH1,TIMP3,CXCL10,COMT,PTEN,BCL2
PMID:20935499	(2010) Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?	8	88	1.02	0.00079	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,CDH1,ATM,HNF4A,SGK1,PTEN,BCL2,VEGFA
PMID:21143851	(2010) Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.	6	37	1.27	0.00079	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000301522,9606.ENSP00000357726,9606.ENSP00000363641,9606.ENSP00000474412	MPO,CCR5,PRDX2,S100A12,TXN,CCL5
PMID:19239705	(2009) Expression profiling and Ingenuity biological function analyses of interleukin-6- versus nerve growth factor-stimulated PC12 cells.	6	37	1.27	0.00079	9606.ENSP00000221930,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000397297,9606.ENSP00000414303	TGFB1,PDGFA,CNTF,GAP43,NTF3,BDNF
PMID:19284653	(2009) Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells.	6	37	1.27	0.00079	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,CCL20,MYD88,CCL5,VEGFA
PMID:19430954	(2009) Vasculogenesis in infantile hemangioma.	6	37	1.27	0.00079	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PTGS2,BCL2,PROM1,VEGFA
PMID:19734090	(2009) The role of chemokines in intestinal inflammation and cancer.	7	60	1.13	0.00079	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5,VEGFA
PMID:19737418	(2009) Meta-coexpression conservation analysis of microarray data: a subset approach provides insight into brain-derived neurotrophic factor regulation.	7	60	1.13	0.00079	9606.ENSP00000216181,9606.ENSP00000285407,9606.ENSP00000306124,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000393312,9606.ENSP00000414303	MYH9,KLF10,PRKCE,GAS6,PDGFA,FGFR1,BDNF
PMID:18554398	(2008) Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response.	6	37	1.27	0.00079	9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CHI3L1,CCR5,EDN1,CCL5,VEGFA
PMID:18775362	(2008) The adipocyte as an endocrine cell.	6	37	1.27	0.00079	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000478570	TIMP3,MMP14,LPL,ANGPT2,CAV1,VEGFA
PMID:25584362	(....) foxo3a: a potential target in prostate cancer.	6	37	1.27	0.00079	9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000426809,9606.ENSP00000478570	SGK1,PTEN,TXN,AR,PROM1,VEGFA
PMID:34947882	(2021) Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.	11	196	0.81	0.00082	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000401399	CD38,VDAC1,ATM,EBF1,STAT5A,PTEN,MAFB,JAK2,G6PD,BCL2,MYD88
PMID:33435254	(2021) Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.	9	121	0.93	0.00083	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000369816,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SOX9,CDH1,CXCL9,PTEN,SHBG,FGFR1,CCL5,VEGFA
PMID:33888557	(2021) Hepatic transcriptional responses to fasting and feeding.	10	157	0.87	0.00083	9606.ENSP00000278840,9606.ENSP00000302630,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000444198	FADS2,ONECUT1,CXCL10,HNF4A,SIRT6,STAT5A,SREBF1,PTGS2,G6PD,CITED2
PMID:33949876	(2021) Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.	9	121	0.93	0.00083	9606.ENSP00000246553,9606.ENSP00000265333,9606.ENSP00000288266,9606.ENSP00000309757,9606.ENSP00000349860,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000418823	FFAR1,VDAC1,APPL1,LPL,GFPT1,RHOA,BDNF,MME,FTO
PMID:34335834	(2021) The Role of TGF-beta Signaling Pathways in Cancer and Its Potential as a Therapeutic Target.	9	121	0.93	0.00083	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000364683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,CDH1,KLF10,CAV1,PTEN,BAMBI,BCL2,RHOA,VEGFA
PMID:34663816	(2021) Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma.	9	121	0.93	0.00083	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	SOX9,ENPP2,TIMP3,CD34,CD247,PLA2G2A,CCL5,APLNR,VEGFA
PMID:34730254	(2021) Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation.	9	121	0.93	0.00083	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000357726,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,THBS1,CXCL10,PDGFA,CCL20,CD247,S100A12,CCL5,VEGFA
PMID:32268506	(2020) Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.	10	157	0.87	0.00083	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,HSPB1,CDH1,ALDH1A1,PTEN,TXN,JAK2,BCL2,PROM1,VEGFA
PMID:33086603	(2020) Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue.	9	121	0.93	0.00083	9606.ENSP00000261037,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000419422	COL8A1,NOX4,ELN,NOX1,TXN,HSPG2,EDN1,BCL2,AGTR1
PMID:33519805	(2020) MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.	9	121	0.93	0.00083	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	CDH1,CD34,SIRT6,STAT5A,PTEN,JAK2,NFE2L2,BCL2,MYD88
PMID:31083655	(2019) Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.	9	121	0.93	0.00083	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000334329,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000400175,9606.ENSP00000426809	TGFB1,IFNG,CD34,HNF4A,UNC5B,CAV1,PDGFA,RHOA,PROM1
PMID:31191544	(2019) Transcriptome Modifications in Porcine Adipocytes via Toll-Like Receptors Activation.	9	121	0.93	0.00083	9606.ENSP00000222139,9606.ENSP00000246553,9606.ENSP00000304767,9606.ENSP00000312987,9606.ENSP00000349860,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000384906,9606.ENSP00000474412	EPOR,FFAR1,P2RY1,HNF4A,GFPT1,CCL20,CXCL9,SAA1,CCL5
PMID:28824643	(2017) Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment.	9	121	0.93	0.00083	9606.ENSP00000260356,9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000362410,9606.ENSP00000363641,9606.ENSP00000363973,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,ALDH1A1,MMP14,CCL20,MAFB,TXN,ALPL,RHOA,VEGFA
PMID:29399439	(2017) Plant flavone apigenin: An emerging anticancer agent.	9	121	0.93	0.00083	9606.ENSP00000248553,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	HSPB1,APC,CDH1,IGF1R,ATM,PTGS2,AR,BCL2,VEGFA
PMID:27009580	(2016) Signaling Networks among Stem Cell Precursors, Transit-Amplifying Progenitors, and their Niche in Developing Hair Follicles.	9	121	0.93	0.00083	9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000310036,9606.ENSP00000334329,9606.ENSP00000354995,9606.ENSP00000384364,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000426809	SOX9,ENPP2,CD34,UNC5B,ABCG1,NPY,FGFR1,BDNF,PROM1
PMID:27483258	(2016) Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis.	9	121	0.93	0.00083	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412	CDH1,CXCL10,CXCL11,STAT5A,CCL20,CXCL9,MYD88,BDNF,CCL5
PMID:26698305	(2015) Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.	9	121	0.93	0.00083	9606.ENSP00000258341,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000393312	LAMC1,IGF1R,CAV1,STAT5A,SGK1,PTEN,AR,BCL2,FGFR1
PMID:34536157	(2022) Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance.	7	61	1.12	0.00085	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000393312,9606.ENSP00000475344,9606.ENSP00000478570	FABP4,LPL,STAT5A,SREBF1,FGFR1,APLNR,VEGFA
PMID:35211123	(2022) The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?	8	89	1.01	0.00085	9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CCL20,CD47,PTGS2,ENTPD1,PTEN,BCL2,PROM1,VEGFA
PMID:35215230	(2022) Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome.	7	61	1.12	0.00085	9606.ENSP00000278616,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000363641,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303	ATM,CNR1,CNR2,TXN,GAP43,BCL2,BDNF
PMID:35250543	(2022) Microglia Polarization From M1 to M2 in Neurodegenerative Diseases.	8	89	1.01	0.00085	9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CD47,JAK2,BCL2,IRAK4,MYD88,BDNF,MME,VEGFA
PMID:35276895	(2022) Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update.	7	61	1.12	0.00085	9606.ENSP00000229135,9606.ENSP00000339191,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,CAV1,CNTF,EDN1,BCL2,BDNF,VEGFA
PMID:35277012	(2022) Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease.	7	61	1.12	0.00085	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641	MAPK1,CDH1,MMP14,SREBF1,PTGS2,PTEN,TXN
PMID:35326620	(2022) Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.	8	89	1.01	0.00085	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000403495	CD38,CD69,ABCG1,CD47,PTEN,BCL2,RHOA,LTA
PMID:35330413	(2022) Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000480291	CDH1,TIMP3,PDGFB,PTEN,NFE2L2,FGFR1,HNF1B
PMID:35336878	(2022) Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex Workers.	7	61	1.12	0.00085	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,ATM,CCR5,CXCL10,BCL2,MYD88,CCL5
PMID:33435311	(2021) Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?	7	61	1.12	0.00085	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CXCL10,CXCL11,CAV1,ADAMTS13,EDN1,BCL2,VEGFA
PMID:33450869	(2021) Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.	7	61	1.12	0.00085	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000426809	IFNG,IGF1R,CAV1,ABCG1,PTEN,RHOA,PROM1
PMID:33467606	(2021) Functional Heterogeneity and Therapeutic Targeting of Tissue-Resident Memory T Cells.	7	61	1.12	0.00085	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250	CD38,CD69,FABP4,CDH1,CXCL10,CXCL9,ENTPD1
PMID:33637686	(2021) The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.	8	89	1.01	0.00085	9606.ENSP00000261769,9606.ENSP00000263774,9606.ENSP00000265333,9606.ENSP00000341208,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,NDUFS3,VDAC1,STAT5A,TXN,EDN1,BCL2,VEGFA
PMID:33644016	(2021) Increased Mesenchymal Stem Cell Functionalization in Three-Dimensional Manufacturing Settings for Enhanced Therapeutic Applications.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,MMP14,ANGPT2,ANG,BCL2,RHOA,VEGFA
PMID:33750787	(2021) Implication of TIGIT(+) human memory B cells in immune regulation.	7	61	1.12	0.00085	9606.ENSP00000226279,9606.ENSP00000259407,9606.ENSP00000306884,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000418525	CD38,BAAT,CXCL11,CD47,ENTPD1,BCL2,MME
PMID:33762015	(2021) Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives.	7	61	1.12	0.00085	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	ATM,ALDH1A1,ABCG1,PTEN,BMP2,PROM1,VEGFA
PMID:33852183	(2021) Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.	7	61	1.12	0.00085	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000478570	THBS1,CDH1,NOX4,EDNRA,ELN,EDN1,VEGFA
PMID:33897833	(2021) Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation.	7	61	1.12	0.00085	9606.ENSP00000225275,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	MPO,CD69,CXCL10,SREBF1,CXCL9,BCL2,CCL5
PMID:33919576	(2021) Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis.	7	61	1.12	0.00085	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000474412	MPO,MMP14,ANGPT2,ADAMTS13,EDN1,PROM1,CCL5
PMID:33946667	(2021) Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats.	7	61	1.12	0.00085	9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000355370,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478319	CD34,GAS6,CNTF,PDGFD,BCL2,BDNF,GREM1
PMID:34062281	(2021) Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.	7	61	1.12	0.00085	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000362057,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,NOX1,LTA,CCL5,VEGFA
PMID:34071457	(2021) Physical Exercise-Induced Myokines in Neurodegenerative Diseases.	7	61	1.12	0.00085	9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303,9606.ENSP00000475344	CXCL10,MAP3K5,CNTF,BCL2,FGFR1,BDNF,APLNR
PMID:34201127	(2021) Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges.	8	89	1.01	0.00085	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CCL20,CD247,CXCL9,CD47,CCL5,VEGFA
PMID:34204889	(2021) Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer.	7	61	1.12	0.00085	9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478570	CXCL10,ANGPT2,CCL20,PTGS2,PTEN,FGFR1,VEGFA
PMID:34230615	(2021) Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.	7	61	1.12	0.00085	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000418525,9606.ENSP00000478570	CD38,CXCL10,CXCL11,CCL20,CXCL9,MME,VEGFA
PMID:34425750	(2021) Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells.	8	89	1.01	0.00085	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,CDH1,STAT5A,ELN,SGK1,PTEN,BCL2,VEGFA
PMID:34440651	(2021) Tissue-Resident T Cells in Chronic Relapsing-Remitting Intestinal Disorders.	7	61	1.12	0.00085	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000360250	CD38,CD69,FABP4,CDH1,CCR5,CCL20,ENTPD1
PMID:34492036	(2021) Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation.	8	89	1.01	0.00085	9606.ENSP00000215832,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368104,9606.ENSP00000474412	MAPK1,FABP4,CCR5,CXCL10,CXCL11,CXCL9,BMP2,CCL5
PMID:34512232	(2021) The mechanisms of wine phenolic compounds for preclinical anticancer therapeutics.	7	61	1.12	0.00085	9606.ENSP00000268035,9606.ENSP00000360250,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	IGF1R,ENTPD1,AR,NFE2L2,BCL2,BDNF,VEGFA
PMID:34527668	(2021) Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment.	8	89	1.01	0.00085	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CD247,ENTPD1,PTEN,MYD88,CCL5,VEGFA
PMID:34539401	(2021) Houttuynia cordata Thunb: An Ethnopharmacological Review.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CDH1,CXCL10,CCL20,EDN1,BCL2,MYD88,CCL5
PMID:34539648	(2021) Critical Role of Synovial Tissue-Resident Macrophage and Fibroblast Subsets in the Persistence of Joint Inflammation.	8	89	1.01	0.00085	9606.ENSP00000261037,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000381185	COL8A1,CXCL10,CXCL11,CD34,GAS6,CXCL9,S100A12,BCL2
PMID:34603044	(2021) Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies.	7	61	1.12	0.00085	9606.ENSP00000248553,9606.ENSP00000256104,9606.ENSP00000259486,9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000354901	HSPB1,FABP4,ENPP2,ANGPT2,CAV1,FMOD,CXCL9
PMID:34671220	(2021) The Hippo pathway: a renewed insight in the craniofacial diseases and hard tissue remodeling.	7	61	1.12	0.00085	9606.ENSP00000261037,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	COL8A1,CDH1,PTEN,BCL2,IRAK4,MYD88,VEGFA
PMID:34680235	(2021) TGFbeta Signaling in the Pancreatic Tumor Microenvironment.	7	61	1.12	0.00085	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,NOX4,MAP3K5,PTEN,PROM1,VEGFA
PMID:34769005	(2021) Current Concepts of Psoriasis Immunopathogenesis.	7	61	1.12	0.00085	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000418009,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CCR5,CXCL10,CCL20,RARRES2,CCL5,VEGFA
PMID:34868034	(2021) O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.	8	89	1.01	0.00085	9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	ATM,STAT5A,GFPT1,PTEN,G6PD,NFE2L2,BCL2,MYD88
PMID:34943825	(2021) Regulation of Hypoxic Signaling and Oxidative Stress via the MicroRNA-SIRT2 Axis and Its Relationship with Aging-Related Diseases.	7	61	1.12	0.00085	9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185	SIRT6,SREBF1,PTGS2,PTEN,JAK2,NFE2L2,BCL2
PMID:34950592	(2021) Biomedical Applications of Non-Small Cell Lung Cancer Spheroids.	7	61	1.12	0.00085	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,BCL2,FGFR1,RHOA,PROM1,VEGFA
PMID:31171626	(2020) Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000400175	CDH1,IGF1R,ATM,AQP5,PTEN,JAK2,RHOA
PMID:32010490	(2020) Roles and Functions of Exosomal Non-coding RNAs in Vascular Aging.	7	61	1.12	0.00085	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000314897,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,ATM,ANGPT2,ALPL,BMP2,BCL2,VEGFA
PMID:32093152	(2020) Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma.	8	89	1.01	0.00085	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,IGF1R,HNF4A,PTEN,BCL2,PROM1,VEGFA
PMID:32211026	(2020) DNA Methylation Biomarkers in Aging and Age-Related Diseases.	7	61	1.12	0.00085	9606.ENSP00000321853,9606.ENSP00000345708,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356832,9606.ENSP00000414303,9606.ENSP00000418823	SERPINF2,KCNJ11,SREBF1,ABCG1,SGK1,BDNF,FTO
PMID:32213977	(2020) The Regulatory Functions of Circular RNAs in Digestive System Cancers.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000371067	CDH1,TIMP3,IGF1R,HNF4A,PTEN,AR,JAK2
PMID:32391269	(2020) Tumor Necrosis Factor alpha Blockade: An Opportunity to Tackle Breast Cancer.	8	89	1.01	0.00085	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CDH1,CAV1,STAT5A,BCL2,BDNF,CCL5,VEGFA
PMID:32466280	(2020) FractalkineCX3CL1 in Neoplastic Processes.	7	61	1.12	0.00085	9606.ENSP00000260356,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCR5,CD34,JAK2,BCL2,CCL5,VEGFA
PMID:32503641	(2020) Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.	7	61	1.12	0.00085	9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000356213,9606.ENSP00000360250,9606.ENSP00000414303,9606.ENSP00000474412	CCR5,CCL20,CD47,VIP,ENTPD1,BDNF,CCL5
PMID:32517267	(2020) Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients.	7	61	1.12	0.00085	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	MAPK1,CDH1,CD34,PTGS2,BCL2,PROM1,VEGFA
PMID:32575472	(2020) MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.	8	89	1.01	0.00085	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	NOX4,IGF1R,PTEN,EDN1,G6PD,BCL2,MYD88,VEGFA
PMID:32641036	(2020) Extracellular vesicles: novel communicators in lung diseases.	8	89	1.01	0.00085	9606.ENSP00000226279,9606.ENSP00000308208,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000383232,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	CD38,MMP14,ENTPD1,PTEN,GGT1,RHOA,CCL5,VEGFA
PMID:32722427	(2020) Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.	8	89	1.01	0.00085	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	ATM,CD34,HNF4A,PTEN,BMP2,JAK2,PROM1,VEGFA
PMID:32793565	(2020) Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer.	8	89	1.01	0.00085	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	HSPB1,CDH1,TIMP3,CD34,PTEN,BCL2,CCL5,VEGFA
PMID:32878000	(2020) Decoding the Role of CD271 in Melanoma.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000426809	CDH1,PTEN,BCL2,NTF3,RHOA,BDNF,PROM1
PMID:33089928	(2020) MicroRNAs are critical in regulating smooth muscle cell mineralization and apoptosis during vascular calcification.	7	61	1.12	0.00085	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185	SOX9,IGF1R,PDGFB,ELN,PTEN,BMP2,BCL2
PMID:33138097	(2020) Drug Repurposing for Triple-Negative Breast Cancer.	7	61	1.12	0.00085	9606.ENSP00000297785,9606.ENSP00000331831,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ALDH1A1,GAS6,PTGS2,AR,JAK2,BCL2,VEGFA
PMID:33154756	(2020) Glioblastoma Immune Landscape and the Potential of New Immunotherapies.	8	89	1.01	0.00085	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000474412	CD38,IFNG,CDH1,CD247,CD47,ENTPD1,PTEN,CCL5
PMID:33172487	(2020) BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes.	8	89	1.01	0.00085	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000426809,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,PTGS2,MYD88,LTA,PROM1,CCL5
PMID:33362782	(2020) NF-kappaB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.	7	61	1.12	0.00085	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,IRAK4,MYD88,CCL5,VEGFA
PMID:33505595	(2020) Effect of metformin on stem cells: Molecular mechanism and clinical prospect.	7	61	1.12	0.00085	9606.ENSP00000245479,9606.ENSP00000337332,9606.ENSP00000346148,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185	SOX9,SIRT6,PRKAA1,CD47,PTEN,EDN1,BCL2
PMID:31073526	(2019) Effect of Weightlessness on the 3D Structure Formation and Physiologic Function of Human Cancer Cells.	8	89	1.01	0.00085	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	SOX9,CDH1,MMP14,CAV1,PTEN,BCL2,RHOA,VEGFA
PMID:31114450	(2019) Biomarkers of blood cadmium and incidence of cardiovascular events in non-smokers: results from a population-based proteomics study.	8	89	1.01	0.00085	9606.ENSP00000225275,9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000330382,9606.ENSP00000351671,9606.ENSP00000351807,9606.ENSP00000357726	MPO,HSPB1,CHI3L1,FABP4,PDGFB,CCL20,ELN,S100A12
PMID:31134198	(2019) Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases.	8	89	1.01	0.00085	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CXCL11,CCL20,CXCL9,HSPG2,CCL5,VEGFA
PMID:31512530	(2019) Proteomics advances for precision therapy in ovarian cancer.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ANGPT2,PTEN,RHOA,MME,PROM1,VEGFA
PMID:31591367	(2019) Extracellular Matrix Alterations in Metastatic Processes.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,CXCL10,CAV1,ELN,PTEN,EDN1,VEGFA
PMID:31847094	(2019) MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis.	7	61	1.12	0.00085	9606.ENSP00000266085,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000381185,9606.ENSP00000478570	TIMP3,LPL,SREBF1,ELN,ABCG1,BCL2,VEGFA
PMID:31878360	(2019) Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy.	8	89	1.01	0.00085	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,HSPB1,IGF1R,CXCL10,AR,JAK2,BCL2,VEGFA
PMID:29558460	(2018) p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.	7	61	1.12	0.00085	9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000381185	ATM,PRKCE,HNF4A,SIRT6,SREBF1,G6PD,BCL2
PMID:29706867	(2018) RNA-Sequencing Reveals Unique Transcriptional Signatures of Running and Running-Independent Environmental Enrichment in the Adult Mouse Dentate Gyrus.	8	89	1.01	0.00085	9606.ENSP00000260356,9606.ENSP00000272645,9606.ENSP00000347041,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	THBS1,POLR2D,FMOD,PTGS2,SGK1,NPY,BDNF,VEGFA
PMID:30305865	(2018) Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.	7	61	1.12	0.00085	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,ATM,SGK1,PTEN,EDN1,BCL2,VEGFA
PMID:30486451	(2018) Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma.	11	197	0.81	0.00085	9606.ENSP00000248553,9606.ENSP00000255409,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	HSPB1,CHI3L1,IGF1R,ATM,CD34,CAV1,PTEN,BCL2,FGFR1,PROM1,VEGFA
PMID:30627525	(2018) Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far?	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185	CDH1,ATM,PTGS2,PTEN,AR,NFE2L2,BCL2
PMID:31380505	(2018) A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention.	8	89	1.01	0.00085	9606.ENSP00000304767,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000475344,9606.ENSP00000478570	P2RY1,EDNRA,NOX1,EDN1,RHOA,CCL5,APLNR,VEGFA
PMID:27034014	(2017) Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,MMP14,CD34,BMP2,BCL2,PROM1,VEGFA
PMID:28403795	(2017) Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.	7	61	1.12	0.00085	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,IGF1R,CD34,NOX1,BCL2,PROM1,VEGFA
PMID:28530743	(2017) Multicellular tumor invasion and plasticity in biomimetic materials.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,CXCL11,MMP14,ELN,HSPG2,RHOA,PROM1
PMID:29165379	(2017) Role of Non-Coding RNAs in the Etiology of Bladder Cancer.	7	61	1.12	0.00085	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,CDH1,TIMP3,MMP14,PTEN,BCL2,VEGFA
PMID:26892968	(2016) MicroRNA Regulation of Atherosclerosis.	8	89	1.01	0.00085	9606.ENSP00000266085,9606.ENSP00000314897,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	TIMP3,ANGPT2,PRKAA1,SREBF1,ABCG1,PTEN,BCL2,RHOA
PMID:26919968	(2016) Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.	7	61	1.12	0.00085	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000360247,9606.ENSP00000401399,9606.ENSP00000477707	IFNG,CDH1,ALDH1A1,SREBF1,CYP2J2,MYD88,NR1H3
PMID:27345301	(2016) Reactive oxygen species and fibrosis: further evidence of a significant liaison.	7	61	1.12	0.00085	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	THBS1,NOX4,PTEN,NOX1,TXN,NFE2L2,VEGFA
PMID:28070230	(2016) Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.	7	61	1.12	0.00085	9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000351908,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	PRDX2,CXCL10,MAP3K5,CXCL9,TXN,CCL5,VEGFA
PMID:28154773	(2016) Role of microRNAs in inflammation-associated liver cancer.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,TIMP3,CXCL10,HNF4A,PTEN,BCL2,VEGFA
PMID:25604264	(2015) Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.	7	61	1.12	0.00085	9606.ENSP00000297785,9606.ENSP00000355361,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478319,9606.ENSP00000478570	ALDH1A1,CD47,AR,BDNF,PROM1,GREM1,VEGFA
PMID:25897257	(2015) Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,ATM,PTEN,NFE2L2,FGFR1,VEGFA
PMID:25904599	(2015) Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	7	61	1.12	0.00085	9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000354995,9606.ENSP00000376865,9606.ENSP00000474412	TIMP3,CXCL10,CD34,CXCL9,ABCG1,PDGFD,CCL5
PMID:26119175	(2015) Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.	8	89	1.01	0.00085	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478319,9606.ENSP00000478570	APC,CDH1,NOX4,EDN1,RHOA,MYD88,GREM1,VEGFA
PMID:24837835	(2014) Role of mitochondria in nonalcoholic fatty liver disease.	7	61	1.12	0.00085	9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000477707	VDAC1,LPL,HNF4A,SIRT6,CAV1,SREBF1,NR1H3
PMID:24866026	(2014) Type I interferons as regulators of human antigen presenting cell functions.	8	89	1.01	0.00085	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CD38,CCR5,CXCL10,CXCL11,CD34,CCL20,CXCL9,CCL5
PMID:25428504	(2014) Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.	8	89	1.01	0.00085	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	TGFB1,CD69,CCR5,CXCL10,CXCL11,CXCL9,PTGS2,CCL5
PMID:23301832	(2013) Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.	8	89	1.01	0.00085	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,SREBF1,PTEN,BMP2,BCL2,PROM1,VEGFA
PMID:23833294	(2013) Molecular and cellular aspects of calcific aortic valve disease.	7	61	1.12	0.00085	9606.ENSP00000245479,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000426809	SOX9,ATM,CD34,FMOD,ELN,BMP2,PROM1
PMID:22610609	(2012) Subchronic oral exposure to benzo(a)pyrene leads to distinct transcriptomic changes in the lungs that are related to carcinogenesis.	7	61	1.12	0.00085	9606.ENSP00000221930,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000414303	TGFB1,ANGPT2,PDGFB,PDGFA,PDGFD,BCL2,BDNF
PMID:22905242	(2012) GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.	7	61	1.12	0.00085	9606.ENSP00000245479,9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CCR5,LPL,CD34,CCL20,CCL5,VEGFA
PMID:21711548	(2011) Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.	7	61	1.12	0.00085	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000315011,9606.ENSP00000351671,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,MMP14,EDNRA,CCL20,EDN1,BCL2,VEGFA
PMID:22054881	(2011) Molecular biology of lung cancer: clinical implications.	8	89	1.01	0.00085	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000365777,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,STAT5A,PTEN,MTHFR,JAK2,BCL2,VEGFA
PMID:19877123	(2010) miRNA control of tumor cell invasion and metastasis.	7	61	1.12	0.00085	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000306124,9606.ENSP00000308208,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,PRKCE,MMP14,PTEN,RHOA,VEGFA
PMID:19648026	(2009) STAT3 in CD4+ T helper cell differentiation and inflammatory diseases.	7	61	1.12	0.00085	9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	STAT5A,CCL20,CNTF,JAK2,BCL2,CCL5,VEGFA
PMID:17374166	(2007) The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases.	7	61	1.12	0.00085	9606.ENSP00000229135,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CNTF,PTGS2,EDN1,JAK2,RHOA,VEGFA
PMID:33603130	(2022) Key chemokines direct migration of immune cells in solid tumors.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,PTGS2,CCL5
PMID:34838648	(2022) The extracellular matrix of hematopoietic stem cell niches.	9	122	0.93	0.00087	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000351807,9606.ENSP00000363827	THBS1,TIMP3,MMP14,CD34,EBF1,CAV1,FMOD,ELN,HSPG2
PMID:35055104	(2022) Peripheral Nerve Injury Treatments and Advances: One Health Perspective.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CCR5,CD34,CNTF,NTF3,BDNF,VEGFA
PMID:35121645	(2022) Targeting KDM4C enhances CD8(+) T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer.	6	38	1.26	0.00087	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	ATM,CXCL10,CXCL11,CXCL9,ENTPD1,CCL5
PMID:35216464	(2022) The Biological Function of MicroRNAs in Bone Tumors.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,TIMP3,PTEN,BMP2,BCL2,VEGFA
PMID:35269988	(2022) Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000380365,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,PTEN,RGN,VEGFA
PMID:35334794	(2022) Anti-Inflammatory Nutrients and Obesity-Associated Metabolic-Inflammation: State of the Art and Future Direction.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000390651,9606.ENSP00000474412	IFNG,CXCL10,SREBF1,PTGS2,IRAK4,CCL5
PMID:35433675	(2022) Lipid Metabolic Process Involved in Oocyte Maturation During Folliculogenesis.	6	38	1.26	0.00087	9606.ENSP00000200676,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000354995	CETP,PLIN1,LPL,CAV1,SREBF1,ABCG1
PMID:33391525	(2021) ERK12 inhibition reduces vascular calcification by activating miR-126-3p-DKK1LRP6 pathway.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000354995,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,HNF4A,ELN,ABCG1,BMP2,VEGFA
PMID:33445755	(2021) Targeting Autophagy to Counteract Obesity-Associated Oxidative Stress.	6	38	1.26	0.00087	9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363641	ATM,CAV1,PRKAA1,SREBF1,PTEN,TXN
PMID:33526881	(2021) The role of MET in chemotherapy resistance.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,ATM,BCL2,PROM1,VEGFA
PMID:33669559	(2021) Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives.	6	38	1.26	0.00087	9606.ENSP00000298352,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000478570	NGB,SREBF1,PTEN,BCL2,LTA,VEGFA
PMID:33764994	(2021) A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000369816,9606.ENSP00000384364,9606.ENSP00000403495,9606.ENSP00000478570	CXCL10,LPL,SHBG,NPY,LTA,VEGFA
PMID:33799957	(2021) An Outline of Renal Artery Stenosis Pathophysiology-A Narrative Review.	6	38	1.26	0.00087	9606.ENSP00000315011,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000419422	EDNRA,ELN,PTGS2,EDN1,MME,AGTR1
PMID:33842333	(2021) TAM-ing the CIA-Tumor-Associated Macrophages and Their Potential Role in Unintended Side Effects of Therapeutics for Cancer-Induced Anemia.	6	38	1.26	0.00087	9606.ENSP00000222139,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	EPOR,AR,BMP2,JAK2,CCL5,VEGFA
PMID:33933084	(2021) Fetal hypoxia and apoptosis following maternal porcine reproductive and respiratory syndrome virus (PRRSV) infection.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,NOX1,BCL2,CCL5,VEGFA
PMID:33985567	(2021) Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR12 and other parameters of vascular health.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CD34,STAT5A,PTGS2,PROM1,VEGFA
PMID:34026646	(2021) miRNA-Based Therapeutics in Breast Cancer: A Systematic Review.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,IGF1R,PTEN,BCL2,PROM1,VEGFA
PMID:34082771	(2021) CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:34188052	(2021) Iron-dependent apoptosis causes embryotoxicity in inflamed and obese pregnancy.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,PTGS2,SAA1,CCL5,VEGFA
PMID:34249714	(2021) Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.	6	38	1.26	0.00087	9606.ENSP00000278616,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	ATM,CAV1,PTEN,AR,BCL2,VEGFA
PMID:34307156	(2021) Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CDH1,CXCL10,AR,CCL5,VEGFA
PMID:34376554	(2021) Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.	6	38	1.26	0.00087	9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412,9606.ENSP00000478570	ATM,CXCL10,PTEN,AR,CCL5,VEGFA
PMID:34395252	(2021) Exploring the Pharmacological Mechanism of Radix Salvia Miltiorrhizae in the Treatment of Radiation Pneumonia by Using Network Pharmacology.	6	38	1.26	0.00087	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185	MAPK1,IFNG,PTGS2,PTEN,EDN1,BCL2
PMID:34422119	(2021) Immune checkpoint inhibitors in ovarian cancer: where do we stand?	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000354901,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000478570,9606.ENSP00000480291	IFNG,CXCL9,CD47,PTEN,VEGFA,HNF1B
PMID:34458508	(2021) Multiple targets identified with genome wide profiling of small RNA and mRNA expression are linked to fracture healing in mice.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000336762,9606.ENSP00000347041,9606.ENSP00000361021,9606.ENSP00000478570	SOX9,MMP14,ANG,FMOD,PTEN,VEGFA
PMID:34502350	(2021) Recent Advancements in the Medical Treatment of Diabetic Retinal Disease.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CD34,ANGPT2,BDNF,CCL5,VEGFA
PMID:34537015	(2021) Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000346508,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFA,LTA,CCL5,VEGFA
PMID:34543699	(2021) Stemprogenitor cells in normal physiology and disease of the pancreas.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000361021,9606.ENSP00000362410,9606.ENSP00000426809,9606.ENSP00000480291	SOX9,ONECUT1,PTEN,MAFB,PROM1,HNF1B
PMID:34629492	(2021) Immunology and Immune Checkpoint Inhibition in Ovarian Cancer - Current Aspects.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,ENTPD1,CCL5,VEGFA
PMID:34634087	(2021) Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates.	6	38	1.26	0.00087	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CD69,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:34638384	(2021) Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids.	10	158	0.86	0.00087	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000376865,9606.ENSP00000426809,9606.ENSP00000474412	TGFB1,IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,PDGFD,PROM1,CCL5
PMID:34641542	(2021) Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives.	6	38	1.26	0.00087	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,ATM,JAK2,NFE2L2,BCL2,VEGFA
PMID:34666676	(2021) Conserved and breed-specific differences in the cervical transcriptome of sheep with divergent fertility at the follicular phase of a natural oestrus cycle.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000384906	CXCL10,CXCL11,CXCL9,PTGS2,S100A12,SAA1
PMID:34698188	(2021) Critical Role of Caveolin-1 LossDysfunction in Pulmonary Hypertension.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CAV1,PTEN,NFE2L2,CCL5,VEGFA
PMID:34765922	(2021) Synthetic liver fibrotic niche extracts achieve in vitro hepatoblasts phenotype enhancement and expansion.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,CD34,HNF4A,PROM1,VEGFA
PMID:34777687	(2021) Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	THBS1,CDH1,JAK2,NFE2L2,BCL2,PROM1
PMID:34830809	(2021) Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics.	6	38	1.26	0.00087	9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000322898,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000418525	EPOR,CD34,EBF1,JAK2,BCL2,MME
PMID:34884703	(2021) Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance.	6	38	1.26	0.00087	9606.ENSP00000226279,9606.ENSP00000362524,9606.ENSP00000368683,9606.ENSP00000369816,9606.ENSP00000380252,9606.ENSP00000478570	CD38,ANGPTL2,EDN1,SHBG,NFE2L2,VEGFA
PMID:34888300	(2021) In Sickness and in Health: The Oxygen Reactive Species and the Bone.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000478319,9606.ENSP00000478570	NOX4,CAV1,NOX1,BMP2,GREM1,VEGFA
PMID:35126110	(2021) Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-betaSmad3 Pathway.	6	38	1.26	0.00087	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000306884,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,CDH1,CXCL11,JAK2,BCL2,FGFR1
PMID:32013065	(2020) Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer.	6	38	1.26	0.00087	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,PTEN,AR,NFE2L2,BCL2,VEGFA
PMID:32059772	(2020) Epithelial Vegfa Specifies a Distinct Endothelial Population in the Mouse Lung.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000475344,9606.ENSP00000478570	CDH1,AQP5,PDGFA,ELN,APLNR,VEGFA
PMID:32104211	(2020) Function and mechanisms of microRNA-20a in colorectal cancer.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,MAP3K5,PTEN,BCL2,VEGFA
PMID:32111033	(2020) Potential Implications of Quercetin and its Derivatives in Cardioprotection.	6	38	1.26	0.00087	9606.ENSP00000248553,9606.ENSP00000263317,9606.ENSP00000354511,9606.ENSP00000356515,9606.ENSP00000368683,9606.ENSP00000381185	HSPB1,NOX4,COMT,UTRN,EDN1,BCL2
PMID:32203100	(2020) Mechanisms of ultrafine particle-induced respiratory health effects.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,TXN,NFE2L2,MME,CCL5,VEGFA
PMID:32226439	(2020) A Computational Model of the Endothelial to Mesenchymal Transition.	9	122	0.93	0.00087	9606.ENSP00000263317,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000311005,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	NOX4,MMP14,CD34,MAPK7,HNF4A,CAV1,EDN1,RHOA,VEGFA
PMID:32384792	(2020) Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000478570	THBS1,CDH1,ANGPT2,PDGFB,PTGS2,VEGFA
PMID:32438055	(2020) Extracellular matrix-derived peptides in tissue remodeling and fibrosis.	6	38	1.26	0.00087	9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000478570	MMP14,ELN,HSPG2,RHOA,MYD88,VEGFA
PMID:32440192	(2020) The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.	6	38	1.26	0.00087	9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	APC,CDH1,CCL20,PTGS2,BCL2,VEGFA
PMID:32582435	(2020) An update on long intergenic noncoding RNA p21: a regulatory molecule with various significant functions in cancer.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,PDGFB,PTEN,JAK2,BCL2,VEGFA
PMID:32784556	(2020) Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000380365,9606.ENSP00000381185,9606.ENSP00000414303	IFNG,PTGS2,NFE2L2,RGN,BCL2,BDNF
PMID:33015193	(2020) Potential Role of Gene Regulator NFAT5 in the Pathogenesis of Diabetes Mellitus.	6	38	1.26	0.00087	9606.ENSP00000278616,9606.ENSP00000293599,9606.ENSP00000356832,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	ATM,AQP5,SGK1,NFE2L2,BCL2,VEGFA
PMID:33142938	(2020) Prevention of Diabetes and Cardiovascular Disease in Obesity.	6	38	1.26	0.00087	9606.ENSP00000309757,9606.ENSP00000345708,9606.ENSP00000354995,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000418823	LPL,KCNJ11,ABCG1,EDN1,NFE2L2,FTO
PMID:33158024	(2020) Signal Transduction Pathways Activated by Innate Immunity in Mast Cells: Translating Sensing of Changes into Specific Responses.	9	122	0.93	0.00087	9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000345708,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	P2RY1,CD34,KCNJ11,ENTPD1,JAK2,IRAK4,MYD88,CCL5,VEGFA
PMID:33265939	(2020) Flavonoids Regulate Inflammation and Oxidative Stress in Cancer.	6	38	1.26	0.00087	9606.ENSP00000268035,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	IGF1R,MAP3K5,PTGS2,PTEN,BCL2,VEGFA
PMID:33299889	(2020) Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.	9	122	0.93	0.00087	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000354511,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CDH1,IGF1R,COMT,PTEN,NFE2L2,BCL2,PROM1,VEGFA
PMID:33311610	(2020) The 46(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Oral Session (O010-O173).	10	158	0.86	0.00087	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	CD38,CD69,IFNG,CXCL10,CD34,STAT5A,ELN,BCL2,MME,CCL5
PMID:33374507	(2020) The Importance of Non-Coding RNAs in Neurodegenerative Processes of Diabetes-Related Molecular Pathways.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,PTEN,BCL2,NPY,BDNF,VEGFA
PMID:30274701	(2019) The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,CXCL10,ANGPT2,CXCL9,JAK2,VEGFA
PMID:30502589	(2019) Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,PTEN,CCL5
PMID:30847302	(2019) Identification of Potential Candidate Genes of Oral Cancer in Response to Chronic Infection With Porphyromonas gingivalis Using Bioinformatical Analyses.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000414303	CXCL10,CXCL11,CXCL9,JAK2,MYD88,BDNF
PMID:30857217	(2019) Dietary Polyphenols Targeting Arterial Stiffness: Interplay of Contributing Mechanisms and Gut Microbiome-Related Metabolism.	6	38	1.26	0.00087	9606.ENSP00000351807,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000419422	ELN,COMT,PTGS2,TXN,EDN1,AGTR1
PMID:30867218	(2019) Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000426809	CDH1,ALDH1A1,STAT5A,AR,JAK2,PROM1
PMID:30899263	(2019) The Ins and Outs of Chemokine-Mediated Immune Cell Trafficking in Skin Cancer.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354782,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CD247,CXCL9,CCL5
PMID:30908559	(2019) Limited differential expression of miRNAs and other small RNAs in LPS-stimulated human monocytes.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000427424	TGFB1,PTGS2,MAFB,IRAK4,MYD88,TNFAIP8
PMID:30923103	(2019) Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.	6	38	1.26	0.00087	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000478570	CD38,CD34,GAS6,STAT5A,JAK2,VEGFA
PMID:31248068	(2019) Nutritional Factors, DNA Methylation, and Risk of Type 2 Diabetes and Obesity: Perspectives and Challenges.	6	38	1.26	0.00087	9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000384364,9606.ENSP00000418823,9606.ENSP00000477707	HNF4A,SREBF1,ABCG1,NPY,FTO,NR1H3
PMID:31297056	(2019) Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000478570	THBS1,ANGPT2,PDGFB,EDN1,JAK2,VEGFA
PMID:31540435	(2019) Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.	9	122	0.93	0.00087	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CCR5,CCL20,CXCL9,FGFR1,MYD88,MME,CCL5,VEGFA
PMID:31569710	(2019) Adipocytes and microRNAs Crosstalk: A Key Tile in the Mosaic of Breast Cancer Microenvironment.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000346148,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000480291	SOX9,CXCL10,PRKAA1,PTGS2,CCL5,HNF1B
PMID:31640178	(2019) Endothelial Dysfunction in Primary Aldosteronism.	6	38	1.26	0.00087	9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000478570	ELN,PTGS2,EDN1,G6PD,RHOA,VEGFA
PMID:31681603	(2019) Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs.	6	38	1.26	0.00087	9606.ENSP00000311005,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	MAPK7,STAT5A,PTEN,JAK2,BCL2,VEGFA
PMID:31781332	(2019) Radiation-Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000381185	CDH1,NOX4,CD34,PTGS2,NOX1,BCL2
PMID:31888734	(2019) Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250	TGFB1,CD69,IFNG,CXCL10,CXCL9,ENTPD1
PMID:29306997	(2018) Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000347041,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412	CXCL10,FMOD,HSPG2,BCL2,FGFR1,CCL5
PMID:29491123	(2018) The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000377192,9606.ENSP00000393312,9606.ENSP00000478570	NOX4,CAV1,ELN,G6PD,FGFR1,VEGFA
PMID:29503620	(2018) Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000362057,9606.ENSP00000380252	CDH1,NOX4,PTGS2,CYP2J2,NOX1,NFE2L2
PMID:29687902	(2018) Impact of Metabolic Diseases on Cerebral Circulation: Structural and Functional Consequences.	6	38	1.26	0.00087	9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000478570	EDNRA,PDGFB,PTEN,EDN1,AGTR1,VEGFA
PMID:29705830	(2018) The Mammary Microenvironment in Mastitis in Humans, Dairy Ruminants, Rabbits and Rodents: A One Health Focus.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CHI3L1,CXCL10,CCL20,CXCL9,CCL5
PMID:29743976	(2018) Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1.	6	38	1.26	0.00087	9606.ENSP00000215832,9606.ENSP00000351908,9606.ENSP00000362524,9606.ENSP00000363641,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,MAP3K5,ANGPTL2,TXN,BDNF,VEGFA
PMID:29845887	(2018) Roles of Pericytes in Stroke Pathogenesis.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000360997,9606.ENSP00000474412,9606.ENSP00000478570	NOX4,CD34,PDGFB,ADAMTS13,CCL5,VEGFA
PMID:29984391	(2018) The role of CD133 in cancer: a concise review.	6	38	1.26	0.00087	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000426809	MAPK1,IFNG,AR,BMP2,BCL2,PROM1
PMID:30082531	(2018) Potential Role of Interleukin-25Interleukin-33Thymic Stromal Lymphopoietin-Fibrocyte Axis in the Pathogenesis of Allergic Airway Diseases.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,CD34,ANG,EDN1,MYD88,VEGFA
PMID:30140678	(2018) Genetic Alterations in Oxidant and Anti-Oxidant Enzymes in the Vascular System.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000478570	CDH1,NOX4,MAP3K5,NOX1,TXN,VEGFA
PMID:30280037	(2018) Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000315011,9606.ENSP00000346148,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000393312	TGFB1,EDNRA,PRKAA1,PTGS2,PTEN,FGFR1
PMID:30291252	(2018) Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000444198	CDH1,HNF4A,PTEN,AR,BCL2,CITED2
PMID:30352680	(2018) The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CCR5,CXCL10,CCL20,CXCL9,PTEN,CCL5
PMID:30426006	(2018) Acupoint Therapy on Diabetes Mellitus and Its Common Chronic Complications: A Review of Its Mechanisms.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,IGF1R,CNTF,BCL2,VEGFA
PMID:30485279	(2018) Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis.	6	38	1.26	0.00087	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000426809,9606.ENSP00000478570	MPO,CD38,CD34,ANGPT2,PROM1,VEGFA
PMID:28118365	(2017) MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.	6	38	1.26	0.00087	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,ATM,PTEN,JAK2,BCL2,RHOA
PMID:28315228	(2017) Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,PTEN,JAK2,CCL5,VEGFA
PMID:28321204	(2017) A Comprehensive View of the beta-Arrestinome.	6	38	1.26	0.00087	9606.ENSP00000246553,9606.ENSP00000339191,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000419422	FFAR1,CAV1,MAP3K5,PTEN,BCL2,AGTR1
PMID:28335502	(2017) Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease.	6	38	1.26	0.00087	9606.ENSP00000225275,9606.ENSP00000354511,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	MPO,COMT,CXCL9,PTGS2,MYD88,VEGFA
PMID:28350359	(2017) NF-kappaB Signaling in Gastric Cancer.	9	122	0.93	0.00087	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CCR5,CCL20,PTGS2,PTEN,BMP2,BCL2,CCL5,VEGFA
PMID:28397794	(2017) Protein malnutrition promotes dysregulation of molecules involved in T cell migration in the thymus of mice infected with Leishmania infantum.	6	38	1.26	0.00087	9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000474412	IGF1R,CCR5,CXCL10,CXCL9,BCL2,CCL5
PMID:28425064	(2017) A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000478570	CDH1,CD34,HNF4A,AR,MYD88,VEGFA
PMID:28464921	(2017) Human adult mesangiogenic progenitor cells reveal an early angiogenic potential, which is lost after mesengenic differentiation.	6	38	1.26	0.00087	9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000426809,9606.ENSP00000478570	CD34,ANGPT2,PDGFB,PDGFA,PROM1,VEGFA
PMID:28469108	(2017) Vascular Calcification: Current Genetics Underlying This Complex Phenomenon.	6	38	1.26	0.00087	9606.ENSP00000216862,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000478570	CYP24A1,PTGS2,S100A12,NOX1,BMP2,VEGFA
PMID:28531112	(2017) Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes.	6	38	1.26	0.00087	9606.ENSP00000225275,9606.ENSP00000306124,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000363641,9606.ENSP00000400175	MPO,PRKCE,SIRT6,CAV1,TXN,RHOA
PMID:28752333	(2017) Significance of long chain polyunsaturated fatty acids in human health.	6	38	1.26	0.00087	9606.ENSP00000278840,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000477707	FADS2,HNF4A,SREBF1,BCL2,PLA2G2A,NR1H3
PMID:28827581	(2017) Asian Zika virus strains target CD14(+) blood monocytes and induce M2-skewed immunosuppression during pregnancy.	6	38	1.26	0.00087	9606.ENSP00000255409,9606.ENSP00000265132,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000356438	CHI3L1,AMBP,CXCL10,LPL,PDGFB,PTGS2
PMID:28903454	(2017) Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.	6	38	1.26	0.00087	9606.ENSP00000312987,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	HNF4A,PDGFA,PTEN,NFE2L2,FGFR1,VEGFA
PMID:29063290	(2017) Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000368683	IFNG,MMP14,CD34,ANG,ELN,EDN1
PMID:29232894	(2017) Significant Down-Regulation of Biological Adhesion Genes in Porcine Oocytes after IVM.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000360250,9606.ENSP00000478570	TGFB1,THBS1,CDH1,CD47,ENTPD1,VEGFA
PMID:29246031	(2017) A molecular view of the radioresistance of gliomas.	6	38	1.26	0.00087	9606.ENSP00000222139,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000426809	EPOR,ATM,PTEN,NFE2L2,BCL2,PROM1
PMID:29270409	(2017) Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000351807,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,CDH1,NOX4,ELN,RHOA,VEGFA
PMID:29317985	(2017) Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	NOX4,NOX1,EDN1,BCL2,BDNF,VEGFA
PMID:27125746	(2016) alphaKlotho and Chronic Kidney Disease.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000368683,9606.ENSP00000369442,9606.ENSP00000403495,9606.ENSP00000419313,9606.ENSP00000478570	NOX4,EDN1,KL,LTA,TRPC1,VEGFA
PMID:27413755	(2016) Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000352264,9606.ENSP00000360522,9606.ENSP00000369442,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD2AP,RBP4,KL,CCL5,VEGFA
PMID:27591403	(2016) Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells.	6	38	1.26	0.00087	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000478570	NOX4,PTEN,NOX1,TXN,NFE2L2,VEGFA
PMID:25586506	(2015) Macrophage recruitment in obese adipose tissue.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,ATM,CCR5,PTGS2,CCL5,VEGFA
PMID:25590798	(2015) Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000418009,9606.ENSP00000478570	CDH1,TXN,NFE2L2,BCL2,RARRES2,VEGFA
PMID:25595133	(2015) Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases.	6	38	1.26	0.00087	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000310036,9606.ENSP00000351671,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CD69,CD34,CCL20,BCL2,PROM1
PMID:25742174	(2015) Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000354995,9606.ENSP00000356438	IFNG,FABP4,VDAC1,LPL,ABCG1,PTGS2
PMID:25869097	(2015) Chronic myelomonocytic leukemia: Forefront of the field in 2015.	6	38	1.26	0.00087	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD34,ANG,STAT5A,JAK2,BCL2,VEGFA
PMID:25883747	(2015) Analysis of chemokines and receptors expression profile in the myelin mutant taiep rat.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:26080813	(2015) Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000232219,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000478570	TGFB1,RBP1,CD34,ANGPT2,ELN,VEGFA
PMID:26199913	(2015) Transcription Profiles of Marker Genes Predict The Transdifferentiation Relationship between Eight Types of Liver Cell during Rat Liver Regeneration.	6	38	1.26	0.00087	9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000368683,9606.ENSP00000383232,9606.ENSP00000414303,9606.ENSP00000426809	CD34,HNF4A,EDN1,GGT1,BDNF,PROM1
PMID:26302807	(2015) Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000351807,9606.ENSP00000364683,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,THBS1,ELN,BAMBI,MYD88,CCL5
PMID:26367079	(2015) Endostatins emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000478570	THBS1,MMP14,LPL,CAV1,HSPG2,VEGFA
PMID:26530832	(2015) MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412	IFNG,THBS1,CDH1,CXCL10,CCL20,CCL5
PMID:26557379	(2015) Pathophysiology of osteoarthritis: canonical NF-kappaBIKKbeta-dependent and kinase-independent effects of IKKalpha in cartilage degradation and chondrocyte differentiation.	6	38	1.26	0.00087	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,TIMP3,SIRT6,PTGS2,CCL5,VEGFA
PMID:24559118	(2014) A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1ABAF250a is associated with AKT phosphorylation.	6	38	1.26	0.00087	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185	HSPB1,CDH1,CAV1,STAT5A,PTEN,BCL2
PMID:24592240	(2014) Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,PDGFA,PTGS2,BDNF,MME,VEGFA
PMID:24606691	(2014) Integrated analysis of microRNAs and their disease related targets in the brain of mice infected with West Nile virus.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000414303,9606.ENSP00000474412	THBS1,CXCL10,CXCL11,PTGS2,BDNF,CCL5
PMID:24858437	(2014) Nasopharyngeal tonsils (adenoids) contain extrathymic corticothymocytes.	6	38	1.26	0.00087	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000418525	MPO,CD38,CD34,CD247,BCL2,MME
PMID:25294045	(2014) Gene-expression profiling of calves 6 and 9 months after inoculation with Mycobacterium avium subspecies paratuberculosis.	6	38	1.26	0.00087	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000414303	TGFB1,IFNG,CDH1,CXCL10,MMP14,BDNF
PMID:23275174	(2013) Repairing neural injuries using human umbilical cord blood.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CD34,BDNF,MME,PROM1,VEGFA
PMID:23947360	(2013) Immunity to viruses: learning from successful human vaccines.	6	38	1.26	0.00087	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	CD38,IFNG,CXCL10,BCL2,MYD88,CCL5
PMID:22333342	(2012) Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum.	6	38	1.26	0.00087	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	LPL,CD34,PDGFA,PROM1,CCL5,VEGFA
PMID:22815789	(2012) Myeloid suppressor cell depletion augments antitumor activity in lung cancer.	6	38	1.26	0.00087	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000354901,9606.ENSP00000478570	CD69,CXCL10,CD34,ANGPT2,CXCL9,VEGFA
PMID:23203112	(2012) Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells.	6	38	1.26	0.00087	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CD34,HNF4A,SIRT6,PROM1,VEGFA
PMID:21385929	(2011) Targeting the BMK1 MAP kinase pathway in cancer therapy.	6	38	1.26	0.00087	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000311005,9606.ENSP00000356832,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,THBS1,MAPK7,SGK1,BCL2,VEGFA
PMID:21689392	(2011) Identification of serum biomarkers for aging and anabolic response.	6	38	1.26	0.00087	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,AR,LTA,CCL5,VEGFA
PMID:21745567	(2011) Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683	CDH1,TIMP3,MMP14,ELN,PTEN,EDN1
PMID:21886602	(2011) microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,PTEN,BCL2,CCL5,VEGFA
PMID:20036817	(2010) Role of myoepithelial cells in breast tumor progression.	6	38	1.26	0.00087	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000418525	THBS1,CDH1,TIMP3,CAV1,ELN,MME
PMID:20396397	(2010) The bright and the dark sides of DNA repair in stem cells.	6	38	1.26	0.00087	9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	ATM,CD34,PDGFB,PTEN,PROM1,VEGFA
PMID:20496295	(2010) Pathogenesis of inflammation and repair in advanced COPD.	6	38	1.26	0.00087	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CXCL10,CXCL9,TXN,CCL5,VEGFA
PMID:20835351	(2010) Strategies to enhance umbilical  cord blood stem cell  engraftment in adult patients.	6	38	1.26	0.00087	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000362524,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CCR5,CD34,ANGPTL2,PROM1,VEGFA
PMID:21044331	(2010) Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000336762,9606.ENSP00000474412	IFNG,THBS1,CXCL10,CXCL11,ANG,CCL5
PMID:19208786	(2009) A new role for the human placenta as a hematopoietic site throughout gestation.	6	38	1.26	0.00087	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809	EPOR,CD38,AMBP,CD34,MME,PROM1
PMID:19660870	(2009) Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.	6	38	1.26	0.00087	9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	HNF4A,PTGS2,AR,PDGFD,BCL2,VEGFA
PMID:17981742	(2008) The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:17197237	(2007) Statins and the vascular endothelial inflammatory response.	6	38	1.26	0.00087	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CCR5,CXCL10,CAV1,EDN1,RHOA,VEGFA
PMID:17324256	(2007) Temporal dynamics of gene expression in the lung in a baboon model of E. coli sepsis.	10	158	0.86	0.00087	9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000351671,9606.ENSP00000357726,9606.ENSP00000363641,9606.ENSP00000384262,9606.ENSP00000478570	IFNG,TIMP3,CXCL10,CXCL11,CAV1,CCL20,S100A12,TXN,HPSE,VEGFA
PMID:17502003	(2007) Pharmacogenomics and the YinYang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides.	6	38	1.26	0.00087	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,HNF4A,AR,BCL2,RHOA,VEGFA
PMID:14613535	(2003) Microvascular endothelial cells of the corpus luteum.	6	38	1.26	0.00087	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000474412	IFNG,CDH1,ANGPT2,EDNRA,EDN1,CCL5
PMID:30523620	(....) molecular biology of kshv in relation to hivaids-associated oncogenesis.	9	122	0.93	0.00087	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CDH1,ATM,CCR5,CCL20,PTEN,NFE2L2,CCL5,VEGFA
PMID:35130279	(2022) Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOFMS and network pharmacology.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CCR5,PTGS2,JAK2,BCL2,VEGFA
PMID:35142670	(2022) Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations.	5	20	1.46	0.00088	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000426809	THBS1,CD34,CNTF,BDNF,PROM1
PMID:35163805	(2022) Matrix Metalloproteinases in Helicobacter pylori-Associated Gastritis and Gastric Cancer.	8	90	1.01	0.00088	9606.ENSP00000225275,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	MPO,APC,CDH1,MMP14,CCL20,PTGS2,JAK2,VEGFA
PMID:35216429	(2022) PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000479617	CDH1,AR,JAK2,BCL2,UHRF1
PMID:35223841	(2022) Synergistic Effects of Toll-Like Receptor 12 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages.	8	90	1.01	0.00088	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,PTGS2,JAK2,MYD88,CCL5
PMID:35299944	(2022) Genetically Predicted Levels of Circulating Inflammatory Cytokines and the Risk and Age at Onset of Parkinsons Disease: A Two-Sample Mendelian Randomization Study.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL9,LTA,CCL5
PMID:35326592	(2022) Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000369816,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,IGF1R,SHBG,BCL2,VEGFA
PMID:35359830	(2022) Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021	IFNG,NOX4,CAV1,PTGS2,PTEN
PMID:32274846	(2021) Advances in Activity-Based Sensing Probes for Isoform-Selective Imaging of Enzymatic Activity.	5	20	1.46	0.00088	9606.ENSP00000259486,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000363641	ENPP2,ALDH1A1,PTGS2,CYP2J2,TXN
PMID:33274785	(2021) Cell softness regulates tumorigenicity and stemness of cancer cells.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000426809	CD38,ALDH1A1,CD34,HNF4A,PROM1
PMID:33418102	(2021) Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic Review.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000400175	NOX4,NOX1,TXN,NFE2L2,RHOA
PMID:33510029	(2021) MAIT cell activation augments adenovirus vector vaccine immunogenicity.	5	20	1.46	0.00088	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CD69,CXCL10,CXCL11,CXCL9,CCL5
PMID:33641215	(2021) Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral Clearance.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000397297	IFNG,CXCL10,CXCL11,CCL20,NTF3
PMID:33652990	(2021) Targeting the Autonomic Nervous System for Risk Stratification, Outcome Prediction and Neuromodulation in Ischemic Stroke.	5	20	1.46	0.00088	9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	JAK2,NFE2L2,BCL2,BDNF,VEGFA
PMID:33736651	(2021) Third-line therapy for chronic myeloid leukemia: current status and future directions.	5	20	1.46	0.00088	9606.ENSP00000215832,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185	MAPK1,CD34,ELN,JAK2,BCL2
PMID:33785874	(2021) 5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000426809	IFNG,CDH1,HNF4A,PTGS2,PROM1
PMID:33806320	(2021) Psychoactive Drugs-From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission. A Review.	5	20	1.46	0.00088	9606.ENSP00000354511,9606.ENSP00000358513,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	COMT,CNR1,BCL2,NPY,BDNF
PMID:33815556	(2021) Network Pharmacology Analysis of Traditional Chinese Medicine Formula Shuang Di Shou Zhen Tablets Treating Nonexudative Age-Related Macular Degeneration.	5	20	1.46	0.00088	9606.ENSP00000215832,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,PTGS2,AR,BCL2,VEGFA
PMID:33972534	(2021) Genoppi is an open-source software for robust and standardized integration of proteomic and genetic data.	5	20	1.46	0.00088	9606.ENSP00000321853,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303	SERPINF2,CNTF,PTEN,BCL2,BDNF
PMID:34034714	(2021) Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000371067,9606.ENSP00000380365	CDH1,CXCL10,CXCL11,JAK2,RGN
PMID:34054522	(2021) Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	IFNG,CXCL10,CXCL9,MYD88,CCL5
PMID:34068809	(2021) Wound Repair and Extremely Low Frequency-Electromagnetic Field: Insight from In Vitro Study and Potential Clinical Application.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000474412,9606.ENSP00000478570	MPO,MMP14,PTGS2,CCL5,VEGFA
PMID:34096467	(2021) The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000265132,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000419422	TGFB1,AMBP,ALDH1A1,BCL2,AGTR1
PMID:34108603	(2021) PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer.	5	20	1.46	0.00088	9606.ENSP00000013807,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000474412	ERCC1,ATM,CCL20,PTEN,CCL5
PMID:34440676	(2021) Role of Neuroglobin in the Neuroprotective Actions of Estradiol and Estrogenic Compounds.	5	20	1.46	0.00088	9606.ENSP00000265333,9606.ENSP00000298352,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000478570	VDAC1,NGB,PTEN,NFE2L2,VEGFA
PMID:34445141	(2021) Angiopoietin-like Proteins in Colorectal Cancer-A Literature Review.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000309757,9606.ENSP00000362524,9606.ENSP00000381185	CDH1,NOX4,LPL,ANGPTL2,BCL2
PMID:34504910	(2021) Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice.	5	20	1.46	0.00088	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000363641,9606.ENSP00000478570	MMP14,CD34,HNF4A,TXN,VEGFA
PMID:34564175	(2021) Antiaging Potential of Peptides from Underused Marine Bioresources.	5	20	1.46	0.00088	9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000380252,9606.ENSP00000381185	ELN,PTEN,KL,NFE2L2,BCL2
PMID:34737845	(2021) Single-Cell Integration Analysis of Heterotopic Ossification and Fibrocartilage Developmental Lineage: Endoplasmic Reticulum Stress Effector Xbp1 Transcriptionally Regulates the Notch Signaling Pathway to Mediate Fibrocartilage ...	8	90	1.01	0.00088	9606.ENSP00000222305,9606.ENSP00000245479,9606.ENSP00000312987,9606.ENSP00000322898,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000414303	USF2,SOX9,HNF4A,EBF1,ELN,BCL2,FGFR1,BDNF
PMID:34740493	(2021) Mesenchymal stem cells as a platform for research on traditional medicine.	5	20	1.46	0.00088	9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	LPL,CD34,BMP2,PROM1,VEGFA
PMID:34789851	(2021) DEspR(high) neutrophils are associated with critical illness in COVID-19.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000265132,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478570	CD38,AMBP,EDN1,MME,VEGFA
PMID:34843456	(2021) Protein domain-based prediction of drugcompound-target interactions and experimental validation on LIM kinases.	5	20	1.46	0.00088	9606.ENSP00000339916,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	LIMK2,PTEN,JAK2,FGFR1,VEGFA
PMID:34937563	(2021) miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809	CDH1,ALDH1A1,BCL2,RHOA,PROM1
PMID:34943023	(2021) Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000474412	NOX4,NOX1,JAK2,NFE2L2,CCL5
PMID:34944574	(2021) Kidney Cancer and Chronic Kidney Disease: Too Close for Comfort.	5	20	1.46	0.00088	9606.ENSP00000317674,9606.ENSP00000363641,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000478570	APOL1,TXN,AR,NFE2L2,VEGFA
PMID:34948174	(2021) A Study on How Methionine Restriction Decreases the Bodys Hepatic and Lipid Deposition in Rice Field Eel (Monopterus albus).	5	20	1.46	0.00088	9606.ENSP00000278840,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000377192	FADS2,LPL,LPA,SREBF1,G6PD
PMID:34970152	(2021) Xiaoxuming Decoction: A Traditional Herbal Recipe for Stroke With Emerging Therapeutic Mechanisms.	5	20	1.46	0.00088	9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000419422,9606.ENSP00000478570	BCL2,MYD88,BDNF,AGTR1,VEGFA
PMID:34976824	(2021) Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019.	8	90	1.01	0.00088	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,CDH1,ATM,HNF4A,STAT5A,JAK2,BCL2,VEGFA
PMID:35011682	(2021) Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy-An Integrated View into Other Neoplasms and Chemokine Networks.	8	90	1.01	0.00088	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CDH1,CCR5,MAPK7,CAV1,STAT5A,PTEN,JAK2,VEGFA
PMID:35059446	(2021) Guanxin V Acts as an Antioxidant in Ventricular Remodeling.	5	20	1.46	0.00088	9606.ENSP00000315011,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000418525	EDNRA,PTGS2,EDN1,MYD88,MME
PMID:35083214	(2021) Extracorporeal Cardiac Shock Wave-Induced Exosome Derived From Endothelial Colony-Forming Cells Carrying miR-140-3p Alleviate Cardiomyocyte HypoxiaReoxygenation Injury via the PTENPI3KAKT Pathway.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809	CD38,CD34,PTEN,BCL2,PROM1
PMID:31254045	(2020) Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000310520,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000393312	TGFB1,ERCC4,PTEN,AR,FGFR1
PMID:31784406	(2020) Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	CD38,ATM,BCL2,MYD88,MME
PMID:31841274	(2020) Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3HIF-1alphaVEGF signaling.	5	20	1.46	0.00088	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,CDH1,CD34,BCL2,VEGFA
PMID:31855296	(2020) High-dimensional single-cell proteomics analysis reveals the landscape of immune cells and stem-like cells in renal tumors.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000426809	CD38,ALDH1A1,CD34,CD47,PROM1
PMID:32155783	(2020) ncRNAs in Type-2 Immunity.	8	90	1.01	0.00088	9606.ENSP00000268035,9606.ENSP00000306124,9606.ENSP00000322898,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000474412	IGF1R,PRKCE,EBF1,STAT5A,PTEN,NFE2L2,BCL2,CCL5
PMID:32425740	(2020) The Pathophysiology of Degenerative Cervical Myelopathy and the Physiology of Recovery Following Decompression.	5	20	1.46	0.00088	9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MAP3K5,BCL2,NTF3,BDNF,VEGFA
PMID:32509141	(2020) Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2HO-1 Pathway in Ovarian Cancer Cells.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000336762,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ANG,NFE2L2,BCL2,VEGFA
PMID:32581669	(2020) Application of Stem Cells in Stroke: A Multifactorial Approach.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000478570	MPO,CD34,CNTF,BDNF,VEGFA
PMID:32582337	(2020) Carotid Disease and Ageing: A Literature Review on the Pathogenesis of Vascular Senescence in Older Subjects.	5	20	1.46	0.00088	9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	SIRT6,ELN,EDN1,CCL5,VEGFA
PMID:32587135	(2020) The Role of Lysophosphatidic Acid in Adult Stem Cells.	5	20	1.46	0.00088	9606.ENSP00000259486,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000478570	ENPP2,ALDH1A1,CD34,PTGS2,VEGFA
PMID:32588948	(2020) Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.	8	90	1.01	0.00088	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000308208,9606.ENSP00000339191,9606.ENSP00000354782,9606.ENSP00000371067,9606.ENSP00000478570	IFNG,CDH1,CCR5,MMP14,CAV1,CD247,JAK2,VEGFA
PMID:32661096	(2020) Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager.	5	20	1.46	0.00088	9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363822	CD69,AMBP,CD34,STAT5A,AR
PMID:32661238	(2020) Circ-ADAM9 targeting PTEN and ATG7 promotes autophagy and apoptosis of diabetic endothelial progenitor cells by sponging mir-20a-5p.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CD34,PTEN,BCL2,PROM1,VEGFA
PMID:32710309	(2020) Novel Murine Models of Cerebral Cavernous Malformations.	5	20	1.46	0.00088	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000400175,9606.ENSP00000478570	THBS1,ANGPT2,PDGFB,RHOA,VEGFA
PMID:32719797	(2020) TILRR Promotes Migration of Immune Cells Through Induction of Soluble Inflammatory Mediators.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CCL20,CCL5
PMID:32767459	(2020) Transcriptional profiling of lung macrophages during pulmonary injury induced by nitrogen mustard.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000308208,9606.ENSP00000356438,9606.ENSP00000477707	TGFB1,IFNG,MMP14,PTGS2,NR1H3
PMID:32824088	(2020) Hepatitis E Virus Mediates Renal Injury via the Interaction between the Immune Cells and Renal Epithelium.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000418525	CDH1,CXCL10,CXCL11,CXCL9,MME
PMID:32873509	(2020) Identification and characterization of a large source of primary mesenchymal stem cells tightly adhered to bone surfaces of human vertebral body marrow cavities.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000310036	IFNG,SOX9,FABP4,LPL,CD34
PMID:32937850	(2020) Preparing the Bone Tissue Regeneration Ground by Exosomes: From Diagnosis to Therapy.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412	IFNG,SOX9,BMP2,BCL2,CCL5
PMID:32960902	(2020) Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts.	5	20	1.46	0.00088	9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000306884	VDAC1,TIMP3,ATM,CXCL10,CXCL11
PMID:32968456	(2020) Targeting tumor-associated macrophages in the tumor microenvironment.	8	90	1.01	0.00088	9606.ENSP00000245479,9606.ENSP00000255409,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	SOX9,CHI3L1,FABP4,CCR5,CXCL10,CCL20,CCL5,VEGFA
PMID:33007849	(2020) Micro-RNAs: Crossroads between the Exposure to Environmental Particulate Pollution and the Obstructive Pulmonary Disease.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,PDGFB,PTEN,EDN1,VEGFA
PMID:33094209	(2020) Androgen Therapy in Neurodegenerative Diseases.	5	20	1.46	0.00088	9606.ENSP00000298352,9606.ENSP00000363822,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	NGB,AR,BDNF,MME,VEGFA
PMID:33102251	(2020) The CD133(+) StemProgenitor-Like Cell Subset Is Increased in Human Milk and Peripheral Blood of HIV-Positive Women.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000426809	CD38,CCR5,CXCL10,CD34,PROM1
PMID:33126871	(2020) Machine learning model demonstrates stunting at birth and systemic inflammatory biomarkers as predictors of subsequent infant growth - a four-year prospective study.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000474412,9606.ENSP00000478570	MPO,IFNG,PDGFB,CCL5,VEGFA
PMID:33196011	(2020) Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000393312	MPO,CD38,CD34,JAK2,FGFR1
PMID:33200553	(2020) Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000293599,9606.ENSP00000312987,9606.ENSP00000400175,9606.ENSP00000478319	CDH1,AQP5,HNF4A,RHOA,GREM1
PMID:33210080	(2020) Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000292303,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000474412	NOX4,CCR5,NOX1,BCL2,CCL5
PMID:33299813	(2020) The role of resveratrol as a natural modulator in glia activation in experimental models of stroke.	5	20	1.46	0.00088	9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	PTGS2,NFE2L2,BCL2,BDNF,VEGFA
PMID:33551872	(2020) The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia.	5	20	1.46	0.00088	9606.ENSP00000288266,9606.ENSP00000354511,9606.ENSP00000365777,9606.ENSP00000384906,9606.ENSP00000418823	APPL1,COMT,MTHFR,SAA1,FTO
PMID:30353645	(2019) The effects of stenting on coronary endothelium from a molecular biological view: Time for improvement?	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,ATM,CD34,PROM1,VEGFA
PMID:30387809	(2019) N-acetylcysteine alleviates H2O2-induced damage via regulating the redox status of intracellular antioxidants in H9c2 cells.	5	20	1.46	0.00088	9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000371067,9606.ENSP00000381185	MAP3K5,PTEN,TXN,JAK2,BCL2
PMID:30761998	(2019) Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic stroke.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000381185	MPO,NOX4,NOX1,G6PD,BCL2
PMID:30764506	(2019) Influence of Platelet-Rich and Platelet-Poor Plasma on Endogenous Mechanisms of Skeletal Muscle RepairRegeneration.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CD34,CNTF,BDNF,PROM1,VEGFA
PMID:30949295	(2019) Long non-coding RNA: The functional regulator of mesenchymal stem cells.	5	20	1.46	0.00088	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000368104,9606.ENSP00000414303,9606.ENSP00000478570	SOX9,IGF1R,BMP2,BDNF,VEGFA
PMID:31128594	(2019) Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer.	5	20	1.46	0.00088	9606.ENSP00000260356,9606.ENSP00000278840,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000478570	THBS1,FADS2,COMT,PTGS2,VEGFA
PMID:31146367	(2019) Formation of gammaH2AX and pATM Foci in Human Mesenchymal Stem Cells Exposed to Low Dose-Rate Gamma-Radiation.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000426809	CD38,CD69,ATM,CD34,PROM1
PMID:31191669	(2019) Exosomes from Human Gingiva-Derived Mesenchymal Stem Cells Combined with Biodegradable Chitin Conduits Promote Rat Sciatic Nerve Regeneration.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000377372,9606.ENSP00000400175,9606.ENSP00000414303	CD34,CNTF,GAP43,RHOA,BDNF
PMID:31252633	(2019) Tumor-Associated Protein Profiles in Kaposi Sarcoma and Mimicking Vascular Tumors, and Their Pathological Implications.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,CAV1,BCL2,VEGFA
PMID:31283440	(2019) In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000401399,9606.ENSP00000474412	CCR5,CXCL10,CCL20,MYD88,CCL5
PMID:31546892	(2019) Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000414303	IFNG,NOX4,CXCL10,AR,BDNF
PMID:31653834	(2019) DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant buffering.	5	20	1.46	0.00088	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000278616,9606.ENSP00000363641,9606.ENSP00000364683	ERCC1,HSPB1,ATM,TXN,BAMBI
PMID:31723838	(2019) AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells.	5	20	1.46	0.00088	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000341208,9606.ENSP00000371067	IGF1R,CD34,GAS6,STAT5A,JAK2
PMID:31801246	(2019) Stem Cell Surgery and Growth Factors in Retinitis Pigmentosa Patients: Pilot Study after Literature Review.	5	20	1.46	0.00088	9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	ANG,CNTF,BCL2,BDNF,VEGFA
PMID:31806995	(2019) Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy.	5	20	1.46	0.00088	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000403495	THBS1,CDH1,CD47,PTGS2,LTA
PMID:31829277	(2019) The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CAV1,PTGS2,MYD88,VEGFA
PMID:31885622	(2019) Strategy for the Generation of Engineered Bone Constructs Based on Umbilical Cord Mesenchymal Stromal Cells Expanded with Human Platelet Lysate.	5	20	1.46	0.00088	9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000347041,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,CD34,FMOD,CCL5,VEGFA
PMID:29352135	(2018) Blocking Zika virus vertical transmission.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,MYD88,CCL5
PMID:29391474	(2018) Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization.	5	20	1.46	0.00088	9606.ENSP00000222139,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000478570	EPOR,CXCL10,CD34,STAT5A,VEGFA
PMID:29499566	(2018) The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000419422,9606.ENSP00000478570	NOX4,PTEN,NOX1,AGTR1,VEGFA
PMID:29506832	(2018) Umbilical mesenchymal stromal cells provide intestinal protection through nitric oxide dependent pathways.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000478570	TGFB1,CXCL10,CD34,ANGPT2,VEGFA
PMID:29596323	(2018) Biofunctionalized Scaffold in Bone Tissue Repair.	5	20	1.46	0.00088	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368104,9606.ENSP00000478570	SOX9,CD34,ELN,BMP2,VEGFA
PMID:29903699	(2018) A Putative Role of Apolipoprotein L1 Polymorphism in Renal Parenchymal Scarring Following Febrile Urinary Tract Infection in Nigerian Under-Five Children: Proposal for a Case-Control Association Study.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000317674,9606.ENSP00000381185,9606.ENSP00000478570	TGFB1,IFNG,APOL1,BCL2,VEGFA
PMID:30283597	(2018) Clinical update on the management of pseudopapillary tumor of pancreas.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000418525	CDH1,CD34,HNF4A,AR,MME
PMID:30518389	(2018) Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000321853,9606.ENSP00000365777,9606.ENSP00000383364,9606.ENSP00000478570	IFNG,SERPINF2,MTHFR,PLA2G2A,VEGFA
PMID:27908890	(2017) Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus.	5	20	1.46	0.00088	9606.ENSP00000357726,9606.ENSP00000362057,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000369442	S100A12,NOX1,BMP2,EDN1,KL
PMID:28030810	(2017) The tumor microenvironment promotes cancer progression and cell migration.	5	20	1.46	0.00088	9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000478570	CHI3L1,CDH1,ELN,BCL2,VEGFA
PMID:28222329	(2017) Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:28251161	(2017) Serum Proteome Alterations in Patients with Cognitive Impairment after Traumatic Brain Injury Revealed by iTRAQ-Based Quantitative Proteomics.	5	20	1.46	0.00088	9606.ENSP00000200676,9606.ENSP00000260356,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000369816	CETP,THBS1,LPL,LPA,SHBG
PMID:28262670	(2017) Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000376865	TGFB1,CXCL10,STAT5A,CXCL9,PDGFD
PMID:28442607	(2017) N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,BCL2,BDNF,CCL5,VEGFA
PMID:28479925	(2017) Inhibition of Cardiac Hypertrophy Effects in D-Galactose-Induced Senescent Hearts by Alpinate Oxyphyllae Fructus Treatment.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000371067,9606.ENSP00000381185	NOX4,IGF1R,MAPK7,JAK2,BCL2
PMID:28761818	(2017) Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells.	8	90	1.01	0.00088	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CD38,CD34,STAT5A,MME,PROM1,CCL5,VEGFA
PMID:28785738	(2017) Involvement of PI3K and MMP1 in PDGF-induced Migration of Human Adipose-derived Stem Cells.	5	20	1.46	0.00088	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000330382,9606.ENSP00000376865,9606.ENSP00000400175	TIMP3,MMP14,PDGFB,PDGFD,RHOA
PMID:28871136	(2017) Small molecule T63 suppresses osteoporosis by modulating osteoblast differentiation via BMP and WNT signaling pathways.	5	20	1.46	0.00088	9606.ENSP00000256104,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000363973,9606.ENSP00000368104	FABP4,HNF4A,SREBF1,ALPL,BMP2
PMID:29156730	(2017) Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000397297,9606.ENSP00000414303	CD34,SREBF1,ABCG1,NTF3,BDNF
PMID:26453912	(2016) Senescence and cancer: An evolving inflammatory paradox.	5	20	1.46	0.00088	9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	ATM,PTEN,JAK2,BCL2,VEGFA
PMID:27045029	(2016) Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors.	5	20	1.46	0.00088	9606.ENSP00000356832,9606.ENSP00000377192,9606.ENSP00000400175,9606.ENSP00000402152,9606.ENSP00000419422	SGK1,G6PD,RHOA,SLC12A3,AGTR1
PMID:27304059	(2016) Crucial factors of the inflammatory microenvironment (IL-1betaTNF-alphaTIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000426809	CD38,CD34,CD47,JAK2,PROM1
PMID:27385098	(2016) TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.	5	20	1.46	0.00088	9606.ENSP00000255409,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CHI3L1,NTF3,BDNF,PROM1,VEGFA
PMID:27525306	(2016) Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3KAktmTOR signaling pathways in lung cancer.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CD34,CAV1,BCL2,VEGFA
PMID:27547442	(2016) Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,CCL20,CXCL9
PMID:27871176	(2016) In Vivo Angiogenic Capacity of Stem Cells from Human Exfoliated Deciduous Teeth with Human Umbilical Vein Endothelial Cells.	5	20	1.46	0.00088	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000418525,9606.ENSP00000478570	MMP14,CD34,PDGFB,MME,VEGFA
PMID:27891127	(2016) Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IVCD26.	8	90	1.01	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000384364,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CD34,ELN,CXCL9,NPY,CCL5
PMID:27965895	(2016) Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000418525	CD38,CD34,PTEN,EDN1,MME
PMID:25578933	(2015) Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network.	5	20	1.46	0.00088	9606.ENSP00000339191,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	CAV1,VIP,PTEN,AR,BCL2
PMID:25727210	(2015) Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000474412	CD38,CXCL10,CXCL9,S100A12,CCL5
PMID:25832774	(2015) Enhanced epithelial-to-mesenchymal transition associated with lysosome dysfunction in podocytes: role of p62Sequestosome 1 as a signaling hub.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000380252	TGFB1,CD38,IFNG,CDH1,NFE2L2
PMID:25835394	(2015) Heme oxygenase-1 protects corexit 9500A-induced respiratory epithelial injury across species.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000377192,9606.ENSP00000381185	CDH1,NOX4,NOX1,G6PD,BCL2
PMID:25873769	(2015) Inflammatory and antioxidant pattern unbalance in clopidogrel-resistant patients during acute coronary syndrome.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	IFNG,CCR5,CXCL10,CXCL11,CXCL9
PMID:25956259	(2015) Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD34,BMP2,BCL2,BDNF,VEGFA
PMID:25977928	(2015) Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice.	5	20	1.46	0.00088	9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	PDGFA,CNTF,NTF3,BDNF,VEGFA
PMID:26013997	(2015) Regulation of NANOG in cancer cells.	5	20	1.46	0.00088	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000363822,9606.ENSP00000426809	MAPK1,CDH1,HNF4A,AR,PROM1
PMID:26136304	(2015) Is retinol binding protein 4 a link between adiposity and cancer?	5	20	1.46	0.00088	9606.ENSP00000232219,9606.ENSP00000341208,9606.ENSP00000360522,9606.ENSP00000371067,9606.ENSP00000478570	RBP1,STAT5A,RBP4,JAK2,VEGFA
PMID:26194645	(2015) Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models.	8	90	1.01	0.00088	9606.ENSP00000245479,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000331831,9606.ENSP00000351807,9606.ENSP00000362524,9606.ENSP00000380252,9606.ENSP00000383232	SOX9,NOX4,CD34,GAS6,ELN,ANGPTL2,NFE2L2,GGT1
PMID:26241750	(2015) Using exosomes, naturally-equipped nanocarriers, for drug delivery.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000418525,9606.ENSP00000478570	IFNG,THBS1,CD47,MME,VEGFA
PMID:26285614	(2015) Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:26286174	(2015) Of mice and women: a comparative tissue biology perspective of breast stem cells and differentiation.	5	20	1.46	0.00088	9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000363822,9606.ENSP00000418525,9606.ENSP00000426809	ALDH1A1,CD34,AR,MME,PROM1
PMID:26487835	(2015) The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	IFNG,STAT5A,JAK2,BCL2,VEGFA
PMID:26640409	(2015) Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000419422	NOX4,NOX1,NFE2L2,BCL2,AGTR1
PMID:26658810	(2015) Deficits in Sustained Attention and Changes in Dopaminergic Protein Levels following Exposure to Proton Radiation Are Related to Basal Dopaminergic Function.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL9,CNTF,CCL5,VEGFA
PMID:26783703	(2015) Mechanisms of Photoaging and Cutaneous Photocarcinogenesis, and Photoprotective Strategies with Phytochemicals.	5	20	1.46	0.00088	9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	ELN,PTGS2,TXN,G6PD,NFE2L2
PMID:27508198	(2015) The androgen receptor as an emerging target in hepatocellular carcinoma.	5	20	1.46	0.00088	9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000401399,9606.ENSP00000478570	HNF4A,PTEN,AR,MYD88,VEGFA
PMID:24423613	(2014) Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000362057,9606.ENSP00000381185	CDH1,NOX4,ATM,NOX1,BCL2
PMID:24452266	(2014) Plasmodium genetic loci linked to host cytokine and chemokine responses.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000377192,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,G6PD,CCL5,VEGFA
PMID:24810570	(2014) Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity.	5	20	1.46	0.00088	9606.ENSP00000245479,9606.ENSP00000310036,9606.ENSP00000418525,9606.ENSP00000426809,9606.ENSP00000478570	SOX9,CD34,MME,PROM1,VEGFA
PMID:25147764	(2014) Molecular biology of gliomas: present and future challenges.	5	20	1.46	0.00088	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000478570	PDGFB,PDGFA,PTEN,PDGFD,VEGFA
PMID:25188497	(2014) Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000357726,9606.ENSP00000368683,9606.ENSP00000426809	CD34,ELN,S100A12,EDN1,PROM1
PMID:25258477	(2014) Calpain activity and Toll-like receptor 4 expression in platelet regulate haemostatic situation in patients undergoing cardiac surgery and coagulation in mice.	5	20	1.46	0.00088	9606.ENSP00000216181,9606.ENSP00000248553,9606.ENSP00000336762,9606.ENSP00000401399,9606.ENSP00000474412	MYH9,HSPB1,ANG,MYD88,CCL5
PMID:25275304	(2014) JAK2STAT3 inhibition attenuates noise-induced hearing loss.	5	20	1.46	0.00088	9606.ENSP00000263317,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000371067,9606.ENSP00000478570	NOX4,STAT5A,NOX1,JAK2,VEGFA
PMID:25409297	(2014) Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865	TGFB1,CDH1,PTEN,AR,PDGFD
PMID:27508182	(2014) Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000444198,9606.ENSP00000478570	CDH1,PTEN,HPSE,CITED2,VEGFA
PMID:22527632	(2013) When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000474412	CCR5,CXCL10,CD34,BDNF,CCL5
PMID:23251296	(2013) Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.	5	20	1.46	0.00088	9606.ENSP00000222572,9606.ENSP00000365777,9606.ENSP00000369442,9606.ENSP00000384364,9606.ENSP00000474412	PON2,MTHFR,KL,NPY,CCL5
PMID:23371317	(2013) Endothelial progenitor cell: a blood cell by many other names may serve similar functions.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000285407,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	CD38,KLF10,CD34,PROM1,VEGFA
PMID:23434932	(2013) Hyperglycemia mediates a shift from cap-dependent to cap-independent translation via a 4E-BP1-dependent mechanism.	5	20	1.46	0.00088	9606.ENSP00000349860,9606.ENSP00000356515,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000478570	GFPT1,UTRN,NFE2L2,BCL2,VEGFA
PMID:23470013	(2013) E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185	CDH1,HNF4A,CAV1,PTGS2,BCL2
PMID:23571017	(2013) Norepinephrine potentiates proinflammatory responses of human vaginal epithelial cells.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000356213,9606.ENSP00000384364,9606.ENSP00000474412	CXCL10,CCL20,VIP,NPY,CCL5
PMID:23577258	(2013) Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185	CDH1,CD34,STAT5A,PTEN,BCL2
PMID:23859963	(2013) Regeneration of neuronal cells following cerebral injury.	5	20	1.46	0.00088	9606.ENSP00000308208,9606.ENSP00000310036,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	MMP14,CD34,BDNF,PROM1,VEGFA
PMID:23878190	(2013) Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.	5	20	1.46	0.00088	9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000474412	CDH1,CCR5,PTEN,AR,CCL5
PMID:23922772	(2013) Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma.	5	20	1.46	0.00088	9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000478570	THBS1,CD34,ANGPT2,PTGS2,VEGFA
PMID:23936423	(2013) Expression proteomics predicts loss of RXR-gamma during progression of epithelial ovarian cancer.	5	20	1.46	0.00088	9606.ENSP00000232219,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185	RBP1,CDH1,ATM,PTEN,BCL2
PMID:24198445	(2013) Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.	5	20	1.46	0.00088	9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000403495,9606.ENSP00000478570	PDGFB,PDGFA,PDGFD,LTA,VEGFA
PMID:26038476	(2013) Recruitment of HIV-1 target cells at topical mucosal sites: a sensitive and early marker for determining the safety of microbicide candidates.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303	MPO,CD38,CD69,IFNG,CCR5
PMID:22093062	(2012) The benefits and risks of stem cell technology.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000314897,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,ANGPT2,NTF3,BDNF,VEGFA
PMID:22266669	(2012) Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CD34,PDGFB,AR,BCL2,VEGFA
PMID:22452977	(2012) Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.	5	20	1.46	0.00088	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CXCL10,EDN1,CCL5,VEGFA
PMID:22537155	(2012) Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000384906,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,SAA1,CCL5,VEGFA
PMID:22555803	(2012) Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,CCL5,VEGFA
PMID:22580107	(2012) Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000478570	CD34,EDNRA,VIP,EDN1,VEGFA
PMID:22659346	(2012) The role of CX3CL1CX3CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,EDN1,CCL5,VEGFA
PMID:22666465	(2012) Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasis.	5	20	1.46	0.00088	9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000380252	SREBF1,MAP3K5,PTEN,AR,NFE2L2
PMID:22685459	(2012) Current strategies for identification of glioma stem cells: adequate or unsatisfactory?	5	20	1.46	0.00088	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000426809,9606.ENSP00000478570	ATM,ALDH1A1,CD34,PROM1,VEGFA
PMID:22734666	(2012) Microvascular repair: post-angiogenesis vascular dynamics.	5	20	1.46	0.00088	9606.ENSP00000260356,9606.ENSP00000330382,9606.ENSP00000334329,9606.ENSP00000381185,9606.ENSP00000478570	THBS1,PDGFB,UNC5B,BCL2,VEGFA
PMID:22792412	(2012) Cell stress proteins in atherothrombosis.	5	20	1.46	0.00088	9606.ENSP00000301522,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	PRDX2,MAP3K5,TXN,NFE2L2,BCL2
PMID:22829758	(2012) Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.	10	159	0.86	0.00088	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000312987,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185	MAPK1,TGFB1,MPO,HNF4A,SIRT6,CAV1,STAT5A,PTEN,NFE2L2,BCL2
PMID:22952953	(2012) The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000300055,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000418525	CD38,PLIN1,PTEN,BCL2,MME
PMID:22980984	(2012) Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes.	5	20	1.46	0.00088	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901	CD69,CCR5,CXCL10,CXCL11,CXCL9
PMID:22981450	(2012) Cytokines that promote nerve regeneration.	5	20	1.46	0.00088	9606.ENSP00000355370,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000414303	CNTF,VIP,PTEN,JAK2,BDNF
PMID:23202514	(2012) HIV-1 induced bystander apoptosis.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000381185	CD38,CCR5,CD34,CAV1,BCL2
PMID:23369517	(2012) Bioinformatics insights into acute lung injuryacute respiratory distress syndrome.	5	20	1.46	0.00088	9606.ENSP00000314897,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000380252,9606.ENSP00000478570	ANGPT2,CAV1,NOX1,NFE2L2,VEGFA
PMID:23616788	(2012) Neuronal toxicity in HIV CNS disease.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,BCL2,BDNF,CCL5,VEGFA
PMID:20980412	(2011) Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study.	5	20	1.46	0.00088	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000377280,9606.ENSP00000418823	WFS1,JAZF1,KCNJ11,FBXO8,FTO
PMID:21347345	(2011) Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	IFNG,CCR5,CXCL10,CXCL9,CCL5
PMID:21349156	(2011) The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival.	5	20	1.46	0.00088	9606.ENSP00000245479,9606.ENSP00000308208,9606.ENSP00000363827,9606.ENSP00000368683,9606.ENSP00000478570	SOX9,MMP14,HSPG2,EDN1,VEGFA
PMID:21746850	(2011) Signal transduction by reactive oxygen species.	5	20	1.46	0.00088	9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641	ATM,MAP3K5,PTEN,NOX1,TXN
PMID:21826185	(2011) Biphasic effect of curcumin on morphine tolerance: a preliminary evidence from cytokinechemokine protein array analysis.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,BDNF,CCL5,VEGFA
PMID:22132145	(2011) Generation of immortal cell lines from the adult pituitary: role of cAMP on differentiation of SOX2-expressing progenitor cells to mature gonadotropes.	5	20	1.46	0.00088	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000355370,9606.ENSP00000363822,9606.ENSP00000414303	SOX9,CDH1,CNTF,AR,BDNF
PMID:20042609	(2010) Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinaseAKT-dependent ...	5	20	1.46	0.00088	9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000361021	IGF1R,HNF4A,CAV1,PTGS2,PTEN
PMID:20116427	(2010) Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000352264,9606.ENSP00000362057,9606.ENSP00000478570	IFNG,NOX4,CD2AP,NOX1,VEGFA
PMID:20154287	(2010) C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412	CCR5,CD34,BCL2,MME,CCL5
PMID:20398328	(2010) Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.	5	20	1.46	0.00088	9606.ENSP00000310036,9606.ENSP00000315011,9606.ENSP00000339191,9606.ENSP00000351807,9606.ENSP00000368683	CD34,EDNRA,CAV1,ELN,EDN1
PMID:20506238	(2010) Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors.	5	20	1.46	0.00088	9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000478570	SOX9,TIMP3,MMP14,CCL20,VEGFA
PMID:20813273	(2010) Biomarkers for late-onset neonatal sepsis: cytokines and beyond.	5	20	1.46	0.00088	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412	CD69,IFNG,CXCL10,CXCL9,CCL5
PMID:20836844	(2010) Impairment of circulating endothelial progenitors in Down syndrome.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	CXCL10,CD34,EDN1,PROM1,VEGFA
PMID:20886000	(2010) Computational analysis of candidate disease genes and variants for salt-sensitive hypertension in indigenous Southern Africans.	5	20	1.46	0.00088	9606.ENSP00000315011,9606.ENSP00000336762,9606.ENSP00000356832,9606.ENSP00000368683,9606.ENSP00000419422	EDNRA,ANG,SGK1,EDN1,AGTR1
PMID:20959517	(2010) Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.	5	20	1.46	0.00088	9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	STAT5A,AR,JAK2,BCL2,VEGFA
PMID:23908783	(2010) Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinsons and Alzheimers disorders?	5	20	1.46	0.00088	9606.ENSP00000354511,9606.ENSP00000377372,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	COMT,GAP43,BCL2,BDNF,VEGFA
PMID:24281068	(2010) Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation.	5	20	1.46	0.00088	9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	MAP3K5,PTGS2,TXN,BCL2,VEGFA
PMID:18841463	(2009) Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?	8	90	1.01	0.00088	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,CD34,CAV1,PTGS2,EDN1,VEGFA
PMID:19039828	(2009) Endogenous lung stem cells and contribution to disease.	5	20	1.46	0.00088	9606.ENSP00000293599,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000426809	AQP5,CD34,ELN,PTEN,PROM1
PMID:19168032	(2009) Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000418009	CCR5,CXCL10,CXCL11,CXCL9,RARRES2
PMID:19202440	(2009) CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19265171	(2009) Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host ...	5	20	1.46	0.00088	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:19321126	(2009) Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.	5	20	1.46	0.00088	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000371067,9606.ENSP00000426809	CD38,CDH1,CD34,JAK2,PROM1
PMID:19567787	(2009) Negative energy balance alters global gene expression and immune responses in the uterus of postpartum dairy cows.	8	90	1.01	0.00088	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000390651,9606.ENSP00000401399	CD69,FABP4,CCR5,STAT5A,PTGS2,S100A12,IRAK4,MYD88
PMID:19881493	(2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.	5	20	1.46	0.00088	9606.ENSP00000330382,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	PDGFB,PTEN,EDN1,BCL2,VEGFA
PMID:20074276	(2009) Clinical Use of Interferon-gamma.	5	20	1.46	0.00088	9606.ENSP00000225275,9606.ENSP00000306884,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351807	MPO,CXCL11,PDGFB,PDGFA,ELN
PMID:20142991	(2009) Erythropoietin: a multimodal neuroprotective agent.	5	20	1.46	0.00088	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000414303	EPOR,IFNG,STAT5A,JAK2,BDNF
PMID:27683326	(2009) 6. Diabetic Nephropathy.	5	20	1.46	0.00088	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000352264,9606.ENSP00000356438,9606.ENSP00000478570	MAPK1,IFNG,CD2AP,PTGS2,VEGFA
PMID:18694974	(2008) Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.	5	20	1.46	0.00088	9606.ENSP00000226760,9606.ENSP00000283928,9606.ENSP00000345708,9606.ENSP00000418823,9606.ENSP00000480291	WFS1,JAZF1,KCNJ11,FTO,HNF1B
PMID:19281078	(2008) Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines.	5	20	1.46	0.00088	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351807,9606.ENSP00000354901,9606.ENSP00000478570	CXCL10,CXCL11,ELN,CXCL9,VEGFA
PMID:19337549	(2008) Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease.	5	20	1.46	0.00088	9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422	IGF1R,ELN,JAK2,BCL2,AGTR1
PMID:19471607	(2008) Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.	10	159	0.86	0.00088	9606.ENSP00000228434,9606.ENSP00000246553,9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000369816,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000480291	CD69,FFAR1,NOX4,CXCL10,PTGS2,MTHFR,SHBG,RHOA,CCL5,HNF1B
PMID:17969379	(2007) Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.	5	20	1.46	0.00088	9606.ENSP00000215832,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000354995,9606.ENSP00000383364	MAPK1,PLIN1,LPL,ABCG1,PLA2G2A
PMID:16250671	(2005) Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CD34,ELN,PROM1,VEGFA
PMID:16351713	(2005) The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.	5	20	1.46	0.00088	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,CCL5,VEGFA
PMID:35005848	(2022) New insights into the role of melatonin in diabetic cardiomyopathy.	7	62	1.11	0.00089	9606.ENSP00000263317,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399	NOX4,EDN1,JAK2,G6PD,NFE2L2,BCL2,MYD88
PMID:35028802	(2022) Potential Application of Exosomes in Vaccine Development and Delivery.	9	123	0.93	0.00089	9606.ENSP00000228434,9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000306884,9606.ENSP00000339191,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000478570	CD69,HSPB1,CDH1,CCR5,CXCL11,CAV1,ENTPD1,PTEN,VEGFA
PMID:35159388	(2022) Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19.	7	62	1.11	0.00089	9606.ENSP00000263317,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000474412	NOX4,CXCL10,CXCL11,LPL,PDGFB,CXCL9,CCL5
PMID:35328719	(2022) Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches.	7	62	1.11	0.00089	9606.ENSP00000260356,9606.ENSP00000304767,9606.ENSP00000310036,9606.ENSP00000360250,9606.ENSP00000360997,9606.ENSP00000371067,9606.ENSP00000474412	THBS1,P2RY1,CD34,ENTPD1,ADAMTS13,JAK2,CCL5
PMID:35406495	(2022) Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem.	9	123	0.93	0.00089	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,ATM,CCL20,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:33391974	(2021) Macrophage imaging and subset analysis using single-cell RNA sequencing.	7	62	1.11	0.00089	9606.ENSP00000256104,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000339191,9606.ENSP00000354995,9606.ENSP00000355361,9606.ENSP00000478570	FABP4,MMP14,GAS6,CAV1,ABCG1,CD47,VEGFA
PMID:33498186	(2021) Little Helpers or Mean Rogue-Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis.	9	123	0.93	0.00089	9606.ENSP00000255409,9606.ENSP00000306884,9606.ENSP00000356438,9606.ENSP00000362410,9606.ENSP00000369442,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL11,PTGS2,MAFB,KL,MYD88,BDNF,CCL5,VEGFA
PMID:33572099	(2021) Hovenia dulcis Thumberg: Phytochemistry, Pharmacology, Toxicology and Regulatory Framework for Its Use in the European Union.	7	62	1.11	0.00089	9606.ENSP00000256104,9606.ENSP00000348069,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	FABP4,SREBF1,BMP2,JAK2,BCL2,MYD88,VEGFA
PMID:33669775	(2021) Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.	7	62	1.11	0.00089	9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000478570	APC,THBS1,MMP14,HNF4A,CAV1,EDN1,VEGFA
PMID:33805398	(2021) Role of Exosomes in Prostate Cancer Metastasis.	9	123	0.93	0.00089	9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000265132,9606.ENSP00000285407,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000478570	TGFB1,HSPB1,THBS1,AMBP,KLF10,PDGFA,PTEN,AR,VEGFA
PMID:33955709	(2021) Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis.	7	62	1.11	0.00089	9606.ENSP00000229135,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000393312	IFNG,FADS2,PLIN1,CAV1,PTGS2,BCL2,FGFR1
PMID:34006631	(2021) Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.	7	62	1.11	0.00089	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000337332,9606.ENSP00000354782,9606.ENSP00000400175,9606.ENSP00000474412	CD38,CD69,IFNG,SIRT6,CD247,RHOA,CCL5
PMID:34188450	(2021) Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.	7	62	1.11	0.00089	9606.ENSP00000225275,9606.ENSP00000309757,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422	MPO,LPL,SREBF1,PTGS2,JAK2,BCL2,AGTR1
PMID:34262602	(2021) Visualization and Analysis of Gene Expression in Stanford Type A Aortic Dissection Tissue Section by Spatial Transcriptomics.	7	62	1.11	0.00089	9606.ENSP00000256104,9606.ENSP00000266085,9606.ENSP00000317674,9606.ENSP00000351807,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000384906	FABP4,TIMP3,APOL1,ELN,CD47,PTEN,SAA1
PMID:34311016	(2021) Interferon beta, an enhancer of the innate immune response against SARS-CoV-2 infection.	7	62	1.11	0.00089	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD69,CXCL10,CD34,CXCL9,JAK2,BCL2,VEGFA
PMID:34539854	(2021) Progress on the study of the anticancer effects of artesunate.	7	62	1.11	0.00089	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,ATM,PTGS2,PTEN,AR,BCL2,VEGFA
PMID:34540690	(2021) Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis.	7	62	1.11	0.00089	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000426809	SOX9,CDH1,IGF1R,PTEN,JAK2,FGFR1,PROM1
PMID:34566899	(2021) Nesfatin-1 Receptor: Distribution, Signaling and Increasing Evidence for a G Protein-Coupled Receptor - A Systematic Review.	7	62	1.11	0.00089	9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000414303	SREBF1,PTGS2,AR,JAK2,BCL2,NPY,BDNF
PMID:34572151	(2021) Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology.	7	62	1.11	0.00089	9606.ENSP00000302630,9606.ENSP00000309757,9606.ENSP00000312987,9606.ENSP00000348069,9606.ENSP00000363822,9606.ENSP00000369816,9606.ENSP00000477707	ONECUT1,LPL,HNF4A,SREBF1,AR,SHBG,NR1H3
PMID:34684894	(2021) Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?	7	62	1.11	0.00089	9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000358513,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000400175,9606.ENSP00000414303	PTGS2,SGK1,CNR1,PTEN,CNR2,RHOA,BDNF
PMID:34720596	(2021) Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.	7	62	1.11	0.00089	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,BCL2,MYD88,LTA,CCL5,VEGFA
PMID:34757794	(2021) A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections.	7	62	1.11	0.00089	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000360250	CD38,CD69,IFNG,CCR5,CXCL10,CXCL9,ENTPD1
PMID:34765085	(2021) Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function.	7	62	1.11	0.00089	9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000414303,9606.ENSP00000477707,9606.ENSP00000478570	SREBF1,MAP3K5,TXN,NFE2L2,BDNF,NR1H3,VEGFA
PMID:34938172	(2021) An Update on Antioxidative Stress Therapy Research for Early Brain Injury After Subarachnoid Hemorrhage.	7	62	1.11	0.00089	9606.ENSP00000225275,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000351908,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252	MPO,MAPK7,SIRT6,MAP3K5,EDN1,JAK2,NFE2L2
PMID:35056369	(2021) Mesenchymal Stem Cell Senescence and Osteogenesis.	7	62	1.11	0.00089	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000384906,9606.ENSP00000478570	CD38,SOX9,IGF1R,ATM,CD34,SAA1,VEGFA
PMID:35058775	(2021) Molecular Mechanism of Puerarin Against Diabetes and its Complications.	7	62	1.11	0.00089	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	IFNG,NOX4,EDN1,JAK2,BCL2,MYD88,VEGFA
PMID:35126116	(2021) Multifactoriality of Parkinsons Disease as Explored Through Human Neural Stem Cells and Their Transplantation in Middle-Aged Parkinsonian Mice.	9	123	0.93	0.00089	9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000377372,9606.ENSP00000380252,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570,9606.ENSP00000480291	CNTF,PTGS2,BMP2,GAP43,NFE2L2,NTF3,BDNF,VEGFA,HNF1B
PMID:30689717	(2020) Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.	7	62	1.11	0.00089	9606.ENSP00000226279,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000363973,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CD38,IGF1R,CCR5,ALPL,JAK2,BCL2,VEGFA
PMID:31092147	(2020) Brain Injury-Mediated Neuroinflammatory Response and Alzheimers Disease.	7	62	1.11	0.00089	9606.ENSP00000229135,9606.ENSP00000245479,9606.ENSP00000351671,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,SOX9,CCL20,NTF3,BDNF,CCL5,VEGFA
PMID:32018053	(2020) New Approaches to SCLC Therapy: From the Laboratory to the Clinic.	7	62	1.11	0.00089	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000474412	IGF1R,CXCL10,CD47,PTEN,BCL2,FGFR1,CCL5
PMID:32031074	(2020) Role of Nuclear Factor Kappa B (NF-kappaB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.	7	62	1.11	0.00089	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000474412	NOX4,PTGS2,PTEN,NFE2L2,BCL2,BDNF,CCL5
PMID:32054074	(2020) Early Programming of Adult Systemic Essential Hypertension.	7	62	1.11	0.00089	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000284031,9606.ENSP00000315011,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000380252	MPO,NOX4,DDAH1,EDNRA,NOX1,EDN1,NFE2L2
PMID:32054088	(2020) Dynamics of Early Signalling Events during Fracture Healing and Potential Serum Biomarkers of Fracture Non-Union in Humans.	7	62	1.11	0.00089	9606.ENSP00000228434,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000314897,9606.ENSP00000364683,9606.ENSP00000478319,9606.ENSP00000478570	CD69,TIMP3,CXCL10,ANGPT2,BAMBI,GREM1,VEGFA
PMID:32092671	(2020) Choosing The Right Animal Model for Renal Cancer Research.	7	62	1.11	0.00089	9606.ENSP00000221930,9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000355361,9606.ENSP00000361021,9606.ENSP00000418525,9606.ENSP00000478570	TGFB1,CDH1,CD34,CD47,PTEN,MME,VEGFA
PMID:32538379	(2020) Nanotechnology for angiogenesis: opportunities and challenges.	7	62	1.11	0.00089	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000363641,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,SOX9,CDH1,PDGFB,TXN,RHOA,VEGFA
PMID:32781778	(2020) CD36 and CD97 in Pancreatic Cancer versus Other Malignancies.	7	62	1.11	0.00089	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000285407,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000381185	THBS1,CDH1,KLF10,CAV1,PTEN,HSPG2,BCL2
PMID:32933095	(2020) Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment.	9	123	0.93	0.00089	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000365777,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	ERCC1,CDH1,CD47,PTGS2,MTHFR,BCL2,FGFR1,PROM1,VEGFA
PMID:32963703	(2020) Hydrogen: A Novel Option in Human Disease Treatment.	7	62	1.11	0.00089	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185	MPO,CDH1,MAP3K5,PTGS2,JAK2,NFE2L2,BCL2
PMID:33066583	(2020) Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective.	7	62	1.11	0.00089	9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000368104,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,HNF4A,ELN,PTGS2,BMP2,PROM1,VEGFA
PMID:33187162	(2020) Tissue-Resident Memory T Cells in the Liver-Unique Characteristics of Local Specialists.	7	62	1.11	0.00089	9606.ENSP00000228434,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412	CD69,FABP4,CXCL10,CXCL11,CXCL9,ENTPD1,CCL5
PMID:33250779	(2020) Alpha-Arbutin Promotes Wound Healing by Lowering ROS and Upregulating InsulinIGF-1 Pathway in Human Dermal Fibroblast.	7	62	1.11	0.00089	9606.ENSP00000268035,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	IGF1R,ELN,PTGS2,PTEN,TXN,NFE2L2,BCL2
PMID:33352882	(2020) Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists.	7	62	1.11	0.00089	9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CCL20,CXCL9,JAK2,MYD88,CCL5,VEGFA
PMID:30407731	(2019) Biofilm-induced profiles of immune response gene expression by oral epithelial cells.	7	62	1.11	0.00089	9606.ENSP00000221930,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000383364,9606.ENSP00000445772,9606.ENSP00000474412	TGFB1,CXCL10,CXCL11,CCL20,PLA2G2A,LTB4R2,CCL5
PMID:30578699	(2019) Role of miRNAs in immune responses and immunotherapy in cancer.	7	62	1.11	0.00089	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CD34,STAT5A,PTEN,BCL2,CCL5,VEGFA
PMID:30783517	(2019) Oxygen in the tumor microenvironment: effects on dendritic cell function.	7	62	1.11	0.00089	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,CCR5,CCL20,MAP3K5,TXN,CCL5,VEGFA
PMID:30881341	(2019) InsulinIGF-1R, SIRT1, and FOXOs Pathways-An Intriguing Interaction Platform for Bone and Osteosarcoma.	7	62	1.11	0.00089	9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000484631	IGF1R,MAPK7,SIRT6,PTGS2,SGK1,PTEN,PMP22
PMID:31354486	(2019) Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.	7	62	1.11	0.00089	9606.ENSP00000013807,9606.ENSP00000222572,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,PON2,ATM,CXCL10,SIRT6,BCL2,VEGFA
PMID:31817718	(2019) Mechanistic Understanding of Curcumins Therapeutic Effects in Lung Cancer.	7	62	1.11	0.00089	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,IGF1R,PTGS2,PTEN,JAK2,BCL2,VEGFA
PMID:29651429	(2018) Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.	7	62	1.11	0.00089	9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	ATM,PRKCE,PTGS2,PTEN,BCL2,FGFR1,VEGFA
PMID:29707000	(2018) MicroRNA and Microvascular Complications of Diabetes.	7	62	1.11	0.00089	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000419313,9606.ENSP00000478570	THBS1,CDH1,NOX4,PTEN,JAK2,TRPC1,VEGFA
PMID:29713631	(2018) Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.	7	62	1.11	0.00089	9606.ENSP00000310036,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000352264,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000418525	CD34,APOL1,LPA,CD2AP,JAK2,RHOA,MME
PMID:30096787	(2018) mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.	7	62	1.11	0.00089	9606.ENSP00000013807,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185	ERCC1,IGF1R,ATM,SIRT6,PTEN,KL,BCL2
PMID:28009990	(2017) Metabolic enzymes: key modulators of functionality in cancer stem-like cells.	7	62	1.11	0.00089	9606.ENSP00000297785,9606.ENSP00000308208,9606.ENSP00000348069,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000426809	ALDH1A1,MMP14,SREBF1,PTGS2,PTEN,GLO1,PROM1
PMID:28646905	(2017) Mechanistic understanding of nanoparticles interactions with extracellular matrix: the cell and immune system.	7	62	1.11	0.00089	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000309757,9606.ENSP00000351807,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000474412	MPO,CXCL10,LPL,ELN,BCL2,RHOA,CCL5
PMID:28680477	(2017) Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions.	7	62	1.11	0.00089	9606.ENSP00000245479,9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000345708,9606.ENSP00000362410,9606.ENSP00000397297,9606.ENSP00000414303	SOX9,ONECUT1,HNF4A,KCNJ11,MAFB,NTF3,BDNF
PMID:29027954	(2017) Marine Sponge Natural Products with Anticancer Potential: An Updated Review.	7	62	1.11	0.00089	9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	ALDH1A1,STAT5A,PTGS2,PTEN,BCL2,PROM1,VEGFA
PMID:29209103	(2017) HIV as a Cause of Immune Activation and Immunosenescence.	7	62	1.11	0.00089	9606.ENSP00000255409,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000478570	CHI3L1,CCR5,CXCL10,CCL20,CXCL9,BCL2,VEGFA
PMID:29246030	(2017) Venom-based peptide therapy: insights into anti-cancer mechanism.	7	62	1.11	0.00089	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,PTEN,BCL2,PLA2G2A,CCL5
PMID:29383201	(2017) MicroRNAs in cancer metastasis and angiogenesis.	7	62	1.11	0.00089	9606.ENSP00000261769,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000361021,9606.ENSP00000478570,9606.ENSP00000479617	CDH1,MMP14,ANGPT2,ANG,PTEN,VEGFA,UHRF1
PMID:29491579	(2017) A critique on nuclear factor-kappa B and signal transducer and activator of transcription 3: The key transcription factors in periodontal pathogenesis.	7	62	1.11	0.00089	9606.ENSP00000341208,9606.ENSP00000351671,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000401399,9606.ENSP00000478570	STAT5A,CCL20,CNTF,PTGS2,JAK2,MYD88,VEGFA
PMID:27013138	(2016) MicroRNA: A new therapeutic strategy for cardiovascular diseases.	7	62	1.11	0.00089	9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CD34,ELN,PTEN,EDN1,BCL2,RHOA,VEGFA
PMID:27017896	(2016) Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival.	7	62	1.11	0.00089	9606.ENSP00000248553,9606.ENSP00000351908,9606.ENSP00000355370,9606.ENSP00000362410,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000400175	HSPB1,MAP3K5,CNTF,MAFB,AR,EDN1,RHOA
PMID:27197066	(2016) Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.	7	62	1.11	0.00089	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,IFNG,TIMP3,CXCL10,CXCL11,CXCL9,CCL5
PMID:27544699	(2016) MicroRNAs in heart failure: Non-coding regulators of metabolic function.	7	62	1.11	0.00089	9606.ENSP00000227868,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000381185	PDHX,IGF1R,SIRT6,CAV1,SREBF1,G6PD,BCL2
PMID:27992511	(2016) Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-- Mice.	7	62	1.11	0.00089	9606.ENSP00000221930,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000330382,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478319	TGFB1,LAMC1,CDH1,PDGFB,HSPG2,CCL5,GREM1
PMID:26699362	(2015) Size of the Ovulatory Follicle Dictates Spatial Differences in the Oviductal Transcriptome in Cattle.	7	62	1.11	0.00089	9606.ENSP00000261037,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000376865,9606.ENSP00000384262,9606.ENSP00000478570	COL8A1,MMP14,ANGPT2,EDN1,PDGFD,HPSE,VEGFA
PMID:26770236	(2015) New Findings on Breast Cancer Stem Cells: A Review.	7	62	1.11	0.00089	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,ALDH1A1,PTGS2,TXN,PROM1,VEGFA
PMID:24712462	(2014) The importance of regulatory T-cell heterogeneity in maintaining self-tolerance.	7	62	1.11	0.00089	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000341208,9606.ENSP00000360250,9606.ENSP00000381185	CD38,CD69,CDH1,CCR5,STAT5A,ENTPD1,BCL2
PMID:23840922	(2013) Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.	7	62	1.11	0.00089	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CXCL11,CCL20,CXCL9,PTGS2,BCL2,CCL5
PMID:23843721	(2013) Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.	7	62	1.11	0.00089	9606.ENSP00000222139,9606.ENSP00000245479,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	EPOR,SOX9,APC,ATM,PTEN,JAK2,VEGFA
PMID:24069219	(2013) Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.	7	62	1.11	0.00089	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384906,9606.ENSP00000478570	TGFB1,THBS1,PTGS2,PTEN,BCL2,SAA1,VEGFA
PMID:22919375	(2012) Predictive biomarkers of bacillus calmette-guerin immunotherapy response in bladder cancer: where are we now?	7	62	1.11	0.00089	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185	ERCC1,TGFB1,IFNG,THBS1,CXCL10,CXCL9,BCL2
PMID:23251077	(2012) Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion.	7	62	1.11	0.00089	9606.ENSP00000222572,9606.ENSP00000228434,9606.ENSP00000248553,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000381185,9606.ENSP00000474412	PON2,CD69,HSPB1,CXCL10,CXCL11,BCL2,CCL5
PMID:21482411	(2011) Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting.	7	62	1.11	0.00089	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000478570	TIMP3,MMP14,ANGPT2,ELN,PTEN,HSPG2,VEGFA
PMID:21541038	(2011) Epigenetic regulation of cancer-associated genes in ovarian cancer.	7	62	1.11	0.00089	9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000426809	CDH1,ALDH1A1,PTEN,JAK2,BCL2,MYD88,PROM1
PMID:21834767	(2011) Cytokine signaling modulates blood-brain barrier function.	7	62	1.11	0.00089	9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000414303	CAV1,EDN1,NPY,NTF3,RHOA,MYD88,BDNF
PMID:21867926	(2011) CD8(+) T cells: foot soldiers of the immune system.	7	62	1.11	0.00089	9606.ENSP00000228434,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000401399	CD69,CCR5,CXCL10,STAT5A,CXCL9,PTEN,MYD88
PMID:21941677	(2011) Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.	7	62	1.11	0.00089	9606.ENSP00000216181,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000346508,9606.ENSP00000368683,9606.ENSP00000478570	MYH9,CXCL11,ANGPT2,EDNRA,PDGFA,EDN1,VEGFA
PMID:20508843	(2010) Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.	7	62	1.11	0.00089	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	FABP4,PLIN1,LPL,PTGS2,EDN1,CCL5,VEGFA
PMID:20832340	(2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.	7	62	1.11	0.00089	9606.ENSP00000225275,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000321334,9606.ENSP00000390651,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CCR5,CXCL10,LPA,IRAK4,CCL5,VEGFA
PMID:18205922	(2008) Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study.	7	62	1.11	0.00089	9606.ENSP00000260356,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,CCL20,PTGS2,BCL2,PLA2G2A,CCL5,VEGFA
PMID:34901546	(2022) Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics.	8	91	1.01	0.00093	9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,THBS1,CDH1,CAV1,JAK2,G6PD,PROM1,VEGFA
PMID:35327421	(2022) Proteomic Studies of Psoriasis.	11	200	0.8	0.00093	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000301522,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000357726,9606.ENSP00000363641,9606.ENSP00000478570	MAPK1,MPO,ATM,PRDX2,CXCL10,CXCL11,CCL20,CXCL9,S100A12,TXN,VEGFA
PMID:33332677	(2021) Essential functions of miR-125b in cancer.	8	91	1.01	0.00093	9606.ENSP00000312987,9606.ENSP00000314897,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000363827,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	HNF4A,ANGPT2,SIRT6,PTEN,HSPG2,BCL2,PROM1,VEGFA
PMID:33668453	(2021) HMGA2 as a Critical Regulator in Cancer Development.	8	91	1.01	0.00093	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000474412,9606.ENSP00000478570	ERCC1,CDH1,ATM,ALDH1A1,BCL2,PROM1,CCL5,VEGFA
PMID:33807608	(2021) Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.	8	91	1.01	0.00093	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,CXCL9,PTEN,JAK2,FGFR1,CCL5,VEGFA
PMID:33811810	(2021) The aging lung: Physiology, disease, and immunity.	8	91	1.01	0.00093	9606.ENSP00000263317,9606.ENSP00000337332,9606.ENSP00000351807,9606.ENSP00000360250,9606.ENSP00000362057,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000401399	NOX4,SIRT6,ELN,ENTPD1,NOX1,KL,BCL2,MYD88
PMID:33827616	(2021) Obesity and intestinal stem cell susceptibility to carcinogenesis.	8	91	1.01	0.00093	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000288266,9606.ENSP00000360522,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000478319	SOX9,FABP4,APPL1,RBP4,PTEN,BMP2,BCL2,GREM1
PMID:34065882	(2021) Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia.	8	91	1.01	0.00093	9606.ENSP00000226279,9606.ENSP00000257430,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	CD38,APC,NOX4,CD34,STAT5A,PTEN,JAK2,BCL2
PMID:34367478	(2021) Immunotherapy against programmed death-1programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells.	8	91	1.01	0.00093	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000348069,9606.ENSP00000360250,9606.ENSP00000371067,9606.ENSP00000426809,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,SREBF1,ENTPD1,JAK2,PROM1,VEGFA
PMID:34685439	(2021) Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies.	8	91	1.01	0.00093	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000368683,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CDH1,NOX4,CD34,ELN,EDN1,PROM1,VEGFA
PMID:34834295	(2021) Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design.	8	91	1.01	0.00093	9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD47,PTGS2,PTEN,AR,BCL2,PROM1,VEGFA
PMID:34976805	(2021) The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment.	8	91	1.01	0.00093	9606.ENSP00000229135,9606.ENSP00000256104,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000368683,9606.ENSP00000478570	IFNG,FABP4,CXCL10,CXCL11,CXCL9,CNTF,EDN1,VEGFA
PMID:33425217	(2020) The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.	8	91	1.01	0.00093	9606.ENSP00000229135,9606.ENSP00000263317,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	IFNG,NOX4,FADS2,PLIN1,NOX1,TXN,G6PD,NFE2L2
PMID:29912608	(2019) Liver-specific knockout of histone methyltransferase G9a impairs liver maturation and dysregulates inflammatory, cytoprotective, and drug-processing genes.	8	91	1.01	0.00093	9606.ENSP00000259407,9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000312987,9606.ENSP00000362057,9606.ENSP00000363822,9606.ENSP00000380252,9606.ENSP00000477707	BAAT,IGF1R,CXCL10,HNF4A,NOX1,AR,NFE2L2,NR1H3
PMID:31546715	(2019) Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver.	8	91	1.01	0.00093	9606.ENSP00000337332,9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000351671,9606.ENSP00000356832,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399	SIRT6,STAT5A,SREBF1,CCL20,SGK1,JAK2,BCL2,MYD88
PMID:31779700	(2019) Functional proteins of mesenchymal stem cell-derived extracellular vesicles.	8	91	1.01	0.00093	9606.ENSP00000268035,9606.ENSP00000304767,9606.ENSP00000336762,9606.ENSP00000376865,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,P2RY1,ANG,PDGFD,BDNF,MME,CCL5,VEGFA
PMID:31933526	(2019) Abstract Proceedings of the 7th International Congress of the Molecular Biology Association of Turkey: Istanbul, Turkey. 27-29 September 2019.	11	200	0.8	0.00093	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000352264,9606.ENSP00000354782,9606.ENSP00000356832,9606.ENSP00000363973,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000383364,9606.ENSP00000414303	HSPB1,CDH1,ATM,CD2AP,CD247,SGK1,ALPL,BMP2,BCL2,PLA2G2A,BDNF
PMID:29652813	(2018) The Microenvironment in Epstein-Barr Virus-Associated Malignancies.	8	91	1.01	0.00093	9606.ENSP00000268035,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000474412,9606.ENSP00000478570	IGF1R,CXCL10,CCL20,CXCL9,JAK2,LTA,CCL5,VEGFA
PMID:29927933	(2018) Changes in mRNAprotein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells.	8	91	1.01	0.00093	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	TGFB1,SOX9,ENPP2,CDH1,ALDH1A1,PTEN,PROM1,VEGFA
PMID:30515368	(2018) Moving Breast Cancer Therapy up a Notch.	8	91	1.01	0.00093	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000384262,9606.ENSP00000426809	CDH1,IGF1R,ATM,ALDH1A1,STAT5A,PTEN,HPSE,PROM1
PMID:27110580	(2016) Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.	8	91	1.01	0.00093	9606.ENSP00000225275,9606.ENSP00000255409,9606.ENSP00000261769,9606.ENSP00000292303,9606.ENSP00000345708,9606.ENSP00000356438,9606.ENSP00000401399,9606.ENSP00000478570	MPO,CHI3L1,CDH1,CCR5,KCNJ11,PTGS2,MYD88,VEGFA
PMID:27679857	(2016) Molecular signaling cascades involved in nonmelanoma skin carcinogenesis.	8	91	1.01	0.00093	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000351908,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000401399	IGF1R,ATM,PRKCE,MAP3K5,SGK1,PTEN,BCL2,MYD88
PMID:27761146	(2016) The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro.	8	91	1.01	0.00093	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	MPO,CDH1,EDN1,BCL2,RHOA,BDNF,MME,VEGFA
PMID:25852818	(2015) The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases.	8	91	1.01	0.00093	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000354901,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	CCR5,CXCL10,CD34,CAV1,CXCL9,MYD88,CCL5,VEGFA
PMID:22035226	(2011) The secret life of kinases: functions beyond catalysis.	8	91	1.01	0.00093	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,IFNG,IGF1R,ATM,STAT5A,MAP3K5,PTEN,BCL2
PMID:22566887	(2011) Chronic inflammation in cancer development.	8	91	1.01	0.00093	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000478570	HSPB1,CDH1,CCL20,PTGS2,BCL2,IRAK4,MYD88,VEGFA
PMID:22642194	(....) matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.	8	91	1.01	0.00093	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000336762,9606.ENSP00000351807,9606.ENSP00000363827,9606.ENSP00000365777,9606.ENSP00000478570	MPO,CDH1,TIMP3,ANG,ELN,HSPG2,MTHFR,VEGFA
PMID:34380881	(2022) The role of miRNA in retinal ganglion cell health and disease.	6	39	1.25	0.00095	9606.ENSP00000355370,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,SGK1,PTEN,BCL2,BDNF,VEGFA
PMID:35054814	(2022) Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000283928,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000480291	CDH1,JAZF1,PTEN,AR,BCL2,HNF1B
PMID:35179961	(2022) The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000363822,9606.ENSP00000371067,9606.ENSP00000381185	CD38,CD34,STAT5A,AR,JAK2,BCL2
PMID:35210800	(2022) Gene Expression Profile Analyses of the Skin Response of Balbc-Nu Mice Model Injected by Staphylococcus aureus.	9	124	0.92	0.00095	9606.ENSP00000263317,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000362524,9606.ENSP00000384906,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000479617	NOX4,ANGPT2,PTGS2,ANGPTL2,SAA1,IRAK4,MYD88,CCL5,UHRF1
PMID:35222377	(2022) Neuroimmunology of Common Parasitic Infections in Africa.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000401399,9606.ENSP00000403495,9606.ENSP00000474412	CXCL10,CXCL9,EDN1,MYD88,LTA,CCL5
PMID:35282345	(2022) Sex-Differences in Aortic Stenosis: Mechanistic Insights and Clinical Implications.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000225275,9606.ENSP00000245479,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000474412	TGFB1,MPO,SOX9,BMP2,BCL2,CCL5
PMID:35294722	(2022) In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000381185	CD38,IFNG,CXCL10,CD34,STAT5A,BCL2
PMID:35406109	(2022) Sodium Benzoate-Harmfulness and Potential Use in Therapies for Disorders Related to the Nervous System: A Review.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000397297,9606.ENSP00000403495,9606.ENSP00000414303	MPO,CNTF,BCL2,NTF3,LTA,BDNF
PMID:35418991	(2022) Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease.	9	124	0.92	0.00095	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000265132,9606.ENSP00000351671,9606.ENSP00000356438,9606.ENSP00000384957,9606.ENSP00000393312,9606.ENSP00000403495,9606.ENSP00000474412	CD38,CD69,AMBP,CCL20,PTGS2,F11,FGFR1,LTA,CCL5
PMID:33397955	(2021) Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stemprogenitor cells in chronic myelogenous leukemia.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000337332,9606.ENSP00000341208	CD38,CDH1,ATM,CD34,SIRT6,STAT5A
PMID:33467663	(2021) A Review of Plant Extracts and Plant-Derived Natural Compounds in the PreventionTreatment of Neonatal Hypoxic-Ischemic Brain Injury.	6	39	1.25	0.00095	9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	CNTF,PTGS2,BCL2,MYD88,BDNF,VEGFA
PMID:33477494	(2021) Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer.	6	39	1.25	0.00095	9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	MAP3K5,PTEN,NOX1,TXN,G6PD,NFE2L2
PMID:33490895	(2021) Engineering approaches for studying immune-tumor cell interactions and immunotherapy.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL9,PTEN,CCL5,VEGFA
PMID:33568170	(2021) Postponing tumor onset and tumor progression can be achieved by alteration of local tumor immunity.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,CXCL9,JAK2,CCL5,VEGFA
PMID:33607290	(2021) SARS CoV2 infection _The longevity study perspectives.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000368683,9606.ENSP00000419422,9606.ENSP00000474412	IFNG,CCR5,CXCL10,EDN1,AGTR1,CCL5
PMID:33747851	(2021) Platelet Microparticle Controversial Role in Cancer.	6	39	1.25	0.00095	9606.ENSP00000260356,9606.ENSP00000308208,9606.ENSP00000331831,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,MMP14,GAS6,RHOA,CCL5,VEGFA
PMID:33768092	(2021) The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia.	6	39	1.25	0.00095	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000337332,9606.ENSP00000381185,9606.ENSP00000478570	SOX9,CDH1,IGF1R,SIRT6,BCL2,VEGFA
PMID:33808220	(2021) Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.	6	39	1.25	0.00095	9606.ENSP00000200676,9606.ENSP00000309757,9606.ENSP00000317674,9606.ENSP00000321334,9606.ENSP00000354995,9606.ENSP00000368683	CETP,LPL,APOL1,LPA,ABCG1,EDN1
PMID:33889158	(2021) The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation.	6	39	1.25	0.00095	9606.ENSP00000310036,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000418525,9606.ENSP00000478570	CD34,PDGFD,BCL2,RHOA,MME,VEGFA
PMID:33924211	(2021) Dysregulation of Multiple Signaling Neurodevelopmental Pathways during Embryogenesis: A Possible Cause of Autism Spectrum Disorder.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000312987,9606.ENSP00000356213,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000414303	CDH1,HNF4A,VIP,PTEN,BCL2,BDNF
PMID:34066338	(2021) Extracellular Vesicles in Synovial Fluid from Rheumatoid Arthritis Patients Contain miRNAs with Capacity to Modulate Inflammation.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185	TGFB1,IGF1R,CCL20,PTEN,JAK2,BCL2
PMID:34067520	(2021) Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities.	6	39	1.25	0.00095	9606.ENSP00000263317,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000381185	NOX4,CD34,PTEN,TXN,NFE2L2,BCL2
PMID:34075069	(2021) In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000357726,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CXCL10,S100A12,CCL5,VEGFA
PMID:34088273	(2021) Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,LTA,BDNF,CCL5,VEGFA
PMID:34149431	(2021) Neuroprotective Potentials of Panax Ginseng Against Alzheimers Disease: A Review of Preclinical and Clinical Evidences.	6	39	1.25	0.00095	9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000418525,9606.ENSP00000478570	MAP3K5,PTGS2,BCL2,BDNF,MME,VEGFA
PMID:34208157	(2021) Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000360250,9606.ENSP00000478570	CD38,IFNG,CCR5,CXCL10,ENTPD1,VEGFA
PMID:34209333	(2021) ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000400175	MPO,IFNG,STAT5A,PTEN,EDN1,RHOA
PMID:34221096	(2021) Cell-blocks and hematolymphoid lesions.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	MPO,CD38,CD34,BCL2,MYD88,MME
PMID:34304732	(2021) French recommendations for the management of systemic sclerosis.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000315011,9606.ENSP00000360997,9606.ENSP00000368683,9606.ENSP00000418525,9606.ENSP00000478570	MPO,EDNRA,ADAMTS13,EDN1,MME,VEGFA
PMID:34349762	(2021) B7-H3CD276: An Emerging Cancer Immunotherapy.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000355361,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,MAPK7,CD47,JAK2,BCL2,VEGFA
PMID:34367731	(2021) Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000355361,9606.ENSP00000356438,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CD47,PTGS2,ENTPD1,CCL5,VEGFA
PMID:34385905	(2021) The Roles of Lpar1 in Central Nervous System Disorders and Diseases.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000351671,9606.ENSP00000380252,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000474412	MAPK1,CCL20,NFE2L2,RHOA,BDNF,CCL5
PMID:34478921	(2021) Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000474412	CXCL10,CXCL11,CXCL9,PTGS2,S100A12,CCL5
PMID:34490053	(2021) Strategies to Improve the Efficiency of Transplantation with Mesenchymal Stem Cells for the Treatment of Ischemic Stroke: A Review of Recent Progress.	6	39	1.25	0.00095	9606.ENSP00000341208,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000377372,9606.ENSP00000414303,9606.ENSP00000478570	STAT5A,BMP2,JAK2,GAP43,BDNF,VEGFA
PMID:34680532	(2021) In Vitro Disease Models of the Endocrine Pancreas.	6	39	1.25	0.00095	9606.ENSP00000226760,9606.ENSP00000245479,9606.ENSP00000345708,9606.ENSP00000351807,9606.ENSP00000362410,9606.ENSP00000478570	WFS1,SOX9,KCNJ11,ELN,MAFB,VEGFA
PMID:34884984	(2021) Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.	6	39	1.25	0.00095	9606.ENSP00000248553,9606.ENSP00000261769,9606.ENSP00000363822,9606.ENSP00000384906,9606.ENSP00000393312,9606.ENSP00000478570	HSPB1,CDH1,AR,SAA1,FGFR1,VEGFA
PMID:34948117	(2021) Adult-Onset Stills Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000357726	MPO,IFNG,CXCL10,CXCL11,CXCL9,S100A12
PMID:34948463	(2021) Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury.	6	39	1.25	0.00095	9606.ENSP00000310036,9606.ENSP00000336762,9606.ENSP00000355370,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CD34,ANG,CNTF,BCL2,BDNF,VEGFA
PMID:35047997	(2021) Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000355361,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CD47,BCL2,CCL5,VEGFA
PMID:35173614	(2021) Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.	6	39	1.25	0.00095	9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000401399,9606.ENSP00000478570	EDN1,NFE2L2,BCL2,FGFR1,MYD88,VEGFA
PMID:31485828	(2020) Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000310036,9606.ENSP00000314897,9606.ENSP00000356438,9606.ENSP00000380252,9606.ENSP00000478570	MPO,CD34,ANGPT2,PTGS2,NFE2L2,VEGFA
PMID:31914968	(2020) Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,LTA,BDNF,CCL5,VEGFA
PMID:31924810	(2020) Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population.	6	39	1.25	0.00095	9606.ENSP00000013807,9606.ENSP00000221930,9606.ENSP00000310520,9606.ENSP00000362463,9606.ENSP00000365777,9606.ENSP00000369442	ERCC1,TGFB1,ERCC4,GLO1,MTHFR,KL
PMID:31979112	(2020) The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000381185,9606.ENSP00000478570	CXCL10,CXCL9,PTEN,ANGPTL2,BCL2,VEGFA
PMID:32033185	(2020) Low Molecular Weight Hyaluronan Induces an Inflammatory Response in Ovarian Stromal Cells and Impairs Gamete Development In Vitro.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	IFNG,CXCL10,CXCL11,CXCL9,LTA,CCL5
PMID:32172808	(2020) Cell-Cell Communication Breakdown and Endothelial Dysfunction.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,PDGFB,CAV1,PROM1,VEGFA
PMID:32340247	(2020) A Systems Biological Approach to Understanding the Mechanisms Underlying the Therapeutic Potential of Red Ginseng Supplements against Metabolic Diseases.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000390651	MAPK1,TGFB1,IFNG,PTGS2,BCL2,IRAK4
PMID:32363188	(2020) Angiogenic Potential of Tissue Engineered Cartilage From Human Mesenchymal Stem Cells Is Modulated by Indian Hedgehog and Serpin E1.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000259486,9606.ENSP00000331831,9606.ENSP00000363973,9606.ENSP00000384262,9606.ENSP00000478570	TGFB1,ENPP2,GAS6,ALPL,HPSE,VEGFA
PMID:32386542	(2020) Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000371067,9606.ENSP00000474412	TGFB1,CD38,CD34,PDGFA,JAK2,CCL5
PMID:32481570	(2020) Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer.	6	39	1.25	0.00095	9606.ENSP00000260356,9606.ENSP00000354782,9606.ENSP00000355361,9606.ENSP00000419422,9606.ENSP00000426809,9606.ENSP00000478570	THBS1,CD247,CD47,AGTR1,PROM1,VEGFA
PMID:32521619	(2020) Redox-Modulating Agents in the Treatment of Viral Infections.	6	39	1.25	0.00095	9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000377192,9606.ENSP00000380252	NOX4,PTGS2,NOX1,TXN,G6PD,NFE2L2
PMID:32565865	(2020) Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review.	6	39	1.25	0.00095	9606.ENSP00000200676,9606.ENSP00000348069,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000477707	CETP,SREBF1,ABCG1,PTGS2,BCL2,NR1H3
PMID:32630408	(2020) Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PTGS2,BCL2,CCL5,VEGFA
PMID:32679734	(2020) Artemisia annua, a Traditional Plant Brought to Light.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000356438,9606.ENSP00000377192,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	TGFB1,PTGS2,G6PD,BCL2,MYD88,VEGFA
PMID:32751658	(2020) The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000348069,9606.ENSP00000363641,9606.ENSP00000380252,9606.ENSP00000477707,9606.ENSP00000478570	MPO,SREBF1,TXN,NFE2L2,NR1H3,VEGFA
PMID:32772766	(2020) Chronic stress and adipose tissue in the anorexic state: endocrine and epigenetic mechanisms.	6	39	1.25	0.00095	9606.ENSP00000309757,9606.ENSP00000354511,9606.ENSP00000358513,9606.ENSP00000384364,9606.ENSP00000414303,9606.ENSP00000418823	LPL,COMT,CNR1,NPY,BDNF,FTO
PMID:32824762	(2020) Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).	6	39	1.25	0.00095	9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000351807,9606.ENSP00000356438,9606.ENSP00000393312,9606.ENSP00000478570	TIMP3,MMP14,ELN,PTGS2,FGFR1,VEGFA
PMID:32839413	(2020) There and Back Again: Leptin Actions in White Adipose Tissue.	6	39	1.25	0.00095	9606.ENSP00000309757,9606.ENSP00000314897,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000384364,9606.ENSP00000414303	LPL,ANGPT2,STAT5A,JAK2,NPY,BDNF
PMID:32934764	(2020) Cell Senescence: A Nonnegligible Cell State under Survival Stress in Pathology of Intervertebral Disc Degeneration.	6	39	1.25	0.00095	9606.ENSP00000260356,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351671,9606.ENSP00000355361,9606.ENSP00000478570	THBS1,NOX4,ATM,CCL20,CD47,VEGFA
PMID:33066585	(2020) Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000363596,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303	IFNG,CXCL10,CNR2,TXN,BCL2,BDNF
PMID:33106668	(2020) A new neutrophil subset promotes CNS neuron survival and axon regeneration.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000377372,9606.ENSP00000418525,9606.ENSP00000474412	MPO,CNTF,PTEN,GAP43,MME,CCL5
PMID:33194618	(2020) TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3beta-beta-Catenin Signaling Pathway.	6	39	1.25	0.00095	9606.ENSP00000312987,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000426809,9606.ENSP00000480291	HNF4A,PTEN,BCL2,RHOA,PROM1,HNF1B
PMID:33196459	(2020) Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.	6	39	1.25	0.00095	9606.ENSP00000248553,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303	HSPB1,NFE2L2,BCL2,NPY,MYD88,BDNF
PMID:33330084	(2020) Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGHBCL3 Rearrangements: Report of Three Chinese Cases and Literature Review.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000225275,9606.ENSP00000278616,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000418525	MAPK1,MPO,ATM,BCL2,MYD88,MME
PMID:33584313	(2020) Loss of FGFR3 Delays Acute Myeloid Leukemogenesis by Programming Weakly Pathogenic CD117-Positive Leukemia Stem-Like Cells.	6	39	1.25	0.00095	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000393312,9606.ENSP00000474412	CCR5,CXCL10,CD34,STAT5A,FGFR1,CCL5
PMID:29080840	(2019) Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.	6	39	1.25	0.00095	9606.ENSP00000248553,9606.ENSP00000260356,9606.ENSP00000265333,9606.ENSP00000266085,9606.ENSP00000363827,9606.ENSP00000381185	HSPB1,THBS1,VDAC1,TIMP3,HSPG2,BCL2
PMID:30557632	(2019) Effective effectors: How T cells access and infiltrate the central nervous system.	6	39	1.25	0.00095	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:30718771	(2019) Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFkappaB signaling.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CD38,CD34,STAT5A,JAK2,CCL5,VEGFA
PMID:30720538	(2019) Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000314897,9606.ENSP00000351671,9606.ENSP00000354901	IFNG,CXCL10,CXCL11,ANGPT2,CCL20,CXCL9
PMID:30759373	(2019) What doesnt kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.	6	39	1.25	0.00095	9606.ENSP00000256104,9606.ENSP00000306884,9606.ENSP00000309757,9606.ENSP00000310036,9606.ENSP00000368104,9606.ENSP00000384364	FABP4,CXCL11,LPL,CD34,BMP2,NPY
PMID:30818786	(2019) A Review of Curcumin and Its Derivatives as Anticancer Agents.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000478570	CDH1,CXCL10,AR,BCL2,MME,VEGFA
PMID:30962865	(2019) Perturbed Biochemical Pathways and Associated Oxidative Stress Lead to Vascular Dysfunctions in Diabetic Retinopathy.	6	39	1.25	0.00095	9606.ENSP00000314897,9606.ENSP00000315011,9606.ENSP00000349860,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	ANGPT2,EDNRA,GFPT1,TXN,BCL2,VEGFA
PMID:31089475	(2019) Myocardial Ischemia and Diabetes Mellitus: Role of Oxidative Stress in the Connection between Cardiac Metabolism and Coronary Blood Flow.	6	39	1.25	0.00095	9606.ENSP00000263317,9606.ENSP00000345708,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000478570	NOX4,KCNJ11,NOX1,EDN1,BCL2,VEGFA
PMID:31275407	(2019) Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review.	6	39	1.25	0.00095	9606.ENSP00000292303,9606.ENSP00000309757,9606.ENSP00000321334,9606.ENSP00000348069,9606.ENSP00000362524,9606.ENSP00000381185	CCR5,LPL,LPA,SREBF1,ANGPTL2,BCL2
PMID:31297369	(2019) Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal StemStromal in Stirred-Tank Bioreactor.	6	39	1.25	0.00095	9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000478570	THBS1,TIMP3,CXCL10,CXCL11,CXCL9,VEGFA
PMID:31612013	(2019) Cancer stem cells in esophageal squamous cell cancer.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000245479,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000356438,9606.ENSP00000426809	CD38,SOX9,ALDH1A1,CD34,PTGS2,PROM1
PMID:31772707	(2019) Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinsons Disease.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000474412	CXCL10,CXCL11,COMT,PTGS2,BCL2,CCL5
PMID:31807906	(2019) Methane and Inflammation - A Review (Fight Fire with Fire).	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000229135,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000478570	MPO,IFNG,NFE2L2,BCL2,MYD88,VEGFA
PMID:31814701	(2019) Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000478570	IFNG,CXCL10,CXCL11,CCL20,CXCL9,VEGFA
PMID:31897341	(2019) Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000361021,9606.ENSP00000362524,9606.ENSP00000380252,9606.ENSP00000393312,9606.ENSP00000478570	IFNG,PTEN,ANGPTL2,NFE2L2,FGFR1,VEGFA
PMID:29220294	(2018) Clinical and Molecular Spectrum of Liposarcoma.	6	39	1.25	0.00095	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000393312	IGF1R,ATM,SREBF1,MAP3K5,PTEN,FGFR1
PMID:29247535	(2018) The role of extracellular matrix stiffness in megakaryocyte and platelet development and function.	6	39	1.25	0.00095	9606.ENSP00000216181,9606.ENSP00000266085,9606.ENSP00000310036,9606.ENSP00000351807,9606.ENSP00000371067,9606.ENSP00000478570	MYH9,TIMP3,CD34,ELN,JAK2,VEGFA
PMID:29266344	(2018) A phase III trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000381185,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL9,BCL2,MME,CCL5,VEGFA
PMID:29348424	(2018) Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,ANG,CXCL9,CCL5,VEGFA
PMID:30057985	(2018) Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,STAT5A,CXCL9,JAK2,CCL5,VEGFA
PMID:30311574	(2018) An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000478570	CD38,CDH1,ALDH1A1,CD34,PTEN,VEGFA
PMID:30524649	(2018) Beneficial Effects Exerted by Paeonol in the Management of Atherosclerosis.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000348069,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000477707,9606.ENSP00000478570	IFNG,SREBF1,EDN1,BCL2,NR1H3,VEGFA
PMID:30563141	(2018) An Overview on the Anticancer Activity of Azadirachta indica (Neem) in Gynecological Cancers.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IGF1R,ATM,PTEN,BCL2,VEGFA
PMID:30589870	(2018) The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000226279,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000292303,9606.ENSP00000474412	TGFB1,CD38,IFNG,IGF1R,CCR5,CCL5
PMID:28123004	(2017) Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000371067	MAPK1,EPOR,CD34,STAT5A,PTEN,JAK2
PMID:28148302	(2017) Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.	6	39	1.25	0.00095	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,CCL5
PMID:28212573	(2017) Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000381185,9606.ENSP00000426809	CDH1,IGF1R,ATM,ALDH1A1,BCL2,PROM1
PMID:28233323	(2017) Non-coding RNAs in cardiac hypertrophy.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000419422	MAPK1,ELN,PTEN,RHOA,MYD88,AGTR1
PMID:28325958	(2017) MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,ATM,PTEN,BCL2,PROM1,VEGFA
PMID:28348567	(2017) Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000418525	CD38,CD69,CXCL10,CD34,CXCL9,MME
PMID:28408205	(2017) Temporal, spatial, and phenotypical changes of PDGFRalpha expressing fibroblasts during late lung development.	6	39	1.25	0.00095	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000310036,9606.ENSP00000346508,9606.ENSP00000351807	SOX9,CDH1,PLIN1,CD34,PDGFA,ELN
PMID:28640192	(2017) Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.	6	39	1.25	0.00095	9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	IGF1R,PTEN,JAK2,BCL2,AGTR1,VEGFA
PMID:28856805	(2017) Reactive astrocyte COX2-PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000397297	CXCL10,CD34,CNTF,PTGS2,EDN1,NTF3
PMID:28969687	(2017) Metabolically conditioned media derived from bone marrow stromal cells or human skin fibroblasts act as effective chemoattractants for mesenchymal stem cells.	6	39	1.25	0.00095	9606.ENSP00000260356,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	THBS1,ANGPT2,ANG,CXCL9,CCL5,VEGFA
PMID:29038618	(2017) Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000336762,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CCR5,ANGPT2,ANG,CCL5,VEGFA
PMID:29071011	(2017) Cancer Chemopreventive Potential of Procyanidin.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,PTEN,AR,BCL2,CCL5,VEGFA
PMID:29208986	(2017) Immune tuning scaffold for the local induction of a pro-regenerative environment.	6	39	1.25	0.00095	9606.ENSP00000306884,9606.ENSP00000346508,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412	CXCL11,PDGFA,CCL20,CXCL9,PTEN,CCL5
PMID:26073083	(2016) A microRNA code for prostate cancer metastasis.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,AR,EDN1,BCL2,FGFR1,VEGFA
PMID:26477313	(2016) TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,CXCL10,CXCL9,PTEN,CCL5,VEGFA
PMID:26658103	(2016) DAB2IP in cancer.	6	39	1.25	0.00095	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000312987,9606.ENSP00000351908,9606.ENSP00000363822,9606.ENSP00000478570	IGF1R,ATM,HNF4A,MAP3K5,AR,VEGFA
PMID:26859458	(2016) Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.	6	39	1.25	0.00095	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000418525	EPOR,CD38,CD34,STAT5A,JAK2,MME
PMID:27005321	(2016) Unlocking the Potential of Purinergic Signaling in Transplantation.	6	39	1.25	0.00095	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000304767,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000360250	CD69,IFNG,P2RY1,CXCL10,CCL20,ENTPD1
PMID:27051643	(2016) The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000368683,9606.ENSP00000380365,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,CAV1,EDN1,RGN,BCL2,VEGFA
PMID:27406916	(2016) Liver X receptor and STAT1 cooperate downstream of Gas6Mer to induce anti-inflammatory arginase 2 expression in macrophages.	6	39	1.25	0.00095	9606.ENSP00000255409,9606.ENSP00000331831,9606.ENSP00000354995,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	CHI3L1,GAS6,ABCG1,PTGS2,JAK2,VEGFA
PMID:27486335	(2016) Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000314897,9606.ENSP00000363822,9606.ENSP00000368683,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,ANGPT2,AR,EDN1,RHOA,VEGFA
PMID:27558344	(2016) Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000478570	MPO,CXCL10,STAT5A,CXCL9,PTEN,VEGFA
PMID:27679560	(2016) Growth Hormone Control of Hepatic Lipid Metabolism.	6	39	1.25	0.00095	9606.ENSP00000341208,9606.ENSP00000348069,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000401399,9606.ENSP00000474412	STAT5A,SREBF1,JAK2,NFE2L2,MYD88,CCL5
PMID:24744128	(2015) Proteome array identification of bioactive soluble proteinspeptides in Matrigel: relevance to stem cell responses.	6	39	1.25	0.00095	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000368683,9606.ENSP00000474412,9606.ENSP00000478570	CXCL10,CXCL11,CXCL9,EDN1,CCL5,VEGFA
PMID:25433271	(2015) Diverse roles of LPA signaling in the intestinal epithelium.	6	39	1.25	0.00095	9606.ENSP00000259486,9606.ENSP00000312987,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	ENPP2,HNF4A,PTGS2,BCL2,RHOA,VEGFA
PMID:25550395	(2015) Caveolin-1 deficiency induces a MEK-ERK12-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis.	6	39	1.25	0.00095	9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000347041,9606.ENSP00000478319,9606.ENSP00000478570	THBS1,CDH1,CAV1,FMOD,GREM1,VEGFA
PMID:25676622	(2015) Advances in mechanisms and signaling pathways of carbon nanotube toxicity.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000311005,9606.ENSP00000339191,9606.ENSP00000356438,9606.ENSP00000478570	MPO,CDH1,MAPK7,CAV1,PTGS2,VEGFA
PMID:26106437	(2015) Fucoxanthin: A Promising Medicinal and Nutritional Ingredient.	6	39	1.25	0.00095	9606.ENSP00000256104,9606.ENSP00000309757,9606.ENSP00000339191,9606.ENSP00000348069,9606.ENSP00000377192,9606.ENSP00000381185	FABP4,LPL,CAV1,SREBF1,G6PD,BCL2
PMID:26113989	(2015) Rational Combinations of Targeted Agents in AML.	6	39	1.25	0.00095	9606.ENSP00000226279,9606.ENSP00000278616,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	CD38,ATM,CD34,STAT5A,JAK2,BCL2
PMID:26437235	(2015) A systems approach to understanding human rhinovirus and influenza virus infection.	9	124	0.92	0.00095	9606.ENSP00000278840,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000368104,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000474412	FADS2,CXCL10,CXCL11,CCL20,BMP2,JAK2,BCL2,MYD88,CCL5
PMID:26447778	(2015) Genetic Response of Rat Supraspinatus Tendon and Muscle to Exercise.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000266085,9606.ENSP00000308208,9606.ENSP00000347041,9606.ENSP00000356438	TGFB1,SOX9,TIMP3,MMP14,FMOD,PTGS2
PMID:24497570	(2014) A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.	6	39	1.25	0.00095	9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000348069,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	IGF1R,ATM,SREBF1,PTEN,AR,BCL2
PMID:24814688	(2014) Advances in diagnostic and treatment modalities for intracranial tumors.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,PTGS2,BCL2,PROM1,VEGFA
PMID:24847381	(2014) Predictive simulation approach for designing cancer therapeutic regimens with novel biological mechanisms.	6	39	1.25	0.00095	9606.ENSP00000268035,9606.ENSP00000346508,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000368683,9606.ENSP00000381185	IGF1R,PDGFA,ELN,PTEN,EDN1,BCL2
PMID:24881868	(2014) Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells.	6	39	1.25	0.00095	9606.ENSP00000310036,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	CD34,CNTF,BMP2,NTF3,BDNF,VEGFA
PMID:24995158	(2014) Microtubules and their role in cellular stress in cancer.	6	39	1.25	0.00095	9606.ENSP00000013807,9606.ENSP00000248553,9606.ENSP00000265333,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	ERCC1,HSPB1,VDAC1,PTEN,BCL2,VEGFA
PMID:25097665	(2014) Endometrial stem cells in regenerative medicine.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000310036,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000426809,9606.ENSP00000478570	CDH1,CD34,NTF3,BDNF,PROM1,VEGFA
PMID:25395895	(2014) How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?	6	39	1.25	0.00095	9606.ENSP00000245479,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000393312,9606.ENSP00000478319	SOX9,IGF1R,ATM,PTEN,FGFR1,GREM1
PMID:25496077	(2014) MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.	6	39	1.25	0.00095	9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000306124,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	SOX9,CDH1,PRKCE,PTEN,AR,BCL2
PMID:23338236	(2013) Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse.	6	39	1.25	0.00095	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000381185	CD69,CXCL10,CXCL11,STAT5A,CXCL9,BCL2
PMID:23606845	(2013) Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000265132,9606.ENSP00000310036,9606.ENSP00000363827,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,AMBP,CD34,HSPG2,CCL5,VEGFA
PMID:23725674	(2013) Targeting protein-protein interactions as an anticancer strategy.	6	39	1.25	0.00095	9606.ENSP00000292303,9606.ENSP00000345708,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000478570	CCR5,KCNJ11,MAP3K5,PTEN,BCL2,VEGFA
PMID:24078831	(2013) Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000371067,9606.ENSP00000403495,9606.ENSP00000478570	CDH1,TIMP3,IGF1R,JAK2,LTA,VEGFA
PMID:24141626	(2013) Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,STAT5A,CXCL9,CCL5,VEGFA
PMID:24345207	(2013) Profiles of cytokines secreted by isolated human endometrial cells under the influence of chorionic gonadotropin during the window of embryo implantation.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000330382,9606.ENSP00000354901,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CXCL10,PDGFB,CXCL9,CCL5,VEGFA
PMID:21994887	(2012) Molecular pathogenesis of cholangiocarcinoma.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000478570	MAPK1,IGF1R,PTEN,BCL2,NPY,VEGFA
PMID:22200848	(2012) miRNAs in breast cancer tumorigenesis (Review).	6	39	1.25	0.00095	9606.ENSP00000261769,9606.ENSP00000266085,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	CDH1,TIMP3,PTEN,BCL2,RHOA,VEGFA
PMID:22489274	(2012) Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.	6	39	1.25	0.00095	9606.ENSP00000349860,9606.ENSP00000351807,9606.ENSP00000362463,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000478570	GFPT1,ELN,GLO1,TXN,EDN1,VEGFA
PMID:22995409	(2012) Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall.	6	39	1.25	0.00095	9606.ENSP00000268035,9606.ENSP00000310036,9606.ENSP00000339191,9606.ENSP00000361021,9606.ENSP00000426809,9606.ENSP00000478570	IGF1R,CD34,CAV1,PTEN,PROM1,VEGFA
PMID:23028203	(2012) Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy.	6	39	1.25	0.00095	9606.ENSP00000308208,9606.ENSP00000314897,9606.ENSP00000321853,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000478570	MMP14,ANGPT2,SERPINF2,PTGS2,EDN1,VEGFA
PMID:21673906	(2011) Mechanisms of estrogens dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia.	6	39	1.25	0.00095	9606.ENSP00000225275,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	MPO,TXN,EDN1,BCL2,BDNF,VEGFA
PMID:21765909	(2011) Transcriptional responses of cultured rat sympathetic neurons during BMP-7-induced dendritic growth.	6	39	1.25	0.00095	9606.ENSP00000285407,9606.ENSP00000322898,9606.ENSP00000355361,9606.ENSP00000400175,9606.ENSP00000444198,9606.ENSP00000478570	KLF10,EBF1,CD47,RHOA,CITED2,VEGFA
PMID:21803292	(2011) Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	6	39	1.25	0.00095	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000368683,9606.ENSP00000444198,9606.ENSP00000478570	FABP4,PLIN1,SIRT6,EDN1,CITED2,VEGFA
PMID:22126011	(2011) Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide.	6	39	1.25	0.00095	9606.ENSP00000265333,9606.ENSP00000268035,9606.ENSP00000351908,9606.ENSP00000363822,9606.ENSP00000381185,9606.ENSP00000478570	VDAC1,IGF1R,MAP3K5,AR,BCL2,VEGFA
PMID:20706642	(2010) Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application.	6	39	1.25	0.00095	9606.ENSP00000229135,9606.ENSP00000355361,9606.ENSP00000355370,9606.ENSP00000401399,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CD47,CNTF,MYD88,CCL5,VEGFA
PMID:22477519	(2010) Abstracts of the 5(th) Cachexia Conference, Barcelona, Spain, December 5-8, 2009.	9	124	0.92	0.00095	9606.ENSP00000263317,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000357726,9606.ENSP00000360522,9606.ENSP00000363822,9606.ENSP00000384364,9606.ENSP00000401399,9606.ENSP00000414303	NOX4,PLIN1,PTGS2,S100A12,RBP4,AR,NPY,MYD88,BDNF
PMID:19175693	(2009) Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.	6	39	1.25	0.00095	9606.ENSP00000222139,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000377192,9606.ENSP00000393312,9606.ENSP00000478570	EPOR,STAT5A,JAK2,G6PD,FGFR1,VEGFA
PMID:19395305	(2009) Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000311005,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,IGF1R,ATM,MAPK7,PTEN,BCL2
PMID:19925653	(2009) Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis.	6	39	1.25	0.00095	9606.ENSP00000259486,9606.ENSP00000297785,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000356515,9606.ENSP00000474412	ENPP2,ALDH1A1,CXCL11,CXCL9,UTRN,CCL5
PMID:14638861	(2003) The stromal cell-derived factor-1alphaCXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas.	6	39	1.25	0.00095	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000474412	MAPK1,CCR5,CXCL10,CD34,CXCL9,CCL5
PMID:12167174	(2002) Early inflammatory markers in elicitation of allergic contact dermatitis.	6	39	1.25	0.00095	9606.ENSP00000221930,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000474412	TGFB1,CCR5,CXCL10,CXCL11,CXCL9,CCL5
PMID:35033181	(2022) Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.	7	63	1.11	0.00096	9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000310036,9606.ENSP00000354901,9606.ENSP00000369816,9606.ENSP00000414303,9606.ENSP00000478570	IFNG,THBS1,CD34,CXCL9,SHBG,BDNF,VEGFA
PMID:35155266	(2022) Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.	7	63	1.11	0.00096	9606.ENSP00000221930,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000480291	TGFB1,SOX9,CDH1,PTEN,BCL2,PROM1,HNF1B
PMID:35159352	(2022) Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities.	7	63	1.11	0.00096	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000315011,9606.ENSP00000354901,9606.ENSP00000403495	CD38,CD69,CXCL10,CXCL11,EDNRA,CXCL9,LTA
PMID:35224964	(2022) [Lung Cancer Stem-like Cells and Drug Resistance].	7	63	1.11	0.00096	9606.ENSP00000278616,9606.ENSP00000297785,9606.ENSP00000312987,9606.ENSP00000339191,9606.ENSP00000362057,9606.ENSP00000381185,9606.ENSP00000426809	ATM,ALDH1A1,HNF4A,CAV1,NOX1,BCL2,PROM1
PMID:35250597	(2022) Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis.	7	63	1.11	0.00096	9606.ENSP00000312987,9606.ENSP00000351807,9606.ENSP00000361021,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000478570	HNF4A,ELN,PTEN,KL,BCL2,FGFR1,VEGFA
PMID:35372035	(2022) The Signaling Pathways Associated With Breast Cancer Bone Metastasis.	7	63	1.11	0.00096	9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000312987,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000393312,9606.ENSP00000478570	CDH1,IGF1R,HNF4A,STAT5A,JAK2,FGFR1,VEGFA
PMID:35433443	(2022) Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer.	7	63	1.11	0.00096	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CDH1,STAT5A,JAK2,BCL2,RHOA,VEGFA
PMID:33229734	(2021) Mechanism underlying treatment of ischemic stroke using acupuncture: transmission and regulation.	7	63	1.11	0.00096	9606.ENSP00000304767,9606.ENSP00000306124,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000401399,9606.ENSP00000414303	P2RY1,PRKCE,JAK2,NFE2L2,BCL2,MYD88,BDNF
PMID:33514544	(2021) Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy.	7	63	1.11	0.00096	9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000474412	CD69,CXCL10,CXCL11,STAT5A,CXCL9,AR,CCL5
PMID:33655322	(2021) Antiangiogenic therapy in diabetic nephropathy: A double-edged sword (Review).	7	63	1.11	0.00096	9606.ENSP00000265333,9606.ENSP00000334329,9606.ENSP00000336762,9606.ENSP00000355361,9606.ENSP00000418009,9606.ENSP00000419422,9606.ENSP00000478570	VDAC1,UNC5B,ANG,CD47,RARRES2,AGTR1,VEGFA
PMID:33776572	(2021) Biomarkers of Joint Damage in Osteoarthritis: Current Status and Future Directions.	7	63	1.11	0.00096	9606.ENSP00000228434,9606.ENSP00000229135,9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	CD69,IFNG,CHI3L1,CXCL10,CCL20,CCL5,VEGFA
PMID:33804985	(2021) The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis.	7	63	1.11	0.00096	9606.ENSP00000227868,9606.ENSP00000265333,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000363822,9606.ENSP00000478570	PDHX,VDAC1,CXCL10,CXCL11,CXCL9,AR,VEGFA
PMID:34179189	(2021) Topological Analysis of Regulatory Networks Reveals Functionally Key Genes and miRNAs Involved in the Differentiation of Mesenchymal Stem Cells.	7	63	1.11	0.00096	9606.ENSP00000245479,9606.ENSP00000256104,9606.ENSP00000285407,9606.ENSP00000361021,9606.ENSP00000368104,9606.ENSP00000381185,9606.ENSP00000414303	SOX9,FABP4,KLF10,PTEN,BMP2,BCL2,BDNF
PMID:34205998	(2021) NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology.	7	63	1.11	0.00096	9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000419313,9606.ENSP00000478570	TGFB1,NOX4,ATM,MAP3K5,NOX1,TRPC1,VEGFA
PMID:34238254	(2021) Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).	7	63	1.11	0.00096	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000310036,9606.ENSP00000341208,9606.ENSP00000356832	MAPK1,IGF1R,ATM,PRKCE,CD34,STAT5A,SGK1
PMID:34282767	(2021) Syndecan-4 in Tumor Cell Motility.	7	63	1.11	0.00096	9606.ENSP00000259486,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	ENPP2,CDH1,CXCL10,MMP14,RHOA,CCL5,VEGFA
PMID:34335286	(2021) Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.	7	63	1.11	0.00096	9606.ENSP00000261769,9606.ENSP00000278840,9606.ENSP00000305651,9606.ENSP00000356438,9606.ENSP00000363641,9606.ENSP00000474412,9606.ENSP00000478570	CDH1,FADS2,CXCL10,PTGS2,TXN,CCL5,VEGFA
PMID:34458273	(2021) The Paradoxical Role of Cellular Senescence in Cancer.	7	63	1.11	0.00096	9606.ENSP00000013807,9606.ENSP00000261769,9606.ENSP00000278616,9606.ENSP00000305651,9606.ENSP00000351671,9606.ENSP00000361021,9606.ENSP00000478570	ERCC1,CDH1,ATM,CXCL10,CCL20,PTEN,VEGFA
PMID:34567001	(2021) Persistent High Percentage of HLA-DR(+)CD38(high) CD8(+) T Cells Associated With Immune Disorder and Disease Severity of COVID-19.	7	63	1.11	0.00096	9606.ENSP00000226279,9606.ENSP00000228434,9606.ENSP00000305651,9606.ENSP00000381185,9606.ENSP00000403495,9606.ENSP00000414303,9606.ENSP00000474412	CD38,CD69,CXCL10,BCL2,LTA,BDNF,CCL5
PMID:34692527	(2021) Mitochondrial Effects on Seeds of Cancer Survival in Leukemia.	7	63	1.11	0.00096	9606.ENSP00000226279,9606.ENSP00000256104,9606.ENSP00000310036,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478570	CD38,FABP4,CD34,MAP3K5,TXN,BCL2,VEGFA
PMID:34835125	(2021) The Roles of Neutrophils in Cytokine Storms.	7	63	1.11	0.00096	9606.ENSP00000225275,9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000371067,9606.ENSP00000418525,9606.ENSP00000474412,9606.ENSP00000478570	MPO,CDH1,CXCL10,JAK2,MME,CCL5,VEGFA
PMID:35071243	(2021) Recent Advances in Single-Cell View of Mesenchymal Stem Cell in Osteogenesis.	7	63	1.11	0.00096	9606.ENSP00000245479,9606.ENSP00000305651,9606.ENSP00000310036,9606.ENSP00000363973,9606.ENSP00000474412,9606.ENSP00000478319,9606.ENSP00000480291	SOX9,CXCL10,CD34,ALPL,CCL5,GREM1,HNF1B
PMID:35126100	(2021) Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application.	7	63	1.11	0.00096	9606.ENSP00000225275,9606.ENSP00000263317,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363596,9606.ENSP00000381185,9606.ENSP00000478570	MPO,NOX4,PTGS2,PTEN,CNR2,BCL2,VEGFA
PMID:31250347	(2020) Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.	7	63	1.11	0.00096	9606.ENSP00000314897,9606.ENSP00000331831,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000393312,9606.ENSP00000426809,9606.ENSP00000478570	ANGPT2,GAS6,AR,BMP2,FGFR1,PROM1,VEGFA
PMID:32000804	(2020) Improved therapeutics of modified mesenchymal stem cells: an update.	7	63	1.11	0.00096	9606.ENSP00000306124,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000475344,9606.ENSP00000478319,9606.ENSP00000478570	PRKCE,JAK2,BCL2,BDNF,APLNR,GREM1,VEGFA
PMID:32117924	(2020) Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy.	7	63	1.11	0.00096	9606.ENSP00000229135,9606.ENSP00000310036,9606.ENSP00000361021,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000474412,9606.ENSP00000478570	IFNG,CD34,PTEN,NTF3,BDNF,CCL5,VEGFA
PMID:32152211	(2020) T Cell Cytokines Impact Epithelial Cell Responses during Helicobacter pylori Infection.	7	63	1.11	0.00096	9606.ENSP00000261769,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000474412	CDH1,CXCL10,CXCL11,MAPK7,CCL20,CXCL9,CCL5
PMID:32183037	(2020) Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes.	7	63	1.11	0.00096	9606.ENSP00000311005,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000384364,9606.ENSP00000401399	MAPK7,SREBF1,MAP3K5,TXN,BCL2,NPY,MYD88
PMID:32373350	(2020) Sirtuin 1: A Dilemma in Transplantation.	7	63	1.11	0.00096	9606.ENSP00000225275,9606.ENSP00000260356,9606.ENSP00000305651,9606.ENSP00000337332,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000478570	MPO,THBS1,CXCL10,SIRT6,PTGS2,BCL2,VEGFA
PMID:32391013	(2020) Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.	7	63	1.11	0.00096	9606.ENSP00000305651,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000356213,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000401399	CXCL10,STAT5A,CD247,VIP,TXN,BCL2,MYD88
PMID:32503922	(2020) Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.	7	63	1.11	0.00096	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000381185	MAPK1,SOX9,CDH1,IGF1R,PTEN,AR,BCL2
PMID:32937885	(2020) The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines.	7	63	1.11	0.00096	9606.ENSP00000255409,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000360250,9606.ENSP00000474412,9606.ENSP00000478570	CHI3L1,CXCL10,CXCL11,CXCL9,ENTPD1,CCL5,VEGFA
PMID:32987769	(2020) Mechanisms of Photoreceptor Death in Retinitis Pigmentosa.	7	63	1.11	0.00096	9606.ENSP00000292303,9606.ENSP00000355370,9606.ENSP00000361021,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000414303,9606.ENSP00000478570	CCR5,CNTF,PTEN,TXN,BCL2,BDNF,VEGFA
PMID:33014151	(2020) Impact of inflammation and immunotherapy in renal cell carcinoma.	7	63	1.11	0.00096	9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000341208,9606.ENSP00000354901,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000478570	CXCL10,CXCL11,STAT5A,CXCL9,PTEN,JAK2,VEGFA
PMID:33050144	(2020) Role of Glutathione in Cancer: From Mechanisms to Therapies.	7	63	1.11	0.00096	9606.ENSP00000301522,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000478253	PRDX2,PTGS2,PTEN,NOX1,TXN,BCL2,MTHFD1L
PMID:33133086	(2020) MicroRNAs and lncRNAs-A New Layer of Myeloid-Derived Suppressor Cells Regulation.	7	63	1.11	0.00096	9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	STAT5A,CD247,PTEN,JAK2,BCL2,PROM1,VEGFA
PMID:30662558	(2019) Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.	7	63	1.11	0.00096	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000361021,9606.ENSP00000400175,9606.ENSP00000403495,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,CXCL10,PTEN,RHOA,LTA,AGTR1,VEGFA
PMID:30945475	(2019) Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science.	7	63	1.11	0.00096	9606.ENSP00000229135,9606.ENSP00000261769,9606.ENSP00000297785,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000426809,9606.ENSP00000478570	IFNG,CDH1,ALDH1A1,PTEN,BCL2,PROM1,VEGFA
PMID:31380268	(2019) Obesity and Breast Cancer: Role of Leptin.	7	63	1.11	0.00096	9606.ENSP00000261769,9606.ENSP00000288266,9606.ENSP00000356438,9606.ENSP00000369816,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000478570	CDH1,APPL1,PTGS2,SHBG,JAK2,BCL2,VEGFA
